PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bye, A; Rosjo, H; Aspenes, ST; Condorelli, G; Omland, T; Wisloff, U				Bye, Anja; Rosjo, Helge; Aspenes, Stian T.; Condorelli, Gianluigi; Omland, Torbjorn; Wisloff, Ulrik			Circulating MicroRNAs and Aerobic Fitness - The HUNT-Study	PLOS ONE			English	Article							HEART-FAILURE; CARDIAC-HYPERTROPHY; CARDIORESPIRATORY FITNESS; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; HYPOXIA; DISEASE; EXPRESSION; BIOMARKER	Aerobic fitness, measured as maximal oxygen uptake (VO2max), is a good indicator of cardiovascular health, and a strong predictor of cardiovascular mortality. Biomarkers associated with low VO2max may therefore represent potential early markers of future cardiovascular disease (CVD). The aim of this study was to assess whether circulating microRNAs (miRs) are associated with VO2max-level in healthy individuals. In a screening study, 720 miRs were measured in serum samples from healthy individuals (40-45 yrs) with high (n = 12) or low (n = 12) VO2max matched for gender, age and physical activity. Candiate miRs were validated in a second cohort of subjects with high (n = 38) or low (n = 38) VO2max. miR-210 and miR-222 were found to be higher in the low VO2max-group (p<0.05). In addition, miR-21 was increased in male participants with low VO2max (p, 0.05). There were no correlations between traditional risk factors for CVD (blood pressure, cholesterol, smoking habit, or obesity) and miR-21, miR-210 and miR-222. DIANA-mirPath identified 611 potential gene-targets of miR-21, miR-210 and miR-222, and pathway analysis indicated alterations in several important signaling systems in subjects with low VO2max. Potential bias involve that blood was collected from non-fasting individuals, and that 8 performed exercise within 24 h before sampling. In conclusion, we found that miR-210, miR-21, and miR-222 were increased in healthy subjects with low VO2max. The lack of association between these three miRs, and other fitness related variables as well as traditional CVD risk factors, suggests that these miRs may have a potential as new independent biomarkers of fitness level and future CVD.	[Bye, Anja; Aspenes, Stian T.; Wisloff, Ulrik] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway; [Rosjo, Helge; Omland, Torbjorn] Akershus Univ Hosp, Div Med, Dept Cardiol, Lorenskog, Norway; [Rosjo, Helge; Omland, Torbjorn] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Condorelli, Gianluigi] Natl Res Council Italy, Inst Genet & Biomed Res, Milan, Italy; [Condorelli, Gianluigi] Humanitas Res & Clin Ctr, Milan, Italy	Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)	Bye, A (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway.	Anja.Bye@ntnu.no	Bye, Anja/K-8041-2019; Wisloff, Ulrik/K-2899-2012; Condorelli, Gianluigi/Q-6736-2017	Wisloff, Ulrik/0000-0002-7211-3587; Bye, Anja/0000-0003-1259-5542; Condorelli, Gianluigi/0000-0003-0481-6843	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; St. Olavs Hospital; Medical Faculty at NTNU (Kontaktutvalget); Norwegian Research Council Funding for Outstanding Young Investigators; Foundation for Cardiovascular Research at St.Olav's Hospital; NTNU	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; St. Olavs Hospital; Medical Faculty at NTNU (Kontaktutvalget); Norwegian Research Council Funding for Outstanding Young Investigators; Foundation for Cardiovascular Research at St.Olav's Hospital; NTNU	The study was supported by grants from the K.G. Jebsen Foundation, the Norwegian Council on Cardiovascular Disease, St. Olavs Hospital and the Medical Faculty at NTNU (Kontaktutvalget), the Norwegian Research Council Funding for Outstanding Young Investigators and Foundation for Cardiovascular Research at St.Olav's Hospital and NTNU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1675, DOI 10.1249/MSS.0b013e318216ea50; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002; Bostjancic E, 2009, DIS MARKERS, V27, P255, DOI 10.3233/DMA-2009-0671; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Farrell SW, 2004, OBES RES, V12, P824, DOI 10.1038/oby.2004.99; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Kavanagh T, 2002, CIRCULATION, V106, P666, DOI 10.1161/01.CIR.0000024413.15949.ED; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; LaMonte MJ, 2005, CIRCULATION, V112, P505, DOI 10.1161/CIRCULATIONAHA.104.503805; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; Li TR, 2011, CLIN CHIM ACTA, V412, P66, DOI 10.1016/j.cca.2010.09.029; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Meyer T, 2005, INT J SPORTS MED, V26, pS19, DOI 10.1055/s-2004-830507; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Raitoharju E, 2011, ATHEROSCLEROSIS, V219, P211, DOI 10.1016/j.atherosclerosis.2011.07.020; Rognmo O, 2004, EUR J CARDIOV PREV R, V11, P216, DOI 10.1097/01.hjr.0000131677.96762.0c; Roy S, 2011, PHYSIOL GENOMICS, V43, P557, DOI 10.1152/physiolgenomics.00160.2010; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Selmer Randi, 2008, Tidsskr Nor Laegeforen, V128, P286; Semenza GL, 2010, ARTERIOSCL THROM VAS, V30, P648, DOI 10.1161/ATVBAHA.108.181644; Shephard RJ, 2000, ENDURANCE SPORT, P301; STOKKE O, 1982, SCAND J SOC MED, P93; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	50	116	120	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57496	10.1371/journal.pone.0057496	http://dx.doi.org/10.1371/journal.pone.0057496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469005	Green Published, gold			2022-12-27	WOS:000315524900104
J	Martin, JA; Witzell, J; Blumenstein, K; Rozpedowska, E; Helander, M; Sieber, TN; Gil, L				Martin, Juan A.; Witzell, Johanna; Blumenstein, Kathrin; Rozpedowska, Elzbieta; Helander, Marjo; Sieber, Thomas N.; Gil, Luis			Resistance to Dutch Elm Disease Reduces Presence of Xylem Endophytic Fungi in Elms (Ulmus spp.)	PLOS ONE			English	Article							RUGULOSIN-PRODUCING ENDOPHYTE; DEFENSIVE MUTUALISM; OPHIOSTOMA-ULMI; PICEA-GLAUCA; FOREST TREES; NOVO-ULMI; U-MINOR; HOST; COMMUNITIES; DIVERSITY	Efforts to introduce pathogen resistance into landscape tree species by breeding may have unintended consequences for fungal diversity. To address this issue, we compared the frequency and diversity of endophytic fungi and defensive phenolic metabolites in elm (Ulmus spp.) trees with genotypes known to differ in resistance to Dutch elm disease. Our results indicate that resistant U. minor and U. pumila genotypes exhibit a lower frequency and diversity of fungal endophytes in the xylem than susceptible U. minor genotypes. However, resistant and susceptible genotypes showed a similar frequency and diversity of endophytes in the leaves and bark. The resistant and susceptible genotypes could be discriminated on the basis of the phenolic profile of the xylem, but not on basis of phenolics in the leaves or bark. As the Dutch elm disease pathogen develops within xylem tissues, the defensive chemistry of resistant elm genotypes thus appears to be one of the factors that may limit colonization by both the pathogen and endophytes. We discuss a potential trade-off between the benefits of breeding resistance into tree species, versus concomitant losses of fungal endophytes and the ecosystem services they provide.	[Martin, Juan A.; Gil, Luis] Univ Politecn Madrid, Escuela Tecn Super Ingn Montes, Dept Silvopascicultura, Madrid, Spain; [Witzell, Johanna; Blumenstein, Kathrin] Swedish Univ Agr Sci, Fac Forest Sci, Southern Swedish Forest Res Ctr, Alnarp, Sweden; [Rozpedowska, Elzbieta] Swedish Univ Agr Sci, Alnarp, Sweden; [Helander, Marjo] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Sieber, Thomas N.] ETH, Inst Integrat Biol, Zurich, Switzerland	Universidad Politecnica de Madrid; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; University of Turku; Swiss Federal Institutes of Technology Domain; ETH Zurich	Witzell, J (corresponding author), Swedish Univ Agr Sci, Fac Forest Sci, Southern Swedish Forest Res Ctr, Alnarp, Sweden.	johanna.witzell@slu.se	Martín, Juan A./B-9729-2012; Witzell, Johanna/H-9987-2019; Gil, Luis/E-3216-2014	Martín, Juan A./0000-0002-3207-1319; Witzell, Johanna/0000-0003-1741-443X; Gil, Luis/0000-0002-5252-2607; Helander, Marjo/0000-0002-9759-4321; Blumenstein, Kathrin/0000-0002-0677-7799	Swedish Research Council FORMAS [2008-1090]; Crafoord Foundation, Sweden [20070906]; Stiftelsen Konsul Faxes Donation, Sweden [KF 23, KF 29]; Ministerio de Ciencia e Innovacion, Spain [AGL2009-09289]; Ministerio de Economia y Competitividad, Spain [CTQ2011-28503-C02-02]; Spanish elm breeding program (Ministerio de Agricultura, Alimentacion y Medio Ambiente) Universidad Politecnica de Madrid); Joint Doctoral Program "Forest and Nature for Society", FONASO; Spanish elm breeding program Universidad Politecnica de Madrid	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Crafoord Foundation, Sweden; Stiftelsen Konsul Faxes Donation, Sweden; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia y Competitividad, Spain(Spanish Government); Spanish elm breeding program (Ministerio de Agricultura, Alimentacion y Medio Ambiente) Universidad Politecnica de Madrid); Joint Doctoral Program "Forest and Nature for Society", FONASO; Spanish elm breeding program Universidad Politecnica de Madrid	This work was supported by the Swedish Research Council FORMAS (www.formas.se), project 2008-1090; the Crafoord Foundation, Sweden (www.crafoord.se), grant 20070906; Stiftelsen Konsul Faxes Donation, Sweden (http://skogstradsforadling.se/stiftelsen-konsul-faxes-donation), projects KF 23 and KF 29; Ministerio de Ciencia e Innovacion, Spain, project AGL2009-09289; Ministerio de Economia y Competitividad, Spain (http://www.mineco.gob.es), project CTQ2011-28503-C02-02; the Spanish elm breeding program (Ministerio de Agricultura, Alimentacion y Medio Ambiente; Universidad Politecnica de Madrid); and the Joint Doctoral Program "Forest and Nature for Society", FONASO (www.fonaso.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlholm J, 2002, ECOL LETT, V5, P648, DOI 10.1046/j.1461-0248.2002.00368.x; Albrectsen BR, 2010, FUNGAL DIVERS, V41, P17, DOI 10.1007/s13225-009-0011-y; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Loayza P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016386; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Aoun M, 2010, PHYSIOL MOL PLANT P, V74, P254, DOI 10.1016/j.pmpp.2010.04.003; Aoun M, 2009, PHYTOPATHOLOGY, V99, P642, DOI 10.1094/PHYTO-99-6-0642; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Atlas RM., 1998, MICROBIAL ECOLOGY FU, V4; Bailey JK, 2005, CAN J BOT, V83, P356, DOI [10.1139/b05-008, 10.1139/B05-008]; Bais HP, 2002, PLANT PHYSIOL BIOCH, V40, P983, DOI 10.1016/S0981-9428(02)01460-2; BERNSTEIN ME, 1977, CAN J BOT, V55, P644, DOI 10.1139/b77-079; Bills Gerald F., 1996, P31; Blaalid R, 2012, MOL ECOL, V21, P1897, DOI 10.1111/j.1365-294X.2011.05214.x; BOEREMA GH, 1973, STUD MYCOL, V3, P1; Brun H, 2010, NEW PHYTOL, V185, P285, DOI 10.1111/j.1469-8137.2009.03049.x; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; Cogolludo-Agustin MA, 2000, HEREDITY, V85, P157, DOI 10.1046/j.1365-2540.2000.00740.x; COLHOUN J, 1973, ANNU REV PHYTOPATHOL, V11, P343, DOI 10.1146/annurev.py.11.090173.002015; Collin E, 2000, ELMS BREEDING CONSER, P281, DOI DOI 10.1007/978-1-4615-4507-1; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cordier T, 2012, FUNGAL ECOL, V5, P509, DOI 10.1016/j.funeco.2011.12.004; de Gruyter J, 2010, MYCOLOGIA, V102, P1066, DOI 10.3852/09-240; DEHOOG GS, 1977, STUD MYCOL, V15, P1; Dvorak M., 2006, Journal of Forest Science, V52, P531; FISHER PJ, 1990, MYCOL RES, V94, P313, DOI 10.1016/S0953-7562(09)80356-0; GAMS W, 1980, NETH J PLANT PATHOL, V86, P45, DOI 10.1007/BF02650394; Ganley RJ, 2008, FOREST ECOL MANAG, V255, P2751, DOI 10.1016/j.foreco.2008.01.052; Gennaro M, 2003, J PHYTOPATHOL, V151, P529, DOI 10.1046/j.1439-0434.2003.00763.x; Gil L, 2004, NATURE, V431, P1053, DOI 10.1038/4311053a; Gotelli Nicholas J., 2011, P39; GRIFFITH GS, 1990, NEW PHYTOL, V116, P407, DOI 10.1111/j.1469-8137.1990.tb00526.x; Guo LD, 2004, FUNGAL DIVERS, V16, P53; Helander M, 2007, NEW PHYTOL, V175, P547, DOI 10.1111/j.1469-8137.2007.02110.x; Hoshino T, 2009, MYCOSCIENCE, V50, P26, DOI 10.1007/s10267-008-0452-2; Knapp DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032570; Kowalski Tadeusz, 1996, P67; Li YC, 2009, CELL BIOL INT, V33, P106, DOI 10.1016/j.cellbi.2008.10.007; Linaldeddu BT, 2005, J PLANT PATHOL, V87, P296; Martin JA, 2008, FOREST PATHOL, V38, P244, DOI 10.1111/j.1439-0329.2007.00542.x; Martin J. A., 2006, Investigacion Agraria, Sistemas y Recursos Forestales, V15, P208; Martin JA, 2008, ENVIRON EXP BOT, V64, P97, DOI 10.1016/j.envexpbot.2008.05.004; Martin JA, 2010, ENVIRON EXP BOT, V69, P175, DOI 10.1016/j.envexpbot.2010.04.001; Martin JA, 2010, EUR J PLANT PATHOL, V127, P21, DOI 10.1007/s10658-009-9567-3; Martin JA, 2009, CAN J FOREST RES, V39, P420, DOI 10.1139/X08-183; Martin-Garcia J, 2012, ANN FOREST SCI, V69, P49, DOI 10.1007/s13595-011-0129-4; Martin-Garcia J, 2011, SILVA FENN, V45, P169, DOI 10.14214/sf.40; McGuire KL, 2010, SOIL BIOL BIOCHEM, V42, P529, DOI 10.1016/j.soilbio.2009.11.016; Mejia LC, 2008, BIOL CONTROL, V46, P4, DOI 10.1016/j.biocontrol.2008.01.012; Miller JD, 2008, J CHEM ECOL, V34, P362, DOI 10.1007/s10886-007-9412-0; Mittempergher L, 2004, INVEST AGRAR-SIST R, V13, P161, DOI DOI 10.5424/821; Mucciarelli M, 2003, NEW PHYTOL, V158, P579, DOI 10.1046/j.1469-8137.2003.00762.x; Mucciarelli M, 2002, MYCOLOGIA, V94, P28, DOI 10.2307/3761843; Newcombe G, 2011, FOR SCI, V80, P251, DOI 10.1007/978-94-007-1599-8_16; Newhouse AE, 2007, PLANT CELL REP, V26, P977, DOI 10.1007/s00299-007-0313-z; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Ouellette GB, 2004, FOREST SYST, V13, P119; PETRINI O, 1982, CAN J BOT, V60, P789, DOI 10.1139/b82-102; Promputtha I, 2007, MICROB ECOL, V53, P579, DOI 10.1007/s00248-006-9117-x; Ragazzi A, 1999, J PHYTOPATHOL, V147, P437, DOI 10.1111/j.1439-0434.1999.tb03847.x; RIOUX D, 1991, CAN J BOT, V69, P2055, DOI 10.1139/b91-258; RODRIGUES KF, 1994, MYCOLOGIA, V86, P376, DOI 10.2307/3760568; Rodriguez RJ, 1997, ADV BOT RES, V24, P169; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Saikkonen K., 2007, Fungal Biology Reviews, V21, P67, DOI 10.1016/j.fbr.2007.05.001; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Schulz B, 1999, MYCOL RES, V103, P1275, DOI 10.1017/S0953756299008540; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; SIEBER T, 1988, J PHYTOPATHOL, V122, P289, DOI 10.1111/j.1439-0434.1988.tb01021.x; Sieber Thomas N., 2007, Fungal Biology Reviews, V21, P75, DOI 10.1016/j.fbr.2007.05.004; SINCLAIR WA, 1975, PHYTOPATHOLOGY, V65, P349, DOI 10.1094/Phyto-65-349; Smith SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003052; Solla A, 2008, PLANT PATHOL, V57, P33, DOI 10.1111/j.1365-3059.2007.01692.x; Solla A, 2005, NEW PHYTOL, V166, P1025, DOI 10.1111/j.1469-8137.2005.01384.x; Srivastava V, 2007, PLANT J, V49, P135, DOI 10.1111/j.1365-313X.2006.02943.x; Stuart RM, 2010, ARCH MICROBIOL, V192, P307, DOI 10.1007/s00203-010-0557-9; Sumarah MW, 2008, MYCOL RES, V112, P731, DOI 10.1016/j.mycres.2008.01.007; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Vieira P. D. de S., 2011, Mycology - An International Journal on Fungal Biology, V2, P91, DOI 10.1080/21501203.2011.584390; WEBBER J, 1981, NATURE, V292, P449, DOI 10.1038/292449a0; White JF, 2010, PHYSIOL PLANTARUM, V138, P440, DOI 10.1111/j.1399-3054.2009.01332.x; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Witzell J, 2008, CAN J FOREST RES, V38, P2711, DOI 10.1139/X08-112; Zalar P, 2008, STUD MYCOL, P21, DOI 10.3114/sim.2008.61.02	87	49	50	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56987	10.1371/journal.pone.0056987	http://dx.doi.org/10.1371/journal.pone.0056987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468900	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900047
J	Stolwijk, NM; Duysens, J; Louwerens, JWK; van de Ven, YHM; Keijsers, NLW				Stolwijk, Niki M.; Duysens, Jacques; Louwerens, Jan Willem K.; van de Ven, Yvonne H. M.; Keijsers, Noel L. W.			Flat Feet, Happy Feet? Comparison of the Dynamic Plantar Pressure Distribution and Static Medial Foot Geometry between Malawian and Dutch Adults	PLOS ONE			English	Article							SOUTH-AFRICAN POPULATIONS; WALKING SPEED; HALLUX VALGUS; OLDER-PEOPLE; RISK-FACTORS; ARCHED FEET; PREVALENCE; METATARSALGIA; BAREFOOT; CHILDREN	In contrast to western countries, foot complaints are rare in Africa. This is remarkable, as many African adults walk many hours each day, often barefoot or with worn-out shoes. The reason why Africans can withstand such loading without developing foot complaints might be related to the way the foot is loaded. Therefore, static foot geometry and dynamic plantar pressure distribution of 77 adults from Malawi were compared to 77 adults from the Netherlands. None of the subjects had a history of foot complaints. The plantar pressure pattern as well as the Arch Index (AI) and the trajectory of the center of pressure during the stance phase were calculated and compared between both groups. Standardized pictures were taken from the feet to assess the height of the Medial Longitudinal Arch (MLA). We found that Malawian adults: (1) loaded the midfoot for a longer and the forefoot for a shorter period during roll off, (2) had significantly lower plantar pressures under the heel and a part of the forefoot, and (3) had a larger AI and a lower MLA compared to the Dutch. These findings demonstrate that differences in static foot geometry, foot loading, and roll off technique exist between the two groups. The advantage of the foot loading pattern as shown by the Malawian group is that the plantar pressure is distributed more equally over the foot. This might prevent foot complaints.	[Stolwijk, Niki M.; van de Ven, Yvonne H. M.; Keijsers, Noel L. W.] Sint Maartensklin, Res Dept, Nijmegen, Netherlands; [Louwerens, Jan Willem K.] Sint Maartensklin, Dept Orthopaed, Nijmegen, Netherlands; [Duysens, Jacques] Katholieke Univ Leuven, Dept Biomed Kinesiol, Res Ctr Movement Control & Neuroplast, Louvain, Belgium	Sint Maartens Clinic; Sint Maartens Clinic; KU Leuven	Stolwijk, NM (corresponding author), Sint Maartensklin, Res Dept, Nijmegen, Netherlands.	n.stolwijk@maartenskliniek.nl		Stolwijk, Niki/0000-0003-0645-8111; Duysens, Jacques/0000-0002-0043-8817	'bijzonder onderzoeksfonds' KU-Leuven [OT/08/034, 348 IDO/07/012]; Rsscan International	'bijzonder onderzoeksfonds' KU-Leuven; Rsscan International	This study was supported by grants from 'bijzonder onderzoeksfonds' KU-Leuven (OT/08/034 and 348 IDO/07/012) and Rsscan International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri Arun Kumar, 2007, J Forensic Leg Med, V14, P279, DOI 10.1016/j.jcfm.2006.10.014; Burzykowski T, 2003, MYCOSES, V46, P496, DOI 10.1046/j.0933-7407.2003.00933.x; CAVANAGH PR, 1987, J BIOMECH, V20, P547, DOI 10.1016/0021-9290(87)90255-7; Cuperus N, 2012, CLIN REHABIL, V26, P1048, DOI 10.1177/0269215512437417; D'Aout K, 2009, FOOTWEAR SCI, V1, P81, DOI 10.1080/19424280903386411; Dunn JE, 2004, AM J EPIDEMIOL, V159, P491, DOI 10.1093/aje/kwh071; Echarri JJ, 2003, J PEDIATR ORTHOP B, V12, P141, DOI 10.1097/00009957-200303000-00012; FREY C, 1993, FOOT ANKLE, V14, P78, DOI 10.1177/107110079301400204; Gorter KJ, 2000, J AM PODIAT MED ASSN, V90, P397, DOI 10.7547/87507315-90-8-397; GOTTSCHALK FAB, 1981, S AFR MED J, V60, P655; GOTTSCHALK FAB, 1980, S AFR MED J, V57, P355; Hills AP, 2001, INT J OBESITY, V25, P1674, DOI 10.1038/sj.ijo.0801785; Hoffmann P., 1905, J BONE JT SURG AM, V2, P105; Igbigbi P S, 2002, J Foot Ankle Surg, V41, P394; Kang JH, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-95; Keijsers NLW, 2010, GAIT POSTURE, V31, P140, DOI 10.1016/j.gaitpost.2009.08.248; Keijsers NLW, 2009, J BIOMECH, V42, P87, DOI 10.1016/j.jbiomech.2008.09.038; Klein C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-159; KLESGES RC, 1990, MED SCI SPORT EXER, V22, P690, DOI 10.1249/00005768-199010000-00022; Levinger P, 2010, GAIT POSTURE, V32, P519, DOI 10.1016/j.gaitpost.2010.07.013; Lieberman DE, 2012, EXERC SPORT SCI REV, V40, P63, DOI 10.1097/JES.0b013e31824ab210; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Menz HB, 2005, GERONTOLOGY, V51, P346, DOI 10.1159/000086373; Murley GS, 2010, CLIN BIOMECH, V25, P728, DOI 10.1016/j.clinbiomech.2010.05.001; Nguyen USDT, 2010, OSTEOARTHR CARTILAGE, V18, P41, DOI 10.1016/j.joca.2009.07.008; Pataky TC, 2008, J BIOMECH, V41, P1987, DOI 10.1016/j.jbiomech.2008.03.034; RAO UB, 1992, J BONE JOINT SURG BR, V74, P525, DOI 10.1302/0301-620X.74B4.1624509; ROBBINS SE, 1987, MED SCI SPORT EXER, V19, P148; Rosenbaum D., 1994, GAIT POSTURE, V2, P191, DOI DOI 10.1016/0966-6362(94)90007-8); SCRANTON PE, 1980, J BONE JOINT SURG AM, V62, P723, DOI 10.2106/00004623-198062050-00005; Simon J, 2006, GAIT POSTURE, V23, P411, DOI 10.1016/j.gaitpost.2005.07.003; Stolwijk NM, 2011, FOOT ANKLE INT, V32, P57, DOI 10.3113/FAI.2011.0057; Stolwijk NM, 2010, MED SCI SPORT EXER, V42, P2264, DOI 10.1249/MSS.0b013e3181e305f4; Tuinhout M, 2009, Foot Ankle Surg, V15, P127, DOI 10.1016/j.fas.2008.09.002; Vela S A, 1998, J Foot Ankle Surg, V37, P416; Waaijman R, 2012, GAIT POSTURE, V35, P1, DOI 10.1016/j.gaitpost.2011.07.006; Werner RA, 2010, PM&R, V2, P110, DOI 10.1016/j.pmrj.2009.11.012; Wu KK, 2000, CURR OPIN RHEUMATOL, V12, P131, DOI 10.1097/00002281-200003000-00007	38	20	23	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57209	10.1371/journal.pone.0057209	http://dx.doi.org/10.1371/journal.pone.0057209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468936	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900058
J	Zhang, M; Xu, JJ; Zhou, RL; Zhang, QY				Zhang, Meng; Xu, Jian-Jun; Zhou, Rou-Li; Zhang, Qing-Yun			cAMP Responsive Element Binding Protein-1 Is a Transcription Factor of Lysosomal-Associated Protein Transmembrane-4 beta in Human Breast Cancer Cells	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; GALLBLADDER CARCINOMA; DOWN-REGULATION; CREB; LAPTM4B-35; EXPRESSION; OVEREXPRESSION; GENE; PHOSPHORYLATION; RESISTANCE	Lysosomal-associated protein transmembrane-4 beta (LAPTM4B) is a potential proto-oncogene, whose overexpression is involved in cancer occurrence and progression. Its transcript is up-regulated in various types of solid tumors including breast cancer. However, its transcriptional regulation mechanism is still unclear. To investigate the mechanism of transcriptional regulation of LAPTM4B in human breast cancer cells, a series of luciferase reporter constructs and construct with mutated binding site for cAMP responsive element binding protein-1 (CREB1) were generated by PCR amplification and transiently transfected into breast cancer cells to determine the transcriptional activities of different promoter regions. The + 10 similar to+ 292 promoter region was possessed the highest transcriptional activity. The ability of CREB1 to bind the LAPMT4B promoter was confirmed by electrophoretic mobility shift assay, super-shift and RNA interference experiments. Our study identified the core promoter region responsible for constitutive expression of LAPTM4B and clarified that CREB1 played an important role in LAPTM4B transcriptional regulation in human breast cancer cells.	[Zhang, Meng; Xu, Jian-Jun; Zhang, Qing-Yun] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Clin Lab, Beijing 100871, Peoples R China; [Zhou, Rou-Li] Peking Univ, Sch Basic Med Sci, Dept Cell Biol, Beijing 100871, Peoples R China	Peking University; Peking University	Zhang, QY (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Clin Lab, Beijing 100871, Peoples R China.	zhqy_208@163.com		Meng, Zhang/0000-0003-1653-9230	National Natural Science Foundation of China [81071422]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81071422). Website: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deng L, 2011, J CELL BIOCHEM, V112, P1046, DOI 10.1002/jcb.23017; Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004; Fusco S, 2012, P NATL ACAD SCI USA, V109, P621, DOI 10.1073/pnas.1109237109; Hsieh TH, 2012, FASEB J, V26, P778, DOI 10.1096/fj.11-191742; Kang Y, 2012, AM J SURG; Kasper G, 2005, CANCER LETT, V224, P93, DOI 10.1016/j.canlet.2004.10.004; Kim CH, 2005, MOL CELL BIOL, V25, P5329, DOI 10.1128/MCB.25.13.5329-5338.2005; Kinjo K, 2005, CELL CYCLE, V4, P1134, DOI 10.4161/cc.4.9.1991; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Makhov P, 2009, GENE, V431, P39, DOI 10.1016/j.gene.2008.10.015; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meng FL, 2010, INT J GYNECOL CANCER, V20, P745, DOI 10.1111/IGC.0b013e3181e02f90; Milkereit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027478; Naderi A, 2012, NEOPLASIA, V14, P283, DOI 10.1593/neo.12294; Naviglio S, 2010, J CELL PHYSIOL, V225, P801, DOI 10.1002/jcp.22288; Peng C, 2005, WORLD J GASTROENTERO, V11, P2704, DOI 10.3748/wjg.v11.i18.2704; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; San-Marina S, 2012, BBA-GENE REGUL MECH, V1819, P1164, DOI 10.1016/j.bbagrm.2012.09.004; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Yang H, 2011, SURG TODAY, V41, P810, DOI 10.1007/s00595-010-4338-5; Yang H, 2010, J SURG ONCOL, V101, P363, DOI 10.1002/jso.21489; Yin MZ, 2011, J SURG ONCOL, V104, P29, DOI 10.1002/jso.21912; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025; Zhou L, 2011, SURGERY, V150, P25, DOI 10.1016/j.surg.2010.12.010; ZHOU QJ, 1995, J VIROL, V69, P4323, DOI 10.1128/JVI.69.7.4323-4330.1995	29	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57520	10.1371/journal.pone.0057520	http://dx.doi.org/10.1371/journal.pone.0057520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469012	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900112
J	Behrends, J; Renauld, JC; Ehlers, S; Holscher, C				Behrends, Jochen; Renauld, Jean-Christophe; Ehlers, Stefan; Hoelscher, Christoph			IL-22 Is Mainly Produced by IFN gamma-Secreting Cells but Is Dispensable for Host Protection against Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; CD4(+) T-CELLS; IMMUNE-RESPONSE; INTERFERON-GAMMA; AUTOIMMUNE INFLAMMATION; DERMAL INFLAMMATION; INDUCIBLE FACTOR; IL-TIF; INTERLEUKIN-22	Anti-inflammatory treatment of autoimmune diseases is associated with an increased risk of reactivation tuberculosis (TB). Besides interleukin (IL-17) A, IL-22 represents a classical T helper (TH) 17 cytokine and shares similar pathological effects in inflammatory diseases such as psoriasis or arthritis. Whereas IL-17A supports protective immune responses during mycobacterial infections, the role of IL-22 after infection with Mycobacterium tuberculosis (Mtb) is yet poorly characterized. Therefore, we here characterize the cell types producing IL-22 and the protective function of this cytokine during experimental TB in mice. Like IL-17A, IL-22 is expressed early after infection with Mtb in an IL-23-dependent manner. Surprisingly, the majority of IL-22-producing cells are not positive for IL-17A but have rather functional characteristics of interferon-gamma-producing TH1 cells. Although we found minor differences in the number of naive and central memory T cells as well as in the frequency of TH1 and polyfunctional T cells in mice deficient for IL-22, the absence of IL-22 does not affect the outcome of Mtb infection. Our study revealed that although produced by TH1 cells, IL-22 is dispensable for protective immune responses during TB. Therefore, targeting of IL-22 in inflammatory disease may represent a therapeutic approach that does not incur the danger of reactivation TB.	[Behrends, Jochen; Ehlers, Stefan; Hoelscher, Christoph] RCB, Borstel, Germany; [Renauld, Jean-Christophe] Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Renauld, Jean-Christophe] Catholic Univ Louvain, Expt Med Unit, B-1200 Brussels, Belgium; [Ehlers, Stefan] Univ Kiel, Kiel, Germany	Forschungszentrum Borstel; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; University of Kiel	Holscher, C (corresponding author), RCB, Borstel, Germany.	choelscher@fz-borstel.de	Ehlers, Stefan/B-4075-2010; Hölscher, Christoph/O-1732-2018; Renauld, Jean-Christophe/B-7268-2012	Hölscher, Christoph/0000-0002-7520-9146; Renauld, Jean-Christophe/0000-0003-1736-2131	BMBF grant [01KI0784]; German Research Foundation Cluster of Excellence "Inflammation at Interfaces'' [EXC306]	BMBF grant(Federal Ministry of Education & Research (BMBF)); German Research Foundation Cluster of Excellence "Inflammation at Interfaces''	This study was supported by a BMBF grant 01KI0784 to C.H. and S.E. and the German Research Foundation Cluster of Excellence "Inflammation at Interfaces'' EXC306 to C.H. and S.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afif W, 2009, GASTROENTEROL CLIN N, V38, P691, DOI 10.1016/j.gtc.2009.07.005; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Benson HL, 2011, AM J RESP CELL MOL, V44, P700, DOI 10.1165/rcmb.2010-0125OC; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; COOPER AM, 1995, CURR OPIN IMMUNOL, V7, P512, DOI 10.1016/0952-7915(95)80096-4; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dhiman R, 2012, J IMMUNOL, V189, P897, DOI 10.4049/jimmunol.1102833; Dhiman R, 2009, J IMMUNOL, V183, P6639, DOI 10.4049/jimmunol.0902587; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Ehlers S, 2005, CLIN INFECT DIS, V41, pS199, DOI 10.1086/429998; Ehlers S, 2001, J EXP MED, V194, P1847, DOI 10.1084/jem.194.12.1847; Ehlers S, 2010, CELL HOST MICROBE, V7, P6, DOI 10.1016/j.chom.2009.12.010; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Hansch HCR, 1996, INT IMMUNOL, V8, P1299, DOI 10.1093/intimm/8.8.1299; Henao-Tamayo MI, 2010, CLIN VACCINE IMMUNOL, V17, P618, DOI 10.1128/CVI.00368-09; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2011, J IMMUNOL, V187, P5402, DOI 10.4049/jimmunol.1101377; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Kumar P, 2013, MUCOSAL IMMUNOL, V6, P69, DOI 10.1038/mi.2012.49; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Li W, 2009, J BIOL CHEM, V284, P218, DOI 10.1074/jbc.M806267200; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Maglione PJ, 2009, EUR J IMMUNOL, V39, P676, DOI 10.1002/eji.200839148; Mitra A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3781; Mohan AK, 2004, CLIN INFECT DIS, V39, P295, DOI 10.1086/421494; Mohan K, 2005, EUR J IMMUNOL, V35, P1702, DOI 10.1002/eji.200425885; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakagome K, 2011, J IMMUNOL, V187, P5077, DOI 10.4049/jimmunol.1001560; ORME IM, 1993, J INFECT DIS, V167, P1481, DOI 10.1093/infdis/167.6.1481; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pearl JE, 2001, CELL IMMUNOL, V211, P43, DOI 10.1006/cimm.2001.1819; Reiling N, 2008, IMMUNOL LETT, V116, P15, DOI 10.1016/j.imlet.2007.11.015; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Stallmach A, 2010, BEST PRACT RES CL GA, V24, P167, DOI 10.1016/j.bpg.2010.01.002; Stange J, 2012, J IMMUNOL, V188, P2410, DOI 10.4049/jimmunol.1102062; Stumhofer JS, 2007, SEMIN IMMUNOL, V19, P394, DOI 10.1016/j.smim.2007.11.006; Torrado E, 2011, TRENDS IMMUNOL, V32, P66, DOI 10.1016/j.it.2010.12.001; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zeng GC, 2011, J IMMUNOL, V187, P190, DOI 10.4049/jimmunol.1004129; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	72	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57379	10.1371/journal.pone.0057379	http://dx.doi.org/10.1371/journal.pone.0057379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460846	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000100
J	Burgos-Robles, A; Bravo-Rivera, H; Quirk, GJ				Burgos-Robles, Anthony; Bravo-Rivera, Hector; Quirk, Gregory J.			Prelimbic and Infralimbic Neurons Signal Distinct Aspects of Appetitive Instrumental Behavior	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; FEAR EXTINCTION; NUCLEUS-ACCUMBENS; EXPRESSION; AMYGDALA; RAT; RESPONSES; MEMORY; NMDA; CONSOLIDATION	It is thought that discrete subregions of the medial prefrontal cortex (mPFC) regulate different aspects of appetitive behavior, however, physiological support for this hypothesis has been lacking. In the present study, we used multichannel single-unit recording to compare the response of neurons in the prelimbic (PL) and infralimbic (IL) subregions of the mPFC, in rats pressing a lever to obtain sucrose pellets on a variable interval schedule of reinforcement (VI-60). Approximately 25% of neurons in both structures exhibited prominent excitatory responses during rewarded, but not unrewarded, lever presses. The time courses of reward responses in PL and IL, however, were markedly different. Most PL neurons exhibited fast and transient responses at the delivery of sucrose pellets, whereas most IL neurons exhibited delayed and prolonged responses associated with the collection of earned sucrose pellets. We further examined the functional significance of reward responses in IL and PL with local pharmacological inactivation. IL inactivation significantly delayed the collection of earned sucrose pellets, whereas PL inactivation produced no discernible effects. These findings support the hypothesis that PL and IL signal distinct aspects of appetitive behavior, and suggest that IL signaling facilitates reward collection.	[Quirk, Gregory J.] Univ Puerto Rico, Sch Med, Dept Psychiat, San Juan, PR 00936 USA; Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Quirk, GJ (corresponding author), Univ Puerto Rico, Sch Med, Dept Psychiat, San Juan, PR 00936 USA.	gregoryjquirk@gmail.com		Bravo-Rivera, Hector/0000-0001-7882-3945	National Institutes of Health [R01-MH058883, R01-MH081975, P50-MH086400]; University of Puerto Rico President's Office; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081975, P50MH086400, R01MH058883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico President's Office; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institutes of Health grants R01-MH058883 and R01-MH081975 to G.J.Q., P50-MH086400 to S.N. Haber, and the University of Puerto Rico President's Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Baldwin AE, 2002, J NEUROSCI, V22, P1063, DOI 10.1523/JNEUROSCI.22-03-01063.2002; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Chang JY, 2002, EXP BRAIN RES, V142, P67, DOI 10.1007/s00221-001-0918-3; Choi JS, 2010, P NATL ACAD SCI USA, V107, P21773, DOI 10.1073/pnas.1010079108; Coutureau E, 2003, BEHAV BRAIN RES, V146, P167, DOI 10.1016/j.bbr.2003.09.025; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Graybiel AM, 2008, ANNU REV NEUROSCI, P31359; Hefner K, 2008, J NEUROSCI, V28, P8074, DOI 10.1523/JNEUROSCI.4904-07.2008; Ishikawa A, 2008, NEUROSCIENCE, V155, P573, DOI 10.1016/j.neuroscience.2008.06.037; Ishikawa A, 2008, J NEUROSCI, V28, P5088, DOI 10.1523/JNEUROSCI.0253-08.2008; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Laurent V, 2009, LEARN MEMORY, V16, P520, DOI 10.1101/lm.1474609; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Miyazaki K, 2004, NEUROREPORT, V15, P721, DOI 10.1097/00001756-200403220-00030; Mulder AB, 2003, BEHAV BRAIN RES, V146, P77, DOI 10.1016/j.bbr.2003.09.016; Murphy ER, 2012, PSYCHOPHARMACOLOGY, V219, P401, DOI 10.1007/s00213-011-2572-1; Ostlund SB, 2005, J NEUROSCI, V25, P7763, DOI 10.1523/JNEUROSCI.1921-05.2005; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pennartz CMA, 2009, J NEUROSCI, V29, P12831, DOI 10.1523/JNEUROSCI.3177-09.2009; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Petrovich GD, 2007, PHYSIOL BEHAV, V91, P397, DOI 10.1016/j.physbeh.2007.04.014; Pratt WE, 2001, BEHAV BRAIN RES, V123, P165, DOI 10.1016/S0166-4328(01)00204-2; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rapanelli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008656; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; Valdes JL, 2006, EUR J NEUROSCI, V23, P1352, DOI 10.1111/j.1460-9568.2006.04659.x; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279	33	64	64	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57575	10.1371/journal.pone.0057575	http://dx.doi.org/10.1371/journal.pone.0057575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460877	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000132
J	Chao, A; Lai, CH; Tsai, CL; Hsueh, S; Hsueh, C; Lin, CY; Chou, HH; Lin, YJ; Chen, HW; Chang, TC; Wang, TH				Chao, Angel; Lai, Chyong-Huey; Tsai, Chia-Lung; Hsueh, Swei; Hsueh, Chuen; Lin, Chiao-Yun; Chou, Hung-Hsueh; Lin, Yu-Jr; Chen, Hsi-Wen; Chang, Ting-Chang; Wang, Tzu-Hao			Tumor Stress-Induced Phosphoprotein1 (STIP1) as a Prognostic Biomarker in Ovarian Cancer	PLOS ONE			English	Article							CARCINOMA; PROTEIN; HSP90; PROLIFERATION; EXPRESSION; INHIBITOR; CANDIDATE; PRION	Stress-induced phosphoprotein 1 (STIP1) has been recently identified as a released biomarker in human ovarian cancer. In addition, STIP1 secreted by human ovarian cancer cells has been shown to promote tumor cell proliferation by binding to ALK2 (activin A receptor, type II-like kinase 2) and activating the SMAD-ID3 signaling pathways. In this study, a total of 330 ovarian cancer tumor samples were evaluated for STIP1 expression by immunohistochemistry and analyzed for a possible correlation with patient characteristics and survival. The quantification of immunoreactivity was accomplished by applying an immunohistochemical scoring system (histoscore). Patients with high-level STIP1 expression (histoscore >= 169) had a significantly worse survival (high STIP1, mean survival time = 76 months; low STIP1, mean survival time = 112 months; P<0.0001). Moreover, STIP1 histoscores were significantly higher in high-grade tumors (grade 3) than in low-grade (grade 1-2) malignancies (P<0.0001), suggesting that STIP1 may be a proxy for tumor aggressiveness. The results of multivariable analysis revealed that high STIP1 histoscores, advanced stages, histologic types, and the presence of residual disease (>= 2 cm) were independent predictors of poor prognosis. The addition of STIP1 histoscores improved the prediction of overall and progression-free survival rates in the multivariable Cox proportional hazard model. The treatment of ovarian cancer cells with recombinant STIP1 stimulated cell proliferation and migration, but co-treatment with anti-STIP1 antibodies abrogated this effect. Our findings suggest that STIP1 expression may be related to prognosis and that the STIP1 pathway may represent a novel therapeutic target for human ovarian cancer.	[Chao, Angel; Lai, Chyong-Huey; Tsai, Chia-Lung; Lin, Chiao-Yun; Chou, Hung-Hsueh; Chang, Ting-Chang; Wang, Tzu-Hao] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan, Taiwan; [Chao, Angel; Lai, Chyong-Huey; Tsai, Chia-Lung; Hsueh, Swei; Hsueh, Chuen; Lin, Chiao-Yun; Chou, Hung-Hsueh; Chang, Ting-Chang; Wang, Tzu-Hao] Chang Gung Univ, Tao Yuan, Taiwan; [Hsueh, Swei; Hsueh, Chuen] Chang Gung Mem Hosp, Dept Clin Pathol, Tao Yuan, Taiwan; [Lin, Yu-Jr] Chang Gung Mem Hosp, Biostat Ctr Clin Res, Tao Yuan, Taiwan; [Chen, Hsi-Wen; Wang, Tzu-Hao] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Wang, Tzu-Hao] Chang Gung Mem Hosp, Genom Med Res Core Lab, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chao, A (corresponding author), Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan, Taiwan.	angel945@cgmh.org.tw; knoxtn@cgmh.org.tw	Lai, Chyong-Huey/AAE-5731-2022	Hsueh, Chuen/0000-0001-7860-5964; Lai, Chyong-Huey/0000-0002-9977-9645	National Science Council [NSC100-2314-B-182-016MY3]; Chang Gung Medical Research Foundation [CMRPG391451/2, CMRPG 391461/2]; Department of Health [DOH101-TD-I-111-TM013, DOH101-TD-C-111-006]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Medical Research Foundation; Department of Health	This study was supported by grants from the National Science Council (NSC100-2314-B-182-016MY3 to THW), the Chang Gung Medical Research Foundation (CMRPG391451/2 to AC, CMRPG 391461/2 to THW), and the Department of Health (DOH101-TD-I-111-TM013 to THW, DOH101-TD-C-111-006 to AC and THW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron JA, 2012, NAT REV CANCER, V12, P368, DOI 10.1038/nrc3260; Berek JS, 2010, BEREK HACKERS GYNECO, P444; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Carta F, 2005, MELANOMA RES, V15, P235, DOI 10.1097/00008390-200508000-00002; Chao A, 2012, ONCOGENE, V31, P764, DOI 10.1038/onc.2011.269; Chao A, 2006, INT J CANCER, V119, P91, DOI 10.1002/ijc.21813; Chao A, 2010, CANCER LETT, V291, P99, DOI 10.1016/j.canlet.2009.10.005; Emmanuel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017617; Erlich RB, 2007, GLIA, V55, P1690, DOI 10.1002/glia.20579; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Horibe T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-8; HOSMER DW, 1991, AM J PUBLIC HEALTH, V81, P1630, DOI 10.2105/AJPH.81.12.1630; JACOBS I, 1989, HUM REPROD, V4, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelloff GJ, 2012, NAT REV DRUG DISCOV, V11, P201, DOI 10.1038/nrd3651; Kim S, 2010, GENE CHROMOSOME CANC, V49, P585, DOI 10.1002/gcc.20769; Kulasingam V, 2010, NAT REV CANCER, V10, P371, DOI 10.1038/nrc2831; Liao CJ, 2011, GYNECOL ONCOL, V120, P135, DOI 10.1016/j.ygyno.2010.10.005; Longshaw VM, 2004, J CELL SCI, V117, P701, DOI 10.1242/jcs.00905; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Pimienta G, 2011, MOL PHARMACEUT, V8, P2252, DOI 10.1021/mp200346y; Pitteri SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007916; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Samadi AK, 2011, CANCER LETT, V312, P158, DOI 10.1016/j.canlet.2011.07.031; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Seidman JD, 2011, BLAUSTEIN'S PATHOLOGY OF THE FEMALE GENITAL TRACT, SIXTH EDITION, P679, DOI 10.1007/978-1-4419-0489-8_14; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sun W, 2007, MOL CELL PROTEOMICS, V6, P1798, DOI 10.1074/mcp.M600449-MCP200; Tsai CL, 2012, CELL REP, V2, P283, DOI 10.1016/j.celrep.2012.07.002; Van Calster B, 2007, JNCI-J NATL CANCER I, V99, P1706, DOI 10.1093/jnci/djm199; Walsh N, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-3; Wang TH, 2010, MOL CELL PROTEOMICS, V9, P1873, DOI 10.1074/mcp.M110.000802	34	36	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57084	10.1371/journal.pone.0057084	http://dx.doi.org/10.1371/journal.pone.0057084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468915	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000060
J	Herenius, MMJ; Oliveira, ASF; Wijbrandts, CA; Gerlag, DM; Tak, PP; Lebre, MC				Herenius, Marieke M. J.; Oliveira, Ana S. F.; Wijbrandts, Carla A.; Gerlag, Danielle M.; Tak, Paul P.; Lebre, Maria C.			Anti-TNF Therapy Reduces Serum Levels of Chemerin in Rheumatoid Arthritis: A New Mechanism by Which Anti-TNF Might Reduce Inflammation	PLOS ONE			English	Article							METABOLIC SYNDROME; JOINT DAMAGE; ATHEROSCLEROSIS; RECEPTOR; MARKERS; CHEMR23	Background: Chemerin is a specific chemoattractant for macrophages and dendritic cells (DC). In addition, it can rapidly stimulate macrophage adhesion to extracellular matrix proteins and adhesion molecules and is able to activate fibroblast-like synoviocytes (FLS), suggesting a role in the pathogenesis of rheumatoid arthritis (RA). Chemerin is also an adipocytokine that has been related to the inflammatory state of endothelial cells and as such could be involved in the changes in endothelial cells in RA and perhaps increased cardiovascular morbidity. We investigated whether anti-Tumor Necrosis Factor (TNF) treatment affects chemerin levels. Materials and Methods: 49 patients with active RA (disease activity score evaluated in 28 joints (DAS28) >= 3.2) were started on adalimumab therapy. Blood was drawn from patients while fasting at baseline and 16 weeks after initiation of treatment. Chemerin serum levels were measured by ELISA and related to disease activity, mediators of inflammation and known risk factors for cardiovascular disease. Results: Adalimumab therapy reduced chemerin serum levels, which was correlated with the reduction in DAS28 (r = 0.37, p = 0.009). In addition, the decrease in chemerin serum levels after anti-TNF treatment was associated with the decrease in serum levels of IL-6 (r = 0.39, p = 0.033) and macrophage migration inhibitory factor (MIF) (r = 0.31, p = 0.049). Baseline chemerin serum levels were not related to traditional risk factors for atherosclerosis, except perhaps for smoking (p = 0.07). Conclusions: This exploratory study shows that adalimumab therapy lowers chemerin levels, which is associated with the reduction in disease activity parameters, and inflammatory mediators IL-6 and MIF. This suggests a possible involvement of chemerin in the migration/retention of macrophages in the synovium.	[Herenius, Marieke M. J.; Oliveira, Ana S. F.; Wijbrandts, Carla A.; Gerlag, Danielle M.; Tak, Paul P.; Lebre, Maria C.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Oliveira, Ana S. F.; Lebre, Maria C.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Herenius, MMJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.m.herenius@amc.uva.nl	Oliveira, Ana/L-1850-2014	Oliveira, Ana/0000-0002-2220-5862	Abbott Laboratories	Abbott Laboratories(Abbott Laboratories)	The clinical part of this study was funded by Abbott Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Bisoendial RJ, 2011, CURR PHARM DESIGN, V17, P21; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Buckley CD, 2003, CLIN MED, V3, P361, DOI 10.7861/clinmedicine.3-4-361; Demoor T, 2011, J IMMUNOL, V186, P5457, DOI 10.4049/jimmunol.1003862; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Hart R, 2010, J IMMUNOL, V185, P3728, DOI 10.4049/jimmunol.0902154; Kaneko K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3475; Kaur J, 2010, BIOCHEM BIOPH RES CO, V391, P1762, DOI 10.1016/j.bbrc.2009.12.150; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Manfredsdottir VF, 2006, RHEUMATOLOGY, V45, P734, DOI 10.1093/rheumatology/kei240; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Pereira RMR, 2009, AUTOIMMUN REV, V8, P415, DOI 10.1016/j.autrev.2009.01.001; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Szekanecz Zoltan, 2010, Front Biosci (Schol Ed), V2, P153; Tak PP, 2006, BEST PRACT RES CL RH, V20, P929, DOI 10.1016/j.berh.2006.06.001; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; van der Heijde D, 2000, J RHEUMATOL, V27, P261; van Gestel AM, 1999, J RHEUMATOL, V26, P705; Wijbrandts CA, 2009, ANN RHEUM DIS, V68, P1316, DOI 10.1136/ard.2007.086728; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Yamawaki H, 2011, BIOL PHARM BULL, V34, P307, DOI 10.1248/bpb.34.307	23	50	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57802	10.1371/journal.pone.0057802	http://dx.doi.org/10.1371/journal.pone.0057802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460910	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000165
J	Rather, MA; Sharma, R; Gupta, S; Ferosekhan, S; Ramya, VL; Jadhao, SB				Rather, Mohd Ashraf; Sharma, Rupam; Gupta, Subodh; Ferosekhan, S.; Ramya, V. L.; Jadhao, Sanjay B.			Chitosan-Nanoconjugated Hormone Nanoparticles for Sustained Surge of Gonadotropins and Enhanced Reproductive Output in Female Fish	PLOS ONE			English	Article							OXIDE NANOPARTICLES; DELIVERY SYSTEMS; COMMON CARP; ABSORPTION; CARRIERS; MATURATION; TELEOST; WATER	A controlled release delivery system helps to overcome the problem of short life of the leutinizing hormone releasing hormone (LHRH) in blood and avoids use of multiple injections to enhance reproductive efficacy. Chitosan- and chitosan-gold nanoconjugates of salmon LHRH of desired size, dispersity and zeta potential were synthesized and evaluated at half the dose rate against full dose of bare LHRH for their reproductive efficacy in the female fish, Cyprinus carpio. Whereas injections of both the nanoconjugates induced controlled and sustained surge of the hormones with peak (P<0.01) at 24 hrs, surge due to bare LHRH reached its peak at 7 hrs and either remained at plateau or sharply declined thereafter. While the percentage of relative total eggs produced by fish were 130 and 67 per cent higher, that of fertilised eggs were 171 and 88 per cent higher on chitosan- and chitosan-gold nanoconjugates than bare LHRH. Chitosan nanoconjugates had a 13 per cent higher and chitosan gold preparation had a 9 per cent higher fertilization rate than bare LHRH. Histology of the ovaries also attested the pronounced effect of nanoparticles on reproductive output. This is the first report on use of chitosan-conjugated nanodelivery of gonadotropic hormone in fish.	[Rather, Mohd Ashraf; Sharma, Rupam; Gupta, Subodh; Ferosekhan, S.; Ramya, V. L.; Jadhao, Sanjay B.] Cent Inst Fisheries Educ, Mumbai, Maharashtra, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Fisheries Education	Jadhao, SB (corresponding author), Cent Inst Fisheries Educ, Mumbai, Maharashtra, India.	sbjadhao@hotmail.com	Ferosekhan, Shajahan/E-5051-2010	Ferosekhan, Shajahan/0000-0003-4662-8306; Gupta, Subodh/0000-0002-9420-480X; Rather, Mohd Ashraf/0000-0001-5710-8176; Jadhao, Sanjay/0000-0003-2859-8529				Bhattarai N, 2006, INT J NANOMED, V1, P181, DOI 10.2147/nano.2006.1.2.181; Bhumkar DR, 2007, PHARM RES-DORDR, V24, P1415, DOI 10.1007/s11095-007-9257-9; Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4; Chae SY, 2005, J CONTROL RELEASE, V102, P383, DOI 10.1016/j.jconrel.2004.10.012; Chen Y, 2008, BIOPOLYMERS, V90, P663, DOI 10.1002/bip.21055; Chondar S, 1994, INDUCED CAR BREEDING, P64; Crim L.W., 1997, RECENT ADV MARINE BI, P369; Dounighi NM, 2012, J VENOM ANIM TOXINS, V18, P44, DOI 10.1590/S1678-91992012000100006; DRORI S, 1994, AQUACULTURE, V119, P393, DOI 10.1016/0044-8486(94)90303-4; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; GOETZ FW, 1983, FISH PHYSIOL, V9, P117; Goren A, 1987, GEN COMP ENDOCR, V79, P291; Hall SJ., 2011, BLUE FRONTIERS MANAG; Hallaj-Nezhadi S, 2011, J PHARM PHARM SCI, V14, P181, DOI 10.18433/J3TP4T; Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009; Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X; Joshi H, 2004, J PHYS CHEM B, V108, P11535, DOI 10.1021/jp048766z; Joshi HM, 2006, LANGMUIR, V22, P300, DOI 10.1021/la051982u; Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P223, DOI 10.1016/S0169-409X(02)00018-2; Kim TH, 2004, BIOMATERIALS, V25, P3783, DOI 10.1016/j.biomaterials.2003.10.063; KOBAYASHI M, 1989, FISH PHYSIOL BIOCHEM, V7, P141, DOI 10.1007/BF00004700; Larsson DGJ, 1997, CAN J FISH AQUAT SCI, V54, P1957, DOI 10.1139/cjfas-54-9-1957; Lasagna-Reeves C, 2010, BIOCHEM BIOPH RES CO, V393, P649, DOI 10.1016/j.bbrc.2010.02.046; Leuschner C, 2006, BREAST CANCER RES TR, V99, P163, DOI 10.1007/s10549-006-9199-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luna L. G., 1968, MANUAL HISTOLOGICAL, P38; Mananos E, 2002, J FISH BIOL, V60, P328, DOI 10.1006/jfbi.2001.1839; Marino G, 2003, AQUACULTURE, V219, P841, DOI 10.1016/S0044-8486(03)00036-X; Marte C, 1989, ADV TROP AQUAC; Mikolajczyk T, 2002, AQUACULTURE, V203, P375, DOI 10.1016/S0044-8486(01)00637-8; Mittal G, 2007, J CONTROL RELEASE, V119, P77, DOI 10.1016/j.jconrel.2007.01.016; NAGAHAMA Y, 1983, FISH PHYSIOL, V9, P223; PANKHURST NW, 1991, PROCEEDINGS OF THE FOURTH INTERNATIONAL SYMPOSIUM ON THE REPRODUCTIVE PHYSIOLOGY OF FISH, P131; Pulavendran S, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-15; Sadeghi AMM, 2008, EUR J PHARM BIOPHARM, V70, P270, DOI 10.1016/j.ejpb.2008.03.004; Salehizadeh H, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-3; Thanou M, 2001, ADV DRUG DELIVER REV, V50, pS91, DOI 10.1016/S0169-409X(01)00180-6; Turkevich J, 1985, GOLD BULL, V18, P125, DOI [10.1007/BF03214694, DOI 10.1007/BF03214690]; Wang C, 2007, CHINESE SCI BULL, V52, P883, DOI 10.1007/s11434-007-0127-y; Wang XM, 2008, EUR J PHARM BIOPHARM, V70, P735, DOI 10.1016/j.ejpb.2008.07.005; Yu JM, 2008, EUR POLYM J, V44, P555, DOI 10.1016/j.eurpolymj.2008.01.013; Zohar J, 1994, US Patent, Patent No. 5288705; Zohar Y, 2001, AQUACULTURE, V197, P99, DOI 10.1016/S0044-8486(01)00584-1; Zohar Y., 1988, Colloques de l'INRA, V44, P47	44	56	57	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57094	10.1371/journal.pone.0057094	http://dx.doi.org/10.1371/journal.pone.0057094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468918	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000061
J	Srinivasan, L; Asaad, WF; Ginat, DT; Gale, JT; Dougherty, DD; Williams, ZM; Sejnowski, TJ; Eskandar, EN				Srinivasan, Lakshminarayan; Asaad, Wael F.; Ginat, Daniel T.; Gale, John T.; Dougherty, Darin D.; Williams, Ziv M.; Sejnowski, Terrence J.; Eskandar, Emad N.			Action Initiation in the Human Dorsal Anterior Cingulate Cortex	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; SUPPLEMENTARY MOTOR AREA; PREFRONTAL CORTEX; NEURAL ACTIVITY; SELECTIVE ATTENTION; RESPONSE-INHIBITION; NEURONAL-ACTIVITY; ARM MOVEMENTS; MONKEY; CINGULOTOMY	The dorsal anterior cingulate cortex (dACC) has previously been implicated in processes that influence action initiation. In humans however, there has been little direct evidence connecting dACC to the temporal onset of actions. We studied reactive behavior in patients undergoing therapeutic bilateral cingulotomy to determine the immediate effects of dACC ablation on action initiation. In a simple reaction task, three patients were instructed to respond to a specific visual cue with the movement of a joystick. Within minutes of dACC ablation, the frequency of false starts increased, where movements occurred prior to presentation of the visual cue. In a decision making task with three separate patients, the ablation effect on action initiation persisted even when action selection was intact. These findings suggest that human dACC influences action initiation, apart from its role in action selection.	[Srinivasan, Lakshminarayan] Univ Calif Los Angeles, Neural Signal Proc Lab, Dept Radiol, Los Angeles, CA 90024 USA; [Asaad, Wael F.] Brown Univ, Dept Neurosurg, Alpert Med Sch, Providence, RI 02912 USA; [Asaad, Wael F.] Rhode Isl Hosp, Brown Inst Brain Sci, Providence, RI 02912 USA; [Asaad, Wael F.] Norman Prince Neurosci Inst, Providence, RI 02912 USA; [Ginat, Daniel T.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Gale, John T.; Dougherty, Darin D.; Williams, Ziv M.; Eskandar, Emad N.] Harvard Univ, Sch Med, Boston, MA USA; [Gale, John T.] Cleveland Clin, Dept Neurosci, Cleveland, OH 44106 USA; [Gale, John T.] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA; [Dougherty, Darin D.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Williams, Ziv M.; Eskandar, Emad N.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Srinivasan, L (corresponding author), Univ Calif Los Angeles, Neural Signal Proc Lab, Dept Radiol, Los Angeles, CA 90024 USA.	ls2@nsplab.org	Asaad, Wael/I-8485-2012; Dougherty, Darin D./G-9896-2012; Sejnowski, Terrence/AAV-5558-2021	Asaad, Wael/0000-0003-4406-9096; 	American Heart Association Scientist Development Grant [11SDG7550015]; DARPA Reliable Neural-Interface Technology (RE-NET) Program; UCLA Radiology Exploratory Development Grant; Massachusetts Biomedical Research Corporation; Howard Hughes Medical Institute; National Science Foundation [IOB 0645886]; National Institutes of Health [NEI R01EY017658, NIDA R01DA026297, NIMH MH086400]; Klingenstein Foundation; NATIONAL EYE INSTITUTE [R01EY017658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026297] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); DARPA Reliable Neural-Interface Technology (RE-NET) Program; UCLA Radiology Exploratory Development Grant; Massachusetts Biomedical Research Corporation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Foundation(Klingenstein Philanthropies); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	LS is supported by the American Heart Association Scientist Development Grant (11SDG7550015), the DARPA Reliable Neural-Interface Technology (RE-NET) Program, and the UCLA Radiology Exploratory Development Grant. WFA is supported by a Tosteson award from the Massachusetts Biomedical Research Corporation. TJS is supported by the Howard Hughes Medical Institute. EE is supported by grants from the National Science Foundation (IOB 0645886), the National Institutes of Health (NEI R01EY017658, NIDA R01DA026297, NIMH MH086400), the Howard Hughes Medical Institute, and the Klingenstein Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Backus DA, 2001, EXP BRAIN RES, V140, P182, DOI 10.1007/s002210100807; Baird A, 2006, BRAIN COGNITION, V60, P166, DOI 10.1016/j.bandc.2005.11.003; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; BRUTKOWSKI S, 1961, SCIENCE, V134, P2040, DOI 10.1126/science.134.3495.2040; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Cohen RA, 1999, J NEUROPSYCH CLIN N, V11, P444, DOI 10.1176/jnp.11.4.444; Cohen RA, 1999, NEUROLOGY, V53, P819, DOI 10.1212/WNL.53.4.819; Crutcher MD, 2004, EXP BRAIN RES, V158, P278, DOI 10.1007/s00221-004-1895-0; Davis KD, 2000, J NEUROPHYSIOL, V83, P3575, DOI 10.1152/jn.2000.83.6.3575; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; Delorme A, 2007, J NEUROSCI, V27, P11949, DOI 10.1523/JNEUROSCI.3477-07.2007; Dougherty DD, 2002, AM J PSYCHIAT, V159, P269, DOI 10.1176/appi.ajp.159.2.269; DREWE E A, 1975, Cortex, V11, P8; DREWE EA, 1975, NEUROPSYCHOLOGIA, V13, P421, DOI 10.1016/0028-3932(75)90065-2; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Gaymard B, 1998, EXP BRAIN RES, V120, P173, DOI 10.1007/s002210050391; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Isomura Y, 2004, REV NEUROSCIENCE, V15, P279; JANER KW, 1991, J COGNITIVE NEUROSCI, V3, P231, DOI 10.1162/jocn.1991.3.3.231; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kuehn S, 2009, NEUROIMAGE, V46, P1187, DOI 10.1016/j.neuroimage.2009.03.020; Lau H, 2006, NEUROIMAGE, V29, P446, DOI 10.1016/j.neuroimage.2005.07.050; LEIMKUHLER ME, 1985, ANN NEUROL, V18, P617, DOI 10.1002/ana.410180518; LUPPINO G, 1991, J COMP NEUROL, V311, P463, DOI 10.1002/cne.903110403; Milea D, 2003, NEUROREPORT, V14, P283, DOI 10.1097/00001756-200302100-00026; Mulert C, 2003, INT J PSYCHOPHYSIOL, V47, P175, DOI 10.1016/S0167-8760(02)00125-3; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Naito E, 2000, J NEUROPHYSIOL, V83, P1701, DOI 10.1152/jn.2000.83.3.1701; Narayanan NS, 2006, NEUROSCIENCE, V139, P865, DOI 10.1016/j.neuroscience.2005.11.072; Oswal A, 2007, J NEUROPHYSIOL, V97, P2722, DOI 10.1152/jn.01238.2006; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Richardson AG, 2008, J NEUROPHYSIOL, V99, P1253, DOI 10.1152/jn.01096.2007; ROMO R, 1987, EXP BRAIN RES, V67, P656; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Rushworth MFS, 2007, NEURON, V54, P669, DOI 10.1016/j.neuron.2007.05.025; Russo GS, 2002, J NEUROPHYSIOL, V88, P2612, DOI 10.1152/jn.00306.2002; Seamans JK, 2008, NEUROTOX RES, V14, P249, DOI 10.1007/BF03033814; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Spangler WJ, 1996, NEUROSURGERY, V38, P1071, DOI 10.1227/00006123-199606000-00001; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; VERFAELLIE M, 1987, ARCH NEUROL-CHICAGO, V44, P1265, DOI 10.1001/archneur.1987.00520240045010; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Yoshiura T, 1997, AM J NEURORADIOL, V18, P865	61	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55247	10.1371/journal.pone.0055247	http://dx.doi.org/10.1371/journal.pone.0055247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460783	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000006
J	Suchorolski, MT; Paulson, TG; Sanchez, CA; Hockenbery, D; Reid, BJ				Suchorolski, Martin T.; Paulson, Thomas G.; Sanchez, Carissa A.; Hockenbery, David; Reid, Brian J.			Warburg and Crabtree Effects in Premalignant Barrett's Esophagus Cell Lines with Active Mitochondria	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; GROWTH-FACTOR; CANCER; EXPRESSION; METABOLISM; ADENOCARCINOMA; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; ANGIOGENESIS; GLYCOLYSIS; STRATEGY	Background: Increased glycolysis is a hallmark of cancer metabolism, yet relatively little is known about this phenotype at premalignant stages of progression. Periodic ischemia occurs in the premalignant condition Barrett's esophagus (BE) due to tissue damage from chronic acid-bile reflux and may select for early adaptations to hypoxia, including upregulation of glycolysis. Methodology/Principal Findings: We compared rates of glycolysis and oxidative phosphorylation in four cell lines derived from patients with BE (CP-A, CP-B, CP-C and CP-D) in response to metabolic inhibitors and changes in glucose concentration. We report that cell lines derived from patients with more advanced genetically unstable BE have up to twofold higher glycolysis compared to a cell line derived from a patient with early genetically stable BE; however, all cell lines preserve active mitochondria. In response to the glycolytic inhibitor 2-deoxyglucose, the most glycolytic cell lines (CP-C and CP-D) had the greatest suppression of extra-cellular acidification, but were able to compensate with upregulation of oxidative phosphorylation. In addition, these cell lines showed the lowest compensatory increases in glycolysis in response to mitochondrial uncoupling by 2,4-dinitrophenol. Finally, these cell lines also upregulated their oxidative phosphorylation in response to glucose via the Crabtree effect, and demonstrate a greater range of modulation of oxygen consumption. Conclusions/Significance: Our findings suggest that cells from premalignant Barrett's esophagus tissue may adapt to an ever-changing selective microenvironment through changes in energy metabolic pathways typically associated with cancer cells.	[Suchorolski, Martin T.] Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA; [Suchorolski, Martin T.; Paulson, Thomas G.; Sanchez, Carissa A.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Paulson, Thomas G.; Sanchez, Carissa A.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Hockenbery, David] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Reid, Brian J.] Univ Washington, Dept Med, Seattle, WA USA; [Reid, Brian J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Suchorolski, MT (corresponding author), Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA.	msuchoro@uw.edu	Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X	NIH [P01 CA91955, 1 P50HG02360]; NATIONAL CANCER INSTITUTE [P01CA091955] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002360] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding for this study was generously provided by the following grants: NIH grant no. P01 CA91955 and NIH grant no. 1 P50HG02360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baatar D, 2002, AM J PATHOL, V161, P1449, DOI 10.1016/S0002-9440(10)64420-3; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berridge MV, 2010, MITOCHONDRION, V10, P584, DOI 10.1016/j.mito.2010.08.002; Birner P, 2001, CLIN CANCER RES, V7, P1661; Boonstra JJ, 2010, JNCI-J NATL CANCER I, V102, P271, DOI 10.1093/jnci/djp499; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801; Chen G, 2009, ANTIOXID REDOX SIGN, V11, P1083, DOI [10.1089/ars.2008.2321, 10.1089/ARS.2008.2321]; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Chinopoulos C, 2010, FASEB J, V24, P2405, DOI 10.1096/fj.09-149898; Cook MB, 2007, CANCER EPIDEM BIOMAR, V16, P2090, DOI 10.1158/1055-9965.EPI-07-0432; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Diers AR, 2012, BIOCH J; Frezza C, 2009, SEMIN CANCER BIOL, V19, P4, DOI 10.1016/j.semcancer.2008.11.008; Galipeau PC, 2007, PLOS MED, V4, P342, DOI 10.1371/jourmal.pmed.0040067; Georgakoudi I, 2002, CANCER RES, V62, P682; Griffiths EA, 2007, BRIT J CANCER, V96, P1377, DOI 10.1038/sj.bjc.6603744; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Koss K, 2004, J CLIN PATHOL, V57, P1156, DOI 10.1136/jcp.2004.018150; Kunz WS, 2003, EXP PHYSIOL, V88, P149, DOI 10.1113/eph8802512; Levine DS, 1992, GASTROINTEST ENDOSC, P395; Lord RVN, 2003, J THORAC CARDIOV SUR, V125, P246, DOI 10.1067/mtc.2003.203; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Neto CACP, 2001, CLIN NUCL MED, V26, P1060, DOI 10.1097/00003072-200112000-00025; Palanca-Wessels MC, 1998, GASTROENTEROLOGY, V114, P295, DOI 10.1016/S0016-5085(98)70480-9; Possemato R, 2011, NATURE; Rockett JC, 1997, BRIT J CANCER, V75, P258, DOI 10.1038/bjc.1997.42; Stoeltzing O, 2004, JNCI-J NATL CANCER I, V96, P946, DOI 10.1093/jnci/djh168; Suganuma K, 2010, LEUKEMIA LYMPHOMA, V51, P2112, DOI 10.3109/10428194.2010.512966; Taylor MD, 2009, EUR J CARDIO-THORAC, V35, P699, DOI 10.1016/j.ejcts.2008.11.029; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; WEINHOUSE S, 1956, SCIENCE, V124, P267, DOI 10.1126/science.124.3215.267; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P4047, DOI 10.4161/cc.10.23.18151; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Younes M, 1997, CANCER EPIDEM BIOMAR, V6, P303; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	42	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56884	10.1371/journal.pone.0056884	http://dx.doi.org/10.1371/journal.pone.0056884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460817	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000042
J	Schmidt, A; Muller, N; Schink, B; Schleheck, D				Schmidt, Alexander; Mueller, Nicolai; Schink, Bernhard; Schleheck, David			A Proteomic View at the Biochemistry of Syntrophic Butyrate Oxidation in Syntrophomonas wolfei	PLOS ONE			English	Article							NOV SP-NOV; GEN-NOV; FUMARATE RESPIRATION; ELECTRON-TRANSPORT; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SIGNAL PEPTIDES; FATTY-ACIDS; METABOLISM; SEQUENCE	In syntrophic conversion of butyrate to methane and CO2, butyrate is oxidized to acetate by secondary fermenting bacteria such as Syntrophomonas wolfei in close cooperation with methanogenic partner organisms, e. g., Methanospirillum hungatei. This process involves an energetically unfavourable shift of electrons from the level of butyryl-CoA oxidation to the substantially lower redox potential of proton and/or CO2 reduction, in order to transfer these electrons to the methanogenic partner via hydrogen and/or formate. In the present study, all prominent membrane-bound and soluble proteins expressed in S. wolfei specifically during syntrophic growth with butyrate, in comparison to pure-culture growth with crotonate, were examined by one-and two-dimensional gel electrophoresis, and identified by peptide fingerprinting-mass spectrometry. A membrane-bound, externally oriented, quinone-linked formate dehydrogenase complex was expressed at high level specifically during syntrophic butyrate oxidation, comprising a selenocystein-linked catalytic subunit with a membrane-translocation pathway signal (TAT), a membrane-bound iron-sulfur subunit, and a membrane-bound cytochrome. Soluble hydrogenases were expressed at high levels specifically during growth with crotonate. The results were confirmed by native protein gel electrophoresis, by formate dehydrogenase and hydrogenase-activity staining, and by analysis of formate dehydrogenase and hydrogenase activities in intact cells and cell extracts. Furthermore, constitutive expression of a membrane-bound, internally oriented iron-sulfur oxidoreductase (DUF224) was confirmed, together with expression of soluble electron-transfer flavoproteins (EtfAB) and two previously identified butyryl-CoA dehydrogenases. Our findings allow to depict an electron flow scheme for syntrophic butyrate oxidation in S. wolfei. Electrons derived from butyryl-CoA are transferred through a membrane-bound EtfAB: quinone oxidoreductase (DUF224) to a menaquinone cycle and further via a b-type cytochrome to an externally oriented formate dehydrogenase. Hence, an ATP hydrolysisdriven proton-motive force across the cytoplasmatic membrane would provide the energy input for the electron potential shift necessary for formate formation.	[Schmidt, Alexander; Mueller, Nicolai; Schink, Bernhard; Schleheck, David] Univ Konstanz, Dept Biol, Constance, Germany; [Schmidt, Alexander; Schink, Bernhard; Schleheck, David] Univ Konstanz, Konstanz Res Sch Chem Biol KoRS CB, Constance, Germany	University of Konstanz; University of Konstanz	Schleheck, D (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	david.schleheck@uni-konstanz.de			Deutsche Forschungsgemeinschaft (DFG) [SCHI 180/10, SCHL 1936/1]; University of Konstanz; Konstanz Young Scholar Fund; Konstanz Research School Chemical Biology	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Konstanz; Konstanz Young Scholar Fund; Konstanz Research School Chemical Biology	This work was funded by the Deutsche Forschungsgemeinschaft (DFG grants SCHI 180/10 to B. S. and SCHL 1936/1 to D. S.), by the University of Konstanz, the Konstanz Young Scholar Fund, and the Konstanz Research School Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; BEATY PS, 1990, APPL ENVIRON MICROB, V56, P3223, DOI 10.1128/AEM.56.10.3223-3224.1990; BEATY PS, 1989, APPL ENVIRON MICROB, V55, P977, DOI 10.1128/AEM.55.4.977-983.1989; BEATY PS, 1987, APPL ENVIRON MICROB, V53, P1183, DOI 10.1128/AEM.53.5.1183-1185.1987; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; BERGMEYER HU, 1975, Z KLIN CHEM KLIN BIO, V13, P507; Beveridge TJ, 1997, FEMS MICROBIOL REV, V20, P99, DOI 10.1016/S0168-6445(97)00043-0; Biel S, 2002, EUR J BIOCHEM, V269, P1974, DOI 10.1046/j.1432-1033.2002.02842.x; Biswas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041415; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calamita HG, 2002, MOL MICROBIOL, V44, P601, DOI 10.1046/j.1365-2958.2002.02872.x; Calamita HG, 2001, P NATL ACAD SCI USA, V98, P15260, DOI 10.1073/pnas.261483798; DIEKERT GB, 1978, J BACTERIOL, V136, P597, DOI 10.1128/JB.136.2.597-606.1978; Dzioba J, 2003, J BACTERIOL, V185, P674, DOI 10.1128/JB.185.2.674-678.2003; Engelhardt H, 2007, J STRUCT BIOL, V160, P115, DOI 10.1016/j.jsb.2007.08.003; Falke D, 2010, FEMS MICROBIOL LETT, V303, P69, DOI 10.1111/j.1574-6968.2009.01862.x; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; GUSTAFSON WG, 1986, J BIOL CHEM, V261, P7733; JONES RW, 1976, BIOCHEM SOC T, V4, P671, DOI 10.1042/bst0040671; Kroger A, 2002, BBA-BIOENERGETICS, V1553, P23, DOI 10.1016/S0005-2728(01)00234-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JW, 2012, BIOENERGETICS, V1, pe104; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; MCINERNEY MJ, 1981, APPL ENVIRON MICROB, V41, P826, DOI 10.1128/AEM.41.3.826-828.1981; MCINERNEY MJ, 1981, APPL ENVIRON MICROB, V41, P1029, DOI 10.1128/AEM.41.4.1029-1039.1981; MCINERNEY MJ, 1979, ARCH MICROBIOL, V122, P129, DOI 10.1007/BF00411351; MCINERNEY MJ, 1992, ARCH MICROBIOL, V158, P344, DOI 10.1007/BF00245363; MCINERNEY MJ, 1988, BIOL ANAEROBIC MICRO, P374; MCKELLAR RC, 1979, J BACTERIOL, V139, P231, DOI 10.1128/JB.139.1.231-238.1979; Muller N, 2010, ENV MICROBIOL REP, V2, P489, DOI 10.1111/j.1758-2229.2010.00147.x; Muller N, 2009, J BACTERIOL, V191, P6167, DOI 10.1128/JB.01605-08; Muller N, 2008, ENVIRON MICROBIOL, V10, P1501, DOI 10.1111/j.1462-2920.2007.01565.x; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rahlfs S, 1997, FEBS LETT, V404, P269, DOI 10.1016/S0014-5793(97)00088-4; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Sato K, 1999, J BIOCHEM-TOKYO, V126, P668, DOI 10.1093/oxfordjournals.jbchem.a022501; Schaffer C, 2004, GLYCOBIOLOGY, V14, p31R, DOI 10.1093/glycob/cwh064; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Sieber JR, 2012, ANNU REV MICROBIOL, V66, P429, DOI 10.1146/annurev-micro-090110-102844; Sieber JR, 2010, ENVIRON MICROBIOL, V12, P2289, DOI 10.1111/j.1462-2920.2010.02237.x; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; WALLRABENSTEIN C, 1994, ARCH MICROBIOL, V162, P136; WIDDEL F, 1983, ARCH MICROBIOL, V134, P286, DOI 10.1007/BF00407804; Widdel F., 1992, PROKARYOTES, P3352, DOI DOI 10.1007/978-1-4757-2191-1_21; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WOFFORD NQ, 1986, J BACTERIOL, V167, P179, DOI 10.1128/jb.167.1.179-185.1986; Worm P, 2011, MICROBIOL-SGM, V157, P280, DOI 10.1099/mic.0.043927-0; ZHAO HX, 1990, INT J SYST BACTERIOL, V40, P40, DOI 10.1099/00207713-40-1-40; [No title captured]	54	53	62	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56905	10.1371/journal.pone.0056905	http://dx.doi.org/10.1371/journal.pone.0056905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468890	Green Submitted, Green Published, gold			2022-12-27	WOS:000315561400017
J	Aragao, GC; Mascarenhas, JDP; Kaiano, JHL; de Lucena, MSS; Siqueira, JAM; Fumian, TM; Hernandez, JD; de Oliveira, CS; Oliveira, DD; Araujo, ED; Soares, LD; Linhares, AC; Gabbay, YB				Aragao, Glicelia Cruz; Pereira Mascarenhas, Joana D'Arc; Lima Kaiano, Jane Haruko; Sousa de Lucena, Maria Silvia; Monteiro Siqueira, Jones Anderson; Fumian, Tulio Machado; Hernandez, Juliana das Merces; de Oliveira, Consuelo Silva; Oliveira, Darleise de Souza; Araujo, Eliete da Cunha; Soares, Luana da Silva; Linhares, Alexandre Costa; Gabbay, Yvone Benchimol			Norovirus Diversity in Diarrheic Children from an African-Descendant Settlement in Belem, Northern Brazil	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; HOSPITALIZED CHILDREN; INFANTILE GASTROENTERITIS; ENZYME-IMMUNOASSAY; UNITED-STATES; OUTBREAKS; COMMUNITY; CALICIVIRUSES	Norovirus (NoV), sapovirus (SaV) and human astrovirus (HAstV) are viral pathogens that are associated with outbreaks and sporadic cases of gastroenteritis. However, little is known about the occurrence of these pathogens in relatively isolated communities, such as the remnants of African-descendant villages ("Quilombola"). The objective of this study was the frequency determination of these viruses in children under 10 years, with and without gastroenteritis, from a "Quilombola" Community, Northern Brazil. A total of 159 stool samples were obtained from April/2008 to July/2010 and tested by an enzyme immunoassay (EIA) and reverse transcription-polymerase chain reaction (RT-PCR) to detect NoV, SaV and HAstV, and further molecular characterization was performed. These viruses were detected only in the diarrheic group. NoV was the most frequent viral agent detected (19.7%-16/81), followed by SaV (2.5%-2/81) and HAstV (1.2%-1/81). Of the 16 NoV-positive samples, 14 were sequenced with primers targeting the B region of the polymerase (ORF1) and the D region of the capsid (ORF2). The results showed a broad genetic diversity of NoV, with 12 strains being classified as GII-4 (5-41.7%), GII-6 (3-25%), GII-7 (2-16.7%), GII-17 (1-8.3%) and GI-2 (1-8.3%), as based on the polymerase region; 12 samples were classified, based on the capsid region, as GII-4 (6-50%, being 3-2006b variant and 3-2010 variant), GII-6 (3-25%), GII-17 (2-16.7%) and GII-20 (1-8.3%). One NoV-strain showed dual genotype specificity, based on the polymerase and capsid region (GII-7/GII-20). This study provides, for the first time, epidemiological and molecular information on the circulation of NoV, SaV and HAstV in African-descendant communities in Northern Brazil and identifies NoV genotypes that were different from those detected previously in studies conducted in the urban area of Belem. It remains to be determined why a broader NoV diversity was observed in such a semi-isolated community.	[Aragao, Glicelia Cruz] Univ Estado Para, Belem, Para, Brazil; [Pereira Mascarenhas, Joana D'Arc; Sousa de Lucena, Maria Silvia; Fumian, Tulio Machado; Hernandez, Juliana das Merces; de Oliveira, Consuelo Silva; Oliveira, Darleise de Souza; Soares, Luana da Silva; Linhares, Alexandre Costa; Gabbay, Yvone Benchimol] Inst Evandro Chagas, Ananindeua, Para, Brazil; [Lima Kaiano, Jane Haruko; Monteiro Siqueira, Jones Anderson] UFPA, Nucleo Med Trop, Belem, Para, Brazil; [Araujo, Eliete da Cunha] UFPA, Inst Ciencias Saude, Belem, Para, Brazil	Universidade do Estado do Para (UEPA); Instituto Evandro Chagas; Universidade Federal do Para; Universidade Federal do Para	Gabbay, YB (corresponding author), Inst Evandro Chagas, Ananindeua, Para, Brazil.	yvonegabbay@iec.pa.gov.br	Soares, Luana Silva/AAC-9134-2019; Fumian, Tulio/AAC-4724-2021	Soares, Luana Silva/0000-0001-9509-4019; Siqueira, Jones Anderson Monteiro/0000-0002-6491-6590	Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA); Instituto Evandro Chagas, Secretaria de Vigilancia em Saude, Ministerio da Saude; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Evandro Chagas, Secretaria de Vigilancia em Saude, Ministerio da Saude; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was financially supported by Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA), and Instituto Evandro Chagas, Secretaria de Vigilancia em Saude, Ministerio da Saude and also received a grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AD, 2001, AM J EPIDEMIOL, V154, P1013, DOI 10.1093/aje/154.11.1013; Aragao GC., 2010, BRAZIL REV PAN AMAZ, V1, P149, DOI [10.5123/s2176-62232010000100021, DOI 10.5123/S2176-]; Ayres M, 2007, BIOESTAT 5 0 STAT AP; Bae JY, 2011, J FOOD PROTECT, V74, P1908, DOI 10.4315/0362-028X.JFP-11-063; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bruggink L, 2010, INTERVIROLOGY, V53, P167, DOI 10.1159/000279764; Chan-It W, 2011, CLIN LAB, V57, P213; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; FELSENSTEIN J, 1995, PHYLIP PHYLOGENY INF; Ferreira MSR, 2008, J MED VIROL, V80, P338, DOI 10.1002/jmv.21059; Ferreira MSR, 2010, J MED VIROL, V82, P1442, DOI 10.1002/jmv.21831; Fioretti JM, 2011, MEM I OSWALDO CRUZ, V106, P942, DOI 10.1590/S0074-02762011000800008; Fumian TM, 2012, ARCH VIROL, V157, P2389, DOI 10.1007/s00705-012-1428-2; GABBAY YB, 1994, AM J EPIDEMIOL, V139, P728, DOI 10.1093/oxfordjournals.aje.a117063; Gabbay YB, 2007, VIRUS RES, V129, P166, DOI 10.1016/j.virusres.2007.07.006; Glass RI, 2001, NOVART FDN SYMP, V238, P5; Barreira DMPG, 2010, J CLIN VIROL, V47, P60, DOI 10.1016/j.jcv.2009.11.012; Gonzalez-Galan V, 2011, CLIN MICROBIOL INFEC, V17, P1895, DOI 10.1111/j.1469-0691.2011.03506.x; Green K. Y., 2007, FIELDS VIROLOGY, V1, P949; Jiang X, 1999, J VIROL METHODS, V83, P145, DOI 10.1016/S0166-0934(99)00114-7; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; Kayano JHL, 2010, 16 C BRAS INF PED; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Levidiotou S, 2009, CLIN MICROBIOL INFEC, V15, P596, DOI 10.1111/j.1469-0691.2009.02855.x; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Lysen M, 2009, J CLIN MICROBIOL, V47, P2411, DOI 10.1128/JCM.02168-08; Mathijs E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-310; Siqueira JAM, 2011, DIAGN MICR INFEC DIS, V71, P391, DOI 10.1016/j.diagmicrobio.2011.08.023; Nakamura LS, 2006, VIRUS REV RES, V11, P95; Nataraju SM, 2011, EPIDEMIOL INFECT, V139, P910, DOI 10.1017/S0950268810001731; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Pang XLL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011599; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Silva José Antonio Novaes da, 2007, Saude soc., V16, P111; Siqueira JAM, 2010, 62 REUN AN SOC BRAS; Svraka S, 2007, J CLIN MICROBIOL, V45, P1389, DOI 10.1128/JCM.02305-06; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Vernacchio L, 2006, PEDIATR INFECT DIS J, V25, P2, DOI 10.1097/01.inf.0000195623.57945.87; Vicentini F, 2011, VIRUS REV RES, V16, P159; Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; Wiegering V, 2011, INT J INFECT DIS, V15, pE401, DOI 10.1016/j.ijid.2011.02.006; Xavier MPTP, 2009, BRAZ J MED BIOL RES, V42, P438, DOI 10.1590/S0100-879X2009000500007; Zeng M, 2012, J MED VIROL, V84, P145, DOI 10.1002/jmv.22248; Zeng M, 2011, JPN J INFECT DIS, V64, P417; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09; Zhou X, 2012, EPIDEMIOLOGY INFECT, V8, P1	53	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56608	10.1371/journal.pone.0056608	http://dx.doi.org/10.1371/journal.pone.0056608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457593	gold, Green Submitted, Green Published			2022-12-27	WOS:000315603700065
J	Lim, JH; Kim, MH; Han, YJ; Lee, DE; Park, SY; Han, JY; Kim, MY; Ryu, HM				Lim, Ji Hyae; Kim, Min Hyoung; Han, You Jung; Lee, Da Eun; Park, So Yeon; Han, Jung Yeol; Kim, Moon Young; Ryu, Hyun Mee			Cell-Free Fetal DNA and Cell-Free Total DNA Levels in Spontaneous Abortion with Fetal Chromosomal Aneuploidy	PLOS ONE			English	Article							MATERNAL PLASMA; HEART-RATE; SERUM; PREGNANCY; TRIMESTER; PLACENTA; METHYLATION; WOMEN; RISK	Background: Cell-free fetal DNA and cell-free total DNA in maternal circulation have been proposed as potential markers for noninvasive monitoring of the placental condition during the pregnancy. However, the correlation of and change in cell-free fetal DNA and cell-free total DNA in spontaneous abortion (SA) with fetal chromosomal aneuploidy have not yet been reported. Therefore, we investigated cell-free fetal DNA and cell-free total DNA levels in SA women with fetal chromosomal aneuploidy. Methodology/Principal Findings: A nested case-control study was conducted with maternal plasma collected from 268 women in their first trimester of pregnancy. Subjects included 41 SA with normal fetal karyotype, 26 SA with fetal chromosomal aneuploidy, and 201 normal controls. The unmethylated PDE9A gene was used to measure the maternal plasma levels of cell-free fetal DNA. The GAPDH gene was used to measure the maternal plasma levels of cell-free total DNA. The diagnostic accuracy was measured using receiver-operating characteristic (ROC) curves. Levels of cell-free fetal DNA and cell-free total DNA were significantly higher in both SA women with normal fetal karyotype and SA women with fetal chromosomal aneuploidy in comparison with the normal controls (P<0.001 in both). The correlation between cell-free fetal DNA and cell-free total DNA levels was stronger in the normal controls (r = 0.843, P<0.001) than in SA women with normal karyotype (r = 0.465, P = 0.002) and SA women with fetal chromosomal aneuploidy (r = 0.412, P = 0.037). The area under the ROC curve for cell-free fetal DNA and cell-free total DNA was 0.898 (95% CI, 0.852-0.945) and 0.939 (95% CI, 0.903-0.975), respectively. Conclusions: Significantly high levels of cell-free fetal DNA and cell-free total DNA were found in SA women with fetal chromosomal aneuploidy. Our findings suggest that cell-free fetal DNA and cell-free total DNA may be useful biomarkers for the prediction of SA with fetal chromosomal aneuploidy, regardless of fetal gender.	[Lim, Ji Hyae; Lee, Da Eun; Park, So Yeon; Ryu, Hyun Mee] Cheil Gen Hosp, Med Res Inst, Med Genet Lab, Seoul, South Korea; [Lim, Ji Hyae; Lee, Da Eun; Park, So Yeon; Ryu, Hyun Mee] Womens Healthcare Ctr, Seoul, South Korea; [Kim, Min Hyoung; Han, You Jung; Han, Jung Yeol; Kim, Moon Young; Ryu, Hyun Mee] Cheil Gen Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Min Hyoung; Han, You Jung; Han, Jung Yeol; Kim, Moon Young; Ryu, Hyun Mee] KwanDong Univ, Coll Med, Womens Healthcare Ctr, Seoul, South Korea	Catholic Kwandong University	Ryu, HM (corresponding author), Cheil Gen Hosp, Med Res Inst, Med Genet Lab, Seoul, South Korea.	hmryu@yahoo.com	Han, You Jung/W-3659-2019; Lim, Ji Hyae/N-4634-2013	Han, You Jung/0000-0003-4087-9198; Lim, Ji Hyae/0000-0002-1105-7235	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111550]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barch MJ, 1997, AGT CYTOGENETICS LAB; Bauer M, 2006, PRENATAL DIAG, V26, P831, DOI 10.1002/pd.1513; Bianchi DW, 1998, AM J HUM GENET, V62, P763, DOI 10.1086/301809; BROMLEY B, 1991, RADIOLOGY, V178, P375, DOI 10.1148/radiology.178.2.1987595; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caramelli E, 2003, PRENATAL DIAG, V23, P367, DOI 10.1002/pd.596; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chittacharoen A, 2004, FERTIL STERIL, V82, P227, DOI 10.1016/j.fertnstert.2003.12.026; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; Farina A, 2005, AM J OBSTET GYNECOL, V193, P421, DOI 10.1016/j.ajog.2004.12.023; Flori E, 2004, HUM REPROD, V19, P723, DOI 10.1093/humrep/deh117; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; Jimbo M, 2003, CLIN CHEM, V49, P1540, DOI 10.1373/49.9.1540; Leung TN, 2001, CLIN CHEM, V47, P137; Lim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027709; Lim JH, 2012, FASEB J, V26, P250, DOI 10.1096/fj.11-191429; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lui YNYN, 2002, CLIN CHEM, V48, P421; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Miura K, 2006, CLIN CHEM, V52, P2121, DOI 10.1373/clinchem.2006.075697; Nagaishi M, 2004, J OBSTET GYNAECOL RE, V30, P237, DOI 10.1111/j.1447-0756.2004.00191.x; Reis FM, 2002, ENDOCR REV, V23, P230, DOI 10.1210/er.23.2.230; Scheffer PG, 2010, OBSTET GYNECOL, V115, P117, DOI 10.1097/AOG.0b013e3181c3c938; Sekizawa A, 2002, CLIN CHEM, V48, P353; Skinner J, 2001, OBSTET GYNECOL, V97, P460, DOI 10.1016/S0029-7844(00)01173-X; TADMOR OP, 1994, J REPROD MED, V39, P459; Urato AC, 2008, PRENATAL DIAG, V28, P186, DOI 10.1002/pd.1950; Vora NL, 2010, PRENATAL DIAG, V30, P325, DOI 10.1002/pd.2456; WARBURTON D, 1964, AM J HUM GENET, V16, P1; WILSON RD, 1984, LANCET, V2, P920; Yin AH, 2007, HUM REPROD, V22, P1736, DOI 10.1093/humrep/dem058; Zhong XY, 2006, PRENATAL DIAG, V26, P1272, DOI 10.1002/pd	32	19	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56787	10.1371/journal.pone.0056787	http://dx.doi.org/10.1371/journal.pone.0056787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457614	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700080
J	Mao, FL; Olman, V; Wang, Y; Xu, Y				Mao, Fenglou; Olman, Victor; Wang, Yan; Xu, Ying			Barcode Server: A Visualization-Based Genome Analysis System	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER	We have previously developed a computational method for representing a genome as a barcode image, which makes various genomic features visually apparent. We have demonstrated that this visual capability has made some challenging genome analysis problems relatively easy to solve. We have applied this capability to a number of challenging problems, including (a) identification of horizontally transferred genes, (b) identification of genomic islands with special properties and (c) binning of metagenomic sequences, and achieved highly encouraging results. These application results inspired us to develop this barcode-based genome analysis server for public service, which supports the following capabilities: (a) calculation of the k-mer based barcode image for a provided DNA sequence; (b) detection of sequence fragments in a given genome with distinct barcodes from those of the majority of the genome, (c) clustering of provided DNA sequences into groups having similar barcodes; and (d) homology-based search using Blast against a genome database for any selected genomic regions deemed to have interesting barcodes. The barcode server provides a job management capability, allowing processing of a large number of analysis jobs for barcode-based comparative genome analyses. The barcode server is accessible at http://csbl1.bmb.uga.edu/Barcode.	[Mao, Fenglou; Olman, Victor; Xu, Ying] Univ Georgia, Computat Syst Biol Lab, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Mao, Fenglou; Olman, Victor; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Mao, Fenglou; Xu, Ying] Univ Georgia, BioEnergy Sci Ctr BESC, Athens, GA 30602 USA; [Wang, Yan; Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); University System of Georgia; University of Georgia; Jilin University	Xu, Y (corresponding author), Univ Georgia, Computat Syst Biol Lab, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	xyn@bmb.uga.edu			BioEnergy Science Center (BESC) grant from the Office of Biological and Environmental Research in the DOE Office of Science; National Science Foundation [DEB-0830024, DBI-0354771, ITR-IIS-0407204, DBI-0542119]; Natural Science Foundation of China [60903097]; Division Of Environmental Biology [0830024] Funding Source: National Science Foundation	BioEnergy Science Center (BESC) grant from the Office of Biological and Environmental Research in the DOE Office of Science; National Science Foundation(National Science Foundation (NSF)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported in part by the BioEnergy Science Center (BESC) grant from the Office of Biological and Environmental Research in the DOE Office of Science and National Science Foundation (DEB-0830024, DBI-0354771, ITR-IIS-0407204, DBI-0542119). This work is also supported by the Natural Science Foundation of China (60903097). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Rosen K.H., 1999, HDB DISCRETE COMBINA; Tsirigos A, 2005, NUCLEIC ACIDS RES, V33, P922, DOI 10.1093/nar/gki187; Wang GQ, 2010, FEBS LETT, V584, P194, DOI 10.1016/j.febslet.2009.11.067; Zhou FF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-546	5	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56726	10.1371/journal.pone.0056726	http://dx.doi.org/10.1371/journal.pone.0056726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457606	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700074
J	Domingo, P; Cabeza, MD; Torres, F; Salazar, J; Gutierrez, MD; Mateo, MG; Martinez, E; Domingo, JC; Fernandez, I; Villarroya, F; Ribera, E; Vidal, F; Baiget, M				Domingo, Pere; del Carmen Cabeza, Maria; Torres, Ferran; Salazar, Juliana; del Mar Gutierrez, Maria; Gracia Mateo, Maria; Martinez, Esteban; Carles Domingo, Joan; Fernandez, Irene; Villarroya, Francesc; Ribera, Esteban; Vidal, Francesc; Baiget, Montserrat			Association of Thymidylate Synthase Polymorphisms with Acute Pancreatitis and/or Peripheral Neuropathy in HIV-Infected Patients on Stavudine-Based Therapy	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; ANTIRETROVIRAL-THERAPY; MITOCHONDRIAL TOXICITY; COMMON MUTATION; RISK-FACTOR; COMBINATION; NUCLEOSIDE; LIPODYSTROPHY; INDIVIDUALS	Background: Low expression thymidylate synthase (TS) polymorphism has been associated with increased stavudine triphosphate intracellular (d4T-TP) levels and the lipodystrophy syndrome. The use of d4T has been associated with acute pancreatitis and peripheral neuropathy. However, no relationship has ever been proved between TS polymorphisms and pancreatitis and/or peripheral neuropathy. Methods: We performed a case-control study to assess the relationship of TS and methylene-tetrahydrofolate reductase (MTHFR) gene polymorphisms with acute pancreatitis and/or peripheral neuropathy in patients exposed to d4T. Student's t test, Pearson's correlations, one-way ANOVA with Bonferroni correction and stepwise logistic regression analyses were done. Results: Forty-three cases and 129 controls were studied. Eight patients (18.6%) had acute pancreatitis, and 35 (81.4%) had peripheral neuropathy. Prior AIDS was more frequent in cases than in controls (OR = 2.36; 95% CI 1.10-5.07, P = 0.0247). L7ow expression TS and MTHFR genotype associated with increased activity were more frequent in patients with acute pancreatitis and/or peripheral neuropathy than in controls (72.1% vs. 46.5%, OR = 2.97; 95% CI: 1.33-6.90, P = 0.0062, and 79.1% vs. 56.6%, OR = 2.90, 95% CI: 1.23-7.41, P = 0.0142, respectively). Independent positive or negative predictors for the development of d4T-associated pancreatitis and/or peripheral neuropathy were: combined TS and MTHFR genotypes (reference: A+A; P = 0.002; ORA+B = 0.34 [95% CI: 0.08 to 1.44], ORB+A = 3.38 [95% CI: 1.33 to 8.57], ORB+B = 1.13 [95% CI: 0.34 to 3.71]), nadir CD4 cell count >200 cells/mm(3) (OR = 0.38; 95% CI: 0.17-0.86, P = 0.021), and HALS (OR = 0.39 95% CI: 0.18-0.85, P = 0.018). Conclusions: Low expression TS plus a MTHFR genotype associated with increased activity is associated with the development of peripheral neuropathy in d4T-exposed patients.	[Domingo, Pere; del Carmen Cabeza, Maria; del Mar Gutierrez, Maria; Gracia Mateo, Maria; Fernandez, Irene] Univ Autonoma Barcelona, Infect Dis Unit, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Torres, Ferran] Univ Autonoma Barcelona, IDIBAPS, Hosp Clin, Biostat Unit,Sch Med, E-08193 Barcelona, Spain; [Salazar, Juliana] CIBERER U 705, Barcelona, Spain; [Martinez, Esteban] Univ Barcelona, Infect Dis Serv, Hosp Clin Univ, Barcelona, Spain; [Carles Domingo, Joan; Fernandez, Irene] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Ribera, Esteban] Univ Autonoma Barcelona, Hosp Vall dHebron, Infect Dis Serv, E-08193 Barcelona, Spain; [Vidal, Francesc] Univ Rovira & Virgili, Hosp Univ Joan XXIII, Tarragona, Spain; [Baiget, Montserrat] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Genet, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona; Autonomous University of Barcelona; Universitat Rovira i Virgili; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau	Domingo, P (corresponding author), Univ Autonoma Barcelona, Infect Dis Unit, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain.	pdomingo@santpau.cat	Domingo, Pere/AAP-7571-2021; Villarroya, Francesc/K-4357-2014; Pedrol, Joan Carles C Domingo/A-4856-2019; Torres, Ferran/D-1296-2011; Domingo, Pere/CAF-3577-2022	Domingo, Pere/0000-0003-1138-5770; Pedrol, Joan Carles C Domingo/0000-0002-6356-0836; Torres, Ferran/0000-0002-7355-7913; Villarroya, Francesc/0000-0003-1266-9142; Vidal, Francesc/0000-0002-6692-6186; Ribera, Esteban/0000-0002-3752-8808	Fondo de Investigaciones Sanitarias [FIS 02/1280, 05/1591, 07/0976, 08/00256]; Fundacion para la Prevencion del SIDA en Espana [FIPSE 36610, 36572/06]; Red de Investigacion en SIDA [RIS RD06/006/0022]; Programa de Intensificacion de Investigadores del Instituto de Salud Carlos III [INT12/383]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion para la Prevencion del SIDA en Espana; Red de Investigacion en SIDA; Programa de Intensificacion de Investigadores del Instituto de Salud Carlos III(Instituto de Salud Carlos III)	This work has been partially funded by Fondo de Investigaciones Sanitarias (FIS 02/1280, 05/1591, 07/0976, 08/00256), Fundacion para la Prevencion del SIDA en Espana (FIPSE 36610, 36572/06), and Red de Investigacion en SIDA (RIS RD06/006/0022). Pere Domingo is supported by Programa de Intensificacion de Investigadores del Instituto de Salud Carlos III (INT12/383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Canter JA, 2008, PHARMACOGENOMICS J, V8, P71, DOI 10.1038/sj.tpj.6500470; CDC, 1993, MMWR-MORBID MORTAL W, V41, P1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Domingo P, 2012, AIDS REV, V14, P112; Domingo P, 2011, ANTIMICROB AGENTS CH, V55, P1428, DOI 10.1128/AAC.01589-10; Domingo P, 2010, CLIN INFECT DIS, V50, P1033, DOI 10.1086/651117; Ellis RJ, 2010, ARCH NEUROL-CHICAGO, V67, P552, DOI 10.1001/archneurol.2010.76; Evans SR, 2011, AIDS, V25, P919, DOI 10.1097/QAD.0b013e328345889d; Felley C, 2004, AIDS, V18, P1521, DOI 10.1097/01.aids.0000131356.52457.7a; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Ghosh S, 2012, AIDS RES HUM RETROV, V28, P36, DOI [10.1089/aid.2011.0116, 10.1089/AID.2011.0116]; Giralt M, 2011, BEST PRACT RES CL EN, V25, P487, DOI 10.1016/j.beem.2010.12.001; Mateo MG, 2012, EXPERT OPIN DRUG SAF, V11, P473, DOI 10.1517/14740338.2012.676639; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Guggr JP, 2007, ANTIVIR THER, V12, P853; Hulgan T, 2005, AIDS, V19, P1341, DOI 10.1097/01.aids.0000180786.02930.a1; Kallianpur AR, 2006, AIDS, V20, P1503, DOI 10.1097/01.aids.0000237366.56864.3c; Kawakami K, 2003, CANCER RES, V63, P6004; Koczor CA, 2010, EXPERT OPIN DRUG MET, V6, P1493, DOI 10.1517/17425255.2010.526602; Lichtenstein KA, 2008, JAIDS-J ACQ IMM DEF, V47, P27, DOI 10.1097/QAI.0b013e31815acacc; Marcuello E, 2006, CANCER CHEMOTH PHARM, V57, P835, DOI 10.1007/s00280-005-0089-1; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moore RD, 2000, AIDS, V14, P273, DOI 10.1097/00002030-200002180-00009; Moore RD, 2001, AIDS, V15, P617, DOI 10.1097/00002030-200103300-00011; Pfutzer RH, 2000, GASTROENTEROLOGY, V119, P615, DOI 10.1053/gast.2000.18017; Reisler RB, 2005, JAIDS-J ACQ IMM DEF, V39, P159; Riedel DJ, 2008, AIDS PATIENT CARE ST, V22, P113, DOI 10.1089/apc.2007.0034; Rutschmann OT, 2000, AIDS, V14, P2145, DOI 10.1097/00002030-200009290-00011; Smith CJ, 2008, AIDS, V22, P47, DOI 10.1097/QAD.0b013e3282f03094; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Vela JE, 2008, ANTIVIR THER, V13, P789; Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958; World Health Organization, 2000, INT GUID MON ALC CON; World Health Organization, 2006, ADD 2006 HIV TREATM	38	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57347	10.1371/journal.pone.0057347	http://dx.doi.org/10.1371/journal.pone.0057347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468971	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900073
J	Guan, YJ; Wang, JC; Tian, YX; Hu, WM; Zhu, LW; Zhu, SJ; Hu, J				Guan, Yajing; Wang, Jianchen; Tian, Yixin; Hu, Weimin; Zhu, Liwei; Zhu, Shuijin; Hu, Jin			The Novel Approach to Enhance Seed Security: Dual Anti-Counterfeiting Methods Applied on Tobacco Pelleted Seeds	PLOS ONE			English	Article							ROOT UPTAKE; GERMINATION; STRESS; MAIZE; TRANSLOCATION; FLUORESCEIN; TOLERANCE; GROWTH	Seed security is of prime importance for agriculture. To protect true seeds from being faked, more secure dual anti-counterfeiting technologies for tobacco (Nicotiana tabacum L.) pelleted seed were developed in this paper. Fluorescein (FR), rhodamine B (RB), and magnetic powder (MP) were used as anti-counterfeiting labels. According to their different properties and the special seed pelleting process, four dual-labeling treatments were conducted for two tobacco varieties, MS Yunyan85 (MSYY85) and Honghua Dajinyuan (HHDJY). Then the seed germination and seedling growth status were investigated, and the fluorescence in cracked pellets and developing seedlings was observed under different excitation lights. The results showed that FR, RB, and MP had no negative effects on the germination, seedling growth, and MDA content of the pelleted seeds, and even some treatments significantly enhanced seedling dry weight, vigor index, and shoot height in MS YY85, and increased SOD activity and chlorophyll content in HHDJY as compared to the control. In addition, the cotyledon tip of seedlings treated with FR and MP together represented bright green fluorescence under illumination of blue light (478 nm). And the seedling cotyledon vein treated with RB and MP together showed red fluorescence under green light (546 nm). All seeds pelleted with magnetic powder of proper concentration could be attracted by a magnet. Thus, it indicated that those new dual-labeling methods that fluorescent compound and magnetic powder simultaneously applied in the same seed pellets definitely improved anti-counterfeiting technology and enhanced the seed security. This technology will ensure that high quality seed will be used in the crop production.	[Guan, Yajing; Wang, Jianchen; Tian, Yixin; Hu, Weimin; Zhu, Liwei; Zhu, Shuijin; Hu, Jin] Zhejiang Univ, Seed Sci Ctr, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, J (corresponding author), Zhejiang Univ, Seed Sci Ctr, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	jhu@zju.edu.cn			Key Project of Natural Science Foundation of Zhejiang Province [Z3100150]; Special Fund for Agro-scientific Research in the Public Interest [201203052]; China Postdoctoral Science Foundation [2012M510150]; Major Special Project of Ministry of Agriculture, P. R. China [2011ZX08005-005]	Key Project of Natural Science Foundation of Zhejiang Province; Special Fund for Agro-scientific Research in the Public Interest; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Major Special Project of Ministry of Agriculture, P. R. China	The research was supported by the Key Project of Natural Science Foundation of Zhejiang Province (No. Z3100150), the Special Fund for Agro-scientific Research in the Public Interest (No. 201203052), China Postdoctoral Science Foundation (No. 2012M510150) and the Major Special Project of Ministry of Agriculture (No. 2011ZX08005-005), P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerlaan AM, 2003, ANN BOT, V91, P729; [Anonymous], VEGETABLES; Badek B, 2006, EUR J AGRON, V24, P45, DOI 10.1016/j.eja.2005.04.004; BRIGGS GG, 1982, PESTIC SCI, V13, P495, DOI 10.1002/ps.2780130506; Cai Y., 2009, SHANGHAI PACKAGING, V2, P40; Cao DD, 2010, SCI HORTIC-AMSTERDAM, V123, P301, DOI 10.1016/j.scienta.2009.10.006; EDGINGTON LV, 1981, ANNU REV PHYTOPATHOL, V19, P107, DOI 10.1146/annurev.py.19.090181.000543; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Gao CH, 2009, PLANT GROWTH REGUL, V57, P31, DOI 10.1007/s10725-008-9315-2; Gao H, 2005, SEED WORLD, V9, P6; Grellier P, 1999, EUR J AGRON, V10, P57, DOI 10.1016/S1161-0301(98)00050-1; Guan YJ, 2011, ACTA PHYSIOL PLANT, V33, P1271, DOI 10.1007/s11738-010-0657-9; Hill H. J., 1994, Hortscience, V29, P1408; HSU FC, 1990, PLANT PHYSIOL, V93, P1573, DOI 10.1104/pp.93.4.1573; Hu J, 2005, SEED SCI TECHNOL, V33, P243, DOI 10.15258/sst.2005.33.1.25; Hu J, 2010, SEED STORAGE PROCESS; ISTA, 2010, INT RUL SEED TEST 20; Lavis LD, 2008, ACS CHEM BIOL, V3, P142, DOI 10.1021/cb700248m; Li YongPing, 2011, Acta Agriculturae Zhejiangensis, V23, P1073; Li YongPing, 2011, Acta Agriculturae Zhejiangensis, V23, P31; Liu Guohong, 2006, J CHANGZHI U, V23, P17; Liu SQ, 2008, J ANHUI AGR SCI, V36, P91; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Noga EJ, 2002, VET PATHOL, V39, P726, DOI 10.1354/vp.39-6-726; Qi FC, 2004, BIOMAGNETISM, V4, P16; RASHID F, 1991, HISTOCHEM J, V23, P450, DOI 10.1007/BF01041375; Salanenka Y.A., 2006, 4 INT S SEED TRANSPL; Sellei J, 1942, AM J BOT, V29, P513, DOI 10.2307/2437099; Shi Y.X., 2001, ZHENGZHOU INSTITUTE, V22, P17; Song C. P., 1998, PLANT SENESCENCE BIO, P30; Tian YX, 2012, SEED SCI TECHNOL, V40, P396, DOI 10.15258/sst.2012.40.3.10; Valeur B., 2001, MOL FLUORESCENCE, P247; Wang Y, 2012, BOTANY, V90, P845, DOI [10.1139/b2012-055, 10.1139/B2012-055]; Wang Z.H., 2009, PRINT TODAY, V2, P76; Xu SC, 2011, PLANT GROWTH REGUL, V63, P279, DOI 10.1007/s10725-010-9528-z; Yanoff M., 2004, OPHTHALMOLOGY, P800; Zhang CF, 2007, SEED SCI TECHNOL, V35, P733, DOI 10.15258/sst.2007.35.3.19	37	10	11	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57274	10.1371/journal.pone.0057274	http://dx.doi.org/10.1371/journal.pone.0057274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468953	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900064
J	Hawkes, SJ; Gomez, GB; Broutet, N				Hawkes, Sarah J.; Gomez, Gabriela B.; Broutet, Nathalie			Early Antenatal Care: Does It Make a Difference to Outcomes of Pregnancy Associated with Syphilis? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; CONGENITAL-SYPHILIS; TRANSMISSION; WOMEN; BORN	Objective: Despite an increase in the proportion of women who access antenatal care, mother-to-child transmission of syphilis continues to be a consequence of undiagnosed, untreated, or inadequately treated maternal syphilis. We reviewed evidence on the optimal timing of antenatal interventions to prevent mother-to-child transmission of syphilis and its associated adverse outcomes. Design: Systematic review and meta-analysis of published literature. English-language articles were included if they (1) reported the gestational age at which the mother was screened or tested for syphilis; (2) reported on pregnancy outcome. No publication date limits were set. Results: We identified a total of 1,199 publications, of which 84 were selected for further review and five were included. All showed a lower prevalence of any adverse outcome among women who received an intervention (to include screening and treatment) in the first and second trimesters of pregnancy compared to the third trimester. The overall odds ratio for any adverse outcome was 2.24 (95% CI 1.28, 3.93). All sub-analyses by type of outcome presented important heterogeneity between studies, except for those studies reporting an infected infant (odds ratio 2.92, 95% CI 0.66, 12.87; I-2 = 48.2%, p = 0.165). Conclusions: Our review has shown that the timing of antenatal care interventions makes a significant difference in the risk of having an adverse outcome due to syphilis. Women who sought care in the first two trimesters of their pregnancy, and received the appropriate intervention, were more likely to have a healthy infant, compared to women screened and treated in the third trimester. Encouraging ALL pregnant women to seek care in the first two trimesters of their pregnancy should be a priority for health programmes. For interventions to be effective within these health programmes, health systems and community engagement programmes need to be strengthened to enable pregnant women to seek antenatal care early.	[Hawkes, Sarah J.] UCL, Inst Global Hlth, London, England; [Gomez, Gabriela B.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Gomez, Gabriela B.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Broutet, Nathalie] World Hlth Org, Geneva, Switzerland	University of London; University College London; Imperial College London; World Health Organization	Hawkes, SJ (corresponding author), UCL, Inst Global Hlth, London, England.	s.hawkes@ucl.ac.uk	Hawkes, Sarah/AAK-7375-2020	Hawkes, Sarah/0000-0003-1062-3538	Wellcome Trust [WPIAP30479]	Wellcome Trust(Wellcome Trust)	No funding was received for this work. GBG was funded by The Wellcome Trust (#WPIAP30479) while working at Imperial College London. No funding organisations had any role in the preparation, review, or approval of the manuscript.	Alexander JM, 1999, OBSTET GYNECOL, V93, P5, DOI 10.1016/S0029-7844(98)00338-X; [Anonymous], 2011, MILL DEV GOALS REP; Berman SM, 2004, B WORLD HEALTH ORGAN, V82, P433; Bertolli J, 1996, J INFECT DIS, V174, P722, DOI 10.1093/infdis/174.4.722; BORISENKO KK, 1989, VESTN DERMATOL VENER, P14; Carles G, 2008, J GYNECOL OBST BIO R, V37, P353, DOI 10.1016/j.jgyn.2007.08.006; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P825; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Egger M., 2001, SYSTEMATIC REV HLTH; General UNS, 2010, GLOB STRAT WOM CHILD; Gust DA, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e79; Hawkes S, 2011, LANCET INFECT DIS, V11, P684, DOI 10.1016/S1473-3099(11)70104-9; HIRA SK, 1990, GENITOURIN MED, V66, P159; Ingraham NRJ, 1951, ACTA DERM VENERE S24, V31, P60; Kamb ML, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/312798; Kirkwood B. R., 2003, MED STAT; Liu JB, 2010, SEX TRANSM INFECT, V86, P292, DOI 10.1136/sti.2009.037549; Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5; Meredith S, 2007, GLOBAL ELIMINATION C; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MSELLATI P, 1995, J ACQ IMMUN DEF SYND, V8, P506; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; Pallikadavath S, 2004, SOC SCI MED, V59, P1147, DOI 10.1016/j.socscimed.2003.11.045; Peled N, 2001, Harefuah, V140, P266; Rawstorne S, 2011, PRINCIPLES PRACTICE; Rouzioux C, 1995, AM J EPIDEMIOL, V142, P1330, DOI 10.1093/oxfordjournals.aje.a117601; Schmid G, 2004, B WORLD HEALTH ORGAN, V82, P402; Schmid GP, 2007, SEX TRANSM DIS, V34, pS5, DOI 10.1097/01.olq.0000261456.09797.1b; Stammova E, 1970, Cesk Dermatol, V45, P164; Su J. R., 2010, Morbidity and Mortality Weekly Report, V59, P413; Walker DG, 2002, LANCET INFECT DIS, V2, P432, DOI 10.1016/S1473-3099(02)00319-5; Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951; Xu Y, 2001, Zhonghua Fu Chan Ke Za Zhi, V36, P460; Zhu LP, 2010, INT J INFECT DIS, V14, pE45, DOI 10.1016/j.ijid.2009.09.009	34	71	80	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56713	10.1371/journal.pone.0056713	http://dx.doi.org/10.1371/journal.pone.0056713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468875	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000315524900032
J	Jaeggi, T; Moretti, D; Kvalsvig, J; Holding, PA; Tjalsma, H; Kortman, GAM; Joosten, I; Mwangi, A; Zimmermann, MB				Jaeggi, Tanja; Moretti, Diego; Kvalsvig, Jane; Holding, Penny A.; Tjalsma, Harold; Kortman, Guus A. M.; Joosten, Irma; Mwangi, Alice; Zimmermann, Michael B.			Iron Status and Systemic Inflammation, but Not Gut Inflammation, Strongly Predict Gender-Specific Concentrations of Serum Hepcidin in Infants in Rural Kenya	PLOS ONE			English	Article							SEX-DIFFERENCES; RISK-FACTORS; DEFICIENCY; HOMEOSTASIS; CHILDREN; HEALTHY; ANEMIA; ERYTHROPOIETIN; EXPRESSION; INDICATORS	Hepcidin regulation by competing stimuli such as infection and iron deficiency has not been studied in infants and it's yet unknown whether hepcidin regulatory pathways are fully functional in infants. In this cross-sectional study including 339 Kenyan infants aged 6.0 +/- 1.1 months (mean +/- SD), we assessed serum hepcidin-25, biomarkers of iron status and inflammation, and fecal calprotectin. Prevalence of inflammation, anemia, and iron deficiency was 31%, 71%, 26%, respectively. Geometric mean (+/- SD) serum hepcidin was 6.0 (+/- 3.4) ng/mL, and was significantly lower in males than females. Inflammation (C-reactive protein and interleukin-6) and iron status (serum ferritin, zinc protoporphyrin and soluble transferrin receptor) were significant predictors of serum hepcidin, explaining nearly 60% of its variance. There were small, but significant differences in serum hepcidin comparing iron deficient anemic (IDA) infants without inflammation to iron-deficient anemic infants with inflammation (1.2 (+/- 4.9) vs. 3.4 (+/- 4.9) ng/mL; P<0.001). Fecal calprotectin correlated with blood/mucus in the stool but not with hepcidin. Similarly, the gut-linked cytokines IL-12 and IL-17 did not correlate with hepcidin. We conclude that hepcidin regulatory pathways are already functional in infancy, but serum hepcidin alone may not clearly discriminate between iron-deficient anemic infants with and without infection. We propose gender-specific reference values for serum hepcidin in iron-replete infants without inflammation.	[Jaeggi, Tanja; Moretti, Diego; Zimmermann, Michael B.] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland; [Kvalsvig, Jane] Univ KwaZulu Natal, Durban, South Africa; [Holding, Penny A.] Int Ctr Behav Studies, Mombasa, Kenya; [Tjalsma, Harold; Kortman, Guus A. M.; Joosten, Irma] Radboud Univ Nijmegen, Dept Lab Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Tjalsma, Harold] Hepcidinanal Com, Nijmegen, Netherlands; [Mwangi, Alice] Univ Nairobi, Dept Food Technol & Nutr, Nairobi, Kenya	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kwazulu Natal; Radboud University Nijmegen; University of Nairobi	Jaeggi, T (corresponding author), ETH, Inst Food Nutr & Hlth, Zurich, Switzerland.	Tanja.jaeggi@hest.ethz.ch	Kortman, Guus AM/F-9690-2010; Moretti, Diego/AAC-9028-2019; Zimmermann, Michael B/C-3062-2016; Moretti, Diego/G-5212-2013; Joosten, Irma/N-4418-2013	Moretti, Diego/0000-0002-7366-2182; Moretti, Diego/0000-0002-7366-2182; Joosten, Irma/0000-0003-2950-4977; Kortman, Guus/0000-0002-8076-0661	National Institutes of Health (NIH) [1U01HD064921-01/202/203]; INSTAPA Project; European Union's Seventh Framework Programme (Fp7) [211484]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD064921] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSTAPA Project; European Union's Seventh Framework Programme (Fp7); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by National Institutes of Health (NIH, Grant Number 1U01HD064921-01/202/203) and realized in collaboration with the INSTAPA Project, funded by the European Union's Seventh Framework Programme (Fp7/2007-2013) under grant agreement Nr 211484. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund S, 2011, AM J CLIN NUTR, V94, P1553, DOI 10.3945/ajcn.111.013938; Beutler E, 2007, BLOOD CELL MOL DIS, V39, P140, DOI 10.1016/j.bcmd.2007.03.009; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Cherayil BJ, 2011, CURR OPIN GASTROEN, V27, P523, DOI 10.1097/MOG.0b013e32834a4cd1; de Mast Q, 2010, HAEMATOL-HEMATOL J, V95, P1068, DOI 10.3324/haematol.2009.019331; de Mast Q, 2009, J INFECT DIS, V199, P253, DOI 10.1086/595790; Domellof M, 2002, PEDIATRICS, V110, P545, DOI 10.1542/peds.110.3.545; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Grant FKE, 2012, AM J CLIN NUTR, V95, P1231, DOI 10.3945/ajcn.111.029900; Grant FKE, 2012, J NUTR, V142, P105, DOI 10.3945/jn.111.146316; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hestvik E, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-9; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Kemna EHJM, 2008, BLOOD CELL MOL DIS, V40, P339, DOI 10.1016/j.bcmd.2007.10.002; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968; Krijt J, 2010, BLOOD CELL MOL DIS, V44, P257, DOI 10.1016/j.bcmd.2010.02.012; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Kung'u JK, 2009, J NUTR, V139, P2124, DOI 10.3945/jn.108.104026; Loennerdal B, 2007, FOOD NUTR BULL, V28, pS491, DOI 10.1177/15648265070284S402; Muller KF, 2012, J PEDIATR-US, V160, P949, DOI 10.1016/j.jpeds.2011.12.030; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Savino F, 2010, NEONATOLOGY, V97, P299, DOI 10.1159/000255161; Schneider JM, 2008, AM J CLIN NUTR, V87, P614, DOI 10.1093/ajcn/87.3.614; Siegemund S, 2009, INT IMMUNOL, V21, P555, DOI 10.1093/intimm/dxp025; Soh P, 2004, EUR J CLIN NUTR, V58, P71, DOI 10.1038/sj.ejcn.1601751; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Ulukol B, 2007, ACTA HAEMATOL-BASEL, V118, P70, DOI 10.1159/000102606; Vendt N, 2009, INT J LAB HEMATOL, V31, P440, DOI 10.1111/j.1751-553X.2008.01060.x; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; WHO, 2001, IRON DEFICIENCY ANAE; Wieringa FT, 2007, BRIT J NUTR, V98, P1070, DOI 10.1017/S0007114507756945; World Health Organization, 2007, WHO ANTHR PERS COMP; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P615	46	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57513	10.1371/journal.pone.0057513	http://dx.doi.org/10.1371/journal.pone.0057513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460869	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000124
J	Karpusas, M; Axarli, I; Chiniadis, L; Papakyriakou, A; Bethanis, K; Scopelitou, K; Clonis, YD; Labrou, NE				Karpusas, Michael; Axarli, Irine; Chiniadis, Lykourgos; Papakyriakou, Athanasios; Bethanis, Kostas; Scopelitou, Katholiki; Clonis, Yannis D.; Labrou, Nikolaos E.			The Interaction of the Chemotherapeutic Drug Chlorambucil with Human Glutathione Transferase A1-1: Kinetic and Structural Analysis	PLOS ONE			English	Article							RESISTANCE PROTEIN-1 MRP1; S-TRANSFERASE; CATALYTIC MECHANISM; BINDING-SITE; CRYSTAL-STRUCTURE; ETHACRYNIC-ACID; AFFINITY LABEL; ACTIVE-SITES; RAT-LIVER; WILD-TYPE	Glutathione transferases (GSTs) are enzymes that contribute to cellular detoxification by catalysing the nucleophilic attack of glutathione (GSH) on the electrophilic centre of a number of xenobiotic compounds, including several chemotherapeutic drugs. In the present work we investigated the interaction of the chemotherapeutic drug chlorambucil (CBL) with human GSTA1-1 (hGSTA1-1) using kinetic analysis, protein crystallography and molecular dynamics. In the presence of GSH, CBL behaves as an efficient substrate for hGSTA1-1. The rate-limiting step of the catalytic reaction between CBL and GSH is viscosity-dependent and kinetic data suggest that product release is rate-limiting. The crystal structure of the hGSTA1-1/CBL-GSH complex was solved at 2.1 angstrom resolution by molecular replacement. CBL is bound at the H-site attached to the thiol group of GSH, is partially ordered and exposed to the solvent, making specific interactions with the enzyme. Molecular dynamics simulations based on the crystal structure indicated high mobility of the CBL moiety and stabilization of the C-terminal helix due to the presence of the adduct. In the absence of GSH, CBL is shown to be an alkylating irreversible inhibitor for hGSTA1-1. Inactivation of the enzyme by CBL followed a biphasic pseudo-first-order saturation kinetics with approximately 1 mol of CBL per mol of dimeric enzyme being incorporated. Structural analysis suggested that the modifying residue is Cys112 which is located at the entrance of the H-site. The results are indicative of a structural communication between the subunits on the basis of mutually exclusive modification of Cys112, indicating that the two enzyme active sites are presumably coordinated.	[Karpusas, Michael; Chiniadis, Lykourgos; Bethanis, Kostas] Agr Univ Athens, Phys Lab, Dept Sci, Athens, Greece; [Axarli, Irine; Scopelitou, Katholiki; Clonis, Yannis D.; Labrou, Nikolaos E.] Agr Univ Athens, Dept Agr Biotechnol, Lab Enzyme Technol, Athens, Greece; [Papakyriakou, Athanasios] NCSR Demokritos, Biol Chem Lab, Inst Phys Chem, Athens, Greece	Agricultural University of Athens; Agricultural University of Athens; National Centre of Scientific Research "Demokritos"	Labrou, NE (corresponding author), Agr Univ Athens, Dept Agr Biotechnol, Lab Enzyme Technol, Athens, Greece.	lambrou@aua.gr	Karpusas, Michael/AAP-5547-2021; Clonis, Yannis/AAI-2420-2019; Labrou, Nikolaos/B-1089-2011; Papakyriakou, Athanasios/K-7033-2012; Chiniadis, Lykourgos/O-4254-2019; Bethanis, Kostas/G-5673-2019	Clonis, Yannis/0000-0001-7626-8212; Labrou, Nikolaos/0000-0003-1925-9867; Papakyriakou, Athanasios/0000-0003-3931-6232; Chiniadis, Lykourgos/0000-0002-7118-9942; Bethanis, Kostas/0000-0002-7402-0798	European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II; action THALES: 'Glutathione transferases: multifunctional molecular tools in red and green biotechnology', falling under the Operational Programme "Education and Lifelong Learning"; European Social Fund	European Union (European Social Fund - ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II; action THALES: 'Glutathione transferases: multifunctional molecular tools in red and green biotechnology', falling under the Operational Programme "Education and Lifelong Learning"; European Social Fund(European Social Fund (ESF))	This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. The work was also supported by the action THALES: 'Glutathione transferases: multifunctional molecular tools in red and green biotechnology', falling under the Operational Programme "Education and Lifelong Learning" and is co-financed by the European Social Fund and National Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axarli I, 2009, EUR J MED CHEM, V44, P2009, DOI 10.1016/j.ejmech.2008.10.009; Axarli I, 2009, BIOCHEM J, V422, P247, DOI 10.1042/BJ20090224; BAILEY J, 1985, BIOCHEMISTRY-US, V35, P2658; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caccuri AM, 2001, J BIOL CHEM, V276, P5432, DOI 10.1074/jbc.M002818200; Caccuri AM, 1996, J BIOL CHEM, V271, P16193, DOI 10.1074/jbc.271.27.16193; Caccuri AM, 1997, J BIOL CHEM, V272, P29681, DOI 10.1074/jbc.272.47.29681; CAMERON AD, 1995, STRUCTURE, V3, P717, DOI 10.1016/S0969-2126(01)00206-4; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CIACCIO PJ, 1991, BIOCHEM PHARMACOL, V42, P1504, DOI 10.1016/0006-2952(91)90468-K; DULIK DM, 1986, BIOCHEM PHARMACOL, V35, P3405, DOI 10.1016/0006-2952(86)90444-2; DULIK DM, 1990, BIOMED ENVIRON MASS, V19, P248, DOI 10.1002/bms.1200190408; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Grahn E, 2006, ACTA CRYSTALLOGR D, V62, P197, DOI 10.1107/S0907444905039296; HU LQ, 1995, J BIOL CHEM, V270, P21875, DOI 10.1074/jbc.270.37.21875; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ISHIKAWA T, 1993, J BIOL CHEM, V268, P20116; IVANETICH KM, 1990, BIOCHEM PHARMACOL, V39, P1999, DOI 10.1016/0006-2952(90)90621-Q; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JAKOBSON I, 1979, BIOCHEM J, V177, P861, DOI 10.1042/bj1770861; JOHNSON WW, 1993, J BIOL CHEM, V268, P11508; KING MM, 1983, BIOCHEMISTRY-US, V22, P1656, DOI 10.1021/bi00276a021; Koeplinger KA, 1999, DRUG METAB DISPOS, V27, P986; Kotzia GA, 2004, EUR J BIOCHEM, V271, P3503, DOI 10.1111/j.0014-2956.2004.04285.x; Koutsoumpli GE, 2012, J MED CHEM, V55, P6802, DOI 10.1021/jm300385f; Kuhnert DC, 2005, J MOL BIOL, V349, P825, DOI 10.1016/j.jmb.2005.04.025; Labrou NE, 2000, EUR J BIOCHEM, V267, P6657, DOI 10.1046/j.1432-1327.2000.01761.x; Lamanna N, 2010, CURR HEMATOL MALIG R, V5, P45, DOI 10.1007/s11899-009-0040-3; Le Trong I, 2002, PROTEINS, V48, P618, DOI 10.1002/prot.10162; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; Lien S, 2001, J BIOL CHEM, V276, P35599, DOI 10.1074/jbc.M103789200; Lo HW, 2007, CURR OPIN PHARMACOL, V7, P367, DOI 10.1016/j.coph.2007.06.009; Lyon RP, 2002, BIOCHEMISTRY-US, V41, P10920, DOI 10.1021/bi0262810; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; MEYER DJ, 1992, BRIT J CANCER, V66, P433, DOI 10.1038/bjc.1992.292; Misquitta SA, 2005, BIOCHEMISTRY-US, V44, P8608, DOI 10.1021/bi050449a; Morrow CS, 1998, J BIOL CHEM, V273, P20114, DOI 10.1074/jbc.273.32.20114; Nebert Daniel W., 2004, Human Genomics, V1, P460; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker LJ, 2008, J MOL BIOL, V380, P131, DOI 10.1016/j.jmb.2008.04.066; Paumi CM, 2001, J BIOL CHEM, V276, P7952, DOI 10.1074/jbc.M009400200; Ricci G, 2003, BIOCHEM J, V376, P71, DOI 10.1042/BJ20030860; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Romero L, 2006, BIOCHEM J, V400, P135, DOI 10.1042/BJ20060110; SAMPSON NS, 1992, BIOCHEMISTRY-US, V31, P8488, DOI 10.1021/bi00151a015; Sau A, 2010, ARCH BIOCHEM BIOPHYS, V500, P116, DOI 10.1016/j.abb.2010.05.012; Segel I.H., 1975, ENZYME KINETICS; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; SINHA U, 1985, ANAL BIOCHEM, V151, P327, DOI 10.1016/0003-2697(85)90183-6; Skopelitou K, 2009, FRONTIERS DRUG DESIG, V4, P23; Skopelitou K, 2010, ANAL BIOCHEM, V405, P201, DOI 10.1016/j.ab.2010.06.007; Smitherman PK, 2004, J PHARMACOL EXP THER, V308, P260, DOI 10.1124/jpet.103.057729; Vargo MA, 2004, PROTEIN SCI, V13, P1586, DOI 10.1110/ps.04694004; Wang JB, 1998, BIOCHEMISTRY-US, V37, P15671, DOI 10.1021/bi981381k; Widersten M, 1996, BIOCHEMISTRY-US, V35, P7731, DOI 10.1021/bi9601619; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Wolf AV, 1985, HDB CHEM PHYSICS, pD; Xiao B, 1999, BIOCHEMISTRY-US, V38, P11887, DOI 10.1021/bi990468i; Zhao ZY, 1999, DRUG METAB DISPOS, V27, P992	60	18	18	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56337	10.1371/journal.pone.0056337	http://dx.doi.org/10.1371/journal.pone.0056337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460799	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000022
J	Major, LD; Partridge, TS; Gardner, J; Kent, SJ; de Rose, R; Suhrbier, A; Schroder, WA				Major, Lee D.; Partridge, Thomas S.; Gardner, Joy; Kent, Stephen J.; de Rose, Robert; Suhrbier, Andreas; Schroder, Wayne A.			Induction of SerpinB2 and Th1/Th2 Modulation by SerpinB2 during Lentiviral Infections In Vivo	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BLOOD MONONUCLEAR-CELLS; CORONARY-HEART-DISEASE; RHESUS MACAQUES; HIV-INFECTION; SIMIAN-HUMAN; EARLY-STAGE; GENE; EXPRESSION	SerpinB2, also known as plasminogen activator inhibitor type 2, is a major product of activated monocytes/macrophages and is often strongly induced during infection and inflammation; however, its physiological function remains somewhat elusive. Herein we show that SerpinB2 is induced in peripheral blood mononuclear cells following infection of pigtail macaques with CCR5-utilizing (macrophage-tropic) SIVmac239, but not the rapidly pathogenic CXCR4-utilizing (T cell-tropic) SHIVmn229. To investigate the role of SerpinB2 in lentiviral infections, SerpinB2(-/-) mice were infected with EcoHIV, a chimeric HIV in which HIV gp120 has been replaced with gp80 from ecotropic murine leukemia virus. EcoHIV infected SerpinB2(-/-) mice produced significantly lower anti-gag IgG1 antibody titres than infected SerpinB2(+/+) mice, and showed slightly delayed clearance of EcoHIV. Analyses of published microarray studies showed significantly higher levels of SerpinB2 mRNA in monocytes from HIV-1 infected patients when compared with uninfected controls, as well as a significant negative correlation between SerpinB2 and T-bet mRNA levels in peripheral blood mononuclear cells. These data illustrate that SerpinB2 can be induced by lentiviral infection in vivo and support the emerging notion that a physiological role of SerpinB2 is modulation of Th1/Th2 responses.	[Major, Lee D.; Partridge, Thomas S.; Gardner, Joy; Suhrbier, Andreas; Schroder, Wayne A.] Queensland Inst Med Res, Dept Immunol, Brisbane, Qld 4006, Australia; [Partridge, Thomas S.; Suhrbier, Andreas] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Kent, Stephen J.; de Rose, Robert] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Suhrbier, Andreas] Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Melbourne; Griffith University	Suhrbier, A (corresponding author), Queensland Inst Med Res, Dept Immunol, Brisbane, Qld 4006, Australia.	andreasS@qimr.edu.au	Kent, Stephen/AAL-5101-2020	Kent, Stephen/0000-0002-8539-4891; De Rose, Robert/0000-0003-4316-3910; Suhrbier, Andreas/0000-0001-8986-9025	Australian National Health and Medical Research Council (NHMRC); Australian Centre for HIV and Hepatitis Virology Research; QIMR	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Virology Research; QIMR	Funding was provided by the Australian National Health and Medical Research Council (NH&MRC) and the Australian Centre for HIV and Hepatitis Virology Research. TSP received a QIMR honours scholarship for this work. AS is a Principle Research Fellow with the NH&MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee K, 2010, AIDS RES HUM RETROV, V26, P445, DOI 10.1089/aid.2009.0223; Batten CJ, 2006, AIDS RES HUM RETROV, V22, P580, DOI 10.1089/aid.2006.22.580; Belisle SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019681; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Buonaguro L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S5; CLAYETTE P, 1995, J MED PRIMATOL, V24, P94, DOI 10.1111/j.1600-0684.1995.tb00152.x; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Dale CJ, 2004, J VIROL, V78, P13819, DOI 10.1128/JVI.78.24.13819-13828.2004; Darnell GA, 2006, J BIOL CHEM, V281, P31348, DOI 10.1074/jbc.M604220200; De Rose R, 2007, J VIROL, V81, P292, DOI 10.1128/JVI.01727-06; Demberg T, 2011, VACCINE, V29, P6017, DOI 10.1016/j.vaccine.2011.06.032; Donahoe SM, 2000, VIROLOGY, V272, P347, DOI 10.1006/viro.2000.0404; Freedman BD, 2003, IMMUNOL RES, V27, P261, DOI 10.1385/IR:27:2-3:261; Gauduin MC, 2004, J IMMUNOL METHODS, V288, P61, DOI 10.1016/j.jim.2004.02.007; Gekonge B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041153; Giri MS, 2009, J IMMUNOL, V182, P4459, DOI 10.4049/jimmunol.0801450; Giri MS, 2006, J LEUKOCYTE BIOL, V80, P1031, DOI 10.1189/jlb.0306157; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Kasyapa CS, 2006, BLOOD, V107, P3693, DOI 10.1182/blood-2005-04-1505; Katsikis PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002055; Kelschenbach JL, 2012, J NEUROIMMUNE PHARM, V7, P380, DOI 10.1007/s11481-011-9316-1; Kent SJ, 2008, VIROLOGY, V374, P528, DOI 10.1016/j.virol.2008.01.006; Kim WK, 2010, J LEUKOCYTE BIOL, V87, P557, DOI 10.1189/jlb.0209082; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007; Lund R, 2003, J IMMUNOL, V171, P5328, DOI 10.4049/jimmunol.171.10.5328; Major L, 2011, EXP CELL RES, V317, P338, DOI 10.1016/j.yexcr.2010.10.016; Mannioui A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-106; McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584; Mehla R, 2012, CURR HIV-AIDS REP, V9, P34, DOI 10.1007/s11904-011-0100-x; Nilsson J, 2007, AIDS, V21, P565, DOI 10.1097/QAD.0b013e3280117204; Ockenhouse CF, 2005, J INFECT DIS, V191, P2064, DOI 10.1086/430321; Palacios R, 2002, LUPUS, V11, P60, DOI 10.1191/0961203302lu141cr; Palafox-Sanchez CA, 2009, CLIN APPL THROMB-HEM, V15, P233, DOI 10.1177/1076029607308868; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Reuter MA, 2012, CYTOKINE GROWTH FACT; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Schroder WA, 2010, PARASITE IMMUNOL, V32, P764, DOI 10.1111/j.1365-3024.2010.01241.x; Schroder WA, 2011, CRIT REV IMMUNOL, V31, P15, DOI 10.1615/CritRevImmunol.v31.i1.20; Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187; Shetty RD, 2012, J CLIN INVEST, V122, P1712, DOI 10.1172/JCI60612; Shimizu Y, 2005, VIROLOGY, V343, P151, DOI 10.1016/j.virol.2005.08.025; Solis M, 2006, VIROLOGY, V352, P86, DOI 10.1016/j.virol.2006.04.010; Stasinopoulos S, 2010, FEBS J, V277, P1331, DOI 10.1111/j.1742-4658.2010.07563.x; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Triant VA, 2012, J INFECT DIS, V205, pS355, DOI 10.1093/infdis/jis195; Van den Bergh R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-53; Vigneault F, 2011, J VIROL, V85, P3015, DOI 10.1128/JVI.01846-10; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	50	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57343	10.1371/journal.pone.0057343	http://dx.doi.org/10.1371/journal.pone.0057343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460840	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000094
J	Maslova, E; Strom, M; Olsen, SF; Halldorsson, TI				Maslova, Ekaterina; Strom, Marin; Olsen, Sjurdur F.; Halldorsson, Thorhallur I.			Consumption of Artificially-Sweetened Soft Drinks in Pregnancy and Risk of Child Asthma and Allergic Rhinitis	PLOS ONE			English	Article							MATERNAL FOOD-CONSUMPTION; MEDITERRANEAN DIET; FISH CONSUMPTION; DOUBLE-BLIND; ASPARTAME; WHEEZE; ECZEMA; DERMATITIS; VEGETABLES; EXPOSURE	Background: Past evidence has suggested a role of artificial sweeteners in allergic disease; yet, the evidence has been inconsistent and unclear. Objective: To examine relation of intake of artificially-sweetened beverages during pregnancy with child asthma and allergic rhinitis at 18 months and 7 years. Methods: We analyzed data from 60,466 women enrolled during pregnancy in the prospective longitudinal Danish National Birth Cohort between 1996 and 2003. At the 25th week of gestation we administered a validated Food Frequency Questionnaire which asked in detail about intake of artificially-sweetened soft drinks. At 18 months, we evaluated child asthma using interview data. We also assessed asthma and allergic rhinitis through a questionnaire at age 7 and by using national registries. Current asthma was defined as self-reported asthma diagnosis and wheeze in the past 12 months. We examined the relation between intake of artificially-sweetened soft drinks and child allergic disease outcomes and present here odds ratios with 95% CI comparing daily vs. no intake. Results: At 18 months, we found that mothers who consumed more artificially-sweetened non-carbonated soft drinks were 1.23 (95% CI: 1.13, 1.33) times more likely to report a child asthma diagnosis compared to non-consumers. Similar results were found for child wheeze. Consumers of artificially-sweetened carbonated drinks were more likely to have a child asthma diagnosis in the patient (1.30, 95% CI: 1.01, 1.66) and medication (1.13, 95% CI: 0.98, 1.29) registry, as well as self-reported allergic rhinitis (1.31, 95% CI: 0.98, 1.74) during the first 7 years of follow-up. We found no associations for sugar-sweetened soft drinks. Conclusion: Carbonated artificially- sweetened soft drinks were associated with registry-based asthma and self-reported allergic rhinitis, while early childhood outcomes were related to non-carbonated soft drinks. These results suggest that consumption of artificially-sweetened soft drinks during pregnancy may play a role in offspring allergic disease development.	[Maslova, Ekaterina; Strom, Marin; Olsen, Sjurdur F.; Halldorsson, Thorhallur I.] Statens Serum Inst, Ctr Fetal Programming, Dept Epidemiol, DK-2300 Copenhagen, Denmark; [Maslova, Ekaterina; Olsen, Sjurdur F.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Halldorsson, Thorhallur I.] Univ Iceland, Fac Food Sci & Nutr, Sch Hlth Sci, Reykjavik, Iceland; [Halldorsson, Thorhallur I.] Landspitali Univ Hosp, Unit Nutr Res, Reykjavik, Iceland	Statens Serum Institut; Harvard University; Harvard T.H. Chan School of Public Health; University of Iceland; Landspitali National University Hospital	Maslova, E (corresponding author), Statens Serum Inst, Ctr Fetal Programming, Dept Epidemiol, DK-2300 Copenhagen, Denmark.	emaslova@post.harvard.edu	Halldorsson, Tohrhallur/M-1823-2015	Halldorsson, Tohrhallur/0000-0001-5115-0162; Halldorsson, Thorhallur/0000-0002-3488-0777; Olsen, Sjurdur/0000-0003-3017-7096; Strom, Marin/0000-0003-1926-6610	Danish Council for Stra-tegic Research [09-067124]; Danish Council for Independent Research \ Medical Sciences, Danish Agency for Science, Technology and Innovation [09-063410]; Lundbeck foundation [R13-A907]; European Union (EU) Integrated Research Project EARNEST [FOOD-CT-2005-007036]; Commission of the European Communities under the FP 6 priority 5: food quality and safety; March of Dimes Birth Defects Foundation; Danish Heart Association; Danish Medical Research Council; Sygekassernes Helsefond; Danish Pharmaceutical Association; Ministry of Health; National Board of Health; Statens Serum Institut; Danish National Research Foundation	Danish Council for Stra-tegic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research \ Medical Sciences, Danish Agency for Science, Technology and Innovation; Lundbeck foundation(Lundbeckfonden); European Union (EU) Integrated Research Project EARNEST; Commission of the European Communities under the FP 6 priority 5: food quality and safety; March of Dimes Birth Defects Foundation(March of Dimes); Danish Heart Association; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sygekassernes Helsefond; Danish Pharmaceutical Association; Ministry of Health; National Board of Health; Statens Serum Institut; Danish National Research Foundation(Danmarks Grundforskningsfond)	Declaration of all sources of funding: the study was supported by the Danish Council for Stra-tegic Research (09-067124); the Danish Council for Independent Research vertical bar Medical Sciences, Danish Agency for Science, Technology and Innovation (09-063410); the Lundbeck foundation (R13-A907); and the European Union (EU) Integrated Research Project EARNEST (FOOD-CT-2005-007036). The EU project EARNEST (http://www.metabolic-programming.org) receives financial support from the Commission of the European Communities under the FP 6 priority 5: food quality and safety. The Danish National Birth Cohort has been financed by the March of Dimes Birth Defects Foundation, the Danish Heart Association, the Danish Medical Research Council, and the Sygekassernes Helsefond, Danish National Research Foundation, Danish Pharmaceutical Association, Ministry of Health, National Board of Health, Statens Serum Institut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Salam OME, 2011, NEUROTOX RES; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Calvani M, 2006, PEDIAT ALLERG IMM-UK, V17, P94, DOI 10.1111/j.1399-3038.2005.00367.x; Chatzi L, 2008, THORAX, V63, P507, DOI 10.1136/thx.2007.081745; Chatzi L, 2007, THORAX, V62, P677, DOI 10.1136/thx.2006.069419; Duffy VB, 2004, J AM DIET ASSOC, V104, P255, DOI 10.1016/j.jada.2003.12.001; Forskningsdatabaser, 2002, DAT DANM STAT; GARRIGA MM, 1991, J ALLERGY CLIN IMMUN, V87, P821, DOI 10.1016/0091-6749(91)90128-B; GEHA R, 1993, J ALLERGY CLIN IMMUN, V92, P513, DOI 10.1016/0091-6749(93)90075-Q; Gultekin F, 2012, CLIN REV ALLERGY IMM; Halldorsson TI, 2010, AM J CLIN NUTR, V92, P626, DOI 10.3945/ajcn.2009.28968; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036328; Hederos CA, 2007, PEDIAT ALLERG IMM-UK, V18, P135, DOI 10.1111/j.1399-3038.2006.00474.x; Hernandez-Diaz S, 2006, AM J EPIDEMIOL, V164, P1115, DOI 10.1093/aje/kwj275; Hill AM, 2003, CONTACT DERMATITIS, V49, P258, DOI 10.1111/j.0105-1873.2003.0225a.x; Jacob Sharon E, 2008, Dermatitis, V19, pE10; Jedrychowski W, 2011, INT ARCH ALLERGY IMM, V155, P275, DOI 10.1159/000320376; Kim JY, 2011, FOOD CHEM TOXICOL, V49, P2899, DOI 10.1016/j.fct.2011.08.001; LaBuda CJ, 2001, LIFE SCI, V69, P443, DOI 10.1016/S0024-3205(01)01136-5; Leth T, 2008, FOOD ADDIT CONTAM A, V25, P662, DOI 10.1080/02652030701765749; Maslova E, 2012, J NUTR SCI, V1, DOI 10.1017/jns.2012.5; Mikkelsen TB, 2006, PUBLIC HEALTH NUTR, V9, P771, DOI 10.1079/PHN2005883; Miyake Y, 2010, EUR RESPIR J, V35, P1228, DOI 10.1183/09031936.00100609; Miyake Y, 2010, ALLERGY, V65, P758, DOI 10.1111/j.1398-9995.2009.02267.x; Miyake Y, 2009, THORAX, V64, P815, DOI 10.1136/thx.2009.115931; Moth G, 2007, ACTA PAEDIATR, V96, P1470, DOI 10.1111/j.1651-2227.2007.00460.x; Moth G, 2007, EUR J CLIN PHARMACOL, V63, P605, DOI 10.1007/s00228-007-0286-4; Nurmatov U, 2012, ALLERGY, V67, P1041, DOI 10.1111/j.1398-9995.2012.02858.x; Nwaru BI, 2010, PEDIAT ALLERG IMM-UK, V21, P29, DOI 10.1111/j.1399-3038.2009.00949.x; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Olsen SF, 2008, AM J CLIN NUTR, V88, P167, DOI 10.1093/ajcn/88.1.167; Pitrez PMC, 2005, BRAZ J MED BIOL RES, V38, P51, DOI 10.1590/S0100-879X2005000100008; Psarras Stelios, 2004, Paediatr Respir Rev, V5 Suppl A, pS179, DOI 10.1016/S1526-0542(04)90034-6; Ramsland PA, 1999, J MOL RECOGNIT, V12, P249, DOI 10.1002/(SICI)1099-1352(199907/08)12:4<249::AID-JMR463>3.0.CO;2-B; Reese I, 2009, J DTSCH DERMATOL GES, V7, P70, DOI 10.1111/j.1610-0387.2008.06894.x; Romieu I, 2007, CLIN EXP ALLERGY, V37, P518, DOI 10.1111/j.1365-2222.2007.02685.x; Salam MT, 2005, J ASTHMA, V42, P513, DOI 10.1081/JAS-200067619; Sausenthaler S, 2007, AM J CLIN NUTR, V85, P530; Saxholt E., 2008, DANISH FOOD COMPOSIT; SCHIFFMAN SS, 1987, NEW ENGL J MED, V317, P1181, DOI 10.1056/NEJM198711053171903; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; SZUCS EF, 1986, FOOD CHEM TOXICOL, V24, P171, DOI 10.1016/0278-6915(86)90353-4; Veien NK, 2012, CONTACT DERMATITIS, V67, P315, DOI 10.1111/j.1600-0536.2012.02147.x; Willers SM, 2007, THORAX, V62, P773, DOI 10.1136/thx.2006.074187; Willers SM, 2008, AM J RESP CRIT CARE, V178, P124, DOI 10.1164/rccm.200710-1544OC	45	46	50	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57261	10.1371/journal.pone.0057261	http://dx.doi.org/10.1371/journal.pone.0057261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460835	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000085
J	Silvent, J; Nassif, N; Helary, C; Azais, T; Sire, JY; Guille, MMG				Silvent, Jeremie; Nassif, Nadine; Helary, Christophe; Azais, Thierry; Sire, Jean-Yves; Guille, Marie Madeleine Giraud			Collagen Osteoid-Like Model Allows Kinetic Gene Expression Studies of Non-Collagenous Proteins in Relation with Mineral Development to Understand Bone Biomineralization	PLOS ONE			English	Article							DENTIN MATRIX PROTEIN-1; OSTEOBLAST-LIKE CELLS; IN-VITRO; HYDROXYAPATITE FORMATION; INHIBITION; DIFFERENTIATION; NUCLEATION; CRYSTALS; CULTURE; STATE	Among persisting questions on bone calcification, a major one is the link between protein expression and mineral deposition. A cell culture system is here proposed opening new integrative studies on biomineralization, improving our knowledge on the role played by non-collagenous proteins in bone. This experimental in vitro model consisted in human primary osteoblasts cultured for 60 days at the surface of a 3D collagen scaffold mimicking an osteoid matrix. Various techniques were used to analyze the results at the cellular and molecular level (adhesion and viability tests, histology and electron microscopy, RT- and qPCR) and to characterize the mineral phase (histological staining, EDX, ATG, SAED and RMN). On long term cultures human bone cells seeded on the osteoid-like matrix displayed a clear osteoblast phenotype as revealed by the osteoblast-like morphology, expression of specific protein such as alkaline phosphatase and expression of eight genes classically considered as osteoblast markers, including BGLAP, COL1A1, and BMP2. Von Kossa and alizarine red allowed us to identify divalent calcium ions at the surface of the matrix, EDX revealed the correct Ca/P ratio, and SAED showed the apatite crystal diffraction pattern. In addition RMN led to the conclusion that contaminant phases were absent and that the hydration state of the mineral was similar to fresh bone. A temporal correlation was established between quantified gene expression of DMP1 and IBSP, and the presence of hydroxyapatite, confirming the contribution of these proteins to the mineralization process. In parallel a difference was observed in the expression pattern of SPP1 and BGLAP, which questioned their attributed role in the literature. The present model opens new experimental possibilities to study spatio-temporal relations between bone cells, dense collagen scaffolds, NCPs and hydroxyapatite mineral deposition. It also emphasizes the importance of high collagen density environment in bone cell physiology.	[Silvent, Jeremie; Nassif, Nadine; Helary, Christophe; Azais, Thierry; Guille, Marie Madeleine Giraud] Univ Paris 06, UMR Chim Mat Condensee Paris 7574, Ecole Prat Hautes Etud, Paris, France; [Silvent, Jeremie; Sire, Jean-Yves] Univ Paris 06, UMR 7138, Equipe Evolut & Dev Squelette, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Chimie ParisTech; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Sire, JY (corresponding author), Univ Paris 06, UMR 7138, Equipe Evolut & Dev Squelette, Paris, France.	jean-yves.sire@upmc.fr; mmgiraud@snv.jussieu.fr	Helary, Christophe/AAD-3476-2022; Helary, Christophe/AAD-9437-2022; Helary, Christophe/J-8128-2013	Helary, Christophe/0000-0001-9312-7278				Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601; Anselme K, 1999, J MATER SCI-MATER M, V10, P815, DOI 10.1023/A:1008992109670; AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E; Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Besseau L, 2002, BIOMATERIALS, V23, P27, DOI 10.1016/S0142-9612(01)00075-8; Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y; Boskey AL, 2008, CHEM REV, V108, P4716, DOI 10.1021/cr0782473; BOSKEY AL, 1995, ANN NY ACAD SCI, V760, P249, DOI 10.1111/j.1749-6632.1995.tb44635.x; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Boskey AL, 1996, CALCIFIED TISSUE INT, V58, P177, DOI 10.1007/s002239900030; Cho GY, 2003, SCIENCE, V300, P1123, DOI 10.1126/science.1078470; Christenson RH, 1997, CLIN BIOCHEM, V30, P573, DOI 10.1016/S0009-9120(97)00113-6; CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7; Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Fratzl-Zelman N, 1998, BONE, V23, P511, DOI 10.1016/S8756-3282(98)00139-2; George A, 1995, Connect Tissue Res, V33, P67, DOI 10.3109/03008209509016984; Glimcher MJ, 2006, REV MINERAL GEOCHEM, V64, P223, DOI 10.2138/rmg.2006.64.8; Gobeaux F, 2007, LANGMUIR, V23, P6411, DOI 10.1021/la070093z; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; Guille MMG, 2010, SOFT MATTER, V6, P4963, DOI 10.1039/c0sm00260g; Hadjipanayi E, 2009, J TISSUE ENG REGEN M, V3, P77, DOI 10.1002/term.136; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Huang SJ, 2009, CHEM MATER, V21, P2583, DOI 10.1021/cm9006537; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; JACKSON SF, 1957, J BIOPHYS BIOCHEM CY, V3, P897, DOI 10.1083/jcb.3.6.897; Jager C, 2006, MAGN RESON CHEM, V44, P573, DOI 10.1002/mrc.1774; Kumaran S Thanga, 2010, Indian J Dent Res, V21, P3, DOI 10.4103/0970-9290.62796; LIAN JB, 2001, OSTEOPOROSIS, P21; Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727; MILLER SC, 1989, SCANNING MICROSCOPY, V3, P953; Nampei A, 2004, J BONE MINER METAB, V22, P176, DOI 10.1007/s00774-003-0468-9; Nassif N, 2010, CHEM MATER, V22, P3653, DOI 10.1021/cm903596q; Nassif N, 2010, CHEM MATER, V22, P3307, DOI 10.1021/cm903594n; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramires PA, 2002, J MATER SCI-MATER M, V13, P797, DOI 10.1023/A:1016183326864; Ramtani S, 2010, J MECH MED BIOL, V10, P35, DOI 10.1142/S0219519410003290; ROMBERG RW, 1986, BIOCHEMISTRY-US, V25, P1176, DOI 10.1021/bi00353a035; Rozen S, 2000, Methods Mol Biol, V132, P365; Stains Joseph P, 2005, Birth Defects Res C Embryo Today, V75, P72, DOI 10.1002/bdrc.20034; Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8; Takitoh T, 2010, J BIOSCI BIOENG, V110, P471, DOI 10.1016/j.jbiosc.2010.04.009; Thula TT, 2011, ACTA BIOMATER, V7, P3158, DOI 10.1016/j.actbio.2011.04.014; Tsai SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031200; Vigier S, 2010, J BIOMED MATER RES A, V94A, P556, DOI 10.1002/jbm.a.32717; Wiesmann HP, 2003, J ORAL MAXIL SURG, V61, P1455, DOI 10.1016/j.joms.2003.05.001; Wu YT, 2002, J BONE MINER RES, V17, P472, DOI 10.1359/jbmr.2002.17.3.472; Yamanouchi K, 2001, J BONE MINER RES, V16, P857, DOI 10.1359/jbmr.2001.16.5.857; Zhang LJ, 2004, MATER LETT, V58, P719, DOI 10.1016/j.matlet.2003.07.009	59	18	19	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57344	10.1371/journal.pone.0057344	http://dx.doi.org/10.1371/journal.pone.0057344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460841	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000095
J	Zimmermann, J; Krauthausen, M; Hofer, MJ; Heneka, MT; Campbell, IL; Muller, M				Zimmermann, Julian; Krauthausen, Marius; Hofer, Markus J.; Heneka, Michael T.; Campbell, Iain L.; Mueller, Marcus			CNS-Targeted Production of IL-17A Induces Glial Activation, Microvascular Pathology and Enhances the Neuroinflammatory Response to Systemic Endotoxemia	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TOXOPLASMA-GONDII INFECTION; BRAIN-BARRIER DISRUPTION; E-DEFICIENT MICE; TRANSGENIC MICE; T-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; MULTIPLE-SCLEROSIS; INTERLEUKIN-17 RECEPTOR	Interleukin-17A (IL-17A) is a key cytokine modulating the course of inflammatory diseases. Whereas effector functions of IL-17A like induction of antimicrobial peptides and leukocyte infiltration could clearly be demonstrated for peripheral organs, CNS specific effects are not well defined and appear controversial. To further clarify the functional significance of IL-17A in the CNS, we generated a transgenic mouse line with astrocyte-restricted expression of the IL-17A gene. GFAP/IL-17A transgenic mice develop normally and do not show any signs of neurological dysfunction. However, histological characterization revealed astrocytosis and activation of microglia. Demyelination, neurodegeneration or prominent tissue damage was not observed but a vascular pathology mimicking microangiopathic features was evident. Histological and flow cytometric analysis demonstrated the absence of parenchymal infiltration of immune cells into the CNS of GFAP/IL-17A transgenic mice. In GFAP/IL-17A mice, LPS-induced endotoxemia led to a more pronounced microglial activation with expansion of a distinct CD45(high)/CD11b(+) population and increased induction of proinflammatory cytokines compared with controls. Our data argues against a direct role of IL-17A in mediating tissue damage during neuroinflammation. More likely IL-17A acts as a modulating factor in the network of induced cytokines. This novel mouse model will be a very useful tool to further characterize the role of IL-17A in neuroinflammatory disease models.	[Zimmermann, Julian; Krauthausen, Marius; Heneka, Michael T.; Mueller, Marcus] Univ Klinikum Bonn, Dept Neurol, Bonn, Germany; [Hofer, Markus J.] Univ Clin Marburg & Giessen, Dept Neuropathol, Marburg, Germany; [Heneka, Michael T.] Univ Bonn, Clin Neurosci Unit, Bonn, Germany; [Campbell, Iain L.; Mueller, Marcus] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Bonn; University of Bonn; University of Sydney	Muller, M (corresponding author), Univ Klinikum Bonn, Dept Neurol, Bonn, Germany.	marcus_m.mueller@ukb.uni-bonn.de	Zimmermann, Julian/ABQ-0926-2022; Hofer, Markus J/C-3688-2013; Heneka, Michael/AAE-8011-2019; Heneka, Michael/E-8072-2015	Zimmermann, Julian/0000-0003-1964-0078; Hofer, Markus J/0000-0001-5111-3978; Heneka, Michael/0000-0003-4996-1630	University of Sydney; Deutsche Forschungsgemeinschaft (DFG) [Mu17-07/3-1]; "Innovative Medical Research'' of the University of Munster Medical School, Germany; University of Bonn Medical School, Germany; DFG [KFO177]	University of Sydney(University of Sydney); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); "Innovative Medical Research'' of the University of Munster Medical School, Germany; University of Bonn Medical School, Germany; DFG(German Research Foundation (DFG))	This work was supported by a start up grant from the University of Sydney to ILC. MM was a post-doctoral fellow from the Deutsche Forschungsgemeinschaft (DFG, Mu17-07/3-1) and was also supported by the fund "Innovative Medical Research'' of the University of Munster Medical School, Germany. JZ was funded by the fund "Bonfor'' from the University of Bonn Medical School, Germany and the DFG (KFO177, University of Bonn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwa Y, 1998, J IMMUNOL, V161, P5016; Audoy-Remus J, 2008, J NEUROSCI, V28, P10187, DOI 10.1523/JNEUROSCI.3510-08.2008; Ay I, 2008, BRAIN RES, V1234, P198, DOI 10.1016/j.brainres.2008.07.121; Bancroft JD, 2002, J NEUROPATH EXP NEUR, V5th; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bohatschek M, 2001, EXP NEUROL, V172, P137, DOI 10.1006/exnr.2001.7764; Boztug K, 2002, J IMMUNOL, V169, P1505, DOI 10.4049/jimmunol.169.3.1505; Bruce D, 2011, INT IMMUNOL, V23, P519, DOI 10.1093/intimm/dxr045; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Campbell IL, 2010, BBA-MOL BASIS DIS, V1802, P903, DOI 10.1016/j.bbadis.2009.10.004; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chiang CS, 1996, J CLIN INVEST, V97, P1512, DOI 10.1172/JCI118574; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; De Haas AH, 2008, GLIA, V56, P888, DOI 10.1002/glia.20663; Erbel C, 2011, BASIC RES CARDIOL, V106, P125, DOI 10.1007/s00395-010-0135-y; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Ge Dongxia, 2008, Int Arch Med, V1, P19, DOI 10.1186/1755-7682-1-19; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Guiton R, 2010, J INFECT DIS, V202, P427, DOI 10.1086/653738; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Hofstetter Hh, 2009, Int MS J, V16, P12; Hoshino A, 2008, J AUTOIMMUN, V31, P79, DOI 10.1016/j.jaut.2008.03.006; Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Huppert J, 2010, FASEB J, V24, P1023, DOI 10.1096/fj.09-141978; Jiang N, 2011, J CLIN NEUROSCI, V18, P1279, DOI 10.1016/j.jocn.2011.02.010; Joshi S, 2011, MOL CELL BIOL, V31, P3653, DOI 10.1128/MCB.05020-11; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Kalueff A, 2006, NEUROREPORT, V17, P717, DOI 10.1097/01.wnr.0000215770.79281.e4; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kap YS, 2011, J NEUROIMMUNE PHARM, V6, P341, DOI 10.1007/s11481-010-9238-3; Kawanokuchi J, 2008, J NEUROIMMUNOL, V194, P54, DOI 10.1016/j.jneuroim.2007.11.006; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krauthausen M, 2011, AM J PATHOL, V179, P2346, DOI 10.1016/j.ajpath.2011.07.041; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li GZ, 2005, SCAND J IMMUNOL, V62, P481, DOI 10.1111/j.1365-3083.2005.01683.x; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Liu YH, 2011, J IMMUNOL, V186, P3197, DOI 10.4049/jimmunol.1002016; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Ma XY, 2010, J IMMUNOL, V184, P4898, DOI 10.4049/jimmunol.1000142; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin AP, 2004, J IMMUNOL, V173, P4791, DOI 10.4049/jimmunol.173.8.4791; MUCKE L, 1991, NEW BIOL, V3, P465; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pagenstecher A, 2000, J IMMUNOL, V164, P4481, DOI 10.4049/jimmunol.164.9.4481; Paintlia MK, 2011, J NEUROCHEM, V116, P508, DOI 10.1111/j.1471-4159.2010.07136.x; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Ploix CC, 2011, BRAIN BEHAV IMMUN, V25, P883, DOI 10.1016/j.bbi.2010.09.014; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Reiman R, 2005, NEUROSCI LETT, V390, P134, DOI 10.1016/j.neulet.2005.08.022; ROUVIER E, 1993, J IMMUNOL, V150, P5445; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; Sarma JD, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-14; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Stalder AK, 1997, J IMMUNOL, V159, P1344; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Suzuki Keiji, 2003, J Stroke Cerebrovasc Dis, V12, P8, DOI 10.1053/jscd.2003.1; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Trajkovic V, 2001, J NEUROIMMUNOL, V119, P183, DOI 10.1016/S0165-5728(01)00391-5; Tran EH, 2000, J IMMUNOL, V164, P2759, DOI 10.4049/jimmunol.164.5.2759; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Uyttenhove C, 2007, ANN NY ACAD SCI, V1110, P330, DOI 10.1196/annals.1423.035; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; von Vietinghoff S, 2010, CYTOKINE GROWTH F R, V21, P463, DOI 10.1016/j.cytogfr.2010.10.003; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wyss-Coray T, 2000, AM J PATHOL, V156, P139, DOI 10.1016/S0002-9440(10)64713-X; Wyss-Coray T, 2000, ANN NY ACAD SCI, V903, P317, DOI 10.1111/j.1749-6632.2000.tb06382.x; WYSSCORAY T, 1995, AM J PATHOL, V147, P53; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zepp J, 2011, TRENDS IMMUNOL, V32, P232, DOI 10.1016/j.it.2011.02.007; Zhang GX, 2003, J IMMUNOL, V170, P2153, DOI 10.4049/jimmunol.170.4.2153; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	97	48	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57307	10.1371/journal.pone.0057307	http://dx.doi.org/10.1371/journal.pone.0057307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468966	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000089
J	Hu, G; Lu, F; Lu, MH; Liu, WC; Xu, WG; Jiang, XH; Zhai, BP				Hu, Gao; Lu, Fang; Lu, Ming-Hong; Liu, Wan-Cai; Xu, Wei-Gen; Jiang, Xue-Hui; Zhai, Bao-Ping			The Influence of Typhoon Khanun on the Return Migration of Nilaparvata lugens (Stal) in Eastern China	PLOS ONE			English	Article							SOGATELLA-FURCIFERA HORVATH; BROWN PLANTHOPPER; RICE PLANTHOPPERS; NORTHWARD MIGRATION; DELPHACIDAE; HOMOPTERA; FLIGHT	Migratory insects adapt to and exploit the atmospheric environment to complete their migration and maintain their population. However, little is known about the mechanism of insect migration under the influence of extreme weather conditions such as typhoons. A case study was conducted to investigate the effect of typhoon Khanun, which made landfall in the eastern China in Sept. 2005, on the migration of brown planthopper, Nilaparvata lugens (Stal). The migration pathways of N. lugens were reconstructed for the period under the influence of the typhoon by calculating trajectories using the MM5, a mesoscale numerical weather prediction model, and migration events were examined in 7 counties of the Yangtze River Delta region with ancillary information. The light trap catches and field observations indicated that the migration peak of N. lugens coincided with the period when the typhoon made landfall in this region. The trajectory analyses revealed that most emigrations from this region during this period were hampered or ended in short distances. The sources of the light-trap catches were mainly located the nearby regions of each station (i.e. mostly less than 100 km away, with a few exceeding 200 km but all less than 300 km). This disrupted emigration was very different from the usual N. lugens migration which would bring them to Hunan, Jiangxi, and southern Anhui from this region at this time of year. This study revealed that the return migration of N. lugens was suppressed by the typhoon Khanun, leading to populations remaining high in the Yangtze River Delta and exacerbating later outbreaks.	[Hu, Gao; Lu, Fang; Zhai, Bao-Ping] Nanjing Agr Univ, Coll Plant Protect, Minist Educ, Key Lab Integrated Management Crop Dis & Insect P, Nanjing, Jiangsu, Peoples R China; [Lu, Ming-Hong; Liu, Wan-Cai] China Natl Agrotec Extens & Serv Ctr, Div Pest Forecasting, Beijing, Peoples R China; [Xu, Wei-Gen; Jiang, Xue-Hui] Plant Protect Stn Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University	Zhai, BP (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Minist Educ, Key Lab Integrated Management Crop Dis & Insect P, Nanjing, Jiangsu, Peoples R China.	bpzhai@njau.edu.cn		Hu, Gao/0000-0002-1000-5687	National '973' Program of China [2010CB126200]; Youth Sci-Tech Innovation Fund of Nanjing Agricultural University [Y0201100097]	National '973' Program of China(National Basic Research Program of China); Youth Sci-Tech Innovation Fund of Nanjing Agricultural University	Funding provided by the National '973' Program of China (2010CB126200) and the Youth Sci-Tech Innovation Fund of Nanjing Agricultural University (Y0201100097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Yun-Xuan, 2005, Acta Ecologica Sinica, V25, P1107; [包云轩 Bao Yunxuan], 2008, [气象科学, Scientia Meteorologlca Sinica], V28, P450; Bottrell DG, 2012, J ASIA-PAC ENTOMOL, V15, P122, DOI 10.1016/j.aspen.2011.09.004; Cai Wenhua, 1998, Acta Phytophylacica Sinica, V25, P325; Chapman J. W., 2010, ENCY ANIMAL BEHAV, P161, DOI DOI 10.1016/B978-0-08-045337-8.00073-5; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; [陈军冰 CHEN Junbing], 2006, [计算机工程, Computer Engineering], V32, P1; Chen L., 2002, INTRO TROPICAL CYCLO; Chen R, 1986, J NANJING AGR U, V3, P23; CHEN RC, 1984, ACTA ENTOMOL SINICA, V27, P121; CHEN RC, 1980, J NANJING AGR U, V2, P42; CHENG SN, 1979, ACTA ENTOMOL SINICA, V22, P1; Cheng X. N., 2003, BROWN PLANTHOPPER OC; China meteorological administration, 2007, YB TROP CYCL 2005, V2005; Deng W., 1981, ACTA PHYTOPHYL SIN, V8, P73; Deveson ED, 2005, AUSTRAL ECOL, V30, P928, DOI 10.1111/j.1442-9993.2005.01536.x; DRAKE VA, 1988, ANNU REV ENTOMOL, V33, P183, DOI 10.1146/annurev.en.33.010188.001151; Feng Chuan-Hong, 2002, Acta Ecologica Sinica, V22, P559; GUO R, 2006, CHIN AGR YB, P376; Holland RA, 2006, SCIENCE, V313, P794, DOI 10.1126/science.1127272; Hu G, 2011, B ENTOMOL RES, V101, P187, DOI 10.1017/S0007485310000313; [胡高 HU Gao], 2007, [生态学报, Acta Ecologica Sinica], V27, P5068; Hu K. W., 1982, ACTA PHYTOPHYLACICA, V9, P73; JIANG GH, 1981, ACTA ENTOMOL SINICA, V24, P251; JIANG GH, 1982, ACTA ENTOMOL SINICA, V25, P147; Jiang YP, 2006, CHINA PLANT PROTECTI, V32, P96; Jiangsu Agricultural College Jiangsu Meteorological Bureau, 1977, JIANGSU AGR SCI, V4, P50; Kennedy J.S., 1985, Contributions in Marine Science, V27, P5; Kisimoto R., 1985, Chinese Journal of Entomology, V4, P39; KISIMOTO R, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P67; [寇媛媛 Kou Yuanyuan], 2009, [气象科学, Scientia Meteorologlca Sinica], V29, P606; Liu C.-H., 1985, Chinese Journal of Entomology, V4, P49; Mu LanFang, 2006, Chinese Bulletin of Entomology, V43, P706; Nanjing Agriculture College Dep. Plant Prot. Guangdong Acad. Agricult. Inst. Prot. Chenzou Prefect Inst. Agricult. & Guilin Prefect, 1981, ACTA ECOL SIN, V1, P49; Ohkubo N, 1971, Japanese Journal of Applied Entomology and Zoology, V15, P8; Ohkubo N, 1973, ACTA ENTOMOL SINICA, V27, P121; Otuka A, 2005, APPL ENTOMOL ZOOL, V40, P221, DOI 10.1303/aez.2005.221; Otuka A, 2005, AGR FOREST ENTOMOL, V7, P1, DOI 10.1111/j.1461-9555.2005.00236.x; Otuka A, 2008, APPL ENTOMOL ZOOL, V43, P527, DOI 10.1303/aez.2008.527; PENDER J, 1994, GRANA, V33, P112, DOI 10.1080/00173139409427843; Qian DL, 2006, ZHEJIANG AGR SCI, V6, P678; RILEY JR, 1994, B ENTOMOL RES, V84, P389, DOI 10.1017/S0007485300032521; RILEY JR, 1991, ECOL ENTOMOL, V16, P471, DOI 10.1111/j.1365-2311.1991.tb00240.x; Rosenberg J., 1999, AEROBIOLOGIA, V15, P167; Tan HQ, 1984, J NANJING AGR COLL, V7, P18; Wang Cui-hua, 2009, Yingyong Shengtai Xuebao, V20, P2506; WATANABE T, 1991, APPL ENTOMOL ZOOL, V26, P457, DOI 10.1303/aez.26.457; Westbrook JK, 1999, AGR FOREST METEOROL, V97, P263, DOI 10.1016/S0168-1923(99)00071-4; Xing JY, 2006, MARINE FORECASTS, V23, P1; [姚德宏 YAO Dehong], 2007, [中国农业气象, Chinese Journal of Agrometeorology], V28, P347; Ye ZC, 1981, CHINESE BULL ENTOMOL, V18, P97; Zeng XX, 2006, MARINE FORECASTS, V22, P13; Zhai B.-P., 2006, CHINESE BULL ENTOMOL, V43, P585; Zhai Bao-Ping, 2011, Chinese Journal of Applied Entomology, V48, P1184; Zhang Z. T., 1992, CHINA PLANT PROTECTI, V18, P48; [赵凯 ZHAO Kai], 2006, [台湾海峡, Journal of Oceanography in Taiwan Strait], V25, P414; Zhao S. F, 1992, JIANGXI NONGYE DAXUE, V4, P74; Zhong DL, 1984, CHINESE BULL ENTOMOL, V22, P97; Zhu Shude, 1994, Entomological Journal of East China, V3, P53; Zhu YQ, 1992, J APPL METEOROL, V3, P328	61	24	38	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57277	10.1371/journal.pone.0057277	http://dx.doi.org/10.1371/journal.pone.0057277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23468954	Green Published, Green Submitted, gold			2022-12-27	WOS:000315186000094
J	Ueda, P; Bonamy, AKE; Granath, F; Cnattingius, S				Ueda, Peter; Bonamy, Anna-Karin Edstedt; Granath, Fredrik; Cnattingius, Sven			Month of Birth and Mortality in Sweden: A Nation-Wide Population-Based Cohort Study	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; HIGH PREVALENCE; PREGNANT-WOMEN; SEASONALITY; WEIGHT; RISK; ADIPOSITY; LONGEVITY; PATTERNS; DISEASE	Background: Month of birth - an indicator for a variety of prenatal and early postnatal exposures - has been associated with life expectancy in adulthood. On the northern hemisphere, people born in the autumn live longer than those born during the spring. Only one study has followed a population longitudinally and no study has investigated the relation between month of birth and mortality risk below 50 years. Methods and results: In this nation-wide Swedish study, we included 6,194,745 subjects, using data from population-based health and administrative registries. The relation between month of birth ( January - December) and mortality risk was assessed by fitting Cox proportional hazard regression models using attained age as the underlying time scale. Analyses were made for ages >30, >30 to 50, >50 to 80 and >80 years. Month of birth was a significant predictor of mortality in the age-spans >30, >50 to 80, and >80 years. In models adjusted for gender and education for ages >30 and >50 to 80 years, the lowest mortality was seen for people born in November and the highest mortality in those born in the spring/summer, peaking in May for mortality >30 years (25 parts per thousand excess hazard ratio compared to November, [95% confidence interval = 16-34]) and in April for mortality >50 to 80 years (42 parts per thousand excess hazard ratio compared to November, [95% confidence interval = 30-55]). In the ages >80 years the pattern was similar but the differences in mortality between birth months were smaller. For mortality within the age-span >30 to 50 years, results were inconclusive. Conclusion: Month of birth is associated to risk of mortality in ages above 50 years in Sweden. Further studies should aim at clarifying the mechanisms behind this association.	[Ueda, Peter; Bonamy, Anna-Karin Edstedt; Granath, Fredrik; Cnattingius, Sven] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden	Karolinska Institutet	Ueda, P (corresponding author), Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden.	peter.ueda@gmail.com	Ueda, Peter/AAB-8961-2020; Bonamy, Anna-Karin E/B-7106-2012; Ueda, Peter/AGH-9915-2022	Ueda, Peter/0000-0002-3275-8743; Bonamy, Anna-Karin E/0000-0003-4552-9912; Ueda, Peter/0000-0002-3275-8743	MD-PhD Program at Karolinska Institutet	MD-PhD Program at Karolinska Institutet	The study was funded by the MD-PhD Program at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker D, 1986, LANCET, V327, P1077, DOI DOI 10.1016/S0140-6736(86)91340-1; Basile LA, 2007, J PERINATOL, V27, P568, DOI 10.1038/sj.jp.7211796; Bobak M, 2001, HUM REPROD, V16, P1512, DOI 10.1093/humrep/16.7.1512; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Chodick G, 2009, HUM BIOL, V81, P463, DOI 10.3378/027.081.0405; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Crozier SR, 2012, AM J CLIN NUTR, V96, P57, DOI 10.3945/ajcn.112.037473; Doblhammer G, 2001, P NATL ACAD SCI USA, V98, P2934, DOI 10.1073/pnas.041431898; Doblhammer G., 2014, LATE LIFE LEGACY VER; FORSDAHL A, 1978, J EPIDEMIOL COMMUN H, V32, P34, DOI 10.1136/jech.32.1.34; Gezmish O, 2010, REPROD SCI, V17, P168, DOI 10.1177/1933719109349536; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; KELLER CA, 1983, AM J EPIDEMIOL, V118, P689, DOI 10.1093/oxfordjournals.aje.a113679; Kihlbom M, 2004, J BIOSOC SCI, V36, P561, DOI 10.1017/S002193200300628X; Krishnaveni GV, 2011, AM J CLIN NUTR, V93, P628, DOI 10.3945/ajcn.110.003921; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Mirzaei F, 2011, ANN NEUROL, V70, P30, DOI 10.1002/ana.22456; Moore SE, 1997, NATURE, V388, P434, DOI 10.1038/41245; Nascimento FAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041740; OECD, 2008, ED GLANC; ORME JE, 1963, BRIT J PSYCHOL, V54, P273, DOI 10.1111/j.2044-8295.1963.tb00882.x; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Pasco JA, 2008, MED HYPOTHESES, V71, P266, DOI 10.1016/j.mehy.2008.01.033; Reffelmann T, 2011, J AM COLL CARDIOL, V57, P887, DOI 10.1016/j.jacc.2010.10.021; Rinaudo P, 2012, ANNU REV PHYSIOL, V74, P107, DOI 10.1146/annurev-physiol-020911-153245; Rousham EK, 1998, AUST NZ J PUBL HEAL, V22, P669, DOI 10.1111/j.1467-842X.1998.tb01467.x; Sachan A, 2005, AM J CLIN NUTR, V81, P1060; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Socialstyrelsen, 2011, DODS 2010 CAUS DEATH; Vaiserman AM, 2003, J ANTI-AGING MED, V6, P11, DOI 10.1089/109454503765361542; van der Meer IM, 2006, AM J CLIN NUTR, V84, P350; Villar J, 1982, Obstet Gynecol Surv, V37, P499, DOI 10.1097/00006254-198208000-00001; WARD WP, 1987, ANN HUM BIOL, V14, P495, DOI 10.1080/03014468700009341	34	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56425	10.1371/journal.pone.0056425	http://dx.doi.org/10.1371/journal.pone.0056425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457566	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700053
J	Moll, S; Ebeling, M; Weibel, F; Farina, A; Del Rosario, AA; Hoflack, JC; Pomposiello, S; Prunotto, M				Moll, Solange; Ebeling, Martin; Weibel, Franziska; Farina, Annarita; Del Rosario, Andrea Araujo; Hoflack, Jean Christophe; Pomposiello, Silvia; Prunotto, Marco			Epithelial Cells as Active Player In Fibrosis: Findings from an In Vitro Model	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; PROXIMAL TUBULE; GROWTH-FACTOR; BETA ANTIBODY; TISSUE; FIBROBLASTS; PROGRESSION; EXPRESSION; INDUCTION; AUTOPHAGY	Kidney fibrosis, a scarring of the tubulo-interstitial space, is due to activation of interstitial myofibroblasts recruited locally or systemically with consecutive extracellular matrix deposition. Newly published clinical studies correlating acute kidney injury (AKI) to chronic kidney disease (CKD) challenge this pathological concept putting tubular epithelial cells into the spotlight. In this work we investigated the role of epithelial cells in fibrosis using a simple controlled in vitro system. An epithelial/mesenchymal 3D cell culture model composed of human proximal renal tubular cells and fibroblasts was challenged with toxic doses of Cisplatin, thus injuring epithelial cells. RT-PCR for classical fibrotic markers was performed on fibroblasts to assess their modulation toward an activated myofibroblast phenotype in presence or absence of that stimulus. Epithelial cell lesion triggered a phenotypical modulation of fibroblasts toward activated myofibroblasts as assessed by main fibrotic marker analysis. Uninjured 3D cell culture as well as fibroblasts alone treated with toxic stimulus in the absence of epithelial cells were used as control. Our results, with the caveats due to the limited, but highly controllable and reproducible in vitro approach, suggest that epithelial cells can control and regulate fibroblast phenotype. Therefore they emerge as relevant target cells for the development of new preventive anti-fibrotic therapeutic approaches.	[Moll, Solange] Univ Hosp Geneva, Inst Clin Pathol, Geneva, Switzerland; [Weibel, Franziska; Del Rosario, Andrea Araujo] F Hoffmann La Roche & Co Ltd, CV & Metab DTA Dept, CH-4002 Basel, Switzerland; [Farina, Annarita] Univ Geneva, Bioinformat & Struct Biol Dept, Geneva, Switzerland	University of Geneva; Roche Holding; University of Geneva	Prunotto, M (corresponding author), F Hoffmann La Roche & Co Ltd, Nonclin Safety, CH-4002 Basel, Switzerland.	marco.prunotto@roche.com	Farina, Annarita/Y-7835-2019	Farina, Annarita/0000-0002-0099-4557				Abbate M, 2002, KIDNEY INT, V61, P2066, DOI 10.1046/j.1523-1755.2002.00380.x; ALPERS CE, 1994, J AM SOC NEPHROL, V5, P201; Breit SN, 2012, NEPHROL DIAL TRANSPL, V27, P70, DOI 10.1093/ndt/gfr575; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Ebrahimkhani MR, 2011, NAT MED, V17, P1668, DOI 10.1038/nm.2490; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; FINE LG, 1995, KIDNEY INT, V47, pS48; Fukasawa H, 2004, KIDNEY INT, V65, P63, DOI 10.1111/j.1523-1755.2004.00393.x; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; HARPER JW, 1993, CELL, V75, P805; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Inoue T, 2002, FASEB J, V16, P268, DOI 10.1096/fj.02-0442fje; Jiang HJ, 2009, DIABETES-METAB RES, V25, P232, DOI 10.1002/dmrr.940; Johnson DW, 1998, KIDNEY INT, V54, P747, DOI 10.1046/j.1523-1755.1998.00048.x; Kern EFO, 2010, AM J KIDNEY DIS, V55, P824, DOI 10.1053/j.ajkd.2009.11.009; Kilic A, 2011, J ALLERGY CLIN IMMUN, V128, P1058, DOI 10.1016/j.jaci.2011.06.017; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Lewis MP, 1996, KIDNEY INT, V49, P48, DOI 10.1038/ki.1996.7; Li YJ, 2012, KIDNEY INT, V81, P880, DOI 10.1038/ki.2011.469; McCormick LL, 1999, J IMMUNOL, V163, P5693; Megyesi J, 1999, P NATL ACAD SCI USA, V96, P10830, DOI 10.1073/pnas.96.19.10830; Nath KA, 2000, KIDNEY INT, V57, P2423, DOI 10.1046/j.1523-1755.2000.00101.x; Simonson MS, 2012, AM J PHYSIOL-RENAL, V302, pF820, DOI 10.1152/ajprenal.00424.2011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Tu ZD, 2007, NEPHROLOGY, V12, P166, DOI 10.1111/j.1440-1797.2007.00772.x; Udo K, 2010, KIDNEY INT, V78, P60, DOI 10.1038/ki.2010.68; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010; Waalen J, 2011, EUR J HAEMATOL, V87, P107, DOI 10.1111/j.1600-0609.2011.01631.x; Wang ZY, 2011, KIDNEY INT, V79, P861, DOI 10.1038/ki.2010.527; Yang L., NAT MED, V16, P143; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	37	35	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56575	10.1371/journal.pone.0056575	http://dx.doi.org/10.1371/journal.pone.0056575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457584	gold, Green Published, Green Submitted			2022-12-27	WOS:000315602700080
J	Grillo, E; Lo Rizzo, C; Bianciardi, L; Bizzarri, V; Baldassarri, M; Spiga, O; Furini, S; De Felice, C; Signorini, C; Leoncini, S; Pecorelli, A; Ciccoli, L; Mencarelli, MA; Hayek, J; Meloni, I; Ariani, F; Mari, F; Renieri, A				Grillo, Elisa; Lo Rizzo, Caterina; Bianciardi, Laura; Bizzarri, Veronica; Baldassarri, Margherita; Spiga, Ottavia; Furini, Simone; De Felice, Claudio; Signorini, Cinzia; Leoncini, Silvia; Pecorelli, Alessandra; Ciccoli, Lucia; Mencarelli, Maria Antonietta; Hayek, Joussef; Meloni, Ilaria; Ariani, Francesca; Mari, Francesca; Renieri, Alessandra			Revealing the Complexity of a Monogenic Disease: Rett Syndrome Exome Sequencing	PLOS ONE			English	Article							OXIDATIVE STRESS; MOUSE MODEL; GENOTYPE; GENES; MECP2; CANDIDATE; DAMAGE	Rett syndrome (OMIM#312750) is a monogenic disorder that may manifest as a large variety of phenotypes ranging from very severe to mild disease. Since there is a weak correlation between the mutation type in the Xq28 disease-gene MECP2/X-inactivation status and phenotypic variability, we used this disease as a model to unveil the complex nature of a monogenic disorder. Whole exome sequencing was used to analyze the functional portion of the genome of two pairs of sisters with Rett syndrome. Although each pair of sisters had the same MECP2 (OMIM*300005) mutation and balanced X-inactivation, one individual from each pair could not speak or walk, and had a profound intellectual deficit (classical Rett syndrome), while the other individual could speak and walk, and had a moderate intellectual disability (Zappella variant). In addition to the MECP2 mutation, each patient has a group of variants predicted to impair protein function. The classical Rett girls, but not their milder affected sisters, have an enrichment of variants in genes related to oxidative stress, muscle impairment and intellectual disability and/or autism. On the other hand, a subgroup of variants related to modulation of immune system, exclusive to the Zappella Rett patients are driving toward a milder phenotype. We demonstrate that genome analysis has the potential to identify genetic modifiers of Rett syndrome, providing insight into disease pathophysiology. Combinations of mutations that affect speaking, walking and intellectual capabilities may represent targets for new therapeutic approaches. Most importantly, we demonstrated that monogenic diseases may be more complex than previously thought.	[Grillo, Elisa; Lo Rizzo, Caterina; Bianciardi, Laura; Bizzarri, Veronica; Baldassarri, Margherita; Mencarelli, Maria Antonietta; Meloni, Ilaria; Ariani, Francesca; Mari, Francesca; Renieri, Alessandra] Univ Siena, I-53100 Siena, Italy; [Lo Rizzo, Caterina; Bizzarri, Veronica; Mencarelli, Maria Antonietta; Mari, Francesca; Renieri, Alessandra] Azienda Osped Univ Senese, Siena, Italy; [Spiga, Ottavia] Univ Siena, Biochem & Mol Biol, I-53100 Siena, Italy; [Furini, Simone] Univ Siena, Dept Surg & Bioengn, I-53100 Siena, Italy; [De Felice, Claudio] Azienda Osped Univ Senese AOUS Siena, Univ Hosp, Neonatal Intens Care Unit, Siena, Italy; [Signorini, Cinzia; Leoncini, Silvia; Pecorelli, Alessandra; Ciccoli, Lucia] Univ Siena, Dept Mol & Dev Med, I-53100 Siena, Italy; [Leoncini, Silvia; Pecorelli, Alessandra; Hayek, Joussef] AOUS, Univ Hosp, Child Neuropsychiat Unit, Siena, Italy	University of Siena; University of Siena; University Hospital of Siena; University of Siena; University of Siena; University of Siena; University Hospital of Siena; University of Siena; University of Siena; University Hospital of Siena	Renieri, A (corresponding author), Univ Siena, Via Laterina 8, I-53100 Siena, Italy.	alessandra.renieri@unisi.it	Meloni, Ilaria/R-6627-2018; Furini, Simone/A-7532-2013; Ariani, Francesca/A-2956-2014; Mari, Francesca/E-7737-2012; Renieri, Alessandra/K-5950-2016; Leoncini, Silvia/ABG-5652-2020; Furini, Simone/AAU-6456-2020; Mencarelli, Maria Antonietta/AAC-5615-2022; De Felice, Claudio/AAB-6859-2022	Meloni, Ilaria/0000-0002-6255-9761; Furini, Simone/0000-0002-1099-8279; Ariani, Francesca/0000-0002-0988-344X; Mari, Francesca/0000-0003-1992-1654; Renieri, Alessandra/0000-0002-0846-9220; Leoncini, Silvia/0000-0002-7027-1207; Furini, Simone/0000-0002-1099-8279; Mencarelli, Maria Antonietta/0000-0001-5131-3718; De Felice, Claudio/0000-0002-9881-3119; hayek, joussef/0000-0002-0440-2491	'Cell Lines and DNA Bank of Rett syndrome, X-linked mental retardation and other genetic diseases' (Medical Genetics Siena) - Telethon Genetic Biobank Network [GTB07001C]; Ministero della Salute [RF-2010-2315597 - Ricerca Finalizzata 2010, RF-TOS-2008-1225570 - Bando malattie rare]; MIUR	'Cell Lines and DNA Bank of Rett syndrome, X-linked mental retardation and other genetic diseases' (Medical Genetics Siena) - Telethon Genetic Biobank Network(Fondazione Telethon); Ministero della Salute(Ministry of Health, Italy); MIUR(Ministry of Education, Universities and Research (MIUR))	This work was supported by 'Cell Lines and DNA Bank of Rett syndrome, X-linked mental retardation and other genetic diseases' (Medical Genetics Siena) - Telethon Genetic Biobank Network (Project No. GTB07001C to AR), by Ministero della Salute Grant No. RF-2010-2315597 - Ricerca Finalizzata 2010 and Grant No. RF-TOS-2008-1225570 - Bando malattie rare to AR. This work was also supported by MIUR (PRIN 2008) to FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala APL, 2010, P NATL ACAD SCI USA, V107, P18208, DOI 10.1073/pnas.1012104107; Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Artuso R, 2011, J HUM GENET, V56, P508, DOI 10.1038/jhg.2011.50; Bebbington A, 2008, NEUROLOGY, V70, P868, DOI 10.1212/01.wnl.0000304752.50773.ec; BERGER R, 1995, SOMAT CELL MOLEC GEN, V21, P121, DOI 10.1007/BF02255787; Bissonnette JM, 2011, FASEB J, V25; Briede JJ, 2010, TOXICOL SCI, V114, P193, DOI 10.1093/toxsci/kfp309; De Felice C, 2012, ANN NY ACAD SCI, V1259, P121, DOI 10.1111/j.1749-6632.2012.06611.x; De Felice C, 2012, GENES NUTR, V7, P447, DOI 10.1007/s12263-012-0285-7; De Felice C, 2011, J LIPID RES, V52, P2287, DOI 10.1194/jlr.P017798; De Felice C, 2009, FREE RADICAL BIO MED, V47, P440, DOI 10.1016/j.freeradbiomed.2009.05.016; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Dorf ME, 2000, J NEUROIMMUNOL, V111, P109, DOI 10.1016/S0165-5728(00)00371-4; Dowling JJ, 2012, BRAIN, V135, P1115, DOI 10.1093/brain/aws036; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Grosser E, 2012, NEUROBIOL DIS; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Leoncini S, 2011, REDOX REP, V16, P145, DOI 10.1179/1351000211Y.0000000004; Ma Q, 2010, PHARMACOL THERAPEUT, V125, P376, DOI 10.1016/j.pharmthera.2009.11.004; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; Mahmood A, 2010, AM J NEURORADIOL, V31, P295, DOI 10.3174/ajnr.A1792; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Panayotis N, 2011, NEUROBIOL DIS, V41, P385, DOI 10.1016/j.nbd.2010.10.006; Pecorelli A, 2011, CLIN BIOCHEM, V44, P368, DOI 10.1016/j.clinbiochem.2011.01.007; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Renieri A, 2009, BRAIN DEV-JPN, V31, P208, DOI 10.1016/j.braindev.2008.04.007; Scala E, 2007, AM J MED GENET A, V143A, P2775, DOI 10.1002/ajmg.a.32002; Signorini C, 2011, CLIN CHIM ACTA, V412, P1399, DOI 10.1016/j.cca.2011.04.016; Tate P, 1996, NAT GENET, V12, P205, DOI 10.1038/ng0296-205; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; ZAPPELLA M, 1992, BRAIN DEV-JPN, V14, P98, DOI 10.1016/S0387-7604(12)80094-5; Zappella M, 2001, AM J MED GENET, V104, P14, DOI 10.1002/ajmg.10005; Zitzler J, 2004, MOL CELL PROTEOMICS, V3, P834, DOI 10.1074/mcp.M400054-MCP200	35	47	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56599	10.1371/journal.pone.0056599	http://dx.doi.org/10.1371/journal.pone.0056599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468869	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900029
J	Lobato-Pascual, A; Saether, PC; Dahle, MK; Gaustad, P; Dissen, E; Fossum, S; Daws, MR				Lobato-Pascual, Ana; Saether, Per Christian; Dahle, Maria K.; Gaustad, Peter; Dissen, Erik; Fossum, Sigbjorn; Daws, Michael R.			Rat Macrophage C-Type Lectin Is an Activating Receptor Expressed by Phagocytic Cells	PLOS ONE			English	Article							INTERSTITIAL MACROPHAGES; CELLULAR ACTIVATION; GENE; SUBPOPULATIONS; IDENTIFICATION; HETEROGENEITY; EFFICIENT; ALVEOLAR; GENERATION; DECTIN-2	Macrophage C-type lectin (MCL) is a membrane surface receptor encoded by the Antigen Presenting Lectin-like gene Complex (APLEC). We generated a mouse monoclonal antibody for the study of this receptor in the rat. We demonstrate that rat MCL is expressed on blood monocytes and neutrophils, as well as on several tissue macrophage populations, including alveolar and peritoneal cavity macrophages. We also demonstrate MCL expression on a subset of resident spleen macrophages. Immunohistochemistry analysis of the spleen showed staining specifically in the marginal zone and red pulp. Exposure to pro-inflammatory mediators or to yeast cell wall extract (zymosan) increased surface MCL expression on peritoneal macrophages. We characterized a rat myeloid cell line, RMW, which expresses high levels of MCL. We found that MCL co-immunoprecipitated with the activating adaptor protein FceRIc in these cells. Moreover, beads coated with anti-MCL antibody increased phagocytosis in the RMW cells. Together, these observations indicate that rat MCL is a receptor that activates phagocytosis in myeloid cells under inflammatory conditions.	[Lobato-Pascual, Ana; Saether, Per Christian; Dahle, Maria K.; Dissen, Erik; Fossum, Sigbjorn; Daws, Michael R.] Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway; [Dahle, Maria K.] Norwegian Vet Inst, Immunol Sect, Oslo, Norway; [Gaustad, Peter] Univ Oslo, Inst Clin Med, Oslo, Norway; [Gaustad, Peter] Oslo Univ Hosp, Dept Microbiol, Oslo, Norway	University of Oslo; Norwegian Veterinary Institute; University of Oslo; University of Oslo	Lobato-Pascual, A (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway.	a.l.pascual@medisin.uio.no	Daws, Michael/I-9179-2012; Dahle, Maria K/AAK-5130-2021	Daws, Michael/0000-0002-4128-4228; Dahle, Maria K/0000-0003-0380-084X	University of Oslo [000160]; Norwegian Research Council [143081, 196398]	University of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was funded by research grants from the University of Oslo (www.uio.no 000160) and the Norwegian Research Council (www.forskningsradet.no, Grant#143081 and 196398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce I, 2004, EUR J IMMUNOL, V34, P210, DOI 10.1002/eji.200324230; Balch SG, 1998, J BIOL CHEM, V273, P18656, DOI 10.1074/jbc.273.29.18656; Balch SG, 2002, EUR J IMMUNOGENET, V29, P61, DOI 10.1046/j.1365-2370.2002.00266.x; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Dissen E, 1997, EUR J IMMUNOL, V27, P2080, DOI 10.1002/eji.1830270836; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; Fujikado N, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1985; Garn H, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-4; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; Gorgani NN, 2008, IMMUNOL CELL BIOL, V86, P246, DOI 10.1038/sj.icb.7100131; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Huh SH, 2007, BIOLOGICALS, V35, P165, DOI 10.1016/j.biologicals.2006.08.004; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Johansson A, 1997, AM J RESP CELL MOL, V16, P582, DOI 10.1165/ajrcmb.16.5.9160840; Kveberg L, 2009, EUR J IMMUNOL, V39, P541, DOI 10.1002/eji.200838891; Landazuri N, 2006, BIOTECHNOL BIOENG, V93, P146, DOI 10.1002/bit.20697; Laskin DL, 2001, J LEUKOCYTE BIOL, V70, P163; LAVNIKOVA N, 1993, AM J RESP CELL MOL, V8, P384, DOI 10.1165/ajrcmb/8.4.384; LOHMANNMATTHES ML, 1994, EUR RESPIR J, V7, P1678; Marshall ASJ, 2006, EUR J IMMUNOL, V36, P2159, DOI 10.1002/eji.200535628; McGreal EP, 2004, MOL IMMUNOL, V41, P1109, DOI 10.1016/j.molimm.2004.06.013; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mesci A, 2007, J IMMUNOL METHODS, V323, P78, DOI 10.1016/j.jim.2007.02.007; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nestvold J, 2004, SCAND J IMMUNOL, V60, P153, DOI 10.1111/j.0300-9475.2004.01436.x; Ritter M, 2010, P NATL ACAD SCI USA, V107, P20459, DOI 10.1073/pnas.1010337107; Saether PC, 2008, J IMMUNOL, V181, P3177, DOI 10.4049/jimmunol.181.5.3177; Schurr JR, 2005, INFECT IMMUN, V73, P532, DOI 10.1128/IAI.73.1.532-545.2005; Steiniger B, 2001, SPLEEN; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106	38	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57406	10.1371/journal.pone.0057406	http://dx.doi.org/10.1371/journal.pone.0057406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468983	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900083
J	Suarez-Arroyo, IJ; Rosario-Acevedo, R; Aguilar-Perez, A; Clemente, PL; Cubano, LA; Serrano, J; Schneider, RJ; Martinez-Montemayor, MM				Suarez-Arroyo, Ivette J.; Rosario-Acevedo, Raysa; Aguilar-Perez, Alexandra; Clemente, Pedro L.; Cubano, Luis A.; Serrano, Juan; Schneider, Robert J.; Martinez-Montemayor, Michelle M.			Anti-Tumor Effects of Ganoderma lucidum (Reishi) in Inflammatory Breast Cancer in In Vivo and In Vitro Models	PLOS ONE			English	Article							PATHWAY ACTIVATION; SIGNALING PATHWAY; PI3K PATHWAY; GROWTH; INHIBITION; CELLS; MTOR; PROLIFERATION; MODULATION; EXPRESSION	The medicinal mushroom Ganoderma lucidum (Reishi) was tested as a potential therapeutic for Inflammatory Breast Cancer (IBC) using in vivo and in vitro IBC models. IBC is a lethal and aggressive form of breast cancer that manifests itself without a typical tumor mass. Studies show that IBC tissue biopsies overexpress E-cadherin and the eukaryotic initiation factor 4GI (eIF4GI), two proteins that are partially responsible for the unique pathological properties of this disease. IBC is treated with a multimodal approach that includes non-targeted systemic chemotherapy, surgery, and radiation. Because of its non-toxic and selective anti-cancer activity, medicinal mushroom extracts have received attention for their use in cancer therapy. Our previous studies demonstrate these selective anti-cancer effects of Reishi, where IBC cell viability and invasion, as well as the expression of key IBC molecules, including eIF4G is compromised. Thus, herein we define the mechanistic effects of Reishi focusing on the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, a regulator of cell survival and growth. The present study demonstrates that Reishi treated IBC SUM-149 cells have reduced expression of mTOR downstream effectors at early treatment times, as we observe reduced eIF4G levels coupled with increased levels of eIF4E bound to 4E-BP, with consequential protein synthesis reduction. Severe combined immunodeficient mice injected with IBC cells treated with Reishi for 13 weeks show reduced tumor growth and weight by similar to 50%, and Reishi treated tumors showed reduced expression of E-cadherin, mTOR, eIF4G, and p70S6K, and activity of extracellular regulated kinase (ERK1/2). Our results provide evidence that Reishi suppresses protein synthesis and tumor growth by affecting survival and proliferative signaling pathways that act on translation, suggesting that Reishi is a potential natural therapeutic for breast and other cancers.	[Suarez-Arroyo, Ivette J.; Rosario-Acevedo, Raysa; Aguilar-Perez, Alexandra; Clemente, Pedro L.; Martinez-Montemayor, Michelle M.] Univ Cent Caribe, Sch Med, Dept Biochem, Bayamon, PR USA; [Cubano, Luis A.] Univ Cent Caribe, Sch Med, Dept Anat & Cell Biol, Bayamon, PR USA; [Serrano, Juan] San Pablo Pathol, Bayamon, PR USA; [Schneider, Robert J.] NYU, Inst Canc, New York, NY USA	New York University	Martinez-Montemayor, MM (corresponding author), Univ Cent Caribe, Sch Med, Dept Biochem, Bayamon, PR USA.	mmmtz92@gmail.com	Martínez-Montemayor, Michelle/X-6880-2019	Martínez-Montemayor, Michelle/0000-0002-6933-9905; Schneider, Robert/0000-0001-5807-5564; Suarez-Arroyo, Ivette/0000-0002-5252-9227	American Institute for Cancer Research (AICR) [PDA-08A095]; National Institutes of Health/National Center for Research Resources/Research Center for Minority Institutions [2G12RR003035]; National Institutes of Health/National Institute on Minority Health and Health Disparities/Research Center for Minority Institutions [8G12MD007583]; Commonwealth of Puerto Rico; US Dept. of Education [P031M105050]; Breast Cancer Research Foundation; Avon Foundation for Women; U.S. Department of Defense; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	American Institute for Cancer Research (AICR); National Institutes of Health/National Center for Research Resources/Research Center for Minority Institutions; National Institutes of Health/National Institute on Minority Health and Health Disparities/Research Center for Minority Institutions; Commonwealth of Puerto Rico; US Dept. of Education; Breast Cancer Research Foundation; Avon Foundation for Women; U.S. Department of Defense(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by a grant from the American Institute for Cancer Research (AICR)-PDA-08A095 to MMM, National Institutes of Health/National Center for Research Resources/Research Center for Minority Institutions 2G12RR003035 and National Institutes of Health/National Institute on Minority Health and Health Disparities/Research Center for Minority Institutions 8G12MD007583 to Universidad Central del Caribe-School of Medicine (UCC-SOM), and a grant from the Commonwealth of Puerto Rico to UCC-SOM-Centro Universitario de Medicina Integral y Complementaria (CUMIC). ISA was supported from Title V PPOHA grant number P031M105050 from the US Dept. of Education to UCC-SOM. RJS was supported by grants from the Breast Cancer Research Foundation, the Avon Foundation for Women, and the U.S. Department of Defense Breast Cancer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amornphimoltham P, 2005, CANCER RES, V65, P9953, DOI 10.1158/0008-5472.CAN-05-0921; Carlson AL, 2006, LASER SURG MED, V38, P928, DOI 10.1002/lsm.20409; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Castillo-Pichardo L, 2009, CLIN EXP METASTAS, V26, P505, DOI 10.1007/s10585-009-9250-2; Chen NH, 2010, PHARMACOL REP, V62, P150, DOI 10.1016/S1734-1140(10)70252-8; Chen X, 2006, INT IMMUNOPHARMACOL, V6, P499, DOI 10.1016/j.intimp.2005.08.026; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Davies CC, 2004, J BIOL CHEM, V279, P1010, DOI 10.1074/jbc.M303820200; Dumstorf CA, 2010, MOL CANCER THER, V9, P3158, DOI 10.1158/1535-7163.MCT-10-0413; Ethier SP, 1996, CANCER RES, V56, P899; Fudge K, 1996, PROSTATE, V29, P282; Gingras AC, 2001, GENE DEV, V15, P2852; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hernandez-Aya LF, 2011, ONCOLOGIST, V16, P404, DOI 10.1634/theoncologist.2010-0402; Jiang JH, 2004, NUTR CANCER, V49, P209, DOI 10.1207/s15327914nc4902_13; Joseph S, 2011, ACTA PHARMACEUT, V61, P335, DOI 10.2478/v10007-011-0030-6; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lin SB, 2003, LIFE SCI, V72, P2381, DOI 10.1016/S0024-3205(03)00124-3; Lin ZB, 2005, J PHARMACOL SCI, V99, P144, DOI 10.1254/jphs.CRJ05008X; Lo AC, 2009, BREAST, V18, P55, DOI 10.1016/j.breast.2008.11.002; Lopez-Knowles E, 2010, INT J CANCER, V126, P1121, DOI 10.1002/ijc.24831; Martinez-Montemayor MM, 2011, NUTR CANCER, V63, P1085, DOI 10.1080/01635581.2011.601845; Martinez-Montemayor MM, 2010, CLIN EXP METASTAS, V27, P465, DOI 10.1007/s10585-010-9336-x; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Robertson FM, 2010, CA-CANCER J CLIN, V60, P351, DOI 10.3322/caac.20082; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Sliva D, 2004, MINI-REV MED CHEM, V4, P873, DOI 10.2174/1389557043403323; Sliva D, 2002, BIOCHEM BIOPH RES CO, V298, P603, DOI 10.1016/S0006-291X(02)02496-8; Slivova V, 2005, NUTR CANCER, V52, P66, DOI 10.1207/s15327914nc5201_9; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Tsutsumi N, 2004, CIRC RES, V94, P1186, DOI 10.1161/01.RES.0000126925.66005.39; Yuen JWM, 2008, NUTR CANCER, V60, P109, DOI 10.1080/01635580701525869; Zhu XL, 2007, J ETHNOPHARMACOL, V111, P219, DOI 10.1016/j.jep.2006.11.013	36	64	69	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57431	10.1371/journal.pone.0057431	http://dx.doi.org/10.1371/journal.pone.0057431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468988	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900088
J	Loftis, JM; Wilhelm, CJ; Vandenbark, AA; Huckans, M				Loftis, Jennifer M.; Wilhelm, Clare J.; Vandenbark, Arthur A.; Huckans, Marilyn			Partial MHC/Neuroantigen Peptide Constructs: A Potential Neuroimmune-Based Treatment for Methamphetamine Addiction	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; BLOOD-BRAIN-BARRIER; MIGRATION INHIBITORY FACTOR; CELL-RECEPTOR LIGAND; WHITE-MATTER; DEPENDENT INDIVIDUALS; MICROGLIAL ACTIVATION; COGNITIVE ENHANCEMENT; PSYCHIATRIC-SYMPTOMS; STIMULANT ADDICTION	Relapse rates following current methamphetamine abuse treatments are very high (similar to 40-60%), and the neuropsychiatric impairments (e. g., cognitive deficits, mood disorders) that arise and persist during remission from methamphetamine addiction likely contribute to these high relapse rates. Pharmacotherapeutic development of medications to treat addiction has focused on neurotransmitter systems with only limited success, and there are no Food and Drug Administration approved pharmacotherapies for methamphetamine addiction. A growing literature shows that methamphetamine alters peripheral and central immune functions and that immune factors such as cytokines, chemokines, and adhesion molecules play a role in the development and persistence of methamphetamine induced neuronal injury and neuropsychiatric impairments. The objective of this study was to evaluate the efficacy of a new immunotherapy, partial MHC/neuroantigen peptide construct (RTL551; pI-A(b)/mMOG-35-55), in treating learning and memory impairments induced by repeated methamphetamine exposure. C57BL/6J mice were exposed to two different methamphetamine treatment regimens (using repeated doses of 4 mg/kg or 10 mg/kg, s.c.). Cognitive performance was assessed using the Morris water maze and CNS cytokine levels were measured by multiplex assay. Immunotherapy with RTL551 improved the memory impairments induced by repeated methamphetamine exposure in both mouse models of chronic methamphetamine addiction. Treatment with RTL551 also attenuated the methamphetamine induced increases in hypothalamic interleukin-2 (IL-2) levels. Collectively, these initial results indicate that neuroimmune targeted therapies, and specifically RTL551, may have potential as treatments for methamphetamine-induced neuropsychiatric impairments.	[Loftis, Jennifer M.; Wilhelm, Clare J.; Vandenbark, Arthur A.; Huckans, Marilyn] Portland VA Med Ctr, Portland, OR USA; [Huckans, Marilyn] Portland VA Med Ctr, Behav Hlth & Clin Neurosci Div, Portland, OR USA; [Loftis, Jennifer M.; Wilhelm, Clare J.; Huckans, Marilyn] Oregon Hlth & Sci Univ, Dept Psychiat, Sch Med, Portland, OR 97201 USA; [Vandenbark, Arthur A.] Oregon Hlth & Sci Univ, Sch Med, Dept Neurol, Portland, OR 97201 USA; [Vandenbark, Arthur A.] Oregon Hlth & Sci Univ, Sch Med, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Loftis, JM (corresponding author), Portland VA Med Ctr, Portland, OR USA.	loftisj@ohsu.edu	Loftis, Jennifer/AAI-5054-2020	Wilhelm, Clare/0000-0003-2437-5387; Loftis, Jennifer/0000-0003-1773-9365	National Institutes of Health [RC1DA028537, R41DA029345]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences Research and Development; Methamphetamine Abuse Research Center, Portland, OR [NIDA P50DA018165]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA018165, RC1DA028537, R41DA029345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences Research and Development(US Department of Veterans Affairs); Methamphetamine Abuse Research Center, Portland, OR; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants RC1DA028537 and R41DA029345 to JML and MH. JML (Research Scientist) and MH (Staff Psychologist and Neuropsychologist) are supported by career development awards from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences Research and Development. This research was supported, in part, by the Methamphetamine Abuse Research Center, Portland, OR (NIDA P50DA018165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DN, 2004, J NEUROCHEM, V88, P1211, DOI 10.1046/j.1471-4159.2003.02247.x; Bae SC, 2006, DRUG ALCOHOL DEPEN, V81, P83, DOI 10.1016/j.drugalcdep.2005.05.016; Berman S, 2008, ANN NY ACAD SCI, V1141, P195, DOI 10.1196/annals.1441.031; Bowyer JF, 2006, SYNAPSE, V60, P521, DOI 10.1002/syn.20324; Calandra T, 1997, CRIT REV IMMUNOL, V17, P77, DOI 10.1615/CritRevImmunol.v17.i1.30; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Carson DS, 2010, ADDICT BIOL, V15, P448, DOI 10.1111/j.1369-1600.2010.00247.x; Chung A, 2007, INT J NEUROPSYCHOPH, V10, P765, DOI 10.1017/Sl461145706007395; Cloak CC, 2009, NEUROLOGY, V72, P2068, DOI 10.1212/01.wnl.0000346516.49126.20; Dai HM, 2004, ANN NY ACAD SCI, V1025, P257, DOI 10.1196/annals.1316.032; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Duvoisin RM, 2010, BEHAV BRAIN RES, V209, P21, DOI 10.1016/j.bbr.2010.01.006; Glasner-Edwards S, 2010, DRUG ALCOHOL REV, V29, P12, DOI 10.1111/j.1465-3362.2009.00081.x; Goncalves J, 2010, EUR J NEUROSCI, V31, P315, DOI 10.1111/j.1460-9568.2009.07059.x; Heinzerling KG, 2010, DRUG ALCOHOL DEPEN, V109, P20, DOI 10.1016/j.drugalcdep.2009.11.023; Hoffman W, 2008, PSYCHOPHARMACOLOGY, V201, P183, DOI 10.1007/s00213-008-1261-1; Hoffman WF, 2006, PSYCHOPHARMACOLOGY, V188, P162, DOI 10.1007/s00213-006-0494-0; Huckans MS, 2011, BRAIN BEHAV IMMUN, V25, pS227; Hulse RE, 2004, J NEUROSCI METH, V136, P87, DOI 10.1016/j.jneumeth.2003.12.023; In SW, 2005, J TOXICOL ENV HEAL A, V68, P2133, DOI 10.1080/15287390500177156; In SW, 2004, J TOXICOL ENV HEAL A, V67, P1923, DOI 10.1080/15287390490514589; Jia F, 2008, J PHARMACOL SCI, V107, P167, DOI 10.1254/jphs.FP0072424; Johnson BA, 2008, INT J NEUROPSYCHOPH, V11, P1, DOI 10.1017/S1461145707007778; King G, 2010, J NEUROIMMUNE PHARM, V5, P582, DOI 10.1007/s11481-010-9206-y; Kuroda KO, 2010, NEUROPSYCHOPHARMACOL, V35, P641, DOI 10.1038/npp.2009.169; Liang H, 2008, AM J PATHOL, V172, P1617, DOI 10.2353/ajpath.2008.070971; Loftis JM, 2011, NEUROTOX RES, V20, P59, DOI 10.1007/s12640-010-9223-x; Loftis JM, 2011, ADDICTION, V106, P1021, DOI 10.1111/j.1360-0443.2010.03354.x; London ED, 2004, ARCH GEN PSYCHIAT, V61, P73, DOI 10.1001/archpsyc.61.1.73; Madden LJ, 2005, NEUROPSYCHOPHARMACOL, V30, P350, DOI 10.1038/sj.npp.1300575; Mahajan SD, 2008, BRAIN RES, V1203, P133, DOI 10.1016/j.brainres.2008.01.093; Martinez LR, 2009, J INFECT DIS, V200, P131, DOI 10.1086/599328; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Newton TF, 2009, AM J ADDICTION, V18, P294, DOI 10.1080/10550490902925920; Oh JS, 2005, NEUROSCI LETT, V384, P76, DOI 10.1016/j.neulet.2005.04.082; Ramirez SH, 2009, J CEREBR BLOOD F MET, V29, P1933, DOI 10.1038/jcbfm.2009.112; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Salo R, 2009, BIOL PSYCHIAT, V65, P122, DOI 10.1016/j.biopsych.2008.08.004; Schwartz DL, 2010, NEUROIMAGE, V50, P1392, DOI 10.1016/j.neuroimage.2010.01.056; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; Shah A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-52; Sharma HS, 2009, J CHEM NEUROANAT, V37, P18, DOI 10.1016/j.jchemneu.2008.08.002; Shoptaw S, 2003, J PSYCHOACTIVE DRUGS, P161, DOI 10.1080/02791072.2003.10400511; Silverstein PS, 2011, J NEUROVIROL, V17, P401, DOI 10.1007/s13365-011-0043-4; Sinha S, 2007, J NEUROSCI, V27, P12531, DOI 10.1523/JNEUROSCI.3599-07.2007; Sinha S, 2009, J NEUROSCI, V29, P3816, DOI 10.1523/JNEUROSCI.5812-08.2009; Sofuoglu M, 2010, ADDICTION, V105, P38, DOI 10.1111/j.1360-0443.2009.02791.x; Subramanian S, 2009, STROKE, V40, P2539, DOI 10.1161/STROKEAHA.108.543991; Thomas DM, 2004, J PHARMACOL EXP THER, V311, P1, DOI 10.1124/jpet.104.070961; Vandenbark AA, 2003, J IMMUNOL, V171, P127, DOI 10.4049/jimmunol.171.1.127; Vandenbark AA, 2012, J AUTOIMMUN; Volkow ND, 2009, JAMA-J AM MED ASSOC, V301, P1148, DOI 10.1001/jama.2009.351; Wang CH, 2006, J NEUROCHEM, V98, P1817, DOI 10.1111/j.1471-4159.2006.04081.x; Wilhelm CJ, 2012, NEUROPHARMACOLOGY, V62, P313, DOI 10.1016/j.neuropharm.2011.07.040; Wires ES, 2012, J NEUROVIROL; Wisor JP, 2011, BRAIN BEHAV IMMUN, V25, P767, DOI 10.1016/j.bbi.2011.02.002; Yamamoto BK, 2008, J NEUROIMMUNE PHARM, V3, P203, DOI 10.1007/s11481-008-9121-7; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x; Ye L, 2008, J VIRAL HEPATITIS, V15, P261, DOI 10.1111/j.1365-2893.2007.00940.x; Zweben JE, 2004, AM J ADDICTION, V13, P181, DOI 10.1080/10550490490436055	61	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56306	10.1371/journal.pone.0056306	http://dx.doi.org/10.1371/journal.pone.0056306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460798	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000021
J	Roy, C; Paglialunga, S; Schaart, G; Moonen-Kornips, E; Meex, RC; Phielix, E; Hoeks, J; Hesselink, MKC; Cianflone, K; Schrauwen, P				Roy, Christian; Paglialunga, Sabina; Schaart, Gert; Moonen-Kornips, Esther; Meex, Ruth C.; Phielix, Esther; Hoeks, Joris; Hesselink, Matthijs K. C.; Cianflone, Katherine; Schrauwen, Patrick			Relationship of C5L2 Receptor to Skeletal Muscle Substrate Utilization	PLOS ONE			English	Article							ACYLATION-STIMULATING PROTEIN; INDUCED INSULIN-RESISTANCE; FATTY-ACID OXIDATION; LIPOPROTEIN-LIPASE; ADIPOSE-TISSUE; TRIACYLGLYCEROL SYNTHESIS; TRIGLYCERIDE SYNTHESIS; GLUCOSE-TRANSPORT; LIPID-CONTENT; IN-VIVO	Objective: To investigate the role of Acylation Stimulating Protein (ASP) receptor C5L2 in skeletal muscle fatty acid accumulation and metabolism as well as insulin sensitivity in both mice and human models of diet-induced insulin resistance. Design and Methods: Male wildtype (WT) and C5L2 knockout (KO) mice were fed a low (LFD) or a high (HFD) fat diet for 10 weeks. Intramyocellular lipid (IMCL) accumulation (by oil red O staining) and beta-oxidation HADH enzyme activity were determined in skeletal muscle. Mitochondria were isolated from hindleg muscles for high-resolution respirometry. Muscle C5L2 protein content was also determined in obese type 2 diabetics and age- and BMI matched men. Results: IMCL levels were increased by six-fold in C5L2KO-HFD compared to WT-HFD mice (p<0.05) and plasma insulin levels were markedly increased in C5L2KO-HFD mice (twofold, p<0.05). Muscle HADH activity was elevated in C5L2KO-LFD mice (+75%, p<0.001 vs. WT-LFD) and C5L2KO-HFD displayed increased mitochondrial fatty acid oxidative capacity compared to WT-HFD mice (+23%, p<0.05). In human subjects, C5L2 protein content was reduced (-48%, p<0.01) in type 2 diabetic patients when compared to obese controls. Further, exercise training increased C5L2 (+45%, p = 0.0019) and ASP (+80%, p<0.001) in obese insulin-resistant men. Conclusion: The results suggest that insulin sensitivity may be permissive for coupling of C5L2 levels to lipid storage and utilization.	[Roy, Christian; Cianflone, Katherine] Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Paglialunga, Sabina; Moonen-Kornips, Esther; Phielix, Esther; Hoeks, Joris; Schrauwen, Patrick] Maastricht Univ Med Ctr, Dept Human Biol, Sch Nutr Toxicol & Metab, NUTRIM, Maastricht, Netherlands; [Schaart, Gert; Meex, Ruth C.; Hesselink, Matthijs K. C.] Maastricht Univ Med Ctr, Dept Human Movement Sci, Sch Nutr Toxicol & Metab, NUTRIM, Maastricht, Netherlands	Laval University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Cianflone, K (corresponding author), Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	katherine.cianflone@criucpq.ulaval.ca	Phielix, Esther/U-8149-2018	Phielix, Esther/0000-0002-2672-0415; Hoeks, Joris/0000-0002-0265-0870; schrauwen, patrick/0000-0002-0973-847X	'VICI' Research Grant for innovative research from the Netherlands Organization for Scientific Research, The Hague, The Netherlands [918.96.618]; 'VIDI' Research Grant for innovative research from the Netherlands Organization for Scientific Research, The Hague, The Netherlands [917.66.359]; NSERC research grant; CIHR doctoral fellowship; FRSQ grant for international traineeship	'VICI' Research Grant for innovative research from the Netherlands Organization for Scientific Research, The Hague, The Netherlands; 'VIDI' Research Grant for innovative research from the Netherlands Organization for Scientific Research, The Hague, The Netherlands; NSERC research grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR doctoral fellowship(Canadian Institutes of Health Research (CIHR)); FRSQ grant for international traineeship	PS is supported by a 'VICI' (Grant 918.96.618) and MH by a 'VIDI' (Grant 917.66.359) Research Grant for innovative research from the Netherlands Organization for Scientific Research, The Hague, The Netherlands. KC holds a Canada Research Chair in Adipose Tissue and this study was supported by an NSERC research grant. CR is supported by a CIHR doctoral fellowship and a FRSQ grant for international traineeship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2003, INT J OBESITY, V27, P1037, DOI 10.1038/sj.ijo.0802369; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; BOIVIN A, 1994, AM J PHYSIOL-ENDOC M, V267, pE620, DOI 10.1152/ajpendo.1994.267.4.E620; Cianflone K, 2004, J LIPID RES, V45, P124, DOI 10.1194/jlr.M300214-JLR200; Cianflone K, 2003, BBA-BIOMEMBRANES, V1609, P127, DOI 10.1016/S0005-2736(02)00686-7; CIANFLONE K, 1994, BIOCHEMISTRY-US, V33, P9489, DOI 10.1021/bi00198a014; Cianflone K, 1999, SEMIN CELL DEV BIOL, V10, P31, DOI 10.1006/scdb.1998.0272; Cui W, 2009, MOL IMMUNOL, V46, P3207, DOI 10.1016/j.molimm.2009.08.013; Faraj M, 2004, AM J PHYSIOL-ENDOC M, V287, pE150, DOI 10.1152/ajpendo.00398.2003; Faraj M, 2004, J LIPID RES, V45, P657, DOI 10.1194/jlr.M300299-JLR200; Faraj M, 2003, J CLIN ENDOCR METAB, V88, P1594, DOI 10.1210/jc.2002-021309; Fisette A, 2012, IMMUNOBIOLO IN PRESS; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; GERMINARIO R, 1993, METABOLISM, V42, P574, DOI 10.1016/0026-0495(93)90215-A; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Hoeks J, 2012, J CELL PHYSIOL, V227, P1026, DOI 10.1002/jcp.22812; Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519; Holloway GP, 2010, DIABETES, V59, P819, DOI 10.2337/db09-1519; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; MacLaren R, 2007, BIOCHEM CELL BIOL, V85, P11, DOI 10.1139/O06-207; Maslowska M, 2006, J LIPID RES, V47, P643, DOI 10.1194/jlr.M500500-JLR200; Maslowska M, 1999, EUR J CLIN INVEST, V29, P679, DOI 10.1046/j.1365-2362.1999.00514.x; Meex RCR, 2010, DIABETES, V59, P572, DOI 10.2337/db09-1322; Murray I, 1997, J LIPID RES, V38, P2492; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Paglialunga S, 2012, DIABETOLOGIA, V55, P2759, DOI 10.1007/s00125-012-2626-x; Paglialunga S, 2007, J ENDOCRINOL, V194, P293, DOI 10.1677/JOE-07-0205; Paglialunga S, 2009, J LIPID RES, V50, P1109, DOI 10.1194/jlr.M800430-JLR200; Phielix E, 2012, DIABETES, V61, P2472, DOI 10.2337/db11-1832; Picard F, 1999, DIABETES, V48, P452, DOI 10.2337/diabetes.48.3.452; RANDLE PJ, 1963, LANCET, V1, P785; Roorda BD, 2005, J LIPID RES, V46, P230, DOI 10.1194/jlr.M400416-JLR200; Roy C, 2008, AM J PHYSIOL-ENDOC M, V294, pE1051, DOI 10.1152/ajpendo.00689.2007; Saleh J, 1998, J LIPID RES, V39, P884; Schrauwen P, 2005, INT J OBESITY, V29, P632, DOI 10.1038/sj.ijo.0802949; Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P968, DOI 10.1016/j.bbabio.2010.02.033; Tao YH, 1997, BBA-LIPID LIPID MET, V1344, P221, DOI 10.1016/S0005-2760(96)00144-0; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Wen Y, 2008, J CELL BIOCHEM, V105, P404, DOI 10.1002/jcb.21838; Xia ZN, 2004, J BIOL CHEM, V279, P4051, DOI 10.1074/jbc.M311319200; Zhang X, 2010, J IMMUNOL, V185, P6741, DOI 10.4049/jimmunol.1000892	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57494	10.1371/journal.pone.0057494	http://dx.doi.org/10.1371/journal.pone.0057494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460866	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000121
J	Tasset-Cuevas, I; Fernandez-Bedmar, Z; Lozano-Baena, MD; Campos-Sanchez, J; de Haro-Bailon, A; Munoz-Serrano, A; Alonso-Moraga, A				Tasset-Cuevas, Inmaculada; Fernandez-Bedmar, Zahira; Dolores Lozano-Baena, Maria; Campos-Sanchez, Juan; de Haro-Bailon, Antonio; Munoz-Serrano, Andres; Alonso-Moraga, Angeles			Protective Effect of Borage Seed Oil and Gamma Linolenic Acid on DNA: In Vivo and In Vitro Studies	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; EICOSAPENTAENOIC ACID; SOMATIC MUTATION; OXIDATIVE STRESS; FATTY-ACIDS; ARACHIDONIC-ACID; LIFE-SPAN; MODEL; CYTOTOXICITY; GENOTOXICITY	Borage (Borago officinalis L.) seed oil has been used as a treatment for various degenerative diseases. Many useful properties of this oil are attributed to its high gamma linolenic acid content (GLA, 18:3 omega-6). The purpose of this study was to demonstrate the safety and suitability of the use of borage seed oil, along with one of its active components, GLA, with respect to DNA integrity, and to establish possible in vivo toxic and in vitro cytotoxic effects. In order to measure these properties, five types of assays were carried out: toxicity, genotoxicity, antigenotoxicity, cytotoxicity (using the promyelocytic leukaemia HL60 cell line), and life span (in vivo analysis using the Drosophila model). Results showed that i) Borage seed oil is not toxic to D. melanogaster at physiological concentrations below 125 ml/ml and the studies on GLA indicated non-toxicity at the lowest concentration analyzed ii) Borage seed oil and GLA are DNA safe (non-genotoxic) and antimutagenic compared to hydrogen peroxide, thereby confirming its antioxidant capacity; iii) Borage seed oil and GLA exhibited cytotoxic activity in low doses (IC50 of 1 mu l/ml and 0.087 mM, respectively) iv) Low doses of borage seed oil (0.19%) increased the health span of D. melanogaster; and v) GLA significantly decreased the life span of D. melanogaster. Based on the antimutagenic and cytotoxic effects along with the ability to increase the health span, we propose supplementation with borage seed oil rather than GLA, because it protects DNA by modulating oxidative genetic damage in D. melanogaster, increases the health span and exerts cytotoxic activity towards promyelocytic HL60 cells.	[Tasset-Cuevas, Inmaculada] Univ Cordoba, Fac Med, Inst Maimonides Invest Biomed Cordoba IMIBIC, Dept Bioquim & Biol Mol, Cordoba, Spain; [Fernandez-Bedmar, Zahira; Campos-Sanchez, Juan; Munoz-Serrano, Andres; Alonso-Moraga, Angeles] Univ Cordoba, Fac Ciencias, Dept Genet, E-14004 Cordoba, Spain; [Dolores Lozano-Baena, Maria; de Haro-Bailon, Antonio] CSIC, Inst Agr Sostenible, Cordoba, Spain	Universidad de Cordoba; Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Tasset-Cuevas, I (corresponding author), Univ Cordoba, Fac Med, Inst Maimonides Invest Biomed Cordoba IMIBIC, Dept Bioquim & Biol Mol, Cordoba, Spain.	b72tacui@uco.es	Cuevas, Inmaculada Tasset/R-4509-2019	Cuevas, Inmaculada Tasset/0000-0003-0730-6750; de Haro-Bailon, Antonio/0000-0001-6726-5343; Lozano-Baena, Maria-Dolores/0000-0001-6249-0955				ABRAHAM SK, 1994, MUTAGENESIS, V9, P383, DOI 10.1093/mutage/9.4.383; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Al-Khamees WA, 2011, J MED TOXICOL, V7, P154, DOI 10.1007/s13181-011-0135-9; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Anter J, 2011, MUTAT RES-GEN TOX EN, V723, P165, DOI 10.1016/j.mrgentox.2011.05.005; Avanesian A, 2010, BIOGERONTOLOGY, V11, P45, DOI 10.1007/s10522-009-9227-1; Bahadorani S, 2008, NUTR RES, V28, P377, DOI 10.1016/j.nutres.2008.03.018; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Boyd O, 2011, FREE RADICAL BIO MED, V50, P1669, DOI 10.1016/j.freeradbiomed.2011.03.011; Brosche T, 2000, ARCH GERONTOL GERIAT, V30, P139, DOI 10.1016/S0167-4943(00)00046-7; CAIRNS J, 1981, NATURE, V289, P353, DOI 10.1038/289353a0; Cameron M., 2011, COCHRANE DB SYST REV, V16; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Chen Q, 1998, ALCOHOL CLIN EXP RES, V22, P782, DOI 10.1097/00000374-199806000-00002; Das UN, 2007, MED SCI MONITOR, V13, pRA119; Das UN, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-130; De Haro A, 2004, ACTA HORTIC, P231, DOI 10.17660/ActaHortic.2004.629.29; del Rio-Celestino M, 2008, J SCI FOOD AGR, V88, P248, DOI 10.1002/jsfa.3080; DELRIO M, 1993, GRASAS ACEITES, V44, P125; Dionne MS, 2008, DIS MODEL MECH, V1, P43, DOI 10.1242/dmm.000307; Festing MFW, 1998, ATLA-ALTERN LAB ANIM, V26, P283; FLEMING JE, 1992, MUTAT RES, V275, P267, DOI 10.1016/0921-8734(92)90031-J; FRANKEL E N, 1980, Progress in Lipid Research, V19, P1, DOI 10.1016/0163-7827(80)90006-5; FREI H, 1995, MUTAT RES-ENVIR MUTA, V334, P247, DOI 10.1016/0165-1161(95)90018-7; FREI H, 1988, MUTAT RES, V203, P297, DOI 10.1016/0165-1161(88)90019-2; GARCES R, 1993, ANAL BIOCHEM, V211, P139, DOI 10.1006/abio.1993.1244; Ge HT, 2009, CELL BIOL INT, V33, P402, DOI 10.1016/j.cellbi.2009.01.014; Gilani AH, 2007, J ETHNOPHARMACOL, V114, P393, DOI 10.1016/j.jep.2007.08.032; Gillis RC, 2002, J SURG RES, V107, P145, DOI 10.1006/jsre.2002.6496; GRAF U, 1984, ENVIRON MUTAGEN, V6, P153, DOI 10.1002/em.2860060206; GUNSTONE FD, 1992, PROG LIPID RES, V31, P145, DOI 10.1016/0163-7827(92)90007-6; Gunstone FD, 1994, LIPID HDB, P561; Guo Y, 2001, Wei Sheng Yan Jiu, V30, P50; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hamilton LA, 2011, NUTR CLIN PRACT, V26, P26, DOI 10.1177/0884533610392922; Helfand SL, 2003, ADV GENET, V49, P67, DOI 10.1016/S0065-2660(03)01002-2; Horrobin D F, 1983, Rev Pure Appl Pharmacol Sci, V4, P339; HORROBIN DF, 1992, PROG LIPID RES, V31, P163, DOI 10.1016/0163-7827(92)90008-7; International Olive Council (COI), 2006, 25 COIT20DOC; Itoh S, 2010, J CLIN BIOCHEM NUTR, V47, P81, DOI 10.3164/jcbn.10-24; Janick J, 1989, HERBS SPICES MED PLA, P210; Jones MA, 2011, EXP GERONTOL, V46, P320, DOI 10.1016/j.exger.2010.08.012; Kim T, 2005, J BIOCHEM MOL BIOL, V38, P121; Kruger MC, 1998, AGING-CLIN EXP RES, V10, P385, DOI 10.1007/BF03339885; LEVENTHAL LJ, 1993, ANN INTERN MED, V119, P867, DOI 10.7326/0003-4819-119-9-199311010-00001; Li YM, 2008, J NUTR BIOCHEM, V19, P376, DOI 10.1016/j.jnutbio.2007.05.009; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Mancuso P, 1997, CRIT CARE MED, V25, P523, DOI 10.1097/00003246-199703000-00024; Menendez JA, 2004, ONCOL REP, V11, P1241; Mockett RJ, 2006, EXP GERONTOL, V41, P566, DOI 10.1016/j.exger.2006.03.015; Olendzki BC, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/827286; Ortiz JGM, 2009, TOXICOL SCI, V107, P416, DOI 10.1093/toxsci/kfn192; Paquot C, 1987, STANDARD METHODS ANA; Pham H, 2006, PROSTAG LEUKOTR ESS, V74, P271, DOI 10.1016/j.plefa.2006.01.004; Pompeia C, 2002, BIOL CELL, V94, P251, DOI 10.1016/S0248-4900(02)01200-5; Pontes-Arruda A, 2011, CRIT CARE, V15, DOI 10.1186/cc10267; PRITCHARD GA, 1989, BRIT J SURG, V76, P1069, DOI 10.1002/bjs.1800761028; Rand MD, 2010, NEUROTOXICOL TERATOL, V32, P74, DOI 10.1016/j.ntt.2009.06.004; Ravichandran D, 1998, EUR J CANCER, V34, P188, DOI 10.1016/S0959-8049(97)00369-9; Ren N, 2007, GENETICS, V176, P2223, DOI 10.1534/genetics.107.072959; Rojas-Molina M, 2005, ENVIRON MOL MUTAGEN, V45, P90, DOI 10.1002/em.20078; Romero-Jimenez M, 2005, MUTAT RES-GEN TOX EN, V585, P147, DOI 10.1016/j.mrgentox.2005.05.004; Saxena Ronika, 2011, Toxicol Int, V18, P73, DOI 10.4103/0971-6580.75871; Scheim DE, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-54; Shichiri M, 2012, J BIOL CHEM, V287, P2926, DOI 10.1074/jbc.M111.321281; Siddique HR, 2005, MUTAGENESIS, V20, P285, DOI 10.1093/mutage/gei032; Soh JW, 2007, MECH AGEING DEV, V128, P581, DOI 10.1016/j.mad.2007.08.004; Tiwari AK, 2011, THERIOGENOLOGY, V76, P197, DOI 10.1016/j.theriogenology.2010.12.027; Trotta V, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-67; Tso P, 2002, J NUTR, V132, P218, DOI 10.1093/jn/132.2.218; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Velasco L, 1999, PHYTOCHEMISTRY, V52, P423, DOI 10.1016/S0031-9422(99)00203-4; Villatoro-Pulido M, 2009, MUTAGENESIS, V24, P51, DOI 10.1093/mutage/gen051; Wauquier F, 2012, BONE, V50, P553, DOI 10.1016/j.bone.2011.05.030; Yan J, 2008, GENETICS, V180, P219, DOI 10.1534/genetics.108.091314	76	46	46	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56986	10.1371/journal.pone.0056986	http://dx.doi.org/10.1371/journal.pone.0056986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460824	Green Published, gold			2022-12-27	WOS:000315519000052
J	Wadelin, FR; Fulton, J; Collins, HM; Tertipis, N; Bottley, A; Spriggs, KA; Falcone, FH; Heery, DM				Wadelin, Frances R.; Fulton, Joel; Collins, Hilary M.; Tertipis, Nikolaos; Bottley, Andrew; Spriggs, Keith A.; Falcone, Franco H.; Heery, David M.			PRAME Is a Golgi-Targeted Protein That Associates with the Elongin BC Complex and Is Upregulated by Interferon-Gamma and Bacterial PAMPs	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; PREFERENTIALLY EXPRESSED ANTIGEN; MESSENGER-RNA LEVELS; GENE-EXPRESSION; CLINICAL IMPORTANCE; UBIQUITIN LIGASE; IDENTIFICATION; LEUKEMIA; PEPTIDOGLYCAN; RECEPTORS	Preferentially expressed antigen in melanoma (PRAME) has been described as a cancer-testis antigen and is associated with leukaemias and solid tumours. Here we show that PRAME gene transcription in leukaemic cell lines is rapidly induced by exposure of cells to bacterial PAMPs (pathogen associated molecular patterns) in combination with type 2 interferon (IFN gamma). Treatment of HL60 cells with lipopolysaccharide or peptidoglycan in combination with IFN gamma resulted in a rapid and transient induction of PRAME transcription, and increased association of PRAME transcripts with polysomes. Moreover, treatment with AMPs/IFN gamma also modulated the subcellular localisation of PRAME proteins in HL60 and U937 cells, resulting in targeting of cytoplasmic PRAME to the Golgi. Affinity purification studies revealed that PRAME associates with Elongin B and Elongin C, components of Cullin E3 ubiquitin ligase complexes. This occurs via direct interaction of PRAME with Elongin C, and PRAME colocalises with Elongins in the Golgi after PAMP/IFN gamma treatment. PRAME was also found to co-immunoprecipitate core histones, consistent with its partial localisation to the nucleus, and was found to bind directly to histone H3 in vitro. Thus, PRAME is upregulated by signalling pathways that are activated in response to infection/inflammation, and its product may have dual functions as a histone-binding protein, and in directing ubiquitylation of target proteins for processing in the Golgi.	[Wadelin, Frances R.; Fulton, Joel; Collins, Hilary M.; Tertipis, Nikolaos; Bottley, Andrew; Spriggs, Keith A.; Falcone, Franco H.; Heery, David M.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Nottingham	Heery, DM (corresponding author), Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Univ Pk, Nottingham NG7 2RD, England.	david.heery@nottingham.ac.uk	Falcone, Franco H/F-9210-2013; Falcone, Franco/AAE-8026-2021	Falcone, Franco H/0000-0002-1732-9932; Falcone, Franco/0000-0002-1732-9932; Heery, David/0000-0002-5035-2392; Collins, Hilary/0000-0001-6220-1236	Leukaemia Lymphoma Research via a clinical training fellowship [07064]; Royal Pharmaceutical Society of Great Britain via an Academic Excellence Award	Leukaemia Lymphoma Research via a clinical training fellowship; Royal Pharmaceutical Society of Great Britain via an Academic Excellence Award	This work was funded by Leukaemia Lymphoma Research via a clinical training fellowship to FRW (07064). JF was funded by the Royal Pharmaceutical Society of Great Britain via an Academic Excellence Award to DMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanackovic D, 2011, AM J HEMATOL, V86, P918, DOI 10.1002/ajh.22141; Birtle Zoe, 2005, BMC Genomics, V6, P120, DOI 10.1186/1471-2164-6-120; Costessi A, 2011, EMBO J, V30, P3786, DOI 10.1038/emboj.2011.262; Doolan P, 2008, BREAST CANCER RES TR, V109, P359, DOI 10.1007/s10549-007-9643-3; Epping MT, 2008, BRIT J CANCER, V99, P398, DOI 10.1038/sj.bjc.6604494; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Kessler JH, 2001, J EXP MED, V193, P73, DOI 10.1084/jem.193.1.73; Kindle KB, 2005, MOL CELL BIOL, V25, P988, DOI 10.1128/MCB.25.3.988-1002.2005; Le Douarin B, 2001, METH MOL B, V176, P227; Lee SA, 2011, BIOCHEM BIOPH RES CO, V408, P132, DOI 10.1016/j.bbrc.2011.03.136; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushita M, 2001, BRIT J HAEMATOL, V112, P916, DOI 10.1046/j.1365-2141.2001.02670.x; Olins AL, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-30; Ortmann CA, 2008, ANN HEMATOL, V87, P809, DOI 10.1007/s00277-008-0514-8; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Paydas S, 2005, AM J HEMATOL, V79, P257, DOI 10.1002/ajh.20425; Paydas S, 2007, LEUKEMIA RES, V31, P365, DOI 10.1016/j.leukres.2006.06.022; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Qin YZ, 2009, LEUKEMIA RES, V33, P384, DOI 10.1016/j.leukres.2008.08.026; Quintarelli C, 2008, BLOOD, V112, P1876, DOI 10.1182/blood-2008-04-150045; Quintarelli C, 2011, BLOOD, V117, P3353, DOI 10.1182/blood-2010-08-300376; Roman-Gomez O, 2007, LEUKEMIA RES, V31, P1521, DOI 10.1016/j.leukres.2007.02.016; Sasagawa Y, 2009, J CELL SCI, V122, P3663, DOI 10.1242/jcs.052415; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Starczynowski DT, 2010, HEMATOL ONCOL CLIN N, V24, P343, DOI 10.1016/j.hoc.2010.02.008; Steinbach D, 2006, CLIN CANCER RES, V12, P2434, DOI 10.1158/1078-0432.CCR-05-2552; Tajeddine N, 2005, CANCER RES, V65, P7348, DOI 10.1158/0008-5472.CAN-04-4011; Tajeddine N, 2006, CLIN CHEM LAB MED, V44, P548, DOI 10.1515/CCLM.2006.106; Tian X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-202; Wadelin F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-226; Williams JM, 1998, MOL MICROBIOL, V27, P171, DOI 10.1046/j.1365-2958.1998.00670.x; Wolska A, 2009, CURR MOL MED, V9, P324, DOI 10.2174/156652409787847182; Yuan Z, 2002, BIOINFORMATICS, V18, P1109, DOI 10.1093/bioinformatics/18.8.1109	43	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58052	10.1371/journal.pone.0058052	http://dx.doi.org/10.1371/journal.pone.0058052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460923	Green Published, Green Submitted			2022-12-27	WOS:000315519000178
J	Hertzberger, RY; Pridmore, RD; Gysler, C; Kleerebezem, M; de Mattos, MJT				Hertzberger, Rosanne Y.; Pridmore, R. David; Gysler, Christof; Kleerebezem, Michiel; de Mattos, M. Joost Teixeira			Oxygen Relieves the CO2 and Acetate Dependency of Lactobacillus johnsonii NCC 533	PLOS ONE			English	Article							POPULATION HETEROGENEITY; TRANSCRIPTOME ANALYSIS; PYRUVATE OXIDASE; STREPTOCOCCUS-THERMOPHILUS; CARBAMOYL-PHOSPHATE; LACTOCOCCUS-LACTIS; AEROBIC GROWTH; PLANTARUM; ACID; BACTERIA	Oxygen relieves the CO2 and acetate dependency of Lactobacillus johnsonii NCC 533. The probiotic Lactobacillus johnsonii NCC 533 is relatively sensitive to oxidative stress; the presence of oxygen causes a lower biomass yield due to early growth stagnation. We show however that oxygen can also be beneficial to this organism as it relieves the requirement for acetate and CO2 during growth. Both on agar- and liquid-media, anaerobic growth of L. johnsonii NCC 533 requires CO2 supplementation of the gas phase. Switching off the CO2 supply induces growth arrest and cell death. The presence of molecular oxygen overcomes the CO2 dependency. Analogously, L. johnsonii NCC 533 strictly requires media with acetate to sustain anaerobic growth, although supplementation at a level that is 100-fold lower (120 microM) than the concentration in regular growth medium for lactobacilli already suffices for normal growth. Analogous to the CO2 requirement, oxygen supply relieves this acetate-dependency for growth. The L. johnsonii NCC 533 genome indicates that this organism lacks genes coding for pyruvate formate lyase (PFL) and pyruvate dehydrogenase (PDH), both CO2 and acetyl-CoA producing systems. Therefore, C1- and C2- compound production is predicted to largely depend on pyruvate oxidase activity (POX). This proposed role of POX in C2/C1-generation is corroborated by the observation that in a POX deficient mutant of L. johnsonii NCC 533, oxygen is not able to overcome acetate dependency nor does it relieve the CO2 dependency.	[Hertzberger, Rosanne Y.; de Mattos, M. Joost Teixeira] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Hertzberger, Rosanne Y.; Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands; [Pridmore, R. David; Gysler, Christof] Nestle Res Ctr, Lausanne, Switzerland; [Kleerebezem, Michiel] Wageningen Univ, Host Microbe Interact Grp, NL-6700 AP Wageningen, Netherlands	University of Amsterdam; NIZO Food Research; Nestle SA; Wageningen University & Research	de Mattos, MJT (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Sci Pk, Amsterdam, Netherlands.	m.j.teixeirademattos@uva.nl	Kleerebezem, Michiel/AAT-2078-2021	Hertzberger, Rosanne/0000-0002-6119-9450; Kleerebezem, Michiel/0000-0001-8552-2235	Nestle Research Centre, Nestec Ltd.	Nestle Research Centre, Nestec Ltd.	The authors have the following interests. This project is a collaboration between NIZO Food Research and Nestle Research Centre, funded by the Nestle Research Centre, Nestec Ltd. DP is employed by Nestle Research Centre and affiliated to the Kluyver centre for Genomics of Industrial Fermentation. CG is employed by Nestle Research Centre who have contributed to the manuscript by supplying the wild type and mutant strains and through regular discussion. RH and CG are also affiliated to the Kluyver centre for Genomics of Industrial Fermentation. RH and MK are affiliated to NIZO food research. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Arioli S, 2009, MICROBIOL-SGM, V155, P1953, DOI 10.1099/mic.0.024737-0; Arsene-Ploetze F, 2006, J BACTERIOL, V188, P8607, DOI 10.1128/JB.00985-06; Bekker M, 2009, J BACTERIOL, V191, P5510, DOI 10.1128/JB.00562-09; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; BERNET MF, 1994, GUT, V35, P483, DOI 10.1136/gut.35.4.483; Bringel F, 2003, APPL ENVIRON MICROB, V69, P2674, DOI 10.1128/AEM.69.5.2674-2683.2003; Bringel F, 2008, J MOL MICROB BIOTECH, V14, P22, DOI 10.1159/000107966; Chervaux C, 2000, APPL ENVIRON MICROB, V66, P5306, DOI 10.1128/AEM.66.12.5306-5311.2000; de Man JC, 1960, J APPL BACTERIOLOGY; den Besten HMW, 2007, APPL ENVIRON MICROB, V73, P4797, DOI 10.1128/AEM.00404-07; den Besten HMW, 2010, APPL ENVIRON MICROB, V76, P927, DOI 10.1128/AEM.01372-09; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; DIRAR H, 1973, J GEN MICROBIOL, V78, P211, DOI 10.1099/00221287-78-2-211; Elli M, 1999, INT DAIRY J, V9, P507, DOI 10.1016/S0958-6946(99)00127-2; Goffin P, 2006, APPL ENVIRON MICROB, V72, P7933, DOI 10.1128/AEM.00659-06; Granato D, 1999, APPL ENVIRON MICROB, V65, P1071; Haller D, 2002, CLIN DIAGN LAB IMMUN, V9, P649, DOI 10.1128/CDLI.9.3.649-657.2002; Haller D, 2000, GUT, V47, P79, DOI 10.1136/gut.47.1.79; Hols P, 1999, J BACTERIOL, V181, P5521, DOI 10.1128/JB.181.17.5521-5526.1999; Ibnou-Zekri N, 2003, INFECT IMMUN, V71, P428, DOI 10.1128/IAI.71.1.428-436.2003; Iino T, 2002, J GEN APPL MICROBIOL, V48, P91, DOI 10.2323/jgam.48.91; Ingham CJ, 2008, APPL ENVIRON MICROB, V74, P7750, DOI 10.1128/AEM.00982-08; Karlsson CLJ, 2011, PEDIATR RES, V70, P282, DOI 10.1203/PDR.0b013e318225f765; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Lorquet F, 2004, J BACTERIOL, V186, P3749, DOI 10.1128/JB.186.12.3749-3759.2004; Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970; Melchiorsen CR, 2002, APPL MICROBIOL BIOT, V58, P338, DOI 10.1007/s00253-001-0892-5; MURPHY MG, 1984, ARCH MICROBIOL, V138, P44, DOI 10.1007/BF00425405; Neeser JR, 2000, GLYCOBIOLOGY, V10, P1193, DOI 10.1093/glycob/10.11.1193; Nicoloff H, 2000, J BACTERIOL, V182, P3416, DOI 10.1128/JB.182.12.3416-3422.2000; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Pridmore RD, 2008, FEMS MICROBIOL LETT, V283, P210, DOI 10.1111/j.1574-6968.2008.01176.x; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Santos F, 2009, APPL ENVIRON MICROB, V75, P3930, DOI 10.1128/AEM.02487-08; Sieuwerts S, 2010, APPL ENVIRON MICROB, V76, P7775, DOI 10.1128/AEM.01122-10; Stevens MJA, 2008, APPL ENVIRON MICROB, V74, P4776, DOI 10.1128/AEM.00136-08; van der Kaaij H, 2004, APPL ENVIRON MICROB, V70, P1869, DOI 10.1128/AEM.70.3.1869-1873.2004	38	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57235	10.1371/journal.pone.0057235	http://dx.doi.org/10.1371/journal.pone.0057235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468944	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400032
J	Liu, YY; Du, YS; Liu, WW; Yang, CH; Liu, Y; Wang, HY; Gong, XH				Liu, Yanyan; Du, Yasong; Liu, Wenwen; Yang, Caohua; Liu, Yan; Wang, Hongyan; Gong, Xiaohong			Lack of Association between NLGN3, NLGN4, SHANK2 and SHANK3 Gene Variants and Autism Spectrum Disorder in a Chinese Population	PLOS ONE			English	Article							MENTAL-RETARDATION; X-CHROMOSOME; NEUROLIGIN GENES; MUTATIONS	Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social communication, absence or delay in language development, and stereotyped or repetitive behaviors. Genetic studies show that neurexin-neuroligin (NRXN-NLGN) pathway genes contribute susceptibility to ASD, which include cell adhesion molecules NLGN3, NLGN4 and scaffolding proteins SHANK2 and SHANK3. Neuroligin proteins play an important role in synaptic function and trans-synaptic signaling by interacting with presynaptic neurexins. Shank proteins are scaffolding molecules of excitatory synapses, which function as central organizers of the postsynaptic density. Sequence level mutations and structural variations in these genes have been identified in ASD cases, while few studies were performed in Chinese population. In this study, we examined the copy numbers of four genes NLGN4, NLGN3, SHANK2, and SHANK3 in 285 ASD cases using multiplex fluorescence competitive polymerase chain reaction (PCR). We also screened the regulatory region including the promoter region and 59/39 untranslated regions (UTR) and the entire coding region of NLGN4 in a cohort of 285 ASD patients and 384 controls by direct sequencing of genomic DNA using the Sanger method. DNA copy number calculation in four genes showed no deletion or duplication in our cases. No missense mutations in NLGN4 were identified in our cohort. Association analysis of 6 common SNPs in NLGN4 did not find significant difference between ASD cases and controls. These findings showed that these genes may not be major disease genes in Chinese ASD cases.	[Liu, Yanyan; Wang, Hongyan; Gong, Xiaohong] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Liu, Yanyan; Wang, Hongyan; Gong, Xiaohong] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Du, Yasong; Liu, Wenwen; Yang, Caohua] Shanghai Mental Hlth Ctr, Dept Child & Adolescent Psychiat, Shanghai, Peoples R China; [Du, Yasong; Liu, Wenwen; Yang, Caohua] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Liu, Yan] Genesky Biotechnol Inc, Shanghai, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Gong, XH (corresponding author), Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China.	gongxh@fudan.edu.cn			National Natural Science Foundation of China [30900404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (30900404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Blasi F, 2006, AM J MED GENET B, V141B, P220, DOI 10.1002/ajmg.b.30287; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Buxbaum Joseph D, 2009, Dialogues Clin Neurosci, V11, P35; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Daoud H, 2009, BIOL PSYCHIAT, V66, P906, DOI 10.1016/j.biopsych.2009.05.008; Du R, 2012, J HUM GENET; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fombonne E, 2002, MOL PSYCHIATR, V7, pS4, DOI 10.1038/sj.mp.4001162; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gauthier J, 2006, MOL PSYCHIATR, V11, P206, DOI 10.1038/sj.mp.4001756; Gauthier J, 2005, AM J MED GENET B, V132B, P74, DOI 10.1002/ajmg.b.30066; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Kelemenova S, 2010, PSYCHIAT GENET, V20, P137, DOI 10.1097/YPG.0b013e32833a1eb3; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Pampanos A, 2009, GENET TEST MOL BIOMA, V13, P611, DOI 10.1089/gtmb.2009.0005; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Petit E, 1996, BIOL PSYCHIAT, V40, P457, DOI 10.1016/0006-3223(96)85270-X; Sato D, 2012, AM J HUM GENET; State MW, 2010, NAT GENET, V42, P478, DOI 10.1038/ng0610-478; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Vaags AK, 2012, AM J HUM GENET, V90, P133, DOI 10.1016/j.ajhg.2011.11.025; Vincent JB, 2005, PSYCHIAT GENET, V15, P83, DOI 10.1097/00041444-200506000-00004; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Ylisaukko-oja T, 2005, EUR J HUM GENET, V13, P1285, DOI 10.1038/sj.ejhg.5201474; Yu JD, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-13; Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009	36	20	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56639	10.1371/journal.pone.0056639	http://dx.doi.org/10.1371/journal.pone.0056639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468870	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400012
J	Smigocki, AC; Ivic-Haymes, S; Li, HY; Savic, J				Smigocki, Ann C.; Ivic-Haymes, Snezana; Li, Haiyan; Savic, Jelena			Pest Protection Conferred by a Beta vulgaris Serine Proteinase Inhibitor Gene	PLOS ONE			English	Article							COLORADO POTATO BEETLE; CYSTEINE PROTEINASE; PROTEASE INHIBITORS; TRANSGENIC POTATO; ORYZACYSTATIN-I; HELICOVERPA-ARMIGERA; INSECT RESISTANCE; PLANT; EXPRESSION; GROWTH	Proteinase inhibitors provide a means of engineering plant resistance to insect pests. A Beta vulgaris serine proteinase inhibitor gene (BvSTI) was fused to the constitutive CaMV35S promoter for over-expression in Nicotiana benthamiana plants to study its effect on lepidopteran insect pests. Independently derived BvSTI transgenic tobacco T2 homozygous progeny were shown to have relatively high BvSTI gene transcript levels. BvSTI-specific polyclonal antibodies cross-reacted with the expected 30 kDA recombinant BvSTI protein on Western blots. In gel trypsin inhibitor activity assays revealed a major clear zone that corresponded to the BvSTI proteinase inhibitor that was not detected in the untransformed control plants. BvSTI-transgenic plants were bioassayed for resistance to five lepidopteran insect pests. Spodoptera frugiperda, S. exigua and Manduca sexta larvae fed BvSTI leaves had significant reductions in larval weights as compared to larvae fed on untransformed leaves. In contrast, larval weights increased relative to the controls when Heliothis virescens and Agrotis ipsilon larvae were fed on BvSTI leaves. As the larvae entered the pupal stage, pupal sizes reflected the overall larval weights. Some developmental abnormalities of the pupae and emerging moths were noted. These findings suggest that the sugar beet BvSTI gene may prove useful for effective control of several different lepidopteran insect pests in genetically modified tobacco and other plants. The sugar beet serine proteinase inhibitor may be more effective for insect control because sugar beet is cropped in restricted geographical areas thus limiting the exposure of the insects to sugar beet proteinase inhibitors and build up of non-sensitive midgut proteases.	[Smigocki, Ann C.; Ivic-Haymes, Snezana; Li, Haiyan; Savic, Jelena] ARS, USDA, Mol Plant Pathol Lab, Beltsville, MD USA	United States Department of Agriculture (USDA)	Smigocki, AC (corresponding author), ARS, USDA, Mol Plant Pathol Lab, Beltsville, MD USA.	Ann.Smigocki@ars.usda.gov		Savic, Jelena/0000-0002-8385-7549	congress	congress	This is a US government facility and the funding is allocated by congress for the type of research being reported in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdeen A, 2005, PLANT MOL BIOL, V57, P189, DOI 10.1007/s11103-004-6959-9; ABE K, 1985, AGR BIOL CHEM TOKYO, V49, P3349, DOI 10.1080/00021369.1985.10867271; ABE M, 1994, J BIOCHEM-TOKYO, V116, P488, DOI 10.1093/oxfordjournals.jbchem.a124551; Ashouri A, 2001, ENVIRON ENTOMOL, V30, P524, DOI 10.1603/0046-225X-30.3.524; BOULTER D, 1990, CROP PROT, V9, P351, DOI 10.1016/0261-2194(90)90005-R; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzin J, 1998, PLANT SCI, V138, P17, DOI 10.1016/S0168-9452(98)00147-2; Cai DG, 2003, PLANT MOL BIOL, V51, P839, DOI 10.1023/A:1023089017906; Campbell LG, 2000, CROP SCI, V40, P867; CHAN J, 1982, J AGR FOOD CHEM, V30, P42, DOI 10.1021/jf00109a008; Charity JA, 2005, FUNCT PLANT BIOL, V32, P35, DOI 10.1071/FP04105; Christeller JT, 1998, EUR J BIOCHEM, V254, P160, DOI 10.1046/j.1432-1327.1998.2540160.x; Cloutier C, 1999, ARCH INSECT BIOCHEM, V40, P69, DOI 10.1002/(SICI)1520-6327(1999)40:2&lt;69::AID-ARCH1&gt;3.0.CO;2-M; Cloutier C, 2000, ARCH INSECT BIOCHEM, V44, P69, DOI 10.1002/1520-6327(200006)44:2&lt;69::AID-ARCH2&gt;3.0.CO;2-6; Cowgill SE, 2002, MOL ECOL, V11, P821, DOI 10.1046/j.1365-294X.2002.01482.x; De Leo F, 2002, NUCLEIC ACIDS RES, V30, P347, DOI 10.1093/nar/30.1.347; Delledonne M, 2001, MOL BREEDING, V7, P35, DOI 10.1023/A:1009605001253; Duan XL, 1996, NAT BIOTECHNOL, V14, P494, DOI 10.1038/nbt0496-494; Dunse KM, 2010, P NATL ACAD SCI USA, V107, P15011, DOI 10.1073/pnas.1009241107; Fan SG, 2005, BOT BULL ACAD SINICA, V46, P273; Graham J, 1997, ANN APPL BIOL, V131, P133, DOI 10.1111/j.1744-7348.1997.tb05401.x; Haymes KM, 1996, PLANT MOL BIOL REP, V14, P280, DOI 10.1007/BF02671664; Jongsma MA, 1997, J INSECT PHYSIOL, V43, P885, DOI 10.1016/S0022-1910(97)00040-1; Jongsma MA, 1996, TRENDS BIOTECHNOL, V14, P331, DOI 10.1016/0167-7799(96)30019-X; KONDO H, 1991, FEBS LETT, V278, P87, DOI 10.1016/0014-5793(91)80090-P; Lara P, 2000, TRANSGENIC RES, V9, P169, DOI 10.1023/A:1008905631440; Lawrence PK, 2002, ELECTRON J BIOTECHN, V5, DOI 10.2225/vol5-issue1-fulltext-3; Lecardonnel A, 1999, PLANT SCI, V140, P71, DOI 10.1016/S0168-9452(98)00197-6; Maheswaran G, 2007, PLANT CELL REP, V26, P773, DOI 10.1007/s00299-006-0281-8; MATSUMOTO I, 1995, EUR J BIOCHEM, V227, P582, DOI 10.1111/j.1432-1033.1995.tb20428.x; Mehlo L, 2005, P NATL ACAD SCI USA, V102, P7812, DOI 10.1073/pnas.0502871102; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ninkovic S, 2007, PLANT CELL TISS ORG, V91, P289, DOI 10.1007/s11240-007-9296-2; Ortego F, 2001, J INSECT PHYSIOL, V47, P1291, DOI 10.1016/S0022-1910(01)00118-4; Pandey PK, 2010, INT J BIOTECH BIOCH, V6, P513; PENDOLA S, 1975, ANN ENTOMOL SOC AM, V68, P341, DOI 10.1093/aesa/68.2.341; Philippe RN, 2009, NEW PHYTOL, V184, P865, DOI 10.1111/j.1469-8137.2009.03028.x; Puthoff DP, 2007, PLANT CELL REP, V26, P71, DOI 10.1007/s00299-006-0201-y; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Samac DA, 2003, PHYTOPATHOLOGY, V93, P799, DOI 10.1094/PHYTO.2003.93.7.799; Savic JM, 2012, EUPHYTICA, V188, P187, DOI 10.1007/s10681-012-0679-z; Schluter U, 2010, J EXP BOT, V61, P4169, DOI 10.1093/jxb/erq166; Schmidt DD, 2005, PLANT PHYSIOL, V138, P1763, DOI 10.1104/pp.105.061192; Schuman MC, 2012, ELIFE, V1, DOI 10.7554/eLife.00007; Senthilkumar R, 2010, PLANT BIOTECHNOL J, V8, P65, DOI 10.1111/j.1467-7652.2009.00466.x; Singh A, 2008, J EXP BOT, V59, P2379, DOI 10.1093/jxb/ern111; Smigocki A. C., 2008, Sugar Tech, V10, P91, DOI 10.1007/s12355-008-0016-y; Smigocki AC, 2009, PLANT CELL TISS ORG, V97, P167, DOI 10.1007/s11240-009-9512-3; Smigocki AC, 2007, AM SOC SUGAR BEET TE, V34, P143; Smigocki AC, 2009, 35 AM SOC SUG BEET T; Srinivasan A, 2006, CELL MOL BIOL LETT, V11, P132, DOI 10.2478/s11658-006-0012-8; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; Tamhane VA, 2007, GENE, V403, P29, DOI 10.1016/j.gene.2007.07.024; Telang M, 2003, PHYTOCHEMISTRY, V63, P643, DOI 10.1016/S0031-9422(03)00239-5; URWIN PE, 1995, PLANT J, V8, P121, DOI 10.1046/j.1365-313X.1995.08010121.x; Ussuf KK, 2001, CURR SCI INDIA, V80, P847; Wang HY, 2003, PLANT SCI, V165, P191, DOI 10.1016/S0168-9452(03)00158-4; Wilhite SE, 2000, ENTOMOL EXP APPL, V97, P229, DOI 10.1023/A:1004009110120	58	28	28	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57303	10.1371/journal.pone.0057303	http://dx.doi.org/10.1371/journal.pone.0057303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468963	Green Submitted, gold, Green Published			2022-12-27	WOS:000315561400037
J	Chi, YG; Xu, M; Shen, RC; Yang, QP; Huang, BR; Wan, SQ				Chi, Yonggang; Xu, Ming; Shen, Ruichang; Yang, Qingpeng; Huang, Bingru; Wan, Shiqiang			Acclimation of Foliar Respiration and Photosynthesis in Response to Experimental Warming in a Temperate Steppe in Northern China	PLOS ONE			English	Article							ELEVATED ATMOSPHERIC CO2; ELECTRON-TRANSPORT RATE; LEAF RESPIRATION; THERMAL-ACCLIMATION; MESOPHYLL CONDUCTANCE; RUBISCO-ACTIVASE; CARBON-DIOXIDE; INTERNAL CONDUCTANCE; GROWTH TEMPERATURE; SEASONAL-VARIATION	Background: Thermal acclimation of foliar respiration and photosynthesis is critical for projection of changes in carbon exchange of terrestrial ecosystems under global warming. Methodology/Principal Findings: A field manipulative experiment was conducted to elevate foliar temperature (T-leaf) by 2.07 degrees C in a temperate steppe in northern China. R-d/T-leaf curves (responses of dark respiration to T-leaf), A(n)/T-leaf curves (responses of light-saturated net CO2 assimilation rates to T-leaf), responses of biochemical limitations and diffusion limitations in gross CO2 assimilation rates (A(g)) to T-leaf, and foliar nitrogen (N) concentration in Stipa krylovii Roshev. were measured in 2010 (a dry year) and 2011 (a wet year). Significant thermal acclimation of R-d to 6-year experimental warming was found. However, A(n) had a limited ability to acclimate to a warmer climate regime. Thermal acclimation of R-d was associated with not only the direct effects of warming, but also the changes in foliar N concentration induced by warming. Conclusions/Significance: Warming decreased the temperature sensitivity (Q(10)) of the response of R-d/A(g) ratio to T-leaf. Our findings may have important implications for improving ecosystem models in simulating carbon cycles and advancing understanding on the interactions between climate change and ecosystem functions.	[Chi, Yonggang; Xu, Ming; Shen, Ruichang; Yang, Qingpeng] Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Chi, Yonggang; Shen, Ruichang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Ming] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, Ctr Remote Sensing & Spatial Anal, New Brunswick, NJ 08903 USA; [Yang, Qingpeng] Chinese Acad Sci, Inst Appl Ecol, Huitong Expt Stn Forest Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Wan, Shiqiang] Henan Univ, Key Lab Plant Stress Biol, Coll Life Sci, Kaifeng, Henan, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Rutgers State University New Brunswick; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Rutgers State University New Brunswick; Henan University	Xu, M (corresponding author), Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	mingxu@igsnrr.ac.cn	Yang, Qingpeng/B-3632-2014; Wan, Shiqiang/L-9166-2019; Wan, Shiqiang/B-5799-2009; Shen, Ruichang/O-4305-2017	Yang, Qingpeng/0000-0003-2471-6233; Wan, Shiqiang/0000-0003-0631-1232; Wan, Shiqiang/0000-0003-0631-1232; Shen, Ruichang/0000-0003-0055-8058; /0000-0002-3418-1992	National Key Research and Development Program of China [2010CB833500]; 100 Talents Program of the Chinese Academy of Sciences; National Natural Science Foundation [30925009]	National Key Research and Development Program of China; 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Financial support came from the National Key Research and Development Program of China (2010CB833500, http://www.973.gov.cn), the 100 Talents Program of the Chinese Academy of Sciences supported M. Xu's work (http://www.cas.cn) and National Natural Science Foundation (30925009, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1995, PHOTOSYNTH RES, V46, P129, DOI 10.1007/BF00020423; ARMOND PA, 1978, PLANT PHYSIOL, V61, P411, DOI 10.1104/pp.61.3.411; Armstrong AF, 2008, PLANT CELL ENVIRON, V31, P1156, DOI 10.1111/j.1365-3040.2008.01830.x; Armstrong AF, 2006, AM J BOT, V93, P1633, DOI 10.3732/ajb.93.11.1633; Atkin OK, 2006, GLOBAL CHANGE BIOL, V12, P500, DOI 10.1111/j.1365-2486.2006.01114.x; Atkin OK, 2005, FUNCT PLANT BIOL, V32, P87, DOI 10.1071/FP03176; Atkin OK, 2000, PLANT PHYSIOL, V122, P915, DOI 10.1104/pp.122.3.915; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Atkin OK, 2009, ANN BOT-LONDON, V103, P581, DOI 10.1093/aob/mcn094; BADGER MR, 1982, PLANT CELL ENVIRON, V5, P85; Bernacchi CJ, 2002, PLANT PHYSIOL, V130, P1992, DOI 10.1104/pp.008250; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Bolstad PV, 2003, TREE PHYSIOL, V23, P969, DOI 10.1093/treephys/23.14.969; Campbell C, 2007, NEW PHYTOL, V176, P375, DOI 10.1111/j.1469-8137.2007.02183.x; Cen YP, 2005, PLANT PHYSIOL, V139, P979, DOI 10.1104/pp.105.066233; Crafts-Brandner SJ, 2000, P NATL ACAD SCI USA, V97, P13430, DOI 10.1073/pnas.230451497; Crous KY, 2011, GLOBAL CHANGE BIOL, V17, P1560, DOI 10.1111/j.1365-2486.2010.02325.x; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Delatorre J, 2008, J PHOTOCH PHOTOBIO B, V92, P67, DOI 10.1016/j.jphotobiol.2008.04.004; Dewar RC, 1999, GLOBAL CHANGE BIOL, V5, P615, DOI 10.1046/j.1365-2486.1999.00253.x; Dillaway DN, 2010, PLANT CELL ENVIRON, V33, P888, DOI 10.1111/j.1365-3040.2010.02114.x; Dreyer E, 2001, TREE PHYSIOL, V21, P223, DOI 10.1093/treephys/21.4.223; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FERRAR PJ, 1989, AUST J PLANT PHYSIOL, V16, P199, DOI 10.1071/PP9890199; Flexas J, 2007, NEW PHYTOL, V175, P501, DOI 10.1111/j.1469-8137.2007.02111.x; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Galmes J, 2007, NEW PHYTOL, V175, P81, DOI 10.1111/j.1469-8137.2007.02087.x; Galmes J, 2011, J EXP BOT, V62, P653, DOI 10.1093/jxb/erq303; Gifford RM, 1995, GLOBAL CHANGE BIOL, V1, P385, DOI 10.1111/j.1365-2486.1995.tb00037.x; Griffin KL, 2002, NEW PHYTOL, V154, P609, DOI 10.1046/j.1469-8137.2002.00410.x; Gunderson CA, 2000, TREE PHYSIOL, V20, P87; Gunderson CA, 2010, GLOBAL CHANGE BIOL, V16, P2272, DOI 10.1111/j.1365-2486.2009.02090.x; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; HARLEY PC, 1992, PLANT CELL ENVIRON, V15, P271, DOI 10.1111/j.1365-3040.1992.tb00974.x; Harley PC, 1991, MODELING CROP PHOTOS, P1; Hartley IP, 2006, GLOBAL CHANGE BIOL, V12, P1954, DOI 10.1111/j.1365-2486.2006.01214.x; Hendrickson L, 2004, PLANT CELL ENVIRON, V27, P795, DOI 10.1111/j.1365-3040.2004.01184.x; Hikosaka K, 2006, J EXP BOT, V57, P291, DOI 10.1093/jxb/erj049; Hikosaka K, 2005, PLANT CELL PHYSIOL, V46, P1283, DOI 10.1093/pcp/pci137; Hikosaka K, 1999, PLANT CELL ENVIRON, V22, P841, DOI 10.1046/j.1365-3040.1999.00442.x; Hikosaka K, 1997, ANN BOT-LONDON, V80, P721, DOI 10.1006/anbo.1997.0512; Kattge J, 2007, PLANT CELL ENVIRON, V30, P1176, DOI 10.1111/j.1365-3040.2007.01690.x; KIRSCHBAUM MUF, 1984, AUST J PLANT PHYSIOL, V11, P519, DOI 10.1071/PP9840519; Lee TD, 2005, FUNCT ECOL, V19, P640, DOI 10.1111/j.1365-2435.2005.01023.x; Leuning R, 2002, PLANT CELL ENVIRON, V25, P1205, DOI 10.1046/j.1365-3040.2002.00898.x; Lin YS, 2012, TREE PHYSIOL, V32, P219, DOI 10.1093/treephys/tpr141; Loveys BR, 2003, GLOBAL CHANGE BIOL, V9, P895, DOI 10.1046/j.1365-2486.2003.00611.x; Luo HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023033; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Luo YQ, 2011, TRENDS ECOL EVOL, V26, P96, DOI 10.1016/j.tree.2010.11.003; MAKINO A, 1994, PLANT PHYSIOL, V105, P173, DOI 10.1104/pp.105.1.173; Medlyn BE, 2002, PLANT CELL ENVIRON, V25, P1155, DOI 10.1046/j.1365-3040.2002.00890.x; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Miao ZW, 2009, PLANT CELL ENVIRON, V32, P109, DOI 10.1111/j.1365-3040.2008.01900.x; MIROSLAVOV EA, 1991, ANN BOT-LONDON, V68, P195, DOI 10.1093/oxfordjournals.aob.a088244; MITCHELL RAC, 1986, PLANTA, V169, P429, DOI 10.1007/BF00392141; MOONEY HA, 1978, PLANT PHYSIOL, V61, P406, DOI 10.1104/pp.61.3.406; Niu SL, 2008, ENVIRON EXP BOT, V63, P91, DOI 10.1016/j.envexpbot.2007.10.016; Niu SL, 2012, NEW PHYTOL, V194, P775, DOI 10.1111/j.1469-8137.2012.04095.x; Onoda Y, 2005, FUNCT PLANT BIOL, V32, P903, DOI 10.1071/FP05024; Ow LF, 2008, NEW PHYTOL, V178, P123, DOI 10.1111/j.1469-8137.2007.02357.x; Ow LF, 2010, GLOBAL CHANGE BIOL, V16, P288, DOI 10.1111/j.1365-2486.2009.01892.x; Rachmilevitch S, 2006, J EXP BOT, V57, P623, DOI 10.1093/jxb/erj047; Rachmilevitch S, 2008, J EXP BOT, V59, P3803, DOI 10.1093/jxb/ern233; Sage RF, 2008, J EXP BOT, V59, P1581, DOI 10.1093/jxb/ern053; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; SHARKEY TD, 1985, PLANT PHYSIOL, V78, P71, DOI 10.1104/pp.78.1.71; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Teskey RO, 1999, TREE PHYSIOL, V19, P519, DOI 10.1093/treephys/19.8.519; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Tjoelker MG, 2008, GLOBAL CHANGE BIOL, V14, P782, DOI 10.1111/j.1365-2486.2008.01548.x; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Turnbull MH, 2005, OECOLOGIA, V143, P271, DOI 10.1007/s00442-004-1803-0; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Walcroft AS, 1997, PLANT CELL ENVIRON, V20, P1338, DOI 10.1046/j.1365-3040.1997.d01-31.x; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang XZ, 2001, P NATL ACAD SCI USA, V98, P2479, DOI 10.1073/pnas.051622998; Warren CR, 2008, TREE PHYSIOL, V28, P11, DOI 10.1093/treephys/28.1.11; Way DA, 2008, PLANT CELL ENVIRON, V31, P1250, DOI 10.1111/j.1365-3040.2008.01842.x; Weston DJ, 2007, AM J BOT, V94, P926, DOI 10.3732/ajb.94.6.926; WILLIAMS DG, 1993, FUNCT ECOL, V7, P623, DOI 10.2307/2390140; WULLSCHLEGER SD, 1993, J EXP BOT, V44, P907, DOI 10.1093/jxb/44.5.907; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Xu CY, 2006, FUNCT ECOL, V20, P778, DOI 10.1111/j.1365-2435.2006.01161.x; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Yamasaki T, 2002, PLANT PHYSIOL, V128, P1087, DOI 10.1104/pp.010919; Yamori W, 2005, PLANT CELL ENVIRON, V28, P536, DOI 10.1111/j.1365-3040.2004.01299.x; Yamori W, 2006, PLANT CELL PHYSIOL, V47, P1069, DOI 10.1093/pcp/pcj077; Yamori W, 2010, PLANT PHYSIOL, V152, P388, DOI 10.1104/pp.109.145862; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; Zhou XH, 2007, J INTEGR PLANT BIOL, V49, P270, DOI 10.1111/j.1744-7909.2007.00374.x	93	31	33	3	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56482	10.1371/journal.pone.0056482	http://dx.doi.org/10.1371/journal.pone.0056482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457574	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700058
J	Johnsen, MT; Wynn, R; Bratlid, T				Johnsen, May Trude; Wynn, Rolf; Bratlid, Trond			Optimal Sleep Duration in the Subarctic with Respect to Obesity Risk Is 8-9 Hours	PLOS ONE			English	Article							BODY-MASS INDEX; SOCIAL JETLAG; WEIGHT-GAIN; ASSOCIATION; OVERWEIGHT; PATTERNS; CHILDREN; LONG	Introduction: Sleep duration, chronotype and social jetlag have been associated with body mass index (BMI) and abdominal obesity. The optimal sleep duration regarding BMI has previously been found to be 7-8 hours, but these studies have not been carried out in the subarctic or have lacked some central variables. The aims of our study were to examine the associations between sleep variables and body composition for people living in the subarctic, taking a range of variables into consideration, including lifestyle variables, health variables and biological factors. Methods: The cross sectional population Tromso Study was conducted in northern Norway, above the Arctic Circle. 6413 persons aged 30-65 years completed questionnaires including self-reported sleep times, lifestyle and health. They also measured height, weight, waist and hip circumference, and biological factors (non-fasting serum level of cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides and glucose). The study period was from 1 October 2007 to 19 December 2008. Results: The optimal sleep length regarding BMI and waist circumference was found to be 8-9 hours. Short sleepers (<6 h) had about 80% increased risk of being in the BMI >= 25 kg/m2 group and male short sleepers had doubled risk of having waist circumference >= 102 cm compared to 8-9 hours sleepers. We found no impact of chronotype or social jetlag on BMI or abdominal obesity after controlling for health, lifestyle, and biological parameters. Conclusions: In our subarctic population, the optimal sleep duration time regarding risk of overweight and abdominal obesity was 8-9 hours, which is one hour longer compared to findings from other studies. Short sleepers had 80% increased risk of being overweight, and men had a doubled risk of having abdominal obesity. We found no associations between chronotype or social jetlag and BMI or abdominal obesity, when we took a range of life-style, health and biological variables into consideration.	[Johnsen, May Trude; Wynn, Rolf; Bratlid, Trond] Univ Tromso, Fac Hlth Sci, Dept Clin Med, Tromso, Norway; [Wynn, Rolf; Bratlid, Trond] Univ Hosp North Norway, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Johnsen, MT (corresponding author), Univ Tromso, Fac Hlth Sci, Dept Clin Med, Tromso, Norway.	maytrude@online.no	Wynn, Rolf/ABE-8410-2020	Wynn, Rolf/0000-0002-2254-3343	North Norway Regional Health Authority	North Norway Regional Health Authority	This was not an industry supported study. The study was funded by the North Norway Regional Health Authority (http://www.helse-nord.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron KG, 2011, OBESITY, V19, P1374, DOI 10.1038/oby.2011.100; Bjorvatn B, 2007, J SLEEP RES, V16, P66, DOI 10.1111/j.1365-2869.2007.00569.x; Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI 10.1016/j.socscimed.2010.05.041; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cournot M, 2004, EUR J CARDIOV PREV R, V11, P291, DOI 10.1097/01.hjr.0000129738.22970.62; CZEISLER CA, 1981, PHOTOCHEM PHOTOBIOL, V34, P239; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Evans DS, 2011, SLEEP, V34, P661, DOI 10.1093/sleep/34.5.661; Fogelholm M, 2007, INT J OBESITY, V31, P1713, DOI 10.1038/sj.ijo.0803663; Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289; Groholt EK, 2008, J PUBLIC HEALTH-UK, V30, P258, DOI 10.1093/pubmed/fdn037; HAMMOND EC, 1964, AM J PUBLIC HEALTH N, V54, P11, DOI 10.2105/AJPH.54.1.11; Horne J, 2008, BIOL PSYCHOL, V77, P266, DOI 10.1016/j.biopsycho.2007.12.003; Howel D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048528; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Johnsen M, 2012, SLEEP MED IN PRESS; Kobayashi D, 2012, SLEEP BREATH, V16, P829, DOI 10.1007/s11325-011-0583-0; Kohatsu ND, 2006, ARCH INTERN MED, V166, P1701, DOI 10.1001/archinte.166.16.1701; Kokkvoll A, 2012, ACTA PAEDIATR, V101, P924, DOI 10.1111/j.1651-2227.2012.02735.x; Kripke DF, 2011, SLEEP MED, V12, P28, DOI 10.1016/j.sleep.2010.04.016; Lauderdale DS, 2009, AM J EPIDEMIOL, V170, P805, DOI 10.1093/aje/kwp230; Leitzmann MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018582; Magee CA, 2008, PUBLIC HEALTH, V122, P1373, DOI 10.1016/j.puhe.2008.05.010; Magee CA, 2011, SLEEP MED, V12, P346, DOI 10.1016/j.sleep.2010.09.013; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; Marshall NS, 2008, SLEEP MED REV, V12, P289, DOI 10.1016/j.smrv.2008.03.001; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; REYNER A, 1995, SLEEP, V18, P127; Rodgers GP, 2012, JAMA-J AM MED ASSOC, V308, P1095, DOI 10.1001/2012.jama.11853; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Rontoyanni VG, 2007, NUTRITION, V23, P773, DOI 10.1016/j.nut.2007.07.005; Sogaard Anne Johanne, 2004, Int J Equity Health, V3, P3; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; St-Onge MP, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/726071; Stranges S, 2008, AM J EPIDEMIOL, V167, P321, DOI 10.1093/aje/kwm302; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Theorell-Haglow J, 2010, SLEEP, V33, P593; Trenell MI, 2007, CLIN EXP PHARMACOL P, V34, P1, DOI 10.1111/j.1440-1681.2007.04541.x; Ursin R, 2005, SLEEP, V28, P1260, DOI 10.1093/sleep/28.10.1260; WEVER RA, 1983, PFLUG ARCH EUR J PHY, V396, P85, DOI 10.1007/BF00584704; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Yi S, 2012, INT J OBES LOND	47	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56756	10.1371/journal.pone.0056756	http://dx.doi.org/10.1371/journal.pone.0056756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457611	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700079
J	Lai, CF; Chen, YM; Chiang, WC; Lin, SL; Kuo, ML; Tsai, TJ				Lai, Chun-Fu; Chen, Yung-Ming; Chiang, Wen-Chih; Lin, Shuei-Liong; Kuo, Min-Liang; Tsai, Tun-Jun			Cysteine-Rich Protein 61 Plays a Proinflammatory Role in Obstructive Kidney Fibrosis	PLOS ONE			English	Article							TISSUE-GROWTH-FACTOR; UNILATERAL URETERAL OBSTRUCTION; RENAL INTERSTITIAL FIBROSIS; TUBULOINTERSTITIAL FIBROSIS; TGF-BETA; CYR61 CCN1; NEPHROPATHY; CELLS; FIBROBLASTS; MECHANISMS	Cysteine-rich protein 61 (Cyr61) is a secreted matrix-associated protein that regulates a broad spectrum of biological and cellular activities. This study aimed to investigate the role of Cyr61 in progressive kidney fibrosis induced by unilateral ureteral obstruction (UUO) surgery in mice. The expression of Cyr61 transcripts and proteins in the obstructed kidneys were increased from day 1 and remained high until day 10 after surgery. Immunohistochemistry indicated that Cyr61 was expressed mainly in renal tubular epithelial cells. The upregulated Cyr61 in UUO kidneys was reduced in mice treated with pan-transforming growth factor-beta (TGF-beta) antibody. The role of TGF-beta in tubular Cyr61 upregulation after obstructive kidney injury was further supported by experiments showing that TGF-beta 1 stimulated Cyr61 expression in cultured tubular epithelial cells. Notably, the upregulation of Cyr61 in UUO kidneys was followed by a marked increase in monocyte chemoattractant protein 1 (MCP-1) transcripts and macrophage infiltration, which were attenuated in mice treated with anti-Cyr61 antibodies. This proinflammatory property of Cyr61 in inducing MCP-1 expression was further confirmed in tubular epithelial cells cultured with Cyr61 protein. The anti-Cyr61 antibody in UUO mice also reduced the levels of collagen type 1-alpha 1 transcripts, collagen fibril accumulation evaluated by picrosirius red staining, and the levels of alpha-smooth muscle actin (alpha-SMA) transcripts and proteins on day 4 after surgery; however, the antifibrotic effect was not sustained. In conclusion, the TGF-beta-mediated increase in tubular Cyr61 expression involved renal inflammatory cell infiltration through MCP-1 induction during obstructive kidney injury. The Cyr61 blockade attenuated kidney fibrosis in the early phase, but the antifibrotic effect could not be sustained.	[Lai, Chun-Fu; Chen, Yung-Ming; Chiang, Wen-Chih; Lin, Shuei-Liong; Tsai, Tun-Jun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lai, Chun-Fu; Chen, Yung-Ming; Chiang, Wen-Chih; Lin, Shuei-Liong; Tsai, Tun-Jun] Coll Med, Taipei, Taiwan; [Lai, Chun-Fu] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Lin, Shuei-Liong] Natl Taiwan Univ, Grad Inst Physiol, Coll Med, Taipei 10764, Taiwan; [Kuo, Min-Liang] Natl Taiwan Univ, Grad Inst Toxicol, Coll Med, Taipei 10764, Taiwan; [Chen, Yung-Ming] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Douliou City, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Tsai, TJ (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	tjtsai@ntuh.gov.tw	Lin, Shuei-Liong/AGR-2002-2022	Lin, Shuei-Liong/0000-0002-1041-5571; Chiang, Wen Chih/0000-0002-8844-0988; CHEN, YUNG-MING/0000-0002-9241-1258; TSAI, TUN-JUN/0000-0002-1666-8940; LAI, CHUN-FU/0000-0003-2109-1522; KUO, MIN-LIANG/0000-0002-7139-0144	National Science Council [NSC 96-2628-B-002-015-MY3]; Far Eastern Memorial Hospital [FEMH-95-C-024]; Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Fund	National Science Council(Ministry of Science and Technology, Taiwan); Far Eastern Memorial Hospital; Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Fund	This study was supported by grants from the National Science Council (NSC 96-2628-B-002-015-MY3), Far Eastern Memorial Hospital (FEMH-95-C-024), Ta-Tung Kidney Foundation and Mrs. Hsiu-Chin Lee Kidney Research Fund for supporting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai T, 2010, J IMMUNOL, V184, P3223, DOI 10.4049/jimmunol.0902792; Bartholin L, 2007, CANCER LETT, V246, P230, DOI 10.1016/j.canlet.2006.02.019; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Boor P, 2007, J AM SOC NEPHROL, V18, P1508, DOI 10.1681/ASN.2006121343; Bottinger EP, 1997, KIDNEY INT, V51, P1355, DOI 10.1038/ki.1997.185; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen Y, 2007, J CELL BIOCHEM, V100, P1337, DOI 10.1002/jcb.21194; Chen YM, 2003, KIDNEY INT, V63, P474, DOI 10.1046/j.1523-1755.2003.00766.x; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; El Chaar M, 2007, AM J PHYSIOL-RENAL, V292, pF1291, DOI 10.1152/ajprenal.00327.2005; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Isaka Y, 2000, KIDNEY INT, V58, P1885, DOI 10.1046/j.1523-1755.2000.00360.x; Jones LK, 2009, NEPHROL DIAL TRANSPL, V24, P3024, DOI 10.1093/ndt/gfp214; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kitagawa K, 2004, AM J PATHOL, V165, P237, DOI 10.1016/S0002-9440(10)63292-0; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; KUNCIO GS, 1991, KIDNEY INT, V39, P550, DOI 10.1038/ki.1991.63; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Lin S. L., 2012, ACTA NEPHROL, V26, P45; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Lin SL, 2002, J AM SOC NEPHROL, V13, P2916, DOI 10.1097/01.ASN.0000034909.10994.8A; Lin SL, 2005, J AM SOC NEPHROL, V16, P2702, DOI 10.1681/ASN.2005040435; Ling H, 2003, J AM SOC NEPHROL, V14, P377, DOI 10.1097/01.ASN.0000042168.43665.9B; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Muramatsu Y, 2002, KIDNEY INT, V62, P1601, DOI 10.1046/j.1523-1755.2002.00633.x; Nguyen TQ, 2008, PHARM RES-DORDR, V25, P2416, DOI 10.1007/s11095-008-9548-9; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Qi W, 2008, INT J BIOCHEM CELL B, V40, P9, DOI 10.1016/j.biocel.2007.01.006; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Sawai K, 2003, J AM SOC NEPHROL, V14, P1154, DOI 10.1097/01.ASN.0000060576.61218.3D; Sawai K, 2007, AM J PHYSIOL-RENAL, V293, pF1363, DOI 10.1152/ajprenal.00205.2007; Schlondorff DO, 2008, KIDNEY INT, V74, P860, DOI 10.1038/ki.2008.351; Todorovic V, 2005, J CELL BIOL, V171, P559, DOI 10.1083/jcb.200504015; Wang WM, 2009, ACTA PHARMACOL SIN, V30, P107, DOI 10.1038/aps.2008.15; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Yokoi H, 2002, AM J PHYSIOL-RENAL, V282, pF933, DOI 10.1152/ajprenal.00122.2001; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	46	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56481	10.1371/journal.pone.0056481	http://dx.doi.org/10.1371/journal.pone.0056481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457573	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700057
J	Mohapatra, NP; Soni, S; Rajaram, MVS; Strandberg, KL; Gunn, JS				Mohapatra, Nrusingh P.; Soni, Shilpa; Rajaram, Murugesan V. S.; Strandberg, Kristi L.; Gunn, John S.			Type A Francisella tularensis Acid Phosphatases Contribute to Pathogenesis	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; PNEUMONIC TULAREMIA; LEISHMANIA-DONOVANI; PHAGOSOMAL ESCAPE; NADPH OXIDASE; WILD-TYPE; IN-VITRO; IDENTIFICATION; MACROPHAGES; APOPTOSIS	Different Francisella spp. produce five or six predicted acid phosphatases (AcpA, AcpB, AcpC, AcpD, HapA and HapB). The genes encoding the histidine acid phosphatases (hapA, hapB) and acpD of F. tularensis subsp. Schu S4 strain are truncated or disrupted. However, deletion of HapA (FTT1064) in F. tularensis Schu S4 resulted in a 33% reduction in acid phosphatase activity and loss of the four functional acid phosphatases in F. tularensis Schu S4 (Delta ABCH) resulted in a>99% reduction in acid phosphatase activity compared to the wild type strain. All single, double and triple mutants tested, demonstrated a moderate decrease in mouse virulence and survival and growth within human and murine phagocytes, whereas the Delta ABCH mutant showed >3.5-fold decrease in intramacrophage survival and 100% attenuation of virulence in mouse. While the Schu S4 Delta ABCH strain was attenuated in the mouse model, it showed only limited protection against wild type challenge. F. tularensis Schu S4 failed to stimulate reactive oxygen species production in phagocytes, whereas infection by the Delta ABCH strain stimulated 5- and 56-fold increase in reactive oxygen species production in neutrophils and human monocyte-derived macrophages, respectively. The Delta ABCH mutant but not the wild type strain strongly co-localized with p47(phox) and replicated in macrophages isolated from p47(phox) knockout mice. Thus, F. tularensis Schu S4 acid phosphatases, including the truncated HapA, play a major role in intramacrophage survival and virulence of this human pathogen.	[Mohapatra, Nrusingh P.; Soni, Shilpa; Rajaram, Murugesan V. S.; Strandberg, Kristi L.; Gunn, John S.] Ohio State Univ, Dept Microbial Infect & Immun, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Gunn, JS (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Ctr Microbial Interface Biol, Columbus, OH 43210 USA.	gunn.43@osu.edu	Gunn, John/E-3167-2011; Rajaram, Murugesan/E-5203-2013	Rajaram, Murugesan/0000-0002-1515-1122	NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program; Region V "Great Lakes" RCE (NIH) [2-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Region V "Great Lakes" RCE (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by the NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program. The authors wish to acknowledge membership within and support from the Region V "Great Lakes" RCE (NIH award 2-U54-AI-057153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon V, 2000, INFECT IMMUN, V68, P1855, DOI 10.1128/IAI.68.4.1855-1863.2000; BACA OG, 1993, INFECT IMMUN, V61, P4232, DOI 10.1128/IAI.61.10.4232-4239.1993; Balagopal A, 2006, INFECT IMMUN, V74, P5114, DOI 10.1128/IAI.00795-06; Barker JH, 2009, MICROBES INFECT, V11, P762, DOI 10.1016/j.micinf.2009.04.016; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; Bell BL, 2010, INFECT IMMUN, V78, P2189, DOI 10.1128/IAI.00021-10; Ben Nasr A, 2006, J LEUKOCYTE BIOL, V80, P774, DOI 10.1189/jlb.1205755; Broekhuijsen M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Buchan BW, 2009, INFECT IMMUN, V77, P2517, DOI 10.1128/IAI.00229-09; Burtnick MN, 2001, MICROBIOL-UK, V147, P111, DOI 10.1099/00221287-147-1-111; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Charity JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000641; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Child R, 2010, INFECT IMMUN, V78, P59, DOI 10.1128/IAI.00965-09; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clay CD, 2008, J IMMUNOL, V181, P5568, DOI 10.4049/jimmunol.181.8.5568; Clemens DL, 2009, INFECT IMMUN, V77, P1757, DOI 10.1128/IAI.01485-08; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; CONLAN JW, 1992, INFECT IMMUN, V60, P5164, DOI 10.1128/IAI.60.12.5164-5171.1992; Dai SP, 2012, INFECT IMMUN, V80, P1088, DOI 10.1128/IAI.06245-11; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Feldman KA, 2001, NEW ENGL J MED, V345, P1601, DOI 10.1056/NEJMoa011374; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; Fuller JR, 2008, INFECT IMMUN, V76, P4934, DOI 10.1128/IAI.00475-08; Fuller JR, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-216; Geier H, 2011, INFECT IMMUN; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Jones CL, 2012, MICROBIOL MOL BIOL R, V76, P383, DOI 10.1128/MMBR.05027-11; Jungnitz H, 1998, INFECT IMMUN, V66, P4640, DOI 10.1128/IAI.66.10.4640-4650.1998; Konecna K, 2010, PROTEOMICS, V10, P4501, DOI 10.1002/pmic.201000248; KUOLEE R, 2011, MICROBES INFECT; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lai XH, 2003, INFECT IMMUN, V71, P4642, DOI 10.1128/IAI.71.8.4642-4646.2003; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; LOFGREN S, 1980, INFECT IMMUN, V29, P335; LOFGREN S, 1980, INFECT IMMUN, V29, P329; LOFGREN S, 1983, INFECT IMMUN, V39, P715; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; Matyas BI, 2007, ANN NY ACAD SCI, V1105, P351, DOI 10.1196/annals.1409.013; McCaffrey RL, 2010, J LEUKOCYTE BIOL, V88, P791, DOI 10.1189/jlb.1209811; McRae S, 2010, J BIOL CHEM, V285, P5171, DOI 10.1074/jbc.M109.039511; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Mohapatra NP, 2008, INFECT IMMUN, V76, P3690, DOI 10.1128/IAI.00262-08; Mohapatra NP, 2007, INFECT IMMUN, V75, P3305, DOI 10.1128/IAI.00351-07; Mohapatra NP, 2007, INFECT IMMUN, V75, P390, DOI 10.1128/IAI.01226-06; Mohapatra NP, 2010, J IMMUNOL, V184, P5141, DOI 10.4049/jimmunol.0903413; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Pierson T, 2011, J PROTEOME RES, V10, P954, DOI 10.1021/pr1009756; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Reilly TJ, 1996, J BIOL CHEM, V271, P10973, DOI 10.1074/jbc.271.18.10973; REMALEY AT, 1985, J BIOL CHEM, V260, P880; REMALEY AT, 1985, EXP PARASITOL, V60, P331, DOI 10.1016/0014-4894(85)90039-6; SAHA AK, 1985, ARCH BIOCHEM BIOPHYS, V243, P150, DOI 10.1016/0003-9861(85)90783-0; Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Santic M, 2008, INFECT IMMUN, V76, P2671, DOI 10.1128/IAI.00185-08; Santic M, 2007, CELL MICROBIOL, V9, P2391, DOI 10.1111/j.1462-5822.2007.00968.x; Santic M, 2010, MICROBES INFECT, V12, P126, DOI 10.1016/j.micinf.2009.11.003; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1489, DOI 10.1099/mic.0.025379-0; Schulert GS, 2006, J LEUKOCYTE BIOL, V80, P563, DOI 10.1189/jlb.0306219; Schwartz JT, 2012, J IMMUNOL, V188, P3351, DOI 10.4049/jimmunol.1102863; Tarnvik A, 2004, SCAND J INFECT DIS, V36, P350, DOI 10.1080/00365540410020442; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Twine SM, 2006, MICROB PATHOGENESIS, V40, P133, DOI 10.1016/j.micpath.2005.12.004; UHLINGER DJ, 1992, BIOCHEM BIOPH RES CO, V187, P940, DOI 10.1016/0006-291X(92)91288-2; VINCENT JB, 1992, TRENDS BIOCHEM SCI, V17, P105, DOI 10.1016/0968-0004(92)90246-6; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x	78	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56834	10.1371/journal.pone.0056834	http://dx.doi.org/10.1371/journal.pone.0056834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457625	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700087
J	Xiao, J; Song, C; Liu, SJ; Tao, M; Hu, J; Wang, J; Liu, W; Zeng, M; Liu, Y				Xiao, Jun; Song, Can; Liu, Shaojun; Tao, Min; Hu, Jie; Wang, Jun; Liu, Wei; Zeng, Ming; Liu, Yun			DNA Methylation Analysis of Allotetraploid Hybrids of Red Crucian Carp (Carassius auratus red var.) and Common Carp (Cyprinus carpio L.)	PLOS ONE			English	Article							CYTOSINE METHYLATION; GENE-EXPRESSION; GENOME DUPLICATION; HYBRIDIZATION; AFLP; PATTERNS; RNA; TRANSCRIPTION; CONSEQUENCES; POLYPLOIDY	Hybridization and polyploidization may lead to divergence in adaptation and boost speciation in angiosperms and some lower animals. Epigenetic change plays a significant role in the formation and adaptation of polyploidy. Studies of the effects of methylation on genomic recombination and gene expression in allopolyploid plants have achieved good progress. However, relevant advances in polyploid animals have been relatively slower. In the present study, we used the bisexual, fertile, genetically stable allotetraploid generated by hybridization of Carassius auratus red var. and Cyprinus carpio L. to investigate cytosine methylation level using methylation-sensitive amplification polymorphism (MSAP) analysis. We observed 38.31% of the methylation changes in the allotetraploid compared with the parents at 355 randomly selected CCGG sites. In terms of methylation status, these results indicate that the level of methylation modification in the allotetraploid may have increased relative to that in the parents. We also found that the major methylation changes were hypermethylation on some genomic fragments and genes related to metabolism or cell cycle regulation. These results provide circumstantial evidence that DNA methylation might be related to the gene expression and phenotype variation in allotetraploid hybrids. Our study partly fulfils the need for epigenetic research in polyploid animals, and provides evidence for the epigenetic regulation of allopolyploids.	[Xiao, Jun; Song, Can; Liu, Shaojun; Tao, Min; Hu, Jie; Wang, Jun; Liu, Wei; Zeng, Ming; Liu, Yun] Hunan Normal Univ, Minist Educ China, Coll Life Sci, Key Lab Prot Chem & Fish Dev Biol, Changsha, Hunan, Peoples R China	Hunan Normal University; Ministry of Education, China	Liu, SJ (corresponding author), Hunan Normal Univ, Minist Educ China, Coll Life Sci, Key Lab Prot Chem & Fish Dev Biol, Changsha, Hunan, Peoples R China.	lsj@hunnu.edu.cn		xiao, Jun/0000-0002-8310-319X	National Special Fund for Scientific Research in public benefits [200903046]; National Natural Science Foundation of China [30930071, 31210103918, 31201980]; Pre-project of the National Key Basic Research and Development Program [2012CB722305]; Natural Science Fund for Innovative Research Team of Hunan Province [10JJ7004]; Doctoral Fund of Ministry of Education of China [20104306110004]; Construction Project of Key Discipline of Hunan Province; Construction Project of Key Discipline of China	National Special Fund for Scientific Research in public benefits; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Pre-project of the National Key Basic Research and Development Program; Natural Science Fund for Innovative Research Team of Hunan Province; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Construction Project of Key Discipline of Hunan Province; Construction Project of Key Discipline of China	This work was funded by the National Special Fund for Scientific Research in public benefits (Grant No.: 200903046), the National Natural Science Foundation of China (Grant No. : 30930071, 31210103918 and 31201980), Pre-project of the National Key Basic Research and Development Program (Grant No. : 2012CB722305), the Natural Science Fund for Innovative Research Team of Hunan Province (Grant No. : 10JJ7004), the Doctoral Fund of Ministry of Education of China (Grant No. : 20104306110004), and the Construction Project of Key Discipline of Hunan Province and China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Chen L, 2009, MOL CELL PROBE, V23, P157, DOI 10.1016/j.mcp.2009.03.001; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; COSTELLO JF, 1994, MOL CELL BIOL, V14, P6515, DOI 10.1128/MCB.14.10.6515; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; Fang JG, 2010, ACTA PHYSIOL PLANT, V32, P1023, DOI 10.1007/s11738-010-0491-0; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Hegarty MJ, 2011, MOL ECOL, V20, P105, DOI 10.1111/j.1365-294X.2010.04926.x; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kashkush K, 2002, GENETICS, V160, P1651; Koroma AP, 2011, PHYSIOL GENOMICS, V43, P1276, DOI 10.1152/physiolgenomics.00110.2011; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Liu B, 2000, GENOME, V43, P874, DOI 10.1139/gen-43-5-874; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Liu JF, 2007, MAR BIOTECHNOL, V9, P329, DOI 10.1007/s10126-006-6123-4; Liu LG, 2009, CHINESE SCI BULL, V54, P2849, DOI 10.1007/s11434-009-0476-9; Liu SJ, 2010, SCI CHINA LIFE SCI, V53, P416, DOI 10.1007/s11427-010-0057-9; Liu SJ, 2001, AQUACULTURE, V192, P171, DOI 10.1016/S0044-8486(00)00451-8; Ma XF, 2005, CYTOGENET GENOME RES, V109, P236, DOI 10.1159/000082406; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Ochogavia AC, 2009, PLANT MOL BIOL, V70, P17, DOI 10.1007/s11103-009-9454-5; Ohno S., 1970, EVOLUTION GENE DUPLI; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Rice JC, 1998, ONCOGENE, V17, P1807, DOI 10.1038/sj.onc.1202086; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Song C, 2012, SCI CHINA LIFE SCI, V55, P301, DOI 10.1007/s11427-012-4310-2; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Verhoeven KJF, 2010, MOL ECOL, V19, P315, DOI 10.1111/j.1365-294X.2009.04460.x; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WATTS GS, 1995, NUCLEIC ACIDS RES, V23, P4740, DOI 10.1093/nar/23.22.4740; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064	43	27	34	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56409	10.1371/journal.pone.0056409	http://dx.doi.org/10.1371/journal.pone.0056409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457564	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700051
J	Wang, RW; Wang, YQ; He, JZ; Li, YT				Wang, Rui-Wu; Wang, Ya-Qiang; He, Jun-Zhou; Li, Yao-Tang			Resource Elasticity of Offspring Survival and the Optimal Evolution of Sex Ratios	PLOS ONE			English	Article							STABLE REPRODUCTIVE STRATEGIES; POPULATION-GROWTH RATE; ORGANISMS; PATTERNS	The fitness of any organisms includes the survival and reproductive rate of adults and the survival of their offspring. Environmental selection pressures might not affect these two aspects of an organism equally. Assuming that an organism first allocates its limited resources to maintain its survival under environmental selection pressure, our model, based on the evolutionarily stable strategy theory, surprisingly shows that the sex ratio is greatly affected by the environmental pressure intensity and by the reproductive resource elasticity of offspring survival. Moreover, the concept of the resource elasticity of offspring survival intrinsically integrates the ecological concepts of K selection and r selection. The model shows that in a species with reproductive strategy K, increased environmental selection pressure will reduce resource allocation to the male function. By contrast, in a species with reproductive strategy r, harsher environmental selection pressure will increase allocation to the male function. The elasticity of offspring survival might vary not only across species, but also across many other factors affecting the same species (e.g., age structure, spatial heterogeneity), which explains sex ratio differences across species or age structures and spatial heterogeneity in the same species.	[Wang, Rui-Wu; Wang, Ya-Qiang] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Wang, Ya-Qiang; Li, Yao-Tang] Yunnan Univ, Sch Math & Stat, Kunming, Yunnan, Peoples R China; [He, Jun-Zhou] Yunnan Univ Finance & Econ, Stat & Math Coll, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Yunnan University of Finance & Economics	Wang, RW (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	ruiwukiz@hotmail.com; liyaotang@ynu.edu.cn	Li, Yao/AAE-3550-2019		National Natural Science Foundation of China [31170408, 71161020]; Yunnan Natural Science Foundation [2009CD104]; Postgraduate Science Foundation of the Yunnan University [ynuy201038]; West Light Foundation of the Chinese Academy of Sciences; Special Fund for the Excellent Youth of the Chinese Academy of Sciences [KSCX2-EW-Q-9]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); Postgraduate Science Foundation of the Yunnan University; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Special Fund for the Excellent Youth of the Chinese Academy of Sciences	This research was supported by the National Natural Science Foundation of China (31170408, 71161020), the Yunnan Natural Science Foundation (2009CD104), the Postgraduate Science Foundation of the Yunnan University (Grant No. ynuy201038), the West Light Foundation of the Chinese Academy of Sciences, Special Fund for the Excellent Youth of the Chinese Academy of Sciences (KSCX2-EW-Q-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; CHARNOV EL, 1979, AM NAT, V113, P465, DOI 10.1086/283407; Faust LJ, 2000, ZOO BIOL, V19, P11, DOI 10.1002/(SICI)1098-2361(2000)19:1<11::AID-ZOO2>3.0.CO;2-V; Fisher RA, 1930, GENETICAL THEORY NAT; MAC ARTHUR ROBERT H., 1967; MEIKLE DB, 1986, J REPROD FERTIL, V78, P587, DOI 10.1530/jrf.0.0780587; MURRAY BG, 1985, OIKOS, V44, P509, DOI 10.2307/3565794; NUR N, 1987, OIKOS, V48, P338, DOI 10.2307/3565523; Otto S.P., 2011, BIOLOGISTS GUIDE MAT; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Samuelson PA, 1992, ECONOMICS; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Stearns S.C., 1992, pi; STENSETH NC, 1983, OIKOS, V41, P152, DOI 10.2307/3544364; Sun R, 1992, ESSENTIAL ANIMAL ECO; TRIVERS RL, 1974, AM ZOOL, V14, P249; Vali U, 2004, BIRD STUDY, V51, P189; Zhang DY, 1996, AM NAT, V147, P1115, DOI 10.1086/285898; ZHANG DY, 1994, AM NAT, V144, P65, DOI 10.1086/285661; Zhang DY, 1997, J THEOR BIOL, V185, P223, DOI 10.1006/jtbi.1996.0304; Zhang DY, 2000, AM NAT, V155, P187, DOI 10.1086/303310	22	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53904	10.1371/journal.pone.0053904	http://dx.doi.org/10.1371/journal.pone.0053904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23468826	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500029
J	Munzbergova, Z; Hadincova, V; Wild, J; Kindlmannova, J				Muenzbergova, Zuzana; Hadincova, Vera; Wild, Jan; Kindlmannova, Jana			Variability in the Contribution of Different Life Stages to Population Growth as a Key Factor in the Invasion Success of Pinus strobus	PLOS ONE			English	Article							COMPARATIVE DEMOGRAPHY; MATRIX ANALYSIS; DYNAMICS; PLANT; MODELS; RATES; DISPERSAL; LANDSCAPE; SPREAD; SHRUB	Background: Despite the increasing number of studies attempting to model population growth in various organisms, we still know relatively little about the population dynamics of long-lived species that reproduce only in the later stages of their life cycle, such as trees. Predictions of the dynamics of these species are, however, urgently needed for planning management actions when species are either endangered or invasive. In long-lived species, a single management intervention may have consequences for several decades, and detailed knowledge of long-term performance can therefore elucidate possible outcomes during the management planning phase. Methodology and Principal Findings: We studied the population dynamics of an invasive tree species, Pinus strobus, in three habitat types represented by their position along the elevation gradient occupied by the species. In agreement with previous studies on the population dynamics of long-lived perennials, our results show that the survival of the largest trees exhibits the highest elasticity in all of the studied habitats. In contrast, life table response experiments (LTRE) analysis showed that different stages contribute the most to population growth rates in different habitats, with generative reproduction being more important in lower slopes and valley bottoms and survival being more important on rock tops and upper slopes. Conclusions: The results indicate that P. strobus exhibits different growth strategies in different habitats that result in similar population growth rates. We propose that this plasticity in growth strategies is a key factor in the invasion success of the white pine. In all of the investigated habitats, the population growth rates are above 1, indicating that the population of the species is still increasing and has the ability to spread and occupy a wide range of habitats.	[Muenzbergova, Zuzana; Hadincova, Vera; Wild, Jan] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Muenzbergova, Zuzana; Kindlmannova, Jana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Wild, Jan] Czech Univ Life Sci, Fac Environm Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; Czech University of Life Sciences Prague	Munzbergova, Z (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	zuzmun@natur.cuni.cz	Münzbergová, Zuzana/F-6321-2013; Wild, Jan/G-2380-2010; Hadincova, Veroslava/D-4572-2013	Münzbergová, Zuzana/0000-0002-4026-6220; Wild, Jan/0000-0003-3007-4070; Hadincova, Veroslava/0000-0002-3825-1919	GACR [526/05/0430, P504/10/0456]; Academy of Sciences RVO [67985939]; MSMT	GACR(Grant Agency of the Czech Republic); Academy of Sciences RVO; MSMT(Ministry of Education, Youth & Sports - Czech Republic)	This project was supported by GACR 526/05/0430 and P504/10/0456 (www.gacr.cz) and partly by the institutional research project of the Academy of Sciences RVO 67985939 (www.cas.cz) and institutional resources of MSMT (www.msmt.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, PLANT ECOL, V198, P169, DOI 10.1007/s11258-007-9393-7; Al-Khafaji K, 2007, J ECOL, V95, P1370, DOI 10.1111/j.1365-2745.2007.01296.x; ALVAREZBUYLLA ER, 1994, ECOLOGY, V75, P255, DOI 10.2307/1939401; Beer V., 2007, SANDSTONE LANDSCAPES, P109; Brown KA, 2008, J APPL ECOL, V45, P1639, DOI 10.1111/j.1365-2664.2008.01550.x; Buckley YM, 2005, J APPL ECOL, V42, P1020, DOI 10.1111/j.1365-2664.2005.01100.x; Buckley YM, 2010, ECOL LETT, V13, P1182, DOI 10.1111/j.1461-0248.2010.01506.x; Burns JH, 2010, J ECOL, V98, P334, DOI 10.1111/j.1365-2745.2009.01634.x; Caplat P, 2012, ECOLOGY, V93, P368, DOI 10.1890/11-0820.1; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2000, ECOLOGY, V81, P619, DOI 10.2307/177364; Cilek V., 2007, SANDSTONE LANDSCAPES, P97; Colling G, 2006, J ECOL, V94, P959, DOI 10.1111/j.1365-2745.2006.01147.x; Cropper WP, 2006, ECOL MODEL, V198, P487, DOI 10.1016/j.ecolmodel.2006.05.034; de Kroon H, 2000, ECOLOGY, V81, P607, DOI 10.1890/0012-9658(2000)081[0607:EAROMA]2.0.CO;2; De-Camino-Beck T, 2009, ECOL MODEL, V220, P3394, DOI 10.1016/j.ecolmodel.2009.09.003; DeWalt SJ, 2006, BIOL INVASIONS, V8, P1145, DOI 10.1007/s10530-005-5277-8; Dostalek T, 2013, FOLIA GEOBOT, V48, P75, DOI 10.1007/s12224-012-9132-2; Dovciak M, 2005, ECOL MONOGR, V75, P363, DOI 10.1890/03-0802; Efron B., 1994, INTRO BOOTSTRAP; Ehrlen J, 2003, AM NAT, V162, P796, DOI 10.1086/379350; Elton C. S., 1958, ECOLOGY INVASIONS AN; Emery SM, 2005, J APPL ECOL, V42, P60, DOI 10.1111/j.1365-2664.2004.00990.x; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Freville H, 2004, ECOLOGY, V85, P694, DOI 10.1890/03-0119; Glockner P, 1995, VLASTIVEDA OKRESU P, P1; Hadincova V, 2007, SANDSTONES LANDSCAPE, P219; Harper J. L, 1977, POPULATION BIOL PLAN; Heinken-Smidova A, 2012, FOLIA GEOBOT, V47, P193, DOI 10.1007/s12224-011-9116-7; Herben T, 2006, J ECOL, V94, P131, DOI 10.1111/j.1365-2745.2005.01063.x; Higgins SI, 1996, ECOL MODEL, V87, P249, DOI 10.1016/0304-3800(95)00022-4; Ibanez I, 2009, ECOL APPL, V19, P359, DOI 10.1890/07-2095.1; Jacquemyn H, 2005, ECOL APPL, V15, P2097, DOI 10.1890/04-1762; Jongejans E, 2005, J ECOL, V93, P681, DOI 10.1111/j.1365-2745.2005.01003.x; Jongejans E, 2008, J ECOL, V96, P687, DOI 10.1111/j.1365-2745.2008.01367.x; Jongejans E, 2008, PERSPECT PLANT ECOL, V9, P153, DOI 10.1016/j.ppees.2007.09.005; Kaneko Y, 2002, J PLANT RES, V115, P341, DOI 10.1007/s10265-002-0042-x; Kaneko Yuko, 1999, Plant Species Biology, V14, P47, DOI 10.1046/j.1442-1984.1999.00007.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kolb A, 2010, ECOLOGY, V91, P3210, DOI 10.1890/09-2207.1; Koop AL, 2005, ECOLOGY, V86, P2661, DOI 10.1890/04-1483; Kozlowski T.T., 1991, PHYSL ECOLOGY WOODY, DOI 10.1016/B978-0-12-424160-2.50005-7; Kozlowski TT., 1971, GROWTH DEV TREES; Kwit C, 2004, CONSERV BIOL, V18, P432, DOI 10.1111/j.1523-1739.2004.00567.x; Lambrecht-McDowell SC, 2005, BIOL INVASIONS, V7, P281, DOI 10.1007/s10530-004-0870-9; Lehtila K, 2006, CONSERV BIOL, V20, P833, DOI 10.1111/j.1523-1739.2006.00368.x; Lloyd AH, 2005, CAN J FOREST RES, V35, P2073, DOI 10.1139/X05-119; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Munzbergova Z, 2007, ANN BOT-LONDON, V100, P1259, DOI 10.1093/aob/mcm204; Marco DE, 2000, ENVIRON MANAGE, V26, P409, DOI 10.1007/s002670010098; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Munzbergova Z, 2006, FOLIA GEOBOT, V41, P137, DOI 10.1007/BF02806475; Munzbergova Z, 2005, AM J BOT, V92, P1987, DOI 10.3732/ajb.92.12.1987; Munzbergova Z, 2005, J APPL ECOL, V42, P1115, DOI 10.1111/j.1365-2664.2005.01099.x; Munzbergova Z, 2005, ECOL APPL, V15, P1377, DOI 10.1890/04-1464; Munzbergova Z, 2010, BIOL INVASIONS, V12, P2471, DOI 10.1007/s10530-009-9656-4; Musil I, 1971, ACTA MUSEI SILESIA C, V1971, P168; Nehrbass N, 2007, ECOL MODEL, V201, P377, DOI 10.1016/j.ecolmodel.2006.10.004; NOZICKA J, 1965, PRACE VYZKUMNEHO UST, V31, P41; Octavio-Aguilar P, 2008, BOT J LINN SOC, V157, P381, DOI 10.1111/j.1095-8339.2008.00814.x; Oostermeijer JGB, 1996, J ECOL, V84, P153, DOI 10.2307/2261351; Pankova H, 2011, AM J BOT, V98, P850, DOI 10.3732/ajb.0900350; Parker IM, 2000, ECOL APPL, V10, P726, DOI 10.1890/1051-0761(2000)010[0726:IDOCSA]2.0.CO;2; Pergl J, 2011, DIVERS DISTRIB, V17, P725, DOI 10.1111/j.1472-4642.2011.00771.x; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pysek Petr, 2002, Preslia (Prague), V74, P97; Ramula S, 2008, J APPL ECOL, V45, P1124, DOI 10.1111/j.1365-2664.2008.01502.x; Richardson DM, 2004, DIVERS DISTRIB, V10, P321, DOI 10.1111/j.1366-9516.2004.00096.x; Rydgren K, 2007, ECOLOGY, V88, P2320, DOI 10.1890/06-1634.1; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schutzenhofer MR, 2007, ECOL APPL, V17, P965, DOI 10.1890/06-1282; Sebert-Cuvillier E, 2007, ECOL MODEL, V201, P127, DOI 10.1016/j.ecolmodel.2006.09.005; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; Sintes T, 2007, ECOL MODEL, V206, P110, DOI 10.1016/j.ecolmodel.2007.03.027; Stott I, 2010, J ECOL, V98, P302, DOI 10.1111/j.1365-2745.2009.01632.x; Tanaka H, 2008, J VEG SCI, V19, P127, DOI 10.3170/2007-8-18342; The Mathworks Inc, 2001, MATLAB VERS 6 1; Van Mantgem PJ, 2005, J ECOL, V93, P737, DOI 10.1111/j.1365-2745.2005.01007.x; Vila M, 2006, ANN BOT-LONDON, V97, P1055, DOI 10.1093/aob/mcl052; Wendel G. W., 1990, AGR HDB, V654, P476; WERNER PA, 1977, ECOLOGY, V58, P1103, DOI 10.2307/1936930	81	10	11	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56953	10.1371/journal.pone.0056953	http://dx.doi.org/10.1371/journal.pone.0056953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468896	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900046
J	Carlsten, C; Dybuncio, A; Pui, MM; Chan-Yeung, M				Carlsten, Chris; Dybuncio, Anne; Pui, Mandy M.; Chan-Yeung, Moira			Respiratory Impairment and Systemic Inflammation in Cedar Asthmatics Removed from Exposure	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SERUM INTERFERON-GAMMA; GROWTH-FACTOR-BETA; OCCUPATIONAL ASTHMA; AIRWAY INFLAMMATION; FOLLOW-UP; INDUCED SPUTUM; THUJA-PLICATA; CESSATION; RESPONSIVENESS	Background: Prior research has shown that removing occupational asthmatics from exposure does not routinely lead to significant improvements in respiratory impairment. These studies were of limited duration and factors determining recovery remain obscure. Our objective was to evaluate residual respiratory impairment and associated sputum and blood biomarkers in subjects with Western red cedar asthma after exposure cessation. Methods: Subjects previously diagnosed with cedar asthma, and removed from exposure to cedar dust for at least one year, were recruited. Subjects completed a questionnaire and spirometry. PC20 (methacholine concentration that produces 20% fall in FEV1 (forced expiratory volume at 1 second)) sputum cellularity and select T(h)1/T(h)2 (T helper cells 1 and 2) cytokine concentrations in peripheral blood were determined. The asthma impairment class was determined and multivariate analyses were performed to determine its relationship with sputum cell counts and serum cytokines. Results: 40 non-smoking males (mean age 62) were examined at a mean interval of 25 years from cedar asthma diagnosis and 17 years from last cedar exposure. 40% were in impairment class 2/3. On average, the PC20 had increased by 2.0 mg/ml; the FEV1 decreased by 1.5 L, with greater decrease in those with greater impairment. Higher impairment was associated with serum interferon-gamma (mean = 1.3 pg/ml in class 2/3 versus 0.62 pg/ml in class 0/1, p = 0.04), mainly due to the FEV1 component (correlation with interferon-gamma = -0.46, p = 0.005). Conclusion: Years after exposure cessation, patients with Western red cedar asthma have persistent airflow obstruction and respiratory impairment, associated with systemic inflammation.	[Carlsten, Chris; Dybuncio, Anne; Pui, Mandy M.; Chan-Yeung, Moira] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Carlsten, C (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	carlsten@mail.ubc.ca			WorkSafe BC [RS2008-OG08]	WorkSafe BC	This study was funded by WorkSafe BC, grant number: RS2008-OG08, website: www.worksafebc.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	American Thoracic Society, 1995, AM J RESP CRIT CARE, V152, P1107; [Anonymous], 1993, AM REV RESP DIS, V147, P1056; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; Carlsten C, 2010, LONG STANDING RESP I; Chan-Yeung M, 1999, AM J RESP CRIT CARE, V159, P1434, DOI 10.1164/ajrccm.159.5.9807007; CHANYEUNG M, 1987, J ALLERGY CLIN IMMUN, V79, P792, DOI 10.1016/0091-6749(87)90212-0; COCKCROFT DW, 1983, CHEST, V83, P751, DOI 10.1378/chest.83.5.751; COTE J, 1990, AM REV RESPIR DIS, V141, P373, DOI 10.1164/ajrccm/141.2.373; Dimich-Ward H, 2007, J OCCUP ENVIRON MED, V49, P1040, DOI 10.1097/JOM.0b013e31814b2e5c; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Lemiere C, 2010, CAN RESPIR J, V17, P61, DOI 10.1155/2010/509807; Litonjua AA, 2003, ANN ALLERG ASTHMA IM, V90, P422, DOI 10.1016/S1081-1206(10)61827-3; Maghni K, 2004, AM J RESP CRIT CARE, V169, P367, DOI 10.1164/rccm.200309-1238OC; Magnussen Helgo, 2009, Proc Am Thorac Soc, V6, P648, DOI 10.1513/pats.200906-053DP; MILNE J, 1969, MED J AUSTRALIA, V2, P741, DOI 10.5694/j.1326-5377.1969.tb107378.x; Panettieri RA, 2009, ALLERGY ASTHMA PROC, V30, P103, DOI 10.2500/aap.2009.30.3202; Perfetti L, 1998, CHEST, V114, P398, DOI 10.1378/chest.114.2.398; PIN I, 1992, THORAX, V47, P25, DOI 10.1136/thx.47.1.25; PISATI G, 1993, BRIT J IND MED, V50, P60; Pizzichini E, 1996, EUR RESPIR J, V9, P1174, DOI 10.1183/09031936.96.09061174; Rachiotis G, 2007, THORAX, V62, P147, DOI 10.1136/thx.2006.061952; Tarlo SM, 2006, EUR RESPIR J, V27, P607, DOI 10.1183/09031936.06.00062105; ten Hacken NHT, 1998, EUR RESPIR J, V11, P312, DOI 10.1183/09031936.98.11020312; van Eeden SF, 2008, RESPIRATION, V75, P224, DOI 10.1159/000111820; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Yacoub MR, 2007, EUR RESPIR J, V29, P889, DOI 10.1183/09031936.00127206	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57166	10.1371/journal.pone.0057166	http://dx.doi.org/10.1371/journal.pone.0057166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468925	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000071
J	Kotnik, P; Keuper, M; Wabitsch, M; Fischer-Posovszky, P				Kotnik, Primoz; Keuper, Michaela; Wabitsch, Martin; Fischer-Posovszky, Pamela			Interleukin-1 beta Downregulates RBP4 Secretion in Human Adipocytes	PLOS ONE			English	Article							INSULIN-RESISTANCE; SERUM RETINOL-BINDING-PROTEIN-4; CYTOKINES; INFLAMMATION; ASSOCIATION; ADIPONECTIN; EXPRESSION; CONSENSUS; OBESITY	Aims/hypothesis: The excessive accumulation of adipose tissue in the obese state is linked to an altered secretion profile of adipocytes, chronic low-grade inflammation and metabolic complications. RBP4 has been implicated in these alterations, especially insulin resistance. The aim of the present study was to determine if a local inflammatory micro-environment in adipose tissue regulates RBP4 expression and secretion. Methods: Human SGBS and primary adipocytes cultured with conditioned media from human THP-1 macrophages were used as an in vitro model for adipose inflammation. Adipocytes were exposed to recombinant TNF-alpha, IL-1 beta, IL-6 or IL-8. In addition, coexpression of IL-1 beta and RBP4 was measured in adipose tissue samples from 18 healthy females. RBP4 expression was studied by quantitative PCR and ELISA. Results: RBP4 mRNA expression and secretion was significantly reduced upon incubation with macrophage-conditioned media in SGBS adipocytes and human primary adipocytes. Out of several factors studied we identified IL-1 beta as a new factor regulating RBP4. IL-1 beta significantly downregulated RBP4 mRNA and secretion in a time-and dose-dependent manner. IL-1 beta mediated its inhibitory effects on RBP4 expression via IL-1 receptor and NF-kappa B, as incubation with the IL-1 receptor blocking antibody and the NF-kappa B inhibitors CAPE and SC-514 reversed its effect. Most interestingly, RBP4 mRNA was negatively correlated with IL-1 beta mRNA in subcutaneous adipose tissue. Conclusions: Adipose tissue inflammation as found in the obese state might lead to a downregulation in local RBP4 levels. IL-1 beta was identified as a major factor contributing to the decrease in RBP4. The increase in circulating RBP4 that often precedes the development of systemic insulin resistance is most likely unrelated to inflammatory processes in adipose tissue.	[Kotnik, Primoz; Keuper, Michaela; Wabitsch, Martin; Fischer-Posovszky, Pamela] Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany; [Kotnik, Primoz] UKC Ljubljana, Univ Childrens Hosp, Dept Pediat Endocrinol Diabet & Metab, Ljubljana, Slovenia	Ulm University; University Medical Centre Ljubljana	Wabitsch, M (corresponding author), Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany.	martin.wabitsch@uniklinik-ulm.de; pamela.fischer@uniklinik-ulm.de		Keuper, Michaela/0000-0003-0319-3509; Fischer-Posovszky, Pamela/0000-0003-3402-9840	Margarete von Wrangell scholarship; Baden-Wuerttemberg Ministry of Science, Research and Arts; European Social Fund; Das zuckerkranke Kind; Centre of Excellence Baden-Wuerttemberg "Metabolic Disorders"	Margarete von Wrangell scholarship; Baden-Wuerttemberg Ministry of Science, Research and Arts; European Social Fund(European Social Fund (ESF)); Das zuckerkranke Kind; Centre of Excellence Baden-Wuerttemberg "Metabolic Disorders"	PFP is funded by a Margarete von Wrangell scholarship financed by the Baden-Wuerttemberg Ministry of Science, Research and Arts and the European Social Fund. This study was supported by "Das zuckerkranke Kind" to PFP and the Centre of Excellence Baden-Wuerttemberg "Metabolic Disorders" to MW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruun JM, 2002, MOL CELL ENDOCRINOL, V190, P91, DOI 10.1016/S0303-7207(02)00007-2; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; Constant VA, 2006, DIABETOLOGIA, V49, P1402, DOI 10.1007/s00125-006-0253-0; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Flower DR, 1996, BIOCHEM J, V318, P1; Friebe D, 2011, INT J PEDIATR OBES, V6, pE345, DOI 10.3109/17477166.2010.491228; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Hauner H, 2000, METH MOL B, V155, P239; Keuper M, 2011, MOL CELL ENDOCRINOL, V339, P105, DOI 10.1016/j.mce.2011.04.004; Klein S, 2007, DIABETES CARE, V30, P1647, DOI 10.2337/dc07-9921; Kotnik P, 2011, EUR J ENDOCRINOL, V165, P703, DOI 10.1530/EJE-11-0431; Lee DC, 2007, METABOLISM, V56, P327, DOI 10.1016/j.metabol.2006.10.011; Levy-Marchal C, 2010, J CLIN ENDOCR METAB, V95, P5189, DOI 10.1210/jc.2010-1047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Sell H, 2007, DIABETOLOGIA, V50, P2221, DOI 10.1007/s00125-007-0764-3; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Simons PJ, 2007, J ENDOCRINOL, V192, P289, DOI 10.1677/JOE-06-0047; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yao-Borengasser A, 2007, J CLIN ENDOCR METAB, V92, P2590, DOI 10.1210/jc.2006-0816	27	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57796	10.1371/journal.pone.0057796	http://dx.doi.org/10.1371/journal.pone.0057796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460908	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000163
J	Olson, DH; Aanensen, DM; Ronnenberg, KL; Powell, CI; Walker, SF; Bielby, J; Garner, TWJ; Weaver, G; Fisher, MC				Olson, Deanna H.; Aanensen, David M.; Ronnenberg, Kathryn L.; Powell, Christopher I.; Walker, Susan F.; Bielby, Jon; Garner, Trenton W. J.; Weaver, George; Fisher, Matthew C.		Bd Mapping Grp	Mapping the Global Emergence of Batrachochytrium dendrobatidis, the Amphibian Chytrid Fungus	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; CHYTRIDIOMYCOSIS; PATHOGEN; DECLINES; EXTINCTION; SUSCEPTIBILITY; EPIDEMIOLOGY; BIODIVERSITY; BULLFROG; DYNAMICS	The rapid worldwide emergence of the amphibian pathogen Batrachochytrium dendrobatidis (Bd) is having a profound negative impact on biodiversity. However, global research efforts are fragmented and an overarching synthesis of global infection data is lacking. Here, we provide results from a community tool for the compilation of worldwide Bd presence and report on the analyses of data collated over a four-year period. Using this online database, we analysed: 1) spatial and taxonomic patterns of infection, including amphibian families that appear over-and under-infected; 2) relationships between Bd occurrence and declining amphibian species, including associations among Bd occurrence, species richness, and enigmatic population declines; and 3) patterns of environmental correlates with Bd, including climate metrics for all species combined and three families (Hylidae, Bufonidae, Ranidae) separately, at both a global scale and regional (U. S. A.) scale. These associations provide new insights for downscaled hypothesis testing. The pathogen has been detected in 52 of 82 countries in which sampling was reported, and it has been detected in 516 of 1240 (42%) amphibian species. We show that detected Bd infections are related to amphibian biodiversity and locations experiencing rapid enigmatic declines, supporting the hypothesis that greater complexity of amphibian communities increases the likelihood of emergence of infection and transmission of Bd. Using a global model including all sampled species, the odds of Bd detection decreased with increasing temperature range at a site. Further consideration of temperature range, rather than maximum or minimum temperatures, may provide new insights into Bd-host ecology. Whereas caution is necessary when interpreting such a broad global dataset, the use of our pathogen database is helping to inform studies of the epidemiology of Bd, as well as enabling regional, national, and international prioritization of conservation efforts. We provide recommendations for adaptive management to enhance the database utility and relevance.	[Olson, Deanna H.; Ronnenberg, Kathryn L.; Weaver, George] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [Aanensen, David M.; Powell, Christopher I.; Walker, Susan F.; Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Bielby, Jon] Zool Soc London, Inst Zool, London NW1 4RY, England; [Garner, Trenton W. J.] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); United States Forest Service; Imperial College London; Zoological Society of London; Oregon State University	Olson, DH (corresponding author), US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA.	dedeolson@fs.fed.us	Fisher, Matthew/B-9094-2011; Garner, Trenton WJ/D-6873-2011; Cunningham, Andrew A/E-7536-2010	Fisher, Matthew/0000-0002-1862-6402; Garner, Trenton WJ/0000-0002-0336-9706; Bielby, Jon/0000-0003-4586-0429	UK Natural Environmental Research Council [E006701/1]; ERAnet BIODIVERSA project RACE; Wellcome Trust [WT08972]; US Forest Service, Pacific Northwest Research Station; Natural Environment Research Council [NE/G001944/1, NE/G002193/1] Funding Source: researchfish; NERC [NE/G002193/1, NE/G001944/1] Funding Source: UKRI	UK Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ERAnet BIODIVERSA project RACE; Wellcome Trust(Wellcome TrustEuropean Commission); US Forest Service, Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funds were provided by the UK Natural Environmental Research Council (E006701/1), The ERAnet BIODIVERSA project RACE, The Wellcome Trust (WT08972), and the US Forest Service, Pacific Northwest Research Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Aanensen DM, 2009, THESIS; Bancroft BA, 2011, BIODIVERS CONSERV, V20, P1911, DOI 10.1007/s10531-011-0066-4; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Colon-Gaud C, 2009, LIMNOL OCEANOGR, V54, P331, DOI 10.4319/lo.2009.54.1.0331; Colon-Gaud C, 2010, J N AM BENTHOL SOC, V29, P1185, DOI 10.1899/09-102.1; Connelly S, 2011, FRESHWATER BIOL, V56, P1863, DOI 10.1111/j.1365-2427.2011.02626.x; Daszak P, 2004, HERPETOL J, V14, P201; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Duffus A, 2011, FROGLOG, V96, P37; El Mouden E. H., 2011, Herpetological Review, V42, P71; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fenton A, 2005, EMERG INFECT DIS, V11, P1815, DOI 10.3201/eid1112.050306; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Forrest MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028444; Garmyn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035038; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; GASCON C, 2007, AMPHIBIAN CONSERVATI; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Johnson PTJ, 2006, P NATL ACAD SCI USA, V103, P3011, DOI 10.1073/pnas.0600293103; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kirshtein JD, 2007, DIS AQUAT ORGAN, V77, P11, DOI 10.3354/dao01831; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Lovich Robert, 2008, Herpetological Review, V39, P315; Lubick N, 2010, NATURE, V465, P680, DOI 10.1038/465680a; Marschang RE, 2011, J HERPETOL MED SURG, V21, P1; McCallum ML, 2007, J HERPETOL, V41, P483, DOI 10.1670/0022-1511(2007)41[483:ADOECD]2.0.CO;2; Mitchell KM, 2008, P ROY SOC B-BIOL SCI, V275, P329, DOI 10.1098/rspb.2007.1356; Mitchell T. D., 2004, TYNDALL CTR CLIMATE, V55, P25; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; OIE, 2008, M OIE AQ AN HLTH STA; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Picco AM, 2008, CONSERV BIOL, V22, P1582, DOI 10.1111/j.1523-1739.2008.01025.x; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; R Core Team, 2020, R LANG ENV STAT COMP; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Speare R, 2004, AUST VET J, V82, P300, DOI 10.1111/j.1751-0813.2004.tb12710.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Swei A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023179; USGS [United States Geological Survey], 2006, GLOB DIG EL MOD GTOP; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x	61	271	300	1	346	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56802	10.1371/journal.pone.0056802	http://dx.doi.org/10.1371/journal.pone.0056802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23463502	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000039
J	Sousa, SA; Feliciano, JR; Pinheiro, PF; Leitao, JH				Sousa, Silvia A.; Feliciano, Joana R.; Pinheiro, Pedro F.; Leitao, Jorge H.			Biochemical and Functional Studies on the Burkholderia cepacia Complex bceN Gene, Encoding a GDP-D-Mannose 4,6-Dehydratase	PLOS ONE			English	Article							L-FUCOSE; EXOPOLYSACCHARIDE; BIOSYNTHESIS; ENZYMES; PROTEIN; LIPOPOLYSACCHARIDE; RESISTANCE; SYSTEM; CHAIN; POLYSACCHARIDE	This work reports the biochemical and functional analysis of the Burkholderia cenocepacia J2315 bceN gene, encoding a protein with GDP-D-mannose 4,6-dehydratase enzyme activity (E.C.4.2.1.47). Data presented indicate that the protein is active when in the tetrameric form, catalyzing the conversion of GDP-D-mannose into GDP-4-keto-6-deoxy-D-mannose. This sugar nucleotide is the intermediary necessary for the biosynthesis of GDP-D-rhamnose, one of the sugar residues of cepacian, the major exopolysaccharide produced by environmental and human, animal and plant pathogenic isolates of the Burkholderia cepacia complex species. V-max and K-m values of 1.5 +/- 0.2 mu mol.min(-1).mg(-1) and 1024 +/- 123 mu M, respectively, were obtained from the kinetic characterization of the B. cenocepacia J2315 BceN protein by NMR spectroscopy, at 25 degrees C and in the presence of 1 mol MgCl2 per mol of protein. The enzyme activity was strongly inhibited by the substrate, with an estimated K-i of 2913 +/- 350 mu M. The lack of a functional bceN gene in a mutant derived from B. cepacia IST408 slightly reduced cepacian production. However, in the B. multivorans ATCC17616 with bceN as the single gene in its genome with predicted GMD activity, a bceN mutant did not produce cepacian, indicating that this gene product is required for cepacian biosynthesis.	[Sousa, Silvia A.; Feliciano, Joana R.; Pinheiro, Pedro F.; Leitao, Jorge H.] Inst Super Tecn, Inst Biotechnol & Bioengn, Ctr Biol & Chem Engn, Lisbon, Portugal; [Leitao, Jorge H.] Univ Tecn Lisboa, Inst Super Tecn, Dept Bioengn, P-1096 Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Leitao, JH (corresponding author), Inst Super Tecn, Inst Biotechnol & Bioengn, Ctr Biol & Chem Engn, Lisbon, Portugal.	jorgeleitao@ist.utl.pt	Feliciano, Joana R/K-1473-2016; Leitão, Jorge H./A-5122-2012; Pinheiro, Pedro F/B-4234-2014; Sousa, Sílvia A./G-8502-2011	Feliciano, Joana R/0000-0002-4906-676X; Leitão, Jorge H./0000-0001-8850-274X; Pinheiro, Pedro F/0000-0001-5584-7856; Sousa, Sílvia A./0000-0001-9291-9169	FEDER; FCT, Portugal [PTDC/EBB-BIO/098352/2008, PTDC/BIA-MIC/119091/2010]	FEDER(European Commission); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partially funded by FEDER and FCT, Portugal (contracts PTDC/EBB-BIO/098352/2008 and PTDC/BIA-MIC/119091/2010, and a doctoral and post-doctoral grant to J. R. F. and S. A. S., respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albermann C, 2000, GLYCOBIOLOGY, V10, P875, DOI 10.1093/glycob/10.9.875; Bisso A, 1999, FEBS LETT, V456, P370, DOI 10.1016/S0014-5793(99)00982-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bylund J, 2006, J BIOL CHEM, V281, P2526, DOI 10.1074/jbc.M510692200; Cescutti P, 2000, BIOCHEM BIOPH RES CO, V273, P1088, DOI 10.1006/bbrc.2000.3059; Conway BAD, 2004, J INFECT DIS, V190, P957, DOI 10.1086/423141; Cunha MV, 2004, J CLIN MICROBIOL, V42, P3052, DOI 10.1128/JCM.42.7.3052-3058.2004; Cuzzi B, 2012, INNATE IMMUN-LONDON, V18, P661, DOI 10.1177/1753425911435954; Exnowitz F, 2012, BBA-PROTEINS PROTEOM, V1824, P443, DOI 10.1016/j.bbapap.2011.10.011; Ferreira AS, 2010, APPL ENVIRON MICROB, V76, P441, DOI 10.1128/AEM.01828-09; HECK HDA, 1971, J AM CHEM SOC, V93, P23, DOI 10.1021/ja00730a004; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; King JD, 2009, FEBS J, V276, P2686, DOI 10.1111/j.1742-4658.2009.06993.x; Kocharova NA, 2000, BIOCHEMISTRY-US, V39, P4755, DOI 10.1021/bi992635k; Leitao J.H., 2011, INT J MICROBIOL, V2011; Leitao JH, 2010, APPL MICROBIOL BIOT, V87, P31, DOI 10.1007/s00253-010-2528-0; Loutet SA, 2009, MICROBIOL-SGM, V155, P2029, DOI 10.1099/mic.0.027607-0; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Molinaro A, 2003, CARBOHYD RES, V338, P277, DOI 10.1016/S0008-6215(02)00433-0; Moreira LM, 2003, BIOCHEM BIOPH RES CO, V312, P323, DOI 10.1016/j.bbrc.2003.10.118; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; OTHS PJ, 1990, CARBOHYD RES, V198, P91, DOI 10.1016/0008-6215(90)84279-4; Parish T, 1997, FEMS MICROBIOL LETT, V154, P151, DOI 10.1016/S0378-1097(97)00317-0; Ramos CG, 2011, J BACTERIOL, V193, P1515, DOI 10.1128/JB.01375-10; Ren Y, 2010, BIOCHEM BIOPH RES CO, V391, P1663, DOI 10.1016/j.bbrc.2009.12.116; Richau JA, 2000, J CLIN MICROBIOL, V38, P1651, DOI 10.1128/JCM.38.4.1651-1655.2000; Richau JA, 2000, BIOCHEM BIOPH RES CO, V276, P71, DOI 10.1006/bbrc.2000.3438; Sambrook J., 2001, MOL CLONING LAB MANU; Senchenkova SN, 1996, EUR J BIOCHEM, V239, P434, DOI 10.1111/j.1432-1033.1996.0434u.x; Somoza JR, 2000, STRUCTURE, V8, P123, DOI 10.1016/S0969-2126(00)00088-5; Sousa SA, 2007, CELL MICROBIOL, V9, P2817, DOI 10.1111/j.1462-5822.2007.00998.x; Sousa SA, 2007, BIOCHEM BIOPH RES CO, V353, P200, DOI 10.1016/j.bbrc.2006.12.016; Sturla L, 1997, FEBS LETT, V412, P126, DOI 10.1016/S0014-5793(97)00762-X; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Vinion-Dubiel AD, 2003, J ENDOTOXIN RES, V9, P201, DOI 10.1179/096805103225001404; Wang B, 2003, FEMS MICROBIOL LETT, V220, P171, DOI 10.1016/S0378-1097(03)00128-9; Webb NA, 2004, PROTEIN SCI, V13, P529, DOI 10.1110/ps.03393904; Wu BY, 2001, BIOCHEM BIOPH RES CO, V285, P364, DOI 10.1006/bbrc.2001.5137; YAMAMOTO K, 1993, ARCH BIOCHEM BIOPHYS, V300, P694, DOI 10.1006/abbi.1993.1096; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zlosnik JEA, 2008, J CLIN MICROBIOL, V46, P1470, DOI 10.1128/JCM.02273-07; Zlosnik JEA, 2010, J INFECT DIS, V202, P770, DOI 10.1086/655663	44	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56902	10.1371/journal.pone.0056902	http://dx.doi.org/10.1371/journal.pone.0056902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460819	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000044
J	Tanaka, H; Zaima, N; Sasaki, T; Hayasaka, T; Goto-Inoue, N; Onoue, K; Ikegami, K; Morita, Y; Yamamoto, N; Mano, Y; Sano, M; Saito, T; Sato, K; Konno, H; Setou, M; Unno, N				Tanaka, Hiroki; Zaima, Nobuhiro; Sasaki, Takeshi; Hayasaka, Takahiro; Goto-Inoue, Naoko; Onoue, Kenji; Ikegami, Koji; Morita, Yoshifumi; Yamamoto, Naoto; Mano, Yuuki; Sano, Masaki; Saito, Takaaki; Sato, Kohji; Konno, Hiroyuki; Setou, Mitsutoshi; Unno, Naoki			Adventitial Vasa Vasorum Arteriosclerosis in Abdominal Aortic Aneurysm	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; SITE-SPECIFICITY; DISTURBED FLOW; CELLS; PROLIFERATION; PATHOGENESIS; EXPRESSION; RESPONSES	Abdominal aortic aneurysm (AAA) is a common disease among elderly individuals. However, the precise pathophysiology of AAA remains unknown. In AAA, an intraluminal thrombus prevents luminal perfusion of oxygen, allowing only the adventitial vaso vasorum (VV) to deliver oxygen and nutrients to the aortic wall. In this study, we examined changes in the adventitial VV wall in AAA to clarify the histopathological mechanisms underlying AAA. We found marked intimal hyperplasia of the adventitial VV in the AAA sac; further, immunohistological studies revealed proliferation of smooth muscle cells, which caused luminal stenosis of the VV. We also found decreased HemeB signals in the aortic wall of the sac as compared with those in the aortic wall of the neck region in AAA. The stenosis of adventitial VV in the AAA sac and the malperfusion of the aortic wall observed in the present study are new aspects of AAA pathology that are expected to enhance our understanding of this disease.	[Tanaka, Hiroki; Morita, Yoshifumi; Yamamoto, Naoto; Mano, Yuuki; Sano, Masaki; Saito, Takaaki; Konno, Hiroyuki; Unno, Naoki] Hamamatsu Univ Sch Med, Dept Surg 2, Hamamatsu, Shizuoka 4313192, Japan; [Tanaka, Hiroki; Zaima, Nobuhiro; Hayasaka, Takahiro; Goto-Inoue, Naoko; Onoue, Kenji; Ikegami, Koji; Morita, Yoshifumi; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Sasaki, Takeshi; Sato, Kohji] Hamamatsu Univ Sch Med, Dept Anat & Neurosci, Hamamatsu, Shizuoka 4313192, Japan; [Zaima, Nobuhiro] Kinki Univ, Dept Appl Biol Chem, Higashiosaka, Osaka 577, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Kindai University (Kinki University)	Setou, M (corresponding author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan.	setou@hama-med.ac.jp; unno@hama-med.ac.jp	Onoue, Kenji/GRJ-6704-2022		Project of Hamamatsu University Research Promotion; Japan Science and Technology Agency; Tokutei Lipid Machinery and Young Scientists [2067004];  [22590522]; Grants-in-Aid for Scientific Research [23650174, 23390289, 22590522] Funding Source: KAKEN	Project of Hamamatsu University Research Promotion; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Tokutei Lipid Machinery and Young Scientists; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the following grants: a Grant-in-Aid for Scientific Research (C) (22590522) (to NZ); Project of Hamamatsu University Research Promotion (to NU); a Grant-in-Aid for SENTAN from the Japan Science and Technology Agency; and Tokutei Lipid Machinery and Young Scientists S (2067004) (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Choke E, 2006, ANN NY ACAD SCI, V1085, P306, DOI 10.1196/annals.1383.005; CLARKE JA, 1965, J ANAT, V99, P877; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Erdozain OJ, 2011, J VASC RES, V48, P163, DOI 10.1159/000318806; Fan LJ, 2010, BIORHEOLOGY, V47, P31, DOI 10.3233/BIR-2010-0561; Ikesue M, 2011, ARTERIOSCL THROM VAS, V31, P1066, DOI 10.1161/ATVBAHA.110.217703; Isoda K, 2003, CIRCULATION, V108, P516, DOI 10.1161/01.CIR.0000085567.18648.21; Kent KC, 2010, J VASC SURG, V52, P539, DOI 10.1016/j.jvs.2010.05.090; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Michel JB, 2007, ARTERIOSCL THROM VAS, V27, P1259, DOI 10.1161/ATVBAHA.106.137851; Norman PE, 2010, CIRCULATION, V121, P560, DOI 10.1161/CIRCULATIONAHA.109.880724; Ponka P, 1997, BLOOD, V89, P1; Ramos-Mozo P, 2011, ARTERIOSCL THROM VAS, V31, P3011, DOI 10.1161/ATVBAHA.111.237537; Riccioni G, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/737282; Ritman EL, 2007, CARDIOVASC RES, V75, P649, DOI 10.1016/j.cardiores.2007.06.020; Sakai M, 1996, ARTERIOSCL THROM VAS, V16, P600, DOI 10.1161/01.ATV.16.4.600; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Schultz K, 2006, AM J PHYSIOL-HEART C, V290, pH2528, DOI 10.1152/ajpheart.01077.2005; Shai SY, 2010, ARTERIOSCL THROM VAS, V30, P1916, DOI 10.1161/ATVBAHA.110.210831; Shimma S, 2008, ANAL CHEM, V80, P878, DOI 10.1021/ac071301v; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Tanaka H, 2010, EUR J VASC ENDOVASC, V40, P657, DOI 10.1016/j.ejvs.2010.08.001; Tanaka H, 2011, ANAL BIOANAL CHEM, V400, P1873, DOI 10.1007/s00216-011-4850-5; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Wan R, 2011, NANOTOXICOLOGY, V5, P568, DOI 10.3109/17435390.2010.537791; WOLINSKY H, 1969, CIRC RES, V25, P677, DOI 10.1161/01.RES.25.6.677; Yang HJ, 2011, J BIOL CHEM; Yang HJ, 2010, MED MOL MORPHOL, V43, P158, DOI 10.1007/s00795-009-0487-2; YOKOTE K, 1993, EUR J BIOCHEM, V217, P723, DOI 10.1111/j.1432-1033.1993.tb18298.x; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	36	49	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57398	10.1371/journal.pone.0057398	http://dx.doi.org/10.1371/journal.pone.0057398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460850	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000104
J	Williams, PT; Zhao, XQ; Marcovina, SM; Brown, BG; Krauss, RM				Williams, Paul T.; Zhao, Xue-Qiao; Marcovina, Santica M.; Brown, B. Greg; Krauss, Ronald M.			Levels of Cholesterol in Small LDL Particles Predict Atherosclerosis Progression and Incident CHD in the HDL-Atherosclerosis Treatment Study (HATS)	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEINS; APOLIPOPROTEIN-CIII; CORONARY-DISEASE; C-III; RISK; PLASMA; NIACIN	Objective: Test whether angiographically-documented changes in percent stenosis and clinical endpoints (coronary-related deaths, myocardial infarctions, stroke, revascularization for worsening ischemia) in the HDL-Atherosclerosis Treatment Study (HATS) were attributable to specific LDL-subclasses. Methods: Gradient gel electrophoresis of on-study LDL-subclass cholesterol concentrations were measured in 32 placebo, 33 simvastatin-niacin, 38 antioxidant, and 39 simvastatin-niacin & antioxidant treated participants. The prespecified primary end point was the mean change per patient from the initial arteriogram to the final arteriogram in the percent stenosis caused by the most severe lesion in each of the nine proximal coronary segments. Results: The change in the percent stenosis of the most severe proximal lesions increased in association with higher concentrations of the small LDL subfractions LDL-IIIb (24.2-24.6 nm) and LDL-IVa (23.3-24.1 nm) before (both P = 0.002) and after (P = 0.01 and P = 0.03 respectively) adjustment for treatment group and on-study HDL-cholesterol, LDL-cholesterol, and triglyceride concentrations. The associations appeared specific to lesions with <30% baseline stenosis. When adjusted for age, sex, baseline BMI and cigarette use, the odds for primary clinical endpoints (death from coronary causes, nonfatal myocardial infarction, stroke, or revascularization for worsening ischemia) were significantly greater in subjects with higher on-study LDL-IIIb levels both before (P = 0.01) and after (P = 0.03) adjustment for treatment group and the standard lipid values. Conclusions: Plasma LDL-IIIb cholesterol concentrations were related to changes in coronary artery stenosis and cardiovascular events in patients with coronary artery disease and low HDL-cholesterol. Trial Registration:ClinicalTrials.gov/ct2/show/NCT00000553	[Williams, Paul T.] Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA USA; [Zhao, Xue-Qiao; Brown, B. Greg] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA; [Marcovina, Santica M.] Univ Washington, Dept Med, Northwest Lipid Res Labs, Seattle, WA USA; [Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Krauss, RM (corresponding author), Childrens Hosp, Oakland Res Inst, 747 52nd St, Oakland, CA 94609 USA.	rkrauss@chori.org			United States National Institutes of Health [R01 HL49546]; Clinical Nutrition Research Unit [DK 35816]; Diabetes Endocrinology Research Center [DK 17047]; Clinical Research Center at the University of Washington [MO1 00037]; Pfizer; Abbott; Merck; Daiichi Sankyo; Roche; Quest Diagnostics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816, P30DK017047] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Nutrition Research Unit; Diabetes Endocrinology Research Center; Clinical Research Center at the University of Washington; Pfizer(Pfizer); Abbott(Abbott Laboratories); Merck(Merck & Company); Daiichi Sankyo(Daiichi Sankyo Company Limited); Roche(Roche Holding); Quest Diagnostics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by grants from the United States National Institutes of Health (R01 HL49546), the Clinical Nutrition Research Unit (DK 35816), and the Diabetes Endocrinology Research Center (DK 17047). A portion of this study was performed in the Clinical Research Center at the University of Washington (under grant MO1 00037). Drugs were supplied by Upsher-Smith Laboratories and Merck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Drugs were supplied for this study by Upsher-Smith Laboratories and Merck. Merck is the manufacturer of Simvastatin and Upsher-Smith the manufacturer of Slo-Niacin and Niacor. PT Williams has provided consulting serves to Celera. XQ Zhao has received grants, supplies, served as a consultant, or received honoraria from Pfizer, Abbott, Merck, and Daiichi Sankyo. RM Krauss received research grants from Merck, Roche, and Quest Diagnostics, serves on the Merck Global Atherosclerosis Advisory Board and as a consultant for Roche, Genentech, and Celera. RM Krauss also receives royalties for patents of gradient gel electrophoresis and ion mobility analyses of lipoprotein subtractions. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hiukka A, 2009, DIABETES, V58, P2018, DOI 10.2337/db09-0206; Kawakami A, 2006, CIRCULATION, V113, P691, DOI 10.1161/CIRCULATIONAHA.105.591743; Kawakami A, 2009, J ATHEROSCLER THROMB, V16, P6, DOI 10.5551/jat.E607; KRAUSS RM, 1982, J LIPID RES, V23, P97; Krauss RM, 2010, CURR OPIN LIPIDOL, V21, P305, DOI 10.1097/MOL.0b013e32833b7756; Kulkarni KR, 2006, CLIN LAB MED, V26, P787, DOI 10.1016/j.cll.2006.07.004; Luc G, 1996, J LIPID RES, V37, P508; Mendivil CO, 2011, CIRCULATION, V124, P2065, DOI 10.1161/CIRCULATIONAHA.111.056986; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Rainwater DL, 1999, INT J OBESITY, V23, P180, DOI 10.1038/sj.ijo.0800813; Sacks FM, 2000, CIRCULATION, V102, P1886, DOI 10.1161/01.CIR.102.16.1886; Shin MJ, 2010, ATHEROSCLEROSIS, V211, P337, DOI 10.1016/j.atherosclerosis.2010.02.025; Strong A, 2012, J CLIN INVEST, V122, P2807, DOI 10.1172/JCI63563; Williams PT, 2003, ARTERIOSCL THROM VAS, V23, P314, DOI 10.1161/01.ATV.0000053385.64132.2D; Zhao Xue-Qiao, 2003, Med Sci Monit, V9, pCR48	19	26	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56782	10.1371/journal.pone.0056782	http://dx.doi.org/10.1371/journal.pone.0056782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460815	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000038
J	Yoshida, M; Takaki, Y; Eitoku, M; Nunoura, T; Takai, K				Yoshida, Mitsuhiro; Takaki, Yoshihiro; Eitoku, Masamitsu; Nunoura, Takuro; Takai, Ken			Metagenomic Analysis of Viral Communities in (Hado)Pelagic Sediments	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; MARINE VIRUSES; MICROCYSTIS-AERUGINOSA; BACTERIAL; DIVERSITY; GENOME; VIRIOPLANKTON; RECOMBINATION; AMPLIFICATION; PREVALENCE	In this study, we analyzed viral metagenomes (viromes) in the sedimentary habitats of three geographically and geologically distinct (hado)pelagic environments in the northwest Pacific; the Izu-Ogasawara Trench (water depth = 9,760 m) (OG), the Challenger Deep in the Mariana Trench (10,325 m) (MA), and the forearc basin off the Shimokita Peninsula (1,181 m) (SH). Virus abundance ranged from 10(6) to 10(11) viruses/cm(3) of sediments (down to 30 cm below the seafloor [cmbsf]). We recovered viral DNA assemblages (viromes) from the (hado) pelagic sediment samples and obtained a total of 37,458, 39,882, and 70,882 sequence reads by 454 GS FLX Titanium pyrosequencing from the virome libraries of the OG, MA, and SH (hado) pelagic sediments, respectively. Only 24-30% of the sequence reads from each virome library exhibited significant similarities to the sequences deposited in the public nr protein database (E-value < 10(-3) in BLAST). Among the sequences identified as potential viral genes based on the BLAST search, 95-99% of the sequence reads in each library were related to genes from single-stranded DNA (ssDNA) viral families, including Microviridae, Circoviridae, and Geminiviridae. A relatively high abundance of sequences related to the genetic markers (major capsid protein [VP1] and replication protein [Rep]) of two ssDNA viral groups were also detected in these libraries, thereby revealing a high genotypic diversity of their viruses (833 genotypes for VP1 and 2,551 genotypes for Rep). A majority of the viral genes predicted from each library were classified into three ssDNA viral protein categories: Rep, VP1, and minor capsid protein. The deep-sea sedimentary viromes were distinct from the viromes obtained from the oceanic and fresh waters and marine eukaryotes, and thus, deep-sea sediments harbor novel viromes, including previously unidentified ssDNA viruses.	[Yoshida, Mitsuhiro; Takaki, Yoshihiro; Eitoku, Masamitsu; Nunoura, Takuro; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Yoshida, M (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa, Japan.	mityoshi@jamstec.go.jp	Nunoura, Takuro/AAL-6266-2020	Nunoura, Takuro/0000-0003-2323-0880	Japan Society for the Promotion of Science (JSPS) [60565555]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Young Scientists (B) (no. 60565555 to MY) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews-Pfannkoch C, 2010, APPL ENVIRON MICROB, V76, P5039, DOI 10.1128/AEM.00204-10; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Casas V, 2007, METHOD ENZYMOL, V421, P259, DOI 10.1016/S0076-6879(06)21020-6; Chen F, 2001, APPL ENVIRON MICROB, V67, P539, DOI 10.1128/AEM.67.2.539-545.2001; Corinaldesi C, 2003, APPL ENVIRON MICROB, V69, P2664, DOI 10.1128/AEM.69.5.2664-2673.2003; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; Danovaro R, 2008, FRESHWATER BIOL, V53, P1186, DOI 10.1111/j.1365-2427.2008.01961.x; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Duhaime MB, 2012, VIROLOGY, V434, P181, DOI 10.1016/j.virol.2012.09.036; Duhaime MB, 2012, ENVIRON MICROBIOL, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Fuhrman JA, 1995, LIMNOL OCEANOGR, V40, P1236, DOI 10.4319/lo.1995.40.7.1236; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gibbs MJ, 2006, MOL BIOL EVOL, V23, P1097, DOI 10.1093/molbev/msj122; Hino S, 2002, REV MED VIROL, V12, P151, DOI 10.1002/rmv.351; Holmfeldt K, 2012, APPL ENVIRON MICROB, V78, P892, DOI 10.1128/AEM.06580-11; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kelley DR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1067; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; Kim MS, 2011, APPL ENVIRON MICROB, V77, P8062, DOI 10.1128/AEM.06331-11; Liu HQ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-276; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Martin DP, 2011, VIRUSES-BASEL, V3, P1699, DOI 10.3390/v3091699; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; Middelboe M, 2011, AQUAT MICROB ECOL, V63, P1, DOI 10.3354/ame01485; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Morono Y, 2009, ISME J, V3, P503, DOI 10.1038/ismej.2009.1; Nagasaki K, 2005, APPL ENVIRON MICROB, V71, P3528, DOI 10.1128/AEM.71.7.3528-3535.2005; Nagata T., 2000, MICROBIAL ECOLOGY OC, P121; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Park EJ, 2011, APPL ENVIRON MICROB, V77, P1284, DOI 10.1128/AEM.01859-10; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rosario K, 2009, ENVIRON MICROBIOL, V11, P2806, DOI 10.1111/j.1462-2920.2009.01964.x; Rosario K, 2009, J GEN VIROL, V90, P2418, DOI 10.1099/vir.0.012955-0; Roux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033641; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandaa RA, 2006, APPL ENVIRON MICROB, V72, P4610, DOI 10.1128/AEM.00168-06; Schrenk MO, 2010, ANNU REV MAR SCI, V2, P279, DOI 10.1146/annurev-marine-120308-081000; Seiter K, 2004, DEEP-SEA RES PT I, V51, P2001, DOI 10.1016/j.dsr.2004.06.014; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2009, ENVIRON MICROBIOL, V11, P2935, DOI 10.1111/j.1462-2920.2009.02081.x; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thurber RLV, 2008, P NATL ACAD SCI USA, V105, P18413, DOI 10.1073/pnas.0808985105; Thurber RV, 2009, CURR OPIN MICROBIOL, V12, P582, DOI 10.1016/j.mib.2009.08.008; Tomaru Y, 2008, AQUAT MICROB ECOL, V50, P103, DOI 10.3354/ame01170; Tomaru Y, 2011, AQUAT MICROB ECOL, V64, P175, DOI 10.3354/ame01517; Tomaru Y, 2011, APPL ENVIRON MICROB, V77, P5285, DOI 10.1128/AEM.00202-11; Tucker KP, 2011, ISME J, V5, P822, DOI 10.1038/ismej.2010.188; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yau S, 2011, P NATL ACAD SCI USA, V108, P6163, DOI 10.1073/pnas.1018221108; Yoon HS, 2011, SCIENCE, V332, P714, DOI 10.1126/science.1203163; Yoshida H, 2009, MAR TECHNOL SOC J, V43, P87, DOI 10.4031/MTSJ.43.5.31; Yoshida M, 2008, APPL ENVIRON MICROB, V74, P3269, DOI 10.1128/AEM.02240-07; Yoshida M, 2010, MICROBES ENVIRON, V25, P211, DOI 10.1264/jsme2.ME10117; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275	79	89	93	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57271	10.1371/journal.pone.0057271	http://dx.doi.org/10.1371/journal.pone.0057271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468952	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000087
J	You, H; Chen, JH; Bogg, L; Wu, Y; Duan, SN; Ye, CY; Liu, XF; Yu, H; Diwan, V; Dong, HJ				You, Hua; Chen, Jianhua; Bogg, Lennart; Wu, Yuan; Duan, Shengnan; Ye, Chiyu; Liu, Xiaofang; Yu, Hai; Diwan, Vinod; Dong, Hengjin			Study on the Factors Associated with Postpartum Visits in Rural China	PLOS ONE			English	Article							HOME VISIT; POSTNATAL CARE; PREDICTORS; BANGLADESH; MOTHERS; TRIAL	Background: Postpartum visits (PPVs) have been advocated as a way to improve health outcomes for mothers and their infants, but the rate of PPVs is still low in rural China. This study aims to investigate the utilization of PPVs and to explore the factors associated with PPVs in rural China. Parity is the most concerned factor in this study. Methods: A cross-sectional household survey was performed in two counties of Zhejiang province. Questions include socioeconomic, health services and women's delivery data. Chi-square tests and multivariate logistic regression analyses were performed to identify factors associated with PPVs. Results: 223 women who had a delivery history in the recent five years were enrolled in analyses. 173 (78%) of them were primiparous. Among the primiparous women, 43 (25%) had not received any PPVs. The majority, 27 (55%) of the 49 multiparous women, had not received any PPVs. Multiparous women were less likely to receive PPVs than primiparous women. Among 223 puerperal women, 47 (21%) had been compensated for delivery fee expenses. Women who received compensation were found to be more likely to receive standard (at least 3) PPVs. Conclusions: It was found that women with "second babies" were less likely to use PPVs. This could be an unintended consequence of the "one-child policy", due to fear that contact with public health facilities could result in sanctions. This phenomenon should be taken seriously by government in order to improve the health of babies and their mothers. Financial compensation for delivery fee charges can improve the use of PPVs, thus free-of-charge delivery should be promoted.	[You, Hua; Chen, Jianhua; Wu, Yuan; Duan, Shengnan; Ye, Chiyu; Liu, Xiaofang; Yu, Hai; Dong, Hengjin] Zhejiang Univ, Sch Med, Ctr Hlth Policy Studies, Hangzhou 310003, Zhejiang, Peoples R China; [Bogg, Lennart; Diwan, Vinod] Karolinska Inst, Inst Global Hlth, Stockholm, Sweden; [Bogg, Lennart] Malardalen Univ, Sch Hlth Care & Welf, Vasteras, Sweden; [Dong, Hengjin] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany	Zhejiang University; Karolinska Institutet; Malardalen University; Ruprecht Karls University Heidelberg	Dong, HJ (corresponding author), Zhejiang Univ, Sch Med, Ctr Hlth Policy Studies, Hangzhou 310003, Zhejiang, Peoples R China.	donghj@zju.edu.cn		Bogg, Lennart/0000-0003-0368-050X	China Medical Board [09-989]; European Union [261304]	China Medical Board; European Union(European Commission)	Funded by China Medical Board: 09-989 (http://www.chinamedicalboard.org/); and European Union: 261304 (http://europa.eu/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers LL, 2000, J MIDWIFERY WOM HEAL, V45, P55, DOI 10.1016/S1526-9523(99)00003-3; Apgar BS, 2005, AM FAM PHYSICIAN, V72, P2443; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Bogg L, 1998, AM J PUBLIC HEALTH, V88, P649, DOI 10.2105/AJPH.88.4.649; Brown MS, 1984, NURSE PRACT, V9, P46; Brown MS, 1984, NURSE PRACT, V9, P42; Bryant AS, 2006, MATERN CHILD HLTH J, V10, P511, DOI 10.1007/s10995-006-0128-5; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Chakraborty N, 2002, HEALTH SOC CARE COMM, V10, P492, DOI 10.1046/j.1365-2524.2002.00389.x; Christie J, 2011, INT J NURS STUD, V48, P689, DOI 10.1016/j.ijnurstu.2010.10.011; Dhakal Sulochana, 2007, BMC Pregnancy Childbirth, V7, P19, DOI 10.1186/1471-2393-7-19; Gorlin R, 1979, Female Patient, V4, P89; Hamburg M V, 1981, SIECUS Rep, V10, P3; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jing Y, 2012, ZHONG GUO FU YOU BAO, V27, P170; Kabakian-Khasholian Tamar, 2006, Health Care Women Int, V27, P839, DOI 10.1080/07399330600880392; Li WJ, 2009, ZHONG GUO FU YOU BAO, V33, P4645; Lu MC, 2002, AM J OBSTET GYNECOL, V187, P1329, DOI 10.1067/mob.2002.126848; Ministry of Health of China, 1989, MAN MEAS SYST MAT HE; Ministry of Health of China, 2004, REP 3 NAT HLTH SERV; Ministry of Health of China UNICEF WHO UNFPA, 2006, JOINT REV MAT CHILD; Quinlivan JA, 2003, LANCET, V361, P893, DOI 10.1016/S0140-6736(03)12770-5; Sword WA, 2006, CAN J PUBLIC HEALTH, V97, P191, DOI 10.1007/BF03405582; Tao FB, 2011, MIDWIFERY, V27, P707, DOI 10.1016/j.midw.2009.10.001; Tian DZ, 2012, 7 MONTH PREGNANT WOM; Wager KA, 2004, PUBLIC HEALTH NURS, V21, P541, DOI 10.1111/j.0737-1209.2004.21606.x; World Health Organization, 1998, BAS NEWB RES PRACT G	27	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55955	10.1371/journal.pone.0055955	http://dx.doi.org/10.1371/journal.pone.0055955			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460789	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000012
J	Zhan, LH; Hanson, KA; Kim, SH; Tare, A; Tibbetts, RS				Zhan, Lihong; Hanson, Keith A.; Kim, Sang Hwa; Tare, Apeksha; Tibbetts, Randal S.			Identification of Genetic Modifiers of TDP-43 Neurotoxicity in Drosophila	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA TARGETS; TARDBP MUTATIONS; MESSENGER-RNA; ALS; NOTCH; DISEASE; UBIQUILIN; PROTEIN; MODEL	Cytosolic aggregation of the nuclear RNA-binding protein TDP-43 is a histopathologic signature of degenerating neurons in amyotrophic lateral sclerosis (ALS), and mutations in the TARDBP gene encoding TDP-43 cause dominantly inherited forms of this condition. To understand the relationship between TDP-43 misregulation and neurotoxicity, we and others have used Drosophila as a model system, in which overexpression of either wild-type TDP-43 or its ALS-associated mutants in neurons is sufficient to induce neurotoxicity, paralysis, and early death. Using microarrays, we have examined gene expression patterns that accompany TDP-43-induced neurotoxicity in the fly system. Constitutive expression of TDP-43 in the Drosophila compound eye elicited widespread gene expression changes, with strong upregulation of cell cycle regulatory genes and genes functioning in the Notch intercellular communication pathway. Inducible expression of TDP-43 specifically in neurons elicited significant expression differences in a more restricted set of genes. Genes that were upregulated in both paradigms included SpindleB and the Notch target Hey, which appeared to be a direct TDP-43 target. Mutations that diminished activity of Notch or disrupted the function of downstream Notch target genes extended the lifespan of TDP-43 transgenic flies, suggesting that Notch activation was deleterious in this model. Finally, we showed that mutation of the nucleoporin Nup50 increased the lifespan of TDP-43 transgenic flies, suggesting that nuclear events contribute to TDP-43-dependent neurotoxicity. The combined findings identified pathways whose deregulation might contribute to TDP-43-induced neurotoxicity in Drosophila.	[Zhan, Lihong; Hanson, Keith A.; Kim, Sang Hwa; Tare, Apeksha; Tibbetts, Randal S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; El Bejjani R, 2012, NEURON, V73, P268, DOI 10.1016/j.neuron.2011.11.017; Estes PS, 2011, HUM MOL GENET, V20, P2308, DOI 10.1093/hmg/ddr124; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Fushimi K, 2011, PROTEIN CELL, V2, P141, DOI 10.1007/s13238-011-1014-5; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Godena VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017808; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Hazelett DJ, 2012, G3-GENES GENOM GENET, V2, P789, DOI 10.1534/g3.112.002998; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kim SH, 2009, J BIOL CHEM, V284, P8083, DOI 10.1074/jbc.M808064200; Kim SH, 2012, HUM MOL GENET; KNUST E, 1987, DEV BIOL, V122, P262, DOI 10.1016/0012-1606(87)90351-4; Kryndushkin D, 2011, PROTEIN CELL, V2, P223, DOI 10.1007/s13238-011-1525-0; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; LI Y, 2010, P NATL ACAD SCI US; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Lin MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020371; Lorca T, 2012, ONCOGENE; Miguel L, 2011, NEUROBIOL DIS, V41, P398, DOI 10.1016/j.nbd.2010.10.007; Monastirioti M, 2010, DEVELOPMENT, V137, P191, DOI 10.1242/dev.043604; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Paaby AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001987; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Reeve SR, 2005, CURR BIOL, V15, P1156, DOI 10.1016/j.cub.2005.05.050; Ren CL, 2009, EXP GERONTOL, V44, P228, DOI 10.1016/j.exger.2008.10.002; Rimkus SA, 2008, GENE DEV, V22, P1205, DOI 10.1101/gad.1639608; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rothenberg C, 2010, AUTOPHAGY, V6, P979, DOI 10.4161/auto.6.7.13118; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Wegorzewska I, 2011, NEURODEGENER DIS, V8, P262, DOI 10.1159/000321547; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Xiao SX, 2011, MOL CELL NEUROSCI, V47, P167, DOI 10.1016/j.mcn.2011.02.013; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zaffran S, 2000, DEVELOPMENT, V127, P1115; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086	68	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57214	10.1371/journal.pone.0057214	http://dx.doi.org/10.1371/journal.pone.0057214			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468938	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000077
J	Li, W; Hu, XP				Li, Wu; Hu, Xiaoping			Robust Tract Skeleton Extraction of Cingulum Based on Active Contour Model from Diffusion Tensor MR Imaging	PLOS ONE			English	Article							WHITE-MATTER; HUMAN BRAIN; TRACTOGRAPHY; TRACKING; SEGMENTATION; CONNECTIVITY; DEFLECTION; CORTEX	Cingulum is widely studied in healthy and psychiatric subjects. For cingulum analysis from diffusion tensor MR imaging, tractography and tract of interest method have been adopted for tract-based analysis. Because tractography performs fiber tracking according to local diffusion measures, they can be sensitive to noise and tracking errors can be accumulated along the fiber. For more accurate localization of cingulum, we attempt to define it by skeleton extraction using the tensors' information throughout the tract of cingulum simultaneously, which is quite different from the idea of tractography. In this study, we introduce an approach to extract the skeleton of cingulum using active contour model, which allows us to optimize the location of cingulum in a global sense based on the diffusion measurements along the entire tract and contour regularity. Validation of this method on synthetic and experimental data proved that our approach is able to reduce the influence of noise and partial volume effect, and extract the skeleton of cingulum robustly and reliably. Our proposed method provides an approach to localize cingulum robustly, which is a very important feature for tract-based analysis and can be of important practical utility.	[Li, Wu] Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China; [Li, Wu; Hu, Xiaoping] Georgia Tech, Dept Biomed Engn, Atlanta, GA USA; [Li, Wu; Hu, Xiaoping] Emory Univ, Atlanta, GA 30322 USA	Chinese Academy of Sciences; Institute of Automation, CAS; University System of Georgia; Georgia Institute of Technology; Emory University	Li, W (corresponding author), Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China.	wu.li@ia.ac.cn; xhu@bme.gatech.edu	zhang, feng/L-7009-2016; Li, Wu/AHA-4320-2022	Hu, Xiaoping/0000-0001-7014-5983	National Institutes of Health [PO1AG026423, P50MH058922]; National Natural Science Foundation of China [30970769, 81171314]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was kindly supported by the National Institutes of Health (PO1AG026423, P50MH058922) and the National Natural Science Foundation of China (30970769, 81171314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awate SP, 2007, IEEE T MED IMAGING, V26, P1525, DOI 10.1109/TMI.2007.907301; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bresson X, 2007, J MATH IMAGING VIS, V28, P151, DOI 10.1007/s10851-007-0002-0; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catheline G, 2010, NEUROBIOL AGING, V31, P1582, DOI 10.1016/j.neurobiolaging.2008.08.012; Cheng P, 2006, NEUROIMAGE, V31, P1075, DOI 10.1016/j.neuroimage.2006.01.028; Chou MC, 2006, J MAGN RESON IMAGING, V24, P451, DOI 10.1002/jmri.20652; Clayden JD, 2007, IEEE T MED IMAGING, V26, P1555, DOI 10.1109/TMI.2007.905826; Cohen LD, 1997, INT J COMPUT VISION, V24, P57, DOI 10.1023/A:1007922224810; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; CRICK F, 1993, NATURE, V361, P109, DOI 10.1038/361109a0; Fillard P, 2011, NEUROIMAGE, V56, P220, DOI 10.1016/j.neuroimage.2011.01.032; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Hamani C, 2011, BIOL PSYCHIAT, V69, P301, DOI 10.1016/j.biopsych.2010.09.034; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Li W, 2004, NEUROIMAGE, V23, P1507, DOI 10.1016/j.neuroimage.2004.08.009; Lori NF, 2002, NMR BIOMED, V15, P493, DOI 10.1002/nbm.779; McCormick LM, 2006, NEUROIMAGE, V32, P1167, DOI 10.1016/j.neuroimage.2006.04.227; Melonakos J, 2008, IEEE T PATTERN ANAL, V30, P412, DOI 10.1109/TPAMI.2007.70713; Melonakos J, 2007, LECT NOTES COMPUT SC, V4791, P36; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Niethammer M, 2009, NEUROIMAGE, V45, pS123, DOI 10.1016/j.neuroimage.2008.11.001; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stenset V, 2011, NEUROBIOL AGING, V32, P581, DOI 10.1016/j.neurobiolaging.2009.04.014; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Wang F, 2004, AM J PSYCHIAT, V161, P573, DOI 10.1176/appi.ajp.161.3.573; Weinstein DM, 1999, 10 IEEE VIS 1999 VIS, P40; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071	41	0	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56113	10.1371/journal.pone.0056113	http://dx.doi.org/10.1371/journal.pone.0056113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468855	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400007
J	Lin, SC; Chen, WY; Lin, KY; Chen, SH; Chang, CC; Lin, SE; Fang, CL				Lin, Shee-Chan; Chen, Wei-Yu; Lin, Kai-Yuan; Chen, Sheng-Hsuan; Chang, Chun-Chao; Lin, Sey-En; Fang, Chia-Lang			Clinicopathological Correlation and Prognostic Significance of Protein Kinase C alpha Overexpression in Human Gastric Carcinoma	PLOS ONE			English	Article							PKC-ALPHA; CELL-PROLIFERATION; MESSENGER-RNA; EXPRESSION; CANCER; BREAST; INVASION; MARKER	Objectives: This study investigated the PKC alpha protein expression in gastric carcinoma, and correlated it with clinicopathological parameters. The prognostic significance of PKC alpha protein expression in gastric carcinoma was analyzed. Methods: Quantitative real-time PCR test was applied to compare the PKC alpha mRNA expression in tumorous and nontumorous tissues of gastric carcinoma in ten randomly selected cases. Then PKC alpha protein expression was evaluated in 215 cases of gastric carcinoma using immunohistochemical method. The immunoreactivity was scored semiquantitatively as: 0 = absent; 1 = weak; 2 = moderate; and 3 = strong. All cases were further classified into two groups, namely PKC alpha overexpression group with score 2 or 3, and non-overexpression group with score 0 or 1. The PKC alpha protein expression was correlated with clinicopathological parameters. Survival analysis was performed to determine the prognostic significance of PKC alpha protein expression in patients with gastric carcinoma. Results: PKC alpha mRNA expression was upregulated in all ten cases of gastric carcinoma via quantitative real-time PCR test. In immunohistochemical study, eighty-eight out of 215 cases (41%) of gastric carcinoma revealed PKC alpha protein overexpression, which was statistically correlated with age (P = 0.0073), histologic type (P < 0.0001), tumor differentiation (P = 0.0110), depth of invasion (P = 0.0003), angiolymphatic invasion (P = 0.0373), pathologic stage (P = 0.0047), and distant metastasis (P = 0.0048). We found no significant difference in overall and disease free survival rates between PKC alpha overexpression and non-overexpression groups (P = 0.0680 and 0.0587). However, PKC alpha protein overexpression emerged as a significant independent prognostic factor in multivariate Cox regression analysis (hazard ratio 0.632, P = 0.0415). Conclusions: PKC alpha protein is upregulated in gastric carcinoma. PKC alpha protein expression is statistically correlated with age, histologic type, tumor differentiation, depth of invasion, angiolymphatic invasion, pathologic stage, and distant metastasis. The PKC alpha protein overexpression in patients with gastric carcinoma is a significant independent prognostic factor in multivariate Cox regression analysis.	[Lin, Shee-Chan] Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Chen, Wei-Yu; Lin, Sey-En; Fang, Chia-Lang] Taipei Med Univ, Dept Pathol, Sch Med, Coll Med, Taipei, Taiwan; [Chen, Wei-Yu; Fang, Chia-Lang] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Lin, Kai-Yuan] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Lin, Kai-Yuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan; [Chen, Sheng-Hsuan; Chang, Chun-Chao] Taipei Med Univ, Coll Med, Dept Internal Med, Sch Med, Taipei, Taiwan; [Chen, Sheng-Hsuan; Chang, Chun-Chao] Taipei Med Univ Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Lin, Sey-En] Taipei Med Univ Hosp, Dept Pathol, Taipei, Taiwan	Mackay Memorial Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital	Fang, CL (corresponding author), Taipei Med Univ, Dept Pathol, Sch Med, Coll Med, Taipei, Taiwan.	ccllfang@tmu.edu.tw		Lin, Sey-En/0000-0002-8994-9452	Mackay Memorial Hospital [94MMH-TMU-16]	Mackay Memorial Hospital	This work was supported by the grant (94MMH-TMU-16) from Mackay Memorial Hospital (www.mmh.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth PD, 2004, EUR J CANCER, V40, P2269, DOI 10.1016/j.ejca.2004.06.027; Cameron AJ, 2008, INT J CANCER, V123, P769, DOI 10.1002/ijc.23560; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Furness JB, 2006, HISTOCHEM CELL BIOL, V126, P537, DOI 10.1007/s00418-006-0190-5; Garcia M, 2007, GLOBAL CANC FACTS FI; Haughian JM, 2009, J CELL PHYSIOL, V220, P112, DOI 10.1002/jcp.21741; Jiang XH, 2004, CANCER RES, V64, P5787, DOI 10.1158/0008-5472.CAN-03-1172; Jinawath N, 2004, ONCOGENE, V23, P6830, DOI 10.1038/sj.onc.1207886; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kerfoot C, 2004, J HISTOCHEM CYTOCHEM, V52, P419, DOI 10.1177/002215540405200314; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Kong CZ, 2005, UROLOGY, V65, P1228, DOI 10.1016/j.urology.2005.01.007; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Kuniyasu H, 1997, JPN J CANCER RES, V88, P103, DOI 10.1111/j.1349-7006.1997.tb00353.x; Lahn M, 2004, EUR J CANCER, V40, P10, DOI 10.1016/j.ejca.2003.08.020; Lahn MM, 2004, MELANOMA RES, V14, P85, DOI 10.1097/00008390-200404000-00002; Lan J, 2003, WORLD J GASTROENTERO, V9, P54, DOI 10.3748/wjg.v9.i1.54; Lin KY, 2008, J SURG ONCOL, V97, P538, DOI 10.1002/jso.20997; Lin X, 2006, CARCINOGENESIS, V27, P1538, DOI 10.1093/carcin/bgl002; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Masur K, 2001, MOL BIOL CELL, V12, P1973, DOI 10.1091/mbc.12.7.1973; Michie AM, 2005, IMMUNOL LETT, V96, P155, DOI 10.1016/j.imlet.2004.08.013; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Pfeifer J.D., 2006, MOL GENETIC TESTING; Teicher BA, 2006, CLIN CANCER RES, V12, P5336, DOI 10.1158/1078-0432.CCR-06-0945; Weichert W, 2003, INT J ONCOL, V23, P633; Wu TT, 2008, J CELL BIOCHEM, V103, P9, DOI 10.1002/jcb.21378; Wu TT, 2007, CLIN CHIM ACTA, V382, P54, DOI 10.1016/j.cca.2007.03.018; Zhang B, 2003, WORLD J GASTROENTERO, V9, P2413	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56675	10.1371/journal.pone.0056675	http://dx.doi.org/10.1371/journal.pone.0056675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468872	Green Published, gold, Green Submitted			2022-12-27	WOS:000315561400013
J	Mundle, ST; Hernandez, H; Hamberger, J; Catalan, J; Zhou, C; Stegalkina, S; Tiffany, A; Kleanthous, H; Delagrave, S; Anderson, SF				Mundle, Sophia T.; Hernandez, Hector; Hamberger, John; Catalan, John; Zhou, Changhong; Stegalkina, Svetlana; Tiffany, Andrea; Kleanthous, Harry; Delagrave, Simon; Anderson, Stephen F.			High-Purity Preparation of HSV-2 Vaccine Candidate ACAM529 Is Immunogenic and Efficacious In Vivo	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; RECURRENT GENITAL HERPES; PLACEBO-CONTROLLED TRIAL; TYPE-1 GENE VECTOR; RECOMBINANT GLYCOPROTEIN; DEXTRAN SULFATE; AFFINITY-CHROMATOGRAPHY; GUINEA-PIGS; PHASE-I	Genital herpes is a sexually transmitted infection (STI) caused by herpes simplex virus 2 (HSV-2) and to a lesser extent herpes simplex virus 1 (HSV-1). Infection by HSV-2 is life-long and is associated with significant cost to healthcare systems and social stigma despite the highly prevalent nature of the disease. For instance, the proportion of HSV-2 seropositive to seronegative adults is approximately 1 in 5 in the US and greater than 4 in 5 in some areas of sub-Saharan Africa. The replication-defective vaccine strain virus dl5-29 was re-derived using cells appropriate for GMP manufacturing and renamed ACAM529. Immunization with dl5-29 was previously reported to be protective both in mice and in guinea pigs, however these studies were performed with vaccine that was purified using methods that cannot be scaled for manufacturing of clinical material. Here we describe methods which serve as a major step towards preparation of ACAM529 which may be suitable for testing in humans. ACAM529 can be harvested from infected cell culture of the trans-complementing cell line AV529 clone 19 (AV529-19) without mechanical cell disruption. ACAM529 may then be purified with respect to host cell DNA and proteins by a novel purification scheme, which includes a combination of endonuclease treatment, depth filtration, anion-exchange chromatography and ultrafiltration/ diafiltration (UF/DF). The resultant virus retains infectivity and is, 200-fold more pure with respect to host cell DNA and proteins than is ACAM529 purified by ultracentrifugation. Additionally, we describe a side-by- side comparison of chromatography-purified ACAM529 with sucrose cushion-purified ACAM529, which shows that both preparations are equally immunogenic and protective when tested in vivo.	[Mundle, Sophia T.; Hernandez, Hector; Hamberger, John; Catalan, John; Zhou, Changhong; Stegalkina, Svetlana; Tiffany, Andrea; Kleanthous, Harry; Delagrave, Simon; Anderson, Stephen F.] Sanofi Pasteur, Discovery North Amer, Cambridge, MA USA	Sanofi-Aventis	Mundle, ST (corresponding author), Sanofi Pasteur, Discovery North Amer, Cambridge, MA USA.	sophia.mundle@sanofipasteur.com						ARENS M, 1988, DIAGN MICR INFEC DIS, V11, P137, DOI 10.1016/0732-8893(88)90015-6; Awasthi S, 2012, J VIROL; BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742; BANFIELD BW, 1995, VIROLOGY, V208, P531, DOI 10.1006/viro.1995.1184; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bernstein DI, 2005, CLIN INFECT DIS, V40, P1271, DOI 10.1086/429240; Casanova G, 2002, CUTIS, V70, P235; Cattamanchi A, 2008, CLIN VACCINE IMMUNOL, V15, P1638, DOI 10.1128/CVI.00167-08; Cunningham AL, 2006, J INFECT DIS, V194, pS11, DOI 10.1086/505359; Da Costa X, 2000, J VIROL, V74, P7963, DOI 10.1128/JVI.74.17.7963-7971.2000; Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P6994, DOI 10.1073/pnas.96.12.6994; de Bruyn G, 2006, VACCINE, V24, P914, DOI 10.1016/j.vaccine.2005.08.088; Delagrave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046714; Dyer AP, 1997, J VIROL, V71, P191, DOI 10.1128/JVI.71.1.191-198.1997; Fisman DN, 2002, SEX TRANSM DIS, V29, P608, DOI 10.1097/00007435-200210000-00008; Goins William F., 2008, V433, P97, DOI 10.1007/978-1-59745-237-3_6; Hoshino Y, 2005, J VIROL, V79, P410, DOI 10.1128/JVI.79.1.410-418.2005; Hoshino Y, 2009, J INFECT DIS, V200, P1088, DOI 10.1086/605645; Jiang CP, 2006, BIOTECHNOL BIOENG, V95, P48, DOI 10.1002/bit.20943; Jiang CP, 2004, J VIROL, V78, P8994, DOI 10.1128/JVI.78.17.8994-9006.2004; Johnston C, 2011, J CLIN INVEST, V121, P4600, DOI 10.1172/JCI57148; Knop DR, 2007, BIOTECHNOL PROGR, V23, P715, DOI 10.1021/bp060373p; Koelle DM, 2008, CLIN VACCINE IMMUNOL, V15, P773, DOI 10.1128/CVI.00020-08; KUTINOVA L, 1988, VACCINE, V6, P223, DOI 10.1016/0264-410X(88)90215-0; LANGENBERG AGM, 1995, ANN INTERN MED, V122, P889, DOI 10.7326/0003-4819-122-12-199506150-00001; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Lotfian P, 2003, BIOTECHNOL PROGR, V19, P209, DOI 10.1021/bp025599g; Mertz KJ, 1998, J INFECT DIS, V178, P1795, DOI 10.1086/314502; Mertz KJ, 1998, J INFECT DIS, V178, P1060, DOI 10.1086/515664; NAHMIAS AJ, 1964, J BACTERIOL, V87, P1060, DOI 10.1128/JB.87.5.1060-1066.1964; NEYTS J, 1995, BIOCHEM PHARMACOL, V50, P743, DOI 10.1016/0006-2952(95)00193-4; O'Keeffe R, 1998, BIOTECHNOL BIOENG, V57, P262, DOI 10.1002/(SICI)1097-0290(19980205)57:3<262::AID-BIT2>3.0.CO;2-F; O'Keeffe RS, 1999, BIOTECHNOL BIOENG, V62, P537, DOI 10.1002/(SICI)1097-0290(19990305)62:5<537::AID-BIT5>3.0.CO;2-1; Paz-Bailey G, 2005, CLIN INFECT DIS, V41, P1304, DOI 10.1086/496979; Pena KC, 2010, J CLIN MICROBIOL, V48, P150, DOI 10.1128/JCM.01336-09; Piret J, 2000, J CLIN MICROBIOL, V38, P110; Sathananthan B, 1997, APMIS, V105, P238, DOI 10.1111/j.1699-0463.1997.tb00564.x; Sia KC, 2007, J VIROL METHODS, V139, P166, DOI 10.1016/j.jviromet.2006.09.023; Skinner GRB, 1997, MED MICROBIOL IMMUN, V186, P31, DOI 10.1007/s004300050043; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Straus SE, 1997, J INFECT DIS, V176, P1129, DOI 10.1086/514103; STRAUS SE, 1994, LANCET, V343, P1460, DOI 10.1016/S0140-6736(94)92581-X; SZILAGYI JF, 1991, J GEN VIROL, V72, P661, DOI 10.1099/0022-1317-72-3-661; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c; Wolff MW, 2011, EXPERT REV VACCINES, V10, P1451, DOI [10.1586/erv.11.111, 10.1586/ERV.11.111]; Yeung SN, 1999, GENE THER, V6, P1536, DOI 10.1038/sj.gt.3300980	46	26	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57224	10.1371/journal.pone.0057224	http://dx.doi.org/10.1371/journal.pone.0057224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468943	Green Submitted, gold, Green Published			2022-12-27	WOS:000315561400031
J	Salomaki, H; Vahatalo, LH; Laurila, K; Jappinen, NT; Penttinen, AM; Ailanen, L; Ilyasizadeh, J; Pesonen, U; Koulu, M				Salomaki, Henriikka; Vahatalo, Laura H.; Laurila, Kirsti; Jappinen, Norma T.; Penttinen, Anna-Maija; Ailanen, Liisa; Ilyasizadeh, Juan; Pesonen, Ullamari; Koulu, Markku			Prenatal Metformin Exposure in Mice Programs the Metabolic Phenotype of the Offspring during a High Fat Diet at Adulthood	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; ACTIVATED PROTEIN-KINASE; INSULIN-SENSITIZING DRUGS; NEONATAL LEPTIN TREATMENT; EPIGENETIC MECHANISMS; GENE-EXPRESSION; INDUCED OBESITY; PREGNANCY; WOMEN; INSIG-1	Aims: The antidiabetic drug metformin is currently used prior and during pregnancy for polycystic ovary syndrome, as well as during gestational diabetes mellitus. We investigated the effects of prenatal metformin exposure on the metabolic phenotype of the offspring during adulthood in mice. Methods: Metformin (300 mg/kg) or vehicle was administered orally to dams on regular diet from the embryonic day E0.5 to E17.5. Gene expression profiles in liver and brain were analysed from 4-day old offspring by microarray. Body weight development and several metabolic parameters of offspring were monitored both during regular diet (RD-phase) and high fat diet (HFD-phase). At the end of the study, two doses of metformin or vehicle were given acutely to mice at the age of 20 weeks, and Insig-1 and GLUT4 mRNA expressions in liver and fat tissue were analysed using qRT-PCR. Results: Metformin exposed fetuses were lighter at E18.5. There was no effect of metformin on the maternal body weight development or food intake. Metformin exposed offspring gained more body weight and mesenteric fat during the HFD-phase. The male offspring also had impaired glucose tolerance and elevated fasting glucose during the HFD-phase. Moreover, the expression of GLUT4 mRNA was down-regulated in epididymal fat in male offspring prenatally exposed to metformin. Based on the microarray and subsequent qRT-PCR analyses, the expression of Insig-1 was changed in the liver of neonatal mice exposed to metformin prenatally. Furthermore, metformin up-regulated the expression of Insig-1 later in development. Gene set enrichment analysis based on preliminary microarray data identified several differentially enriched pathways both in control and metformin exposed mice. Conclusions: The present study shows that prenatal metformin exposure causes long-term programming effects on the metabolic phenotype during high fat diet in mice. This should be taken into consideration when using metformin as a therapeutic agent during pregnancy.	[Salomaki, Henriikka; Vahatalo, Laura H.; Jappinen, Norma T.; Penttinen, Anna-Maija; Ailanen, Liisa; Ilyasizadeh, Juan; Pesonen, Ullamari; Koulu, Markku] Univ Turku, Inst Biomed, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Laurila, Kirsti] Aalto Univ, Sch Econ, Dept Informat & Serv Econ, Helsinki, Finland; [Laurila, Kirsti] Aalto Univ, Sch Sci, Dept Informat & Comp Sci, Helsinki, Finland	University of Turku; Aalto University; Aalto University	Koulu, M (corresponding author), Univ Turku, Inst Biomed, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland.	markku.koulu@utu.fi		Pesonen, Ullamari/0000-0002-9962-212X	Academy of Finland [134131]; FinPharma Doctoral Program (Finland)	Academy of Finland(Academy of Finland); FinPharma Doctoral Program (Finland)	This work was supported by The Academy of Finland (grant number 134131 to MK) and partially by FinPharma Doctoral Program (Finland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Attig L, 2008, INT J OBESITY, V32, P1153, DOI 10.1038/ijo.2008.39; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Bhalla K, 2012, CANCER PREV RES, V5, P544, DOI 10.1158/1940-6207.CAPR-11-0228; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Caton PW, 2011, DIABETES OBES METAB, V13, P1097, DOI 10.1111/j.1463-1326.2011.01466.x; Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Glueck CJ, 2004, HUM REPROD, V19, P1323, DOI 10.1093/humrep/deh263; Glueck CJ, 2004, DIABETIC MED, V21, P829, DOI 10.1111/j.1464-5491.2004.01251.x; Goh JEL, 2011, DIABETIC MED, V28, P1082, DOI 10.1111/j.1464-5491.2011.03361.x; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hou M, 2010, BIOCHEM BIOPH RES CO, V397, P537, DOI 10.1016/j.bbrc.2010.05.152; Hundal RS, 2003, DRUGS, V63, P1879, DOI 10.2165/00003495-200363180-00001; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Ijas H, 2011, BJOG-INT J OBSTET GY, V118, P880, DOI 10.1111/j.1471-0528.2010.02763.x; Itoh H, 2011, ACTA PHYSIOL, V202, P159, DOI 10.1111/j.1748-1716.2011.02268.x; Jakubowicz DJ, 2002, J CLIN ENDOCR METAB, V87, P524, DOI 10.1210/jc.87.2.524; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Legro RS, 2010, J CLIN ENDOCR METAB, V95, P5199, DOI 10.1210/jc.2010-2301; Leonie E, 2012, ENDOCRINOLOGY, V153, P2861, DOI 10.1210/en.2011-1754; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Li JP, 2003, P NATL ACAD SCI USA, V100, P9476, DOI 10.1073/pnas.1133426100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morin-Papunen L, 2012, J CLIN ENDOCR METAB, V97, P1492, DOI 10.1210/jc.2011-3061; Nestler JE, 2002, FERTIL STERIL, V77, P209, DOI 10.1016/S0015-0282(01)02963-6; Nishimura D, 2001, BIOTECH SOFTWARE INT, V2, P117, DOI DOI 10.1089/152791601750294344; Norman RJ, 2004, CURR OPIN OBSTET GYN, V16, P245, DOI 10.1097/00001703-200406000-00007; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Pinney SE, 2010, TRENDS ENDOCRIN MET, V21, P223, DOI 10.1016/j.tem.2009.10.002; Raychaudhuri N, 2008, J BIOL CHEM, V283, P13611, DOI 10.1074/jbc.M800128200; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012; Rowan JA, 2011, DIABETES CARE, V34, P2279, DOI 10.2337/dc11-0660; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Sinnett-Smith J, 2013, BIOCHEM BIOPH RES CO, V430, P352, DOI 10.1016/j.bbrc.2012.11.010; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tertti Kristiina, 2008, Rev Diabet Stud, V5, P95, DOI 10.1900/RDS.2008.5.95; Vanky E, 2005, FERTIL STERIL, V83, P1575, DOI 10.1016/j.fertnstert.2004.11.051; Velazquez EM, 1997, METABOLISM, V46, P454, DOI 10.1016/S0026-0495(97)90066-4; Vickers MH, 2008, ENDOCRINOLOGY, V149, P1906, DOI 10.1210/en.2007-0981; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Yura S, 2008, OBESITY, V16, P1289, DOI 10.1038/oby.2008.57; Zakikhani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049513; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	63	59	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56594	10.1371/journal.pone.0056594	http://dx.doi.org/10.1371/journal.pone.0056594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457588	Green Published, gold			2022-12-27	WOS:000315603700063
J	Treer, D; Van Bocxlaer, I; Matthijs, S; Du Four, D; Janssenswillen, S; Willaert, B; Bossuyt, F				Treer, Dag; Van Bocxlaer, Ines; Matthijs, Severine; Du Four, Dimitri; Janssenswillen, Sunita; Willaert, Bert; Bossuyt, Franky			Love Is Blind: Indiscriminate Female Mating Responses to Male Courtship Pheromones in Newts (Salamandridae)	PLOS ONE			English	Article							TRITURUS-VULGARIS-VULGARIS; RED-SPOTTED NEWT; SMOOTH NEWT; SEXUAL-BEHAVIOR; MATE CHOICE; AMPHIBIA-SALAMANDRIDAE; TERRESTRIAL SALAMANDER; CYNOPS-PYRRHOGASTER; FECUND FEMALES; PALMATE NEWT	Internal fertilization without copulation or prolonged physical contact is a rare reproductive mode among vertebrates. In many newts (Salamandridae), the male deposits a spermatophore on the substrate in the water, which the female subsequently takes up with her cloaca. Because such an insemination requires intense coordination of both sexes, male newts have evolved a courtship display, essentially consisting of sending pheromones under water by tail-fanning towards their potential partner. Behavioral experiments until now mostly focused on an attractant function, i.e. showing that olfactory cues are able to bring both sexes together. However, since males start their display only after an initial contact phase, courtship pheromones are expected to have an alternative function. Here we developed a series of intraspecific and interspecific two-female experiments with alpine newt (Ichthyosaura alpestris) and palmate newt (Lissotriton helveticus) females, comparing behavior in male courtship water and control water. We show that male olfactory cues emitted during tail-fanning are pheromones that can induce all typical features of natural female mating behavior. Interestingly, females exposed to male pheromones of their own species show indiscriminate mating responses to conspecific and heterospecific females, indicating that visual cues are subordinate to olfactory cues during courtship.	[Treer, Dag; Van Bocxlaer, Ines; Matthijs, Severine; Du Four, Dimitri; Janssenswillen, Sunita; Willaert, Bert; Bossuyt, Franky] Vrije Univ Brussel, Amphibian Evolut Lab, Brussels, Belgium	Vrije Universiteit Brussel	Bossuyt, F (corresponding author), Vrije Univ Brussel, Amphibian Evolut Lab, Brussels, Belgium.	fbossuyt@vub.ac.be	Van Bocxlaer, Ines/L-4852-2015; Treer, Dag/D-8098-2017	Treer, Dag/0000-0003-4847-7361; Bossuyt, Franky/0000-0001-6804-9271	Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO); European Research Council (ERC) [204509]	Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); European Research Council (ERC)(European Research Council (ERC))	This work was supported by Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO) and the European Research Council (ERC-starting grant 204509 - project TAPAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Arnold S.J., 1977, P141; ARNOLD SJ, 1976, Z TIERPSYCHOL, V42, P247; Arnold SJ., 1982, BIOCH ASP EVOL BIOL, P173; BELVEDERE P, 1988, MONIT ZOOL ITAL, V22, P397; Denoel M, 2001, J HERPETOL, V35, P62, DOI 10.2307/1566024; Denoel Mathieu, 1996, Cahiers d'Ethologie, V16, P133; Denoel M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1171, DOI 10.1007/s00265-010-0933-0; Denoel Mathieu, 1999, Cahiers d'Ethologie, V19, P221; Drechsler Axel, 2010, Herpetology Notes, V3, P13; Dytham C., 2011, CHOOSING USING STAT; Gabor CR, 1997, BEHAV ECOL, V8, P162, DOI 10.1093/beheco/8.2.162; GREEN AJ, 1992, ANIM BEHAV, V43, P170, DOI 10.1016/S0003-3472(05)80086-7; GREEN AJ, 1991, ANIM BEHAV, V41, P367, DOI 10.1016/S0003-3472(05)80489-0; GRIFFITHS RA, 1985, ANIM BEHAV, V33, P573, DOI 10.1016/S0003-3472(85)80081-6; Griffiths RA, 1996, NEWTS SALAMANDERS EU; Halliday T, 1974, J HERPETOL, P277; Halliday T.R., 1983, P3; Halliday T.R., 1990, Advances in the Study of Behavior, V19, P137, DOI 10.1016/S0065-3454(08)60202-8; HALLIDAY TR, 1975, ANIM BEHAV, V23, P291, DOI 10.1016/0003-3472(75)90078-0; HIMSTEDT W, 1979, COPEIA, P40; Houck LD, 2007, ANIM BEHAV, V73, P315, DOI 10.1016/j.anbehav.2006.07.008; Houck LD, 2003, REPROD BIOL PHYLOGEN, V1, P383; Houck LD, 2008, CHEM SIGNAL, V11, P213, DOI 10.1007/978-0-387-73945-8_20; Iwata T, 1999, FEBS LETT, V457, P400, DOI 10.1016/S0014-5793(99)01062-5; Iwata T, 2004, PEPTIDES, V25, P1537, DOI 10.1016/j.peptides.2003.10.027; Kiemnec-Tyburczy KM, 2009, GENE, V432, P75, DOI 10.1016/j.gene.2008.11.007; Kikuyama S, 1999, REV REPROD, V4, P1; MACGREGOR HC, 1990, J EVOLUTION BIOL, V3, P329, DOI 10.1046/j.1420-9101.1990.3050329.x; MALACARNE G, 1986, B ZOOL, V53, P79, DOI 10.1080/11250008609355487; MALACARNE G, 1987, COPEIA, P245; MALACARNE G, 1982, BEHAV PROCESS, V7, P307, DOI 10.1016/0376-6357(82)90003-1; Malmgren JC, 2008, ETHOL ECOL EVOL, V20, P71, DOI 10.1080/08927014.2008.9522545; Nakada T, 2007, PEPTIDES, V28, P774, DOI 10.1016/j.peptides.2006.12.006; NOBLE G. K., 1927, ANN NEW YORK ACAD SCI, V30, P31, DOI 10.1111/j.1749-6632.1927.tb55359.x; Ortiz-Santaliestra ME, 2009, ENVIRON TOXICOL CHEM, V28, P1500, DOI 10.1897/08-580.1; Osikowski A, 2012, ZOOL SCI, V29, P390, DOI 10.2108/zsj.29.390; Palmer CA, 2007, EVOLUTION, V61, P202, DOI 10.1111/j.1558-5646.2007.00017.x; Park D, 2001, ENVIRON HEALTH PERSP, V109, P669, DOI 10.2307/3454782; Poschadel JR, 2007, ACTA ETHOL, V10, P35, DOI 10.1007/s10211-007-0025-y; RAFINSKI J, 1992, FOLIA BIOL-KRAKOW, V40, P155; Robalo J.I., 2002, Acta Ethologica, V4, P81; Rollmann SM, 1999, SCIENCE, V285, P1907, DOI 10.1126/science.285.5435.1907; Rusconi M, 1821, AMOURS SALAMANDRES A; Secondi J, 2005, ETHOLOGY, V111, P726, DOI 10.1111/j.1439-0310.2005.01096.x; Secondi J, 2007, ETHOLOGY, V113, P711, DOI 10.1111/j.1439-0310.2007.01375.x; Secondi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030391; SEVER DM, 1990, HERPETOLOGICA, V46, P160; Spallanzani L, 1780, THESIS; Sparreboom M, 1996, ETHOLOGY, V102, P672; *SPSS INC, 2005, SPSS WIND REL 14 0 0; TEYSSEDRE C, 1986, ETHOLOGY, V71, P89; Tinbergen N., 1938, Levende Natuur Amsterdam, V43, P232; TOYODA F, 1994, PHYSIOL BEHAV, V55, P569, DOI 10.1016/0031-9384(94)90118-X; Toyoda F, 2004, PEPTIDES, V25, P1531, DOI 10.1016/j.peptides.2003.10.025; Vaccaro EA, 2009, ANIM BEHAV, V78, P1421, DOI 10.1016/j.anbehav.2009.09.018; VERRELL P, 1988, J ZOOL, V214, P533, DOI 10.1111/j.1469-7998.1988.tb03758.x; VERRELL PA, 1986, J HERPETOL, V20, P416, DOI 10.2307/1564504; VERRELL PA, 1986, J ZOOL, V210, P101; VERRELL PA, 1985, HERPETOLOGICA, V41, P382; Verrell PA, 1983, THESIS OPEN U MILTON; Waights V, 1996, ETHOLOGY, V102, P736; Wambreuse P., 1985, Cahiers d'Ethologie Appliquee, V4, P193; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wilburn DB, 2012, EVOLUTION IN PRESS; Woodley SK, 2010, J COMP PHYSIOL A, V196, P713, DOI 10.1007/s00359-010-0540-6; Zippelius H, 1948, VERH DTSCH ZOOL KIEL, V1948, P127	67	33	33	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56538	10.1371/journal.pone.0056538	http://dx.doi.org/10.1371/journal.pone.0056538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457580	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700061
J	Hu, ZH; Gao, J; Zhang, DY; Liu, Q; Yan, LM; Gao, LL; Liu, JJ; Liu, DW; Zhang, SL; Lin, B				Hu, Zhenhua; Gao, Jian; Zhang, Danye; Liu, Qing; Yan, Limei; Gao, Lili; Liu, Juanjuan; Liu, Dawo; Zhang, Shulan; Lin, Bei			High Expression of Lewis y Antigen and CD44 Is Correlated with Resistance to Chemotherapy in Epithelial Ovarian Cancers	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; RMG-1 CELLS; PROMOTES RESISTANCE; DRUG-RESISTANCE; APOPTOSIS; GLYCOSYLATION; TRANSFECTION; HYALURONAN; CARBOPLATIN; BREAST	Objectives: To measure Lewis y antigen and CD44 antigen expression in epithelial ovarian carcinoma and to correlate the levels of these antigens with clinical response to chemotherapy. Methods: The study cases included 34 cases of ovarian carcinoma with resistance to chemotherapeutic drugs, 6 partially drug-sensitive cases, and 52 drug-sensitive cases (92 total). Results: The rates of expression of Lewis y antigen and CD44 antigen were significantly greater in the drug-resistant group than that in the partially-sensitive or sensitive groups. Surgical stage, residual tumor size and expression of CD44 and Lewis y antigen in ovarian carcinoma tissues were independent risk factors for chemotherapeutic drug resistance. Conclusions: Over-expression of Lewis y and CD44 antigen are strong risk factors for chemotherapeutic drug resistance in ovarian carcinoma patients.	[Hu, Zhenhua; Gao, Jian; Zhang, Danye; Liu, Qing; Yan, Limei; Gao, Lili; Liu, Juanjuan; Liu, Dawo; Zhang, Shulan; Lin, Bei] China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Liaoning Provin, Peoples R China	China Medical University	Lin, B (corresponding author), China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Liaoning Provin, Peoples R China.	linbei88@hotmail.com			National Natural Science Foundation of China [30872757, 81072118, 81172491, 81101527]; Ph.D. Programs Foundation of Ministry of Education of China [20112104110016, 20112104120019]; Science Committee Foundation of Shenyang City, China [F10-14-9-9-52]; Shengjing Free Researcher Project [200807]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Science Committee Foundation of Shenyang City, China; Shengjing Free Researcher Project	This work is supported by the National Natural Science Foundation of China (No. 30872757, 81072118, 81172491, 81101527); Ph.D. Programs Foundation of Ministry of Education of China (No. 20112104110016, 20112104120019); Science Committee Foundation of Shenyang City, China (No. F10-14-9-9-52); Shengjing Free Researcher Project (No. 200807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson S, 2012, STEM CELLS, V30, P415, DOI 10.1002/stem.1029; Beretta GL, 2010, BIOCHEM PHARMACOL, V79, P1108, DOI 10.1016/j.bcp.2009.12.002; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Colone M, 2008, J INVEST DERMATOL, V128, P957, DOI 10.1038/sj.jid.5701082; Cong JP, 2010, PROG BIOCHEM BIOPHYS, V37, P175, DOI 10.3724/SP.J.1206.2009.00459; English NM, 1998, CANCER RES, V58, P3736; Gao LL, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-15; Hertweck MK, 2011, ANN HEMATOL, V90, P493, DOI 10.1007/s00277-011-1161-z; Iwamori M, 2005, CANCER SCI, V96, P26, DOI 10.1111/j.1349-7006.2005.00005.x; Kudo T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-32; Lakshman M, 2005, J CELL PHYSIOL, V203, P583, DOI 10.1002/jcp.20260; Lakshman M, 2004, EXP MOL PATHOL, V77, P18, DOI 10.1016/j.yexmp.2004.03.002; Liu JJ, 2010, ONCOL REP, V23, P833, DOI 10.3892/or_00000705; Liu JJ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-154; Makrydimas G, 2003, IN VIVO, V17, P633; Ohashi R, 2007, CANCER LETT, V252, P225, DOI 10.1016/j.canlet.2006.12.025; Oliver L, 2002, CLIN EXP METASTAS, V19, P175, DOI 10.1023/A:1014510508664; Santiskulvong C, 2011, CLIN CANCER RES, V17, P2373, DOI 10.1158/1078-0432.CCR-10-2289; Shi MF, 2010, CELL MOL LIFE SCI, V67, P3915, DOI 10.1007/s00018-010-0420-9; Slomiany MG, 2009, CLIN CANCER RES, V15, P7593, DOI 10.1158/1078-0432.CCR-09-2317; Wang CZ, 2011, ANAT REC, V294, P961, DOI 10.1002/ar.21398; Wang SJ, 2007, ARCH OTOLARYNGOL, V133, P281, DOI 10.1001/archotol.133.3.281; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P771, DOI 10.1001/archotol.132.7.771; Wang YF, 2011, INT J MOL SCI, V12, P3409, DOI 10.3390/ijms12063409; Xie ZG, 2008, CANCER CHEMOTH PHARM, V62, P949, DOI 10.1007/s00280-008-0684-z; Yan LM, 2010, BIOCHIMIE, V92, P852, DOI 10.1016/j.biochi.2010.02.012; Yap YHY, 2011, CANCER LETT, V306, P111, DOI 10.1016/j.canlet.2011.02.040; Zhao Y, 2008, PROG BIOCHEM BIOPHYS, V35, P1175	29	19	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57250	10.1371/journal.pone.0057250	http://dx.doi.org/10.1371/journal.pone.0057250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468946	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900061
J	Lin, CY; Lin, TY; Lee, MC; Chen, SC; Chang, JS				Lin, Ching-Yuang; Lin, Tze-Yi; Lee, Min-Chun; Chen, Shih-Chieh; Chang, Jeng-Shou			Hyperglycemia: GDNF-EGR1 Pathway Target Renal Epithelial Cell Migration and Apoptosis in Diabetic Renal Embryopathy	PLOS ONE			English	Article							CONGENITAL-MALFORMATIONS; GLYCEMIC CONTROL; GROWTH; MORPHOGENESIS; EXPRESSION; DEFECTS; GENE; PREGNANCY; AGENESIS; RECEPTOR	Maternal hyperglycemia can inhibit morphogenesis of ureteric bud branching, Glial cell line-derived neurotrophilic factor (GDNF) is a key regulator of the initiation of ureteric branching. Early growth response gene-1 (EGR-1) is an immediate early gene. Preliminary study found EGR-1 persistently expressed with GDNF in hyperglycemic environment. To evaluate the potential relationship of hyperglycemia-GDNF-EGR-1 pathway, in vitro human renal proximal tubular epithelial (HRPTE) cells as target and in vivo streptozotocin-induced mice model were used. Our in vivo microarray, real time-PCR and confocal morphological observation confirmed apoptosis in hyperglycemia-induced fetal nephropathy via activation of the GDNF/MAPK/EGR-1 pathway at E12-E15. Detachment between ureteric branch and metanephrons, coupled with decreasing number and collapse of nephrons on Day 1 newborn mice indicate hyperglycemic environment suppress ureteric bud to invade metanephric rudiment. In vitro evidence proved that high glucose suppressed HRPTE cell migration and enhanced GDNF-EGR-1 pathway, inducing HRPTE cell apoptosis. Knockdown of EGR-1 by siRNA negated hyperglycemic suppressed GDNF-induced HRPTE cells. EGR-1 siRNA also reduced GDNF/EGR-1-induced cRaf/MEK/ERK phosphorylation by 80%. Our findings reveal a novel mechanism of GDNF/MAPK/EGR-1 activation playing a critical role in HRPTE cell migration, apoptosis and fetal hyperglycemic nephropathy.	[Lin, Ching-Yuang; Chen, Shih-Chieh; Chang, Jeng-Shou] China Med Univ Hosp, Clin Immunol Ctr, Taichung, Taiwan; [Lin, Tze-Yi] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Lin, Ching-Yuang; Lin, Tze-Yi] China Med Univ, Coll Med, Taichung, Taiwan; [Lee, Min-Chun] Buddhist Tzu Chi Gen Hosp, Dept Pediat, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital	Lin, CY (corresponding author), China Med Univ Hosp, Clin Immunol Ctr, Taichung, Taiwan.	cylin@mail.cmuh.org.tw			National Science council, Taiwan [NSC94-2314-B309-005, NSC 96-2314-B-039-050-MY3]	National Science council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grant of National Science council, Taiwan. (NSC94-2314-B309-005 and NSC 96-2314-B-039-050-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amri R, 1999, DIABETES, V48, P2240, DOI 10.2337/diabetes.48.11.2240; BECERRA JE, 1990, PEDIATRICS, V85, P1; Blessing E, 2008, ATHEROSCLEROSIS, V199, P295, DOI 10.1016/j.atherosclerosis.2007.10.037; Bridgewater D, 2009, PEDIATR NEPHROL, V24, P1611, DOI 10.1007/s00467-008-1048-y; CAO XM, 1993, J BIOL CHEM, V268, P16949; Cao Y, 2011, TNF ALPHA INDUCES EA, DOI [10.1007/s00592-010-0248-7, DOI 10.1007/S00592-010-0248-7]; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; CHRISTY B, 1989, MOL CELL BIOL, V9, P4889, DOI 10.1128/MCB.9.11.4889; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; Davies JA, 1999, PEDIATR NEPHROL, V482, P1; ERIKSSON UJ, 1995, DIABETES METAB REV, V11, P63, DOI 10.1002/dmr.5610110106; Fan HY, 2010, EXP LUNG RES, V36, P323; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Gururajan M, 2008, J IMMUNOL, V181, P4590, DOI 10.4049/jimmunol.181.7.4590; Hieda Y, 1997, DEV GROWTH DIFFER, V39, P1; Jain S, 2006, GENE DEV, V20, P321, DOI 10.1101/gad.1387206; Kashimata M, 2000, DEV BIOL, V220, P183, DOI 10.1006/dbio.2000.9639; Khwaja A, 1998, J BIOL CHEM, V273, P18793, DOI 10.1074/jbc.273.30.18793; KITZMILLER JL, 1991, JAMA-J AM MED ASSOC, V265, P731, DOI 10.1001/jama.265.6.731; Kuure S, 2000, MECH DEVELOP, V92, P31, DOI 10.1016/S0925-4773(99)00323-8; Liu CT, 1998, CANCER GENE THER, V5, P3; Lynch SA, 1997, CLIN DYSMORPHOL, V6, P75; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; MELLSTROM B, 1994, ENDOCRINOLOGY, V135, P583, DOI 10.1210/en.135.2.583; MILLS JL, 1982, TERATOLOGY, V25, P385, DOI 10.1002/tera.1420250316; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pignatelli M, 2003, BIOCHEM J, V373, P739, DOI 10.1042/BJ20021918; Pignatelli M, 1999, FEBS LETT, V461, P37, DOI 10.1016/S0014-5793(99)01420-9; Rukhsana N, 2008, CIRC RES, V102, P42, DOI [10.1161/CIRCRESAHA.107.155143, DOI 10.1161/CIRCRESAHA.107.155143]; Sainio K, 1997, DEVELOPMENT, V124, P4077; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; SCHMIDT RE, 1989, LAB INVEST, V61, P77; SOLER NG, 1976, Q J MED, V45, P303; Suhonen L, 2000, DIABETOLOGIA, V43, P79, DOI 10.1007/s001250050010; Tran S, 2008, J AM SOC NEPHROL, V19, P943, DOI 10.1681/ASN.2007080864; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Wang HH, 2008, KIDNEY INT, V74, P808, DOI 10.1038/ki.2008.330; Wang HH, 2011, J CELL PHYSIOL, V226, P94, DOI 10.1002/jcp.22309; Watkins CC, 2000, J CLIN INVEST, V106, P373, DOI 10.1172/JCI8273; Woolf AS, 1997, ARCH DIS CHILD, V77, P471, DOI 10.1136/adc.77.6.471; Wrzos HF, 1997, DIGEST DIS SCI, V42, P2106, DOI 10.1023/A:1018830820537; Zandi-Nejad K, 2006, HYPERTENSION, V47, P502, DOI 10.1161/01.HYP.0000198544.09909.1a	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56731	10.1371/journal.pone.0056731	http://dx.doi.org/10.1371/journal.pone.0056731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468876	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900033
J	Pei, LX; Bao, YW; Liu, S; Zheng, J; Chen, XP				Pei, Lixia; Bao, Yuanwu; Liu, Sheng; Zheng, Jin; Chen, Xiuping			Material Basis of Chinese Herbal Formulas Explored by Combining Pharmacokinetics with Network Pharmacology	PLOS ONE			English	Article							PSORALEA-CORYLIFOLIA L.; MASS-SPECTROMETRY; DRUG CANDIDATES; MEDICINE; PHARMACODYNAMICS; COMBINATIONS; COMPONENTS; PLASMA; CELLS	The clinical application of Traditional Chinese medicine (TCM), using several herbs in combination (called formulas), has a history of more than one thousand years. However, the bioactive compounds that account for their therapeutic effects remain unclear. We hypothesized that the material basis of a formula are those compounds with a high content in the decoction that are maintained at a certain level in the system circulation. Network pharmacology provides new methodological insights for complicated system studies. In this study, we propose combining pharmacokinetic (PK) analysis with network pharmacology to explore the material basis of TCM formulas as exemplified by the Bushen Zhuanggu formula (BZ) composed of Psoralea corylifolia L., Aconitum carmichaeli Debx., and Cnidium monnieri (L.) Cuss. A sensitive and credible liquid chromatography tandem mass spectrometry (LC-MS/MS) method was established for the simultaneous determination of 15 compounds present in the three herbs. The concentrations of these compounds in the BZ decoction and in rat plasma after oral BZ administration were determined. Up to 12 compounds were detected in the BZ decoction, but only 5 could be analyzed using PK parameters. Combined PK results, network pharmacology analysis revealed that 4 compounds might serve as the material basis for BZ. We concluded that a sensitive, reliable, and suitable LC-MS/MS method for both the composition and pharmacokinetic study of BZ has been established. The combination of PK with network pharmacology might be a potent method for exploring the material basis of TCM formulas.	[Pei, Lixia; Bao, Yuanwu; Liu, Sheng; Zheng, Jin] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Pharmacol Lab Tradit Chinese Med, Shanghai, Peoples R China; [Chen, Xiuping] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China	Shanghai University of Traditional Chinese Medicine; University of Macau	Chen, XP (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.	xpchen@umac.mo	Chen, Xiuping/O-8927-2017; Chen, Xiuping/AAG-3086-2020	Chen, Xiuping/0000-0003-2675-7645; 	Foundation of Shanghai Municipal Health Bureau [20114060]; Higher Education Institutions of Shanghai [shzy019]; Major Science and Technology Project for the 12th National Five-Year Plan-Clinical Evaluation and Research Technology Platform for TCM New Drug Research [2011ZX09302-006-04]; Macao Science and Technology Development Fund [045/2011/A]	Foundation of Shanghai Municipal Health Bureau; Higher Education Institutions of Shanghai; Major Science and Technology Project for the 12th National Five-Year Plan-Clinical Evaluation and Research Technology Platform for TCM New Drug Research; Macao Science and Technology Development Fund	The study was supported by the Foundation of Shanghai Municipal Health Bureau (No. 20114060), the Young Teachers Program of the Higher Education Institutions of Shanghai (No. shzy019), the Major Science and Technology Project for the 12th National Five-Year Plan-Clinical Evaluation and Research Technology Platform for TCM New Drug Research (Cancer and Related Diseases; No. 2011ZX09302-006-04), and the Macao Science and Technology Development Fund (No. 045/2011/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman SM, 2004, ANNU REV PHARMACOL, V44, P111, DOI 10.1146/annurev.pharmtox.44.101802.121347; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; [陈修平 CHEN Xiu-ping], 2010, [中草药, Chinese Traditional and Herbal Drugs], V41, P1; COLBURN WA, 1988, J CLIN PHARMACOL, V28, P769, DOI 10.1002/j.1552-4604.1988.tb03215.x; Di Wang, 2008, Zhongguo Zhong Yao Za Zhi, V33, P1687; Dingemanse J, 2007, CLIN PHARMACOKINET, V46, P713, DOI 10.2165/00003088-200746090-00001; Feng L, 2010, ARCH PHARM RES, V33, P225, DOI 10.1007/s12272-010-0206-5; Fujimura Takashi, 2007, J Gastrointest Cancer, V38, P78, DOI 10.1007/s12029-008-9035-x; Graziose Rocky, 2010, Curr Drug Discov Technol, V7, P2; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; IWASA JUNZO, 1966, YAKUGAKU ZASSHI, V86, P585; Ji L, 1995, Zhongguo Zhong Yao Za Zhi, V20, P120; Kang YJ, 2008, EXP BIOL MED, V233, P1059, DOI 10.3181/0802-MR-47; Kao SJ, 2012, TOXICOL APPL PHARM, V261, P105, DOI 10.1016/j.taap.2012.03.020; Kwoh CK, 2007, CELL MOL LIFE SCI, V64, P1739, DOI 10.1007/s00018-007-7053-7; Lan K, 2010, CURR DRUG METAB, V11, P105, DOI 10.2174/138920010791110926; Li Q, 2010, ACTA U TRADITIONIS M, V24, P6; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Li S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S6; Li XM, 2009, CURR OPIN ALLERGY CL, V9, P161, DOI 10.1097/ACI.0b013e328329226f; Lin JH, 2002, E SCHERING RES FDN W, V37, P33; Liu Chang-xiao, 2005, Yao Xue Xue Bao, V40, P395; Liu S, 2011, CHIN J INTEGR MED, V31, P6; Lu T, 2008, DRUG METAB DISPOS, V36, P1578, DOI 10.1124/dmd.108.021592; Luo KW, 2011, CHEMOTHERAPY, V57, P449, DOI 10.1159/000331641; Okamura N, 1999, J PHARMACEUT BIOMED, V20, P363, DOI 10.1016/S0731-7085(99)00065-5; Okamura N, 1999, J PHARMACEUT BIOMED, V19, P603, DOI 10.1016/S0731-7085(98)00262-3; Ruan B, 2007, J ASIAN NAT PROD RES, V9, P41, DOI 10.1080/10286020500289618; Ruiz-Garcia A, 2008, J PHARM SCI-US, V97, P654, DOI 10.1002/jps.21009; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; SUN W J, 1990, Yaoxue Xuebao, V25, P530; Tang W, 2009, CURR PHARM DESIGN, V15, P2170, DOI 10.2174/138161209788682451; Todorovic N, 2011, BIOMARK MED, V5, P855, DOI [10.2217/BMM.11.59, 10.2217/bmm.11.59]; Wang J, 2009, J CHROMATOGR A, V1216, P2169, DOI 10.1016/j.chroma.2008.11.077; Wang JF, 2008, CURR TOP MED CHEM, V8, P1656, DOI 10.2174/156802608786786633; Wang Steven, 2010, Curr Drug Discov Technol, V7, P67; Wang XJ, 2011, ANALYST, V136, P5068, DOI 10.1039/c1an15752c; Xu XM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-33; Yan DM, 2009, PHYTOTHER RES, V23, P317, DOI 10.1002/ptr.2622; Yang Xian, 2007, Yaoxue Xuebao, V42, P877; Yue H, 2009, TALANTA, V77, P1800, DOI 10.1016/j.talanta.2008.10.022; Zhang AH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-20; Zhang N, 2013, J NAT MED-TOKYO, V67, P36, DOI 10.1007/s11418-012-0641-3; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063; Zhao LH, 2005, CHEM PHARM BULL, V53, P1054, DOI 10.1248/cpb.53.1054	46	28	30	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57414	10.1371/journal.pone.0057414	http://dx.doi.org/10.1371/journal.pone.0057414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468985	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900085
J	Vrins, CLJ; Out, R; van Santbrink, P; van der Zee, A; Mahmoudi, T; Groenendijk, M; Havekes, LM; van Berkel, TJC; van Dijk, KW; Biessen, EAL				Vrins, Carlos L. J.; Out, Ruud; van Santbrink, Peter; van der Zee, Andre; Mahmoudi, Tokameh; Groenendijk, Martine; Havekes, Louis M.; van Berkel, Theo J. C.; van Dijk, Ko Willems; Biessen, Erik A. L.			Znf202 Affects High Density Lipoprotein Cholesterol Levels and Promotes Hepatosteatosis in Hyperlipidemic Mice	PLOS ONE			English	Article							FINGER PROTEIN ZNF202; HDL CHOLESTEROL; GENE-EXPRESSION; KNOCKOUT MICE; ABCA1; ZINC-FINGER-PROTEIN-202; TRIGLYCERIDES; METABOLISM; RECEPTOR; DISEASE	Background: The zinc finger protein Znf202 is a transcriptional suppressor of lipid related genes and has been linked to hypoalphalipoproteinemia. A functional role of Znf202 in lipid metabolism in vivo still remains to be established. Methodology and Principal Findings: We generated mouse Znf202 expression vectors, the functionality of which was established in several in vitro systems. Next, effects of adenoviral znf202 overexpression in vivo were determined in normoas well as hyperlipidemic mouse models. Znf202 overexpression in mouse hepatoma cells mhAT3F2 resulted in downregulation of members of the Apoe/c1/c2 and Apoa1/c3/a4 gene cluster. The repressive activity of Znf202 was firmly confirmed in an apoE reporter assay and Znf202 responsive elements within the ApoE promoter were identified. Adenoviral Znf202 transfer to Ldlr-/- mice resulted in downregulation of apoe, apoc1, apoa1, and apoc3 within 24 h after gene transfer. Interestingly, key genes in bile flux (abcg5/8 and bsep) and in bile acid synthesis (cyp7a1) were also downregulated. At 5 days post-infection, the expression of the aforementioned genes was normalized, but mice had developed severe hepatosteatosis accompanied by hypercholesterolemia and hypoalphalipoproteinemia. A much milder phenotype was observed in wildtype mice after 5 days of hepatic Znf202 overexpression. Interestingly and similar to Ldl-/- mice, HDL-cholesterol levels in wildtype mice were lowered after hepatic Znf202 overexpression. Conclusion/Significance: Znf202 overexpression in vivo reveals an important role of this transcriptional regulator in liver lipid homeostasis, while firmly establishing the proposed key role in the control of HDL levels.	[Vrins, Carlos L. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Vrins, Carlos L. J.; Out, Ruud; van Santbrink, Peter; van Berkel, Theo J. C.] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands; [Vrins, Carlos L. J.; van der Zee, Andre; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Mahmoudi, Tokameh] Erasmus Univ, Med Ctr, Dept Biochem, Rotterdam, Netherlands; [Groenendijk, Martine; Havekes, Louis M.] TNO Prevent & Hlth, Gaubius Lab, Leiden, Netherlands; [Havekes, Louis M.; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Gen Internal Med, Leiden, Netherlands; [Biessen, Erik A. L.] Maastricht Univ, Med Ctr, Dept Pathol, Maastricht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University	Vrins, CLJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c_vrins@hotmail.com	Van Berkel, Theo/ABD-7677-2021; van Dijk, Ko Willems/AAT-4681-2021; van Dijk, Ko Willems/A-1798-2008	van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; Biessen, Erik/0000-0002-6454-8548	Netherlands Heart Foundation [NHS98.144, M93.001]; Netherlands Organisation for Scientific Research [ZonMW 016.026.019]; Top Institute Pharma [T2-110]	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Top Institute Pharma	This study was supported by grants NHS98.144 (Carlos Vrins) and M93.001 (Peter van Santbrink) from the Netherlands Heart Foundation (www.hartstichting.nl), grant ZonMW 016.026.019 (Erik Biessen) from the Netherlands Organisation for Scientific Research (www.zonmw.nl), and grant T2-110 (Ruud Out) from Top Institute Pharma (www.tipharma.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama TE, 2001, J BIOL CHEM, V276, P39088, DOI 10.1074/jbc.M107073200; ANTOINE B, 1992, EXP CELL RES, V200, P175, DOI 10.1016/S0014-4827(05)80086-2; CHANG DJ, 1990, J BIOL CHEM, V265, P9496; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Elferink RO, 2002, BBA-MOL BASIS DIS, V1586, P129; Fallaux FJ, 1998, HUM GENE THER, V9, P1909, DOI 10.1089/hum.1998.9.13-1909; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; Haase CL, 2010, J CLIN ENDOCR METAB, V95, pE500, DOI 10.1210/jc.2010-0450; Han S, 2009, J CLIN INVEST, V119, P1029, DOI 10.1172/JCI36523; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Honer C, 2001, BBA-GENE STRUCT EXPR, V1517, P441, DOI 10.1016/S0167-4781(00)00274-8; Kobayashi K, 1996, J BIOL CHEM, V271, P6852, DOI 10.1074/jbc.271.12.6852; Kort EN, 2000, AM J HUM GENET, V66, P1845, DOI 10.1086/302945; Langmann T, 2003, J LIPID RES, V44, P968, DOI 10.1194/jlr.M300016-JLR200; LAROSA JC, 1970, BIOCHEM BIOPH RES CO, V41, P57, DOI 10.1016/0006-291X(70)90468-7; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Mensenkamp AR, 2001, J HEPATOL, V35, P816, DOI 10.1016/S0168-8278(01)00249-5; Monaco C, 1998, GENOMICS, V52, P358, DOI 10.1006/geno.1998.5419; PAIK YK, 1988, J BIOL CHEM, V263, P13340; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Porsch-Ozcurumez M, 2001, J BIOL CHEM, V276, P12427, DOI 10.1074/jbc.M100218200; Rader DJ, 2007, NAT CLIN PRACT CARD, V4, P102, DOI 10.1038/ncpcardio0768; Repa JJ, 2005, J LIPID RES, V46, P779, DOI 10.1194/jlr.M400475-JLR200; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Sakai N, 1997, J BIOL CHEM, V272, P7506, DOI 10.1074/jbc.272.11.7506; Santamarina-Fojo S, 1998, ENDOCRIN METAB CLIN, V27, P551, DOI 10.1016/S0889-8529(05)70025-6; Schaap FG, 2004, J BIOL CHEM, V279, P27941, DOI 10.1074/jbc.M403240200; Schmitz G, 2004, CURR OPIN LIPIDOL, V15, P199, DOI 10.1097/00041433-200404000-00013; Schmitz G, 1999, PATHOBIOLOGY, V67, P236, DOI 10.1159/000028100; Stene MC, 2006, J LIPID RES, V47, P944, DOI 10.1194/jlr.M500521-JLR200; Stene MCA, 2008, J AM COLL CARDIOL, V52, P369, DOI 10.1016/j.jacc.2008.03.059; Stene MCA, 2006, ATHEROSCLEROSIS, V188, P43, DOI 10.1016/j.atherosclerosis.2005.10.014; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Valasek MA, 2005, J BIOL CHEM, V280, P28103, DOI 10.1074/jbc.M504609200; van der Vliet HN, 2002, BIOCHEM BIOPH RES CO, V295, P1156, DOI 10.1016/S0006-291X(02)00808-2; Vega GL, 1996, CURR OPIN LIPIDOL, V7, P209, DOI 10.1097/00041433-199608000-00007; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wagner S, 2000, J BIOL CHEM, V275, P15685, DOI 10.1074/jbc.M910152199; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; ZAMBON A, 1993, J LIPID RES, V34, P1021	45	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57492	10.1371/journal.pone.0057492	http://dx.doi.org/10.1371/journal.pone.0057492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469003	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900102
J	Chu, CYS; King, JC; Berrini, M; Alexander, RT; Cordat, E				Chu, Carmen Y. S.; King, Jennifer C.; Berrini, Mattia; Alexander, R. Todd; Cordat, Emmanuelle			Functional Rescue of a Kidney Anion Exchanger 1 Trafficking Mutant in Renal Epithelial Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; TUBULAR-ACIDOSIS; CYSTIC-FIBROSIS; HEREDITARY SPHEROCYTOSIS; AUTOSOMAL-DOMINANT; CL-/HCO3-EXCHANGER; ASIAN OVALOCYTOSIS; INTRACELLULAR PH; PLASMA-MEMBRANE; GLYCOPHORIN-A	Mutations in the SLC4A1 gene encoding the anion exchanger 1 (AE1) can cause distal renal tubular acidosis (dRTA), a disease often due to mis-trafficking of the mutant protein. In this study, we investigated whether trafficking of a Golgi-retained dRTA mutant, G701D kAE1, or two dRTA mutants retained in the endoplasmic reticulum, C479W and R589H kAE1, could be functionally rescued to the plasma membrane of Madin-Darby Canine Kidney (MDCK) cells. Treatments with DMSO, glycerol, the corrector VX-809, or low temperature incubations restored the basolateral trafficking of G701D kAE1 mutant. These treatments had no significant rescuing effect on trafficking of the mis-folded C479W or R589H kAE1 mutants. DMSO was the only treatment that partially restored G701D kAE1 function in the plasma membrane of MDCK cells. Our experiments show that trafficking of intracellularly retained dRTA kAE1 mutants can be partially restored, and that one chemical treatment rescued both trafficking and function of a dRTA mutant. These studies provide an opportunity to develop alternative therapeutic solutions for dRTA patients.	[Chu, Carmen Y. S.; King, Jennifer C.; Berrini, Mattia; Alexander, R. Todd; Cordat, Emmanuelle] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	University of Alberta	Cordat, E (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB, Canada.	cordat@ualberta.ca	Alexander, R. Todd/G-1373-2012		Canadian Institutes of Health Research [MOP 106565]; Alberta Innovates Health Solution Graduate studentship; KRESCENT; Canadian Institutes of Health Research; Alberta Innovates Health Solution Clinical Investigator award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solution Graduate studentship; KRESCENT; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solution Clinical Investigator award	This work was supported by funding from the Canadian Institutes of Health Research (MOP 106565) (http://www.cihr-irsc.gc.ca). C.Y.S.C. is the recipient of an Alberta Innovates Health Solution Graduate studentship (http://www.aihealthsolutions.ca). E. C. is supported by a KRESCENT New Investigator award (http://www.krescent.ca). R. T. A. is the recipient of a Clinician Scientist award from the Canadian Institutes of Health Research and an Alberta Innovates Health Solution Clinical Investigator award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloisio N, 1997, BLOOD, V90, P414; Almomani EY, 2011, BIOCHEM CELL BIOL, V89, P157, DOI [10.1139/O10-153, 10.1139/o10-153]; Alper SL, 2010, J NEPHROL, V23, pS57; BALIGA BS, 1969, J BIOL CHEM, V244, P4480; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Bruce LJ, 2000, BIOCHEM J, V350, P41, DOI 10.1042/0264-6021:3500041; Bruce LJ, 1997, J CLIN INVEST, V100, P1693, DOI 10.1172/JCI119694; Chang YH, 2009, KIDNEY INT, V76, P774, DOI 10.1038/ki.2009.258; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chu C, 2010, BIOCHEM J, V426, P379, DOI 10.1042/BJ20091525; Cordat E, 2006, TRAFFIC, V7, P117, DOI 10.1111/j.1600-0854.2005.00366.x; Cordat E, 2003, TRAFFIC, V4, P642, DOI 10.1034/j.1600-0854.2003.00123.x; Cordat E, 2006, BIOCHEM CELL BIOL, V84, P949, DOI 10.1139/O06-200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Fry AC, 2012, J AM SOC NEPHROL; GROVES JD, 1992, J BIOL CHEM, V267, P22163; Jarolim P, 1998, J BIOL CHEM, V273, P6380, DOI 10.1074/jbc.273.11.6380; Jurkuvenaite A, 2010, AM J RESP CELL MOL, V42, P363, DOI 10.1165/rcmb.2008-0434OC; Karet FE, 1998, P NATL ACAD SCI USA, V95, P6337, DOI 10.1073/pnas.95.11.6337; Keskanokwong T, 2007, J BIOL CHEM, V282, P23205, DOI 10.1074/jbc.M702139200; Kittanakom S, 2004, J BIOL CHEM, V279, P40960, DOI 10.1074/jbc.M405356200; Loiselle FB, 2010, METHODS MOL BIOL, V637, P311, DOI 10.1007/978-1-60761-700-6_17; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Patterson ST, 2010, J BIOL CHEM, V285, P33423, DOI 10.1074/jbc.M110.144261; PIMPLIKAR SW, 1986, J BIOL CHEM, V261, P9770; Quilty JA, 2002, AM J PHYSIOL-RENAL, V282, pF810, DOI 10.1152/ajprenal.00216.2001; RAMJEESINGH M, 1981, BIOCHIM BIOPHYS ACTA, V641, P173, DOI 10.1016/0005-2736(81)90581-2; Ribeiro ML, 2000, BLOOD, V96, P1602; Sawasdee N, 2010, BIOCHEM BIOPH RES CO, V401, P85, DOI 10.1016/j.bbrc.2010.09.015; Shao LP, 2010, ENDOCRINE, V37, P473, DOI 10.1007/s12020-010-9340-6; Sterling D, 1999, BIOCHEM J, V344, P221, DOI 10.1042/0264-6021:3440221; Su Y, 2011, AM J PHYSIOL-RENAL, V300, pF157, DOI 10.1152/ajprenal.00228.2010; Tanphaichitr VS, 1998, J CLIN INVEST, V102, P2173, DOI 10.1172/JCI4836; Toye AM, 2004, J CELL SCI, V117, P1399, DOI 10.1242/jcs.00974; Ungsupravate D, 2010, MOL MEMBR BIOL, V27, P92, DOI 10.3109/09687681003588020; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vasuvattakul S, 1999, KIDNEY INT, V56, P1674, DOI 10.1046/j.1523-1755.1999.00756.x; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Wu F, 2010, J AM SOC NEPHROL, V21, P1456, DOI 10.1681/ASN.2009090921	39	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57062	10.1371/journal.pone.0057062	http://dx.doi.org/10.1371/journal.pone.0057062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460825	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000057
J	Gill, SS; Gupta, N; Bell, CM; Rochon, PA; Austin, PC; Laupacis, A				Gill, Sudeep S.; Gupta, Neeraj; Bell, Chaim M.; Rochon, Paula A.; Austin, Peter C.; Laupacis, Andreas			The Timing of Drug Funding Announcements Relative to Elections: A Case Study Involving Dementia Medications	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DOUBLE-BLIND; CHOLINESTERASE-INHIBITORS; SCIENTIFIC EVIDENCE; COST-EFFECTIVENESS; CANCER DRUGS; DONEPEZIL; POLICY; COVERAGE; MEMANTINE	Background: Following initial regulatory approval of prescription drugs, many factors may influence insurers and health systems when they decide whether to add these drugs to their formularies. The role of political pressures on drug funding announcements has received relatively little attention, and elections represent an especially powerful form of political pressure. We examined the temporal relationship between decisions to add one class of drugs to publicly funded formularies in Canada's ten provinces and elections in these jurisdictions. Methods: Dates of provincial formulary listings for cholinesterase inhibitors, which are drugs used to treat Alzheimer's disease and related dementias, were compared to the dates of provincial elections. Medical journal articles, media reports, and proceedings from provincial legislatures were reviewed to assemble information on the chronology of events. We tested whether there was a statistically significant increase in the probability of drug funding announcements within the 60-day intervals preceding provincial elections. Results: Decisions to fund the cholinesterase inhibitors were made over a nine-year span from 1999 to 2007 in the ten provinces. In four of ten provinces, the drugs were added to formularies in a time period closely preceding a provincial election (P = 0.032); funding announcements in these provinces were made between 2 and 47 days prior to elections. Statements made in provincial legislatures highlight the key role of political pressures in these funding announcements. Conclusions: Impending elections appeared to affect the timing of drug funding announcements in this case study. Despite an established structure for evidence-based decision-making, drug funding remains a complex process open to influence from many sources. Awareness of such influences is critical to maintain effective drug policy and public health decision-making.	[Gill, Sudeep S.; Gupta, Neeraj] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Gill, Sudeep S.; Bell, Chaim M.; Rochon, Paula A.; Austin, Peter C.; Laupacis, Andreas] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Bell, Chaim M.; Rochon, Paula A.; Austin, Peter C.; Laupacis, Andreas] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bell, Chaim M.; Rochon, Paula A.; Austin, Peter C.; Laupacis, Andreas] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Bell, Chaim M.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Rochon, Paula A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Laupacis, Andreas] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	Queens University - Canada; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Gill, SS (corresponding author), Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada.	sudeep.gill@ices.on.ca	Rochon, Paula A/J-2918-2016; Bell, Chaim/C-4611-2015	Rochon, Paula A/0000-0002-5973-4151; Bell, Chaim/0000-0002-3778-9469; Austin, Peter/0000-0003-3337-233X	Canadian Institutes of Health Research (CIHR); CIHR; Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care; Heart and Stroke Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care; Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	SSG is supported by a Canadian Institutes of Health Research (CIHR) New Investigator Award. CMB is supported by a CIHR and Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care. PCA is supported by a Career Investigator award from the Heart and Stroke Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions, results and conclusions are those of the authors. No endorsement by the Ontario Ministry of Health and Long-Term Care, the Institute for Clinical Evaluative Sciences (ICES), ICES@Queen's or the funding sources is intended or should be inferred.	Ames D, 2008, INT PSYCHOGERIATR, V20, P259, DOI 10.1017/S1041610207006680; Andrews E, 2004, PHARMACOEPIDEM DR S, V13, P599, DOI 10.1002/pds.899; Anis AH, 2001, MED CARE, V39, P315, DOI 10.1097/00005650-200104000-00003; [Anonymous], 1998, GLOBE MAIL A    0813, P9; [Anonymous], 1999, CBC NEWS; [Anonymous], 2009, CBS NEWS 60 MIN; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; BC Therapeutics Initiative, 2005, THERAPEUTICS LET APR; Bentham P, 2004, LANCET, V363, P2105; Booth CM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-110; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Chambers JD, 2011, NEW ENGL J MED, V364, P1687, DOI 10.1056/NEJMp1103057; Choi BCK, 2005, J EPIDEMIOL COMMUN H, V59, P632, DOI 10.1136/jech.2004.031765; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Detsky AS, 2007, JAMA-J AM MED ASSOC, V298, P221, DOI 10.1001/jama.298.2.221; Dhalla I, 2008, CAN MED ASSOC J, V178, P428, DOI 10.1503/cmaj.070799; Doyle Y, 2001, BRIT MED J, V323, P222, DOI 10.1136/bmj.323.7306.222; Elie LM, 1998, CAN MED ASSOC J, V158, P1014; Foy R, 1999, BRIT MED J, V318, P456, DOI 10.1136/bmj.318.7181.456; Gellad WF, 2008, J GEN INTERN MED, V23, P1435, DOI 10.1007/s11606-008-0689-7; Goldberg DS, 2012, AM J PUBLIC HEALTH, V102, P44, DOI 10.2105/AJPH.2011.300325; Gostin LO, 2012, JAMA-J AM MED ASSOC, V308, P571, DOI 10.1001/jama.2012.9061; Government of Newfoundland and Labrador Department of Health and Community Services, 2003, GOV CREAT NEW SEN DR; Government of Nova Scotia Department of Health, 2003, PLAN ALZH DRUG COV R; Haas M, 2009, HEALTH POLICY, V92, P288, DOI 10.1016/j.healthpol.2009.05.002; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Humphreys K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1316; IMS Healthlink Incorporated, 2011, TOP 20 GLOB PROD 201; Jewell CJ, 2008, MILBANK Q, V86, P177, DOI 10.1111/j.1468-0009.2008.00519.x; Mah CL, 2011, AM J PUBLIC HEALTH, V101, P1850, DOI 10.2105/AJPH.2011.300205; Martin DK, 2001, LANCET, V358, P1676, DOI 10.1016/S0140-6736(01)06714-9; Menon D, 2005, CAN J PUBLIC HEALTH, V96, P454, DOI 10.1007/BF03405189; Morden NE, 2007, J AM GERIATR SOC, V55, P622, DOI 10.1111/j.1532-5415.2007.01106.x; Morrison S, 1998, HAMILTON SPECTA 0718; Neuman P, 2009, NEW ENGL J MED, V361, P406, DOI 10.1056/NEJMhpr0809949; Neumann PJ, 2012, NEW ENGL J MED, V366, P585, DOI 10.1056/NEJMp1200390; Okie S, 2011, NEW ENGL J MED, V365, P1069, DOI 10.1056/NEJMp1107288; Oliver TR, 2006, ANNU REV PUBL HEALTH, V27, P195, DOI 10.1146/annurev.publhealth.25.101802.123126; Ontario Ministry of Health and Long-Term Care, 1999, ONT STRAT ALZH DIS R; Province of Newfoundland and Labrador, 2000, NEWF LABR HOUS ASS P, VXLIV; Province of Newfoundland and Labrador, 2005, NEWF LABR HOUS ASS P, VXLV; Province of Newfoundland and Labrador, 1999, NEWF LABR HOUS ASS P, VXLIV; Province of Newfoundland and Labrador, 2006, NEWF LABR HOUS ASS P, VXLV; Province of Nova Scotia, 2002, NOV SCOT HOUS ASS DE; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; Schiff GD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001220; Schwartz LM, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1086; Simon GE, 2005, J GEN INTERN MED, V20, P964, DOI 10.1111/j.1525-1497.2005.0232.x; Voelker R, 2008, JAMA-J AM MED ASSOC, V299, P1763, DOI 10.1001/jama.299.15.1763	53	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56921	10.1371/journal.pone.0056921	http://dx.doi.org/10.1371/journal.pone.0056921			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460820	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000045
J	Nelson, AW; Harvey, RC; Parker, RA; Kastner, C; Doble, A; Gnanapragasam, VJ				Nelson, Adam W.; Harvey, Rebecca C.; Parker, Richard A.; Kastner, Christof; Doble, Andrew; Gnanapragasam, Vincent J.			Repeat Prostate Biopsy Strategies after Initial Negative Biopsy: Meta-Regression Comparing Cancer Detection of Transperineal, Transrectal Saturation and MRI Guided Biopsy	PLOS ONE			English	Article							ULTRASOUND BIOPSY; CORE DISTRIBUTION; ANTIGEN LEVELS; NEEDLE-BIOPSY; PSA LEVELS; RESONANCE-SPECTROSCOPY; TEMPLATE BIOPSY; ENDORECTAL MRI; TUMOR FOCI; HIGH-RISK	Introduction: There is no consensus on how to investigate men with negative transrectal ultrasound guided prostate biopsy (TRUS-B) but ongoing suspicion of cancer. Three strategies used are transperineal (TP-B), transrectal saturation (TS-B) and MRI-guided biopsy (MRI-B). We compared cancer yields of these strategies. Methods: Papers were identified by search of Pubmed, Embase and Ovid Medline. Included studies investigated biopsy diagnostic yield in men with at least one negative TRUS-B and ongoing suspicion of prostate cancer. Data including age, PSA, number of previous biopsy episodes, number of cores at re-biopsy, cancer yield, and Gleason score of detected cancers were extracted. Meta-regression analyses were used to analyse the data. Results: Forty-six studies were included; 12 of TS-B, 14 of TP-B, and 20 of MRI-B, representing 4,657 patients. Mean patient age, PSA and number of previous biopsy episodes were similar between the strategies. The mean number of biopsy cores obtained by TP-B and TS-B were greater than MRI-B. Cancer detection rates were 30.0%, 36.8%, and 37.6% for TS-B, TP-B, and MRI-B respectively. Meta-regression analysis showed that MRI-B had significantly higher cancer detection than TS-B. There were no significant differences however between MRI-B and TP-B, or TP-B and TS-B. In a sensitivity analysis incorporating number of previous biopsy episodes (36 studies) the difference between MRI-B and TP-B was not maintained resulting in no significant difference in cancer detection between the groups. There were no significant differences in median Gleason scores detected comparing the three strategies. Conclusions: In the re-biopsy setting, it is unclear which strategy offers the highest cancer detection rate. MRI-B may potentially detect more prostate cancers than other modalities and can achieve this with fewer biopsy cores. However, well-designed prospective studies with standardised outcome measures are needed to accurately compare modalities and define an optimum re-biopsy approach.	[Nelson, Adam W.; Kastner, Christof; Doble, Andrew; Gnanapragasam, Vincent J.] Addenbrookes Hosp, Dept Urol, Cambridge CB2 2QQ, England; [Harvey, Rebecca C.; Parker, Richard A.] Univ Cambridge, Ctr Appl Med Stat, Cambridge, England; [Gnanapragasam, Vincent J.] Univ Cambridge, Translat Prostate Canc Grp, Hutchison MRC Res Ctr, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge	Gnanapragasam, VJ (corresponding author), Addenbrookes Hosp, Dept Urol, Cambridge CB2 2QQ, England.	vjg29@cam.ac.uk	Nelson, Adam/AAY-2315-2021	Harvey, Rebecca/0000-0001-8444-6365; Kastner, Christof/0000-0001-7340-4303				Abdollah F, 2011, UROLOGY, V77, P921, DOI 10.1016/j.urology.2010.08.048; Aganovic Damir, 2011, Med Arh, V65, P109; Amsellem-Ouazana D, 2005, EUR UROL, V47, P582, DOI 10.1016/j.eururo.2005.01.015; Anastasiadis AG, 2006, EUR UROL, V50, P738, DOI 10.1016/j.eururo.2006.03.007; Bangma CH, 2012, CRIT REV ONCOL HEMAT; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Ben Cheikh A, 2009, EUR RADIOL, V19, P770, DOI 10.1007/s00330-008-1190-8; Beyersdorff D, 2002, RADIOLOGY, V224, P701, DOI 10.1148/radiol.2243011553; Bhatia Cathleeyakorn, 2007, Journal of the Medical Association of Thailand, V90, P1391; Bittner N, 2009, UROLOGY, V74, P171, DOI 10.1016/j.urology.2008.12.013; Borboroglu PG, 2000, J UROLOGY, V163, P158, DOI 10.1016/S0022-5347(05)67994-3; Bott SRJ, 2006, UROLOGY, V68, P1037, DOI 10.1016/j.urology.2006.05.033; Chiang IN, 2007, J FORMOS MED ASSOC, V106, P929, DOI 10.1016/S0929-6646(08)60063-7; Cirillo S, 2008, CLIN RADIOL, V63, P871, DOI 10.1016/j.crad.2007.10.020; D'Amico AV, 2000, J UROLOGY, V164, P385, DOI 10.1016/S0022-5347(05)67366-1; Demura T, 2005, CANCER-AM CANCER SOC, V103, P1826, DOI 10.1002/cncr.21020; Dimmen M, 2012, BJU INT, V110, pE69, DOI 10.1111/j.1464-410X.2011.10759.x; Eichler K, 2006, J UROLOGY, V175, P1605, DOI 10.1016/S0022-5347(05)00957-2; Engelhard K, 2006, EUR RADIOL, V16, P1237, DOI 10.1007/s00330-005-0100-6; Fleshner N, 2002, UROLOGY, V60, P93, DOI 10.1016/S0090-4295(02)01625-4; Franiel T, 2011, RADIOLOGY, V259, P162, DOI 10.1148/radiol.10101251; Furuno T, 2004, PROSTATE, V58, P76, DOI 10.1002/pros.10298; Hadaschik BA, 2011, J UROLOGY, V186, P2214, DOI 10.1016/j.juro.2011.07.102; Hambrock T, 2010, J UROLOGY, V183, P520, DOI 10.1016/j.juro.2009.10.022; Heidenreich A, 2011, EUR UROL, V59, P61, DOI 10.1016/j.eururo.2010.10.039; Hoeks CMA, 2012, EUR UROL, V62, P902, DOI 10.1016/j.eururo.2012.01.047; Igel TC, 2001, J UROLOGY, V165, P1575, DOI 10.1016/S0022-5347(05)66351-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lattouf JB, 2007, BJU INT, V99, P1041, DOI 10.1111/j.1464-410X.2006.06690.x; Lawrence EM, 2012, NAT REV UROL, V9, P94, DOI 10.1038/nrurol.2011.222; Lawrentschuk N, 2009, BJU INT, V103, P730, DOI 10.1111/j.1464-410X.2008.08205.x; Luciani LG, 2006, UROLOGY, V67, P555, DOI 10.1016/j.urology.2005.09.036; Merrick GS, 2007, EUR UROL, V52, P715, DOI 10.1016/j.eururo.2007.02.041; Miyagawa T, 2010, INT J UROL, V17, P855, DOI 10.1111/j.1442-2042.2010.02612.x; Moore CM, 2013, EUR UROL, V63, P125, DOI 10.1016/j.eururo.2012.06.004; Moran BJ, 2006, J UROLOGY, V176, P1376, DOI 10.1016/j.juro.2006.06.030; Novara G, 2010, BJU INT, V105, P1242, DOI 10.1111/j.1464-410X.2009.08954.x; Pal RP, 2012, BJU INT, V109, P367, DOI 10.1111/j.1464-410X.2011.10355.x; Park BK, 2008, INVEST RADIOL, V43, P789, DOI 10.1097/RLI.0b013e318183725e; Patel AR, 2004, UROLOGY, V63, P87, DOI 10.1016/j.urology.2003.08.040; Pepe P, 2007, UROLOGY, V70, P1131, DOI 10.1016/j.urology.2007.07.068; Perrotti M, 1999, J UROLOGY, V162, P1314, DOI 10.1016/S0022-5347(05)68275-4; Pinkstaff DM, 2005, UROLOGY, V65, P735, DOI 10.1016/j.urology.2004.10.067; Pinto PA, 2011, J UROLOGY, V186, P1281, DOI 10.1016/j.juro.2011.05.078; Pondman KM, 2008, EUR UROL, V54, P517, DOI 10.1016/j.eururo.2008.06.001; Prando A, 2005, RADIOLOGY, V236, P903, DOI 10.1148/radiol.2363040615; Pryor Michael B, 2002, Clin Prostate Cancer, V1, P172, DOI 10.3816/CGC.2002.n.019; Rabets JC, 2004, J UROLOGY, V172, P94, DOI 10.1097/01.ju.0000132134.10470.75; Roehl KA, 2002, J UROLOGY, V167, P2435, DOI 10.1016/S0022-5347(05)64999-3; Roethke M, 2012, WORLD J UROL, V30, P213, DOI 10.1007/s00345-011-0675-2; Sajadi KP, 2007, UROLOGY, V70, P691, DOI 10.1016/j.urology.2007.05.017; Satoh T, 2005, UROLOGY, V66, P114, DOI 10.1016/j.urology.2005.01.051; Scattoni V, 2007, EUR UROL, V52, P1309, DOI 10.1016/j.eururo.2007.08.006; Scattoni V, 2011, EUR UROL, V60, P834, DOI 10.1016/j.eururo.2011.07.036; Scattoni V, 2010, INT J UROL, V17, P432, DOI 10.1111/j.1442-2042.2010.02479.x; Sciarra A, 2010, CLIN CANCER RES, V16, P1875, DOI 10.1158/1078-0432.CCR-09-2195; Serag H, 2012, BRIT J CANCER, V106, P436, DOI 10.1038/bjc.2011.596; Simon J, 2008, BJU INT, V102, P459, DOI 10.1111/j.1464-410X.2008.07560.x; Singh AK, 2008, BJU INT, V101, P841, DOI 10.1111/j.1464-410X.2007.07348.x; Stav K, 2008, UROLOGY, V71, P399, DOI 10.1016/j.urology.2007.11.007; Stewart CS, 2001, J UROLOGY, V166, P86, DOI 10.1016/S0022-5347(05)66083-1; Taira AV, 2010, PROSTATE CANCER P D, V13, P71, DOI 10.1038/pcan.2009.42; Team RDC, 2012, R LANG ENV STAT COMP; Testa C, 2010, NMR BIOMED, V23, P1017, DOI 10.1002/nbm.1522; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Walz J, 2006, EUR UROL, V50, P498, DOI 10.1016/j.eururo.2006.03.026; Wetter A, 2005, EUR RADIOL, V15, P645, DOI 10.1007/s00330-004-2562-3; Yuasa Takeshi, 2008, BMC Urol, V8, P14, DOI 10.1186/1471-2490-8-14; Yuen JSP, 2004, J UROLOGY, V171, P1482, DOI 10.1097/01.ju.0000118380.90871.ef; Zaytoun OM, 2011, J UROLOGY, V186, P850, DOI 10.1016/j.juro.2011.04.069; Zaytoun OM, 2011, INT J UROL, V18, P557, DOI 10.1111/j.1442-2042.2011.02798.x	71	61	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57480	10.1371/journal.pone.0057480	http://dx.doi.org/10.1371/journal.pone.0057480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460864	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000119
J	Pholwat, S; Stroup, S; Foongladda, S; Houpt, E				Pholwat, Suporn; Stroup, Suzanne; Foongladda, Suporn; Houpt, Eric			Digital PCR to Detect and Quantify Heteroresistance in Drug Resistant Mycobacterium tuberculosis	PLOS ONE			English	Article							GENE; DNA	Drug resistance in Mycobacterium tuberculosis presents an enormous public health threat. It is typically defined as >1% of drug resistant colonies using the agar proportion method. Detecting small numbers of drug resistant Tb in a population, also known as heteroresistance, is challenging with current methodologies. Here we have utilized digital PCR to detect heteroresistance within M. tuberculosis populations with excellent accuracy versus the agar proportion method. We designed dual TaqMan-MGB probes to detect wild-type and mutant sequences of katG (315), rpoB (531), gyrA (94,95) and rrs (1401), genes that associate with resistance to isoniazid, rifampin, fluoroquinolone, and aminoglycoside respectively. We generated heteroresistant mixtures of susceptible and extensively drug resistant Tb, followed by DNA extraction and digital PCR. Digital PCR yielded a close approximation to agar proportion's percentages of resistant colonies, and yielded 100% concordance with agar proportion's susceptible/resistant results. Indeed, the digital PCR method was able to identify mutant sequence in mixtures containing as little as 1000: 1 susceptible: resistant Tb. By contrast, real-time PCR or PCR followed by Sanger sequencing were less sensitive and had little resolution to detect heteroresistance, requiring fully 1: 1 or 10: 1 susceptible: resistant ratios in order to detect resistance. Our assay can also work in sputum so long as sufficient quantities of Tb are present (>1000 cfu/ml). This work demonstrates the utility of digital PCR to detect and quantify heteroresistance in drug resistant Tb, which may be useful to inform treatment decisions faster than agar proportion.	[Pholwat, Suporn; Stroup, Suzanne; Houpt, Eric] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA; [Foongladda, Suporn] Mahidol Univ, Dept Microbiol, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand	University of Virginia; Mahidol University	Houpt, E (corresponding author), Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.	erh6k@virginia.edu	Pholwat, Suporn/CAG-9380-2022		National Institutes of Health [R01 AI093358]; Virginia Department of Health; Tuberculosis Foundation of Virginia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Department of Health; Tuberculosis Foundation of Virginia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health grant R01 AI093358 (to EH), the Virginia Department of Health, and the Tuberculosis Foundation of Virginia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Chakravorty S, 2011, J CLIN MICROBIOL, V49, P932, DOI 10.1128/JCM.02271-10; Clinical and Laboratory Standards Institute (CLSI), 2011, M24A2 CLSI; Espasa M, 2005, J ANTIMICROB CHEMOTH, V55, P860, DOI 10.1093/jac/dki132; Hofmann-Thiel S, 2009, EUR RESPIR J, V33, P368, DOI 10.1183/09031936.00089808; Lee H, 2003, J CLIN MICROBIOL, V41, P2213, DOI 10.1128/JCM.41.5.2213-2218.2003; Morand B, 2007, P NATL ACAD SCI USA, V104, P14098, DOI 10.1073/pnas.0702377104; Pholwat S, 2012, J CLIN MICROBIOL, V50, P754, DOI 10.1128/JCM.01315-11; Rinder H, 2001, J MED MICROBIOL, V50, P1018, DOI 10.1099/0022-1317-50-12-1018; Rinder H, 2001, INT J TUBERC LUNG D, V5, P339; Tolani MP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-9; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; WHO, 2011, WHO GLOBAL TUBERCULO; Yesilkaya H, 2006, J CLIN MICROBIOL, V44, P3826, DOI 10.1128/JCM.00225-06; Zhang XB, 2012, J CLIN MICROBIOL, V50, P1471, DOI 10.1128/JCM.05793-11	16	48	56	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57238	10.1371/journal.pone.0057238	http://dx.doi.org/10.1371/journal.pone.0057238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468945	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000082
J	Waltz, JA; Kasanova, Z; Ross, TJ; Salmeron, BJ; McMahon, RP; Gold, JM; Stein, EA				Waltz, James A.; Kasanova, Zuzana; Ross, Thomas J.; Salmeron, Betty J.; McMahon, Robert P.; Gold, James M.; Stein, Elliot A.			The Roles of Reward, Default, and Executive Control Networks in Set-Shifting Impairments in Schizophrenia	PLOS ONE			English	Article							TEMPORAL DIFFERENCE MODELS; PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; BRAIN; REPRESENTATION; DYSFUNCTION; COGNITION; INHIBITION; INTENTION; OUTCOMES	Patients with schizophrenia (SZ) show deficits on tasks of rapid reinforcement learning, like probabilistic reversal learning (PRL), but the neural bases for those impairments are not known. Recent evidence of relatively intact sensitivity to negative outcomes in the ventral striatum (VS) in many SZ patients suggests that PRL deficits may be largely attributable to processes downstream from feedback processing, involving both the activation of executive control task regions and deactivation of default mode network (DMN) components. We analyzed data from 29 chronic SZ patients and 21 matched normal controls (NCs) performing a PRL task in an MRI scanner. Subjects were presented with eight pairs of fractal stimuli, for 50 trials each. For each pair, subjects learned to choose the more frequently-rewarded (better) stimulus. Each time a criterion was reached, the better stimulus became the worse one, and the worse became the better. Responses to feedback events were assessed through whole-brain and regions-of-interest (ROI) analyses in DMN. We also assessed correlations between BOLD signal contrasts and clinical measures in SZs. Relative to NCs, SZ patients showed comparable deactivation of VS in response to negative feedback, but reduced deactivation of DMN components including medial prefrontal cortex (mPFC). The magnitudes of patients' punishment-evoked deactivations in VS and ventromedial PFC correlated significantly with clinical ratings for avolition/anhedonia. These findings suggest that schizophrenia is associated with a reduced ability to deactivate components of default mode networks, following the presentation of informative feedback and that motivational deficits in SZ relate closely to feedback-evoked activity in reward circuit components. These results also confirm a role for ventrolateral and dorsomedial PFC in the execution of response-set shifts.	[Waltz, James A.; Kasanova, Zuzana; McMahon, Robert P.; Gold, James M.] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Dept Psychiat, Baltimore, MD 21201 USA; [Ross, Thomas J.; Salmeron, Betty J.; Stein, Elliot A.] NIDA, Neuroimaging Res Branch, Intramural Res Program, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Waltz, JA (corresponding author), Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Dept Psychiat, Baltimore, MD 21201 USA.	jwaltz@mprc.umaryland.edu	Ross, Thomas/B-7469-2008; Waltz, James/AAU-8304-2020; Salmeron, Betty Jo/M-1793-2016; McMahon, Robert P/C-5462-2009	Ross, Thomas/0000-0002-7745-3572; Waltz, James/0000-0002-9236-3719; Salmeron, Betty Jo/0000-0003-1699-9333; Kasanova, Zuzana/0000-0002-8795-5373	National Institutes of Health (NIH) [K12 RR023250, R01 MH080066]; National Institute on Drug Abuse - Intramural Research Program (NIDA-IRP);  [HHSN271200599091C/ADB];  [N01DA-5-9909]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000583] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse - Intramural Research Program (NIDA-IRP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work supported by National Institutes of Health (NIH) grants K12 RR023250, R01 MH080066, a project grant from HHSN271200599091C/ADB Contract # N01DA-5-9909 and by the National Institute on Drug Abuse - Intramural Research Program (NIDA-IRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDINGTON D, 1992, SCHIZOPHR RES, V6, P201, DOI 10.1016/0920-9964(92)90003-N; Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Ashburner J., 2004, HUMAN BRAIN FUNCTION, V2nd, P695; Barbas H, 2007, J ANAT, V211, P237, DOI 10.1111/j.1469-7580.2007.00777.x; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; DeRenzo E G, 1998, J Health Care Law Policy, V1, P66; Drummond SPA, 2005, SLEEP, V28, P1059; Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105; ELLIOTT R, 1995, PSYCHOL MED, V25, P619, DOI 10.1017/S0033291700033523; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; First M. B., 1997, STRUCTURED CLIN INTE; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Friston Karl J., 1996, P363; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gold JM, 2008, SCHIZOPHRENIA BULL, V34, P835, DOI 10.1093/schbul/sbn068; Greening SG, 2011, NEUROIMAGE, V54, P1432, DOI 10.1016/j.neuroimage.2010.09.017; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hahn B, 2007, J NEUROSCI, V27, P3477, DOI 10.1523/JNEUROSCI.5129-06.2007; Hesse MD, 2006, NEUROSCIENCE, V140, P1209, DOI 10.1016/j.neuroscience.2006.03.030; Hong LE, 2009, ARCH GEN PSYCHIAT, V66, P431, DOI 10.1001/archgenpsychiatry.2009.2; Jimura K, 2004, NEUROIMAGE, V22, P1578, DOI 10.1016/j.neuroimage.2004.04.012; Jocham G, 2009, J NEUROSCI, V29, P7489, DOI 10.1523/JNEUROSCI.0349-09.2009; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Linke J, 2010, NEUROIMAGE, V49, P2618, DOI 10.1016/j.neuroimage.2009.09.013; Lund TE, 2006, NEUROIMAGE, V29, P54, DOI 10.1016/j.neuroimage.2005.07.005; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Paulus MP, 2004, NEUROIMAGE, V21, P733, DOI 10.1016/j.neuroimage.2003.09.060; Pfohl B., 1997, STRUCTURED INTERVIEW; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rogers RD, 2000, J COGNITIVE NEUROSCI, V12, P142, DOI 10.1162/089892900561931; Rushworth MFS, 2008, ANN NY ACAD SCI, V1124, P181, DOI 10.1196/annals.1440.014; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; SEIDMAN LJ, 1995, NEUROPSYCHOLOGY, V9, P481; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Simon JJ, 2010, SCHIZOPHR RES, V118, P154, DOI 10.1016/j.schres.2009.11.007; Singh-Curry V, 2009, NEUROPSYCHOLOGIA, V47, P1434, DOI 10.1016/j.neuropsychologia.2008.11.033; Waltz JA, 2007, BIOL PSYCHIAT, V62, P756, DOI 10.1016/j.biopsych.2006.09.042; Waltz JA, 2007, SCHIZOPHR RES, V93, P296, DOI 10.1016/j.schres.2007.03.010; Waltz JA, 2011, NEUROPSYCHOLOGY, V25, P86, DOI 10.1037/a0020882; Waltz JA, 2010, NEUROPSYCHOPHARMACOL, V35, P2427, DOI 10.1038/npp.2010.126; Waltz JA, 2009, NEUROPSYCHOPHARMACOL, V34, P1567, DOI 10.1038/npp.2008.214; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2001, WECHSLER TEST ADULT; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Wilk CM, 2005, NEUROPSYCHOLOGY, V19, P778, DOI 10.1037/0894-4105.19.6.778; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010	70	78	78	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57257	10.1371/journal.pone.0057257	http://dx.doi.org/10.1371/journal.pone.0057257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23468948	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000084
J	Yadav, UCS; Naura, AS; Aguilera-Aguirre, L; Boldogh, I; Boulares, HA; Calhoun, WJ; Ramana, KV; Srivastava, SK				Yadav, Umesh C. S.; Naura, Amarjit S.; Aguilera-Aguirre, Leopoldo; Boldogh, Istvan; Boulares, Hamid A.; Calhoun, William J.; Ramana, Kota V.; Srivastava, Satish K.			Aldose Reductase Inhibition Prevents Allergic Airway Remodeling through PI3K/AKT/GSK3 beta Pathway in Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSFORMING GROWTH-FACTOR-BETA-1; OXIDATIVE STRESS; LUNG FIBROBLASTS; FLOW LIMITATION; SMOOTH-MUSCLE; P38 MAPK; ASTHMA	Background: Long-term and unresolved airway inflammation and airway remodeling, characteristic features of chronic asthma, if not treated could lead to permanent structural changes in the airways. Aldose reductase (AR), an aldo-sugar and lipid aldehyde metabolizing enzyme, mediates allergen- induced airway inflammation in mice, but its role in the airway remodeling is not known. In the present study, we have examined the role of AR on airway remodeling using ovalbumin (OVA)-induced chronic asthma mouse model and cultured human primary airway epithelial cells (SAECs) and mouse lung fibroblasts (mLFs). Methods: Airway remodeling in chronic asthma model was established in mice sensitized and challenged twice a week with OVA for 6 weeks. AR inhibitor, fidarestat, was administered orally in drinking water after first challenge. Inflammatory cells infiltration in the lungs and goblet cell metaplasia, airway thickening, collagen deposition and airway hyper- responsiveness (AHR) in response to increasing doses of methacholine were assessed. The TGF beta 1-induced epithelial-mesenchymal transition (EMT) in SAECs and changes in mLFs were examined to investigate AR- mediated molecular mechanism(s) of airway remodeling. Results: In the OVA-exposed mice for 6 wks inflammatory cells infiltration, levels of inflammatory cytokines and chemokines, goblet cell metaplasia, collagen deposition and AHR were significantly decreased by treatment with AR inhibitor, fidarestat. Further, inhibition of AR prevented TGF beta 1-induced altered expression of E-cadherin, Vimentin, Occludin, and MMP-2 in SAECs, and alpha-smooth muscle actin and fibronectin in mLFs. Further, in SAECs, AR inhibition prevented TGF beta 1-induced activation of PI3K/AKT/GSK3 beta pathway but not the phosphorylation of Smad2/3. Conclusion: Our results demonstrate that allergen-induced airway remodeling is mediated by AR and its inhibition blocks the progression of remodeling via inhibiting TGF beta 1-induced Smad-independent and PI3K/AKT/GSK3 beta-dependent pathway.	[Yadav, Umesh C. S.; Ramana, Kota V.; Srivastava, Satish K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Aguilera-Aguirre, Leopoldo; Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Boulares, Hamid A.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA; [Naura, Amarjit S.; Boulares, Hamid A.] Louisiana State Univ, Hlth Sci Ctr, Stanley Scot Canc Ctr, New Orleans, LA USA; [Naura, Amarjit S.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA USA; [Calhoun, William J.] Univ Texas Med Branch, Dept Internal Med Pulm Crit Care, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas Medical Branch Galveston	Srivastava, SK (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	ssrivast@utmb.edu	Aguilera-Aguirre, Leopoldo/B-9864-2012	Aguilera-Aguirre, Leopoldo/0000-0001-7964-7402; Calhoun, William/0000-0001-7075-712X	American Asthma Foundation grant [AAF 08-0219]; National Institutes of Health [HL072889]; American Cancer Society [RSG-116608]; National Institute of Environmental Health Sciences (NIEHS) grant [ES018948]; NIEHS core facility grant [ES00667616A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948] Funding Source: NIH RePORTER	American Asthma Foundation grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Institute of Environmental Health Sciences (NIEHS) grant; NIEHS core facility grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by funds from American Asthma Foundation grant (AAF 08-0219) to SKS. SKS is a William Bowes Senior Fellow of the American Asthma Foundation. HAB is supported by grants from National Institutes of Health (HL072889) and from American Cancer Society (RSG-116608). IB is supported from National Institute of Environmental Health Sciences (NIEHS) grant (ES018948). This study was also supported by NIEHS core facility grant (ES00667616A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2007, AM J RESP CRIT CARE, V176, P974, DOI 10.1164/rccm.200702-334OC; Alexiou P, 2009, CURR MED CHEM, V16, P734, DOI 10.2174/092986709787458362; Bai TR, 2010, CURR OPIN ALLERGY CL, V10, P82, DOI 10.1097/ACI.0b013e32833363b2; Bergeron C, 2010, CAN RESPIR J, V17, pE85, DOI 10.1155/2010/318029; Bergeron Celine, 2009, Proc Am Thorac Soc, V6, P301, DOI 10.1513/pats.200808-089RM; Brown SD, 2012, J ALLERGY CLIN IMMUN, V129, P388, DOI 10.1016/j.jaci.2011.11.037; Chen RH, 1998, ONCOGENE, V17, P1959, DOI 10.1038/sj.onc.1202111; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Davies Donna E, 2009, Proc Am Thorac Soc, V6, P678, DOI 10.1513/pats.200907-067DP; Fahy J V, 2000, Curr Opin Pulm Med, V6, P15, DOI 10.1097/00063198-200001000-00004; Farghaly HSM, 2008, MOL PHARMACOL, V73, P1530, DOI 10.1124/mol.108.045419; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hesselmar B, 2000, PEDIATR ALLERGY IMMU, V11, P74, DOI 10.1034/j.1399-3038.2000.00070.x; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hwang YYC, 2004, FASEB J, V18, P1192, DOI 10.1096/fj.03-1400com; Kador PF, 2011, J PERIODONTOL, V82, P926, DOI 10.1902/jop.2010.100442; Laprise C, 1999, EUR RESPIR J, V14, P63, DOI 10.1034/j.1399-3003.1999.14a12.x; Le Saux CJ, 2008, J BIOL CHEM, V283, P5760, DOI 10.1074/jbc.M701572200; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Lim DH, 2009, AM J PHYSIOL-LUNG C, V296, pL210, DOI 10.1152/ajplung.90275.2008; Makinde T, 2007, IMMUNOL CELL BIOL, V85, P348, DOI 10.1038/sj.icb.7100044; Martin MM, 2007, AM J PHYSIOL-LUNG C, V293, pL790, DOI 10.1152/ajplung.00099.2007; Mauad T, 2007, J ALLERGY CLIN IMMUN, V120, P997, DOI 10.1016/j.jaci.2007.06.031; MEYER WR, 1992, AM J OBSTET GYNECOL, V167, P1837, DOI 10.1016/0002-9378(92)91784-8; Moir LM, 2011, J PHARMACOL EXP THER, V337, P557, DOI 10.1124/jpet.110.173583; Morcillo EJ, 2006, CURR OPIN PULM MED, V12, P1, DOI 10.1097/01.mcp.0000198064.27586.37; Nadeem A, 2003, J ALLERGY CLIN IMMUN, V111, P72, DOI 10.1067/mai.2003.17; Nadeem Ahmed, 2008, Ther Adv Respir Dis, V2, P215, DOI 10.1177/1753465808094971; Narula M K, 2007, Indian J Physiol Pharmacol, V51, P289; Naura AS, 2010, J IMMUNOL, V185, P3076, DOI 10.4049/jimmunol.0904214; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Rahman I, 2003, J BIOCHEM MOL BIOL, V36, P95; Ramana KV, 2006, J BIOL CHEM, V281, P33019, DOI 10.1074/jbc.M603819200; Ravindranath TM, 2009, J IMMUNOL, V183, P8128, DOI 10.4049/jimmunol.0900720; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Rogers DF, 2004, CURR OPIN PHARMACOL, V4, P241, DOI 10.1016/j.coph.2004.01.011; Rowan WC, 2012, BIOCHEM SOC T, V40, P240, DOI 10.1042/BST20110665; Sagara H, 2002, J ALLERGY CLIN IMMUN, V110, P249, DOI 10.1067/mai.2002.126078; Shimizu K, 2010, RESP MED, V104, P1809, DOI 10.1016/j.rmed.2010.06.013; Shiraishi Y, 2009, J ALLERGY CLIN IMMUN, V123, pS56, DOI 10.1016/j.jaci.2008.11.047; Srivastava SK, 2011, CHEM-BIOL INTERACT, V191, P330, DOI 10.1016/j.cbi.2011.02.023; Steiling Katrina, 2009, Proc Am Thorac Soc, V6, P697, DOI 10.1513/pats.200907-076DP; Sugiura H, 2008, ANTIOXID REDOX SIGN, V10, P785, DOI 10.1089/ars.2007.1937; Sumi Yuki, 2007, Allergol Int, V56, P341, DOI 10.2332/allergolint.R-07-153; Tagaya Etsuko, 2007, Allergol Int, V56, P331; Takahashi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030134; Tammali R, 2011, CARCINOGENESIS, V32, P1259, DOI 10.1093/carcin/bgr102; Tsukagoshi H, 2002, TOXICOL APPL PHARM, V184, P127, DOI 10.1006/taap.2002.9514; Undevia NS, 2004, AM J PHYSIOL-LUNG C, V287, pL515, DOI 10.1152/ajplung.00044.2004; Vedantham Srinivasan, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P234; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Yadav UCS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014440; Yadav UCS, 2009, J IMMUNOL, V183, P4723, DOI 10.4049/jimmunol.0901177; Yadav UCS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006535; Yamaguchi M, 2008, J INVEST ALLERG CLIN, V18, P202	56	30	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57442	10.1371/journal.pone.0057442	http://dx.doi.org/10.1371/journal.pone.0057442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460857	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000111
J	Ulivi, P; Mercatali, L; Casoni, GL; Scarpi, E; Bucchi, L; Silvestrini, R; Sanna, S; Monteverde, M; Amadori, D; Poletti, V; Zoli, W				Ulivi, Paola; Mercatali, Laura; Casoni, Gian-Luca; Scarpi, Emanuela; Bucchi, Lauro; Silvestrini, Rosella; Sanna, Stefano; Monteverde, Marco; Amadori, Dino; Poletti, Venerino; Zoli, Wainer			Multiple Marker Detection in Peripheral Blood for NSCLC Diagnosis	PLOS ONE			English	Article							LUNG-CANCER PATIENTS; CIRCULATING PLASMA DNA; PROMOTER METHYLATION; TUMOR; EXPRESSION; QUANTIFICATION; SERUM; BIOMARKERS; MORTALITY; DISEASE	Background: Non-invasive early detection of lung cancer could reduce the number of patients diagnosed with advanced disease, which is associated with a poor prognosis. We analyzed the diagnostic accuracy of a panel of peripheral blood markers in detecting non small cell lung cancer (NSCLC). Methods: 100 healthy donors and 100 patients with NSCLC were enrolled onto this study. Free circulating DNA, circulating mRNA expression of peptidylarginine deiminase type 4 (PAD4/PADI4), pro-platelet basic protein (PPBP) and haptoglobin were evaluated using a Real-Time PCR-based method. Results: Free circulating DNA, PADI4, PPBP and haptoglobin levels were significantly higher in NSCLC patients than in healthy donors (p<0.0001, p<0.0001, p = 0.0002 and p = 0.0001, respectively). The fitted logistic regression model demonstrated a significant direct association between marker expression and lung cancer risk. The odds ratios of individual markers were 6.93 (95% CI 4.15-11.58; p<0.0001) for free DNA, 6.99 (95% CI 3.75-13.03; p, 0.0001) for PADI4, 2.85 (95% CI 1.71-4.75; p<0.0001) for PPBP and 1.16 (95% CI 1.01-1.33; p = 0.031) for haptoglobin. Free DNA in combination with PPBP and PADI4 gave an area under the ROC curve of 0.93, 95% CI = 0.90-0.97, with sensitivity and specificity over 90%. Conclusions: Free circulating DNA analysis combined with PPBP and PADI4 expression determination appears to accurately discriminate between healthy donors and NSCLC patients. This non-invasive multimarker approach warrants further research to assess its potential role in the diagnostic or screening workup of subjects with suspected lung cancer.	[Ulivi, Paola; Mercatali, Laura; Silvestrini, Rosella; Zoli, Wainer] IRCCS Ist Sci Romagnolo Studio & Cura Tumori, Biosci Lab, Meldola, Italy; [Casoni, Gian-Luca; Poletti, Venerino] Morgagni Pierantoni Hosp, Dept Thorac Dis, Forli, Italy; [Scarpi, Emanuela] IRCCS Ist Sci Romagnolo Studio & Cura Tumori, Unit Biostat & Clin Trials, Meldola, Italy; [Bucchi, Lauro] IRCCS Ist Sci Romagnolo Studio & Cura Tumori, Romagna Canc Registry, Meldola, Italy; [Sanna, Stefano; Monteverde, Marco] Morgagni Pierantoni Hosp, Dept Thorac Dis, Forli, Italy; [Amadori, Dino] IRCCS Ist Sci Romagnolo Studio & Cura Tumori, Dept Med Oncol, Meldola, Italy	IRCCS Meldola (IRST); IRCCS Meldola (IRST); IRCCS Meldola (IRST); IRCCS Meldola (IRST)	Ulivi, P (corresponding author), IRCCS Ist Sci Romagnolo Studio & Cura Tumori, Biosci Lab, Meldola, Italy.	p.ulivi@irst.emr.it	Casoni, Gian Luca/K-6113-2016; Bucchi, Lauro/W-5033-2018; Poletti, Venerino/K-8821-2016; Sanna, Stefano/AAV-1425-2020; Mercatali, Laura/J-9154-2016; Scarpi, Emanuela/AAD-7036-2019	Bucchi, Lauro/0000-0002-6771-8119; Poletti, Venerino/0000-0002-8634-2284; Mercatali, Laura/0000-0003-2162-8238; Scarpi, Emanuela/0000-0001-7230-9267; Ulivi, Paola/0000-0002-4334-9662; Casoni, Gian Luca/0000-0002-7218-7914	Italian Ministry of Health "Programma Integrato Oncologia (PIO)" [RO 06.5]	Italian Ministry of Health "Programma Integrato Oncologia (PIO)"	This study was supported by the Italian Ministry of Health "Programma Integrato Oncologia (PIO) RO 06.5". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah M, 2009, PATHOL RES PRACT, V205, P639, DOI 10.1016/j.prp.2009.04.007; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Andriani F, 2004, INT J CANCER, V108, P91, DOI 10.1002/ijc.11510; Armitage P, 1987, STATISTICAL METHODS, P387; Belinsky SA, 2005, CLIN CANCER RES, V11, P6505, DOI 10.1158/1078-0432.CCR-05-0625; Casoni GL, 2010, INT J BIOL MARKER, V25, P229, DOI 10.5301/JBM.2010.6115; Chang XT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-40; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; de Gonzalez AB, 2008, J MED SCREEN, V15, P153, DOI 10.1258/jms.2008.008052; Fujiwara K, 2005, CLIN CANCER RES, V11, P1219; Gautschi O, 2004, J CLIN ONCOL, V22, P4157, DOI 10.1200/JCO.2004.11.123; Herrera LJ, 2005, CLIN CHEM, V51, P113, DOI 10.1373/clinchem.2004.039263; Kneip C, 2011, J THORAC ONCOL, V6, P1632, DOI 10.1097/JTO.0b013e318220ef9a; Ludovini V, 2008, J THORAC ONCOL, V3, P365, DOI 10.1097/JTO.0b013e318168c7d0; McWilliams A, 2005, CURR OPIN PULM MED, V11, P272; Paci M, 2009, LUNG CANCER, V64, P92, DOI 10.1016/j.lungcan.2008.07.012; Rami-Porta R, 2007, J THORAC ONCOL, V2, P593, DOI 10.1097/JTO.0b013e31807a2f81; SAITO Y, 1992, J THORAC CARDIOV SUR, V104, P401; Schmidt B, 2008, ANN NY ACAD SCI, V1137, P207, DOI 10.1196/annals.1448.034; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; Sozzi G, 2001, CANCER RES, V61, P4675; Sozzi G, 2009, AM J RESP CRIT CARE, V179, P69, DOI 10.1164/rccm.200807-1068OC; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Sung HJ, 2008, BMB REP, V41, P615, DOI 10.5483/BMBRep.2008.41.9.615; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Ulivi P, 2008, THORAX, V63, P843, DOI 10.1136/thx.2008.102178; Ulivi P, 2006, J CELL PHYSIOL, V206, P611, DOI 10.1002/jcp.20503; Wardwell NR, 2005, SEMIN ONCOL, V32, P259, DOI 10.1053/j.seminoncol.2005.02.009; Xie GS, 2004, CHINESE MED J-PEKING, V117, P1485; Yee J, 2009, J CLIN ONCOL, V27, P2787, DOI 10.1200/JCO.2008.19.4233; Yoon KA, 2009, J MOL DIAGN, V11, P182, DOI 10.2353/jmoldx.2009.080098; Zander T, 2011, CLIN CANCER RES, V17, P3360, DOI 10.1158/1078-0432.CCR-10-0533; Zhang RF, 2010, LUNG CANCER, V69, P225, DOI 10.1016/j.lungcan.2009.11.009; Zheng DL, 2011, INT J CLIN EXP PATHO, V4, P575	34	59	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57401	10.1371/journal.pone.0057401	http://dx.doi.org/10.1371/journal.pone.0057401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468981	gold, Green Published, Green Submitted			2022-12-27	WOS:000315561400041
J	Barr, TP; Albrecht, PJ; Hou, QZ; Mongin, AA; Strichartz, GR; Rice, FL				Barr, Travis P.; Albrecht, Phillip J.; Hou, Quanzhi; Mongin, Alexander A.; Strichartz, Gary R.; Rice, Frank L.			Air-Stimulated ATP Release from Keratinocytes Occurs through Connexin Hemichannels	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; P2X(3)/P2X(2/3) RECEPTOR ANTAGONIST; HUMAN SKIN; GLUTAMATE RELEASE; NEUROPATHIC PAIN; INFLAMMATORY MEDIATORS; INTRACELLULAR CALCIUM; PURINERGIC RECEPTORS; BARRIER DISRUPTION; MOUSE ASTROCYTES	Cutaneous ATP release plays an important role in both epidermal stratification and chronic pain, but little is known about ATP release mechanisms in keratinocytes that comprise the epidermis. In this study, we analyzed ATP release from cultured human neonatal keratinocytes briefly exposed to air, a process previously demonstrated to trigger ATP release from these cells. We show that exposing keratinocytes to air by removing media for 15 seconds causes a robust, long-lasting ATP release. This air-stimulated ATP release was increased in calcium differentiated cultures which showed a corresponding increase in connexin 43 mRNA, a major component of keratinocyte hemichannels. The known connexin hemichannel inhibitors 1-octanol and carbenoxolone both significantly reduced air-stimulated ATP release, as did two drugs traditionally used as ABC transporter inhibitors (glibenclamide and verapamil). These same 4 inhibitors also prevented an increase in the uptake of a connexin permeable dye induced by air exposure, confirming that connexin hemichannels are open during air-stimulated ATP release. In contrast, activity of the MDR1 ABC transporter was reduced by air exposure and the drugs that inhibited air-stimulated ATP release had differential effects on this transporter. These results indicate that air exposure elicits non-vesicular release of ATP from keratinocytes through connexin hemichannels and that drugs used to target connexin hemichannels and ABC transporters may cross-inhibit. Connexins represent a novel, peripheral target for the treatment of chronic pain and dermatological disease.	[Barr, Travis P.; Strichartz, Gary R.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Pain Res Ctr, Boston, MA 02115 USA; [Albrecht, Phillip J.; Hou, Quanzhi; Mongin, Alexander A.; Rice, Frank L.] Albany Med Coll, Ctr Neurosci & Neuropharmacol, Albany, NY 12208 USA; [Strichartz, Gary R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Albany Medical College; Harvard University; Harvard Medical School	Rice, FL (corresponding author), Albany Med Coll, Ctr Neurosci & Neuropharmacol, Albany, NY 12208 USA.	ricef@mail.amc.edu	Albrecht, Phillip J./AAC-6144-2021; Mongin, Alexander A./A-5526-2008	Mongin, Alexander A./0000-0002-2501-3778	Rosenblatt Fund for Neurofibromytosis Research; United States Public Health Service [R-01 CA080153]; NATIONAL CANCER INSTITUTE [R01CA080153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061953] Funding Source: NIH RePORTER	Rosenblatt Fund for Neurofibromytosis Research; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded in part by the Rosenblatt Fund for Neurofibromytosis Research (to FLR) and United States Public Health Service grant R-01 CA080153 (to GRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Azorin N, 2011, EXP DERMATOL, V20, P401, DOI 10.1111/j.1600-0625.2010.01219.x; Ballerini P, 2002, NEUROREPORT, V13, P1789, DOI 10.1097/00001756-200210070-00019; Bao L, 2004, AM J PHYSIOL-CELL PH, V287, pC1389, DOI 10.1152/ajpcell.00220.2004; Barclay J, 2002, J NEUROSCI, V22, P8139; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Burrell HE, 2005, J BIOL CHEM, V280, P29667, DOI 10.1074/jbc.M505381200; Cao C, 2007, J CELL PHYSIOL, V212, P252, DOI 10.1002/jcp.21026; Celetti SJ, 2010, J CELL SCI, V123, P1363, DOI 10.1242/jcs.056093; Chen Y, 2005, PAIN, V119, P38, DOI 10.1016/j.pain.2005.09.007; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; Denda M, 2006, EXP DERMATOL, V15, P455, DOI 10.1111/j.0906-6705.2006.00430.x; Denda M, 2002, J INVEST DERMATOL, V119, P1034, DOI 10.1046/j.1523-1747.2002.19505.x; Denda M, 1998, J INVEST DERMATOL, V111, P873, DOI 10.1046/j.1523-1747.1998.00364.x; Denda M, 1998, J INVEST DERMATOL, V111, P858, DOI 10.1046/j.1523-1747.1998.00333.x; Denda M, 2007, SKIN RES TECHNOL, V13, P195, DOI 10.1111/j.1600-0846.2007.00210.x; Denda M, 2007, EXP DERMATOL, V16, P157, DOI 10.1111/j.1600-0625.2006.00529.x; Djalilian AR, 2006, J CLIN INVEST, V116, P1243, DOI 10.1172/JCI27186; Dussor G, 2009, BRAIN RES REV, V60, P24, DOI 10.1016/j.brainresrev.2008.12.013; Fan HT, 2001, BRIT J PHARMACOL, V133, P1096, DOI 10.1038/sj.bjp.0704159; Gangatirkar P, 2007, NAT PROTOC, V2, P178, DOI 10.1038/nprot.2006.448; GOLIGER JA, 1994, DEV DYNAM, V200, P1, DOI 10.1002/aja.1002000102; Golstein PE, 1999, PFLUG ARCH EUR J PHY, V437, P652, DOI 10.1007/s004240050829; Greig AVH, 2003, J INVEST DERMATOL, V120, P1007, DOI 10.1046/j.1523-1747.2003.12261.x; Hamilton SG, 2000, BRAIN, V123, P1238, DOI 10.1093/brain/123.6.1238; Hamilton SG, 1999, BRIT J PHARMACOL, V126, P326, DOI 10.1038/sj.bjp.0702258; Hanstein Regina, 2010, Open Pain J, V3, P123; Henry PD, 1979, PRACTICAL CARDIOL, V5, P145; Honore P, 2002, PAIN, V99, P11, DOI 10.1016/S0304-3959(02)00032-5; Hou Q, 2011, PAIN; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Khodorova A, 2003, NAT MED, V9, P1055, DOI 10.1038/nm885; Kielar D, 2003, J INVEST DERMATOL, V121, P465, DOI 10.1046/j.1523-1747.2003.12404.x; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Lee H, 2005, PFLUG ARCH EUR J PHY, V451, P160, DOI 10.1007/s00424-005-1438-y; Liu HT, 2008, CELL RES, V18, P558, DOI 10.1038/cr.2008.49; Liu HT, 2006, GLIA, V54, P343, DOI 10.1002/glia.20400; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; Malin SA, 2008, PAIN, V138, P484, DOI 10.1016/j.pain.2008.01.026; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; McGaraughty S, 2003, BRIT J PHARMACOL, V140, P1381, DOI 10.1038/sj.bjp.0705574; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Paukert M, 2001, J BIOL CHEM, V276, P21077, DOI 10.1074/jbc.M101465200; PILLAI S, 1992, J CLIN INVEST, V90, P42, DOI 10.1172/JCI115854; Roman RM, 2001, J MEMBRANE BIOL, V183, P165, DOI 10.1007/s00232-001-0064-7; SALOMON D, 1994, J INVEST DERMATOL, V103, P240, DOI 10.1111/1523-1747.ep12393218; Scheckenbach K. L., 2010, AM J RESP CELL MOL B; SCHMIDANTOMARCHI H, 1987, BIOCHEM BIOPH RES CO, V146, P21, DOI 10.1016/0006-291X(87)90684-X; SHEPPARD DN, 1992, J GEN PHYSIOL, V100, P573, DOI 10.1085/jgp.100.4.573; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Simpson CL, 2010, METHODS MOL BIOL, V585, P127, DOI 10.1007/978-1-60761-380-0_10; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Wu G, 2004, EUR J PHARMACOL, V504, P45, DOI 10.1016/j.ejphar.2004.09.056; Xu GY, 2002, J NEUROSCI, V22, P93, DOI 10.1523/JNEUROSCI.22-01-00093.2002; Yamamura H, 2008, BIOCHEM BIOPH RES CO, V373, P155, DOI 10.1016/j.bbrc.2008.06.008; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zhao P, 2008, PAIN, V139, P90, DOI 10.1016/j.pain.2008.03.016; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	64	39	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56744	10.1371/journal.pone.0056744	http://dx.doi.org/10.1371/journal.pone.0056744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457608	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700076
J	Serriere, J; Fenel, D; Schoehn, G; Gouet, P; Guillon, C				Serriere, Jennifer; Fenel, Daphna; Schoehn, Guy; Gouet, Patrice; Guillon, Christophe			Biophysical Characterization of the Feline Immunodeficiency Virus p24 Capsid Protein Conformation and In Vitro Capsid Assembly	PLOS ONE			English	Article							ROUS-SARCOMA-VIRUS; C-TERMINAL DOMAIN; DIMERIZATION DOMAIN; ELECTRON-MICROSCOPY; PEPTIDE INHIBITOR; SELF-ASSOCIATION; HIV-1CA PROTEIN; TYPE-1; CORE; PARTICLES	The Feline Immunodeficiency Virus (FIV) capsid protein p24 oligomerizes to form a closed capsid that protects the viral genome. Because of its crucial role in the virion, FIV p24 is an interesting target for the development of therapeutic strategies, although little is known about its structure and assembly. We defined and optimized a protocol to overexpress recombinant FIV capsid protein in a bacterial system. Circular dichroism and isothermal titration calorimetry experiments showed that the structure of the purified FIV p24 protein was comprised mainly of alpha-helices. Dynamic light scattering (DLS) and cross-linking experiments demonstrated that p24 was monomeric at low concentration and dimeric at high concentration. We developed a protocol for the in vitro assembly of the FIV capsid. As with HIV, an increased ionic strength resulted in FIV p24 assembly in vitro. Assembly appeared to be dependent on temperature, salt concentration, and protein concentration. The FIV p24 assembly kinetics was monitored by DLS. A limit end-point diameter suggested assembly into objects of definite shapes. This was confirmed by electron microscopy, where FIV p24 assembled into spherical particles. Comparison of FIV p24 with other retroviral capsid proteins showed that FIV assembly is particular and requires further specific study.	[Serriere, Jennifer; Gouet, Patrice; Guillon, Christophe] Univ Lyon, Lab Biocristallog & Biol Struct Cibles Therapeut, IBCP, SFR BioSci Gerland Lyon Sud,BMSSI,CNRS,UMR 5086, Lyon, France; [Fenel, Daphna; Schoehn, Guy] CEA, Inst Biol Struct Jean Pierre Ebel, UMR 5075, Grenoble, France; [Fenel, Daphna; Schoehn, Guy] CNRS, Inst Biol Struct Jean Pierre Ebel, UMR 5075, Grenoble, France; [Fenel, Daphna; Schoehn, Guy] Univ Grenoble 1, Inst Biol Struct Jean Pierre Ebel, UMR 5075, Grenoble, France; [Schoehn, Guy] UJF, Unit Virus Host Cell Interact, UMI 3265, CNRS,EMBL, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Guillon, C (corresponding author), Univ Lyon, Lab Biocristallog & Biol Struct Cibles Therapeut, IBCP, SFR BioSci Gerland Lyon Sud,BMSSI,CNRS,UMR 5086, Lyon, France.	christophe.guillon@ibcp.fr	Guillon, Christophe/A-4084-2015	Guillon, Christophe/0000-0001-6378-3303; Schoehn, Guy/0000-0002-1459-3201; gouet, patrice/0000-0001-9485-6157	Agence Nationale de Recherche sur le SIDA; Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale de Recherche sur le SIDA(ANRSFrench National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche	This project was supported by the Agence Nationale de Recherche sur le SIDA. J.S. was the recipient of a grant from the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurahman S, 2008, ANTIMICROB AGENTS CH, V52, P3737, DOI 10.1128/AAC.00265-08; Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Affranchino JL, 2010, VIRUS RES, V150, P153, DOI 10.1016/j.virusres.2010.03.012; Bailey GD, 2009, STRUCTURE, V17, P737, DOI 10.1016/j.str.2009.03.010; Barklis E, 2009, J MOL BIOL, V387, P376, DOI 10.1016/j.jmb.2009.01.058; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; BENDINELLI M, 1995, CLIN MICROBIOL REV, V8, P87, DOI 10.1128/CMR.8.1.87; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Bharat T.A.M., 2012, NATURE; Bhattacharya S, 2008, J BIOL CHEM, V283, P16274, DOI 10.1074/jbc.C800048200; Bocanegra R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023877; Briggs JAG, 2006, STRUCTURE, V14, P15, DOI 10.1016/j.str.2005.09.010; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Campbell S, 1999, J VIROL, V73, P2270, DOI 10.1128/JVI.73.3.2270-2279.1999; CAMPBELL S, 1995, J VIROL, V69, P6487, DOI 10.1128/JVI.69.10.6487-6497.1995; Chen B, 2010, PROTEIN SCI, V19, P716, DOI 10.1002/pro.348; Cortines JR, 2011, J MOL BIOL, V410, P641, DOI 10.1016/j.jmb.2011.03.052; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; Dickson C, 1984, MOL BIOL TUMOR VIRUS, P513; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Ehrlich LS, 2001, BIOPHYS J, V81, P586, DOI 10.1016/S0006-3495(01)75725-6; Fuller SD, 1997, CURR BIOL, V7, P729, DOI 10.1016/S0960-9822(06)00331-9; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2012, ADV EXP MED BIOL, V726, P441, DOI 10.1007/978-1-4614-0980-9_20; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Garzon MT, 2004, PROTEIN SCI, V13, P1512, DOI 10.1110/ps.03555304; GELDERBLOM HR, 1987, VIROLOGY, V156, P171, DOI 10.1016/0042-6822(87)90449-1; Grattinger M, 1999, VIROLOGY, V257, P247, DOI 10.1006/viro.1999.9668; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Gross I, 2000, EMBO J, V19, P103, DOI 10.1093/emboj/19.1.103; Hoglund S, 2002, ANTIMICROB AGENTS CH, V46, P3597, DOI 10.1128/AAC.46.11.3597-3605.2002; Hyun JK, 2010, J BIOL CHEM, V285, P15056, DOI 10.1074/jbc.M110.108209; Kelly BN, 2007, J MOL BIOL, V373, P355, DOI 10.1016/j.jmb.2007.07.070; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Krausslich HG, 1996, CURR TOP MICROBIOL, V214, P25; Lanman J, 2002, J VIROL, V76, P6900, DOI 10.1128/JVI.76.14.6900-6908.2002; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Manrique ML, 2001, VIRUS RES, V76, P103, DOI 10.1016/S0168-1702(01)00249-0; Mayo K, 2003, J MOL BIOL, V325, P225, DOI 10.1016/S0022-2836(02)01176-2; Monaco-Malbet S, 2000, STRUCTURE, V8, P1069, DOI 10.1016/S0969-2126(00)00507-4; NERMUT MV, 1994, VIROLOGY, V198, P288, DOI 10.1006/viro.1994.1032; NIEDRIG M, 1994, J GEN VIROL, V75, P1469, DOI 10.1099/0022-1317-75-6-1469; Purdy JG, 2008, J VIROL, V82, P5951, DOI 10.1128/JVI.00214-08; Purdy JG, 2009, J MOL BIOL, V389, P438, DOI 10.1016/j.jmb.2009.04.006; REICIN AS, 1995, J VIROL, V69, P642, DOI 10.1128/JVI.69.2.642-650.1995; ROSE S, 1992, PROTEINS, V13, P112, DOI 10.1002/prot.340130204; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Vogt V. M., 1997, P27; Vogt VM, 1999, J VIROL, V73, P7050, DOI 10.1128/JVI.73.8.7050-7055.1999; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wilk T, 2001, J VIROL, V75, P759, DOI 10.1128/JVI.75.2.759-771.2001; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Willett BJ, 1997, IMMUNOL TODAY, V18, P182, DOI 10.1016/S0167-5699(97)84665-8; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Yelamos B, 1999, EUR J BIOCHEM, V266, P1081, DOI 10.1046/j.1432-1327.1999.00952.x; Zhang H, 2008, J MOL BIOL, V378, P565, DOI 10.1016/j.jmb.2008.02.066; Zhang YQ, 1998, J VIROL, V72, P1782, DOI 10.1128/JVI.72.3.1782-1789.1998	65	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56424	10.1371/journal.pone.0056424	http://dx.doi.org/10.1371/journal.pone.0056424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457565	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700052
J	Sun, Z; Zou, L; Zhang, JJ; Mo, SN; Shao, SS; Zhong, R; Ke, JT; Lu, XZ; Miao, XP; Song, RR				Sun, Zhao; Zou, Li; Zhang, Jiajia; Mo, Shengnan; Shao, Shanshan; Zhong, Rong; Ke, Juntao; Lu, Xuzai; Miao, Xiaoping; Song, Ranran			Prevalence and Associated Risk Factors of Dyslexic Children in a Middle-Sized City of China: A Cross-Sectional Study	PLOS ONE			English	Article							READING-DISABILITY; DEVELOPMENTAL DYSLEXIA; DEFICIT HYPOTHESIS; DIFFICULTIES; BEHAVIOR	Background: There are many discussions about dyslexia based on studies conducted in western countries, and some risk factors to dyslexia, such as gender and home literacy environment, have been widely accepted based on these studies. However, to our knowledge, there are few studies focusing on the risk factors of dyslexia in China. Therefore, the aim of our study was to investigate the prevalence of dyslexia and its potential risk factors. Methods: A cross-sectional study was conducted in Qianjiang, a city in Hubei province, China. Two stages sampling strategy was applied to randomly selected 5 districts and 9 primary schools in Qianjiang. In total, 6,350 students participated in this study and there were 5,063 valid student questionnaires obtained for the final analyses. Additional questionnaires (such as Dyslexia Checklist for Chinese Children and Pupil Rating Scale) were used to identify dyslexic children. The chi-square test and multivariate logistic regression were employed to reveal the potential risk factors to dyslexia. Results: Our study revealed that the prevalence of dyslexia was 3.9% in Qianjiang city, which is a middle-sized city in China. Among dyslexic children, the gender ratio (boys to girls) was nearly 3:1. According to the P-value in the multivariate logistic regression, the gender (P<0.01), mother's education level (P<0.01), and learning habits (P<0.01) (active learning, scheduled reading time) were associated with dyslexia. Conclusion: The prevalence rate of dyslexic children in middle-sized cities is 3.9%. The potential risk factors of dyslexic children revealed in this study will have a great impact on detecting and treating dyslexic children in China as early as possible, although more studies are still needed to further investigate the risk factors of dyslexic children in China.	[Sun, Zhao; Zou, Li; Shao, Shanshan; Song, Ranran] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, Wuhan 430074, Peoples R China; [Zou, Li; Zhong, Rong; Ke, Juntao; Lu, Xuzai; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Zou, Li; Zhong, Rong; Ke, Juntao; Lu, Xuzai; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Zhang, Jiajia] Univ S Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Mo, Shengnan] Wuhan Univ, Renmin Hosp, Adm Off, Wuhan 430072, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Wuhan University	Song, RR (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, Wuhan 430074, Peoples R China.	ranransong@gmail.com	Song, Ranran/Z-3997-2019; Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	Song, Ranran/0000-0002-8354-7698; miao, xiaoping/0000-0002-6818-9722	National Natural Science Foundation of China [81273092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China, Project No. 81273092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badian NA, 1999, J LEARN DISABIL, V32, P138, DOI 10.1177/002221949903200204; Beitchman JH, 1996, J AM ACAD CHILD PSY, V35, P815, DOI 10.1097/00004583-199606000-00022; CASEY R, 1992, J DEV BEHAV PEDIATR, V13, P256; DEFRIES JC, 1989, J LEARN DISABIL-US, V22, P544, DOI 10.1177/002221948902200905; Donfrancesco R, 2010, ANN DYSLEXIA, V60, P175, DOI 10.1007/s11881-010-0037-6; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Heiervang E, 2001, NORD J PSYCHIAT, V55, P251; Ho CSH, 2007, J EXP CHILD PSYCHOL, V97, P61, DOI 10.1016/j.jecp.2007.01.002; Ho CSH, 2000, READ WRIT, V13, P57, DOI 10.1023/A:1008040922662; Ho CSH, 2004, COGNITION, V91, P43, DOI 10.1016/S0010-0277(03)00163-X; Ho CSH, 2002, DEV PSYCHOL, V38, P543, DOI 10.1037//0012-1649.38.4.543; Jin H, 2009, J S CHINA NORMAL U, V5, P39; Katusic SK, 2001, MAYO CLIN PROC, V76, P1081, DOI 10.4065/76.11.1081; Kempe C, 2011, SCAND J PSYCHOL, V52, P242, DOI 10.1111/j.1467-9450.2011.00870.x; Lyytinen P, 2003, J LEARN DISABIL-US, V36, P74, DOI 10.1177/00222194030360010901; Maughan B, 2003, J ABNORM CHILD PSYCH, V31, P219, DOI 10.1023/A:1022534527021; McBride-Chang C, 2011, J CHILD PSYCHOL PSYC, V52, P204, DOI 10.1111/j.1469-7610.2010.02299.x; Meng XZ, 2007, BRAIN RES, V1179, P119, DOI 10.1016/j.brainres.2007.08.046; Morgan PL, 2008, J LEARN DISABIL-US, V41, P387, DOI 10.1177/0022219408321112; National Bureau of Statistics of China, 2011, CHIN CIT STAT YB; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; Normand MT, 2008, CLIN LINGUIST PHONET, V22, P47; Rashid FL, 2005, J LEARN DISABIL-US, V38, P2, DOI 10.1177/00222194050380010101; Rutter M, 2004, JAMA-J AM MED ASSOC, V291, P2007, DOI 10.1001/jama.291.16.2007; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Shu H, 2006, J EDUC PSYCHOL, V98, P122, DOI 10.1037/0022-0663.98.1.122; Shu H., 2003, READING DEV CHINESE, P199; Siok WT, 2008, P NATL ACAD SCI USA, V105, P5561, DOI 10.1073/pnas.0801750105; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; STEVENSON HW, 1982, CHILD DEV, V53, P1164, DOI 10.2307/1129005; Undheim AM, 2008, SCAND J PSYCHOL, V49, P377, DOI 10.1111/j.1467-9450.2008.00661.x; Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368; Zhang C., 1996, J PSYCHOL SCI, V19, P222	34	36	39	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56688	10.1371/journal.pone.0056688	http://dx.doi.org/10.1371/journal.pone.0056688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457604	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700073
J	Dobrovolny, HM; Reddy, MB; Kamal, MA; Rayner, CR; Beauchemin, CAA				Dobrovolny, Hana M.; Reddy, Micaela B.; Kamal, Mohamed A.; Rayner, Craig R.; Beauchemin, Catherine A. A.			Assessing Mathematical Models of Influenza Infections Using Features of the Immune Response	PLOS ONE			English	Article							A VIRUS-INFECTION; CYTOTOXIC T-CELLS; DYNAMICS IN-VIVO; OSELTAMIVIR-RESISTANT; PANDEMIC INFLUENZA; H1N1 VIRUS; IMMUNOCOMPROMISED PATIENTS; NEURAMINIDASE INHIBITORS; NEUTRALIZING ANTIBODY; TARGETED DISRUPTION	The role of the host immune response in determining the severity and duration of an influenza infection is still unclear. In order to identify severity factors and more accurately predict the course of an influenza infection within a human host, an understanding of the impact of host factors on the infection process is required. Despite the lack of sufficiently diverse experimental data describing the time course of the various immune response components, published mathematical models were constructed from limited human or animal data using various strategies and simplifying assumptions. To assess the validity of these models, we assemble previously published experimental data of the dynamics and role of cytotoxic T lymphocytes, antibodies, and interferon and determined qualitative key features of their effect that should be captured by mathematical models. We test these existing models by confronting them with experimental data and find that no single model agrees completely with the variety of influenza viral kinetics responses observed experimentally when various immune response components are suppressed. Our analysis highlights the strong and weak points of each mathematical model and highlights areas where additional experimental data could elucidate specific mechanisms, constrain model design, and complete our understanding of the immune response to influenza.	[Dobrovolny, Hana M.] Texas Christian Univ, Dept Phys & Astron, Ft Worth, TX 76129 USA; [Reddy, Micaela B.; Kamal, Mohamed A.] F Hoffmann La Roche Inc, Nutley, NJ USA; [Rayner, Craig R.] Roche Prod Pty Ltd, Melbourne, Vic, Australia; [Rayner, Craig R.] Monash Univ, Fac Pharm & Pharmaceut Sci, Melbourne, Vic 3004, Australia; [Dobrovolny, Hana M.; Beauchemin, Catherine A. A.] Ryerson Univ, Dept Phys, Toronto, ON, Canada	Texas Christian University; Roche Holding; Monash University; Toronto Metropolitan University	Beauchemin, CAA (corresponding author), Ryerson Univ, Dept Phys, Toronto, ON, Canada.	cbeau@ryerson.ca	Dobrovolny, Hana M./A-2447-2013; Beauchemin, Catherine AA/G-4619-2011; Kamal, Mohammad Amjad/J-2918-2014	Dobrovolny, Hana M./0000-0003-3592-6770; Beauchemin, Catherine AA/0000-0003-0599-0069; Kamal, Mohammad Amjad/0000-0003-0088-0565	Natural Sciences and Engineering Research Council of Canada; F. Hoffmann-La Roche Ltd.; F. Hoffmann-La Roche Ltd	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); F. Hoffmann-La Roche Ltd(Hoffmann-La Roche)	This work was supported in part by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (CAAB), with additional support provided by F. Hoffmann-La Roche Ltd. The project was developed jointly by F. Hoffmann-La Roche Ltd and CAAB's research group. However, F. Hoffmann-La Roche Ltd had no role in data collection and analysis. F. Hoffmann-La Roche Ltd was involved in the decision to publish and in the preparation of the manuscript.; MBR, MAK & CRR are employed by the pharmaceutical company F. Hoffmann-La Roche Ltd. CAAB received a consultancy fee as part of a research contract with F. Hoffmann-La Roche Ltd, while HMD was supported in part by the research contract between CAAB and F. Hoffmann-La Roche Ltd. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abed Y, 2002, J INFECT DIS, V186, P1074, DOI 10.1086/344237; Agrati C, 2010, J INFECT DIS, V202, P681, DOI 10.1086/655469; Anton A, 2010, DIAGN MICR INFEC DIS, V68, P214, DOI 10.1016/j.diagmicrobio.2010.08.003; Azambuja MI, 2010, MED HYPOTHESES, V74, P681, DOI 10.1016/j.mehy.2009.10.050; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; BAGLIONI C, 1981, AM SCI, V69, P392; BAGLIONI C, 1979, CELL, V17, P255, DOI 10.1016/0092-8674(79)90151-X; Bal A, 2012, HISTOPATHOLOGY, V60, P326, DOI 10.1111/j.1365-2559.2011.04081.x; Balci O., 1994, ANN OPER RES, V53, P121, DOI [10.1007/BF02136828, https://doi.org/10.1007/BF02136828, DOI 10.1007/BF02136828]; BARBER WH, 1978, INFECT IMMUN, V21, P221, DOI 10.1128/IAI.21.1.221-228.1978; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Beauchemin C, 2005, J THEOR BIOL, V232, P223, DOI 10.1016/j.jtbi.2004.08.001; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; BOCHAROV GA, 1994, J THEOR BIOL, V167, P323, DOI 10.1006/jtbi.1994.1074; Boivin G, 2002, CLIN INFECT DIS, V34, pE23, DOI 10.1086/338870; CALLARD RE, 1990, IMMUNOL TODAY, V11, P200, DOI 10.1016/0167-5699(90)90082-K; Campanini G, 2010, J CLIN VIROL, V48, P220, DOI 10.1016/j.jcv.2010.03.027; Canini L, 2011, J VIROL, V85, P2764, DOI 10.1128/JVI.01318-10; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chang DB, 2007, J THEOR BIOL, V246, P621, DOI 10.1016/j.jtbi.2007.02.004; Cohen-Daniel L, 2009, J CLIN VIROL, V44, P138, DOI 10.1016/j.jcv.2008.11.014; Couturier BA, 2010, INFLUENZA OTHER RESP, V4, P199, DOI 10.1111/j.1750-2659.2010.00144.x; Craver CF, 2006, SYNTHESE, V153, P355, DOI 10.1007/s11229-006-9097-x; Dobrovolny HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013811; Dobrovolny HM, 2011, J THEOR BIOL, V269, P234, DOI 10.1016/j.jtbi.2010.10.017; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; EATON JW, 2008, GNU OCTAVE VERSION 3; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Epperson S., 2008, Morbidity and Mortality Weekly Report, V57, P692; EPSTEIN LB, 1974, J IMMUNOL, V112, P617; EVANS KD, 1995, PEDIATR INFECT DIS J, V14, P332, DOI 10.1097/00006454-199504000-00022; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FRANKOVA V, 1977, ARCH VIROL, V53, P265, DOI 10.1007/BF01314671; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Frolov A F, 1984, J Hyg Epidemiol Microbiol Immunol, V29, P303; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Gentile DA, 2001, ANN ALLERG ASTHMA IM, V87, P496, DOI 10.1016/S1081-1206(10)62263-6; Ghattas C, 2012, TRANSPL INFECT DIS, V14, pE41, DOI 10.1111/j.1399-3062.2012.00766.x; GIOVANELLA BC, 1984, METHOD ENZYMOL, V108, P348; Gooskens J, 2009, J INFECT DIS, V199, P1435, DOI 10.1086/598684; GRAY PW, 1982, NATURE, V298, P859, DOI 10.1038/298859a0; Groesser SN, 2012, SYST DYNAM REV, V28, P157, DOI 10.1002/sdr.1466; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Haley PJ, 2003, TOXICOLOGY, V188, P49, DOI 10.1016/S0300-483X(03)00043-X; Hancioglu B, 2007, J THEOR BIOL, V246, P70, DOI 10.1016/j.jtbi.2006.12.015; Handel A, 2007, PLOS COMPUT BIOL, V3, P2456, DOI 10.1371/journal.pcbi.0030240; Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067; Handel A, 2009, J THEOR BIOL, V256, P117, DOI 10.1016/j.jtbi.2008.09.021; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hill-Cawthorne GA, 2010, EMERG INFECT DIS, V16, P1185, DOI 10.3201/eid1607.091579; HOLFORD NHG, 1981, CLIN PHARMACOKINET, V6, P429, DOI 10.2165/00003088-198106060-00002; HOSHINO A, 1983, ANTIVIR RES, V3, P59, DOI 10.1016/0166-3542(83)90015-3; HOUGLUM JE, 1983, CLIN PHARMACY, V2, P20; Hsieh SM, 2006, J IMMUNOL, V176, P4530, DOI 10.4049/jimmunol.176.8.4530; Hung IFN, 2011, CLIN INFECT DIS, V52, P447, DOI 10.1093/cid/ciq106; Hung IFN, 2010, CLIN INFECT DIS, V51, P274, DOI 10.1086/653940; Ison MG, 2006, J INFECT DIS, V193, P760, DOI 10.1086/500465; IWASAKI T, 1977, J IMMUNOL, V118, P256; KLIMOV AI, 1995, J INFECT DIS, V172, P1352, DOI 10.1093/infdis/172.5.1352; Koerner I, 2012, J GEN VIROL, V93, P970, DOI 10.1099/vir.0.035782-0; KRIS RM, 1988, IMMUNOLOGY, V63, P349; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Lawrence BP, 2000, J TOXICOL ENV HEAL A, V61, P39, DOI 10.1080/00984100050116771; Lee HY, 2009, J VIROL, V83, P7151, DOI 10.1128/JVI.00098-09; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Mbawuike IN, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-44; MCLAREN C, 1978, INFECT IMMUN, V22, P189, DOI 10.1128/IAI.22.1.189-194.1978; Mehta T, 2010, J CLIN MICROBIOL, V48, P4326, DOI 10.1128/JCM.01190-10; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MERLIN G, 1985, J GEN VIROL, V66, P1149, DOI 10.1099/0022-1317-66-5-1149; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Mitchell H, 2011, J VIROL, V85, P1125, DOI 10.1128/JVI.01722-10; Mitchell M, ENGAUGE DIGITIZER FR; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Narang V, 2012, IMMUNOL RES, V53, P251, DOI 10.1007/s12026-012-8305-7; Narasaraju T, 2009, MICROBES INFECT, V11, P2, DOI 10.1016/j.micinf.2008.09.013; Neff-LaFord HD, 2003, CELL IMMUNOL, V226, P54, DOI 10.1016/j.cellimm.2003.11.005; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; PANTELOURIS EM, 1976, J GEN VIROL, V32, P149, DOI 10.1099/0022-1317-32-1-149; Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pinsky BA, 2010, EMERG INFECT DIS, V16, P1165, DOI 10.3201/eid1607.091248; POSSEE RD, 1982, J GEN VIROL, V58, P373, DOI 10.1099/0022-1317-58-2-373; Renaud C, 2011, EMERG INFECT DIS, V17, P653, DOI 10.3201/eid1704.101429; RENEGAR KB, 1992, LAB ANIM SCI, V42, P222; Robinson S, 2008, J OPER RES SOC, V59, P278, DOI 10.1057/palgrave.jors.2602368; Rogge L, 1998, J IMMUNOL, V161, P6567; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Staeheli P, 1987, Interferon, V8, P1; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; Tamura SI, 2005, JPN J INFECT DIS, V58, P195; TAYLOR HP, 1985, J GEN VIROL, V66, P903, DOI 10.1099/0022-1317-66-4-903; TAYLOR HP, 1985, J EXP MED, V161, P198, DOI 10.1084/jem.161.1.198; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Tridane A, 2010, MATH BIOSCI ENG, V7, P171, DOI 10.3934/mbe.2010.7.171; TSANG CF, 1991, GROUND WATER, V29, P825, DOI 10.1111/j.1745-6584.1991.tb00568.x; Vahlenkamp TW, 2006, BERL MUNCH TIERARZTL, V119, P123; van der Vries E, 2008, NEW ENGL J MED, V359, P1074, DOI 10.1056/NEJMc0803120; WALDMAN RH, 1968, J IMMUNOL, V100, P80; Weinstock DM, 2003, NEW ENGL J MED, V348, P867, DOI 10.1056/NEJM200302273480923; WELLS MA, 1981, J IMMUNOL, V126, P1036; Wu R, 2009, VET MICROBIOL, V138, P85, DOI 10.1016/j.vetmic.2009.03.010; YAP KL, 1979, CELL IMMUNOL, V43, P341, DOI 10.1016/0008-8749(79)90178-3; YAP KL, 1978, SCAND J IMMUNOL, V7, P73, DOI 10.1111/j.1365-3083.1978.tb00428.x; ZAHRADNIK JM, 1983, J MED VIROL, V11, P277, DOI 10.1002/jmv.1890110403; ZWEERINK HJ, 1977, NATURE, V267, P354, DOI 10.1038/267354a0	118	68	69	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57088	10.1371/journal.pone.0057088	http://dx.doi.org/10.1371/journal.pone.0057088			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468916	Green Published, gold			2022-12-27	WOS:000315524900051
J	Friedrichsen, M; Poulsen, P; Wojtaszewski, J; Hansen, PR; Vaag, A; Rasmussen, HB				Friedrichsen, Martin; Poulsen, Pernille; Wojtaszewski, Jorgen; Hansen, Peter Riis; Vaag, Allan; Rasmussen, Henrik Berg			Carboxylesterase 1 Gene Duplication and mRNA Expression in Adipose Tissue are Linked to Obesity and Metabolic Function	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; FATTY-ACIDS; RISK; CES1; HERITABILITY; ASSOCIATION; LIPASES; PROFILE; HEALTH	Context and aims: Carboxylesterase 1 (CES1) appears to play an important role in the control of the metabolism of triglycerides and cholesterol in adipocytes and other cell types including hepatocytes. Therefore, it is relevant to gain insights into the genetic versus non-genetic mechanisms involved in the control of CES1 mRNA expression. Here, we investigated CES1 mRNA expression level in adipose tissue and its association with measures of adiposity and metabolic function in a population of elderly twins. Furthermore, the heritability of CES1 mRNA expression level in adipose tissue and the effect of CES1 gene duplication were assessed. Methodology: A total of 295 monozygotic and dizygotic twin subjects (62-83 years) with (n = 48) or without (n = 247) type 2 diabetes mellitus were enrolled in the study. They were subjected to a standard oral glucose tolerance test and excision of abdominal subcutaneous fat biopsies during the fasting state. Levels of CES1 mRNA and copy number of the gene were assessed by quantitative PCR. Results: CES1 mRNA expression level in adipose tissue was positively associated with body-mass index (P < 0.001), homeostasis model assessment-insulin resistance (P = 0.003) and level of fasting glucose (P = 0.002), insulin (P = 0.006), and triglycerides (P = 0.003). The heritability for the expression of CES1 mRNA in adipose tissue was high. CES1 gene duplication was positively associated with insulin sensitivity (P = 0.05) as well as glucose tolerance (P = 0.03) and negatively associated with homeostasis model assessment-insulin resistance (P = 0.02). Duplication of CES1 was not linked to mRNA level of this gene (P = 0.63). Conclusion: CES1 mRNA in adipose tissue appears to be under strong genetic control and was associated with measures of metabolic function raising the possibility of a potential role of this enzyme in the development of type 2 diabetes mellitus. Further studies are needed to understand the potential effect of CES1 gene duplication on adipocyte and whole-body metabolic functions.	[Friedrichsen, Martin; Vaag, Allan] Rigshosp, Dept Diabet & Metab, DK-2100 Copenhagen, Denmark; [Friedrichsen, Martin; Wojtaszewski, Jorgen] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Poulsen, Pernille] Novo Nordisk AS, Global Dev, DK-2880 Bagsvaerd, Denmark; [Hansen, Peter Riis] Copenhagen Univ Hosp Gentofte, Dept Cardiol, Hellerup, Denmark; [Rasmussen, Henrik Berg] Copenhagen Univ Hosp, Mental Hlth Ctr Sct Hans, Res Inst Biol Psychiat, Roskilde, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Novo Nordisk; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Rasmussen, HB (corresponding author), Copenhagen Univ Hosp, Mental Hlth Ctr Sct Hans, Res Inst Biol Psychiat, Roskilde, Denmark.	henrik.berg.rasmussen@regionh.dk	Wojtaszewski, Jørgen FP/P-6583-2014; Hansen, Peter Riis/AAR-7659-2020	Wojtaszewski, Jørgen FP/0000-0001-9785-6830; Vaag, Allan Arthur/0000-0002-3690-2191; Hansen, Peter Riis/0000-0002-9056-535X; wojtaszewski, jorgen/0000-0001-8185-3408	Danish Council for Strategic Research, the Programme Commission on Individual and Society [10-092792/DSF]	Danish Council for Strategic Research, the Programme Commission on Individual and Society	The study was supported by grant no. 10-092792/DSF from the Danish Council for Strategic Research, the Programme Commission on Individual and Society (http://en.fi.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner P, 2007, CURR OPIN LIPIDOL, V18, P246, DOI 10.1097/MOL.0b013e32811e16fb; BECKER A, 1994, ARTERIOSCLER THROMB, V14, P1346, DOI 10.1161/01.ATV.14.8.1346; Bencharit S, 2006, J MOL BIOL, V363, P201, DOI 10.1016/j.jmb.2006.08.025; Blais DR, 2010, J BIOL CHEM, V285, P25602, DOI 10.1074/jbc.M110.135483; Boden G, 2003, EXP CLIN ENDOCR DIAB, V111, P121, DOI 10.1055/s-2003-39781; Bruxel EM, 2013, PHARMACOGENOMICS J, V13, P476, DOI 10.1038/tpj.2012.25; Chiefari E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1040; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Field AE, 2007, OBESITY, V15, P967, DOI 10.1038/oby.2007.616; Friedrichsen M, 2010, DIABETOLOGIA, V53, P1998, DOI 10.1007/s00125-010-1795-8; Fukami T, 2008, PHARMACOGENET GENOM, V18, P911, DOI 10.1097/FPC.0b013e32830b0c5e; Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108; Geshi E, 2005, HYPERTENS RES, V28, P719, DOI 10.1291/hypres.28.719; HAVEL RJ, 1972, NEW ENGL J MED, V287, P1186, DOI 10.1056/NEJM197212072872307; Jernas M, 2009, BIOCHEM BIOPH RES CO, V383, P63, DOI 10.1016/j.bbrc.2009.03.120; Lee HY, 2000, EUR J CLIN NUTR, V54, P768, DOI 10.1038/sj.ejcn.1601089; Lian J, 2012, HEPATOLOGY BALTIMORE, DOI [10.1002/hep.25881, DOI 10.1002/HEP.25881]; Marrades MP, 2010, OBESITY FACTS, V3, P312, DOI 10.1159/000321451; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mayer EJ, 1996, AM J EPIDEMIOL, V143, P323; Nagashima S, 2011, J ATHEROSCLER THROMB, V18, P190, DOI 10.5551/jat.6478; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Palsgaard J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006575; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Piehler AP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-165; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Poulsen P, 2005, DIABETES, V54, P275, DOI 10.2337/diabetes.54.1.275; Poulsen P, 1999, BRIT MED J, V319, P151, DOI 10.1136/bmj.319.7203.151; Poulsen P, 2009, DIABETES, V58, P1350, DOI 10.2337/db08-1714; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Quiroga AD, 2012, HEPATOLOGY, V56, P2188, DOI 10.1002/hep.25961; Quiroga AD, 2011, TRENDS ENDOCRIN MET, V22, P218, DOI 10.1016/j.tem.2011.03.003; Satoh T, 2006, CHEM-BIOL INTERACT, V162, P195, DOI 10.1016/j.cbi.2006.07.001; Siri-Tarino PW, 2010, CURR ATHEROSCLER REP, V12, P384, DOI 10.1007/s11883-010-0131-6; Tanimoto K, 2007, PHARMACOGENET GENOM, V17, P1, DOI 10.1097/01.fpc.0000230110.18957.50; Vaag A, 2007, CURR OPIN CLIN NUTR, V10, P591, DOI 10.1097/MCO.0b013e3282ab9ea6; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Watt MJ, 2008, BIOCHEM J, V414, P313, DOI 10.1042/BJ20080305; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; Wood AC, 2010, J AM ACAD CHILD PSY, V49, P874, DOI 10.1016/j.jaac.2010.06.006; Yamada S, 2010, PHARMACOGENOMICS J, V10, P524, DOI 10.1038/tpj.2010.5; Yang DF, 2009, BIOCHEM PHARMACOL, V77, P238, DOI 10.1016/j.bcp.2008.10.005; Yu BL, 2010, OBES REV, V11, P560, DOI 10.1111/j.1467-789X.2009.00699.x	45	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56861	10.1371/journal.pone.0056861	http://dx.doi.org/10.1371/journal.pone.0056861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468884	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900040
J	Gerhardt, C; Lier, JM; Kuschel, S; Ruther, U				Gerhardt, Christoph; Lier, Johanna M.; Kuschel, Stefanie; Ruether, Ulrich			The Ciliary Protein Ftm Is Required for Ventricular Wall and Septal Development	PLOS ONE			English	Article							PLANAR CELL POLARITY; BASAL BODY PROTEIN; PRIMARY CILIUM; INTERVENTRICULAR SEPTUM; HEART-DEFECTS; INTRAFLAGELLAR TRANSPORT; JOUBERT-SYNDROME; SONIC HEDGEHOG; MOUSE HEART; IN-SITU	Ventricular septal defects (VSDs) are the most common congenital heart defects in humans. Despite several studies of the molecular mechanisms involved in ventricular septum (VS) development, very little is known about VS-forming signaling. We observed perimembranous and muscular VSDs in Fantom (Ftm)-negative mice. Since Ftm is a ciliary protein, we investigated presence and function of cilia in murine hearts. Primary cilia could be detected at distinct positions in atria and ventricles at embryonic days (E) 10.5-12.5. The loss of Ftm leads to shortened cilia and a reduced proliferation in distinct atrial and ventricular ciliary regions at E11.5. Consequently, wall thickness is diminished in these areas. We suggest that ventricular proliferation is regulated by cilia-mediated Sonic hedgehog (Shh) and platelet-derived growth factor receptor alpha (Pdgfr alpha) signaling. Accordingly, we propose that primary cilia govern the cardiac proliferation which is essential for proper atrial and ventricular wall development and hence for the fully outgrowth of the VS. Thus, our study suggests ciliopathy as a cause of VSDs.	[Gerhardt, Christoph; Lier, Johanna M.; Kuschel, Stefanie; Ruether, Ulrich] Univ Dusseldorf, Inst Anim Dev & Mol Biol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Ruther, U (corresponding author), Univ Dusseldorf, Inst Anim Dev & Mol Biol, D-40225 Dusseldorf, Germany.	ruether@hhu.de	Gerhardt, Christoph/AAO-4596-2020	Gerhardt, Christoph/0000-0002-6340-549X	Deutsche Forschungsgemeinschaft [Sonderforschungsbereiche 590, 612]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereiche 590 and 612) to U. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Altaba ARI, 1999, NAT CELL BIOL, V1, pE147, DOI 10.1038/14099; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Besse L, 2011, DEVELOPMENT, V138, P2079, DOI 10.1242/dev.059808; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Christensen ST, 2008, CURR TOP DEV BIOL, V85, P261, DOI 10.1016/S0070-2153(08)00810-7; Clement CA, 2009, J CELL SCI, V122, P3070, DOI 10.1242/jcs.049676; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; D'Angelo Anna, 2009, Pathogenetics, V2, P3, DOI 10.1186/1755-8417-2-3; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Franco D, 2001, CARDIOVASC RES, V49, P417, DOI 10.1016/S0008-6363(00)00252-2; Franco D, 2006, DEV BIOL, V294, P366, DOI 10.1016/j.ydbio.2006.02.045; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Goddeeris MM, 2008, DEVELOPMENT, V135, P1887, DOI 10.1242/dev.016147; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GOOR DA, 1970, CHEST, V58, P453, DOI 10.1378/chest.58.5.453; HARH JY, 1975, J EMBRYOL EXP MORPH, V33, P13; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Henderson DJ, 1998, CIRC RES, V83, P523, DOI 10.1161/01.RES.83.5.523; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Icten N, 1996, SURG RADIOL ANAT, V18, P97, DOI 10.1007/BF01795226; Komatsu K, 2007, DEV BIOL, V303, P82, DOI 10.1016/j.ydbio.2006.10.037; Kovacs AH, 2005, AM HEART J, V150, P193, DOI 10.1016/j.ahj.2004.08.025; Lamers WH, 2002, CIRC RES, V91, P93, DOI 10.1161/01.RES.0000027135.63141.89; Lancaster MA, 2010, TRENDS MOL MED, V16, P349, DOI 10.1016/j.molmed.2010.05.004; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; MEREDITH MA, 1979, ANAT REC, V194, P417, DOI 10.1002/ar.1091940308; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Nilsson MB, 2010, ONCOGENE, V29, P2938, DOI 10.1038/onc.2010.60; PATTEN BM, 1964, HEART FDN EMBRYOLOGY, P545; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Richarte AM, 2007, DEV BIOL, V306, P785, DOI 10.1016/j.ydbio.2007.04.023; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; RYCHTER Z, 1979, HERZ, V4, P86; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Satir P, 2008, HISTOCHEM CELL BIOL, V129, P687, DOI 10.1007/s00418-008-0416-9; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schild C, 2009, MOL CARCINOGEN, V48, P1149, DOI 10.1002/mc.20569; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Scully BB, 2010, ANN THORAC SURG, V89, P544, DOI 10.1016/j.athoracsur.2009.10.057; Slough J, 2008, DEV DYNAM, V237, P2304, DOI 10.1002/dvdy.21669; Soufflet V, 2010, AM J CARDIOL, V105, P404, DOI 10.1016/j.amjcard.2009.09.047; STEDING G, 1980, THORAC CARDIOV SURG, V28, P386, DOI 10.1055/s-2007-1022440; Takeuchi JK, 2003, DEVELOPMENT, V130, P5953, DOI 10.1242/dev.00797; Tan SY, 2007, J CLIN INVEST, V117, P3742, DOI 10.1172/JCI33284; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Van der Heiden K, 2006, DEV DYNAM, V235, P19, DOI 10.1002/dvdy.20557; Van Mierop L H, 1985, Heart Vessels, V1, P114; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wolf MTF, 2007, KIDNEY INT, V72, P1520, DOI 10.1038/sj.ki.5002630; Yun SP, 2009, AM J PHYSIOL-CELL PH, V296, pC317, DOI 10.1152/ajpcell.00415.2008	64	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57545	10.1371/journal.pone.0057545	http://dx.doi.org/10.1371/journal.pone.0057545			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469020	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900119
J	Lang, XE; Wang, X; Zhang, KR; Lv, JY; Jin, JH; Li, QS				Lang, Xiao-E; Wang, Xiong; Zhang, Ke-Rang; Lv, Ji-Yuan; Jin, Jian-Hua; Li, Qing-Shan			Isoflurane Preconditioning Confers Cardioprotection by Activation of ALDH2	PLOS ONE			English	Article							PROTEIN-KINASE-C; MYOCARDIAL INFARCT SIZE; ISCHEMIA-REPERFUSION INJURY; K-ATP CHANNELS; CARDIAC PROTECTION; PKC-EPSILON; ALDEHYDE DEHYDROGENASE; RABBIT CARDIOMYOCYTES; FREE-RADICALS; CELL INJURY	The volatile anesthetic, isoflurane, protects the heart from ischemia/reperfusion (I/R) injury. Aldehyde dehydrogenase 2 (ALDH2) is thought to be an endogenous mechanism against ischemia-reperfusion injury possibly through detoxification of toxic aldehydes. We investigated whether cardioprotection by isoflurane depends on activation of ALDH2. Anesthetized rats underwent 40 min of coronary artery occlusion followed by 120 min of reperfusion and were randomly assigned to the following groups: untreated controls, isoflurane preconditioning with and without an ALDH2 inhibitor, the direct activator of ALDH2 or a protein kinase C (PKC epsilon) inhibitor. Pretreatment with isoflurane prior to ischemia reduced LDH and CK-MB levels and infarct size, while it increased phosphorylation of ALDH2, which could be blocked by the ALDH2 inhibitor, cyanamide. Isolated neonatal cardiomyocytes were treated with hypoxia followed by reoxygenation. Hypoxia/reoxygenation (H/R) increased cardiomyocyte apoptosis and injury which were attenuated by isoflurane and forced the activation of ALDH2. In contrast, the effect of isoflurane-induced protection was almost abolished by knockdown of ALDH2. Activation of ALDH2 and cardioprotection by isoflurane were substantially blocked by the PKC epsilon inhibitor. Activation of ALDH2 by mitochondrial PKC epsilon plays an important role in the cardioprotection of isoflurane in myocardium I/R injury.	[Lang, Xiao-E; Wang, Xiong; Lv, Ji-Yuan] Shanxi Med Univ, Clin Med Coll 1, Dept Cardiol, Taiyuan, Shanxi, Peoples R China; [Zhang, Ke-Rang] Shanxi Med Univ, Clin Med Coll 1, Dept Psychiat, Taiyuan, Shanxi, Peoples R China; [Jin, Jian-Hua] Shanxi Med Univ, Clin Med Coll 1, Dept Nucl Med, Taiyuan, Shanxi, Peoples R China; [Li, Qing-Shan] Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University	Lang, XE (corresponding author), Shanxi Med Univ, Clin Med Coll 1, Dept Cardiol, Taiyuan, Shanxi, Peoples R China.	langxiaoe2007@126.com			National Natural Science Foundation of China [81172938]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Natural Science Foundation of China (81172938). The funder's website is www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bian Y, 2010, TOHOKU J EXP MED, V221, P107, DOI 10.1620/tjem.221.107; Bouwman RA, 2010, EUR J PHARMACOL, V647, P132, DOI 10.1016/j.ejphar.2010.08.014; Budas GR, 2010, CARDIOVASC RES, V88, P83, DOI 10.1093/cvr/cvq154; Budas GR, 2010, J MOL CELL CARDIOL, V48, P757, DOI 10.1016/j.yjmcc.2009.10.030; Cason BA, 1997, ANESTHESIOLOGY, V87, P1182, DOI 10.1097/00000542-199711000-00023; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen CH, 2010, CARDIOVASC RES, V88, P51, DOI 10.1093/cvr/cvq192; Churchill EN, 2009, J MOL CELL CARDIOL, V46, P278, DOI 10.1016/j.yjmcc.2008.09.713; Cortinez G, 2009, ALCOHOL, V43, P97, DOI 10.1016/j.alcohol.2008.12.007; De Hert SG, 2002, ANESTHESIOLOGY, V97, P42, DOI 10.1097/00000542-200207000-00007; de Peppo AP, 1999, ANN THORAC SURG, V68, P112, DOI 10.1016/S0003-4975(99)00466-X; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607; Fliss H, 1996, CIRC RES, V79, P949, DOI 10.1161/01.RES.79.5.949; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Hu ZY, 2009, ANAESTH INTENS CARE, V37, P532, DOI 10.1177/0310057X0903700402; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kersten JR, 1996, ANESTHESIOLOGY, V85, P794, DOI 10.1097/00000542-199610000-00015; Kersten JR, 1997, ANESTHESIOLOGY, V87, P361, DOI 10.1097/00000542-199708000-00024; Kimura M, 2006, ALCOHOL ALCOHOLISM, V41, P368, DOI 10.1093/alcalc/agl028; Lagranha CJ, 2010, CIRC RES, V106, P1681, DOI 10.1161/CIRCRESAHA.109.213645; Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426; Li SY, 2006, J MOL CELL CARDIOL, V40, P283, DOI 10.1016/j.yjmcc.2005.11.006; Liu GS, 1999, J MOL CELL CARDIOL, V31, P1937, DOI 10.1006/jmcc.1999.1026; Ljubkovic M, 2007, AM J PHYSIOL-CELL PH, V292, pC1583, DOI 10.1152/ajpcell.00221.2006; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Meldrum DR, 1998, CIRCULATION, V98, pII214; Mio Y, 2008, ANESTHESIOLOGY, V108, P612, DOI 10.1097/ALN.0b013e318167af2d; Mullenheim J, 2002, ANESTHESIOLOGY, V96, P934; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Novalija E, 2003, ANESTHESIOLOGY, V99, P421, DOI 10.1097/00000542-200308000-00024; Obal D, 2005, BRIT J ANAESTH, V94, P166, DOI 10.1093/bja/aei022; Ogbi M, 2004, BIOCHEM J, V382, P923, DOI 10.1042/BJ20040468; Pain T, 2000, CIRC RES, V87, P460; Park M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019143; Pravdic D, 2010, BRIT J PHARMACOL, V160, P220, DOI 10.1111/j.1476-5381.2010.00698.x; Raphael J, 2005, BRIT J ANAESTH, V95, P756, DOI 10.1093/bja/aei264; Singh KK, 2011, BIOCHEM BIOPH RES CO, V411, P421, DOI 10.1016/j.bbrc.2011.06.169; Sun LH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002067; Suzuki K, 2001, CIRCULATION, V104, pI308; Tanaka K, 2002, ANESTHESIOLOGY, V97, P1485, DOI 10.1097/00000542-200212000-00021; Toller WG, 1999, ANESTHESIOLOGY, V91, P1437, DOI 10.1097/00000542-199911000-00037; Toma O, 2004, ANESTHESIOLOGY, V101, P1372; Tsutsumi YM, 2006, ANESTHESIOLOGY, V104, P495, DOI 10.1097/00000542-200603000-00017; Uecker M, 2003, ANESTHESIOLOGY, V99, P138, DOI 10.1097/00000542-200307000-00023; Xu F, 2007, TOHOKU J EXP MED, V213, P215, DOI 10.1620/tjem.213.215; Zhang H, 2012, EUR HEART J, V33, P1606, DOI 10.1093/eurheartj/ehs061	48	33	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e52469	10.1371/journal.pone.0052469	http://dx.doi.org/10.1371/journal.pone.0052469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468836	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900004
J	Latek, D; Pasznik, P; Carlomagno, T; Filipek, S				Latek, Dorota; Pasznik, Pawel; Carlomagno, Teresa; Filipek, Slawomir			Towards Improved Quality of GPCR Models by Usage of Multiple Templates and Profile-Profile Comparison	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; HIDDEN MARKOV-MODELS; STRUCTURE PREDICTION; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; SEQUENCE ALIGNMENT; HOMOLOGY MODELS; LIGAND-BINDING; SERVER; GENERATION	G-protein coupled receptors (GPCRs) are targets of nearly one third of the drugs at the current pharmaceutical market. Despite their importance in many cellular processes the crystal structures are available for less than 20 unique GPCRs of the Rhodopsin-like class. Fortunately, even though involved in different signaling cascades, this large group of membrane proteins has preserved a uniform structure comprising seven transmembrane helices that allows quite reliable comparative modeling. Nevertheless, low sequence similarity between the GPCR family members is still a serious obstacle not only in template selection but also in providing theoretical models of acceptable quality. An additional level of difficulty is the prediction of kinks and bulges in transmembrane helices. Usage of multiple templates and generation of alignments based on sequence profiles may increase the rate of success in difficult cases of comparative modeling in which the sequence similarity between GPCRs is exceptionally low. Here, we present GPCRM, a novel method for fast and accurate generation of GPCR models using averaging of multiple template structures and profile-profile comparison. In particular, GPCRM is the first GPCR structure predictor incorporating two distinct loop modeling techniques: Modeller and Rosetta together with the filtering of models based on the Z-coordinate. We tested our approach on all unique GPCR structures determined to date and report its performance in comparison with other computational methods targeting the Rhodopsin-like class. We also provide a database of precomputed GPCR models of the human receptors from that class. Availability: GPCRM server and database: http://gpcrm.biomodellab.eu	[Latek, Dorota; Pasznik, Pawel] Int Inst Mol & Cell Biol, Warsaw, Poland; [Carlomagno, Teresa] EMBL, Struct & Computat Biol Unit, Heidelberg, Germany; [Filipek, Slawomir] Univ Warsaw, Fac Chem, Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; European Molecular Biology Laboratory (EMBL); University of Warsaw	Latek, D (corresponding author), Int Inst Mol & Cell Biol, Warsaw, Poland.	dlatek@iimcb.gov.pl; sfilipek@chem.uw.edu.pl	; Filipek, Slawomir/A-2985-2008	Latek, Dorota/0000-0002-0429-0637; Filipek, Slawomir/0000-0003-3147-3858; Carlomagno, Teresa/0000-0002-2437-2760	National Center of Science [DEC-2011/03/B/NZ1/03204]; POIG 'Dotacje na innowacje' [02.03.00-00-003-09]	National Center of Science(National Science Centre, Poland); POIG 'Dotacje na innowacje'	The research leading to the described results has received funding from the National Center of Science DEC-2011/03/B/NZ1/03204 and a POIG 'Dotacje na innowacje' grant No. 02.03.00-00-003-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol R, 2011, METHODS MOL BIOL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bera I, 2011, J MOL MODEL, V17, P1207, DOI 10.1007/s00894-010-0803-8; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Hanson RM, 2010, J APPL CRYSTALLOGR, V43, P1250, DOI 10.1107/S0021889810030256; Hildebrand PW, 2009, NUCLEIC ACIDS RES, V37, pW571, DOI 10.1093/nar/gkp338; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Huber T, 2008, BIOCHEMISTRY-US, V47, P11013, DOI 10.1021/bi800891r; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; JONES DT, 1994, FEBS LETT, V339, P269, DOI 10.1016/0014-5793(94)80429-X; Kelm S, 2010, BIOINFORMATICS, V26, P2833, DOI 10.1093/bioinformatics/btq554; Kneissl B, 2009, J MED CHEM, V52, P3166, DOI 10.1021/jm8014487; Kolinski A, 2004, ACTA BIOCHIM POL, V51, P349; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; Margelevicius M, 2010, BIOINFORMATICS, V26, P1905, DOI 10.1093/bioinformatics/btq306; Marti-Renom MA, 2004, PROTEIN SCI, V13, P1071, DOI 10.1110/ps.03379804; Mobarec JC, 2009, J MED CHEM, V52, P5207, DOI 10.1021/jm9005252; Muller T, 2001, Bioinformatics, V17 Suppl 1, pS182; Ng PC, 2000, BIOINFORMATICS, V16, P760, DOI 10.1093/bioinformatics/16.9.760; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Oldziej S, 2005, P NATL ACAD SCI USA, V102, P7547, DOI 10.1073/pnas.0502655102; Pabuwal V, 2011, BIOPOLYMERS, V95, P31, DOI 10.1002/bip.21528; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Panchenko AR, 2003, NUCLEIC ACIDS RES, V31, P683, DOI 10.1093/nar/gkg154; Papasaikas PK, 2003, SAR QSAR ENVIRON RES, V14, P413, DOI 10.1080/10629360310001623999; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rodriguez D, 2012, MOL INFORM, V31, P334, DOI 10.1002/minf.201100162; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Sgourakis NG, 2005, BIOINFORMATICS, V21, P4101, DOI 10.1093/bioinformatics/bti679; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tomii K, 2004, BIOINFORMATICS, V20, P594, DOI 10.1093/bioinformatics/btg474; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Worth CL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-185; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zhang J, 2010, BIOINFORMATICS, V26, P3004, DOI 10.1093/bioinformatics/btq563; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	60	44	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56742	10.1371/journal.pone.0056742	http://dx.doi.org/10.1371/journal.pone.0056742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468878	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900035
J	Leivonen, SK; Lazaridis, K; Decock, J; Chantry, A; Edwards, DR; Kahari, VM				Leivonen, Suvi-Katri; Lazaridis, Konstantinos; Decock, Julie; Chantry, Andrew; Edwards, Dylan R.; Kahari, Veli-Matti			TGF-beta-Elicited Induction of Tissue Inhibitor of Metalloproteinases (TIMP)-3 Expression in Fibroblasts Involves Complex Interplay between Smad3, p38 alpha, and ERK1/2	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACTIVATED PROTEIN-KINASE; DEPENDENT TRANSCRIPTIONAL ACTIVATION; HUMAN GINGIVAL FIBROBLASTS; TIMP-3 PROMOTES APOPTOSIS; HUMAN SKIN FIBROBLASTS; GENE-EXPRESSION; MATRIX METALLOPROTEINASES; CARCINOMA-CELLS; CROSS-TALK	Transforming growth factor-beta (TGF-beta) promotes extracellular matrix deposition by down-regulating the expression of matrix degrading proteinases and upregulating their inhibitors. Tissue inhibitor of metalloproteinases (TIMP)-3 is an ECM-associated specific inhibitor of matrix degrading metalloproteinases. Here, we have characterized the signaling pathways mediating TGF-beta-induced expression of TIMP-3. Basal and TGF-beta-induced TIMP-3 mRNA expression was abolished in Smad4-deficient mouse embryonic fibroblasts and restoring Smad4 expression rescued the response. Inhibition of Smad signaling by expression of Smad7 and dominant negative Smad3 completely abolished TGF-beta-elicited expression of TIMP-3 in human fibroblasts, whereas overexpression of Smad3 enhanced it. Inhibition of extracellular signal-regulated kinase 1/2 (ERK1/2) activation with PD98059 and p38 mitogen-activated protein kinase activity by SB203580 resulted in suppression of TGF-beta-induced TIMP-3 expression, indicating that ERK1/2 and p38 MAPK mediate the effect of TGF-beta on TIMP-3 expression. Specific activation of p38 alpha and ERK1/2 by constitutively active mutants of MKK3b or MEK1, respectively, and simultaneous co-expression of Smad3 resulted in induction of TIMP-3 expression in the absence of TGF-beta indicating that Smad3 co-operates with p38 and ERK1/2 in the induction of TIMP-3 expression. These results demonstrate the complex interplay between Smad3, p38 alpha, and ERK1/2 signaling in the regulation of TIMP-3 gene expression in fibroblasts, which may play a role in inflammation, tissue repair, and fibrosis.	[Leivonen, Suvi-Katri; Kahari, Veli-Matti] Univ Turku, Dept Dermatol, Turku, Finland; [Leivonen, Suvi-Katri; Kahari, Veli-Matti] Turku Univ Hosp, FIN-20520 Turku, Finland; [Leivonen, Suvi-Katri; Kahari, Veli-Matti] Univ Turku, MediCity Res Lab, Turku, Finland; [Lazaridis, Konstantinos; Decock, Julie; Chantry, Andrew; Edwards, Dylan R.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Turku; University of Turku; University of Turku; University of East Anglia	Edwards, DR (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	dylan.edwards@uea.ac.uk; veli-matti.kahari@utu.fi	Kahari, Veli-Matti/T-4925-2019; Leivonen, Suvi-Katri/AAK-3096-2021; Kähäri, Veli-Matti/E-5144-2011; Lazaridis, Konstantinos/AAB-2761-2022; Decock, Julie/A-1453-2010; Edwards, Dylan R/B-4734-2009	Kahari, Veli-Matti/0000-0003-2421-9368; Kähäri, Veli-Matti/0000-0003-2421-9368; Decock, Julie/0000-0002-4409-100X; Edwards, Dylan R/0000-0002-3292-2064; Lazaridis, Konstantinos/0000-0003-4386-2578; Leivonen, Suvi-Katri/0000-0003-3224-0757	Academy of Finland [137687]; Finnish Cancer Research Foundation; Sigrid Juselius Foundation; Turku University Hospital [13336]; European Union [LSHC-CT-2003-503297]; Biotechnology and Biological Sciences Research Council; Big C Appeal; Cancer Foundation Finland sr [120097, 110087] Funding Source: researchfish	Academy of Finland(Academy of Finland); Finnish Cancer Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Hospital; European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Big C Appeal; Cancer Foundation Finland sr	The study was financially supported by grants from the Academy of Finland (project 137687), the Finnish Cancer Research Foundation, Sigrid Juselius Foundation, Turku University Hospital EVO grant (project 13336), European Union Framework Programme 6 "Cancerdegradome" project (LSHC-CT-2003-503297) (DRE and V-MK) and the Biotechnology and Biological Sciences Research Council and the Big C Appeal (DRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Ahonen M, 2002, MOL THER, V5, P705, DOI 10.1006/mthe.2002.0606; Ahonen M, 1998, CANCER RES, V58, P2310; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Baker AH, 1998, J CLIN INVEST, V101, P1478, DOI 10.1172/JCI1584; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brown JD, 1999, J BIOL CHEM, V274, P8797, DOI 10.1074/jbc.274.13.8797; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dennler S, 2000, J BIOL CHEM, V275, P28858, DOI 10.1074/jbc.M910358199; Edwards DR, 1996, EXP GERONTOL, V31, P207, DOI 10.1016/0531-5565(95)02010-1; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Gill SE, 2010, AM J PATHOL, V176, P64, DOI 10.2353/ajpath.2010.090158; Hall MC, 2003, J BIOL CHEM, V278, P10304, DOI 10.1074/jbc.M212334200; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Heikkinen PT, 2010, J BIOL CHEM, V285, P3740, DOI 10.1074/jbc.M109.042978; KAHARI VM, 1990, J CLIN INVEST, V86, P1489, DOI 10.1172/JCI114866; KAHARI VM, 1992, LAB INVEST, V66, P580; Kallio JP, 2011, INT J CANCER, V128, P991, DOI 10.1002/ijc.25404; KESKIOJA J, 1988, J BIOL CHEM, V263, P3111; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; LECO KJ, 1994, J BIOL CHEM, V269, P9352; Leivonen SK, 2006, ONCOGENE, V25, P2588, DOI 10.1038/sj.onc.1209291; Leivonen SK, 2002, J BIOL CHEM, V277, P46338, DOI 10.1074/jbc.M206535200; Leivonen SK, 2005, J INVEST DERMATOL, V124, P1162, DOI 10.1111/j.0022-202X.2005.23750.x; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; Mattila L, 1998, J INVEST DERMATOL, V110, P416, DOI 10.1046/j.1523-1747.1998.00138.x; Murthy A, 2012, J IMMUNOL, V188, P2876, DOI 10.4049/jimmunol.1102199; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Qureshi HY, 2008, BBA-MOL CELL RES, V1783, P1605, DOI 10.1016/j.bbamcr.2008.04.005; Ravanti L, 2001, FASEB J, V15, P1098, DOI 10.1096/fj.00-0588fje; Ravanti L, 1999, J BIOL CHEM, V274, P37292, DOI 10.1074/jbc.274.52.37292; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Schiller M, 2004, J DERMATOL SCI, V35, P83, DOI 10.1016/j.jdermsci.2003.12.006; Sebe A, 2008, NEPHROL DIAL TRANSPL, V23, P1537, DOI 10.1093/ndt/gfm789; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; Su SM, 1996, DNA CELL BIOL, V15, P1039, DOI 10.1089/dna.1996.15.1039; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Ungefroren H, 2005, J BIOL CHEM, V280, P2644, DOI 10.1074/jbc.M411925200; Ungefroren H, 2003, J BIOL CHEM, V278, P11041, DOI 10.1074/jbc.M300035200; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; Vindevoghel L, 1998, J BIOL CHEM, V273, P13053, DOI 10.1074/jbc.273.21.13053; Wang YB, 1998, J BIOL CHEM, V273, P5423, DOI 10.1074/jbc.273.10.5423; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; WILKINSON GWG, 1992, NUCLEIC ACIDS RES, V20, P2233, DOI 10.1093/nar/20.9.2233; Young DA, 2002, BIOCHEM J, V364, P89, DOI 10.1042/bj3640089; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200	55	41	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57474	10.1371/journal.pone.0057474	http://dx.doi.org/10.1371/journal.pone.0057474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468994	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900093
J	Muller, P; Pfluger, V; Wittwer, M; Ziegler, D; Chandre, F; Simard, F; Lengeler, C				Mueller, Pie; Pflueger, Valentin; Wittwer, Matthias; Ziegler, Dominik; Chandre, Fabrice; Simard, Frederic; Lengeler, Christian			Identification of Cryptic Anopheles Mosquito Species by Molecular Protein Profiling	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; GAMBIAE COMPLEX; FORMS; ARABIENSIS; CLASSIFICATION; SPECIATION; DIVERGENCE; RESISTANCE; EVOLUTION; RESPONSES	Vector control is the mainstay of malaria control programmes. Successful vector control profoundly relies on accurate information on the target mosquito populations in order to choose the most appropriate intervention for a given mosquito species and to monitor its impact. An impediment to identify mosquito species is the existence of morphologically identical sibling species that play different roles in the transmission of pathogens and parasites. Currently PCR diagnostics are used to distinguish between sibling species. PCR based methods are, however, expensive, time-consuming and their development requires a priori DNA sequence information. Here, we evaluated an inexpensive molecular proteomics approach for Anopheles species: matrix assisted laser desorption/ ionization time-of-flight mass spectrometry (MALDI-TOF MS). MALDI-TOF MS is a well developed protein profiling tool for the identification of microorganisms but so far has received little attention as a diagnostic tool in entomology. We measured MS spectra from specimens of 32 laboratory colonies and 2 field populations representing 12 Anopheles species including the A. gambiae species complex. An important step in the study was the advancement and implementation of a bioinformatics approach improving the resolution over previously applied cluster analysis. Borrowing tools for linear discriminant analysis from genomics, MALDI-TOF MS accurately identified taxonomically closely related mosquito species, including the separation between the M and S molecular forms of A. gambiae sensu stricto. The approach also classifies specimens from different laboratory colonies; hence proving also very promising for its use in colony authentication as part of quality assurance in laboratory studies. While being exceptionally accurate and robust, MALDI-TOF MS has several advantages over other typing methods, including simple sample preparation and short processing time. As the method does not require DNA sequence information, data can also be reviewed at any later stage for diagnostic or functional patterns without the need for re-designing and re-processing biological material.	[Mueller, Pie] Swiss Trop & Publ Hlth Inst, Dept Med Serv & Diagnost, Basel, Switzerland; [Mueller, Pie; Lengeler, Christian] Univ Basel, Basel, Switzerland; [Pflueger, Valentin; Ziegler, Dominik] Mabritec AG, Riehen, Switzerland; [Wittwer, Matthias] Swiss Fed Dept Def, Spiez Lab, Spiez, Switzerland; [Chandre, Fabrice; Simard, Frederic] Inst Rech Dev, Montpellier, France; [Lengeler, Christian] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Institut de Recherche pour le Developpement (IRD); University of Basel; Swiss Tropical & Public Health Institute	Muller, P (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Serv & Diagnost, Basel, Switzerland.	pie.mueller@unibas.ch	Chandre, Fabrice/Q-3429-2019; Frederic, SIMARD/AFV-5001-2022; Wittwer, Matthias/K-4512-2014; SIMARD, Frederic/J-9489-2016; Muller, Pie/R-7275-2018	Chandre, Fabrice/0000-0002-1994-9705; Frederic, SIMARD/0000-0002-2871-5329; Wittwer, Matthias/0000-0003-4713-8392; SIMARD, Frederic/0000-0002-2871-5329; Muller, Pie/0000-0003-0181-5781				Ahdesmaki M, 2010, ANN APPL STAT, V4, P503, DOI 10.1214/09-AOAS277; Ahdesmaki M, 2011, SHRINKAGE DISCRIMINA; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Bass C, 2008, ACTA TROP, V107, P50, DOI 10.1016/j.actatropica.2008.04.009; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Bonizzoni M, 2009, AM J TROP MED HYG, V81, P1030, DOI 10.4269/ajtmh.2009.09-0333; Campbell PM, 2004, SYSTEMATIC ENTOMOLOG, V30, P186; Caputo B, 2007, INSECT BIOCHEM MOLEC, V37, P389, DOI 10.1016/j.ibmb.2007.01.002; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Collins FH, 1996, INSECT MOL BIOL, V5, P1, DOI 10.1111/j.1365-2583.1996.tb00034.x; Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5; Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-566; Dekker T, 1998, MED VET ENTOMOL, V12, P136, DOI 10.1046/j.1365-2915.1998.00073.x; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Dickinson DN, 2004, J MICROBIOL METH, V58, P1, DOI 10.1016/j.mimet.2004.02.011; Dotson E, 2011, MR4 METHODS ANOPHELE; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Felix RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-312; Feltens R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-95; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Giebel R, 2010, ADV APPL MICROBIOL, V71, P149, DOI 10.1016/S0065-2164(10)71006-6; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; Gimonneau G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-65; Gimonneau G, 2010, BEHAV ECOL, V21, P1087, DOI 10.1093/beheco/arq114; GITHEKO AK, 1994, ACTA TROP, V58, P307, DOI 10.1016/0001-706X(94)90024-8; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Karger A, 2012, TICKS TICK-BORNE DIS, V3, P78, DOI 10.1016/j.ttbdis.2011.11.002; Kaufmann C, 2011, MED VET ENTOMOL, V25, P32, DOI 10.1111/j.1365-2915.2010.00927.x; Kaufmann C, 2012, PARASITOLOGY, V139, P248, DOI 10.1017/S0031182011001764; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192; Perera MR, 2005, ENTOMOL EXP APPL, V117, P243, DOI 10.1111/j.1570-7458.2005.00353.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Santolamazza F, 2004, AM J TROP MED HYG, V70, P604, DOI 10.4269/ajtmh.2004.70.604; Santolamazza F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-215; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sikulu M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-49; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Tuszynski J., 2010, CAMASSCLASS PROCESSI; Wegener C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r131; White BJ, 2011, ANNU REV ECOL EVOL S, V42, P111, DOI 10.1146/annurev-ecolsys-102710-145028; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; Wilkins EE, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-125; Wittwer M, 2011, SYST APPL MICROBIOL, V34, P12, DOI 10.1016/j.syapm.2010.11.006; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	53	67	67	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57486	10.1371/journal.pone.0057486	http://dx.doi.org/10.1371/journal.pone.0057486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469000	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900099
J	Obuku, EA; Parikh, SM; Nankabirwa, V; Kakande, NI; Mafigiri, DK; Mayanja-Kizza, H; Kityo, CM; Mugyenyi, PN; Salata, RA				Obuku, Ekwaro A.; Parikh, Sujal M.; Nankabirwa, Victoria; Kakande, Nelson I.; Mafigiri, David K.; Mayanja-Kizza, Harriet; Kityo, Cissy M.; Mugyenyi, Peter N.; Salata, Robert A.			Determinants of Clinician Knowledge on Aging and HIV/AIDS: A Survey of Practitioners and Policy Makers in Kampala District, Uganda	PLOS ONE			English	Article							HIV-INFECTION; DOUBLE-BLIND; ATTITUDES; EFFICACY; OLDER; TRANSMISSION; PREVENTION; ZIDOVUDINE; PROVIDERS; REGIMEN	Objective: The HIV/AIDS epidemic has evolved with an increasing burden in older adults. We assessed for knowledge about aging and HIV/AIDS, among clinicians in Kampala district, Uganda. Methods: A cross-sectional survey of 301 clinicians complemented by 9 key-informant interviews between May and October 2011. Data was analyzed by multivariable logistic regression for potential determinants of clinician knowledge about HIV/AIDS in older adults, estimating their adjusted Odds Ratios (aOR) and 95% confidence intervals (95% CI) using Stata 11.2 software. Results: Two-hundred and sixty-two questionnaires (87.7%) were returned. Respondents had a median age of 30 years (IQR 27-34) and 57.8% were general medical doctors. The mean knowledge score was 49% (range 8.8%-79.4%). Questions related to co-morbidities in HIV/AIDS (non-AIDS related cancers and systemic diseases) and chronic antiretroviral treatment toxicities (metabolic disorders) accounted for significantly lower scores (mean, 41.7%, 95% CI: 39.3%-44%) compared to HIV/AIDS epidemiology and prevention (mean, 65.7%, 95% CI: 63.7%-67.7%). Determinants of clinician knowledge in the multivariable analysis included (category, aOR, 95% CI): clinician age (30-39 years; 3.28: 1.65-9.75), number of persons with HIV/AIDS seen in the past year (less than 50; 0.34: 0.14-0.86) and clinical profession (clinical nurse practitioner; 0.31: 0.11-0.83). Having diploma level education had a marginal association with lower knowledge about HIV and aging (p = 0.09). Conclusion: Our study identified gaps and determinants of knowledge about HIV/AIDS in older adults among clinicians in Kampala district, Uganda. Clinicians in low and middle income countries could benefit from targeted training in chronic care for older adults with HIV/AIDS and long-term complications of antiretroviral treatment.	[Obuku, Ekwaro A.; Kakande, Nelson I.; Kityo, Cissy M.; Mugyenyi, Peter N.] Joint Clin Res Ctr, Kampala, Uganda; [Salata, Robert A.] Case Western Reserve Univ, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Parikh, Sujal M.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Nankabirwa, Victoria] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Mafigiri, David K.] Makerere Univ, Coll Humanities & Social Sci, Dept Social Work & Social Adm, Kampala, Uganda; [Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Mafigiri, David K.] Case Western Reserve Univ, Dept Anthropol, Ctr Social Sci Res AIDS, Coll Arts & Sci, Cleveland, OH 44106 USA	Joint Clinic Research Center - United Arab Emirates; Case Western Reserve University; University of Michigan System; University of Michigan; Columbia University; Makerere University; Makerere University; Case Western Reserve University	Obuku, EA (corresponding author), Joint Clin Res Ctr, Kampala, Uganda.	eobuku@jcrc.org.ug	Obuku, Ekwaro A./H-4988-2011; Mayanja-Kizza, Harriet/AAM-5372-2020	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Mafigiri, David/0000-0002-2699-4248; Nankabirwa, Victoria/0000-0002-9952-8942	Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; Fogarty International Centre, National Institutes of Health, USA; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; Fogarty International Centre, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Relief and Recovery Act, Fogarty International Centre, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africa Health Workforce Observatory, 2009, HUM RES HLTH COUNTR; [Anonymous], 2012, WHAT IS THE 80 20 RU; Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Delobelle P, 2009, J ADV NURS, V65, P1061, DOI 10.1111/j.1365-2648.2009.04973.x; Demographic and Health Surveys, 2010, KEN DHS 2008 09 FIN; Demographic and Health Surveys, 2004, KEN DHS 2003 FIN REP; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; FISCHL MA, 1988, JAMA-J AM MED ASSOC, V259, P1185, DOI 10.1001/jama.259.8.1185; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; GEMSON DH, 1991, ARCH INTERN MED, V151, P1102, DOI 10.1001/archinte.151.6.1102; Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Heinisch O., 1963, PREIS S BIOM J, V1965, P203, DOI [10.1002/bimj.19650070312, DOI 10.1002/BIMJ.19650070312]; HEREK GM, 1984, J HOMOSEXUAL, V10, P39, DOI 10.1300/J082v10n01_03; Hillman JL, 1998, SEX DISABIL, V16, P181, DOI 10.1023/A:1023094909068; Holmes MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000244; Hughes AK, 2009, THESIS U MARYLAND BA; Hughes AK, 2011, AIDS PATIENT CARE ST, V25, P539, DOI 10.1089/apc.2011.0026; JAFFE HW, 1983, J INFECT DIS, V148, P339, DOI 10.1093/infdis/148.2.339; Killingley B, 2007, DRUG TODAY, V43, P427, DOI 10.1358/dot.2007.43.7.1086178; Meissner H, 2011, BEST PRACTICES MIXED; Mills EJ, 2011, BMJ, V343; Ministry of Health Department of Planning, 2007, UG HLTH FAC INV SPRE; Ministry of Health (MOH) Uganda and Macro International Inc, 2008, UG SERV PROV ASS SUR; Ministry of Health (MOH) [Uganda] and ORC Macro, 2006, UG HIV AIDS SER BEH; Morgan D, 2002, BRIT MED J, V324, P193, DOI 10.1136/bmj.324.7331.193; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Negin J, 2012, AIDS BEHAV, V16, P63, DOI 10.1007/s10461-011-9994-y; Negin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026546; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Palamountain K, 2012, MONTR ADV TB DIAGN R; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Schmid GP, 2009, B WORLD HEALTH ORGAN, V87, P162, DOI 10.2471/BLT.09.064030; SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9; Skiest DJ, 1997, ARCH FAM MED, V6, P289, DOI 10.1001/archfami.6.3.289; Walusimbi M, 2004, APPL NURS RES, V17, P92, DOI 10.1016/j.apnr.2004.02.005; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2012, KNOWL TRANSL AG HLTH	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57028	10.1371/journal.pone.0057028	http://dx.doi.org/10.1371/journal.pone.0057028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23468905	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900048
J	Ruiz, GRS				Ruiz, Gustavo R. S.			Proposal and Phylogenetic Relationships of Lapsamita, a New Genus of Lapsiines, and Description of a New Species (Araneae, Salticidae)	PLOS ONE			English	Article							SPIDERS	Lapsamita maddisoni gen. et sp. nov. is described from Bahia, Brazil. The presence of palpal claws in females, long ventral spines on front tibiae and metatarsi and long retrolateral tibial apophyses in male palps suggested that the species was closely related to or even nested within Soesiladeepakius Makhan, 2007. To evaluate its phylogenetic position, a cladistic analysis was carried out using a data matrix comprising 24 morphological characters, scored for 13 taxa. The analysis showed L. maddisoni as the sister group of Soesiladeepakius, supporting the proposal of the new genus. Character evolution is discussed and compared to a previous study on the group.	Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil	Universidade Federal do Para	Ruiz, GRS (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	gustavoruiz86@hotmail.com	Ruiz, Gustavo/AAB-4928-2019	Ruiz, Gustavo/0000-0002-7326-7000				Edwards G.B., 2004, OCCAS PAP FLORIDA ST, V11, P1; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; GOLOBOFF P, 2000, TNT TREE ANAL USING; HUBER BA, 1995, ZOOL J LINN SOC-LOND, V113, P151, DOI 10.1111/j.1096-3642.1995.tb00931.x; Maddison WP, 2007, ZOOTAXA, P23; Maddison WP, 2006, ZOOTAXA, P37; Maddison WP, 2006, ZOOTAXA, P29; Maddison WP, 2006, ZOOTAXA, P17; Maddison WP, 2003, INVERTEBR SYST, V17, P529, DOI 10.1071/IS02044; MADDISON WP, 2006, MESQUITE MODULAR SYS; Makhan Dewanand, 2007, Calodema, P1; Nixon K.C., 2002, WINCLADA VER 1 00 08; Petrunkevitch A., 1925, Transactions of the Connecticut Academy of Arts and Science, V27, P51; Ruiz GRS, 2012, ZOOL J LINN SOC-LOND, V165, P274, DOI 10.1111/j.1096-3642.2012.00815.x; SWOFFORD DL, 1987, MATH BIOSCI, V87, P199, DOI 10.1016/0025-5564(87)90074-5	15	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56188	10.1371/journal.pone.0056188	http://dx.doi.org/10.1371/journal.pone.0056188			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468857	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900019
J	Ascunce, MS; Toups, MA; Kassu, G; Fane, J; Scholl, K; Reed, DL				Ascunce, Marina S.; Toups, Melissa A.; Kassu, Gebreyes; Fane, Jackie; Scholl, Katlyn; Reed, David L.			Nuclear Genetic Diversity in Human Lice (Pediculus humanus) Reveals Continental Differences and High Inbreeding among Worldwide Populations	PLOS ONE			English	Article							BARTONELLA-QUINTANA; HEAD LICE; BODY LICE; CARBONIC-ANHYDRASE; HOMELESS PERSONS; RESISTANCE; SOFTWARE; ORIGIN; LOUSE; EVOLUTION	Understanding the evolution of parasites is important to both basic and applied evolutionary biology. Knowledge of the genetic structure of parasite populations is critical for our ability to predict how an infection can spread through a host population and for the design of effective control methods. However, very little is known about the genetic structure of most human parasites, including the human louse (Pediculus humanus). This species is composed of two ecotypes: the head louse (Pediculus humanus capitis De Geer), and the clothing (body) louse (Pediculus humanus humanus Linnaeus). Hundreds of millions of head louse infestations affect children every year, and this number is on the rise, in part because of increased resistance to insecticides. Clothing lice affect mostly homeless and refugee-camp populations and although they are less prevalent than head lice, the medical consequences are more severe because they vector deadly bacterial pathogens. In this study we present the first assessment of the genetic structure of human louse populations by analyzing the nuclear genetic variation at 15 newly developed microsatellite loci in 93 human lice from 11 sites in four world regions. Both ecotypes showed heterozygote deficits relative to Hardy-Weinberg equilibrium and high inbreeding values, an expected pattern given their parasitic life history. Bayesian clustering analyses assigned lice to four distinct genetic clusters that were geographically structured. The low levels of gene flow among louse populations suggested that the evolution of insecticide resistance in lice would most likely be affected by local selection pressures, underscoring the importance of tailoring control strategies to population-specific genetic makeup and evolutionary history. Our panel of microsatellite markers provides powerful data to investigate not only ecological and evolutionary processes in lice, but also those in their human hosts because of the long-term coevolutionary association between lice and humans.	[Ascunce, Marina S.; Toups, Melissa A.; Kassu, Gebreyes; Fane, Jackie; Scholl, Katlyn; Reed, David L.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Ascunce, MS (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	ascunce@ufl.edu	Ascunce, Marina/AAW-2139-2020	Toups, Melissa/0000-0002-9752-7380	National Science Foundation [DEB 0717165, DEB 0845392]; University of Florida; Division Of Environmental Biology [0845392] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Florida(University of Florida); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by grants to DLR from the National Science Foundation (www.nsf.gov: DEB 0717165 and DEB 0845392) and the University of Florida (www.research.ufl.edu: SEED Fund Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Alves I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002837; Angelakis E, 2011, EMERG INFECT DIS, V17, P2357, DOI 10.3201/eid1712.110453; Araujo A, 2000, PARASITOL TODAY, V16, P269, DOI 10.1016/S0169-4758(00)01694-X; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Bialek R, 2011, NEW ENGL J MED, V364, P386, DOI 10.1056/NEJMc1007171; Bonilla DL, 2009, EMERG INFECT DIS, V15, P912, DOI 10.3201/eid1506.090054; Burgess Ian F., 1995, Advances in Parasitology, V36, P271, DOI 10.1016/S0065-308X(08)60493-5; Burgess IE, 2004, ANNU REV ENTOMOL, V49, P457, DOI 10.1146/annurev.ento.49.061802.123253; Clark J. Marshall, 2009, Journal of Asia-Pacific Entomology, V12, P1, DOI 10.1016/j.aspen.2008.10.007; Corena MD, 2002, J EXP BIOL, V205, P591; Cutler S, 2012, COMP IMMUNOL MICROB, V35, P17, DOI 10.1016/j.cimid.2011.09.007; Dittmar K, 2012, BLACKW COMPANION ANT, P170; Drali R, 2012, J CLIN MICROBIOL, V50, P2229, DOI 10.1128/JCM.00808-12; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Figueroa CC, 2007, INSECT SCI, V14, P29, DOI 10.1111/j.1744-7917.2007.00123.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foucault C, 2006, EMERG INFECT DIS, V12, P217, DOI 10.3201/eid1202.050874; Goldberger J, 1896, PUB HLTH REP, V27, P297, DOI [10.2307/4567527, DOI 10.2307/4567527]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Gratz NG, 1997, HUMAN LICE THEIR PRE; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Hartley CJ, 2006, P NATL ACAD SCI USA, V103, P8757, DOI 10.1073/pnas.0509590103; Hodgdon HE, 2010, PEST MANAG SCI, V66, P1031, DOI 10.1002/ps.1979; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Kittler R, 2004, CURR BIOL, V14, P2309, DOI 10.1016/j.cub.2004.12.024; Kittler R, 2003, CURR BIOL, V13, P1414, DOI 10.1016/S0960-9822(03)00507-4; Kolman CJ, 1996, GENETICS, V142, P1321; Lalueza-Fox C, 2011, CURR BIOL, V21, pR1002, DOI 10.1016/j.cub.2011.11.021; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Lee SH, 2000, PESTIC BIOCHEM PHYS, V66, P130, DOI 10.1006/pest.1999.2460; Lee SH, 2010, PESTIC BIOCHEM PHYS, V97, P109, DOI 10.1016/j.pestbp.2009.04.017; Leo NP, 2005, HEREDITY, V95, P34, DOI 10.1038/sj.hdy.6800663; Li WJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000641; Light JE, 2008, MOL PHYLOGENET EVOL, V47, P1203, DOI 10.1016/j.ympev.2008.03.014; Light JE, 2008, J PARASITOL, V94, P1275, DOI 10.1645/GE-1618.1; Linser PJ, 2009, J EXP BIOL, V212, P1662, DOI 10.1242/jeb.028084; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; MURRAY ES, 1975, ANN NY ACAD SCI, V266, P25, DOI 10.1111/j.1749-6632.1975.tb35086.x; Nair S, 2003, MOL BIOL EVOL, V20, P1526, DOI 10.1093/molbev/msg162; Nozais JP, 2003, MEM I OSWALDO CRUZ, V98, P13, DOI 10.1590/S0074-02762003000900004; Oakeshott JG, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-202; Pannebakker BA, 2010, INSECT MOL BIOL, V19, P91, DOI 10.1111/j.1365-2583.2009.00915.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rannala B, 1996, GENET RES, V67, P147, DOI 10.1017/S0016672300033607; Raoult D, 1997, EMERG INFECT DIS, V3, P357, DOI 10.3201/eid0303.970313; Raoult D, 2008, J INFECT DIS, V197, P535, DOI 10.1086/526520; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DL, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-7; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Reed DL, 2009, PRIMATE PARASITE ECO, P531; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rydkina EB, 1999, EMERG INFECT DIS, V5, P176, DOI 10.3201/eid0501.990126; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Sasaki T, 2006, J MED ENTOMOL, V43, P110, DOI 10.1603/0022-2585(2006)043[0110:FMEOBQ]2.0.CO;2; Seki N, 2006, JPN J INFECT DIS, V59, P31; TORRONI A, 1993, AM J HUM GENET, V53, P591; Toups MA, 2011, MOL BIOL EVOL, V28, P29, DOI 10.1093/molbev/msq234; TURBECK BO, 1970, BIOCHIM BIOPHYS ACTA, V212, P139, DOI 10.1016/0005-2744(70)90187-7; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veracx A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037804; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yang MA, 2012, MOL BIOL EVOL, V29, P2987, DOI 10.1093/molbev/mss117	76	35	37	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57619	10.1371/journal.pone.0057619	http://dx.doi.org/10.1371/journal.pone.0057619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460886	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000141
J	Emery, JA; Hermon, K; Hamid, NKA; Donald, JA; Turchini, GM				Emery, James A.; Hermon, Karen; Hamid, Noor K. A.; Donald, John A.; Turchini, Giovanni M.			Delta-6 Desaturase Substrate Competition: Dietary Linoleic Acid (18:2n-6) Has Only Trivial Effects on alpha-Linolenic Acid (18:3n-3) Bioconversion in the Teleost Rainbow Trout	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; FISH-OIL REPLACEMENT; IN-VIVO; ACYL DESATURASE; MURRAY COD; METABOLISM; PUFA; N-3; BIOSYNTHESIS; HEPATOCYTES	It is generally accepted that, in vertebrates, omega-3 (n-3) and omega-6 (n-6) poly-unsaturated fatty acids (PUFA) compete for Delta-6 desaturase enzyme in order to be bioconverted into long-chain PUFA (LC-PUFA). However, recent studies into teleost fatty acid metabolism suggest that these metabolic processes may not conform entirely to what has been previously observed in mammals and other animal models. Recent work on rainbow trout has led us to question specifically if linoleic acid (LA, 18:2n-6) and alpha-linolenic acid (ALA, 18:3n-3) (Delta-6 desaturase substrates) are in direct competition for access to Delta-6 desaturase. Two experimental diets were formulated with fixed levels of ALA, while LA levels were varied (high and low) to examine if increased availability of LA would result in decreased bioconversion of ALA to its LC-PUFA products through substrate competition. No significant difference in ALA metabolism towards n-3 LC-PUFA was exhibited between diets while significant differences were observed in LA metabolism towards n-6 LC-PUFA. These results are evidence for minor if any competition between substrates for Delta-6 desaturase, suggesting that, paradoxically, the activity of Delta-6 desaturase on n-3 and n-6 substrates is independent. These results call for a paradigm shift in the way we approach teleost fatty acid metabolism. The findings are also important with regard to diet formulation in the aquaculture industry as they indicate that there should be no concern for possible substrate competition between 18: 3n-3 and 18:2n-6, when aiming at increased n-3 LC-PUFA bioconversion in vivo.	[Emery, James A.; Hermon, Karen; Turchini, Giovanni M.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Hamid, Noor K. A.; Donald, John A.] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic 3217, Australia	Deakin University; Deakin University	Turchini, GM (corresponding author), Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia.	giovanni.turchini@deakin.edu.au	Hamid, Noor K. A/Q-9142-2018; Turchini, Giovanni M/A-9147-2008; Donald, John/B-4656-2012	Turchini, Giovanni M/0000-0003-0694-4283; Donald, John/0000-0001-5930-2642	Australian Research Council's Discovery Projects funding scheme [DP1093570]	Australian Research Council's Discovery Projects funding scheme(Australian Research Council)	This research was supported under the Australian Research Council's Discovery Projects funding scheme (Project DP1093570). The views expressed herein are those of the authors and are not necessarily those of the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON JL, 1984, CAN J FISH AQUAT SCI, V41, P1384, DOI 10.1139/f84-170; Barcelo-Coblijn G, 2009, PROG LIPID RES, V48, P355, DOI 10.1016/j.plipres.2009.07.002; Bell J.G., 2011, FISH OIL REPLACEMENT; Brenna JT, 2009, PROSTAG LEUKOTR ESS, V80, P85, DOI 10.1016/j.plefa.2009.01.004; Brown TD, 2010, AQUACULTURE, V300, P148, DOI 10.1016/j.aquaculture.2009.12.020; Buzzi M, 1996, BBA-LIPID LIPID MET, V1299, P235, DOI 10.1016/0005-2760(95)00211-1; Cleveland BJ, 2012, J NUTR, V142, P1449, DOI 10.3945/jn.112.161497; de Antueno RJ, 2001, FEBS LETT, V509, P77, DOI 10.1016/S0014-5793(01)03135-0; EMKEN EA, 1994, BBA-LIPID LIPID MET, V1213, P277, DOI 10.1016/0005-2760(94)00054-9; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis DS, 2009, J AGR FOOD CHEM, V57, P4381, DOI 10.1021/jf900094w; Gurr MI, 2002, LIPID BIOCH, P13; Hastings N, 2001, P NATL ACAD SCI USA, V98, P14304, DOI 10.1073/pnas.251516598; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; Mathias RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044926; MOHRHAUER H, 1963, J NUTR, V81, P67, DOI 10.1093/jn/81.1.67; Monroig O, 2011, COMP BIOCHEM PHYS B, V159, P206, DOI 10.1016/j.cbpb.2011.04.007; Morais S, 2012, BBA-MOL CELL BIOL L, V1821, P660, DOI 10.1016/j.bbalip.2011.12.011; Olsen Y, 2011, AQUACULT ENV INTERAC, V1, P187, DOI 10.3354/aei00019; Palmeri G, 2007, FOOD CHEM, V102, P796, DOI 10.1016/j.foodchem.2006.06.018; Pickova J, 2007, EUR J LIPID SCI TECH, V109, P256, DOI 10.1002/ejlt.200600222; Poureslami R, 2010, BRIT J NUTR, V104, P189, DOI 10.1017/S0007114510000395; RAHM JJ, 1964, J NUTR, V84, P15, DOI 10.1093/jn/84.1.15; Ramsden Christopher E, 2009, Curr Treat Options Cardiovasc Med, V11, P289; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Rosenlund G., 2011, FISH OIL REPLACEMENT, P487; Sprecher H, 1995, J LIPID RES, V36, P2471; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Thanuthong T, 2011, LIPIDS, V46, P1111, DOI 10.1007/s11745-011-3607-4; Thanuthong T, 2011, AQUACULTURE, V322, P99, DOI 10.1016/j.aquaculture.2011.09.026; Tocher D., 2009, Lipid Technology, V21, P13, DOI 10.1002/lite.200800079; Torstensen B. E., 2011, FISH OIL REPLACEMENT, P405, DOI 10.1201/9781439808634-c13; Turchini GM, 2008, LIPIDS, V43, P977, DOI 10.1007/s11745-008-3213-2; Turchini GM, 2007, LIPIDS, V42, P1065, DOI 10.1007/s11745-007-3105-x; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Vagner M, 2011, AQUACULTURE, V315, P131, DOI 10.1016/j.aquaculture.2010.11.031; VOSS A, 1991, J BIOL CHEM, V266, P19995; WAYS P, 1964, J LIPID RES, V5, P318; Williams CM, 2006, P NUTR SOC, V65, P42, DOI 10.1079/PNS2005473	42	39	42	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57463	10.1371/journal.pone.0057463	http://dx.doi.org/10.1371/journal.pone.0057463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460861	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000115
J	Kranz, K; Paquet-Durand, F; Weiler, R; Janssen-Bienhold, U; Dedek, K				Kranz, Katharina; Paquet-Durand, Francois; Weiler, Reto; Janssen-Bienhold, Ulrike; Dedek, Karin			Testing for a Gap Junction-Mediated Bystander Effect in Retinitis Pigmentosa: Secondary Cone Death Is Not Altered by Deletion of Connexin36 from Cones	PLOS ONE			English	Article							PHOTORECEPTOR CELL-DEATH; ADAPTED MOUSE RETINA; BIPOLAR CELLS; TARGETED DISRUPTION; ROD DEGENERATION; MUTANT MOUSE; RAT RETINA; MICE; MODEL; GENE	Retinitis pigmentosa (RP) relates to a group of hereditary neurodegenerative diseases of the retina. On the cellular level, RP results in the primary death of rod photoreceptors, caused by rod-specific mutations, followed by a secondary degeneration of genetically normal cones. Different mechanisms may influence the spread of cell death from one photoreceptor type to the other. As one of these mechanisms a gap junction-mediated bystander effect was proposed, i.e., toxic molecules generated in dying rods and propagating through gap junctions induce the death of healthy cone photoreceptors. We investigated whether disruption of rod-cone coupling can prevent secondary cone death and reduce the spread of degeneration. We tested this hypothesis in two different mouse models for retinal degeneration (rhodopsin knockout and rd1) by crossbreeding them with connexin36-deficient mice as connexin36 represents the gap junction protein on the cone side and lack thereof most likely disrupts rod-cone coupling. Using immunohistochemistry, we compared the progress of cone degeneration between connexin36-deficient mouse mutants and their connexin36-expressing littermates at different ages and assessed the accompanied morphological changes during the onset (rhodopsin knockout) and later stages of secondary cone death (rd1 mutants). Connexin36-deficient mouse mutants showed the same time course of cone degeneration and the same morphological changes in second order neurons as their connexin36-expressing littermates. Thus, our results indicate that disruption of connexin36-mediated rod-cone coupling does not stop, delay or spatially restrict secondary cone degeneration and suggest that the gap junction-mediated bystander effect does not contribute to the progression of RP.	[Kranz, Katharina; Weiler, Reto; Janssen-Bienhold, Ulrike; Dedek, Karin] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-26111 Oldenburg, Germany; [Paquet-Durand, Francois] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany	Carl von Ossietzky Universitat Oldenburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kranz, K (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-26111 Oldenburg, Germany.	karin.dedek@uni-oldenburg.de	Dedek, Karin/R-6948-2018; Paquet-Durand, Francois/G-6709-2015	Dedek, Karin/0000-0003-1490-0141; Paquet-Durand, Francois/0000-0001-7355-5742	European Commission [RETICIRC HEALTH-F2-2009-223156]; Ministry for Science and Culture of Lower Saxony; Deutsche Forschungsgemeinschaft [PA1751/1-1]; Kerstan Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministry for Science and Culture of Lower Saxony; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kerstan Foundation(European Commission)	The authors are supported by European Commission FP7 Grant RETICIRC HEALTH-F2-2009-223156 (to R.W), Ministry for Science and Culture of Lower Saxony (to R.W.), Deutsche Forschungsgemeinschaft PA1751/1-1 (to F.P.-D.), Kerstan Foundation (to F.P.-D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Barr MM, 2009, J NEUROPHYSIOL, V102, P1945, DOI 10.1152/jn.00142.2009; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; Busskamp V, 2011, CURR OPIN NEUROBIOL, V21, P942, DOI 10.1016/j.conb.2011.06.001; Cangiano L, 2012, J PHYSIOL-LONDON, V590, P3841, DOI 10.1113/jphysiol.2011.226878; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; Cotrina ML, 1998, J NEUROSCI, V18, P2520; Cuenca N, 2004, NEUROSCIENCE, V127, P301, DOI 10.1016/j.neuroscience.2004.04.042; Cusato K, 2003, J NEUROSCI, V23, P6413; Dang L, 2004, MOL VIS, V10, P323; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Feigenspan A, 2004, J NEUROSCI, V24, P3325, DOI 10.1523/JNEUROSCI.5598-03.2004; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; FREEMAN SM, 1993, CANCER RES, V53, P5274; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Gimenez E, 2001, LAB ANIM-UK, V35, P153, DOI 10.1258/0023677011911525; Gonzalez-Nieto D, 2008, P NATL ACAD SCI USA, V105, P17169, DOI 10.1073/pnas.0804189105; Guldenagel M, 2001, J NEUROSCI, V21, P6036, DOI 10.1523/JNEUROSCI.21-16-06036.2001; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Haverkamp S, 2008, J COMP NEUROL, V507, P1087, DOI 10.1002/cne.21612; Heikkinen H, 2011, J NEUROPHYSIOL, V105, P2309, DOI 10.1152/jn.00536.2010; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jaissle GB, 2001, INVEST OPHTH VIS SCI, V42, P506; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; Kranz K, 2013, J COMP NEUROL, V521, P1119, DOI 10.1002/cne.23223; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Leveillard Thierry, 2004, Novartis Found Symp, V255, P117; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; Mataruga A, 2007, J COMP NEUROL, V502, P1123, DOI 10.1002/cne.21367; Mesnil M, 1996, P NATL ACAD SCI USA, V93, P1831, DOI 10.1073/pnas.93.5.1831; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Naus CCG, 2001, CELL COMMUN ADHES, V8, P325, DOI 10.3109/15419060109080747; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; Pang JJ, 2010, P NATL ACAD SCI USA, V107, P395, DOI 10.1073/pnas.0907178107; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P897, DOI 10.1113/jphysiol.2003.059543; Paquet-Durand F, 2010, J NEUROCHEM, V115, P930, DOI 10.1111/j.1471-4159.2010.06983.x; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; Paschon V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045449; Patel LS, 2006, CELL COMMUN ADHES, V13, P41, DOI 10.1080/15419060600631474; Pennesi ME, 2012, INVEST OPHTH VIS SCI, V53, P4644, DOI 10.1167/iovs.12-9611; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rami A, 2000, EXP NEUROL, V170, P297, DOI 10.1006/exnr.2001.7712; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Ripps H, 2002, EXP EYE RES, V74, P327, DOI 10.1006/exer.2002.1155; Rogue RS, 1999, BRAIN RES, V836, P110, DOI 10.1016/S0006-8993(99)01625-X; Rohrer B, 2004, J BIOL CHEM, V279, P41903, DOI 10.1074/jbc.M405085200; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Sonntag S, 2012, J NEUROSCI, V32, P10713, DOI 10.1523/JNEUROSCI.0442-12.2012; Stohr H, 2005, J COMP NEUROL, V481, P31, DOI 10.1002/cne.20367; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Strettoi E, 2002, J NEUROSCI, V22, P5492; Strettoi E, 2003, VISION RES, V43, P867, DOI 10.1016/S0042-6989(02)00594-1; Striedinger K, 2005, EUR J NEUROSCI, V22, P605, DOI 10.1111/j.1460-9568.2005.04228.x; Trifunovic D, 2012, CURR MOL MED, V12, P598, DOI 10.2174/156652412800620048; Trumpler J, 2008, J NEUROSCI, V28, P6818, DOI 10.1523/JNEUROSCI.1564-08.2008; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Wang SM, 2005, J COMP NEUROL, V491, P400, DOI 10.1002/cne.20695; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303	66	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57163	10.1371/journal.pone.0057163	http://dx.doi.org/10.1371/journal.pone.0057163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468924	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000070
J	Moustafa, ME; Carlson, BA; Anver, MR; Bobe, G; Zhong, NX; Ward, JM; Perella, CM; Hoffmann, VJ; Rogers, K; Combs, GF; Schweizer, U; Merlino, G; Gladyshev, VN; Hatfield, DL				Moustafa, Mohamed E.; Carlson, Bradley A.; Anver, Miriam R.; Bobe, Gerd; Zhong, Nianxin; Ward, Jerrold M.; Perella, Christine M.; Hoffmann, Victoria J.; Rogers, Keith; Combs, Gerald F., Jr.; Schweizer, Ulrich; Merlino, Glenn; Gladyshev, Vadim N.; Hatfield, Dolph L.			Selenium and Selenoprotein Deficiencies Induce Widespread Pyogranuloma Formation in Mice, while High Levels of Dietary Selenium Decrease Liver Tumor Size Driven by TGF alpha	PLOS ONE			English	Article							SELENOCYSTEINE TRANSFER-RNA; EXPRESSION; HEPATOCARCINOGENESIS; INFLAMMATION; POPULATION; DELETION; DISEASES; LACKING; RESCUE; COLON	Changes in dietary selenium and selenoprotein status may influence both anti- and pro-cancer pathways, making the outcome of interventions different from one study to another. To characterize such outcomes in a defined setting, we undertook a controlled hepatocarcinogenesis study involving varying levels of dietary selenium and altered selenoprotein status using mice carrying a mutant (A37G) selenocysteine tRNA transgene (Trsp(tG37)) and/or a cancer driver TGF alpha transgene. The use of Trsp(tG37) altered selenoprotein expression in a selenoprotein and tissue specific manner and, at sufficient dietary selenium levels, separate the effect of diet and selenoprotein status. Mice were maintained on diets deficient in selenium (0.02 ppm selenium) or supplemented with 0.1, 0.4 or 2.25 ppm selenium or 30 ppm triphenylselenonium chloride (TPSC), a non-metabolized selenium compound. Trsp(tG37) transgenic and TGF alpha/Trsp(tG37) bi-transgenic mice subjected to selenium-deficient or TPSC diets developed a neurological phenotype associated with early morbidity and mortality prior to hepatocarcinoma development. Pathology analyses revealed widespread disseminated pyogranulomatous inflammation. Pyogranulomas occurred in liver, lungs, heart, spleen, small and large intestine, and mesenteric lymph nodes in these transgenic and bi-transgenic mice. The incidence of liver tumors was significantly increased in mice carrying the TGF alpha transgene, while dietary selenium and selenoprotein status did not affect tumor number and multiplicity. However, adenoma and carcinoma size and area were smaller in TGF alpha transgenic mice that were fed 0.4 and 2.25 versus 0.1 ppm of selenium. Thus, selenium and selenoprotein deficiencies led to widespread pyogranuloma formation, while high selenium levels inhibited the size of TGF alpha-induced liver tumors.	[Moustafa, Mohamed E.; Carlson, Bradley A.; Zhong, Nianxin; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, NIH, Bethesda, MD 20892 USA; [Anver, Miriam R.; Rogers, Keith] Sci Applicat Int Corp Frederick Inc, Pathol Histotechnol Lab, Frederick Natl Lab Canc Res, Frederick, MD USA; [Bobe, Gerd] Oregon State Univ, Dept Anim & Rangeland Sci, Coll Agr, Corvallis, OR 97331 USA; [Bobe, Gerd] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Ward, Jerrold M.] NIAID, Immunopathol Sect, NIH, Bethesda, MD 20892 USA; [Perella, Christine M.] Sci Applicat Int Corp Frederick Inc, Lab Anim Sci Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Hoffmann, Victoria J.] NCI, Off Director, Diagnost & Res Serv Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Combs, Gerald F., Jr.] USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA; [Schweizer, Ulrich] Charite, Inst Expt Endokrinol, D-13353 Berlin, Germany; [Merlino, Glenn] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Oregon State University; Oregon State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Agriculture (USDA); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hatfield, DL (corresponding author), NCI, Mol Biol Selenium Sect, Lab Canc Prevent, NIH, Bethesda, MD 20892 USA.	hatfield@dc37a.nci.nih.gov	Moustafa, Mohamed E/E-9002-2018; Gladyshev, Vadim N/J-6187-2013; Schweizer, Ulrich/E-8105-2013; Moustafa, Mohamed/AAM-2211-2021; Gladyshev, Vadim N/A-9894-2013	Schweizer, Ulrich/0000-0003-1380-4780; Moustafa, Mohamed/0000-0003-1308-6221; Gladyshev, Vadim/0000-0002-0372-7016	Intramural Research Program of the National Institutes of Health (NIH); National Cancer Institute; Center for Cancer Research; NIH; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [R01CA080946, ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM061603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038004] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research to DLH, NIH grants to VNG and the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The authors express their sincere appreciation to BAC, R. Irons and C. D. Davis who made the video shown in the Online Supplementary Information in DLH's laboratory. The content of this publication does not necessarily reflect the views of policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brigelius-Flohe R, 2008, CHEM BIODIVERS, V5, P389, DOI 10.1002/cbdv.200890039; Brigelius-Flohe R, 2009, BBA-GEN SUBJECTS, V1790, P1555, DOI 10.1016/j.bbagen.2009.03.006; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Carlson BA, 2007, J BIOL CHEM, V282, P32591, DOI 10.1074/jbc.M707036200; Carlson BA, 2012, CARCINOGENESIS, V33, P1806, DOI 10.1093/carcin/bgs230; Carlson BA, 2010, P NUTR SOC, V69, P300, DOI 10.1017/S002966511000176X; Carlson BA, 2009, MOLECULES, V14, P3509, DOI 10.3390/molecules14093509; Coash M, 2012, J FORMOS MED ASSOC, V111, P3, DOI 10.1016/j.jfma.2011.11.023; Conrad M, 2010, ANTIOXID REDOX SIGN, V12, P851, DOI 10.1089/ars.2009.2912; Davis CD, 2002, J NUTR, V132, P292, DOI 10.1093/jn/132.2.292; Diwadkar-Navsariwala V, 2006, P NATL ACAD SCI USA, V103, P8179, DOI 10.1073/pnas.0508218103; Felix K, 2004, CANCER RES, V64, P2910, DOI 10.1158/0008-5472.CAN-03-2672; HATFIELD D, 1979, BIOCHIM BIOPHYS ACTA, V564, P414, DOI 10.1016/0005-2787(79)90032-7; HATFIELD D, 1991, NUCLEIC ACIDS RES, V19, P939, DOI 10.1093/nar/19.4.939; Hatfield DL, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P1, DOI 10.1007/978-1-4614-1025-6; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hatfield DL, 2009, BBA-GEN SUBJECTS, V1790, P1541, DOI 10.1016/j.bbagen.2009.03.001; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hudson TS, 2012, CARCINOGENESIS, V33, P1225, DOI 10.1093/carcin/bgs129; Ip C, 2000, ANTICANCER RES, V20, P4179; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Kasaikina MV, 2012, BBA-MOL CELL RES, V1823, P1633, DOI 10.1016/j.bbamcr.2012.02.018; KELMERS AD, 1971, ANAL BIOCHEM, V44, P486, DOI 10.1016/0003-2697(71)90236-3; MCSHANE LM, 1991, AM J CLIN NUTR, V53, P1354, DOI 10.1093/ajcn/53.6.1354; Moustafa ME, 2001, MOL CELL BIOL, V21, P3840, DOI 10.1128/MCB.21.11.3840-3852.2001; MURAKAMI H, 1993, CANCER RES, V53, P1719; Novoselov SV, 2005, ONCOGENE, V24, P8003, DOI 10.1038/sj.onc.1208940; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Santoro D, 2008, J SMALL ANIM PRACT, V49, P552, DOI 10.1111/j.1748-5827.2008.00638.x; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schweizer U, 2004, BIOCHEM J, V378, P21, DOI 10.1042/BJ20031795; Song E, 2011, CLIN MOL ALLERGY, V9, P10, DOI [10.1186/1476-7961-9-10, DOI 10.1186/1476-7961-9-10]; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Tsuji PA, 2012, PLOS ONE IN PRESS; Valentine WM, 2005, TOXICOL PATHOL, V33, P570, DOI 10.1080/01926230500243045; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974	39	20	21	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57389	10.1371/journal.pone.0057389	http://dx.doi.org/10.1371/journal.pone.0057389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460847	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000101
J	Morgan, JA; Bombell, S; McGuire, W				Morgan, Jessie A.; Bombell, Sarah; McGuire, William			Association of Plasminogen Activator Inhibitor-Type 1 (-675 4G/5G) Polymorphism with Pre-Eclampsia: Systematic Review	PLOS ONE			English	Review							HARDY-WEINBERG EQUILIBRIUM; GENE POLYMORPHISMS; GESTATIONAL HYPERTENSION; ENDOTHELIAL DYSFUNCTION; EMPIRICAL-EVALUATION; PREGNANCY; RISK; METAANALYSIS; EPIDEMIOLOGY; PLASMA	Background and Aims: Excessive generation of plasminogen activator inhibitor-type 1 (PAI-1) is implicated in the pathogenesis of pre-eclampsia and related conditions. The PAI-1 (2675 4G/5G) promoter polymorphism (rs1799889) affects transcriptional activity and is a putative genetic risk factor for pre-eclampsia. The aim of this study was identify, appraise and synthesise the available evidence for the association of the PAI-1 (2675 4G/5G) polymorphism with pre-eclampsia. Methods: Systematic review and random effects meta-analysis of genetic association studies. Results: We found 12 eligible genetic association studies in which a total of 1511 women with pre-eclampsia, eclampsia or HELLP syndrome and 3492 controls participated. The studies were generally small (median number of cases 102, range 24 to 403) and underpowered to detect plausible association sizes. Meta-analysis of all of the studies detected statistically significant gene-disease associations in the recessive [pooled odds ratio 1.28 (95% confidence interval 1.09, 1.50); population attributable risk 7.7%] and dominant [pooled odds ratio 1.21 (95% confidence interval 1.01, 1.44); population attributable risk 13.7%] models. We did not find evidence of statistical heterogeneity, funnel plot asymmetry or small study bias. Conclusions: These data suggest that the fibrinolytic pathway regulated by the PAI-1 gene may contribute to the pathogenesis of pre-eclampsia and related conditions. This association, if confirmed in larger genetic association studies, may inform research efforts to develop novel interventions or help to prioritise therapeutic targets that merit evaluation in randomised clinical trials.	[Morgan, Jessie A.; McGuire, William] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Morgan, Jessie A.; McGuire, William] Univ York, NIHR Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Bombell, Sarah] Goulburn Base Hosp, Dept Obstet, Goulburn, NSW, Australia	University of Hull; University of York - UK; University of York - UK	McGuire, W (corresponding author), Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England.	william.mcguire@hyms.ac.uk		McGuire, William/0000-0001-8572-3467	National Institute for Health Research (NIHR) under its Academic Clinical Fellowship funding scheme	National Institute for Health Research (NIHR) under its Academic Clinical Fellowship funding scheme(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Academic Clinical Fellowship funding scheme. The views expressed in this paper are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaziz NA., 2008, EGYPT J HOSP MED, V33, P503; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Belo L, 2002, BJOG-INT J OBSTET GY, V109, P1250, DOI 10.1016/S1470-0328(02)01957-2; Bertolino OW, 2009, IT J GYNAEC OBSTET, V21, P129; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Clausen T, 2002, PLACENTA, V23, P380, DOI 10.1053/plac.2002.0828; COLE P, 1971, BRIT J PREV SOC MED, V25, P242; D'Aniello G, 2003, J HYPERTENS, V21, P1915, DOI 10.1097/00004872-200310000-00019; D'Elia AV, 2011, SEMIN THROMB HEMOST, V37, P97, DOI 10.1055/s-0030-1270334; Dalmaz CA, 2006, BLOOD CELL MOL DIS, V37, P107, DOI 10.1016/j.bcmd.2006.07.005; DE Maat MPM, 2004, J THROMB HAEMOST, V2, P1588, DOI 10.1111/j.1538-7836.2004.00861.x; Dudding T, 2008, J THROMB HAEMOST, V6, P1868, DOI 10.1111/j.1538-7836.2008.03134.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ESTELLES A, 1989, BLOOD, V74, P1332; Fabbro D, 2003, GYNECOL OBSTET INVES, V56, P17, DOI 10.1159/000072326; Gerhardt A, 2005, J THROMB HAEMOST, V3, P686, DOI 10.1111/j.1538-7836.2005.01226.x; Glueck CJ, 2001, OBSTET GYNECOL, V97, P44, DOI 10.1016/S0029-7844(00)01094-2; Glueck CJ, 2000, METABOLISM, V49, P845, DOI 10.1053/meta.2000.6749; Goddard KAB, 2007, HUM HERED, V63, P1, DOI 10.1159/000097926; Gohil R, 2009, THROMB HAEMOSTASIS, V102, P360, DOI 10.1160/TH09-01-0013; GOPEC Consortium, 2005, AM J HUM GENET, V77, P127; Guan Li-xue, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P173; Hakli T, 2003, GENET TEST, V7, P265, DOI 10.1089/109065703322537313; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Helewa ME, 1997, CAN MED ASSOC J, V157, P715; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang J, 2012, BLOOD; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Ivanov P, 2007, Akush Ginekol (Sofiia), V46, P3; Kamal M, 2011, J INVEST MED, V59, P1147, DOI 10.2310/JIM.0b013e31822c5bdf; Kathiresan S, 2005, CIRCULATION, V112, P1129; Kobashi G, 2006, J EPIDEMIOL, V16, P1, DOI 10.2188/jea.16.1; Kobashi G, 2009, J EPIDEMIOL, V19, P275, DOI 10.2188/jea.JE20090003; KOH SCL, 1993, GYNECOL OBSTET INVES, V35, P214, DOI 10.1159/000292703; Koleva R, 2005, Akush Ginekol (Sofiia), V44, P18; Kosmas IP, 2004, J HYPERTENS, V22, P1655, DOI 10.1097/00004872-200409000-00004; Kosmas IP, 2003, J HYPERTENS, V21, P1221, DOI 10.1097/00004872-200307000-00002; Larciprete G, 2007, J OBSTET GYNAECOL RE, V33, P423, DOI 10.1111/j.1447-0756.2007.00550.x; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Malysheva OV, 2002, BALK J MED GENET, V5, P19; Morrison ER, 2002, THROMB HAEMOSTASIS, V87, P779, DOI 10.1055/s-0037-1613083; Muetze S, 2009, J THROMB THROMBOLYS, V27, P141, DOI 10.1007/s11239-007-0175-9; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Pegoraro RJ, 2003, ACTA OBSTET GYN SCAN, V82, P313, DOI 10.1034/j.1600-0412.2003.00085.x; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Rodger MA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000292; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Roes EM, 2002, AM J OBSTET GYNECOL, V187, P1019, DOI 10.1067/mob.2002.126280; Sagoo GS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000028; Said JM, 2012, J THROMB HAEMOST, V10, P881, DOI 10.1111/j.1538-7836.2012.04700.x; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; Serrano NC, 2006, PLOS MED, V3, P2304, DOI 10.1371/journal.pmed.0030520; Shaik AP, 2011, J OBSTET GYNAECOL, V31, P603, DOI 10.3109/01443615.2011.598971; Tempfer CB, 2004, J SOC GYNECOL INVEST, V11, P227, DOI 10.1016/j.jsgi.2003.12.002; Williams PJ, 2011, BEST PRACT RES CL OB, V25, P405, DOI 10.1016/j.bpobgyn.2011.02.007; Wiwanitkit Viroj, 2006, Archives of Gynecology and Obstetrics, V273, P322, DOI 10.1007/s00404-005-0117-8; Wu O, 2006, HEALTH TECHNOL ASSES, V10, P1; Yamada N, 2000, J HUM GENET, V45, P138, DOI 10.1007/s100380050200; Yesupriya A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-31	62	31	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56907	10.1371/journal.pone.0056907	http://dx.doi.org/10.1371/journal.pone.0056907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457639	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700097
J	Farnie, G; Willan, PM; Clarke, RB; Bundred, NJ				Farnie, Gillian; Willan, Pamela M.; Clarke, Robert B.; Bundred, Nigel J.			Combined Inhibition of ErbB1/2 and Notch Receptors Effectively Targets Breast Ductal Carcinoma In Situ (DCIS) Stem/Progenitor Cell Activity Regardless of ErbB2 Status	PLOS ONE			English	Article							CANCER CELLS; INITIATING CELLS; STEM-CELLS; RADIOTHERAPY; POPULATION	Pathways involved in DCIS stem and progenitor signalling are poorly understood yet are critical to understand DCIS biology and to develop new therapies. Notch and ErbB1/2 receptor signalling cross talk has been demonstrated in invasive breast cancer, but their role in DCIS stem and progenitor cells has not been investigated. We have utilised 2 DCIS cell lines, MCF10DCIS.com (ErbB2-normal) and SUM225 (ErbB2-overexpressing) and 7 human primary DCIS samples were cultured in 3D matrigel and as mammospheres in the presence, absence or combination of the Notch inhibitor, DAPT, and ErbB1/2 inhibitors, lapatinib or gefitinib. Western blotting was applied to assess downstream signalling. In this study we demonstrate that DAPT reduced acini size and mammosphere formation in MCF10DCIS.com whereas there was no effect in SUM225. Lapatinb reduced acini size and mammosphere formation in SUM225, whereas mammosphere formation and Notch1 activity were increased in MCF10DCIS.com. Combined DAPT/lapatinib treatment was more effective at reducing acini size in both DCIS cell lines. Mammosphere formation in cell lines and human primary DCIS was reduced further by DAPT/lapatinib or DAPT/gefitinib regardless of ErbB2 receptor status. Our pre-clinical human models of DCIS demonstrate that Notch and ErbB1/2 both play a role in DCIS acini growth and stem cell activity. We report for the first time that cross talk between the two pathways in DCIS occurs regardless of ErbB2 receptor status and inhibition of Notch and ErbB1/2 was more efficacious than either alone. These data provide further understanding of DCIS biology and suggest treatment strategies combining Notch and ErbB1/2 inhibitors should be investigated regardless of ErbB2 receptor status.	[Farnie, Gillian; Willan, Pamela M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Paterson Inst Canc Res, Inst Canc Sci,Christie NHS Fdn Trust, Manchester, Lancs, England; [Clarke, Robert B.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Paterson Inst Canc Res,Inst Canc Sci, Breast Biol Grp,Christie NHS Fdn Trust, Manchester, Lancs, England; [Bundred, Nigel J.] Wythenshawe Hosp, Acad Dept Surg, Univ Hosp South Manchester NHS Fdn Trust, Educ & Res Ctr, Manchester M23 9LT, Lancs, England	Christie NHS Foundation Trust; Paterson Institute for Cancer Research; University of Manchester; Christie NHS Foundation Trust; Paterson Institute for Cancer Research; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Farnie, G (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Paterson Inst Canc Res, Inst Canc Sci,Christie NHS Fdn Trust, Manchester, Lancs, England.	gfarnie@picr.man.ac.uk	farnie, gillian/GLT-8777-2022; Clarke, Robert/AAA-3442-2021	Clarke, Robert/0000-0001-5407-3123; Farnie, Gillian/0000-0002-1407-2529	Breast Cancer Campaign; Breast Cancer Now [MAN-Q1] Funding Source: researchfish	Breast Cancer Campaign; Breast Cancer Now	The authors would like to acknowledge the Breast Cancer Campaign for funding this project. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bijker N, 2006, J CLIN ONCOL, V24, P3381, DOI 10.1200/JCO.2006.06.1366; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Dong YY, 2010, CANCER RES, V70, P5465, DOI 10.1158/0008-5472.CAN-10-0173; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Grudzien P, 2010, ANTICANCER RES, V30, P3853; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Meurette O, 2009, CANCER RES, V69, P5015, DOI 10.1158/0008-5472.CAN-08-3478; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149; PAGE DL, 1995, CANCER, V76, P1197, DOI 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0; Pandya K, 2011, BRIT J CANCER, V105, P796, DOI 10.1038/bjc.2011.321; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Pradeep CR, 2012, ONCOGENE, V31, P907, DOI 10.1038/onc.2011.279; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sakorafas GH, 2008, CANCER TREAT REV, V34, P483, DOI 10.1016/j.ctrv.2008.03.001	20	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56840	10.1371/journal.pone.0056840	http://dx.doi.org/10.1371/journal.pone.0056840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457626	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700098
J	Massey, J; Rothwell, S; Rusbridge, C; Tauro, A; Addicott, D; Chinoy, H; Cooper, RG; Ollier, WER; Kennedy, LJ				Massey, Jonathan; Rothwell, Simon; Rusbridge, Clare; Tauro, Anna; Addicott, Diane; Chinoy, Hector; Cooper, Robert G.; Ollier, William E. R.; Kennedy, Lorna J.			Association of an MHC Class II Haplotype with Increased Risk of Polymyositis in Hungarian Vizsla Dogs	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CANINE INFLAMMATORY MYOPATHIES; MULTIPLE-SCLEROSIS; DERMATOMYOSITIS; SUSCEPTIBILITY; MYOSITIS	A breed-specific polymyositis is frequently observed in the Hungarian Vizsla. Beneficial clinical response to immunosuppressive therapies has been demonstrated which points to an immune-mediated aetiology. Canine inflammatory myopathies share clinical and histological similarities with the human immune-mediated myopathies. As MHC class II associations have been reported in the human conditions we investigated whether an MHC class II association was present in the canine myopathy seen in this breed. 212 Hungarian Vizsla pedigree dogs were stratified both on disease status and degree of relatedness to an affected dog. This generated a group of 29 cases and 183 "graded" controls: 93 unaffected dogs with a first degree affected relative, 44 unaffected dogs with a second degree affected relative, and 46 unaffected dogs with no known affected relatives. Eleven DLA class II haplotypes were identified, of which, DLA-DRB1* 02001/DQA1*00401/DQB1*01303, was at significantly raised frequency in cases compared to controls (OR = 1.92, p = 0.032). When only control dogs with no family history of the disease were compared to cases, the association was further strengthened (OR = 4.08, p = 0.00011). Additionally, a single copy of the risk haplotype was sufficient to increase disease risk, with the risk substantially increasing for homozygotes. There was a trend of increasing frequency of this haplotype with degree of relatedness, indicating low disease penetrance. These findings support the hypothesis of an immune-mediated aetiology for this canine myopathy and give credibility to potentially using the Hungarian Vizsla as a genetic model for comparative studies with human myositis.	[Massey, Jonathan; Rothwell, Simon; Cooper, Robert G.; Ollier, William E. R.; Kennedy, Lorna J.] Univ Manchester, CIGMR, Inst Populat Hlth, Fac Med & Human Sci, Manchester, Lancs, England; [Rusbridge, Clare] Stone Lion Vet Hosp, London, England; [Tauro, Anna] Alcombe Vet Surg, London, England; [Addicott, Diane] Hungarian Vizsla Breed Club, Royal Tunbridge Wells, England; [Chinoy, Hector; Cooper, Robert G.] 6 Univ Manchester, Ctr Rheumat Dis, Manchester Acad Hlth Sci Ctr, Salford Royal NHS Fdn Trust, Salford, Lancs, England	University of Manchester; Salford Royal NHS Foundation Trust	Massey, J (corresponding author), Univ Manchester, CIGMR, Inst Populat Hlth, Fac Med & Human Sci, Manchester, Lancs, England.	jonathan.massey@manchester.ac.uk	Rusbridge, Clare/A-3794-2019; Rusbridge, Clare/K-6560-2019; Kennedy, Lorna/AAK-8767-2020; Chinoy, Hector/C-7832-2013	Rusbridge, Clare/0000-0002-3366-2110; Rusbridge, Clare/0000-0002-3366-2110; Kennedy, Lorna/0000-0002-3087-4548; Massey, Jonathan/0000-0002-4576-1124; Chinoy, Hector/0000-0001-6492-1288; Rothwell, Simon/0000-0003-2123-9902	Arthritis Research UK [18474] Funding Source: Medline; National Institute for Health Research [CL-2006-06-010] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); National Institute for Health Research(National Institute for Health Research (NIHR))		Aguirre-Hernandez J, 2010, TISSUE ANTIGENS, V76, P476, DOI 10.1111/j.1399-0039.2010.01554.x; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Clark LA, 2005, VET DERMATOL, V16, P392, DOI 10.1111/j.1365-3164.2005.00469.x; Evans J, 2004, J VET INTERN MED, V18, P679, DOI 10.1892/0891-6640(2004)18&lt;679:CIMACR&gt;2.0.CO;2; Foale RD, 2008, P 50 BSAVA C BIRM CL; Greer KA, 2010, TISSUE ANTIGENS, V76, P110, DOI 10.1111/j.1399-0039.2010.01484.x; Haley AC, 2011, J VET INTERN MED, V25, P393, DOI 10.1111/j.1939-1676.2010.0660.x; Hankel S, 2006, VET IMMUNOL IMMUNOP, V113, P1, DOI 10.1016/j.vetimm.2006.03.025; HARGIS AM, 1986, AM J PATHOL, V123, P480; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Kennedy LJ, 2008, TISSUE ANTIGENS, V71, P51, DOI 10.1111/j.1399-0039.2007.00964.x; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P272, DOI 10.1111/j.1399-0039.2006.00779.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P467, DOI 10.1111/j.1399-0039.2006.00716.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P82, DOI 10.1111/j.1399-0039.2006.00614.x; MACGREGOR A, 1995, J RHEUMATOL, V22, P1032; O'Hanlon TP, 2005, MEDICINE, V84, P338, DOI 10.1097/01.md.0000189818.63141.8c; ODDIS CV, 1990, J RHEUMATOL, V17, P1329; Paciello O, 2007, NEUROMUSCULAR DISORD, V17, P313, DOI 10.1016/j.nmd.2007.01.012; Rusbridge C, 2011, VET REC, V168, P85, DOI 10.1136/vr.d372; Shelton GD, 2006, VET IMMUNOL IMMUNOP, V113, P200, DOI 10.1016/j.vetimm.2006.05.005; Wahl JM, 2008, VET DERMATOL, V19, P52, DOI 10.1111/j.1365-3164.2008.00655.x; Wilbe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012332; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; Wilbe M, 2009, IMMUNOGENETICS, V61, P557, DOI 10.1007/s00251-009-0387-6	24	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56490	10.1371/journal.pone.0056490	http://dx.doi.org/10.1371/journal.pone.0056490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457575	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700075
J	Uzarski, JS; Scott, EW; McFetridge, PS				Uzarski, Joseph S.; Scott, Edward W.; McFetridge, Peter S.			Adaptation of Endothelial Cells to Physiologically-Modeled, Variable Shear Stress	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; WALL SHEAR; IN-VIVO; VASCULAR ENDOTHELIUM; HEMODYNAMIC FORCES; STEADY SHEAR; WAVE-FORMS; EXPRESSION; ATHEROSCLEROSIS; ATHEROGENESIS	Endothelial cell (EC) function is mediated by variable hemodynamic shear stress patterns at the vascular wall, where complex shear stress profiles directly correlate with blood flow conditions that vary temporally based on metabolic demand. The interactions of these more complex and variable shear fields with EC have not been represented in hemodynamic flow models. We hypothesized that EC exposed to pulsatile shear stress that changes in magnitude and duration, modeled directly from real-time physiological variations in heart rate, would elicit phenotypic changes as relevant to their critical roles in thrombosis, hemostasis, and inflammation. Here we designed a physiological flow (PF) model based on short-term temporal changes in blood flow observed in vivo and compared it to static culture and steady flow (SF) at a fixed pulse frequency of 1.3 Hz. Results show significant changes in gene regulation as a function of temporally variable flow, indicating a reduced wound phenotype more representative of quiescence. EC cultured under PF exhibited significantly higher endothelial nitric oxide synthase (eNOS) activity (PF: 176.0 +/- 11.9 nmol/10(5) EC; SF: 115.0 +/- 12.5 nmol/10(5) EC, p = 0.002) and lower TNF-a-induced HL-60 leukocyte adhesion (PF: 37 +/- 6 HL-60 cells/mm(2); SF: 111 +/- 18 HL-60/mm(2), p = 0.003) than cells cultured under SF which is consistent with a more quiescent anti-inflammatory and anti-thrombotic phenotype. In vitro models have become increasingly adept at mimicking natural physiology and in doing so have clarified the importance of both chemical and physical cues that drive cell function. These data illustrate that the variability in metabolic demand and subsequent changes in perfusion resulting in constantly variable shear stress plays a key role in EC function that has not previously been described.	[Uzarski, Joseph S.; McFetridge, Peter S.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA; [Scott, Edward W.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	McFetridge, PS (corresponding author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.	pmcfetridge@bme.ufl.edu	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	National Institutes of Health [R01-HL088207, R01-HL088207-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (grants R01-HL088207 and R01-HL088207-S1) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alef MJ, 2012, NITRIC OXIDE; Bagi Z, 2005, ARTERIOSCL THROM VAS, V25, P1590, DOI 10.1161/01.ATV.0000170136.71970.5f; Blackman BR, 2002, J BIOMECH ENG-T ASME, V124, P397, DOI 10.1115/1.1486468; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; Butler PJ, 2000, MICROCIRCULATION, V7, P53, DOI 10.1038/sj.mn.7300093; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Dai GH, 2004, P NATL ACAD SCI USA, V101, P14871, DOI 10.1073/pnas.0406073101; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; Davies PF, 2008, ANN BIOMED ENG, V36, P563, DOI [10.1007/s10439-007-9400-0, 10.1007/S10439-007-9400-0]; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Doriot PA, 2000, CORONARY ARTERY DIS, V11, P495, DOI 10.1097/00019501-200009000-00008; FRANGOS JA, 1988, BIOTECHNOL BIOENG, V32, P1053, DOI 10.1002/bit.260320812; Frangos JA, 1996, BIOCHEM BIOPH RES CO, V224, P660, DOI 10.1006/bbrc.1996.1081; FURLONG B, 1987, BRIT J PHARMACOL, V90, P687, DOI 10.1111/j.1476-5381.1987.tb11221.x; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; Gimbrone MA, 1999, AM J PATHOL, V155, P1, DOI 10.1016/S0002-9440(10)65090-0; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Hahn C, 2008, ARTERIOSCL THROM VAS, V28, P2101, DOI 10.1161/ATVBAHA.108.165951; Himburg HA, 2007, AM J PHYSIOL-HEART C, V293, pH645, DOI 10.1152/ajpheart.01087.2006; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; KUCHAN MJ, 1994, AM J PHYSIOL, V267, pC753, DOI 10.1152/ajpcell.1994.267.3.C753; Li M, 2009, ANN BIOMED ENG, V37, P1082, DOI 10.1007/s10439-009-9684-3; Li Y, 2004, BIOL REPROD, V70, P785, DOI 10.1095/biolreprod.103.022293; Lindemann S, 2000, THROMB RES, V97, P113, DOI 10.1016/S0049-3848(99)00162-0; Luu NT, 2010, J VASC RES, V47, P451, DOI 10.1159/000302613; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; NEREM RM, 1983, ANN NY ACAD SCI, V416, P709, DOI 10.1111/j.1749-6632.1983.tb35222.x; Newcomer SC, 2011, J APPL PHYSIOL, V111, P311, DOI 10.1152/japplphysiol.00033.2011; Papaioannou TG, 2006, INT J CARDIOL, V113, P12, DOI 10.1016/j.ijcard.2006.03.035; RANJAN V, 1995, AM J PHYSIOL-HEART C, V269, pH550, DOI 10.1152/ajpheart.1995.269.2.H550; Reneman RS, 2008, MED BIOL ENG COMPUT, V46, P499, DOI 10.1007/s11517-008-0330-2; Rouleau L, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001891; Rouleau L, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001217; Sakamoto N, 2010, BIOCHEM BIOPH RES CO, V398, P426, DOI 10.1016/j.bbrc.2010.06.092; Schulz E, 2009, CIRC RES, V104, P422, DOI 10.1161/CIRCRESAHA.109.194274; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Sparacino-Watkins CE, 2012, CIRCULATION; Syedain ZH, 2008, P NATL ACAD SCI USA, V105, P6537, DOI 10.1073/pnas.0711217105; Thorin E, 2010, PFLUG ARCH EUR J PHY, V459, P951, DOI 10.1007/s00424-009-0763-y; Wang NP, 2006, BIOCHEM BIOPH RES CO, V341, P1244, DOI 10.1016/j.bbrc.2006.01.089; White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128; Wu KK, 1996, ANNU REV MED, V47, P315; Yee A, 2008, ANN BIOMED ENG, V36, P571, DOI 10.1007/s10439-008-9452-9	52	52	54	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e57004	10.1371/journal.pone.0057004	http://dx.doi.org/10.1371/journal.pone.0057004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457646	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700105
J	Shi, ZY; Wedd, AG; Gras, SL				Shi, Zhenyu; Wedd, Anthony G.; Gras, Sally L.			Parallel In Vivo DNA Assembly by Recombination: Experimental Demonstration and Theoretical Approaches	PLOS ONE			English	Article							METABOLIC FLUX ANALYSIS; IDENTIFYING DETERMINANTS; SACCHAROMYCES-CEREVISIAE; CHEMICAL-SYNTHESIS; FLP RECOMBINASE; CLONING; CONSTRUCTION; GENES; PLASMID; PROTEIN	The development of synthetic biology requires rapid batch construction of large gene networks from combinations of smaller units. Despite the availability of computational predictions for well-characterized enzymes, the optimization of most synthetic biology projects requires combinational constructions and tests. A new building-brick-style parallel DNA assembly framework for simple and flexible batch construction is presented here. It is based on robust recombination steps and allows a variety of DNA assembly techniques to be organized for complex constructions (with or without scars). The assembly of five DNA fragments into a host genome was performed as an experimental demonstration.	[Shi, Zhenyu; Wedd, Anthony G.] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia; [Gras, Sally L.] Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3052, Australia; [Shi, Zhenyu; Wedd, Anthony G.; Gras, Sally L.] Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic, Australia	University of Melbourne; University of Melbourne	Shi, ZY (corresponding author), Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia.	shiz@student.unimelb.edu.au	Gras, Sally L/G-2025-2014	Gras, Sally L/0000-0002-4660-1245	University of Melbourne; Bio21 Molecular Science and Biotechnology Institute, School of Chemistry, University of Melbourne; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne	University of Melbourne(University of Melbourne); Bio21 Molecular Science and Biotechnology Institute, School of Chemistry, University of Melbourne; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne	This research was supported from funds provided by the University of Melbourne and the Bio21 Molecular Science and Biotechnology Institute, School of Chemistry, University of Melbourne (http://www.chemistry.unimelb.edu.au) and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne (http://www.bio21.unimelb.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bennett GN, 2003, United States Patent, Patent No. 7267984; Bitinaite J, 2007, NUCLEIC ACIDS RES, V35, P1992, DOI 10.1093/nar/gkm041; Chen QJ, 2010, PLANT PHYSIOL, V153, P41, DOI 10.1104/pp.109.152249; Chiang CJ, 2008, BIOTECHNOL BIOENG, V101, P985, DOI 10.1002/bit.21976; Chitale M, 2011, COMPUTATIONAL PROTEI; Czar MJ, 2009, NUCLEIC ACIDS RES, V37, pW40, DOI 10.1093/nar/gkp361; Dafhnis-Calas F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni192; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DORGAI L, 1995, J MOL BIOL, V252, P178, DOI 10.1006/jmbi.1995.0486; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Esposito Dominic, 2009, V498, P31, DOI 10.1007/978-1-59745-196-3_3; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Fu CL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn167; Fu J, 2012, NAT BIOTECHNOL; Gahan CGM, 2012, CURR GENE THER, V12, P12; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Goler JA, 2004, 2004003 AITR; Griffiths AJ, 2000, INTRO GENETIC ANAL, V7th; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hartley JL, 1999, United States Patent, Patent No. [US5888732, 5888732]; Husseiny MI, 2005, INFECT IMMUN, V73, P1598, DOI 10.1128/IAI.73.3.1598-1605.2005; Itaya M, 1999, J BACTERIOL, V181, P1045, DOI 10.1128/JB.181.3.1045-1048.1999; Itaya M, 2008, NAT METHODS, V5, P41, DOI 10.1038/NMETH1143; Jang YS, 2012, BIOTECHNOL J, V7, P186, DOI 10.1002/biot.201100059; Kirby J, 2008, NAT PROD REP, V25, P656, DOI 10.1039/b802939c; Knight T., 2003, IDEMPOTENT VECTOR DE; Kouprina N, 2003, EMBO REP, V4, P257, DOI 10.1038/sj.embor.embor766; Kuhlman TE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1193; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; Leem SH, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng029; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; Li B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-7; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Lin L, 2003, P NATL ACAD SCI USA, V100, P5962, DOI 10.1073/pnas.0931425100; LOBBAN PE, 1973, J MOL BIOL, V78, P453, DOI 10.1016/0022-2836(73)90468-3; Ma L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019883; Minaeva NI, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-63; Mirschel S, 2009, BIOINFORMATICS, V25, P687, DOI 10.1093/bioinformatics/btp029; Niklas J, 2010, CURR OPIN BIOTECH, V21, P63, DOI 10.1016/j.copbio.2010.01.011; Noh K, 2011, APPL MICROBIOL BIOT, V91, P1247, DOI 10.1007/s00253-011-3390-4; Norville Julie E, 2010, J Biol Eng, V4, P17, DOI 10.1186/1754-1611-4-17; Noskov VN, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-16; PAN GH, 1993, MOL CELL BIOL, V13, P3167, DOI 10.1128/MCB.13.6.3167; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Ravin NV, 2011, PLASMID, V65, P102, DOI 10.1016/j.plasmid.2010.12.004; Sael Lee, 2012, Journal of Structural and Functional Genomics, V13, P111, DOI 10.1007/s10969-012-9126-6; Schweizer HP, 2003, J MOL MICROB BIOTECH, V5, P67, DOI 10.1159/000069976; Schwender J, 2008, CURR OPIN BIOTECH, V19, P131, DOI 10.1016/j.copbio.2008.02.006; SENECOFF JF, 1985, P NATL ACAD SCI USA, V82, P7270, DOI 10.1073/pnas.82.21.7270; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Shetty R, 2011, METHOD ENZYMOL, V498, P311, DOI 10.1016/B978-0-12-385120-8.00013-9; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Shi Z, 2012, VEXCUTOR ALL I UNPUB; Sleight SC, 2010, NUCLEIC ACIDS RES, V38, P2624, DOI 10.1093/nar/gkq179; Spiekermann P, 1999, ARCH MICROBIOL, V171, P73, DOI 10.1007/s002030050681; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Trinh CT, 2009, APPL MICROBIOL BIOT, V81, P813, DOI 10.1007/s00253-008-1770-1; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Wiechert W, 2002, GENET ENG P, V24, P215; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x; YAGIL E, 1995, J MOL BIOL, V252, P163, DOI 10.1006/jmbi.1995.0485; Zamboni N, 2011, CURR OPIN BIOTECH, V22, P103, DOI 10.1016/j.copbio.2010.08.009; Zhang L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00141	75	2	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56854	10.1371/journal.pone.0056854	http://dx.doi.org/10.1371/journal.pone.0056854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468883	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900039
J	Wang, W; Pechacek, P; Zhang, MX; Xiao, NW; Zhu, JG; Li, JS				Wang, Wei; Pechacek, Peter; Zhang, Mingxia; Xiao, Nengwen; Zhu, Jianguo; Li, Junsheng			Effectiveness of Nature Reserve System for Conserving Tropical Forests: A Statistical Evaluation of Hainan Island, China	PLOS ONE			English	Article							PROTECTED AREAS; SPECIES COMPOSITION; GAP ANALYSIS; RAIN-FOREST; DEGRADATION; PARKS; DYNAMICS; RECOVERY; IMPACT; GROWTH	Evaluating the effectiveness of existing nature reserve systems for the conservation of tropical forests is an urgent task to save the remaining biodiversity. Here, we tested the effectiveness of the reserve system on Hainan Island by conducting a three-way comparison of changes in forest area in locations within the reserves, adjacent to the reserves, and far outside of the reserves. We used a general linear model to control for the effects of covariates (historical forest area, elevation, slope, and distance to nearest roads), which may also be correlated with the changes in forest area, to better explain the effectiveness of the reserve system. From 2000 to 2010, the forest area inside Hainan's nature reserve system showed an increase while adjacent unprotected areas and the wider, unprotected landscape both experienced deforestation. However, the simple inside-outside comparisons may overestimate the protective effect of the reserve system. Most nature reserves (>60%) showed increasing fragmentation. And the risk of rapid deforestation remained high at low elevations, where remaining forests tend to be easily logged and converted to commercial plantations. Future conservation efforts should pay more attention to those sites with less challenging environmental conditions.	[Wang, Wei; Pechacek, Peter; Xiao, Nengwen; Li, Junsheng] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [Wang, Wei; Pechacek, Peter; Xiao, Nengwen; Li, Junsheng] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China; [Zhang, Mingxia] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Xishuangbanna, Yunnan, Peoples R China; [Zhang, Mingxia; Zhu, Jianguo] Chinese Acad Sci, Kunming Inst Zool, Conservat & Environm Ctr, Kunming, Yunnan, Peoples R China	Chinese Research Academy of Environmental Sciences; Chinese Research Academy of Environmental Sciences; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology	Li, JS (corresponding author), Chinese Res Inst Environm Sci, Beijing, Peoples R China.	lijsh@craes.org.cn	Xiao, Nengwen/ACW-1426-2022	Xiao, NengWen/0000-0002-7482-135X; wang, wei/0000-0002-3864-4931	Public Welfare Scientific Research Project, Ministry of Environmental Protection of the People's Republic of China [201209028]	Public Welfare Scientific Research Project, Ministry of Environmental Protection of the People's Republic of China	The study was supported by a Public Welfare Scientific Research Project, Ministry of Environmental Protection of the People's Republic of China (Grant No. 201209028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Chai SL, 2009, BIOL CONSERV, V142, P2484, DOI 10.1016/j.biocon.2009.05.020; Chape S., 2009, BIOSCIENCE, V59, P623; Dalle SP, 2011, ECOL APPL, V21, P1557, DOI 10.1890/10-0700.1; Deng F, 2007, J S CHINA U TROP AGR, V13, P19; Deng F, 2008, FOREST ECOL MANAG, V255, P1820, DOI 10.1016/j.foreco.2007.12.004; Dunn RR, 2004, CONSERV BIOL, V18, P302, DOI 10.1111/j.1523-1739.2004.00151.x; Fellowes John R., 2008, Asian Primates Journal, V1, P2; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kutner M., 2005, APPL LINEAR STAT MOD; Letcher SG, 2009, BIOTROPICA, V41, P608, DOI 10.1111/j.1744-7429.2009.00517.x; Leverington F., 2008, MANAGEMENT EFFECTIVE; Liebsch D, 2008, BIOL CONSERV, V141, P1717, DOI 10.1016/j.biocon.2008.04.013; Liu JG, 2003, SCIENCE, V300, P1240, DOI 10.1126/science.1078868; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mas JF, 2005, ENVIRON MONIT ASSESS, V105, P69, DOI 10.1007/s10661-005-3156-5; Meng JH, 2011, TROP ECOL, V52, P177; MEP, 2012, 2011 LIST NAT RES CH; Nagendra H, 2008, AMBIO, V37, P330, DOI 10.1579/06-R-184.1; Oldfield TEE, 2004, BIOL CONSERV, V120, P303, DOI 10.1016/j.biocon.2004.03.003; Ren GP, 2009, FOREST ECOL MANAG, V258, P26, DOI 10.1016/j.foreco.2009.03.043; Sanchez-Azofeifa GA, 2003, BIOL CONSERV, V109, P123, DOI 10.1016/S0006-3207(02)00145-3; Sang WG, 2011, BIOSCIENCE, V61, P720, DOI 10.1525/bio.2011.61.9.11; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Silver WL, 2004, ECOL APPL, V14, P1115, DOI 10.1890/03-5123; Southworth J, 2004, APPL GEOGR, V24, P303, DOI 10.1016/j.apgeog.2004.07.003; Stoll-Kleemann S, 2010, BASIC APPL ECOL, V11, P377, DOI 10.1016/j.baae.2010.06.004; Tang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019116; Turner IM, 1996, TRENDS ECOL EVOL, V11, P330, DOI 10.1016/0169-5347(96)10046-X; Wang W, 2008, J WILDLIFE MANAGE, V72, P1335, DOI 10.2193/2007-077; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Wu RD, 2011, FRONT ECOL ENVIRON, V9, P383, DOI 10.1890/100093; Wu RD, 2011, ENVIRON SCI POLLUT R, V18, P800, DOI 10.1007/s11356-011-0440-5; Xu JC, 2011, NATURE, V477, P370, DOI 10.1038/477371a; Young JE, 2006, FOREST ECOL MANAG, V230, P151, DOI 10.1016/j.foreco.2006.04.031; Zhang MX, 2010, BIOL CONSERV, V143, P1397, DOI 10.1016/j.biocon.2010.03.014; Zhang YQ, 2000, CAN J FOREST RES, V30, P1913, DOI 10.1139/cjfr-30-12-1913	46	24	38	8	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57561	10.1371/journal.pone.0057561	http://dx.doi.org/10.1371/journal.pone.0057561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469024	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900123
J	Zhang, ZG; Zhang, Q; Wu, JX; Zheng, X; Zheng, S; Sun, XH; Qiu, QS; Lu, TG				Zhang, Zhiguo; Zhang, Quian; Wu, Jinxia; Zheng, Xia; Zheng, Sheng; Sun, Xuehui; Qiu, Quansheng; Lu, Tiegang			Gene Knockout Study Reveals That Cytosolic Ascorbate Peroxidase 2(OsAPX2) Plays a Critical Role in Growth and Reproduction in Rice under Drought, Salt and Cold Stresses	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; OXYGEN; ARABIDOPSIS; EXPRESSION; RESPONSES; LIGHT; NETWORK; FAMILY	Plant ascorbate peroxidases (APXs), enzymes catalyzing the dismutation of H2O2 into H2O and O-2, play an important role in reactive oxygen species homeostasis in plants. The rice genome has eight OsAPXs, but their physiological functions remain to be determined. In this report, we studied the function of OsAPX2 gene using a T-DNA knockout mutant under the treatment of drought, salt and cold stresses. The Osapx2 knockout mutant was isolated by a genetic screening of a rice TDNA insertion library under 20% PEG-2000 treatment. Loss of function in OsAPX2 affected the growth and development of rice seedlings, resulting in semi-dwarf seedlings, yellow-green leaves, leaf lesion mimic and seed sterility. OsAPX2 expression was developmental-and spatial-regulated, and was induced by drought, salt, and cold stresses. Osapx2 mutants had lower APX activity and were sensitive to abiotic stresses; overexpression of OsAPX2 increased APX activity and enhanced stress tolerance. H2O2 and MDA levels were high in Osapx2 mutants but low in OsAPX2-OX transgenic lines relative to wild-type plants after stress treatments. Taken together, the cytosolic ascorbate peroxidase OsAPX2 plays an important role in rice growth and development by protecting the seedlings from abiotic stresses through scavenging reactive oxygen species.	[Zhang, Zhiguo; Zhang, Quian; Wu, Jinxia; Zheng, Xia; Sun, Xuehui; Lu, Tiegang] Chinese Acad Agr Sci, Biotechnol Res Inst, Natl Key Facil Gene Resources & Genet Improvement, Beijing 100193, Peoples R China; [Zheng, Sheng; Qiu, Quansheng] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Lanzhou University	Qiu, QS (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China.	qiuqsh@lzu.edu.cn; lutiegang@caas.cn			National Natural Science Foundation of China (NSFC) [30771089, 31070222]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from The National Natural Science Foundation of China (NSFC) (30771089 to Tiegang Lu) and (31070222 to Quansheng Qiu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2003, GENE, V322, P93, DOI 10.1016/j.gene.2003.08.017; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; BOYER JS, 1969, ANN REV PLANT PHYSIO, V20, P351, DOI 10.1146/annurev.pp.20.060169.002031; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAKMAK I, 1991, PHYSIOL PLANTARUM, V83, P463, DOI 10.1111/j.1399-3054.1991.tb00121.x; CHEN GX, 1989, PLANT CELL PHYSIOL, V30, P987; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Fridovich I, 1998, PROTEIN SCI, V7, P2688, DOI 10.1002/pro.5560071225; Gilchrist E, 2010, BRIEF FUNCT GENOMICS, V9, P103, DOI 10.1093/bfgp/elp059; Guan QJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041233; Guan YS, 2010, J EXP BOT, V61, P4145, DOI 10.1093/jxb/erq212; Kangasjarvi S, 2008, BIOCHEM J, V412, P275, DOI 10.1042/BJ20080030; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Koussevitzky S, 2008, J BIOL CHEM, V283, P34197, DOI 10.1074/jbc.M806337200; Li SC, 2006, J INTEGR PLANT BIOL, V48, P307, DOI 10.1111/j.1744-7909.2006.00228.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZQ, 2007, PLANT CELL REP, V26, P1909, DOI 10.1007/s00299-007-0395-7; Malamy JE, 1997, DEVELOPMENT, V124, P33; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mullineaux PM, 2006, PLANT PHYSIOL, V141, P346, DOI 10.1104/pp.106.078162; Niwa R, 2008, CELL PRESS, P34; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Panchuk II, 2005, PLANTA, V222, P926, DOI 10.1007/s00425-005-0028-8; Peng H, 2005, PLANT SCI, V168, P1571, DOI 10.1016/j.plantsci.2005.02.011; Pnueli L, 2003, PLANT J, V34, P187, DOI 10.1046/j.1365-313X.2003.01715.x; Prochazkova D, 2001, PLANT SCI, V161, P765, DOI 10.1016/S0168-9452(01)00462-9; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Rosa SB, 2010, PHYTOCHEMISTRY, V71, P548, DOI 10.1016/j.phytochem.2010.01.003; Rossel JB, 2006, PLANT CELL ENVIRON, V29, P269, DOI 10.1111/j.1365-3040.2005.01419.x; Sato Y, 2011, PLANT CELL REP, V30, P399, DOI 10.1007/s00299-010-0985-7; Scandalios John G., 2002, Trends in Biochemical Sciences, V27, P483, DOI 10.1016/S0968-0004(02)02170-9; Teixeira FK, 2006, PLANTA, V224, P300, DOI 10.1007/s00425-005-0214-8; Yang YZ, 2004, PLANT SCI, V167, P281, DOI 10.1016/j.plantsci.2004.03.026; Zou LP, 2011, PLANT PHYSIOL, V156, P1589, DOI 10.1104/pp.111.176016	38	132	144	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57472	10.1371/journal.pone.0057472	http://dx.doi.org/10.1371/journal.pone.0057472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468992	Green Submitted, gold, Green Published			2022-12-27	WOS:000315524900092
J	Dudschig, C; Souman, J; Lachmair, M; de la Vega, I; Kaup, B				Dudschig, Carolin; Souman, Jan; Lachmair, Martin; de la Vega, Irmgard; Kaup, Barbara			Reading "Sun" and Looking Up: The Influence of Language on Saccadic Eye Movements in the Vertical Dimension	PLOS ONE			English	Article							COVERT SHIFTS; ATTENTION; INFORMATION	Traditionally, language processing has been attributed to a separate system in the brain, which supposedly works in an abstract propositional manner. However, there is increasing evidence suggesting that language processing is strongly interrelated with sensorimotor processing. Evidence for such an interrelation is typically drawn from interactions between language and perception or action. In the current study, the effect of words that refer to entities in the world with a typical location (e. g., sun, worm) on the planning of saccadic eye movements was investigated. Participants had to perform a lexical decision task on visually presented words and non-words. They responded by moving their eyes to a target in an upper (lower) screen position for a word (non-word) or vice versa. Eye movements were faster to locations compatible with the word's referent in the real world. These results provide evidence for the importance of linguistic stimuli in directing eye movements, even if the words do not directly transfer directional information.	[Dudschig, Carolin; Souman, Jan; Lachmair, Martin; de la Vega, Irmgard; Kaup, Barbara] Univ Tubingen, Dept Psychol, Tubingen, Germany	Eberhard Karls University of Tubingen	Dudschig, C (corresponding author), Univ Tubingen, Dept Psychol, Tubingen, Germany.	carolin.dudschig@uni-tuebingen.de	Kaup, Barbara/M-6786-2013; Lachmair, Martin/HCH-2667-2022	Kaup, Barbara/0000-0002-7400-0789; Souman, Jan L./0000-0003-3027-1090; Lachmair, Martin/0000-0002-0469-9168	Margarete-von-Wrangell Fellowship (European Social Fund); Ministry of Science, Research and the Arts Baden-Wurttemberg; German Research Foundation [SFB833/B4]; German Research Foundation; University of Tuebingen	Margarete-von-Wrangell Fellowship (European Social Fund); Ministry of Science, Research and the Arts Baden-Wurttemberg; German Research Foundation(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); University of Tuebingen	This project was supported by a Margarete-von-Wrangell Fellowship appointed to Carolin Dudschig (European Social Fund and the Ministry of Science, Research and the Arts Baden-Wurttemberg) and by the SFB833/B4 project of Barbara Kaup (German Research Foundation). The authors also acknowledge support by the German Research Foundation and the Open Access Publishing Fund of the University of Tuebingen for funding publication fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bergen BK, 2007, COGNITIVE SCI, V31, P733, DOI 10.1080/03640210701530748; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Dudschig C, 2012, MEM COGNITION, V40, P1081, DOI 10.3758/s13421-012-0201-9; Dudschig C, 2012, COGN PROCESS, V13, pS151, DOI 10.1007/s10339-012-0480-x; EBERHARD KM, 1995, J PSYCHOLINGUIST RES, V24, P409, DOI 10.1007/BF02143160; Estes Z, 2008, PSYCHOL SCI, V19, P93, DOI 10.1111/j.1467-9280.2008.02051.x; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Goldring J, 1997, EXP BRAIN RES, V113, P88, DOI 10.1007/BF02454145; Gozli DG, 2013, J EXP PSYCHOL GEN, V142, P1028, DOI 10.1037/a0030362; Hanna JE, 2007, J MEM LANG, V57, P596, DOI 10.1016/j.jml.2007.01.008; Hodgson T, 2007, BRAIN, V130, P1525, DOI 10.1093/brain/awm064; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 2001, PSYCHOL SCI, V12, P360, DOI 10.1111/1467-9280.00367; Huettig F, 2011, ACTA PSYCHOL, V137, P151, DOI 10.1016/j.actpsy.2010.11.003; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kleiner M, 2007, WHATS NEW PSYCHOTO S, V36; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Lachmair M, 2011, PSYCHON B REV, V18, P1180, DOI 10.3758/s13423-011-0158-x; LAKOFF G, 1980, COGNITIVE SCI, V4, P195, DOI 10.1207/s15516709cog0402_4; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; LOGAN GD, 1995, COGNITIVE PSYCHOL, V28, P103, DOI 10.1006/cogp.1995.1004; Lu CH, 2001, Q J EXP PSYCHOL-A, V54, P95, DOI 10.1080/02724980042000048; Maddox WT, 2001, PERCEPT PSYCHOPHYS, V63, P1183, DOI 10.3758/BF03194533; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peterson MS, 2004, PERCEPT PSYCHOPHYS, V66, P398, DOI 10.3758/BF03194888; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; R Core Team, 2012, R LANG ENV STAT COMP; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; Schwarz W, 2004, PERCEPT PSYCHOPHYS, V66, P651, DOI 10.3758/BF03194909; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tanenhaus MK, 2008, PHILOS T R SOC B, V363, P1105, DOI 10.1098/rstb.2007.2162; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Thornton T, 2013, J EXP PSYCHOL HUMAN, V39, P964, DOI 10.1037/a0030467; Verges M, 2009, COGNITIVE SCI, V33, P1157, DOI 10.1111/j.1551-6709.2009.01038.x; Zwaan RA, 2002, PSYCHOL SCI, V13, P168, DOI 10.1111/1467-9280.00430; Zwaan RolfA., 2005, GROUNDING COGNITION, P224, DOI DOI 10.1017/CBO9780511499968.010	44	46	46	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56872	10.1371/journal.pone.0056872	http://dx.doi.org/10.1371/journal.pone.0056872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460816	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000040
J	Qian, J; Song, JY; Gao, HH; Zhu, YJ; Xu, J; Pang, XH; Yao, H; Sun, C; Li, XE; Li, CY; Liu, JA; Xu, HB; Chen, SL				Qian, Jun; Song, Jingyuan; Gao, Huanhuan; Zhu, Yingjie; Xu, Jiang; Pang, Xiaohui; Yao, Hui; Sun, Chao; Li, Xian'en; Li, Chuyuan; Liu, Juyan; Xu, Haibin; Chen, Shilin			The Complete Chloroplast Genome Sequence of the Medicinal Plant Salvia miltiorrhiza	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PLASTID GENOME; PHYLOGENETIC-RELATIONSHIPS; TRANSFER-RNAS; DNA; EVOLUTION; IDENTIFICATION; ORGANIZATION; BIOTECHNOLOGY; MULTIPLE	Salvia miltiorrhiza is an important medicinal plant with great economic and medicinal value. The complete chloroplast (cp) genome sequence of Salvia miltiorrhiza, the first sequenced member of the Lamiaceae family, is reported here. The genome is 151,328 bp in length and exhibits a typical quadripartite structure of the large (LSC, 82,695 bp) and small (SSC, 17,555 bp) single-copy regions, separated by a pair of inverted repeats (IRs, 25,539 bp). It contains 114 unique genes, including 80 protein-coding genes, 30 tRNAs and four rRNAs. The genome structure, gene order, GC content and codon usage are similar to the typical angiosperm cp genomes. Four forward, three inverted and seven tandem repeats were detected in the Salvia miltiorrhiza cp genome. Simple sequence repeat (SSR) analysis among the 30 asterid cp genomes revealed that most SSRs are AT-rich, which contribute to the overall AT richness of these cp genomes. Additionally, fewer SSRs are distributed in the protein-coding sequences compared to the non-coding regions, indicating an uneven distribution of SSRs within the cp genomes. Entire cp genome comparison of Salvia miltiorrhiza and three other Lamiales cp genomes showed a high degree of sequence similarity and a relatively high divergence of intergenic spacers. Sequence divergence analysis discovered the ten most divergent and ten most conserved genes as well as their length variation, which will be helpful for phylogenetic studies in asterids. Our analysis also supports that both regional and functional constraints affect gene sequence evolution. Further, phylogenetic analysis demonstrated a sister relationship between Salvia miltiorrhiza and Sesamum indicum. The complete cp genome sequence of Salvia miltiorrhiza reported in this paper will facilitate population, phylogenetic and cp genetic engineering studies of this medicinal plant.	[Qian, Jun; Song, Jingyuan; Gao, Huanhuan; Zhu, Yingjie; Xu, Jiang; Pang, Xiaohui; Yao, Hui; Sun, Chao; Li, Xian'en; Xu, Haibin; Chen, Shilin] Chinese Acad Med Sci, Natl Engn Lab Breeding Endangered Med Mat, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Qian, Jun; Song, Jingyuan; Gao, Huanhuan; Zhu, Yingjie; Xu, Jiang; Pang, Xiaohui; Yao, Hui; Sun, Chao; Li, Xian'en; Xu, Haibin; Chen, Shilin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Chuyuan; Liu, Juyan] Guangzhou Pharmaceut Holding Ltd, Guangzhou, Guangdong, Peoples R China; [Chen, Shilin] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Xu, HB (corresponding author), Chinese Acad Med Sci, Natl Engn Lab Breeding Endangered Med Mat, Inst Med Plant Dev, Beijing 100730, Peoples R China.	xuhaibin@implad.ac.cn; slchen@implad.ac.cn	Zhu, Yingjie/W-3315-2017; Yao, hui/AAM-2391-2021	Zhu, Yingjie/0000-0003-1849-6019; 	Key National Natural Science Foundation of China [81130069]; National Key Technology RD Program [2012BAI29B01]; Program for Changjiang Scholars and Innovative Research Team of the University of Ministry of Education of China [IRT1150]	Key National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); Program for Changjiang Scholars and Innovative Research Team of the University of Ministry of Education of China	This work was supported by the Key National Natural Science Foundation of China (Grant no. 81130069), the National Key Technology R&D Program (Grant no. 2012BAI29B01) and the Program for Changjiang Scholars and Innovative Research Team of the University of Ministry of Education of China (Grant no. IRT1150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENDICH AJ, 1987, BIOESSAYS, V6, P279, DOI 10.1002/bies.950060608; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bock R, 2004, TRENDS BIOTECHNOL, V22, P311, DOI 10.1016/j.tibtech.2004.03.005; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Cheng TO, 2007, INT J CARDIOL, V121, P9, DOI 10.1016/j.ijcard.2007.01.004; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; Cui LY, 2006, NUCLEIC ACIDS RES, V34, pD692, DOI 10.1093/nar/gkj055; Daniell H, 2007, P NATL ACAD SCI USA, V104, P6879, DOI 10.1073/pnas.0702219104; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Hirao T, 2009, CURR GENET, V55, P311, DOI 10.1007/s00294-009-0247-9; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hung YC, 2010, BBA-PROTEINS PROTEOM, V1804, P1310, DOI 10.1016/j.bbapap.2010.02.001; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lee CY, 2008, PLANTA MED, V74, P780, DOI 10.1055/s-2008-1074527; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Li MH, 2008, J ETHNOPHARMACOL, V120, P419, DOI 10.1016/j.jep.2008.09.013; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Ma XY, 2010, BIOL PHARM BULL, V33, P1919, DOI 10.1248/bpb.33.1919; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Pauwels M, 2012, NEW PHYTOL, V193, P916, DOI 10.1111/j.1469-8137.2011.04003.x; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Provan J, 1997, GENOME, V40, P104, DOI 10.1139/g97-014; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Rose O, 1998, MOL BIOL EVOL, V15, P613, DOI 10.1093/oxfordjournals.molbev.a025964; Ruhlman T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-222; Samson N, 2007, PLANT BIOTECHNOL J, V5, P339, DOI 10.1111/j.1467-7652.2007.00245.x; Schaferhoff B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-352; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Stevens P.F., 2012, ANGIOSPERM PHYLOGENY; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Takano A, 2011, J PLANT RES, V124, P245, DOI 10.1007/s10265-010-0367-9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UMESONO K, 1984, NUCLEIC ACIDS RES, V12, P9551, DOI 10.1093/nar/12.24.9551; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Walker JB, 2007, ANN BOT-LONDON, V100, P375, DOI 10.1093/aob/mcl176; Walker JB, 2004, AM J BOT, V91, P1115, DOI 10.3732/ajb.91.7.1115; Wang BQ, 2010, J MED PLANTS RES, V4, P2813; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WOLFE KH, 1992, J MOL EVOL, V35, P304, DOI 10.1007/BF00161168; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xiao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029713; Xue JH, 2012, AM J BOT, V99, pE240, DOI 10.3732/ajb.1100547; Yan YP, 2007, PLANT CELL TISS ORG, V88, P175, DOI 10.1007/s11240-006-9187-y; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Yao H, 2009, PLANTA MED, V75, P667, DOI 10.1055/s-0029-1185385; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Yue F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S25; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; Zhang TW, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-38; Zhong GX, 2009, J AGR FOOD CHEM, V57, P6879, DOI 10.1021/jf901462s; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	79	218	240	5	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57607	10.1371/journal.pone.0057607	http://dx.doi.org/10.1371/journal.pone.0057607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460883	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000138
J	Skaaby, T; Husemoen, LLN; Martinussen, T; Thyssen, JP; Melgaard, M; Thuesen, BH; Pisinger, C; Jorgensen, T; Johansen, JD; Menne, T; Carlsen, B; Szecsi, PB; Stender, S; Fenger, RV; Fenger, M; Linneberg, A				Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Martinussen, Torben; Thyssen, Jacob P.; Melgaard, Michael; Thuesen, Betina Heinsbaek; Pisinger, Charlotta; Jorgensen, Torben; Johansen, Jeanne D.; Menne, Torkil; Carlsen, Berit; Szecsi, Pal B.; Stender, Steen; Fenger, Runa Vavia; Fenger, Mogens; Linneberg, Allan			Vitamin D Status, Filaggrin Genotype, and Cardiovascular Risk Factors: A Mendelian Randomization Approach	PLOS ONE			English	Article							METABOLIC SYNDROME; GENERAL-POPULATION; BLOOD-PRESSURE; SERUM; 25-HYDROXYVITAMIN-D; SUPPLEMENTATION; SENSITIVITY; PROTEIN; DETERMINANTS; OVERWEIGHT	Background: Vitamin D deficiency is associated with increased cardiovascular disease risk in observational studies. Whether these associations are causal is not clear. Loss-of-function mutations in the filaggrin gene result in up to 10% higher serum vitamin D concentrations, supposedly due to a decreased UV-protection of the keratinocytes. We used a Mendelian randomization approach to estimate the causal effect of vitamin D status on serum lipids, blood pressure, body mass index, waist circumference, and the metabolic syndrome. Methods: Three population based studies were included, Monica10 (2,656 individuals aged 40-71 years), Inter99 (6,784 individuals aged 30-60 years), and Health2006 (3,471 individuals aged 18-69 years) conducted in 1993-94, 1999-2001, and 2006-2008, respectively. Participants were genotyped for the two most common filaggrin gene mutations in European descendants R501X and 2282del4, in all three studies and further for the R2447X mutation in the Inter99 and Health2006 studies. Filaggrin genotype was used as instrumental variable for vitamin D status. Baseline measurements of serum 25-hydroxyvitamin D were performed in all three studies. Results: Instrumental variable analyses showed a 23.8% (95% confidence interval, CI 3.0, 48.6) higher HDL cholesterol level and a 30.5% (95% CI: 0.8, 51.3) lower serum level of triglycerides per doubling of vitamin D. These associations were, however, not statistically significant when applying the Bonferroni adjusted significance level. The remaining lipids showed non-significant changes in a favorable direction. Doubling of vitamin D gave a non-significantly lower odds ratio = 0.26 (95% CI: 0.06, 1.17) of the metabolic syndrome. There were no statistically significant causal effects of vitamin D status on blood pressure, body mass index, or waist circumference. Conclusion: Our results support a causal effect of higher vitamin D status on a more favorable lipid profile, although more studies in other populations are needed to confirm our results.	[Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Pisinger, Charlotta; Jorgensen, Torben; Fenger, Runa Vavia; Linneberg, Allan] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Martinussen, Torben] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Thyssen, Jacob P.; Johansen, Jeanne D.; Menne, Torkil; Carlsen, Berit] Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Natl Allergy Res Ctr, Hellerup, Denmark; [Melgaard, Michael; Szecsi, Pal B.; Stender, Steen] Univ Copenhagen, Gentofte Hosp, Dept Clin Biochem, Hellerup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Fenger, Mogens] Univ Copenhagen, Hvidovre Hosp, Dept Clin Biochem, DK-2650 Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Aalborg University; University of Copenhagen	Skaaby, T (corresponding author), Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.	tea.skaaby.01@regionh.dk	Thyssen, Jacob/ABD-8517-2020; Johansen, Jeanne/AAM-6382-2021; Jørgensen, Torben/Z-1335-2018	Johansen, Jeanne/0000-0002-3537-8463; Thyssen, Jacob Pontoppidan/0000-0003-3770-1743; Pisinger, Charlotta/0000-0002-7970-3168; Linneberg, Allan/0000-0002-0994-0184; Thuesen, Betina/0000-0001-9772-4344; Skaaby, Tea/0000-0003-0031-5726; Szecsi, Pal/0000-0003-3446-0411	Health Insurance Foundation [2010 B 131]	Health Insurance Foundation	The study was supported by The Health Insurance Foundation (grant number 2010 B 131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2009, PREV MED, V48, P326, DOI 10.1016/j.ypmed.2009.01.015; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Ambye L, 2005, DIABETES RES CLIN PR, V67, P175, DOI 10.1016/j.diabres.2004.06.013; Berg ND, 2012, J ALLERGY CLIN IMMUN, V129, P374, DOI 10.1016/j.jaci.2011.08.045; Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683; Cho HJ, 2005, BIOL PHARM BULL, V28, P1418, DOI 10.1248/bpb.28.1418; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Conen D, 2010, AM J EPIDEMIOL, V172, P1431, DOI 10.1093/aje/kwq308; Davey Smith G, 2008, ANN MED, V40, P524, DOI 10.1080/07853890802010709; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Friedrich N, 2012, DIABETES CARE, V35, P768, DOI 10.2337/dc11-1833; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Jorde R, 2010, EUR J CLIN NUTR, V64, P1457, DOI 10.1038/ejcn.2010.176; Jorde R, 2010, J INTERN MED, V267, P462, DOI 10.1111/j.1365-2796.2009.02181.x; Jorde R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037295; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kamycheva E, 2007, J ENDOCRINOL INVEST, V30, P126, DOI 10.1007/BF03347410; Konradsen S, 2008, EUR J NUTR, V47, P87, DOI 10.1007/s00394-008-0700-4; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Maki KC, 2011, INT J FOOD SCI NUTR, V62, P318, DOI 10.3109/09637486.2010.536146; Maki KC, 2009, J CLIN LIPIDOL, V3, P289, DOI 10.1016/j.jacl.2009.07.003; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; McGill AT, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-4; Meldgaard M, 2012, CLIN CHIM ACTA, V413, P1488, DOI 10.1016/j.cca.2012.06.014; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; OCKE MC, 1995, J CLIN EPIDEMIOL, V48, P1077, DOI 10.1016/0895-4356(94)00232-F; Ogbuanu IU, 2009, EMERG THEMES EPIDEMI, V6, DOI 10.1186/1742-7622-6-3; Olsen MH, 2007, EUR HEART J, V28, P1374, DOI 10.1093/eurheartj/ehl448; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Palmer TM, 2012, STAT METHODS MED RES, V21, P223, DOI 10.1177/0962280210394459; Palmer TM, 2011, AM J EPIDEMIOL, V173, P1392, DOI 10.1093/aje/kwr026; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; SCRAGG R, 1995, EUR J CLIN NUTR, V49, P640; Skaaby T., 2012, PLOS ONE, V7; Skaaby T., 2012, ENDOCRINE; Skaaby T, 2012, CARDIOLOGY, V123, P62, DOI 10.1159/000341277; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Snellman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011555; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Thyssen JP, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000062; Thyssen JP, 2012, J ALLERGY CLIN IMMUN; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433; Wielders JPM, 2009, CLIN CHEM, V55, P1584, DOI 10.1373/clinchem.2008.117366; Witham MD, 2009, J HYPERTENS, V27, P1948, DOI 10.1097/HJH.0b013e32832f075b; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	49	47	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57647	10.1371/journal.pone.0057647	http://dx.doi.org/10.1371/journal.pone.0057647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460889	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000144
J	Qiao, JB; Lee, S; Paul, P; Qiao, L; Taylor, CJ; Schlegel, C; Colon, NC; Chung, DH				Qiao, Jingbo; Lee, Sora; Paul, Pritha; Qiao, Lan; Taylor, Chase J.; Schlegel, Cameron; Colon, Nadja C.; Chung, Dai H.			Akt2 Regulates Metastatic Potential in Neuroblastoma	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; GROWTH-FACTOR; N-MYC; OVEREXPRESSION; EXPRESSION; INVASION; BREAST	Activation of PI3K/AKT pathway correlates with poor prognosis in patients with neuroblastoma. Our previous studies have demonstrated that PI3K/AKT signaling is critical for the oncogenic transformations induced by gastrin-releasing peptide (GRP) and its receptor, GRP-R, in neuroblastoma. Moreover, PI3K/AKT-dependent oncogenic transformations require N-myc, an extensively studied oncogene in neuroblastoma. Whether AKT directly regulates the expression of N-myc oncogene is yet to be determined. Here, we report a novel finding that of the three AKT isoforms, AKT2 specifically regulated N-myc expression in neuroblastoma cells. We also confirmed that GRP-R is upstream of AKT2 and in turn, regulated N-myc expression via AKT2 in neuroblastoma cells. Functional assays demonstrated that attenuation of AKT2 impaired cell proliferation and anchorage-independent cell growth, and decreased the secretion of angiogenic factor VEGF in vitro. Furthermore, silencing AKT2 inhibited migration and invasion of neuroblastoma cells in vitro. Xenografts established by injecting AKT2 silenced human neuroblastoma cells into murine spleen expressed decreased levels of AKT2 and resulted in fewer liver metastases compared to controls in vivo. Hence, our study highlights the potential molecular mechanism(s) mediating the oncogenic role of GRP/GRP-R and demonstrates a novel role for AKT2 in neuroblastoma tumorigenesis, indicating that targeting the GRP/GRP-R/AKT2 axis may be important for developing novel therapeutics in the treatment of clinically aggressive neuroblastoma.	[Qiao, Jingbo; Lee, Sora; Paul, Pritha; Qiao, Lan; Taylor, Chase J.; Schlegel, Cameron; Colon, Nadja C.; Chung, Dai H.] Vanderbilt Univ, Med Ctr, Dept Pediat Surg, Nashville, TN 37203 USA; [Lee, Sora; Paul, Pritha; Chung, Dai H.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Chung, DH (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat Surg, Nashville, TN 37203 USA.	dai.chung@vanderbilt.edu			National Institutes of Health [R01 DK61470]; Rally Foundation for Cancer Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rally Foundation for Cancer Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (R01 DK61470) and Rally Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rally Foundation: http://rallyfoundation.org. NIH RO1: http://grants.nih.gov/grants/funding/r01.htm.	Altomare DA, 2003, J CELL BIOCHEM, V88, P470, DOI 10.1002/jcb.10287; Arboleda MJ, 2003, CANCER RES, V63, P196; Bordow SB, 1998, J CLIN ONCOL, V16, P3286, DOI 10.1200/JCO.1998.16.10.3286; Chanthery YH, 2012, SCI TRANSL MED, V4; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Gustafson WC, 2010, ONCOGENE, V29, P1249, DOI 10.1038/onc.2009.512; Gustafson WC, 2005, WORLD J SURG, V29, P281, DOI 10.1007/s00268-004-7815-4; Ishola TA, 2007, BBA-GEN SUBJECTS, V1770, P927, DOI 10.1016/j.bbagen.2007.02.002; Kang J, 2008, ONCOGENE, V27, P3999, DOI 10.1038/onc.2008.15; Kang JH, 2007, CANCER LETT, V253, P273, DOI 10.1016/j.canlet.2007.02.007; Kim S, 2002, ANN SURG, V235, P621, DOI 10.1097/00000658-200205000-00003; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Misawa A, 2000, CANCER RES, V60, P64; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Qiao JB, 2005, ANN SURG, V241, P684, DOI 10.1097/01.sla.0000161173.47717.71; Qiao JB, 2008, P NATL ACAD SCI USA, V105, P12891, DOI 10.1073/pnas.0711861105; Riley RD, 2004, CLIN CANCER RES, V10, P4, DOI 10.1158/1078-0432.CCR-1051-2; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105	22	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56382	10.1371/journal.pone.0056382	http://dx.doi.org/10.1371/journal.pone.0056382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468863	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400009
J	Kaufmann, MR; Barr, RG; Lima, JAC; Praestgaard, A; Jain, A; Tandri, H; Bluemke, DA; Kawut, SM				Kaufmann, Michael R.; Barr, R. Graham; Lima, Joao A. C.; Praestgaard, Amy; Jain, Aditya; Tandri, Harikrishna; Bluemke, David A.; Kawut, Steven M.			Right Ventricular Morphology and the Onset of Dyspnea: The MESA-Right Ventricle Study	PLOS ONE			English	Article							AIR-FLOW OBSTRUCTION; QUALITY-OF-LIFE; HEART-FAILURE; DIASTOLIC DYSFUNCTION; MAGNETIC-RESONANCE; ATHEROSCLEROSIS; GENDER; SEX; EMPHYSEMA; PRESSURE	Background: The association of right ventricular (RV) structure and function with symptoms in individuals without cardiopulmonary disease is unknown. We hypothesized that greater RV mass and RV end-diastolic volume (RVEDV), smaller RV stroke volume (RVSV), and lower RV ejection fraction (RVEF) measured by cardiac magnetic resonance imaging (MRI) in participants free of clinical cardiovascular disease at baseline would be associated with a greater risk of self-reported dyspnea. Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) performed cardiac MRIs on participants without clinical cardiovascular disease between 2000 and 2002. We excluded subjects who reported "prevalent" dyspnea at the first assessment (24 months). The presence of dyspnea was assessed at 24 months, 42 months, and 60 months from baseline. Cox proportional hazards models were used to examine the relationship between RV measures and incident dyspnea. Results: In the final study sample (N = 2763), there were significant interactions between RV measures and sex in terms of the risk of dyspnea (p<0.05). Among men (N = 1453), lower RV mass (p = 0.003), smaller RVEDV (p<0.001), smaller RV endsystolic volume (RVESV) (p = 0.03) and decreased RVSV (p<0.001) were associated with an increased risk of developing dyspnea after adjusting for covariates. Associations remained after adjusting for left ventricular function and lung function. However, there were no significant associations between RV measures and the risk of dyspnea in women. Conclusions: Lower RV mass and smaller RV volumes were associated with an increased risk of dyspnea in men, but not in women.	[Kaufmann, Michael R.; Kawut, Steven M.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Kaufmann, Michael R.; Kawut, Steven M.] Univ Penn, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Barr, R. Graham] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Barr, R. Graham] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Lima, Joao A. C.; Jain, Aditya; Tandri, Harikrishna] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Praestgaard, Amy; Kawut, Steven M.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Bluemke, David A.] Natl Inst Biomed Imaging & Bioengn, Radiol & Imaging Sci NIH Clin Ctr, Bethesda, MD USA	University of Pennsylvania; University of Pennsylvania; Columbia University; Columbia University; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Kaufmann, MR (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	kawut@upenn.edu	Ventetuolo, Corey/W-4871-2017; Bluemke, David/GYU-8169-2022	Ventetuolo, Corey/0000-0002-4223-4775; Bluemke, David/0000-0002-8323-8086	National Institutes of Health [R01-HL086719, R01-HL077612, N01-HC95159, N01-HC95160, N01-HC95161, N01-HC95162, N01-HC95163, N01-HC95164, N01-HC95165, N01-HC95166, N01-HC95167, N01-HC95168, N01-HC95169]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095166, N01HC095160, N01HC095159, N01HC095161, N01HC095168, N01HC095165, N01HC095163, N01HC095169, N01HC095164, N01HC095162, N01HC095167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086719, R01HL077612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); CLINICAL CENTER	This work was supported by National Institutes of Health [grants R01-HL086719, R01-HL077612, N01-HC95159 through N01-HC95169]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bluemke DA, 2008, J AM COLL CARDIOL, V52, P2148, DOI 10.1016/j.jacc.2008.09.014; Bowden JA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-33; Chahal H, 2012, CHEST, V141, P388, DOI 10.1378/chest.11-0172; Chahal H, 2010, AM J CARDIOL, V106, P110, DOI 10.1016/j.amjcard.2010.02.022; Chhabra SK, 2011, J ASTHMA, V48, P609, DOI 10.3109/02770903.2011.587577; Dokainish H, 2007, AM J CARDIOL, V99, P961, DOI 10.1016/j.amjcard.2006.11.042; Field ME, 2006, J CARD FAIL, V12, P616, DOI 10.1016/j.cardfail.2006.06.472; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Han MLK, 2010, RESP MED, V104, P724, DOI 10.1016/j.rmed.2009.11.019; Hardziyenka M, 2011, J AM COLL CARDIOL, V57, P921, DOI 10.1016/j.jacc.2010.08.648; Hoffman EA, 2009, ACAD RADIOL, V16, P689, DOI 10.1016/j.acra.2008.12.024; Hudsmith LE, 2005, J CARDIOVASC MAGN R, V7, P775, DOI 10.1080/10976640500295516; Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515; Maceira AM, 2006, EUR HEART J, V27, P2879, DOI 10.1093/eurheartj/ehl336; Martinez FJ, 2007, AM J RESP CRIT CARE, V176, P243, DOI 10.1164/rccm.200606-828OC; Meluzin J, 2005, INT J CARDIOL, V105, P164, DOI 10.1016/j.ijcard.2004.12.031; Meyer P, 2010, CIRCULATION, V121, P252, DOI 10.1161/CIRCULATIONAHA.109.887570; Natori S, 2006, AM J ROENTGENOL, V186, pS357, DOI 10.2214/AJR.04.1868; Rodriguez J, 2010, ANN INTERN MED, V152, P201, DOI 10.7326/0003-4819-152-4-201002160-00004; Yu HCM, 1999, CLIN CARDIOL, V22, P504, DOI 10.1002/clc.4960220804	22	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56826	10.1371/journal.pone.0056826	http://dx.doi.org/10.1371/journal.pone.0056826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457622	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700084
J	Chen, EJH; Shaffer, MH; Williamson, EK; Huang, YP; Burkhardt, JK				Chen, Emily J. H.; Shaffer, Meredith H.; Williamson, Edward K.; Huang, Yanping; Burkhardt, Janis K.			Ezrin and Moesin Are Required for Efficient T Cell Adhesion and Homing to Lymphoid Organs	PLOS ONE			English	Article							PROTEIN-KINASE-C; L-SELECTIN CD62L; ERM PROTEINS; ENDOTHELIAL-CELLS; IN-VIVO; TRANSENDOTHELIAL MIGRATION; RAP1-INDUCED ADHESION; CHEMOKINE STIMULATION; VASCULAR ENDOTHELIUM; INTEGRIN ACTIVATION	T cell trafficking between the blood and lymphoid organs is a complex, multistep process that requires several highly dynamic and coordinated changes in cyto-architecture. Members of the ezrin, radixin and moesin (ERM) family of actin-binding proteins have been implicated in several aspects of this process, but studies have yielded conflicting results. Using mice with a conditional deletion of ezrin in CD4+ cells and moesin-specific siRNA, we generated T cells lacking ERM proteins, and investigated the effect on specific events required for T cell trafficking. ERM-deficient T cells migrated normally in multiple in vitro and in vivo assays, and could undergo efficient diapedesis in vitro. However, these cells were impaired in their ability to adhere to the beta 1 integrin ligand fibronectin, and to polarize appropriately in response to fibronectin and VCAM-1 binding. This defect was specific for beta 1 integrins, as adhesion and polarization in response to ICAM-1 were normal. In vivo, ERM-deficient T cells showed defects in homing to lymphoid organs. Taken together, these results show that ERM proteins are largely dispensable for T cell chemotaxis, but are important for beta 1 integrin function and homing to lymphoid organs.	[Burkhardt, Janis K.] Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Burkhardt, JK (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	jburkhar@mail.med.upenn.edu	Shaffer, Meredith/N-5984-2017	Burkhardt, Janis/0000-0002-8176-1375; Shaffer, Meredith/0000-0002-6982-7968	National Institutes of Health [PO1CA093615]; Cancer Research Institute, Predoctoral Emphasis Pathway in Tumor Immunology; NATIONAL CANCER INSTITUTE [P01CA093615, P30CA016520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute, Predoctoral Emphasis Pathway in Tumor Immunology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health PO1CA093615 to JKB and by a Cancer Research Institute, Predoctoral Emphasis Pathway in Tumor Immunology to EJHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport JR, 1997, J EXP MED, V186, P517, DOI 10.1084/jem.186.4.517; Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Baekkevold ES, 2001, J EXP MED, V193, P1105, DOI 10.1084/jem.193.9.1105; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Banerjee P, 2008, LAB INVEST, V88, P196, DOI 10.1038/labinvest.3700703; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Bretscher A, 1997, J CELL SCI, V110, P3011; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Burbach BJ, 2007, IMMUNOL REV, V218, P65, DOI 10.1111/j.1600-065X.2007.00527.x; Campbell JJ, 1998, J CELL BIOL, V141, P1053, DOI 10.1083/jcb.141.4.1053; Cannon JL, 2011, MOL BIOL CELL, V22, P954, DOI 10.1091/mbc.E10-07-0586; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Conant CG, 2010, J BIOMOL SCREEN, V15, P102, DOI 10.1177/1087057109353789; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; de Bruyn KMT, 2002, J BIOL CHEM, V277, P29468, DOI 10.1074/jbc.M204990200; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Escotte S, 2006, AM J RESP CELL MOL, V34, P348, DOI 10.1165/rcmb.2005-0191OC; Evans R, 2011, BLOOD, V117, P3331, DOI 10.1182/blood-2010-06-289140; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Ferreira AM, 2006, MICROCIRCULATION, V13, P439, DOI 10.1080/10739680600776062; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Finkelstein LD, 2005, J IMMUNOL, V175, P5923, DOI 10.4049/jimmunol.175.9.5923; Flint MS, 2011, BRAIN BEHAV IMMUN, V25, P1187, DOI 10.1016/j.bbi.2011.03.009; Galkina E, 2007, EUR J IMMUNOL, V37, P1243, DOI 10.1002/eji.200636481; Garcia-Bernal D, 2009, IMMUNITY, V31, P953, DOI 10.1016/j.immuni.2009.09.021; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gez S, 2007, BBA-PROTEINS PROTEOM, V1774, P1173, DOI 10.1016/j.bbapap.2007.06.011; Ghandour H, 2007, BLOOD, V110, P3682, DOI 10.1182/blood-2007-03-077628; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; HAMANN A, 1988, J IMMUNOL, V140, P693; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; HASSLEN SR, 1995, HISTOCHEM J, V27, P547; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Kuijpers TW, 1997, J CLIN INVEST, V100, P1725, DOI 10.1172/JCI119697; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Liu Y, 2012, BLOOD, V119, P445, DOI 10.1182/blood-2011-07-368860; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Nagira M, 1997, J BIOL CHEM, V272, P19518, DOI 10.1074/jbc.272.31.19518; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Nijhara R, 2004, J IMMUNOL, V173, P4985, DOI 10.4049/jimmunol.173.8.4985; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Ohta K, 2012, J STRUCT BIOL, V177, P513, DOI 10.1016/j.jsb.2011.10.012; OPPENHEIMERMARKS N, 1990, J IMMUNOL, V145, P140; OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913; Parameswaran N, 2011, J IMMUNOL, V186, P4088, DOI 10.4049/jimmunol.1001139; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Ploix CC, 2011, BRAIN BEHAV IMMUN, V25, P883, DOI 10.1016/j.bbi.2010.09.014; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Shaffer MH, 2009, J IMMUNOL, V182, P1021, DOI 10.4049/jimmunol.182.2.1021; Shamri R, 2002, J BIOL CHEM, V277, P40027, DOI 10.1074/jbc.M206806200; Shcherbina A, 1999, BLOOD, V93, P2128; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Soriano SF, 2011, J IMMUNOL, V187, P2356, DOI 10.4049/jimmunol.1100935; Stewart MP, 1996, J IMMUNOL, V156, P1810; Tangemann K, 1998, J IMMUNOL, V161, P6330; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Verrills NM, 2006, PROTEOMICS, V6, P1681, DOI 10.1002/pmic.200500417; Wang HY, 2009, P NATL ACAD SCI USA, V106, P12436, DOI 10.1073/pnas.0900510106; Werner L, 2011, J LEUKOCYTE BIOL, V90, P583, DOI 10.1189/jlb.0111101; Wong D, 1999, J NEUROPATH EXP NEUR, V58, P138, DOI 10.1097/00005072-199902000-00004; Woods ML, 2001, J LEUKOCYTE BIOL, V69, P874; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497	74	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e52368	10.1371/journal.pone.0052368	http://dx.doi.org/10.1371/journal.pone.0052368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468835	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900003
J	Meng, X; Hu, JJ; Xu, XX; Wang, ZQ; Hu, QB; Jin, FL; Ren, SX				Meng, Xiang; Hu, Junjie; Xu, Xiaoxia; Wang, Zeqing; Hu, Qiongbu; Jin, Fengliang; Ren, Shunxiang			Toxic Effect of Destruxin A on Abnormal Wing Disc-Like (SLAWD) in Spodoptera litura Fabricius (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							AUTONOMOUS LETHAL MUTATION; INSECTICIDAL ACTIVITY; DIPHOSPHATE KINASE; TUMOR-METASTASIS; IMAGINAL DISKS; DROSOPHILA-AWD; GENE; MUTANTS; HOMOLOG; PROTEIN	Background: Destruxin A (DA) is a microbial insecticide with potent bioactivity against Spodoptera litura larvae. A previous proteomic analysis of S. litura (SL-1) cells exposed to DA showed the abnormal expression of wing disc-like protein of S. litura (SLAWD). To further understand the effect of DA on SLAWD expression, a functional study was carried out. Principal Findings: The SLAWD gene (SLAWD) was cloned and an open reading frame of 537 bp encoding a polypeptide of 178 amino acids was detected. Real-time fluorescence quantitative PCR (qRT-PCR) suggested that SLAWD is expressed in all developmental stages of S. litura, but expression was highest during the pupal and adult stages. RNAi knockdown of SLAWD expression in 6th-stage larvae was achieved by the microinjection of a specific double-stranded RNA (dsRNA). The results showed a significant decrease in SLAWD mRNA expression levels between the prepupal and adult stages. Interestingly, SLAWD expression was similarly down-regulated by treating 6th-stage larvae with DA. Growth-and development-related statistics confirmed the observed abnormalities in S. litura development after either RNAi or DA treatment. Conclusions: SLAWD appears to have a biosynthetic function in the pupal and adult stages of S. litura. The toxic effect of DA on S. litura development is due the negative effect of DA on SLAWD gene expression.	[Meng, Xiang; Hu, Junjie; Xu, Xiaoxia; Hu, Qiongbu; Jin, Fengliang; Ren, Shunxiang] South China Agr Univ SCAU, Minist Educ, Engn Res Ctr Biol Control, Guangzhou, Guangdong, Peoples R China; [Meng, Xiang] Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China; [Hu, Junjie] Guangzhou Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Zeqing] Guangdong New Scene Biol Engn Co LTD, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; Guangzhou University	Jin, FL (corresponding author), South China Agr Univ SCAU, Minist Educ, Engn Res Ctr Biol Control, Guangzhou, Guangdong, Peoples R China.	jflbang@yahoo.com.cn; rensxcn@yahoo.com.cn			National Natural Science Foundation of China [31071685]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20114404110019]; National Science Foundation of Guangdong, China [S2012020010591]; Special Project on the Integration of Industry, Education and Research of Guangdong Province [2012B091000168]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Science Foundation of Guangdong, China(National Natural Science Foundation of Guangdong Province); Special Project on the Integration of Industry, Education and Research of Guangdong Province	This work was supported by The National Natural Science Foundation of China (31071685), Specialized Research Fund for the Doctoral Program of Higher Education of China (20114404110019), National Science Foundation of Guangdong, China (S2012020010591), and Special Project on the Integration of Industry, Education and Research of Guangdong Province (2012B091000168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri-Besheli B, 2000, MYCOL RES, V104, P447, DOI 10.1017/S095375629900146X; Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Arakane Y, 2011, INSECT BIOCHEM MOLEC, V41, P42, DOI 10.1016/j.ibmb.2010.09.011; ARKING R, 1975, GENETICS, V80, P519; Bandani AR, 2001, BBA-BIOMEMBRANES, V1510, P367, DOI 10.1016/S0005-2736(00)00370-9; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010133; CHIADMI M, 1993, STRUCTURE, V1, P283, DOI 10.1016/0969-2126(93)90016-A; Dammai V, 2003, GENE DEV, V17, P2812, DOI 10.1101/gad.1096903; DEAROLF CR, 1988, DEV BIOL, V129, P169, DOI 10.1016/0012-1606(88)90171-6; DEAROLF CR, 1988, DEV BIOL, V129, P159, DOI 10.1016/0012-1606(88)90170-4; deCelis JF, 1996, DEVELOPMENT, V122, P359; Egoz-Matia N, 2011, DEV BIOL, V351, P99, DOI 10.1016/j.ydbio.2010.12.039; ETMAN AAM, 1979, ANN ENTOMOL SOC AM, V72, P119, DOI 10.1093/aesa/72.1.119; Feeroza Khalique, 2005, Pakistan Journal of Biological Sciences, V8, P475, DOI 10.3923/pjbs.2005.475.478; Gildea JJ, 2000, GENETICS, V156, P645; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hu QB, 2007, J APPL ENTOMOL, V131, P262, DOI 10.1111/j.1439-0418.2007.01159.x; Hu QB, 2006, TOXICON, V48, P491, DOI 10.1016/j.toxicon.2006.06.018; Hu QB, 2009, TOXICON, V53, P115, DOI 10.1016/j.toxicon.2008.10.019; Jiang DF, 2010, AFR J BIOTECHNOL, V9, P7372; Kango-Singh M, 2001, J BIOSCIENCE, V26, P167, DOI 10.1007/BF02703641; KAWASAKI H, 1987, Journal of Sericultural Science of Japan, V56, P65; KISS I, 1976, THEOR APPL GENET, V48, P217, DOI 10.1007/BF00281284; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Lee DW, 2011, INSECT BIOCHEM MOLEC, V41, P236, DOI 10.1016/j.ibmb.2011.01.001; Matsuura H, 1997, APPL ENTOMOL ZOOL, V32, P167, DOI 10.1303/aez.32.167; Meng X, 2011, TOXICON, V58, P327, DOI 10.1016/j.toxicon.2011.06.002; Nallamothu G, 2009, MOL CELL BIOCHEM, V329, P35, DOI 10.1007/s11010-009-0112-7; Pal S, 2007, J BIOL CHEM, V282, P8969, DOI 10.1074/jbc.M605927200; Qi C, 2000, ENTOMOLOGICAL KNOWLE, V1, P8; [秦厚国 Qin Houguo], 2004, [中国生态农业学报, Chinese journal of eco-agriculture], V12, P40; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; RUSSELL MA, 1974, DEV BIOL, V40, P24, DOI 10.1016/0012-1606(74)90104-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; SHEARN A, 1971, P NATL ACAD SCI USA, V68, P2594, DOI 10.1073/pnas.68.10.2594; Sree KS, 2008, PEST MANAG SCI, V64, P119, DOI 10.1002/ps.1480; Sree KS, 2010, PESTIC BIOCHEM PHYS, V97, P168, DOI 10.1016/j.pestbp.2010.01.002; Surakasi VP, 2011, J INSECT PHYSIOL, V57, P1537, DOI 10.1016/j.jinsphys.2011.08.006; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; TIMMONS L, 1993, DEV BIOL, V158, P364, DOI 10.1006/dbio.1993.1195; Vey A, 2002, J INVERTEBR PATHOL, V80, P177, DOI 10.1016/S0022-2011(02)00104-0; Woolworth JA, 2009, MOL CELL BIOL, V29, P4679, DOI 10.1128/MCB.00297-09; Zhao X, 2009, THESIS ZHEJIANG SCI, P45; ZHAO XN, 2009, BOMBYX MORI B SERICU, V40, P13; Zhou QX, 2004, INT J DEV BIOL, V48, P1113, DOI 10.1387/ijdb.041845qz	48	16	17	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57213	10.1371/journal.pone.0057213	http://dx.doi.org/10.1371/journal.pone.0057213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468937	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900059
J	Bechsgaard, JS; Hoffmann, AA; Sgro, C; Loeschcke, V; Bilde, T; Kristensen, TN				Bechsgaard, Jesper S.; Hoffmann, Ary A.; Sgro, Carla; Loeschcke, Volker; Bilde, Trine; Kristensen, Torsten N.			A Comparison of Inbreeding Depression in Tropical and Widespread Drosophila Species	PLOS ONE			English	Article							RAIN-FOREST DROSOPHILA; LIMITS; PATTERNS; TRAITS	The evolutionary history of widespread and specialized species is likely to cause a different genetic architecture of key ecological traits in the two species groups. This may affect how these two groups respond to inbreeding. Here we investigate inbreeding effects in traits related to performance in 5 widespread and 5 tropical restricted species of Drosophila with the aim of testing whether the two species groups suffered differently from inbreeding depression. The traits investigated were egg-to-adult viability, developmental time and resistance to heat, cold and desiccation. Our results showed that levels of inbreeding depression were species and trait specific and did not differ between the species groups for stress resistance traits. However, for the life history traits developmental time and egg-to adult viability, more inbreeding depression was observed in the tropical species. The results reported suggest that for life history traits tropical species of Drosophila will suffer more from inbreeding depression than widespread species in case of increases in the rate of inbreeding e. g. due to declines in population sizes.	[Bechsgaard, Jesper S.; Loeschcke, Volker; Bilde, Trine; Kristensen, Torsten N.] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Hoffmann, Ary A.] Univ Melbourne, Dept Genet, Melbourne, Vic, Australia; [Hoffmann, Ary A.] Univ Melbourne, Inst Bio21, Melbourne, Vic, Australia; [Sgro, Carla] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Kristensen, Torsten N.] Aarhus Univ, Dept Mol Biol & Genet, Tjele, Denmark; [Kristensen, Torsten N.] NordGen Nord Genet Resource Ctr, As, Norway	Aarhus University; University of Melbourne; University of Melbourne; Monash University; Aarhus University	Bechsgaard, JS (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	torsten.nygaard@nordgen.org	Loeschcke, Volker/J-2527-2013; Hoffmann, Ary/R-2972-2019; Hoffmann, Ary/C-2961-2011; Kristensen, Torsten N/C-5031-2015; Sgro, Carla M/G-5166-2010; Bilde, Trine/J-2872-2013; Bilde, Trine/AAS-2098-2020	Loeschcke, Volker/0000-0003-1450-0754; Hoffmann, Ary/0000-0001-9497-7645; Kristensen, Torsten N/0000-0001-6204-8753; Bilde, Trine/0000-0002-0341-161X; Bilde, Trine/0000-0002-0341-161X	Danish Natural Research Council; Steno stipend; Australian Research Council	Danish Natural Research Council(Danish Natural Science Research Council); Steno stipend; Australian Research Council(Australian Research Council)	This work was funded by the Danish Natural Research Council with a Steno stipend to TNK and a frame grant to VL. AAH was supported via Australian Research Council Fellowship and Discovery grant schemes.	Angilletta MJ, 2009, THERMAL ADAPTATION T, Vxii; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; DeRose MA, 1999, EVOLUTION, V53, P1288, DOI 10.2307/2640831; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Falconer D. S., 1996, INTRO QUANTITATIVE G; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; HOFFMANN AA, 1993, AM NAT, V142, pS93, DOI 10.1086/285525; Hoffmann AA, 2003, SCIENCE, V301, P100, DOI 10.1126/science.1084296; Hoffmann AA, 1997, EXTREME ENV CHANGE E, Vxii; Kellermann V, 2012, EVOLUTION IN PRESS; Kellermann V, 2012, P NATL ACAD SCI USA, V109, P16228, DOI 10.1073/pnas.1207553109; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Kristensen TN, 2005, ANIM SCI, V80, P121, DOI 10.1079/ASC41960121; Kristensen TN, 2011, EVOLUTION, V65, P3195, DOI 10.1111/j.1558-5646.2011.01359.x; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Lynch Michael, 1998; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Overgaard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032758; Overgaard J, 2011, AM NAT, V178, pS80, DOI 10.1086/661780; Reed DH, 2003, CONSERV GENET, V4, P405, DOI 10.1023/A:1024081416729; Solomon S, 2007, CLIMATE CHANGE 2007, Vviii; Swindell WR, 2006, J EVOLUTION BIOL, V19, P1257, DOI 10.1111/j.1420-9101.2005.01074.x; van Heerwaarden B, 2009, P ROY SOC B-BIOL SCI, V276, P1517, DOI 10.1098/rspb.2008.1288; Wang JL, 1999, GENET RES, V74, P165, DOI 10.1017/S0016672399003900	25	10	10	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e51176	10.1371/journal.pone.0051176	http://dx.doi.org/10.1371/journal.pone.0051176			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460779	Green Published, gold			2022-12-27	WOS:000315519000002
J	Bolton, JL; Stewart, MCW; Wilson, JF; Anderson, N; Price, JF				Bolton, Jennifer L.; Stewart, Marlene C. W.; Wilson, James F.; Anderson, Niall; Price, Jackie F.			Improvement in Prediction of Coronary Heart Disease Risk over Conventional Risk Factors Using SNPs Identified in Genome-Wide Association Studies	PLOS ONE			English	Article							PROSPECTIVE GENETIC-ANALYSIS; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; PROSPECTIVE COHORT; EDINBURGH ARTERY; SCORE; MEN; POLYMORPHISMS; POPULATION; WOMEN	Objective: We examined whether a panel of SNPs, systematically selected from genome-wide association studies (GWAS), could improve risk prediction of coronary heart disease (CHD), over-and-above conventional risk factors. These SNPs have already demonstrated reproducible associations with CHD; here we examined their use in long-term risk prediction. Study Design and Setting: SNPs identified from meta-analyses of GWAS of CHD were tested in 840 men and women aged 55-75 from the Edinburgh Artery Study, a prospective, population-based study with 15 years of follow-up. Cox proportional hazards models were used to evaluate the addition of SNPs to conventional risk factors in prediction of CHD risk. CHD was classified as myocardial infarction (MI), coronary intervention (angioplasty, or coronary artery bypass surgery), angina and/or unspecified ischaemic heart disease as a cause of death; additional analyses were limited to MI or coronary intervention. Model performance was assessed by changes in discrimination and net reclassification improvement (NRI). Results: There were significant improvements with addition of 27 SNPs to conventional risk factors for prediction of CHD (NRI of 54%, P<0.001; C-index 0.671 to 0.740, P=0.001), as well as MI or coronary intervention, (NRI of 44%, P<0.001; C-index 0.717 to 0.750, P = 0.256). ROC curves showed that addition of SNPs better improved discrimination when the sensitivity of conventional risk factors was low for prediction of MI or coronary intervention. Conclusion: There was significant improvement in risk prediction of CHD over 15 years when SNPs identified from GWAS were added to conventional risk factors. This effect may be particularly useful for identifying individuals with a low prognostic index who are in fact at increased risk of disease than indicated by conventional risk factors alone.	[Bolton, Jennifer L.; Stewart, Marlene C. W.; Wilson, James F.; Anderson, Niall; Price, Jackie F.] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Wilson, James F.] Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Bolton, JL (corresponding author), Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Teviot Pl, Edinburgh, Midlothian, Scotland.	J.Bolton@ed.ac.uk	Wilson, James F/A-5704-2009	Wilson, James F/0000-0001-5751-9178; Price, Jackie/0000-0003-3251-3970; Stewart, Marlene/0000-0001-7939-7001	British Heart Foundation [BHF RG/98002 - R34429]; Chief Scientist Office of Scotland [CZB/4/672]; College of Medicine and Veterinary Medicine at the University of Edinburgh; Overseas Research Students Award; Chief Scientist Office [CZB/4/710, CZB/4/672] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Chief Scientist Office of Scotland; College of Medicine and Veterinary Medicine at the University of Edinburgh; Overseas Research Students Award; Chief Scientist Office	The EAS was supported by the British Heart Foundation (BHF RG/98002 - R34429). Genotyping for this project was funded by a project grant from the Chief Scientist Office of Scotland (CZB/4/672). Jennifer Bolton was supported by a PhD studentship from the College of Medicine and Veterinary Medicine at the University of Edinburgh, and an Overseas Research Students Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bare LA, 2007, GENET MED, V9, P682, DOI 10.1097/GIM.0b013e318156fb62; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Davies RW, 2010, CIRC-CARDIOVASC GENE, V3, P468, DOI 10.1161/CIRCGENETICS.110.946269; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Fischer M, 2005, CIRCULATION, V111, P855, DOI 10.1161/01.CIR.0000155611.41961.BB; Foulkes A. S., 2009, APPL STAT GENETICS R, P1; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; Harrell, 2010, HMISC HARRELL MISCEL; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Humphries SE, 2007, CLIN CHEM, V53, P8, DOI 10.1373/clinchem.2006.074591; Humphries SE, 2010, CIRCULATION, V121, P2235, DOI 10.1161/CIRCULATIONAHA.109.914192; Iles MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040033; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Martin CJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-49; Medina MW, 2009, TRENDS CARDIOVAS MED, V19, P173, DOI 10.1016/j.tcm.2009.10.003; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; NICE, 2010, LIP MOD CARD RISK AS, V67; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Price JF, 2001, ATHEROSCLEROSIS, V157, P241, DOI 10.1016/S0021-9150(00)00719-X; Ridker PM, 2004, CIRCULATION, V109, P6, DOI 10.1161/01.CIR.0000133444.17867.56; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Schunkert H, 2011, NAT GENET, V43, P4; Schunkert H, 2010, EUR HEART J, V31, P918, DOI 10.1093/eurheartj/ehq038; Sing T, 2009, ROCR VISUALIZING PER; Talmud PJ, 2008, CLIN CHEM, V54, P467, DOI 10.1373/clinchem.2007.095489; Thanassoulis G, 2010, CIRCULATION, V122, P2323, DOI 10.1161/CIRCULATIONAHA.109.909309; Therneau T, 2010, SURVIVAL SURVIVAL AN; Therneau T. M., 2010, RPART RECURSIVE PART; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zdravkovic S, 2007, EUR J HUM GENET, V15, P872, DOI 10.1038/sj.ejhg.5201846; Zee RYL, 2006, J THROMB HAEMOST, V4, P341, DOI 10.1111/j.1538-7836.2006.01754.x; Zee RYL, 2004, HUM MOL GENET, V13, P389, DOI 10.1093/hmg/ddh039; Zhao JH, 2010, GAP GENETIC ANAL PAC	37	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57310	10.1371/journal.pone.0057310	http://dx.doi.org/10.1371/journal.pone.0057310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468967	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000090
J	Friis, CM; Qvigstad, E; Roland, MCP; Godang, K; Voldner, N; Bollerslev, J; Henriksen, T				Friis, Camilla M.; Qvigstad, Elisabeth; Roland, Marie Cecilie Paasche; Godang, Kristin; Voldner, Nanna; Bollerslev, Jens; Henriksen, Tore			Newborn Body Fat: Associations with Maternal Metabolic State and Placental Size	PLOS ONE			English	Article							FETAL-GROWTH; NUTRIENT TRANSPORT; TROPHOBLAST CELLS; MASS INDEX; BIRTH; PREGNANCY; INSULIN; WEIGHT; DETERMINANTS; ADIPOSITY	Background: Neonatal body composition has implications for the health of the newborn both in short and long term perspective. The objective of the current study was first to explore the association between maternal BMI and metabolic parameters associated with BMI and neonatal percentage body fat and to determine to which extent any associations were modified if adjusting for placental weight. Secondly, we examined the relations between maternal metabolic parameters associated with BMI and placental weight. Methods: The present work was performed in a subcohort (n = 207) of the STORK study, an observational, prospective study on the determinants of fetal growth and birthweight in healthy pregnancies at Oslo University Hospital, Norway. Fasting glucose, insulin, triglycerides, free fatty acids, HDL- and total cholesterol were measured at week 30-32. Newborn body composition was determined by Dual-Energy X-Ray Absorptiometry (DXA). Placenta was weighed at birth. Linear regression models were used with newborn fat percentage and placental weight as main outcomes. Results: Maternal BMI, fasting glucose and gestational age were independently associated with neonatal fat percentage. However, if placental weight was introduced as a covariate, only placental weight and gestational age remained significant. In the univariate model, the determinants of placenta weight included BMI, insulin, triglycerides, total- and HDL-cholesterol (negatively), gestational weight gain and parity. In the multivariable model, BMI, total cholesterol HDL-cholesterol, gestational weight gain and parity remained independent covariates. Conclusion: Maternal BMI and fasting glucose were independently associated with newborn percentage fat. This effect disappeared by introducing placental weight as a covariate. Several metabolic factors associated with maternal BMI were associated with placental weight, but not with neonatal body fat. Our findings are consistent with a concept that the effects of maternal BMI and a number of BMI-related metabolic factors on fetal fat accretion to a significant extent act by modifying placental weight.	[Friis, Camilla M.; Roland, Marie Cecilie Paasche; Voldner, Nanna; Henriksen, Tore] Oslo Univ Hosp, Rikshosp, Women & Childrens Div, Sect Obstet, Oslo, Norway; [Qvigstad, Elisabeth; Godang, Kristin; Bollerslev, Jens] Oslo Univ Hosp, Rikshosp, Div Med, Outpatient Clin Specialized Endocrinol, Oslo, Norway; [Bollerslev, Jens; Henriksen, Tore] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo	Friis, CM (corresponding author), Oslo Univ Hosp, Rikshosp, Women & Childrens Div, Sect Obstet, Oslo, Norway.	camilla.friis@ous-hf.no		Qvigstad, Elisabeth/0000-0002-9119-9187	South-Eastern Norway Regional Health Authority, The National Resource Centre for Women's Health, Division of Obstetrics and Gynaecology, Oslo University Hospital, Rikshospitalet; Department of Obstetrics, Women and Children's Division, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Faculty of Medicine, Thematic Research Area, University of Oslo	South-Eastern Norway Regional Health Authority, The National Resource Centre for Women's Health, Division of Obstetrics and Gynaecology, Oslo University Hospital, Rikshospitalet; Department of Obstetrics, Women and Children's Division, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Faculty of Medicine, Thematic Research Area, University of Oslo	The project has been financially supported by South-Eastern Norway Regional Health Authority, The National Resource Centre for Women's Health, Division of Obstetrics and Gynaecology, Oslo University Hospital, Rikshospitalet; The Department of Obstetrics, Women and Children's Division, Oslo University Hospital, Rikshospitalet, Oslo, Norway; The Faculty of Medicine, Thematic Research Area, University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BJOG; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; CATALANO PM, 1995, AM J OBSTET GYNECOL, V172, P1464, DOI 10.1016/0002-9378(95)90479-4; Challier JC, 2008, PLACENTA, V29, P274, DOI 10.1016/j.placenta.2007.12.010; Coall DA, 2009, PEDIATR DEVEL PATHOL, V12, P200, DOI 10.2350/08-02-0413.1; Di Cianni G, 2005, DIABETIC MED, V22, P21, DOI 10.1111/j.1464-5491.2004.01336.x; Fowden AL, 2009, J PHYSIOL-LONDON, V587, P3459, DOI 10.1113/jphysiol.2009.173013; Fowden AL, 2006, J PHYSIOL-LONDON, V572, P5, DOI 10.1113/jphysiol.2005.104141; Friis CM, INTERLEUKINS IL 6 IL; Godang K, 2010, J CLIN DENSITOM, V13, P151, DOI 10.1016/j.jocd.2010.01.121; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Harvey NC, 2007, J CLIN ENDOCR METAB, V92, P523, DOI 10.1210/jc.2006-0456; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jones HN, 2007, PLACENTA, V28, P763, DOI 10.1016/j.placenta.2007.05.002; Jones HN, 2009, AM J PHYSIOL-CELL PH, V297, pC1228, DOI 10.1152/ajpcell.00195.2009; KARL PI, 1992, AM J PHYSIOL, V262, pC834, DOI 10.1152/ajpcell.1992.262.4.C834; Lager S, 2010, PLACENTA; Lain Kristine Y., 2006, Metabolic Syndrome and Related Disorders, V4, P91, DOI 10.1089/met.2006.4.91; Langley-Evans AJ, 2003, J R SOC PROMO HEALTH, V123, P210, DOI 10.1177/146642400312300409; Leary SD, 2003, PLACENTA, V24, P276, DOI 10.1053/plac.2002.0888; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Magnusson-Olsson AL, 2006, J LIPID RES, V47, P2551, DOI 10.1194/jlr.M600098-JLR200; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Modi N, 2011, PEDIATR RES, V70, P287, DOI 10.1203/PDR.0b013e318225f9b1; MOLTENI RA, 1978, J REPROD MED, V21, P327; Nathanielsz PW, CLIN PERINATOL, V34, P515; Ong KK, 2008, DIABETES CARE, V31, P2193, DOI 10.2337/dc08-1111; Ouyang F, 2012, OBESITY SILVER SPRIN; Radaelli T, 2006, J SOC GYNECOL INVEST, V13, P53, DOI 10.1016/j.jsgi.2005.10.003; Radaelli T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.019; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; ROBINSON JS, 1994, AUST NZ J OBSTET GYN, V34, P240, DOI 10.1111/j.1479-828X.1994.tb01065.x; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Roos S, 2009, AM J PHYSIOL-CELL PH, V297, pC723, DOI 10.1152/ajpcell.00191.2009; Salafia CM, 2008, PAEDIATR PERINAT EP, V22, P229, DOI 10.1111/j.1365-3016.2008.00935.x; Schaefer-Graf UM, 2011, DIABETIC MED, V28, P1053, DOI 10.1111/j.1464-5491.2011.03346.x; Sewell MF, 2007, J REPROD MED, V52, P907; Sewell MF, 2006, AM J OBSTET GYNECOL, V195, P1100, DOI 10.1016/j.ajog.2006.06.014; SPARKS JW, 1984, SEMIN PERINATOL, V8, P74; Thompson JMD, 2007, BJOG-INT J OBSTET GY, V114, P715, DOI 10.1111/j.1471-0528.2007.01327.x; Voldner N, 2008, ACTA OBSTET GYN SCAN, V87, P423, DOI 10.1080/00016340801989825; Wallace JM, 2012, PLACENTA	44	44	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57467	10.1371/journal.pone.0057467	http://dx.doi.org/10.1371/journal.pone.0057467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460863	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000118
J	Gallmeier, E; Bader, DC; Kriegl, L; Berezowska, S; Seeliger, H; Goke, B; Kirchner, T; Bruns, C; De Toni, EN				Gallmeier, Eike; Bader, Dominik C.; Kriegl, Lydia; Berezowska, Sabina; Seeliger, Hendrik; Goeke, Burkhard; Kirchner, Thomas; Bruns, Christiane; De Toni, Enrico N.			Loss of TRAIL-Receptors Is a Recurrent Feature in Pancreatic Cancer and Determines the Prognosis of Patients with No Nodal Metastasis after Surgery	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; DEATH-RECEPTORS; MONOCLONAL-ANTIBODY; PHASE-II; EXPRESSION; RESISTANCE; PATHWAYS; CELLS; CARCINOMA; TRIAL	Introduction: Agonistic antibodies targeting TRAIL-receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are being developed as a novel therapeutic approach in cancer therapy including pancreatic cancer. However, the cellular distribution of these receptors in primary pancreatic cancer samples has not been sufficiently investigated and no study has yet addressed the issue of their prognostic significance in this tumor entity. Aims and Methods: Applying tissue microarray (TMA) analysis, we performed an immunohistochemical assessment of TRAIL-receptors in surgical samples from 84 consecutive patients affected by pancreatic adenocarcinoma and in 26 additional selected specimens from patients with no lymph nodes metastasis at the time of surgery. The prognostic significance of membrane staining and staining intensity for TRAIL-receptors was evaluated. Results: The fraction of pancreatic cancer samples with positive membrane staining for TRAIL-R1 and TRAIL-R2 was lower than that of cells from surrounding non-tumor tissues (TRAIL-R1: p < 0.001, TRAIL-R2: p = 0.006). In addition, subgroup analyses showed that loss of membrane staining for TRAIL-R2 was associated with poorer prognosis in patients without nodal metastases (multivariate Cox regression analysis, Hazard Ratio: 0.44 [95% confidence interval: 0.2220.87]; p = 0.019). In contrast, analysis of decoy receptors TRAIL-R3 and -R4 in tumor samples showed an exclusively cytoplasmatic staining pattern and no prognostic relevance. Conclusion: This is a first report on the prognostic significance of TRAIL-receptors expression in pancreatic cancer showing that TRAIL-R2 might represent a prognostic marker for patients with early stage disease. In addition, our data suggest that loss of membrane-bound TRAIL-receptors could represent a molecular mechanism for therapeutic failure upon administration of TRAIL-receptors-targeting antibodies in pancreatic cancer. This hypothesis should be evaluated in future clinical trials.	[Gallmeier, Eike; Bader, Dominik C.; Goeke, Burkhard; De Toni, Enrico N.] Univ Munich, Dept Med 2, Univ Hosp Grosshadern, Munich, Germany; [Kriegl, Lydia; Berezowska, Sabina; Kirchner, Thomas] Univ Munich, Inst Pathol, D-80539 Munich, Germany; [Seeliger, Hendrik; Bruns, Christiane] Univ Munich, Dept Surg, Univ Hosp Grosshadern, Munich, Germany	University of Munich; University of Munich; University of Munich	De Toni, EN (corresponding author), Univ Munich, Dept Med 2, Univ Hosp Grosshadern, Munich, Germany.	Enrico.deToni@med.uni-muenchen.de	Berezowska, Sabina/AAJ-4557-2021; De Toni, Enrico N/C-6496-2008	Berezowska, Sabina/0000-0001-5442-9791; 	Deutsche Forschungsgemeinschaft (DFG) [DFG TO 605/2-1, DFG GA762/3-2]; Else Kroner-Fresenius Stiftung [2011_A226]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) with grants DFG TO 605/2-1 to EDT and DFG GA762/3-2 to EG and by the Else Kroner-Fresenius Stiftung with the grant 2011_A226 to EDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt A, 2010, CANC LETT; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Bae SI, 2008, ONCOGENE, V27, P490, DOI 10.1038/sj.onc.1210655; Bavi P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-203; Chen JJ, 2012, ONCOTARGET, V3, P833; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; De Toni EN, 2008, CLIN CANCER RES, V14, P4713, DOI 10.1158/1078-0432.CCR-07-5019; Forero-Torres A, 2010, CANCER BIOTHER RADIO, V25, P13, DOI 10.1089/cbr.2009.0673; Fulda S, 2012, EXP CELL RES, V318, P1208, DOI 10.1016/j.yexcr.2012.02.005; Fulda S, 2009, J CELL MOL MED, V13, P1221, DOI 10.1111/j.1582-4934.2009.00748.x; Ganten TM, 2009, J MOL MED, V87, P995, DOI 10.1007/s00109-009-0510-z; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Granci V, 2008, EUR J CANCER, V44, P2312, DOI 10.1016/j.ejca.2008.06.042; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Guo F, 2004, CANCER RES, V64, P2580, DOI 10.1158/0008-5472.CAN-03-2629; Hamacher R, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-64; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeng YM, 2002, CANCER LETT, V181, P205, DOI 10.1016/S0304-3835(02)00051-4; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Khanbolooki S, 2006, MOL CANCER THER, V5, P2251, DOI 10.1158/1535-7163.MCT-06-0075; Kong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037222; Kriegl L, 2010, CLIN CANCER RES, V16, P5529, DOI 10.1158/1078-0432.CCR-09-3403; McCarthy MM, 2005, CLIN CANCER RES, V11, P5188, DOI 10.1158/1078-0432.CCR-05-0158; Merchant MS, 2004, CANCER RES, V64, P8349, DOI 10.1158/0008-5472.CAN-04-1705; Niemoller O, 2009, RESULTS PROBL CELL D, V49, P219, DOI 10.1007/400_2009_17; Niemoeller OM, 2011, CANC LETT; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Pineda DM, 2012, CANCER BIOL THER, V13, P946, DOI 10.4161/cbt.20952; Roder C, 2011, EUR J CELL BIOL, V90, P450, DOI 10.1016/j.ejcb.2010.10.008; Sanlioglu AD, 2009, PANCREAS, V38, P154, DOI 10.1097/MPA.0b013e31818db9e3; Schafer C, 2012, J CELL MOL MED, V16, P1776, DOI 10.1111/j.1582-4934.2011.01473.x; Schuler S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-80; Shankar S, 2005, PROSTATE, V62, P165, DOI 10.1002/pros.20126; Shin MS, 2001, CANCER RES, V61, P4942; Soria JC, 2011, J CLIN ONCOL, V29, P4442, DOI 10.1200/JCO.2011.37.2623; Stadel D, 2010, CLIN CANCER RES, V16, P5734, DOI 10.1158/1078-0432.CCR-10-0985; Strater J, 2002, CLIN CANCER RES, V8, P3734; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Trarbach T, 2010, BRIT J CANCER, V102, P506, DOI 10.1038/sj.bjc.6605507; van Noesel MM, 2002, CANCER RES, V62, P2157; Walczak H, 2006, APOPTOSIS CANC THERA, P31; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yue HH, 2005, CELL DEATH DIFFER, V12, P94, DOI 10.1038/sj.cdd.4401523; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313; Zhu H, 2010, CANCER LETT, V297, P155, DOI 10.1016/j.canlet.2010.04.030	46	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56760	10.1371/journal.pone.0056760	http://dx.doi.org/10.1371/journal.pone.0056760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460812	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000035
J	Ji, LN; Tong, XL; Wang, HY; Tian, HM; Zhou, HM; Zhang, LL; Li, QF; Wang, YZ; Li, HM; Liu, M; Yang, HJ; Gao, YB; Li, Y; Li, QM; Guo, XH; Yang, GY; Zhang, ZG; Zhou, ZG; Ning, G; Chen, YL; Paul, S				Ji, Linong; Tong, Xiaolin; Wang, Hongyuan; Tian, Haoming; Zhou, Huimin; Zhang, Lili; Li, Qifu; Wang, Yizhong; Li, Hongmei; Liu, Min; Yang, Hongjie; Gao, Yanbin; Li, Yan; Li, Quanmin; Guo, Xiaohui; Yang, Gangyi; Zhang, Zhongai; Zhou, Zhiguang; Ning, Guang; Chen, Yingli; Paul, Sanjoy		Evidence-Based Med Res Xiaoke Pill	Efficacy and Safety of Traditional Chinese Medicine for Diabetes: A Double-Blind, Randomised, Controlled Trial	PLOS ONE			English	Article							THERAPY	Background: Treatment of diabetes mellitus with Traditional Chinese Medicine has a long history. The aim of this study is to establish the safety and efficacy of traditional Chinese medicine combined with glibenclamide to treat type 2 diabetes mellitus. Methods: In a controlled, double blind, multicentre non-inferiority trial, 800 patients with unsatisfactory glycemic control (fasting glucose 7-13 mmol/L and HbA1c 7-11%) were randomly assigned to receive Xiaoke Pill, a compound of Chinese herbs combined with glibenclamide, or Glibenclamide in two study groups - drug naive group, and patients previously treated with metformin monotherapy (metformin group). Outcome measures at 48 weeks were the incidence and rate of hypoglycemia, mean difference in HbA1c, and proportion of patients with HbA1c<6.5%. Findings: In drug naive group, the total hypoglycemia rate and the mild hypoglycemic episode in the Xiaoke Pill arm were 38% (p = 0.024) and 41% (p = 0.002) less compared to Glibenclamide arm; in Metformin group, the average annual rate of hypoglycemia was 62% lower in Xiaoke Pill arm (p = 0.003). Respective mean changes in HbA1c from baseline were -0.70% and -0.66% for Xiaoke Pill and Glibenclamide, with a between-group difference (95% CI) of -0.04% (-0.20, 0.12) in the drug naive group, and those in metformin group were -0.45% and -0.59%, 0.14% (-0.12, 0.39) respectively. The respective proportions of patients with a HbA1c level <6.5% were 26.6% and 23.4% in the drug naive group and 20.1% and 18.9% in the metformin group. Interpretation: In patients with type 2 diabetes and inadequate glycaemic control, treatment with Xiaoke Pill led to significant reduction in risk of hypoglycemia and similar improvements in glycemic control after 48 weeks compared to Glibenclamide. Trial Registration: Chinese Clinical Trial Register number, ChiCTR-TRC-08000074	[Ji, Linong; Chen, Yingli] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Tong, Xiaolin] China Acad Chinese Medicial Sci, Guanganmen Hosp, Beijing, Peoples R China; [Wang, Hongyuan] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Tian, Haoming] Sichuan Univ, West China Hosp, Chengdu 610064, Peoples R China; [Zhou, Huimin] Hebei Med Univ, Hosp 1, Shijiazhuang, Peoples R China; [Zhang, Lili] Peking Univ Tradit Chinese & Western Med, Affiliated Hosp 3, Beijing, Peoples R China; [Li, Qifu] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China; [Wang, Yizhong] China Aerosp Corp, Cent Hosp, Beijing, Peoples R China; [Li, Hongmei] China Meitan Gen Hosp, Beijing, Peoples R China; [Liu, Min] Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Yang, Hongjie] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China; [Gao, Yanbin] Beijing Univ Tradit Chinese Med, Dongfang Hosp, Beijing, Peoples R China; [Li, Yan] Zhongshan Univ, Sun Yai Sen Mem Hosp, Zhongshan, Peoples R China; [Li, Quanmin] PLA Second Artillery, Gen Hosp, Beijing, Peoples R China; [Guo, Xiaohui] Peking Univ, Hosp 1, Beijing 100871, Peoples R China; [Yang, Gangyi] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China; [Zhang, Zhongai] Nanjing Hosp Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China; [Zhou, Zhiguang] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Ning, Guang] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai 200030, Peoples R China; [Paul, Sanjoy] Univ Queensland, Queensland Clin Trials & Biostat Ctr, Sch Populat Hlth, Brisbane, Qld 4072, Australia	Peking University; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Peking University; Sichuan University; Hebei Medical University; Chongqing Medical University; Guangzhou University of Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Beijing University of Chinese Medicine; Sun Yat Sen University; Peking University; Chongqing Medical University; Central South University; Shanghai Jiao Tong University; University of Queensland	Ji, LN (corresponding author), Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China.	jiln@bjmu.edu.cn; s.paul@sph.uq.edu.au	Paul, Sanjoy K/F-8199-2010; Linong, Ji/AAB-6543-2020	Paul, Sanjoy K/0000-0003-0848-7194; Li, Qifu/0000-0003-3904-410X; Zhou, Zhiguang/0000-0002-0374-1838; Hongjie, Yang/0000-0002-8054-9313	National Basic Research Program of China (973 program) [2011CB504001]; National High Technology Research and Development Program (863 program) [2006AA02A409]; Guangzhou Zhongyi Pharmaceutical; Eli Lilly; Bristol-Myers Squibb; Novartis; Novo Nordisk; Merck; Bayer; Takeda; Sanofi-Aventis; GlaxoSmithKline; Roche; Johnson Johnson; boehingeringelheim	National Basic Research Program of China (973 program)(National Basic Research Program of China); National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China); Guangzhou Zhongyi Pharmaceutical; Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Novartis(Novartis); Novo Nordisk(Novo Nordisk); Merck(Merck & Company); Bayer(Bayer AG); Takeda(Takeda Pharmaceutical Company Ltd); Sanofi-Aventis(Sanofi-Aventis); GlaxoSmithKline(GlaxoSmithKline); Roche(Roche Holding); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); boehingeringelheim	This work was supported by grants from National Basic Research Program of China (973 program, No. 2011CB504001), National High Technology Research and Development Program (863 program, No. 2006AA02A409), and Guangzhou Zhongyi Pharmaceutical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have declared that no competing interests exist. Several authors have received speaking honoraria from several pharmaceutical companies as follows: Dr. Ji reports receiving consulting and lecture fees from Eli Lilly, Bristol-Myers Squibb, Novartis, Novo Nordisk, Merck, Bayer, Takeda, Sanofi-Aventis, GlaxoSmithKline, Roche, Johnson & Johnson, boehingeringelheim, and Guangzhou Zhongyi Pharmaceutical, and grants from Guangzhou Zhongyi Pharmaceutical and Bayer. Dr. Q Li reports receiving consulting and lecture fees from Eli Lilly, Novo Nordisk, and Sanofi-Aventis. Dr. Tian reports receiving lecture fees from Bristol-Myers Squibb, Novo Nordisk, Bayer, and Sanofi-Aventis. Dr. Y. Li reports receiving consulting fees from Novartis, Novo Nordisk, and Sanofi-Aventis and lecture fees from Novo Nordisk and Sanofi-Aventis. Dr. Guo reports receiving consulting fees from Novartis, Sanofi-Aventis, and Guangzhou Zhongyi Pharmaceutical and lecture fees from Sanofi-Aventis, Guangzhou Zhongyi Pharmaceutical, and Novo Nordisk. Dr. Y. Gao reports receiving consulting fees from Novartis, Sanofi-Aventis, and Guangzhou Zhongyi Pharmaceutical and lecture fees from Sanofi-Aventis, Guangzhou Zhongyi Pharmaceutical, and Novo Nordisk. Dr. M. Liu reports receiving lecture fees from Eli Lilly, Novo Nordisk, and Bayer. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Cang Chung-Ching HH, 1983, CHIN KUEI YOU LUEH; Chen G, 2003, ZHONG YAO XIN YAO YU, V14, P84; Cheng JT, 2000, J CLIN PHARMACOL, V40, P445, DOI 10.1177/00912700022009198; European Medicines Agency, 2005, PUBL STAT RISK ASS U; Home PD, 2007, DIABETIC MED, V24, P626, DOI 10.1111/j.1464-5491.2007.02160.x; Hsu HY, 1978, B ORIENTAL HEALING A, V3, P12; Kenward MG, 2007, STAT METHODS MED RES, V16, P199, DOI 10.1177/0962280206075304; Li M, 2009, INT J OBESITY, V33, P424, DOI 10.1038/ijo.2009.44; Li WL, 2004, J ETHNOPHARMACOL, V92, P1, DOI 10.1016/j.jep.2003.12.031; Liu J.P., 2004, COCHRANE DB SYST REV, V3; Ni M., 1995, YELLOW EMPERORS CLAS; Pharmacopoeia Commission, 2010, PHARM PEOPL REP CHIN; Sang Z, 2010, AM J CHINESE MED, V38, P1027, DOI 10.1142/S0192415X10008445; Sena M, 2009, FASEB J, V23, P900; Tang JL, 1999, BMJ-BRIT MED J, V319, P160, DOI 10.1136/bmj.319.7203.160; Wang E, 2008, DIABETES EDUCATOR, V34, P645, DOI 10.1177/0145721708320559; Wang G, 2007, CLIN THER, V29, P1456, DOI 10.1016/j.clinthera.2007.07.023; Wu JL, 2005, SHI YONG ZHONG XI YI, V5, P18; Xie W., 2011, EVID-BASED COMPL ALT, V2011, DOI DOI 10.1155/2011/726723; [徐晓虹 XU Xiaohong], 2008, [中国药学杂志, Chinese Pharmaceutical Journal], V43, P1308; Ye TS, 2006, RECORD MED PRACTICE; Yeh GY, 2003, DIABETES CARE, V26, P1277, DOI 10.2337/diacare.26.4.1277; Zhang H, 2010, EUR J INTEGR MED, V2, P41, DOI 10.1016/j.eujim.2010.02.004; Zhang HZ, 1999, ZHONG YI YAO YAN JIU, V15, P19; Zhang YX, 2004, INT CONGR SER, V1260, P421, DOI 10.1016/S0531-5131(03)01684-4; Zhao YC, 1998, CHANGCHUN ZHONG YI X, V14, P15; Zheng X, 2010, PRINCIPAL GUIDELINE; Zhou R, 2003, ZHONGGUO YAOWU YU LI, V3, P131; Zhu DX, 1993, HEART ESSENCE DAN XI	30	56	67	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56703	10.1371/journal.pone.0056703	http://dx.doi.org/10.1371/journal.pone.0056703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460810	Green Published, gold			2022-12-27	WOS:000315519000033
J	Jourdi, H; Kabbaj, M				Jourdi, Hussam; Kabbaj, Mohamed			Acute BDNF Treatment Upregulates GluR1-SAP97 and GluR2-GRIP1 Interactions: Implications for Sustained AMPA Receptor Expression	PLOS ONE			English	Article							LONG-TERM POTENTIATION; IONOTROPIC GLUTAMATE RECEPTORS; SYNAPSE-ASSOCIATED PROTEIN-97; METHYL-D-ASPARTATE; NEUROTROPHIC FACTOR; DOWN-REGULATION; PKM-ZETA; TYROSINE PHOSPHORYLATION; SURFACE EXPRESSION; ACID RECEPTORS	Brain-derived neurotrophic factor (BDNF) plays several prominent roles in synaptic plasticity and in learning and memory formation. Reduced BDNF levels and altered BDNF signaling have been reported in several brain diseases and behavioral disorders, which also exhibit reduced levels of AMPAr subunits. BDNF treatment acutely regulates AMPA receptor expression and function, including synaptic AMPAr subunit trafficking, and implicates several well defined signaling molecules that are required to elicit long term potentiation and depression (LTP and LTD, respectively). Long term encoding of synaptic events, as in long term memory formation, requires AMPAr stabilization and maintenance. However, factors regulating AMPAr stabilization in neuronal cell membranes and synaptic sites are not well characterized. In this study, we examine the effects of acute BDNF treatment on levels of AMPAr-associated scaffolding proteins and on AMPAr subunit-scaffolding protein interactions. We also examine the effects of BDNF-dependent enhanced interactions between AMPAr subunits with their specific scaffolding proteins on the accumulation of both types of proteins. Our results show that acute BDNF treatment upregulates the interactions between AMPAr subunits (GluR1 and GluR2) with their scaffold proteins SAP97 and GRIP1, respectively, leading to prolonged increased accumulation of both categories of proteins, albeit with distinct mechanisms for GluR1 and GluR2. Our findings reveal a new role for BDNF in the long term maintenance of AMPA receptor subunits and associated scaffolding proteins at synapses and further support the role of BDNF as a key regulator of synaptic consolidation. These results have potential implications for recent findings implicating BDNF and AMPAr subunits in various brain diseases and behavioral disorders.	[Jourdi, Hussam; Kabbaj, Mohamed] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Jourdi, H (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	hjourdi@fsu.edu	Kabbaj, Mohamed/M-9240-2016; Jourdi, Hussam/ABI-4842-2020	Jourdi, Hussam/0000-0003-0712-5693	Japanese Ministry of Education, Culture, Sports, Science, and Technology; College of Medicine, Florida State University	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); College of Medicine, Florida State University	This work was partially supported by a doctoral fellowship from the Japanese Ministry of Education, Culture, Sports, Science, and Technology to HJ while at the laboratory of Dr. H. Nawa, Niigata University (Niigata, Japan) and by an SGP grant from the College of Medicine, Florida State University to HJ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaneya Y, 1997, J NEUROSCI, V17, P6707; Bi RF, 1998, BRAIN RES, V797, P154, DOI 10.1016/S0006-8993(98)00433-8; Bi XN, 1998, INT REV NEUROBIOL, V42, P227, DOI 10.1016/S0074-7742(08)60612-1; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Broutman G, 2001, J NEUROSCI, V21, P27, DOI 10.1523/JNEUROSCI.21-01-00027.2001; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Choi KH, 2009, J PSYCHIATR NEUROSCI, V34, P450; Chung HJ, 2000, J NEUROSCI, V20, P7258; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 2012, PHILOS T R SOC B, V367, P2475, DOI 10.1098/rstb.2011.0357; Fortin DA, 2012, J NEUROSCI, V32, P8127, DOI 10.1523/JNEUROSCI.6034-11.2012; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Hanley JG, 2008, CELL ADHES MIGR, V2, P276, DOI 10.4161/cam.2.4.6510; Hayashi T, 2004, J NEUROSCI, V24, P6152, DOI 10.1523/JNEUROSCI.0799-04.2004; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Henley JM, 2003, NEUROSCI RES, V45, P243, DOI 10.1016/S0168-0102(02)00229-8; Ibaraki K, 1999, J NEUROCHEM, V73, P408, DOI 10.1046/j.1471-4159.1999.0730408.x; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Jia YS, 2010, J NEUROSCI, V30, P14440, DOI 10.1523/JNEUROSCI.3310-10.2010; Jourdi H, 2005, J PHARMACOL EXP THER, V314, P16, DOI 10.1124/jpet.105.083873; Jourdi H, 2005, NEUROCHEM INT, V46, P31, DOI 10.1016/j.neuint.2004.07.002; Jourdi H, 2003, DEV BIOL, V263, P216, DOI 10.1016/j.ydbio.2003.07.008; Jourdi H, 2010, J NEUROSCI, V30; Jourdi Hussam, 2002, Acta Medica et Biologica, V50, P107; Jourdi H, 2009, J NEUROSCI, V29, P8688, DOI 10.1523/JNEUROSCI.6078-08.2009; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Koike H, 2011, NEUROPHARMACOLOGY, V61, P1419, DOI 10.1016/j.neuropharm.2011.08.034; Koike H, 2011, BEHAV BRAIN RES, V224, P107, DOI 10.1016/j.bbr.2011.05.035; Kulangara K, 2007, J BIOL CHEM, V282, P2395, DOI 10.1074/jbc.M606471200; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; Lu XY, 2001, J NEUROCHEM, V77, P1553, DOI 10.1046/j.1471-4159.2001.00359.x; Lynch G, 2008, EUR J PHARMACOL, V585, P2, DOI 10.1016/j.ejphar.2007.11.082; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Marcello E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.015; MASSICOTTE G, 1990, MOL PHARMACOL, V37, P278; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; MCNEILL RB, 1995, J BIOL CHEM, V270, P10043, DOI 10.1074/jbc.270.17.10043; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Nagano T, 2003, MOL CELL NEUROSCI, V24, P340, DOI 10.1016/S1044-7431(03)00172-6; Nagano T, 1998, J BIOCHEM-TOKYO, V124, P869, DOI 10.1093/oxfordjournals.jbchem.a022200; Namba H, 2006, MOL CELL NEUROSCI, V31, P628, DOI 10.1016/j.mcn.2005.12.002; Narisawa-Saito M, 1999, NEUROSCIENCE, V88, P1009, DOI 10.1016/S0306-4522(98)00496-5; Narisawa-Saito M, 1999, P NATL ACAD SCI USA, V96, P2461, DOI 10.1073/pnas.96.5.2461; Narisawa-Saito M, 2002, J BIOL CHEM, V277, P40901, DOI 10.1074/jbc.M202158200; Nash JE, 2005, FASEB J, V19, P583, DOI 10.1096/fj.04-1854fje; Nawa H, 2006, NEUROSCI RES, V56, P2, DOI 10.1016/j.neures.2006.06.002; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rex CS, 2006, J NEUROPHYSIOL, V96, P677, DOI 10.1152/jn.00336.2006; Rong YQ, 2001, J NEUROCHEM, V79, P382, DOI 10.1046/j.1471-4159.2001.00565.x; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Sato J, 2008, J NEURAL TRANSM, V115, P1355, DOI 10.1007/s00702-008-0085-9; Takahashi M, 2000, MOL PSYCHIATR, V5, P293, DOI 10.1038/sj.mp.4000718; Takei N, 2009, J BIOL CHEM, V284, P26340, DOI 10.1074/jbc.M109.023010; Toyooka K, 2002, PSYCHIAT RES, V110, P249, DOI 10.1016/S0165-1781(02)00127-0; Toyooka K, 2002, J NEUROCHEM, V83, P797, DOI 10.1046/j.1471-4159.2002.01181.x; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009; Wakabayashi K, 1999, NEUROBIOL AGING, V20, P287, DOI 10.1016/S0197-4580(99)00035-4; Watanabe Y, 2010, PSYCHIAT CLIN NEUROS, V64, P217, DOI 10.1111/j.1440-1819.2010.02094.x; Wu S, 2007, NEUR M PLANN SAN DIE; Wu SH, 2010, J BIOL CHEM, V285, P40472, DOI 10.1074/jbc.M110.171371; Xiong H, 2002, NEUROPHARMACOLOGY, V42, P903, DOI 10.1016/S0028-3908(02)00043-6; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Yokomaku D, 2005, NEUROSCIENCE, V136, P1037, DOI 10.1016/j.neuroscience.2005.08.014; Zheng CY, 2011, NEUROSCIENTIST, V17, P493, DOI 10.1177/1073858410386384; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	76	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57124	10.1371/journal.pone.0057124	http://dx.doi.org/10.1371/journal.pone.0057124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460828	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000065
J	Kwon, M; Lee, JY; Won, WY; Park, JW; Min, JA; Hahn, C; Gu, X; Choi, JH; Kim, DJ				Kwon, Min; Lee, Joon-Yeop; Won, Wang-Youn; Park, Jae-Woo; Min, Jung-Ah; Hahn, Changtae; Gu, Xinyu; Choi, Ji-Hye; Kim, Dai-Jin			Development and Validation of a Smartphone Addiction Scale (SAS)	PLOS ONE			English	Article							INTERNET ADDICTION	Objective: The aim of this study was to develop a self-diagnostic scale that could distinguish smartphone addicts based on the Korean self-diagnostic program for Internet addiction (K-scale) and the smartphone's own features. In addition, the reliability and validity of the smartphone addiction scale (SAS) was demonstrated. Methods: A total of 197 participants were selected from Nov. 2011 to Jan. 2012 to accomplish a set of questionnaires, including SAS, K-scale, modified Kimberly Young Internet addiction test (Y-scale), visual analogue scale (VAS), and substance dependence and abuse diagnosis of DSM-IV. There were 64 males and 133 females, with ages ranging from 18 to 53 years (M = 26.06; SD = 5.96). Factor analysis, internal-consistency test, t-test, ANOVA, and correlation analysis were conducted to verify the reliability and validity of SAS. Results: Based on the factor analysis results, the subscale "disturbance of reality testing" was removed, and six factors were left. The internal consistency and concurrent validity of SAS were verified (Cronbach's alpha = 0.967). SAS and its subscales were significantly correlated with K-scale and Y-scale. The VAS of each factor also showed a significant correlation with each subscale. In addition, differences were found in the job (p < 0.05), education (p < 0.05), and self-reported smartphone addiction scores (p < 0.001) in SAS. Conclusions: This study developed the first scale of the smartphone addiction aspect of the diagnostic manual. This scale was proven to be relatively reliable and valid.	[Kwon, Min] Catholic Univ Korea, Addict Clin, Dept Psychiat, Seoul St Marys Hosp, Seoul, South Korea; [Lee, Joon-Yeop] Catholic Univ Korea, Coll Med, Seoul, South Korea; [Won, Wang-Youn] Catholic Univ Korea, Coll Med, Dept Psychiat, Seoul St Pauls Hosp, Seoul, South Korea; [Park, Jae-Woo] Catholic Univ Korea, Dept Psychol, Coll Social Sci, Puchon, South Korea; [Min, Jung-Ah; Hahn, Changtae; Kim, Dai-Jin] Catholic Univ Korea, Dept Psychiat, Seoul St Marys Hosp, Coll Med, Seoul, South Korea; [Gu, Xinyu; Choi, Ji-Hye] Catholic Univ Korea, Res Inst Addict, Seoul St Marys Hosp, Dept Psychiat, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Kim, DJ (corresponding author), Catholic Univ Korea, Dept Psychiat, Seoul St Marys Hosp, Coll Med, Seoul, South Korea.	kdj922@chollian.net		Kwon, Min/0000-0003-0947-5830	Ministry of Health and Welfare, Republic of Korea [A120157]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	The study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A120157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Chang MK, 2008, COMPUT HUM BEHAV, V24, P2597, DOI 10.1016/j.chb.2008.03.001; Dong-il Kim, 2008, [Korea Journal of Counseling, 상담학연구], V9, P1703; Holden C, 2001, SCIENCE, V294, P980, DOI 10.1126/science.294.5544.980; Hope D, 2010, IPHONE ADDICTIVE SUR; Infocomm Development Authority of Singapore, 2008, ANN SURV INF US HOUS, P22; Kim CT, 2002, STUDY INTERNET ADDIC, P106; Kim EJ, 2008, EUR PSYCHIAT, V23, P212, DOI 10.1016/j.eurpsy.2007.10.010; Kim JH, 2006, J KOREAN MED ASSOC, V49, P202, DOI 10.5124/jkma.2006.49.3.202; O'Brien C, 2011, ADDICTION, V106, P866, DOI 10.1111/j.1360-0443.2010.03144.x; OReilly M, 1996, CAN MED ASSOC J, V154, P1882; Porter G, 2010, INT SYMP TECHNOL SOC, P435, DOI 10.1109/ISTAS.2010.5514609; Rush S., 2011, THESIS CENTRAL QUEEN; Shaw M, 2008, CNS DRUGS, V22, P353, DOI 10.2165/00023210-200822050-00001; Shin KW, 2011, DEV KOREAN SMART PHO, P42; Sim MS, 2011, SMART PHONE USE SURV, P21; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	17	600	621	32	260	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56936	10.1371/journal.pone.0056936	http://dx.doi.org/10.1371/journal.pone.0056936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468893	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000047
J	Podnecky, NL; Elrod, MG; Newton, BR; Dauphin, LA; Shi, JR; Chawalchitiporn, S; Baggett, HC; Hoffmaster, AR; Gee, JE				Podnecky, Nicole L.; Elrod, Mindy G.; Newton, Bruce R.; Dauphin, Leslie A.; Shi, Jianrong; Chawalchitiporn, Sutthinan; Baggett, Henry C.; Hoffmaster, Alex R.; Gee, Jay E.			Comparison of DNA Extraction Kits for Detection of Burkholderia pseudomallei in Spiked Human Whole Blood Using Real-Time PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; III SECRETION SYSTEM; CLINICAL SPECIMENS; MELIOIDOSIS; IDENTIFICATION; ASSAY; DIAGNOSIS; RECOVERY	Burkholderia pseudomallei, the etiologic agent of melioidosis, is endemic in northern Australia and Southeast Asia and can cause severe septicemia that may lead to death in 20% to 50% of cases. Rapid detection of B. pseudomallei infection is crucial for timely treatment of septic patients. This study evaluated seven commercially available DNA extraction kits to determine the relative recovery of B. pseudomallei DNA from spiked EDTA-containing human whole blood. The evaluation included three manual kits: the QIAamp DNA Mini kit, the QIAamp DNA Blood Mini kit, and the High Pure PCR Template Preparation kit; and four automated systems: the MagNAPure LC using the DNA Isolation Kit I, the MagNAPure Compact using the Nucleic Acid Isolation Kit I, and the QIAcube using the QIAamp DNA Mini kit and the QIAamp DNA Blood Mini kit. Detection of B. pseudomallei DNA extracted by each kit was performed using the B. pseudomallei specific type III secretion real-time PCR (TTS1) assay. Crossing threshold (C-T) values were used to compare the limit of detection and reproducibility of each kit. This study also compared the DNA concentrations and DNA purity yielded for each kit. The following kits consistently yielded DNA that produced a detectable signal from blood spiked with 5.5x10(4) colony forming units per mL: the High Pure PCR Template Preparation, QIAamp DNA Mini, MagNA Pure Compact, and the QIAcube running the QIAamp DNA Mini and QIAamp DNA Blood Mini kits. The High Pure PCR Template Preparation kit yielded the lowest limit of detection with spiked blood, but when this kit was used with blood from patients with confirmed cases of melioidosis, the bacteria was not reliably detected indicating blood may not be an optimal specimen.	[Podnecky, Nicole L.; Elrod, Mindy G.; Hoffmaster, Alex R.; Gee, Jay E.] Ctr Dis Control & Prevent, Bacterial Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Newton, Bruce R.; Dauphin, Leslie A.] Ctr Dis Control & Prevent, Bioterrorism Rapid Response & Adv Technol Lab, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Shi, Jianrong] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Chawalchitiporn, Sutthinan] Nakhon Phanom Prov Hlth Off, Nakhon Phanom, Thailand; [Baggett, Henry C.] Thailand Minist Publ Hlth US Ctr Dis Control & Pr, Int Emerging Infect Program, Global Dis Detect Reg Ctr, Nonthaburi, Thailand	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Gee, JE (corresponding author), Ctr Dis Control & Prevent, Bacterial Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	xzg4@cdc.gov	Podnecky, Nicole L./AAG-5225-2019	Podnecky, Nicole L./0000-0002-1745-934X; Gee, Jay/0000-0003-4308-1659	Centers for Disease Control and Prevention; Emerging Infectious Disease Fellowship Program	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Emerging Infectious Disease Fellowship Program	Nicole Podnecky was supported by the Emerging Infectious Disease Fellowship Program administered by the Association of Public Health Laboratories and funded by the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro A, 2008, LETT APPL MICROBIOL, V47, P8, DOI 10.1111/j.1472-765X.2008.02372.x; [Anonymous], 2006, MM3A2 CLSI; Brook MD, 1997, J APPL MICROBIOL, V82, P589, DOI 10.1111/j.1365-2672.1997.tb02867.x; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2006, AM J TROP MED HYG, V74, P330, DOI 10.4269/ajtmh.2006.74.330; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; DANCE DAB, 1989, J CLIN PATHOL, V42, P645, DOI 10.1136/jcp.42.6.645; DANCE DAB, 1991, CLIN MICROBIOL REV, V4, P52, DOI 10.1128/CMR.4.1.52-60.1991; Daniel WW., 1999, BIOSTATISTICS FDN AN, V7; Dauphin LA, 2010, J APPL MICROBIOL, V108, P163, DOI 10.1111/j.1365-2672.2009.04404.x; Dauphin LA, 2009, J MICROBIOL METH, V76, P30, DOI 10.1016/j.mimet.2008.09.004; Gal D, 2005, AM J TROP MED HYG, V73, P1162, DOI 10.4269/ajtmh.2005.73.1162; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1178, DOI 10.3201/eid0810.020393; KUNAKORN M, 1995, J CLIN MICROBIOL, V33, P2131, DOI 10.1128/JCM.33.8.2131-2135.1995; MANCHESTER KL, 1995, BIOTECHNIQUES, V19, P208; Merk S, 2006, J VET MED B, V53, P281, DOI 10.1111/j.1439-0450.2006.00956.x; Meumann EM, 2006, J CLIN MICROBIOL, V44, P3028, DOI 10.1128/JCM.00913-06; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; Queipo-Ortuno MI, 2008, EUR J CLIN MICROBIOL, V27, P109, DOI 10.1007/s10096-007-0409-y; Rantakokko-Jalava K, 2002, J CLIN MICROBIOL, V40, P4211, DOI 10.1128/JCM.40.11.4211-4217.2002; Rattanathongkom A, 1997, MOL CELL PROBE, V11, P25, DOI 10.1006/mcpr.1996.0072; Richardson LJ, 2012, J MICROBIOL METH, V88, P179, DOI 10.1016/j.mimet.2011.10.023; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Simpson AJH, 1999, J CLIN PATHOL, V52, P616, DOI 10.1136/jcp.52.8.616; Sirisinha S, 2000, ACTA TROP, V74, P235, DOI 10.1016/S0001-706X(99)00076-5; Supaprom C, 2007, J CLIN MICROBIOL, V45, P2894, DOI 10.1128/JCM.00291-07; Sura T, 1997, DIAGN MICR INFEC DIS, V29, P121, DOI 10.1016/S0732-8893(97)81800-7; Tiangpitayakorn C, 1997, AM J TROP MED HYG, V57, P96, DOI 10.4269/ajtmh.1997.57.96; Tomaso H, 2005, MOL CELL PROBE, V19, P9, DOI 10.1016/j.mcp.2004.08.001; Vitale Maria, 2005, Rev Cubana Med Trop, V57, P51; Walsh AL, 1995, CLIN INFECT DIS, V21, P1498, DOI 10.1093/clinids/21.6.1498; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wuthiekanun V, 2007, AM J TROP MED HYG, V77, P812, DOI 10.4269/ajtmh.2007.77.812	33	14	14	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58032	10.1371/journal.pone.0058032	http://dx.doi.org/10.1371/journal.pone.0058032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460920	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000175
J	Rao, SAK; Carolan, JC; Wilkinson, TL				Rao, Sohail A. K.; Carolan, James C.; Wilkinson, Tom L.			Proteomic Profiling of Cereal Aphid Saliva Reveals Both Ubiquitous and Adaptive Secreted Proteins	PLOS ONE			English	Article							PEA APHID; ACYRTHOSIPHON-PISUM; GLUCOSE-OXIDASE; EVOLUTION; IDENTIFICATION; LOCALIZATION; HEMIPTERA; FAMILY; BLOOD; GENE	The secreted salivary proteins from two cereal aphid species, Sitobion avenae and Metopolophium dirhodum, were collected from artificial diets and analysed by tandem mass spectrometry. Protein identification was performed by searching MS data against the official protein set from the current pea aphid (Acyrthosiphon pisum) genome assembly and revealed 12 and 7 proteins in the saliva of S. avenae and M. dirhodum, respectively. When combined with a comparable dataset from A. pisum, only three individual proteins were common to all the aphid species; two paralogues of the GMC oxidoreductase family (glucose dehydrogenase; GLD) and ACYPI009881, an aphid specific protein previously identified as a putative component of the salivary sheath. Antibodies were designed from translated protein sequences obtained from partial cDNA sequences for ACYPI009881 and both saliva associated GLDs. The antibodies detected all parent proteins in secreted saliva from the three aphid species, but could only detect ACYPI009881, and not saliva associated GLDs, in protein extractions from the salivary glands. This result was confirmed by immunohistochemistry using whole and sectioned salivary glands, and in addition, localised ACYPI009881 to specific cell types within the principal salivary gland. The implications of these findings for the origin of salivary components and the putative role of the proteins identified are discussed in the context of our limited understanding of the functional relationship between aphid saliva and the plants they feed on. The mass spectrometry data have been deposited to the ProteomeXchange and can be accessed under the identifier PXD000113.	[Rao, Sohail A. K.; Carolan, James C.; Wilkinson, Tom L.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	University College Dublin	Wilkinson, TL (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	tom.wilkinson@ucd.ie	Khan, Rao Sohail Ahmad/AAA-6364-2019	Khan, Rao Sohail Ahmad/0000-0002-1118-9000; Carolan, James/0000-0001-5092-674X; Wilkinson, Tom/0000-0003-4353-1103	Department of Agriculture, Food and the Marine Research Stimulus Grant [07/553]; Science Foundation Ireland Principal Investigator Grant [03/IN3/B381]; UCD [SF268]	Department of Agriculture, Food and the Marine Research Stimulus Grant; Science Foundation Ireland Principal Investigator Grant(Science Foundation Ireland); UCD	Financial support was provided through Department of Agriculture, Food and the Marine Research Stimulus Grant 07/553, and in part by Science Foundation Ireland Principal Investigator Grant 03/IN3/B381 and UCD Seed Funding SF268. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman R.L., 2000, J ECON ENTOMOL, V2; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; Cooper WR, 2011, ENVIRON ENTOMOL, V40, P151, DOI 10.1603/EN10153; Corena MD, 2002, J EXP BIOL, V205, P591; COXFOSTER DL, 1994, J INSECT PHYSIOL, V40, P235, DOI 10.1016/0022-1910(94)90047-7; Cui F, 2012, INSECT SCI, V19, P429, DOI 10.1111/j.1744-7917.2011.01487.x; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Douglas AE, 2006, J EXP BIOL, V209, P1395, DOI 10.1242/jeb.02148; Drapeau MD, 2006, GENOME RES, V16, P1385, DOI 10.1101/gr.5012006; Drapeau MD, 2003, BIOCHEM BIOPH RES CO, V311, P1, DOI 10.1016/j.bbrc.2003.09.106; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferguson LC, 2011, MOL BIOL EVOL, V28, P257, DOI 10.1093/molbev/msq192; Fitzroy CIJ, 2010, THESIS U COLL DUBLIN; Francis F, 2006, INSECT BIOCHEM MOLEC, V36, P219, DOI 10.1016/j.ibmb.2006.01.018; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Han D, 2002, BIOCHEM J, V368, P333; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Hewer A, 2010, J EXP BIOL, V213, P4030, DOI 10.1242/jeb.046326; Hovius JWR, 2008, PLOS MED, V5, P202, DOI 10.1371/journal.pmed.0050043; Iida K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-75; Iordachescu M, 2008, J INTEGR PLANT BIOL, V50, P1223, DOI 10.1111/j.1744-7909.2008.00736.x; Kiernan JA., 2015, HISTOLOGICAL HISTOCH, P184; Krober T., 1991, Biocontrol News and Information, V12, P357; Madhusudhan VV, 1998, ENTOMOL EXP APPL, V86, P25, DOI 10.1023/A:1003053327444; Martin B, 1997, J GEN VIROL, V78, P2701, DOI 10.1099/0022-1317-78-10-2701; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; MILES PW, 1993, ENTOMOL EXP APPL, V67, P275, DOI 10.1007/BF02383437; MILES PW, 1970, EXPERIENTIA, V26, P611, DOI 10.1007/BF01898717; MILES PW, 1968, ANNU REV PHYTOPATHOL, V6, P137, DOI 10.1146/annurev.py.06.090168.001033; MILES PW, 1989, J INSECT PHYSIOL, V35, P865, DOI 10.1016/0022-1910(89)90102-9; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P128, DOI 10.1002/arch.20039; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Nakajima Y, 2000, J BIOCHEM-TOKYO, V127, P901, DOI 10.1093/oxfordjournals.jbchem.a022685; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Oerke E. C., 1994, CROP PRODUCTION CROP, P179; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; PONSEN M B, 1972, Mededelingen Landbouwhogeschool Wageningen, V72, P1; Ponsen M.B., 1987, World Crop Pests, V2A, P79; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Quan GX, 2001, INSECT BIOCHEM MOLEC, V31, P97, DOI 10.1016/S0965-1748(00)00112-0; Rao SAK, 2011, THESIS U COLL DUBLIN; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; SCHALLER GERHARD, 1960, ENT EXPTL ET APPL, V3, P128; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shima S, 2007, FEBS J, V274, P1192, DOI 10.1111/j.1742-4658.2007.05658.x; Tian DL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036168, 10.1371/journal.pone.0042833]; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Urbanska A, 1998, ENTOMOL EXP APPL, V86, P197, DOI 10.1023/A:1003119900578; Valenzuela JG, 2004, PARASITOLOGY, V129, pS83, DOI 10.1017/S0031182004005189; van Emden H, 2007, APHIDS AS CROP PESTS, pXXI; VICKERMAN GP, 1979, B ENTOMOL RES, V69, P1, DOI 10.1017/S0007485300017855; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; WEIDEMANN HL, 1968, ENTOMOL EXP APPL, V11, P450, DOI 10.1111/j.1570-7458.1968.tb02073.x; Will T, 2012, BIOCH PHLOE IN PRESS; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Xia AH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-195	64	85	94	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57413	10.1371/journal.pone.0057413	http://dx.doi.org/10.1371/journal.pone.0057413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460852	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000315519000106
J	Xu, ZQ; Wei, K; Wu, Y; Shen, FX; Chen, Q; Li, MZ; Yao, MS				Xu, Zhenqiang; Wei, Kai; Wu, Yan; Shen, Fangxia; Chen, Qi; Li, Mingzhen; Yao, Maosheng			Enhancing Bioaerosol Sampling by Andersen Impactors Using Mineral-Oil-Spread Agar Plate	PLOS ONE			English	Article							PORTABLE MICROBIAL IMPACTORS; SAMPLERS; TIME; ENUMERATION; COLLECTION; BACTERIA; BIOEFFICIENCY; PERFORMANCE; EXPOSURE; LIQUID	As a bioaerosol sampling standard, Andersen type impactor is widely used since its invention in 1950s, including the investigation of the anthrax attacks in the United States in 2001. However, its related problems such as impaction and desiccation stress as well as particle bounce have not been solved. Here, we improved its biological collection efficiencies by plating a mineral oil layer (100 mL) onto the agar plate. An Andersen six-stage sampler and a BioStage impactor were tested with mineral-oil-spread agar plates in collecting indoor and outdoor bacterial and fungal aerosols. The effects of sampling times (5, 10 and 20 min) were also studied using the BioStage impactor when sampling environmental bioaerosols as well as aerosolized Bacillus subtilis (G+) and Escherichia coli (G-). In addition, particle bounce reduction by mineral-oil-plate was also investigated using an optical particle counter (OPC). Experimental results revealed that use of mineral-oil-spread agar plate can substantially enhance culturable bioaerosol recoveries by Andersen type impactors (p-values<0.05). The recovery enhancement was shown to depend on bioaerosol size, type, sampling time and environment. In general, more enhancements (extra 20%) were observed for last stage of the Andersen six-stage samplers compared to the BioStage impactor for 10 min sampling. When sampling aerosolized B. subtilis, E. coli and environmental aerosols, the enhancement was shown to increase with increasing sampling time, ranging from 50% increase at 5 min to similar to 100% at 20 min. OPC results indicated that use of mineral oil can effectively reduce the particle bounce with an average of 66% for 10 min sampling. Our work suggests that enhancements for fungal aerosols were primarily attributed to the reduced impaction stress, while for bacterial aerosols reduced impaction, desiccation and particle bounce played major roles. The developed technology can readily enhance the agar-based techniques including those high volume portable samplers for bioaerosol monitoring.	[Xu, Zhenqiang; Wei, Kai; Wu, Yan; Shen, Fangxia; Chen, Qi; Li, Mingzhen; Yao, Maosheng] Peking Univ, State Key Joint Lab Environm Simulat & Pollut Con, Coll Environm Sci & Engn, Beijing 100871, Peoples R China	Peking University	Yao, MS (corresponding author), Peking Univ, State Key Joint Lab Environm Simulat & Pollut Con, Coll Environm Sci & Engn, Beijing 100871, Peoples R China.	yao@pku.edu.cn	Chen, QH/GXH-3158-2022; Shen, Fangxia/F-3718-2018; shen, fangxia/HGA-6200-2022; Shen, Fangxia/I-5774-2016	Shen, Fangxia/0000-0003-4166-4615; shen, fangxia/0000-0003-4166-4615; 	National Science Foundation of China [21277007, 21077005, 20877004]; State Key Joint Laboratory of Environment Simulation and Pollution Control	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Joint Laboratory of Environment Simulation and Pollution Control	This study was supported by the National Science Foundation of China (Grants 21277007, 21077005 and 20877004), and special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AA, 1958, J BACTERIOL, V76, P471, DOI 10.1128/JB.76.5.471-484.1958; Ayres JG, 2009, EUR RESPIR J, V34, P295, DOI 10.1183/09031936.00003409; BRACHMAN PS, 1964, SCIENCE, V144, P1295; Bundy KW, 2009, ANN ALLERG ASTHMA IM, V103, P26, DOI 10.1016/S1081-1206(10)60139-1; Christner BC, 2008, SCIENCE, V319, P1214, DOI 10.1126/science.1149757; COWN WB, 1957, APPL MICROBIOL, V5, P119, DOI 10.1128/AEM.5.2.119-124.1957; Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032; Durand KTH, 2002, ANN OCCUP HYG, V46, P113, DOI 10.1093/annhyg/mef007; Greenburg L, 1992, NEW INSTRUMENT SAMPL; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; He QS, 2011, J ENVIRON MONITOR, V13, P706, DOI 10.1039/c0em00559b; Lin WH, 1998, AEROSOL SCI TECH, V28, P511, DOI 10.1080/02786829808965542; Lin XJ, 1999, ATMOS ENVIRON, V33, P4291, DOI 10.1016/S1352-2310(99)00169-7; Mainelis G, 2010, AEROSOL SCI TECH, V44, P75, DOI 10.1080/02786820903390372; Morris CE, 2007, INFECT GENET EVOL, V7, P84, DOI 10.1016/j.meegid.2006.05.002; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; ROOKS R, 1948, J ALLERGY, V19, P200, DOI 10.1016/0021-8707(48)90053-7; STEWART SL, 1995, APPL ENVIRON MICROB, V61, P1232, DOI 10.1128/AEM.61.4.1232-1239.1995; Wang Z, 2001, J AEROSOL SCI, V32, P661, DOI 10.1016/S0021-8502(00)00108-7; Weis CP, 2002, JAMA-J AM MED ASSOC, V288, P2853, DOI 10.1001/jama.288.22.2853; WILLEKE K, 1995, J AEROSOL SCI, V26, pS883; Winslow CEA, 1908, SCIENCE, V28, P28, DOI 10.1126/science.28.705.28; Xu ZQ, 2011, AEROSOL SCI TECH, V45, P1143, DOI 10.1080/02786826.2011.582195; Yao MS, 2007, J OCCUP ENVIRON HYG, V4, P514, DOI 10.1080/15459620701407388; Yao MS, 2007, J EXPO SCI ENV EPID, V17, P31, DOI 10.1038/sj.jes.7500517; Yao MH, 2006, J AEROSOL SCI, V37, P1467, DOI 10.1016/j.jaerosci.2006.06.005; Yao MS, 2006, AEROSOL SCI TECH, V40, P595, DOI 10.1080/02786820600729146; Zhen SQ, 2009, J AEROSOL SCI, V40, P503, DOI 10.1016/j.jaerosci.2009.02.003	28	25	29	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56896	10.1371/journal.pone.0056896	http://dx.doi.org/10.1371/journal.pone.0056896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460818	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000043
J	Zhang, MR; Red, SD; Lin, AH; Patel, SS; Sereno, AB				Zhang, Marsha R.; Red, Stuart D.; Lin, Angela H.; Patel, Saumil S.; Sereno, Anne B.			Evidence of Cognitive Dysfunction after Soccer Playing with Ball Heading Using a Novel Tablet-Based Approach	PLOS ONE			English	Article							NEUROPSYCHOLOGICAL CONSEQUENCE; TASK-PERFORMANCE; PLAYERS; SCHIZOPHRENIA; ASSOCIATIONS; EXERCISE; FEMALE	Does frequent head-to-ball contact cause cognitive dysfunctions and brain injury to soccer players? An iPad-based experiment was designed to examine the impact of ball-heading among high school female soccer players. We examined both direct, stimulus-driven, or reflexive point responses (Pro-Point) as well as indirect, goal-driven, or voluntary point responses (Anti-Point), thought to require cognitive functions in the frontal lobe. The results show that soccer players were significantly slower than controls in the Anti-Point task but displayed no difference in Pro-Point latencies, indicating a disruption specific to voluntary responses. These findings suggest that even subconcussive blows in soccer can result in cognitive function changes that are consistent with mild traumatic brain injury of the frontal lobes. There is great clinical and practical potential of a tablet-based application for quick detection and monitoring of cognitive dysfunction.	[Zhang, Marsha R.; Red, Stuart D.; Lin, Angela H.; Patel, Saumil S.; Sereno, Anne B.] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [Patel, Saumil S.] Baylor Coll Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Sereno, AB (corresponding author), Univ Texas Hlth Sci Ctr Houston, Houston, TX USA.	Anne.B.Sereno@uth.tmc.edu		Patel, Saumil/0000-0002-2386-8940	NSF [BS 0924636]; NIH [P30EY010608]; Division Of Behavioral and Cognitive Sci [0924636] Funding Source: National Science Foundation; NATIONAL EYE INSTITUTE [P30EY010608] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by NSF BS 0924636 and NIH P30EY010608 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audiffren M, 2008, ACTA PSYCHOL, V129, P410, DOI 10.1016/j.actpsy.2008.09.006; Autti T, 1997, LANCET, V349, P1144, DOI 10.1016/S0140-6736(05)63019-X; Broerse A, 2001, PSYCHIAT RES, V103, P167, DOI 10.1016/S0165-1781(01)00275-X; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Gooding DC, 2004, PSYCHOL MED, V34, P921, DOI 10.1017/S003329170300165X; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; Hill SK, 2008, SCHIZOPHRENIA BULL, V34, P494, DOI 10.1093/schbul/sbm112; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V22, P1; Kelly JC, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/371970; Khatoon S, 2002, VISION RES, V42, P2693, DOI 10.1016/S0042-6989(02)00327-9; Kim N, 2011, MAKING SOCCER SAFER; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Rieder C, 2011, ARCH CLIN NEUROPSYCH, V26, P583, DOI 10.1093/arclin/acr055; Rutherford A, 2003, NEUROPSYCHOL REV, V13; SERENO AB, 1995, BIOL PSYCHIAT, V37, P394, DOI 10.1016/0006-3223(94)00127-O; Sereno AB, 2009, ENCY NEUROSCIENCE, P117; Shrestha Y, 2011, TABLET BASED STIMULU, P64; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Toni I, 2001, EXP BRAIN RES, V141, P359, DOI 10.1007/s002210100877; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wise SP, 2000, TRENDS NEUROSCI, V23, P271, DOI 10.1016/S0166-2236(00)01570-8; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8	29	62	63	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57364	10.1371/journal.pone.0057364	http://dx.doi.org/10.1371/journal.pone.0057364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460843	Green Published, gold			2022-12-27	WOS:000315519000097
J	Chen, T; Guo, ZP; Li, L; Li, MM; Wang, TT; Jia, RZ; Cao, N; Li, JY				Chen, Tao; Guo, Zai-pei; Li, Li; Li, Meng-meng; Wang, Ting-ting; Jia, Rui-zhen; Cao, Na; Li, Jing-yi			TWEAK Enhances E-selectin and ICAM-1 Expression, and May Contribute to the Development of Cutaneous Vasculitis	PLOS ONE			English	Article							GENERALIZED SHWARTZMAN REACTION; CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL-CELLS; NEUTROPHIL RECRUITMENT; WEAK INDUCER; APOPTOSIS; PATHWAYS; ADHESION; LIGAND; GROWTH	Our previous work indicated that TWEAK is associated with various types of cutaneous vasculitis (CV). Herein, we investigate the effects of TWEAK on vascular injury and adhesion molecule expression in CV mice. We showed that TWEAK priming in mice induced a local CV. Furthermore, TWEAK priming also increased the extravasation of FITC-BSA, myeloperoxidase activity and the expression of E-selectin and ICAM-1. Conversely, TWEAK blockade ameliorated the LPS-induced vascular damage, leukocyte infiltrates and adhesion molecules expression in LPS-induced CV. In addition, TWEAK treatment of HDMECs up-regulated E-selectin and ICAM-1 expression at both mRNA and protein levels. TWEAK also enhanced the adhesion of PMNs to HDMECs. Finally, western blot data revealed that TWEAK can induce phosphorylation of p38, JNK and ERK in HDMECs. These data suggest that TWEAK acted as an inducer of E-selectin and ICAM-1 expression in CV mice and HDMECs, may contribute to the development of CV.	[Chen, Tao; Guo, Zai-pei; Li, Li; Li, Meng-meng; Wang, Ting-ting; Cao, Na; Li, Jing-yi] Sichuan Univ, West China Hosp, Dept Dermatovenereol, Chengdu 610064, Sichuan, Peoples R China; [Jia, Rui-zhen] Sichuan Univ, West China Hosp 2, Open Lab, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Guo, ZP (corresponding author), Sichuan Univ, West China Hosp, Dept Dermatovenereol, Chengdu 610064, Sichuan, Peoples R China.	guozp930@163.com	li, mengmeng/GRS-6883-2022; wang, tingting/AAK-2640-2020		Natural Science Foundation of China [81101198, 81271752]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (NO. 81101198) to TC and NO. 81271752 to Z-PG). URL: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basuroy S, 2011, AM J PHYSIOL-CELL PH, V300, pC256, DOI 10.1152/ajpcell.00272.2010; Blanco-Colio LM, 2007, FRONT BIOSCI-LANDMRK, V12, P3648, DOI 10.2741/2341; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Chen CY, 2008, BLOOD, V112, P3205, DOI 10.1182/blood-2008-03-143479; Chen T, 2011, CLIN EXP IMMUNOL, V166, P64, DOI 10.1111/j.1365-2249.2011.04442.x; Chen T, 2011, RHEUMATOL INT, V31, P321, DOI 10.1007/s00296-009-1254-3; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; Desplat-Jego S, 2005, CLIN IMMUNOL, V117, P15, DOI 10.1016/j.clim.2005.06.005; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Hotta K, 2011, KIDNEY INT, V79, P179, DOI 10.1038/ki.2010.379; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; Jakubowski A, 2002, J CELL SCI, V115, P267; Kerfoot SM, 2001, AM J PATHOL, V159, P1531, DOI 10.1016/S0002-9440(10)62538-2; Koide N, 1996, FEMS IMMUNOL MED MIC, V16, P205, DOI 10.1111/j.1574-695X.1996.tb00137.x; Koide N, 1999, INFECT IMMUN, V67, P4112, DOI 10.1128/IAI.67.8.4112-4118.1999; Kralisch S, 2008, ATHEROSCLEROSIS, V199, P440, DOI 10.1016/j.atherosclerosis.2007.10.022; Li H, 2009, J BIOL CHEM, V284, P4439, DOI 10.1074/jbc.M805546200; Li XY, 2009, J ETHNOPHARMACOL, V125, P83, DOI 10.1016/j.jep.2009.06.008; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Meyer T, 2010, PLATELETS, V21, P571, DOI 10.3109/09537104.2010.512403; Munoz-Garcia B, 2011, CARDIOVASC RES, V89, P225, DOI 10.1093/cvr/cvq278; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Nakayama M, 2003, J IMMUNOL, V170, P341, DOI 10.4049/jimmunol.170.1.341; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Onur E, 2011, CUTAN OCUL TOXICOL, V30, P217, DOI 10.3109/15569527.2011.554480; Perper SJ, 2006, J IMMUNOL, V177, P2610, DOI 10.4049/jimmunol.177.4.2610; Qian F, 2009, EMBO J, V28, P2896, DOI 10.1038/emboj.2009.234; Scholzen TE, 2003, ENDOCRINOLOGY, V144, P360, DOI 10.1210/en.2002-220651; Schwartz N, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2816; Sunderkotter C, 2001, EXP DERMATOL, V10, P391, DOI 10.1034/j.1600-0625.2001.100602.x; van Kuijk AWR, 2010, ANN RHEUM DIS, V69, P301, DOI 10.1136/ard.2008.090548; Wang C, 2012, CLIN RHEUMATOL, V31, P335, DOI 10.1007/s10067-011-1865-4; Wang YL, 2010, J BIOL CHEM, V285, P37872, DOI 10.1074/jbc.M110.146290; Watabe D, 2007, BRIT J DERMATOL, V157, P259, DOI 10.1111/j.1365-2133.2007.08039.x; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Williams MR, 2011, AM J PHYSIOL-CELL PH, V301, pC777, DOI 10.1152/ajpcell.00250.2011; Yazid S, 2010, ARTERIOSCL THROM VAS, V30, P1718, DOI 10.1161/ATVBAHA.110.209536; Yepes M, 2007, MOL NEUROBIOL, V35, P255, DOI 10.1007/s12035-007-0024-z; Yilmaz MI, 2009, CLIN J AM SOC NEPHRO, V4, P1716, DOI 10.2215/CJN.02760409; Zhao Z, 2007, J IMMUNOL, V179, P7949, DOI 10.4049/jimmunol.179.11.7949; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	43	4	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56830	10.1371/journal.pone.0056830	http://dx.doi.org/10.1371/journal.pone.0056830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457623	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700085
J	Hu, LD; Wang, LM				Hu, Liangdong; Wang, Limin			Using Consensus Bayesian Network to Model the Reactive Oxygen Species Regulatory Pathway	PLOS ONE			English	Article							DNA-DAMAGE; DATABASE; REPAIR	Bayesian network is one of the most successful graph models for representing the reactive oxygen species regulatory pathway. With the increasing number of microarray measurements, it is possible to construct the Bayesian network from microarray data directly. Although large numbers of Bayesian network learning algorithms have been developed, when applying them to learn Bayesian networks from microarray data, the accuracies are low due to that the databases they used to learn Bayesian networks contain too few microarray data. In this paper, we propose a consensus Bayesian network which is constructed by combining Bayesian networks from relevant literatures and Bayesian networks learned from microarray data. It would have a higher accuracy than the Bayesian networks learned from one database. In the experiment, we validated the Bayesian network combination algorithm on several classic machine learning databases and used the consensus Bayesian network to model the Escherichia coli's ROS pathway.	[Hu, Liangdong; Wang, Limin] Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Changchun 130023, Jilin, Peoples R China	Jilin University	Wang, LM (corresponding author), Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Changchun 130023, Jilin, Peoples R China.	wanglim@jlu.edu.cn			Special Science Foundation for the Doctoral Program of China [200801831011]; Postdoctoral Science Foundation of China [20100481053]	Special Science Foundation for the Doctoral Program of China; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This research is supported by Special Science Foundation for the Doctoral Program of China (No. 200801831011) and Postdoctoral Science Foundation of China (No. 20100481053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Bohr VA, 1999, BIOCHIMIE, V81, P155, DOI 10.1016/S0300-9084(99)80048-0; Cano A, 2011, IEEE T SYST MAN CY B, V41, P1382, DOI 10.1109/TSMCB.2011.2148197; Cheng J, 2002, ARTIF INTELL, V137, P43, DOI 10.1016/S0004-3702(02)00191-1; CHOW CK, 1968, IEEE T INFORM THEORY, V14, P462, DOI 10.1109/TIT.1968.1054142; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; del Sagrado J, 2003, INT J INTELL SYST, V18, P237, DOI 10.1002/int.10086; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Hodges AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009513; Irene M, 2002, BIOINFORMATICS, V18, pS241; Jensen FV, 2007, BAYESIAN NETWORKS DE; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Pavlin G, 2010, INFORM FUSION, V11, P267, DOI 10.1016/j.inffus.2009.09.007; PEARL J, 1986, ARTIF INTELL, V29, P241, DOI 10.1016/0004-3702(86)90072-X; RAMOTAR D, 1991, MOL CELL BIOL, V11, P4537, DOI 10.1128/MCB.11.9.4537; Tsamardinos I, 2006, MACH LEARN, V65, P31, DOI 10.1007/s10994-006-6889-7; Utz CM, 2010, THESIS U OKLAHOMA; Wai Lam, 1994, Computational Intelligence, V10, P269, DOI 10.1111/j.1467-8640.1994.tb00166.x; Wong SKM, 2001, IEEE T KNOWL DATA EN, V13, P395, DOI 10.1109/69.929898; Yang ZQ, 2006, IEEE T KNOWL DATA EN, V18, P1253, DOI 10.1109/TKDE.2006.147; Zhang L W, 2006, INTRO BAYESIAN NETWO; Zhang Y., 2011, J INFORM COMPUTATION, V8, P194	25	2	2	10	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56832	10.1371/journal.pone.0056832	http://dx.doi.org/10.1371/journal.pone.0056832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457624	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700086
J	Jensen, R; Stanojevic, S; Gibney, K; Salazar, JG; Gustafsson, P; Subbarao, P; Ratjen, F				Jensen, Renee; Stanojevic, Sanja; Gibney, Karyn; Salazar, Juliana Giraldo; Gustafsson, Per; Subbarao, Padmaja; Ratjen, Felix			Multiple Breath Nitrogen Washout: A Feasible Alternative to Mass Spectrometry	PLOS ONE			English	Article							LUNG CLEARANCE INDEX; INERT-GAS WASHOUT; CYSTIC-FIBROSIS; PRESCHOOL-CHILDREN; PULMONARY-FUNCTION; YOUNG-CHILDREN; DISEASE; SPIROMETRY; STANDARDIZATION; INFANTS	Background: The lung clearance index (LCI), measured by multiple breath washout (MBW), reflects global ventilation inhomogeneity and is a sensitive marker of early cystic fibrosis (CF) lung disease. Current evidence is based on a customized mass spectrometry system that uses sulfur hexafluoride (SF6) as a tracer gas, which is not widely available. Nitrogen (N-2) washout may be better suited for clinical use and multi-center trials. Objective: To compare the results obtained from a N-2 washout system to those generated by the SF6 based system in healthy children and children with CF. Methods: Children with CF were recruited from outpatient clinics; healthy children were recruited from the Research4Kids online portal. Participants performed MBWSF6 (Amis 2000, Innovision, Denmark) and MBWN2 (ExhalyzerD, EcoMedics, Switzerland) in triplicate, in random order on the same day. Agreement between systems was assessed by Bland-Altman plot. Results: Sixty-two healthy and 61 children with CF completed measurements on both systems. In health there was good agreement between systems (limits of agreement -0.7 to 1.9); on average N-2 produced higher values of LCI (mean difference 0.58 (95% CI 0.42 to 0.74)). In CF the difference between systems was double that in health with a clear bias towards disproportionately higher LCIN2 compared to LCISF6 at higher mean values of LCI. Conclusion: LCIN2 and LCISF6 have similar discriminative power and intra-session repeatability but are not interchangeable. MBWN2 offers a valid new tool to investigate early obstructive lung disease in CF, but requires independent normative values.	[Jensen, Renee; Stanojevic, Sanja; Gibney, Karyn; Salazar, Juliana Giraldo; Subbarao, Padmaja; Ratjen, Felix] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Resp Med, Toronto, ON M5G 1X8, Canada; [Stanojevic, Sanja] Univ Toronto, Hosp Sick Children, Child Hlth Evaluat Sci, Res Inst, Toronto, ON M5G 1X8, Canada; [Gustafsson, Per] Cent Hosp Skovde, Dept Pediat, S-54185 Skovde, Sweden	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ratjen, F (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, Div Resp Med, Toronto, ON M5G 1X8, Canada.	felix.ratjen@sickkids.ca	Stanojevic, Sanja/A-4243-2010	Jensen, Renee/0000-0002-0877-9579; Subbarao, Padmaja/0000-0003-0394-1933; Stanojevic, Sanja/0000-0001-7931-8051; Ratjen, Felix/0000-0003-4057-6592	Cystic Fibrosis Foundation Therapeutics	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation)	This study was funded by Cystic Fibrosis Foundation Therapeutics (www.cff.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurora P, 2004, THORAX, V59, P1068, DOI 10.1136/thx.2004.022590; Aurora P, 2005, AM J RESP CRIT CARE, V171, P249, DOI 10.1164/rccm.200407-895OC; Aurora P, 2011, AM J RESP CRIT CARE, V183, P752, DOI 10.1164/rccm.200911-1646OC; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bush A, 2005, CURR OPIN PULM MED, V11, P534, DOI 10.1097/01.mcp.0000181477.30929.3f; COREY M, 1976, AM REV RESPIR DIS, V114, P1085; Ellemunter H, 2010, RESP MED, V104, P1834, DOI 10.1016/j.rmed.2010.06.010; Fuchs SI, 2006, PEDIATR PULM, V41, P1218, DOI 10.1002/ppul.20524; Fuchs SI, 2010, PEDIATR PULM, V45, P301, DOI 10.1002/ppul.21180; Gustafsson PM, 2008, THORAX, V63, P129, DOI 10.1136/thx.2007.077784; Gustafsson Per M, 2005, Paediatr Respir Rev, V6, P239, DOI 10.1016/j.prrv.2005.09.009; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Latzin P, 2007, PEDIATR PULM, V42, P888, DOI 10.1002/ppul.20674; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mott LS, 2012, THORAX, V67, P509, DOI 10.1136/thoraxjnl-2011-200912; Owens CM, 2011, THORAX, V66, P481, DOI 10.1136/thx.2010.150375; Pillow JJ, 2004, EUR RESPIR J, V23, P763, DOI 10.1183/09031936.04.00091504; Robinson PD, 2012, EUR RESP J IN PRESS; Rosenfeld Margaret, 2007, Proc Am Thorac Soc, V4, P299, DOI 10.1513/pats.200611-178HT; Singer F, 2012, PEDIAT PULMONOL; Singer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036083; Stanojevic S, 2009, AM J RESP CRIT CARE, V180, P547, DOI 10.1164/rccm.200903-0323OC; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Yammine S, 2012, THORAX	27	88	88	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56868	10.1371/journal.pone.0056868	http://dx.doi.org/10.1371/journal.pone.0056868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457632	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700092
J	Chan, S; Fushing, H; Beisner, BA; McCowan, B				Chan, Stephanie; Fushing, Hsieh; Beisner, Brianne A.; McCowan, Brenda			Joint Modeling of Multiple Social Networks to Elucidate Primate Social Dynamics: I. Maximum Entropy Principle and Network-Based Interactions	PLOS ONE			English	Article							RHESUS MACAQUES; AGGRESSION	In a complex behavioral system, such as an animal society, the dynamics of the system as a whole represent the synergistic interaction among multiple aspects of the society. We constructed multiple single-behavior social networks for the purpose of approximating from multiple aspects a single complex behavioral system of interest: rhesus macaque society. Instead of analyzing these networks individually, we describe a new method for jointly analyzing them in order to gain comprehensive understanding about the system dynamics as a whole. This method of jointly modeling multiple networks becomes valuable analytical tool for studying the complex nature of the interaction among multiple aspects of any system. Here we develop a bottom-up, iterative modeling approach based upon the maximum entropy principle. This principle is applied to a multi-dimensional link-based distributional framework, which is derived by jointly transforming the multiple directed behavioral social network data, for extracting patterns of synergistic inter-behavioral relationships. Using a rhesus macaque group as a model system, we jointly modeled and analyzed four different social behavioral networks at two different time points (one stable and one unstable) from a rhesus macaque group housed at the California National Primate Research Center (CNPRC). We report and discuss the inter-behavioral dynamics uncovered by our joint modeling approach with respect to social stability.	[Chan, Stephanie; Fushing, Hsieh] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Beisner, Brianne A.; McCowan, Brenda] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Beisner, Brianne A.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [McCowan, Brenda] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Davis	McCowan, B (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	bjmccowan@ucdavis.edu			National Institute of Health [R24-OD011136, P51OD011107]; National Science Foundation [DMS-1007219]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068335] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR024396] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107, R24OD011136] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by R24-OD011136 (McCowan) and #P51OD011107 (CNPRC base grant) from National Institute of Health and National Science Foundation grant DMS-1007219 (Fushing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Beisner BA, 2012, APPL ANIM BEHAV SCI, V137, P137, DOI 10.1016/j.applanim.2011.07.008; Beisner BA, 2011, AM J PRIMATOL, V73, P790, DOI 10.1002/ajp.20907; Beisner BA, P ROYAL SOC B UNPUB; Beisner BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016365; Berger AL, 1996, COMPUT LINGUIST, V22, P39; BIALEK W, 2007, ARXIV07124397V1QBIOQ; DEWAAL FBM, 1985, AM J PRIMATOL, V9, P73, DOI 10.1002/ajp.1350090202; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2007, P NATL ACAD SCI USA, V104, P1581, DOI 10.1073/pnas.0603565104; JAYNES ET, 1957, PHYS REV, V108, P171, DOI 10.1103/PhysRev.108.171; Lezon TR, 2006, P NATL ACAD SCI USA, V103, P19033, DOI 10.1073/pnas.0609152103; McCowan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022350; Rosenkrantz RD, 1983, ET JAYNES PAPERS PRO; SADE DS, 1969, AM J PHYS ANTHROPOL, V31, P261; Schneidman E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.238701; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Stephens GJ, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066119; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Thierry Bernard, 2004, Cambridge Studies in Biological and Evolutionary Anthropology, V41, P267; Tkacik G, 2009, ARXIV09125409QBIONC	23	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e51903	10.1371/journal.pone.0051903	http://dx.doi.org/10.1371/journal.pone.0051903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23468833	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900001
J	De Sibio, MT; Luvizotto, RAM; Olimpio, RMC; Correa, CR; Marino, J; de Oliveira, M; Conde, SJ; Ferreira, ALD; Padovani, CR; Nogueira, CR				De Sibio, Maria Teresa; Melo Luvizotto, Renata Azevedo; Castro Olimpio, Regiane Marques; Correa, Camila Renata; Marino, Juliana; de Oliveira, Miriane; Conde, Sandro Jose; dos Anjos Ferreira, Ana Lucia; Padovani, Carlos Roberto; Nogueira, Celia Regina			A Comparative Genotoxicity Study of a Supraphysiological Dose of Triiodothyronine (T-3) in Obese Rats Subjected to Either Calorie-Restricted Diet or Hyperthyroidism	PLOS ONE			English	Article							HIGH-FAT DIET; BODY-WEIGHT GAIN; OXIDATIVE STRESS; GENE-EXPRESSION; THYROID-HORMONE; LEPTIN CONCENTRATIONS; RADICAL GENERATION; CIRCULATING LEPTIN; BLOOD-PRESSURE; PLASMA LEPTIN	This study was designed to determine the genotoxicity of a supraphysiological dose of triiodothyronine (T-3) in both obese and calorie-restricted obese animals. Fifty male Wistar rats were randomly assigned to one of the two following groups: control (C; n = 10) and obese (OB; n = 40). The C group received standard food, whereas the OB group was fed a hypercaloric diet for 20 weeks. After this period, half of the OB animals (n = 20) were subjected to a 25%-calorie restriction of standard diet for 8 weeks forming thus a new group (OR), whereas the remaining OB animals were kept on the initial hypercaloric diet. During the following two weeks, 10 OR animals continued on the calorie restriction diet, whereas the remaining 10 rats of this group formed a new group (ORS) given a supraphysiological dose of T-3 (25 mu g/100 g body weight) along with the calorie restriction diet. Similarly, the remaining OB animals were divided into two groups, one that continued on the hypercaloric diet (OB, n = 10), and one that received the supraphysiological dose of T-3 (25 mu g/100 g body weight) along with the hypercaloric diet (OS, n = 10) for two weeks. The OB group showed weight gain, increased adiposity, insulin resistance, increased leptin levels and genotoxicity; T-3 administration in OS animals led to an increase in genotoxicity and oxidative stress when compared with the OB group. The OR group showed weight loss and normalized levels of adiposity, insulin resistance, serum leptin and genotoxicity, thus having features similar to those of the C group. On the other hand, the ORS group, compared to OR animals, showed higher genotoxicity. Our results indicate that regardless of diet, a supraphysiological dose of T-3 causes genotoxicity and potentiates oxidative stress.	[De Sibio, Maria Teresa; Melo Luvizotto, Renata Azevedo; Castro Olimpio, Regiane Marques; Marino, Juliana; de Oliveira, Miriane; Conde, Sandro Jose; dos Anjos Ferreira, Ana Lucia; Nogueira, Celia Regina] Univ Sao Paulo State UNESP, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil; [Correa, Camila Renata] Univ Sao Paulo State UNESP, Botucatu Med Sch, Dept Pathol, Botucatu, SP, Brazil; [Padovani, Carlos Roberto] Univ Sao Paulo State UNESP, Biosci Inst, Dept Biostat, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	De Sibio, MT (corresponding author), Univ Sao Paulo State UNESP, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil.	mt_bio@yahoo.com.br	Correa, Camila/Q-2071-2019; Padovani, Carlos Roberto/A-3656-2013; Conde, Sandro J/E-6249-2013; De Sibio, Maria/AAM-4561-2020; Nogueira, Celia Regina/AAF-7440-2022; Nogueira, Celia Regina/AFK-0463-2022	Correa, Camila/0000-0002-6915-4230; Padovani, Carlos Roberto/0000-0002-7719-9682; Conde, Sandro J/0000-0003-1876-5418; Nogueira, Celia Regina/0000-0002-4014-0660; Nogueira, Celia Regina/0000-0002-4014-0660; Correa, Camila Renata/0000-0001-8493-5329	CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel; FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/57310-3]	CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel and FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (process no 2008/57310-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2003, MOL ENDOCRINOL, V17, P1767, DOI 10.1210/me.2003-0109; Ahmed OM, 2012, INT J DEV NEUROSCI, V30, P517, DOI 10.1016/j.ijdevneu.2012.04.005; Ainslie DA, 2000, AM J CLIN NUTR, V71, P438; ASTRUP A, 1994, AM J CLIN NUTR, V59, P350, DOI 10.1093/ajcn/59.2.350; Barnes MJ, 2003, BRAIN RES BULL, V61, P511, DOI 10.1016/S0361-9230(03)00188-6; Bell-Anderson Kim S, 2004, Treat Endocrinol, V3, P11, DOI 10.2165/00024677-200403010-00002; Brown JL, 2002, ENDOCRINE, V19, P327, DOI 10.1385/ENDO:19:3:327; Claret M, 2004, OBES RES, V12, P1596, DOI 10.1038/oby.2004.199; Cowburn G, 1997, BRIT MED BULL, V53, P389, DOI 10.1093/oxfordjournals.bmb.a011619; Daly ME, 2006, DIABETIC MED, V23, P15, DOI 10.1111/j.1464-5491.2005.01760.x; Dimitriadis GD, 2001, EXP CLIN ENDOCR DIAB, V109, pS225, DOI 10.1055/s-2001-18584; Elliott JC, 2004, MOL BRAIN RES, V128, P150, DOI 10.1016/j.molbrainres.2004.06.010; Estadella D, 2004, NUTRITION, V20, P218, DOI 10.1016/j.nut.2003.10.008; FERNANDEZ V, 1985, ENDOCRINOLOGY, V117, P496, DOI 10.1210/endo-117-2-496; Fukuchi M, 2002, LIFE SCI, V71, P1059, DOI 10.1016/S0024-3205(02)01791-5; Gaiva MHG, 2001, BRIT J NUTR, V86, P371, DOI 10.1079/BJN2001392; Giannocco G, 2004, MOL CELL ENDOCRINOL, V226, P19, DOI 10.1016/j.mce.2004.07.007; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HARRIS RBS, 1994, INT J OBESITY, V18, P632; Henning B, 2001, J AM COLL NUTR, V20, P97, DOI 10.1080/07315724.2001.10719021; Heydari AR, 2007, NUCLEIC ACIDS RES, V35, P7485, DOI 10.1093/nar/gkm860; Hudig F, 1997, J ENDOCRINOL, V152, P413, DOI 10.1677/joe.0.1520413; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; Kautzky-Willer A, 1999, EUR J CLIN INVEST, V29, P395, DOI 10.1046/j.1365-2362.1999.00470.x; Levin BE, 2002, AM J PHYSIOL-REG I, V283, pR941, DOI 10.1152/ajpregu.00245.2002; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR771, DOI 10.1152/ajpregu.00650.2003; Li L, 2009, EYE, V23, P1464, DOI 10.1038/eye.2008.281; Lopez-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6; Luvizotto RAM, 2011, HORM METAB RES, V43, P452, DOI 10.1055/s-0031-1277187; Magsino CH, 2000, METABOLISM, V49, P799, DOI 10.1053/meta.2000.6263; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Miyamae Y, 1998, Mutat Res, V415, P229, DOI 10.1016/S1383-5718(97)00192-7; Nascimento AF, 2011, LIFE SCI, V88, P1031, DOI 10.1016/j.lfs.2011.03.015; Nikolich-Zugich J, 2005, EXP GERONTOL, V40, P884, DOI 10.1016/j.exger.2005.06.007; O'Brien PE, 2002, AM J SURG, V184, p4S, DOI 10.1016/S0002-9610(02)01172-8; Oldham KM, 2002, JPEN-PARENTER ENTER, V26, P189, DOI 10.1177/0148607102026003189; Parks E J, 2001, Curr Atheroscler Rep, V3, P462, DOI 10.1007/s11883-001-0036-5; Pinkney JH, 1998, CLIN ENDOCRINOL, V49, P583, DOI 10.1046/j.1365-2265.1998.00573.x; Reinehr T, 2010, MOL CELL ENDOCRINOL, V316, P165, DOI 10.1016/j.mce.2009.06.005; Roberts CK, 2002, CIRCULATION, V106, P2530, DOI 10.1161/01.CIR.0000040584.91836.0D; Rotondi M, 2011, J CLIN ENDOCR METAB, V96, P344, DOI 10.1210/jc.2010-2515; Rybus-Kalinowska Barbara, 2008, Pol Arch Med Wewn, V118, P420; Sanchez-Suarez P, 2008, MUTAT RES-FUND MOL M, V640, P8, DOI 10.1016/j.mrfmmm.2007.11.008; Schrauwen P, 2000, BRIT J NUTR, V84, P417, DOI 10.1017/S0007114500001720; Setia S, 2007, CLIN CHIM ACTA, V376, P37, DOI 10.1016/j.cca.2006.07.007; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Thompson WG, 2005, OBES RES, V13, P1344, DOI 10.1038/oby.2005.163; TICE RR, 1991, ADV EXP MED BIOL, V283, P157; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; Vasselli JR, 2005, OBES RES, V13, P693, DOI 10.1038/oby.2005.78; Venditti P, 2006, CELL MOL LIFE SCI, V63, P414, DOI 10.1007/s00018-005-5457-9; Vendrell J, 2004, OBES RES, V12, P962, DOI 10.1038/oby.2004.118; Videla LA, 2000, REDOX REP, V5, P265, DOI 10.1179/135100000101535807; Viguerie N, 2005, DIABETOLOGIA, V48, P123, DOI 10.1007/s00125-004-1618-x; Willett WC, 2001, J INTERN MED, V249, P395, DOI 10.1046/j.1365-2796.2001.00822.x; Wolfe BE, 2004, CLIN ENDOCRINOL, V61, P332, DOI 10.1111/j.1365-2265.2004.02101.x; Wynder EL, 1997, JNCI-J NATL CANCER I, V89, P766, DOI 10.1093/jnci/89.11.766; Zabrocka L, 2006, LIFE SCI, V79, P1114, DOI 10.1016/j.lfs.2006.03.009	59	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56913	10.1371/journal.pone.0056913	http://dx.doi.org/10.1371/journal.pone.0056913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468891	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900043
J	Hung, SC; Lin, YP; Huang, HL; Pu, HF; Tarng, DC				Hung, Szu-Chun; Lin, Yao-Ping; Huang, Hsin-Lei; Pu, Hsiao-Fung; Tarng, Der-Cherng			Aldosterone and Mortality in Hemodialysis Patients: Role of Volume Overload	PLOS ONE			English	Article							PLASMA-ALDOSTERONE; CHRONIC KIDNEY; AORTIC STIFFNESS; HEART-FAILURE; SPIRONOLACTONE; EPLERENONE; SURVIVAL; RENIN; DEATH; RISK	Background: Elevated aldosterone is associated with increased mortality in the general population. In patients on dialysis, however, the association is reversed. This paradox may be explained by volume overload, which is associated with lower aldosterone and higher mortality. Methods: We evaluated the relationship between aldosterone and outcomes in a prospective cohort of 328 hemodialysis patients stratified by the presence or absence of volume overload (defined as extracellular water/total body water >48%, as measured with bioimpedance). Baseline plasma aldosterone was measured before dialysis and categorized as low (<140 pg/mL), middle (140 to 280 pg/mL) and high (>280 pg/mL). Results: Overall, 36% (n = 119) of the hemodialysis patients had evidence of volume overload. Baseline aldosterone was significantly lower in the presence of volume overload than in its absence. During a median follow-up of 54 months, 83 deaths and 70 cardiovascular events occurred. Cox multivariate analysis showed that by using the low aldosterone as the reference, high aldosterone was inversely associated with decreased hazard ratios for mortality (0.49; 95% confidence interval, 0.25-0.76) and first cardiovascular event (0.70; 95% confidence interval, 0.3320.78) in the presence of volume overload. In contrast, high aldosterone was associated with an increased risk for mortality (1.97; 95% confidence interval, 1.69-3.75) and first cardiovascular event (2.01; 95% confidence interval, 1.2824.15) in the absence of volume overload. Conclusions: The inverse association of aldosterone with adverse outcomes in hemodialysis patients is due to the confounding effect of volume overload. These findings support treatment of hyperaldosteronemia in hemodialysis patients who have achieved strict volume control.	[Hung, Szu-Chun] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Div Nephrol, Taipei, Taiwan; [Lin, Yao-Ping; Tarng, Der-Cherng] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Lin, Yao-Ping; Tarng, Der-Cherng] Taipei Vet Gen Hosp, Immunol Res Ctr, Taipei, Taiwan; [Huang, Hsin-Lei; Pu, Hsiao-Fung; Tarng, Der-Cherng] Natl Yang Ming Univ, Sch Med, Dept & Inst Physiol, Taipei 112, Taiwan	Buddhist Tzu Chi General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Tarng, DC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan.	dctarng@vghtpe.gov.tw			National Science Council [NSC 96-2628-B-010-001-MY3, 99-2314-B-010-004-MY3]; Taipei City Hospital [97001-62-002]; National Yang-Ming University Hospital [RD2011-025]; Ministry of Education	National Science Council(Ministry of Science and Technology, Taiwan); Taipei City Hospital; National Yang-Ming University Hospital; Ministry of Education	This study was supported by grants from the National Science Council (NSC 96-2628-B-010-001-MY3 and 99-2314-B-010-004-MY3), Taipei City Hospital (97001-62-002), National Yang-Ming University Hospital (RD2011-025), and Ministry of Education's aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2010, HYPERTENSION, V56, P512, DOI 10.1161/HYPERTENSIONAHA.110.154815; BARENBROCK M, 1994, KIDNEY INT, V45, P1397, DOI 10.1038/ki.1994.182; BERL T, 1978, KIDNEY INT, V14, P228, DOI 10.1038/ki.1978.114; Beygui F, 2006, CIRCULATION, V114, P2604, DOI 10.1161/CIRCULATIONAHA.106.634626; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Bomback AS, 2009, J RENIN-ANGIO-ALDO S, V10, P230, DOI 10.1177/1470320309352353; Cice G, 2010, J AM COLL CARDIOL, V56, P1701, DOI 10.1016/j.jacc.2010.03.105; Contreras G, 2010, J AM SOC NEPHROL, V21, P2131, DOI 10.1681/ASN.2009121285; Covic A, 2006, NEPHROL DIAL TRANSPL, V21, P854, DOI 10.1093/ndt/gfk086; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Diskin CJ, 2004, NEPHROL DIAL TRANSPL, V19, P1331, DOI 10.1093/ndt/gfh081; Edwards NC, 2009, J AM COLL CARDIOL, V54, P505, DOI 10.1016/j.jacc.2009.03.066; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Green D, 2011, AM J KIDNEY DIS, V57, P921, DOI 10.1053/j.ajkd.2011.02.376; Guder G, 2007, CIRCULATION, V115, P1754, DOI 10.1161/CIRCULATIONAHA.106.653964; HENE RJ, 1982, KIDNEY INT, V21, P98, DOI 10.1038/ki.1982.14; Hostetter TH, 2003, J AM SOC NEPHROL, V14, P2395, DOI 10.1097/01.ASN.0000086472.65806.73; Ibrahim HN, 1998, J AM SOC NEPHROL, V9, P72; Juknevicius I, 2004, AM J PHYSIOL-RENAL, V286, pF1059, DOI 10.1152/ajprenal.00202.2003; Kalantar-Zadeh K, 2009, CIRCULATION, V119, P671, DOI 10.1161/CIRCULATIONAHA.108.807362; Klemmer PJ, 2009, BLOOD PURIFICAT, V27, P92, DOI 10.1159/000167016; Kohagura K, 2006, HYPERTENS RES, V29, P597, DOI 10.1291/hypres.29.597; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; London GM, 1996, J HYPERTENS, V14, P1139, DOI 10.1097/00004872-199609000-00015; London GM, 2001, J AM SOC NEPHROL, V12, P2759, DOI 10.1681/ASN.V12122759; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; McLaughlin N, 2004, CURR HYPERTENS REP, V6, P327, DOI 10.1007/s11906-004-0029-1; PARMAR M, 1995, SURVIVAL ANAL PRACTI; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; RATGE D, 1983, INT J ARTIF ORGANS, V6, P255, DOI 10.1177/039139888300600508; Ritz E, 2010, BLOOD PURIFICAT, V29, P111, DOI 10.1159/000245635; Rossignol P, 2011, J AM COLL CARDIOL, V58, P1958, DOI 10.1016/j.jacc.2011.04.049; Sato A, 2004, HYPERTENS RES, V27, P303, DOI 10.1291/hypres.27.303; Tomaschitz A, 2011, AM J KIDNEY DIS, V57, P403, DOI 10.1053/j.ajkd.2010.10.047; Tomaschitz A, 2010, EUR HEART J, V31, P1237, DOI 10.1093/eurheartj/ehq019; Vuurmans JLT, 2002, J AM SOC NEPHROL, V13, P177, DOI 10.1681/ASN.V131177; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; Young M, 2004, ENDOCRINOLOGY, V145, P3153, DOI 10.1210/en.2004-0005	39	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57511	10.1371/journal.pone.0057511	http://dx.doi.org/10.1371/journal.pone.0057511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469009	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900109
J	Kidenya, BR; Kabangila, R; Peck, RN; Mshana, SE; Webster, LE; Koenig, SP; Johnson, WD; Fitzgerald, DW				Kidenya, Benson R.; Kabangila, Rodrick; Peck, Robert N.; Mshana, Stephen E.; Webster, Lauren E.; Koenig, Serena P.; Johnson, Warren D., Jr.; Fitzgerald, Daniel W.			Early and Efficient Detection of Mycobacterium tuberculosis in Sputum by Microscopic Observation of Broth Cultures	PLOS ONE			English	Article							DRUG-SUSCEPTIBILITY ASSAY; MULTIDRUG-RESISTANT TUBERCULOSIS; PULMONARY TUBERCULOSIS; RESUSCITATION; DIAGNOSIS; SENSITIVITY; PREVALENCE; POVERTY	Early, efficient and inexpensive methods for the detection of pulmonary tuberculosis are urgently needed for effective patient management as well as to interrupt transmission. These methods to detect M. tuberculosis in a timely and affordable way are not yet widely available in resource-limited settings. In a developing-country setting, we prospectively evaluated two methods for culturing and detecting M. tuberculosis in sputum. Sputum samples were cultured in liquid assay (micro broth culture) in microplate wells and growth was detected by microscopic observation, or in Lowenstein-Jensen (LJ) solid media where growth was detected by visual inspection for colonies. Sputum samples were collected from 321 tuberculosis (TB) suspects attending Bugando Medical Centre, in Mwanza, Tanzania, and were cultured in parallel. Pulmonary tuberculosis cases were diagnosed using the American Thoracic Society diagnostic standards. There were a total of 200 (62.3%) pulmonary tuberculosis cases. Liquid assay with microscopic detection detected a significantly higher proportion of cases than LJ solid culture: 89.0% (95% confidence interval [CI], 84.7% to 93.3%) versus 77.0% (95% CI, 71.2% to 82.8%) (p = 0.0007). The median turn around time to diagnose tuberculosis was significantly shorter for micro broth culture than for the LJ solid culture, 9 days (interquartile range [IQR] 7-13), versus 21 days (IQR 14-28) (p<0.0001). The cost for micro broth culture (labor inclusive) in our study was US $4.56 per sample, versus US $11.35 per sample for the LJ solid culture. The liquid assay (micro broth culture) is an early, feasible, and inexpensive method for detection of pulmonary tuberculosis in resource limited settings.	[Kidenya, Benson R.] Catholic Univ Hlth & Allied Sci, Sch Med, Dept Biochem & Mol Biol, Mwanza, Tanzania; [Kidenya, Benson R.; Kabangila, Rodrick] Weill Cornell Med Coll, Fac Grad Sch, New York, NY USA; [Kabangila, Rodrick; Peck, Robert N.] Catholic Univ Hlth & Allied Sci, Sch Med, Dept Internal Med, Mwanza, Tanzania; [Mshana, Stephen E.] Catholic Univ Hlth & Allied Sci, Sch Med, Dept Microbiol & Immunol, Mwanza, Tanzania; [Peck, Robert N.; Webster, Lauren E.; Johnson, Warren D., Jr.; Fitzgerald, Daniel W.] Weill Cornell Med Coll, Div Infect Dis, Ctr Global Hlth, New York, NY USA; [Koenig, Serena P.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA USA	Cornell University; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kidenya, BR (corresponding author), Catholic Univ Hlth & Allied Sci, Sch Med, Dept Biochem & Mol Biol, Mwanza, Tanzania.	benkidenya@yahoo.com		Peck, Robert/0000-0002-4526-2480	United States National Institutes of Health Fogarty International Center [TW 00018]; Pfizer Inc; DAAD (BMBF, Germany) [A/05/33342]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI098627] Funding Source: NIH RePORTER	United States National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Pfizer Inc(Pfizer); DAAD (BMBF, Germany); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by research grant TW 00018 from the United States National Institutes of Health Fogarty International Center and a scholarship supported by Pfizer Inc to BRK, and equipment was donated by DAAD (BMBF, Germany) with grant number A/05/33342 to SEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardito F, 2000, MICROBIOLOGICA, V23, P151; BASS JB, 1990, AM REV RESPIR DIS, V142, P725; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brady Mark F, 2008, J Vis Exp, DOI 10.3791/845; Buderer NMF, 1996, ACAD EMERG MED, V3, P895, DOI 10.1111/j.1553-2712.1996.tb03538.x; Burgess AL, 2001, AIDS, V15, P1875, DOI 10.1097/00002030-200109280-00018; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Central TB Division, 2009, REV NAT TB CONTR PRO; Cepheid, 2012, CEPH ANN 1 PHAS XPER; Chien HP, 2000, INT J TUBERC LUNG D, V4, P866; Davies PDO, 2003, ANN MED, V35, P235, DOI 10.1080/07853890310005713; Davis JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016321; Drummond M, 2006, J EPIDEMIOLOGY COMMU, V60, P823; Ejigu GS, 2008, INT J TUBERC LUNG D, V12, P332; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Fitzgerald DW, 2000, LANCET, V356, P1470, DOI 10.1016/S0140-6736(00)02870-1; Harries AD, 1997, T ROY SOC TROP MED H, V91, P416, DOI 10.1016/S0035-9203(97)90262-5; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Kiraz N, 2007, INT J TUBERC LUNG D, V11, P904; Koenig SP, 2010, CLIN INFECT DIS, V51, P600, DOI 10.1086/655762; Lazarus RP, 2012, INDIAN J MED MICROBI, V30, P64, DOI 10.4103/0255-0857.93039; Leung E, 2012, INT J TUBERC LUNG D, V16, P16, DOI 10.5588/ijtld.10.0065; Lyamuya EF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-19; Michael JS, 2010, INT J TUBERC LUNG D, V14, P482; Minion J, 2010, LANCET INFECT DIS, V10, P688, DOI 10.1016/S1473-3099(10)70165-1; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC; Ndung'u PW, 2012, J INFECT DEV COUNTR, V6, P33, DOI 10.3855/jidc.2281; PAPE JW, 1993, LANCET, V342, P268, DOI 10.1016/0140-6736(93)91817-6; Park WG, 2002, J CLIN MICROBIOL, V40, P4750, DOI 10.1128/JCM.40.12.4750-4752.2002; Ploubidis GB, 2012, EUR RESPIR J, V40, P925, DOI 10.1183/09031936.00184011; Shiferaw G, 2007, J CLIN MICROBIOL, V45, P1093, DOI 10.1128/JCM.01949-06; Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581; World Health Organization, 2011, GLOB TB CONTR REP 20; World Health Organization, 1998, WHO PUBL, VMSA/MDN/98.2, P55; World Health Organization/Stop TB partnership, 2010, 2010 2011 TUB GLOB F; Zhu WM, 2003, TUBERCULOSIS, V83, P261, DOI 10.1016/S1472-9792(03)00052-0	39	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57527	10.1371/journal.pone.0057527	http://dx.doi.org/10.1371/journal.pone.0057527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469014	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900114
J	Li, X; Xiao, ZJ; Chang, CK; Xu, F; Wu, LY; He, Q; Xu, ZF; Song, LX; Zhang, Z; Zhou, LY; Su, JY; Zhang, X; Guo, J				Li, Xiao; Xiao, Zhi-jian; Chang, Chun-kang; Xu, Feng; Wu, Ling-yun; He, Qi; Xu, Ze-feng; Song, Lu-xi; Zhang, Zheng; Zhou, Li-yu; Su, Ji-ying; Zhang, Xi; Guo, Juan			Distinct Clinical and Experimental Characteristics in the Patients Younger than 60 Years Old with Myelodysplastic Syndromes	PLOS ONE			English	Article							CYTOGENETIC FEATURES; CHINESE PATIENTS; UNITED-STATES; POPULATION; CLASSIFICATION; EPIDEMIOLOGY; PROPOSALS; LEUKEMIA; JAPANESE; SYSTEM	Myelodysplastic syndromes (MDS) mainly occur in elderly individuals in Western countries. However, MDS is commonly found in young individuals (<60 years) in Asia. The reason for the high incidence in younger individuals is still unclear, and the differences in disease features between young and elderly patients with MDS have been not well recognized. To explore these issues, in this study, we analyzed the clinical and experimental characteristics of MDS in the patients younger and older than 60 years old and characterized the potential age-associated differences. The results showed that over half of the patients with MDS (61.9%) were younger than 60 years old upon the first diagnosis. The younger patients were more likely to be female, who have lower risk and less advanced MDS. The occurrence of trisomy 8 and bone marrow failure were more frequent in the younger patients than the older ones. The marrow CD34+ cells in the younger patients showed lower proliferation and higher apoptosis in comparison with that in the older ones. Obvious amplification of T cells and low CFU formation could be found in the younger patients. CFU formation was significantly increased in the younger patients after the removal of activated T cells. In addition, the younger patients had a lower frequency of p15(INK4B) methylation, longer survival expectancy and less AML transformation. In summary, the younger patients with MDS in China may show more benign disease features than the older ones. Enhanced immunological response may be involved in the pathogenesis of MDS in the patients younger than 60 years.	[Li, Xiao; Chang, Chun-kang; Xu, Feng; Wu, Ling-yun; He, Qi; Song, Lu-xi; Zhang, Zheng; Zhou, Li-yu; Su, Ji-ying; Zhang, Xi; Guo, Juan] Shanghai Jiao Tong Univ, Dept Hematol, Hosp 6, Shanghai 200030, Peoples R China; [Xiao, Zhi-jian; Xu, Ze-feng] Chinese Acad Med Sci, Inst Hematol, Dept Clin Hematol, Tianjin, Peoples R China; [Xiao, Zhi-jian; Xu, Ze-feng] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Xiao, Zhi-jian; Xu, Ze-feng] Peking Union Med Coll, Tianjin, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, X (corresponding author), Shanghai Jiao Tong Univ, Dept Hematol, Hosp 6, Shanghai 200030, Peoples R China.	lixiao3326@yahoo.com.cn	Wu, Ling/GZN-2235-2022; GUO, JUAN/HIK-2220-2022		Appropriate Technology Program; Shanghai Shen-kang Hospital Development Centre, China [SHDC12010202]; National Natural Science Foundation of China [81270584/H0807]	Appropriate Technology Program; Shanghai Shen-kang Hospital Development Centre, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Appropriate Technology Program, Shanghai Shen-kang Hospital Development Centre, China (Item No. SHDC12010202), and the National Natural Science Foundation of China (Grant No. 81270584/H0807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUL C, 1992, BRIT J HAEMATOL, V82, P358, DOI 10.1111/j.1365-2141.1992.tb06430.x; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Chen B, 2005, LEUKEMIA, V19, P767, DOI 10.1038/sj.leu.2403688; Fitzgerald KG, 2008, OLDER PERSONS EMERGE; Garcia JRG, 2006, BLOOD, V108, P3952, DOI 10.1182/blood-2006-06-031351; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg PL, 2011, J NATL COMPR CANC NE, V9, P30, DOI 10.6004/jnccn.2011.0005; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Intragumtornchai T, 1998, LEUKEMIA RES, V22, P453, DOI 10.1016/S0145-2126(98)00022-8; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Kent D, 2008, CLIN CANCER RES, V14, P1926, DOI 10.1158/1078-0432.CCR-07-5134; Kuendgen A, 2006, J CLIN ONCOL, V24, P5358, DOI 10.1200/JCO.2006.07.5598; Lee JH, 2003, LEUKEMIA, V17, P305, DOI 10.1038/sj.leu.2402798; Li L, 2009, LEUKEMIA RES, V33, P1194, DOI 10.1016/j.leukres.2008.11.021; Li X, 2010, HEMATOL ONCOL, V28, P98, DOI 10.1002/hon.907; LOKEN MR, 1987, BLOOD, V70, P1316; Matsuda A, 2005, BLOOD, V106, P2633, DOI 10.1182/blood-2005-01-0040; Maynadie M, 1996, BRIT J CANCER, V74, P288, DOI 10.1038/bjc.1996.354; Mufti GJ, 2008, HAEMATOL-HEMATOL J, V93, P1712, DOI 10.3324/haematol.13405; Multani AS, 1996, ANTICANCER RES, V16, P3435; OGUMA S, 1995, LEUKEMIA RES, V19, P219, DOI 10.1016/0145-2126(94)00135-W; RADLUND A, 1995, EUR J HAEMATOL, V54, P153; Rollison DE, 2008, BLOOD, V112, P45, DOI 10.1182/blood-2008-01-134858; Tada Y, 2006, CLIN EXP RHEUMATOL, V24, pS115; Tien HF, 1998, LEUKEMIA LYMPHOMA, V31, P93, DOI 10.3109/10428199809057588; Valent P, 2009, EUR J CLIN INVEST, V39, P548, DOI 10.1111/j.1365-2362.2009.02151.x; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; WHO website, DEF OLD PERS PROP WO; Wu L, 2008, INT J LAB HEMATOL, V30, P390, DOI 10.1111/j.1751-553X.2007.00970.x; Xiao M, 2000, LEUKEMIA LYMPHOMA, V38, P489, DOI 10.3109/10428190009059267; Xu F, 2011, ANN HEMATOL, V90, P643, DOI 10.1007/s00277-010-1128-5; Zhang Z, 2011, EUR J HAEMATOL, V86, P47, DOI 10.1111/j.1600-0609.2010.01535.x; Zhang Z, 2010, EXP HEMATOL, V38, P677, DOI 10.1016/j.exphem.2010.04.002	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57392	10.1371/journal.pone.0057392	http://dx.doi.org/10.1371/journal.pone.0057392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468979	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900080
J	Liu, M; Wu, RH; Yang, FY; Wang, T; Zhang, PP; Gu, JR; Wan, DF; Yang, SL				Liu, Mei; Wu, Ronghua; Yang, Fuye; Wang, Tao; Zhang, Pingping; Gu, Jianren; Wan, Dafang; Yang, Shengli			Identification of FN1BP1 as a Novel Cell Cycle Regulator through Modulating G1 Checkpoint in Human Hepatocarcinoma Hep3B Cells	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; CANCER; GROWTH; P53; OVEREXPRESSION; TRANSCRIPTION; PROGRESSION; METASTASIS; SUPPRESSOR	A novel human gene, FN1BP1 (fibronectin 1 binding protein 1), was identified using the human placenta cDNA library. Northern blotting showed a transcript of similar to 2.8 kb in human placenta, liver, and skeletal muscle tissues. This mRNA transcript length was similar to the full FN1BP1 sequence obtained previously. We established a conditionally induced stable cell line of Hep3B-Tet-on-FN1BP1 to investigate the preliminary function and mechanism of the secretory FN1BP1 protein. Cell-proliferation and colony-conformation assays demonstrated that FN1BP1 protein suppressed Hep3B cell growth and colonization in vitro. Analysis of Atlas human cDNA expression indicated that after FN1BP1 Dox-inducing expression for 24 h, 19 genes were up-regulated and 22 genes were down-regulated more than two-fold. Most of these gene changes were related to cell-cycle-arrest proteins (p21cip1, p15, and cyclin E1), transcription factors (general transcription factors, zinc finger proteins, transcriptional enhancer factors), SWI/SNF (SWItch/Sucrose NonFermentable) complex units, early-response proteins, and nerve growth or neurotrophic factors. Down-regulated genes were subject to colony-stimulating factors (e. g., GMSFs), and many repair genes were involved in DNA damage(RAD, ERCC, DNA topoisomerase, polymerase, and ligase). Some interesting genes(p21cip1, ID2, GMSF, ERCC5, and RPA1), which changed in the cDNA microarray analysis, were confirmed by semi-qRT-PCR, and similar changes in expression were observed. FCMcell-cycle analysis indicated that FN1BP1 over-expression could result in G1 phase arrest. FN1BP1 might inhibit cell growth and/or colony conformation through G1 phase arrest of the Hep3B cell cycle. These results indicate the potential role of FN1BP1 as a treatment target for hepatocellular carcinoma.	[Liu, Mei; Wu, Ronghua] Nantong Univ, Jingsu Key Lab Neuroregenerat, Nantong, Jiangsu, Peoples R China; [Liu, Mei; Yang, Fuye; Wang, Tao; Zhang, Pingping; Gu, Jianren; Wan, Dafang; Yang, Shengli] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai 200030, Peoples R China	Nantong University; Shanghai Jiao Tong University	Yang, SL (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai 200030, Peoples R China.	slyang@srcb.ac.cn	Liu, Mei/K-9005-2019	Liu, Mei/0000-0003-1168-6119	National Grant of Key Basic Research Program (973) [2004CB518704]; State Key Laboratory for Oncogenes and Related Genes [90-07-01]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Grant of Key Basic Research Program (973); State Key Laboratory for Oncogenes and Related Genes; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was supported by the National Grant of Key Basic Research Program (973) (Grant No. 2004CB518704), the project supported by State Key Laboratory for Oncogenes and Related Genes (Grant No. 90-07-01), and funding from the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADLEY MO, 1981, P NATL ACAD SCI-BIOL, V78, P3619, DOI 10.1073/pnas.78.6.3619; Chaudhry MA, 2002, ONCOGENE, V21, P1934, DOI 10.1038/sj.onc.1205264; Chi TY, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-27; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Gu F, 2007, SCI CHINA SER C, V50, P457, DOI 10.1007/s11427-007-0059-4; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; [刘梅 Liu Mei], 2006, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V33, P781; Muylaert I, 2010, J BIOL CHEM, V285, P13761, DOI 10.1074/jbc.M110.107920; Nguyen HG, 2005, BLOOD, V106, P1559, DOI 10.1182/blood-2005-02-0638; Pan DN, 2006, CANCER LETT, V235, P26, DOI 10.1016/j.canlet.2005.03.045; Pluta K, 2005, J GENE MED, V7, P803, DOI 10.1002/jgm.712; Qin LF, 1998, INT J CANCER, V79, P424, DOI 10.1002/(SICI)1097-0215(19980821)79:4<424::AID-IJC19>3.0.CO;2-4; Sherratt MJ, 2010, J PATHOL, V222, P32, DOI 10.1002/path.2730; Uchida F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-321; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; [王俊茹 Wang Junru], 2002, [肿瘤, Tumor], V22, P191; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wong Robert, 2011, Gastroenterol Hepatol (N Y), V7, P16; Xie L, 2005, ACTA BIOCH BIOPH SIN, V37, P618, DOI 10.1111/j.1745-7270.2005.00086.x; Xie L, 2007, ONCOL REP, V17, P605; Xu L, 2001, CANCER RES, V61, P3176; Yu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034185; Zhang FR, 2006, BBA-GENE STRUCT EXPR, V1759, P514, DOI 10.1016/j.bbaexp.2006.10.002; Zhang PP, 2006, CLIN CANCER RES, V12, P6617, DOI 10.1158/1078-0432.CCR-06-1307; Zhu K, 2005, GYNECOL ONCOL, V97, P405, DOI 10.1016/j.ygyno.2004.12.063	26	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57574	10.1371/journal.pone.0057574	http://dx.doi.org/10.1371/journal.pone.0057574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469028	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900127
J	Rieder, F; Siegmund, B; Bundschuh, DS; Lehr, HA; Endres, S; Eigler, A				Rieder, Florian; Siegmund, Britta; Bundschuh, Daniela S.; Lehr, Hans-Anton; Endres, Stefan; Eigler, Andreas			The Selective Phosphodiesterase 4 Inhibitor Roflumilast and Phosphodiesterase 3/4 Inhibitor Pumafentrine Reduce Clinical Score and TNF Expression in Experimental Colitis in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INFLAMMATORY-BOWEL-DISEASE; OBSTRUCTIVE PULMONARY-DISEASE; SODIUM-INDUCED COLITIS; PDE4 INHIBITOR; ULCERATIVE-COLITIS; MURINE COLITIS; FACTOR-ALPHA; IN-VITRO; ROLIPRAM	Objective: The specific inhibition of phosphodiesterase (PDE) 4 and dual inhibition of PDE3 and PDE4 has been shown to decrease inflammation by suppression of pro-inflammatory cytokine synthesis. We examined the effect of roflumilast, a selective PDE4 inhibitor marketed for severe COPD, and the investigational compound pumafentrine, a dual PDE3/PDE4 inhibitor, in the preventive dextran sodium sulfate (DSS)-induced colitis model. Methods: The clinical score, colon length, histologic score and colon cytokine production from mice with DSS-induced colitis (3.5% DSS in drinking water for 11 days) receiving either roflumilast (1 or 5 mg/kg body weight/d p.o.) or pumafentrine (1.5 or 5 mg/kg/d p.o.) were determined and compared to vehicle treated control mice. In the pumafentrine-treated animals, splenocytes were analyzed for interferon-gamma (IFN gamma) production and CD69 expression. Results: Roflumilast treatment resulted in dose-dependent improvements of clinical score (weight loss, stool consistency and bleeding), colon length, and local tumor necrosis factor-alpha (TNF alpha) production in the colonic tissue. These findings, however, were not associated with an improvement of the histologic score. Administration of pumafentrine at 5 mg/kg/d alleviated the clinical score, the colon length shortening, and local TNF alpha production. In vitro stimulated splenocytes after in vivo treatment with pumafentrine showed a significantly lower state of activation and production of IFN gamma compared to no treatment in vivo. Conclusions: These series of experiments document the ameliorating effect of roflumilast and pumafentrine on the clinical score and TNF expression of experimental colitis in mice.	[Rieder, Florian; Siegmund, Britta; Endres, Stefan; Eigler, Andreas] Univ Munich, Div Clin Pharmacol, Munich, Germany; [Rieder, Florian; Siegmund, Britta; Endres, Stefan; Eigler, Andreas] Univ Munich, Gastroenterol Sect, Munich, Germany; [Rieder, Florian] Univ Regensburg, Dept Internal Med 1, D-93053 Regensburg, Germany; [Siegmund, Britta] Charite, Dept Med 1, D-13353 Berlin, Germany; [Bundschuh, Daniela S.] Takeda Pharmaceut Int GmbH, Zurich, Switzerland; [Lehr, Hans-Anton] CHU Vaudois, Inst Univ Pathol, Lausanne, Switzerland	University of Munich; University of Munich; University of Regensburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Eigler, A (corresponding author), Univ Munich, Div Clin Pharmacol, Munich, Germany.	andreas.eigler@med.uni-muenchen.de	Siegmund, Britta/E-6929-2018	Siegmund, Britta/0000-0002-0055-958X	Takeda Pharmaceuticals International GmbH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK083251] Funding Source: NIH RePORTER	Takeda Pharmaceuticals International GmbH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partly supported by Takeda Pharmaceuticals International GmbH (formerly Nycomed GmbH), the employer of Daniela S. Bundschuh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banner KH, 2009, BRIT J PHARMACOL, V157, P892, DOI 10.1111/j.1476-5381.2009.00170.x; Banner KH, 2004, TRENDS PHARMACOL SCI, V25, P430, DOI 10.1016/j.tips.2004.06.008; Bielekova B, 2000, J IMMUNOL, V164, P1117, DOI 10.4049/jimmunol.164.2.1117; Bundschuh DS, 2001, J PHARMACOL EXP THER, V297, P280; Calverley PMA, 2009, LANCET, V374, P685, DOI 10.1016/S0140-6736(09)61255-1; COLIGAN JE, 1992, CURRENT PROTOCOLS IM; COOPER HS, 1993, LAB INVEST, V69, P238; Diaz-Granados N, 2000, AM J PATHOL, V156, P2169, DOI 10.1016/S0002-9440(10)65087-0; Dony E, 2008, EUR RESPIR J, V31, P599, DOI 10.1183/09031936.00002007; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Giembycz MA., 2005, P AM THORAC SOC, V2, P340; Grootendorst DC, 2007, THORAX, V62, P1081, DOI 10.1136/thx.2006.075937; Hartmann G, 2000, J PHARMACOL EXP THER, V292, P22; Hatzelmann A, 2001, J PHARMACOL EXP THER, V297, P267; Hatzelmann A, 2004, PULM PHARMACOL THER, V23, P235; Ichikawa H, 2008, INFLAMM BOWEL DIS, V14, P1483, DOI 10.1002/ibd.20524; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; Kumar RK, 2003, J PHARMACOL EXP THER, V307, P349, DOI 10.1124/jpet.103.053819; Loher F, 2003, J PHARMACOL EXP THER, V305, P549, DOI 10.1124/jpet.102.039529; MURCH SH, 1993, GUT, V34, P1705, DOI 10.1136/gut.34.12.1705; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Nyman U, 1997, CLIN EXP IMMUNOL, V108, P415, DOI 10.1046/j.1365-2249.1997.3931291.x; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rabe KF, 2005, LANCET, V366, P563, DOI 10.1016/S0140-6736(05)67100-0; Rutgeerts P, 1999, GASTROENTEROLOGY, V117, P761, DOI 10.1016/S0016-5085(99)70332-X; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 1999, INFLAMM BOWEL DIS, V5, P119, DOI 10.1097/00054725-199905000-00008; Schreiber S, 2007, GASTROENTEROLOGY, V132, P76, DOI 10.1053/j.gastro.2006.11.029; SEMMLER J, 1993, INT J IMMUNOPHARMACO, V15, P409, DOI 10.1016/0192-0561(93)90052-Z; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; SINHA B, 1995, EUR J IMMUNOL, V25, P147, DOI 10.1002/eji.1830250125; SOMMER N, 1995, NAT MED, V1, P244, DOI 10.1038/nm0395-244; STURGESS I, 1990, BRIT J CLIN PHARMACO, V29, P369, DOI 10.1111/j.1365-2125.1990.tb03651.x; Tomoyose M, 1998, SCAND J GASTROENTERO, V33, P435; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Videla S, 2006, J PHARMACOL EXP THER, V316, P940, DOI 10.1124/jpet.105.090837; ZIEGLER SF, 1994, J IMMUNOL, V152, P1228; ZIEGLERHEITBROCK HWL, 1992, IMMUNOLOGY, V75, P264	40	16	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56867	10.1371/journal.pone.0056867	http://dx.doi.org/10.1371/journal.pone.0056867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468885	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900041
J	Shen, HN; Wang, WC; Lu, CL; Li, CY				Shen, Hsiu-Nien; Wang, Wen-Ching; Lu, Chin-Li; Li, Chung-Yi			Effects of Gender on Severity, Management and Outcome in Acute Biliary Pancreatitis	PLOS ONE			English	Article							GALLSTONE PANCREATITIS; RISK-FACTORS; SEX; MORTALITY; EPIDEMIOLOGY; DIFFERENCE; DISEASE; SURGERY; MEN; CHOLECYSTECTOMY	Background: We conducted a population-based cross-sectional study to examine gender differences in severity, management, and outcome among patients with acute biliary pancreatitis (ABP) because available data are insufficient and conflicting. Methods: We analyzed 13,110 patients (50.6% male) with first-attack ABP from Taiwan's National Health Insurance Research Database between 2000 and 2009. The primary outcome was hospital mortality. Secondary outcomes included the development of severe ABP and the provision of treatment measures. Gender difference was assessed using multivariable analyses with generalized estimating equations models. Results: The odds of gastrointestinal bleeding (adjusted odds ratio [aOR] 1.44, 95% confidence interval [CI] 1.18-1.76) and local complication (aOR 1.38, 95% CI 1.05-1.82) were 44% and 38% higher in men than in women, respectively. Compared with women, men had 24% higher odds of receiving total parenteral nutrition (aOR 1.24, 95% CI 1.00-1.52), but had 18% and 41% lower odds of receiving cholecystectomy (aOR 0.82, 95% CI 0.72-0.93) and hemodialysis (aOR 0.59, 95% CI 0.42-0.83), respectively. Hospital mortality was higher in men than in women (1.8% vs. 1.1%, p = 0.001). After adjustment for potential confounders, men had 81% higher odds of in-hospital death than women (aOR 1.81, 95% CI 1.15-2.86). Among patients with severe ABP, hospital mortality was 11.0% and 7.5% in men and women (p<0.001), respectively. The adjusted odds of death remained higher in men than in women with severe ABP (aOR 1.72, 95% CI 1.10-2.68). Conclusions: Gender is an important determinant of outcome in patients with ABP and may affect their treatment measures.	[Shen, Hsiu-Nien] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Wang, Wen-Ching] Chi Mei Med Ctr, Dept Gen Surg, Tainan, Taiwan; [Lu, Chin-Li] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Shen, Hsiu-Nien; Lu, Chin-Li; Li, Chung-Yi] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Li, Chung-Yi] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; National Cheng Kung University; China Medical University Taiwan	Li, CY (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan.	cyli99@mail.ncku.edu.tw	LI, CHUNG-YI/ABI-1419-2020; Shen, Hsiu-Nien/H-2803-2019	LI, CHUNG-YI/0000-0002-0321-8908; Lu, Chin-Li/0000-0002-0818-4823	hospital and the National Scientific Council [CMFHR10183, NSC101-2314-B-006 -076-MY3]	hospital and the National Scientific Council	The study was performed in Chi Mei Medical Center and supported by grant CMFHR10183 from the hospital and the National Scientific Council (NSC101-2314-B-006 -076-MY3). The institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES DM, 1987, AM J SURG, V153, P532, DOI 10.1016/0002-9610(87)90149-8; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chrousos GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3143pe36; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Giger UF, 2006, J AM COLL SURGEONS, V203, P723, DOI 10.1016/j.jamcollsurg.2006.07.018; Gravante G, 2009, PANCREATOLOGY, V9, P601, DOI 10.1159/000212097; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Judkins SE, 2011, AM J SURG, V202, P673, DOI 10.1016/j.amjsurg.2011.06.031; Kaplan RC, 2001, J AM GERIATR SOC, V49, P126, DOI 10.1046/j.1532-5415.2001.49032.x; KELLY TR, 1988, SURGERY, V104, P600; KURATA JH, 1985, AM J PUBLIC HEALTH, V75, P625, DOI 10.2105/AJPH.75.6.625; Lankisch PG, 2001, DIGEST DIS SCI, V46, P2470, DOI 10.1023/A:1012332121574; Liu ES, 2001, J GASTROEN HEPATOL, V16, P740, DOI 10.1046/j.1440-1746.2001.02506.x; Mitter N, 2010, J THORAC CARDIOV SUR, V140, P1367, DOI 10.1016/j.jtcvs.2010.02.021; Nguyen GC, 2010, PANCREAS, V39, pE42, DOI 10.1097/MPA.0b013e3181bd6387; Oertelt-Prigione S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-70; Pezzilli R, 1998, HEPATO-GASTROENTEROL, V45, P1859; Phillip V, 2011, CLIN GASTROENTEROL H, V9, P995, DOI 10.1016/j.cgh.2011.06.016; Pitchumoni CS, 2005, J CLIN GASTROENTEROL, V39, P798, DOI 10.1097/01.mcg.0000177257.87939.00; RANSON JHC, 1974, SURG GYNECOL OBSTET, V139, P69; Russell JC, 1998, ANN SURG, V227, P195, DOI 10.1097/00000658-199802000-00007; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; Shen HN, 2012, PANCREAS, V41, P696, DOI 10.1097/MPA.0b013e31823db941; Shen HN, 2012, DIABETES CARE, V35, P1061, DOI 10.2337/dc11-1925; Shen HN, 2011, PANCREAS, V40, P10, DOI 10.1097/MPA.0b013e3181f7e750; Shimozawa N, 2006, GASTROENTEROLOGY, V131, P1826, DOI 10.1053/j.gastro.2006.09.005; TAYLOR TV, 1980, LANCET, V1, P848; TAYLOR TV, 1991, ANN SURG, V214, P667, DOI 10.1097/00000658-199112000-00005; Tingen CM, 2010, WOMENS HEALTH, V6, P511, DOI 10.2217/WHE.10.45; Wu HC, 2008, DIGEST DIS SCI, V53, P2650, DOI 10.1007/s10620-007-0177-7; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52; Yol Serdar, 2006, JSLS, V10, P359	33	14	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57504	10.1371/journal.pone.0057504	http://dx.doi.org/10.1371/journal.pone.0057504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469006	Green Published, Green Submitted			2022-12-27	WOS:000315524900106
J	Tency, I; Verstraelen, H; Saerens, B; Verhasselt, B; Vaneechoutte, M; Degomme, O; Verhelst, R; Temmerman, M				Tency, Inge; Verstraelen, Hans; Saerens, Bart; Verhasselt, Bruno; Vaneechoutte, Mario; Degomme, Olivier; Verhelst, Rita; Temmerman, Marleen			Elevated Soluble Triggering Receptor Expressed on Myeloid Cells (sTREM)-1 Levels in Maternal Serum during Term and Preterm Labor	PLOS ONE			English	Article							INTRAUTERINE INFECTION; INFLAMMATORY MARKERS; AMNIOTIC-FLUID; TREM-1; MEMBRANES; RISK; INTERLEUKIN-6; PARTURITION; PREGNANCY; DIAGNOSIS	Background: Infection and inflammation are important mechanisms leading to preterm birth. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) belongs to a family of cell surface receptors that seems to play an important role in fine-tuning the immune response. It has been demonstrated that sTREM-1 is involved in bacterial infection as well as in noninfectious inflammatory conditions. Few studies have investigated serum sTREM-1 expression during preterm labor. Therefore, the purpose of this study was to assess sTREM-1 concentrations in maternal serum during term and preterm labor. Methods: This case control study included 176 singleton pregnancies in the following groups: patients in (1) preterm labor, delivered before 34 weeks (PTB) (n = 52); (2) GA matched controls, not in labor, matched for gestational age (GA) with the PTB group (n = 52); (3) at term in labor (n = 40) and (4) at term not in labor (n = 32). sTREM-1 concentrations were determined by enzyme-linked immunoassay. Results: sTREM-1 was detected in all serum samples. Median sTREM-1 concentrations were significantly higher in women with PTB vs. GA matched controls (367 pg/ml, interquartile range (IQR) 304-483 vs. 273 pg/ml, IQR 208-334; P < 0.001) and in women at term in labor vs. at term not in labor (300 pg/ml, IQR 239-353 vs. 228 pg/ml, IQR 174-285; P < 0.001). Women with PTB had significantly higher levels of sTREM-1 compared to women at term in labor (P = 0.004). Multiple regression analysis, with groups recoded as three key covariates (labor, preterm and rupture of the membranes), showed significantly higher sTREM-1 concentrations for labor (+30%, P < 0.001) and preterm (+15%, P = 0.005) after adjusting for educational level, history of PTB and sample age. Conclusions: sTREM-1 concentrations in maternal serum were elevated during spontaneous term and preterm labor and sTREM-1 levels were significantly higher in preterm labor.	[Tency, Inge; Verstraelen, Hans; Temmerman, Marleen] Univ Ghent, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Saerens, Bart; Verhasselt, Bruno; Vaneechoutte, Mario] Univ Ghent, Dept Clin Chem Microbiol & Immunol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Degomme, Olivier; Verhelst, Rita; Temmerman, Marleen] Univ Ghent, Int Ctr Reprod Hlth, Dept Obstet & Gynecol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Tency, I (corresponding author), Univ Ghent, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	inge.tency@ugent.be	Verstraelen, Hans/A-5602-2008; Verstraelen, Hans/AAA-8694-2019; Vaneechoutte, Mario/A-6189-2009	Verstraelen, Hans/0000-0002-4070-1587; Vaneechoutte, Mario/0000-0002-4586-203X; Verhasselt, Bruno/0000-0002-4645-1144	Special Research fund of Ghent University	Special Research fund of Ghent University(Ghent University)	This research was supported by the Special Research fund of Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Cobo T, 2012, ACTA OBSTET GYNECOL; Cobo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043677; Cobo T, 2012, ACTA OBSTET GYN SCAN, V91, P930, DOI 10.1111/j.1600-0412.2012.01427.x; Collins CE, 2009, ANN RHEUM DIS, V68, P1768, DOI 10.1136/ard.2008.089557; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Friebe A, 2008, ARCH PATHOL LAB MED, V132, P1802, DOI 10.1043/1543-2165-132.11.1802; Gibot S, 2005, CRIT CARE MED, V33, P792, DOI 10.1097/01.CCM.0000159089.16462.4A; Gibot S, 2006, SEMIN RESP CRIT CARE, V27, P29, DOI 10.1055/s-2006-933671; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Gotsch F, 2009, J MATERN-FETAL NEO M, V22, P5, DOI 10.1080/14767050902860690; Jackman RP, 2011, CLIN VACCINE IMMUNOL, V18, P318, DOI 10.1128/CVI.00465-10; Jing JY, 2009, INTENS CARE MED, V35, P587, DOI 10.1007/s00134-008-1333-z; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Knudsen LS, 2008, BIOMARKERS, V13, P59, DOI 10.1080/13547500701615017; Kramer MS, 2010, CYTOKINE, V49, P10, DOI 10.1016/j.cyto.2009.08.014; Kusanovic JP, 2010, J MATERN-FETAL NEO M, V23, P34, DOI 10.3109/14767050903009248; Lee SM, 2011, PLACENTA, V32, P516, DOI 10.1016/j.placenta.2011.03.012; Menon R, 2008, REPROD SCI, V15, P825, DOI 10.1177/1933719108320090; Norman Jane E, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS7, DOI 10.1186/1471-2393-7-S1-S7; Park JJ, 2009, DIGEST DIS SCI, V54, P1525, DOI 10.1007/s10620-008-0514-5; Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Seong HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.040; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Tency I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049042; Tsiartas P, 2012, BJOG-INT J OBSTET GY, V119, P866, DOI 10.1111/j.1471-0528.2012.03328.x; Tworoger SS, 2006, CANCER EPIDEM BIOMAR, V15, P1578, DOI 10.1158/1055-9965.EPI-06-0629; Vogel I, 2007, J REPROD IMMUNOL, V75, P133, DOI 10.1016/j.jri.2007.02.008; Youssef RE, 2009, REPROD SCI, V16, P843, DOI 10.1177/1933719109336621; Yuan M, 2009, MOL HUM REPROD, V15, P713, DOI 10.1093/molehr/gap054	36	0	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56050	10.1371/journal.pone.0056050	http://dx.doi.org/10.1371/journal.pone.0056050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468854	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900017
J	Wang, XF; Zhang, SZ; Su, L; Liu, X; Hao, YJ				Wang, Xiaofei; Zhang, Shizhong; Su, Ling; Liu, Xin; Hao, Yujin			A Genome-Wide Analysis of the LBD (LATERAL ORGAN BOUNDARIES Domain) Gene Family in Malus domestica with a Functional Characterization of MdLBD11	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; AUXIN-RESPONSE-FACTOR; ROOT-FORMATION; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; ASYMMETRIC LEAVES1; REPRESS BREVIPEDICELLUS; AS2/LOB FAMILY; EXPRESSION; MEMBERS	The plant-specific LBD (LATERAL ORGAN BOUNDARIES domain) genes belong to a major family of transcription factor that encode a zinc finger-like domain. It has been shown that LBD genes play crucial roles in the growth and development of Arabidopsis and other plant species. However, no detailed information concerning this family is available for apple. In the present study, we analyzed the apple (Malus domestica) genome and identified 58 LBD genes. This gene family was tested for its phylogenetic relationships with homologous genes in the Arabidopsis genome, as well as its location in the genome, structure and expression. We also transformed one MdLBD gene into Arabidopsis to evaluate its function. Like Arabidopsis, apple LBD genes also have a conserved CX2CX6CX3C zinc finger-like domain in the N terminus and can be divided into two classes. The expression profile indicated that apple LBD genes exhibited a variety of expression patterns, suggesting that they have diverse functions. At the same time, the expression analysis implied that members of this apple gene family were responsive to hormones and stress and that they may participate in hormone-mediated plant organogenesis, which was demonstrated with the overexpression of the apple LBD gene MdLBD11, resulting in an abnormal phenotype. This phenotype included upward curling leaves, delayed flowering, downward-pointing flowers, siliques and other abnormal traits. Based on these data, we concluded that the MdLBD genes may play an important role in apple growth and development as in Arabidopsis and other species.	[Wang, Xiaofei; Zhang, Shizhong; Su, Ling; Liu, Xin; Hao, Yujin] Shandong Agr Univ, Natl Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Wang, Xiaofei; Zhang, Shizhong; Su, Ling; Liu, Xin; Hao, Yujin] Shandong Agr Univ, Natl Res Ctr Apple Engn & Technol, Tai An, Shandong, Peoples R China; [Wang, Xiaofei; Zhang, Shizhong; Su, Ling; Liu, Xin; Hao, Yujin] Shandong Agr Univ, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Shandong Agricultural University	Hao, YJ (corresponding author), Shandong Agr Univ, Natl Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	haoyujin@sdau.edu.cn			National Public Benefit (Agricultural) Research Foundation of China [201203075-3]; Natural Science Foundation of China [30971969]; 948 project from Ministry of Agriculture of China [2011-G21]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1155]	National Public Benefit (Agricultural) Research Foundation of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 948 project from Ministry of Agriculture of China; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Public Benefit (Agricultural) Research Foundation of China (201203075-3), Natural Science Foundation of China (30971969), 948 project from Ministry of Agriculture of China (2011-G21) and Program for Changjiang Scholars and Innovative Research Team in University (IRT1155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bai TH, 2012, MOL GENET GENOMICS, V287, P437, DOI 10.1007/s00438-012-0689-5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Belles-Boix E, 2006, PLANT CELL, V18, P1900, DOI 10.1105/tpc.106.041988; Xu B, 2008, PLANT PHYSIOL, V146, P566, DOI 10.1104/pp.107.113787; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Bureau M, 2008, PLANT SIGNAL BEHAV, V3, P145, DOI 10.4161/psb.3.2.5080; Byrne ME, 2002, DEVELOPMENT, V129, P1957; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chalfun A, 2005, PLANT MOL BIOL, V57, P559, DOI 10.1007/s11103-005-0698-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Gomez MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018760; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan MZ, 2012, CELL RES, V22, P1169, DOI 10.1038/cr.2012.63; Feng ZH, 2012, PLANTA, V236, P1227, DOI 10.1007/s00425-012-1673-3; Goh T, 2012, DEVELOPMENT, V139, P883, DOI 10.1242/dev.071928; Grennan AK, 2006, PLANT PHYSIOL, V141, P1164, DOI 10.1104/pp.104.900198; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo MJ, 2008, PLANT CELL, V20, P48, DOI 10.1105/tpc.107.056127; Hay A, 2006, DEVELOPMENT, V133, P3955, DOI 10.1242/dev.02545; Husbands A, 2007, NUCLEIC ACIDS RES, V35, P6663, DOI 10.1093/nar/gkm775; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; Iwakawa H, 2007, PLANT J, V51, P173, DOI 10.1111/j.1365-313X.2007.03132.x; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jung S, 2008, NUCLEIC ACIDS RES, V36, pD1034, DOI 10.1093/nar/gkm803; Kessler S, 2004, CURR OPIN PLANT BIOL, V7, P65, DOI 10.1016/j.pbi.2003.11.002; Lee DK, 2009, DEVELOPMENT, V136, P2423, DOI 10.1242/dev.031971; Lee HW, 2013, PLANT J, V73, P212, DOI 10.1111/tpj.12013; Lee HW, 2009, PLANT PHYSIOL, V151, P1377, DOI 10.1104/pp.109.143685; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li H, 2005, PLANT CELL, V17, P2157, DOI 10.1105/tpc.105.033449; Liu HJ, 2005, PLANT J, V43, P47, DOI 10.1111/j.1365-313X.2005.02434.x; Liu Ren-Hu, 2003, Yichuan, V25, P317; Majer C, 2011, TRENDS PLANT SCI, V16, P47, DOI 10.1016/j.tplants.2010.09.009; Mangeon A, 2011, J EXP BOT, V62, P221, DOI 10.1093/jxb/erq259; Matsumura Y, 2009, PLANT J, V58, P525, DOI 10.1111/j.1365-313X.2009.03797.x; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Naito T, 2007, BIOSCI BIOTECH BIOCH, V71, P1269, DOI 10.1271/bbb.60681; Nakazawa M, 2003, PLANT J, V34, P741, DOI 10.1046/j.1365-313X.2003.01758.x; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Phelps-Durr TL, 2005, PLANT CELL, V17, P2886, DOI 10.1105/tpc.105.035477; Qi YP, 2004, PLANTA, V219, P270, DOI 10.1007/s00425-004-1248-z; Rast MI, 2012, PLANT CELL, V24, P2917, DOI 10.1105/tpc.112.099978; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Semiarti E, 2001, DEVELOPMENT, V128, P1771; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Soyano T, 2008, PLANT CELL, V20, P3359, DOI 10.1105/tpc.108.061796; Sun SB, 2012, MOL BIOL REP, V39, P4927, DOI 10.1007/s11033-011-1288-y; Sun SB, 2010, MOL BIOL REP, V37, P3973, DOI 10.1007/s11033-010-0056-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thatcher LF, 2012, PLANT PHYSIOL, V160, P407, DOI 10.1104/pp.112.199067; Theodoris G, 2003, P NATL ACAD SCI USA, V100, P6837, DOI 10.1073/pnas.1132113100; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; Wu Xiaoming, 2002, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V19, P455; Xu L, 2003, DEVELOPMENT, V130, P4097, DOI 10.1242/dev.00622; Yang Y, 2006, MOL PHYLOGENET EVOL, V39, P248, DOI 10.1016/j.ympev.2005.09.016; Yao YX, 2007, PLANT PHYSIOL BIOCH, V45, P139, DOI 10.1016/j.plaphy.2007.01.010; Yordanov YS, 2010, PLANT CELL, V22, P3662, DOI 10.1105/tpc.110.078634; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhu QH, 2007, BIOINFORMATICS, V23, P1307, DOI 10.1093/bioinformatics/btm113	63	39	48	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57044	10.1371/journal.pone.0057044	http://dx.doi.org/10.1371/journal.pone.0057044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468909	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900050
J	Gaither, MR; Aeby, G; Vignon, M; Meguro, Y; Rigby, M; Runyon, C; Toonen, RJ; Wood, CL; Bowen, BW				Gaither, Michelle R.; Aeby, Greta; Vignon, Matthias; Meguro, Yu-ichiro; Rigby, Mark; Runyon, Christina; Toonen, Robert J.; Wood, Chelsea L.; Bowen, Brian W.			An Invasive Fish and the Time-Lagged Spread of Its Parasite across the Hawaiian Archipelago	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; BIOLOGICAL INVASIONS; GENETIC DIVERSITY; ECONOMIC COSTS; GENOMIC DNA; CONSEQUENCES; HOST; MANAGEMENT; SERRANIDAE; PATHOGENS	Efforts to limit the impact of invasive species are frustrated by the cryptogenic status of a large proportion of those species. Half a century ago, the state of Hawai'i introduced the Bluestripe Snapper, Lutjanus kasmira, to O'ahu for fisheries enhancement. Today, this species shares an intestinal nematode parasite, Spirocamallanus istiblenni, with native Hawaiian fishes, raising the possibility that the introduced fish carried a parasite that has since spread to naive local hosts. Here, we employ a multidisciplinary approach, combining molecular, historical, and ecological data to confirm the alien status of S. istiblenni in Hawai'i. Using molecular sequence data we show that S. istiblenni from Hawai'i are genetically affiliated with source populations in French Polynesia, and not parasites at a geographically intermediate location in the Line Islands. S. istiblenni from Hawai'i are a genetic subset of the more diverse source populations, indicating a bottleneck at introduction. Ecological surveys indicate that the parasite has found suitable intermediate hosts in Hawai'i, which are required for the completion of its life cycle, and that the parasite is twice as prevalent in Hawaiian Bluestripe Snappers as in source populations. While the introduced snapper has spread across the entire 2600 km archipelago to Kure Atoll, the introduced parasite has spread only half that distance. However, the parasite faces no apparent impediments to invading the entire archipelago, with unknown implications for naive indigenous Hawaiian fishes and the protected Papahanaumokuakea Marine National Monument.	[Gaither, Michelle R.] Calif Acad Sci, San Francisco, CA 94118 USA; [Gaither, Michelle R.; Aeby, Greta; Runyon, Christina; Toonen, Robert J.; Bowen, Brian W.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Vignon, Matthias] Univ Pau & Pays Adour, UMR Ecobiop 1224, UFR Sci & Tech Cote Basque, Anglet, France; [Vignon, Matthias] INRA, UMR Ecobiop 1224, St Pee Sur Nivelle, France; [Meguro, Yu-ichiro] Hokkaido Univ, Div Marine Biosci, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan; [Rigby, Mark] Parsons, South Jordan, UT USA; [Rigby, Mark] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Wood, Chelsea L.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Wood, Chelsea L.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	California Academy of Sciences; University of Hawaii System; University of Hawaii Manoa; Universite de Pau et des Pays de l'Adour; INRAE; Universite de Pau et des Pays de l'Adour; Hokkaido University; University of California System; University of California Santa Barbara; Stanford University; Stanford University	Gaither, MR (corresponding author), Calif Acad Sci, San Francisco, CA 94118 USA.	michellergaither@gmail.com	Vignon, Matthias/N-1122-2019; Toonen, Rob/V-6230-2019; Gaither, Michelle/J-3137-2015	Vignon, Matthias/0000-0001-9222-8966; Toonen, Rob/0000-0001-6339-4340; Gaither, Michelle/0000-0002-0371-5621; Meguro, Yu-ichiro/0000-0002-2811-9789	University of Hawai'i Sea Grant Program [UNIHI-SEAGRANT-JC-09-52]; Hawai'i Sea Grant [NA05OAR4171048]; National Science Foundation [OIA0554657, OCE-0453167, OCE-0929031]; NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies Grant [NA07NOS4780188]; NOAA Coral Reef Conservation Program; Hawai'i Undersea Research Laboratory [NA05OAR4301108]; NOAA National Marine Sanctuaries Program MOA [2005-008/66882]	University of Hawai'i Sea Grant Program; Hawai'i Sea Grant; National Science Foundation(National Science Foundation (NSF)); NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies Grant; NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Hawai'i Undersea Research Laboratory; NOAA National Marine Sanctuaries Program MOA	We thank Papahanaumokea kea Marine National Monument co-trustees NOAA Office of National Marine Sanctuaries, U. S. Fish and Wildlife Service (USFWS), and the State of Hawai'i. Randall Kosaki, Greg Concepcion, Matt Craig, Jonathan Dale, Toby Daly-Engel, Jeff Eble, Matt Iacchei, Stephen Karl, Carl Meyer, Mike Neumann, Yannis Papastamatiou, Luiz Rocha, Zoli Szabo, Daniel Wagner, Jill Zamzow, Joshua Reece, and the crew of the R. V. Hi'ialakai helped collect specimens. 'Aulani Wilhelm, Jo-Ann Leong, Hoku Johnson, Danielle Carter, Daniel Polhemus, Randall Kosaki, Ann Mooney, Elizabeth Keenen, and Kelly Gleason provided crucial logistic assistance to this project. We thank Mac Aveina for processing the fish from American Samoa and Shelley Jones and all the members of the ToBo lab and staff at HIMB for their assistance, support and feedback throughout this project. This is contribution #1538 from the Hawai'i Institute of Marine Biology, #8850 from the School of Ocean and Earth Science and Technology and UNIHI-SEAGRANT-JC-09-52 from the University of Hawai'i Sea Grant Program.; This study was supported by the Hawai'i Sea Grant No. NA05OAR4171048 (BWB), National Science Foundation (grants No. OIA0554657, OCE-0453167, OCE-0929031 to BWB), NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies Grant NA07NOS4780188, NOAA Coral Reef Conservation Program and Hawai'i Undersea Research Laboratory Grant NA05OAR4301108, NOAA National Marine Sanctuaries Program MOA No. 2005-008/66882 (RJT). The views expressed herein are those of the authors and do not necessarily reflect the views of NSF, NOAA USFWS, the State of Hawai'i, or any of their sub-agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bondad-Reantaso MG, 2005, VET PARASITOL, V132, P249, DOI 10.1016/j.vetpar.2005.07.005; Bush AO, 2000, J PARASITOL, V86, P212, DOI 10.2307/3284757; Carlton JT, 1996, ECOLOGY, V77, P1653, DOI 10.2307/2265767; Concepcion GT, 2010, MAR ECOL PROG SER, V401, P113, DOI 10.3354/meps08364; Cowie RH, 1998, BIODIVERS CONSERV, V7, P349, DOI 10.1023/A:1008881712635; Cox G. W., 1999, ALIEN SPECIES N AM H; Cribb TH, 2000, INT J PARASITOL, V30, P1445, DOI 10.1016/S0020-7519(00)00121-1; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Font William F., 2000, Bishop Museum Occasional Papers, V64, P53; Gaither MR, 2012, P ROY SOC B-BIOL SCI, V279, P3948, DOI 10.1098/rspb.2012.1481; Gaither MR, 2010, MOL ECOL, V19, P1107, DOI 10.1111/j.1365-294X.2010.04535.x; Godwin S, 2006, REDUCING POTENTIAL I; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; GUEGAN JF, 1993, PARASITOLOGY, V106, P91, DOI 10.1017/S0031182000074862; HOLMES JC, 1961, J PARASITOL, V47, P209, DOI 10.2307/3275291; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Meguid MA, 1996, J PARASITOL, V82, P118, DOI 10.2307/3284126; Menezes RC, 2006, MEM I OSWALDO CRUZ, V101, P683, DOI 10.1590/S0074-02762006000600018; Miura O, 2006, P NATL ACAD SCI USA, V103, P19818, DOI 10.1073/pnas.0609603103; Nadler SA, 2007, PARASITOLOGY, V134, P1421, DOI 10.1017/S0031182007002880; Nei M., 1987, MOL EVOLUTIONARY GEN; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Phillips BL, 2010, ECOLOGY, V91, P872, DOI 10.1890/09-0530.1; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; RANDALL JE, 1987, B MAR SCI, V41, P490; Randall JE, 1998, ZOOL STUD, V37, P227; RANDALL JE, 1982, SEA FRONTIERS, V18, P144; READ CP, 1951, J PARASITOL, V37, P174, DOI 10.2307/3273449; Rigby MC, 2001, J PARASITOL, V87, P1210, DOI 10.1645/0022-3395(2001)087[1210:SROTDB]2.0.CO;2; Rigby MC, 1996, J PARASITOL, V82, P405, DOI 10.2307/3284076; Rigby MC, 1997, J HELMINTHOL SOC W, V64, P227; Rigby MC, 2013, HDB ZOOLOGY NATURAL; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Schlaepfer MA, 2005, ECOL LETT, V8, P241, DOI 10.1111/j.1461-0248.2005.00730.x; Schumacher BD, 2005, BIOL INVASIONS, V7, P925, DOI 10.1007/s10530-004-2983-6; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Simberloff D, 2005, J AGR ENVIRON ETHIC, V18, P595, DOI 10.1007/s10806-005-2851-0; Skillings Derek J., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/783030; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Stefani F, 2012, BIOL INVASIONS, V14, P1725, DOI 10.1007/s10530-012-0183-3; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vignon M, 2010, ENVIRON BIOL FISH, V87, P1, DOI 10.1007/s10641-009-9553-9; Vignon M, 2009, DIS AQUAT ORGAN, V85, P133, DOI 10.3354/dao02071; Vignon M, 2009, PARASITOL RES, V104, P775, DOI 10.1007/s00436-008-1254-3; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wu SG, 2009, VET PARASITOL, V164, P248, DOI 10.1016/j.vetpar.2009.04.030	60	27	30	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56940	10.1371/journal.pone.0056940	http://dx.doi.org/10.1371/journal.pone.0056940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468894	Green Published, gold			2022-12-27	WOS:000315519000049
J	Geerling, JJ; Wang, YA; Havekes, LM; Romijn, JA; Rensen, PCN				Geerling, Janine J.; Wang, Yanan; Havekes, Louis M.; Romijn, Johannes A.; Rensen, Patrick C. N.			Acute Central Neuropeptide Y Administration Increases Food Intake but Does Not Affect Hepatic Very Low-Density Lipoprotein (Vldl) Production in Mice	PLOS ONE			English	Article							NERVOUS-SYSTEM; TRIGLYCERIDE SECRETION; PREPRONEUROPEPTIDE-Y; HYPOTHALAMIC CONTROL; SERUM TRIGLYCERIDE; ENERGY-METABOLISM; RECEPTOR GENE; POLYMORPHISM; EXPRESSION; ASSOCIATION	Objective: Central neuropeptide Y (NPY) administration stimulates food intake in rodents. In addition, acute modulation of central NPY signaling increases hepatic production of very low-density lipoprotein (VLDL)-triglyceride (TG) in rats. As hypertriglyceridemia is an important risk factor for atherosclerosis, for which well-established mouse models are available, we set out to validate the effect of NPY on hepatic VLDL-TG production in mice, to ultimately investigate whether NPY, by increasing VLDL production, contributes to the development of atherosclerosis. Research Design and Methods: Male C57Bl/6J mice received an intracerebroventricular (i.c.v.) cannula into the lateral (LV) or third (3V) ventricle of the brain. One week later, after a 4 h fast, the animals received an intravenous (i.v.) injection of Tran(35)S (100 mu Ci) followed by tyloxapol (500 mg/kg body weight; BW), enabling the study of hepatic VLDL-apoB and VLDL-TG production, respectively. Immediately after the i. v. injection of tyloxapol, the animals received either an i. c. v. injection of NPY (0.2 mg/kg BW in artificial cerebrospinal fluid; aCSF), synthetic Y-1 receptor antagonist GR231118 (0.5 mg/kg BW in aCSF) or vehicle (aCSF), or an i. v. injection of PYY3-36 (0.5 mg/kg BW in PBS) or vehicle (PBS). Results: Administration of NPY into both the LV and 3V increased food intake within one hour after injection (+164%, p<0.001 and +367%, p<0.001, respectively). NPY administration neither in the LV nor in the 3V affected hepatic VLDL-TG or VLDL-apoB production. Likewise, antagonizing central NPY signaling by either PYY3-36 or GR231118 administration did not affect hepatic VLDL production. Conclusion: In mice, as opposed to rats, acute central administration of NPY increases food intake without affecting hepatic VLDL production. These results are of great significance when extrapolating findings on the central regulation of hepatic VLDL production between species.	[Geerling, Janine J.; Wang, Yanan; Havekes, Louis M.; Rensen, Patrick C. N.] Leiden Univ, Dept Gen Internal Med Endocrinol & Metab Dis, Med Ctr, Leiden, Netherlands; [Havekes, Louis M.] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Havekes, Louis M.] Netherlands Org Appl Sci Res Metab Hlth Res, Gaubius Lab, Leiden, Netherlands; [Romijn, Johannes A.] Univ Amsterdam, Acad Med Ctr, Dept Med, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; University of Amsterdam; Academic Medical Center Amsterdam	Rensen, PCN (corresponding author), Leiden Univ, Dept Gen Internal Med Endocrinol & Metab Dis, Med Ctr, Leiden, Netherlands.	P.C.N.Rensen@lumc.nl	Rensen, Patrick C.N./D-7176-2018; Wang, Yanan/C-4143-2019	Rensen, Patrick C.N./0000-0002-8455-4988; Wang, Yanan/0000-0002-0327-0458	Netherlands Diabetes Foundation [DFN2007.00.010]; Netherlands Heart Foundation [2007B081]	Netherlands Diabetes Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was supported by research grants from the Netherlands Diabetes Foundation (DFN2007.00.010 to P.C.N.R.; http://www.diabetesfonds.nl) and the Netherlands Heart Foundation (2007B081 to P.C.N.R.). P.C.N. Rensen is an Established Investigator of the Netherlands Heart Foundation (2009T038 to P.C.N.R.; http://www.hartstichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Beck B, 2006, PHILOS T R SOC B, V361, P1159, DOI 10.1098/rstb.2006.1855; Blumenthal JB, 2002, CLIN GENET, V62, P196, DOI 10.1034/j.1399-0004.2002.620302.x; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Bruinstroop E, 2012, DIABETES, V61, P1043, DOI 10.2337/db11-1142; Burkhoff AM, 1998, MOL BRAIN RES, V53, P311, DOI 10.1016/S0169-328X(97)00302-1; Chambers Adam P, 2012, Handb Exp Pharmacol, P23, DOI 10.1007/978-3-642-24716-3_2; Christie MJ, 2000, CLIN EXP PHARMACOL P, V27, P520, DOI 10.1046/j.1440-1681.2000.03291.x; CHUA SC, 1991, MOL BRAIN RES, V9, P95, DOI 10.1016/0169-328X(91)90134-J; Dumont Y, 2006, EXP SUPPL, V95, P7; Dumont Y, 1998, J COMP NEUROL, V402, P372; Erkkila AT, 2002, MOL GENET METAB, V75, P260, DOI 10.1006/mgme.2002.3302; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Iyengar S, 1999, J PHARMACOL EXP THER, V289, P1031; Kalsbeek A, 2010, ANN NY ACAD SCI, V1212, P114, DOI 10.1111/j.1749-6632.2010.05800.x; Karvonen MK, 2000, J CLIN ENDOCR METAB, V85, P1455, DOI 10.1210/jc.85.4.1455; Koenner AC, 2009, PHYSIOL BEHAV, V97, P632, DOI 10.1016/j.physbeh.2009.03.027; Leibowitz SF, 2004, PEPTIDES, V25, P473, DOI 10.1016/j.peptides.2004.02.006; LEVINE AS, 1984, PEPTIDES, V5, P1025, DOI 10.1016/0196-9781(84)90165-7; Li XH, 1996, J LIPID RES, V37, P210; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; MORLEY JE, 1987, AM J PHYSIOL, V253, pR516, DOI 10.1152/ajpregu.1987.253.3.R516; Mullins DE, 2000, EUR J PHARMACOL, V395, P87, DOI 10.1016/S0014-2999(00)00255-7; Nguyen AD, 2011, CURR OPIN ENDOCRINOL, V18, P56, DOI 10.1097/MED.0b013e3283422f0a; Niswender K, 2010, DIABETES OBES METAB, V12, P267, DOI 10.1111/j.1463-1326.2009.01175.x; Pu SY, 1999, ENDOCRINOLOGY, V140, P933, DOI 10.1210/en.140.2.933; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Simpson KA, 2009, ARQ BRAS ENDOCRINOL, V53, P120, DOI 10.1590/S0004-27302009000200002; Stafford JM, 2008, DIABETES, V57, P1482, DOI 10.2337/db07-1702; Takiguchi E, 2010, METABOLISM, V59, P1591, DOI 10.1016/j.metabol.2010.02.014; Talayero Beatriz G, 2011, Curr Cardiol Rep, V13, P544, DOI 10.1007/s11886-011-0220-3; van den Hoek AM, 2004, DIABETES, V53, P2529, DOI 10.2337/diabetes.53.10.2529; van den Hoek AM, 2008, DIABETES, V57, P2304, DOI 10.2337/db07-1658; Wallerstedt SM, 2004, J HYPERTENS, V22, P1277, DOI 10.1097/01.hjh.0000125415.50839.7b; Weinberg DH, 1996, J BIOL CHEM, V271, P16435, DOI 10.1074/jbc.271.28.16435	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55217	10.1371/journal.pone.0055217	http://dx.doi.org/10.1371/journal.pone.0055217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460782	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000005
J	Juraschek, SP; Kovell, LC; Miller, ER; Gelber, AC				Juraschek, Stephen P.; Kovell, Lara C.; Miller, Edgar R.; Gelber, Allan C.			Dose-Response Association of Uncontrolled Blood Pressure and Cardiovascular Disease Risk Factors with Hyperuricemia and Gout	PLOS ONE			English	Article							SERUM URIC-ACID; ATHEROSCLEROSIS RISK; INCIDENT HYPERTENSION; METABOLIC SYNDROME; NATIONAL-HEALTH; POPULATION; PREVALENCE; EPIDEMIOLOGY; PATHOGENESIS; CRITERIA	Background: First-line therapy of hypertension includes diuretics, known to exert a multiplicative increase on the risk of gout. Detailed insight into the underlying prevalence of hyperuricemia and gout in persons with uncontrolled blood pressure (BP) and common comorbidities is informative to practitioners initiating antihypertensive agents. We quantify the prevalence of hyperuricemia and gout in persons with uncontrolled BP and additional cardiovascular disease (CVD) risk factors. Methods and Findings: We performed a cross-sectional study of non-institutionalized US adults, 18 years and older, using the National Health and Nutrition Examination Surveys in 1988-1994 and 1999-2010. Hyperuricemia was defined as serum uric acid >6.0 mg/dL in women; >7.0 mg/dL in men. Gout was ascertained by self-report of physician-diagnosed gout. Uncontrolled BP was based on measured systolic BP >= 140 mmHg and diastolic BP >= 90 mmHg. Additional CVD risk factors included obesity, reduced glomerular filtration rate, and dyslipidemia. The prevalence of hyperuricemia was 6-8% among healthy US adults, 10-15% among adults with uncontrolled BP, 22-25% with uncontrolled BP and one additional CVD risk factor, and 34-37% with uncontrolled BP and two additional CVD risk factors. Similarly, the prevalence of gout was successively greater, at 1-2%, 4-5%, 6-8%, and 8-12%, respectively, across these same health status categories. In 2007-2010, those with uncontrolled BP and 2 additional CVD risk factors compared to those without CVD risk factors had prevalence ratios of 4.5 (95% CI 3.5-5.6) and 4.5 (95% CI: 3.1-6.3) for hyperuricemia and gout respectively (P < 0.01). Conclusions: Health care providers should be cognizant of the incrementally higher prevalence of hyperuricemia and gout among patients with uncontrolled BP and additional CVD risk factors. With one in three people affected by hyperuricemia among those with several CVD risk factors, physicians should consider their anti-hypertensive regimens carefully and potentially screen for hyperuricemia or gout.	[Juraschek, Stephen P.; Miller, Edgar R.; Gelber, Allan C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Juraschek, Stephen P.; Miller, Edgar R.; Gelber, Allan C.] Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Kovell, Lara C.; Miller, Edgar R.; Gelber, Allan C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Gelber, AC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	agelber@jhmi.edu		Kovell, Lara C/0000-0002-7919-2361; Juraschek, Stephen/0000-0003-4168-2696	National Institutes of Health/NIH Heart, Lung and Blood Institute [T32HL007024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER	National Institutes of Health/NIH Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SPJ is supported by a National Institutes of Health/NIH Heart, Lung and Blood Institute T32HL007024 cardiovascular Epidemiology Training Grant. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Anderson G, 2004, PUBLIC HEALTH REP, V119, P263, DOI 10.1016/j.phr.2004.04.005; Boner G, 1974, Adv Exp Med Biol, V41, P781; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; CDC, 2008, NAT AMB MED CAR SURV; Centers for Disease Control, 1999, NHANES 1999 2010 MAN; Centers for Disease Control, 1988, NHANES 3 REP REF MAN; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P109, DOI 10.1002/art.22466; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; DeMarco MAM, 2012, ARTHRITIS RHEUM-US, V64, P121, DOI 10.1002/art.33315; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Forman JP, 2007, J AM SOC NEPHROL, V18, P287, DOI 10.1681/ASN.2006080865; GREENE HL, 1978, J CLIN INVEST, V62, P321, DOI 10.1172/JCI109132; HERMAN JB, 1982, LANCET, V2, P240; HOCHBERG MC, 1995, ARTHRITIS RHEUM-US, V38, P628, DOI 10.1002/art.1780380508; Kim KY, 2003, CLIN THER, V25, P1593, DOI 10.1016/S0149-2918(03)80158-3; KLAG MJ, 1990, HYPERTENSION, V16, P700, DOI 10.1161/01.HYP.16.6.700; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; McAdams MA, 2011, J RHEUMATOL, V38, P135, DOI 10.3899/jrheum.100418; McAdams-DeMarco MA, 2012, J CLIN HYPERTENS, V14, P675, DOI 10.1111/j.1751-7176.2012.00674.x; Mellen PB, 2006, HYPERTENSION, V48, P1037, DOI 10.1161/01.HYP.0000249768.26560.66; National Heart Lung and Blood Institute, 2002, 3 NAT HEART LUNG BLO; National Heart Lung and Blood Institute, 2004, 7 NAT HEART LUNG BLO; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Puig JG, 2008, NUCLEOS NUCLEOT NUCL, V27, P620, DOI 10.1080/15257770802138582; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Reyes AJ, 2003, CARDIOVASC DRUG THER, V17, P397, DOI 10.1023/B:CARD.0000015855.02485.e3; Rodriguez G, 2010, ANN RHEUM DIS, V69, P2090, DOI 10.1136/ard.2010.130013; Ryu S, 2012, AM J EPIDEMIOL, V175, P133, DOI 10.1093/aje/kwr291; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Tsai J, 2012, ADDICT BEHAV, V37, P78, DOI 10.1016/j.addbeh.2011.09.002; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; World Health Organization, 1995, 854 WHO, V854; YANO K, 1977, J CHRON DIS, V30, P171, DOI 10.1016/0021-9681(77)90083-2	42	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56546	10.1371/journal.pone.0056546	http://dx.doi.org/10.1371/journal.pone.0056546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460805	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000028
J	Pu, H; Li, J; Li, DW; Han, CG; Yu, JL				Pu, Heng; Li, Jiang; Li, Dawei; Han, Chenggui; Yu, Jialin			Identification of an Internal RNA Element Essential for Replication and Translational Enhancement of Tobacco Necrosis Virus A(C)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CAP-INDEPENDENT TRANSLATION; TURNIP-CRINKLE-VIRUS; MESSENGER-RNA; COAT PROTEIN; SUBGENOMIC RNAS; GENOME STRUCTURE; BETA-GLUCURONIDASE; ETCH VIRUS; ENTRY SITE	Different regulatory elements function are involved in plant virus gene expression and replication by long-distance RNA-RNA interactions. A cap-independent functional element of the Barley yellow dwarf virus (BYDV) - like translational enhancer (BTE) is present in Tobacco necrosis virus A (TNV-A), a Necrovirus member in the Tombusviridae family. In this paper, an RNA stretch flanking the 5' proximal end of the TNV-A(C) coat protein (CP) gene was shown to be essential for viral replication in Chenopodium amaranticolor plants and tobacco cells. This internal sequence functioned in transient expression of beta-glucuronidase (GUS) when present at either the 5' or 3' sides of the GUS open reading frame. Serial deletion analyses revealed that nine nucleotides from nt 2609 to 2617 (-3 to +6 of the CP initiation site) within TNV-A(C) RNA are indispensable for viral replication in whole plants and tobacco cells. Fusion of this RNA element in mRNAs translated in tobacco cells resulted in a remarkable enhancement of luciferase expression from in vitro synthesised chimaeric RNAs or DNA expression vectors. Interestingly, the element also exhibited increased translational activity when fused downstream of the reporter genes, although the efficiency was lower than with upstream fusions. These results provide evidence that an internal RNA element in the genomic (g) RNA of TNV-A(C), ranging approximately from nt 2543 to 2617, plays a bifunctional role in viral replication and translation enhancement during infection, and that this element may use novel strategies differing from those previously reported for other viruses.	[Pu, Heng; Li, Jiang; Li, Dawei; Han, Chenggui; Yu, Jialin] China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Yu, JL (corresponding author), China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China.	yjl@cau.edu.cn	Li, Dawei/I-8751-2016	Li, Dawei/0000-0003-4133-1263	National Nature Science Foundation of China [30270063, 30325001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (30270063 and 30325001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbergenov RZ, 2004, NUCLEIC ACIDS RES, V32, P239, DOI 10.1093/nar/gkh176; BARLOW JJ, 1963, BIOCHEM BIOPH RES CO, V13, P61, DOI 10.1016/0006-291X(63)90163-3; BASSO J, 1994, J GEN VIROL, V75, P3157, DOI 10.1099/0022-1317-75-11-3157; Callaway A, 2001, ANNU REV PHYTOPATHOL, V39, P419, DOI 10.1146/annurev.phyto.39.1.419; Cao Y, 2002, ARCH VIROL, V147, P2431, DOI 10.1007/s00705-002-0896-1; Cao YH, 2006, PROG BIOCHEM BIOPHYS, V33, P127; CARRINGTON JC, 1989, VIROLOGY, V170, P219, DOI 10.1016/0042-6822(89)90369-3; CARRINGTON JC, 1990, J VIROL, V64, P1590, DOI 10.1128/JVI.64.4.1590-1597.1990; Choi IR, 2002, J BIOL CHEM, V277, P3760, DOI 10.1074/jbc.M109067200; CONDIT C, 1979, VIROLOGY, V97, P122, DOI 10.1016/0042-6822(79)90378-7; COUTTS RHA, 1991, J GEN VIROL, V72, P1521, DOI 10.1099/0022-1317-72-7-1521; DAY MJD, 1993, PLANT MOL BIOL, V23, P97, DOI 10.1007/BF00021423; Fabian MR, 2006, RNA, V12, P1304, DOI 10.1261/rna.69506; Fabian MR, 2004, J BIOL CHEM, V279, P28862, DOI 10.1074/jbc.M401272200; Fauquet C, 2005, VIRUS TAXONOMY CLASS, P359; GEIER GE, 1979, J BIOL CHEM, V254, P1408; GRIECO F, 1989, NUCLEIC ACIDS RES, V17, P6383, DOI 10.1093/nar/17.15.6383; Guo L, 2001, MOL CELL, V7, P1103, DOI 10.1016/S1097-2765(01)00252-0; HEARNE PQ, 1990, VIROLOGY, V177, P141, DOI 10.1016/0042-6822(90)90468-7; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiwan SD, 2011, VIROLOGY, V418, P1, DOI 10.1016/j.virol.2011.07.005; Karetnikov A, 2007, J GEN VIROL, V88, P286, DOI 10.1099/vir.0.82307-0; Kim KH, 1999, RNA, V5, P636, DOI 10.1017/S1355838299982006; Krizbai L, 2010, ARCH VIROL, V155, P999, DOI 10.1007/s00705-010-0660-x; LESNAW JA, 1970, P NATL ACAD SCI USA, V66, P140, DOI 10.1073/pnas.66.1.140; LEVIS C, 1993, VIRUS GENES, V7, P367, DOI 10.1007/BF01703392; Li J, 2008, CHINESE SCI BULL, V53, P1682, DOI 10.1007/s11434-008-0204-x; Lin HX, 2004, EMBO J, V23, P3365, DOI 10.1038/sj.emboj.7600336; Meulewaeter F, 2004, NUCLEIC ACIDS RES, V32, P1721, DOI 10.1093/nar/gkh338; MEULEWAETER F, 1990, VIROLOGY, V177, P699, DOI 10.1016/0042-6822(90)90536-Z; MEULEWAETER F, 1992, J VIROL, V66, P6419, DOI 10.1128/JVI.66.11.6419-6428.1992; Meulewaeter F, 1999, ENCY VIROLOGY, P901; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Miller WA, 2006, ANNU REV PHYTOPATHOL, V44, P447, DOI 10.1146/annurev.phyto.44.070505.143353; Molnar A, 1997, J GEN VIROL, V78, P1235, DOI 10.1099/0022-1317-78-6-1235; Na H, 2006, VIROLOGY, V345, P305, DOI 10.1016/j.virol.2005.09.008; Niepel M, 1999, J VIROL, V73, P9080, DOI 10.1128/JVI.73.11.9080-9088.1999; Ohki Takehiro, 2005, Journal of General Plant Pathology, V71, P74, DOI 10.1007/s10327-004-0163-2; Qu F, 2003, J VIROL, V77, P511, DOI 10.1128/JVI.77.1.511-522.2003; Quaedvlieg NEM, 1998, PLANT MOL BIOL, V38, P861, DOI 10.1023/A:1006182623165; RUBINO L, 1995, ARCH VIROL, V140, P2027, DOI 10.1007/BF01322690; Sambrook J., 2001, MOL CLONING LAB MANU; Shen RZ, 2007, VIROLOGY, V358, P448, DOI 10.1016/j.virol.2006.08.054; Shen RZ, 2004, J VIROL, V78, P4655, DOI 10.1128/JVI.78.9.4655-4664.2004; Sit TL, 1998, SCIENCE, V281, P829, DOI 10.1126/science.281.5378.829; Szittya G, 2001, J VIROL, V75, P2411, DOI 10.1128/JVI.75.5.2411-2420.2001; Thomas CL, 2003, VIROLOGY, V306, P33, DOI 10.1016/S0042-6822(02)00018-1; Wang JL, 1999, VIROLOGY, V259, P234, DOI 10.1006/viro.1999.9781; Weiland JJ, 2007, PHYTOPATHOLOGY, V97, P1245, DOI 10.1094/PHYTO-97-10-1245; Wu BD, 1999, J VIROL, V73, P8982, DOI 10.1128/JVI.73.11.8982-8988.1999; Xi DeHui, 2007, Acta Phytopathologica Sinica, V37, P595; Xi DH, 2008, VIRUS GENES, V36, P259, DOI 10.1007/s11262-007-0185-x; Xu J, 2012, J GEN VIROL, V93, P2718, DOI 10.1099/vir.0.045641-0; Xu W, 2008, VIROLOGY, V371, P430, DOI 10.1016/j.virol.2007.09.035; Yuan XF, 2006, J GEN VIROL, V87, P3077, DOI 10.1099/vir.0.81928-0; Zeenko V, 2005, J BIOL CHEM, V280, P26813, DOI 10.1074/jbc.M503576200; Zhang GC, 1999, RNA, V5, P550, DOI 10.1017/S1355838299982080; Zhao YJ, 2000, MOL PLANT MICROBE IN, V13, P1015, DOI 10.1094/MPMI.2000.13.9.1015; Zhong X, 2005, CURR PROTOC MICROBIO	59	1	1	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57938	10.1371/journal.pone.0057938	http://dx.doi.org/10.1371/journal.pone.0057938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460916	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000171
J	Shan, JC; Liu, CM; Chiu, MJ; Liu, CC; Chien, YL; Hwang, TJ; Lin, YT; Hsieh, MH; Jaw, FS; Hwu, HG				Shan, Jia-Chi; Liu, Chih-Min; Chiu, Ming-Jang; Liu, Chen-Chung; Chien, Yi-Ling; Hwang, Tzung-Jeng; Lin, Yi-Ting; Hsieh, Ming H.; Jaw, Fu-Shan; Hwu, Hai-Gwo			A Diagnostic Model Incorporating P50 Sensory Gating and Neuropsychological Tests for Schizophrenia	PLOS ONE			English	Article							BIPOLAR DISORDER; SUSTAINED ATTENTION; NEUROPHYSIOLOGICAL ENDOPHENOTYPES; UNAFFECTED SIBLINGS; DEFICITS; RELATIVES; METAANALYSIS; SUPPRESSION; PERFORMANCE; NORMALIZATION	Objectives: Endophenotypes in schizophrenia research is a contemporary approach to studying this heterogeneous mental illness, and several candidate neurophysiological markers (e.g. P50 sensory gating) and neuropsychological tests (e.g. Continuous Performance Test (CPT) and Wisconsin Card Sorting Test (WCST)) have been proposed. However, the clinical utility of a single marker appears to be limited. In the present study, we aimed to construct a diagnostic model incorporating P50 sensory gating with other neuropsychological tests in order to improve the clinical utility. Methods: We recruited clinically stable outpatients meeting DSM-IV criteria of schizophrenia and age-and gender-matched healthy controls. Participants underwent P50 sensory gating experimental sessions and batteries of neuropsychological tests, including CPT, WCST and Wechsler Adult Intelligence Scale Third Edition (WAIS-III). Results: A total of 106 schizophrenia patients and 74 healthy controls were enrolled. Compared with healthy controls, the patient group had significantly a larger S2 amplitude, and thus poorer P50 gating ratio (gating ratio = S2/S1). In addition, schizophrenia patients had a poorer performance on neuropsychological tests. We then developed a diagnostic model by using multivariable logistic regression analysis to differentiate patients from healthy controls. The final model included the following covariates: abnormal P50 gating (defined as P50 gating ratio >0.4), three subscales derived from the WAIS-III (Arithmetic, Block Design, and Performance IQ), sensitivity index from CPT and smoking status. This model had an adequate accuracy (concordant percentage = 90.4%; c-statistic = 0.904; Hosmer-Lemeshow Goodness-of-Fit Test, p = 0.64>0.05). Conclusion: To the best of our knowledge, this is the largest study to date using P50 sensory gating in subjects of Chinese ethnicity and the first to use P50 sensory gating along with other neuropsychological tests to develop a diagnostic model for schizophrenia. Further research to validate the predictive accuracy of this model by applying it on other samples is warranted.	[Shan, Jia-Chi] Cathay Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Shan, Jia-Chi; Liu, Chih-Min; Liu, Chen-Chung; Chien, Yi-Ling; Hwang, Tzung-Jeng; Lin, Yi-Ting; Hsieh, Ming H.; Hwu, Hai-Gwo] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Liu, Chih-Min; Liu, Chen-Chung; Chien, Yi-Ling; Hwang, Tzung-Jeng; Hsieh, Ming H.; Hwu, Hai-Gwo] Natl Taiwan Univ, Coll Med, Dept Psychiat, Taipei 10764, Taiwan; [Liu, Chih-Min; Chiu, Ming-Jang; Liu, Chen-Chung; Hwang, Tzung-Jeng; Hsieh, Ming H.; Jaw, Fu-Shan; Hwu, Hai-Gwo] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hsieh, Ming H.; Jaw, Fu-Shan] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Lin, Yi-Ting] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Psychiat, Yunlin, Taiwan	Cathay General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Hsieh, MH (corresponding author), Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan.	mingh@ntuh.gov.tw	Hwang, TJ/K-4768-2019; H.Hsieh, Ming/B-2970-2010; Chiu, Ming-Jang/AAR-3940-2020	H.Hsieh, Ming/0000-0002-3585-7843; Chiu, Ming-Jang/0000-0002-4158-4423; HWU, HAI-GWO/0000-0002-2582-2807; Lin, Yi-Ting/0000-0003-3821-4744; Hwang, Tzung-Jeng/0000-0001-7894-9484; LIU, CHIH-MIN/0000-0001-7016-8990; Shan, Jia-Chi/0000-0002-2852-8224; LIU, CHEN-CHUNG/0000-0002-9290-110X; CHIEN, YI-LING/0000-0002-3477-3015	National Science Council, Taiwan [NSC-101-2314-B-002-137-, NSC-98-2314-B-002-047-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan (NSC-101-2314-B-002-137-, NSC-98-2314-B-002-047-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; ADLER LE, 1992, BIOL PSYCHIAT, V32, P607, DOI 10.1016/0006-3223(92)90073-9; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; Ancin I, 2010, ACTA PSYCHIAT SCAND, V122, P235, DOI 10.1111/j.1600-0447.2009.01532.x; Andreasen N C, 1990, Mod Probl Pharmacopsychiatry, V24, P73; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009; Boutros N, 2008, SCHIZOPHR RES, V103, P336, DOI 10.1016/j.schres.2008.02.017; Boutros NN, 2004, PSYCHIAT RES, V126, P203, DOI 10.1016/j.psychres.2004.01.007; Braff David L, 2005, Dialogues Clin Neurosci, V7, P125; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Brockhaus-Dumke A, 2008, BIOL PSYCHIAT, V64, P376, DOI 10.1016/j.biopsych.2008.02.006; Cabranes JA, 2012, EUR NEUROPSYCHOPHARM, V6, P6; Chang WP, 2011, PSYCHOPHYSIOLOGY, V48, P980, DOI 10.1111/j.1469-8986.2010.01168.x; Chen TF, 2009, HUM BRAIN MAPP, V30, P3826, DOI 10.1002/hbm.20810; Chen WJ, 1998, SCHIZOPHRENIA BULL, V24, P163, DOI 10.1093/oxfordjournals.schbul.a033308; Chen WJ, 1998, AM J PSYCHIAT, V155, P1214, DOI 10.1176/ajp.155.9.1214; Clementz BA, 1998, SCHIZOPHR RES, V30, P71, DOI 10.1016/S0920-9964(97)00122-9; Wilde OM, 2007, SCHIZOPHR RES, V97, P137, DOI 10.1016/j.schres.2007.04.028; de Wilde OM, 2007, SCHIZOPHRENIA BULL, V33, P1319, DOI 10.1093/schbul/sbm001; DELEON J, 1995, AM J PSYCHIAT, V152, P453; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; Doyle AE, 2009, PSYCHOL MED, V39, P1253, DOI 10.1017/S0033291708004832; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P49, DOI 10.1093/schbul/sbl055; Hashimoto T, 2008, PROG NEURO-PSYCHOPH, V32, P288, DOI 10.1016/j.pnpbp.2007.08.021; Heaton R.K., 1993, WISCONSIN CARD SORTI; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Holstein DH, 2012, PSYCHIAT RES; Johannesen JK, 2012, SCHIZOPHR B, V27, P27; Kalkstein S, 2010, CURR TOP BEHAV NEURO, V4, P373, DOI 10.1007/7854_2010_42; Light Gregory A, 2010, Curr Protoc Neurosci, VChapter 6, DOI 10.1002/0471142301.ns0625s52; Lijffijt M, 2009, J PSYCHOPHYSIOL, V23, P52, DOI 10.1027/0269-8803.23.2.52; Lin YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034454; Liu SK, 2002, AM J PSYCHIAT, V159, P975, DOI 10.1176/appi.ajp.159.6.975; Sanchez-Morla EM, 2013, SCHIZOPHR RES, V143, P102, DOI 10.1016/j.schres.2012.10.017; NAGAMOTO HT, 1989, BIOL PSYCHIAT, V25, P549, DOI 10.1016/0006-3223(89)90215-1; Niznikiewicz MA, 2004, SCHIZOPHRENIA NEUROI, P293; Olincy A, 2005, AM J PSYCHIAT, V162, P43, DOI 10.1176/appi.ajp.162.1.43; Pardo PJ, 2006, SCHIZOPHR RES, V87, P297, DOI 10.1016/j.schres.2006.05.007; Patterson JV, 2008, PSYCHIAT RES, V158, P226, DOI 10.1016/j.psychres.2007.02.009; Pineda D, 1998, INT J NEUROSCI, V96, P177, DOI 10.3109/00207459808986466; Potter D, 2006, SCHIZOPHRENIA BULL, V32, P692, DOI 10.1093/schbul/sbj050; Price GW, 2006, BIOL PSYCHIAT, V60, P1, DOI 10.1016/j.biopsych.2005.09.010; Reichenberg Abraham, 2010, Dialogues Clin Neurosci, V12, P383; Riccio CA, 2001, ANN NY ACAD SCI, V931, P113; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Sevik AE, 2011, SCHIZOPHR RES, V130, P195, DOI 10.1016/j.schres.2011.04.018; Shan JC, 2010, SCHIZOPHR RES, V122, P270, DOI 10.1016/j.schres.2010.05.026; SIEGEL C, 1984, ARCH GEN PSYCHIAT, V41, P607; Su L, 2012, PSYCHIAT DANUB, V24, P44; Thaker GK, 2008, SCHIZOPHRENIA BULL, V34, P760, DOI 10.1093/schbul/sbn049; Thomas C, 2010, NEUROBIOL AGING, V31, P416, DOI 10.1016/j.neurobiolaging.2008.05.002; Tsuchiya E, 2005, BRAIN DEV-JPN, V27, P233, DOI 10.1016/j.braindev.2004.06.008; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Uc EY, 2003, J NEUROL SCI, V212, P1, DOI 10.1016/S0022-510X(03)00082-0; WALDO MC, 1994, SCHIZOPHR RES, V12, P93, DOI 10.1016/0920-9964(94)90067-1; Weschler D., 2002, WAIS 3 CHINESE VERSI; Winterer G, 2010, CURR OPIN PSYCHIATR, V23, P112, DOI 10.1097/YCO.0b013e3283366643	60	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57197	10.1371/journal.pone.0057197	http://dx.doi.org/10.1371/journal.pone.0057197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460831	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000075
J	Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich, H; Eller, P; Pilger, E; Brodmann, M				Gary, Thomas; Pichler, Martin; Belaj, Klara; Hafner, Franz; Gerger, Armin; Froehlich, Harald; Eller, Philipp; Pilger, Ernst; Brodmann, Marianne			Neutrophil-to-Lymphocyte Ratio and Its Association with Critical Limb Ischemia in PAOD Patients	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; PREOPERATIVE NEUTROPHIL; LOWER-EXTREMITY; RESECTION	Background: The Neutrophil-to-Lymphocyte ratio (NLR) is an easy to perform test from the white blood cell count. An increase in NLR has been associated with vascular endpoints reflecting inflammation in atherosclerotic lesions. Atherosclerosis is a global threat and vascular endpoints, like myocardial infarction or critical limb ischemia (CLI), are a leading cause of death in industrialized countries. We therefore investigated NLR and its association with CLI and other vascular endpoints in peripheral arterial occlusive disease (PAOD) patients. Methods and Findings: We evaluated 2121 PAOD patients treated at our institution from 2005 to 2010. NLR was calculated and the cohort was divided into tertiles according to the NLR. An optimal cut-off value for the continuous NLR was calculated by applying a receiver operating curve analysis to discriminate between CLI and non-CLI. In our cohort occurrence of CLI significantly increased with an increase in NLR. As an optimal cut-off a NLR of 3.95 was identified. Two groups were categorized, one containing 1441 patients (NLR>3.95) and a second group with 680 patients (NLR. 3.95). CLI was more frequent in NLR. 3.95 patients (330(48.5%)) compared to NLR<3.95 patients (350(24.3%)) (p<0.001), as were prior myocardial infarction (48(7.0%) vs. 47(3.3%), p<0.001) and stroke (73(10.7) vs. 98(6.8%), p<0.001). Regarding other inflammatory parameters, C-reactive protein (median 5.6 mg/l (2.3-19.1) vs. median 3 mg/l (1.5-5.5)) and fibrinogen (median 412 mg/dl (345.5-507.5) vs. 344 mg/dl (308-403.5)) also significantly differed in the two patient groups (both p<0.001). A NLR>3.95 was associated with an OR of 2.5 (95% CI 2.3-2.7) for CLI even after adjustment for other vascular risk factors. Conclusions: An increased NLR is significantly associated with patients at high risk for CLI and other vascular endpoints. The NLR is an easy to perform test, which could be used to highlight patients at high risk for vascular endpoints.	[Gary, Thomas; Belaj, Klara; Hafner, Franz; Froehlich, Harald; Eller, Philipp; Pilger, Ernst; Brodmann, Marianne] Med Univ Graz, Dept Internal Med, Div Vasc Med, Graz, Austria; [Pichler, Martin; Gerger, Armin] Med Univ Graz, Div Oncol, Dept Internal Med, Graz, Austria	Medical University of Graz; Medical University of Graz	Gary, T (corresponding author), Med Univ Graz, Dept Internal Med, Div Vasc Med, Graz, Austria.	thomas.gary@medunigraz.at		Froehlich, Harald/0000-0003-4415-9809; Pichler, Martin/0000-0002-8701-9462				Aerden D, 2011, ANN VASC SURG, V25, P770, DOI 10.1016/j.avsg.2010.12.025; Bertele V, 1999, EUR J VASC ENDOVASC, V18, P401, DOI 10.1053/ejvs.1999.0934; Bertomeu V, 2008, EUR J VASC ENDOVASC, V36, P189, DOI 10.1016/j.ejvs.2008.02.004; Gary T, 2012, ATHEROSCLEROSIS, V225, P517, DOI 10.1016/j.atherosclerosis.2012.10.025; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Hartaigh BO, 2012, ATHEROSCLEROSIS, V224, P161, DOI 10.1016/j.atherosclerosis.2012.04.012; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; Iso Y, 2010, ATHEROSCLEROSIS, V209, P167, DOI 10.1016/j.atherosclerosis.2009.08.028; Jabre P, 2011, CIRCULATION, V123, P2094, DOI 10.1161/CIRCULATIONAHA.110.990192; Mohri Y, 2010, WORLD J SURG, V34, P285, DOI 10.1007/s00268-009-0302-1; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Novo S., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P219, DOI 10.2174/1568006043335989; Powell RJ, 2010, J VASC SURG, V52, P1525, DOI 10.1016/j.jvs.2010.07.044; Spark JI, 2010, J VASC SURG, V52, P632, DOI 10.1016/j.jvs.2010.03.067; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Turak O, 2012, AM J CARDIOL	18	53	56	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56745	10.1371/journal.pone.0056745	http://dx.doi.org/10.1371/journal.pone.0056745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457609	Green Submitted, gold, Green Published			2022-12-27	WOS:000315603700077
J	Niehorster, DC; Peli, E; Haun, A; Li, L				Niehorster, Diederick C.; Peli, Eli; Haun, Andrew; Li, Li			Influence of Hemianopic Visual Field Loss on Visual Motor Control	PLOS ONE			English	Article							LINE BISECTION; HOMONYMOUS HEMIANOPIA; DRIVING PERFORMANCE; STEERING CONTROL; ACTIVE CONTROL; NEGLECT; REHABILITATION; APHASIA; STRATEGIES; DISORDERS	Background: Homonymous hemianopia (HH) is an anisotropic visual impairment characterized by the binocular inability to see one side of the visual field. Patients with HH often misperceive visual space. Here we investigated how HH affects visual motor control. Methods and Findings: Seven patients with complete HH and no neglect or cognitive decline and seven gender-and age-matched controls viewed displays in which a target moved randomly along the horizontal or the vertical axis. They used a joystick to control the target movement to keep it at the center of the screen. We found that the mean deviation of the target position from the center of the screen along the horizontal axis was biased toward the blind side for five out of seven HH patients. More importantly, while the normal vision controls showed more precise control and larger response amplitudes when the target moved along the horizontal rather than the vertical axis, the control performance of the HH patients was not different between these two target motion experimental conditions. Conclusions: Compared with normal vision controls, HH affected patients' control performance when the target moved horizontally (i.e., along the axis of their visual impairment) rather than vertically. We conclude that hemianopia affects the use of visual information for online control of a moving target specific to the axis of visual impairment. The implications of the findings for driving in hemianopic patients are discussed.	[Niehorster, Diederick C.; Li, Li] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Peli, Eli; Haun, Andrew] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst,Dept Ophthalmol, Boston, MA USA	University of Hong Kong; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Niehorster, DC (corresponding author), Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China.	dcniehorster@hku.hk; lili@hku.hk	Niehorster, Diederick C/E-9325-2010; Haun, Andrew/I-4956-2012	Niehorster, Diederick C/0000-0002-4672-8756; Haun, Andrew/0000-0001-9458-8957; Peli, Eli/0000-0002-1340-9257	Research Grants Council of Hong Kong [HKU 7478/08H]; NIH [EY12890]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028122] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY012890, R01EY012890] Funding Source: NIH RePORTER	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by a grant from the Research Grants Council of Hong Kong (HKU 7478/08H) to L. Li, http://www.ugc.edu.hk, and a grant from the NIH (EY12890) to E. Peli, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RW, 1981, JPL P 17 ANN C MAN C; Andersen GJ, 2006, VIS COGN, V13, P119, DOI 10.1080/13506280500405675; Barton JJS, 1998, BRAIN, V121, P1117, DOI 10.1093/brain/121.6.1117; Barton JJS, 1998, J NEUROL NEUROSUR PS, V64, P660, DOI 10.1136/jnnp.64.5.660; Beall AC, 1996, PERCEPTION, V25, P481, DOI 10.1068/p250481; Bowers AR, 2010, INVEST OPHTH VIS SCI, V51, P6605, DOI 10.1167/iovs.10-5310; Bowers AR, 2009, INVEST OPHTH VIS SCI, V50, P5137, DOI 10.1167/iovs.09-3799; Bowers AR, 2010, AM AC OPT M 2010; Casson EJ, 2000, CAN J OPHTHALMOL, V35, P192, DOI 10.1016/S0008-4182(00)80030-7; Croquelois A, 2011, CEREBROVASC DIS, V31, P392, DOI 10.1159/000323217; Doricchi F, 2005, BRAIN, V128, P1386, DOI 10.1093/brain/awh461; Elgin J, 2010, AM J OCCUP THER, V64, P268, DOI 10.5014/ajot.64.2.268; Ferber S, 1999, J NEUROL NEUROSUR PS, V67, P572, DOI 10.1136/jnnp.67.5.572; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giorgi RG, 2009, OPTOMETRY VISION SCI, V86, P492, DOI 10.1097/OPX.0b013e31819f9e4d; Hildreth EC, 2000, J EXP PSYCHOL HUMAN, V26, P1106, DOI 10.1037//0096-1523.26.3.1106; Hillis AE, 2007, NEUROLOGY, V69, P200, DOI 10.1212/01.wnl.0000265600.69385.6f; International Council of Ophthalmology, 2006, VIS STAND VIS REQ DR; Jagacinski R.J., 2003, CONTROL THEORY HUMAN; Jex HR, 1974, AIAA LIF SCI SYST C; JONES RD, 1986, MED BIOL ENG COMPUT, V24, P536, DOI 10.1007/BF02443972; KERKHOFF G, 1992, RESTOR NEUROL NEUROS, V4, P245, DOI 10.3233/RNN-1992-4402; Kerkhoff G, 2009, NERVENARZT, V80, P1190, DOI 10.1007/s00115-009-2811-4; Kerkhoff G, 2008, CORTEX, V44, P200, DOI 10.1016/j.cortex.2006.07.002; Kerkhoff G, 2011, CORTEX, V47, P53, DOI 10.1016/j.cortex.2010.06.014; Kooijman A, 2004, VIS IMPAIR RES, V6, P1, DOI [10.1080/13882350390486965, DOI 10.1080/13882350390486965]; Krendel, 1959, J FRANKLIN I, V267, P381, DOI [10.1016/0016-0032(59)90091-2, DOI 10.1016/0016-0032(59)90091-2]; Kuhn C, 2010, NEUROPSYCHOLOGIA, V48, P3205, DOI 10.1016/j.neuropsychologia.2010.06.035; Li L, 2005, J NEUROPHYSIOL, V93, P2873, DOI 10.1152/jn.00200.2004; Li L, 2006, IEEE T SYST MAN CY A, V36, P1124, DOI 10.1109/TSMCA.2006.878951; Li L, 2010, J VISION, V10, DOI 10.1167/10.11.16; Li WO, 2009, J VISION, V9, DOI 10.1167/9.6.5; LYNN PA, 1979, MED BIOL ENG COMPUT, V17, P344, DOI 10.1007/BF02443821; LYNN PA, 1977, MED BIOL ENG COMPUT, V15, P184, DOI 10.1007/BF02442962; Mandel AJ, 2008, P 9 INT C LOW VIS NE; Mannan SK, 2010, J NEUROL, V257, P1812, DOI 10.1007/s00415-010-5615-3; McRuer D. T., 1965, AFFDLTR6515 WRIGHT P; MCRUER DT, 1977, HUM FACTORS, V19, P381, DOI 10.1177/001872087701900406; McRuer DT, 1974, AGARDAG188 GROUP AER; Michon J. A., 1985, HUMAN BEHAV TRAFFIC, P487; Miesner N., 2004, TOP GERIATR REHABIL, V20, P212, DOI DOI 10.1097/00013614-200407000-00009; Pambakian A, 2005, J NEURO-OPHTHALMOL, V25, P136; Peli E, 2000, OPTOMETRY VISION SCI, V77, P453, DOI 10.1097/00006324-200009000-00006; Peli E., 2002, DRIVING CONFIDENCE P; Peli E., 2008, ALBERT JOKOBIECS PRI, V4, P5369, DOI [10.1007/978-3-319-90495-5_245-1, DOI 10.1007/978-3-319-90495-5_245-1]; Racette L, 2005, OPTOMETRY VISION SCI, V82, P668, DOI 10.1097/01.opx.0000174719.25799.37; SCARPA M, 1987, CORTEX, V23, P331, DOI 10.1016/S0010-9452(87)80044-8; SCHENKENBERG T, 1980, NEUROLOGY, V30, P509, DOI 10.1212/WNL.30.5.509; Schofield TM, 2009, CURR OPIN NEUROL, V22, P36, DOI 10.1097/WCO.0b013e32831f1b2c; Schuett S, 2011, CORTEX, V47, P47, DOI 10.1016/j.cortex.2010.01.008; Silveira S, 2007, CLIN EXP OPHTHALMOL, V35, P612, DOI 10.1111/j.1442-9071.2007.01544.x; Stein AC, 1984, NASA AM RES CTR 20 A; STERZI R, 1993, J NEUROL NEUROSUR PS, V56, P308, DOI 10.1136/jnnp.56.3.308; STONE SP, 1993, AGE AGEING, V22, P46, DOI 10.1093/ageing/22.1.46; SZLYK JP, 1993, OPTOMETRY VISION SCI, V70, P1031, DOI 10.1097/00006324-199312000-00007; Tant MLM, 2002, NEUROPSYCHOL REHABIL, V12, P419, DOI 10.1080/09602010244000183; Trauzettel-Klosinski S, 1998, INVEST OPHTH VIS SCI, V39, P2177; Trauzettel-Klosinski S, 2008, ESSENT OPHTHALMOL, P301, DOI 10.1007/978-3-540-33679-2_17; Vallar G, 1997, PHILOS T ROY SOC B, V352, P1401, DOI 10.1098/rstb.1997.0126; Vanier M, 1990, NEUROPSYCHOLOGY, V4, P87, DOI 10.1037/0894-4105.4.2.87; Wood JM, 2009, INVEST OPHTH VIS SCI, V50, P577, DOI 10.1167/iovs.08-2506; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22; ZIHL J, 1995, NEUROPSYCHOLOGIA, V33, P287, DOI 10.1016/0028-3932(94)00119-A; Zihl J, 2000, REHABILIATION VISUAL	64	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56615	10.1371/journal.pone.0056615	http://dx.doi.org/10.1371/journal.pone.0056615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457594	Green Published, gold			2022-12-27	WOS:000315603700066
J	Rosenbluth, KH; Martin, AJ; Mittermeyer, S; Eschermann, J; Dickinson, PJ; Bankiewicz, KS				Rosenbluth, Kathryn H.; Martin, Alastair J.; Mittermeyer, Stephan; Eschermann, Jan; Dickinson, Peter J.; Bankiewicz, Krystof S.			Rapid Inverse Planning for Pressure-Driven Drug Infusions in the Brain	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; RECURRENT MALIGNANT GLIOMA; PRIMATE BRAIN; GENE-THERAPY; PARKINSON-DISEASE; NEUROTROPHIC FACTOR; PHASE-I; PLATFORM; TRIAL; ALGORITHM	Infusing drugs directly into the brain is advantageous to oral or intravenous delivery for large molecules or drugs requiring high local concentrations with low off-target exposure. However, surgeons manually planning the cannula position for drug delivery in the brain face a challenging three-dimensional visualization task. This study presents an intuitive inverse-planning technique to identify the optimal placement that maximizes coverage of the target structure while minimizing the potential for leakage outside the target. The technique was retrospectively validated using intraoperative magnetic resonance imaging of infusions into the striatum of non-human primates and into a tumor in a canine model and applied prospectively to upcoming human clinical trials.	[Rosenbluth, Kathryn H.; Bankiewicz, Krystof S.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Mittermeyer, Stephan; Eschermann, Jan] Brainlab, Feldkirchen, Bavaria, Germany; [Martin, Alastair J.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Dickinson, Peter J.] Univ Calif Davis, Dept Surg & Radiol Sci, Davis, CA 95616 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Rosenbluth, KH (corresponding author), Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA.	Kate.Rosenbluth@ucsf.edu	Dickinson, Peter/GPT-0703-2022	Martin, Alastair/0000-0002-7963-4000	National Institutes of Health [PO1 CA118816]; NATIONAL CANCER INSTITUTE [P01CA118816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health PO1 CA118816. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankiewicz KS, 2006, MOL THER, V14, P564, DOI 10.1016/j.ymthe.2006.05.005; Bankiewicz KS, 2000, EXP NEUROL, V164, P2, DOI 10.1006/exnr.2000.7408; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Daadi MM, 2006, NEUROREPORT, V17, P201, DOI 10.1097/01.wnr.0000198952.38563.05; Dickinson PJ, 2008, J NEUROSURG, V108, P989, DOI 10.3171/JNS/2008/108/5/0989; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Fiandaca MS, 2008, NEUROTHERAPEUTICS, V5, P123, DOI 10.1016/j.nurt.2007.10.064; Fiandaca MS, 2011, TOXINS, V3, P369, DOI 10.3390/toxins3040369; Krauze MT, 2007, NEURO-ONCOLOGY, V9, P393, DOI 10.1215/15228517-2007-019; Krauze MT, 2005, BRAIN RES PROTOC, V16, P20, DOI 10.1016/j.brainresprot.2005.08.003; Krauze MT, 2005, J NEUROSURG, V103, P923, DOI 10.3171/jns.2005.103.5.0923; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Lidar Z, 2004, J NEUROSURG, V100, P472, DOI 10.3171/jns.2004.100.3.0472; Lonser RR, 2002, J NEUROSURG, V97, P905, DOI 10.3171/jns.2002.97.4.0905; Marks WJ, 2009, PHASE 1 2 TRIAL ASSE; Morrison PF, 2007, J NEUROSURG, V107, P74, DOI 10.3171/JNS-07/07/0074; Noble CO, 2006, CANCER RES, V66, P2801, DOI 10.1158/0008-5472.CAN-05-3535; Ostertag D, 2012, NEURO-ONCOLOGY, V14, P145, DOI 10.1093/neuonc/nor199; Richardson RM, 2011, MOL THER, V19, P1048, DOI 10.1038/mt.2011.11; Richardson RM, 2011, STEREOT FUNCT NEUROS, V89, P141, DOI 10.1159/000323544; Rosenbluth KH, 2011, J NEUROSCI METH, V196, P118, DOI 10.1016/j.jneumeth.2010.12.022; Rosenbluth KH, 2012, NEUROIMAGE, V59, P2423, DOI 10.1016/j.neuroimage.2011.08.107; Saito R, 2005, EXP NEUROL, V196, P381, DOI 10.1016/j.expneurol.2005.08.016; Salegio EA, 2010, HUM GENE THER, V21, P1093, DOI 10.1089/hum.2010.040; Salegio EA, 2012, HUM GENE THER; SAMPSON JH, 2009, J NEUROSURG; Sampson JH, 2007, NEURO-ONCOLOGY, V9, P343, DOI 10.1215/15228517-2007-007; San Sebastian W, 2012, HUM GENE THER, V23, P210, DOI 10.1089/hum.2011.162; Smith Y, 2008, MOVEMENT DISORD, V23, pS534, DOI 10.1002/mds.22027; Su XM, 2009, HUM GENE THER, V20, P1627, DOI 10.1089/hum.2009.103; Tai CK, 2005, MOL THER, V12, P842, DOI 10.1016/j.ymthe.2005.03.017; Valles F, 2010, NEUROSURGERY, V67, P1377, DOI 10.1227/NEU.0b013e3181f53a5c; Villard Caroline, 2005, Computer Methods in Biomechanics and Biomedical Engineering, V8, P215, DOI 10.1080/10255840500289988; Yin D., 2009, NEUROIMAGE; Yin DL, 2010, J NEUROSURG, V113, P240, DOI 10.3171/2010.2.JNS091744; Yin DL, 2011, NEUROIMAGE, V54, pS196, DOI 10.1016/j.neuroimage.2009.08.069	37	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56397	10.1371/journal.pone.0056397	http://dx.doi.org/10.1371/journal.pone.0056397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457563	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700050
J	Sander, PR; Peer, M; Grandl, M; Bogdahn, U; Schmitz, G; Kalbitzer, HR				Sander, Paul Ramm; Peer, Markus; Grandl, Margot; Bogdahn, Ulrich; Schmitz, Gerd; Kalbitzer, Hans Robert			NMR Spectroscopy of Macrophages Loaded with Native, Oxidized or Enzymatically Degraded Lipoproteins	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HIGH-THROUGHPUT QUANTIFICATION; H-1-NMR VISIBLE LIPIDS; SPECTROMETRY ESI-MS/MS; IN-VIVO; MOBILE LIPIDS; GENE-THERAPY; RAT-BRAIN; CHOLESTERYL ESTER; MODIFIED LDL	Oxidized and enzymatically modified low-density lipoproteins (oxLDL and eLDL) play a key role in early stages of atherogenesis. Their uptake by recruited macrophages leads to endolysosomal phospholipidosis or foam cell formation, respectively, each of which is preceded by highly differential lipid restructuring processes. We applied H-1-NMR spectroscopy (NMRS) to elucidate these structural rearrangements both in consequence of lipoprotein modifications and following phagocytosis. Being specifically sensitive to the mobile lipid subset, NMRS of oxLDL and eLDL revealed a partial and total immobilization of lipids, respectively. NMRS of intact macrophages showed a sixfold increase in mobile lipids in case of loading with eLDL but no significant changes for oxLDL or native LDL. This finding reflected the disparate lipid storage in lipid droplets and in multilamellar endolysosomal clusters when loaded with either eLDL or oxLDL, respectively. Moreover, a significant shift of the degree of saturation towards mainly polyunsaturated fatty acid chains was found for the mobile lipid pool in eLDL-loaded macrophages. Additional analyses of lipid extracts by NMRS and mass spectrometry (MS) reflected these changes in lipid content and in fatty acid composition only partially. In summary, in-cell NMRS represents a unique lipidomics tool to investigate structural changes within the mobile lipid pool following atherogenic triggers that can be not detected by the analysis of lipid extracts by MS or NMRS.	[Sander, Paul Ramm; Kalbitzer, Hans Robert] Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Sander, Paul Ramm; Bogdahn, Ulrich; Kalbitzer, Hans Robert] CMRCB, Regensburg, Germany; [Sander, Paul Ramm; Bogdahn, Ulrich] Univ Regensburg, Dept Neurol, D-93053 Regensburg, Germany; [Peer, Markus; Grandl, Margot; Schmitz, Gerd] Univ Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Kalbitzer, HR (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, Univ Str 31, D-93053 Regensburg, Germany.	Hans-Robert.Kalbitzer@biologie.uni-regensburg.de		Kalbitzer, Hans Robert/0000-0002-6514-2355; Schmitz, Gerd/0000-0002-1325-1007	Fonds of the Chemical Industry (FCI); European Community's Seventh Framework Programme (FP7) [202272]; IP-Project LipidomicNet; BMBF network project "Systems Biology Consortium on Metabotypes (SysMBo)"	Fonds of the Chemical Industry (FCI)(Fonds der Chemischen Industrie); European Community's Seventh Framework Programme (FP7); IP-Project LipidomicNet; BMBF network project "Systems Biology Consortium on Metabotypes (SysMBo)"	This work was supported by the Fonds of the Chemical Industry (FCI) and by funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 202272, IP-Project LipidomicNet and the BMBF network project "Systems Biology Consortium on Metabotypes (SysMBo)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Korpela M, 1998, J LIPID RES, V39, P1705; ALAKORPELA M, 1995, CHEM PHYS LETT, V242, P95, DOI 10.1016/0009-2614(95)00707-B; ALAKORPELA M, 1994, J LIPID RES, V35, P2292; Aranibar N, 2006, ANAL BIOCHEM, V355, P62, DOI 10.1016/j.ab.2006.04.014; BARENGHI L, 1990, FREE RADICAL RES COM, V8, P175, DOI 10.3109/10715769009087991; BEHAR KL, 1994, MAGNET RESON MED, V32, P294, DOI 10.1002/mrm.1910320304; BEHAR KL, 1991, MAGNET RESON MED, V17, P285, DOI 10.1002/mrm.1910170202; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; CHAO FF, 1992, J BIOL CHEM, V267, P4992; Cooper WA, 2001, MAGNET RESON MED, V45, P1001, DOI 10.1002/mrm.1133; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Grandl M, 2006, CYTOM PART A, V69A, P189, DOI 10.1002/cyto.a.20232; Griffin JL, 2003, CANCER RES, V63, P3195; Hakumaki JM, 1999, NAT MED, V5, P1323, DOI 10.1038/15279; Hakumaki JM, 2000, TRENDS BIOCHEM SCI, V25, P357, DOI 10.1016/S0968-0004(00)01614-5; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Iorio E, 2003, BBA-MOL CELL BIOL L, V1634, P1, DOI 10.1016/j.bbalip.2003.07.001; Kapinsky M, 2001, ARTERIOSCL THROM VAS, V21, P1004, DOI 10.1161/01.ATV.21.6.1004; KAUPPINEN RA, 1993, NMR BIOMED, V6, P242, DOI 10.1002/nbm.1940060403; King N J, 1994, Immunomethods, V4, P188, DOI 10.1006/immu.1994.1019; Kumar V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018841; Le Moyec L, 2000, ANTICANCER RES, V20, P4513; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liimatainen T, 2009, NMR BIOMED, V22, P272, DOI 10.1002/nbm.1320; LINDGREN FT, 1975, LIPIDS, V10, P750, DOI 10.1007/BF02532316; LODGE JK, 1995, BBA-LIPID LIPID MET, V1256, P130, DOI 10.1016/0005-2760(94)00253-U; Loewenbruck KF, 2011, REJUV RES, V14, P371, DOI 10.1089/rej.2010.1102; Mallol R, 2012, ANAL BIOANAL CHEM, V402, P2407, DOI 10.1007/s00216-011-5705-9; Mlynarik V, 2008, J MAGN RESON, V194, P163, DOI 10.1016/j.jmr.2008.06.019; Orso E, 2011, CHEM PHYS LIPIDS, V164, P479, DOI 10.1016/j.chemphyslip.2011.06.001; OTVOS JD, 1992, CLIN CHEM, V38, P1632; Postle AD, 2012, CURR OPIN CLIN NUTR, V15, P127, DOI 10.1097/MCO.0b013e32834fb003; Quintero M, 2007, BBA-MOL CELL BIOL L, V1771, P31, DOI 10.1016/j.bbalip.2006.10.003; Ramm P, 2011, STEM CELLS DEV; Ramm P, 2009, STEM CELLS, V27, P420, DOI 10.1634/stemcells.2008-0816; Remy C, 1997, CANCER RES, V57, P407; Scherer M, 2010, J LIPID RES, V51, P2001, DOI 10.1194/jlr.D005322; Schmitz G, 2009, BBA-MOL CELL BIOL L, V1791, P524, DOI 10.1016/j.bbalip.2008.12.007; Soininen P, 2007, BIOCHEM BIOPH RES CO, V360, P290, DOI 10.1016/j.bbrc.2007.06.058; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Tkac I, 2009, MAGN RESON MED, V62, P868, DOI 10.1002/mrm.22086; Torzewski M, 1998, ARTERIOSCL THROM VAS, V18, P369, DOI 10.1161/01.ATV.18.3.369; Tukiainen T, 2008, BIOCHEM BIOPH RES CO, V375, P356, DOI 10.1016/j.bbrc.2008.08.007; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Zoula S, 2003, NMR BIOMED, V16, P199, DOI 10.1002/nbm.831	48	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56360	10.1371/journal.pone.0056360	http://dx.doi.org/10.1371/journal.pone.0056360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457556	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700044
J	Sharma, S; Joshi, G; Dash, PK; Thomas, M; Athmaram, TN; Kumar, JS; Desai, A; Vasanthapuram, R; Patro, IK; Rao, PVL; Parida, M				Sharma, Shashi; Joshi, Gaurav; Dash, Paban K.; Thomas, Maria; Athmaram, Thimmasandra N.; Kumar, Jyoti S.; Desai, Anita; Vasanthapuram, Ravi; Patro, Ishan K.; Rao, Putcha V. L.; Parida, Manmohan			Molecular Epidemiology and Complete Genome Characterization of H1N1pdm Virus from India	PLOS ONE			English	Article							INFLUENZA-A H1N1; EMERGENCE	Background: Influenza A virus is one of world's major uncontrolled pathogen, causing seasonal epidemic as well as global pandemic. This was evidenced by recent emergence and continued prevalent 2009 swine origin pandemic H1N1 Influenza A virus, provoking first true pandemic in the past 40 years. In the course of its evolution, the virus acquired many mutations and multiple unidentified molecular determinants are likely responsible for the ability of the 2009 H1N1 virus to cause increased disease severity in humans. Availability of limited data on complete genome hampers the continuous monitoring of this type of events. Outbreaks with considerable morbidity and mortality have been reported from all parts of the country. Methods/Results: Considering a large number of clinical cases of infection complete genome based sequence characterization of Indian H1N1pdm virus and their phylogenetic analysis with respect to circulating global viruses was undertaken, to reveal the phylodynamic pattern of H1N1pdm virus in India from 2009-2011. The Clade VII was observed as a major circulating clade in phylogenetic analysis. Selection pressure analysis revealed 18 positively selected sites in major surface proteins of H1N1pdm virus. Conclusions: This study clearly revealed that clade VII has been identified as recent circulating clade in India as well globally. Few clade VII specific well identified markers undergone positive selection during virus evolution. Continuous monitoring of the H1N1pdm virus is warranted to track of the virus evolution and further transmission. This study will serve as a baseline data for future surveillance and also for development of suitable therapeutics.	[Sharma, Shashi; Joshi, Gaurav; Dash, Paban K.; Athmaram, Thimmasandra N.; Kumar, Jyoti S.; Rao, Putcha V. L.; Parida, Manmohan] DRDE, Div Virol, Gwalior, India; [Thomas, Maria; Desai, Anita; Vasanthapuram, Ravi] NIMHANS, Dept Neurovirol, Bangalore, Karnataka, India; [Patro, Ishan K.] Jiwaji Univ, Sch Studies Neurosci, Gwalior, India	Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE); National Institute of Mental Health & Neurosciences - India; Jiwaji University Gwalior	Parida, M (corresponding author), DRDE, Div Virol, Gwalior, India.	paridamm@rediffmail.com	Vasanthapuram, Ravi/AAD-5555-2019; Dash, Paban K/E-9935-2013; JOSHI, GAURAV/E-9634-2013	Dash, Paban K/0000-0003-4322-2044; Dash, Pramod/0000-0001-6746-1002; JOSHI, GAURAV/0000-0002-5028-4350	Defence Research and Development Establishment (DRDE), Gwalior an Institute under ministry of defence, Government of India	Defence Research and Development Establishment (DRDE), Gwalior an Institute under ministry of defence, Government of India	This work was funded by Defence Research and Development Establishment (DRDE), Gwalior an Institute under ministry of defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookes SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009068; Broor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029129; CDC, 2009, CDC PROT REAL TIM RT; Chakrabarti AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007846; Chen GW, 2009, EMERG INFECT DIS, V15, P1897, DOI 10.3201/eid1512.090845; Choudhry A, 2012, INDIAN J MED RES, V135, P534; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hoskins JM, 1976, VIROLOGICAL PROCEDUR, P184; Li W, 2011, VIROL J, V8, P183; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rana Himanshu, 2012, J Assoc Physicians India, V60, P95; Rao SRJ, 2011, INDIAN J PATHOL MICR, V54, P323, DOI [10.4103/0377-4929.81588, 10.4103/0377-4929.81618]; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schrauwen EJA, 2011, EMERG INFECT DIS, V17, P200, DOI 10.3201/eid1702.101268; Sharma S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-280; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; World Health Organization, 2009, HUM INF PAND H1N1 20; York I, 2012, CURR TOP MICROBIOL I	28	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56364	10.1371/journal.pone.0056364	http://dx.doi.org/10.1371/journal.pone.0056364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457559	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700047
J	Bissig, D; Goebel, D; Berkowitz, BA				Bissig, David; Goebel, Dennis; Berkowitz, Bruce A.			Diminished Vision in Healthy Aging Is Associated with Increased Retinal L-Type Voltage Gated Calcium Channel Ion Influx	PLOS ONE			English	Article							MANGANESE-ENHANCED MRI; HIPPOCAMPAL CA1 NEURONS; RESONANCE-IMAGING MEMRI; GANGLION-CELL LAYER; CONTRAST SENSITIVITY; RAT RETINA; EXPERIMENTAL RETINOPATHY; DEPENDENT CALCIUM; RODENT RETINA; CA2+ CURRENTS	Extensive evidence implicates an increase in hippocampal L-type voltage-gated calcium channel (L-VGCC) expression, and ion influx through these channels, in age-related cognitive declines. Here, we ask if this "calcium hypothesis" applies to the neuroretina: Is increased influx via L-VGCCs related to the well-documented but poorly-understood vision declines in healthy aging? In Long-Evans rats we find a significant age-related increase in ion flux through retinal L-VGCCs in vivo (manganese-enhanced MRI (MEMRI)) that are longitudinally linked with progressive vision declines (optokinetic tracking). Importantly, the degree of retinal Mn2+ uptake early in adulthood significantly predicted later visual contrast sensitivity declines. Furthermore, as in the aging hippocampus, retinal expression of a drug-insensitive L-VGCC isoform (alpha(1D)) increased - a pattern confirmed in vivo by an age-related decline in sensitivity to L-VGCC blockade. These data highlight mechanistic similarities between retinal and hippocampal aging, and raise the possibility of new treatment targets for minimizing vision loss during healthy aging.	[Bissig, David; Goebel, Dennis; Berkowitz, Bruce A.] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48202 USA; [Berkowitz, Bruce A.] Wayne State Univ, Dept Ophthalmol, Detroit, MI USA	Wayne State University; Wayne State University	Berkowitz, BA (corresponding author), Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48202 USA.	baberko@med.wayne.edu		Bissig, David/0000-0001-9664-5433	National Institutes of Health (NIH) [EY018109]; Juvenile Diabetes Research Foundation [NIH AG034752]; Wayne State University School of Medicine MD/PhD program; Research to Prevent Blindness (Kresge Eye Institute); NATIONAL EYE INSTITUTE [R21EY018109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG034752] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Wayne State University School of Medicine MD/PhD program; Research to Prevent Blindness (Kresge Eye Institute)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (NIH) EY018109 (BAB), Juvenile Diabetes Research Foundation (BAB), NIH AG034752 (DB), Wayne State University School of Medicine MD/PhD program (DB), and an unrestricted grant from Research to Prevent Blindness (Kresge Eye Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens E, 2005, TOXICOL IN VITRO, V19, P79, DOI 10.1016/j.tiv.2004.06.004; Alamouti B, 2003, BRIT J OPHTHALMOL, V87, P899, DOI 10.1136/bjo.87.7.899; BARRETT RJ, 1988, J PHARM PHARMACOL, V40, P408, DOI 10.1111/j.2042-7158.1988.tb06305.x; Berkowitz BA, 2007, INVEST OPHTH VIS SCI, V48, P4733, DOI 10.1167/iovs.06-1516; Berkowitz BA, 2007, INVEST OPHTH VIS SCI, V48, P3796, DOI 10.1167/iovs.06-1278; Berkowitz BA, 2006, INVEST OPHTH VIS SCI, V47, P2668, DOI 10.1167/iovs.05-1588; Berkowitz BA, 2011, MOL VIS, V17, P2516; Birch DG, 2002, ARCH OPHTHALMOL-CHIC, V120, P1045; Bissig D, 2011, NEUROIMAGE, V58, P749, DOI 10.1016/j.neuroimage.2011.06.062; Boehm AG, 2003, GRAEF ARCH CLIN EXP, V241, P34, DOI 10.1007/s00417-002-0592-6; BOSE S, 1995, OPHTHALMOLOGY, V102, P1236, DOI 10.1016/S0161-6420(95)30884-6; BRETON ME, 1994, INVEST OPHTH VIS SCI, V35, P295; CARLSON RO, 1994, J NEUROSCI, V14, P2272; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Charng J, 2011, INVEST OPHTH VIS SCI, V52, P8891, DOI 10.1167/iovs.11-7602; Chuang KH, 2009, MAGN RESON MED, V61, P1528, DOI 10.1002/mrm.21962; Chui TYP, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/956705; Cross DJ, 2007, AM J NEURORADIOL, V28, P1865, DOI 10.3174/ajnr.A0693; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; Eschenko O, 2010, MAGN RESON IMAGING, V28, P1165, DOI 10.1016/j.mri.2009.12.022; Feng LX, 2007, VISUAL NEUROSCI, V24, P799, DOI 10.1017/S0952523807070721; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GLOSSMANN H, 1983, FEBS LETT, V160, P226, DOI 10.1016/0014-5793(83)80972-7; GONZALEZ GG, 1993, INVEST OPHTH VIS SCI, V34, P3329; Hariri S, 2009, OPT EXPRESS, V17, P24304, DOI 10.1364/OE.17.024304; Harman A, 2000, ANAT REC, V260, P124; Harman AM, 2003, GERONTOLOGY, V49, P350, DOI 10.1159/000073762; Hasegawa AE, 1997, ANESTH ANALG, V85, P633, DOI 10.1097/00000539-199709000-00026; HENKEL AW, 1994, ANAL BIOCHEM, V223, P329, DOI 10.1006/abio.1994.1595; Jackson SJ, 2011, BEHAV BRAIN RES, V216, P293, DOI 10.1016/j.bbr.2010.08.007; KAGEYAMA M, 1995, J OCUL PHARMACOL TH, V11, P553, DOI 10.1089/jop.1995.11.553; Kang S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2149; Karst H, 1997, SYNAPSE, V26, P155; KATZ ML, 1986, EXP EYE RES, V42, P293, DOI 10.1016/0014-4835(86)90022-9; KOCH KW, 1985, J BIOL CHEM, V260, P6788; Kolesnikov AV, 2010, J NEUROSCI, V30, P11222, DOI 10.1523/JNEUROSCI.4239-09.2010; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; LINDNER MD, 1991, BEHAV BRAIN RES, V45, P45, DOI 10.1016/S0166-4328(05)80179-2; Melena J, 2001, EXP EYE RES, V72, P393, DOI 10.1006/exer.2000.0968; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; Norris CM, 1998, J NEUROSCI, V18, P3171; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Protti DA, 1998, J NEUROSCI, V18, P3715; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Qu YX, 2011, PEDIATR RES, V69, P479, DOI 10.1203/PDR.0b013e318217a0df; Rubin GS, 1997, INVEST OPHTH VIS SCI, V38, P557; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; Shah GM, 1995, ANAL BIOCHEM, V232, P251, DOI 10.1006/abio.1995.0016; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; SPEAR PD, 1993, VISION RES, V33, P2589, DOI 10.1016/0042-6989(93)90218-L; Srinivasan VJ, 2006, OPT LETT, V31, P2308, DOI 10.1364/OL.31.002308; Srinivasan VJ, 2006, INVEST OPHTH VIS SCI, V47, P5522, DOI 10.1167/iovs.06-0195; Tarabova B, 2007, EUR J PHARMACOL, V573, P39, DOI 10.1016/j.ejphar.2007.06.050; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thibault O, 2001, J NEUROSCI, V21, P9744, DOI 10.1523/JNEUROSCI.21-24-09744.2001; Tofts PS, 2010, BRAIN RES BULL, V81, P333, DOI 10.1016/j.brainresbull.2009.06.002; Tombaugh GC, 2005, J NEUROSCI, V25, P2609, DOI 10.1523/JNEUROSCI.5023-04.2005; van Alphen B, 2009, INVEST OPHTH VIS SCI, V50, P2451, DOI 10.1167/iovs.08-2594; Veng LM, 2003, MOL BRAIN RES, V110, P193, DOI 10.1016/S0169-328X(02)00643-5; Veng LM, 2002, MOL BRAIN RES, V107, P120, DOI 10.1016/S0169-328X(02)00453-9; VINORES SA, 1990, J HISTOCHEM CYTOCHEM, V38, P1341, DOI 10.1177/38.9.2117624; Xu HP, 2002, NEUROSCI LETT, V329, P297, DOI 10.1016/S0304-3940(02)00688-2; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9	67	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56340	10.1371/journal.pone.0056340	http://dx.doi.org/10.1371/journal.pone.0056340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457553	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700069
J	de Bruyn, JR; Goiko, M; Mozaffari, M; Bator, D; Dauphinee, RL; Liao, YY; Flemming, RL; Bramble, MS; Hunter, GK; Goldberg, HA				de Bruyn, John R.; Goiko, Maria; Mozaffari, Maryam; Bator, Daniel; Dauphinee, Ron L.; Liao, Yinyin; Flemming, Roberta L.; Bramble, Michael S.; Hunter, Graeme K.; Goldberg, Harvey A.			Dynamic Light Scattering Study of Inhibition of Nucleation and Growth of Hydroxyapatite Crystals by Osteopontin	PLOS ONE			English	Article							BINDING-PROPERTIES; BONE SIALOPROTEIN; CALCIUM-PHOSPHATE; IN-VITRO; PHOSPHORYLATION; CRYSTALLIZATION; PROTEINS; CALCIFICATION; KINETICS	We study the effect of isoforms of osteopontin (OPN) on the nucleation and growth of crystals from a supersaturated solution of calcium and phosphate ions. Dynamic light scattering is used to monitor the size of the precipitating particles and to provide information about their concentration. At the ion concentrations studied, immediate precipitation was observed in control experiments with no osteopontin in the solution, and the size of the precipitating particles increased steadily with time. The precipitate was identified as hydroxyapatite by X-ray diffraction. Addition of native osteopontin (nOPN) extracted from rat bone caused a delay in the onset of precipitation and reduced the number of particles that formed, but the few particles that did form grew to a larger size than in the absence of the protein. Recombinant osteopontin (rOPN), which lacks phosphorylation, caused no delay in initial calcium phosphate precipitation but severely slowed crystal growth, suggesting that rOPN inhibits growth but not nucleation. rOPN treated with protein kinase CK2 to phosphorylate the molecule (p-rOPN) produced an effect similar to that of nOPN, but at higher protein concentrations and to a lesser extent. These results suggest that phosphorylations are critical to OPN's ability to inhibit nucleation, whereas the growth of the hydroxyapatite crystals is effectively controlled by the highly acidic OPN polypeptide. This work also demonstrates that dynamic light scattering can be a powerful tool for delineating the mechanism of protein modulation of mineral formation.	[de Bruyn, John R.; Goiko, Maria; Mozaffari, Maryam; Dauphinee, Ron L.] Univ Western Ontario, Dept Phys & Astron, London, ON, Canada; [Bator, Daniel; Hunter, Graeme K.] Univ Western Ontario, Dept Chem, London, ON, Canada; [Liao, Yinyin; Hunter, Graeme K.; Goldberg, Harvey A.] Univ Western Ontario, Sch Dent, London, ON, Canada; [Liao, Yinyin; Hunter, Graeme K.; Goldberg, Harvey A.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Flemming, Roberta L.; Bramble, Michael S.] Univ Western Ontario, Dept Earth Sci, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	de Bruyn, JR (corresponding author), Univ Western Ontario, Dept Phys & Astron, London, ON, Canada.	debruyn@uwo.ca	Goldberg, Harvey/B-5742-2015	Bramble, Michael/0000-0002-9440-4756	Canadian Institutes of Health Research; Natural Science and Engineering Research Council of Canada; Academic Development Fund of the University of Western Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Academic Development Fund of the University of Western Ontario	This research was supported by the Canadian Institutes of Health Research, the Natural Science and Engineering Research Council of Canada, and the Academic Development Fund of the University of Western Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2001, Z Kardiol, V90 Suppl 3, P92; Azzopardi PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009330; Baht GS, 2010, BIOCHEM J, V428, P385, DOI 10.1042/BJ20091864; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; BOSKEY AL, 1992, CLIN ORTHOP RELAT R, P244; BUTLER WT, 1995, ANN NY ACAD SCI, V760, P6, DOI 10.1111/j.1749-6632.1995.tb44615.x; CHEN Y, 1992, J BIOL CHEM, V267, P24871; De Yoreo JJ, 2004, SCIENCE, V306, P1301, DOI 10.1126/science.1100889; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Flemming RL, 2007, CAN J EARTH SCI, V44, P1333, DOI 10.1139/e07-020; Frisken BJ, 2001, APPL OPTICS, V40, P4087, DOI 10.1364/AO.40.004087; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; Giachelli C M, 2005, Orthod Craniofac Res, V8, P229, DOI 10.1111/j.1601-6343.2005.00345.x; Grohe B, 2007, J AM CHEM SOC, V129, P14946, DOI 10.1021/ja0745613; Grohe B, 2009, LANGMUIR, V25, P11635, DOI 10.1021/la901145d; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Hincke M.T., 2000, CHEM BIOL MINERALIZE, P13; Hoyer JR, 2001, KIDNEY INT, V60, P77, DOI 10.1046/j.1523-1755.2001.00772.x; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; Kamiya N, 2011, B CHEM SOC JPN, V84, P344, DOI 10.1246/bcsj.20100228; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; Li SY, 2012, CRYSTENGCOMM, V14, P8037, DOI 10.1039/c2ce26140e; Lowenstam HA, 1989, BIOMINERALIZATION; Mann S., 2001, BIOMINERALIZATION PR; NANCOLLAS GH, 1970, ARCH ORAL BIOL, V15, P731, DOI 10.1016/0003-9969(70)90037-3; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Onuma K, 2000, J PHYS CHEM B, V104, P10563, DOI 10.1021/jp002697g; Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c; Oyane A, 1999, J PHYS CHEM B, V103, P8230, DOI 10.1021/jp9910340; Pampena DA, 2004, BIOCHEM J, V378, P1083, DOI 10.1042/BJ20031150; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; QI Z, 1990, J BIOL CHEM, V265, P7583; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; SINGH K, 1993, J BIOCHEM-TOKYO, V114, P702, DOI 10.1093/oxfordjournals.jbchem.a124240; TOMSON MB, 1978, SCIENCE, V200, P1059, DOI 10.1126/science.200.4345.1059; Wang LJ, 2008, J PHYS CHEM B, V112, P9151, DOI 10.1021/jp804282u; Xu R, 2000, PARTICLE CHARACTERIZ	40	35	36	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56764	10.1371/journal.pone.0056764	http://dx.doi.org/10.1371/journal.pone.0056764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457612	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700092
J	Hofkens, W; Schelbergen, R; Storm, G; van den Berg, WB; van Lent, PL				Hofkens, Wouter; Schelbergen, Rik; Storm, Gert; van den Berg, Wim B.; van Lent, Peter L.			Liposomal Targeting of Prednisolone Phosphate to Synovial Lining Macrophages during Experimental Arthritis Inhibits M1 Activation but Does Not Favor M2 Differentiation	PLOS ONE			English	Article							IMMUNE-COMPLEX ARTHRITIS; NITRIC-OXIDE SYNTHASE; JOINT INFLAMMATION; HUMAN MONOCYTES; GLUCOCORTICOIDS INDUCE; CARTILAGE DESTRUCTION; RHEUMATOID-ARTHRITIS; CHONDROCYTE DEATH; II ARTHRITIS; CELLS	Background: To determine the effects of liposomal targeting of prednisolone phosphate (Lip-PLP) to synovial lining macrophages on M1 and M2 polarization in vitro and during experimental arthritis. Material and Methods: Experimental arthritis (antigen and immune complex induced) was elicited in mice and prednisolone containing liposomes were given systemically. Synovium was investigated using microarray analysis, RT-PCR and histology. Bone-marrow macrophages were stimulated towards M1 using LPS and IFN gamma before treatment by PLP-liposomes. M1 and M2 markers were determined using RT-PCR. Results: Microarray analysis of biopsies of inflamed synovium during antigen induced arthritis (AIA) showed an increased M1 signature characterized by upregulation of IL-1 beta, IL-6 and Fc gamma RI starting from day 1 and lasting up until day 7 after arthritis induction. The M2 signature remained low throughout the 7 day course of arthritis. Treatment of AIA with intravenously delivered Lip-PLP strongly suppressed joint swelling and synovial infiltration whereas colloidal gold containing liposomes exclusively targeted the macrophages within the inflamed synovial intima layer. In vitro studies showed that Lip-PLP phagocytosed by M1 macrophages resulted in a suppression of the M1 phenotype and induction of M2 markers (IL-10, TGF-beta, IL-1RII, CD163, CD206 and Ym1). In vivo, Lip-PLP treatment strongly suppressed M1 markers (TNF-alpha, IL-1 beta, IL-6, IL-12p40, iNOS, Fc gamma RI, Ciita and CD86) after local M1 activation of lining macrophages with LPS and IFN-gamma and during experimental AIA and immune complex arthritis (ICA). In contrast, M2 markers were not significantly upregulated in antigen-induced arthritis and down regulated in immune complex arthritis. Conclusion: This study clearly shows that systemic treatment with PLP-liposomes selectively targets synovial lining macrophages and inhibits M1 activation. In contrast to in vitro findings, PLP-liposomes do not cause a shift of synovial lining macrophages towards M2.	[Hofkens, Wouter; Schelbergen, Rik; van den Berg, Wim B.; van Lent, Peter L.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Storm, Gert] Univ Utrecht, Dept Pharmaceut, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Radboud University Nijmegen; Utrecht University	van Lent, PL (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands.	p.vanlent@reuma.umcn.nl	van den Berg, W.B./H-8010-2014; van Lent, Peter/A-4047-2014; van Lent, Peter/A-4269-2014; Storm, Gerrit/O-8696-2016		Dutch Technology Foundation STW	Dutch Technology Foundation STW(Technologiestichting STW)	This study was supported by a research grant from the Dutch Technology Foundation STW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Cai YP, 2009, J IMMUNOL, V182, P5393, DOI 10.4049/jimmunol.0803874; DIROSA M, 1986, AGENTS ACTIONS, V17, P284; Drexler SK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2481; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Frankenberger M, 2005, INT IMMUNOPHARMACOL, V5, P289, DOI 10.1016/j.intimp.2004.09.033; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; Hofkens W, 2011, INT J PHARM; Hofkens W, 2011, J CONTROL RELEASE; JACOBS MJM, 1994, IMMUNOLOGY, V83, P390; Joosten LAB, 1999, INFLAMM RES, V48, P48, DOI 10.1007/s000110050396; Khanduja KL, 2011, MOL CELL BIOCHEM, V346, P31, DOI 10.1007/s11010-010-0588-1; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; KRUIJSEN MWM, 1981, AGENTS ACTIONS, V11, P640, DOI 10.1007/BF01978775; Metselaar JM, 2004, ANN RHEUM DIS, V63, P348, DOI 10.1136/ard.2003.009944; Metselaar JM, 2003, ARTHRITIS RHEUM-US, V48, P2059, DOI 10.1002/art.11140; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nabbe KCAM, 2005, ARTHRITIS RES THER, V7, pR392, DOI 10.1186/ar1502; Pousset F, 2001, J NEUROCHEM, V76, P901, DOI 10.1046/j.1471-4159.2001.00103.x; Raes G, 2005, J IMMUNOL, V174, P6561, DOI 10.4049/jimmunol.174.11.6561; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Takahashi N, 2008, ARTHRITIS RHEUM-US, V58, P3471, DOI 10.1002/art.23956; van Lent P, 2003, AM J PATHOL, V163, P1839, DOI 10.1016/S0002-9440(10)63543-2; van Lent PL, 1995, SCAND J RHEUMATOL S, P83; van Lent PLEM, 1998, J RHEUMATOL, V25, P1135; van Lent PLEM, 2004, ARTHRITIS RHEUM, V50, P103, DOI 10.1002/art.11422; van Lent PLEM, 2002, OSTEOARTHR CARTILAGE, V10, P234, DOI 10.1053/joca.2001.0501; Van Lent PLEM, 1998, ANN RHEUM DIS, V57, P408, DOI 10.1136/ard.57.7.408; VANDENBERG WB, 1981, BRIT J EXP PATHOL, V62, P308; VANLENT PLEM, 1992, AM J PATHOL, V140, P1451; VanMeurs JBJ, 1997, RHEUMATOL INT, V16, P197, DOI 10.1007/BF01330296; Varga G, 2008, J LEUKOCYTE BIOL, V84, P644, DOI 10.1189/jlb.1107768; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Yeager MP, 2008, ANESTH ANALG, V107, P1726, DOI 10.1213/ane.0b013e3181875fb0	37	39	39	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e54016	10.1371/journal.pone.0054016	http://dx.doi.org/10.1371/journal.pone.0054016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468840	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900008
J	Kong, YA; Wang, JY; Liu, WL; Chen, QL; Yang, J; Wei, WD; Wu, MQ; Yang, L; Xie, XH; Lv, N; Guo, JL; Li, LS; Gao, J; Xie, XM; Dai, SQ				Kong, Yanan; Wang, Junye; Liu, Wanli; Chen, Qiaolun; Yang, Juan; Wei, Weidong; Wu, Mingqing; Yang, Lu; Xie, Xinhua; Lv, Ning; Guo, Jiaoli; Li, Laisheng; Gao, Jie; Xie, Xiaoming; Dai, Shuqin			Cytokeratin19-2g2, a Novel Fragment of Cytokeratin19 in Serum, Indicating a More Invasive Behavior and Worse Prognosis in Breast Cancer Patients	PLOS ONE			English	Article							POLYPEPTIDE-SPECIFIC ANTIGEN; CIRCULATING TUMOR-CELLS; HER2 EXTRACELLULAR DOMAIN; DIAGNOSTIC-VALUE; FREE SURVIVAL; CA 15.3; CEA; MARKER; CA-15.3; TISSUE	Background: Various studies have been searching for new tumor biomarkers for breast cancer for years. However, so far, few markers have been proved clinically useful except CA153. Based on knowledge that most adenocarcinomas including breast carcinoma expressed Cytokeratin19, the authors studied CK19-2G2, a novel fragment of cytokeratin19 shedding into serum in breast cancer patients. Patients and Methods: The serum samples of four hundred and seventeen patients including three hundred and three (fifty-four DCIS and two hundred and forty-nine stage I-III) PBC patients and one hundred and fourteen MBC patients, eighty-one healthy controls and twenty-one breast benign disease patients were provided for measurement of CK19-2G2, CEA and CA153. The correlation between clinicopathological characters, prognosis and CK19-2G2 levels was further studied. Results: The serum CK19-2G2 levels in breast cancer patients were significantly higher than that in healthy and benign controls. For breast cancer patients, CK19-2G2 levels in MBC were significantly higher than that in PBC patients. The sensitivities of CK19-2G2 for breast carcinoma are as high as CEA and CA153, and up to 71% in MBC patients. Serum CK19-2G2 levels (>= 2 mU/mL) were associated with pathological stages, tumor size (>= 2 cm), lymph node involvement, and HER2 status. Multivariate analysis revealed that high serum CK19-2G2 level was an independent factor for relapse (P=0.029) and death (P=0.040) in breast cancer patients. Conclusion: Serum CK19-2G2 may be an independent indicator for prognosis and a candidate marker for monitoring metastasis in breast cancer.	[Kong, Yanan; Wei, Weidong; Wu, Mingqing; Yang, Lu; Xie, Xinhua; Lv, Ning; Guo, Jiaoli; Li, Laisheng; Gao, Jie; Xie, Xiaoming] Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Kong, Yanan; Wang, Junye; Liu, Wanli; Chen, Qiaolun; Yang, Juan; Wei, Weidong; Wu, Mingqing; Yang, Lu; Xie, Xinhua; Lv, Ning; Guo, Jiaoli; Li, Laisheng; Gao, Jie; Xie, Xiaoming; Dai, Shuqin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Wanli; Chen, Qiaolun; Yang, Juan; Dai, Shuqin] Sun Yat Sen Univ, Ctr Canc, Dept Med Examinat, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Junye] Sun Yat Sen Univ, Ctr Canc, Dept Chest Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xie, XM (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China.	xiexm@sysucc.org.cn; daishq@sysucc.org.cn	Lv, Ning/V-5706-2019	Kong, Yanan/0000-0002-3145-5492; Xie, Xiaoming/0000-0003-0687-4238	Key Program of National Natural Science Foundation of China [31030061]; Natural Science Foundation of Guangdong Province, China [9151008901000124]; Science and Technology Planning Project of Guangzhou, China [10C32060205]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangzhou, China	The authors are supported by the Key Program of National Natural Science Foundation of China (31030061) http://www.nsfc.gov.cn/Portal0/default152.htm; Natural Science Foundation of Guangdong Province, China (9151008901000124) http://gdsf.gdstc.gov.cn/; Science and Technology Planning Project of Guangzhou, China (10C32060205) http://www.gzmstpf.org.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SK, 2013, INT J CANCER, V132, P875, DOI 10.1002/ijc.27727; American Cancer Society, 2012, CANC FACTS FIG 2012; Bartsch R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-81; Brotherick I, 1998, CYTOMETRY, V32, P301, DOI 10.1002/(SICI)1097-0320(19980801)32:4<301::AID-CYTO7>3.3.CO;2-R; Chen Y, 2010, INT J BIOL MARKER, V25, P59, DOI 10.1177/172460081002500201; D'Alessandro R, 2001, BREAST CANCER RES TR, V68, P9, DOI 10.1023/A:1017903724176; Daskalaki A, 2009, BRIT J CANCER, V101, P589, DOI 10.1038/sj.bjc.6605183; Ebeling FG, 2002, BRIT J CANCER, V86, P1217, DOI 10.1038/sj.bjc.6600248; Gao Jia, 2008, Zhonghua Zhongliu Zazhi, V30, P930; Gion M, 2001, EUR J CANCER, V37, P355, DOI 10.1016/S0959-8049(00)00396-8; Giovanella L, 2002, CLIN CHEM LAB MED, V40, P298, DOI 10.1515/CCLM.2002.047; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; HILKENS J, 1984, INT J CANCER, V34, P197, DOI 10.1002/ijc.2910340210; Iwaya K, 2003, CANCER SCI, V94, P864, DOI 10.1111/j.1349-7006.2003.tb01368.x; KATH R, 1993, ANN ONCOL, V4, P585, DOI 10.1093/oxfordjournals.annonc.a058593; Kong YA, 2012, J CANCER RES CLIN, V138, P275, DOI 10.1007/s00432-011-1095-9; Kostler WJ, 2004, CLIN CANCER RES, V10, P1618, DOI 10.1158/1078-0432.CCR-0385-3; Lauro S, 1999, ANTICANCER RES, V19, P3511; Leary AF, 2009, J CLIN ONCOL, V27, P1694, DOI 10.1200/JCO.2008.17.3989; Li Y, 2010, CANCER RES, V70, P8159, DOI 10.1158/0008-5472.CAN-10-1073; Ludovini V, 2008, ANN ONCOL, V19, P883, DOI 10.1093/annonc/mdm585; Martin A, 2006, ANTICANCER RES, V26, P3965; Molina R, 2003, ANTICANCER RES, V23, P1035; Molina R, 2010, CLIN CHEM, V56, P1148, DOI 10.1373/clinchem.2009.135566; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nakata B, 2004, BRIT J CANCER, V91, P873, DOI 10.1038/sj.bjc.6602074; Nakata B, 2000, CANCER, V89, P1285, DOI 10.1002/1097-0142(20000915)89:6<1285::AID-CNCR13>3.0.CO;2-G; Saloustros E, 2010, FUTURE ONCOL, V6, P209, DOI 10.2217/FON.09.147; Soletormos G, 2000, CLIN CHEM LAB MED, V38, P453, DOI 10.1515/CCLM.2000.066; TORRES M, 1995, INT J BIOL MARKER, V10, P94, DOI 10.1177/172460089501000205; Valik D, 2000, BRIT J CANCER, V82, P1756; Xenidis N, 2009, J CLIN ONCOL, V27, P2177, DOI 10.1200/JCO.2008.18.0497	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57092	10.1371/journal.pone.0057092	http://dx.doi.org/10.1371/journal.pone.0057092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468917	Green Submitted, gold, Green Published			2022-12-27	WOS:000315524900052
J	Ruiz-Alcaraz, AJ; Lipina, C; Petrie, JR; Murphy, MJ; Morris, AD; Sutherland, C; Cuthbertson, DJ				Ruiz-Alcaraz, Antonio J.; Lipina, Christopher; Petrie, John R.; Murphy, Michael J.; Morris, Andrew D.; Sutherland, Calum; Cuthbertson, Daniel J.			Obesity-Induced Insulin Resistance in Human Skeletal Muscle Is Characterised by Defective Activation of p42/p44 MAP Kinase	PLOS ONE			English	Article							IRS1; MECHANISMS	Insulin resistance (IR), an impaired cellular, tissue and whole body response to insulin, is a major pathophysiological defect of type 2 diabetes mellitus. Although IR is closely associated with obesity, the identity of the molecular defect(s) underlying obesity-induced IR in skeletal muscle remains controversial; reduced post-receptor signalling of the insulin receptor substrate 1 (IRS1) adaptor protein and downstream effectors such as protein kinase B (PKB) have previously been implicated. We examined expression and/or activation of a number of components of the insulin-signalling cascade in skeletal muscle of 22 healthy young men (with body mass index (BMI) range, 20-37 kg/m(2)). Whole body insulin sensitivity (M value) and body composition was determined by the hyperinsulinaemic (40 mU. min(-1).m(-2).), euglycaemic clamp and by dual energy X-ray absorptiometry (DEXA) respectively. Skeletal muscle (vastus lateralis) biopsies were taken before and after one hour of hyperinsulinaemia and the muscle insulin signalling proteins examined by western blot and immunoprecipitation assay. There was a strong inverse relationship between M-value and BMI. The most striking abnormality was significantly reduced insulin-induced activation of p42/44 MAP kinase, measured by specific assay, in the volunteers with poor insulin sensitivity. However, there was no relationship between individuals' BMI or M-value and protein expression/phosphorylation of IRS1, PKB, or p42/44 MAP kinase protein, under basal or hyperinsulinaemic conditions. In the few individuals with poor insulin sensitivity but preserved p42/44 MAP kinase activation, other signalling defects were evident. These findings implicate defective p42/44 MAP kinase signalling as a potential contributor to obesity-related IR in a non-diabetic population, although clearly multiple signalling defects underlie obesity associated IR.	[Ruiz-Alcaraz, Antonio J.] Univ Murcia, Sch Med, Dept Biochem & Mol Biol & Immunol B, Murcia, Spain; [Lipina, Christopher] Univ Dundee, Div Cell Signalling & Immunol, Dundee, Scotland; [Petrie, John R.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Murphy, Michael J.; Morris, Andrew D.; Sutherland, Calum] Univ Dundee, Ninewells Hosp, Div Cardiovasc & Diabet Med, Dundee, Scotland; [Cuthbertson, Daniel J.] Aintree Univ Hosp NHS Fdn Trust, Ctr Clin Sci, Dept Obes & Endocrinol, Liverpool L9 7AL, Merseyside, England; [Cuthbertson, Daniel J.] Univ Liverpool, Inst Aging & Chron Dis, Dept Obes & Endocrinol, Liverpool L69 3BX, Merseyside, England	University of Murcia; University of Dundee; University of Glasgow; University of Dundee; Aintree University Hospitals NHS Foundation Trust; University of Liverpool; University of Liverpool	Cuthbertson, DJ (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Ctr Clin Sci, Dept Obes & Endocrinol, Liverpool L9 7AL, Merseyside, England.	daniel.cuthbertson@liverpool.ac.uk	Murphy, Michael J/K-4008-2012; Ruiz-Alcaraz, Antonio José/Z-5867-2019	Murphy, Michael J/0000-0001-6735-125X; Ruiz-Alcaraz, Antonio José/0000-0001-6913-0610; Lipina, Christopher/0000-0001-7327-2857; Cuthbertson, Daniel/0000-0002-6128-0822; Sutherland, Calum/0000-0003-4398-7434	Diabetes UK [03/0002583]; CSO [CZB/4/125]; Diabetes UK [10/0004131] Funding Source: researchfish; Medical Research Council [G0801507] Funding Source: researchfish; MRC [G0801507] Funding Source: UKRI	Diabetes UK(Diabetes UK); CSO; Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Diabetes UK Project Grant number (03/0002583) and CSO project grant number (CZB/4/125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babraj JA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1042, DOI 10.1152/ajpendo.90811.2008; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Corbould A, 2006, DIABETES, V55, P751, DOI 10.2337/diabetes.55.03.06.db05-0453; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Cuthbertson DJ, 2007, DIABETES, V56, P2078, DOI 10.2337/db06-1716; Cuthbertson DJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE731, DOI 10.1152/ajpendo.00415.2005; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Friedrichsen M, 2010, DIABETOLOGIA, V53, P1998, DOI 10.1007/s00125-010-1795-8; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Jager J, 2011, DIABETOLOGIA, V54, P180, DOI 10.1007/s00125-010-1944-0; Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284; Krook A, 1998, DIABETES, V47, P1281, DOI 10.2337/diabetes.47.8.1281; Langlais P, 2011, DIABETOLOGIA, V54, P2878, DOI 10.1007/s00125-011-2271-9; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Meyer MM, 2002, DIABETOLOGIA, V45, P813, DOI 10.1007/s00125-002-0830-9; Petersen KF, 2002, J ROY SOC MED, V95, P8; Rajkhowa M, 2009, BIOCHEM J, V418, P665, DOI 10.1042/BJ20082176; Ruiz-Alcaraz AJ, 2005, BIOCHEM J, V392, P345, DOI 10.1042/BJ20051194; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schmitz-Peiffer C, 2000, CELL SIGNAL, V12, P583, DOI 10.1016/S0898-6568(00)00110-8; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Tan K, 2007, DIABETES, V56, P714, DOI 10.2337/db06-0921; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Woods Yvonne L., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P187	27	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56928	10.1371/journal.pone.0056928	http://dx.doi.org/10.1371/journal.pone.0056928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468892	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000315524900044
J	Taylor, AC; Horvat-Gordon, M; Moore, A; Bartell, PA				Taylor, Alexander C.; Horvat-Gordon, Maria; Moore, Ashli; Bartell, Paul A.			The Effects of Melatonin on the Physical Properties of Bones and Egg Shells in the Laying Hen	PLOS ONE			English	Article							RECEPTOR SUBTYPES; ZINC; STRENGTH; EXPRESSION; STRONTIUM; CHICK; PINEALECTOMY; DEFICIENCY; VOLUME; RATS	Laying hens often experience unbalanced calcium utilization which can cause deficiencies in bone and egg mineralization. Because melatonin has been shown to affect bone mineralization in other animals, we examined whether treating hens with melatonin would affect eggshell thickness and improve skeletal performance, thereby reducing skeletal and egg shell defects. Birds were given a diet containing either low (30 mu g/kg), medium (300 mu g/kg), or high (3 mu g/kg) concentrations of melatonin, or control feed through approximately one laying cycle. We examined the weight, length, and strength of egg, femur, tibia, and keel. Hens treated with a high concentration of melatonin showed significant strengthening in their femur and tibia, as measured by maximum force sustained and breaking force, compared to controls. Egg weights from hens treated with melatonin were significantly greater than those from hens that were not treated with melatonin. Conversely, egg shell mass of hens treated with melatonin was significantly lower than those of hens not treated with melatonin. Our data suggest that melatonin may affect the allocation of calcium to bone at the expense of egg shell mineralization.	[Taylor, Alexander C.; Horvat-Gordon, Maria; Bartell, Paul A.] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA; [Taylor, Alexander C.; Bartell, Paul A.] Penn State Univ, Intercoll Grad Degree Program Physiol, University Pk, PA 16802 USA; [Moore, Ashli] Univ Virginia, Dept Biol, Charlottesville, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Virginia	Bartell, PA (corresponding author), Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA.	pab43@psu.edu			USDA National Institute of Food and Agriculture [2010-65206-20779]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This project was supported by Competitive Grant no. 2010-65206-20779 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltaci AK, 2007, ACTA BIOL HUNG, V58, P335, DOI 10.1556/ABiol.58.2007.4.1; BRANDAONETO J, 1995, NUTR RES, V15, P335, DOI 10.1016/0271-5317(95)00003-8; Cardinali DP, 2003, J PINEAL RES, V34, P81, DOI 10.1034/j.1600-079X.2003.00028.x; Eberle J, 1999, J TRACE ELEM MED BIO, V13, P21, DOI 10.1016/S0946-672X(99)80019-4; ETCHES RJ, 1987, J NUTR, V117, P619, DOI 10.1093/jn/117.3.619; Everts V, 2005, J CELL PHYSL, V150, P221; Fagan AB, 2009, EUR SPINE J, V18, P1154, DOI 10.1007/s00586-009-0927-7; Fleming RH, 1998, RES VET SCI, V64, P63, DOI 10.1016/S0034-5288(98)90117-5; Geary GG, 1998, BRIT J PHARMACOL, V123, P1533, DOI 10.1038/sj.bjp.0701761; Greives TJ, 2012, BIOL LETTERS, V8, P330, DOI 10.1098/rsbl.2011.1100; Guard-Bouldin J, 2006, POULTRY SCI, V85, P129, DOI 10.1093/ps/85.1.129; Hosea HJ, 2004, EXP BIOL MED, V229, P303, DOI 10.1177/153537020422900404; JIANG ZG, 1995, BRAIN RES, V687, P125, DOI 10.1016/0006-8993(95)00478-9; Jones C, 2012, CHRONOBIOL INT, V29, P189, DOI 10.3109/07420528.2011.642912; Koyama H, 2002, J BONE MINER RES, V17, P1219, DOI 10.1359/jbmr.2002.17.7.1219; MACHIDA M, 1995, J BONE JOINT SURG BR, V77B, P134, DOI 10.1302/0301-620X.77B1.7822371; Miller SC, 1992, POULTRY SCI S, V23; Nakade O, 1999, J PINEAL RES, V27, P106, DOI 10.1111/j.1600-079X.1999.tb00603.x; Natesan AK, 2002, VISUAL NEUROSCI, V19, P265, DOI 10.1017/S0952523802192042; Noddegaard F, 1999, J PINEAL RES, V27, P129; Ozturk G, 2008, EXP AGING RES, V34, P453, DOI 10.1080/03610730802271922; Olszanska B, 2007, J PINEAL RES, V42, P310, DOI 10.1111/j.1600-079X.2007.00421.x; Ovesen J, 2001, BONE, V29, P565, DOI 10.1016/S8756-3282(01)00616-0; Park KH, 2011, J PINEAL RES, V51, P187, DOI 10.1111/j.1600-079X.2011.00875.x; Rada JAS, 2006, INVEST OPHTH VIS SCI, V47, P25, DOI 10.1167/iovs.05-0195; REPPERT SM, 1995, NEURON, V15, P1003, DOI 10.1016/0896-6273(95)90090-X; Sazanov AA, 2007, POULTRY SCI, V86, P202, DOI 10.1093/ps/86.1.202; Shahnazari M, 2007, CALCIFIED TISSUE INT, V80, P160, DOI 10.1007/s00223-006-0176-2; Shahnazari M, 2006, J BONE MINER RES, V21, P1696, DOI 10.1359/JBMR.060724; Sjoblom M, 2003, AM J PHYSIOL-GASTR L, V284, pG1034, DOI 10.1152/ajpgi.00500.2002; Sundaresan NR, 2009, VET RES COMMUN, V33, P49, DOI 10.1007/s11259-008-9071-9; Tournis S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P266; Whitehead CC, 2004, POULTRY SCI, V83, P193, DOI 10.1093/ps/83.2.193	33	14	16	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e55663	10.1371/journal.pone.0055663	http://dx.doi.org/10.1371/journal.pone.0055663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468846	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900012
J	Gronemeyer, T; Wiese, S; Ofman, R; Bunse, C; Pawlas, M; Hayen, H; Eisenacher, M; Stephan, C; Meyer, HE; Waterham, HR; Erdmann, R; Wanders, RJ; Warscheid, B				Gronemeyer, Thomas; Wiese, Sebastian; Ofman, Rob; Bunse, Christian; Pawlas, Magdalena; Hayen, Heiko; Eisenacher, Martin; Stephan, Christian; Meyer, Helmut E.; Waterham, Hans R.; Erdmann, Ralf; Wanders, Ronald J.; Warscheid, Bettina			The Proteome of Human Liver Peroxisomes: Identification of Five New Peroxisomal Constituents by a Label-Free Quantitative Proteomics Survey	PLOS ONE			English	Article							MOUSE KIDNEY PEROXISOMES; RAT-LIVER; MASS-SPECTROMETRY; SUBCELLULAR-LOCALIZATION; PROTEINS; BIOCHEMISTRY; MEMBRANE; DATABASE; ENZYMES; METABOLISM	The peroxisome is a key organelle of low abundance that fulfils various functions essential for human cell metabolism. Severe genetic diseases in humans are caused by defects in peroxisome biogenesis or deficiencies in the function of single peroxisomal proteins. To improve our knowledge of this important cellular structure, we studied for the first time human liver peroxisomes by quantitative proteomics. Peroxisomes were isolated by differential and Nycodenz density gradient centrifugation. A label-free quantitative study of 314 proteins across the density gradient was accomplished using high resolution mass spectrometry. By pairing statistical data evaluation, cDNA cloning and in vivo colocalization studies, we report the association of five new proteins with human liver peroxisomes. Among these, isochorismatase domain containing 1 protein points to the existence of a new metabolic pathway and hydroxysteroid dehydrogenase like 2 protein is likely involved in the transport or beta-oxidation of fatty acids in human peroxisomes. The detection of alcohol dehydrogenase 1A suggests the presence of an alternative alcohol-oxidizing system in hepatic peroxisomes. In addition, lactate dehydrogenase A and malate dehydrogenase 1 partially associate with human liver peroxisomes and enzyme activity profiles support the idea that NAD(+) becomes regenerated during fatty acid beta-oxidation by alternative shuttling processes in human peroxisomes involving lactate dehydrogenase and/or malate dehydrogenase. Taken together, our data represent a valuable resource for future studies of peroxisome biochemistry that will advance research of human peroxisomes in health and disease.	[Gronemeyer, Thomas] Univ Ulm, Dept Mol Genet & Cell Biol, D-89069 Ulm, Germany; [Wiese, Sebastian; Warscheid, Bettina] Univ Freiburg, Inst Biol 2, Fak Biol, Freiburg, Germany; [Wiese, Sebastian; Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Ofman, Rob; Waterham, Hans R.; Wanders, Ronald J.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, Dept Clin Chem & Pediat, NL-1105 AZ Amsterdam, Netherlands; [Bunse, Christian; Pawlas, Magdalena; Eisenacher, Martin; Stephan, Christian; Meyer, Helmut E.] Ruhr Univ Bochum, Med Proteom Ctr, Bochum, Germany; [Hayen, Heiko] Leibniz Inst Analyt Wissensch ISAS eV, Dortmund, Germany; [Erdmann, Ralf] Ruhr Univ Bochum, Abt Syst Biochem, Fak Med, Bochum, Germany	Ulm University; University of Freiburg; University of Freiburg; University of Amsterdam; Academic Medical Center Amsterdam; Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Ruhr University Bochum	Warscheid, B (corresponding author), Univ Freiburg, Inst Biol 2, Fak Biol, Schanzlestr 1, Freiburg, Germany.	bettina.warscheid@biologie.uni-freiburg.de	Eisenacher, Martin/J-8044-2014	Eisenacher, Martin/0000-0003-2687-7444; Warscheid, Bettina/0000-0001-5096-1975	FP6 European Union Project "Peroxisome'' [LSHG-CT-2004-512018]; Deutsche Forschungsgemeinschaft; Excellence Initiative of the German Federal and State Governments [EXC 294]	FP6 European Union Project "Peroxisome''; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	This research is supported by the FP6 European Union Project "Peroxisome'' (LSHG-CT-2004-512018) as well as by the Deutsche Forschungsgemeinschaft and the Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS Centre for Biological Signalling Studies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2006, EMBO REP, V7, P874, DOI 10.1038/sj.embor.7400780; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Baumgart E, 1996, J BIOL CHEM, V271, P3846; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DECRAEMER D, 1995, HEPATOLOGY, V22, P744, DOI 10.1016/0270-9139(95)90292-9; Dunkley TPJ, 2004, MOL CELL PROTEOMICS, V3, P1128, DOI 10.1074/mcp.T400009-MCP200; Edqvist A, 2006, MOL THER, V14, P139, DOI 10.1016/j.ymthe.2005.12.018; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; HANDLER JA, 1990, J BIOL CHEM, V265, P1510; Islinger M, 2010, BBA-MOL CELL RES, V1803, P881, DOI 10.1016/j.bbamcr.2010.03.013; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; Juillerat A, 2005, CHEMBIOCHEM, V6, P1263, DOI 10.1002/cbic.200400431; Kalish JE, 1996, EMBO J, V15, P3275, DOI 10.1002/j.1460-2075.1996.tb00692.x; KELLER GA, 1989, J CELL BIOL, V108, P1353, DOI 10.1083/jcb.108.4.1353; KETCHUM CH, 1988, CLIN BIOCHEM, V21, P231, DOI 10.1016/S0009-9120(88)80006-7; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kowalik D, 2009, J STEROID BIOCHEM, V117, P117, DOI 10.1016/j.jsbmb.2009.08.001; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; McClelland GB, 2003, BIOCHEM BIOPH RES CO, V304, P130, DOI 10.1016/S0006-291X(03)00550-3; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Ofman R, 2006, BIOCHEM J, V393, P537, DOI 10.1042/BJ20050893; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Popov VN, 1998, FEBS LETT, V440, P55, DOI 10.1016/S0014-5793(98)01422-7; Reidegeld KA, 2008, PROTEOMICS, V8, P1129, DOI 10.1002/pmic.200701073; SAKURABA H, 1995, J BIOL CHEM, V270, P37, DOI 10.1074/jbc.270.1.37; Schluter A, 2007, NUCLEIC ACIDS RES, V35, pD815, DOI 10.1093/nar/gkl935; Seuchter SA, 2004, METHOD INFORM MED, V43, P184; Skogsberg J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000036; Stephan C, 2006, PROTEOMICS, V6, P5015, DOI 10.1002/pmic.200600294; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; WALSH CT, 1990, CHEM REV, V90, P1105, DOI 10.1021/cr00105a003; Wanders RJA, 2005, CLIN GENET, V67, P107, DOI 10.1111/j.1399-0004.2004.00329.x; WANDERS RJA, 1994, BBA-MOL BASIS DIS, V1227, P177, DOI 10.1016/0925-4439(94)90092-2; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; WIEMER EAC, 1992, J IMMUNOL METHODS, V151, P165, DOI 10.1016/0022-1759(92)90115-A; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Wiese S, 2012, INT J MASS SPECTROM, V312, P30, DOI 10.1016/j.ijms.2011.09.005; Yan W, 2009, J PROTEOMICS, V72, P4, DOI 10.1016/j.jprot.2008.11.017; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711	46	66	68	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57395	10.1371/journal.pone.0057395	http://dx.doi.org/10.1371/journal.pone.0057395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460848	gold, Green Submitted, Green Published			2022-12-27	WOS:000315519000102
J	Lin, PY; Grewal, NS; Morin, C; Johnson, WD; Zak, PJ				Lin, Pei-Ying; Grewal, Naomi Sparks; Morin, Christophe; Johnson, Walter D.; Zak, Paul J.			Oxytocin Increases the Influence of Public Service Advertisements	PLOS ONE			English	Article							EMPATHY; BEHAVIOR; RESPONSES; RELEASE; ACTH; GENEROSITY; STRANGERS; ATTENTION; ATTITUDE	This paper presents a neurophysiologic model of effective public service advertisements (PSAs) and reports two experiments that test the model. In Experiment 1, we show that after watching 16 PSAs participants who received oxytocin, compared to those given a placebo, donated to 57% more causes, donated 56% more money, and reported 17% greater concern for those in the ads. In Experiment 2, we measured adrenocorticotropin hormone (ACTH) and oxytocin levels in blood before and after participants watched a PSA. As predicted by the model, donations occurred when participants had increases in both ACTH and oxytocin. Our results indicate that PSAs with social content that cause OT release will be more effective than those that do not. Our results also explain why some individuals do not respond to PSAs.	[Lin, Pei-Ying] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Grewal, Naomi Sparks] Claremont Grad Univ, Dept Psychol, Claremont, CA USA; [Morin, Christophe] Fielding Grad Univ, Santa Barbara, CA USA; [Johnson, Walter D.; Zak, Paul J.] Claremont Grad Univ, Ctr Neuroecon Studies, Claremont, CA 91711 USA	University of Southern California; Claremont Colleges; Claremont Graduate School; Claremont Colleges; Claremont Graduate School	Zak, PJ (corresponding author), Claremont Grad Univ, Ctr Neuroecon Studies, Claremont, CA 91711 USA.	paul.zak@cgu.edu			Center for Neuroeconomics Studies	Center for Neuroeconomics Studies	This research was supported by the Center for Neuroeconomics Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I., 2008, ATTITUDES ATTITUDE C; [Anonymous], KANT MED REP US ADV; Arnett DB, 2003, J MARKETING, V67, P89, DOI 10.1509/jmkg.67.2.89.18614; BAGOZZI RP, 1994, J MARKETING, V58, P56, DOI 10.2307/1252251; Barraza JA, 2012, OXYTOCIN VASOPRESSIN; Barraza JA, 2011, HORM BEHAV, V60, P148, DOI 10.1016/j.yhbeh.2011.04.008; Barraza JA, 2009, ANN NY ACAD SCI, V1167, P182, DOI 10.1111/j.1749-6632.2009.04504.x; BATSON CD, 1987, J PERS, V55, P19, DOI 10.1111/j.1467-6494.1987.tb00426.x; Batson CD, 1997, J PERS SOC PSYCHOL, V73, P495, DOI 10.1037/0022-3514.73.3.495; BATSON CD, 1990, AM PSYCHOL, V45, P336, DOI 10.1037/0003-066X.45.3.336; BATSON CD, 2002, ALTRUISM ALTRUISTIC; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; BORN J, 1990, PSYCHOPHARMACOLOGY, V101, P34, DOI 10.1007/BF02253714; Campbell DT, 1963, PSYCHOL STUDY SCI; Cesario J, 2004, J PERS SOC PSYCHOL, V86, P388, DOI 10.1037/0022-3514.86.3.388; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; De Weid D, 1970, PROGR BRAIN RES; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Feldman R, 2010, PSYCHONEUROENDOCRINO, V35, P1133, DOI 10.1016/j.psyneuen.2010.01.013; FILE SE, 1978, PHARMACOL BIOCHEM BE, V9, P161, DOI 10.1016/0091-3057(78)90159-4; Fisher RJ, 2008, J CONSUM RES, V35, P519, DOI 10.1086/586909; GAILLARD AWK, 1979, PHYSIOL BEHAV, V23, P79, DOI 10.1016/0031-9384(79)90126-4; Geddes L, 2010, NEW SCI; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Hoffman Martin L., 1982, DEV PROSOCIAL BEHAV, V281, P281, DOI DOI 10.1016/B978-0-12-234980-5.50016-X; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Janiszewski C, 1998, J CONSUM RES, V25, P290, DOI 10.1086/209540; Kaiser FG, 1998, J APPL SOC PSYCHOL, V28, P395, DOI 10.1111/j.1559-1816.1998.tb01712.x; Kaiser FG, 2004, PERS INDIV DIFFER, V36, P1531, DOI 10.1016/j.paid.2003.06.003; Kaiser FG, 2007, J ENVIRON PSYCHOL, V27, P242, DOI 10.1016/j.jenvp.2007.06.004; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; LARSEN RJ, 1987, J RES PERS, V21, P1, DOI 10.1016/0092-6566(87)90023-7; Loggia ML, 2008, PAIN, V136, P168, DOI 10.1016/j.pain.2007.07.017; Lohse GL, 1997, J ADVERTISING, V26, P61, DOI 10.1080/00913367.1997.10673518; Matthiesen AS, 2001, BIRTH-ISS PERINAT C, V28, P13, DOI 10.1046/j.1523-536x.2001.00013.x; MAURI A, 1994, FETAL DIAGN THER, V9, P300, DOI 10.1159/000263952; Milosavljevic M, 2008, INT J ADVERT, V27, P381, DOI 10.2501/S0265048708080037; Morhenn VB, 2008, EVOL HUM BEHAV, V29, P375, DOI 10.1016/j.evolhumbehav.2008.04.004; Murry JP, 1996, PUBLIC OPIN QUART, V60, P1, DOI 10.1086/297737; Nicolson N, 2007, HDB PHYSL RES METHOD, P37, DOI DOI 10.4135/9781412976244.N3; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Odendaal JSJ, 2003, VET J, V165, P296, DOI 10.1016/S1090-0233(02)00237-X; Penenberg A., 2011, FAST CO; Petty R.E., 1986, ADV EXPT SOCIAL PSYC, V19, P123, DOI [10.1016/S0065-2601(08)60214-2, DOI 10.1016/S0065-2601(08)60214-2, https://doi.org/10.1016/S0065-2601(08)60214-2]; Reddon AR, 2012, ANIM BEHAV, V84, P753, DOI 10.1016/j.anbehav.2012.07.021; Sacharin K, 2000, ATTENTION INTERRUPT; Salonia A, 2005, HORM BEHAV, V47, P164, DOI 10.1016/j.yhbeh.2004.10.002; SANDMAN CA, 1977, J CLIN ENDOCR METAB, V44, P884, DOI 10.1210/jcem-44-5-884; SANDMAN CA, 1975, PHYSIOL BEHAV, V15, P427, DOI 10.1016/0031-9384(75)90209-7; SHELTON ML, 1981, J APPL SOC PSYCHOL, V11, P366, DOI 10.1111/j.1559-1816.1981.tb00829.x; Shen LJ, 2010, HUM COMMUN RES, V36, DOI 10.1111/j.1468-2958.2010.01381.x; SMITH RE, 1983, J MARKETING RES, V20, P257, DOI 10.2307/3151829; SPRUIJT BM, 1992, NEUROBIOL AGING, V13, P153, DOI 10.1016/0197-4580(92)90023-Q; Strong EK, 1925, J APPL PSYCHOL, V9, P75, DOI 10.1037/h0070123; Zak P. J., 2012, MORAL MOL SOURCE LOV; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128; Zak PJ, 2011, J ECON BEHAV ORGAN, V77, P212, DOI 10.1016/j.jebo.2010.09.004; Zak PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008330; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zak PJ, 2004, PHILOS T R SOC B, V359, P1737, DOI 10.1098/rstb.2004.1544	63	18	18	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56934	10.1371/journal.pone.0056934	http://dx.doi.org/10.1371/journal.pone.0056934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460821	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000046
J	Ma, LJ; Murea, M; Snipes, JA; Marinelarena, A; Kruger, J; Hicks, PJ; Langberg, KA; Bostrom, MA; Cooke, JN; Suzuki, D; Babazono, T; Uzu, T; Tang, SCW; Mondal, AK; Sharma, NK; Kobes, S; Antinozzi, PA; Davis, M; Das, SK; Rasouli, N; Kern, PA; Shores, NJ; Rudel, LL; Bluuher, M; Stumvoll, M; Bowden, DW; Maeda, S; Parks, JS; Kovacs, P; Hanson, RL; Baier, LJ; Elbein, SC; Freedman, BI				Ma, Lijun; Murea, Mariana; Snipes, James A.; Marinelarena, Alejandra; Krueger, Jacqueline; Hicks, Pamela J.; Langberg, Kurt A.; Bostrom, Meredith A.; Cooke, Jessica N.; Suzuki, Daisuke; Babazono, Tetsuya; Uzu, Takashi; Tang, Sydney C. W.; Mondal, Ashis K.; Sharma, Neeraj K.; Kobes, Sayuko; Antinozzi, Peter A.; Davis, Matthew; Das, Swapan K.; Rasouli, Neda; Kern, Philip A.; Shores, Nathan J.; Rudel, Lawrence L.; Blueher, Matthias; Stumvoll, Michael; Bowden, Donald W.; Maeda, Shiro; Parks, John S.; Kovacs, Peter; Hanson, Robert L.; Baier, Leslie J.; Elbein, Steven C.; Freedman, Barry I.			An ACACB Variant Implicated in Diabetic Nephropathy Associates with Body Mass Index and Gene Expression in Obese Subjects	PLOS ONE			English	Article							FATTY-ACID OXIDATION; ADIPOSE-TISSUE; MICE LACKING; MUTANT MICE; POLYMORPHISMS; METABOLISM; KNOCKOUT; GLUCOSE; DIETARY; ACC2	Acetyl coenzyme A carboxylase B gene (ACACB) single nucleotide polymorphism (SNP) rs2268388 is reproducibly associated with type 2 diabetes (T2DM)-associated nephropathy (DN). ACACB knock-out mice are also protected from obesity. This study assessed relationships between rs2268388, body mass index (BMI) and gene expression in multiple populations, with and without T2DM. Among subjects without T2DM, rs2268388 DN risk allele (T) associated with higher BMI in Pima Indian children (n = 2021; p-additive = 0.029) and African Americans (AAs) (n = 177; p-additive = 0.05), with a trend in European Americans (EAs) (n = 512; p-additive = 0.09), but not Germans (n = 858; p-additive = 0.765). Association with BMI was seen in a meta-analysis including all non-T2DM subjects (n = 3568; p-additive = 0.02). Among subjects with T2DM, rs2268388 was not associated with BMI in Japanese (n = 2912) or EAs (n = 1149); however, the T allele associated with higher BMI in the subset with BMI >= 30 kg/m(2) (n = 568 EAs; p-additive = 0.049, n = 196 Japanese; p-additive = 0.049). Association with BMI was strengthened in a T2DM meta-analysis that included an additional 756 AAs (p-additive = 0.080) and 48 Hong Kong Chinese (p-additive = 0.81) with BMI >= 30 kg/m(2) (n = 1575; p-additive = 0.0033). The effect of rs2268388 on gene expression revealed that the T risk allele associated with higher ACACB messenger levels in adipose tissue (41 EAs and 20 AAs with BMI > 30 kg/m(2); p-additive = 0.018) and ACACB protein levels in the liver tissue (mixed model p-additive = 0.03, in 25 EA bariatric surgery patients with BMI > 30 kg/m(2) for 75 exams). The T allele also associated with higher hepatic triglyceride levels. These data support a role for ACACB in obesity and potential roles for altered lipid metabolism in susceptibility to DN.	[Ma, Lijun; Murea, Mariana; Snipes, James A.; Hicks, Pamela J.; Langberg, Kurt A.; Bostrom, Meredith A.; Cooke, Jessica N.; Mondal, Ashis K.; Sharma, Neeraj K.; Antinozzi, Peter A.; Davis, Matthew; Das, Swapan K.; Shores, Nathan J.; Rudel, Lawrence L.; Bowden, Donald W.; Parks, John S.; Elbein, Steven C.; Freedman, Barry I.] Wake Forest Sch Med, Winston Salem, NC USA; [Marinelarena, Alejandra; Kobes, Sayuko; Hanson, Robert L.; Baier, Leslie J.] NIDDKD, PECRB, Phoenix, AZ USA; [Krueger, Jacqueline; Blueher, Matthias; Stumvoll, Michael; Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, D-04109 Leipzig, Germany; [Suzuki, Daisuke] Tokai Univ, Div Nephrol & Metab, Dept Internal Med, Tokyo 151, Japan; [Babazono, Tetsuya] Tokyo Womens Med Univ, Ctr Diabet, Tokyo, Japan; [Uzu, Takashi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Tang, Sydney C. W.] Univ Hong Kong, Dept Internal Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Rasouli, Neda] Univ Colorado, Dept Internal Med, Sch Med, Aurora, CO USA; [Kern, Philip A.] Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY USA; [Shores, Nathan J.] Tulane Univ Med Ctr Hosp & Clin, Abdominal Transplant Inst, New Orleans, LA USA; [Maeda, Shiro] RIKEN, Ctr Genom Med, Lab Endocrinol & Metab, Yokohama, Kanagawa, Japan	Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Leipzig University; Tokai University; Tokyo Women's Medical University; Shiga University of Medical Science; University of Hong Kong; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Kentucky; Tulane University; RIKEN	Ma, LJ (corresponding author), Wake Forest Sch Med, Winston Salem, NC USA.	lima@wakehealth.edu	Stumvoll, Michael/ABE-1121-2021; Tang, Sydney Chi Wai/C-4411-2009; Cooke Bailey, Jessica Nicole/AFQ-5925-2022; Koya, Daisuke/J-3257-2014; Bailey, Jessica Cooke/Q-5062-2019; Hanson, Robert L/O-3238-2015	Stumvoll, Michael/0000-0001-6225-8240; Tang, Sydney Chi Wai/0000-0002-6862-1941; Cooke Bailey, Jessica Nicole/0000-0002-4001-8702; Bailey, Jessica Cooke/0000-0002-4001-8702; Hanson, Robert L/0000-0002-4252-7068; Kovacs, Peter/0000-0002-0290-5423; Das, Swapan/0000-0002-2197-8855; Herold, Jacqueline/0000-0003-3059-0374; Rasouli, Neda/0000-0003-1269-3580	Wake Forest School of Medicine Translational Science Institute Synergy Grant [K99 DK081350]; National Institutes of Health [R01 DK071891, R01 HL67348, R01 DK53591, R01 DK039311]; Veterans Administration; NIDDK; Ministry of Education, Culture, Sports, Science and Technology, Japan; Boehringer Ingelheim Foundation;  [R0171349]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117, UL1TR001998] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071349, R01DK039311, R01DK053591, R01DK071891, ZIADK069028, ZIADK069071, K99DK081350] Funding Source: NIH RePORTER	Wake Forest School of Medicine Translational Science Institute Synergy Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Boehringer Ingelheim Foundation(Boehringer Ingelheim); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by a Wake Forest School of Medicine Translational Science Institute Synergy Grant K99 DK081350, National Institutes of Health extramural grants R01 DK071891, R01 HL67348, R01 DK53591, R01 DK039311, and partially supported by R0171349, a Merit Grant from the Veterans Administration, and NIDDK intramural research program. The Japanese study was partly supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (S. M.). P. K. (Leipzig) was funded by Boehringer Ingelheim Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Abu-Elheiga L, 2012, J BIOL CHEM, V287, P12578, DOI 10.1074/jbc.M111.309559; Agarwal S, 2011, DIABETES CARE, V34, P1219, DOI 10.2337/dc11-0008; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Das SK, 2011, J CLIN ENDOCR METAB, V96, pE1308, DOI 10.1210/jc.2011-0101; Das SK, 2010, J LIPID RES, V51, P2121, DOI 10.1194/jlr.M004275; Divers J, 2010, J CLIN ENDOCR METAB, V95, P5382, DOI 10.1210/jc.2010-0793; Elbein SC, 2007, DIABETOLOGIA, V50, P1621, DOI 10.1007/s00125-007-0717-x; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hanson RL, 2012, COMMUNICATION; Hanson RL, 2007, DIABETES, V56, P3045, DOI 10.2337/db07-0462; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Knowler WC, 2007, COMMUNICATION; Lenz LS, 2011, J BIOL CHEM, V286, P35578, DOI 10.1074/jbc.M111.226530; Ma LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023860; Maeda S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000842; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Olson DP, 2010, P NATL ACAD SCI USA, V107, P7598, DOI 10.1073/pnas.0913492107; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; Park CW, 2006, KIDNEY INT, V69, P1511, DOI 10.1038/sj.ki.5000209; Phillips CM, 2010, J LIPID RES, V51, P3500, DOI 10.1194/jlr.M008474; Riancho JA, 2011, MOL GENET METAB, V104, P670, DOI 10.1016/j.ymgme.2011.08.013; Rosario Rey F, 2006, Curr Diab Rep, V6, P455, DOI 10.1007/s11892-006-0079-7; Schreurs M, 2009, DIABETES OBES METAB, V11, P987, DOI 10.1111/j.1463-1326.2009.01078.x; Shores NJ, 2011, DIGEST DIS SCI, V56, P2145, DOI 10.1007/s10620-011-1602-5; Stouffer S. A., 1949, AM SOLDIER, V1; Taneja D, 2010, J LIPID RES, V51, P1464, DOI 10.1194/jlr.M002972; Tang SCW, 2010, NEPHROL DIAL TRANSPL, V25, P3931, DOI 10.1093/ndt/gfq303; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Zhuang LN, 2011, J BIOL CHEM, V286, P28396, DOI 10.1074/jbc.M111.223206	35	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56193	10.1371/journal.pone.0056193	http://dx.doi.org/10.1371/journal.pone.0056193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460794	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000017
J	Rubin, JE; Costa, MO; Hill, JE; Kittrell, HE; Fernando, C; Huang, YY; O'Connor, B; Harding, JCS				Rubin, Joseph E.; Costa, Matheus O.; Hill, Janet E.; Kittrell, Heather E.; Fernando, Champika; Huang, Yanyun; O'Connor, Brendan; Harding, John C. S.			Reproduction of Mucohaemorrhagic Diarrhea and Colitis Indistinguishable from Swine Dysentery following Experimental Inoculation with "Brachyspira hampsonii" Strain 30446	PLOS ONE			English	Article							SELECTIVE MEDIUM; PIGS; DIFFERENTIATION; FECES	Background: Mucohaemorrhagic diarrhea caused by Brachyspira hyodysenteriae, swine dysentery, is a severe production limiting disease of swine. Recently, pigs in western Canada with clinical signs indistinguishable from swine dysentery were observed. Despite the presence of spirochetes on fecal smears, recognized Brachyspira spp. including B. hyodysenteriae could not be identified. A phylogenetically distinct Brachyspira, called "B. hampsonii" strain 30446, however was isolated. The purpose of this study was to experimentally reproduce mucohaemorrhagic colitis and characterize strain 30446 shedding following inoculation. Methods and Findings: Eighteen 13-week-old pigs were randomly assigned to inoculation (n = 12) or control (n = 6) groups in each of two trials. In trial 1, pigs were inoculated with a tissue homogenate collected from clinically affected field cases. In trial 2, pigs were inoculated with a pure broth culture of strain 30446. In both trials, mucohaemorrhagic diarrhea was significantly more common in inoculated pigs than controls, all of which remained healthy. In animals with mucohaemorrhagic diarrhea, significantly more spirochetes were observed on Gram stained fecal smears, and higher numbers of strain 30446 genome equivalents were detected by quantitative PCR (qPCR). Strain 30446 was cultured from colon and/or feces of all affected but no control animals at necropsy. Conclusions: "Brachyspira hampsonii" strain 30446 causes mucohaemorrhagic diarrhea in pigs following a 4-9 day incubation period. Fecal shedding was detectable by day 4 post inoculation, and rarely preceded the onset of mucoid or haemorrhagic diarrhea by more than 2 days. Culture and 30446-specific qPCR are reliable methods of detection of this organism in feces and tissues of diarrheic pigs. The emergence of a novel Brachyspira spp., such as "B. hampsonii", creates diagnostic challenges including higher risk of false negative diagnostic tests. We therefore recommend diagnostic laboratories routinely use Brachyspira culture, nox-based and species-specific PCR, and DNA sequencing to diagnose Brachyspira-associated colitis in pigs.	[Rubin, Joseph E.; Costa, Matheus O.; Hill, Janet E.; Fernando, Champika] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Rubin, Joseph E.; Kittrell, Heather E.; Huang, Yanyun; Harding, John C. S.] Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada; [O'Connor, Brendan] Prairie Diagnost Serv Inc, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Harding, JCS (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada.	john.harding@usask.ca	Hill, Janet E./B-5001-2011; Rubin, Joseph E/B-3374-2009	Hill, Janet E./0000-0002-2187-6277; Rubin, Joseph E/0000-0002-2636-406X	Canadian Swine Health Board; University of Saskatchewan Industry Liaison Office, Western College of Veterinary Medicine Research Trust; Merck-Merial Veterinary Scholars Summer Research Program	Canadian Swine Health Board; University of Saskatchewan Industry Liaison Office, Western College of Veterinary Medicine Research Trust; Merck-Merial Veterinary Scholars Summer Research Program	This research was supported by grants from the Canadian Swine Health Board (www.swinehealth.ca) and by internal funding from the University of Saskatchewan Industry Liaison Office, Western College of Veterinary Medicine Research Trust (www.usask.ca). Salary support for HK was provided by the Merck-Merial Veterinary Scholars Summer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atyeo RF, 1999, VET MICROBIOL, V67, P47, DOI 10.1016/S0378-1135(99)00030-9; Burrough E, 2012, VET MICROBIOL; Burrough ER, 2012, J VET DIAGN INVEST; Chander Y, 2012, J VET DIAGN INVEST, V24, P903, DOI 10.1177/1040638712456975; Duhamel Gerald E., 2001, Animal Health Research Reviews, V2, P3; Gebhart C.J., 2012, P IPVS KOR, VI, P48; Harding J, 2010, P ANN W CAN ASS SWIN, P65; Harding JCS, 2011, C PIJ S SWIN DYS AD, P27; Harding JCS, 2010, INT PIG VET SOC C JU, P740; Harding JCS, 2008, J VET DIAGN INVEST, V20, P274, DOI 10.1177/104063870802000303; Jacobson M, 2004, J MED MICROBIOL, V53, P273, DOI 10.1099/jmm.0.05323-0; JENKINSON SR, 1981, VET REC, V109, P384, DOI 10.1136/vr.109.17.384; Jensen TK, 2010, VET PATHOL, V47, P334, DOI 10.1177/0300985809359054; JONES GF, 1993, J CLIN MICROBIOL, V31, P2611, DOI 10.1128/JCM.31.10.2611-2615.1993; KINYON JM, 1977, INFECT IMMUN, V15, P638, DOI 10.1128/IAI.15.2.638-646.1977; Komarek V, 2009, VET MICROBIOL, V134, P311, DOI 10.1016/j.vetmic.2008.08.017; KUNKLE RA, 1988, J CLIN MICROBIOL, V26, P2357, DOI 10.1128/JCM.26.11.2357-2360.1988; NEEF NA, 1994, INFECT IMMUN, V62, P2395, DOI 10.1128/IAI.62.6.2395-2403.1994; Primus A., 2011, Evidence-based practice: how do we get there? American Association of Swine Veterinarians 42nd Annual Meeting Proceedings, 5-8 March, 2011, Phoenix, Arizona, USA, P109; Rasback T, 2007, MICROBIOL-SGM, V153, P4074, DOI 10.1099/mic.0.2007/008540-0; Rasback T, 2005, VET MICROBIOL, V109, P229, DOI 10.1016/j.vetmic.2005.05.009; Rasback T, 2007, ENVIRON MICROBIOL, V9, P983, DOI 10.1111/j.1462-2920.2006.01220.x; Rohde J, 2002, J CLIN MICROBIOL, V40, P2598, DOI 10.1128/JCM.40.7.2598-2600.2002; Song Y, 2009, VET MICROBIOL, V137, P129, DOI 10.1016/j.vetmic.2008.12.020; TAYLOR DJ, 1971, BRIT VET J, V127, pR58, DOI 10.1016/S0007-1935(17)37282-2; Trott DJ, 1996, INT J SYST BACTERIOL, V46, P206, DOI 10.1099/00207713-46-1-206; Whiting R. A., 1921, SWINE DYSENTERY, V257, P3; WILCOCK BP, 1979, VET PATHOL, V16, P450, DOI 10.1177/030098587901600409	28	57	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57146	10.1371/journal.pone.0057146	http://dx.doi.org/10.1371/journal.pone.0057146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460829	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000067
J	Wadghiri, YZ; Li, JL; Wang, JH; Hoang, DM; Sun, YJ; Xu, H; Tsui, W; Li, YS; Boutajangout, A; Wang, A; de Leon, M; Wisniewski, T				Wadghiri, Youssef Zaim; Li, Jialin; Wang, Jinhuan; Hoang, Dung Minh; Sun, Yanjie; Xu, Hong; Tsui, Wai; Li, Yongsheng; Boutajangout, Allal; Wang, Andrew; de Leon, Mony; Wisniewski, Thomas			Detection of Amyloid Plaques Targeted by Bifunctional USPIO in Alzheimer's Disease Transgenic Mice Using Magnetic Resonance Microimaging	PLOS ONE			English	Article							PEGYLATED POLYCYANOACRYLATE NANOPARTICLES; SUPERPARAMAGNETIC IRON-OXIDE; CENTRAL-NERVOUS-SYSTEM; IN-VIVO MRI; THERAPEUTIC APPROACH; NEURITIC PLAQUES; BETA PLAQUES; BRAIN; MODEL; VITRO	Amyloid plaques are a key pathological hallmark of Alzheimer's disease (AD). The detection of amyloid plaques in the brain is important for the diagnosis of AD, as well as for following potential amyloid targeting therapeutic interventions. Our group has developed several contrast agents to detect amyloid plaques in vivo using magnetic resonance microimaging (mu MRI) in AD transgenic mice, where we used mannitol to enhance blood brain barrier (BBB) permeability. In the present study, we used bifunctional ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles, chemically coupled with A beta 1-42 peptide to image amyloid plaque deposition in the mouse brain. We coupled the nanoparticles to polyethylene glycol (PEG) in order to improve BBB permeability. These USPIO-PEG-A beta 1-42 nanoparticles were injected intravenously in AD model transgenic mice followed by initial in vivo and subsequent ex vivo mu MRI. A 3D gradient multi-echo sequence was used for imaging with a 100 mu m isotropic resolution. The amyloid plaques detected by T2*-weighted mu MRI were confirmed with matched histological sections. The region of interest-based quantitative measurement of T2* values obtained from the in vivo mu MRI showed contrast injected AD Tg mice had significantly reduced T2* values compared to wild-type mice. In addition, the ex vivo scans were examined with voxel-based analysis (VBA) using statistical parametric mapping (SPM) for comparison of USPIO-PEG-A beta 1-42 injected AD transgenic and USPIO alone injected AD transgenic mice. The regional differences seen by VBA in the USPIO-PEG-A beta 1-42 injected AD transgenic correlated with the amyloid plaque distribution histologically. Our results indicate that USPIO-PEG-A beta 1-42 can be used for amyloid plaque detection in vivo by intravenous injection without the need to co-inject an agent which increases permeability of the BBB. This technique could aid the development of novel amyloid targeting drugs by allowing therapeutic effects to be followed longitudinally in model AD mice.	[Wadghiri, Youssef Zaim; Hoang, Dung Minh] NYU, Sch Med, Dept Radiol, New York, NY 10003 USA; [Sun, Yanjie; Li, Yongsheng; Boutajangout, Allal; Wisniewski, Thomas] NYU, Sch Med, Dept Neurol, New York, NY USA; [Tsui, Wai; de Leon, Mony; Wisniewski, Thomas] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Pathol, New York, NY USA; [de Leon, Mony] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Xu, Hong; Wang, Andrew] Ocean NanoTech LLC, Springdale, AR USA; [Li, Jialin; Wang, Jinhuan] Tianjin Huanhu Hosp, Tianjin, Peoples R China	New York University; New York University; New York University; New York University; Nathan Kline Institute for Psychiatric Research	Wadghiri, YZ (corresponding author), NYU, Sch Med, Dept Radiol, New York, NY 10003 USA.	Youssef.ZaimWadghiri@nyumc.org; Thomas.wisniewski@nyumc.org	Wisniewski, Thomas/Q-6525-2019; li, jia/GVT-7587-2022; Wadghiri, Youssef/E-6848-2016; Wadghiri, Youssef Zaim/Q-5110-2019; de Leon, Mony/AAP-7890-2021	Wisniewski, Thomas/0000-0002-3379-8966; Wadghiri, Youssef/0000-0001-7175-9397; Wadghiri, Youssef Zaim/0000-0001-7175-9397; de Leon, Mony/0000-0003-2245-4380	NIH [AG20245, NS073502]; Alzheimer Association [IIRG-08-91618]; American Health Assistance Foundation [ADR-A2008-155]; Tianjin Municipal Science and Technology Commission [09JCZDJC20200]; Tianjin Public Health Bureau [(06KG09).73502]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020245, P30AG008051] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); American Health Assistance Foundation; Tianjin Municipal Science and Technology Commission; Tianjin Public Health Bureau; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This manuscript was supported by NIH grants AG20245 and NS073502 to TW. In addition, it was supported by the Alzheimer Association (IIRG-08-91618) and the American Health Assistance Foundation (ADR-A2008-155) to YZW. This research was also supported by funds from the Tianjin Municipal Science and Technology Commission (09JCZDJC20200), as well as by funds from the Tianjin Public Health Bureau (06KG09).73502 to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, ALZH DIS FACTS FIG; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Baltes C, 2011, METHODS MOL BIOL, V711, P511, DOI 10.1007/978-1-61737-992-5_26; Benveniste H, 1999, P NATL ACAD SCI USA, V96, P14079, DOI 10.1073/pnas.96.24.14079; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Braakman N, 2006, J MAGN RESON IMAGING, V24, P530, DOI 10.1002/jmri.20675; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Calvo P, 2001, PHARMACEUT RES, V18, P1157, DOI 10.1023/A:1010931127745; Calvo P, 2002, EUR J NEUROSCI, V15, P1317, DOI 10.1046/j.1460-9568.2002.01967.x; Chamberlain R, 2011, CURR MED IMAGING, V7, P3, DOI 10.2174/157340511794653522; Dubois A, 2008, NEUROIMAGE, V40, P482, DOI 10.1016/j.neuroimage.2007.11.054; Dubois A, 2010, NEUROIMAGE, V51, P586, DOI 10.1016/j.neuroimage.2010.02.074; Engberink RDO, 2010, NMR BIOMED, V23, P1087, DOI 10.1002/nbm.1536; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Jack CR, 2005, J NEUROSCI, V25, P10041, DOI 10.1523/JNEUROSCI.2588-05.2005; Jack CR, 2004, MAGN RESON MED, V52, P1263, DOI 10.1002/mrm.20266; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Koffie RM, 2011, P NATL ACAD SCI USA, V108, P18837, DOI 10.1073/pnas.1111405108; Ku ST, 2010, BIOCHEM BIOPH RES CO, V394, P871, DOI 10.1016/j.bbrc.2010.03.006; Larbanoix L, 2010, NEUROBIOL AGING, V31, P1679, DOI 10.1016/j.neurobiolaging.2008.09.021; Li JW, 2011, BIOMATERIALS, V32, P4943, DOI 10.1016/j.biomaterials.2011.03.031; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; Matsuda H, 2012, NEUROIMAG CLIN N AM, V22, P57, DOI 10.1016/j.nic.2011.11.005; McCarty DM, 2009, GENE THER, V16, P1340, DOI 10.1038/gt.2009.85; MCLACHLAN SJ, 1994, JMRI-J MAGN RESON IM, V4, P301, DOI 10.1002/jmri.1880040313; Nieman BJ, 2009, MAGN RESON MED, V61, P1148, DOI 10.1002/mrm.21945; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Poduslo JF, 2002, NEUROBIOL DIS, V11, P315, DOI 10.1006/nbdi.2002.0550; Provenzale JM, 2009, AM J NEURORADIOL, V30, P1293, DOI 10.3174/ajnr.A1590; Ramakrishnan M, 2009, BIOCHEMISTRY-US, V48, P10405, DOI 10.1021/bi900523q; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; Scholtzova H, 2008, J NEUROSCI RES, V86, P2784, DOI 10.1002/jnr.21713; Sigurdsson EM, 2008, NEUROBIOL AGING, V29, P836, DOI 10.1016/j.neurobiolaging.2006.12.018; Sigurdsson Einar M., 2004, P47; Sigurdsson EM, 2001, AM J PATHOL, V159, P439, DOI 10.1016/S0002-9440(10)61715-4; Sigurdsson EM, 2002, NEUROBIOL AGING, pA1307; Vanhoutte G, 2005, MAGN RESON MED, V53, P607, DOI 10.1002/mrm.20385; Wadghiri Y. Z., 2005, AMYLOID PROTEINS MET, P365; Wadghiri YZ, 2012, METHODS MOL BIOL, V849, P435, DOI 10.1007/978-1-61779-551-0_30; Wadghiri YZ, 2003, MAGN RESON MED, V50, P293, DOI 10.1002/mrm.10529; WEISSLEDER R, 1990, RADIOLOGY, V175, P494, DOI 10.1148/radiology.175.2.2326475; WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474; Winer JL, 2011, WORLD NEUROSURG, V75, P626, DOI 10.1016/j.wneu.2011.02.016; Wisniewski T, 2008, LANCET NEUROL, V7, P805, DOI 10.1016/S1474-4422(08)70170-4; Wisniewski T, 2010, BBA-MOL BASIS DIS, V1802, P847, DOI 10.1016/j.bbadis.2010.05.004; Wisniewski T, 2010, MT SINAI J MED, V77, P17, DOI 10.1002/msj.20156; Yang J, 2011, NEUROIMAGE, V55, P1600, DOI 10.1016/j.neuroimage.2011.01.023; Yasuhara T, 2010, J CELL MOL MED, V14, P914, DOI 10.1111/j.1582-4934.2008.00671.x	52	78	79	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57097	10.1371/journal.pone.0057097	http://dx.doi.org/10.1371/journal.pone.0057097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468919	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000062
J	Wavre-Shapton, ST; Tolmachova, T; da Silva, ML; Futter, CE; Seabra, MC				Wavre-Shapton, Silene T.; Tolmachova, Tanya; da Silva, Mafalda Lopes; Futter, Clare E.; Seabra, Miguel C.			Conditional Ablation of the Choroideremia Gene Causes Age-Related Changes in Mouse Retinal Pigment Epithelium	PLOS ONE			English	Article							MACULAR DEGENERATION; RAB GTPASES; MODELS; RPE; PHAGOSOMES; PROTEOME; DISEASE; CELLS	The retinal pigment epithelium (RPE) is a pigmented monolayer of cells lying between the photoreceptors and a layer of fenestrated capillaries, the choriocapillaris. Choroideremia (CHM) is an X-linked progressive degeneration of these three layers caused by the loss of function of Rab Escort protein-1 (REP1). REP1 is involved in the prenylation of Rab proteins, key regulators of membrane trafficking. To study the pathological consequences of chronic disruption of membrane traffic in the RPE we used a cell type-specific knock-out mouse model of the disease, where the Chm/Rep1 gene is deleted only in pigmented cells (Chm(Flox), Tyr-Cre+). Transmission electron microscopy (TEM) was used to quantitate the melanosome distribution in the RPE and immunofluorescent staining of rhodopsin was used to quantitate phagocytosed rod outer segments in retinal sections. The ultrastructure of the RPE and Bruch's membrane at different ages was characterised by TEM to analyse age-related changes occurring as a result of defects in membrane traffic pathways. Chm/Rep1 gene knockout in RPE cells resulted in reduced numbers of melanosomes in the apical processes and delayed phagosome degradation. In addition, the RPE accumulated pathological changes at 5-6 months of age similar to those observed in 2-year old controls. These included the intracellular accumulation of lipofuscin-containing deposits, disorganised basal infoldings and the extracellular accumulation of basal laminar and basal linear deposits. The phenotype of the Chm(Flox), Tyr-Cre+ mice suggests that loss of the Chm/Rep1 gene causes premature accumulation of features of aging in the RPE. Furthermore, the striking similarities between the present observations and some of the phenotypes reported in age-related macular degeneration (AMD) suggest that membrane traffic defects may contribute to the pathogenesis of AMD.	[Wavre-Shapton, Silene T.; Tolmachova, Tanya; da Silva, Mafalda Lopes; Seabra, Miguel C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, London, England; [Wavre-Shapton, Silene T.; da Silva, Mafalda Lopes; Futter, Clare E.] UCL, UCL Inst Ophthalmol, London, England; [Seabra, Miguel C.] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1200 Lisbon, Portugal; [Seabra, Miguel C.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Imperial College London; University of London; University College London; Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia	Futter, CE (corresponding author), UCL, UCL Inst Ophthalmol, London, England.	c.futter@ucl.ac.uk; m.seabra@imperial.ac.uk	Seabra, Miguel/AAC-3099-2019; Seabra, Miguel C/M-3280-2013	Seabra, Miguel C/0000-0002-6404-4892; Tolmachova, Tanya/0000-0002-8841-0797; Futter, Clare/0000-0001-5559-9389; Lopes da Silva, Mafalda/0000-0001-7651-8656	Medical Research Council; Wellcome trust; MRC [G0700778] Funding Source: UKRI; Medical Research Council [G0700778] Funding Source: researchfish; Fight for Sight [1936/38] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight	Funding came from the Medical Research Council (http://www.mrc.ac.uk) and the Wellcome trust (http://www.wellcome.ac.uk/). The authors also acknowledge contribution from Choroideremia Research Foundation Inc.(http://choroideremia.org/) and Tommy Salisbury fund (http://www.fightforsight.org.uk/tommysalisburyfund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; Bonilha VL, 2008, OPHTHALMIC GENET, V29, P99, DOI 10.1080/13816810802206499; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; Futter CE, 2004, MOL BIOL CELL, V15, P2264, DOI 10.1091/mbc.E03-10-0772; Gibbs D, 2004, J CELL SCI, V117, P6473, DOI 10.1242/jcs.01580; Gordiyenko NV, 2009, INVEST OPHTH VIS SCI, V51, P1143; Guymer RH, 2004, INVEST OPHTH VIS SCI, V45, P1660, DOI 10.1167/iovs.03-0913; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Knupp C, 2002, J STRUCT BIOL, V139, P181, DOI 10.1016/S1047-8477(02)00534-8; Knupp C, 2002, J STRUCT BIOL, V137, P31, DOI 10.1006/jsbi.2002.4449; MISHIMA H, 1978, A GRAEF ARCH KLIN EX, V209, P1, DOI 10.1007/BF00419157; MISHIMA H, 1981, EXP EYE RES, V33, P75, DOI 10.1016/S0014-4835(81)80083-8; Rakoczy PE, 2006, EXP EYE RES, V82, P741, DOI 10.1016/j.exer.2005.10.012; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Reale E, 2001, MATRIX BIOL, V20, P37, DOI 10.1016/S0945-053X(00)00132-3; Roberts EA, 2006, J CELL BIOL, V174, P923, DOI 10.1083/jcb.200603026; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Strunnikova NV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008402; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Tolmachova T, 2006, J CLIN INVEST, V116, P386, DOI 10.1172/JCI26617; Tolmachova T, 2010, INVEST OPHTH VIS SCI, V51, P4913, DOI 10.1167/iovs.09-4892; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160	28	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57769	10.1371/journal.pone.0057769	http://dx.doi.org/10.1371/journal.pone.0057769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460904	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000159
J	Yonezawa, K; Igarashi, M; Ueno, K; Takada, A; Ito, K				Yonezawa, Kouki; Igarashi, Manabu; Ueno, Keisuke; Takada, Ayato; Ito, Kimihito			Resampling Nucleotide Sequences with Closest-Neighbor Trimming and Its Comparison to Other Methods	PLOS ONE			English	Article							PHYLOGENETIC TREES; INFLUENZA; EVOLUTION	A large number of nucleotide sequences of various pathogens are available in public databases. The growth of the datasets has resulted in an enormous increase in computational costs. Moreover, due to differences in surveillance activities, the number of sequences found in databases varies from one country to another and from year to year. Therefore, it is important to study resampling methods to reduce the sampling bias. A novel algorithm-called the closest-neighbor trimming method-that resamples a given number of sequences from a large nucleotide sequence dataset was proposed. The performance of the proposed algorithm was compared with other algorithms by using the nucleotide sequences of human H3N2 influenza viruses. We compared the closest-neighbor trimming method with the naive hierarchical clustering algorithm and k-medoids clustering algorithm. Genetic information accumulated in public databases contains sampling bias. The closest-neighbor trimming method can thin out densely sampled sequences from a given dataset. Since nucleotide sequences are among the most widely used materials for life sciences, we anticipate that our algorithm to various datasets will result in reducing sampling bias.	[Yonezawa, Kouki] Nagahama Inst Biosci & Technol, Dept Comp Biosci, Nagahama, Shiga, Japan; [Igarashi, Manabu; Ueno, Keisuke; Ito, Kimihito] Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido, Japan; [Takada, Ayato] Hokkaido Univ, Div Global Epidemiol, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Ito, K (corresponding author), Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido, Japan.	itok@czc.hokudai.ac.jp	Igarashi, Manabu/F-6871-2012; Ito, Kimihito/E-9975-2012	Ito, Kimihito/0000-0003-4986-1795	Global COE Program "Establishment of International Collaboration Centers for Zoonosis Control" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24700289]; PRESTO from Japan Science and Technology Agency (JST); SORST from Japan Science and Technology Agency (JST)	Global COE Program "Establishment of International Collaboration Centers for Zoonosis Control" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); PRESTO from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); SORST from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by the Global COE Program "Establishment of International Collaboration Centers for Zoonosis Control", the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), KAKENHI 24700289, all from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and PRESTO and SORST from Japan Science and Technology Agency (JST) Basic Research Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2010, HIV SEQ COMP 2010; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; ITO K, 2011, PLOS ONE, V6; Jukes T.H., 1969, EVOLUTION PROTEIN MO, P21; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Pevzner PA, 2001, COMPUTATIONAL MOL BI, P123; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Socal RR, 1958, U KANSAS SCI B, V38, P1409; VINOD HD, 1969, J AM STAT ASSOC, V64, P506, DOI 10.2307/2283635; Zaslavsky L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-237	17	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57684	10.1371/journal.pone.0057684	http://dx.doi.org/10.1371/journal.pone.0057684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460894	Green Published, gold			2022-12-27	WOS:000315519000149
J	Bonartsev, A; Yakovlev, S; Boskhomdzhiev, A; Zharkova, I; Bagrov, D; Myshkina, V; Mahina, T; Kharitonova, E; Samsonova, O; Zernov, A; Zhuikov, V; Efremov, Y; Voinova, V; Bonartseva, G; Shaitan, K				Bonartsev, Anton; Yakovlev, Sergey; Boskhomdzhiev, Arasha; Zharkova, Irina; Bagrov, Dmitrii; Myshkina, Vera; Mahina, Tatiana; Kharitonova, Elena; Samsonova, Olga; Zernov, Anton; Zhuikov, Vsevolod; Efremov, Yurii; Voinova, Vera; Bonartseva, Garina; Shaitan, Konstantin			The Terpolymer Produced by Azotobacter Chroococcum 7B: Effect of Surface Properties on Cell Attachment	PLOS ONE			English	Article							POLY(ETHYLENE GLYCOL); MOLECULAR-WEIGHT; IN-VITRO; CRYSTALLIZATION; COPOLYMER; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE); POLYHYDROXYALKANOATES; BIOCOMPATIBILITY; BIODEGRADATION; BIOSYNTHESIS	The copolymerization of poly(3-hydroxybutyrate) (PHB) is a promising trend in bioengineering to improve biomedical properties, e. g. biocompatibility, of this biodegradable polymer. We used strain Azotobacter chroococcum 7B, an effective producer of PHB, for biosynthesis of not only homopolymer and its main copolymer, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB-HV), but also novel terpolymer, poly(3-hydroxybutyrate-co-3-hydroxyvalerate)-poly(ethylene glycol) (PHB-HV-PEG), using sucrose as the primary carbon source and valeric acid and poly(ethylene glycol) 300 (PEG 300) as additional carbon sources. The chemical structure of PHB-HV-PEG was confirmed by 1 H nuclear-magnetic resonance analysis. The physico-chemical properties (molecular weight, crystallinity, hydrophilicity, surface energy) of produced biopolymer, the protein adsorption to the terpolymer, and cell growth on biopolymer films were studied. Despite of low EG-monomers content in bacterial-origin PHB-HV-PEG polymer, the terpolymer demonstrated significant improvement in biocompatibility in vitro in contrast to PHB and PHB-HV polymers, which may be coupled with increased protein adsorption, hydrophilicity and surface roughness of PEG-containing copolymer.	[Bonartsev, Anton; Zharkova, Irina; Bagrov, Dmitrii; Samsonova, Olga; Zhuikov, Vsevolod; Efremov, Yurii; Voinova, Vera; Shaitan, Konstantin] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Bonartsev, Anton; Yakovlev, Sergey; Boskhomdzhiev, Arasha; Myshkina, Vera; Mahina, Tatiana; Zernov, Anton; Voinova, Vera; Bonartseva, Garina] Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia; [Kharitonova, Elena] Moscow MV Lomonosov State Univ, Fac Phys, Moscow, Russia	Lomonosov Moscow State University; Research Center of Biotechnology RAS; Russian Academy of Sciences; Lomonosov Moscow State University	Bonartsev, A (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia.	ant_bonar@mail.ru	Shaitan, Konstantin V/F-2316-2014; Zhuikov, Vsevolod/L-7180-2018; Zharkova, Irina/S-4349-2016; Voinova, Vera/AAQ-4252-2021; Yakovlev, Sergey G/E-2747-2014; Bonartseva, Garina A/F-7593-2017; Efremov, Yuri M./F-2716-2012; Bagrov, Dmitry V./E-5867-2014; Bonartsev, Anton/A-8737-2014; Voinova, Vera Vladimirovna/S-4428-2016	Shaitan, Konstantin V/0000-0002-5137-303X; Zhuikov, Vsevolod/0000-0003-2852-8002; Zharkova, Irina/0000-0001-5601-2850; Voinova, Vera/0000-0002-0253-6461; Yakovlev, Sergey G/0000-0002-7892-2940; Bonartseva, Garina A/0000-0003-0701-2402; Efremov, Yuri M./0000-0001-7040-253X; Bagrov, Dmitry V./0000-0002-6355-7282; Bonartsev, Anton/0000-0001-5894-9524; Voinova, Vera Vladimirovna/0000-0002-0253-6461; Kharitonova, Elena/0000-0002-6849-7805; Dague, Etienne/0000-0003-3290-9166	Federal Target Programs of RF Ministry of Education and Science [16.512.11.2019, 14.740.11.1077, 16.740.11.0652]; Ministry of Industry and Trade [12411.1008799.13.148]	Federal Target Programs of RF Ministry of Education and Science; Ministry of Industry and Trade	The work is supported by Federal Target Programs of RF Ministry of Education and Science (http://www.fcpir.ru,http://www.fcpk.ru) projects # 16.512.11.2019, 14.740.11.1077, 16.740.11.0652 and Ministry of Industry and Trade (http://www.minpromtorg.gov.ru) projects # 12411.1008799.13.148. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpar B, 2000, Clin Oral Investig, V4, P219, DOI 10.1007/s007840000079; Ashby RD, 2002, APPL MICROBIOL BIOT, V60, P154, DOI 10.1007/s00253-002-1110-9; Ashby RD, 1997, TETRAHEDRON, V53, P15209, DOI 10.1016/S0040-4020(97)00958-7; Ashby RD, 1999, BIOTECHNOL BIOENG, V62, P106, DOI 10.1002/(SICI)1097-0290(19990105)62:1<106::AID-BIT12>3.0.CO;2-X; Asrar J, 2002, BIOMACROMOLECULES, V3, P1006, DOI 10.1021/bm025543a; AVELLA M, 1988, POLYMER, V29, P1731, DOI 10.1016/0032-3861(88)90384-9; BARHAM PJ, 1984, J MATER SCI, V19, P2781, DOI 10.1007/BF01026954; Bonartsev AP, 2011, BIOCHEM MOSC-SUPPL S, V5, P10, DOI 10.1134/S1990750811010045; Bonartseva GA, 2003, Patent RF, Patent No. 2201453; Bonartseva GA, 2007, Patent RF, Patent No. 2307159; BONI LT, 1984, BIOCHIM BIOPHYS ACTA, V775, P409, DOI 10.1016/0005-2736(84)90198-6; Boskhomdzhiev AP, 2010, BIOCHEM MOSC-SUPPL S, V4, P177, DOI 10.1134/S1990750810020083; Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036; Cheng GX, 2003, J MATER SCI-MATER M, V14, P1073, DOI 10.1023/B:JMSM.0000004004.37103.f4; Chibowski E, 2009, CONTACT ANGLE, WETTABILITY AND ADHESION, VOL 6, P283; Choi GG, 2004, J MICROBIOL, V42, P346; Cochran David, 1994, Int J Oral Maxillofac Implants, V9, P289; Collier T O, 1997, Biomed Sci Instrum, V33, P178; ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B; Jenkins M, 2007, WOODHEAD PUBL MATER, P1; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Kuo SM, 1997, ARTIF CELL BLOOD SUB, V25, P551, DOI 10.3109/10731199709117452; Lentz BR, 1999, MOL MEMBR BIOL, V16, P279, DOI 10.1080/096876899294508; Lenz RW, 2005, BIOMACROMOLECULES, V6, P1, DOI 10.1021/bm049700c; Li GY, 2011, J BIOMED MATER RES A, V98A, P88, DOI 10.1002/jbm.a.33100; Li X, 2005, BIOMACROMOLECULES, V6, P2740, DOI 10.1021/bm050234g; Misra SK, 2009, J R SOC INTERFACE, V6, P401, DOI 10.1098/rsif.2008.0278; Moisenovich MM, 2011, J BIOMED MATER RES A, V96A, P125, DOI 10.1002/jbm.a.32968; Moisenovich MM, 2012, BIOMATERIALS, V33, P3887, DOI 10.1016/j.biomaterials.2012.02.013; Myshkina VL, 2008, APPL BIOCHEM MICRO+, V44, P482, DOI 10.1134/S0003683808050050; Myshkina VL, 2010, APPL BIOCHEM MICRO+, V46, P289, DOI 10.1134/S0003683810030075; PAGE WJ, 1995, CAN J MICROBIOL, V41, P106, DOI 10.1139/m95-176; Pan JY, 2009, BIOMATERIALS, V30, P2975, DOI 10.1016/j.biomaterials.2009.02.005; PEARCE RP, 1994, MACROMOLECULES, V27, P3869, DOI 10.1021/ma00092a029; Prudskova TN, 2006, Patent RF, Patent No. 2333962; Qu XH, 2006, BIOMATERIALS, V27, P2944, DOI 10.1016/j.biomaterials.2006.01.013; Savenkova L, 2000, PROCESS BIOCHEM, V36, P445, DOI 10.1016/S0032-9592(00)00235-1; Shi FY, 1996, MACROMOLECULES, V29, P10, DOI 10.1021/ma950707j; Shi FY, 1996, MACROMOLECULES, V29, P7753, DOI 10.1021/ma960805k; Shimizu RN, 2000, J APPL POLYM SCI, V76, P1831, DOI 10.1002/(SICI)1097-4628(20000620)76:12<1831::AID-APP14>3.0.CO;2-Q; Shtilman MI, 2003, POLYM BIOMATERIALS 1; Smidt E, 2010, THERMOCHIM ACTA, V501, P91, DOI 10.1016/j.tca.2010.01.015; STEINBUCHEL A, 1992, FEMS MICROBIOL LETT, V103, P217, DOI 10.1016/0378-1097(92)90313-D; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O; Xiao RZ, 2010, INT J NANOMED, V5, P1057, DOI [10.2147/ijn.S14912, 10.2147/IJN.S14912]; YAMAZAKI M, 1990, BIOCHEMISTRY-US, V29, P1309, DOI 10.1021/bi00457a029; Zanzig J, 2003, J BIOACT COMPAT POL, V18, P339, DOI 10.1177/0883911503038229; Zharkova I. I., 2012, Biomeditsinskaya Khimiya, V58, P579; Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041; Zorlutuna P, 2008, J BIOMAT SCI-POLYM E, V19, P399, DOI 10.1163/156856208783720976	50	32	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57200	10.1371/journal.pone.0057200	http://dx.doi.org/10.1371/journal.pone.0057200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468935	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400030
J	Yaniv, Y; Spurgeon, HA; Ziman, BD; Lakatta, EG				Yaniv, Yael; Spurgeon, Harold A.; Ziman, Bruce D.; Lakatta, Edward G.			Ca2+/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity and Sinoatrial Nodal Pacemaker Cell Energetics	PLOS ONE			English	Article							CA2+ RELEASES; K+ CHANNELS; CALMODULIN; CALCIUM; CONTRACTION; PHOSPHORYLATION; RAT	Ca2+-activated basal adenylate cyclase (AC) in rabbit sinoatrial node cells (SANC) guarantees, via basal cAMP/PKA-calmodulin/CaMKII-dependent protein phosphorylation, the occurrence of rhythmic, sarcoplasmic-reticulum generated, sub-membrane Ca2+ releases that prompt rhythmic, spontaneous action potentials (APs). This high-throughput signaling consumes ATP. Aims: We have previously demonstrated that basal AC-cAMP/PKA signaling directly, and Ca2+ indirectly, regulate mitochondrial ATP production. While, clearly, Ca2+-calmodulin-CaMKII activity regulates ATP consumption, whether it has a role in the control of ATP production is unknown. Methods and Results: We superfused single, isolated rabbit SANC at 37 degrees C with physiological saline containing CaMKII inhibitors, (KN-93 or autocamtide-2 Related Inhibitory Peptide (AIP)), or a calmodulin inhibitor (W-7) and measured cytosolic Ca2+, flavoprotein fluorescence and spontaneous AP firing rate. We measured cAMP, ATP and O-2 consumption in cell suspensions. Graded reductions in basal CaMKII activity by KN-93 (0.5-3 mu mol/L) or AIP (2-10 mu mol/L) markedly slow the kinetics of intracellular Ca2+ cycling, decrease the spontaneous AP firing rate, decrease cAMP, and reduce O-2 consumption and flavoprotein fluorescence. In this context of graded reductions in ATP demand, however, ATP also becomes depleted, indicating reduced ATP production. Conclusions: CaMKII signaling, a crucial element of normal automaticity in rabbit SANC, is also involved in SANC bioenergetics.	[Yaniv, Yael; Spurgeon, Harold A.; Ziman, Bruce D.; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Intramural Res Program,NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lakatta, EG (corresponding author), NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Intramural Res Program,NIH, Baltimore, MD 21224 USA.	LakattaE@mail.nih.gov	Yaniv, Yael/B-3311-2015; Lakatta, Edward G/AAL-1447-2020	Yaniv, Yael/0000-0002-5183-6284; Lakatta, Edward/0000-0002-4772-0035	Intramural Research Program of the National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000874] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported entirely by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2011, J MOL CELL CARDIOL; Boyett MR, 2000, CARDIOVASC RES, V47, P658, DOI 10.1016/S0008-6363(00)00135-8; Covian R, 2012, AM J PHYSL HEART CIR; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047; Fukuzaki K, 2008, J PHYSIOL-LONDON, V586, P2767, DOI 10.1113/jphysiol.2007.148932; Gao Z, 2011, CIRC-ARRHYTHMIA ELEC, V4, P379, DOI 10.1161/CIRCEP.110.961771; Ke YB, 2007, CIRC RES, V100, P1317, DOI 10.1161/01.RES.0000266742.51389.a4; Khan SZ, 2000, BIOCHEM PHARMACOL, V60, P1797, DOI 10.1016/S0006-2952(00)00505-0; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; Lee DI, 2012, PHYSIOLOGY, V27, P248, DOI 10.1152/physiol.00011.2012; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Mattick P, 2007, J PHYSIOL-LONDON, V582, P1195, DOI 10.1113/jphysiol.2007.133439; Rigg L, 2003, CARDIOVASC RES, V57, P497, DOI 10.1016/S0008-6363(02)00668-5; Saks V, 2008, INT J MOL SCI, V9, P751, DOI 10.3390/ijms9050751; Sham JSK, 1997, J PHYSIOL-LONDON, V500, P285, DOI 10.1113/jphysiol.1997.sp022020; Sirenko S, 2008, CIRCULATION, V118, pS346; SPURGEON HA, 1990, AM J PHYSIOL, V258, pH574, DOI 10.1152/ajpheart.1990.258.2.H574; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; Vinogradova T., 2011, CIRCULATION, V124; Vinogradova TM, 2008, CIRC RES, V102, P761, DOI 10.1161/CIRCRESAHA.107.161679; Vinogradova TM, 2010, CIRC RES, V107, P767, DOI 10.1161/CIRCRESAHA.110.220517; Vinogradova TM, 2000, CIRC RES, V87, P760, DOI 10.1161/01.RES.87.9.760; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Wu YJ, 2009, P NATL ACAD SCI USA, V106, P5972, DOI 10.1073/pnas.0806422106; YAMADA EW, 1988, J BIOL CHEM, V263, P11498; Yaniv Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037582; Yaniv Y, 2011, J MOL CELL CARDIOL, V51, P740, DOI 10.1016/j.yjmcc.2011.07.018; Younes A, 2008, J BIOL CHEM, V283, P14461, DOI 10.1074/jbc.M707540200; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215	32	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57079	10.1371/journal.pone.0057079	http://dx.doi.org/10.1371/journal.pone.0057079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23459256	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500062
J	Ung, CY; Lam, SH; Zhang, X; Li, H; Zhang, LX; Li, BW; Gong, ZY				Ung, Choong Yong; Lam, Siew Hong; Zhang, Xun; Li, Hu; Zhang, Louxin; Li, Baowen; Gong, Zhiyuan			Inverted Expression Profiles of Sex-Biased Genes in Response to Toxicant Perturbations and Diseases	PLOS ONE			English	Article							ZEBRAFISH SPOTTED-MICROARRAY; X-CHROMOSOME INACTIVATION; DEPENDENT ASSOCIATION; BLOOD INSTITUTE; NATIONAL HEART; POLYMORPHISMS; SELECTION; WOMEN; AGE; MAINTENANCE	The influence of sex factor is widely recognized in various diseases, but its molecular basis, particularly how sex-biased genes, those with sexually dimorphic expression, behave in response to toxico-pathological changes is poorly understood. In this study, zebrafish toxicogenomic data and transcriptomic data from human pathological studies were analysed for the responses of male- and female-biased genes. Our analyses revealed obvious inverted expression profiles of sex-biased genes, where affected males tended to up-regulate genes of female-biased expression and down-regulate genes of male-biased expression, and vice versa in affected females, in a broad range of toxico-pathological conditions. Intriguingly, the extent of these inverted profiles correlated well to the susceptibility or severity of a given toxico-pathological state, suggesting that inverted expression profiles of sex-biased genes observed in this study can be used as important indicators to assess biological disorders.	[Ung, Choong Yong; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Ung, Choong Yong] Univ Malaya, Inst Biol Sci, Bioinformat Programme, Kuala Lumpur, Malaysia; [Zhang, Xun; Zhang, Louxin; Li, Baowen; Gong, Zhiyuan] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Zhang, Xun; Li, Baowen] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore; [Zhang, Xun; Li, Baowen] Natl Univ Singapore, Ctr Computat Sci & Engn, Singapore 117548, Singapore; [Li, Hu] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Zhang, Louxin] Natl Univ Singapore, Dept Math, Singapore 117548, Singapore	National University of Singapore; Universiti Malaya; National University of Singapore; National University of Singapore; National University of Singapore; Boston University; National University of Singapore	Ung, CY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Kent Ridge, Singapore 117548, Singapore.	zencyung@gmail.com; dbsgzy@nus.edu.sg	Zhang, Louxin/M-4865-2016; Gong, Zhiyuan/H-8794-2012; Li, Baowen/G-3003-2011; Lam, Siew Hong/H-8483-2012	Zhang, Louxin/0000-0003-0260-824X; Gong, Zhiyuan/0000-0002-9660-5260; Li, Baowen/0000-0002-8728-520X; 	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme; Environment & Water Industry Programme Office (EWI) of the PUB [R-154-000-328-272]	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme; Environment & Water Industry Programme Office (EWI) of the PUB	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, NATURE, V411, P692, DOI 10.1038/35079590; Anderson GD, 2005, J WOMENS HEALTH, V14, P19, DOI 10.1089/jwh.2005.14.19; Barnes MG, 2009, ARTHRITIS RHEUM-US, V60, P2102, DOI 10.1002/art.24601; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Candolin U, 2008, TRENDS ECOL EVOL, V23, P446, DOI 10.1016/j.tree.2008.04.008; Chen WY, 2004, BIOCHEM BIOPH RES CO, V319, P866, DOI 10.1016/j.bbrc.2004.05.060; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Connallon T, 2005, TRENDS GENET, V21, P495, DOI 10.1016/j.tig.2005.07.006; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Ellsworth DL, 2001, J MOL MED-JMM, V79, P390, DOI 10.1007/s001090100235; Galamb O, 2008, HELICOBACTER, V13, P112, DOI 10.1111/j.1523-5378.2008.00584.x; Giordano TJ, 2009, CLIN CANCER RES, V15, P668, DOI 10.1158/1078-0432.CCR-08-1067; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; HANSEN PS, 1994, CLIN GENET, V45, P78; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Kaltz O, 2002, EVOLUTION, V56, P1743; Kim AM, 2010, NATURE, V465, P688, DOI 10.1038/465688a; Kim ESH, 2008, J AM COLL CARDIOL, V52, P672, DOI 10.1016/j.jacc.2008.05.025; Kwekel JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-675; Lam SH, 2006, PHYSIOL GENOMICS, V27, P351, DOI 10.1152/physiolgenomics.00201.2005; Lam Siew Hong, 2009, V546, P175, DOI 10.1007/978-1-60327-977-2_12; Lam Siew Hong, 2009, V546, P197, DOI 10.1007/978-1-60327-977-2_13; Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Leung KH, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-19; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Matanoski G, 2006, CANCER-AM CANCER SOC, V107, P1112, DOI 10.1002/cncr.22008; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Pennisi E, 2011, SCIENCE, V334, P1486, DOI 10.1126/science.334.6062.1486; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Richards SM, 2006, EXP EYE RES, V82, P13, DOI 10.1016/j.exer.2005.04.014; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; RISCH HA, 1993, AM J EPIDEMIOL, V138, P281, DOI 10.1093/oxfordjournals.aje.a116857; Schott E, 2007, J HEPATOL, V46, P372, DOI 10.1016/j.jhep.2006.09.011; Siller S, 2001, NATURE, V411, P689, DOI 10.1038/35079578; Stearns SC, 2010, P NATL ACAD SCI USA, V107, P1691, DOI 10.1073/pnas.0914475107; Ung CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027819; Vandenbroeck K, 2003, ARTHRITIS RHEUM-US, V48, P2773, DOI 10.1002/art.11236; Vanni H, 2009, CHEST, V135, P1197, DOI 10.1378/chest.08-1024; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337; Verma AS, 2006, J GASTROEN HEPATOL, V21, P1004, DOI 10.1111/j.1440-1746.2005.03948.x; Whitlock MC, 2009, EVOLUTION, V63, P569, DOI 10.1111/j.1558-5646.2008.00558.x; WILLIAMS GC, 1991, Q REV BIOL, V66, P1, DOI 10.1086/417048; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6	53	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56668	10.1371/journal.pone.0056668	http://dx.doi.org/10.1371/journal.pone.0056668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457601	gold, Green Submitted, Green Published			2022-12-27	WOS:000315602700090
J	Ramani, RG; Jacob, SG				Ramani, R. Geetha; Jacob, Shomona Gracia			Prediction of P53 Mutants (Multiple Sites) Transcriptional Activity Based on Structural (2D&3D) Properties	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; TUMOR-SUPPRESSOR GENE; CANCER RESCUE MUTANTS; PROTEIN; CLASSIFICATION; MUTATIONS; INFORMATION; PATTERNS; FEATURES; CRITERIA	Prediction of secondary site mutations that reinstate mutated p53 to normalcy has been the focus of intense research in the recent past owing to the fact that p53 mutants have been implicated in more than half of all human cancers and restoration of p53 causes tumor regression. However laboratory investigations are more often laborious and resource intensive but computational techniques could well surmount these drawbacks. In view of this, we formulated a novel approach utilizing computational techniques to predict the transcriptional activity of multiple site (one-site to five-site) p53 mutants. The optimal MCC obtained by the proposed approach on prediction of one-site, two-site, three-site, four-site and five-site mutants were 0.775,0.341,0.784,0.916 and 0.655 respectively, the highest reported thus far in literature. We have also demonstrated that 2D and 3D features generate higher prediction accuracy of p53 activity and our findings revealed the optimal results for prediction of p53 status, reported till date. We believe detection of the secondary site mutations that suppress tumor growth may facilitate better understanding of the relationship between p53 structure and function and further knowledge on the molecular mechanisms and biological activity of p53, a targeted source for cancer therapy. We expect that our prediction methods and reported results may provide useful insights on p53 functional mechanisms and generate more avenues for utilizing computational techniques in biological data analysis.	[Ramani, R. Geetha] Anna Univ, Coll Engn, Dept Informat Sci & Technol, Chennai 600025, Tamil Nadu, India; [Jacob, Shomona Gracia] Anna Univ, Fac Informat & Commun Engn, Chennai 600025, Tamil Nadu, India	Anna University; Anna University Chennai; Anna University; Anna University Chennai	Jacob, SG (corresponding author), Anna Univ, Fac Informat & Commun Engn, Chennai 600025, Tamil Nadu, India.	graciarun@gmail.com	r, geetharamani/AHH-4747-2022; Jacob, Shomona/GZB-1912-2022	r, geetharamani/0000-0003-2283-3428; 	All India Council for Technical Education (AICTE), India [8023/RID/RPS-56/2010-11, 200-62/FIN/04/05/1624]	All India Council for Technical Education (AICTE), India	This research work is a part of the All India Council for Technical Education (AICTE), India funded Research Promotion Scheme project titled "Efficient Classifier for clinical life data (Parkinson, Breast Cancer and P53 mutants) through feature relevance analysis and classification" with Reference No:8023/RID/RPS-56/2010-11, No:200-62/FIN/04/05/1624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires Rachel, 2009, TECHNICAL REPORT; [Anonymous], 2012, EUR J SCI RES, V78, P468; [Anonymous], 1999, CORRELATION BASED FE; Bai L, 2006, J CANC MOL, V2, P141; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Baroni TE, 2004, P NATL ACAD SCI USA, V101, P4930, DOI 10.1073/pnas.0401162101; Bazzan ALC, 2002, BIOINFORMATICS, V18, pS35, DOI 10.1093/bioinformatics/18.suppl_2.S35; Brachmann KR, 2005, [Global Suppressors of P53 Mutations, PCT No.: PCT/US03/0024], VUS2005/0065332, Patent No. 20050065332; Breiman Leo, RANDOM TREES; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; CMP, CMP DATA MINING STAT; Danziger SA, 2006, IEEE ACM T COMPUT BI, V3, P114, DOI 10.1109/TCBB.2006.22; Danziger SA, 2007, BIOINFORMATICS, V23, pI104, DOI 10.1093/bioinformatics/btm166; Danziger SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000498; Deng HT, 2011, LECT NOTES COMPUT SC, V6792, P293, DOI 10.1007/978-3-642-21738-8_38; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Freund Y., 1995, DECISION THEORETIC G; Friedman J., 1998, ADDITIVE LOGISTIC RE; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Geisser S., 2017, PREDICTIVE INFERENCE; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Hainaut P, 2000, ADV CANCER RES, V77, P81; Harris CC, 1996, CARCINOGENESIS, V17, P1187, DOI 10.1093/carcin/17.6.1187; Harris CC, 1996, JNCI-J NATL CANCER I, V88, P1442, DOI 10.1093/jnci/88.20.1442; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; Hayat M, 2011, J THEOR BIOL, V271, P10, DOI 10.1016/j.jtbi.2010.11.017; Heckerman D., 1995, TECHNICAL REPORT; HEIMDAL K, 1993, GENE CHROMOSOME CANC, V6, P92, DOI 10.1002/gcc.2870060205; Hock AK, 2011, EMBO J, V30, P4921, DOI 10.1038/emboj.2011.419; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022940; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Iba W, 1992, P 9 INT C MACH LEARN, P233, DOI DOI 10.1016/B978-1-55860-247-2.50035-8; Jacob SG, 2012, P INT C ADV COMP COM, P997, DOI [10.1145/2345396.2345557, DOI 10.1145/2345396.2345557]; Jacob SG, 2011, P IEEE INT C COMP IN, P661; Jacob SG., 2011, INT J COMPUTERS APPL, V32, P46, DOI DOI 10.5120/3920-5521; Jacob Shomona Gracia, 2012, P INT C COMP APPL PO, DOI 10.73445/ISBN_0768; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jiang X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-89; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Joshi RR, 2010, PROTEIN PEPTIDE LETT, V17, P1198; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kotsiantis SB, 2007, INFORMATICA, P31249; Le Gall J-F, 2005, RANDOM TREES APPL N; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; Mathe E, 2006, HUM MUTAT, V0, P1; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; Mitchell T.M, 2003, MACH LEARN; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Oliver JJ, 1994, LECT NOTES COMPUTER, V784, P231, DOI [DOI 10.1007/3-540-57868-4-61, 10.1007/3-540-57868-4-61]; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Pourret O., 2008, BAYESIAN NETWORKS PR; Ray A, 2008, MACHINE LEARNING PRE; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Selvakuberan K, 2008, J INFORM COMPUTING S, V3, P083; Soussi T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G; UCI, MACH LEARN REP; Uebersax J, 2004, GENETIC COUNSELLING; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Zakeri P, 2011, J THEOR BIOL, V269, P208, DOI 10.1016/j.jtbi.2010.10.026; Zhang T, 2004, ANN STAT, V32, P56; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	73	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55401	10.1371/journal.pone.0055401	http://dx.doi.org/10.1371/journal.pone.0055401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23468845	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300032
J	Annadurai, RS; Neethiraj, R; Jayakumar, V; Damodaran, AC; Rao, SN; Katta, MAVSK; Gopinathan, S; Sarma, SP; Senthilkumar, V; Niranjan, V; Gopinath, A; Mugasimangalam, RC				Annadurai, Ramasamy S.; Neethiraj, Ramprasad; Jayakumar, Vasanthan; Damodaran, Anand C.; Rao, Sudha Narayana; Katta, Mohan A. V. S. K.; Gopinathan, Sreeja; Sarma, Santosh Prasad; Senthilkumar, Vanitha; Niranjan, Vidya; Gopinath, Ashok; Mugasimangalam, Raja C.			De Novo Transcriptome Assembly (NGS) of Curcuma longa L. Rhizome Reveals Novel Transcripts Related to Anticancer and Antimalarial Terpenoids	PLOS ONE			English	Article							CELL-CYCLE; MULTIDRUG-RESISTANCE; FRUIT-DEVELOPMENT; ESSENTIAL OILS; APOPTOSIS; EXPRESSION; HYPERICIN; DISCOVERY; PATHWAYS; MARKERS	Herbal remedies are increasingly being recognised in recent years as alternative medicine for a number of diseases including cancer. Curcuma longa L., commonly known as turmeric is used as a culinary spice in India and in many Asian countries has been attributed to lower incidences of gastrointestinal cancers. Curcumin, a secondary metabolite isolated from the rhizomes of this plant has been shown to have significant anticancer properties, in addition to antimalarial and antioxidant effects. We sequenced the transcriptome of the rhizome of the 3 varieties of Curcuma longa L. using Illumina reversible dye terminator sequencing followed by de novo transcriptome assembly. Multiple databases were used to obtain a comprehensive annotation and the transcripts were functionally classified using GO, KOG and PlantCyc. Special emphasis was given for annotating the secondary metabolite pathways and terpenoid biosynthesis pathways. We report for the first time, the presence of transcripts related to biosynthetic pathways of several anti-cancer compounds like taxol, curcumin, and vinblastine in addition to anti-malarial compounds like artemisinin and acridone alkaloids, emphasizing turmeric's importance as a highly potent phytochemical. Our data not only provides molecular signatures for several terpenoids but also a comprehensive molecular resource for facilitating deeper insights into the transcriptome of C. longa.	[Annadurai, Ramasamy S.; Neethiraj, Ramprasad; Jayakumar, Vasanthan; Damodaran, Anand C.; Rao, Sudha Narayana; Katta, Mohan A. V. S. K.; Gopinathan, Sreeja; Sarma, Santosh Prasad; Senthilkumar, Vanitha; Niranjan, Vidya; Gopinath, Ashok; Mugasimangalam, Raja C.] Genotyp Technol Private Ltd, Res & Dev Unit, Bangalore, Karnataka, India		Mugasimangalam, RC (corresponding author), Genotyp Technol Private Ltd, Res & Dev Unit, Bangalore, Karnataka, India.	raja@genotypic.co.in	Niranjan, Vidya/AAF-5553-2019; Niranjan, Vidya/O-6464-2016	Niranjan, Vidya/0000-0001-9187-7753; Niranjan, Vidya/0000-0001-9187-7753; Jayakumar, Vasanthan/0000-0002-6067-4184	Genotypic Technology Research and Development Fund; Genotypic Technology Private Limited	Genotypic Technology Research and Development Fund; Genotypic Technology Private Limited	The funds for this study were provided by Genotypic Technology Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The following authors have affiliations to Genotypic Technology Private Limited, the commercial funders of this research, and confirm that this affiliation does not in anyway alter the authors adherence of all PLOS ONE policies on sharing data and materials. 1. Ramasamy S Annadurai 2. Ramprasad Neethiraj 3. Vasanthan Jayakumar 4. Anand C Damodaran 5. Sudha Narayana Rao 6. Mohan AVSK Katta 7. Sreeja Gopinathan 8. Santosh Prasad Sarma 9. Vanitha Senthilkumar 10. Vidya Niranjan 11. Ashok Gopinath 12. Raja C Mugasimangalam The authors Ramasamy S Annadurai and Ashok Gopinath were working at Genotypic Technology Pvt Ltd when they carried out their work. Dr. Ramasamy S Annadurai and Dr. Ashok Gopinath's affiliations to ITC Limited and Sanofi Synthelabo India Limited respectively does not affect the project in any way. These companies were neither funders nor sponsors for this study.	Agostinis P, 2002, INT J BIOCHEM CELL B, V34, P221, DOI 10.1016/S1357-2725(01)00126-1; Ajaiyeoba EO, 2008, PHARM BIOL, V46, P279, DOI 10.1080/13880200701741138; Alappat L, 2010, NUTR REV, V68, P729, DOI 10.1111/j.1753-4887.2010.00341.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carnesecchi S, 2001, J PHARMACOL EXP THER, V298, P197; Chae L, 2012, CURR OPIN PLANT BIOL, V15, P177, DOI 10.1016/j.pbi.2012.01.006; Choudhuri T, 2005, J BIOL CHEM, V280, P20059, DOI 10.1074/jbc.M410670200; Cui L, 2007, ANTIMICROB AGENTS CH, V51, P488, DOI 10.1128/AAC.01238-06; Du HY, 2003, INT J ONCOL, V23, P1401; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Gajate C, 2005, J BIOL CHEM, V280, P11641, DOI 10.1074/jbc.M411781200; Ganta S, 2009, MOL PHARMACEUT, V6, P928, DOI 10.1021/mp800240j; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gupta SC, 2013, MOL NUTR FOOD RES, V57, P1510, DOI 10.1002/mnfr.201100741; Gupta SC, 2012, CLIN EXP PHARMACOL P, V39, P283, DOI 10.1111/j.1440-1681.2011.05648.x; Haddad M, 2011, PLANTA MED, V77, P672, DOI 10.1055/s-0030-1250549; Hamaguchi T, 2010, CNS NEUROSCI THER, V16, P285, DOI 10.1111/j.1755-5949.2010.00147.x; Honda S, 2006, J AGR FOOD CHEM, V54, P9055, DOI 10.1021/jf061788t; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Kawase M, 2005, IN VIVO, V19, P705; Kelly JX, 2009, NATURE, V459, P270, DOI 10.1038/nature07937; Krazeisen A, 2001, MOL CELL ENDOCRINOL, V171, P151, DOI 10.1016/S0303-7207(00)00422-6; Kudapa H, 2012, MOL PLANT, V5, P1020, DOI 10.1093/mp/ssr111; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee B, 2012, BIOCHEM BIOPH RES CO, V421, P76, DOI 10.1016/j.bbrc.2012.03.114; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Q, 2009, ONCOLOGY-BASEL, V77, P335, DOI 10.1159/000264627; Li S., 2011, PHARM CROPS, V2, P28, DOI [DOI 10.2174/2210290601102010028, 10.2174/2210290601102010028]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lu HF, 2009, ONCOL REP, V22, P97, DOI 10.3892/or_00000411; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; Mohandas K M, 1999, Indian J Gastroenterol, V18, P118; Nandakumar DN, 2006, ANTIMICROB AGENTS CH, V50, P1859, DOI 10.1128/AAC.50.5.1859-1860.2006; Negi PS, 1999, J AGR FOOD CHEM, V47, P4297, DOI 10.1021/jf990308d; Park MJ, 2002, INT J ONCOL, V21, P379; Peuhu E, 2010, ONCOGENE, V29, P898, DOI 10.1038/onc.2009.386; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Schatz MC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-243; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Shytle RD, 2009, CURR ALZHEIMER RES, V6, P564, DOI 10.2174/156720509790147115; Stevens JF, 2004, PHYTOCHEMISTRY, V65, P1317, DOI 10.1016/j.phytochem.2004.04.025; Subramaniyam S, 2011, PLANT CELL REP, V30, P2075, DOI 10.1007/s00299-011-1114-y; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; WANG YS, 1995, CELL GROWTH DIFFER, V6, P1071; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Yow CMN, 2012, PHOTOCHEM PHOTOBIOL, V88, P626, DOI 10.1111/j.1751-1097.2012.01085.x; Yoysungnoen P, 2006, CLIN HEMORHEOL MICRO, V34, P109; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	65	58	61	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56217	10.1371/journal.pone.0056217	http://dx.doi.org/10.1371/journal.pone.0056217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468859	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900021
J	De Marco, MA; Porru, S; Cordioli, P; Cesana, BM; Moreno, A; Calzoletti, L; Bonfanti, L; Boni, A; Di Carlo, AS; Arici, C; Carta, A; Castrucci, MR; Donatelli, I; Tomao, P; Peri, VM; Di Trani, L; Vonesch, N				De Marco, Maria A.; Porru, Stefano; Cordioli, Paolo; Cesana, Bruno M.; Moreno, Ana; Calzoletti, Laura; Bonfanti, Lebana; Boni, Arianna; Di Carlo, Antonio Scotto; Arici, Cecilia; Carta, Angela; Castrucci, Maria R.; Donatelli, Isabella; Tomao, Paola; Peri, Vittoria M.; Di Trani, Livia; Vonesch, Nicoletta			Evidence of Cross-Reactive Immunity to 2009 Pandemic Influenza A Virus in Workers Seropositive to Swine H1N1 Influenza Viruses Circulating in Italy	PLOS ONE			English	Article							GENETIC REASSORTMENT; SEROLOGIC EVIDENCE; POULTRY WORKERS; PIGS; TRANSMISSION; INFECTION; EMERGENCE; EVOLUTION; HUMANS; RISK	Background: Pigs play a key epidemiologic role in the ecology of influenza A viruses (IAVs) emerging from animal hosts and transmitted to humans. Between 2008 and 2010, we investigated the health risk of occupational exposure to swine influenza viruses (SIVs) in Italy, during the emergence and spread of the 2009 H1N1 pandemic (H1N1pdm) virus. Methodology/Principal Findings: Serum samples from 123 swine workers (SWs) and 379 control subjects (Cs), not exposed to pig herds, were tested by haemagglutination inhibition (HI) assay against selected SIVs belonging to H1N1 (swH1N1), H1N2 (swH1N2) and H3N2 (swH3N2) subtypes circulating in the study area. Potential cross-reactivity between swine and human IAVs was evaluated by testing sera against recent, pandemic and seasonal, human influenza viruses (H1N1 and H3N2 antigenic subtypes). Samples tested against swH1N1 and H1N1pdm viruses were categorized into sera collected before (n. 84 SWs; n. 234 Cs) and after (n. 39 SWs; n. 145 Cs) the pandemic peak. HI-antibody titers >= 10 were considered positive. In both pre-pandemic and post-pandemic peak subperiods, SWs showed significantly higher swH1N1 seroprevalences when compared with Cs (52.4% vs. 4.7% and 59% vs. 9.7%, respectively). Comparable HI results were obtained against H1N1pdm antigen (58.3% vs. 7.7% and 59% vs. 31.7%, respectively). No differences were found between HI seroreactivity detected in SWs and Cs against swH1N2 (33.3% vs. 40.4%) and swH3N2 (51.2 vs. 55.4%) viruses. These findings indicate the occurrence of swH1N1 transmission from pigs to Italian SWs. Conclusion/Significance: A significant increase of H1N1pdm seroprevalences occurred in the post-pandemic peak subperiod in the Cs (p<0.001) whereas SWs showed no differences between the two subperiods, suggesting a possible occurrence of cross-protective immunity related to previous swH1N1 infections. These data underline the importance of risk assessment and occupational health surveillance activities aimed at early detection and control of SIVs with pandemic potential in humans.	[De Marco, Maria A.; Calzoletti, Laura; Castrucci, Maria R.; Donatelli, Isabella] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [De Marco, Maria A.] Inst Environm Protect & Res ISPRA, Bologna, Italy; [Porru, Stefano; Di Carlo, Antonio Scotto; Arici, Cecilia; Carta, Angela] Univ Brescia, Dept Expt & Appl Med, Brescia, Italy; [Cordioli, Paolo; Moreno, Ana] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Cesana, Bruno M.] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Bonfanti, Lebana] Ist Zooprofilatt Sperimentale Venezie, Padua, Italy; [Boni, Arianna; Di Trani, Livia] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Tomao, Paola; Peri, Vittoria M.; Vonesch, Nicoletta] Italian Workers Compensat Author Res Area INAIL, Dept Occupat Med, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); Italian Institute for Environmental Protection & Research (ISPRA); University of Brescia; IZS Lombardia e Emilia; University of Brescia; IZS delle Venezie; Istituto Superiore di Sanita (ISS)	De Marco, MA (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	mariaalessandra.demarco@iss.it	Carta, Angela/AAL-5182-2021; Arici, Cecilia/AAO-7689-2020; CASTRUCCI, MARIA RITA/C-2535-2016; Moreno, Ana/Q-2173-2019; CARTA, Angela/AAS-4990-2021	Arici, Cecilia/0000-0003-1493-590X; CASTRUCCI, MARIA RITA/0000-0002-8574-3473; Moreno, Ana/0000-0002-8497-9708; CARTA, Angela/0000-0002-3620-8765; boni, arianna/0000-0002-4561-3578	Italian Workers' Compensation Authority (INAIL); Ministry of Health, Progetto Finalizzato [RF-IPS-2006-364585]	Italian Workers' Compensation Authority (INAIL); Ministry of Health, Progetto Finalizzato	The study was co-funded by the Italian Workers' Compensation Authority (INAIL) and by the Ministry of Health, Progetto Finalizzato RF-IPS-2006-364585. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, LANCET, V25; Ayora-Talavera G, 2005, EMERG INFECT DIS, V11, P158, DOI 10.3201/eid1101.040554; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; Brown IH, 2012, CURR TOP MICROBIOL I, DOI [10.1007/82_2011_19, DOI 10.1007/82_2011_19]; Campitelli L, 1997, VIROLOGY, V232, P310, DOI 10.1006/viro.1997.8514; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Chiapponi C., 2011, 6th International Symposium on Emerging and Re-emerging Pig Diseases, Barcelona, Spain, 12-15 June 2011, P250; Dudareva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021340; European Committee for Proprietary Medicinal Products, 1997, CPMPBWP21496 EUR AG; Gerloff NA, 2011, EMERG INFECT DIS, V17, P403, DOI [10.3201/eid1703100581, 10.3201/eid1703.100851]; Gray GC, 2007, CLIN PHARMACOL THER, V82, P638, DOI 10.1038/sj.clpt.6100391; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Gray GC, 2007, VACCINE, V25, P4376, DOI 10.1016/j.vaccine.2007.03.036; Italian National Statistical Institute, 6 CENS GEN AGR; Kash JC, 2010, INFLUENZA OTHER RESP, V4, P121, DOI 10.1111/j.1750-2659.2010.00132.x; Kitikoon P, 2011, VET MICROBIOL, V148, P413, DOI 10.1016/j.vetmic.2010.09.019; Krumbholz A, 2010, J MED VIROL, V82, P1617, DOI 10.1002/jmv.21869; Kyriakis CS, 2011, ZOONOSES PUBLIC HLTH, V58, P93, DOI 10.1111/j.1863-2378.2009.01301.x; Kyriakis CS, 2010, EMERG INFECT DIS, V16, P96, DOI 10.3201/eid1601.091190; Lopez-Robles G, 2012, TRANSBOUND EMERG DIS, V59, P183, DOI 10.1111/j.1865-1682.2011.01250.x; Maiorano G, 2009, SLOVAK J ANIM SCI, V42, P159; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Moreno A, 2012, VET MICROBIOL, V156, P265, DOI 10.1016/j.vetmic.2011.11.004; Moreno A, 2011, VET MICROBIOL, V149, P472, DOI 10.1016/j.vetmic.2010.12.011; Moreno Martin A, 2008, 20 INT PIG VET SOC C, P25; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nichol ST, 2000, P NATL ACAD SCI USA, V97, P12411, DOI 10.1073/pnas.210382297; Olsen CW, 2002, EMERG INFECT DIS, V8, P814, DOI 10.3201/eid0808.010474; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Perera RAPM, 2011, EMERG INFECT DIS, V17, P1897, DOI 10.3201/eid1710.110629; Ramirez A, 2006, EMERG INFECT DIS, V12, P997, DOI 10.3201/eid1206.051576; Rizzo C., 2010, EURO SURVEILL, V15; Terebuh P, 2010, INFLUENZA OTHER RESP, V4, P387, DOI 10.1111/j.1750-2659.2010.00175.x; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Vincent AL, 2010, INFLUENZA OTHER RESP, V4, P53, DOI 10.1111/j.1750-2659.2009.00121.x; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; World Health Organization, 2002, WHO MAN AN INFL DIAG	40	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57576	10.1371/journal.pone.0057576	http://dx.doi.org/10.1371/journal.pone.0057576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469029	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900128
J	Friedman, DR; Lucas, JE; Weinberg, JB				Friedman, Daphne R.; Lucas, Joseph E.; Weinberg, J. Brice			Clinical and Biological Relevance of Genomic Heterogeneity in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							CIRCULAR BINARY SEGMENTATION; GENE-EXPRESSION SIGNATURE; ZAP-70 EXPRESSION; MUTATION STATUS; B-CLL; IDENTIFICATION; ACTIVATION; DELETION; SURVIVAL; MARKERS	Background: Chronic lymphocytic leukemia (CLL) is typically regarded as an indolent B-cell malignancy. However, there is wide variability with regards to need for therapy, time to progressive disease, and treatment response. This clinical variability is due, in part, to biological heterogeneity between individual patients' leukemias. While much has been learned about this biological variation using genomic approaches, it is unclear whether such efforts have sufficiently evaluated biological and clinical heterogeneity in CLL. Methods: To study the extent of genomic variability in CLL and the biological and clinical attributes of genomic classification in CLL, we evaluated 893 unique CLL samples from fifteen publicly available gene expression profiling datasets. We used unsupervised approaches to divide the data into subgroups, evaluated the biological pathways and genetic aberrations that were associated with the subgroups, and compared prognostic and clinical outcome data between the subgroups. Results: Using an unsupervised approach, we determined that approximately 600 CLL samples are needed to define the spectrum of diversity in CLL genomic expression. We identified seven genomically-defined CLL subgroups that have distinct biological properties, are associated with specific chromosomal deletions and amplifications, and have marked differences in molecular prognostic markers and clinical outcomes. Conclusions: Our results indicate that investigations focusing on small numbers of patient samples likely provide a biased outlook on CLL biology. These findings may have important implications in identifying patients who should be treated with specific targeted therapies, which could have efficacy against CLL cells that rely on specific biological pathways.	[Friedman, Daphne R.; Weinberg, J. Brice] Duke Univ, Dept Med, Durham, NC 27710 USA; [Lucas, Joseph E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Weinberg, J. Brice] Durham VA Med Ctr, Durham, VA USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Friedman, DR (corresponding author), Duke Univ, Dept Med, Durham, NC 27710 USA.	daphne.friedman@duke.edu			Veterans Affairs Research Service; Biomarker Factory; National Institutes of Health [UL1RR024128]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER	Veterans Affairs Research Service(US Department of Veterans Affairs); Biomarker Factory; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The investigators were funded in part by the Veterans Affairs Research Service, the Biomarker Factory, and the National Institutes of Health Clinical and Translational Science Award (UL1RR024128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto Y, 2001, LEUKEMIA, V15, P1721, DOI 10.1038/sj.leu.2402282; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; BINET JL, 1977, CANCER-AM CANCER SOC, V40, P855, DOI 10.1002/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO;2-1; Chang JT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-443; Chen LG, 2008, BLOOD, V111, P2685, DOI 10.1182/blood-2006-12-062265; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Deaglio S, 2007, BLOOD, V110, P4012, DOI 10.1182/blood-2007-06-094029; Del Giudice I, 2009, BLOOD, V114, P638, DOI 10.1182/blood-2008-12-196568; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Durig J, 2003, BLOOD, V101, P2748, DOI 10.1182/blood-2002-09-2683; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Fabris S, 2008, GENE CHROMOSOME CANC, V47, P781, DOI 10.1002/gcc.20579; Falt S, 2005, EXP HEMATOL, V33, P883, DOI 10.1016/j.exphem.2005.05.007; Fernandez V, 2010, CANCER RES, V70, P1408, DOI 10.1158/0008-5472.CAN-09-3419; Friedman DR, 2009, CLIN CANCER RES, V15, P6947, DOI 10.1158/1078-0432.CCR-09-1132; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giannopoulos K, 2009, LEUKEMIA, V23, P1771, DOI 10.1038/leu.2009.98; Gobessi S, 2007, BLOOD, V109, P2032, DOI 10.1182/blood-2006-03-011759; Gutierrez NC, 2007, LEUKEMIA, V21, P541, DOI 10.1038/sj.leu.2404520; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Jelinek DF, 2003, MOL CANCER RES, V1, P346; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Mosca L, 2010, CLIN CANCER RES, V16, P5641, DOI 10.1158/1078-0432.CCR-10-0151; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ouillette P, 2008, CANCER RES, V68, P1012, DOI 10.1158/0008-5472.CAN-07-3105; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Richardson SJ, 2006, BLOOD, V107, P3584, DOI 10.1182/blood-2005-04-1718; Rodriguez A, 2007, LEUKEMIA, V21, P1984, DOI 10.1038/sj.leu.2404831; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Saiya-Cork K, 2011, CLIN CANCER RES, V17, P2679, DOI 10.1158/1078-0432.CCR-10-2058; Shehata M, 2010, LEUKEMIA, V24, P2122, DOI 10.1038/leu.2010.220; Stamatopoulos B, 2009, HAEMATOL-HEMATOL J, V94, P790, DOI 10.3324/haematol.2008.002626; Stratowa C, 2001, INT J CANCER, V91, P474, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1078>3.0.CO;2-C; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vargova K, 2011, BLOOD, V117, P3816, DOI 10.1182/blood-2010-05-285064; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Zenz T, 2010, J CLIN ONCOL, V28, P4473, DOI 10.1200/JCO.2009.27.8762; Zum Buschenfelde CM, 2010, LEUKEMIA, V24, P141, DOI 10.1038/leu.2009.216	45	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57356	10.1371/journal.pone.0057356	http://dx.doi.org/10.1371/journal.pone.0057356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468975	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900077
J	Maco, B; Holtmaat, A; Cantoni, M; Kreshuk, A; Straehle, CN; Hamprecht, FA; Knott, GW				Maco, Bohumil; Holtmaat, Anthony; Cantoni, Marco; Kreshuk, Anna; Straehle, Christoph N.; Hamprecht, Fred A.; Knott, Graham W.			Correlative In Vivo 2 Photon and Focused Ion Beam Scanning Electron Microscopy of Cortical Neurons	PLOS ONE			English	Article							TISSUE; LIGHT; GFP	Correlating in vivo imaging of neurons and their synaptic connections with electron microscopy combines dynamic and ultrastructural information. Here we describe a semi-automated technique whereby volumes of brain tissue containing axons and dendrites, previously studied in vivo, are subsequently imaged in three dimensions with focused ion beam scanning electron microcopy. These neurites are then identified and reconstructed automatically from the image series using the latest segmentation algorithms. The fast and reliable imaging and reconstruction technique avoids any specific labeling to identify the features of interest in the electron microscope, and optimises their preservation and staining for 3D analysis.	[Maco, Bohumil; Cantoni, Marco; Knott, Graham W.] Ecole Polytech Fed Lausanne, BioEM Facil, Ctr Electron Microscopy, CH-1015 Lausanne, Switzerland; [Maco, Bohumil] Ecole Polytech Fed Lausanne, CV Lab, CH-1015 Lausanne, Switzerland; [Holtmaat, Anthony] Univ Geneva, Univ Med Ctr CMU, Dept Neurosci, Geneva, Switzerland; [Kreshuk, Anna; Straehle, Christoph N.; Hamprecht, Fred A.] Heidelberg Univ, Heidelberg Collaboratory Image Proc HCI, Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; Ruprecht Karls University Heidelberg	Knott, GW (corresponding author), Ecole Polytech Fed Lausanne, BioEM Facil, Ctr Electron Microscopy, CH-1015 Lausanne, Switzerland.	Graham.Knott@epfl.ch	Cantoni, Marco/C-4227-2011	Cantoni, Marco/0000-0002-1356-9541; Knott, Graham W/0000-0002-2956-9052; Kreshuk, Anna/0000-0003-1334-6388; Holtmaat, Anthony/0000-0002-7577-0769; Maco, Bohumil/0000-0001-8444-313X	Swiss National Science Foundation [CRF II313470/1, CRSI33-127289, 3100AO-120685, 31003A-135631]; IRP/Hans Wilsdorf Foundations	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); IRP/Hans Wilsdorf Foundations	This work was supported by Swiss National Science Foundation Synergia grants CRF II313470/1 (GK), CRSI33-127289 (AH), 3100AO-120685 (AH), 31003A-135631 (AH), and the IRP/Hans Wilsdorf Foundations (AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop D, 2011, NAT METHODS, V8, P568, DOI [10.1038/NMETH.1622, 10.1038/nmeth.1622]; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Chen XB, 2011, J NEUROSCI, V31, P6329, DOI 10.1523/JNEUROSCI.5968-10.2011; Da Costa NM, 2009, J COMP NEUROL, V516, P264, DOI 10.1002/cne.22133; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2001, J MICROSC-OXFORD, V202, P468, DOI 10.1046/j.1365-2818.2001.00926.x; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Knott GW, 2009, NAT PROTOC, V4, P1145, DOI 10.1038/nprot.2009.114; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Soto G E, 1994, Neuroimage, V1, P230, DOI 10.1006/nimg.1994.1008; Straehle CN, 2011, LECT NOTES COMPUT SC, V6891, P653, DOI 10.1007/978-3-642-23623-5_82; Tapia JC, 2012, NAT PROTOC, V7, P193, DOI 10.1038/nprot.2011.439	17	59	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57405	10.1371/journal.pone.0057405	http://dx.doi.org/10.1371/journal.pone.0057405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468982	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900082
J	Wong, HE; Irwin, JA; Kwon, I				Wong, H. Edward; Irwin, Jacob A.; Kwon, Inchan			Halogenation Generates Effective Modulators of Amyloid-Beta Aggregation and Neurotoxicity	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; A-BETA; FIBRILLAR OLIGOMERS; PROTEIN-STRUCTURE; MTT REDUCTION; IN-VIVO; PEPTIDE; MECHANISM; A-BETA-40; COMMON	Halogenation of organic compounds plays diverse roles in biochemistry, including selective chemical modification of proteins and improved oral absorption/blood-brain barrier permeability of drug candidates. Moreover, halogenation of aromatic molecules greatly affects aromatic interaction-mediated self-assembly processes, including amyloid fibril formation. Perturbation of the aromatic interaction caused by halogenation of peptide building blocks is known to affect the morphology and other physical properties of the fibrillar structure. Consequently, in this article, we investigated the ability of halogenated ligands to modulate the self-assembly of amyloidogenic peptide/protein. As a model system, we chose amyloid-beta peptide (A beta), which is implicated in Alzheimer's disease, and a novel modulator of A beta aggregation, erythrosine B (ERB). Considering that four halogen atoms are attached to the xanthene benzoate group in ERB, we hypothesized that halogenation of the xanthene benzoate plays a critical role in modulating A beta aggregation and cytotoxicity. Therefore, we evaluated the modulating capacities of four ERB analogs containing different types and numbers of halogen atoms as well as fluorescein as a negative control. We found that fluorescein is not an effective modulator of A beta aggregation and cytotoxicity. However, halogenation of either the xanthenes or benzoate ring of fluorescein substantially enhanced the inhibitory capacity on A beta aggregation. Such A beta aggregation inhibition by ERB analogs except rose bengal correlated well to the inhibition of A beta cytotoxicity. To our knowledge, this is the first report demonstrating that halogenation of aromatic rings substantially enhance inhibitory capacities of small molecules on A beta-associated neurotoxicity via A beta aggregation modulation.	[Wong, H. Edward; Irwin, Jacob A.; Kwon, Inchan] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22903 USA; [Kwon, Inchan] Univ Virginia, Inst Aging, Charlottesville, VA USA	University of Virginia; University of Virginia	Kwon, I (corresponding author), Univ Virginia, Dept Chem Engn, Charlottesville, VA 22903 USA.	ik4t@virginia.edu		Kwon, Inchan/0000-0003-0806-4116	KSEA Young Investigator Grant; Commonwealth of Virginia's Alzheimer's and Related Diseases Research Award Fund [13-6]	KSEA Young Investigator Grant; Commonwealth of Virginia's Alzheimer's and Related Diseases Research Award Fund	This study was supported by the KSEA Young Investigator Grant and in part by Award No. 13-6 from the Commonwealth of Virginia's Alzheimer's and Related Diseases Research Award Fund, administered by the Virginia Center on Aging, Virginia Commonwealth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Agarwala SS, 2009, J CLIN ONCOL, V27; Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Bartolini M, 2007, CHEMBIOCHEM, V8, P2152, DOI 10.1002/cbic.200700427; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bose PP, 2010, ACS CHEM NEUROSCI, V1, P315, DOI 10.1021/cn900041x; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Chalker JM, 2009, J AM CHEM SOC, V131, P16346, DOI 10.1021/ja907150m; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Claessens CG, 1997, J PHYS ORG CHEM, V10, P254, DOI 10.1002/(SICI)1099-1395(199705)10:5<254::AID-POC875>3.0.CO;2-3; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Feng Y, 2009, BIOCHEM BIOPH RES CO, V390, P1250, DOI 10.1016/j.bbrc.2009.10.130; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gazit E, 2002, BIOINFORMATICS, V18, P880, DOI 10.1093/bioinformatics/18.6.880; Hamaguchi T, 2006, CELL MOL LIFE SCI, V63, P1538, DOI 10.1007/s00018-005-5599-9; Harada T, 2011, BIOPOLYMERS, V95, P127, DOI 10.1002/bip.21543; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawkes CA, 2009, DRUG DEVELOP RES, V70, P111, DOI 10.1002/ddr.20290; Hernandes MZ, 2010, CURR DRUG TARGETS, V11, P303, DOI 10.2174/138945010790711996; Hertel C, 1996, J NEUROCHEM, V67, P272; Hirohashi T, 1997, J PHARMACOL EXP THER, V280, P813; Hu Y, 2010, CHEMBIOCHEM, V11, P2409, DOI 10.1002/cbic.201000435; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Irwin JA, 2013, BIOMACROMOLECULES, V14, P264, DOI 10.1021/bm3016994; JONES GR, 1984, J CHEM SOC FARAD T 2, V80, P1201, DOI 10.1039/f29848001201; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kimura N, 2005, NEUROPATH APPL NEURO, V31, P170, DOI 10.1111/j.1365-2990.2004.00624.x; Kitevski-LeBlanc JL, 2012, PROG NUCL MAG RES SP, V62, P1, DOI 10.1016/j.pnmrs.2011.06.003; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Liu YB, 1997, J NEUROCHEM, V69, P2285; Ma CQ, 1996, ANAL CHIM ACTA, V333, P83, DOI 10.1016/0003-2670(96)00280-2; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Moss MA, 2004, MOL PHARMACOL, V66, P592; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Ojida A, 2005, TETRAHEDRON LETT, V46, P3301, DOI 10.1016/j.tetlet.2005.03.094; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; Park JW, 2008, CHEMBIOCHEM, V9, P2602, DOI 10.1002/cbic.200800343; Perez M, 2005, NEUROSCIENCE, V130, P339, DOI 10.1016/j.neuroscience.2004.09.029; POLLACK SJ, 1995, NEUROSCI LETT, V197, P211, DOI 10.1016/0304-3940(95)11939-T; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Reinke AA, 2007, CHEM BIOL DRUG DES, V70, P206, DOI 10.1111/j.1747-0285.2007.00557.x; Ryan DM, 2010, SOFT MATTER, V6, P3220, DOI 10.1039/c0sm00018c; Sarroukh R, 2011, CELL MOL LIFE SCI, V68, P1429, DOI 10.1007/s00018-010-0529-x; Shin HJ, 2000, BBA-PROTEIN STRUCT M, V1481, P139, DOI 10.1016/S0167-4838(00)00106-0; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Terasaki T, 1999, ADV DRUG DELIVER REV, V36, P195, DOI 10.1016/S0169-409X(98)00088-X; Thakker DR, 2009, P NATL ACAD SCI USA, V106, P4501, DOI 10.1073/pnas.0813404106; Thapa A, 2011, BIOCHEMISTRY-US, V50, P2445, DOI 10.1021/bi101731d; Thompson JF, 2008, MELANOMA RES, V18, P405, DOI 10.1097/CMR.0b013e32831328c7; Torok B, 2012, CHEMMEDCHEM, V7, P910, DOI 10.1002/cmdc.201100569; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Vlasova IM, 2010, RUSS J PHYS CHEM A+, V84, P1065, DOI 10.1134/S0036024410060312; Waheed AA, 2000, ANAL BIOCHEM, V287, P73, DOI 10.1006/abio.2000.4793; Wahlstrom A, 2012, BIOCHEMISTRY-US, V51, P4280, DOI 10.1021/bi300341j; Williams AD, 2005, P NATL ACAD SCI USA, V102, P7115, DOI 10.1073/pnas.0408582102; Wong HE, 2011, ACS CHEM NEUROSCI, V2, P645, DOI 10.1021/cn200056g; Wong HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025752; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	69	14	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57288	10.1371/journal.pone.0057288	http://dx.doi.org/10.1371/journal.pone.0057288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468958	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900067
J	Bertrand, A; Pasquier, A; Petiet, A; Wiggins, C; Kraska, A; Joseph-Mathurin, N; Aujard, F; Mestre-Frances, N; Dhenain, M				Bertrand, Anne; Pasquier, Adrien; Petiet, Alexandra; Wiggins, Christopher; Kraska, Audrey; Joseph-Mathurin, Nelly; Aujard, Fabienne; Mestre-Frances, Nadine; Dhenain, Marc			Micro-MRI Study of Cerebral Aging: Ex Vivo Detection of Hippocampal Subfield Reorganization, Microhemorrhages and Amyloid Plaques in Mouse Lemur Primates	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; APP/PS1 TRANSGENIC MICE; HIGH-RESOLUTION MRI; ALZHEIMERS-DISEASE; QUANTITATIVE-ANALYSIS; T2-WEIGHTED MRI; SENILE PLAQUES; BRAIN; AGE; MURINUS	Mouse lemurs are non-human primate models of cerebral aging and neurodegeneration. Much smaller than other primates, they recapitulate numerous features of human brain aging, including progressive cerebral atrophy and correlation between regional atrophy and cognitive impairments. Characterization of brain atrophy in mouse lemurs has been done by MRI measures of regional CSF volume and by MRI measures of regional atrophy. Here, we further characterize mouse lemur brain aging using ex vivo MR microscopy (31 mu m in-plane resolution). First, we performed a non-biased, direct volumetric quantification of dentate gyrus and extended Ammon's horn. We show that both dentate gyrus and Ammon's horn undergo an age-related reorganization leading to a growth of the dentate gyrus and an atrophy of the Ammon's horn, even in the absence of global hippocampal atrophy. Second, on these first MR microscopic images of the mouse lemur brain, we depicted cortical and hippocampal hypointense spots. We demonstrated that their incidence increases with aging and that they correspond either to amyloid deposits or to cerebral microhemorrhages.	[Bertrand, Anne; Pasquier, Adrien; Petiet, Alexandra; Kraska, Audrey; Joseph-Mathurin, Nelly; Dhenain, Marc] CNRS, URA2210, Fontenay Aux Roses, France; [Bertrand, Anne; Pasquier, Adrien; Petiet, Alexandra; Kraska, Audrey; Joseph-Mathurin, Nelly; Dhenain, Marc] CEA Commissariat Energie Atom & Energies Alternat, DSV, Inst Imagerie BioMed I2BM, MIRCen Mol Imaging Reseach CENter, Fontenay Aux Roses, France; [Bertrand, Anne; Petiet, Alexandra; Wiggins, Christopher; Dhenain, Marc] CEA Commissariat Energie Atom & Energies Alternat, Inst Imagerie BioMed I2BM, Neurospin, Gif Sur Yvette, France; [Aujard, Fabienne] CNRS, MNHN, UMR 7179, Unite Mixte Rech,Mecadev MECanismes ADaptatifs &, Brunoy, France; [Mestre-Frances, Nadine] Univ Montpellier 2, INSERM, U710, EPHE, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier	Dhenain, M (corresponding author), CNRS, URA2210, Fontenay Aux Roses, France.	Marc.Dhenain@cea.fr	Bertrand, Anne/C-9882-2010; Mestre-Francés, Nadine/V-6289-2019; Dhenain, Marc/K-5630-2013	Bertrand, Anne/0000-0001-7683-507X; Mestre-Francés, Nadine/0000-0002-6856-3067; Dhenain, Marc/0000-0001-8804-4101; Joseph-Mathurin, Nelly/0000-0002-9735-5152	France-Alzheimer association; CNRS; National Foundation for Alzheimer's Disease and Related Disorders; NIH [R01-AG020197]; French Society of Radiology (SFR); French Society of NeuroRadiology (SFNR); French Ministry of Foreign Affairs (EGIDE funding); Philippe Fundation; NATIONAL INSTITUTE ON AGING [R01AG020197] Funding Source: NIH RePORTER	France-Alzheimer association; CNRS(Centre National de la Recherche Scientifique (CNRS)); National Foundation for Alzheimer's Disease and Related Disorders; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Society of Radiology (SFR); French Society of NeuroRadiology (SFNR); French Ministry of Foreign Affairs (EGIDE funding); Philippe Fundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the France-Alzheimer association, the Longevity program from the CNRS, the National Foundation for Alzheimer's Disease and Related Disorders, and the NIH (R01-AG020197). Anne Bertrand was funded by the French Society of Radiology (SFR), the French Society of NeuroRadiology (SFNR), the French Ministry of Foreign Affairs (EGIDE funding) and the Philippe Fundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benveniste H, 1999, P NATL ACAD SCI USA, V96, P14079, DOI 10.1073/pnas.96.24.14079; Bobinski M, 2000, NEUROSCIENCE, V95, P721; Bons N, 2006, GENES BRAIN BEHAV, V5, P120, DOI 10.1111/j.1601-183X.2005.00149.x; Bons N, 1998, BRAIN RES BULL, V46, P1; BONS N, 1992, NEUROBIOL AGING, V13, P99, DOI 10.1016/0197-4580(92)90016-Q; Carne RP, 2006, J CLIN NEUROSCI, V13, P60, DOI 10.1016/j.jocn.2005.02.013; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Dhenain M, 2000, NEUROBIOL AGING, V21, P81, DOI 10.1016/S0197-4580(00)00098-1; Dhenain M, 1997, NEUROBIOL AGING, V18, P517, DOI 10.1016/S0197-4580(97)00105-X; Dhenain M, 2003, MAGNET RESON MED, V50, P984, DOI 10.1002/mrm.10612; Dhenain M, 2006, MAGN RESON MED, V55, P687, DOI 10.1002/mrm.20810; Dhenain M, 2001, DEV BIOL, V232, P458, DOI 10.1006/dbio.2001.0189; Dhenain M, 2002, NMR BIOMED, V15, P197, DOI 10.1002/nbm.760; Dhenain M, 1998, NEUROBIOL AGING, V19, P65, DOI 10.1016/S0197-4580(98)00005-0; DOUGLAS RJ, 1981, GERONTOLOGY, V27, P127, DOI 10.1159/000212460; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; El Tayara NET, 2007, MAGN RESON MED, V58, P179, DOI 10.1002/mrm.21266; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FOX MW, 1966, EXPERIENTIA, V22, P447, DOI 10.1007/BF01900975; FUKUTANI Y, 1995, NEUROSCI LETT, V200, P57, DOI 10.1016/0304-3940(95)12083-G; Giannakopoulos P, 1997, ACTA NEUROPATHOL, V94, P131, DOI 10.1007/s004010050684; Golomb J, 1996, NEUROLOGY, V47, P810, DOI 10.1212/WNL.47.3.810; Jack CR, 2004, MAGN RESON MED, V52, P1263, DOI 10.1002/mrm.20266; JACK CR, 1992, NEUROLOGY, V42, P183, DOI 10.1212/WNL.42.1.183; Kraska A, 2011, NEUROBIOL AGING, V32, P894, DOI 10.1016/j.neurobiolaging.2009.05.018; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Lee SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025930; Lee SP, 2004, MAGN RESON MED, V52, P538, DOI 10.1002/mrm.20196; Lister JP, 2009, ARCH NEUROL-CHICAGO, V66, P829, DOI 10.1001/archneurol.2009.125; Luo F, 2010, J PHARMACOL EXP THER, V335, P580, DOI 10.1124/jpet.110.172932; Meadowcroft MD, 2009, J MAGN RESON IMAGING, V29, P997, DOI 10.1002/jmri.21731; Mueller SG, 2007, NEUROBIOL AGING, V28, P719, DOI 10.1016/j.neurobiolaging.2006.03.007; Mueller SG, 2010, HUM BRAIN MAPP, V31, P1339, DOI 10.1002/hbm.20934; Mueller SG, 2009, HIPPOCAMPUS, V19, P558, DOI 10.1002/hipo.20614; Niewenhuys R, 2007, HUMAN CENTRAL NERVOU; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Perret M, 1997, J BIOL RHYTHM, V12, P136, DOI 10.1177/074873049701200205; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Petiet A, 2012, NEUROBIOL AGING, V33, P1533, DOI 10.1016/j.neurobiolaging.2011.03.009; Picq JL, 2012, NEUROBIOL AGING, V33, P1096, DOI 10.1016/j.neurobiolaging.2010.09.009; Pluta J, 2012, J ALZHEIMERS DIS, V31, P85, DOI 10.3233/JAD-2012-111931; Raz N, 1998, NEUROPSYCHOLOGY, V12, P95, DOI 10.1037/0894-4105.12.1.95; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Shamy JLT, 2006, NEUROBIOL AGING, V27, P1405, DOI 10.1016/j.neurobiolaging.2005.07.019; Sherwood CC, 2011, P NATL ACAD SCI USA, V108, P13029, DOI 10.1073/pnas.1016709108; Shing YL, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00002; Small SA, 1999, ANN NEUROL, V45, P466, DOI 10.1002/1531-8249(199904)45:4<466::AID-ANA8>3.0.CO;2-Q; Trouche SG, 2009, VACCINE, V27, P957, DOI 10.1016/j.vaccine.2008.12.012; Weisbecker V, 2012, BRAIN STRUCT FUNCT, V217, P677, DOI 10.1007/s00429-011-0366-1; West M, 1994, LANCET, V2, P769, DOI DOI 10.1016/S0140-6736(94)92338-8; Wisco JJ, 2008, NEUROBIOL AGING, V29, P1563, DOI 10.1016/j.neurobiolaging.2007.03.022	54	16	16	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56593	10.1371/journal.pone.0056593	http://dx.doi.org/10.1371/journal.pone.0056593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460806	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000029
J	Dayton, PK; Kim, S; Jarrell, SC; Oliver, JS; Hammerstrom, K; Fisher, JL; O'Connor, K; Barber, JS; Robilliard, G; Barry, J; Thurber, AR; Conlan, K				Dayton, Paul K.; Kim, Stacy; Jarrell, Shannon C.; Oliver, John S.; Hammerstrom, Kamille; Fisher, Jennifer L.; O'Connor, Kevin; Barber, Julie S.; Robilliard, Gordon; Barry, James; Thurber, Andrew R.; Conlan, Kathy			Recruitment, Growth and Mortality of an Antarctic Hexactinellid Sponge, Anoxycalyx joubini	PLOS ONE			English	Article							MCMURDO-SOUND; COMMUNITIES; PATTERNS; CLIMATE; PHYTOPLANKTON; PREDATORS; BIOLOGY; SEA	Polar ecosystems are sensitive to climate forcing, and we often lack baselines to evaluate changes. Here we report a nearly 50-year study in which a sudden shift in the population dynamics of an ecologically important, structure-forming hexactinellid sponge, Anoxycalyx joubini was observed. This is the largest Antarctic sponge, with individuals growing over two meters tall. In order to investigate life history characteristics of Antarctic marine invertebrates, artificial substrata were deployed at a number of sites in the southern portion of the Ross Sea between 1967 and 1975. Over a 22-year period, no growth or settlement was recorded for A. joubini on these substrata; however, in 2004 and 2010, A. joubini was observed to have settled and grown to large sizes on some but not all artificial substrata. This single settlement and growth event correlates with a region-wide shift in phytoplankton productivity driven by the calving of a massive iceberg. We also report almost complete mortality of large sponges followed over 40 years. Given our warming global climate, similar system-wide changes are expected in the future.	[Dayton, Paul K.; Jarrell, Shannon C.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Kim, Stacy; Oliver, John S.; Hammerstrom, Kamille; O'Connor, Kevin] Moss Landing Marine Labs, Moss Landing, CA 95039 USA; [Fisher, Jennifer L.] Oregon State Univ, Hatfield Marine Sci Ctr, Newport, OR 97365 USA; [Barber, Julie S.] Swinomish Indian Tribal Community, La Conner, WA USA; [Robilliard, Gordon] Cardno Entrix, Gig Harbor, WA USA; [Barry, James] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Thurber, Andrew R.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Conlan, Kathy] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada	University of California System; University of California San Diego; Scripps Institution of Oceanography; Moss Landing Marine Laboratories; Oregon State University; Monterey Bay Aquarium Research Institute; Oregon State University	Dayton, PK (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	pdayton@ucsd.edu	Barber, Julie/AAH-1823-2020; Barber, Julie S/V-7557-2017	Barber, Julie/0000-0002-5394-0747; Barber, Julie S/0000-0002-5394-0747	Division of Polar Programs, National Science Foundation [25264A-416451-440005]; Division Of Polar Programs [0842064] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1103428] Funding Source: National Science Foundation	Division of Polar Programs, National Science Foundation; Division Of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by the Division of Polar Programs, National Science Foundation, over the years. Grant number: 25264A-416451-440005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Arrigo KR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014160; BARRY JP, 1988, POLAR BIOL, V8, P367, DOI 10.1007/BF00442028; BARRY JP, 1988, POLAR BIOL, V8, P377, DOI 10.1007/BF00442029; BARTHEL D, 1992, OPHELIA, V36, P111, DOI 10.1080/00785326.1992.10430362; BARTHEL D, 1991, MAR ECOL PROG SER, V69, P303, DOI 10.3354/meps069303; Barthel D, 1994, SYNOPSES ANTARCTIC B, P9; Cerrano C, 2000, POLAR BIOL, V23, P441, DOI 10.1007/s003000050466; Conlan KE, 2010, MAR POLLUT BULL, V60, P419, DOI 10.1016/j.marpolbul.2009.10.009; Dayton P K, 1979, BIOLOGIE SPONGIARES, P271; DAYTON PK, 1986, POLAR BIOL, V6, P207, DOI 10.1007/BF00443397; DAYTON PK, 1969, SCIENCE, V163, P273, DOI 10.1126/science.163.3864.273; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; DAYTON PK, 1977, SCIENCE, V197, P55, DOI 10.1126/science.197.4298.55; DAYTON PK, 1989, SCIENCE, V245, P1484, DOI 10.1126/science.245.4925.1484; Dinniman MS, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004036; Fallon SJ, 2010, NUCL INSTRUM METH B, V268, P1241, DOI 10.1016/j.nimb.2009.10.143; Gili JM, 2006, DEEP-SEA RES PT II, V53, P1029, DOI 10.1016/j.dsr2.2005.10.021; Gutt J, 2003, POLAR BIOL, V26, P276, DOI 10.1007/s00300-002-0468-6; Gutt J, 2007, ANTARCT SCI, V19, P165, DOI 10.1017/S0954102007000247; Kahn AS, 2012, DEEP-SEA RES PT I, V70, P36, DOI 10.1016/j.dsr.2012.08.001; Leys SP, 2007, ADV MAR BIOL, V52, P1, DOI 10.1016/S0065-2881(06)52001-2; Lohrer AM, 2012, ECOSYSTEMS, P1; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; McClintock JB, 2005, INTEGR COMP BIOL, V45, P359, DOI 10.1093/icb/45.2.359; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; OLIVER JS, 1985, OPHELIA, V24, P155, DOI 10.1080/00785326.1985.10429725; OREJAS C, 2000, CONTRIB SCI, V1, P299; Reiswig H. G., 1990, NEW PERSPECTIVES SPO, P7; Seibel BA, 2003, BIOL BULL-US, V205, P93, DOI 10.2307/1543229; Suhr SB, 2008, MAR ECOL PROG SER, V371, P155, DOI 10.3354/meps07693; Teixido N, 2006, DEEP-SEA RES PT II, V53, P972, DOI 10.1016/j.dsr2.2006.02.008; Thorson G., 1966, Netherlands Journal of Sea Research, V3, P267, DOI 10.1016/0077-7579(66)90015-9; Thrush SF, 2011, MAR ECOL-EVOL PERSP, V32, P289, DOI 10.1111/j.1439-0485.2011.00462.x; Thurber AR, 2007, MAR ECOL PROG SER, V351, P77, DOI 10.3354/meps07122; Yahel G, 2006, AQUAT MICROB ECOL, V45, P181, DOI 10.3354/ame045181	36	52	52	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56939	10.1371/journal.pone.0056939	http://dx.doi.org/10.1371/journal.pone.0056939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460822	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000048
J	Han, GS; Yu, ZG; Anh, V; Krishnajith, APD; Tian, YC				Han, Guo Sheng; Yu, Zu Guo; Vo Anh; Krishnajith, Anaththa P. D.; Tian, Yu-Chu			An Ensemble Method for Predicting Subnuclear Localizations from Primary Protein Structures	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; RECURRENCE QUANTIFICATION ANALYSIS; GAUSSIAN KERNEL OPTIMIZATION; SUPPORT VECTOR MACHINES; SUBCELLULAR-LOCALIZATION; GENE ONTOLOGY; EUKARYOTIC PROTEINS; HOMOLOGY DETECTION; FOLD RECOGNITION; CLASSIFICATION	Background: Predicting protein subnuclear localization is a challenging problem. Some previous works based on non-sequence information including Gene Ontology annotations and kernel fusion have respective limitations. The aim of this work is twofold: one is to propose a novel individual feature extraction method; another is to develop an ensemble method to improve prediction performance using comprehensive information represented in the form of high dimensional feature vector obtained by 11 feature extraction methods. Methodology/Principal Findings: A novel two-stage multiclass support vector machine is proposed to predict protein subnuclear localizations. It only considers those feature extraction methods based on amino acid classifications and physicochemical properties. In order to speed up our system, an automatic search method for the kernel parameter is used. The prediction performance of our method is evaluated on four datasets: Lei dataset, multi-localization dataset, SNL9 dataset and a new independent dataset. The overall accuracy of prediction for 6 localizations on Lei dataset is 75.2% and that for 9 localizations on SNL9 dataset is 72.1% in the leave-one-out cross validation, 71.7% for the multi-localization dataset and 69.8% for the new independent dataset, respectively. Comparisons with those existing methods show that our method performs better for both single-localization and multi-localization proteins and achieves more balanced sensitivities and specificities on large-size and small-size subcellular localizations. The overall accuracy improvements are 4.0% and 4.7% for single-localization proteins and 6.5% for multi-localization proteins. The reliability and stability of our classification model are further confirmed by permutation analysis. Conclusions: It can be concluded that our method is effective and valuable for predicting protein subnuclear localizations. A web server has been designed to implement the proposed method. It is freely available at http://bioinformatics.awowshop.com/snlpred_page.php.	[Han, Guo Sheng; Yu, Zu Guo] Xiangtan Univ, Sch Math & Computat Sci, Xiangtan, Hunan, Peoples R China; [Yu, Zu Guo; Vo Anh] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Krishnajith, Anaththa P. D.; Tian, Yu-Chu] Queensland Univ Technol, Sch Elect Engn & Comp Sci, Brisbane, Qld 4001, Australia	Xiangtan University; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Yu, ZG (corresponding author), Xiangtan Univ, Sch Math & Computat Sci, Xiangtan, Hunan, Peoples R China.	yuzuguo@yahoo.com.cn	Tian, Yu-Chu/I-9948-2012; peng, chen/HHS-8720-2022; Anh, Vo V/I-9590-2012; peng, chen/L-7111-2019	Tian, Yu-Chu/0000-0002-8709-5625; Anh, Vo V/0000-0003-2463-2099; 	Natural Science Foundation of China [11071282]; Chinese Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1179]; Research Foundation of Education Commission of Hunan Province of China [11A122]; Hunan Provincial Natural Science Foundation of China [10JJ7001]; Science and Technology Planning Project of Hunan Province of China [2011FJ2011]; Lotus Scholars Program of Hunan Province of China; Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province of China; Australian Research Council [DP0559807]; Hunan Provincial Postgraduate Research and Innovation Project of China [CX2010B243]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT); Research Foundation of Education Commission of Hunan Province of China; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Science and Technology Planning Project of Hunan Province of China; Lotus Scholars Program of Hunan Province of China; Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province of China; Australian Research Council(Australian Research Council); Hunan Provincial Postgraduate Research and Innovation Project of China	This project was supported by the Natural Science Foundation of China (grant 11071282), the Chinese Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (grant IRT1179), the Research Foundation of Education Commission of Hunan Province of China (grant 11A122), Hunan Provincial Natural Science Foundation of China (grant 10JJ7001), Science and Technology Planning Project of Hunan Province of China (grant 2011FJ2011), the Lotus Scholars Program of Hunan Province of China, the Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province of China, and the Australian Research Council (grant DP0559807), and Hunan Provincial Postgraduate Research and Innovation Project of China (grant CX2010B243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 1997, J MOL GRAPH MODEL, V15, P279, DOI 10.1016/S1093-3263(97)00106-X; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Blum T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-274; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Carmo-Fonseca M, 2002, CELL, V108, P513, DOI 10.1016/S0092-8674(02)00650-5; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang JM, 2008, PROTEINS, V72, P693, DOI 10.1002/prot.21944; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Chou KC, 2000, BIOCHEM BIOPH RES CO, V278, P477, DOI 10.1006/bbrc.2000.3815; Chou KC, 2004, BIOCHEM BIOPH RES CO, V320, P1236, DOI 10.1016/j.bbrc.2004.06.073; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; CHOU KC, 1988, BIOPHYS CHEM, V30, P3, DOI 10.1016/0301-4622(88)85002-6; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Dellaire G, 2003, NUCLEIC ACIDS RES, V31, P328, DOI 10.1093/nar/gkg018; DILL KA, 1985, BIOCHEMISTRY-US, V24, P1501, DOI 10.1021/bi00327a032; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Feng Shi, 2008, Journal of Biomedical Science & Engineering, V1, P59, DOI 10.4236/jbise.2008.11009; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Giuliani A, 2002, CHEM REV, V102, P1471, DOI 10.1021/cr0101499; Gubbi Jayavardhana, 2006, Genome Inform, V17, P259; Guda C, 2005, BIOINFORMATICS, V21, P3963, DOI 10.1093/bioinformatics/bti650; Guo J, 2006, BIOINFORMATICS, V22, P1784, DOI 10.1093/bioinformatics/btl180; Guo-Sheng Han, 2009, Proceedings of the 2009 Sixth International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2009), P42, DOI 10.1109/FSKD.2009.248; Han GS, 2011, CHINESE PHYS B, V20, DOI 10.1088/1674-1056/20/10/100504; Hancock R, 2004, BIOL CELL, V96, P595, DOI 10.1016/j.biolcel.2004.05.003; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang WL, 2007, BIOSYSTEMS, V90, P573, DOI 10.1016/j.biosystems.2007.01.001; Kandaswamy A, 2004, COMPUT BIOL MED, V34, P523, DOI 10.1016/S0010-4825(03)00092-1; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Lei ZD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-291; Lei ZD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-491; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Liu TG, 2010, AMINO ACIDS, V38, P721, DOI 10.1007/s00726-009-0276-1; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mei SY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S17; Mori K, 1996, WEAR, V195, P162, DOI 10.1016/0043-1648(95)06817-1; Mundra P, 2007, PATTERN RECOGN LETT, V28, P1610, DOI 10.1016/j.patrec.2007.04.001; Murphy LR, 2000, PROTEIN ENG, V13, P149, DOI 10.1093/protein/13.3.149; Murphy R F, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P251; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39; Nguyen MN, 2007, INT J DATA MIN BIOIN, V1, P248, DOI 10.1504/IJDMB.2007.011612; Nguyen MN, 2005, PROTEINS, V59, P30, DOI 10.1002/prot.20404; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng ZL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-420; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Platt JC, 2000, ADV NEUR IN, V12, P547; Riley E.B.M.A., 2005, TUTORIALS CONT NONLI; Rong-Quan Xiao, 2009, Journal of Biomedical Science & Engineering, V2, P51, DOI 10.4236/jbise.2009.21009; Sanchez-Flores A, 2008, PROTEINS, V70, P248, DOI 10.1002/prot.21506; Sarda D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-152; Shen HB, 2005, BIOCHEM BIOPH RES CO, V337, P752, DOI 10.1016/j.bbrc.2005.09.117; Shen HB, 2007, PROTEIN ENG DES SEL, V20, P561, DOI 10.1093/protein/gzm057; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Shi SP, 2011, BBA-MOL CELL RES, V1813, P424, DOI 10.1016/j.bbamcr.2011.01.011; Shin CJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-28; SILHAVY TJ, 1983, MICROBIOL REV, V47, P313, DOI 10.1128/MMBR.47.3.313-344.1983; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tan YX, 2005, NUCLEIC ACIDS RES, V33, P56, DOI 10.1093/nar/gki144; Wang J, 2009, PATTERN RECOGN, V42, P1237, DOI 10.1016/j.patcog.2008.11.024; Wang JR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-174; Webb-Robertson BJM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-145; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; WOLD S, 1993, ANAL CHIM ACTA, V277, P239, DOI 10.1016/0003-2670(93)80437-P; Yang JY, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-S1-I1, 10.1186/1471-2164-9-S1-11]; Yang JY, 2011, PROTEINS, V79, P2053, DOI 10.1002/prot.23025; Yang JY, 2009, J THEOR BIOL, V257, P618, DOI 10.1016/j.jtbi.2008.12.027; Yang L, 2010, AMINO ACIDS, V38, P1497, DOI 10.1007/s00726-009-0362-4; Yang YC, 2008, J THEOR BIOL, V252, P145, DOI 10.1016/j.jtbi.2008.01.028; Yin JB, 2011, NEUROCOMPUTING, V74, P3816, DOI 10.1016/j.neucom.2011.07.017; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yu ZG, 2004, PHYSICA A, V337, P171, DOI 10.1016/j.physa.2004.01.057; Yu ZG, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015206; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zheng XQ, 2009, AMINO ACIDS, V37, P427, DOI 10.1007/s00726-008-0172-0; Zhou Y, 2007, PHYS LETT A, V368, P314, DOI 10.1016/j.physleta.2007.04.012	92	43	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57225	10.1371/journal.pone.0057225	http://dx.doi.org/10.1371/journal.pone.0057225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460833	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000081
J	Janos, DP; Scott, J; Aristizabal, C; Bowman, DMJS				Janos, David P.; Scott, John; Aristizabal, Catalina; Bowman, David M. J. S.			Arbuscular-Mycorrhizal Networks Inhibit Eucalyptus tetrodonta Seedlings in Rain Forest Soil Microcosms	PLOS ONE			English	Article							IRON CHLOROSIS PARADOX; INTERSPECIFIC TRANSFER; PLANTS; FUNGI; GROWTH; GLOMALIN; PHOSPHORUS; CARBON; TREES; ROOT	Eucalyptus tetrodonta, a co-dominant tree species of tropical, northern Australian savannas, does not invade adjacent monsoon rain forest unless the forest is burnt intensely. Such facilitation by fire of seedling establishment is known as the "ashbed effect." Because the ashbed effect might involve disruption of common mycorrhizal networks, we hypothesized that in the absence of fire, intact rain forest arbuscular mycorrhizal (AM) networks inhibit E. tetrodonta seedlings. Although arbuscular mycorrhizas predominate in the rain forest, common tree species of the northern Australian savannas (including adult E. tetrodonta) host ectomycorrhizas. To test our hypothesis, we grew E. tetrodonta and Ceiba pentandra (an AM-responsive species used to confirm treatments) separately in microcosms of ambient or methyl-bromide fumigated rain forest soil with or without severing potential mycorrhizal fungus connections to an AM nurse plant, Litsea glutinosa. As expected, C. pentandra formed mycorrhizas in all treatments but had the most root colonization and grew fastest in ambient soil. E. tetrodonta seedlings also formed AM in all treatments, but severing hyphae in fumigated soil produced the least colonization and the best growth. Three of ten E. tetrodonta seedlings in ambient soil with intact network hyphae died. Because foliar chlorosis was symptomatic of iron deficiency, after 130 days we began to fertilize half the E. tetrodonta seedlings in ambient soil with an iron solution. Iron fertilization completely remedied chlorosis and stimulated leaf growth. Our microcosm results suggest that in intact rain forest, common AM networks mediate belowground competition and AM fungi may exacerbate iron deficiency, thereby enhancing resistance to E. tetrodonta invasion. Common AM networks-previously unrecognized as contributors to the ashbed effect-probably help to maintain the rain forest-savanna boundary.	[Janos, David P.; Aristizabal, Catalina] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Scott, John] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Bowman, David M. J. S.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia	University of Miami; Charles Darwin University; University of Tasmania	Janos, DP (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	davidjanos@miami.edu	Janos, David P/B-2264-2008; Bowman, David/A-2930-2011	Janos, David P/0000-0002-3877-0110; Bowman, David/0000-0001-8075-124X	Cooperative Research Centre (CRC) for Tropical Savannas; Parks and Wildlife Commission of the Northern Territory; University of Tasmania	Cooperative Research Centre (CRC) for Tropical Savannas; Parks and Wildlife Commission of the Northern Territory; University of Tasmania	The Cooperative Research Centre (CRC) for Tropical Savannas, and the Parks and Wildlife Commission of the Northern Territory funded this research. The University of Tasmania supported DPJ as a visiting scholar to prepare the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams F, 2006, AUST J BOT, V54, P271, DOI 10.1071/BT05028; Allen E. B., 1993, Mycorrhiza, V2, P147, DOI 10.1007/BF00210583; Allen EB, 2003, ECOL APPL, V13, P1701, DOI 10.1890/02-5309; ARNEBRANT K, 1993, NEW PHYTOL, V124, P231, DOI 10.1111/j.1469-8137.1993.tb03812.x; Ashton DH, 1996, J VEG SCI, V7, P487, DOI 10.2307/3236297; Bavaresco L, 1999, J PLANT NUTR, V22, P1589, DOI 10.1080/01904169909365739; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Booth MG, 2010, ECOLOGY, V91, P2294, DOI 10.1890/09-1139.1; Bowman D.M., 2000, AUSTR RAINFORESTS IS; Bowman D. M. J. S., 1995, Australian Forestry, V58, P46; Bowman DMJS, 2010, LANDSCAPE ECOL, V25, P1247, DOI 10.1007/s10980-010-9496-8; BOWMAN DMJS, 1992, AUST J BOT, V40, P89, DOI 10.1071/BT9920089; Brundrett MC, 1996, PLANT SOIL, V184, P173, DOI 10.1007/BF00029286; Cardoso IM, 2006, COMMUN SOIL SCI PLAN, V37, P1537, DOI 10.1080/00103620600710074; CHAMBERS DP, 1994, AUST J BOT, V42, P739, DOI 10.1071/BT9940739; CHIARIELLO N, 1982, SCIENCE, V217, P941, DOI 10.1126/science.217.4563.941; Collier FA, 2009, J ECOL, V97, P950, DOI 10.1111/j.1365-2745.2009.01544.x; Courty PE, 2010, SOIL BIOL BIOCHEM, V42, P679, DOI 10.1016/j.soilbio.2009.12.006; Egerton-Warburton LM, 2007, J EXP BOT, V58, P1473, DOI 10.1093/jxb/erm009; EISSENSTAT DM, 1990, FUNCT ECOL, V4, P95, DOI 10.2307/2389658; FLORENCE RG, 1962, ECOLOGY, V43, P670, DOI 10.2307/1933456; FRANCIS R, 1984, NATURE, V307, P53, DOI 10.1038/307053a0; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Hopkins MS, 1996, J TROP ECOL, V12, P871, DOI 10.1017/S0266467400010130; Humphreys F.R., 1965, SOIL RES, V3, P81; Ilesa TM, 2010, AUST J BOT, V58, P133, DOI 10.1071/BT08124; Janos DP, 2008, J TROP ECOL, V24, P177, DOI 10.1017/S0266467408004860; Janos DP, 2008, SOIL BIOL BIOCHEM, V40, P728, DOI 10.1016/j.soilbio.2007.10.007; Janos DP, 2007, MYCORRHIZA, V17, P75, DOI 10.1007/s00572-006-0094-1; JANOS DP, 1980, BIOTROPICA, V12, P56, DOI 10.2307/2388157; Janos DP, 2001, PLANT SOIL, V233, P85, DOI 10.1023/A:1010329618152; Janouskova M, 2011, MYCORRHIZA, V21, P641, DOI 10.1007/s00572-011-0372-4; Knorr MA, 2003, MYCORRHIZA, V13, P205, DOI 10.1007/s00572-002-0218-1; KOIDE RT, 1989, NEW PHYTOL, V111, P35, DOI 10.1111/j.1469-8137.1989.tb04215.x; Kytoviita MM, 2003, ECOLOGY, V84, P898, DOI 10.1890/0012-9658(2003)084[0898:ATOMAI]2.0.CO;2; Launonen TM, 2004, PLANT SOIL, V267, P179, DOI 10.1007/s11104-005-4794-7; Leake JR, 2004, CAN J BOT, V82, P1016, DOI [10.1139/B04-060, 10.1139/b04-060]; Lekberg Y, 2010, FEMS MICROBIOL ECOL, V74, P336, DOI 10.1111/j.1574-6941.2010.00956.x; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; McGonigle TP, 2001, MYCORRHIZA, V10, P249, DOI 10.1007/s005720000080; McGuire KL, 2007, ECOLOGY, V88, P567, DOI 10.1890/05-1173; McMullan-Fisher SJM, 2011, AUST J BOT, V59, P70, DOI 10.1071/BT10059; MENGEL K, 1994, PLANT SOIL, V165, P275, DOI 10.1007/BF00008070; Moora M, 1998, CAN J BOT, V76, P613, DOI 10.1139/cjb-76-4-613; Morales F, 1998, J PLANT NUTR, V21, P815, DOI 10.1080/01904169809365444; NEWMAN EI, 1988, ADV ECOL RES, V18, P243, DOI 10.1016/S0065-2504(08)60182-8; Nunez MA, 2009, ECOLOGY, V90, P2352, DOI 10.1890/08-2139.1; Parsons RF, 2007, AUSTRALAS PLANT PATH, V36, P415, DOI 10.1071/AP07043; Preger AC, 2007, SOIL BIOL BIOCHEM, V39, P445, DOI 10.1016/j.soilbio.2006.08.014; REDDELL P, 1992, AUST J BOT, V40, P223, DOI 10.1071/BT9920223; Romheld V, 2000, J PLANT NUTR, V23, P1629, DOI 10.1080/01904160009382129; RUSSELLSMITH J, 1991, J VEG SCI, V2, P259, DOI 10.2307/3235959; Selosse MA, 2006, TRENDS ECOL EVOL, V21, P621, DOI 10.1016/j.tree.2006.07.003; Simard SW, 2004, CAN J BOT, V82, P1140, DOI [10.1139/b04-116, 10.1139/B04-116]; Simard SW, 1997, NATURE, V388, P579, DOI 10.1038/41557; STOCKER G C, 1969, Australian Forest Research, V4, P31; SZANISZLO PJ, 1981, MYCOLOGIA, V73, P1158, DOI 10.2307/3759685; Teste FP, 2010, J ECOL, V98, P429, DOI 10.1111/j.1365-2745.2009.01624.x; TREEBY MT, 1992, SOIL BIOL BIOCHEM, V24, P857, DOI 10.1016/0038-0717(92)90006-J; TURTON SM, 1992, AUST J ECOL, V17, P415, DOI 10.1111/j.1442-9993.1992.tb00824.x; VANKESSEL C, 1985, PLANT PHYSIOL, V79, P562, DOI 10.1104/pp.79.2.562; Wang MY, 2008, BIOL FERT SOILS, V45, P65, DOI 10.1007/s00374-008-0290-6; WARCUP JH, 1991, MYCOL RES, V95, P329, DOI 10.1016/S0953-7562(09)81243-4; Wilson BA, 1990, 49 CONS COMM NO TERR; Wilson GWT, 2006, FUNCT ECOL, V20, P427, DOI 10.1111/j.1365-2435.2006.01134.x; WOODS FW, 1964, ECOLOGY, V45, P886, DOI 10.2307/1934943; Wright SF, 1998, PLANT SOIL, V198, P97, DOI 10.1023/A:1004347701584	67	18	19	4	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57716	10.1371/journal.pone.0057716	http://dx.doi.org/10.1371/journal.pone.0057716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460899	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000154
J	Noti, JD; Blachere, FM; McMillen, CM; Lindsley, WG; Kashon, ML; Slaughter, DR; Beezhold, DH				Noti, John D.; Blachere, Francoise M.; McMillen, Cynthia M.; Lindsley, William G.; Kashon, Michael L.; Slaughter, Denzil R.; Beezhold, Donald H.			High Humidity Leads to Loss of Infectious Influenza Virus from Simulated Coughs	PLOS ONE			English	Article							RELATIVE-HUMIDITY; TRANSMISSION; SURVIVAL; VENTILATION; DISPERSION; EXPOSURE; AEROSOL	Background: The role of relative humidity in the aerosol transmission of influenza was examined in a simulated examination room containing coughing and breathing manikins. Methods: Nebulized influenza was coughed into the examination room and Bioaerosol samplers collected size-fractionated aerosols (<1 mu M, 1-4 mu M, and >4 mu M aerodynamic diameters) adjacent to the breathing manikin's mouth and also at other locations within the room. At constant temperature, the RH was varied from 7-73% and infectivity was assessed by the viral plaque assay. Results: Total virus collected for 60 minutes retained 70.6-77.3% infectivity at relative humidity <= 23% but only 14.6-22.2% at relative humidity >= 43%. Analysis of the individual aerosol fractions showed a similar loss in infectivity among the fractions. Time interval analysis showed that most of the loss in infectivity within each aerosol fraction occurred 0-15 minutes after coughing. Thereafter, losses in infectivity continued up to 5 hours after coughing, however, the rate of decline at 45% relative humidity was not statistically different than that at 20% regardless of the aerosol fraction analyzed. Conclusion: At low relative humidity, influenza retains maximal infectivity and inactivation of the virus at higher relative humidity occurs rapidly after coughing. Although virus carried on aerosol particles,4 mM have the potential for remaining suspended in air currents longer and traveling further distances than those on larger particles, their rapid inactivation at high humidity tempers this concern. Maintaining indoor relative humidity >40% will significantly reduce the infectivity of aerosolized virus.	[Noti, John D.; Blachere, Francoise M.; McMillen, Cynthia M.; Lindsley, William G.; Kashon, Michael L.; Slaughter, Denzil R.; Beezhold, Donald H.] NIOSH, HELD, Ctr Dis Control & Prevent CDC, Morgantown, WV USA; [McMillen, Cynthia M.] W Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); West Virginia University	Noti, JD (corresponding author), NIOSH, HELD, Ctr Dis Control & Prevent CDC, Morgantown, WV USA.	ivr2@cdc.gov		McMillen, Cynthia/0000-0001-9211-7908; Lindsley, William/0000-0003-0720-5829; Beezhold, Donald/0000-0001-5543-5747	National Institute for Occupational Safety and Health; Centers for Disease Control and Prevention	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the National Institute for Occupational Safety and Health and the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHRAE Standard, 2010, 55 ASHRAE; Bjorn E, 2002, INDOOR AIR, V12, P147, DOI 10.1034/j.1600-0668.2002.08126.x; Blachere FM, 2011, J VIROL METHODS, V176, P120, DOI 10.1016/j.jviromet.2011.05.030; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Hanley BP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-98; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; HEMMES JH, 1960, NATURE, V188, P430, DOI 10.1038/188430a0; HOOD AM, 1963, J HYG-CAMBRIDGE, V61, P331, DOI 10.1017/S0022172400039619; Huynh KN, 2008, CLIN INFECT DIS, V46, P93, DOI 10.1086/523000; ISO, 2005, 7730 ISO, DOI DOI 10.1016/J.SOILDYN.2004.11.005; ISO, 2007, 1697612007E ISOTS; Lindsley WG, 2006, J ENVIRON MONITOR, V8, P1136, DOI 10.1039/b609083d; Lindsley WG, 2012, J OCCUP ENVIRON HYG, V9, P681, DOI 10.1080/15459624.2012.725986; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Milton DK, 2010, APR 18 20 ATL GEORG; Noti JD, 2012, CLIN INFECT DIS, V54, P1569, DOI 10.1093/cid/cis237; Pantelic J, 2009, J R SOC INTERFACE, V6, pS715, DOI 10.1098/rsif.2009.0311.focus; Qian H, 2006, INDOOR AIR, V16, P111, DOI 10.1111/j.1600-0668.2005.00407.x; Qian H, 2010, INDOOR AIR, V20, P284, DOI 10.1111/j.1600-0668.2010.00653.x; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; SHECHMEISTER IL, 1950, J INFECT DIS, V87, P128, DOI 10.1093/infdis/87.2.128; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Teunis PFM, 2010, EPIDEMICS-NETH, V2, P215, DOI 10.1016/j.epidem.2010.10.001; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Wein LM, 2009, RISK ANAL, V29, P949, DOI 10.1111/j.1539-6924.2009.01232.x; Yang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021481	34	82	87	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57485	10.1371/journal.pone.0057485	http://dx.doi.org/10.1371/journal.pone.0057485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460865	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000120
J	Simonato, M; Battisti, A; Kerdelhue, C; Burban, C; Lopez-Vaamonde, C; Pivotto, I; Salvato, P; Negrisolo, E				Simonato, Mauro; Battisti, Andrea; Kerdelhue, Carole; Burban, Christian; Lopez-Vaamonde, Carlos; Pivotto, Isabelle; Salvato, Paola; Negrisolo, Enrico			Host and Phenology Shifts in the Evolution of the Social Moth Genus Thaumetopoea	PLOS ONE			English	Article							PINE PROCESSIONARY MOTH; COMPLETE MITOCHONDRIAL GENOME; MULTIPLE SEQUENCE ALIGNMENT; PITYOCAMPA LEPIDOPTERA; PHYLOGENETIC ANALYSIS; TRANSFER-RNA; PLANT USE; DNA; BUTTERFLIES; INSECTA	The genus Thaumetopoea contains the processionary moths, a group of lepidopteran associated with forest trees, well known for the social behaviour of the larvae and for carrying urticating setae. The taxonomy of the genus is partly unresolved and a phylogenetic approach is lacking. The goal of this work is to produce a phylogeny for Thaumetopoea and to identify the main traits driving the evolution of this group. Eighteen mitochondrial and three nuclear genes were fully/partly sequenced. Markers were aligned and analysed singularly or in various combinations. Phylogenetic analyses were performed according to maximum likelihood and Bayesian inference methods. Trees obtained from largest data sets provided identical topologies that received strong statistical support. Three main clades were identified within Thaumetopoea and were further supported by several signatures located in the mitochondrial tRNAs and intergenic spacers. The reference topology was used to investigate the evolution of life history traits related to biogeography, host plant, ecology, and morphology. A multigenic approach allowed to produce a robust phylogenetic analysis of the genus Thaumetopoea, with the identification of three major clades linked to different ecological and life history traits. The first clade is associated with Angiosperm host plants and has a fast spring development of larvae on young foliage. The other clades have originated by one event of host plant shift to Gymnosperm Pinaceae, which implied a longer larval developmental time due to the lower nutritional quality of leaves. These clades showed different adaptations to such a constraint, the first with a switch of larval feeding to cold season (winter pine processionary moths), and the second with a retraction to high altitude and latitude and a development cycle extended over two years (summer pine processionary moths). Recent global warming is affecting all species and seems able to further shape the evolution of the group.	[Simonato, Mauro; Battisti, Andrea; Salvato, Paola] Univ Padua, DAFNAE Entomol, Padua, Italy; [Kerdelhue, Carole] INRA CIRAD IRD Montpellier Supagro, UMR CBGP, INRA, Montferrier Sur Lez, France; [Burban, Christian; Pivotto, Isabelle] Univ Bordeaux, INRA, BIOGECO UMR1202, INRA, Cestas, France; [Lopez-Vaamonde, Carlos] INRA, URZF UR033, Orleans, France; [Negrisolo, Enrico] Univ Padua, BCA Dept Comparat Biomed & Food Safety, Padua, Italy	University of Padua; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE; University of Padua	Negrisolo, E (corresponding author), Univ Padua, BCA Dept Comparat Biomed & Food Safety, Padua, Italy.	enrico.negrisolo@unipd.it	Battisti, Andrea/F-6243-2015; Yakovlev, Roman/J-7243-2013; Vaamonde, Carlos Lopez/A-5548-2009; Kerdelhue, Carole/GVS-0309-2022; Negrisolo, Enrico/K-8124-2015	Battisti, Andrea/0000-0002-2497-3064; Vaamonde, Carlos Lopez/0000-0003-2278-2368; Negrisolo, Enrico/0000-0002-6244-805X; Kerdelhue, Carole/0000-0001-7667-902X	European Union [QLK5-CT-2002-00852]; University of Padova	European Union(European Commission); University of Padova	The work presented in this paper has started with a grant from the European Union (Promoth QLK5-CT-2002-00852, P.I. AB) and has been continued with several grants of the University of Padova to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Adachi J, 1996, J MOL EVOL, V42, P459; Agenjo R., 1941, Eos Madrid, V17, P69; Aimi A, 2008, AGR FOREST ENTOMOL, V10, P225, DOI 10.1111/j.1461-9563.2008.00378.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Barbaro L, 2011, BIOL CONTROL, V56, P107, DOI 10.1016/j.biocontrol.2010.10.009; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; BATTISTI A, 1988, J APPL ENTOMOL, V105, P393, DOI 10.1111/j.1439-0418.1988.tb00202.x; Battisti A, 2011, ANNU REV ENTOMOL, V56, P203, DOI 10.1146/annurev-ento-120709-144844; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bohm SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017857; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Costa J., 2006, OTHER INSECT SOC; de Freina J., 1987, BOMBYCES SPHINGES WE, VI; de Freina J.J., 1982, Atalanta (Marktleuthen), V13, P309; DEMOLIN G, 1969, Annales des Sciences Forestieres (Paris), V26, P81; Doganlar Miktat, 2001, Turkiye Entomoloji Dergisi, V25, P19; Doganlar Miktat, 2005, Entomofauna, V26, P229; Dussourd David E., 1993, P92; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; FEARNLEY IM, 1987, BIOCHEMISTRY-US, V26, P8247, DOI 10.1021/bi00399a034; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Fitzgerald Terrence D., 1993, P372; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FURTH D G, 1979, Israel Journal of Entomology, V13, P1; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; Gowri-Shankar V., 2006, PHASE SOFTWARE PACKA; Groenen F, 2012, AGR FOREST ENTOMOL, V14, P147, DOI 10.1111/j.1461-9563.2011.00552.x; HALPERIN J, 1990, J APPL ENTOMOL, V110, P1, DOI 10.1111/j.1439-0418.1990.tb00088.x; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kerdelhue C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-220; Kim I, 2005, GENE, V353, P155, DOI 10.1016/j.gene.2005.04.019; Kiriakoff S.G., 1970, GENERA INSECT, V219, P1; KRAMER P J, 1979, P811; Lavrov DV, 2000, MOL BIOL EVOL, V17, P813, DOI 10.1093/oxfordjournals.molbev.a026360; Liao F, 2010, INT J BIOL SCI, V6, P172; Lill JT, 2002, NATURE, V417, P170, DOI 10.1038/417170a; Lopez-Vaamonde C, 2003, EVOLUTION, V57, P1804, DOI 10.1111/j.0014-3820.2003.tb00588.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; MILANI N, 1990, Redia, V73, P149; Mitchell A, 1997, MOL BIOL EVOL, V14, P381, DOI 10.1093/oxfordjournals.molbev.a025774; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Negrisolo E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-221; Nijhout HF, 2010, PHILOS T R SOC B, V365, P567, DOI 10.1098/rstb.2009.0249; Ohshima I, 2006, MOL PHYLOGENET EVOL, V38, P231, DOI 10.1016/j.ympev.2005.06.010; Paiva MR, 2011, J APPL ENTOMOL, V135, P195, DOI 10.1111/j.1439-0418.2010.01550.x; PATWARY MU, 1994, J SHELLFISH RES, V13, P547; Perez-Contreras T, 2003, ANN ZOOL FENN, V40, P505; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Qiao CY, 2007, ANN BOT-LONDON, V100, P573, DOI 10.1093/aob/mcm134; Ratcliffe JM, 2008, NATURE, V455, P96, DOI 10.1038/nature07087; Ronnas C, 2010, ECOL ENTOMOL, V35, P436, DOI 10.1111/j.1365-2311.2010.01199.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousselet J, 2010, J BIOGEOGR, V37, P1478, DOI 10.1111/j.1365-2699.2010.02289.x; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Salvato P, 2002, MOL ECOL, V11, P2435, DOI 10.1046/j.1365-294X.2002.01631.x; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Santos H, 2011, J EVOLUTION BIOL, V24, P1897, DOI 10.1111/j.1420-9101.2011.02318.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Simonato M, 2007, MOL ECOL, V16, P2273, DOI 10.1111/j.1365-294X.2007.03302.x; SMITH AE, 1968, J MOL BIOL, V38, P241, DOI 10.1016/0022-2836(68)90409-9; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stastny M, 2006, ECOL ENTOMOL, V31, P481, DOI 10.1111/j.1365-2311.2006.00807.x; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Strong D., 1984, INSECTS PLANTS COMMU; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trought T., 1954, Entomologist's Record Bishop's Stortford, V66, P188; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wiltshire E.P., 1980, Journal of Oman Studies Special Report, P187; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Zakharov EV, 2004, SYST BIOL, V53, P193, DOI 10.1080/10635150490423403; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	91	23	23	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57192	10.1371/journal.pone.0057192	http://dx.doi.org/10.1371/journal.pone.0057192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460830	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000074
J	Ukkola-Vuoti, L; Kanduri, C; Oikkonen, J; Buck, G; Blancher, C; Raijas, P; Karma, K; Lahdesmaki, H; Jarvela, I				Ukkola-Vuoti, Liisa; Kanduri, Chakravarthi; Oikkonen, Jaana; Buck, Gemma; Blancher, Christine; Raijas, Pirre; Karma, Kai; Lahdesmaki, Harri; Jarvela, Irma			Genome-Wide Copy Number Variation Analysis in Extended Families and Unrelated Individuals Characterized for Musical Aptitude and Creativity in Music	PLOS ONE			English	Article							PROTOCADHERIN-ALPHA FAMILY; PREFRONTAL CORTEX; GENE; ASSOCIATION; BINDING; DISORDER; MICRODELETION; SCHIZOPHRENIA; POLYMORPHISM; PERFORMANCE	Music perception and practice represent complex cognitive functions of the human brain. Recently, evidence for the molecular genetic background of music related phenotypes has been obtained. In order to further elucidate the molecular background of musical phenotypes we analyzed genome wide copy number variations (CNVs) in five extended pedigrees and in 172 unrelated subjects characterized for musical aptitude and creative functions in music. Musical aptitude was defined by combination of the scores of three music tests (COMB scores): auditory structuring ability, Seashores test for pitch and for time. Data on creativity in music (herein composing, improvising and/or arranging music) was surveyed using a web-based questionnaire. Several CNVRs containing genes that affect neurodevelopment, learning and memory were detected. A deletion at 5q31.1 covering the protocadherin-a gene cluster (Pcdha 1-9) was found co-segregating with low music test scores (COMB) in both sample sets. Pcdha is involved in neural migration, differentiation and synaptogenesis. Creativity in music was found to co-segregate with a duplication covering glucose mutarotase gene (GALM) at 2p22. GALM has influence on serotonin release and membrane trafficking of the human serotonin transporter. Interestingly, genes related to serotonergic systems have been shown to associate not only with psychiatric disorders but also with creativity and music perception. Both, Pcdha and GALM, are related to the serotonergic systems influencing cognitive and motor functions, important for music perception and practice. Finally, a 1.3 Mb duplication was identified in a subject with low COMB scores in the region previously linked with absolute pitch (AP) at 8q24. No differences in the CNV burden was detected among the high/low music test scores or creative/non-creative groups. In summary, CNVs and genes found in this study are related to cognitive functions. Our result suggests new candidate genes for music perception related traits and supports the previous results from AP study.	[Ukkola-Vuoti, Liisa; Kanduri, Chakravarthi; Oikkonen, Jaana; Jarvela, Irma] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Kanduri, Chakravarthi; Lahdesmaki, Harri] Aalto Univ, Dept Informat & Comp Sci, Espoo, Finland; [Buck, Gemma; Blancher, Christine] Wellcome Trust Ctr Human Genet, Oxford, England; [Raijas, Pirre] Sibelius Acad, DocMus Dept, Helsinki, Finland; [Karma, Kai] Sibelius Acad, Dept Mus Educ, Helsinki, Finland	University of Helsinki; Aalto University; University of Oxford; Wellcome Centre for Human Genetics; University of the Arts Helsinki; University of the Arts Helsinki	Ukkola-Vuoti, L (corresponding author), Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland.	liisa.ukkola@helsinki.fi	Kanduri, Chakravarthi/AAL-1021-2020; Ukkola-Vuoti, Liisa/E-6564-2016; Jarvela, Irma E/L-5836-2013	Kanduri, Chakravarthi/0000-0002-4783-9060; Ukkola-Vuoti, Liisa/0000-0002-0770-361X; Jarvela, Irma E/0000-0002-1770-6187; Buck, Gemma/0000-0001-5289-1050; Oikkonen, Jaana/0000-0002-1063-2736	Academy of Finland [13371]; Biocentrum Helsinki Foundation	Academy of Finland(Academy of Finland); Biocentrum Helsinki Foundation	The work was financially supported by the Academy of Finland (grant 13371) and the Biocentrum Helsinki Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2002, NATURE, V416, P12, DOI 10.1038/416012a; Almal SH, 2012, J HUM GENET, V57, P6, DOI 10.1038/jhg.2011.108; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Bengtsson SL, 2007, J COGNITIVE NEUROSCI, V19, P830, DOI 10.1162/jocn.2007.19.5.830; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Blum K, 2010, MED HYPOTHESES, V74, P513, DOI 10.1016/j.mehy.2009.10.008; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Dauber A, 2011, AM J HUM GENET, V89, P751, DOI 10.1016/j.ajhg.2011.10.014; Dellinger AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq040; Djurovic S, 2009, PSYCHIAT RES, V168, P256, DOI 10.1016/j.psychres.2008.08.007; Drevets WC, 2007, NUCL MED BIOL, V34, P865, DOI 10.1016/j.nucmedbio.2007.06.008; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Fukuda E, 2008, EUR J NEUROSCI, V28, P1362, DOI 10.1111/j.1460-9568.2008.06428.x; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Granota RY, 2007, EVOL HUM BEHAV, V28, P313, DOI 10.1016/j.evolhumbehav.2007.05.003; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Gu W, 2008, CYTOGENET GENOME RES, V123, P54, DOI 10.1159/000184692; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Haworth CMA, 2009, J CHILD PSYCHOL PSYC, V50, P1318, DOI 10.1111/j.1469-7610.2009.02114.x; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Justus T, 2005, MUSIC PERCEPT, V23, P1, DOI 10.1525/mp.2005.23.1.1; Karlsson R, 2012, BIOL PSYCHIAT, V71, P922, DOI 10.1016/j.biopsych.2012.01.020; Karma K., 2007, PSYCHOMUSICOLOGY, V19, P79, DOI [10.1037/h0094033, DOI 10.1037/H0094033]; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Keri S, 2009, PSYCHOL SCI, V20, P1070, DOI 10.1111/j.1467-9280.2009.02398.x; Knight S, 2009, GENET EPIDEMIOL, V33, pS99, DOI 10.1002/gepi.20480; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Koelsch S, 2005, CURR OPIN NEUROBIOL, V15, P207, DOI 10.1016/j.conb.2005.03.005; Kousi M, 2012, J MED GENET, V49, P391, DOI 10.1136/jmedgenet-2012-100859; Kyaga S, 2011, BRIT J PSYCHIAT, V199, P373, DOI 10.1192/bjp.bp.110.085316; Li X, 2010, J GENET GENOMICS, V37, P779, DOI 10.1016/S1673-8527(09)60095-3; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Liu X, 2011, MOL PSYCHIATR, V16, P584, DOI 10.1038/mp.2011.1; Magri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013422; Matsson H, 2011, BEHAV GENET, V41, P134, DOI 10.1007/s10519-010-9431-4; McDermott J, 2007, COGNITION, V104, P654, DOI 10.1016/j.cognition.2006.07.011; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Moghimi S, 2012, NEUROSCI LETT, V525, P7, DOI 10.1016/j.neulet.2012.07.009; Morley AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031763; Noguchi Y, 2009, J BIOL CHEM, V284, P32002, DOI 10.1074/jbc.M109.046938; Norio R, 2003, HUM GENET, V112, P457, DOI 10.1007/s00439-002-0876-2; Park H, 2012, J MED GENET, V49, P747, DOI 10.1136/jmedgenet-2012-101209; Park JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031243; Pedrosa E, 2008, SCHIZOPHR RES, V102, P210, DOI 10.1016/j.schres.2008.04.013; Perani D, 2010, P NATL ACAD SCI USA, V107, P4758, DOI 10.1073/pnas.0909074107; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Petrin AL, 2010, AM J MED GENET A, V152A, P3164, DOI 10.1002/ajmg.a.33749; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; PORTER D, 1984, J EXP PSYCHOL ANIM B, V10, P138; Pulli K, 2008, J MED GENET, V45, P451, DOI 10.1136/jmg.2007.056366; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reuter M, 2006, IDENTIFICATION 1 CAN; Sakai T, 2008, NEUROPATHOLOGY, V28, P143, DOI 10.1111/j.1440-1789.2007.00867.x; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Salyakina D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026049; Schlattl A, 2011, GENOME RES, V21, P2004, DOI 10.1101/gr.122614.111; Seashore CE., 1960, SEASHORE MEASURES MU; Shin OH, 2005, J BIOL CHEM, V280, P1641, DOI 10.1074/jbc.M407305200; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Sternberg RJ, 2006, INTERNATIONAL HANDBOOK OF CREATIVITY, P1; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Theusch E, 2009, AM J HUM GENET, V85, P112, DOI 10.1016/j.ajhg.2009.06.010; Trehub SE, 2001, ANN NY ACAD SCI, V930, P1; Ukkola LT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005534; Ukkola-Vuoti L, 2011, J HUM GENET, V56, P324, DOI 10.1038/jhg.2011.13; Watanabe S, 1999, BEHAV PROCESS, V47, P53, DOI 10.1016/S0376-6357(99)00049-2; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Yeo RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016339; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0; Zhang P, 2010, BIPOLAR DISORD, V12, P786, DOI 10.1111/j.1399-5618.2010.00883.x; Zollino M, 2012, NAT GENET, V44, P636, DOI 10.1038/ng.2257	79	52	54	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56356	10.1371/journal.pone.0056356	http://dx.doi.org/10.1371/journal.pone.0056356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460800	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000023
J	Ferreira, RM; Rybarczyk-Filho, JL; Dalmolin, RJS; Castro, MAA; Moreira, JCF; Brunnet, LG; de Almeida, RMC				Ferreira, Ricardo M.; Rybarczyk-Filho, Jose Luiz; Dalmolin, Rodrigo J. S.; Castro, Mauro A. A.; Moreira, Jose C. F.; Brunnet, Leonardo G.; de Almeida, Rita M. C.			Preferential Duplication of Intermodular Hub Genes: An Evolutionary Signature in Eukaryotes Genome Networks	PLOS ONE			English	Article							MODULARITY; PROTEINS; CONNECTIVITY; INTEGRATION; PLASTICITY; ORIGIN	Whole genome protein-protein association networks are not random and their topological properties stem from genome evolution mechanisms. In fact, more connected, but less clustered proteins are related to genes that, in general, present more paralogs as compared to other genes, indicating frequent previous gene duplication episodes. On the other hand, genes related to conserved biological functions present few or no paralogs and yield proteins that are highly connected and clustered. These general network characteristics must have an evolutionary explanation. Considering data from STRING database, we present here experimental evidence that, more than not being scale free, protein degree distributions of organisms present an increased probability for high degree nodes. Furthermore, based on this experimental evidence, we propose a simulation model for genome evolution, where genes in a network are either acquired de novo using a preferential attachment rule, or duplicated with a probability that linearly grows with gene degree and decreases with its clustering coefficient. For the first time a model yields results that simultaneously describe different topological distributions. Also, this model correctly predicts that, to produce protein-protein association networks with number of links and number of nodes in the observed range for Eukaryotes, it is necessary 90% of gene duplication and 10% of de novo gene acquisition. This scenario implies a universal mechanism for genome evolution.	[Ferreira, Ricardo M.; Rybarczyk-Filho, Jose Luiz; Castro, Mauro A. A.; Brunnet, Leonardo G.; de Almeida, Rita M. C.] Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil; [Castro, Mauro A. A.; de Almeida, Rita M. C.] Univ Fed Rio Grande do Sul, Natl Inst Sci & Technol Complex Syst, Porto Alegre, RS, Brazil; [Dalmolin, Rodrigo J. S.; Moreira, Jose C. F.] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	de Almeida, RMC (corresponding author), Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil.	rita@if.ufrgs.br	Brunnet, Leonardo G/S-2397-2016; Filho, José Luiz Rybarczyk/ABC-6502-2020; Castro, Mauro A. A./A-5467-2008; Rybarczyk-Filho, José/F-8221-2012; de Almeida, Rita M. C./K-9239-2014; moreira, jose claudio/AAO-6400-2021; Dalmolin, Rodrigo J/L-3718-2013	Brunnet, Leonardo G/0000-0003-1156-3565; Filho, José Luiz Rybarczyk/0000-0002-0757-3608; Castro, Mauro A. A./0000-0003-4942-8131; de Almeida, Rita M. C./0000-0003-3897-1841; Dalmolin, Rodrigo J/0000-0002-1688-6155	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Centro de Fisica Computacional, Universidade Federal do Rio Grande do Sul	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Centro de Fisica Computacional, Universidade Federal do Rio Grande do Sul	This work has been partially funded by Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge fruitful discussions with Prof. Diego Bonnato, Centro de Biotecnologia, and support from the Centro de Fisica Computacional, Universidade Federal do Rio Grande do Sul.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Castro MAA, 2008, NUCLEIC ACIDS RES, V36, P6269, DOI 10.1093/nar/gkn636; Colizza V, 2005, PHYSICA A, V352, P1, DOI 10.1016/j.physa.2004.12.030; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Dalmolin RJS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-22; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Evlampiev K, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-49; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232; Koonin EV, 2010, NAT REV GENET, V11, P487, DOI 10.1038/nrg2810; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Li L, 2006, MOL BIOL EVOL, V23, P2467, DOI 10.1093/molbev/msl121; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mittal N, 2011, J MOL BIOL, V409, P466, DOI 10.1016/j.jmb.2011.03.064; Prachumwat A, 2006, MOL BIOL EVOL, V23, P30, DOI 10.1093/molbev/msi249; Rybarczyk JL, 2011, NUCLEIC ACIDS RES, V39, P3005, DOI 10.1093/nar/gkq1269; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Szklarczyk R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-337; Takemoto K, 2007, MATH BIOSCI, V208, P454, DOI 10.1016/j.mbs.2006.11.002; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056104; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	37	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56579	10.1371/journal.pone.0056579	http://dx.doi.org/10.1371/journal.pone.0056579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468868	Green Published, gold			2022-12-27	WOS:000315561400011
J	Noda, T; Sakase, M; Fukushima, M; Harayama, H				Noda, Taichi; Sakase, Mitsuhiro; Fukushima, Moriyuki; Harayama, Hiroshi			Novel Approach for the Detection of the Vestiges of Testicular mRNA Splicing Errors in Mature Spermatozoa of Japanese Black Bulls	PLOS ONE			English	Article							SOLUBLE ADENYLYL-CYCLASE; REPRODUCTIVE-PERFORMANCE; PROTEIN-PHOSPHORYLATION; ORTHOLOG PROTEINS; SPERM-MOTILITY; GERM-CELLS; BICARBONATE; EXPRESSION; SPERMATOGENESIS; MONOPHOSPHATE	There is a serious problem with the reduction of male reproductive performance of the livestock in the world. We have a hypothesis that the splicing error-caused derivation of aberrant sperm motility-related proteins may be one of its causal factors. It is thought that fresh testicular tissues are necessary for the detection of splicing errors of the mRNA. However, it is difficult to obtain testicular tissues from a number of agriculturally important bulls by surgical methods, because such procedures may have deleterious effects on bulls' reproductive performance. The aim of this study was to examine the usefulness of mRNA fragments collected from ejaculated spermatozoa as alternative analytical samples for detection of the splicing errors. In the first experiment, we characterized the alternative splicing and splicing error of bull testicular ADCY10 mRNA which coded the synthase of the regulatory molecule for sperm motility "cAMP". In testes, the exon 11-lacking variant coding the truncated ADCY10 was derived by alternative splicing. However, splicing errors, which accompanied the frame shift in the second cyclase domain, were occasionally observed in the exon 11-lacking variant. This aberrant variant retained intronic nucleotides (4 bases, CCAG) connecting the initial part of exon 10 due to splicing errors and consequently yielded the cleavage site for a restriction enzyme (Cac8I) which recognized the nucleotide sequences (GCNNGC). In the second experiment, we recovered residual testicular mRNA fragments from ejaculated spermatozoa and observed the splicing error-caused derivation of the aberrant variant of ADCY 10. Ejaculated spermatozoa conserved mRNA fragments of the exon 11-lacking variant coding exons 9, 10, 12 and 13. Moreover, the above-mentioned aberrant variant of ADCY10 mRNA fragment was detectable by Cac8I digestion treatment using the sperm mRNAs. These results indicate the utility of sperm mRNA fragments for the detection of splicing errors in bull testicular mRNAs.	[Noda, Taichi; Harayama, Hiroshi] Kobe Univ, Grad Sch Agr Sci, Reprod Biol Lab, Kobe, Hyogo 657, Japan; [Sakase, Mitsuhiro; Fukushima, Moriyuki] Gen Technol Ctr Hyogo Prefecture Agr Forest & Fis, Northern Ctr Agr Technol, Asago, Japan	Kobe University	Noda, T (corresponding author), Kobe Univ, Grad Sch Agr Sci, Reprod Biol Lab, Kobe, Hyogo 657, Japan.	089a214a@stu.kobe-u.ac.jp	NODA, Taichi/K-1785-2018	NODA, Taichi/0000-0003-0260-7861	Japan Society for the Promotion of Science [20580310]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid (20580310) from the Japan Society for the Promotion of Science to H.H. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2007, MOL BIOL CELL, P329; Amano R, 2007, J REPROD DEVELOP, V53, P127, DOI 10.1262/jrd.18077; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Buck J, 2011, SENSORS-BASEL, V11, P2112, DOI 10.3390/s110202112; Buffone MG, 2012, MOL REPROD DEV, V79, P4, DOI 10.1002/mrd.21393; Butler WR, 2000, ANIM REPROD SCI, V60, P449, DOI 10.1016/S0378-4320(00)00076-2; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; DELMAS V, 1993, MOL ENDOCRINOL, V7, P1502, DOI 10.1210/me.7.11.1502; Dochi O, 2010, J REPROD DEVELOP, V56, pS61, DOI 10.1262/jrd.1056S61; Eddy EM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P3; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Galon N, 2010, J REPROD DEVELOP, V56, pS8, DOI 10.1262/jrd.1056S08; Grunewald S, 2005, ANDROLOGIA, V37, P69, DOI 10.1111/j.1439-0272.2005.00656.x; Harayama H, 2010, MOL REPROD DEV, V77, P910, DOI 10.1002/mrd.21233; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Horowitz E, 2005, MOL HUM REPROD, V11, P307, DOI 10.1093/molehr/gah163; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Johnson GD, 2011, MOL HUM REPROD, V17, P721, DOI 10.1093/molehr/gar054; Lalancette C, 2008, J CELL BIOCHEM, V104, P1570, DOI 10.1002/jcb.21756; Liegel R, 2011, MOL GENET METAB, V103, P51, DOI 10.1016/j.ymgme.2011.02.002; Livera G, 2005, MOL ENDOCRINOL, V19, P1277, DOI 10.1210/me.2004-0318; Magnan DR, 2009, MOL GENET METAB, V97, P155, DOI 10.1016/j.ymgme.2009.02.010; Noda T, 2012, THERIOGENOLOGY, V77, P1360, DOI 10.1016/j.theriogenology.2011.10.043; OKAMURA N, 1985, J BIOL CHEM, V260, P9699; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Sironen A, 2006, P NATL ACAD SCI USA, V103, P5006, DOI 10.1073/pnas.0506318103; TAJIMA Y, 1987, BIOCHIM BIOPHYS ACTA, V924, P519; TASH JS, 1982, BIOL REPROD, V26, P745, DOI 10.1095/biolreprod26.4.745; TASH JS, 1983, BIOL REPROD, V28, P75, DOI 10.1095/biolreprod28.1.75; Tate S, 2010, J REPROD DEVELOP, V56, P271, DOI 10.1262/jrd.09-180N; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; VANDERHOORN FA, 1992, P NATL ACAD SCI USA, V89, P703, DOI 10.1073/pnas.89.2.703; Walsh SW, 2011, ANIM REPROD SCI, V123, P127, DOI 10.1016/j.anireprosci.2010.12.001; Wuttke M S, 2001, JOP, V2, P154; Xie F, 2004, DEV BIOL, V265, P196, DOI 10.1016/j.ydbio.2003.09.020; Zippin JH, 2001, TRENDS ENDOCRIN MET, V12, P366, DOI 10.1016/S1043-2760(01)00454-4	39	8	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57296	10.1371/journal.pone.0057296	http://dx.doi.org/10.1371/journal.pone.0057296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468960	gold, Green Published, Green Submitted			2022-12-27	WOS:000315561400036
J	Taki, H; Okochi, I; Okabe, K; Inoue, T; Goto, H; Matsumura, T; Makino, S				Taki, Hisatomo; Okochi, Isamu; Okabe, Kimiko; Inoue, Takenari; Goto, Hideaki; Matsumura, Takeshi; Makino, Shun'ichi			Succession Influences Wild Bees in a Temperate Forest Landscape: The Value of Early Successional Stages in Naturally Regenerated and Planted Forests	PLOS ONE			English	Article							FORAGING RANGE; POLLINATION; COMMUNITIES; ABUNDANCE; AREA; CONSERVATION; BIODIVERSITY; HYMENOPTERA; DIVERSITY; HABITATS	In many temperate terrestrial forest ecosystems, both natural human disturbances drive the reestablishment of forests. Succession in plant communities, in addition to reforestation following the creation of open sites through harvesting or natural disturbances, can affect forest faunal assemblages. Wild bees perform an important ecosystem function in human-altered and natural or seminatural ecosystems, as they are essential pollinators for both crops and wild flowering plants. To maintain high abundance and species richness for pollination services, it is important to conserve and create seminatural and natural land cover with optimal successional stages for wild bees. We examined the effects of forest succession on wild bees. In particular, we evaluated the importance of early successional stages for bees, which has been suspected but not previously demonstrated. A range of successional stages, between 1 and 178 years old, were examined in naturally regenerated and planted forests. In total 4465 wild bee individuals, representing 113 species, were captured. Results for total bees, solitary bees, and cleptoparasitic bees in both naturally regenerated and planted conifer forests indicated a higher abundance and species richness in the early successional stages. However, higher abundance and species richness of social bees in naturally regenerated forest were observed as the successional stages progressed, whereas the abundance of social bees in conifer planted forest showed a concave-shaped relationship when plotted. The results suggest that early successional stages of both naturally regenerated and conifer planted forest maintain a high abundance and species richness of solitary bees and their cleptoparasitic bees, although social bees respond differently in the early successional stages. This may imply that, in some cases, active forest stand management policies, such as the clear-cutting of planted forests for timber production, would create early successional habitats, leading to significant positive effects for bees in general.	[Taki, Hisatomo; Okabe, Kimiko] Forestry & Forest Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki 305, Japan; [Okochi, Isamu; Makino, Shun'ichi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan; [Inoue, Takenari] Forestry & Forest Prod Res Inst, Hachioji, Tokyo, Japan; [Goto, Hideaki] Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Kumamoto, Japan	Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan	Taki, H (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki 305, Japan.	htaki@affrc.go.jp			Research Institute for Humanity and Nature; Global Environment Research Fund of the Ministry of the Environment, Japan [S-9]	Research Institute for Humanity and Nature; Global Environment Research Fund of the Ministry of the Environment, Japan	This study was funded as a project of the Research Institute for Humanity and Nature and was also supported in part by the Global Environment Research Fund (S-9) of the Ministry of the Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANASZAK J, 1992, AGR ECOSYST ENVIRON, V40, P179, DOI 10.1016/0167-8809(92)90091-O; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DYER FC, 1991, BEHAV ECOL SOCIOBIOL, V28, P227, DOI 10.1007/BF00175094; FAO, 2007, STAT WORLDS FOR 2007; Fontaine JB, 2009, FOREST ECOL MANAG, V257, P1496, DOI 10.1016/j.foreco.2008.12.030; Fujimori T, 2001, ECOLOGICAL SILVICULT; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Hirata A, 2011, FOREST ECOL MANAG, V262, P1280, DOI 10.1016/j.foreco.2011.06.025; Inoue Takenari, 2005, Japanese Journal of Entomology (New Series), V8, P43; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2012, J APPL ECOL, V49, P723, DOI 10.1111/j.1365-2664.2012.02144.x; Klein AM, 2003, AM J BOT, V90, P153, DOI 10.3732/ajb.90.1.153; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Krauss J, 2009, J APPL ECOL, V46, P194, DOI 10.1111/j.1365-2664.2008.01582.x; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Makino S, 2006, ENVIRON MONIT ASSESS, V120, P477, DOI 10.1007/s10661-005-9074-8; Makino S, 2007, ECOL RES, V22, P372, DOI 10.1007/s11284-007-0359-y; Michener C.D., 2007, BEES WORLD, Vsecond; Mizoguchi Y, 2002, ECOL STU AN, V158, P11; Morandin LA, 2005, ECOL APPL, V15, P871, DOI 10.1890/03-5271; NAGY A, 1988, INT TRADE FOREST PRO; Oliver C.D., 1996, FOREST STAND DYNAMIC; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; OSBORNE JL, 1991, BEE WORLD, V72, P99, DOI 10.1080/0005772X.1991.11099088; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; PICKETT STA, 1978, BIOL CONSERV, V13, P27, DOI 10.1016/0006-3207(78)90016-2; R Development Core Team, 2012, R LANG ENV STAT COMP; SAKAGAMI S F, 1977, Journal of the Faculty of Science Hokkaido University Series VI Zoology, V21, P92; Sasaki M, 1999, WONDERS JAPANESE HON; Sheffield C.S., 2008, CAN ENTOMOL, V140, P235, DOI 10.4039/n07-058; Slaa EJ, 2006, APIDOLOGIE, V37, P293, DOI 10.1051/apido:2006022; Spies Thomas A., 1999, P95, DOI 10.1017/CBO9780511613029.006; *STAT DEP, 2008, 82 STAT YB MIN AGR F; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2001, ECOGRAPHY, V24, P83, DOI 10.1034/j.1600-0587.2001.240110.x; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Taki H, 2007, LANDSCAPE ECOL, V22, P1575, DOI 10.1007/s10980-007-9153-z; Taki H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00132; Taki H, 2010, BASIC APPL ECOL, V11, P594, DOI 10.1016/j.baae.2010.08.004; Taki H, 2009, ANN APPL BIOL, V155, P121, DOI 10.1111/j.1744-7348.2009.00326.x; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Winfree R, 2007, CONSERV BIOL, V21, P213, DOI 10.1111/j.1523-1739.2006.00574.x; Winfree R, 2011, ANNU REV ECOL EVOL S, V42, P1, DOI 10.1146/annurev-ecolsys-102710-145042; Winfree R, 2010, ANN NY ACAD SCI, V1195, P169, DOI 10.1111/j.1749-6632.2010.05449.x; Wolf S, 2008, APIDOLOGIE, V39, P419, DOI 10.1051/apido:2008020; Yamaura Y, 2012, BIODIVERS CONSERV, V21, P3107, DOI 10.1007/s10531-012-0357-4; Yamaura Y, 2012, BIODIVERS CONSERV, V21, P1365, DOI 10.1007/s10531-012-0244-z; Yamaura Y, 2009, BIOL CONSERV, V142, P2155, DOI 10.1016/j.biocon.2009.04.015; Yoshida T, 2000, REARING METHOD ECOLO; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	57	51	55	3	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56678	10.1371/journal.pone.0056678	http://dx.doi.org/10.1371/journal.pone.0056678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457602	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700071
J	Buc, E; Dubois, D; Sauvanet, P; Raisch, J; Delmas, J; Darfeuille-Michaud, A; Pezet, D; Bonnet, R				Buc, Emmanuel; Dubois, Damien; Sauvanet, Pierre; Raisch, Jennifer; Delmas, Julien; Darfeuille-Michaud, Arlette; Pezet, Denis; Bonnet, Richard			High Prevalence of Mucosa-Associated E-coli Producing Cyclomodulin and Genotoxin in Colon Cancer	PLOS ONE			English	Article							DISTENDING TOXIN CDT; CROHNS-DISEASE; CELL-CYCLE; PHYLOGENETIC DISTRIBUTION; COLORECTAL-CANCER; SHIGA TOXIN; IN-VITRO; DNA; EXPRESSION; PROMOTES	Some Escherichia coli strains produce toxins designated cyclomodulins (CMs) which interfere with the eukaryotic cell cycle of host cells, suggesting a possible link between these bacteria and cancers. There are relatively few data available concerning the colonization of colon tumors by cyclomodulin- and genotoxic-producing E. coli. We did a qualitative and phylogenetic analysis of mucosa-associated E. coli harboring cyclomodulin-encoding genes from 38 patients with colorectal cancer (CRC) and 31 with diverticulosis. The functionality of these genes was investigated on cell cultures and the genotoxic activity of strains devoid of known CM-encoding gene was investigated. Results showed a higher prevalence of B2 phylogroup E. coli harboring the colibatin-producing genes in biopsies of patients with CRC (55.3%) than in those of patients with diverticulosis (19.3%), (p<0.01). Likewise, a higher prevalence of B2 E. coli harboring the CNF1-encoding genes in biopsies of patients with CRC (39.5%) than in those of patients with diverticulosis (12.9%), (p = 0.01). Functional analysis revealed that the majority of these genes were functional. Analysis of the ability of E. coli to adhere to intestinal epithelial cells Int-407 indicated that highly adherent E. coli strains mostly belonged to A and D phylogroups, whatever the origin of the strains (CRC or diverticulosis), and that most E. coli strains belonging to B2 phylogroup displayed very low levels of adhesion. In addition, 27.6% (n = 21/76) E. coli strains devoid of known cyclomodulin-encoding genes induced DNA damage in vitro, as assessed by the comet assay. In contrast to cyclomodulin-producing E. coli, these strains mainly belonged to A or D E. coli phylogroups, and exhibited a non significant difference in the distribution of CRC and diverticulosis specimens (22% versus 32.5%, p = 0.91). In conclusion, cyclomodulin-producing E. coli belonging mostly to B2 phylogroup colonize the colonic mucosa of patients with CRC.	[Buc, Emmanuel; Dubois, Damien; Sauvanet, Pierre; Raisch, Jennifer; Delmas, Julien; Darfeuille-Michaud, Arlette; Pezet, Denis; Bonnet, Richard] Univ Clermont Ferrand 2, Univ Auvergne, INSERM, UMR 1071, Clermont Ferrand, France; [Buc, Emmanuel; Dubois, Damien; Sauvanet, Pierre; Raisch, Jennifer; Delmas, Julien; Darfeuille-Michaud, Arlette; Pezet, Denis; Bonnet, Richard] INRA, USC 2018, Clermont Ferrand, France; [Dubois, Damien; Delmas, Julien; Darfeuille-Michaud, Arlette; Bonnet, Richard] CHU Clermont Ferrand, Serv Bacteriol, Clermont Ferrand, France; [Buc, Emmanuel; Sauvanet, Pierre; Pezet, Denis] CHU Clermont Ferrand, Serv Chirurg Digest, Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); INRAE; CHU Clermont Ferrand; CHU Clermont Ferrand	Bonnet, R (corresponding author), Univ Clermont Ferrand 2, Univ Auvergne, INSERM, UMR 1071, Clermont Ferrand, France.	rbonnet@chu-clermontferrand.fr	Bonnet, Richard/C-8544-2015; Pezet, Denis/I-4423-2017	Pezet, Denis/0000-0001-9416-2876	Ministere Francais de l'Education Nationale, de la Recherche et de la Technologie, l'Institut national de la sante et de la recherche medicale (Inserm) [U1071]; l'Institut National de la Recherche Agronomique [USC-2018]; la Ligue contre le cancer	Ministere Francais de l'Education Nationale, de la Recherche et de la Technologie, l'Institut national de la sante et de la recherche medicale (Inserm); l'Institut National de la Recherche Agronomique; la Ligue contre le cancer(Ligue nationale contre le cancer)	This work was supported by the Ministere Francais de l'Education Nationale, de la Recherche et de la Technologie, l'Institut national de la sante et de la recherche medicale (Inserm U1071), l'Institut National de la Recherche Agronomique (USC-2018) and la Ligue contre le cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Arthur JC, 2012, GASTROENTEROLOGY, V142, pS639; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; BARTHOLD SW, 1977, CANCER RES, V37, P4352; Bidet P, 2007, APPL ENVIRON MICROB, V73, P2373, DOI 10.1128/AEM.02341-06; Bielaszewska M, 2004, INFECT IMMUN, V72, P1812, DOI 10.1128/IAI.72.3.1812-1816.2004; BLEDAY R, 1993, DIS COLON RECTUM, V36, P844, DOI 10.1007/BF02047381; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; Bronowski C, 2008, MICROBIOL-SGM, V154, P571, DOI 10.1099/mic.0.2007/013086-0; Carvalho FA, 2009, J EXP MED, V206, P2179, DOI 10.1084/jem.20090741; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Collins D, 2011, LANCET ONCOL, V12, P504, DOI 10.1016/S1470-2045(10)70186-8; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; De Rycke J, 1999, VET RES, V30, P221; De Rycke J, 2001, FEMS MICROBIOL LETT, V203, P141, DOI 10.1016/S0378-1097(01)00344-5; Dubois D, 2010, J CLIN MICROBIOL, V48, P2122, DOI 10.1128/JCM.02365-09; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Escobar-Paramo P, 2004, MOL PHYLOGENET EVOL, V30, P243, DOI 10.1016/S1055-7903(03)00181-7; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Fiorentini C, 1998, EXP CELL RES, V242, P341, DOI 10.1006/excr.1998.4057; Fox JG, 2010, GUT, V59, P88, DOI 10.1136/gut.2009.183749; Ge ZM, 2008, CELL MICROBIOL, V10, P1599, DOI 10.1111/j.1462-5822.2008.01173.x; Ge ZM, 2007, CELL MICROBIOL, V9, P2070, DOI 10.1111/j.1462-5822.2007.00939.x; Gervaz P, 2002, SURGERY, V131, P190, DOI 10.1067/msy.2002.119816; Green GL, 2006, J APPL MICROBIOL, V100, P460, DOI 10.1111/j.1365-2672.2005.02783.x; Half E, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-22; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Hirata H, 2008, J UROLOGY, V179, P2020, DOI 10.1016/j.juro.2008.01.009; Hopkins AM, 2003, J CELL SCI, V116, P725, DOI 10.1242/jcs.00300; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08; Johnson TJ, 2010, VET MICROBIOL, V144, P100, DOI 10.1016/j.vetmic.2009.12.022; Jubelin G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001128; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karsa LV, 2010, BEST PRACT RES CL GA, V24, P381, DOI 10.1016/j.bpg.2010.06.004; Koessler T, 2008, GUT, V57, P1097, DOI 10.1136/gut.2007.137265; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Kwak EL, 2007, CLIN COLORECTAL CANC, V6, P340, DOI 10.3816/CCC.2007.n.002; Lecuit M, 2004, NEW ENGL J MED, V350, P239, DOI 10.1056/NEJMoa031887; Lemonnier M, 2007, FEMS MICROBIOL REV, V31, P515, DOI 10.1111/j.1574-6976.2007.00078.x; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Loukiadis E, 2008, J BACTERIOL, V190, P275, DOI 10.1128/JB.00844-07; Maddocks ODK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005517; Malorni W, 2006, FASEB J, V20, P606, DOI 10.1096/fj.05-4706hyp; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Nagamine CM, 2008, INFECT IMMUN, V76, P2758, DOI 10.1128/IAI.01604-07; Nagamine CM, 2008, INT J CANCER, V122, P832, DOI 10.1002/ijc.23175; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Orden JA, 2007, INT MICROBIOL, V10, P47, DOI 10.2436/20.1501.01.7; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; Pandey M, 2003, J CLIN MICROBIOL, V41, P5277, DOI 10.1128/JCM.41.11.5277-5281.2003; Peres SY, 1997, MOL MICROBIOL, V24, P1095, DOI 10.1046/j.1365-2958.1997.4181785.x; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Poxton IR, 1997, CLIN INFECT DIS, V25, pS111, DOI 10.1086/516189; SCHAUER DB, 1995, J CLIN MICROBIOL, V33, P2064, DOI 10.1128/JCM.33.8.2064-2068.1995; Scholzel S, 2000, AM J PATHOL, V156, P595, DOI 10.1016/S0002-9440(10)64764-5; Sert V, 1999, ONCOGENE, V18, P6296, DOI 10.1038/sj.onc.1203007; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Taieb F, 2006, CELL MICROBIOL, V8, P1910, DOI 10.1111/j.1462-5822.2006.00757.x; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Vogelmann R, 2007, CURR OPIN MICROBIOL, V10, P76, DOI 10.1016/j.mib.2006.12.004; WANG G, 1993, NUCLEIC ACIDS RES, V21, P5930, DOI 10.1093/nar/21.25.5930; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Zhang LX, 2002, J CLIN MICROBIOL, V40, P3951, DOI 10.1128/JCM.40.11.3951-3955.2002	73	290	295	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56964	10.1371/journal.pone.0056964	http://dx.doi.org/10.1371/journal.pone.0056964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457644	Green Published, gold			2022-12-27	WOS:000315602700103
J	von Falck, C; Bratanova, V; Rodt, T; Meyer, B; Waldeck, S; Wacker, F; Shin, HO				von Falck, Christian; Bratanova, Vesela; Rodt, Thomas; Meyer, Bernhard; Waldeck, Stephan; Wacker, Frank; Shin, Hoen-oh			Influence of Sinogram Affirmed Iterative Reconstruction of CT Data on Image Noise Characteristics and Low-Contrast Detectability: An Objective Approach	PLOS ONE			English	Article							ABDOMINAL COMPUTED-TOMOGRAPHY; FILTERED BACK-PROJECTION; RADIATION-DOSE REDUCTION; QUALITY; PERFORMANCE; FIDELITY; PHANTOM; LESIONS	Objectives: To utilize a novel objective approach combining a software phantom and an image quality metric to systematically evaluate the influence of sinogram affirmed iterative reconstruction (SAFIRE) of multidetector computed tomography (MDCT) data on image noise characteristics and low-contrast detectability (LCD). Materials and Methods: A low-contrast and a high-contrast phantom were examined on a 128-slice scanner at different dose levels. The datasets were reconstructed using filtered back projection (FBP) and SAFIRE and virtual low-contrast lesions (-20HU) were inserted. LCD was evaluated using the multiscale structural similarity index (MS-SIM*). Image noise texture and spatial resolution were objectively evaluated. Results: The use of SAFIRE led to an improvement of LCD for all dose levels and lesions sizes. The relative improvement of LCD was inversely related to the dose level, declining from 208%(+/- 37%), 259%(+/- 30%) and 309%(+/- 35%) at 25mAs to 106%(+/- 6%), 119%(+/- 9%) and 123%(+/- 8%) at 200mAs for SAFIRE filter strengths of 1, 3 and 5 (p<0.05). SAFIRE reached at least the LCD of FBP at a relative dose of 50%. There was no statistically significant difference in spatial resolution. The use of SAFIRE led to coarser image noise granularity. Conclusion: A novel objective approach combining a software phantom and the MS-SSIM* image quality metric was used to analyze the detectability of virtual low-contrast lesions against the background of image noise as created using SAFIRE in comparison to filtered back-projection. We found, that image noise characteristics using SAFIRE at 50% dose were comparable to the use of FBP at 100% dose with respect to lesion detectability. The unfamiliar imaging appearance of iteratively reconstructed datasets may in part be explained by a different, coarser noise characteristic as demonstrated by a granulometric analysis.	[von Falck, Christian; Bratanova, Vesela; Rodt, Thomas; Meyer, Bernhard; Wacker, Frank; Shin, Hoen-oh] Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany; [Waldeck, Stephan] Bundeswehrzentralkrankenhaus, Dept Radiol, Koblenz, Germany	Hannover Medical School	von Falck, C (corresponding author), Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany.	Falck.Christian.von@mh-hannover.de	von Falck, Christian/AAO-2108-2020; Meyer, Bernhard/AAH-3329-2019	Meyer, Bernhard/0000-0001-6486-7955	German Research Foundation project "Open Access Publication"; Visage Imaging; Siemens Healthcare; Terumo	German Research Foundation project "Open Access Publication"; Visage Imaging; Siemens Healthcare(Siemens AG); Terumo	The publication of this study is supported by the German Research Foundation project "Open Access Publication". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. CvF, TR, BM and FW have received or receive grants from Visage Imaging. FW has received grants from Siemens Healthcare. TR has received grants from Terumo. All grants are unrelated to the topic of this study. The authors acknowledge the support during data acquisition of Dr. Christianne Leidecker of Siemens Healthcare. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Baker ME, 2012, AM J ROENTGENOL, V199, P8, DOI 10.2214/AJR.11.7421; Beister M, 2012, PHYS MEDICA, V28, P94, DOI 10.1016/j.ejmp.2012.01.003; Burgess AE, 2011, SEMIN NUCL MED, V41, P419, DOI 10.1053/j.semnuclmed.2011.06.005; Federal Office for Radiation Protection, 2010, ANN REP ENV RAD RAD; Funama Y, 2006, EUR RADIOL, V16, P837, DOI 10.1007/s00330-005-0012-5; Hoe CL, 2006, RADIOLOGY, V238, P699, DOI 10.1148/radiol.2381050477; Husarik DB, 2012, INVEST RADIOL, V47, P468, DOI 10.1097/RLI.0b013e318251eafd; Kalra MK, 2012, J COMPUT ASSIST TOMO, V36, P339, DOI 10.1097/RCT.0b013e31825586c0; Karantzavelos K, 2013, ACAD RADIOL IN PRESS; Lee H, 2010, MED PHYS, V37, P4238, DOI 10.1118/1.3457471; Leipsic J, 2010, AM J ROENTGENOL, V195, P649, DOI 10.2214/AJR.10.4285; May MS, 2011, INVEST RADIOL, V46, P465, DOI 10.1097/RLI.0b013e31821690a1; McCollough CH, 2012, RADIOLOGY, V264, P567, DOI 10.1148/radiol.12112265; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Prieto G, 2011, MED PHYS, V38, P4512, DOI 10.1118/1.3605634; Prieto G, 2009, IFMBE PROC, V25, P518, DOI 10.1007/978-3-642-03879-2_145; Qi LP, 2012, BRIT J RADIOL, V85, pE906, DOI 10.1259/bjr/66327067; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Rouse DM, 2008, SPIE C SERIES, V6806, P38; Singh S, 2012, J COMPUT ASSIST TOMO, V36, P347, DOI 10.1097/RCT.0b013e31824e639e; von Falck C, 2008, INVEST RADIOL, V43, P229, DOI 10.1097/RLI.0b013e3181614f2d; von Falck C, 2012, EUR J RADIOL, V81, P3166, DOI 10.1016/j.ejrad.2012.06.003; von Falck C, 2011, INVEST RADIOL, V46, P632, DOI 10.1097/RLI.0b013e31821e3080; von Falck C, 2010, RADIOGRAPHICS, V30, P317, DOI 10.1148/rg.302096007; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Winklehner A, 2011, EUR RADIOL, V21, P2521, DOI 10.1007/s00330-011-2227-y	27	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56875	10.1371/journal.pone.0056875	http://dx.doi.org/10.1371/journal.pone.0056875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23468886	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300203
J	Choi, YL; Sun, JM; Cho, J; Rampal, S; Han, J; Parasuraman, B; Guallar, E; Lee, G; Lee, J; Shim, YM				Choi, Yoon-La; Sun, Jong-Mu; Cho, Juhee; Rampal, Sanjay; Han, Joungho; Parasuraman, Bhash; Guallar, Eliseo; Lee, Genehee; Lee, Jeeyun; Shim, Young Mog			EGFR Mutation Testing in Patients with Advanced Non-Small Cell Lung Cancer: A Comprehensive Evaluation of Real-World Practice in an East Asian Tertiary Hospital	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; PULMONARY ADENOCARCINOMA; GEFITINIB; CHEMOTHERAPY; GENE	Introduction: Guidelines for management of non-small cell lung cancer (NSCLC) strongly recommend EGFR mutation testing. These recommendations are particularly relevant in Asians that have higher EGFR mutation prevalence. This study aims to explore current testing practices, logistics of testing, types of EGFR mutation, and prevalence of EGFR mutations in patients with advanced NSCLC in a large comprehensive cancer center in Korea. Methods: Our retrospective cohort included 1,503 NSCLC patients aged >= 18 years, with stage IIIB/IV disease, who attended the Samsung Medical Center in Seoul, Korea, from January 2007 through July 2010. Trained oncology nurses reviewed and abstracted data from electronic medical records. Results: This cohort had a mean age (SD) of 59.6 (11.1) years, 62.7% were males, and 52.9% never-smokers. The most common NSCLC histological types were adenocarcinoma (70.5%) and squamous cell carcinoma (18.0%). Overall, 39.5% of patients were tested for EGFR mutations. The proportion of patients undergoing EGFR testing during January 2007 through July 2008, August 2008 through September 2009, and October 2009 through July 2010 were 23.3%, 38.3%, and 63.5%, respectively (P < 0.001). The median time elapsed between cancer diagnoses and receiving EGFR testing results was 21 days. EGFR testing was most frequently ordered by oncologists (57.7%), pulmonologists (31.9%), and thoracic surgeons (6.6%). EGFR testing was more commonly requested for women, younger patients, stage IV disease, non-smokers, and adenocarcinoma histology. Of 586 cases successfully tested for EGFR mutations, 209 (35.7%) were positive, including 118 cases with exon 19 deletions and 62 with L858R mutations. EGFR mutation positive patients were more likely to be female, never-smokers, never-drinkers and to have adenocarcinoma. Conclusions: In a large cancer center in Korea, the proportion of EGFR testing increased from 2007 through 2010. The high frequency of EGFR mutation positive cases warrants the need for generalized testing in Asian NSCLC patients.	[Choi, Yoon-La; Han, Joungho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Choi, Yoon-La; Cho, Juhee] Sungkyunkwan Univ, Dept Hlth Sci & Technol, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea; [Sun, Jong-Mu; Lee, Jeeyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Cho, Juhee] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Cho, Juhee; Rampal, Sanjay; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Rampal, Sanjay; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Med, Baltimore, MD USA; [Rampal, Sanjay; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Rampal, Sanjay] Univ Malaya, Julius Ctr, Dept Social & Prevent Med, Fac Med, Kuala Lumpur, Malaysia; [Parasuraman, Bhash] AstraZeneca, Wilmington, DE USA; [Lee, Genehee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Nursing, Seoul, South Korea; [Lee, Genehee; Shim, Young Mog] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universiti Malaya; AstraZeneca; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Shim, YM (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea.	ymshim3482@gmail.com	Rampal, Sanjay/B-9691-2010; Lee, Jeeyun/I-7171-2015; Guallar, Eliseo/D-3807-2014; sun, jm/O-5938-2014; Cho, Juhee/ABD-2280-2021; Lee, Jee Yun/C-9646-2011	Rampal, Sanjay/0000-0002-0105-6407; Guallar, Eliseo/0000-0002-4471-9565; Lee, Genehee/0000-0002-6361-4822	AstraZeneca	AstraZeneca(AstraZeneca)	This study was funded in part by AstraZeneca. AstraZeneca provided guidance and support in the development of the research protocol, data analysis and interpretation of findings. No additional external funding was received for this study.	Dacic S, 2008, ADV ANAT PATHOL, V15, P241, DOI 10.1097/PAP.0b013e31817bf5a9; Gately K, 2012, J CLIN PATHOL, V65, P1, DOI 10.1136/jclinpath-2011-200275; Gupta R, 2009, MODERN PATHOL, V22, P128, DOI 10.1038/modpathol.2008.182; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leary AF, 2012, EUR J CANCER, V48, P61, DOI 10.1016/j.ejca.2011.09.022; Lynch JA, 2011, CANC EPIDEMIOL BIO S, V20, pB79; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; National Comprehensive Cancer Network, 2011, NCCN CLIN PRACT GUID; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Salto-Tellez M, 2011, J THORAC ONCOL, V6, P1663, DOI 10.1097/JTO.0b013e318227816a; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sun PL, 2012, J THORAC ONCOL, V7, P323, DOI 10.1097/JTO.0b013e3182381515; Tanaka K, 2012, INTERNAL MED, V51, P659, DOI 10.2169/internalmedicine.51.6386	19	70	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56011	10.1371/journal.pone.0056011	http://dx.doi.org/10.1371/journal.pone.0056011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468851	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900015
J	Ji, WY; Shi, HD; Zhang, HQ; Sun, R; Xi, JY; Wen, DQ; Feng, JC; Chen, YW; Qin, X; Ma, YR; Luo, WH; Deng, LN; Lin, HC; Yu, RF; Ouyang, Q				Ji, Weiyue; Shi, Handuo; Zhang, Haoqian; Sun, Rui; Xi, Jingyi; Wen, Dingqiao; Feng, Jingchen; Chen, Yiwei; Qin, Xiao; Ma, Yanrong; Luo, Wenhan; Deng, Linna; Lin, Hanchi; Yu, Ruofan; Ouyang, Qi			A Formalized Design Process for Bacterial Consortia That Perform Logic Computing	PLOS ONE			English	Article							BIOLOGY	The concept of microbial consortia is of great attractiveness in synthetic biology. Despite of all its benefits, however, there are still problems remaining for large-scaled multicellular gene circuits, for example, how to reliably design and distribute the circuits in microbial consortia with limited number of well-behaved genetic modules and wiring quorum-sensing molecules. To manage such problem, here we propose a formalized design process: (i) determine the basic logic units (AND, OR and NOT gates) based on mathematical and biological considerations; (ii) establish rules to search and distribute simplest logic design; (iii) assemble assigned basic logic units in each logic operating cell; and (iv) fine-tune the circuiting interface between logic operators. We in silico analyzed gene circuits with inputs ranging from two to four, comparing our method with the pre-existing ones. Results showed that this formalized design process is more feasible concerning numbers of cells required. Furthermore, as a proof of principle, an Escherichia coli consortium that performs XOR function, a typical complex computing operation, was designed. The construction and characterization of logic operators is independent of "wiring" and provides predictive information for fine-tuning. This formalized design process provides guidance for the design of microbial consortia that perform distributed biological computation.	[Ji, Weiyue; Shi, Handuo; Zhang, Haoqian; Sun, Rui; Xi, Jingyi; Wen, Dingqiao; Feng, Jingchen; Chen, Yiwei; Qin, Xiao; Ma, Yanrong; Luo, Wenhan; Deng, Linna; Lin, Hanchi; Yu, Ruofan] Peking Univ, Peking Univ Team Int Genet Engn Machine Competit, Beijing 100871, Peoples R China; [Zhang, Haoqian; Xi, Jingyi; Ouyang, Qi] Ctr Quantitat Biol, Beijing, Peoples R China; [Zhang, Haoqian; Xi, Jingyi; Ouyang, Qi] Peking Tsinghua Joint Ctr Life Sci, Beijing, Peoples R China; [Ouyang, Qi] Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing 100871, Peoples R China	Peking University; Peking University	Ouyang, Q (corresponding author), Ctr Quantitat Biol, Beijing, Peoples R China.	qi@pku.edu.cn	Chen, Yi/HIR-2608-2022	Zhang, Haoqian/0000-0002-2537-1903; Yu, Ruofan/0000-0002-5281-2508; Wen, Dingqiao/0000-0001-8229-2294; Shi, Handuo/0000-0002-1688-6905	Teaching Center for Experimental Biology; National Undergraduate Innovational Experimentation Program; National Science Foundation of China [11074009, 10721463]; National Found for Fostering of Basic Science of China [J1030623, J1103505, J1030310, J1103205]; National Basic Research Program of China ('973' Program) [2009CB918500]	Teaching Center for Experimental Biology; National Undergraduate Innovational Experimentation Program; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Found for Fostering of Basic Science of China; National Basic Research Program of China ('973' Program)(National Basic Research Program of China)	The authors are very grateful for the support by the Teaching Center for Experimental Biology and the National Undergraduate Innovational Experimentation Program, and also thank the fundings from National Science Foundation of China (11074009, 10721463), National Found for Fostering of Basic Science of China (J1030623, J1103505, J1030310, and J1103205) and the National Basic Research Program of China ('973' Program: 2009CB918500). BioBrick Foundation provided biobricks used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Cosentino Lagomarsino M, 2007, P NATL ACAD SCI USA, V104, P5516, DOI 10.1073/pnas.0609023104; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Egland KA, 2000, J BACTERIOL, V182, P805, DOI 10.1128/JB.182.3.805-811.2000; Eiteman Mark A, 2008, J Biol Eng, V2, P3, DOI 10.1186/1754-1611-2-3; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ghazali FM, 2004, INT BIODETER BIODEGR, V54, P61, DOI 10.1016/j.ibiod.2004.02.002; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hosoda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017105; Hu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010619; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kerner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034032; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Li BC, 2011, NATURE, V469, P171, DOI 10.1038/469171a; Ran T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00641; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; RUSSELL BERTRAND, 1945, HIST W PHILOS, P462; Saeidi N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.55; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Scharle TW., 1965, NOTRE DAME J FORM L, V6, P209, DOI [10.1305/ndjfl/1093958259, DOI 10.1305/NDJFL/1093958259]; Slusarczyk AL, 2012, NAT REV GENET, V13, P406, DOI 10.1038/nrg3227; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Weiss R., 2003, Natural Computing, V2, P47, DOI 10.1023/A:1023307812034; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Zhan JA, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.42	32	16	18	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57482	10.1371/journal.pone.0057482	http://dx.doi.org/10.1371/journal.pone.0057482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468999	gold, Green Published			2022-12-27	WOS:000315524900098
J	Chanvorachote, P; Chunhacha, P				Chanvorachote, Pithi; Chunhacha, Preedakorn			Caveolin-1 Regulates Endothelial Adhesion of Lung Cancer Cells via Reactive Oxygen Species-Dependent Mechanism	PLOS ONE			English	Article							PROSTATE-CANCER; CARCINOMA CELLS; ANOIKIS; METASTASIS; INHIBITION; GROWTH; DEGRADATION; EXPRESSION; STABILITY; APOPTOSIS	The knowledge regarding the role of caveolin-1 (Cav-1) protein on endothelium adhesion of cancer cells is unclear. The present study revealed that Cav-1 plays a negative regulatory role on cancer-endothelium interaction. Endogenous Cav-1 was shown to down-regulate during cell detachment and the level of such a protein was conversely associated with tumor-endothelial adhesion. Furthermore, the ectopic overexpression of Cav-1 attenuated the ability of the cancer cells to adhere to endothelium while shRNA-mediated Cav-1 knock-down exhibited the opposite effect. We found that cell detachment increased cellular hydrogen peroxide and hydroxyl radical generation and such reactive oxygen species (ROS) were responsible for the increasing interaction between cancer cells and endothelial cells through vascular endothelial cell adhesion molecule-1 (VCAM-1). Importantly, Cav-1 was shown to suppress hydrogen peroxide and hydroxyl radical formation by sustaining the level of activated Akt which was critical for the role of Cav-1 in attenuating the cell adhesion. Together, the present study revealed the novel role of Cav-1 and underlying mechanism on tumor adhesion which explain and highlight an important role of Cav-1 on lung cancer cell metastasis.	[Chunhacha, Preedakorn] Chulalongkorn Univ, Dept Physiol & Pharmacol, Fac Pharmaceut Sci, Bangkok, Thailand; Chulalongkorn Univ, Cell Based Drug & Hlth Prod Dev Res Unit, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University	Chunhacha, P (corresponding author), Chulalongkorn Univ, Dept Physiol & Pharmacol, Fac Pharmaceut Sci, Bangkok, Thailand.	Preedakorn.chun@gmail.com		Chunhacha, Preedakorn/0000-0002-5060-7113; chanvorachote, pithi/0000-0002-3103-3249	Thailand Research Fund; Ratchadaphiseksompot Endowment Fund, Chulalongkorn University	Thailand Research Fund(Thailand Research Fund (TRF)); Ratchadaphiseksompot Endowment Fund, Chulalongkorn University	This work is supported by grants from the Thailand Research Fund (P. Chanvorachote) and postdoctoral fellowship (Ratchadaphiseksompot Endowment Fund, Chulalongkorn University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chanvorachote P, 2009, J BIOL CHEM, V284, P28476, DOI 10.1074/jbc.M109.050864; Chen Q, 2012, CLIN CANCER RES, V18, P5520, DOI 10.1158/1078-0432.CCR-11-2904; Chunhacha P, 2012, AM J PHYSIOL-CELL PH, V302, pC1284, DOI 10.1152/ajpcell.00318.2011; Coll MAL, 2005, ONCOGENE, V24, P1727, DOI 10.1038/sj.onc.1208379; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; FRA AM, 1995, FEBS LETT, V375, P11, DOI 10.1016/0014-5793(95)95228-O; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Georgescu Maria-Magdalena, 2010, Genes Cancer, V1, P1170, DOI 10.1177/1947601911407325; Halim H, 2012, ANTICANCER RES, V32, P1649; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hileman EO, 2004, CANCER CHEMOTH PHARM, V53, P209, DOI 10.1007/s00280-003-0726-5; Ho CC, 2008, LUNG CANCER, V59, P105, DOI 10.1016/j.lungcan.2007.07.024; Kobayashi H, 2007, CURR MED CHEM, V14, P377, DOI 10.2174/092986707779941032; Kobayashi K, 2000, CANCER RES, V60, P3978; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Lloyd PG, 2011, AM J PHYSIOL-CELL PH, V300, pC232, DOI 10.1152/ajpcell.00483.2010; Luanpitpong S, 2010, J BIOL CHEM, V285, P38832, DOI 10.1074/jbc.M110.124958; Newham P, 1997, J BIOL CHEM, V272, P19429, DOI 10.1074/jbc.272.31.19429; Rungtabnapa P, 2011, AM J PHYSIOL-CELL PH, V300, pC235, DOI 10.1152/ajpcell.00249.2010; Sloan EK, 2004, ONCOGENE, V23, P7893, DOI 10.1038/sj.onc.1208062; Suchaoin W, 2012, ANTICANCER RES, V32, P483; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Suzuki K, 1999, BIOCHEM BIOPH RES CO, V257, P214, DOI 10.1006/bbrc.1999.0431; Tahir SA, 2001, CANCER RES, V61, P3882; TOZAWA K, 1995, CANCER RES, V55, P4162; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004	33	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57466	10.1371/journal.pone.0057466	http://dx.doi.org/10.1371/journal.pone.0057466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460862	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000117
J	Gotea, V; Petrykowska, HM; Elnitski, L				Gotea, Valer; Petrykowska, Hanna M.; Elnitski, Laura			Bidirectional Promoters as Important Drivers for the Emergence of Species-Specific Transcripts	PLOS ONE			English	Article							POSITIVE SELECTION; FACTOR-BINDING; ALU REPEATS; GENE; EVOLUTION; RNA; DNA; REGIONS; DUPLICATION; VARIABILITY	The diversification of gene functions has been largely attributed to the process of gene duplication. Novel examples of genes originating from previously untranscribed regions have been recently described without regard to a unifying functional mechanism for their emergence. Here we propose a model mechanism that could generate a large number of lineage-specific novel transcripts in vertebrates through the activation of bidirectional transcription from unidirectional promoters. We examined this model in silico using human transcriptomic and genomic data and identified evidence consistent with the emergence of more than 1,000 primate-specific transcripts. These are transcripts with low coding potential and virtually no functional annotation. They initiate at less than 1 kb upstream of an oppositely transcribed conserved protein coding gene, in agreement with the generally accepted definition of bidirectional promoters. We found that the genomic regions upstream of ancestral promoters, where the novel transcripts in our dataset reside, are characterized by preferential accumulation of transposable elements. This enhances the sequence diversity of regions located upstream of ancestral promoters, further highlighting their evolutionary importance for the emergence of transcriptional novelties. By applying a newly developed test for positive selection to transposable element-derived fragments in our set of novel transcripts, we found evidence of adaptive evolution in the human lineage in nearly 3% of the novel transcripts in our dataset. These findings indicate that at least some novel transcripts could become functionally relevant, and thus highlight the evolutionary importance of promoters, through their capacity for bidirectional transcription, for the emergence of novel genes.	[Gotea, Valer; Petrykowska, Hanna M.; Elnitski, Laura] NHGRI, DIR GTB Genom Funct Anal Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Elnitski, L (corresponding author), NHGRI, DIR GTB Genom Funct Anal Sect, NIH, Bethesda, MD 20892 USA.	elnitski@mail.nih.gov	Elnitski, Laura/AAD-3595-2021	Elnitski, Laura/0000-0003-1065-019X; Gotea, Valer/0000-0001-7857-3309	Intramural program of the National Human Genome Research Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200323] Funding Source: NIH RePORTER	Intramural program of the National Human Genome Research Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural program of the National Human Genome Research Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Anno YN, 2011, NUCLEIC ACIDS RES, V39, P3116, DOI 10.1093/nar/gkq1301; Begun DJ, 2007, GENETICS, V176, P1131, DOI 10.1534/genetics.106.069245; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Carvunis A.-R., 2012, NATURE; Conant GC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r50; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; FITCH WM, 1966, J MOL BIOL, V16, P17, DOI 10.1016/S0022-2836(66)80259-0; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Howald C, 2012, GENOME RES, V22, P1698, DOI 10.1101/gr.134478.111; INGRAM VM, 1961, NATURE, V189, P704, DOI 10.1038/189704a0; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jacox E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012274; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kalitsis P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-498; Katzman S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000960; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Kostka D, 2012, MOL BIOL EVOL, V29, P1047, DOI 10.1093/molbev/msr279; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407; Liu BC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S2; MAKALOWSKI W, 1994, TRENDS GENET, V10, P188, DOI 10.1016/0168-9525(94)90254-2; Muller HJ, 1918, GENETICS, V3, P422; Muller HJ, 1935, J HERED, V26, P469, DOI 10.1093/oxfordjournals.jhered.a104010; NEI M, 1969, NATURE, V221, P40, DOI 10.1038/221040a0; OHNO S., 1970, Evolution by gene duplication.; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Piontkivska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-189; Pohl AA, 2009, BIOINFORMATICS, V25, P2442, DOI 10.1093/bioinformatics/btp414; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Ratnakumar A, 2010, PHILOS T R SOC B, V365, P2571, DOI 10.1098/rstb.2010.0007; RUBIN CM, 1994, NUCLEIC ACIDS RES, V22, P5121, DOI 10.1093/nar/22.23.5121; Saxena A, 2011, BIOESSAYS, V33, P830, DOI 10.1002/bies.201100084; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shimada MK, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-122; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SPOFFORD JB, 1969, AM NAT, V103, P407, DOI 10.1086/282611; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tang H, 1999, GENETICS, V153, P485; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Witherspoon DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-530; Woolfe A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r20; Xie HH, 2009, NUCLEIC ACIDS RES, V37, P4331, DOI 10.1093/nar/gkp393; Yang ZF, 2011, FEBS LETT, V585, P641, DOI 10.1016/j.febslet.2011.01.017; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	54	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57323	10.1371/journal.pone.0057323	http://dx.doi.org/10.1371/journal.pone.0057323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460838	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000092
J	Griffin, LD; Wahab, MH; Newell, AJ				Griffin, Lewis D.; Wahab, M. Husni; Newell, Andrew J.			Distributional Learning of Appearance	PLOS ONE			English	Article							TEXTURE CLASSIFICATION; OBJECT CATEGORIES; IMAGE FEATURES; REPRESENTATION; CONTEXT	Opportunities for associationist learning of word meaning, where a word is heard or read contemperaneously with information being available on its meaning, are considered too infrequent to account for the rate of language acquisition in children. It has been suggested that additional learning could occur in a distributional mode, where information is gleaned from the distributional statistics (word co-occurrence etc.) of natural language. Such statistics are relevant to meaning because of the Distributional Principle that 'words of similar meaning tend to occur in similar contexts'. Computational systems, such as Latent Semantic Analysis, have substantiated the viability of distributional learning of word meaning, by showing that semantic similarities between words can be accurately estimated from analysis of the distributional statistics of a natural language corpus. We consider whether appearance similarities can also be learnt in a distributional mode. As grounds for such a mode we advance the Appearance Hypothesis that 'words with referents of similar appearance tend to occur in similar contexts'. We assess the viability of such learning by looking at the performance of a computer system that interpolates, on the basis of distributional and appearance similarity, from words that it has been explicitly taught the appearance of, in order to identify and name objects that it has not been taught about. Our experiment tests with a set of 660 simple concrete noun words. Appearance information on words is modelled using sets of images of examples of the word. Distributional similarity is computed from a standard natural language corpus. Our computation results support the viability of distributional learning of appearance.	[Griffin, Lewis D.; Wahab, M. Husni; Newell, Andrew J.] UCL, London, England	University of London; University College London	Griffin, LD (corresponding author), UCL, London, England.	L.Griffin@cs.ucl.ac.uk						Aherne FJ, 1998, KYBERNETIKA, V34, P363; Amery H, 1997, 1 1000 WORDS STICKER; Andrews M, 2009, PSYCHOL REV, V116, P463, DOI 10.1037/a0016261; Berlin B., 1969, BASIC COLOR TERMS TH; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Bloom P, 2002, MIND LANG, V17, P37, DOI 10.1111/1468-0017.00188; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Burgess C, 1997, LANG COGNITIVE PROC, V12, P177, DOI 10.1080/016909697386844; Chapelle O., 2006, IEEE T NEURAL NETWOR, V20, P542; Chomsky N., 1984, MODULAR APPROACHES S; Cilibrasi RL, 2007, IEEE T KNOWL DATA EN, V19, P370, DOI 10.1109/TKDE.2007.48; Consortium BNC, 2007, BRIT NATL CORPUS VER; Costa ARA, 2001, PSYCHOL REC, V51, P343, DOI 10.1007/BF03395403; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Crosier M, 2010, INT J COMPUT VISION, V88, P447, DOI 10.1007/s11263-009-0315-0; Csurka G, 2004, P ECCV 2004 WORKSH S; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Deng J, 2010, LECT NOTES COMPUT SC, V6315, P71, DOI 10.1007/978-3-642-15555-0_6; Deselaers T, 2011, PROC CVPR IEEE, P1777, DOI 10.1109/CVPR.2011.5995474; Dickinson S. J., 2009, OBJECT CATEGORIZATIO; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fan JP, 2010, PROC CVPR IEEE, P802, DOI 10.1109/CVPR.2010.5540135; Fellbaum Christiane, 1998, WORDNET ELECT DATABA; Feng H., 2003, P 5 ACM SIGMM INT WO; Fergus R, 2005, IEEE I CONF COMP VIS, P1816; Fergus R, 2010, LECT NOTES COMPUT SC, V6311, P762, DOI 10.1007/978-3-642-15549-9_55; Firth J.R., 1957, STUDIES LINGUISTIC A, P1; Frege G., 1892, Z PHILOS PHILOS KRIT, V100, P25; Gardenfors P., 2004, CONCEPTUAL SPACES GE; Griffin G, 2008, PROC CVPR IEEE, P533; Griffin LD, 2006, J R SOC INTERFACE, V3, P71, DOI 10.1098/rsif.2005.0076; Griffin L, 2011, PERCEPTION, V40, P110; Griffin LD, 2006, INT J COMPUT VISION, V70, P213, DOI 10.1007/s11263-006-6355-9; Griffin LD, 2009, LECT NOTES COMPUT SC, V5567, P343, DOI 10.1007/978-3-642-02256-2_29; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; Harris ZS, 1954, WORD, V10, P146, DOI 10.1080/00437956.1954.11659520; Johns BT, 2012, TOP COGN SCI, V4, P103, DOI 10.1111/j.1756-8765.2011.01176.x; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; Kripke S., 1980, NAMING NECESSITY; Lampert CH, 2009, PROC CVPR IEEE, P951, DOI 10.1109/CVPRW.2009.5206594; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Landauer TK, 2013, HDB LATENT SEMANTIC; Larkey LB, 2005, COGNITIVE SCI, V29, P1061, DOI 10.1207/s15516709cog0000_30; Leung T, 2001, INT J COMPUT VISION, V43, P29, DOI 10.1023/A:1011126920638; Lodhi H, 2002, J MACH LEARN RES, V2, P419, DOI 10.1162/153244302760200687; Louwerse M.M., 2008, SYMBOLS EMBODIMENT D, P309, DOI [DOI 10.1093/ACPROF:OSO/9780199217274.003.0015, 10.1093/acprof:oso/9780199217274.003.0015]; Louwerse M, 2011, COGNITIVE SCI, V35, P381, DOI 10.1111/j.1551-6709.2010.01157.x; Louwerse MM, 2008, PSYCHON B REV, V15, P838, DOI 10.3758/PBR.15.4.838; Louwerse MM, 2011, TOP COGN SCI, V3, P273, DOI 10.1111/j.1756-8765.2010.01106.x; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; McDonald S, 2001, P 23 ANN C COGN SCI, P611; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Miller George A., 1994, P WORKSH HUM LANG TE, P240, DOI DOI 10.3115/1075812.1075866; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nguyen N., 2008, P INT C KNOWL DISC D, P551; Nowak E, 2006, LECT NOTES COMPUT SC, V3954, P490; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Patwardhan S., 2006, P EACL 2006 WORKSH M, P1; Pedersen T, 2004, DEMONSTRATION PAPERS, P38; Peirce CS, 1923, COLLECTED PAPERS CS; Redington M, 1998, COGNITIVE SCI, V22, P425, DOI 10.1016/S0364-0213(99)80046-9; Rohde D. L. T., 2009, COGNITIVE SCI, P1; Rohrbach M, 2010, PROC CVPR IEEE, P910, DOI 10.1109/CVPR.2010.5540121; Romberg AR, 2010, WIRES COGN SCI, V1, P906, DOI 10.1002/wcs.78; RUBENSTEIN H, 1965, COMMUN ACM, V8, P627, DOI 10.1145/365628.365657; Russell B., 1905, MIND, V14, P479, DOI [10.1093/mind/XIV.4.479, 10.2307/j.ctv2nrzgz1.4]; Schutze H, 1998, COMPUT LINGUIST, V24, P97; SEARLE JR, 1980, BEHAV BRAIN SCI, V3, P417, DOI 10.1017/S0140525X00006038; Shengli Yuan, 2010, Proceedings 2010 IEEE Global Communications Conference (GLOBECOM 2010), DOI 10.1109/GLOCOM.2010.5683786; Sivic J, 2005, IEEE I CONF COMP VIS, P370; SWAIN MJ, 1991, INT J COMPUT VISION, V7, P11, DOI 10.1007/BF00130487; Tirilly P., 2008, P INT C CONT BAS IM; Torralba A, 2007, IEEE T PATTERN ANAL, V29, P854, DOI 10.1109/TPAMI.2007.1055; Torresani L, 2010, LECT NOTES COMPUT SC, V6311, P776, DOI 10.1007/978-3-642-15549-9_56; Vapnik V.N., 1995, NATURE STAT LEARNING; Varma M, 2003, PROC CVPR IEEE, P691; Veksler VV, 2007, P COGN SCI 2007; Weaver W., 1955, MACHINE TRANSLATION, V14, P10; Wiemer-Hastings P, 2000, PROCEEDINGS OF THE TWENTY-SECOND ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P989; Wilson E.O., 1975, P1; Winn J, 2005, IEEE I CONF COMP VIS, P1800; Zehnder P, 2006, INT C PATT RECOG, P797; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4; Zhu X, 2009, MORGAN CLAYPOOL, DOI DOI 10.1007/978-3-031-01548-9; Zipf George, 1935, PSYCHOBIOLOGY LANGUA	88	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58074	10.1371/journal.pone.0058074	http://dx.doi.org/10.1371/journal.pone.0058074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460927	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000182
J	Hall-Mendelin, S; Allcock, R; Kresoje, N; van den Hurk, AF; Warrilow, D				Hall-Mendelin, Sonja; Allcock, Richard; Kresoje, Nina; van den Hurk, Andrew F.; Warrilow, David			Detection of Arboviruses and Other Micro-Organisms in Experimentally Infected Mosquitoes Using Massively Parallel Sequencing	PLOS ONE			English	Article							AEDES-AEGYPTI; CYTOPLASMIC INCOMPATIBILITY; LARVAL DEVELOPMENT; FEEDING-BEHAVIOR; BLOCKS DENGUE; CULEX-PIPIENS; NATURAL FOOD; YELLOW-FEVER; WOLBACHIA; CHIKUNGUNYA	Human disease incidence attributed to arbovirus infection is increasing throughout the world, with effective control interventions limited by issues of sustainability, insecticide resistance and the lack of effective vaccines. Several promising control strategies are currently under development, such as the release of mosquitoes trans-infected with virus-blocking Wolbachia bacteria. Implementation of any control program is dependent on effective virus surveillance and a thorough understanding of virus-vector interactions. Massively parallel sequencing has enormous potential for providing comprehensive genomic information that can be used to assess many aspects of arbovirus ecology, as well as to evaluate novel control strategies. To demonstrate proof-of-principle, we analyzed Aedes aegypti or Aedes albopictus experimentally infected with dengue, yellow fever or chikungunya viruses. Random amplification was used to prepare sufficient template for sequencing on the Personal Genome Machine. Viral sequences were present in all infected mosquitoes. In addition, in most cases, we were also able to identify the mosquito species and mosquito micro-organisms, including the bacterial endosymbiont Wolbachia. Importantly, naturally occurring Wolbachia strains could be differentiated from strains that had been trans-infected into the mosquito. The method allowed us to assemble near full-length viral genomes and detect other micro-organisms without prior sequence knowledge, in a single reaction. This is a step toward the application of massively parallel sequencing as an arbovirus surveillance tool. It has the potential to provide insight into virus transmission dynamics, and has applicability to the post-release monitoring of Wolbachia in mosquito populations.	[Hall-Mendelin, Sonja; van den Hurk, Andrew F.; Warrilow, David] Queensland Hlth Forens & Sci Serv, Publ Hlth Virol Lab, Archerfield, Qld, Australia; [Allcock, Richard; Kresoje, Nina] Univ Western Australia, Sch Pathol & Lab Med, LotteryWest State Biomed Facil Genom, Perth, WA 6009, Australia; [Allcock, Richard] Royal Perth Hosp, Dept Clin Immunol, Pathwest Lab Med WA, Perth, WA 6001, Australia	Queensland Health; University of Western Australia; Royal Perth Hospital; University of Western Australia	Warrilow, D (corresponding author), Queensland Hlth Forens & Sci Serv, Publ Hlth Virol Lab, Archerfield, Qld, Australia.	David_Warrilow@health.qld.gov.au	van den Hurk, Andrew/X-9831-2019; van den Hurk, Andrew F/G-7992-2012	van den Hurk, Andrew/0000-0001-6262-831X; 	Queensland Health	Queensland Health	This project was internally funded by Queensland Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861; Bishop-Lilly KA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000878; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; BOUBLIK Y, 1994, VIROLOGY, V200, P752, DOI 10.1006/viro.1994.1239; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; Chouaia B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S2; Chouaia B, 2010, APPL ENVIRON MICROB, V76, P7444, DOI 10.1128/AEM.01747-10; da Costa GL, 1998, J BASIC MICROB, V38, P343, DOI 10.1002/(SICI)1521-4028(199811)38:5/6&lt;343::AID-; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Endersby NM, 2011, J MED ENTOMOL, V48, P999, DOI 10.1603/ME10264; Engelstadter J, 2009, HEREDITY, V103, P196, DOI 10.1038/hdy.2009.53; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hinman EH, 1930, AM J HYG, V12, P238, DOI 10.1093/oxfordjournals.aje.a115265; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Horsfall WR, 1955, MOSQUITOES THEIR BIO; HOWLAND L. J., 1930, BULL ENT RES [LONDON], V21, P431, DOI 10.1017/S0007485300024779; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84; Jansen CC, 2009, AM J TROP MED HYG, V81, P849, DOI 10.4269/ajtmh.2009.09-0008; Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5; JONES JACK COLVARD, 1960, ANN ENT SOC AMER, V53, P459; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758; MERRITT RW, 1990, J AM MOSQUITO CONTR, V6, P35; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; ONEILL SL, 1995, J GEN VIROL, V76, P2067, DOI 10.1099/0022-1317-76-8-2067; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pucat A. M., 1965, Quaestiones Entomologicae, V1, P41; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Radford AD, 2012, J GEN VIROL; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2; THIERY I, 1991, APPL ENVIRON MICROB, V57, P1354, DOI 10.1128/AEM.57.5.1354-1359.1991; van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892; van den Hurk AF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/325659; Vazquez-Martinez MG, 2003, J AM MOSQUITO CONTR, V19, P155; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Zhai YG, 2008, J GEN VIROL, V89, P195, DOI 10.1099/vir.0.83221-0; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x; Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388	58	21	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58026	10.1371/journal.pone.0058026	http://dx.doi.org/10.1371/journal.pone.0058026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460918	gold, Green Submitted, Green Published			2022-12-27	WOS:000315519000173
J	Lang, SM; Bynoe, MOF; Karki, R; Tartell, MA; Means, RE				Lang, Sabine M.; Bynoe, Meisha O. F.; Karki, Roshan; Tartell, Michael A.; Means, Robert E.			Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins Down Regulate Both DC-SIGN and DC-SIGNR	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; E3 UBIQUITIN LIGASES; PEPTIDE-LOADING COMPLEX; CLASS-I MOLECULES; WEST-NILE-VIRUS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; DNA-SEQUENCES; MYCOBACTERIUM-TUBERCULOSIS; PRODUCTIVE INFECTION	Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of multicentric Castleman's disease, primary effusion lymphoma and Kaposi's sarcoma. In this study, we show that like the C-type lectin DC-SIGN, the closely related DC-SIGNR can also enhance KSHV infection. Following infection, they are both targeted for down modulation and our data indicate that the KSHV MARCH-family ubiquitin ligase K5 is mediating this regulation and subsequent targeting for degradation of DC-SIGN and DC-SIGNR in the context of the virus. The closely related viral K3 protein, is also able to target these lectins in exogenous expressions studies, but only weakly during viral infection. In addition to requiring a functional RING-CH domain, several protein trafficking motifs in the C-terminal region of both K3 and K5 are important in regulation of DC-SIGN and DC-SIGNR. Further exploration of this modulation revealed that DC-SIGN is endocytosed from the cell surface in THP-1 monocytes, but degraded from an internal location with minimal endocytosis in HEK-293 cells. Pull-down data indicate that both K3 and K5 preferentially associate with immature forms of the lectins, mediating their ubiquitylation and degradation. Together, these data emphasize the molecular complexities of K3 and K5, while expanding the repertoire of targets of these two viral proteins.	[Lang, Sabine M.; Bynoe, Meisha O. F.; Karki, Roshan; Tartell, Michael A.; Means, Robert E.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University	Means, RE (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	robert.means@yale.edu		Tartell, Michael/0000-0002-4518-4187	NIH/NCI [R01CA121925]; ASM Robert D. Watkins Graduate Research Fellowship; Howard Hughes Medical Institute Gilliam Fellowship; NATIONAL CANCER INSTITUTE [R01CA121925] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ASM Robert D. Watkins Graduate Research Fellowship; Howard Hughes Medical Institute Gilliam Fellowship(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for these studies was received from NIH/NCI R01CA121925 (to REM), an ASM Robert D. Watkins Graduate Research Fellowship (to FB) and a Howard Hughes Medical Institute Gilliam Fellowship (to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Boname JM, 2005, EUR J IMMUNOL, V35, P171, DOI 10.1002/eji.200425459; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chang HS, 2005, J VIROL, V79, P14371, DOI 10.1128/JVI.79.22.14371-14382.2005; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Geijtenbeek TBH, 2003, APMIS, V111, P698, DOI 10.1034/j.1600-0463.2003.11107803.x; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Geijtenbeek TBH, 2009, FUTURE MICROBIOL, V4, P879, DOI 10.2217/FMB.09.51; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Karki R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001331; Kerur N, 2010, VIROLOGY, V406, P103, DOI 10.1016/j.virol.2010.07.012; Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08; Li QL, 2007, J VIROL, V81, P2117, DOI 10.1128/JVI.01961-06; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Mansouri M, 2008, J VIROL, V82, P9615, DOI 10.1128/JVI.02633-07; Mansouri M, 2006, BLOOD, V108, P1932, DOI 10.1182/blood-2005-11-4404; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Means RE, 2002, EMBO J, V21, P1638, DOI 10.1093/emboj/21.7.1638; Means RE, 2007, J VIROL, V81, P6573, DOI 10.1128/JVI.02751-06; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Puig-Kroger A, 2004, J BIOL CHEM, V279, P25680, DOI 10.1074/jbc.M311516200; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Rappocciolo G, 2008, J VIROL, V82, P4793, DOI 10.1128/JVI.01587-07; Rhodes DA, 2010, P NATL ACAD SCI USA, V107, P16240, DOI 10.1073/pnas.1003421107; Rimessi P, 2001, J VIROL, V75, P7161, DOI 10.1128/JVI.75.15.7161-7174.2001; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Sanchez DJ, 2005, J CLIN INVEST, V115, P1369, DOI 10.1172/JCI200524041; Schneider-Schaulies J, 2008, ADV VIRUS RES, V71, P173, DOI 10.1016/S0065-3527(08)00004-3; Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049	59	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58056	10.1371/journal.pone.0058056	http://dx.doi.org/10.1371/journal.pone.0058056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460925	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000180
J	Melnychuk, MC; Banobi, JA; Hilborn, R				Melnychuk, Michael C.; Banobi, Jeannette A.; Hilborn, Ray			Effects of Management Tactics on Meeting Conservation Objectives for Western North American Groundfish Fisheries	PLOS ONE			English	Article							BERING-SEA; REFERENCE POINTS; CATCH SHARES; FISH STOCKS; COAST; SUSTAINABILITY; RISK; EXPLOITATION; UNCERTAINTY; INDICATORS	There is considerable variability in the status of fish populations around the world and a poor understanding of how specific management characteristics affect populations. Overfishing is a major problem in many fisheries, but in some regions the recent tendency has been to exploit stocks at levels below their maximum sustainable yield. In Western North American groundfish fisheries, the status of individual stocks and management systems among regions are highly variable. In this paper, we show the current status of groundfish stocks from Alaska, British Columbia, and the U. S. West Coast, and quantify the influence on stock status of six management tactics often hypothesized to affect groundfish. These tactics are: the use of harvest control rules with estimated biological reference points; seasonal closures; marine reserves; bycatch constraints; individual quotas (i.e., 'catch shares'); and gear type. Despite the high commercial value of many groundfish and consequent incentives for maintaining stocks at their most productive levels, most stocks were managed extremely conservatively, with current exploitation rates at only 40% of management targets and biomass 33% above target biomass on average. Catches rarely exceeded TACs but on occasion were far below TACs (mean catch: TAC ratio of 57%); approximately $150 million of potential landed value was foregone annually by underutilizing TACs. The use of individual quotas, marine reserves, and harvest control rules with estimated limit reference points had little overall effect on stock status. More valuable fisheries were maintained closer to management targets and were less variable over time than stocks with lower catches or ex-vessel prices. Together these results suggest there is no single effective management measure for meeting conservation objectives; if scientifically established quotas are set and enforced, a variety of means can be used to ensure that exploitation rates and biomass levels are near to or more conservative than management targets.	[Melnychuk, Michael C.; Banobi, Jeannette A.; Hilborn, Ray] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Melnychuk, MC (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	mmel@u.washington.edu	Hilborn, Ray W/D-6332-2013; Melnychuk, Michael/A-4680-2013	Melnychuk, Michael/0000-0002-6088-7657	CAMEO grant through National Science Foundation; National Oceanic and Atmospheric Administration [1041570]; Walton Family Foundation; Natural Sciences and Engineering Research Council of Canada [BPDF-424586-2012]; Directorate For Geosciences [1041570] Funding Source: National Science Foundation	CAMEO grant through National Science Foundation; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Walton Family Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this study was provided by a CAMEO grant through National Science Foundation and National Oceanic and Atmospheric Administration (cameo.noaa.gov; grant number 1041570), by the Walton Family Foundation (www.waltonfamilyfoundation.org/), and by a Natural Sciences and Engineering Research Council of Canada fellowship (www.nserc-crsng.gc.ca; number BPDF-424586-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerstein SA, 1998, J SEA RES, V39, P153, DOI 10.1016/S1385-1101(97)00055-5; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Branch TA, 2008, CAN J FISH AQUAT SCI, V65, P1435, DOI 10.1139/F08-065; Branch TA, 2006, B MAR SCI, V78, P669; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Brodziak J, 2002, N AM J FISH MANAGE, V22, P258, DOI 10.1577/1548-8675(2002)022<0258:ISOOHR>2.0.CO;2; Chuenpagdee R, 2003, FRONT ECOL ENVIRON, V1, P517; Cochrane K. L., 2002, FAO Fisheries Technical Paper; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Crowder LB, 1998, FISHERIES, V23, P8, DOI 10.1577/1548-8446(1998)023&lt;0008:FBIFM&gt;2.0.CO;2; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Davies TD, 2012, SCI REP-UK, V2, DOI 10.1038/srep00561; Degnbol P, 2006, MAR POLICY, V30, P534, DOI 10.1016/j.marpol.2005.07.002; Deroba JJ, 2008, FISH RES, V94, P210, DOI 10.1016/j.fishres.2008.01.003; DiCosimo J, 2010, ICES J MAR SCI, V67, P1861, DOI 10.1093/icesjms/fsq060; Essington TE, 2012, CONSERV LETT, V5, P186, DOI 10.1111/j.1755-263X.2012.00226.x; Essington TE, 2010, P NATL ACAD SCI USA, V107, P754, DOI 10.1073/pnas.0907252107; FAO, 2012, STAT WORLD FISH AQ; Fraser and Associates, 2008, LINK PRIM FISH PROD; Froese R, 2010, FISH FISH, V11, P194, DOI 10.1111/j.1467-2979.2009.00349.x; Fujita RM, 1998, ECOL APPL, V8, pS139, DOI 10.2307/2641372; Grafton RQ, 2006, CAN J FISH AQUAT SCI, V63, P699, DOI 10.1139/f05-247; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hiddink JG, 2006, CAN J FISH AQUAT SCI, V63, P721, DOI 10.1139/F05-266; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Hilborn R, 2002, N AM J FISH MANAGE, V22, P365, DOI 10.1577/1548-8675(2002)022<0365:ERRPFW>2.0.CO;2; Hilborn R, 2007, FISH FISH, V8, P285, DOI 10.1111/j.1467-2979.2007.00263_2.x; Hilborn R, 2007, AMBIO, V36, P296, DOI 10.1579/0044-7447(2007)36[296:MTSBLF]2.0.CO;2; Hilborn R, 2012, CONSERV BIOL, V26, DOI 10.1111/j.1523-1739.2011.01800.x; Hilborn R, 2010, MAR POLICY, V34, P193, DOI 10.1016/j.marpol.2009.04.013; Ianelli J, 2005, B MAR SCI, V76, P321; Levin PS, 2006, CONSERV BIOL, V20, P1181, DOI 10.1111/j.1523-1739.2006.00400.x; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Mace PM, 2001, FISH FISH, V2, P2, DOI 10.1046/j.1467-2979.2001.00033.x; Mawani T, 2009, EVALUATION COMMERCIA; Melnychuk MC, 2012, FISH FISH, V13, P267, DOI 10.1111/j.1467-2979.2011.00429.x; Murawski SA, 2010, ICES J MAR SCI, V67, P1830, DOI 10.1093/icesjms/fsq125; Parker SJ, 2000, FISHERIES, V25, P22, DOI 10.1577/1548-8446(2000)025<0022:MOPR>2.0.CO;2; Parma AM, 2006, B MAR SCI, V78, P411; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Piet GJ, 2010, ICES J MAR SCI, V67, P559, DOI 10.1093/icesjms/fsp293; PORTER RB, 1974, AM ECON REV, V64, P200; R Core Team, 2021, R LANGUAGE ENV STAT; Ralston S, 2002, N AM J FISH MANAGE, V22, P249, DOI 10.1577/1548-8675(2002)022<0249:WCGHP>2.0.CO;2; Restrepo VR, 1998, NMFSFSPO31 NAT OC AT; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Rice JC, 2007, ICES J MAR SCI, V64, P718, DOI 10.1093/icesjms/fsm011; ROSENBERG AA, 1994, CAN J FISH AQUAT SCI, V51, P2715, DOI 10.1139/f94-271; Rosenberg AA, 2006, FRONT ECOL ENVIRON, V4, P303, DOI 10.1890/1540-9295(2006)4[303:RUFPAP]2.0.CO;2; Schaefer MB, 1954, SOME ASPECTS DYNAMIC; Sethi SA, 2010, P NATL ACAD SCI USA, V107, P12163, DOI 10.1073/pnas.1003236107; Sethi SA, 2012, CAN J FISH AQUAT SCI, V69, P487, DOI 10.1139/F2011-170; Sutinen JG, 1999, ICES J MAR SCI, V56, P1051, DOI 10.1006/jmsc.1999.0551; Turris B. R., 2000, FAO Fisheries Technical Paper, P254; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Yamanaka KL, 2010, MAR COAST FISH, V2, P28, DOI 10.1577/C08-036.1; Zuur Alain F., 2009, P1	59	27	27	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56684	10.1371/journal.pone.0056684	http://dx.doi.org/10.1371/journal.pone.0056684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460809	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000032
J	Qiu, EC; Wang, Y; Ma, L; Tian, LX; Liu, RZ; Dong, Z; Xu, X; Zou, ZT; Yu, SY				Qiu, Enchao; Wang, Yan; Ma, Lin; Tian, Lixia; Liu, Ruozhuo; Dong, Zhao; Xu, Xian; Zou, Zhitong; Yu, Shengyuan			Abnormal Brain Functional Connectivity of the Hypothalamus in Cluster Headaches	PLOS ONE			English	Article							REGIONAL HOMOGENEITY; ALZHEIMERS-DISEASE; PAIN; STIMULATION; CORTEX; RESPONSES; ACTIVATION; NETWORK	The aim of this study was to detect the abnormality of the brain functional connectivity of the hypothalamus during acute spontaneous cluster headache (CH) attacks ('in attack') and headache-free intervals ('out of attack') using resting-state functional magnetic resonance imaging (RS-fMRI) technique. The RS-fMRI data from twelve male CH patients during 'in attack' and 'out of attack' periods and twelve age- and sex-matched normal controls were analyzed by the region-of-interest-based functional connectivity method using SPM5 software. Abnormal brain functional connectivity of the hypothalamus is present in CH, which is located mainly in the pain system during the spontaneous CH attacks. It extends beyond the pain system during CH attack intervals.	[Qiu, Enchao; Liu, Ruozhuo; Dong, Zhao; Yu, Shengyuan] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Yan; Ma, Lin; Xu, Xian; Zou, Zhitong] Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing, Peoples R China; [Qiu, Enchao] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Neurol, Beijing, Peoples R China; [Tian, Lixia] Beijing Jiaotong Univ, Sch Comp & Informat Technol, Dept Biomed Engn, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Beijing Jiaotong University	Yu, SY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China.	yusy1963@126.com	Ma, Lin/AAF-8728-2019; Qiu, Enchao/GXG-8556-2022		National Natural Science Foundation of China [30970417, 81171058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, Grant Nos. 30970417 and 81171058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Bingel U, 2007, PAIN, V131, P21, DOI 10.1016/j.pain.2006.12.005; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Chen LM, 2007, INT ANESTHESIOL CLIN, V45, P39, DOI 10.1097/AIA.0b013e31803419d3; DaSilva Alexandre F M, 2007, Curr Pain Headache Rep, V11, P131, DOI 10.1007/s11916-007-0010-1; Derbyshire SWG, 2002, NEUROIMAGE, V16, P158, DOI 10.1006/nimg.2002.1066; Diener HC, 1997, HEADACHE, V37, P622, DOI 10.1046/j.1526-4610.1997.3710622.x; Dodick DW, 2000, CEPHALALGIA, V20, P787, DOI 10.1046/j.1468-2982.2000.00118.x; Farooq K, 2008, BJA EDUC, V8, P138, DOI 10.1093/bjaceaccp/mkn025; Fattah QA, 2006, CEPHALALGIA, V26, P492, DOI 10.1111/j.1468-2982.2006.01052.x; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 1993, HUM BRAIN MAPP, V1, P69, DOI DOI 10.1002/HBM.460010108; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hsieh JC, 1996, PAIN, V67, P59, DOI 10.1016/0304-3959(96)03066-7; International Headache Society, 2004, CEPHALALGIA S1, V24, pS1; Leone M, 2004, BRAIN, V127, P2259, DOI 10.1093/brain/awh245; Leone M, 2003, NEUROL SCI, V24, pS143; Liu Y, 2008, NEUROPSYCHOLOGIA, V46, P1648, DOI 10.1016/j.neuropsychologia.2008.01.027; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; May A, 2006, J NEUROSCI, V26, P3589, DOI 10.1523/JNEUROSCI.4609-05.2006; May A, 1999, NAT MED, V5, P836, DOI 10.1038/10561; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; May A, 2000, NEUROLOGY, V55, P1328, DOI 10.1212/WNL.55.9.1328; Morelli N, 2009, J HEADACHE PAIN, V10, P11, DOI 10.1007/s10194-008-0085-z; Morrison I, 2007, CEREB CORTEX, V17, P2214, DOI 10.1093/cercor/bhl129; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploner M, 2004, NERVENARZT, V75, P962, DOI 10.1007/s00115-004-1739-y; Qiu EC, 2012, CHINESE MED J-PEKING, V125, P705, DOI 10.3760/cma.j.issn.0366-6999.2012.04.027; Raij TT, 2005, P NATL ACAD SCI USA, V102, P2147, DOI 10.1073/pnas.0409542102; Rocca MA, 2010, CEPHALALGIA, V30, P1383, DOI 10.1177/0333102410365164; Seminowicz DA, 2006, PAIN, V120, P297, DOI 10.1016/j.pain.2005.11.008; Sprenger T, 2007, CEPHALALGIA, V27, P1033, DOI 10.1111/j.1468-2982.2007.01386.x; Sprenger T, 2004, NEUROLOGY, V62, P516, DOI 10.1212/WNL.62.3.516; Svensson P, 1997, J NEUROPHYSIOL, V78, P450, DOI 10.1152/jn.1997.78.1.450; Teepker M, 2012, HEADACHE, V52, P274, DOI 10.1111/j.1526-4610.2011.02000.x; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Vetrugno R, 2007, HEADACHE, V47, P1085, DOI 10.1111/j.1526-4610.2007.00864.x; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang SJ, 2006, J NEUROL NEUROSUR PS, V77, P622, DOI 10.1136/jnnp.2005.081836; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081	47	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57896	10.1371/journal.pone.0057896	http://dx.doi.org/10.1371/journal.pone.0057896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460913	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000168
J	Adame, MF; Kauffman, JB; Medina, I; Gamboa, JN; Torres, O; Caamal, JP; Reza, M; Herrera-Silveira, JA				Adame, Maria Fernanda; Kauffman, J. Boone; Medina, Israel; Gamboa, Julieta N.; Torres, Olmo; Caamal, Juan P.; Reza, Miriam; Herrera-Silveira, Jorge A.			Carbon Stocks of Tropical Coastal Wetlands within the Karstic Landscape of the Mexican Caribbean	PLOS ONE			English	Article							MANGROVE FORESTS; NUTRIENT DYNAMICS; BRAZILIAN AMAZON; ORGANIC-MATTER; SEA-LEVEL; SEDIMENTS; IGNITION; BIOMASS; FLORIDA; FIRE	Coastal wetlands can have exceptionally large carbon (C) stocks and their protection and restoration would constitute an effective mitigation strategy to climate change. Inclusion of coastal ecosystems in mitigation strategies requires quantification of carbon stocks in order to calculate emissions or sequestration through time. In this study, we quantified the ecosystem C stocks of coastal wetlands of the Sian Ka'an Biosphere Reserve (SKBR) in the Yucatan Peninsula, Mexico. We stratified the SKBR into different vegetation types (tall, medium and dwarf mangroves, and marshes), and examined relationships of environmental variables with C stocks. At nine sites within SKBR, we quantified ecosystem C stocks through measurement of above and belowground biomass, downed wood, and soil C. Additionally, we measured nitrogen (N) and phosphorus (P) from the soil and interstitial salinity. Tall mangroves had the highest C stocks (987 +/- 338 Mg ha(-1)) followed by medium mangroves (623 +/- 41 Mg ha(-1)), dwarf mangroves (381 +/- 52 Mg ha(-1)) and marshes (177 +/- 73 Mg ha(-1)). At all sites, soil C comprised the majority of the ecosystem C stocks (78-99%). Highest C stocks were measured in soils that were relatively low in salinity, high in P and low in N: P, suggesting that P limits C sequestration and accumulation potential. In this karstic area, coastal wetlands, especially mangroves, are important C stocks. At the landscape scale, the coastal wetlands of Sian Ka'an covering approximate to 172,176 ha may store 43.2 to 58.0 million Mg of C.	[Adame, Maria Fernanda; Medina, Israel; Gamboa, Julieta N.; Caamal, Juan P.; Herrera-Silveira, Jorge A.] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados CINVESTAV, Merida, Mexico; [Adame, Maria Fernanda] Griffith Univ Brisbane, Australian Rivers Inst, Brisbane, Qld, Australia; [Kauffman, J. Boone] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Kauffman, J. Boone] Ctr Int Forest Res, Bogor, Indonesia; [Torres, Olmo] Colectividad Razonatura AC, Mexico City, DF, Mexico; [Reza, Miriam] Amigos de Sian Kaan, Cancun, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Griffith University; Oregon State University; CGIAR; Center for International Forestry Research (CIFOR)	Adame, MF (corresponding author), Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados CINVESTAV, Merida, Mexico.	f.adame@griffith.edu.au	Adame, Maria Fernanda/N-8463-2014	Adame, Maria Fernanda/0000-0001-9620-9252	US Agency for International Development (USAID/Mexico) through USFS; US Agency for International Development (USAID/Mexico) through Fondo Mexicano para la Conservacion	US Agency for International Development (USAID/Mexico) through USFS(United States Agency for International Development (USAID)); US Agency for International Development (USAID/Mexico) through Fondo Mexicano para la Conservacion(United States Agency for International Development (USAID))	Funding for the study was provided by the US Agency for International Development (USAID/Mexico) as part of a workshop on quantification of wetland carbon stocks, http://www.usaid.gov/, through USFS http://www.fs.fed.us/ and Fondo Mexicano para la Conservacion http://fmcn.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame MF, 2013, BIOTROPICA, V45, P147, DOI 10.1111/btp.12000; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; [Anonymous], 1974, ANN REV ECOL SYST, DOI DOI 10.1146/ANNUREV.ES.05.110174.000351; [Anonymous], 2007, AR4 CLIM CHANG 2007; ASPILA KI, 1976, ANALYST, V101, P187, DOI 10.1039/an9760100187; Bauer-Gottwein P, 2011, HYDROGEOL J, V19, P507, DOI 10.1007/s10040-010-0699-5; Bedford BL, 1999, ECOLOGY, V80, P2151, DOI 10.1890/0012-9658(1999)080[2151:PINAAP]2.0.CO;2; BYERS SC, 1978, HYDROBIOLOGIA, V58, P43, DOI 10.1007/BF00018894; Chen RH, 1999, ESTUARIES, V22, P955, DOI 10.2307/1353075; Cintron G., 1984, MANGROVE ECOSYSTEM R, P91; Conabio, 2009, MANGLARES MEXICO EXT, P100; CONABIO National Commission on Biodiversity, NAT COMM BIOD; Coronado-Molina C., 2004, Wetlands Ecology and Management, V12, P157, DOI 10.1023/B:WETL.0000034071.17156.c0; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; DeBusk WF, 1998, SOIL SCI SOC AM J, V62, P1460, DOI 10.2136/sssaj1998.03615995006200050045x; Donato D.C., 2012, 86 CIFOR BOGOR; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Ellison AM, 1996, BIOTROPICA, V28, P549, DOI 10.2307/2389096; FELLER IC, 1995, ECOL MONOGR, V65, P477, DOI 10.2307/2963499; Gilman EL, 2008, AQUAT BOT, V89, P237, DOI 10.1016/j.aquabot.2007.12.009; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Gondwe BRN, 2010, WETLANDS, V30, P1, DOI 10.1007/s13157-009-0016-z; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hernandez-Terrones L, 2011, WATER AIR SOIL POLL, V218, P517, DOI 10.1007/s11270-010-0664-x; Herrera-Silveira JA, 2009, MAR POLLUT BULL, V59, P72, DOI 10.1016/j.marpolbul.2008.11.017; Hughes RF, 1999, ECOLOGY, V80, P1892; Hughes RF, 2000, ECOL APPL, V10, P515, DOI 10.1890/1051-0761(2000)010[0515:ESIODA]2.0.CO;2; INEGI, NAT I STAT GEOGR; International Energy Agency (IEA), 2011, CO2 EM FUEL COMB 201; Jaramillo VJ, 2003, ECOSYSTEMS, V6, P609, DOI 10.1007/s10021-002-0195-4; Kauffman JB, 2011, WETLANDS, V31, P343, DOI 10.1007/s13157-011-0148-9; KAUFFMAN JB, 1995, OECOLOGIA, V104, P397, DOI 10.1007/BF00341336; Kitayama K, 2002, J ECOL, V90, P37, DOI 10.1046/j.0022-0477.2001.00634.x; Komiyama A, 2005, J TROP ECOL, V21, P471, DOI 10.1017/S0266467405002476; Laffoley D., 2009, MANAGEMENT NATURAL C; Lopez-Medellin X, 2011, J VEG SCI, V22, P143, DOI 10.1111/j.1654-1103.2010.01232.x; Lovelock CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021279; Mckee KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P545, DOI 10.1111/j.1466-8238.2007.00317.x; Medina I, 2011, THESIS; MORAES JL, 1995, SOIL SCI SOC AM J, V59, P244, DOI 10.2136/sssaj1995.03615995005900010038x; Murdiyarso D, 2009, 48 CTR INT FOR RES; Murray MR, 2003, FOREST ECOL MANAG, V174, P265, DOI 10.1016/S0378-1127(02)00036-1; Nellemann C, 2009, BLUE CARBON RAPID RE; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Parsons T.R., 1984, MANUAL BIOL CHEM MET; POOL DJ, 1977, BIOTROPICA, V9, P195, DOI 10.2307/2387881; PRIMAVERA JH, 1995, HYDROBIOLOGIA, V295, P303, DOI 10.1007/BF00029137; Rejmankova E, 1996, INT REV GES HYDROBIO, V81, P223, DOI 10.1002/iroh.19960810208; Rejmankova E, 2001, PLANT SOIL, V236, P33, DOI 10.1023/A:1011953715153; Robertson A.I., 1992, TROPICAL MANGROVE EC; Rocha AV, 2010, J GEOPHYS RES, V115, P1; Ross Michael S., 2001, Wetlands Ecology and Management, V9, P27, DOI 10.1023/A:1008411103288; Santisteban JI, 2004, J PALEOLIMNOL, V32, P287, DOI 10.1023/B:JOPL.0000042999.30131.5b; Siikamaki J, 2012, P NATL ACAD SCI USA, V109, P14369, DOI 10.1073/pnas.1200519109; Smith SM, 2001, J ENVIRON QUAL, V30, P1998, DOI 10.2134/jeq2001.1998; Smith Thomas J. III, 2006, Wetlands Ecology and Management, V14, P409, DOI 10.1007/s11273-005-6243-z; SMN-CAN, NAT MET SYST NAT WAT; Spaulding M, 2010, WORLD ATLAS MANGROVE; URBAN NH, 1993, AQUAT BOT, V46, P203, DOI 10.1016/0304-3770(93)90002-E; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; VANWAGNER CE, 1968, FOREST SCI, V14, P20; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Zanne AE, 2009, GLOBAL WOOD DENSITY	65	182	191	7	192	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56569	10.1371/journal.pone.0056569	http://dx.doi.org/10.1371/journal.pone.0056569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457583	Green Published, gold			2022-12-27	WOS:000315602700079
J	Huisman, CM; Zwart, JJ; Roos-Hesselink, JW; Duvekot, JJ; van Roosmalen, J				Huisman, Claartje M.; Zwart, Joost J.; Roos-Hesselink, Jolien W.; Duvekot, Johannes J.; van Roosmalen, Jos			Incidence and Predictors of Maternal Cardiovascular Mortality and Severe Morbidity in the Netherlands: A Prospective Cohort Study	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; PULMONARY-EDEMA; PERIPARTUM CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; PROSTAGLANDIN ANALOG; CARDIAC-DISEASE; PREGNANCY; WOMEN; ASSOCIATION; MANAGEMENT	Objective: To assess incidence and possible risk factors of severe maternal morbidity and mortality from cardiovascular disease in the Netherlands. Design: A prospective population based cohort study. Setting: All 98 maternity units in the Netherlands. Population: All women delivering in the Netherlands between August 2004 and August 2006 (n = 371,021) Methods: Cases of severe maternal morbidity and mortality from cardiovascular disease were prospectively collected during a two-year period in the Netherlands. Women with cardiovascular complications during pregnancy or postpartum who were admitted to the ward, intensive care or coronary care unit were included. Cardiovascular morbidity was defined as cardiomyopathy, valvular disease, ischaemic heart disease, arrhythmias or aortic dissection. All women delivering in the same period served as a reference cohort. Main outcome measures: Incidence, case fatality rates and possible risk factors. Results: Incidence of severe maternal morbidity due to cardiovascular disease was 2.3 per 10,000 deliveries (84/358,874). Maternal mortality rate from cardiovascular disease was 3.0 per 100,000 deliveries (11/358,874). Case fatality rate in women with severe maternal morbidity due to cardiovascular disease was 13% (11/84). Case fatality rate was highest in aortic dissection (83%). Pre-existing acquired or congenital heart disease was identified in 34% of women. Thirty-one percent of women were of advanced maternal age (>35 years of age) and 5 percent above 40 years of age. Possible risk factors for cardiovascular morbidity were caesarean section (either resulting in or as a result of cardiovascular disease), multiple pregnancy, prior caesarean section, non-Western ethnicity and obesity. Conclusions: In the Netherlands cardiovascular disease is a rare cause of severe maternal morbidity with an incidence of 2.3 per 10,000 deliveries and a high case fatality rate of 13%. Cardiovascular complications develop mostly in women not known with cardiac disease pre-pregnancy.	[Huisman, Claartje M.] Bronovo Hosp, Dept Obstet & Gynaecol, The Hague, Netherlands; [Huisman, Claartje M.; Zwart, Joost J.; van Roosmalen, Jos] Leiden Univ, Dept Obstet, Med Ctr, Leiden, Netherlands; [Zwart, Joost J.] Deventer Hosp, Dept Obstet & Gynaecol, Deventer, Netherlands; [Roos-Hesselink, Jolien W.] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [Duvekot, Johannes J.] Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [van Roosmalen, Jos] Vrije Univ Amsterdam, Dept Med Humanities, EMGO Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands	Haaglanden Medical Center; Bronovo Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Deventer Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	Huisman, CM (corresponding author), Bronovo Hosp, Dept Obstet & Gynaecol, The Hague, Netherlands.	c.m.a.huisman@gmail.com		Huisman, Claartje/0000-0003-0616-2847	Dutch Organisation for Health Research (ZonMw) [3610.0024]; Matty Brand Foundation	Dutch Organisation for Health Research (ZonMw)(Netherlands Organization for Health Research and Development); Matty Brand Foundation	The LEMMoN-study was supported by the Dutch Organisation for Health Research (ZonMw; grant 3610.0024) and the Matty Brand Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafeh JMR, 2006, CRIT CARE NURS Q, V29, P32, DOI 10.1097/00002727-200601000-00004; Balci A, 2011, AM HEART J, V161, P269, DOI 10.1016/j.ahj.2010.10.024; Bax A, 1999, ACTA OBSTET GYN SCAN, V78, P915; Bedard E, 2008, BRIT MED BULL, V85, P151, DOI 10.1093/bmb/ldn005; BLICKSTEIN I, 1988, AM J OBSTET GYNECOL, V159, P332, DOI 10.1016/S0002-9378(88)80078-4; Bonneux L, 2008, Ned Tijdschr Geneeskd, V152, P2697; Brace V, 2004, BJOG-INT J OBSTET GY, V111, P481, DOI 10.1111/j.1471-0528.2004.00101.x; Chang Jeani, 2003, MMWR Surveill Summ, V52, P1; Chen YC, 2009, TAIWAN J OBSTET GYNE, V48, P181, DOI 10.1016/S1028-4559(09)60284-9; Chu SY, 2008, AM J OBSTET GYNECOL, V199, pE18, DOI [10.1016/j.ajog.2008.02.038, 10.1016/j.ajog.2007.12.020]; Curry R, 2009, CURR OPIN OBSTET GYN, V21, P508, DOI 10.1097/GCO.0b013e328332a762; Drenthen W, 2007, J AM COLL CARDIOL, V49, P2303, DOI 10.1016/j.jacc.2007.03.027; Dutch Society of Obstetricians and Gynaecologists (NVOG), 2011, NAT IVF RES; Farmacotherapeutisch Kompas, 2009, MED FARM VOORL UITG, P579; FLIERS E, 1991, BRIT MED J, V302, P416, DOI 10.1136/bmj.302.6773.416-a; Fornet I, 2006, Rev Esp Anestesiol Reanim, V53, P312; Gelson E, 2009, BJOG-INT J OBSTET GY, V116, P609, DOI 10.1111/j.1471-0528.2008.02082.x; Kwee A, 2007, EUR J OBSTET GYN R B, V132, P171, DOI 10.1016/j.ejogrb.2006.07.017; la Chapelle CF, 2012, BJOG-INT J OBSTET GY, V119, P86, DOI 10.1111/j.1471-0528.2011.03178.x; Lewis Ge, 2007, SAVING MOTHERS LIVES, P117; LVR, 2011, NETH PER REG; Ntusi NBA, 2009, INT J CARDIOL, V131, P168, DOI 10.1016/j.ijcard.2008.06.054; PALMER CM, 1990, ANESTH ANALG, V70, P36; Regitz-Zagrosek V, 2011, EUR HEART J, V32, P3147, DOI 10.1093/eurheartj/ehr218; Roos-Hesselink JW, 2012, EUR HEART J IN PRESS; Schutte JM, 2010, BJOG-INT J OBSTET GY, V117, P399, DOI 10.1111/j.1471-0528.2009.02382.x; Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120; STOCK A, 1995, ACTA OBSTET GYN SCAN, V74, P156, DOI 10.3109/00016349509008927; ULMANN A, 1992, ACTA OBSTET GYN SCAN, V71, P278, DOI 10.3109/00016349209021052; Usta IM, 2008, AM J PERINAT, V25, P521, DOI 10.1055/s-0028-1085620; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; Wen SW, 2005, CAN MED ASSOC J, V173, P759, DOI 10.1503/cmaj.045156; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	33	35	38	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56494	10.1371/journal.pone.0056494	http://dx.doi.org/10.1371/journal.pone.0056494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457576	gold, Green Published, Green Submitted			2022-12-27	WOS:000315602700076
J	Moreira, S; Bishopp, A; Carvalho, H; Campilho, A				Moreira, Sofia; Bishopp, Anthony; Carvalho, Helena; Campilho, Ana			AHP6 Inhibits Cytokinin Signaling to Regulate the Orientation of Pericycle Cell Division during Lateral Root Initiation	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; FOUNDER CELLS; AUXIN; SHOOT; MERISTEM; DIFFERENTIATION; ORGANOGENESIS; SPECIFICATION; PATTERN; GROWTH	In Arabidopsis thaliana, lateral roots (LRs) initiate from anticlinal cell divisions of pericycle founder cells. The formation of LR primordia is regulated antagonistically by the phytohormones cytokinin and auxin. It has previously been shown that cytokinin has an inhibitory effect on the patterning events occurring during LR formation. However, the molecular players involved in cytokinin repression are still unknown. In a similar manner to protoxylem formation in Arabidopsis roots, in which AHP6 (ARABIDOPSIS HISTIDINE PHOSPHOTRANSFER PROTEIN 6) acts as a cytokinin inhibitor, we reveal that AHP6 also functions as a cytokinin repressor during early stages of LR development. We show that AHP6 is expressed at different developmental stages during LR formation and is required for the correct orientation of cell divisions at the onset of LR development. Moreover, we demonstrate that AHP6 influences the localization of the auxin efflux carrier PIN1, which is necessary for patterning the LR primordia. In summary, we show that the inhibition of cytokinin signaling through AHP6 is required to establish the correct pattern during LR initiation.	[Moreira, Sofia; Carvalho, Helena; Campilho, Ana] Univ Porto, Inst Mol & Cell Biol IBMC, P-4100 Oporto, Portugal; [Bishopp, Anthony] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	Universidade do Porto; University of Helsinki	Campilho, A (corresponding author), Univ Porto, Inst Mol & Cell Biol IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	anacampilho@ibmc.up.pt	Carvalho, Helena G/E-9357-2012; Campilho, Ana/H-8790-2013; Campilho, Ana/U-8263-2019; Carvalho, Helena/M-6733-2019	Carvalho, Helena G/0000-0003-0651-7601; Campilho, Ana/0000-0002-3470-1943; Campilho, Ana/0000-0002-3470-1943; Carvalho, Helena/0000-0003-0651-7601; Moreira, Sofia/0000-0002-7530-4768; Bishopp, Anthony/0000-0003-2962-9542; Moreira, Sofia/0000-0002-2085-5001	'Programa Ciencia' (FCT); University of Helsinki; University of Porto	'Programa Ciencia' (FCT); University of Helsinki; University of Porto	AC was funded by 'Programa Ciencia' (FCT). AB was funded by University of Helsinki. HC was funded by University of Porto. No external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; De Rybel B, 2010, CURR BIOL, V20, P1697, DOI 10.1016/j.cub.2010.09.007; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dubrovsky JG, 2008, P NATL ACAD SCI USA, V105, P8790, DOI 10.1073/pnas.0712307105; Dubrovsky JG, 2012, PLANT CELL, V24, P4, DOI 10.1105/tpc.111.089698; Dubrovsky JG, 2011, NEW PHYTOL, V191, P970, DOI 10.1111/j.1469-8137.2011.03757.x; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Laplaze L, 2007, PLANT CELL, V19, P3889, DOI 10.1105/tpc.107.055863; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marhavy P, 2011, DEV CELL, V21, P796, DOI 10.1016/j.devcel.2011.08.014; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; ten Tusscher K, 2011, CURR OPIN GENET DEV, V21, P799, DOI 10.1016/j.gde.2011.09.008; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Willemsen V, 1998, DEVELOPMENT, V125, P521; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126	26	40	41	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56370	10.1371/journal.pone.0056370	http://dx.doi.org/10.1371/journal.pone.0056370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457561	gold, Green Submitted, Green Published			2022-12-27	WOS:000315602700071
J	Muller-Juge, V; Cullati, S; Blondon, KS; Hudelson, P; Maitre, F; Vu, NV; Savoldelli, GL; Nendaz, MR				Muller-Juge, Virginie; Cullati, Stephane; Blondon, Katherine S.; Hudelson, Patricia; Maitre, Fabienne; Vu, Nu V.; Savoldelli, Georges L.; Nendaz, Mathieu R.			Interprofessional Collaboration on an Internal Medicine Ward: Role Perceptions and Expectations among Nurses and Residents	PLOS ONE			English	Article							CARE-UNIT TEAM; PHYSICIAN COLLABORATION; CRISES; HOSPITALS; ATTITUDES; OUTCOMES; DOCTORS; QUALITY	Background: Effective interprofessional collaboration requires that team members share common perceptions and expectations of each other's roles. Objective: Describe and compare residents' and nurses' perceptions and expectations of their own and each other's professional roles in the context of an Internal Medicine ward. Methods: A convenience sample of 14 residents and 14 nurses volunteers from the General Internal Medicine Division at the University Hospitals of Geneva, Switzerland, were interviewed to explore their perceptions and expectations of residents' and nurses' professional roles, for their own and the other profession. Interviews were analysed using thematic content analysis. The same respondents also filled a questionnaire asking their own intended actions and the expected actions from the other professional in response to 11 clinical scenarios. Results: Three main themes emerged from the interviews: patient management, clinical reasoning and decision-making processes, and roles in the team. Nurses and residents shared general perceptions about patient management. However, there was a lack of shared perceptions and expectations regarding nurses' autonomy in patient management, nurses' participation in the decision-making process, professional interdependence, and residents' implication in teamwork. Results from the clinical scenarios showed that nurses' intended actions differed from residents' expectations mainly regarding autonomy in patient management. Correlation between residents' expectations and nurses' intended actions was 0.56 (p = 0.08), while correlation between nurses' expectations and residents' intended actions was 0.80 (p < 0.001). Conclusions: There are discordant perceptions and unmet expectations among nurses and residents about each other's roles, including several aspects related to the decision-making process. Interprofessional education should foster a shared vision of each other's roles and clarify the boundaries of autonomy of each profession.	[Muller-Juge, Virginie; Vu, Nu V.; Savoldelli, Georges L.; Nendaz, Mathieu R.] Univ Geneva, UDREM, Fac Med, Geneva, Switzerland; [Cullati, Stephane] Univ Hosp Geneva, Qual Care Serv, Geneva, Switzerland; [Cullati, Stephane] Univ Geneva, Inst Demog & Life Course Studies, Fac Econ & Social Sci, Geneva, Switzerland; [Blondon, Katherine S.; Maitre, Fabienne; Nendaz, Mathieu R.] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Hudelson, Patricia] Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland; [Savoldelli, Georges L.] Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Nendaz, MR (corresponding author), Univ Geneva, UDREM, Fac Med, Geneva, Switzerland.	Mathieu.Nendaz@hcuge.ch	Cullati, Stephane/F-7991-2011; Blondon, Katherine S/H-9219-2019; Nendaz, Mathieu R/X-6786-2019; Savoldelli, Georges/AAF-9692-2020	Cullati, Stephane/0000-0002-3881-446X; Blondon, Katherine S/0000-0002-9407-8516; Nendaz, Mathieu R/0000-0003-3795-3254; Savoldelli, Georges/0000-0002-8968-6920; Hudelson, Patricia/0000-0003-2601-7479; Vu, Nu Viet/0000-0001-7733-0364; Muller-Juge, Virginie/0000-0002-2346-8904	Fondation Ernst et Lucie Schmidheiny [ME 8676]; Projet de Recherche et de Developpement, Direction medicale, Hopitaux Universitaires de Geneve [PRD 2010-II-5]	Fondation Ernst et Lucie Schmidheiny; Projet de Recherche et de Developpement, Direction medicale, Hopitaux Universitaires de Geneve	The study was funded by the "Fondation Ernst et Lucie Schmidheiny" (ME 8676) and the "Projet de Recherche et de Developpement, Direction medicale, Hopitaux Universitaires de Geneve" (PRD 2010-II-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Milstein J, 2011, J CRIT CARE, V26; Baggs JG, 1999, CRIT CARE MED, V27, P1991, DOI 10.1097/00003246-199909000-00045; Baggs JG, 1997, RES NURS HEALTH, V20, P71, DOI 10.1002/(SICI)1098-240X(199702)20:1<71::AID-NUR8>3.0.CO;2-R; Curley C, 1998, MED CARE, V36, pAS4, DOI 10.1097/00005650-199808001-00002; Delva D, 2008, J INTERPROF CARE, V22, P598, DOI 10.1080/13561820802201819; Donald F, 2009, CAN J AGING, V28, P77, DOI 10.1017/S0714980809090060; Evans S A, 1992, Am J Crit Care, V1, P25; Fewster-Thuente Lori, 2008, Nurs Adm Q, V32, P40; Gordon MB, 2011, ARCH PEDIAT ADOL MED, V165, P424, DOI 10.1001/archpediatrics.2011.54; Henderson V, 2006, J ADV NURS, V53, P21, DOI 10.1111/j.1365-2648.2006.03660.x; HENDERSON V, 1978, J ADV NURS, V3, P113, DOI 10.1111/j.1365-2648.1978.tb00837.x; Kenaszchuk C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-29; Krairiksh M, 2001, J NURS ADMIN, V31, P16, DOI 10.1097/00005110-200101000-00005; Krippendorf Klaus, 2004, CONTENT ANAL INTRO I; Krogstad U, 2004, INT J QUAL HEALTH C, V16, P491, DOI 10.1093/intqhc/mzh082; Leech NL, 2009, QUAL QUANT, V43, P265, DOI 10.1007/s11135-007-9105-3; Lingard L, 2004, CRIT CARE, V8, pR403, DOI 10.1186/cc2958; Liston BW, 2011, ACAD MED, V86, P872, DOI 10.1097/ACM.0b013e31821d699b; Martin JS, 2010, SWISS MED WKLY, V140, P33, DOI 10.4414/smw.2010.13062; McGrail KA, 2009, J GEN INTERN MED, V24, P198, DOI 10.1007/s11606-008-0869-5; Piquette D, 2009, J INTERPROF CARE, V23, P273, DOI 10.1080/13561820802697818; Piquette D, 2009, CRIT CARE MED, V37, P1251, DOI 10.1097/CCM.0b013e31819c1496; Reeves S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002213.pub2; Reeves S, 2009, J INTERPROF CARE, V23, P633, DOI 10.3109/13561820902886295; Sexton JB, 2000, BMJ-BRIT MED J, V320, P745, DOI 10.1136/bmj.320.7237.745; Snelgrove S, 2000, J ADV NURS, V31, P661, DOI 10.1046/j.1365-2648.2000.01321.x; Stacy T., 2007, MED SURG NURSING, V16, P104; Svensson R, 1996, SOCIOL HEALTH ILL, V18, P379, DOI 10.1111/1467-9566.ep10934735; Thomas EJ, 2003, CRIT CARE MED, V31, P956, DOI 10.1097/01.CCM.0000056183.89175.76; Thomson Stacy, 2007, Medsurg Nurs, V16, P87; Verschuren PJM, 1997, SOC SCI MED, V45, P1135, DOI 10.1016/S0277-9536(97)00043-9; Ward J, 2008, J INTERPROF CARE, V22, P375, DOI 10.1080/13561820802190533; Weller JM, 2008, MED EDUC, V42, P382, DOI 10.1111/j.1365-2923.2007.02971.x; WHO Department of Human Resources for Health, 2010, WHOHRHHPN103 DEP HUM; Zwarentein M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000072.pub2	35	38	38	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57570	10.1371/journal.pone.0057570	http://dx.doi.org/10.1371/journal.pone.0057570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23469027	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900126
J	Tambe, DT; Croutelle, U; Trepat, X; Park, CY; Kim, JH; Millet, E; Butler, JP; Fredberg, JJ				Tambe, Dhananjay T.; Croutelle, Ugo; Trepat, Xavier; Park, Chan Young; Kim, Jae Hun; Millet, Emil; Butler, James P.; Fredberg, Jeffrey J.			Monolayer Stress Microscopy: Limitations, Artifacts, and Accuracy of Recovered Intercellular Stresses	PLOS ONE			English	Article							CELL; MECHANICS; MORPHOGENESIS; FORCES; MIGRATION; STIFFNESS; TENSION	In wound healing, tissue growth, and certain cancers, the epithelial or the endothelial monolayer sheet expands. Within the expanding monolayer sheet, migration of the individual cell is strongly guided by physical forces imposed by adjacent cells. This process is called plithotaxis and was discovered using Monolayer Stress Microscopy (MSM). MSM rests upon certain simplifying assumptions, however, concerning boundary conditions, cell material properties and system dimensionality. To assess the validity of these assumptions and to quantify associated errors, here we report new analytical, numerical, and experimental investigations. For several commonly used experimental monolayer systems, the simplifying assumptions used previously lead to errors that are shown to be quite small. Out-of-plane components of displacement and traction fields can be safely neglected, and characteristic features of intercellular stresses that underlie plithotaxis remain largely unaffected. Taken together, these findings validate Monolayer Stress Microscopy within broad but well-defined limits of applicability.	[Tambe, Dhananjay T.; Park, Chan Young; Kim, Jae Hun; Millet, Emil; Butler, James P.; Fredberg, Jeffrey J.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Croutelle, Ugo] Univ Paris 07, Dept Phys, Paris, France; [Trepat, Xavier] Inst Bioengn Catalonia ICREA, Barcelona, Spain; [Trepat, Xavier] Univ Barcelona, Unitat Biofis & Bioengn CIBERES, Barcelona, Spain; [Butler, James P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; UDICE-French Research Universities; Universite Paris Cite; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; ICREA; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Harvard University; Harvard Medical School	Tambe, DT (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	dhananjay@alumni.brown.edu	Fredberg, Jeffrey/M-9877-2019; Trepat, Xavier/I-3912-2015	Trepat, Xavier/0000-0002-7621-5214; Tambe, Dhananjay/0000-0002-6534-6577	Spanish Ministry for Science and Innovation [BFU2009-07595, BFU2012-38146]; European Research Council [242993]; National Institutes of Health [R01HL102373, R01HL107561]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102373, R01HL107561] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Spanish Ministry for Science and Innovation(Spanish Government); European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ICREA(ICREA)	This research was supported by the Spanish Ministry for Science and Innovation (BFU2009-07595 and BFU2012-38146), the European Research Council (Grant Agreement 242993) and the National Institutes of Health (R01HL102373, R01HL107561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2009, SCIENCE, V325, P1319, DOI 10.1126/science.1181224; Bagorda A, 2008, J CELL SCI, V121, P2621, DOI 10.1242/jcs.018077; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Chen XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015003; del Alamo JC, 2007, P NATL ACAD SCI USA, V104, P13343, DOI 10.1073/pnas.0705815104; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher D, 2009, ANN BIOMED ENG, V37, P847, DOI 10.1007/s10439-009-9661-x; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Eisenhoffer GT, 2012, NATURE; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2009, SCIENCE, V324, P208, DOI 10.1126/science.1170107; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fung Y.C., 1993, BIOMECHANICS MECH PR; Gov N, 2011, NAT MATER, V10, P412, DOI 10.1038/nmat3036; Harris AR, 2012, P NATL ACAD SCI; Hur SS, 2012, P NATL ACAD SCI USA, V109, P11110, DOI 10.1073/pnas.1207326109; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin YC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041918; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Marinari E, 2012, NATURE; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; MCCARTHY JB, 1983, J CELL BIOL, V97, P772, DOI 10.1083/jcb.97.3.772; Murrell M, 2011, BIOPHYS J, V101, P297, DOI 10.1016/j.bpj.2011.05.048; Notbohm J, 2012, BIOPHYS J, V102, P1323, DOI 10.1016/j.bpj.2012.02.016; Park CY, 2010, AM J PHYSIOL-CELL PH, V298, pC1245, DOI 10.1152/ajpcell.00417.2009; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Roh-Johnson M, 2012, SCIENCE, V335, P1232, DOI 10.1126/science.1217869; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Thery M, 2012, NAT PHYS, V8, P583, DOI 10.1038/nphys2374; Ting LH, 2012, AM J PHYSIOL-HEART C, V302, pH2220, DOI 10.1152/ajpheart.00975.2011; Trepat X, 2011, TRENDS CELL BIOL, V21, P638, DOI 10.1016/j.tcb.2011.06.006; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Woolner S, 2012, DEV CELL, V22, P775, DOI 10.1016/j.devcel.2012.01.002	42	113	114	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e55172	10.1371/journal.pone.0055172	http://dx.doi.org/10.1371/journal.pone.0055172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468843	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900010
J	Totte, P; Yaya, A; Sery, A; Wesonga, H; Wade, A; Naessens, J; Niang, M; Thiaucourt, F				Totte, Philippe; Yaya, Aboubakar; Sery, Amadou; Wesonga, Hezron; Wade, Abel; Naessens, Jan; Niang, Mamadou; Thiaucourt, Francois			Characterization of Anamnestic T-cell Responses Induced by Conventional Vaccines against Contagious Bovine Pleuropneumonia	PLOS ONE			English	Article							MEMORY; CORRELATE; PROTECTION; IMMUNITY; QUALITY; GAMMA	A better understanding of how T1 vaccination confers immunity would facilitate the rational design of improved vaccines against contagious bovine pleuropneumonia (CBPP). We show here that mycoplasmas-induced recall proliferation and IFN-gamma responses are detected in cattle that received multiple shots of T1 vaccines. These anamnestic responses were under the strict control of CD4(+) T lymphocytes. Moreover, CD62L expression indicated that both CD4(+) effector memory (Tem) and central memory (Tcm) T lymphocytes are elicited in these animals. Comparative analysis with data from cattle that completely recovered from CBPP infection revealed similar anamnestic T-cell responses albeit at a lower magnitude for T1-vaccinated animals, particularly in the Tcm compartment. In conclusion, we discuss how our current understanding of T-cell responses will contribute to ongoing efforts for the improvement of future CBPP vaccines.	[Totte, Philippe; Thiaucourt, Francois] Ctr Int Rech Agron Dev, UMR CMAEE, Montpellier, France; [Totte, Philippe; Thiaucourt, Francois] Inst Natl Rech Agronom, CMAEE UMR1309, Montpellier, France; [Yaya, Aboubakar; Wade, Abel] Natl Vet Lab, Garoua, Cameroon; [Sery, Amadou; Niang, Mamadou] Cent Vet Lab, Bamako, Mali; [Wesonga, Hezron] Kenya Agr Res Inst, Kikuyu, Kenya; [Naessens, Jan] Int Livestock Res Inst, Nairobi, Kenya	CIRAD; Universite de Montpellier; INRAE; CGIAR; International Livestock Research Institute (ILRI)	Totte, P (corresponding author), Ctr Int Rech Agron Dev, UMR CMAEE, Montpellier, France.	philippe.totte@cirad.fr			European Union, under the supervision of OAU/IBAR (Kenya); Australian aid program; CSIRO-AUSaid grant	European Union, under the supervision of OAU/IBAR (Kenya); Australian aid program; CSIRO-AUSaid grant	This study was funded in parts by grants from the European Union, under the supervision of OAU/IBAR (Kenya), and from the Australian aid program. J.N. was sponsored by a CSIRO-AUSaid grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, 4 FAO OIE AU IBAR IA; Dedieu L, 2005, SCAND J IMMUNOL, V62, P528, DOI 10.1111/j.1365-3083.2005.01690.x; Dedieu L, 2005, VET IMMUNOL IMMUNOP, V107, P217, DOI 10.1016/j.vetimm.2005.04.011; Goletti D, 2006, J INFECT DIS, V194, P984, DOI 10.1086/507427; Hamsten C, 2009, MOL CELL PROTEOMICS, V8, P2544, DOI 10.1074/mcp.M900009-MCP200; Hope JC, 2011, CLIN VACCINE IMMUNOL, V18, P373, DOI 10.1128/CVI.00543-10; HUDSON JR, 1968, AUST VET J, V44, P123, DOI 10.1111/j.1751-0813.1968.tb09052.x; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Masiga WN, 1996, REV SCI TECH, V18, P59; Nkando I, 2012, RES VET SCI, V93, P568, DOI 10.1016/j.rvsc.2011.08.020; REVELL S G, 1973, Tropical Animal Health and Production, V5, P246, DOI 10.1007/BF02240425; ROBERTS DH, 1973, INFECT IMMUN, V8, P349, DOI 10.1128/IAI.8.3.349-354.1973; Sacchini F, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-44; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; SHERIFF D., 1952, Veterinary Record, V64, P615; Soloff AC, 2009, EUR J IMMUNOL, V39, P2437, DOI 10.1002/eji.200839130; Tambi NE, 2006, REV SCI TECH OIE, V25, P999, DOI 10.20506/rst.25.3.1710; Thiaucourt F, 2004, DEV BIOLOGICALS, V119, P99; Thiaucourt F, 2000, ANN NY ACAD SCI, V916, P71, DOI 10.1111/j.1749-6632.2000.tb05276.x; Totte P, 2010, DEV COMP IMMUNOL, V34, P177, DOI 10.1016/j.dci.2009.09.005; Totte P, 2008, VET RES, V39, DOI 10.1051/vetres:2007046; Wesonga H. O., 2000, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V53, P313; Whelan AO, 2008, VACCINE, V26, P166, DOI 10.1016/j.vaccine.2007.11.005; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108	24	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57509	10.1371/journal.pone.0057509	http://dx.doi.org/10.1371/journal.pone.0057509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469008	Green Published, gold			2022-12-27	WOS:000315524900108
J	Lee, J; Ballikaya, S; Schonig, K; Ball, CR; Glimm, H; Kopitz, J; Gebert, J				Lee, Jennifer; Ballikaya, Seda; Schoenig, Kai; Ball, Claudia R.; Glimm, Hanno; Kopitz, Juergen; Gebert, Johannes			Transforming Growth Factor Beta Receptor 2 (TGFBR2) Changes Sialylation in the Microsatellite Unstable (MSI) Colorectal Cancer Cell Line HCT116	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; SURFACE SIALYLATION; ADHESION RECEPTORS; IDENTIFICATION; GLYCOSYLATION; MUTATIONS; INTEGRINS; GENES; DNA; INACTIVATION	Aberrant glycosylation is a common feature of many malignancies including colorectal cancers (CRCs). About 15% of CRC show the microsatellite instability (MSI) phenotype that is associated with a high frequency of biallelic frameshift mutations in the A10 coding mononucleotide microsatellite of the transforming growth factor beta receptor 2 (TGFBR2) gene. If and how impaired TGFBR2 signaling in MSI CRC cells affects cell surface glycan pattern is largely unexplored. Here, we used the TGFBR2-deficient MSI colon carcinoma cell line HCT116 as a model system. Stable clones conferring doxycycline (dox)inducible expression of a single copy wildtype TGFBR2 transgene were generated by recombinase-mediated cassette exchange (RMCE). In two independent clones, dox-inducible expression of wildtype TGFBR2 protein and reconstitution of its signaling function was shown. Metabolic labeling experiments using the tritiated sialic acid precursor N-acetyl-D-mannosamine (ManNAc) revealed a significant decline (similar to 30%) of its incorporation into newly synthesized sialoglycoproteins in a TGFBR2-dependent manner. In particular, we detected a significant decrease of sialylated beta 1-integrin upon reconstituted TGFBR2 signaling which did not influence beta 1-integrin protein turnover. Notably, TGFBR2 reconstitution did not affect the transcript levels of any of the known human sialyltransferases when examined by real-time RT-PCR analysis. These results suggest that reconstituted TGFBR2 signaling in an isogenic MSI cell line model system can modulate sialylation of cell surface proteins like beta 1-integrin. Moreover, our model system will be suitable to uncover the underlying molecular mechanisms of altered MSI tumor glycobiology.	[Lee, Jennifer; Ballikaya, Seda; Kopitz, Juergen; Gebert, Johannes] Univ Heidelberg Hosp, Inst Pathol, Dept Appl Tumor Biol, Heidelberg, Germany; [Lee, Jennifer; Ballikaya, Seda; Kopitz, Juergen; Gebert, Johannes] German Canc Res Ctr, Clin Cooperat Unit Appl Tumor Biol, Heidelberg, Germany; [Schoenig, Kai] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Mol Biol, Mannheim, Germany; [Ball, Claudia R.; Glimm, Hanno] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, Heidelberg, Germany; [Ball, Claudia R.; Glimm, Hanno] German Canc Res Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Gebert, J (corresponding author), Univ Heidelberg Hosp, Inst Pathol, Dept Appl Tumor Biol, Heidelberg, Germany.	johannes.gebert@med.uni-heidelberg.de		Ball, Claudia/0000-0002-1749-3791	DFG [GE592/6-1, KFO 227]	DFG(German Research Foundation (DFG))	Financial support was provided by DFG (GE592/6-1) to J.K. and J.G. and DFG (KFO 227) to C. R. B. and H. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; ALTEVOGT P, 1983, CANCER RES, V43, P5138; Baker K, 2007, J PATHOL, V213, P257, DOI 10.1002/path.2235; Bellis SL, 1999, J CELL PHYSIOL, V181, P33, DOI 10.1002/(SICI)1097-4652(199910)181:1<33::AID-JCP4>3.0.CO;2-#; Berns A, 2008, NAT GENET, V40, P1149, DOI 10.1038/ng1008-1149; Costa-Nogueira C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-431; Dall'Olio F, 1999, INT J CANCER, V81, P243, DOI 10.1002/(SICI)1097-0215(19990412)81:2<243::AID-IJC13>3.0.CO;2-O; Dall'Olio F, 2012, FRONT BIOSCI-LANDMRK, V17, P670, DOI 10.2741/3951; Duval A, 2002, CANCER RES, V62, P2447; Egrie JC, 2003, EXP HEMATOL, V31, P290, DOI 10.1016/S0301-472X(03)00006-7; FYNAN TM, 1993, CRIT REV ONCOGENESIS, V4, P493; Gabius HJ, 2009, SUGAR CODE, P419; Geng Y, 2012, ANN BIOMED ENG, V40, P790, DOI 10.1007/s10439-011-0463-6; Guo HB, 2002, CANCER RES, V62, P6837; HEINO J, 1989, J BIOL CHEM, V264, P380; Hsu LJ, 2009, J BIOL CHEM, V284, P16049, DOI 10.1074/jbc.M806688200; Hua XX, 1999, P NATL ACAD SCI USA, V96, P13130, DOI 10.1073/pnas.96.23.13130; IGNOTZ RA, 1989, J BIOL CHEM, V264, P389; Ilyas M, 1999, P NATL ACAD SCI USA, V96, P3087, DOI 10.1073/pnas.96.6.3087; Ito H, 1997, INT J CANCER, V71, P556, DOI 10.1002/(SICI)1097-0215(19970516)71:4<556::AID-IJC9>3.3.CO;2-J; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Kawamura YI, 2005, CANCER RES, V65, P6220, DOI 10.1158/0008-5472.CAN-05-0639; Kemmner W, 2003, BBA-GEN SUBJECTS, V1621, P272, DOI 10.1016/S0304-4165(03)00079-5; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim SJ, 2000, CYTOKINE GROWTH F R, V11, P159, DOI 10.1016/S1359-6101(99)00039-8; Lawes DA, 2003, EUR J SURG ONCOL, V29, P201, DOI 10.1053/ejso.2002.1399; Loew Rainer, 2006, J Mol Genet Med, V2, P107; Ma JY, 1999, J BIOL CHEM, V274, P8046, DOI 10.1074/jbc.274.12.8046; Malagolini N, 2007, GLYCOBIOLOGY, V17, P688, DOI 10.1093/glycob/cwm040; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Matallanas D, 2003, J BIOL CHEM, V278, P4572, DOI 10.1074/jbc.M209807200; MORGENTHALER J, 1990, BIOCHEM BIOPH RES CO, V171, P860, DOI 10.1016/0006-291X(90)91225-H; Mori Y, 2001, CANCER RES, V61, P6046; Moro L, 2004, J BIOL CHEM, V279, P1692, DOI 10.1074/jbc.M307857200; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; NATSUKA S, 1994, J BIOL CHEM, V269, P20806; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; Park SY, 2012, INT J CANCER, V130, P2366, DOI 10.1002/ijc.26288; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Patsos G, 2009, GLYCOBIOLOGY, V19, P726, DOI 10.1093/glycob/cwp040; Petretti T, 2000, GUT, V46, P359, DOI 10.1136/gut.46.3.359; Royrvik Ellen C., 2007, Critical Reviews in Oncogenesis, V13, P229; Saxena A, 1997, BIOCHEMISTRY-US, V36, P7481, DOI 10.1021/bi963156d; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Wang LY, 2007, J CELL BIOCHEM, V100, P230, DOI 10.1002/jcb.21071; Weidenfeld I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp108; Welman A, 2006, NAT PROTOC, V1, P803, DOI 10.1038/nprot.2006.117; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421; Woerner SM, 2001, INT J CANCER, V93, P12, DOI 10.1002/ijc.1299; YOGEESWARAN G, 1981, SCIENCE, V212, P1514, DOI 10.1126/science.7233237; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	60	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57074	10.1371/journal.pone.0057074	http://dx.doi.org/10.1371/journal.pone.0057074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468914	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000059
J	Proietti, V; Pisacane, A; Cassia, VM				Proietti, Valentina; Pisacane, Antonella; Cassia, Viola Macchi			Natural Experience Modulates the Processing of Older Adult Faces in Young Adults and 3-Year-Old Children	PLOS ONE			English	Article							OWN-AGE BIAS; EARLY MATURITY; RACE BIAS; RECOGNITION; IDENTIFICATION; MEMORY; INTEGRATION; EXPERTISE; PREDICTS; ACCOUNT	Just like other face dimensions, age influences the way faces are processed by adults as well as by children. However, it remains unclear under what conditions exactly such influence occurs at both ages, in that there is some mixed evidence concerning the presence of a systematic processing advantage for peer faces (own-age bias) across the lifespan. Inconsistency in the results may stem from the fact that the individual's face representation adapts to represent the most predominant age traits of the faces present in the environment, which is reflective of the individual's specific living conditions and social experience. In the current study we investigated the processing of younger and older adult faces in two groups of adults (Experiment 1) and two groups of 3-year-old children (Experiment 2) who accumulated different amounts of experience with elderly people. Contact with elderly adults influenced the extent to which both adult and child participants showed greater discrimination abilities and stronger sensitivity to configural/featural cues in younger versus older adult faces, as measured by the size of the inversion effect. In children, the size of the inversion effect for older adult faces was also significantly correlated with the amount of contact with elderly people. These results show that, in both adults and children, visual experience with older adult faces can tune perceptual processing strategies to the point of abolishing the discrimination disadvantage that participants typically manifest for those faces in comparison to younger adult faces.	[Proietti, Valentina; Pisacane, Antonella; Cassia, Viola Macchi] Univ Milano Bicocca, Dept Psychol, Milan, Italy	University of Milano-Bicocca	Cassia, VM (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	viola.macchicassia@unimib.it	Macchi Cassia, Viola/HCI-2058-2022	Proietti, Valentina/0000-0001-9055-7328; macchi cassia, viola/0000-0002-9983-8254	University of Milano-Bicocca	University of Milano-Bicocca	This research was supported by a grant from the University of Milano-Bicocca to the last author and a scholarship from the same University to the first author. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JM, 2006, PSYCHOL SCI, V17, P836, DOI 10.1111/j.1467-9280.2006.01790.x; Anastasi J.S., 2006, N AM J PSYCHOL, V8, P237; Anastasi JS, 2005, PSYCHON B REV, V12, P1043, DOI 10.3758/BF03206441; BACKMAN L, 1991, MEM COGNITION, V19, P63, DOI 10.3758/BF03198496; BARTLETT JC, 1986, MEM COGNITION, V14, P371, DOI 10.3758/BF03197012; Bukach CM, 2006, J COGNITIVE NEUROSCI, V18, P48, DOI 10.1162/089892906775250094; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; Cassia VM, 2012, J EXP CHILD PSYCHOL, V113, P372, DOI 10.1016/j.jecp.2012.06.014; Cassia VM, 2011, BRIT J PSYCHOL, V102, P816, DOI 10.1111/j.2044-8295.2011.02046.x; Cassia VM, 2009, PSYCHOL SCI, V20, P853, DOI 10.1111/j.1467-9280.2009.02376.x; Cassia VM, 2009, Q J EXP PSYCHOL, V62, P1099, DOI 10.1080/17470210802617654; CHIRORO P, 1995, Q J EXP PSYCHOL-A, V48, P879, DOI 10.1080/14640749508401421; Chung M. S., 1997, KOREAN J DEV PSYCHOL, V10, P167; Corenblum B, 2006, J EXP CHILD PSYCHOL, V93, P187, DOI 10.1016/j.jecp.2005.09.001; Crookes K, 2009, COGNITION, V111, P219, DOI 10.1016/j.cognition.2009.02.004; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; DIAMOND R, 1977, J EXP CHILD PSYCHOL, V23, P1, DOI 10.1016/0022-0965(77)90069-8; Ebner NC, 2009, EMOTION, V9, P329, DOI 10.1037/a0015179; Enlow DH, 1996, ESSENTIALS FACIAL GR; FULTON A, 1991, PSYCHOL AGING, V6, P623, DOI 10.1037/0882-7974.6.4.623; Gilchrist A, 2003, VIS COGN, V10, P769, DOI 10.1080/13506280344000022; GOLDSTEIN AG, 1964, CHILD DEV, V35, P129, DOI 10.1111/j.1467-8624.1964.tb05924.x; Harrison V, 2009, PSYCHON B REV, V16, P264, DOI 10.3758/PBR.16.2.264; Havard C, 2009, MEMORY, V17, P847, DOI 10.1080/09658210903277318; He Y, 2011, SOC COGNITION, V29, P97, DOI 10.1521/soco.2011.29.1.97; Hills PJ, 2012, DEV PSYCHOL, V48, P499, DOI 10.1037/a0026524; Hills PJ, 2011, Q J EXP PSYCHOL, V64, P17, DOI 10.1080/17470218.2010.537926; Hugenberg K, 2010, PSYCHOL REV, V117, P1168, DOI 10.1037/a0020463; Kuefner D, 2008, J EXP PSYCHOL HUMAN, V34, P811, DOI 10.1037/0096-1523.34.4.811; Kuefner D, 2010, VIS COGN, V18, P11, DOI 10.1080/13506280802396507; Levin DT, 2000, J EXP PSYCHOL GEN, V129, P559, DOI 10.1037//0096-3445.129.4.559; Lindholm T, 2005, MEMORY, V13, P21, DOI 10.1080/09658210344000549; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Minear M, 2004, BEHAV RES METHODS, V36, P130; Pascalis O, 1998, BEHAV PROCESS, V43, P87, DOI 10.1016/S0376-6357(97)00090-9; Perfect T. J, 2005, MEASURING MIND SPEED, P317, DOI [DOI 10.1093/ACPROF:OSO/9780198566427.003.0013, 10.1093/acprof:oso/9780198566427.003.0013]; Picozzi M, 2009, J EXP CHILD PSYCHOL, V102, P487, DOI 10.1016/j.jecp.2008.11.001; Ramsey-Rennels JL, 2006, CURR DIR PSYCHOL SCI, V15, P59, DOI 10.1111/j.0963-7214.2006.00407.x; Rehnman J, 2006, MEMORY, V14, P289, DOI 10.1080/09658210500233581; RHODES G, 1989, BRIT J PSYCHOL, V80, P313, DOI 10.1111/j.2044-8295.1989.tb02323.x; Rhodes MG, 2012, PSYCHOL BULL, V138, P146, DOI 10.1037/a0025750; Rhodes MG, 2009, APPL COGNITIVE PSYCH, V23, P1, DOI 10.1002/acp.1442; RODIN MJ, 1987, SOC COGNITION, V5, P144, DOI 10.1521/soco.1987.5.2.144; Rossion B, 2008, PLOS ONE, V3, pe231; Ruble D. N., 2006, HDB CHILD PSYCHOL SO, P858; Sangrigoli S, 2004, DEVELOPMENTAL SCI, V7, P74, DOI 10.1111/j.1467-7687.2004.00324.x; Scherf KS, 2012, DEV PSYCHOBIOL, V54, P643, DOI 10.1002/dev.21013; Scott LS, 2006, INFANCY, V10, P171, DOI 10.1207/s15327078in1002_4; Short LA, 2010, PERCEPTION, V39, P1562, DOI 10.1068/p6758; Slessor G, 2010, EMOTION, V10, P555, DOI 10.1037/a0019152; Sporer SL, 2001, PSYCHOL PUBLIC POL L, V7, P36, DOI 10.1038//1076-8971.7.1.36; Tanaka JW, 2004, COGNITION, V93, pB1, DOI 10.1016/j.cognition.2003.09.011; Wiese H, 2008, NEUROPSYCHOLOGIA, V46, P2973, DOI 10.1016/j.neuropsychologia.2008.06.007; Wright DB, 2002, LAW HUMAN BEHAV, V26, P641, DOI 10.1023/A:1020981501383; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	56	26	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57499	10.1371/journal.pone.0057499	http://dx.doi.org/10.1371/journal.pone.0057499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460867	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000122
J	Streinzer, M; Brockmann, A; Nagaraja, N; Spaethe, J				Streinzer, Martin; Brockmann, Axel; Nagaraja, Narayanappa; Spaethe, Johannes			Sex and Caste-Specific Variation in Compound Eye Morphology of Five Honeybee Species	PLOS ONE			English	Article							APIS-MELLIFERA L; CERANA-JAPONICA RADOSZKOWSKI; DRONE FLIGHT; REPRODUCTIVE ISOLATION; MATING FLIGHTS; VISUAL ADAPTATIONS; CONGREGATION AREAS; TEMPORAL PERIOD; SPERM TRANSFER; BODY-SIZE	Ranging from dwarfs to giants, the species of honeybees show remarkable differences in body size that have placed evolutionary constrains on the size of sensory organs and the brain. Colonies comprise three adult phenotypes, drones and two female castes, the reproductive queen and sterile workers. The phenotypes differ with respect to tasks and thus selection pressures which additionally constrain the shape of sensory systems. In a first step to explore the variability and interaction between species size-limitations and sex and caste-specific selection pressures in sensory and neural structures in honeybees, we compared eye size, ommatidia number and distribution of facet lens diameters in drones, queens and workers of five species (Apis andreniformis, A. florea, A. dorsata, A. mellifera, A. cerana). In these species, male and female eyes show a consistent sex-specific organization with respect to eye size and regional specialization of facet diameters. Drones possess distinctly enlarged eyes with large dorsal facets. Aside from these general patterns, we found signs of unique adaptations in eyes of A. florea and A. dorsata drones. In both species, drone eyes are disproportionately enlarged. In A. dorsata the increased eye size results from enlarged facets, a likely adaptation to crepuscular mating flights. In contrast, the relative enlargement of A. florea drone eyes results from an increase in ommatidia number, suggesting strong selection for high spatial resolution. Comparison of eye morphology and published mating flight times indicates a correlation between overall light sensitivity and species-specific mating flight times. The correlation suggests an important role of ambient light intensities in the regulation of species-specific mating flight times and the evolution of the visual system. Our study further deepens insights into visual adaptations within the genus Apis and opens up future perspectives for research to better understand the timing mechanisms and sensory physiology of mating related signals.	[Streinzer, Martin; Spaethe, Johannes] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Biozentrum, D-97070 Wurzburg, Germany; [Streinzer, Martin] Univ Vienna, Fac Life Sci, Dept Evolutionary Biol, Vienna, Austria; [Brockmann, Axel] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Nagaraja, Narayanappa] Bangalore Univ, Acad Staff Coll, Univ Grants Commiss, Bangalore 560056, Karnataka, India	University of Wurzburg; University of Vienna; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Bangalore University	Streinzer, M (corresponding author), Univ Wurzburg, Dept Behav Physiol & Sociobiol, Biozentrum, D-97070 Wurzburg, Germany.	martin.streinzer@uni-wuerzburg.de	Spaethe, Johannes/B-8826-2014; Streinzer, Martin/AAE-2359-2019	Streinzer, Martin/0000-0002-6656-7224; Spaethe, Johannes/0000-0002-0734-2869	Austrian Academy of Sciences at the Department of Behavioral Physiology and Sociobiology, University of Wurzburg; Department of Evolutionary Biology, University of Vienna; German Research Foundation (DFG); University of Wurzburg	Austrian Academy of Sciences at the Department of Behavioral Physiology and Sociobiology, University of Wurzburg; Department of Evolutionary Biology, University of Vienna; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	M.S. is recipient of a DOC-fellowship of the Austrian Academy of Sciences at the Department of Behavioral Physiology and Sociobiology, University of Wurzburg and the Department of Evolutionary Biology, University of Vienna. This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD G, 1985, CELL TISSUE RES, V242, P593, DOI 10.1007/BF00225425; ARNOLD G, 1988, INT J INSECT MORPHOL, V17, P185, DOI 10.1016/0020-7322(88)90036-0; Berg S, 1997, APIDOLOGIE, V28, P449, DOI 10.1051/apido:19970611; Boucher M, 2009, ANIM BEHAV, V78, P247, DOI 10.1016/j.anbehav.2009.04.019; Brockmann A, 1998, NATURWISSENSCHAFTEN, V85, P283, DOI 10.1007/s001140050500; Brockmann A, 2001, NATURWISSENSCHAFTEN, V88, P78, DOI 10.1007/s001140000199; Brockmann A., 2003, INDIAN BEE J, V55, P131; Brockmann A, 2006, J CHEM ECOL, V32, P657, DOI 10.1007/s10886-005-9027-2; Buawangpang N, 2009, APIDOLOGIE, V40, P20, DOI 10.1051/apido:2008059; Burgett D. M., 2007, Natural History Bulletin of the Siam Society, V55, P99; Burgett DM, 2005, J APICULT RES, V44, P36, DOI 10.1080/00218839.2005.11101145; CANE JH, 1987, J KANSAS ENTOMOL SOC, V60, P145; Erickson E. H., 1990, Gleanings in Bee Culture, V118, P98; ESSLEN J, 1976, ZOOMORPHOLOGIE, V83, P227, DOI 10.1007/BF00993511; FUJIWARA S, 1994, APIDOLOGIE, V25, P331, DOI 10.1051/apido:19940309; Greiner B, 2006, J COMP NEUROL, V495, P255, DOI 10.1002/cne.20882; Greiner B, 2005, CELL TISSUE RES, V322, P313, DOI 10.1007/s00441-005-0034-y; Greiner B, 2004, CELL TISSUE RES, V316, P377, DOI 10.1007/s00441-004-0883-9; Gries M, 1996, J COMP PHYSIOL A, V179, P539, DOI 10.1007/BF00192319; Groh C, 2008, ARTHROPOD STRUCT DEV, V37, P459, DOI 10.1016/j.asd.2008.04.001; Haddad N, 2012, 5 EURB C HALL GERM; Hadisoesilo S, 1996, APIDOLOGIE, V27, P361, DOI 10.1051/apido:19960504; Hadisoesilo S, 2001, DRONE FLIGHT TIMES A; Hepburn HR, 2011, HONEYBEES OF ASIA, P133, DOI 10.1007/978-3-642-16422-4_7; Hepburn H.R., 1998, HONEYBEES AFRICA; Hepburn HR, 2005, APIDOLOGIE, V36, P359, DOI 10.1051/apido:2005023; Jordan LA, 2007, APIDOLOGIE, V38, P436, DOI 10.1051/apido:2007028; Kapustjanskij A, 2007, FUNCT ECOL, V21, P1130, DOI 10.1111/j.1365-2435.2007.01329.x; Kelber A, 2006, BEHAV ECOL, V17, P63, DOI 10.1093/beheco/arj001; KOENIGER G, 1989, INSECT SOC, V36, P129, DOI 10.1007/BF02225908; Koeniger G, 2000, APIDOLOGIE, V31, P301, DOI 10.1051/apido:2000124; Koeniger G, 2011, HONEYBEES OF ASIA, P159, DOI 10.1007/978-3-642-16422-4_8; Koeniger N, 1996, APIDOLOGIE, V27, P353, DOI 10.1051/apido:19960503; KOENIGER N, 1988, APIDOLOGIE, V19, P103, DOI 10.1051/apido:19880108; Koeniger N, 2000, APIDOLOGIE, V31, P313, DOI 10.1051/apido:2000125; KOENIGER N, 1994, APIDOLOGIE, V25, P249, DOI 10.1051/apido:19940211; KOENIGER N, 1989, APIDOLOGIE, V20, P413, DOI 10.1051/apido:19890506; Koeniger N, 2011, HONEYBEES OF ASIA, P23, DOI 10.1007/978-3-642-16422-4_2; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; LENSKY Y, 1985, COMP BIOCHEM PHYS A, V81, P229, DOI 10.1016/0300-9629(85)90127-6; LOPER GM, 1987, APIDOLOGIE, V18, P163, DOI 10.1051/apido:19870206; LOPER GM, 1992, J KANSAS ENTOMOL SOC, V65, P223; MATHEW KP, 1990, BEE WORLD, V71, P61, DOI 10.1080/0005772X.1990.11099038; MENZEL JG, 1991, TISSUE CELL, V23, P525, DOI 10.1016/0040-8166(91)90010-Q; Michener C. D., 2000, The bees of the world; Nagaraja N, 2009, NATURE PRECEDINGS; Narendra A, 2011, P ROY SOC B-BIOL SCI, V278, P1141, DOI 10.1098/rspb.2010.1378; Narendra A, 2010, P ROY SOC B-BIOL SCI, V277, P1531, DOI 10.1098/rspb.2009.2324; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Oldroyd BP, 2006, INSECT SOC, V53, P428, DOI 10.1007/s00040-005-0889-2; Otis GW, 2000, P 7 INT C TROP BEES, P137; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; PUNCHIHEWA RWK, 1990, APIDOLOGIE, V21, P201, DOI 10.1051/apido:19900305; Radloff SE, 2003, APIDOLOGIE, V34, P353, DOI 10.1051/apido:2003031; RIBI WA, 1989, ENTOMOL GEN, V14, P233; RINDERER TE, 1993, J APICULT RES, V32, P27, DOI 10.1080/00218839.1993.11101284; Ruttner F., 1972, Journal apic Res, V11, P141; Ruttner F., 2003, NATURGESCHICHTE HONI; Sasaki M., 1990, Advances in Invertebrate Reproduction, V5, P503; Seidl R., 1980, VERH ZOOL GESELL, P359; Somanathan H, 2008, J COMP PHYSIOL A, V194, P97, DOI 10.1007/s00359-007-0291-1; Somanathan H, 2009, J EXP BIOL, V212, P2448, DOI 10.1242/jeb.031484; Somanathan H, 2009, J COMP PHYSIOL A, V195, P571, DOI 10.1007/s00359-009-0432-9; Spaethe J, 2003, J EXP BIOL, V206, P3447, DOI 10.1242/jeb.00570; Spaethe J, 2007, NATURWISSENSCHAFTEN, V94, P733, DOI 10.1007/s00114-007-0251-1; STAVENGA DG, 1992, TRENDS NEUROSCI, V15, P213, DOI 10.1016/0166-2236(92)90038-A; TABER STEPHEN, 1964, ANN ENTOMOL SOC AMER, V57, P769; Tan NQ, 1999, APIDOLOGIE, V30, P339, DOI 10.1051/apido:19990410; Tan SJ, 2005, CURR BIOL, V15, pR540, DOI 10.1016/j.cub.2005.07.019; TYCHSEN PH, 1971, J INSECT PHYSIOL, V17, P2139, DOI 10.1016/0022-1910(71)90174-0; UNDERWOOD BA, 1990, APIDOLOGIE, V21, P501, DOI 10.1051/apido:19900602; VALLET AM, 1993, J COMP PHYSIOL A, V172, P183; VANPRAAGH JP, 1980, J COMP PHYSIOL, V136, P263, DOI 10.1007/BF00657542; VERMA L R, 1990, Journal of Insect Science, V3, P130; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Warrant E, 1996, P ROY SOC B-BIOL SCI, V263, P1521, DOI 10.1098/rspb.1996.0222; Warrant E, 2011, ANNU REV ENTOMOL, V56, P239, DOI 10.1146/annurev-ento-120709-144852; Wcislo WT, 2009, BIOL REV, V84, P19, DOI 10.1111/j.1469-185X.2008.00059.x; Winston M.L., 1991, BIOL HONEY BEE; Wongsiri S, 1997, BEE WORLD, V78, P23, DOI 10.1080/0005772X.1997.11099328; Woyke J, 2005, J APICULT RES, V44, P130, DOI 10.1080/00218839.2005.11101165; Woyke J, 2001, APIDOLOGIE, V32, P407, DOI 10.1051/apido:2001140; Woyke J., 1975, Journal apic Res, V14, P153; YOSHIDA T, 1994, APIDOLOGIE, V25, P353, DOI 10.1051/apido:19940401	84	50	51	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57702	10.1371/journal.pone.0057702	http://dx.doi.org/10.1371/journal.pone.0057702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460896	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000315519000151
J	Wong, J; Mehta, V; Voronova, A; Coutu, J; Ryan, T; Shelton, M; Skerjanc, IS				Wong, Jacob; Mehta, Virja; Voronova, Anastassia; Coutu, Josee; Ryan, Tammy; Shelton, Michael; Skerjanc, Ilona S.			beta-catenin Is Essential for Efficient In Vitro Premyogenic Mesoderm Formation but Can Be Partially Compensated by Retinoic Acid Signalling	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; SKELETAL MYOGENESIS; MUSCLE DEVELOPMENT; GENE-EXPRESSION; P19 CELLS; MOUSE EMBRYO; MYOD; SOMITES; FAMILY; EYA2	Previous studies have shown that P19 cells expressing a dominant negative beta-catenin mutant (beta-cat/EnR) cannot undergo myogenic differentiation in the presence or absence of muscle-inducing levels of retinoic acid ( RA). While RA could upregulate premyogenic mesoderm expression, including Pax3/7 and Meox1, only Pax3/7 and Gli2 could be upregulated by RA in the presence of beta-cat/EnR. However, the use of a dominant negative construct that cannot be compensated by other factors is limiting due to the possibility of negative chromatin remodelling overriding compensatory mechanisms. In this study, we set out to determine if beta-catenin function is essential for myogenesis with and without RA, by creating P19 cells with reduced beta-catenin transcriptional activity using an shRNA approach, termed P19[sh beta-cat] cells. The loss of beta-catenin resulted in a reduction of skeletal myogenesis in the absence of RA as early as premyogenic mesoderm, with the loss of Pax3/7, Eya2, Six1, Meox1, Gli2, Foxc1/2, and Sox7 transcript levels. Chromatin immunoprecipitation identified an association of beta-catenin with the promoter region of the Sox7 gene. Differentiation of P19[sh beta-cat] cells in the presence of RA resulted in the upregulation or lack of repression of all of the precursor genes, on day 5 and/or 9, with the exception of Foxc2. However, expression of Sox7, Gli2, the myogenic regulatory factors and terminal differentiation markers remained inhibited on day 9 and overall skeletal myogenesis was reduced. Thus, beta-catenin is essential for in vitro formation of premyogenic mesoderm, leading to skeletal myogenesis. RA can at least partially compensate for the loss of beta-catenin in the expression of many myogenic precursor genes, but not for myoblast gene expression or overall myogenesis.	[Wong, Jacob; Mehta, Virja; Voronova, Anastassia; Coutu, Josee; Ryan, Tammy; Shelton, Michael; Skerjanc, Ilona S.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa	Skerjanc, IS (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	iskerjan@uottawa.ca	Skerjanc, Ilona/AAN-3318-2020; Voronova, Anastassia/GLR-8891-2022	Voronova, Anastassia/0000-0001-7504-1905; Ryan, Tammy/0000-0002-0428-8932	Canadian Institutes of Health Research [MOP-84458]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP-84458; http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Madhoun AS, 2011, EMBO J, V30, P2477, DOI 10.1038/emboj.2011.153; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Brannon M, 1996, DEV BIOL, V180, P344, DOI 10.1006/dbio.1996.0306; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; EDWARDS MKS, 1983, MOL CELL BIOL, V3, P2280, DOI 10.1128/MCB.3.12.2280; FRANZ T, 1993, ANAT EMBRYOL, V187, P153; Galli LM, 2004, DEV BIOL, V269, P489, DOI 10.1016/j.ydbio.2004.01.041; Gianakopoulos PJ, 2011, J BIOL CHEM, V286, P2517, DOI 10.1074/jbc.M110.163709; Grifone R, 2007, DEV BIOL, V302, P602, DOI 10.1016/j.ydbio.2006.08.059; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Ikeya M, 1998, DEVELOPMENT, V125, P4969; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; Kim CH, 2008, MOL CELL BIOL, V28, P2941, DOI 10.1128/MCB.01682-07; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Lagha M, 2009, DEV CELL, V17, P892, DOI 10.1016/j.devcel.2009.10.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; MIURA N, 1993, FEBS LETT, V326, P171, DOI 10.1016/0014-5793(93)81785-X; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Oliver G, 1995, DEVELOPMENT, V121, P4045; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Petropoulos H, 2004, J BIOL CHEM, V279, P23874, DOI 10.1074/jbc.M312612200; Petropoulos H, 2002, J BIOL CHEM, V277, P15393, DOI 10.1074/jbc.M112141200; Reijntjes S, 2007, INT J DEV BIOL, V51, P753, DOI 10.1387/ijdb.072332sr; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; ROSSANT J, 1982, J EMBRYOL EXP MORPH, V70, P99; Ryan T, 2012, STEM CELL REV REP, V8, P482, DOI 10.1007/s12015-011-9284-0; SASAKI H, 1993, DEVELOPMENT, V118, P47; Savage J, 2010, DIFFERENTIATION, V79, P31, DOI 10.1016/j.diff.2009.08.008; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Shi DL, 2002, DEV BIOL, V245, P124, DOI 10.1006/dbio.2002.0633; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; VIDRICAIRE G, 1994, DEVELOPMENT, V120, P115; Voronova A, 2013, J BIOL CHEM, V288, P4389, DOI 10.1074/jbc.M112.400184; Voronova A, 2012, NUCLEIC ACIDS RES, V40, P3329, DOI 10.1093/nar/gkr1232; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; Wilm B, 2004, DEV BIOL, V271, P176, DOI 10.1016/j.ydbio.2004.03.034; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhang C, 2005, DEV BIOL, V278, P526, DOI 10.1016/j.ydbio.2004.11.008	52	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57501	10.1371/journal.pone.0057501	http://dx.doi.org/10.1371/journal.pone.0057501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460868	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000123
J	Wright, AJ; Maar, M; Mohn, C; Nabe-Nielsen, J; Siebert, U; Jensen, LF; Baagoe, HJ; Teilmann, J				Wright, Andrew J.; Maar, Marie; Mohn, Christian; Nabe-Nielsen, Jacob; Siebert, Ursula; Jensen, Lasse Fast; Baagoe, Hans J.; Teilmann, Jonas			Possible Causes of a Harbour Porpoise Mass Stranding in Danish Waters in 2005	PLOS ONE			English	Article							PHYSETER-MACROCEPHALUS STRANDINGS; PHOCOENA-PHOCOENA; NORTH-SEA; POSTMORTEM FINDINGS; WHALE STRANDINGS; GERMAN WATERS; CETACEANS; SONAR; COASTLINES; MORTALITY	An unprecedented 85 harbour porpoises stranded freshly dead along approximately 100 km of Danish coastline from 7-15 April, 2005. This total is considerably above the mean weekly stranding rate for the whole of Denmark, both for any time of year, 1.23 animals/week (ranging from 0 to 20 during 2003-2008, excluding April 2005), and specifically in April, 0.65 animals/week (0 to 4, same period). Bycatch was established as the cause of death for most of the individuals through typical indications of fisheries interactions, including net markings in the skin and around the flippers, and loss of tail flukes. Local fishermen confirmed unusually large porpoise bycatch in nets set for lumpfish (Cyclopterus lumpus) and the strandings were attributed to an early lumpfish season. However, lumpfish catches for 2005 were not unusual in terms of season onset, peak or total catch, when compared to 2003-2008. Consequently, human activity was combined with environmental factors and the variation in Danish fisheries landings (determined through a principal component analysis) in a two-part statistical model to assess the correlation of these factors with both the presence of fresh strandings and the numbers of strandings on the Danish west coast. The final statistical model (which was forward selected using Akaike information criterion; AIC) indicated that naval presence is correlated with higher rates of porpoise strandings, particularly in combination with certain fisheries, although it is not correlated with the actual presence of strandings. Military vessels from various countries were confirmed in the area from the 7th April, en route to the largest naval exercise in Danish waters to date (Loyal Mariner 2005, 11-28 April). Although sonar usage cannot be confirmed, it is likely that ships were testing various equipment prior to the main exercise. Thus naval activity cannot be ruled out as a possible contributing factor.	[Wright, Andrew J.; Maar, Marie; Mohn, Christian; Nabe-Nielsen, Jacob; Teilmann, Jonas] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Siebert, Ursula] Univ Vet Med, Inst Terr & Aquat Wildlife Res, Hannover, Busum, Germany; [Jensen, Lasse Fast] Fisheries & Maritime Museum, Esbjerg V, Denmark; [Baagoe, Hans J.] Univ Copenhagen, Zool Museum, Nat Hist Museum Denmark, DK-2100 Copenhagen, Denmark	Aarhus University; University of Veterinary Medicine Hannover, Foundation; University of Copenhagen	Wright, AJ (corresponding author), Aarhus Univ, Dept Biosci, Roskilde, Denmark.	marinebrit@gmail.com	Wright, Andrew/HDM-9615-2022; Teilmann, Jonas/J-7828-2013; Maar, Marie/C-5837-2008; Mohn, Christian/F-3468-2011; Nabe-Nielsen, Jacob/A-5891-2010	Teilmann, Jonas/0000-0002-4376-4700; Maar, Marie/0000-0001-8594-2993; Mohn, Christian/0000-0002-4331-1365; Nabe-Nielsen, Jacob/0000-0002-0716-9525; Wright, Andrew/0000-0002-8718-8143	Aarhus University; Danish research school SNAK; Carlsberg Foundation; SNAK Ph.D. school	Aarhus University; Danish research school SNAK; Carlsberg Foundation(Carlsberg Foundation); SNAK Ph.D. school	This work formed part of the lead author's PhD, which was funded by the Aarhus University (http://www.au.dk/), the Danish research school SNAK (http://www.snak.biology.sdu.dk/) and the Carlsberg Foundation (http://www.carlsbergfondet.dk/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The work contained in this paper formed part of the lead author's Ph.D., which was funded by Aarhus University, the Carlsberg Foundation, and the SNAK Ph.D. school. Many thanks to Sidsel B. Meier (Danish Directorate of Fisheries) & Majbritt Aminde (Danish Meteorological Institute; DMI) for supplying raw data. Thanks also go to the Danish Nature Agency for their role in the strandings network, as well as all those who have collected strandings data and/or carcases on their behalf. Many thanks to Zhenwen Wan (DMI) for providing the DMI-BSHcmod model data. Thanks also to Jakob Tougaard (AU) for obtaining seismic survey information and Daniel Spelling Clausen for producing the map of strandings. Thanks are also due to David Hathaway (NASA), Klaus Vanselow (Kiel University) and Claudia Stolle (DTU), for assistance with locating appropriate data on solar cycles, solar activity and geomagnetic fields, as well as Peter H. Voss (GEUS) and Maureen Aspinwall (ISC) for their help locating earthquake information. Special thanks are due to Donald Hurlbert and James Di Loreto (Smithsonian Institution), and Juana Jacobsen and Kathe Mogelvang (AU) for helping to format the figures appropriately. Finally, thanks to Leslie Walsh and three anonymous reviewers for their helpful comments on earlier versions of this manuscript.	Baird Robin W., 1995, Reports of the International Whaling Commission Special Issue, V16, P159; BAKER JR, 1992, VET REC, V130, P554, DOI 10.1136/vr.130.25.554; Bouquegneau J. M., 1997, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V67, P75; Breland K., 1966, ANIMAL BEHAV; Buscaino G, 2009, FISHERIES SCI, V75, P537, DOI 10.1007/s12562-009-0059-3; Chan AAYH, 2010, ANIM BEHAV, V80, P1075, DOI 10.1016/j.anbehav.2010.09.025; Chan AAYH, 2010, BIOL LETTERS, V6, P458, DOI 10.1098/rsbl.2009.1081; CLAUSEN B, 1988, Danish Review of Game Biology, V13, P1; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; Culik BM, 2001, MAR ECOL PROG SER, V211, P255, DOI 10.3354/meps211255; D'Amico Angela, 2009, Aquatic Mammals, V35, P452, DOI 10.1578/AM.35.4.2009.452; Dudok van Heel W. H., 1966, WHALES DOLPHINS PORP, P597; Dukas R, 2004, BRAIN BEHAV EVOLUT, V63, P197, DOI 10.1159/000076781; Evans D.L., 2001, JOINT INTERIM REPORT; Fernandez A, 2005, VET PATHOL, V42, P446, DOI 10.1354/vp.42-4-446; Filadelfo Ronald, 2009, Aquatic Mammals, V35, P445, DOI 10.1578/AM.35.4.2009.445; Filadelfo Ronald, 2009, Aquatic Mammals, V35, P435, DOI 10.1578/AM.35.4.2009.435; FRANSE R., 2005, EFFECTIVENESS ACOUST; Gonener S, 2009, TURK J FISH AQUAT SC, V9, P151, DOI 10.4194/trjfas.2009.0205; Haelters J., 2009, HARBOUR PORPOISE SO; Hamer DJ, 2010, SC62BC3 IWC; Harkonen T, 2008, VET REC, V162, P555, DOI 10.1136/vr.162.17.555; Hathaway DH, 2010, LIVING REV SOL PHYS, V7, DOI 10.12942/lrsp-2010-1; Hildebrand J, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P101; Hildebrand J. A, 2005, J CETACEAN RES MAN S, V7, P284; Hooker SK, 2012, P ROY SOC B-BIOL SCI, V279, P1041, DOI 10.1098/rspb.2011.2088; International Seismological Centre, 2010, ON LIN B INT SEIS CE; Jauniaux T., 1997, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V67, P63; Jauniaux T, 2002, J COMP PATHOL, V126, P243, DOI 10.1053/jcpa.2001.0547; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Jepson PD, 2005, ENVIRON TOXICOL CHEM, V24, P238, DOI 10.1897/03-663.1; Jepson PD, 2000, VET REC, V146, P721, DOI 10.1136/vr.146.25.721; Jepson PD, 2009, INVESTIGATION COMMON; Jepson PD, 2006, POSTMORTEM RES FEASI; Johnston DW, 2005, MAR ECOL PROG SER, V295, P279, DOI 10.3354/meps295279; Joiris Claude R., 1997, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V67, P69; Jolliffe I.T., 1986, PRINCIPAL COMPONENT, P487, DOI [DOI 10.1007/B98835, 10.1007/978-1-4757-1904-8_8]; KLINOWSKA M, 1988, J NAVIGATION, V41, P52, DOI 10.1017/S037346330000905X; Kuiken M, 1993, EUROPEAN CETACEAN SO, V17; Lambertsen Richard H., 1997, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V67, P105; Maar M, 2011, ECOL MODEL, V222, P1696, DOI 10.1016/j.ecolmodel.2011.03.006; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; Mazzariol S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019417; McCarthy E, 2011, MAR MAMMAL SCI, V27, pE206, DOI 10.1111/j.1748-7692.2010.00457.x; Mignucci-Giannoni AA, 2000, J MAR BIOL ASSOC UK, V80, P759, DOI 10.1017/S0025315499002702; Muller G, 2000, VET MICROBIOL, V75, P17, DOI 10.1016/S0378-1135(00)00209-1; Nieukirk SL, 2012, J ACOUST SOC AM, V131, P1102, DOI 10.1121/1.3672648; Norman SA, 2004, NOAA TECH MEMO NMFS; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Nowacek DP, 2004, P ROY SOC B-BIOL SCI, V271, P227, DOI 10.1098/rspb.2003.2570; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Orphanides CD, 2009, 0914 US DEP COMM NE; Parsons ECM, 2008, MAR POLLUT BULL, V56, P1248, DOI 10.1016/j.marpolbul.2008.04.025; Peltier H, 2012, ECOL INDIC, V18, P278, DOI 10.1016/j.ecolind.2011.11.014; Purser J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017478; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Ross A, 2004, NET EFFECT REV CETAC; Ross HM, 1996, P ROY SOC B-BIOL SCI, V263, P283, DOI 10.1098/rspb.1996.0043; SCANS-II, 2008, SMALL CET EUR ATL N; Siebert U, 2009, J APPL MICROBIOL, V106, P329, DOI 10.1111/j.1365-2672.2008.04006.x; Siebert U, 1999, MAR POLLUT BULL, V38, P285, DOI 10.1016/S0025-326X(98)00147-7; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; Siebert U, 2006, J SEA RES, V56, P65, DOI 10.1016/j.seares.2006.01.003; Siemers BM, 2011, P ROY SOC B-BIOL SCI, V278, P1646, DOI 10.1098/rspb.2010.2262; Southall Brandon L., 2007, Aquatic Mammals, V33, pI; Sveegaard S, 2012, MAR BIOL, V159, P1029, DOI 10.1007/s00227-012-1883-z; Sveegaard S, 2011, MAR MAMMAL SCI, V27, P230, DOI 10.1111/j.1748-7692.2010.00379.x; Swenshon M, 1998, J CLIN MICROBIOL, V36, P1902, DOI 10.1128/JCM.36.7.1902-1906.1998; Teilmann J, 2006, MAR MAMMAL SCI, V22, P240, DOI 10.1111/j.1748-7692.2006.00031.x; Todd S, 1996, CAN J ZOOL, V74, P1661, DOI 10.1139/z96-184; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; Vanselow KH, 2005, J SEA RES, V53, P319, DOI 10.1016/j.seares.2004.07.006; Vanselow Klaus Heinrich, 2009, Open Marine Biology Journal, V3, P89; Vinther Morten, 2004, Journal of Cetacean Research and Management, V6, P19; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; Weir Caroline R., 2000, European Research on Cetaceans, V14, P61; Wobeser G.A., 1994, INVESTIGATION MANAGE; Wood F.G., 1979, P129; Wright AJ, 2005, MAR MAMMAL SCI, V21, P145, DOI 10.1111/j.1748-7692.2005.tb01214.x; Wunschmann A, 2001, VET REC, V148, P715, DOI 10.1136/vr.148.23.715	84	19	19	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55553	10.1371/journal.pone.0055553	http://dx.doi.org/10.1371/journal.pone.0055553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460787	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000010
J	McCracken, JP; Schwartz, J; Diaz, A; Bruce, N; Smith, KR				McCracken, John P.; Schwartz, Joel; Diaz, Anaite; Bruce, Nigel; Smith, Kirk R.			Longitudinal Relationship between Personal CO and Personal PM2.5 among Women Cooking with Woodfired Cookstoves in Guatemala	PLOS ONE			English	Article							INDOOR AIR-POLLUTION; WOOD SMOKE EXPOSURE; PARTICULATE MATTER; CARBON-MONOXIDE; BIOMASS COMBUSTION; HIGHLAND GUATEMALA; STOVES; CHILDREN; INTERVENTION; REDUCTION	Household air pollution (HAP) due to solid fuel use is a major public health threat in low-income countries. Most health effects are thought to be related to exposure to the fine particulate matter (PM) component of HAP, but it is currently impractical to measure personal exposure to PM in large studies. Carbon monoxide (CO) has been shown in cross-sectional analyses to be a reliable surrogate for particles <2.5 mu m in diameter (PM2.5) in kitchens where wood-burning cookfires are a dominant source, but it is unknown whether a similar PM2.5-CO relationship exists for personal exposures longitudinally. We repeatedly measured (216 measures, 116 women) 24-hour personal PM2.5 (median [IQR] = 0.11 [0.05, 0.21] mg/m(3)) and CO (median [IQR] = 1.18 [0.50, 2.37] mg/m(3)) among women cooking over open woodfires or chimney woodstoves in Guatemala. Pollution measures were natural-log transformed for analyses. In linear mixed effects models with random subject intercepts, we found that personal CO explained 78% of between-subject variance in personal PM2.5. We did not see a difference in slope by stove type. This work provides evidence that in settings where there is a dominant source of biomass combustion, repeated measures of personal CO can be used as a reliable surrogate for an individual's PM2.5 exposure. This finding has important implications for the feasibility of reliably estimating long-term (months to years) PM2.5 exposure in large-scale epidemiological and intervention studies of HAP.	[McCracken, John P.; Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Diaz, Anaite] Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala; [Bruce, Nigel] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Smith, Kirk R.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Harvard University; Harvard T.H. Chan School of Public Health; Universidad del Valle de Guatemala; University of Liverpool; University of California System; University of California Berkeley	Smith, KR (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	krksmith@berkeley.edu			National Institutes of Health [R01ES010178, P01-ES09825, T-32 ES07069-25, ES-0002, ES015172]; World Health Organization; U.S. Environmental Protection Agency [R827353, R832416]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007069, R01ES010178, P30ES000002, P01ES009825, R01ES015172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Health Organization(World Health Organization); U.S. Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (grants R01ES010178, P01-ES09825, T-32 ES07069-25, ES-0002, and ES015172), the World Health Organization, and the U.S. Environmental Protection Agency (grants R827353 and R832416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan K, 2011, GLOBAL HLTH ACTION, V4; Baumgartner J, 2011, INDOOR AIR, V21, P479, DOI 10.1111/j.1600-0668.2011.00730.x; Bruce N, 2004, J EXPO ANAL ENV EPID, V14, pS26, DOI 10.1038/sj.jea.7500355; Cynthia AA, 2008, INDOOR AIR, V18, P93, DOI 10.1111/j.1600-0668.2007.00509.x; Dionisio KL, 2012, ENVIRON SCI TECHNOL, V46, P3519, DOI 10.1021/es203047e; Ezzati M, 2000, ENVIRON HEALTH PERSP, V108, P833, DOI 10.2307/3434990; McCracken J, 2011, ENVIRON HEALTH PERSP, V119, P1562, DOI 10.1289/ehp.1002834; McCracken JP, 2007, ENVIRON HEALTH PERSP, V115, P996, DOI 10.1289/ehp.9888; Naeher LP, 2000, INDOOR AIR, V10, P200; Naeher LP, 2001, ENVIRON SCI TECHNOL, V35, P575, DOI 10.1021/es991225g; Northcross A, 2010, J ENVIRON MONITOR, V12, P873, DOI 10.1039/b916068j; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; Smith K, 2003, STRAD, V114, P279; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Smith KR, 2010, ENVIRON HEALTH PERSP, V118, P1643, DOI 10.1289/ehp.1002517; Smith KR, 2000, ANNU REV ENERG ENV, V25, P741, DOI 10.1146/annurev.energy.25.1.741; Smith KR., 1987, BIOFUELS AIR POLLUTI; Wallington TJ, 2008, METEOROL Z, V17, P109, DOI 10.1127/0941-2948/2008/0275; Zuk M, 2007, J EXPO SCI ENV EPID, V17, P224, DOI 10.1038/sj.jes.7500499	20	55	55	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e55670	10.1371/journal.pone.0055670	http://dx.doi.org/10.1371/journal.pone.0055670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468847	gold, Green Published			2022-12-27	WOS:000315561400004
J	Eckler, AM; Wilder, C; Castanon, A; Ferris, VM; Lamere, RA; Perrin, BA; Pearlman, R; White, B; Byrd, C; Ludvik, N; Nichols, N; Poole-Sumrall, K; Sztul, E; Styers, ML				Eckler, Alan M.; Wilder, Caroline; Castanon, Antonio; Ferris, Veronica M.; Lamere, Rachael A.; Perrin, Benjamin A.; Pearlman, Ross; White, Blaise; Byrd, Clifton; Ludvik, Nicholas; Nichols, Nona; Poole-Sumrall, Kristen; Sztul, Elizabeth; Styers, Melanie L.			Haploinsufficiency of the Sec7 Guanine Nucleotide Exchange Factor Gea1 Impairs Septation in Fission Yeast	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; TRANS-GOLGI NETWORK; AFFECTS MEMBRANE TRAFFICKING; CELL-WALL INTEGRITY; BREFELDIN-A; SCHIZOSACCHAROMYCES-POMBE; ENDOPLASMIC-RETICULUM; ARF PROTEINS; DISTINCT PHENOTYPES; SYNTHASE SUBUNIT	Membrane trafficking is essential to eukaryotic life and is controlled by a complex network of proteins that regulate movement of proteins and lipids between organelles. The GBF1/GEA family of Guanine nucleotide Exchange Factors (GEFs) regulates trafficking between the endoplasmic reticulum and Golgi by catalyzing the exchange of GDP for GTP on ADP Ribosylation Factors (Arfs). Activated Arfs recruit coat protein complex 1 (COP-/I) to form vesicles that ferry cargo between these organelles. To further explore the function of the GBF1/GEA family, we have characterized a fission yeast mutant lacking one copy of the essential gene gea1 (gea1+/-), the Schizosaccharomyces pombe ortholog of GBF1. The haploinsufficient gea1+/- strain was shown to be sensitive to the GBF1 inhibitor brefeldin A (BFA) and was rescued from BFA sensitivity by gea1p overexpression. No overt defects in localization of arf1p or arf6p were observed in gea1+/- cells, but the fission yeast homolog of the COP-/I cargo sac1 was mislocalized, consistent with impaired COP-/I trafficking. Although Golgi morphology appeared normal, a slight increase in vacuolar size was observed in the gea1+/- mutant strain. Importantly, gea1+/- cells exhibited dramatic cytokinesis-/related defects, including disorganized contractile rings, an increased septation index, and alterations in septum morphology. Septation defects appear to result from altered secretion of enzymes required for septum dynamics, as decreased secretion of eng1p, a beta-/glucanase required for septum breakdown, was observed in gea1+/- cells, and overexpression of eng1p suppressed the increased septation phenotype. These observations implicate gea1 in regulation of septum breakdown and establish S. pombe as a model system to explore GBF1/GEA function in cytokinesis.	[Eckler, Alan M.; Wilder, Caroline; Castanon, Antonio; Ferris, Veronica M.; Lamere, Rachael A.; Perrin, Benjamin A.; Pearlman, Ross; White, Blaise; Byrd, Clifton; Ludvik, Nicholas; Nichols, Nona; Poole-Sumrall, Kristen; Styers, Melanie L.] Birmingham Southern Coll, Dept Biol, Birmingham, AL USA; [Sztul, Elizabeth] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Styers, ML (corresponding author), Birmingham Southern Coll, Dept Biol, Birmingham, AL USA.	mstyers@bsc.edu						ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711; Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BALCH WE, 1992, J BIOL CHEM, V267, P13053; Boal F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009898; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; BOMAN AL, 1995, TRENDS BIOCHEM SCI, V20, P147, DOI 10.1016/S0968-0004(00)88991-4; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Bui QT, 2009, MOL GENET GENOMICS, V282, P329, DOI 10.1007/s00438-009-0473-3; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Cherfils J, 2005, BIOCHEM SOC T, V33, P635, DOI 10.1042/BST0330635; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; Codlin S, 2008, TRAFFIC, V9, P936, DOI 10.1111/j.1600-0854.2008.00735.x; Cortes JCG, 2002, J CELL SCI, V115, P4081, DOI 10.1242/jcs.00085; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Dekker N, 2004, MOL BIOL CELL, V15, P3903, DOI 10.1091/mbc.E04-04-0319; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; Dumaresq-Doiron K, 2010, J CELL SCI, V123, P2273, DOI 10.1242/jcs.055798; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; GOLDSTEIN JL, 1976, CURR TOP CELL REGUL, V11, P147; Gould KL, 1997, GENE DEV, V11, P2939, DOI 10.1101/gad.11.22.2939; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Holloway ZG, 2007, AM J PHYSIOL-CELL PH, V293, pC1753, DOI 10.1152/ajpcell.00253.2007; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Kita A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016842; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kondo Y, 2012, CELL STRUCT FUNCT, V37, P141, DOI 10.1247/csf.12015; Krapp A, 2004, CURR BIOL, V14, pR722, DOI 10.1016/j.cub.2004.08.049; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; KTISTAKIS NT, 1995, MOL BIOL CELL, V6, P135, DOI 10.1091/mbc.6.2.135; Le Goff X, 1999, CURR GENET, V35, P571, DOI 10.1007/s002940050455; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lefrancois P, 2007, TRAFFIC, V8, P1440, DOI 10.1111/j.1600-0854.2007.00623.x; Li YW, 2004, FASEB J, V18, P1834, DOI 10.1096/fj.04-2273com; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Lippincott-Schwartz J, 1998, HISTOCHEM CELL BIOL, V109, P449, DOI 10.1007/s004180050247; Liu JH, 1999, GENETICS, V153, P1193; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; MARKS J, 1985, EUR J CELL BIOL, V39, P27; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Matsuyama A, 2009, METHODS MOL BIOL, V577, P11, DOI 10.1007/978-1-60761-232-2_2; Mayinger P, 2011, COLD SPRING HARB PER, V3, P1; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; MITCHISON JM, 1985, J CELL SCI, V75, P357; MITCHISON JM, 1969, J CELL SCI, V5, P373; Miyatake M, 2007, GENETICS, V175, P1695, DOI 10.1534/genetics.107.070946; Morinaga N, 1999, J BIOL CHEM, V274, P17417, DOI 10.1074/jbc.274.25.17417; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Morohashi Y, 2010, BIOCHEM J, V427, P401, DOI 10.1042/BJ20091681; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Nelson NJ, 1955, METHOD ENZYMOL, V3, P85; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Park JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006179; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Peyroche A, 2001, J CELL SCI, V114, P2241; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; REGAZZI R, 1991, BIOCHEM J, V275, P639, DOI 10.1042/bj2750639; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Rothman JE, 1996, PROTEIN SCI, V5, P185; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; SANSEGUNDO P, 1993, J BACTERIOL, V175, P3823, DOI 10.1128/JB.175.12.3823-3837.1993; Santos B, 2005, EUKARYOT CELL, V4, P1639, DOI 10.1128/EC.4.10.1639-1645.2005; Santos B, 2003, EUKARYOT CELL, V2, P521, DOI 10.1128/EC.2.3.521-533.2003; Sata M, 1998, P NATL ACAD SCI USA, V95, P4204, DOI 10.1073/pnas.95.8.4204; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Shima DT, 1999, CURR BIOL, V9, P821, DOI 10.1016/S0960-9822(99)80365-0; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Shuster CB, 2002, P NATL ACAD SCI USA, V99, P3633, DOI 10.1073/pnas.052342699; Sipiczki M, 2007, FEMS YEAST RES, V7, P761, DOI 10.1111/j.1567-1364.2007.00266.x; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035; Spang A, 2010, FEBS LETT, V584, P2646, DOI 10.1016/j.febslet.2010.04.005; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; Styers ML, 2008, AM J PHYSIOL-CELL PH, V294, pC1485, DOI 10.1152/ajpcell.00010.2008; Suda Y, 2011, YEAST GOLGI APPARATU; Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769; Szul Tomasz, 2011, Cell Logist, V1, P69; Tahirovic S, 2003, CURR GENET, V43, P71, DOI 10.1007/s00294-003-0380-9; TEAL SB, 1994, J BIOL CHEM, V269, P3135; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; TURI TG, 1994, J BIOL CHEM, V269, P24229; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang HY, 2003, GENETICS, V164, P1323; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Wang SS, 2012, J CELL SCI, V125, P461, DOI 10.1242/jcs.092551; YOSHIDA T, 1994, J CELL SCI, V107, P1725; Zakrzewska E, 2003, GENETICS, V165, P985; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200; Zhang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032135; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420	111	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56807	10.1371/journal.pone.0056807	http://dx.doi.org/10.1371/journal.pone.0056807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457617	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700082
J	Maruyama, EO; Yu, HMI; Jiang, M; Fu, J; Hsu, W				Maruyama, Eri Ohfuchi; Yu, H-M Ivy; Jiang, Ming; Fu, Jiang; Hsu, Wei			Gpr177 Deficiency Impairs Mammary Development and Prohibits Wnt-Induced Tumorigenesis	PLOS ONE			English	Article							CANCER STEM-CELLS; SIGNALING PATHWAY; MOUSE MODELS; BETA-CATENIN; TGF-BETA; EXPRESSION; PROTEINS; GLAND; GENE; TRAFFICKING	Aberrant regulation of the Wnt pathway, essential for various developmental processes, is tightly linked to human breast cancers. By hijacking this evolutionary conserved signaling pathway, cancer cells acquire sustaining proliferation ability, leading to modification of physiologic properties necessary for tumor initiation and progression. An enormous wealth of knowledge on the importance of Wnt signaling in breast development and cancer has been obtained, but the cell types responsible for production of this proliferative signal operating within normal and malignant tissues remains poorly understood. Here we report that Wnt production mediated by Gpr177 is essential for mammary morphogenesis. The loss of Gpr177 interferes with mammary stem cells, leading to deficiencies in cell proliferation and differentiation. Genetic analysis further demonstrates an indispensable role of Gpr177 in Wnt-induced tumorigenesis. The Gpr177-deficiency mice are resistant to malignant transformation. This study not only demonstrates the necessity of Wnt in mammary organogenesis but also provides a proof-of-principle for targeting of Gpr177 as a potential new treatment for human diseases with aberrant Wnt stimulation.	[Maruyama, Eri Ohfuchi; Yu, H-M Ivy; Jiang, Ming; Fu, Jiang; Hsu, Wei] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Biomed Genet,Ctr Oral Biol, Rochester, NY 14642 USA	University of Rochester	Hsu, W (corresponding author), Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Biomed Genet,Ctr Oral Biol, Rochester, NY 14642 USA.	Wei_Hsu@urmc.rochester.edu	Hsu, Wei/ABG-6856-2021	Hsu, Wei/0000-0001-6738-6030; Maruyama, Eri/0000-0003-3797-2754	National Institutes of Health [CA106308]; USAMRMC Breast Cancer Research Program [W81XWH-07-1-0405]; NATIONAL CANCER INSTITUTE [R01CA106308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAMRMC Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by National Institutes of Health grant CA106308 and USAMRMC Breast Cancer Research Program grant W81XWH-07-1-0405 to W.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bai LX, 2010, GENE DEV, V24, P1882, DOI 10.1101/gad.1932810; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Ching W, 2006, CELL, V125, P432, DOI 10.1016/j.cell.2006.04.018; Chiu SY, 2008, PLOS BIOL, V6, P2801, DOI 10.1371/journal.pbio.0060310; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Fu J, 2012, J INVEST DERMATOL; Fu JA, 2011, DEV DYNAM, V240, P365, DOI 10.1002/dvdy.22541; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Hsu W, 2001, J CELL BIOL, V155, P1055, DOI 10.1083/jcb.200107066; Hsu W, 2010, DEV DYNAM, V239, P338, DOI 10.1002/dvdy.22044; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jiang M, 2010, CELL DEATH DIFFER; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liu B, 2008, NEOPLASIA, V10, P1004, DOI 10.1593/neo.08548; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maruyama T., 2012, J BONE MINER RES; Maruyama T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000727; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Miraoui H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146re9; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Willert K, 2003, NATURE; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Yu HMI, 2005, P NATL ACAD SCI USA, V102, P8615, DOI 10.1073/pnas.0500124102; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Yu HMI, 2010, DEV DYNAM, V239, P2102, DOI 10.1002/dvdy.22336; Yu HMI, 2007, MECH DEVELOP, V124, P146, DOI 10.1016/j.mod.2006.10.002; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	53	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56644	10.1371/journal.pone.0056644	http://dx.doi.org/10.1371/journal.pone.0056644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457599	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700070
J	Yan, SM; Tang, JJ; Huang, CY; Xi, SY; Huang, MY; Liang, JZ; Jiang, YX; Li, YH; Zhou, ZW; Ernberg, I; Wu, QL; Du, ZM				Yan, Shu-Mei; Tang, Jian-Jun; Huang, Chun-Yu; Xi, Shao-Yan; Huang, Ma-Yan; Liang, Jian-Zhong; Jiang, Yuan-Xue; Li, Yu-Hong; Zhou, Zhi-Wei; Ernberg, Ingemar; Wu, Qiu-Liang; Du, Zi-Ming			Reduced Expression of ZDHHC2 Is Associated with Lymph Node Metastasis and Poor Prognosis in Gastric Adenocarcinoma	PLOS ONE			English	Article							ANTIPROLIFERATIVE FACTOR; TUMOR-SUPPRESSOR; ALLELIC LOSS; INTERSTITIAL CYSTITIS; CANCER METASTASIS; SHORT ARM; PALMITOYLATION; IDENTIFICATION; CHROMOSOME-8; DELETION	Background: Zinc finger, DHHC-type containing 2 (ZDHHC2), originally named as reduced expression associated with metastasis protein (REAM), has been proposed as a putative tumor/metastasis suppressor gene and is often aberrantly decreased in human cancers. However ZDHHC2 expression pattern and its clinical significance have not yet been investigated in gastric adenocarcinoma. Methodology/Principal Findings: Quantitative Real-Time PCR (qRT-PCR) and immunostaining were performed to detect ZDHHC2 expression in gastric adenocarcinoma, and then the correlation between ZDHHC2 expression and clinicpathologic parameters, and patient survival was analyzed. Compared to the adjacent normal tissues, ZDHHC2 expression was significantly reduced in gastric tumor tissues as shown by qRT-PCR and immunostaining. Low expression of ZDHHC2 was observed in 44.7% (211/472) of gastric adenocarcinoma patients, and was associated significantly with lymph node metastasis (p<0.001) and histological grade (p<0.001). Multivariate Cox regression analysis indicated that ZDHHC2 expression had a significant, independent predictive value for survival of gastric cancer patients (HR = 0.627, p = 0.001). Conclusions/Significance: Our data suggest that reduced ZDHHC2 expression is associated with lymph node metastasis and independently predicts an unfavorable prognosis in gastric adenocarcinoma patients.	[Yan, Shu-Mei; Xi, Shao-Yan; Huang, Ma-Yan; Liang, Jian-Zhong; Wu, Qiu-Liang; Du, Zi-Ming] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Yan, Shu-Mei; Xi, Shao-Yan; Huang, Ma-Yan; Liang, Jian-Zhong; Wu, Qiu-Liang; Du, Zi-Ming] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Chun-Yu; Zhou, Zhi-Wei] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Yuan-Xue; Li, Yu-Hong] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Jian-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Ernberg, Ingemar] Karolinska Inst, Dept Microbiolgy Tumor & Cell Biol, Stockholm, Sweden	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Karolinska Institutet	Wu, QL (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	wuql@sysucc.org.cn; duzm@sysucc.org.cn			National Natural Science Foundation of China [81172565, 81202135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81172565 and No. 81202135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbazhagan R, 1998, AM J PATHOL, V152, P815; BOVA GS, 1993, CANCER RES, V53, P3869; Conrads TP, 2006, J BIOL CHEM, V281, P37836, DOI 10.1074/jbc.M604581200; Croxtall JD, 2010, DRUGS, V70, P2259, DOI 10.2165/11205900-000000000-00000; Du ZM, 2009, INT J CANCER, V125, P1832, DOI 10.1002/ijc.24531; EMI M, 1993, GENE CHROMOSOME CANC, V7, P152, DOI 10.1002/gcc.2870070307; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FUJIWARA Y, 1994, GENE CHROMOSOME CANC, V10, P7, DOI 10.1002/gcc.2870100103; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Giannakis M, 2008, P NATL ACAD SCI USA, V105, P4358, DOI 10.1073/pnas.0800668105; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016; Jia LX, 2011, J BIOL CHEM, V286, P13695, DOI 10.1074/jbc.M110.193763; Kanwal R, 2012, CLIN GENET, V81, P303, DOI 10.1111/j.1399-0004.2011.01809.x; Keay S, 2003, PHYSIOL GENOMICS, V14, P107, DOI 10.1152/physiolgenomics.00055.2003; KNOWLES MA, 1993, ONCOGENE, V8, P1357; Li YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043555; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Nault JC, 2011, SEMIN LIVER DIS, V31, P173, DOI 10.1055/s-0031-1276646; OHATA H, 1993, GENE CHROMOSOME CANC, V7, P85, DOI 10.1002/gcc.2870070204; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Oyama T, 2000, GENE CHROMOSOME CANC, V29, P9, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1001>3.0.CO;2-#; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; Shibata MA, 1999, EMBO J, V18, P2692, DOI 10.1093/emboj/18.10.2692; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; Singaraja RR, 2009, CIRC RES, V105, P138, DOI 10.1161/CIRCRESAHA.108.193011; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; STANBRIDGE EJ, 1990, SCIENCE, V247, P12, DOI 10.1126/science.2403692; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024897; Yaremko ML, 1996, GENE CHROMOSOME CANC, V16, P189, DOI 10.1002/(SICI)1098-2264(199607)16:3<189::AID-GCC6>3.0.CO;2-V; Zagouri F, 2011, CANCER TREAT REV, V37, P599, DOI 10.1016/j.ctrv.2011.03.007; Zeidman R, 2011, MOL MEMBR BIOL, V28, P473, DOI 10.3109/09687688.2011.630682; Zhang CO, 2005, J UROLOGY, V174, P2382, DOI 10.1097/01.ju.0000180417.11976.99; Zhang J, 2008, MOL CELL PROTEOMICS, V7, P1378, DOI 10.1074/mcp.M800069-MCP200	44	28	28	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56366	10.1371/journal.pone.0056366	http://dx.doi.org/10.1371/journal.pone.0056366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457560	Green Submitted, gold, Green Published			2022-12-27	WOS:000315603700048
J	Oishi, T; Uezumi, A; Kanaji, A; Yamamoto, N; Yamaguchi, A; Yamada, H; Tsuchida, K				Oishi, Teruyo; Uezumi, Akiyoshi; Kanaji, Arihiko; Yamamoto, Naoki; Yamaguchi, Asami; Yamada, Harumoto; Tsuchida, Kunihiro			Osteogenic Differentiation Capacity of Human Skeletal Muscle-Derived Progenitor Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TOTAL HIP-ARTHROPLASTY; SPINAL-CORD INJURY; HETEROTOPIC OSSIFICATION; SATELLITE CELLS; BONE-FORMATION; ECTOPIC OSSIFICATION; IN-VITRO; IDENTIFICATION; INHIBITION	Heterotopic ossification (HO) is defined as the formation of ectopic bone in soft tissue outside the skeletal tissue. HO is thought to result from aberrant differentiation of osteogenic progenitors within skeletal muscle. However, the precise origin of HO is still unclear. Skeletal muscle contains two kinds of progenitor cells, myogenic progenitors and mesenchymal progenitors. Myogenic and mesenchymal progenitors in human skeletal muscle can be identified as CD56(+) and PDGFR alpha(+) cells, respectively. The purpose of this study was to investigate the osteogenic differentiation potential of human skeletal muscle-derived progenitors. Both CD56(+) cells and PDGFR alpha(+) cells showed comparable osteogenic differentiation potential in vitro. However, in an in vivo ectopic bone formation model, PDGFR alpha(+) cells formed bone-like tissue and showed successful engraftment, while CD56(+) cells did not form bone-like tissue and did not adapt to an osteogenic environment. Immunohistological analysis of human HO sample revealed that many PDGFR alpha(+) cells were localized in proximity to ectopic bone formed in skeletal muscle. MicroRNAs (miRNAs) are known to regulate many biological processes including osteogenic differentiation. We investigated the participation of miRNAs in the osteogenic differentiation of PDGFR alpha(+) cells by using microarray. We identified miRNAs that had not been known to be involved in osteogenesis but showed dramatic changes during osteogenic differentiation of PDGFR alpha(+) cells. Upregulation of miR-146b-5p and -424 and downregulation of miR-7 during osteogenic differentiation of PDGFR alpha(+) cells were confirmed by quantitative real-time RT-PCR. Inhibition of upregulated miRNAs, miR-146b-5p and -424, resulted in the suppression of osteocyte maturation, suggesting that these two miRNAs have the positive role in the osteogenesis of PDGFR alpha(+) cells. Our results suggest that PDGFR alpha(+) cells may be the major source of HO and that the newly identified miRNAs may regulate osteogenic differentiation process of PDGFR alpha(+) cells.	[Oishi, Teruyo; Yamaguchi, Asami; Yamada, Harumoto] Fujita Hlth Univ, Sch Med, Dept Orthopaed Surg, Toyoake, Aichi 47011, Japan; [Oishi, Teruyo; Uezumi, Akiyoshi; Tsuchida, Kunihiro] Fujita Hlth Univ, Div Therapies Intractable Dis, Inst Comprehens Med Sci, Toyoake, Aichi, Japan; [Kanaji, Arihiko] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Yamamoto, Naoki] Fujita Hlth Univ, Lab Mol Biol & Histochem, Joint Res Lab, Toyoake, Aichi, Japan	Fujita Health University; Fujita Health University; Keio University; Fujita Health University	Yamada, H (corresponding author), Fujita Hlth Univ, Sch Med, Dept Orthopaed Surg, Toyoake, Aichi 47011, Japan.	hayamada@fujita-hu.ac.jp	Tsuchida, Kunihiro/A-4501-2012; Yamamoto, Naoki/L-2603-2019; Uezumi, Akiyoshi/ABF-7359-2020	Tsuchida, Kunihiro/0000-0002-3983-5756; Uezumi, Akiyoshi/0000-0003-4294-0116	MEXT [23126527, S1001034]; NCNP [23-5]; Grants-in-Aid for Scientific Research [24590363] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NCNP; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, MEXT (23126527); Intramural Research Grant (23-5) for Neurological and Psychiatric Disorders of NCNP; and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1001034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENGART L, 1991, CLIN ORTHOP RELAT R, P49; Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Banovac K, 2000, J Spinal Cord Med, V23, P40; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; BANOVAC K, 1993, PARAPLEGIA, V31, P660, DOI 10.1038/sc.1993.106; Banovac K, 1997, J Spinal Cord Med, V20, P60; Banovac Kresimir, 2004, J Spinal Cord Med, V27, P376; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Favier B, 2010, FASEB J, V24, P689, DOI 10.1096/fj.09-135194; FIDZIANSKA A, 1995, FOLIA NEUROPATHOL, V33, P125; Flannery SM, 2011, J BIOL CHEM, V286, P23688, DOI 10.1074/jbc.M111.248351; Hardy MP, 2004, J BIOL CHEM, V279, P27699, DOI 10.1074/jbc.M403068200; Hulsmans M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032794; ILLA I, 1992, ANN NEUROL, V31, P46, DOI 10.1002/ana.410310109; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Jackson WM, 2009, J ORTHOP RES, V27, P1645, DOI 10.1002/jor.20924; Kan LX, 2009, STEM CELLS, V27, P150, DOI 10.1634/stemcells.2008-0576; Kaplan FS, 2007, J BONE JOINT SURG AM, V89A, P347, DOI 10.2106/JBJS.F.00472; Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Lecourt S, 2010, EXP CELL RES, V316, P2513, DOI 10.1016/j.yexcr.2010.04.020; Levy MM, 2001, BONE, V29, P317, DOI 10.1016/S8756-3282(01)00585-3; Li GH, 2011, J MOL CELL BIOL, V3, P369, DOI 10.1093/jmcb/mjr014; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lindstrom M, 2009, HISTOCHEM CELL BIOL, V132, P141, DOI 10.1007/s00418-009-0606-0; Mastrogiacomo M, 2005, J CELL PHYSIOL, V204, P594, DOI 10.1002/jcp.20325; Naraghi FF, 1996, ORTHOPEDICS, V19, P145; Nesti LJ, 2008, J BONE JOINT SURG AM, V90A, P2390, DOI 10.2106/JBJS.H.00049; Nilsson Olle S., 1999, Current Opinion in Rheumatology, V11, P127, DOI 10.1097/00002281-199903000-00008; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Otsuru S, 2007, BIOCHEM BIOPH RES CO, V354, P453, DOI 10.1016/j.bbrc.2006.12.226; RITTER MA, 1977, J BONE JOINT SURG AM, V59, P345, DOI 10.2106/00004623-197759030-00009; SCHUBERT W, 1989, P NATL ACAD SCI USA, V86, P307, DOI 10.1073/pnas.86.1.307; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Starkey JD, 2011, J HISTOCHEM CYTOCHEM, V59, P33, DOI 10.1369/jhc.2010.956995; Suda RK, 2009, STEM CELLS, V27, P2209, DOI 10.1002/stem.150; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; THOMAS BJ, 1992, ORTHOP CLIN N AM, V23, P347; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wosczyna MN, 2012, J BONE MINER RES, V27, P1004, DOI 10.1002/jbmr.1562; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210	53	59	60	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56641	10.1371/journal.pone.0056641	http://dx.doi.org/10.1371/journal.pone.0056641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457598	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700088
J	Watamura, SE; Devine, KA; Robertson, SS				Watamura, Sarah Enos; Devine, Katie A.; Robertson, Steven S.			The Dynamics of Attention during Free Looking	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; SPATIAL ATTENTION; TIME-COURSE; SELECTIVE ATTENTION; VISUAL-ATTENTION; SHIFTS; ALLOCATION; EXECUTION; LOCATION; GAIN	Simple methods to study attention dynamics in challenging research and practical applications are limited. We explored the utility of examining attention dynamics during free looking with steady-state visual evoked potentials (SSVEPs), which reflect the effects of attention on early sensory processing. This method can be used with participants who cannot follow verbal instructions and patients without voluntary motor control. In our healthy participants, there were robust fluctuations in the strength of SSVEPs driven by the fixated and non-fixated stimuli (rapidly changing pictures of faces) in the seconds leading up to the moment they chose to shift their gaze to the next stimulus sequence. Furthermore, the amplitude of SSVEPs driven by the fixated stimuli predicted subsequent recognition of individual stimuli. The results illustrate how information about the temporal course of attention during free looking can be obtained with simple methods based on the attentional modulation of SSVEPs.	[Watamura, Sarah Enos] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Devine, Katie A.] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA; [Robertson, Steven S.] Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA	University of Denver; University of Rochester; Cornell University	Robertson, SS (corresponding author), Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA.	ssr4@cornell.edu	Devine, Katie/K-1298-2019	Devine, Katie/0000-0002-1003-8905; Watamura, Sarah/0000-0001-7860-0290	National Institutes of Health (NIH) [R01-HD23814]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023814] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (NIH) grant R01-HD23814 to SSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2008, CLIN NEUROPHYSIOL, V119, P399, DOI 10.1016/j.clinph.2007.09.121; Baldauf D, 2008, EXP BRAIN RES, V184, P411, DOI 10.1007/s00221-007-1114-x; Ballard DH, 1997, BEHAV BRAIN SCI, V20, P723, DOI 10.1017/S0140525X97001611; Belmonte M, 1998, COGNITIVE BRAIN RES, V6, P295, DOI 10.1016/S0926-6410(98)00007-X; Burkitt GR, 2000, CLIN NEUROPHYSIOL, V111, P246, DOI 10.1016/S1388-2457(99)00194-7; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Di Russo F, 2002, CLIN NEUROPHYSIOL, V113, P1771, DOI 10.1016/S1388-2457(02)00262-6; Di Russo F, 2001, VISION RES, V41, P2435, DOI 10.1016/S0042-6989(01)00134-1; Di Russo F, 2007, HUM BRAIN MAPP, V28, P323, DOI 10.1002/hbm.20276; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; Fuchs S, 2008, NEUROIMAGE, V41, P1086, DOI 10.1016/j.neuroimage.2008.02.040; Gersch TM, 2004, VISION RES, V44, P1469, DOI 10.1016/j.visres.2003.12.014; Godijn R, 2003, J EXP PSYCHOL HUMAN, V29, P882, DOI 10.1037/0096-1523.29.5.882; HARVEY LO, 1972, AMER J OPT ARCH AM A, V49, P748; Henderson JM, 1999, PSYCHOL SCI, V10, P438, DOI 10.1111/1467-9280.00183; Hillyard SA, 1997, HUM BRAIN MAPP, V5, P287, DOI 10.1002/(SICI)1097-0193(1997)5:4<287::AID-HBM14>3.0.CO;2-B; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Irwin DE, 1998, VIS COGN, V5, P127, DOI 10.1080/713756783; Kelly SP, 2005, IEEE T BIO-MED ENG, V52, P1588, DOI 10.1109/TBME.2005.851510; Kelly SP, 2005, IEEE T NEUR SYS REH, V13, P172, DOI 10.1109/TNSRE.2005.847369; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Malinowski P, 2007, NEUROSCI LETT, V414, P65, DOI 10.1016/j.neulet.2006.12.001; Middendorf M, 2000, IEEE T REHABIL ENG, V8, P211, DOI 10.1109/86.847819; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Muller MM, 2008, CEREB CORTEX, V18, P1892, DOI 10.1093/cercor/bhm215; Muller MM, 2008, BIOL PSYCHOL, V77, P292, DOI 10.1016/j.biopsycho.2007.11.003; Muller-Putz GR, 2008, IEEE T BIO-MED ENG, V55, P361, DOI 10.1109/TBME.2007.897815; Muller MM, 1997, BRAIN TOPOGR, V9, P163, DOI 10.1007/BF01190385; Muller MM, 2000, CLIN NEUROPHYSIOL, V111, P1544, DOI 10.1016/S1388-2457(00)00371-0; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; Pastor MA, 2003, J NEUROSCI, V23, P11621; Regan D., 1989, HUMAN BRAIN ELECTROP; Robertson SS, 2012, P NATL ACAD SCI USA, V109, P11460, DOI 10.1073/pnas.1203482109; Silberstein Richard B., 1995, P272; Skoczenski AM, 1999, INVEST OPHTH VIS SCI, V40, P2411; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Wu ZH, 2007, BRAIN TOPOGR, V20, P97, DOI 10.1007/s10548-007-0035-0	43	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56428	10.1371/journal.pone.0056428	http://dx.doi.org/10.1371/journal.pone.0056428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457567	gold, Green Submitted, Green Published			2022-12-27	WOS:000315602700072
J	Wongtrakoongate, P; Jones, M; Gokhale, PJ; Andrews, PW				Wongtrakoongate, Patompon; Jones, Mark; Gokhale, Paul J.; Andrews, Peter W.			STELLA Facilitates Differentiation of Germ Cell and Endodermal Lineages of Human Embryonic Stem Cells	PLOS ONE			English	Article							EXPRESSION PATTERNS; DNA DEMETHYLATION; CARCINOMA; LINES; SPECIFICATION; PLURIPOTENCY; ADAPTATION; DERIVATION; DEAMINASE; REVEALS	Stella is a developmentally regulated gene highly expressed in mouse embryonic stem (ES) cells and in primordial germ cells (PGCs). In human, the gene encoding the STELLA homologue lies on chromosome 12p, which is frequently amplified in long-term cultured human ES cells. However, the role played by STELLA in human ES cells has not been reported. In the present study, we show that during retinoic acid (RA)-induced differentiation of human ES cells, expression of STELLA follows that of VASA, a marker of germline differentiation. By contrast, human embryonal carcinoma cells express STELLA at a higher level compared with both karyotypically normal and abnormal human ES cell lines. We found that over-expression of STELLA does not interfere with maintenance of the stem cell state of human ES cells, but following retinoic acid induction it leads to up-regulation of germline- and endodermal-associated genes, whereas neural markers PAX6 and NEUROD1 are down-regulated. Further, STELLA over-expression facilitates the differentiation of human ES cells into BE12-positive cells, in which the expression of germline- and endodermal-associated genes is enriched, and suppresses differentiation of the neural lineage. Taken together, this finding suggests a role for STELLA in facilitating germline and endodermal differentiation of human ES cells.	[Wongtrakoongate, Patompon; Jones, Mark; Gokhale, Paul J.; Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Wongtrakoongate, P (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	p.wongtrakoongate@gmail.com; p.w.andrews@sheffield.ac.uk	Wongtrakoongate, Patompon/M-2021-2019	Andrews, Peter/0000-0001-7215-4410; Wongtrakoongate, Patompon/0000-0001-6070-1843; Gokhale, Paul/0000-0001-7225-4403	Thai government; Royal Thai Government; Medical Research Council	Thai government; Royal Thai Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PW is a PhD student supported by the Thai government. This work was supported by the Royal Thai Government. PWA is supported by a grant from the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Alagaratnam S, 2013, STEM CELLS DEV, V22, P1136, DOI 10.1089/scd.2012.0369; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bortvin Alex, 2004, BMC Developmental Biology, V4; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; de Jong J, 2008, GENE CHROMOSOME CANC, V47, P185, DOI 10.1002/gcc.20520; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Harrison NJ, 2009, STEM CELLS, V27, P1057, DOI 10.1002/stem.41; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Lagarkova MA, 2006, CELL CYCLE, V5, P416, DOI 10.4161/cc.5.4.2440; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; McIntyre A, 2007, BRIT J CANCER, V97, P1707, DOI 10.1038/sj.bjc.6604079; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nettersheim D, 2011, INT J ANDROL, V34, pE189, DOI 10.1111/j.1365-2605.2011.01172.x; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Qu XB, 2008, DEV GROWTH DIFFER, V50, P585, DOI 10.1111/j.1440-169X.2008.01056.x; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tonge PD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010901; Wei W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004013; Wright A, 2011, INT J ANDROL, V34, pE175, DOI 10.1111/j.1365-2605.2011.01185.x; Wu J, 2002, ZYGOTE, V10, P333, DOI 10.1017/S0967199402004070	39	41	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56893	10.1371/journal.pone.0056893	http://dx.doi.org/10.1371/journal.pone.0056893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457636	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000315602700101
J	Blanchin, M; Hardouin, JB; Guillemin, F; Falissard, B; Sebille, V				Blanchin, Myriam; Hardouin, Jean-Benoit; Guillemin, Francis; Falissard, Bruno; Sebille, Veronique			Power and Sample Size Determination for the Group Comparison of Patient-Reported Outcomes with Rasch Family Models	PLOS ONE			English	Article							ITEM RESPONSE THEORY	Background: Patient-reported outcomes (PRO) that comprise all self-reported measures by the patient are important as endpoint in clinical trials and epidemiological studies. Models from the Item Response Theory (IRT) are increasingly used to analyze these particular outcomes that bring into play a latent variable as these outcomes cannot be directly observed. Preliminary developments have been proposed for sample size and power determination for the comparison of PRO in cross-sectional studies comparing two groups of patients when an IRT model is intended to be used for analysis. The objective of this work was to validate these developments in a large number of situations reflecting real-life studies. Methodology: The method to determine the power relies on the characteristics of the latent trait and of the questionnaire (distribution of the items), the difference between the latent variable mean in each group and the variance of this difference estimated using Cramer-Rao bound. Different scenarios were considered to evaluate the impact of the characteristics of the questionnaire and of the variance of the latent trait on performances of the Cramer-Rao method. The power obtained using Cramer-Rao method was compared to simulations. Principal Findings: Powers achieved with the Cramer-Rao method were close to powers obtained from simulations when the questionnaire was suitable for the studied population. Nevertheless, we have shown an underestimation of power with the Cramer-Rao method when the questionnaire was less suitable for the population. Besides, the Cramer-Rao method stays valid whatever the values of the variance of the latent trait. Conclusions: The Cramer-Rao method is adequate to determine the power of a test of group effect at design stage for two-group comparison studies including patient-reported outcomes in health sciences. At the design stage, the questionnaire used to measure the intended PRO should be carefully chosen in relation to the studied population.	[Blanchin, Myriam; Hardouin, Jean-Benoit; Sebille, Veronique] Univ Nantes, EA 4275, Nantes, France; [Guillemin, Francis] Univ Paris 05, Univ Lorraine, EA 4360 Apemac, Nancy, France; [Falissard, Bruno] Univ Paris 11, INSERM 669, Paris, France; [Falissard, Bruno] Univ Paris 05, Paris, France; [Falissard, Bruno] Hop Paul Brousse, AP HP, Dept Sante Publ, Villejuif, France	Nantes Universite; UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Blanchin, M (corresponding author), Univ Nantes, EA 4275, Nantes, France.	blanchin@univ-nantes.fr	Hardouin, Jean-benoit/J-8225-2015; Blanchin, Myriam/D-3169-2019; Blanchin, Myriam/L-8989-2015; Sebille, Veronique/I-3309-2015; Sébille, Véronique/L-8761-2015	Blanchin, Myriam/0000-0003-1318-7620; Sebille, Veronique/0000-0002-0780-7742; Hardouin, Jean-Benoit/0000-0001-8664-623X	French National Research Agency [2010 PRSP 008 01]	French National Research Agency(French National Research Agency (ANR))	This study was supported by the French National Research Agency, under reference N 2010 PRSP 008 01. (http://www.agence-nationale-recherche.fr/programmes-de-recherche/appel-detail/programme-de-recherche-en-sante-publique-prsp-2009/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Acquadro C, 2003, VALUE HEALTH, V6, P522, DOI 10.1046/j.1524-4733.2003.65309.x; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; [Anonymous], 1968, STAT THEORIES MENTAL; BOCK RD, 1981, PSYCHOMETRIKA, V46, P443, DOI 10.1007/BF02293801; Bottomley A, 2009, EUR J CANCER, V45, P347, DOI 10.1016/j.ejca.2008.09.032; Chow SC, 2011, WIRES COMPUT STAT, V3, P414, DOI 10.1002/wics.155; Deshpande Prasanna R, 2011, Perspect Clin Res, V2, P137, DOI 10.4103/2229-3485.86879; Edelen MO, 2007, QUAL LIFE RES, V16, P5, DOI 10.1007/s11136-007-9198-0; Embretson SE, 2000, MULTIVARIATE APPL SE; Fayers PM, 2007, QUAL LIFE RES, V16, P187, DOI 10.1007/s11136-007-9197-1; Fischer G.H., 1995, RASCH MODELS FDN REC; Grunfeld E, 2011, J CLIN ONCOL, V29, P4755, DOI 10.1200/JCO.2011.36.8373; Hardouin JB, 2012, STAT MED, V31, P1277, DOI 10.1002/sim.4387; Holman Rebecca, 2005, Health Qual Life Outcomes, V3, P83, DOI 10.1186/1477-7525-3-83; Linacre J., 1994, RASCH MEASUREMENT T, V7, P328; Rasch G., 1980, PROBABILISTIC MODELS; Reeve BB, 2007, QUAL LIFE RES, V16, P1, DOI 10.1007/s11136-007-9220-6; Sebille V, 2010, BMC MED RES METHODOL, V25, P10; Snyder CF, 2012, QUAL LIFE RES, V21, P1305, DOI 10.1007/s11136-011-0054-x; Verhelst NDG, 1995, RASCH MODELS FDN REC; Watanabe T, 2011, J INT MED RES, V39, P129	23	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57279	10.1371/journal.pone.0057279	http://dx.doi.org/10.1371/journal.pone.0057279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23468955	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900065
J	Roos, S; Dicksved, J; Tarasco, V; Locatelli, E; Ricceri, F; Grandin, U; Savino, F				Roos, Stefan; Dicksved, Johan; Tarasco, Valentina; Locatelli, Emanuela; Ricceri, Fulvio; Grandin, Ulf; Savino, Francesco			454 Pyrosequencing Analysis on Faecal Samples from a Randomized DBPC Trial of Colicky Infants Treated with Lactobacillus reuteri DSM 17938	PLOS ONE			English	Article							GUT MICROBIOTA; MICROFLORA; DIVERSITY; CHILDREN; EUROPE	Objective: To analyze the global microbial composition, using large-scale DNA sequencing of 16 S rRNA genes, in faecal samples from colicky infants given L. reuteri DSM 17938 or placebo. Methods: Twenty-nine colicky infants (age 10-60 days) were enrolled and randomly assigned to receive either Lactobacillus reuteri (10(8) cfu) or a placebo once daily for 21 days. Responders were defined as subjects with a decrease of 50% in daily crying time at day 21 compared with the starting point. The microbiota of faecal samples from day 1 and 21 were analyzed using 454 pyrosequencing. The primers: Bakt_341F and Bakt_805R, complemented with 454 adapters and sample specific barcodes were used for PCR amplification of the 16 S rRNA genes. The structure of the data was explored by using permutational multivariate analysis of variance and effects of different variables were visualized with ordination analysis. Results: The infants' faecal microbiota were composed of Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes as the four main phyla. The composition of the microbiota in infants with colic had very high inter-individual variability with Firmicutes/Bacteroidetes ratios varying from 4000 to 0.025. On an individual basis, the microbiota was, however, relatively stable over time. Treatment with L. reuteri DSM 17938 did not change the global composition of the microbiota, but when comparing responders with non-responders the group responders had an increased relative abundance of the phyla Bacteroidetes and genus Bacteroides at day 21 compared with day 0. Furthermore, the phyla composition of the infants at day 21 could be divided into three enterotype groups, dominated by Firmicutes, Bacteroidetes, and Actinobacteria, respectively. Conclusion: L. reuteri DSM 17938 did not affect the global composition of the microbiota. However, the increase of Bacteroidetes in the responder infants indicated that a decrease in colicky symptoms was linked to changes of the microbiota. Trial Registration: ClinicalTrials.gov NCT00893711.	[Roos, Stefan] Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden; [Tarasco, Valentina; Locatelli, Emanuela; Savino, Francesco] Univ Turin, Dept Pediat, Regina Margherita Children Hosp, I-10124 Turin, Italy; [Ricceri, Fulvio] Human Genet Fdn, Mol & Genet Epidemiol Unit, Turin, Italy; [Dicksved, Johan] Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden; [Grandin, Ulf] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden	Swedish University of Agricultural Sciences; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Savino, F (corresponding author), Univ Turin, Dept Pediat, Regina Margherita Children Hosp, I-10124 Turin, Italy.	francesco.savino@unito.it	Ricceri, Fulvio/I-9910-2018; Savino, Francesco/J-6935-2019	Ricceri, Fulvio/0000-0001-8749-9737; Savino, Francesco/0000-0001-9163-1016; Roos, Stefan/0000-0002-1606-1794; Dicksved, Johan/0000-0002-7515-4480; Grandin, Ulf/0000-0003-0320-0692	University of Turin (Italy)- Dipartimento di Scienze Pediatriche e dell'Adolescenza; Swedish University of Agricultural Sciences, Department of Microbiology, Uppsala, Sweden	University of Turin (Italy)- Dipartimento di Scienze Pediatriche e dell'Adolescenza; Swedish University of Agricultural Sciences, Department of Microbiology, Uppsala, Sweden	This study was supported by the University of Turin (Italy)- Dipartimento di Scienze Pediatriche e dell'Adolescenza and the Swedish University of Agricultural Sciences, Department of Microbiology, Uppsala, Sweden, which both received a donation from the manufacturer of L. reuteri DSM 17938, BioGaia AB, Lund, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Partty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032495; Preidis GA, 2012, FASEB J, V26, P1960, DOI 10.1096/fj.10-177980; Rhoads JM, 2009, J PEDIATR-US, V155, P823, DOI 10.1016/j.jpeds.2009.05.012; Savino F, 2005, ACTA PAEDIATR, V94, P129, DOI 10.1080/08035320510043691; Savino F, 2004, ACTA PAEDIATR, V93, P825, DOI [10.1080/08035250410027625, 10.1111/j.1651-2227.2004.tb03025.x]; Savino F, 2009, ACTA PAEDIATR, V98, P1582, DOI 10.1111/j.1651-2227.2009.01419.x; Savino F, 2007, ACTA PAEDIATR, V96, P1259, DOI 10.1111/j.1651-2227.2007.00428.x; Savino F, 2007, PEDIATRICS, V119, pE124, DOI 10.1542/peds.2006-1222; Savino F, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-157; Savino F, 2010, CURR OPIN PEDIATR, V22, P791, DOI 10.1097/MOP.0b013e32833fac24; Savino F, 2010, PEDIATRICS, V126, pE526, DOI 10.1542/peds.2010-0433; Shimizu K, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01653.x; Szajewska H, 2013, J PEDIATR-US, V162, P257, DOI 10.1016/j.jpeds.2012.08.004; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; WESSEL MA, 1954, PEDIATRICS, V14, P421; Yalcin SS, 2010, PAEDIATR PERINAT EP, V24, P584, DOI 10.1111/j.1365-3016.2010.01150.x	31	73	77	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56710	10.1371/journal.pone.0056710	http://dx.doi.org/10.1371/journal.pone.0056710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468874	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900031
J	Sadeghian, F; Raei, M; Ntani, G; Coggon, D				Sadeghian, Farideh; Raei, Mehdi; Ntani, Georgia; Coggon, David			Predictors of Incident and Persistent Neck/Shoulder Pain in Iranian Workers: A Cohort Study	PLOS ONE			English	Article							CHRONIC WIDESPREAD PAIN; RISK-FACTORS; MUSCULOSKELETAL DISORDERS; NECK PAIN; PERCEIVED DEMANDS; SYMPTOMS; SHOULDER; NURSES; ONSET	Background: Pain in the neck and shoulder has been linked with various psychosocial risk factors, as well as with occupational physical activities. However, most studies to date have been cross-sectional, making it difficult to exclude reverse causation. Moreover, they have been carried out largely in northern Europe, and the relationship to psychosocial factors might be different in other cultural environments. Methods: To explore causes of neck/shoulder pain, we carried out a longitudinal study in Iranian nurses and office workers. Participants (n = 383) completed a baseline questionnaire about neck/shoulder pain in the past month and possible risk factors, and were again asked about pain 12 months later. Associations with pain at follow-up were explored by Poisson regression and summarised by prevalence rate ratios (PRRs). Results: After adjustment for other risk factors, new pain at follow-up was more frequent in office workers than nurses (PRR 1.9, 95% CI 1.3-2.8), among those with worst mental health (PRR 1.8, 95% CI 1.0-3.0), in those who reported incentives from piecework or bonuses (PRR1.4, 95% CI 1.0-2.0), and in those reporting job dissatisfaction (PRR 1.5, 95% CI 1.0-2.1). The strongest predictor of pain persistence was somatising tendency. Conclusions: Our findings are consistent with a hazard of neck/shoulder pain from prolonged use of computer keyboards, although it is possible that the association is modified by health beliefs and expectations. They also indicate that the association of low mood with neck/shoulder pain extends to non-European populations, and is not entirely attributable to reverse causation. Psychosocial aspects of work appeared to have relatively weak impact.	[Sadeghian, Farideh] Shahroud Univ Med Sci, Fac Hlth, Dept Occupat Hlth, Shahroud, Iran; [Raei, Mehdi] Qom Univ Med Sci, Sch Med, Dept Biostat, Qom, Iran; [Ntani, Georgia; Coggon, David] Univ Southampton, Med Res Council Lifecourse Epidemiol Unit, Southampton, Hants, England	Shahroud University Medical Sciences; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Southampton	Coggon, D (corresponding author), Univ Southampton, Med Res Council Lifecourse Epidemiol Unit, Southampton, Hants, England.	dnc@mrc.soton.ac.uk	sadeghian, farideh/N-2607-2019; Raei, Mehdi/S-2232-2017	Raei, Mehdi/0000-0002-5899-4744; Sadeghian, Farideh/0000-0001-7173-6451	Shahroud University of Medical Sciences; Medical Research Council [G0400490, MC_UP_A620_1018] Funding Source: researchfish; MRC [MC_UP_A620_1018, G0400490] Funding Source: UKRI	Shahroud University of Medical Sciences; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the Research Deputy of Shahroud University of Medical Sciences for financial support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Choobineh A, 2006, INT J OCCUP SAF ERGO, V12, P409, DOI 10.1080/10803548.2006.11076699; Choobineh A, 2010, IND HEALTH, V48, P74, DOI 10.2486/indhealth.48.74; Coggon D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039820; Croft PR, 2001, PAIN, V93, P317, DOI 10.1016/S0304-3959(01)00334-7; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Eltayeb S, 2009, J OCCUP REHABIL, V19, P315, DOI 10.1007/s10926-009-9196-x; Gupta A, 2007, RHEUMATOLOGY, V46, P666, DOI 10.1093/rheumatology/kel363; Harcombe H, 2010, INJURY PREV, V16, P96, DOI 10.1136/ip.2009.021766; Hoe VCW, 2012, OCCUP ENVIRON MED, V69, P198, DOI 10.1136/oemed-2011-100302; IJmker S, 2011, OCCUP ENVIRON MED, V68, P502, DOI 10.1136/oem.2010.056267; Kiss P, 2012, INT ARCH OCC ENV HEA, V85, P197, DOI 10.1007/s00420-011-0645-4; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; LEINO P, 1993, PAIN, V53, P89, DOI 10.1016/0304-3959(93)90060-3; Madan I, 2008, INT J EPIDEMIOL, V37, P1181, DOI 10.1093/ije/dyn085; McBeth J, 2001, RHEUMATOLOGY, V40, P95, DOI 10.1093/rheumatology/40.1.95; McBeth J, 2001, ARTHRITIS RHEUM, V44, P940, DOI 10.1002/1529-0131(200104)44:4<940::AID-ANR151>3.0.CO;2-S; Paksaichol A, 2012, OCCUP ENVIRON MED, V69, P610, DOI 10.1136/oemed-2011-100459; Palmer KT, 2007, SCAND J WORK ENV HEA, V33, P165, DOI 10.5271/sjweh.1134; Ryall C, 2006, OCCUP MED-OXFORD, V56, P137, DOI 10.1093/occmed/kqj024; Sobti A, 1997, AM J IND MED, V32, P76, DOI 10.1002/(SICI)1097-0274(199707)32:1<76::AID-AJIM9>3.0.CO;2-P; Viikari-Juntura E, 2001, OCCUP ENVIRON MED, V58, P345, DOI 10.1136/oem.58.5.345; Waersted M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-79; Walker-Bone K, 2005, ANN RHEUM DIS, V64, P1391, DOI 10.1136/ard.2003.020016; Walker-Bone K, 2006, OCCUP MED-OXFORD, V56, P243, DOI 10.1093/occmed/kql016; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	26	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57544	10.1371/journal.pone.0057544	http://dx.doi.org/10.1371/journal.pone.0057544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23469019	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000315524900118
J	Takacs, CN; Hocking, J; Cabeen, MT; Bui, NK; Poggio, S; Vollmer, W; Jacobs-Wagner, C				Takacs, Constantin N.; Hocking, Jason; Cabeen, Matthew T.; Bui, Nhat Khai; Poggio, Sebastian; Vollmer, Waldemar; Jacobs-Wagner, Christine			Growth Medium-Dependent Glycine Incorporation into the Peptidoglycan of Caulobacter crescentus	PLOS ONE			English	Article							CELL-WALL; DIVISION SITE; CROSS-LINKING; AMINO ACIDS; MUREIN; BIOSYNTHESIS; L,D-TRANSPEPTIDASES; IDENTIFICATION; MORPHOGENESIS; RESISTANCE	The peptidoglycan (PG) is a macromolecular component of the bacterial cell wall that maintains the shape and integrity of the cell. The PG of Caulobacter crescentus, unlike that of many other Gram-negative bacteria, has repeatedly been shown to contain significant amounts of glycine. This compositional peculiarity has been deemed an intrinsic characteristic of this species. By performing a comprehensive qualitative and quantitative analysis of the C. crescentus PG by high-performance liquid chromatography (HPLC) and mass spectrometry (MS), we show here that glycine incorporation into the C. crescentus PG depends on the presence of exogenous glycine in the growth medium. High levels of glycine were detected at the fifth position of the peptide side chains of PG isolated from C. crescentus cells grown in the complex laboratory medium PYE or in defined medium (M2G) supplemented with casamino acids or glycine alone. In contrast, glycine incorporation was undetectable when cells were grown in M2G medium lacking glycine. Remarkably, glycine incorporation into C. crescentus peptidoglycan occurred even in the presence of low millimolar to sub-millimolar concentrations of free glycine. High glycine content in the PG had no obvious effects on growth rates, mode of PG incorporation or cell morphology. Hence, the C. crescentus PG is able to retain its physiological functions in cell growth and morphogenesis despite significant alterations in its composition, in what we deem to be unprecedented plasticity.	[Takacs, Constantin N.; Cabeen, Matthew T.; Poggio, Sebastian; Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Hocking, Jason; Jacobs-Wagner, Christine] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; [Bui, Nhat Khai; Vollmer, Waldemar] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jacobs-Wagner, Christine] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA	Yale University; Howard Hughes Medical Institute; Yale University; Newcastle University - UK; Yale University	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu		Jacobs-Wagner, Christine/0000-0003-0980-5334; Poggio, Sebastian/0000-0001-9494-3365	National Institutes of Health [GM076698, GM065835]; Howard Hughes Medical Institute; Yale College Dean's Office Science, Technology and Research Scholars (STARS II) fellowship; NSF GRFP; Mustard Seed Foundation; PEW Latin American Fellowship; DIVINOCELL project of the European Commission [FP7-Health-2007-B-223431]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076698, R01GM065835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Yale College Dean's Office Science, Technology and Research Scholars (STARS II) fellowship; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Mustard Seed Foundation; PEW Latin American Fellowship; DIVINOCELL project of the European Commission; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM076698 and GM065835 to C.J-W) and the Howard Hughes Medical Institute (to C.J-W.). C.N.T was in part supported by a Yale College Dean's Office Science, Technology and Research Scholars (STARS II) fellowship. M.T.C. was supported in part by the NSF GRFP and by the Mustard Seed Foundation. S.P. was supported by a PEW Latin American Fellowship. W.V. was supported by the DIVINOCELL project of the European Commission (FP7-Health-2007-B-223431). C.J.-W. is a Howard Hughes Medical Institute investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron M, 2007, MOL MICROBIOL, V64, P938, DOI 10.1111/j.1365-2958.2007.05720.x; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; BD, 2006, BD BION TECHN MAN AD, P1; BillotKlein D, 1996, J BACTERIOL, V178, P4696, DOI 10.1128/jb.178.15.4696-4703.1996; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; Cabeen MT, 2010, J BACTERIOL, V192, P3368, DOI 10.1128/JB.01371-09; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Cava F, 2011, EMBO J, V30, P3442, DOI 10.1038/emboj.2011.246; Cava F, 2011, CELL MOL LIFE SCI, V68, P817, DOI 10.1007/s00018-010-0571-8; Costa K, 1999, J BACTERIOL, V181, P3710, DOI 10.1128/JB.181.12.3710-3715.1999; deJonge BLM, 1996, ANTIMICROB AGENTS CH, V40, P1498, DOI 10.1128/AAC.40.6.1498; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; DUNCAN K, 1990, BIOCHEMISTRY-US, V29, P2379, DOI 10.1021/bi00461a023; ELY B, 1991, METHOD ENZYMOL, V204, P372; Entcheva-Dimitrov P, 2004, J BACTERIOL, V186, P8254, DOI 10.1128/JB.186.24.8254-8266.2004; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; HAMMES W, 1973, J BACTERIOL, V116, P1029, DOI 10.1128/JB.116.2.1029-1053.1973; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; Hocking J, 2012, J BACTERIOL, V194, P3116, DOI 10.1128/JB.00260-12; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Magnet S, 2008, J BACTERIOL, V190, P4782, DOI 10.1128/JB.00025-08; Magnet S, 2007, J BACTERIOL, V189, P3927, DOI 10.1128/JB.00084-07; MARKIEWICZ Z, 1983, J BACTERIOL, V156, P649, DOI 10.1128/JB.156.2.649-655.1983; MARKIEWICZ Z, 1985, ACTA MICROBIOL POL, V34, P5; MARKIEWICZ Z, 1985, FEMS MICROBIOL LETT, V29, P1; MARTIN SA, 1987, J BIOL CHEM, V262, P7514; NOLAN RA, 1971, MYCOLOGIA, V63, P1231, DOI 10.2307/3757997; Poggio S, 2010, MOL MICROBIOL, V77, P74, DOI 10.1111/j.1365-2958.2010.07223.x; POINDEXTER JS, 1981, MICROBIOL REV, V45, P123, DOI 10.1128/MMBR.45.1.123-179.1981; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; QUINTELA JC, 1995, FEMS MICROBIOL LETT, V125, P95, DOI 10.1016/0378-1097(94)00479-B; Sato M, 2005, J BIOSCI BIOENG, V99, P623, DOI 10.1263/jbb.99.623; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Takacs CN, 2010, J BACTERIOL, V192, P1671, DOI 10.1128/JB.01311-09; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	50	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57579	10.1371/journal.pone.0057579	http://dx.doi.org/10.1371/journal.pone.0057579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469030	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900129
J	Xing, CY; Cao, TS; Yuan, LJ; Wang, Z; Wang, K; Ren, HR; Yang, Y; Duan, YY				Xing, Chang-yang; Cao, Tie-sheng; Yuan, Li-jun; Wang, Zhen; Wang, Kun; Ren, Hua-ri; Yang, Yong; Duan, Yun-you			Mechanism Study of Pulsus Paradoxus Using Mechanical Models	PLOS ONE			English	Article							EXPERIMENTAL CARDIAC-TAMPONADE; MITRAL FLOW VELOCITY; PERICARDIAL-EFFUSION; VENTRICULAR INTERACTION; RESPIRATORY VARIATION; STROKE VOLUME; RIGHT HEART; ECHOCARDIOGRAPHY; MOTION; ASTHMA	Pulsus paradoxus is an exaggeration of the normal inspiratory decrease in systolic blood pressure. Despite a century of attempts to explain this sign consensus is still lacking. To solve the controversy and reveal the exact mechanism, we reexamined the characteristic anatomic arrangement of the circulation system in the chest and designed these mechanical models based on related hydromechanic principles. Model 1 was designed to observe the primary influence of respiratory intrathoracic pressure change (RIPC) on systemic and pulmonary venous return systems (SVR and PVR) respectively. Model 2, as an equivalent mechanical model of septal swing, was to study the secondary influence of RIPC on the motion of the interventriclar septum (IVS), which might be the direct cause for pulsus paradoxus. Model 1 demonstrated that the simulated RIPC had different influence on the simulated SVR and PVR. It increased the volume of the simulated right ventricle (SRV) when the internal pressure was kept constant (8.16 cmH(2)O), while it had the opposite effect on PVR. Model 2 revealed the three major factors determining the respiratory displacement of IVS in normal and different pathophysiological conditions: the magnitude of RIPC, the pressure difference between the two ventricles and the intrapericardial pressure. Our models demonstrate that the different anatomical arrangement of the two venous return systems leads to a different effect of RIPC on right and left ventricles, and thus a pressure gradient across IVS that tends to shift IVS left-and rightwards. When the leftward displacement of IVS reaches a considerable amplitude in some pathologic condition such as cardiac tamponade, the pulsus paradoxus occurs.	[Xing, Chang-yang; Cao, Tie-sheng; Yuan, Li-jun; Wang, Zhen; Wang, Kun; Ren, Hua-ri; Yang, Yong; Duan, Yun-you] Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China	Air Force Military Medical University	Cao, TS (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China.	caotsxcy@yahoo.cn; yuanlj@fmmu.edu.cn	Xing, Changyang/AAE-2899-2019	Xing, Changyang/0000-0003-1605-8285	National Science Foundation of China NSFC [81171348]	National Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC))	This study was funded by the National Science Foundation of China NSFC 81171348. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton JJ, 1997, LANCET, V349, P1720, DOI 10.1016/S0140-6736(96)05109-4; Bandinelli G, 2007, INTERN EMERG MED, V2, P33, DOI 10.1007/s11739-007-0007-0; Bilchick KC, 2002, LANCET, V359, P1940, DOI 10.1016/S0140-6736(02)08763-9; BLAUSTEIN AS, 1986, J AM COLL CARDIOL, V8, P529, DOI 10.1016/S0735-1097(86)80179-6; Chung DC, 1997, AM J PHYSIOL-HEART C, V272, pH2942, DOI 10.1152/ajpheart.1997.272.6.H2942; CRAIG R J, 1968, American Journal of Cardiology, V22, P65, DOI 10.1016/0002-9149(68)90248-8; CURTISS EI, 1988, AM HEART J, V115, P391, DOI 10.1016/0002-8703(88)90487-5; DCRUZ IA, 1975, CIRCULATION, V52, P460, DOI 10.1161/01.CIR.52.3.460; DITCHEY R, 1981, CIRC RES, V48, P701, DOI 10.1161/01.RES.48.5.701; DORNHORST AC, 1952, LANCET, V262, P746; GONZALEZ MS, 1991, J AM COLL CARDIOL, V18, P243, DOI 10.1016/S0735-1097(10)80246-3; GONZALEZ MS, 1991, J AM COLL CARDIOL, V17, P239, DOI 10.1016/0735-1097(91)90733-P; GUNTHEROTH WG, 1967, CIRC RES, V20, P381, DOI 10.1161/01.RES.20.4.381; Hoit B D, 1991, J Am Soc Echocardiogr, V4, P559; KINGMA I, 1983, CIRCULATION, V68, P1304, DOI 10.1161/01.CIR.68.6.1304; LANGE RL, 1966, CIRCULATION, V33, P763, DOI 10.1161/01.CIR.33.5.763; METCALFE J, 1952, CIRCULATION, V5, P518, DOI 10.1161/01.CIR.5.4.518; Ramachandran D, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-15; ROBOTHAM JL, 1983, CRIT CARE MED, V11, P783, DOI 10.1097/00003246-198310000-00005; RUSKIN J, 1973, CIRCULATION, V48, P79, DOI 10.1161/01.CIR.48.1.79; SANTAMORE WP, 1990, AM J PHYSIOL, V259, pH181, DOI 10.1152/ajpheart.1990.259.1.H181; SETTLE HP, 1977, CIRCULATION, V56, P951, DOI 10.1161/01.CIR.56.6.951; SHABETAI R, 1965, J CLIN INVEST, V44, P1882, DOI 10.1172/JCI105295; SHABETAI R, 1961, DIS CHEST, V39, P557; SIMEONIDOU E, 1994, ANGIOLOGY, V45, P213, DOI 10.1177/000331979404500306; Sun K, 1999, J 4 MILITARY MED U, V20, P736; Sun K, 1999, CHINESE J ULTRASOUND, V15, P49; TAYLOR RR, 1967, AM J PHYSIOL, V213, P711, DOI 10.1152/ajplegacy.1967.213.3.711; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053917; Wright RO, 1996, ARCH PEDIAT ADOL MED, V150, P914, DOI 10.1001/archpedi.1996.02170340028005; Yuan LJ, 2007, ECHOCARDIOGR-J CARD, V24, P472, DOI 10.1111/j.1540-8175.2007.00433.x; Yuan LJ, 2004, ECHOCARDIOGR-J CARD, V21, P391, DOI 10.1111/j.0742-2822.2004.03086.x	32	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57512	10.1371/journal.pone.0057512	http://dx.doi.org/10.1371/journal.pone.0057512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469010	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900110
J	Davey, RT; Lynfield, R; Dwyer, DE; Losso, MH; Cozzi-Lepri, A; Wentworth, D; Lane, HC; Dewar, R; Rupert, A; Metcalf, JA; Pett, SL; Uyeki, TM; Bruguera, JM; Angus, B; Cummins, N; Lundgren, J; Neaton, JD				Davey, Richard T., Jr.; Lynfield, Ruth; Dwyer, Dominic E.; Losso, Marcello H.; Cozzi-Lepri, Alessandro; Wentworth, Deborah; Lane, H. Clifford; Dewar, Robin; Rupert, Adam; Metcalf, Julia A.; Pett, Sarah L.; Uyeki, Timothy M.; Maria Bruguera, Jose; Angus, Brian; Cummins, Nathan; Lundgren, Jens; Neaton, James D.		Insight FLU 002 Study Grp; Insight FLU 003 Study Grp	The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies	PLOS ONE			English	Article							PANDEMIC H1N1 2009; CYTOKINE RESPONSE; SURVEILLANCE; PATHOGENESIS; PNEUMONIA	Background: Prospective studies establishing the temporal relationship between the degree of inflammation and human influenza disease progression are scarce. To assess predictors of disease progression among patients with influenza A(H1N1)pdm09 infection, 25 inflammatory biomarkers measured at enrollment were analyzed in two international observational cohort studies. Methods: Among patients with RT-PCR-confirmed influenza A(H1N1) pdm09 virus infection, odds ratios (ORs) estimated by logistic regression were used to summarize the associations of biomarkers measured at enrollment with worsened disease outcome or death after 14 days of follow-up for those seeking outpatient care (FLU 002) or after 60 days for those hospitalized with influenza complications (FLU 003). Biomarkers that were significantly associated with progression in both studies (p<0.05) or only in one (p<0.002 after Bonferroni correction) were identified. Results: In FLU 002 28/528 (5.3%) outpatients had influenza A(H1N1) pdm09 virus infection that progressed to a study endpoint of complications, hospitalization or death, whereas in FLU 003 28/170 (16.5%) inpatients enrolled from the general ward and 21/39 (53.8%) inpatients enrolled directly from the ICU experienced disease progression. Higher levels of 12 of the 25 markers were significantly associated with subsequent disease progression. Of these, 7 markers (IL-6, CD163, IL-10, LBP, IL-2, MCP-1, and IP-10), all with ORs for the 3rd versus 1st tertile of 2.5 or greater, were significant (p<0.05) in both outpatients and inpatients. In contrast, five markers (sICAM-1, IL-8, TNF-alpha, D-dimer, and sVCAM-1), all with ORs for the 3rd versus 1st tertile greater than 3.2, were significantly (p <=.002) associated with disease progression among hospitalized patients only. Conclusions: In patients presenting with varying severities of influenza A(H1N1)pdm09 virus infection, a baseline elevation in several biomarkers associated with inflammation, coagulation, or immune function strongly predicted a higher risk of disease progression. It is conceivable that interventions designed to abrogate these baseline elevations might affect disease outcome.	[Davey, Richard T., Jr.; Lane, H. Clifford; Metcalf, Julia A.] NIAID, NIH, Bethesda, MD 20892 USA; [Lynfield, Ruth] Minnesota Dept Hlth, Div Infect Dis, St Paul, MN USA; [Dwyer, Dominic E.] Westmead Hosp, Dept Virol, Ctr Infect Dis & Microbiol, Westmead, NSW 2145, Australia; [Dwyer, Dominic E.] Univ Sydney, Westmead, NSW 2145, Australia; [Losso, Marcello H.] Hosp Jose Maria Ramos Mejia, Dept Med, HIV Unit, Buenos Aires, DF, Argentina; [Cozzi-Lepri, Alessandro] UCL, Res Dept Infect & Populat Hlth, London, England; [Wentworth, Deborah; Neaton, James D.] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Dewar, Robin] SAIC Frederick Inc, Frederick Natl Lab, Virus Isolat & Serol Lab, Frederick, MD USA; [Rupert, Adam] SAIC Frederick Inc, AIDS Monitoring Lab, Frederick, MD USA; [Pett, Sarah L.] Univ New S Wales, Fac Med, Kirby Inst, Sydney, NSW, Australia; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Maria Bruguera, Jose] Hosp Jose Maria Ramos Mejia, Serv Inmunocomprometidos, Buenos Aires, DF, Argentina; [Angus, Brian] Univ Oxford, Nuffield Dept Med, Oxford, England; [Cummins, Nathan] Mayo Clin, Div Infect Dis, Rochester, MN USA; [Lundgren, Jens] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Lundgren, Jens] Univ Copenhagen, Copenhagen, Denmark	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Minnesota Department of Health (MHD); University of Sydney; University of Sydney; Hospital Ramos Mejia; University of London; University College London; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Science Applications International Corporation (SAIC); SAIC-Frederick; University of New South Wales Sydney; Kirby Institute; Centers for Disease Control & Prevention - USA; Hospital Ramos Mejia; University of Oxford; Mayo Clinic; Rigshospitalet; University of Copenhagen; University of Copenhagen	Davey, RT (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rdavey@niaid.nih.gov	Soriano, Vicente/O-5730-2018; Ostergaard, Lars/AAA-3020-2020; Emery, Sean/J-3825-2017; Burgmann, Heinz/N-2409-2013; Lundgren, Jens/AAE-6876-2019; Angus, Brian/L-9246-2019; Emery, Sean/O-9122-2019	Soriano, Vicente/0000-0002-4624-5199; Ostergaard, Lars/0000-0003-2459-0511; Emery, Sean/0000-0001-6072-8309; Angus, Brian/0000-0003-3598-7784; Emery, Sean/0000-0001-6072-8309; Ostergaard, Lars/0000-0002-7619-605X; Estrada, Vicente/0000-0002-7795-5986; Newport, Melanie/0000-0002-8946-7525; Leen, Clifford/0000-0001-8439-7719; Lundgren, Jens/0000-0001-8901-7850	United States National Institutes of Health [UOI-AI068641]; SAIC-Frederick, Inc., NCI-Frederick, Maryland [HHSN261200800001E]; MRC [MC_U122886352, MC_UU_12023/16] Funding Source: UKRI; Medical Research Council [MC_UU_12023/16, MC_U122886352] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000936, U01AI068641, ZIAAI000984] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SAIC-Frederick, Inc., NCI-Frederick, Maryland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	INSIGHT is funded by United States National Institutes of Health Grant UOI-AI068641, and the FLU 002 and FLU 003 studies are partially funded by SAIC-Frederick, Inc., Prime Contract HHSN261200800001E, NCI-Frederick, Maryland 21702. Disclosure: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2010, J INFECT DIS, V202, P681, DOI 10.1086/655469; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Briand S, 2011, PUBLIC HEALTH, V125, P247, DOI 10.1016/j.puhe.2010.12.007; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dwyer DE, 2011, VACCINE, V29, pB56, DOI 10.1016/j.vaccine.2011.04.105; Estella A, 2011, J INFECT DEV COUNTR, V5, P540, DOI 10.3855/jidc.1618; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Heltzer ML, 2009, J LEUKOCYTE BIOL, V85, P1036, DOI 10.1189/jlb.1108710; Hutchinson AF, 2010, INFLUENZA OTHER RESP, V4, P33, DOI 10.1111/j.1750-2659.2009.00113.x; Ison MG, 2010, J INFECT DIS, V201, P1654, DOI 10.1086/652498; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kang YM, 2011, ARCH VIROL, V156, P759, DOI 10.1007/s00705-010-0914-7; Kim YH, 2011, PEDIATR PULM, V46, P1233, DOI 10.1002/ppul.21496; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Liu Y, 2012, MOL BIOL REP, V39, P1163, DOI 10.1007/s11033-011-0846-7; Murphy EA, 2011, J INTERF CYTOK RES, V31, P501, DOI 10.1089/jir.2010.0143; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Paquette SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038214; Sato M, 2009, CYTOKINE, V47, P65, DOI 10.1016/j.cyto.2009.05.003; Shen HH, 2011, EMERG INFECT DIS, V17, P1053, DOI [10.3201/eid1706.100643, 10.3201/eid/1706.100643]; Sumino KC, 2010, THORAX, V65, P639, DOI 10.1136/thx.2009.132480; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044; Zuniga J, 2011, AUTOIMMUNITY, V44, P562, DOI 10.3109/08916934.2011.592885	30	40	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57121	10.1371/journal.pone.0057121	http://dx.doi.org/10.1371/journal.pone.0057121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468921	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000064
J	Ding, Q; Shi, Y; Fan, B; Fan, ZJ; Ding, L; Li, F; Tu, WJ; Jin, XH; Wang, J				Ding, Qi; Shi, Ying; Fan, Bo; Fan, Zhijiang; Ding, Li; Li, Feng; Tu, Wenjian; Jin, Xiaohua; Wang, Jing			The Interleukin-10 Promoter Polymorphism rs1800872 (-592C > A), Contributes to Cancer Susceptibility: Meta-Analysis of 16 785 Cases and 19 713 Controls	PLOS ONE			English	Article							CYTOKINE GENE POLYMORPHISMS; GASTRIC-CANCER; PROSTATE-CANCER; BREAST-CANCER; IL-10 PROMOTER; COLORECTAL-CANCER; INCREASED RISK; SERUM-LEVELS; NSAID USE; ASSOCIATION	Interleukin-10 (IL-10) is a multifunctional cytokine which participates in the development and progression of various malignant tumors. To date, a number of case-control studies were conducted to detect the association between IL-10-592C>A polymorphism and cancer risk in humans. However, the results of these studies on the association remain conflicting. In an effort to solve this controversy, we performed a meta-analysis based on 70 case-control studies from 65 articles, including 16 785 cancer cases and 19 713 controls. We used odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of the association. The overall results suggested that the variant homozygote genotype AA of the IL-10-592C>A polymorphism was associated with a moderately decreased risk of all cancer types ( OR = 0.90, 95% CI = 0.83-0.98 for homozygote comparison, OR = 0.92, 95% CI = 0.86-0.98 for recessive model). In the stratified analyses, the risk remained for studies of smoking-related cancer, Asian populations and hospital-based studies. These results suggested that the IL-10-592C>A polymorphism might contribute to the cancer susceptibility, especially in smoking-related cancer, Asians and hospital-based studies. Further studies are needed to confirm the relationship.	[Ding, Qi; Fan, Bo; Fan, Zhijiang; Ding, Li; Li, Feng; Tu, Wenjian; Jin, Xiaohua; Wang, Jing] Soochow Univ, Dept Urol, Changshu Hosp, Changshu, Peoples R China; [Shi, Ying] Soochow Univ, Dept Gastroenterol, Changshu Hosp, Changshu, Peoples R China	Soochow University - China; Soochow University - China	Wang, J (corresponding author), Soochow Univ, Dept Urol, Changshu Hosp, Changshu, Peoples R China.	csyyjingwang@gmail.com	Kim, Seongman/N-6910-2014					Alonso R, 2005, MELANOMA RES, V15, P53, DOI 10.1097/00008390-200502000-00009; Alpizar-Alpizar W, 2005, CLIN EXP MED, V5, P169, DOI 10.1007/s10238-005-0082-3; Andersen V, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-183; Ando T, 2009, INT J CANCER, V125, P2595, DOI 10.1002/ijc.24666; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Basturk B, 2005, CYTOKINE, V30, P41, DOI 10.1016/j.cyto.2004.10.016; BLOT WJ, 1988, CANCER RES, V48, P3282; Braicu EI, 2007, GYNECOL ONCOL, V104, P680, DOI 10.1016/j.ygyno.2006.10.014; Breslow N E, 1987, IARC Sci Publ, P1; Cacev T, 2008, CARCINOGENESIS, V29, P1572, DOI 10.1093/carcin/bgn164; Colakogullari M, 2008, CELL BIOCHEM FUNCT, V26, P283, DOI 10.1002/cbf.1419; Cozar JM, 2007, HUM IMMUNOL, V68, P698, DOI 10.1016/j.humimm.2007.05.002; Crivello A, 2006, ANN NY ACAD SCI, V1089, P98, DOI 10.1196/annals.1386.002; Crusius JBA, 2008, ANN ONCOL, V19, P1894, DOI 10.1093/annonc/mdn400; De Vita F, 2000, CHEST, V117, P365, DOI 10.1378/chest.117.2.365; Eder T, 2007, EUR J CANCER, V43, P472, DOI 10.1016/j.ejca.2006.11.003; Edwards-Smith CJ, 1999, HEPATOLOGY, V30, P526, DOI 10.1002/hep.510300207; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; Erdogan M, 2008, J ENDOCRINOL INVEST, V31, P750, DOI 10.1007/BF03349252; Eskdale J, 1998, P NATL ACAD SCI USA, V95, P9465, DOI 10.1073/pnas.95.16.9465; Faupel-Badger JM, 2008, CANCER CAUSE CONTROL, V19, P119, DOI 10.1007/s10552-007-9077-6; Fortis C, 1996, CANCER LETT, V104, P1, DOI 10.1016/0304-3835(96)04213-9; Garcia-Gonzalez MA, 2007, AM J GASTROENTEROL, V102, P1878, DOI 10.1111/j.1572-0241.2007.01423.x; Gonullu G, 2007, SAUDI MED J, V28, P1728; Guzowski Dorothy, 2005, J Biomol Tech, V16, P154; Hart K, 2011, LUNG CANCER, V71, P123, DOI 10.1016/j.lungcan.2010.04.016; He BS, 2012, GENET TEST MOL BIOMA, V16, P9, DOI 10.1089/gtmb.2011.0078; Heneghan Michael A, 2003, Int J Gastrointest Cancer, V34, P19; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Howell WM, 2001, GENES IMMUN, V2, P25, DOI 10.1038/sj.gene.6363726; Huang SY, 1999, J INTERF CYTOK RES, V19, P697, DOI 10.1089/107999099313532; Hutchinson I V, 1999, Rev Immunogenet, V1, P323; Ivansson EL, 2007, INT J CANCER, V121, P2451, DOI 10.1002/ijc.22989; Kamangar F, 2006, CANCER CAUSE CONTROL, V17, P117, DOI 10.1007/s10552-005-0439-7; Kang JM, 2009, J CLIN GASTROENTEROL, V43, P420, DOI 10.1097/MCG.0b013e318178d1d3; Kingo K, 2005, J DERMATOL SCI, V37, P111, DOI 10.1016/j.jdermsci.2004.10.002; Kong FJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-72; Kube D, 2008, CLIN CANCER RES, V14, P3777, DOI 10.1158/1078-0432.CCR-07-5182; Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160; Langsenlehner U, 2005, BREAST CANCER RES TR, V90, P113, DOI 10.1007/s10549-004-3607-7; Lech-Maranda E, 2004, BLOOD, V103, P3529, DOI 10.1182/blood-2003-06-1850; Lech-Maranda E, 2007, LEUKEMIA LYMPHOMA, V48, P2235, DOI 10.1080/10428190701615926; Lee JY, 2005, CANCER LETT, V225, P207, DOI 10.1016/j.canlet.2004.11.028; Li YL, 2011, CANCER EPIDEMIOL, V35, P362, DOI 10.1016/j.canep.2011.01.005; Lim S, 1998, LANCET, V352, P113, DOI 10.1016/S0140-6736(98)85018-6; Liu J, 2011, WORLD J GASTROENTERO, V17, P1362, DOI 10.3748/wjg.v17.i10.1362; Liu J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-456; Lowe PR, 2003, CRIT CARE MED, V31, P34, DOI 10.1097/00003246-200301000-00005; Macarthur M, 2005, CANCER EPIDEM BIOMAR, V14, P1613, DOI 10.1158/1055-9965.EPI-04-0878; Martinez-Escribano JA, 2002, MELANOMA RES, V12, P465, DOI 10.1097/00008390-200209000-00008; MATSUDA M, 1994, J EXP MED, V180, P2371, DOI 10.1084/jem.180.6.2371; Mazur G, 2005, IMMUNOL LETT, V96, P241, DOI 10.1016/j.imlet.2004.08.015; MIDGETTE AS, 1994, MED DECIS MAKING, V14, P108, DOI 10.1177/0272989X9401400203; Mocellin S, 2004, CYTOKINE GROWTH F R, V15, P61, DOI 10.1016/j.cytogfr.2003.11.001; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Munro LR, 2003, LEUKEMIA LYMPHOMA, V44, P2083, DOI 10.1080/1042819031000119316; Pooja S, 2012, CYTOKINE, V60, P122, DOI 10.1016/j.cyto.2012.06.241; Pratesi C, 2006, CANCER IMMUNOL IMMUN, V55, P23, DOI 10.1007/s00262-005-0688-z; Purdue MP, 2007, CARCINOGENESIS, V28, P704, DOI 10.1093/carcin/bgl200; Purdue MP, 2007, CANCER EPIDEM BIOMAR, V16, P77, DOI 10.1158/1055-9965.EPI-06-0573; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roh JW, 2002, CANCER LETT, V184, P57, DOI 10.1016/S0304-3835(02)00193-3; SALAZARONFRAY F, 1995, J IMMUNOL, V154, P6291; Savage SA, 2004, CANCER EPIDEM BIOMAR, V13, P1547; Schoof N, 2009, GENES IMMUN, V10, P586, DOI 10.1038/gene.2009.40; Scola L, 2006, ANN NY ACAD SCI, V1089, P104, DOI 10.1196/annals.1386.017; Setiawan VW, 2007, AM J EPIDEMIOL, V166, P932, DOI 10.1093/aje/kwm170; Sharma N, 1999, CANCER RES, V59, P2271; Shekari M, 2011, AM J CLIN ONCOL; Shih CM, 2005, LUNG CANCER, V50, P291, DOI 10.1016/j.lungcan.2005.07.007; Sicinschi LA, 2006, INT J CANCER, V118, P649, DOI 10.1002/ijc.21364; SPITS H, 1992, INT ARCH ALLERGY IMM, V99, P8, DOI 10.1159/000236329; Stearns ME, 2003, CLIN CANCER RES, V9, P1191; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P1443, DOI 10.1111/j.1440-1746.2006.04613.x; Sun T, 2004, JNCI-J NATL CANCER I, V96, P1030, DOI 10.1093/jnci/djh187; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Tseng LH, 2006, TISSUE ANTIGENS, V67, P127, DOI 10.1111/j.1399-0039.2006.00536.x; Tsilidis KK, 2009, CANCER CAUSE CONTROL, V20, P1739, DOI 10.1007/s10552-009-9427-7; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; VanCleave TT, 2010, PROSTATE, V70, P341, DOI 10.1002/pros.21067; Vassallo R, 2005, J IMMUNOL, V175, P2684, DOI 10.4049/jimmunol.175.4.2684; Vogel U, 2008, MUTAT RES-FUND MOL M, V639, P89, DOI 10.1016/j.mrfmmm.2007.11.004; Vogel U, 2007, MUTAT RES-FUND MOL M, V617, P138, DOI 10.1016/j.mrfmmm.2007.01.005; Wang MH, 2009, PROSTATE, V69, P874, DOI 10.1002/pros.20933; Wei QY, 2000, J NATL CANCER I, V92, P1764; Wei YS, 2007, TISSUE ANTIGENS, V70, P12, DOI 10.1111/j.1399-0039.2007.00806.x; Wu MS, 2003, INT J CANCER, V104, P617, DOI 10.1002/ijc.10987; Yao JG, 2008, CLIN CHIM ACTA, V388, P84, DOI 10.1016/j.cca.2007.10.012; Zabaleta J, 2008, CARCINOGENESIS, V29, P573, DOI 10.1093/carcin/bgm277; Zambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.2004.10.013; Zeng X, 2011, MOL BIOL CELL, V22; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037846; Zhang ZZ, 2004, CLIN CHIM ACTA, V342, P137, DOI 10.1016/j.cccn.2003.12.010; Zoodsma M, 2005, INT J GYNECOL CANCER, V15, P282, DOI 10.1111/j.1525-1438.2005.00433.x	94	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57246	10.1371/journal.pone.0057246	http://dx.doi.org/10.1371/journal.pone.0057246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460834	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000083
J	Kong, XP; Lv, W; Zhang, D; Jiang, SS; Zhang, SZ; Li, DQ				Kong, Xiangpei; Lv, Wei; Zhang, Dan; Jiang, Shanshan; Zhang, Shizhong; Li, Dequan			Genome-Wide Identification and Analysis of Expression Profiles of Maize Mitogen-Activated Protein Kinase Kinase Kinase	PLOS ONE			English	Article							MAP KINASE; CELL-DEATH; OSMOTIC-STRESS; SALT STRESS; GENE FAMILY; ARABIDOPSIS-THALIANA; SIGNALING PATHWAYS; DEFENSE RESPONSES; INNATE IMMUNITY; LOW-TEMPERATURE	Mitogen-activated protein kinase (MAPK) cascades are highly conserved signal transduction model in animals, yeast and plants. Plant MAPK cascades have been implicated in development and stress responses. Although MAPKKKs have been investigated in several plant species including Arabidopsis and rice, no systematic analysis has been conducted in maize. In this study, we performed a bioinformatics analysis of the entire maize genome and identified 74 MAPKKK genes. Phylogenetic analyses of MAPKKKs from maize, rice and Arabidopsis have classified them into three subgroups, which included Raf, ZIK and MEKK. Evolutionary relationships within subfamilies were also supported by exon-intron organizations and the conserved protein motifs. Further expression analysis of the MAPKKKs in microarray databases revealed that MAPKKKs were involved in important signaling pathways in maize different organs and developmental stages. Our genomics analysis of maize MAPKKK genes provides important information for evolutionary and functional characterization of this family in maize.	[Kong, Xiangpei; Lv, Wei; Zhang, Dan; Jiang, Shanshan; Li, Dequan] Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Shizhong] Shandong Agr Univ, Coll Hort Sci & Engn, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Li, DQ (corresponding author), Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	dqli@sdau.edu.cn			Nation Natural Science Foundation of China [31071337, 31271633]	Nation Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Grants from the Nation Natural Science Foundation of China [Grant numbers 31071337, 31271633]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Beck M, 2011, NEW PHYTOL, V189, P1069, DOI 10.1111/j.1469-8137.2010.03565.x; Beck M, 2010, PLANT CELL, V22, P755, DOI 10.1105/tpc.109.071746; Berberich T, 1999, MOL GEN GENET, V262, P534, DOI 10.1007/s004380051115; Bethke G, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0810206106; Chen LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046744; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Fiil BK, 2009, CURR OPIN PLANT BIOL, V12, P615, DOI 10.1016/j.pbi.2009.07.017; Gao L, 2008, PLANT MOL BIOL, V67, P125, DOI 10.1007/s11103-008-9306-8; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Hashimoto M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-103; Huang YF, 2000, PLANT PHYSIOL, V122, P1301, DOI 10.1104/pp.122.4.1301; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Jammes F, 2009, P NATL ACAD SCI USA, V106, P20520, DOI 10.1073/pnas.0907205106; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Kong FL, 2012, GENE, V499, P108, DOI 10.1016/j.gene.2012.01.048; Kong Q, 2012, PLANT CELL, V24, P2225, DOI 10.1105/tpc.112.097253; Kong XP, 2011, PLANT CELL REP, V30, P2097, DOI 10.1007/s00299-011-1116-9; Kong XP, 2011, PLANT CELL ENVIRON, V34, P1291, DOI 10.1111/j.1365-3040.2011.02329.x; Kumar K, 2011, PLANT SIGNAL BEHAV, V6, P316, DOI 10.4161/psb.6.3.13063; Lampard GR, 2009, PLANT CELL, V21, P3506, DOI 10.1105/tpc.109.070110; Lee JS, 2008, PLANT SIGNAL BEHAV, V3, P1037, DOI 10.4161/psb.3.12.6848; Lin F, 2009, J EXP BOT, V60, P3221, DOI 10.1093/jxb/erp157; Liu YK, 2012, MOL BIOL REP, V39, P2957, DOI 10.1007/s11033-011-1057-y; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Munnik T, 2001, FEBS LETT, V498, P172, DOI 10.1016/S0014-5793(01)02492-9; Murakami-Kojima M, 2002, PLANT CELL PHYSIOL, V43, P675, DOI 10.1093/pcp/pcf084; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Ning J, 2011, PLANT CELL, V23, P4334, DOI 10.1105/tpc.111.093419; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; Pan JW, 2012, PLANTA, V235, P661, DOI 10.1007/s00425-011-1510-0; Pitzschke A, 2009, MOL PLANT, V2, P120, DOI 10.1093/mp/ssn079; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Sasabe M, 2006, GENE DEV, V20, P1004, DOI 10.1101/gad.1408106; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Song D, 2006, PLANT BIOLOGY, V8, P587, DOI 10.1055/s-2006-924149; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Takahashi Y, 2010, PLANT CELL PHYSIOL, V51, P1766, DOI 10.1093/pcp/pcq135; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Wang Y, 2008, PLANT BIOLOGY, V10, P548, DOI 10.1111/j.1438-8677.2008.00072.x; Wu T, 2011, MOL BIOL REP, V38, P3967, DOI 10.1007/s11033-010-0514-3; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; Xu J, 2008, J BIOL CHEM, V283, P26996, DOI 10.1074/jbc.M801392200; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Zeng QN, 2011, PLANT J, V67, P895, DOI 10.1111/j.1365-313X.2011.04642.x; Zhang LA, 2011, FEBS J, V278, P1367, DOI 10.1111/j.1742-4658.2011.08056.x; Zhang MY, 2012, J PLANT PHYSIOL, V169, P1501, DOI 10.1016/j.jplph.2012.06.008; Zhang ZB, 2012, CELL HOST MICROBE, V11, P253, DOI 10.1016/j.chom.2012.01.015; Zhou Y, 2012, PLANT PHYSIOL BIOCH, V58, P174, DOI 10.1016/j.plaphy.2012.06.020	57	47	57	6	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57714	10.1371/journal.pone.0057714	http://dx.doi.org/10.1371/journal.pone.0057714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460898	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000153
J	Lin, Y; Berger, U; Grimm, V; Huth, F; Weiner, J				Lin, Yue; Berger, Uta; Grimm, Volker; Huth, Franka; Weiner, Jacob			Plant Interactions Alter the Predictions of Metabolic Scaling Theory	PLOS ONE			English	Article							GENERAL QUANTITATIVE THEORY; DENSITY RELATIONSHIP; SIZE SYMMETRY; MASS-DENSITY; TREE GROWTH; COMPETITION; ALLOMETRY; PROTOCOL; MODELS	Metabolic scaling theory (MST) is an attempt to link physiological processes of individual organisms with macroecology. It predicts a power law relationship with an exponent of -4/3 between mean individual biomass and density during density-dependent mortality (self-thinning). Empirical tests have produced variable results, and the validity of MST is intensely debated. MST focuses on organisms' internal physiological mechanisms but we hypothesize that ecological interactions can be more important in determining plant mass-density relationships induced by density. We employ an individual-based model of plant stand development that includes three elements: a model of individual plant growth based on MST, different modes of local competition (size-symmetric vs. -asymmetric), and different resource levels. Our model is consistent with the observed variation in the slopes of self-thinning trajectories. Slopes were significantly shallower than -4/3 if competition was size-symmetric. We conclude that when the size of survivors is influenced by strong ecological interactions, these can override predictions of MST, whereas when surviving plants are less affected by interactions, individual-level metabolic processes can scale up to the population level. MST, like thermodynamics or biomechanics, sets limits within which organisms can live and function, but there may be stronger limits determined by ecological interactions. In such cases MST will not be predictive.	[Lin, Yue; Berger, Uta] Tech Univ Dresden, Inst Forest Growth & Comp Sci, Tharandt, Germany; [Lin, Yue; Grimm, Volker] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Grimm, Volker] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Huth, Franka] Tech Univ Dresden, Inst Silviculture & Forest Protect, Tharandt, Germany; [Weiner, Jacob] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark	Technische Universitat Dresden; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Potsdam; Technische Universitat Dresden; University of Copenhagen	Lin, Y (corresponding author), Tech Univ Dresden, Inst Forest Growth & Comp Sci, Tharandt, Germany.	yue.lin.tud@gmail.com	Weiner, Jacob/E-1839-2011	Weiner, Jacob/0000-0002-0736-7943; Lin, Yue/0000-0002-0346-6493	Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	This work is supported by Helmholtz Impulse and Networking Fund through Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2008, FUNCT ECOL, V22, P197, DOI 10.1111/j.1365-2435.2007.01376.x; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Berger U, 2008, PERSPECT PLANT ECOL, V9, P121, DOI 10.1016/j.ppees.2007.11.002; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chu CJ, 2010, ANN BOT-LONDON, V106, P647, DOI 10.1093/aob/mcq145; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Coomes DA, 2011, J ECOL, V99, P748, DOI 10.1111/j.1365-2745.2011.01811.x; Dai XF, 2009, BIOL LETTERS, V5, P571, DOI 10.1098/rsbl.2009.0228; Deng JM, 2006, J ECOL, V94, P953, DOI 10.1111/j.1365-2745.2006.01141.x; Enquist BJ, 2002, TREE PHYSIOL, V22, P1045, DOI 10.1093/treephys/22.15-16.1045; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hou C, 2008, SCIENCE, V322, P736, DOI 10.1126/science.1162302; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Lambers H., 2008, PLANT PHYSL ECOLOGY, P134; Li HT, 2006, J INTEGR PLANT BIOL, V48, P268, DOI 10.1111/j.1744-7909.2006.00222.x; Lin Y, 2012, J ECOL, V100, P1482, DOI 10.1111/j.1365-2745.2012.02019.x; Martin BT, 2012, METHODS ECOL EVOL, V3, P445, DOI 10.1111/j.2041-210X.2011.00168.x; Martin BT, AM NAT IN PRESS; Morris EC, 2003, ECOL RES, V18, P287, DOI 10.1046/j.1440-1703.2003.00555.x; Ruger N, 2012, FUNCT ECOL, V26, P759, DOI 10.1111/j.1365-2435.2012.01981.x; Schwinning S, 1998, OECOLOGIA, V113, P447, DOI 10.1007/s004420050397; Stoll P, 2002, P ROY SOC B-BIOL SCI, V269, P2191, DOI 10.1098/rspb.2002.2137; Weiner J, 1997, OIKOS, V79, P85, DOI 10.2307/3546093; WEINER J, 1992, ECOLOGY, V73, P648, DOI 10.2307/1940771; Weiner J, 2001, AM NAT, V158, P438, DOI 10.1086/321988; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; WESTOBY M, 1984, ADV ECOL RES, V14, P167, DOI 10.1016/S0065-2504(08)60171-3; Wilensky U., 1999, NETLOGO; Zhang WP, 2011, ECOL RES, V26, P819, DOI 10.1007/s11284-011-0843-2	34	25	25	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57612	10.1371/journal.pone.0057612	http://dx.doi.org/10.1371/journal.pone.0057612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460884	gold, Green Published			2022-12-27	WOS:000315519000139
J	Mettke-Hofmann, C; Winkler, H; Hamel, PB; Greenberg, R				Mettke-Hofmann, Claudia; Winkler, Hans; Hamel, Paul B.; Greenberg, Russell			Migratory New World Blackbirds (Icterids) Are More Neophobic than Closely Related Resident Icterids	PLOS ONE			English	Article							ECOLOGICAL PLASTICITY; NOVELTY RESPONSES; EXPERIENCE; ASSEMBLAGE; SONG; INFORMATION; EXPLORATION; PHYLOGENIES; BEHAVIOR; RAT	Environments undergo short-term and long-term changes due to natural or human-induced events. Animals differ in their ability to cope with such changes which can be related to their ecology. Changes in the environment often elicit avoidance reactions (neophobia) which protect animals from dangerous situations but can also inhibit exploration and familiarization with novel situations and thus, learning about new resources. Studies investigating the relationship between a species' ecology and its neophobia have so far been restricted to comparing only a few species and mainly in captivity. The current study investigated neophobia reactions to experimentally-induced changes in the natural environment of six closely-related blackbird species (Icteridae), including two species represented by two distinct populations. For analyses, neophobic reactions (difference in number of birds feeding and time spent feeding with and without novel objects) were related to several measures of ecological plasticity and the migratory strategy (resident or migratory) of the population. Phylogenetic relationships were incorporated into the analysis. The degree of neophobia was related to migratory strategy with migrants expressing much higher neophobia (fewer birds feeding and for a shorter time with objects present) than residents. Furthermore, neophobia showed a relationship to diet breadth with fewer individuals of diet generalists than specialists returning when objects were present supporting the dangerous niche hypothesis. Residents may have evolved lower neophobia as costs of missing out on opportunities may be higher for residents than migrants as the former are restricted to a smaller area. Lower neophobia allows them approaching changes in the environment (e. g. novel objects) quickly, thereby securing access to resources. Additionally, residents have a greater familiarity with similar situations in the area than migrants and the latter may, therefore, initially stay behind resident species.	[Mettke-Hofmann, Claudia] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England; [Mettke-Hofmann, Claudia; Greenberg, Russell] Smithsonian Inst, Natl Zool Pk, Smithsonian Migratory Bird Ctr, Washington, DC 20008 USA; [Winkler, Hans] Univ Vet Med, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria; [Hamel, Paul B.] US Forest Serv, Southern Hardwood Lab, Stoneville, MS USA	Liverpool John Moores University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Veterinary Medicine Vienna; United States Department of Agriculture (USDA); United States Forest Service	Mettke-Hofmann, C (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England.	C.C.Mettke-Hofmann@ljmu.ac.uk			Max Kade Foundation; Max Planck Institute for Ornithology, Andechs, Germany; German Ethological Society; Society for Tropical Ornithology, Germany; Point Reyes Bird Observatory, CA; USDA Forest Service, Center for Bottomland Hardwoods, MS	Max Kade Foundation; Max Planck Institute for Ornithology, Andechs, Germany; German Ethological Society; Society for Tropical Ornithology, Germany; Point Reyes Bird Observatory, CA; USDA Forest Service, Center for Bottomland Hardwoods, MS	The study was supported by a grant from the Max Kade Foundation. Assistants, travel and material were supported by the Max Planck Institute for Ornithology, Andechs, Germany, the German Ethological Society, and the Society for Tropical Ornithology, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Point Reyes Bird Observatory, CA, and the USDA Forest Service, Center for Bottomland Hardwoods, MS, for providing housing and support, the National Park Service Point Reyes National Seashore, CA, Yazoo NWR, Leroy Percy SP, Delta Research and Experimental Center, (all MS), and all cooperating farmers for permitting experiments on their land and Gerhard Hofmann for his assistance with the experiments.	Avery Michael L., 1995, Birds of North America, V200, P1; BARNETT SA, 1958, BRIT J PSYCHOL, V49, P195, DOI 10.1111/j.2044-8295.1958.tb00657.x; Beedy Edward C., 1999, Birds of North America, V423, P1; Boogert NJ, 2006, ANIM BEHAV, V72, P1229, DOI 10.1016/j.anbehav.2006.02.021; Conti LH, 2004, BEHAV GENET, V34, P93, DOI 10.1023/B:BEGE.0000009479.02183.1f; Dobson A. J, 2002, INTRO GEN LINEAR MOD; Echeverria AI, 2006, CAN J ZOOL, V84, P974, DOI 10.1139/Z06-089; Echeverria AI, 2008, ETHOLOGY, V114, P616, DOI 10.1111/j.1439-0310.2008.01512.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; GAVIN TA, 1991, AUK, V108, P602, DOI 10.2307/4088101; GREENBERG R, 1992, ETHOLOGY, V91, P17; GREENBERG R, 1990, ANIM BEHAV, V39, P375, DOI 10.1016/S0003-3472(05)80884-X; Greenberg R, 2001, CURR ORNITHOL, V16, P119; Greenberg R, 1999, CONSERV BIOL, V13, P553, DOI 10.1046/j.1523-1739.1999.97478.x; GREENBERG R, 1989, CAN J ZOOL, V67, P1194, DOI 10.1139/z89-172; GREENBERG R, 1983, AM NAT, V122, P444, DOI 10.1086/284148; Greenberg Russell, 2003, P175; Gros-Louis J, 2003, BEHAV ECOL SOCIOBIOL, V53, P163, DOI 10.1007/s00265-002-0560-5; GRUNBERGER S, 1993, J ORNITHOL, V134, P352, DOI 10.1007/BF01640433; HEINRICH B, 1988, CONDOR, V90, P950, DOI 10.2307/1368859; Hocking RR, 1977, STAT METHODS DIGITAL, P39; Jaramillo A., 1999, NEW WORLD BLACKBIRDS; Johnson KP, 1999, AUK, V116, P759, DOI 10.2307/4089336; Lecuelle S, 2011, APPL ANIM BEHAV SCI, V135, P78, DOI 10.1016/j.applanim.2011.08.007; Lowther Peter E., 1993, Birds of North America, V47, P1; Marples NM, 2007, BEHAV ECOL, V18, P803, DOI 10.1093/beheco/arm053; Martin LB, 2005, BEHAV ECOL, V16, P702, DOI 10.1093/beheco/ari044; Martin Stephen G., 2002, Birds of North America, V616, P1; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Mettke-Hofmann C, 2005, BEHAVIOUR, V142, P1357, DOI 10.1163/156853905774539427; Mettke-Hofmann C, 2005, BEHAV ECOL, V16, P247, DOI 10.1093/beheco/arh159; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; Monkkonen M, 1997, CAN J ZOOL, V75, P2077, DOI 10.1139/z97-842; Moussus JP, 2011, OIKOS, V120, P991, DOI 10.1111/j.1600-0706.2010.18955.x; Niven D., 2004, AM BIRDS, V58, P10; Peer Brain D., 1997, Birds of North America, V271, P1; RANA B D, 1989, Pavo, V27, P35; Ray J, 2005, DEV PSYCHOBIOL, V47, P136, DOI 10.1002/dev.20080; Renken WJ, 2008, APPL ANIM BEHAV SCI, V109, P128, DOI 10.1016/j.applanim.2007.03.014; Rockwell C, 2012, BEHAV ECOL, V23, P676, DOI 10.1093/beheco/ars015; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Shirihai H., 1996, BIRDS ISRAEL, P503; Sol D, 2000, OIKOS, V90, P599, DOI 10.1034/j.1600-0706.2000.900317.x; Sol D, 2005, P ROY SOC B-BIOL SCI, V272, P1433, DOI 10.1098/rspb.2005.3099; Starck JM, 1996, J ZOOL, V238, P53, DOI 10.1111/j.1469-7998.1996.tb05379.x; Tebbich S, 2012, ETHOLOGY, V118, P135, DOI 10.1111/j.1439-0310.2011.02001.x; Thomas RJ, 2010, BEHAV ECOL, V21, P669, DOI 10.1093/beheco/arq037; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; van Oers K, 2004, P ROY SOC B-BIOL SCI, V271, P65, DOI 10.1098/rspb.2003.2518; Voelkl B, 2006, ANIM BEHAV, V72, P365, DOI 10.1016/j.anbehav.2005.10.013; Webster SJ, 2000, WILSON BULL, V112, P424, DOI 10.1676/0043-5643(2000)112[0424:NBTLAB]2.0.CO;2; Webster SJ, 2001, ANIM BEHAV, V62, P23, DOI 10.1006/anbe.2000.1725; Yasukawa Ken, 1995, Birds of North America, V184, P1	53	23	23	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57565	10.1371/journal.pone.0057565	http://dx.doi.org/10.1371/journal.pone.0057565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460875	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000130
J	Bray, TC; Mohammed, OB; Alagaili, AN				Bray, Timothy C.; Mohammed, Osama B.; Alagaili, Abdulaziz N.			Phylogenetic and Demographic Insights into Kuhl's Pipistrelle, Pipistrellus kuhlii, in the Middle East	PLOS ONE			English	Article							BAT; VESPERTILIONIDAE; CHIROPTERA; PHYLOGEOGRAPHY; ARTIODACTYLA; CONSERVATION; SOFTWARE; BEHAVIOR; ORIGIN; TESTS	Kuhl's pipistrelle is found from Europe and North Africa all of the way to Asia, yet studies have thus far concentrated on the western limit of its distribution. Here we form a multi-marker picture of the diversity of Kuhl's pipistrelle at a mid point in the Arabian peninsula in an attempt to redress the western sampling bias and to represent a region from which no genetic data has thus far been presented for this species. The three Arabian Cytochrome b haplotypes showed a clear divergence of 19 substitutions from those found in either Europe or North Africa. Molecular dating suggests the Arabian population split from the remaining Kuhl's somewhere between 0.7 and 1.7 million years before present around the time of a series of aridification events across northern Africa. Well supported lineages within Arabia are typical of that which may be seen after an expansion from multiple Pleistocene refugia, but may also reflect the loss of intermediate haplotypes during historical population fluctuations. A long-term population contraction coincides with climatic changes towards those conditions more typical of contemporary Arabia.	[Bray, Timothy C.; Mohammed, Osama B.; Alagaili, Abdulaziz N.] King Saud Univ, Dept Zool, KSU Mammals Res Chair, Riyadh, Saudi Arabia	King Saud University	Bray, TC (corresponding author), King Saud Univ, Dept Zool, KSU Mammals Res Chair, Riyadh, Saudi Arabia.	tim_c_bray@hotmail.com	Mohammed, Osama B/C-3226-2011; Alagaili, Abdulaziz/C-4278-2018	Mohammed, Osama B/0000-0001-5457-2555; Alagaili, Abdulaziz/0000-0002-9733-4220	King Saud University [RGP_VPP_020]	King Saud University(King Saud University)	Funding was provided by the Deanship of Scientific Research at the King Saud University through the research group project number RGP_VPP_020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ammerman Loren K., 2009, Endangered Species Research, V8, P87, DOI 10.3354/esr00169; [Anonymous], IUCN 2011 IUCN RED L; Baker Robert J., 2000, Occasional Papers Museum of Texas Tech University, V202, P1; BATES P. J. J., 1991, MAMMALS ARABIA; Benda P, 2011, ACTA CHIROPTEROL, V13, P245, DOI 10.3161/150811011X624749; Benda Petr, 2008, Journal of the National Museum Prague Natural History Series, V177, P53; Cabrera VM, 2009, VERTEBR PALEOBIOL PA, P79, DOI 10.1007/978-90-481-2719-1_6; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cremaschi M, 2006, HOLOCENE, V16, P293, DOI 10.1191/0959683606hl926rr; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Engel M, 2012, QUATERN INT, V266, P131, DOI 10.1016/j.quaint.2011.04.028; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evin A, 2011, J ZOOL, V284, P31, DOI 10.1111/j.1469-7998.2010.00778.x; FERGUSON WW, 1981, MAMMALIA, V45, P453, DOI 10.1515/mamm.1981.45.4.453; Garcia-Mudarra JL, 2009, BIOL J LINN SOC, V96, P434, DOI 10.1111/j.1095-8312.2008.01128.x; Hall T.A, 2005, BIOEDIT 705; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HORACEK I., 1984, MYOTIS, V21-22, P20; Hulva P, 2004, MOL PHYLOGENET EVOL, V32, P1023, DOI 10.1016/j.ympev.2004.04.007; Hulva P, 2010, MOL ECOL, V19, P5417, DOI 10.1111/j.1365-294X.2010.04899.x; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Knight Tessa, 2009, Endangered Species Research, V8, P79, DOI 10.3354/esr00194; Lerp H, 2011, ORG DIVERS EVOL, V11, P317, DOI 10.1007/s13127-011-0057-z; Mallon DP, 2011, ZOOL MIDDLE EAST, P13, DOI 10.1080/09397140.2011.10648896; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; NADER IA, 1982, J ZOOL, V198, P69; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Ostrowski S, 2006, J COMP PHYSIOL B, V176, P191, DOI 10.1007/s00360-005-0040-0; Parker A.G., 2008, P SEMINAR ARABIAN ST, V38, P25; Parker AG, 2006, QUATERNARY RES, V66, P465, DOI 10.1016/j.yqres.2006.07.001; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Pestano J, 2003, MOL PHYLOGENET EVOL, V26, P56, DOI 10.1016/S1055-7903(02)00307-X; Pianka ER, 1978, EVOL ECOL, V2nd; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; RACEY PA, 1985, J ANIM ECOL, V54, P205, DOI 10.2307/4631; Racey PA, 2007, BIOL J LINN SOC, V90, P539, DOI 10.1111/j.1095-8312.2007.00746.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; SAHLEY CT, 1993, J MAMMAL, V74, P594, DOI 10.2307/1382278; Sendor T, 2003, J ANIM ECOL, V72, P308, DOI 10.1046/j.1365-2656.2003.00702.x; Speakman JR, 1999, ANIM BEHAV, V58, P787, DOI 10.1006/anbe.1999.1203; Stadelmann B, 2004, J MAMMAL, V85, P133, DOI 10.1644/1545-1542(2004)085<0133:MSOTFB>2.0.CO;2; Stokes S, 1997, NATURE, V388, P154, DOI 10.1038/40596; Storz JF, 2002, EVOLUTION, V56, P154; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON MJA, 1987, J ZOOL, V211, P209, DOI 10.1111/j.1469-7998.1987.tb01529.x; Wei L, 2009, CONSERV GENET, V10, P677, DOI 10.1007/s10592-008-9613-2; Yom-Tov Yoram, 1998, Diversity and Distributions, V4, P63, DOI 10.1046/j.1472-4642.1998.00012.x	55	6	6	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57306	10.1371/journal.pone.0057306	http://dx.doi.org/10.1371/journal.pone.0057306			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468965	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400038
J	Habbout, A; Guenancia, C; Lorin, J; Rigal, E; Fassot, C; Rochette, L; Vergely, C				Habbout, Ahmed; Guenancia, Charles; Lorin, Julie; Rigal, Eve; Fassot, Celine; Rochette, Luc; Vergely, Catherine			Postnatal Overfeeding Causes Early Shifts in Gene Expression in the Heart and Long-Term Alterations in Cardiometabolic and Oxidative Parameters	PLOS ONE			English	Article							IMMUNOCYTOCHEMICAL LOCALIZATION; LEPTIN RECEPTOR; PEPTIDE APELIN; NEUROPEPTIDE-Y; BLOOD-PRESSURE; INSULIN; OBESITY; ADIPOSITY; LACTATION; ADULTHOOD	Background: Postnatal overfeeding (OF) in rodents induces a permanent moderate increase in body weight in adulthood. However, the repercussions of postnatal OF on cardiac gene expression, cardiac metabolism and nitro-oxidative stress are less well known. Methodology/Principal Findings: Immediately after birth, litters of C57BL/6 mice were either maintained at 10 (normal-fed group, NF), or reduced to 3 in order to induce OF. At weaning, mice of both groups received a standard diet. The cardiac gene expression profile was determined at weaning and cardiac metabolism and oxidative stress were assessed at 7 months. The cardiac expression of several genes, including members of the extracellular matrix and apelin pathway, was modified in juvenile OF mice. In adult mice, OF led to an increase in body weight (+30%) and to significant increases in plasma cholesterol, insulin and leptin levels. Myocardial oxidative stress, SOD and catalase activity and mRNA expression were increased in OF mice. In vivo, diastolic and systolic blood pressures were significantly higher and LV shortening and ejection fraction were decreased in OF mice. Ex vivo, after 30 min of ischemia, hearts isolated from OF mice showed lower functional recovery and larger infarct size (31% vs. 54%, p<0.05). Increases in collagen deposition and expression/activity of matrix-metalloproteinase-2 were observed in adult OF mouse hearts. Moreover, an increase in the expression of SOCS-3 and a decrease in STAT-3 phosphorylation were observed in ventricular tissues from OF mice. Conclusions/Significance: Our study emphasizes that over-nutrition during the immediate postnatal period in mice leads to early changes in cardiac gene expression, which may permanently modify the heart's structural organization and metabolism and could contribute to a greater susceptibility to myocardial ischemia-reperfusion injury.	[Habbout, Ahmed; Guenancia, Charles; Lorin, Julie; Rigal, Eve; Rochette, Luc; Vergely, Catherine] Univ Burgundy, Fac Med, LPPCM, INSERM,UMR866, Dijon, France; [Habbout, Ahmed; Guenancia, Charles; Lorin, Julie; Rigal, Eve; Rochette, Luc; Vergely, Catherine] Univ Burgundy, Fac Pharm, LPPCM, INSERM,UMR866, Dijon, France; [Fassot, Celine] INSERM, Biol Neurovasc & Mitochondriale Integree UMR1083, Angers, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Vergely, C (corresponding author), Univ Burgundy, Fac Med, LPPCM, INSERM,UMR866, Dijon, France.	cvergely@u-bourgogne.fr	Vergely, Catherine/L-9534-2015; Guenancia, Charles/M-5558-2013; Fassot, Celine/K-1494-2015	Vergely, Catherine/0000-0003-4009-776X; Guenancia, Charles/0000-0002-3554-7714; Rochette, Luc/0000-0001-9973-8803	French Ministry of Research; Institut National de la Sante et de la Recherche Medicale (INSERM); Regional Council of Burgundy	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	This work was supported by grants from the French Ministry of Research, from the Institut National de la Sante et de la Recherche Medicale (INSERM) and from the Regional Council of Burgundy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2007, AM J PHYSIOL-HEART C, V292, pH2387, DOI 10.1152/ajpheart.00579.2006; Aebi H, 1984, Methods Enzymol, V105, P121; Alcazar MAA, 2012, ENDOCRINOLOGY, V153, P1397, DOI 10.1210/en.2011-1670; Balonan LC, 2000, PEDIATR RES, V48, P668, DOI 10.1203/00006450-200011000-00019; Berry MF, 2004, CIRCULATION, V110, pII187, DOI 10.1161/01.CIR.0000138382.57325.5c; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; Dalloz F, 1999, FREE RADICAL BIO MED, V26, P785, DOI 10.1016/S0891-5849(98)00259-7; Davidowa H, 2007, NEUROREPORT, V18, P521, DOI 10.1097/WNR.0b013e32805dfb93; Cunha ACDR, 2009, J NUTR BIOCHEM, V20, P435, DOI 10.1016/j.jnutbio.2008.05.002; Ecarnot-Laubriet Aline, 2003, Heart Dis, V5, P308, DOI 10.1097/01.hdx.0000089836.03515.a9; Fuglesteg BN, 2008, BASIC RES CARDIOL, V103, P444, DOI 10.1007/s00395-008-0728-x; Gualillo O, 2007, TRENDS CARDIOVAS MED, V17, P275, DOI 10.1016/j.tcm.2007.09.005; Habbout A, 2012, BIOCHIMIE, V94, P117, DOI 10.1016/j.biochi.2011.09.023; Hattori R, 2001, J MOL CELL CARDIOL, V33, P1929, DOI 10.1006/jmcc.2001.1456; Hwang DM, 1997, CIRCULATION, V96, P4146; Kappeler L, 2009, ENDOCRINOLOGY, V150, P314, DOI 10.1210/en.2008-0981; Kelly RF, 2010, BASIC RES CARDIOL, V105, P763, DOI 10.1007/s00395-010-0125-0; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Kleinz MJ, 2004, REGUL PEPTIDES, V118, P119, DOI 10.1016/j.regpep.2003.11.002; Laight DW, 1999, EUR J PHARMACOL, V377, P89, DOI 10.1016/S0014-2999(99)00407-0; Lopez M, 2005, DIABETOLOGIA, V48, P140, DOI 10.1007/s00125-004-1596-z; Lorgis L, 2010, ATHEROSCLEROSIS, V213, P616, DOI 10.1016/j.atherosclerosis.2010.09.018; Oudot A, 2006, FREE RADICAL BIO MED, V40, P2214, DOI 10.1016/j.freeradbiomed.2006.02.020; Perego L, 2005, J CLIN ENDOCR METAB, V90, P4087, DOI 10.1210/jc.2004-1963; Pereira RO, 2006, REGUL PEPTIDES, V136, P117, DOI 10.1016/j.regpep.2006.05.002; Plagemann A, 1999, BRAIN RES, V836, P146, DOI 10.1016/S0006-8993(99)01662-5; Rajia S, 2010, J NEUROENDOCRINOL, V22, P905, DOI 10.1111/j.1365-2826.2010.02005.x; Schulze PC, 2003, EUR J HEART FAIL, V5, P33, DOI 10.1016/S1388-9842(02)00177-0; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Suleman N, 2008, CARDIOVASC RES, V79, P127, DOI 10.1093/cvr/cvn067; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Velkoska E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1236, DOI 10.1152/ajpendo.00505.2004; Vergely C, 2001, FREE RADICAL RES, V35, P475, DOI 10.1080/10715760100301491; Vincent HK, 1999, INT J OBESITY, V23, P67, DOI 10.1038/sj.ijo.0800761	36	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56981	10.1371/journal.pone.0056981	http://dx.doi.org/10.1371/journal.pone.0056981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468899	Green Published, gold			2022-12-27	WOS:000315561400019
J	Manzano, D				Manzano, Daniel			Quantum Transport in Networks and Photosynthetic Complexes at the Steady State	PLOS ONE			English	Article							COHERENCE	Recently, several works have analysed the efficiency of photosynthetic complexes in a transient scenario and how that efficiency is affected by environmental noise. Here, following a quantum master equation approach, we study the energy and excitation transport in fully connected networks both in general and in the particular case of the Fenna-Matthew-Olson complex. The analysis is carried out for the steady state of the system where the excitation energy is constantly "flowing" through the system. Steady state transport scenarios are particularly relevant if the evolution of the quantum system is not conditioned on the arrival of individual excitations. By adding dephasing to the system, we analyse the possibility of noise-enhancement of the quantum transport.	[Manzano, Daniel] Univ Granada, Inst Carlos Fis Teor & Computac 1, Granada, Spain; [Manzano, Daniel] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria	University of Granada; University of Innsbruck	Manzano, D (corresponding author), Univ Granada, Inst Carlos Fis Teor & Computac 1, Granada, Spain.	daniel.manzano@uibk.ac.at	Manzano, Daniel/F-5823-2013	Manzano, Daniel/0000-0001-9241-5884	Austrian Science Fund (FWF) [F04011, F04012]; Spanish MEC-FEDER [FIS2009-08451]; Campus de Excelencia Internacional; Junta de Andalucia (Spain) [FQM-165]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Spanish MEC-FEDER(Spanish Government); Campus de Excelencia Internacional; Junta de Andalucia (Spain)(Junta de Andalucia)	The research was funded by the Austrian Science Fund (FWF): F04011 and F04012 and by Spanish MEC-FEDER, project FIS2009-08451, together with the Campus de Excelencia Internacional and the Junta de Andalucia, project FQM-165 (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs T, 2006, BIOPHYS J, V91; Asadian A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012109; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; Breuer F. P. Heinz-Peter, 2002, THEORY OPEN QUANTUM; Brumer P, 2012, P NATL ACAD SCI USA, V109, P19575, DOI 10.1073/pnas.1211209109; Cao JS, 1997, J CHEM PHYS, V107, P3204, DOI 10.1063/1.474670; Caruso F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3223548; Caruso F, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.062346; Chin AW, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065002; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Jacobs K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.040106; Linden N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.130401; Mancal L, 2010, NJP, V12; Manzano D, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.061118; Mohseni M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3002335; Olaya-Castro A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085115; Panitchayangkoon G, 2010, P NATL ACAD SCI USA, V107, P12766, DOI 10.1073/pnas.1005484107; Plenio S, 2008, J NEW PHYS, V10; Rebentrost P, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033003; Rivas A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113032; Scholak T, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/18/184012; Scholak T, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021912; Tiersch M, 2012, PHILOS T R SOC A, V370, P3771, DOI 10.1098/rsta.2011.0202; Wu JL, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/105012	25	39	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57041	10.1371/journal.pone.0057041	http://dx.doi.org/10.1371/journal.pone.0057041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468907	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400023
J	Seabloom, EW; Borer, ET; Lacroix, C; Mitchell, CE; Power, AG				Seabloom, Eric W.; Borer, Elizabeth T.; Lacroix, Christelle; Mitchell, Charles E.; Power, Alison G.			Richness and Composition of Niche-Assembled Viral Pathogen Communities	PLOS ONE			English	Article							BARLEY-YELLOW-DWARF; WEST-NILE-VIRUS; INFECTIOUS-DISEASE; SPECIES-DIVERSITY; PLANT-DISEASE; HEPATITIS-C; T-CELL; HOST; COMPETITION; CALIFORNIA	The pathogen and parasite community that inhabits every free-living organism can control host vital rates including lifespan and reproductive output. To date, however, there have been few experiments examining pathogen community assembly replicated at large-enough spatial scales to inform our understanding of pathogen dynamics in natural systems. Pathogen community assembly may be driven by neutral stochastic colonization and extinction events or by niche differentiation that constrains pathogen distributions to particular environmental conditions, hosts, or vectors. Here, we present results from a regionally-replicated experiment investigating the community of barley and cereal yellow dwarf viruses (B/CYDV's) in over 5000 experimentally planted individuals of six grass species along a 700 km latitudinal gradient along the Pacific coast of North America (USA) in response to experimentally manipulated nitrogen and phosphorus supplies. The composition of the virus community varied predictably among hosts and across nutrient-addition treatments, indicating niche differentiation among virus species. There were some concordant responses among the viral species. For example, the prevalence of most viral species increased consistently with perennial grass cover, leading to a 60% increase in the richness of the viral community within individual hosts (i.e., coinfection) in perennial-dominated plots. Furthermore, infection rates of the six host species in the field were highly correlated with vector preferences assessed in laboratory trials. Our results reveal the importance of niche differentiation in structuring virus assemblages. Virus species distributions reflected a combination of local host community composition, host species-specific vector preferences, and virus responses to host nutrition. In addition, our results suggest that heterogeneity among host species in their capacity to attract vectors or support pathogens between growing seasons can lead to positive covariation among virus species.	[Seabloom, Eric W.; Borer, Elizabeth T.; Lacroix, Christelle] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Mitchell, Charles E.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Power, Alison G.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; Cornell University	Seabloom, EW (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	seabloom@umn.edu	Mitchell, Charles E/I-3709-2014; Lacroix, Christelle/G-9569-2011	Mitchell, Charles E/0000-0002-1633-1993; Lacroix, Christelle/0000-0001-8808-4752; Seabloom, Eric/0000-0001-6780-9259; Borer, Elizabeth/0000-0003-2259-5853	National Science Foundation (NSF) as part of the joint NSF-National Institutes of Health Ecology of Infectious Disease program [EF-0525666, DEB-1015805, EF-05-25641, DEB-10-15909, EF-0525669, DEB-1015903]	National Science Foundation (NSF) as part of the joint NSF-National Institutes of Health Ecology of Infectious Disease program(National Science Foundation (NSF))	Support for this project was provided, in part, by National Science Foundation (NSF) grants EF-0525666 and DEB-1015805 to E. T. Borer and E. W. Seabloom, EF-05-25641 and DEB-10-15909 to C. E. Mitchell, and EF-0525669 and DEB-1015903 to A. G. Power as part of the joint NSF-National Institutes of Health Ecology of Infectious Disease program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 1978, PLANT PATHOLOGY; Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Al-Naimi FA, 2005, OECOLOGIA, V143, P449, DOI 10.1007/s00442-004-1814-x; Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2010, R LANG ENV STAT COMP; Beck MA, 2000, J INFECT DIS, V182, pS93, DOI 10.1086/315918; Bentwich Z, 1999, IMMUNOL TODAY, V20, P485, DOI 10.1016/S0167-5699(99)01499-1; Borer ET, 2007, P NATL ACAD SCI USA, V104, P5473, DOI 10.1073/pnas.0608573104; Borer ET, 2010, ECOL LETT, V13, P810, DOI 10.1111/j.1461-0248.2010.01475.x; Borer ET, 2009, ECOL APPL, V19, P1187, DOI 10.1890/08-1205.1; Borer ET, 2009, P NATL ACAD SCI USA, V106, P503, DOI 10.1073/pnas.0808778106; Borer ET, 2011, ECOHEALTH; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; Carlsson-Graner U, 2006, EVOL ECOL RES, V8, P659; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Clasen JL, 2007, FRESHWATER BIOL, V52, P112, DOI 10.1111/j.1365-2427.2006.01677.x; COLHOUN J, 1973, ANNU REV PHYTOPATHOL, V11, P343, DOI 10.1146/annurev.py.11.090173.002015; Crawley M.J., 2007, R BOOK; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Cumming GS, 2006, ECOHEALTH, V3, P163, DOI 10.1007/s10393-006-0028-6; D'Arcy C. J., 1995, BARLEY YELLOW DWARF, P9; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Dobson A, 2006, PLOS MED, V3, P714, DOI 10.1371/journal.pmed.0030231; Dodds P, 2009, FUNCT PLANT BIOL, V36, P395, DOI 10.1071/FP08320; Dove ADM, 2006, TRENDS PARASITOL, V22, P568, DOI 10.1016/j.pt.2006.09.008; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; FLOR HH, 1955, PHYTOPATHOLOGY, V45, P680; Gaidet N, 2012, P ROY SOC B-BIOL SCI, V279, P1131, DOI 10.1098/rspb.2011.1417; Garcia-Arenal F, 2003, INT MICROBIOL, V6, P225, DOI 10.1007/s10123-003-0142-z; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Halbert Susan, 1995, P217; Hall GS, 2010, PLANT PATHOL, V59, P1152, DOI 10.1111/j.1365-3059.2010.02351.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Hood ME, 2003, AM NAT, V162, P122, DOI 10.1086/375539; IRWIN ME, 1990, ANNU REV PHYTOPATHOL, V28, P393, DOI 10.1146/annurev.py.28.090190.002141; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Jones LR, 1924, AM J BOT, V11, P601, DOI 10.2307/2435541; Kamal SM, 2001, J INFECT DIS, V184, P972, DOI 10.1086/323352; Kamal SM, 2001, GASTROENTEROLOGY, V121, P646, DOI 10.1053/gast.2001.27024; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Kniskern JM, 2006, ECOLOGY, V87, P675, DOI 10.1890/05-1327; Kosova K, 2008, CZECH J GENET PLANT, V44, P1, DOI 10.17221/6/2008-CJGPB; LAL RB, 1994, CLIN DIAGN LAB IMMUN, V1, P5, DOI 10.1128/CDLI.1.1.5-10.1994; Laneri K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000898; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Lindenfors P, 2007, GLOBAL ECOL BIOGEOGR, V16, P496, DOI 10.1111/j.1466-8238.2006.00301.x; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; Malmstrom CM, 2005, NEW PHYTOL, V168, P217, DOI 10.1111/j.1469-8137.2005.01479.x; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Miller WA, 1997, ANNU REV PHYTOPATHOL, V35, P167, DOI 10.1146/annurev.phyto.35.1.167; Minakawa N, 2006, AM J TROP MED HYG, V75, P448, DOI 10.4269/ajtmh.2006.75.448; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Pope K, 2005, ECOL APPL, V15, P1223, DOI 10.1890/04-0934; POULIN R, 1995, ECOL MONOGR, V65, P283, DOI 10.2307/2937061; Power A.G., 2003, IMPORTANCE SPECIES P, P330; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Power AG, 1996, ECOLOGY, V77, P1004, DOI 10.2307/2265571; Rizzo DM, 2003, FRONT ECOL ENVIRON, V1, P197, DOI 10.1890/1540-9295(2003)001[0197:SODECA]2.0.CO;2; ROCHOW WF, 1970, SCIENCE, V167, P875, DOI 10.1126/science.167.3919.875; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sacristan S, 2008, MOL PLANT PATHOL, V9, P369, DOI 10.1111/J.1364-3703.2007.00460.X; Scholz M, 2009, THEOR APPL GENET, V119, P837, DOI 10.1007/s00122-009-1093-3; Seabloom EW, 2006, ECOL APPL, V16, P1338, DOI 10.1890/1051-0761(2006)016[1338:HIPIAI]2.0.CO;2; Seabloom EW, 2010, ECOLOGY, V91, P721, DOI 10.1890/08-2170.1; Seabloom EW, 2009, J ECOL, V97, P1264, DOI 10.1111/j.1365-2745.2009.01550.x; Seabloom EW, 2009, AM NAT, V173, pE79, DOI 10.1086/596529; SERVICE MW, 1991, REV SAUDE PUBL, V25, P165, DOI 10.1590/S0034-89101991000300002; Smith VH, 2005, FRONT ECOL ENVIRON, V3, P268; SOTA T, 1989, MED VET ENTOMOL, V3, P337, DOI 10.1111/j.1365-2915.1989.tb00240.x; Springer YP, 2007, OECOLOGIA, V151, P10, DOI 10.1007/s00442-006-0566-1; STRONG DR, 1975, P NATL ACAD SCI USA, V72, P2116, DOI 10.1073/pnas.72.6.2116; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Thrall PH, 2003, PLANT PATHOL, V52, P350, DOI 10.1046/j.1365-3059.2003.00863.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tirado SMC, 2003, VIRAL IMMUNOL, V16, P69, DOI 10.1089/088282403763635465; Tompkins DM, 2003, ECOL LETT, V6, P189, DOI 10.1046/j.1461-0248.2003.00417.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WEN F, 1991, J GEN VIROL, V72, P791, DOI 10.1099/0022-1317-72-4-791; Yoshida-Takashima Y, 2012, APPL ENVIRON MICROB, V78, P1311, DOI 10.1128/AEM.06491-11; Zhang ZY, 2009, J GENET GENOMICS, V36, P567, DOI 10.1016/S1673-8527(08)60148-4	91	24	25	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e55675	10.1371/journal.pone.0055675	http://dx.doi.org/10.1371/journal.pone.0055675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468848	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400005
J	Alexandrescu, AT				Alexandrescu, Andrei T.			Amide Proton Solvent Protection in Amylin Fibrils Probed by Quenched Hydrogen Exchange NMR	PLOS ONE			English	Article							ISLET-AMYLOID-POLYPEPTIDE; GENE-RELATED PEPTIDE; ALPHA-HELIX; PROTEIN; FOLD; CONFORMATION; MECHANISM; MUTATION; MODEL; DEATH	Amylin is an endocrine hormone that accumulates in amyloid plaques in patients with advanced type 2 diabetes. The amyloid plaques have been implicated in the destruction of pancreatic beta-cells, which synthesize amylin and insulin. To better characterize the secondary structure of amylin in amyloid fibrils we assigned the NMR spectrum of the unfolded state in 95% DMSO and used a quenched hydrogen-deuterium exchange technique to look at amide proton solvent protection in the fibrils. In this technique, partially exchanged fibrils are dissolved in 95% DMSO and information about amide proton occupancy in the fibrils is determined from DMSO-denatured monomers. Hydrogen exchange lifetimes at pH 7.6 and 37 degrees C vary between similar to 5 h for the unstructured N-terminus to 600 h for amide protons in the two beta-strands that form intermolecular hydrogen bonds between amylin monomers along the length of the fibril. Based on the protection data we conclude that residues A8-H18 and I26-Y37 comprise the two beta-strands in amylin fibrils. There is variation in protection within the beta-strands, particularly for strand beta 1 where only residues F15-H18 are strongly protected. Differences in protection appear to be due to restrictions on backbone dynamics imposed by the packing of two-layers of C2-symmetry-related beta-hairpins in the protofilament structure, with strand beta 1 positioned on the surface and beta 2 in the interior.	Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Alexandrescu, AT (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	andrei@uconn.edu			American Diabetes Association Basic Science Award [1-10-BS-04]	American Diabetes Association Basic Science Award(American Diabetes Association)	Funding provided by American Diabetes Association Basic Science Award 1-10-BS-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2005, BIOCHEMISTRY-US, V44, P16284, DOI 10.1021/bi051432v; Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Alexandrescu A T, 2001, Pac Symp Biocomput, P67; ALEXANDRESCU AT, 2008, PROTEIN MISFOLDING; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Brender JR, 2008, BIOCHEMISTRY-US, V47, P12680, DOI 10.1021/bi801427c; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; COOPER GJS, 1994, ENDOCR REV, V15, P163, DOI 10.1210/er.15.2.163; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Damo SM, 2010, J BIOL CHEM, V285, P32303, DOI 10.1074/jbc.M110.114504; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Engel MFM, 2009, CHEM PHYS LIPIDS, V160, P1, DOI 10.1016/j.chemphyslip.2009.03.008; Englander SW, 1997, PROTEIN SCI, V6, P1101, DOI 10.1002/pro.5560060517; Guardino KM, 2009, INT J MOL SCI, V10, P2412, DOI 10.3390/ijms10052412; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; IDF Diabetes Atlas, 2011, IDF DIAB ATL; Jaravine VA, 2000, PROTEIN SCI, V9, P290; Jha S, 2011, J BIOL CHEM, V286, P22894, DOI 10.1074/jbc.M110.215814; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Lin YS, 2009, J PHYS CHEM B, V113, P592, DOI 10.1021/jp807528q; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Meng FL, 2008, BIOCHEMISTRY-US, V47, P6016, DOI 10.1021/bi702518m; Morgan GJ, 2008, J MOL BIOL, V375, P487, DOI 10.1016/j.jmb.2007.10.033; Moriarty DF, 1999, BIOCHEMISTRY-US, V38, P1811, DOI 10.1021/bi981658g; Newgard CB, 2010, NAT MED, V16, P388, DOI 10.1038/nm0410-388; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Padrick SB, 2001, J MOL BIOL, V308, P783, DOI 10.1006/jmbi.2001.4608; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wang L, 2011, J AM CHEM SOC, V133, P16062, DOI 10.1021/ja204035k; Watson E, 2007, BIOCHEMISTRY-US, V46, P9484, DOI 10.1021/bi700532j; WESTERMARK P, 1986, BIOCHEM BIOPH RES CO, V140, P827, DOI 10.1016/0006-291X(86)90708-4; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Wilson LM, 2007, J MOL BIOL, V366, P1639, DOI 10.1016/j.jmb.2006.12.040; Yang LW, 2006, NUCLEIC ACIDS RES, V34, pW24, DOI 10.1093/nar/gkl084; ZHANG YZ, 1995, PROTEIN SCI, V4, P804	45	28	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56467	10.1371/journal.pone.0056467	http://dx.doi.org/10.1371/journal.pone.0056467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457571	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700056
J	Chitrampalam, P; Inderbitzin, P; Maruthachalam, K; Wu, BM; Subbarao, KV				Chitrampalam, Periasamy; Inderbitzin, Patrik; Maruthachalam, Karunakaran; Wu, Bo-Ming; Subbarao, Krishna V.			The Sclerotinia sclerotiorum Mating Type Locus (MAT) Contains a 3.6-kb Region That Is Inverted in Every Meiotic Generation	PLOS ONE			English	Article							ASCOSPORE DIMORPHISM; DROSOPHILA INVERSION; NEUROSPORA-CRASSA; GENE; RECOGNITION; LETTUCE; FUNGUS; COMPATIBILITY; STRATEGIES; EVOLUTION	Sclerotinia sclerotiorum is a fungal plant pathogen and the causal agent of lettuce drop, an economically important disease of California lettuce. The structure of the S. sclerotiorum mating type locus MAT has previously been reported and consists of two idiomorphs that are fused end-to-end as in other homothallics. We investigated the diversity of S. sclerotiorum MAT using a total of 283 isolates from multiple hosts and locations, and identified a novel MAT allele that differed by a 3.6-kb inversion and was designated Inv+, as opposed to the previously known S. sclerotiorum MAT that lacked the inversion and was Inv-. The inversion affected three of the four MAT genes: MAT1-2-1 and MAT1-2-4 were inverted and MAT1-1-1 was truncated at the 3'-end. Expression of MAT genes differed between Inv+ and Inv-isolates. In Inv+ isolates, only one of the three MAT1-2-1 transcript variants of Inv- isolates was detected, and the alpha1 domain of Inv+ MAT1-1-1 transcripts was truncated. Both Inv- and Inv+ isolates were self-fertile, and the inversion segregated in a 1:1 ratio regardless of whether the parent was Inv- or Inv+. This suggested the involvement of a highly regulated process in maintaining equal proportions of Inv- and Inv+, likely associated with the sexual state. The MAT inversion region, defined as the 3.6-kb MAT inversion in Inv+ isolates and the homologous region of Inv- isolates, was flanked by a 250-bp inverted repeat on either side. The 250-bp inverted repeat was a partial MAT1-1-1 that through mediation of loop formation and crossing over, may be involved in the inversion process. Inv+ isolates were widespread, and in California and Nebraska constituted half of the isolates examined. We speculate that a similar inversion region may be involved in mating type switching in the filamentous ascomycetes Chromocrea spinulosa, Sclerotinia trifoliorum and in certain Ceratocystis species.	[Chitrampalam, Periasamy; Inderbitzin, Patrik; Maruthachalam, Karunakaran; Wu, Bo-Ming; Subbarao, Krishna V.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Subbarao, KV (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	kvsubbarao@ucdavis.edu	Subbarao, Krishna/X-3870-2019	Subbarao, Krishna/0000-0002-2075-1835	California Leafy Greens Board [2011-05, 2011-06]	California Leafy Greens Board	Financial support for this research was provided by the California Leafy Greens Board (www.caleafygreens.ca.gov/), contracts 2011-05 and 2011-06. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PB, 1979, PHYTOPATHOLOGY, V69, P896, DOI 10.1094/Phyto-69-896; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Andrew M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029943; Arnaise S, 1997, MOL GEN GENET, V256, P169, DOI 10.1007/PL00008611; Betley JN, 2002, CURR BIOL, V12, P1756, DOI 10.1016/S0960-9822(02)01220-4; Bidard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021476; BISTIS GN, 1981, MYCOLOGIA, V73, P959, DOI 10.2307/3759806; Bobrowicz P, 2002, MOL MICROBIOL, V45, P795, DOI 10.1046/j.1365-2958.2002.03052.x; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Bourdot GW, 2001, BIOCONTROL SCI TECHN, V11, P119, DOI 10.1080/09583150020029808; Codron D, 1974, ANN SCI NATURELLES B, P12; Debuchy R, 1999, FUNGAL GENET BIOL, V27, P218, DOI 10.1006/fgbi.1999.1142; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; DRAYTON FL, 1952, MYCOLOGIA, V44, P119, DOI 10.1080/00275514.1952.12024177; Drummond A.J., 2010, GENEIOUS V4 8 5; Ekins M, 2006, MYCOL RES, V110, P1193, DOI 10.1016/j.mycres.2006.07.014; Faretra F, 1996, MYCOL RES, V100, P620, DOI 10.1016/S0953-7562(96)80018-9; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; FORD EJ, 1995, MYCOL RES, V99, P241, DOI 10.1016/S0953-7562(09)80893-9; Garza E, 2011, WORLD J MICROB BIOT, V27, P449, DOI 10.1007/s11274-010-0451-2; GLASS NL, 1988, SCIENCE, V241, P570, DOI 10.1126/science.2840740; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; Guillen Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-53; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Harrington TC, 1997, CURR GENET, V32, P52, DOI 10.1007/s002940050247; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Hoang ML, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001228; HolstJensen A, 1997, MYCOLOGIA, V89, P885, DOI 10.2307/3761109; Hurles ME, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P341, DOI 10.1007/978-1-59745-039-3_24; Inderbitzin P, 2005, P NATL ACAD SCI USA, V102, P11390, DOI 10.1073/pnas.0501918102; Inderbitzin P, 2006, CAN J BOT, V84, P1304, DOI 10.1139/B06-067; Keszthelyi A, 2007, ANTON LEEUW INT J G, V91, P373, DOI 10.1007/s10482-006-9123-5; Klix V, 2010, EUKARYOT CELL, V9, P894, DOI 10.1128/EC.00019-10; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LESLIE JF, 1986, PHYTOPATHOLOGY, V76, P1142; Leubner-Metzger G, 1997, MOL GEN GENET, V256, P661, DOI 10.1007/s004380050614; Lu SW, 2011, FUNGAL GENET BIOL, V48, P714, DOI 10.1016/j.fgb.2011.04.006; Malvarez G, 2007, PHYTOPATHOLOGY, V97, P470, DOI 10.1094/PHYTO-97-4-0470; Martin T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015199; MATHIESON MJ, 1952, ANN BOT-LONDON, V16, P449, DOI 10.1093/oxfordjournals.aob.a083327; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; PERKINS DD, 1987, GENETICS, V115, P215; Poggeler S, 2006, MOL GENET GENOMICS, V275, P492, DOI 10.1007/s00438-006-0107-y; Puig M, 2004, P NATL ACAD SCI USA, V101, P9013, DOI 10.1073/pnas.0403090101; PURDY LH, 1979, PHYTOPATHOLOGY, V69, P875, DOI 10.1094/Phyto-69-875; Raju NB, 2009, J BIOSCIENCES, V34, P139, DOI 10.1007/s12038-009-0015-5; RAJU NB, 1980, EUR J CELL BIOL, V23, P208; Raju NB, 2000, FUNGAL GENET BIOL, V30, P213, DOI 10.1006/fgbi.2000.1217; Sambrook J., 2001, MOL CLONING; Samuels GJ, 1996, MYCOLOGIA, V88, P302, DOI 10.2307/3760935; Schafer MR, 2006, MYCOLOGIA, V98, P593, DOI 10.3852/mycologia.98.4.593; Selden RF, 1989, SHORT PROTOCOLS MOL, P75; Shiu PKT, 2000, CURR OPIN MICROBIOL, V3, P183, DOI 10.1016/S1369-5274(00)00073-4; SIMON M, 1980, SCIENCE, V209, P1370, DOI 10.1126/science.6251543; Subbarao KV, 1998, PLANT DIS, V82, P1068, DOI 10.1094/PDIS.1998.82.10.1068; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turgeon B. Gillian, 2007, P93; TURGEON BG, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P199; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; UHM JY, 1983, PHYTOPATHOLOGY, V73, P565, DOI 10.1094/Phyto-73-565; UHM JY, 1983, PHYTOPATHOLOGY, V73, P569, DOI 10.1094/Phyto-73-569; Witthuhn RC, 2000, CURR GENET, V38, P48, DOI 10.1007/s002940000131; Woudenberg JHC, 2012, MOL PLANT PATHOL, V13, P350, DOI 10.1111/j.1364-3703.2011.00751.x; Wu BM, 2007, MYCOLOGIA, V99, P33, DOI 10.3852/mycologia.99.1.33; Wu BM, 2006, PHYTOPATHOLOGY, V96, P1322, DOI 10.1094/PHYTO-96-1322; YODER OC, 1986, PHYTOPATHOLOGY, V76, P383, DOI 10.1094/Phyto-76-383; Yun SH, 1999, P NATL ACAD SCI USA, V96, P5592, DOI 10.1073/pnas.96.10.5592; Yun SH, 2000, FUNGAL GENET BIOL, V31, P7, DOI 10.1006/fgbi.2000.1226; ZICKLER D, 1995, GENETICS, V140, P493	71	40	47	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56895	10.1371/journal.pone.0056895	http://dx.doi.org/10.1371/journal.pone.0056895			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457637	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700095
J	Varadarajan, S; Tanaka, K; Smalley, JL; Bampton, ETW; Pellecchia, M; Dinsdale, D; Willars, GB; Cohen, GM				Varadarajan, Shankar; Tanaka, Kayoko; Smalley, Joshua L.; Bampton, Edward T. W.; Pellecchia, Maurizio; Dinsdale, David; Willars, Gary B.; Cohen, Gerald M.			Endoplasmic Reticulum Membrane Reorganization Is Regulated by Ionic Homeostasis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; SPINDLE POLE BODY; 2-AMINOETHOXYDIPHENYL BORATE; CA2+ ENTRY; CALMODULIN ANTAGONISTS; STRESS-RESPONSE; SMALL MOLECULES; CALCIUM-UPTAKE; CELLS; BCL-2	Recently we described a new, evolutionarily conserved cellular stress response characterized by a reversible reorganization of endoplasmic reticulum (ER) membranes that is distinct from canonical ER stress and the unfolded protein response (UPR). Apogossypol, a putative broad spectrum BCL-2 family antagonist, was the prototype compound used to induce this ER membrane reorganization. Following microarray analysis of cells treated with apogossypol, we used connectivity mapping to identify a wide range of structurally diverse chemicals from different pharmacological classes and established their ability to induce ER membrane reorganization. Such structural diversity suggests that the mechanisms initiating ER membrane reorganization are also diverse and a major objective of the present study was to identify potentially common features of these mechanisms. In order to explore this, we used hierarchical clustering of transcription profiles for a number of chemicals that induce membrane reorganization and discovered two distinct clusters. One cluster contained chemicals with known effects on Ca2+ homeostasis. Support for this was provided by the findings that ER membrane reorganization was induced by agents that either deplete ER Ca2+ (thapsigargin) or cause an alteration in cellular Ca2+ handling (calmodulin antagonists). Furthermore, overexpression of the ER luminal Ca2+ sensor, STIM1, also evoked ER membrane reorganization. Although perturbation of Ca2+ homeostasis was clearly one mechanism by which some agents induced ER membrane reorganization, influx of extracellular Na+ but not Ca2+ was required for ER membrane reorganization induced by apogossypol and the related BCL-2 family antagonist, TW37, in both human and yeast cells. Not only is this novel, non-canonical ER stress response evolutionary conserved but so also are aspects of the mechanism of formation of ER membrane aggregates. Thus perturbation of ionic homeostasis is important in the regulation of ER membrane reorganization.	[Varadarajan, Shankar; Smalley, Joshua L.; Bampton, Edward T. W.; Dinsdale, David; Cohen, Gerald M.] Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England; [Tanaka, Kayoko; Cohen, Gerald M.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Willars, Gary B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Pellecchia, Maurizio] Sanford Burnham Inst, La Jolla, CA USA	University of Leicester; University of Leicester; University of Leicester; Sanford Burnham Prebys Medical Discovery Institute	Cohen, GM (corresponding author), Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England.	gmc2@le.ac.uk	Pellecchia, Maurizio/Y-7072-2018; Smalley, Joshua L./ABF-8150-2020	Smalley, Joshua/0000-0002-7437-6655; VARADARAJAN, SHANKAR/0000-0002-8827-6567; Tanaka, Kayoko/0000-0002-2905-3603; Smalley, Joshua/0000-0002-5642-3948	Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C, 1993, EXPT FISSION YEAST L; Barata H, 1999, MOL CELL BIOCHEM, V195, P227, DOI 10.1023/A:1006953126740; Bartolommei G, 2006, J BIOL CHEM, V281, P9547, DOI 10.1074/jbc.M510550200; Becattini B, 2004, CHEM BIOL, V11, P389, DOI 10.1016/j.chembiol.2004.02.020; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bilmen JG, 2002, BIOCHEM J, V366, P255, DOI 10.1042/bj20020431; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Choi SY, 2001, BRIT J PHARMACOL, V132, P411, DOI 10.1038/sj.bjp.0703840; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Distelhorst CW, 2004, ONCOGENE, V23, P2875, DOI 10.1038/sj.onc.1207519; ELENO N, 1987, AGENTS ACTIONS, V22, P189, DOI 10.1007/BF02009045; Funaya C, 2012, CURR BIOL, V22, P562, DOI 10.1016/j.cub.2012.02.042; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Godoy C, 1996, YEAST, V12, P983, DOI 10.1002/(SICI)1097-0061(199608)12:10<983::AID-YEA2>3.0.CO;2-D; Gonzalez Y, 2009, J CELL SCI, V122, P2464, DOI 10.1242/jcs.049999; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; ITOH H, 1984, J BIOCHEM-TOKYO, V96, P1721, DOI 10.1093/oxfordjournals.jbchem.a135004; Khan SZ, 2000, BIOCHEM PHARMACOL, V60, P1797, DOI 10.1016/S0006-2952(00)00505-0; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Kucherenko Y, 2012, CELL PHYSIOL BIOCHEM, V30, P407, DOI 10.1159/000339034; Kuum M, 2012, J CELL SCI, V125, P625, DOI 10.1242/jcs.090126; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; MARTINEZ F, 1993, COMP BIOCHEM PHYS C, V104, P165, DOI 10.1016/0742-8413(93)90129-9; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Miwa S, 2000, CARDIOVASC DRUG REV, V18, P61; Peppiatt CM, 2004, BIOCHEM J, V381, P929, DOI 10.1042/BJ20040097; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Shuttleworth TJ, 2009, CELL CALCIUM, V45, P602, DOI 10.1016/j.ceca.2009.02.001; Smyth JT, 2012, CURR BIOL, V22, P1487, DOI 10.1016/j.cub.2012.05.057; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Sprocati T, 2006, J CELL SCI, V119, P3249, DOI 10.1242/jcs.03058; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; VANDONSELAAR M, 1994, NAT STRUCT BIOL, V1, P795, DOI 10.1038/nsb1194-795; Varadarajan S, 2012, CELL DEATH DIFFER, V19, P1896, DOI 10.1038/cdd.2012.108; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; WILCOX RA, 1993, MOL PHARMACOL, V44, P810; Xu SZ, 2005, BRIT J PHARMACOL, V145, P405, DOI 10.1038/sj.bjp.0706197	56	21	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56603	10.1371/journal.pone.0056603	http://dx.doi.org/10.1371/journal.pone.0056603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457590	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700064
J	Kuhlmann, L; Foster, BL; Liley, DTJ				Kuhlmann, Levin; Foster, Brett L.; Liley, David T. J.			Modulation of Functional EEG Networks by the NMDA Antagonist Nitrous Oxide	PLOS ONE			English	Article							PROPOFOL ANESTHESIA; GENERAL-ANESTHESIA; CONNECTIVITY; MECHANISMS; GENUINE; STATES; INDEX; SLOW	Parietal networks are hypothesised to play a central role in the cortical information synthesis that supports conscious experience and behavior. Significant reductions in parietal level functional connectivity have been shown to occur during general anesthesia with propofol and a range of other GABAergic general anesthetic agents. Using two analysis approaches (1) a graph theoretic analysis based on surrogate-corrected zero-lag correlations of scalp EEG, and (2) a global coherence analysis based on the EEG cross-spectrum, we reveal that sedation with the NMDA receptor antagonist nitrous oxide (N2O), an agent that has quite different electroencephalographic effects compared to the inductive general anesthetics, also causes significant alterations in parietal level functional networks, as well as changes in full brain and frontal level networks. A total of 20 subjects underwent N2O inhalation at either 20%, 40% or 60% peak N2O/O-2 gas concentration levels. N2O-induced reductions in parietal network level functional connectivity (on the order of 50%) were exclusively detected by utilising a surface Laplacian derivation, suggesting that superficial, smaller spatial scale, cortical networks were most affected. In contrast reductions in frontal network functional connectivity were optimally discriminated using a common-reference derivation (reductions on the order of 10%), indicating that the NMDA antagonist N2O induces spatially coherent and widespread perturbations in frontal activity. Our findings not only give important weight to the idea of agent invariant final network changes underlying drug-induced reductions in consciousness, but also provide significant impetus for the application and development of multiscale functional analyses to systematically characterise the network level cortical effects of NMDA receptor related hypofunction. Future work at the source space level will be needed to verify the consistency between cortical network changes seen at the source level and those presented here at the EEG sensor space level.	[Kuhlmann, Levin; Liley, David T. J.] Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Hawthorn, Vic 3122, Australia; [Foster, Brett L.] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA	Swinburne University of Technology; Stanford University	Liley, DTJ (corresponding author), Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Hawthorn, Vic 3122, Australia.	dliley@swin.edu.au	Kuhlmann, Levin/N-7418-2015; Kuhlmann, Levin/P-8769-2019	Kuhlmann, Levin/0000-0002-5108-6348; Kuhlmann, Levin/0000-0002-5108-6348	Swinburne University of Technology	Swinburne University of Technology	This work was supported by Swinburne University of Technology intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; Barrett AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029072; Bokil H, 2010, J NEUROSCI METH, V192; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Brown EN, 2011, ANNU REV NEUROSCI, V34, P601, DOI 10.1146/annurev-neuro-060909-153200; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cimenser A, 2011, P NATL ACAD SCI USA, V108, P8832, DOI 10.1073/pnas.1017041108; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deng S, 2012, IEEE T BIOMED ENG; Deshpande G, 2010, BRAIN RES, V1318, P110, DOI 10.1016/j.brainres.2009.12.075; FEIN G, 1988, ELECTROEN CLIN NEURO, V69, P581, DOI 10.1016/0013-4694(88)90171-X; FIELD LM, 1993, BRIT J ANAESTH, V70, P154, DOI 10.1093/bja/70.2.154; Fitzgibbon S., 2012, IEEE T BIOMED ENG; Foster BL, 2013, CLIN NEUROPHYSIOL, V124, P417, DOI 10.1016/j.clinph.2012.08.007; Foster BL, 2011, ANESTH ANALG, V113, P758, DOI 10.1213/ANE.0b013e318227b688; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Gorunescu F, 2011, INTEL SYST REF LIBR, P1, DOI 10.1007/978-3-642-19721-5; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; HORNBEIN TF, 1982, ANESTH ANALG, V61, P553; Hudetz A, 2010, SUPPRESSING THE MIND: ANESTHETIC MODULATION OF MEMORY AND CONSCIOUSNESS, P1, DOI 10.1007/978-1-60761-462-3_1; Jain A. K., 1989, FUNDAMENTALS DIGITAL; Jelles B, 2008, CLIN NEUROPHYSIOL, V119, P837, DOI 10.1016/j.clinph.2007.12.002; Jevtovic-Todorovic V, 1998, NAT MED, V4, P460, DOI 10.1038/nm0498-460; John ER, 2001, CONSCIOUS COGN, V10, P165, DOI 10.1006/ccog.2001.0507; KATOH T, 1993, ANESTH ANALG, V77, P1012; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; Lagerlund TD, 2005, ELECTROENCEPHALOGRAP, P829; Langsjo JW, 2012, J NEUROSCI, V32, P4935, DOI 10.1523/JNEUROSCI.4962-11.2012; Lee U, 2011, ANESTHESIOLOGY, V114, P872, DOI 10.1097/ALN.0b013e31821102c9; Messner M, 2003, ANESTH ANALG, V97, P488, DOI 10.1213/01.ANE.0000072741.78244.C0; Mitra P., 2007, OBSERVED BRAIN DYNAM; Muller M, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/10009; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Murrough JW, 2010, NAT MED, V16, P1384, DOI 10.1038/nm1210-1384; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Perouansky M, 2010, MILLERS ANESTHESIA, P515; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P671, DOI 10.1097/00000542-199809000-00017; Reinstrup P, 2008, BRIT J ANAESTH, V100, P66, DOI 10.1093/bja/aem334; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Rummel C, 2010, J NEUROSCI METH, V191, P94, DOI 10.1016/j.jneumeth.2010.05.022; Sanders RD, 2012, ANESTHESIOLOGY, V116, P946, DOI 10.1097/ALN.0b013e318249d0a7; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Schroter M, 2012, J NEUROSCI, V32; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Tandonnet C, 2005, CLIN NEUROPHYSIOL, V116, P18, DOI 10.1016/j.clinph.2004.07.021; TINKER JH, 1977, ANESTHESIOLOGY, V46, P252, DOI 10.1097/00000542-197704000-00005; YAMAMURA T, 1981, ANESTH ANALG, V60, P283; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	54	21	22	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56434	10.1371/journal.pone.0056434	http://dx.doi.org/10.1371/journal.pone.0056434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457568	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700073
J	van der Aa, NE; Benders, MJNL; Vincken, KL; Groenendaal, F; de Vries, LS				van der Aa, Niek E.; Benders, Manon J. N. L.; Vincken, Koen L.; Groenendaal, Floris; de Vries, Linda S.			The Course of Apparent Diffusion Coefficient Values following Perinatal Arterial Ischemic Stroke	PLOS ONE			English	Article							NEONATAL CEREBRAL INFARCTION; MAGNETIC-RESONANCE; HYPOXIA-ISCHEMIA; BRAIN-INJURY; TENSOR MRI; TRANSIENT; EVOLUTION; LESIONS; TIME; INSIGHTS	Background: Diffusion weighted MR imaging (DWI) plays an important role in the diagnosis of perinatal arterial ischemic stroke (PAIS) during the acute phase. Its derived apparent diffusion coefficient (ADC) can be used to quantify the diffusion restriction. Aim of the current study was to identify the changes in ADC values in the acute phase following PAIS. Methods: A cohort of 36 infants with a confirmed PAIS who were examined once during the first ten days of life was studied. ADC values in the core of the ischemic tissue (iADC) were determined and correlated with postnatal age. ADC ratios (rADC) were calculated by dividing the iADC value by the ADC value of the corresponding area in the contralateral 'healthy' hemisphere. Results: Infants were scanned between days two and ten. A non-linear increase in iADC and rADC values was observed over time and large middle cerebral artery strokes resulted in lower iADC and rADC values. Normalisation of rADC values was observed after day seven. rADC values were lower when compared to previously published rADC values of infants with hypoxic ischemic encephalopathy, suggesting more severe injury. Conclusions: Following PAIS, DWI showed decreased ADC values with a non-linear increase during the first week, and pseudonormalization after day 7, which limits the use of DWI to assess PAIS to the first week. Compared to previous studies, ADC values were lower when compared to infants with hypoxic ischemic encephalopathy, most likely due to more severe injury.	[van der Aa, Niek E.; Benders, Manon J. N. L.; Groenendaal, Floris; de Vries, Linda S.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands; [Vincken, Koen L.] Univ Med Ctr, Image Sci Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center	de Vries, LS (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands.	l.s.devries@umcutrecht.nl	Vincken, Koen/AAP-3558-2021; de Vries, Linda S/AAB-6454-2021; Groenendaal, Floris/P-6872-2019	Groenendaal, Floris/0000-0002-9284-1637	Wilhelmina Childrens' Hospital Research fund; Dutch Phelps Foundation	Wilhelmina Childrens' Hospital Research fund; Dutch Phelps Foundation	NE van der Aa was supported by grants of the Wilhelmina Childrens' Hospital Research fund and of the Dutch Phelps Foundation (www.phelps-stichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderliesten T, 2011, RADIOLOGY, V261, P235, DOI 10.1148/radiol.11110213; Amiel-Tison C, 1986, NEUROLOGICAL ASSESSM; An HY, 2011, STROKE, V42, P1276, DOI 10.1161/STROKEAHA.110.610501; Bednarek N, 2012, NEUROLOGY, V78, P1420, DOI 10.1212/WNL.0b013e318253d589; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Chabrier S, 2011, THROMB RES, V127, P13, DOI 10.1016/j.thromres.2010.10.003; CLAEYS V, 1983, HELV PAEDIATR ACTA, V38, P439; COWAN EM, 1994, NEUROPEDIATRICS, V25, P172, DOI 10.1055/s-2008-1073018; Cowan F, 2005, ARCH DIS CHILD-FETAL, V90, P252, DOI 10.1136/adc.2004.055558; De Vries LS, 2005, NEUROPEDIATRICS, V36, P12, DOI 10.1055/s-2005-837544; Dudink J, 2009, AM J NEURORADIOL, V30, P998, DOI 10.3174/ajnr.A1480; Gadian DG, 2000, J CHILD NEUROL, V15, P279, DOI 10.1177/088307380001500502; Govaert P, 2008, NEUROIMAGE, V39, P1850, DOI 10.1016/j.neuroimage.2007.10.056; Griffiths R., 1976, ABILITIES BABIES STU; Groenendaal F, 2006, SEMIN PERINATOL, V30, P146, DOI 10.1053/j.semperi.2006.04.005; Gunn AJ, 2008, CURR OPIN OBSTET GYN, V20, P175, DOI 10.1097/GCO.0b013e3282f4ef9e; Haku T, 2006, BRAIN RES, V1100, P136, DOI 10.1016/j.brainres.2006.05.018; HASEGAWA Y, 1994, NEUROLOGY, V44, P1484, DOI 10.1212/WNL.44.8.1484; Thierry AGM, 2006, EUR RADIOL, V16, P1651, DOI 10.1007/s00330-006-0175-8; Husson B, 2010, PEDIATRICS, V126, pE912, DOI 10.1542/peds.2009-3611; Kirton A, 2007, STROKE, V38, P974, DOI 10.1161/01.STR.0000258101.67119.72; Kirton A, 2011, PEDIATRICS, V128, pE1402, DOI 10.1542/peds.2011-1148; Kuker W, 2004, CHILD NERV SYST, V20, P742, DOI 10.1007/s00381-004-0988-1; Li FH, 2000, STROKE, V31, P946, DOI 10.1161/01.STR.31.4.946; Liu YR, 2007, STROKE, V38, P138, DOI 10.1161/01.STR.0000252127.07428.9c; Mader I, 2002, STROKE, V33, P1142, DOI 10.1161/hs0402.105883; McKinstry RC, 2002, NEUROLOGY, V59, P824, DOI 10.1212/WNL.59.6.824; Mercuri E, 2004, PEDIATRICS, V113, P95, DOI 10.1542/peds.113.1.95; Nelson KB, 2004, LANCET NEUROL, V3, P150, DOI 10.1016/S1474-4422(04)00679-9; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Ramaswamy V, 2004, NEUROLOGY, V62, P2088, DOI 10.1212/01.WNL.0000129909.77753.C4; REITH W, 1995, NEUROLOGY, V45, P172, DOI 10.1212/WNL.45.1.172; Robertson RL, 1999, AM J NEURORADIOL, V20, P1658; Rumpel H, 1997, PEDIATR RES, V42, P54, DOI 10.1203/00006450-199707000-00009; Rutherford M, 2004, PEDIATRICS, V114, P1004, DOI 10.1542/peds.2004-0222; Rutherford M, 2010, LANCET NEUROL, V9, P39, DOI 10.1016/S1474-4422(09)70295-9; Schlaug G, 1999, NEUROLOGY, V53, P1528, DOI 10.1212/WNL.53.7.1528; Schulzke S, 2005, J PERINAT MED, V33, P170, DOI 10.1515/JPM.2005.032; Touwen B. C. L, 1979, EXAMINATION CHILD MI; Winbeck K, 2004, STROKE, V35, P1095, DOI 10.1161/01.STR.0000125720.02983.fe; Winter JD, 2007, PEDIATR NEUROL, V37, P255, DOI 10.1016/j.pediatrneurol.2007.06.005; Wintermark P, 2012, TRANSL STROKE RES, V3, P255, DOI 10.1007/s12975-011-0122-0; Wu YW, 2005, SEMIN NEUROL, V25, P424, DOI 10.1055/s-2005-923536	43	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56784	10.1371/journal.pone.0056784	http://dx.doi.org/10.1371/journal.pone.0056784			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457613	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700093
J	Crowell, V; Yukich, JO; Briet, OJT; Ross, A; Smith, TA				Crowell, Valerie; Yukich, Joshua O.; Briet, Olivier J. T.; Ross, Amanda; Smith, Thomas A.			A Novel Approach for Measuring the Burden of Uncomplicated Plasmodium falciparum Malaria: Application to Data from Zambia	PLOS ONE			English	Article							TROPHOZOITE-INDUCED INFECTIONS; SUB-SAHARAN AFRICA; RETROSPECTIVE EXAMINATION; CLINICAL IMMUNITY; MORBIDITY; CHILDREN; VACCINE; IMPACT; SURVEILLANCE; MORTALITY	Measurement of malaria burden is fraught with complexity, due to the natural history of the disease, delays in seeking treatment or failure of case management. Attempts to establish an appropriate case definition for a malaria episode has often resulted in ambiguities and challenges because of poor information about treatment seeking, patterns of infection, recurrence of fever and asymptomatic infection. While the primary reason for treating malaria is to reduce disease burden, the effects of treatment are generally ignored in estimates of the burden of malaria morbidity, which are usually presented in terms of numbers of clinical cases or episodes, with the main data sources being reports from health facilities and parasite prevalence surveys. The use of burden estimates that do not consider effects of treatment, leads to under-estimation of the impact of improvements in case management. Official estimates of burden very likely massively underestimate the impact of the roll-out of ACT as first-line therapy across Africa. This paper proposes a novel approach for estimating burden of disease based on the point prevalence of malaria attributable disease, or equivalently, the days with malaria fever in unit time. The technique makes use of data available from standard community surveys, analyses of fever patterns in malaria therapy patients, and data on recall bias. Application of this approach to data from Zambia for 2009-2010 gave an estimate of 2.6 (95% credible interval: 1.5-3.7) malaria attributable fever days per child-year. The estimates of recall bias, and of the numbers of days with illness contributing to single illness recalls, could be applied more generally. To obtain valid estimates of the overall malaria burden using these methods, there remains a need for surveys to include the whole range of ages of hosts in the population and for data on seasonality patterns in confirmed case series.	[Crowell, Valerie; Briet, Olivier J. T.; Ross, Amanda; Smith, Thomas A.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Crowell, Valerie; Briet, Olivier J. T.; Ross, Amanda; Smith, Thomas A.] Univ Basel, Basel, Switzerland; [Yukich, Joshua O.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA USA	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Tulane University	Smith, TA (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	thomas-a.smith@unibas.ch	Smith, Thomas/B-5569-2015; Briët, Olivier/K-1917-2015	Smith, Thomas/0000-0002-3650-9381; Briët, Olivier/0000-0003-1186-2688; Ross, Amanda/0000-0001-6027-5645	Bill & Melinda Gates Foundation [1032350]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was supported by Bill & Melinda Gates Foundation grant 1032350. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba S, 2011, INT J EPIDEMIOL, V40, P405, DOI 10.1093/ije/dyq240; [Anonymous], 2009, WORLD MAL REP 2009; Cibulskis RE, 2007, AM J TROP MED HYG, V77, P133; Clark TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011759; Collins WE, 1999, AM J TROP MED HYG, V61, P4, DOI 10.4269/tropmed.1999.61-04; Collins WE, 1999, AM J TROP MED HYG, V61, P36, DOI 10.4269/tropmed.1999.61-036; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; GENTON B, 1995, ANN TROP MED PARASIT, V89, P377, DOI 10.1080/00034983.1995.11812966; Government of the Republic of Zambia Ministry of Health, 2010, ZAMB NAT MAL IND SUR; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Maire N, 2006, AM J TROP MED HYG, V75, P111, DOI 10.4269/ajtmh.2006.75.111; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; Missinou MA, 2003, CLIN INFECT DIS, V36, P1198, DOI 10.1086/374555; Penny MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003193; Roca-Feltrer A, 2008, TROP MED INT HEALTH, V13, P771, DOI 10.1111/j.1365-3156.2008.02076.x; SMITH T, 1993, ACTA TROP, V54, P55, DOI 10.1016/0001-706X(93)90068-M; Smith T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001157; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; SNOW RW, 2002, B CHWATTS ESSENTIAL, P85; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; Tediosi F, 2006, AM J TROP MED HYG, V75, P90, DOI 10.4269/ajtmh.2006.75.90; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2009, MON EV TOOLK HIV TUB; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yukich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042861	29	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57297	10.1371/journal.pone.0057297	http://dx.doi.org/10.1371/journal.pone.0057297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468961	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900069
J	Frieboes, HB; Wu, M; Lowengrub, J; Decuzzi, P; Cristini, V				Frieboes, Hermann B.; Wu, Min; Lowengrub, John; Decuzzi, Paolo; Cristini, Vittorio			A Computational Model for Predicting Nanoparticle Accumulation in Tumor Vasculature	PLOS ONE			English	Article							INDUCED ANGIOGENESIS; SOLID TUMORS; MACROMOLECULAR THERAPEUTICS; TUMORITROPIC ACCUMULATION; NONLINEAR SIMULATION; COMPUTER-SIMULATION; GROWTH; DELIVERY; DRUG; STRATEGIES	Vascular targeting of malignant tissues with systemically injected nanoparticles (NPs) holds promise in molecular imaging and anti-angiogenic therapies. Here, a computational model is presented to predict the development of tumor neovasculature over time and the specific, vascular accumulation of blood-borne NPs. A multidimensional tumor-growth model is integrated with a mesoscale formulation for the NP adhesion to blood vessel walls. The fraction of injected NPs depositing within the diseased vasculature and their spatial distribution is computed as a function of tumor stage, from 0 to day 24 post-tumor inception. As the malignant mass grows in size, average blood flow and shear rates increase within the tumor neovasculature, reaching values comparable with those measured in healthy, pre-existing vessels already at 10 days. The NP vascular affinity, interpreted as the likelihood for a blood-borne NP to firmly adhere to the vessel walls, is a fundamental parameter in this analysis and depends on NP size and ligand density, and vascular receptor expression. For high vascular affinities, NPs tend to accumulate mostly at the inlet tumor vessels leaving the inner and outer vasculature depleted of NPs. For low vascular affinities, NPs distribute quite uniformly intra-tumorally but exhibit low accumulation doses. It is shown that an optimal vascular affinity can be identified providing the proper balance between accumulation dose and uniform spatial distribution of the NPs. This balance depends on the stage of tumor development (vascularity and endothelial receptor expression) and the NP properties (size, ligand density and ligand-receptor molecular affinity). Also, it is demonstrated that for insufficiently developed vascular networks, NPs are transported preferentially through the healthy, pre-existing vessels, thus bypassing the tumor mass. The computational tool described here can effectively select an optimal NP formulation presenting high accumulation doses and uniform spatial intra-tumor distributions as a function of the development stage of the malignancy.	[Frieboes, Hermann B.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA; [Frieboes, Hermann B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Frieboes, Hermann B.; Cristini, Vittorio] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Wu, Min; Lowengrub, John] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Decuzzi, Paolo] Methodist Hosp, Res Inst, Dept Translat Imaging, Houston, TX 77030 USA; [Decuzzi, Paolo] Methodist Hosp, Res Inst, Dept Nanomed, Houston, TX 77030 USA; [Cristini, Vittorio] Univ New Mexico, Dept Chem Engn, Albuquerque, NM 87131 USA	University of Louisville; University of Louisville; University of New Mexico; University of California System; University of California Irvine; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; University of New Mexico	Frieboes, HB (corresponding author), Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA.	hbfrie01@louisville.edu	Cristini, Vittorio/N-3540-2013; Decuzzi, Paolo/F-1899-2016	Decuzzi, Paolo/0000-0001-6050-4188; Cristini, Vittorio/0000-0002-7909-4278; Wu, Min/0000-0003-4728-6475	National Institutes of Health/National Cancer Institute (NIH/NCI) Physical Sciences - Oncology Center (PS-OC) Young Investigator Trans-Network, Methodist [U54CA143837]; University of Southern California (USC) PS-OC Centers [U54CA143907]; National Science Foundation (NSF), Division of Mathematical Sciences; NIH [P50GM76516]; Center of Excellence in Systems Biology at the University of California, Irvine.; NIH/NCI PS-OC [U54CA143837]; National Institutes of Health Integrative Cancer Biology Program (NIH-ICBP) [U54CA151668]; Cullen Trust for Health Care; NIH-ICBP [U54CA149196]; NSF [DMS-0818104]; NATIONAL CANCER INSTITUTE [U54CA151668, U54CA149196, U54CA143837, U54CA143907] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI) Physical Sciences - Oncology Center (PS-OC) Young Investigator Trans-Network, Methodist; University of Southern California (USC) PS-OC Centers; National Science Foundation (NSF), Division of Mathematical Sciences(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Systems Biology at the University of California, Irvine.; NIH/NCI PS-OC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Integrative Cancer Biology Program (NIH-ICBP); Cullen Trust for Health Care; NIH-ICBP; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/National Cancer Institute (NIH/NCI) Physical Sciences - Oncology Center (PS-OC) Young Investigator Trans-Network Award to HF as a part of the Methodist (U54CA143837) and University of Southern California (USC) (U54CA143907) PS-OC Centers. JL acknowledges funding by the National Science Foundation (NSF), Division of Mathematical Sciences, and NIH grant P50GM76516 for a Center of Excellence in Systems Biology at the University of California, Irvine. PD acknowledges funding by NIH/NCI PS-OC grant U54CA143837 and National Institutes of Health Integrative Cancer Biology Program (NIH-ICBP) grant U54CA151668. VC acknowledges funding by the Cullen Trust for Health Care, NIH/NCI PS-OC grant U54CA143837, NIH-ICBP grant U54CA149196, and NSF grant DMS-0818104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; AUERBACH R, 1991, INT J RADIAT BIOL, V60, P1, DOI 10.1080/09553009114551401; Boso DP, 2011, INT J NANOMED, V6, P1517, DOI 10.2147/IJN.S20283; Caputo KE, 2005, BIOPHYS J, V89, P187, DOI 10.1529/biophysj.104.054171; Cristini V, 2003, J MATH BIOL, V46, P191, DOI 10.1007/s00285-002-0174-6; Decuzzi P, 2006, BIOMATERIALS, V27, P5307, DOI 10.1016/j.biomaterials.2006.05.024; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; Drummond DC, 1999, PHARMACOL REV, V51, P691; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Frieboes HB, 2011, CANCER RES, V71, P298, DOI 10.1158/0008-5472.CAN-10-2676; Frieboes HB, 2010, J THEOR BIOL, V264, P1254, DOI 10.1016/j.jtbi.2010.02.036; Frieboes HB, 2009, CANCER RES, V69, P4484, DOI 10.1158/0008-5472.CAN-08-3740; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; JAIN RK, 1990, CANCER RES, V50, pS814; Jain RK, 2001, J CONTROL RELEASE, V74, P7, DOI 10.1016/S0168-3659(01)00306-6; Jain RK, 2011, NAT MED, V7, P987; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; Lee SY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/49/495101; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; MATSUMURA Y, 1986, CANCER RES, V46, P6387; McDougall SR, 2002, B MATH BIOL, V64, P673, DOI 10.1006/bulm.2002.0293; McDougall SR, 2006, J THEOR BIOL, V241, P564, DOI 10.1016/j.jtbi.2005.12.022; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Pham K, 2011, J R SOC INTERFACE, V8, P16, DOI 10.1098/rsif.2010.0194; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; Pries AR, 1998, AM J PHYSIOL-HEART C, V275, pH349; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Sinek JP, 2009, J MATH BIOL, V58, P485, DOI 10.1007/s00285-008-0214-y; Smith BR, 2008, NANO LETT, V8, P2599, DOI 10.1021/nl080141f; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; van de Ven AL, 2012, AIP ADV, V2, DOI 10.1063/1.3699060; van de Ven AL, 2012, J CONTROL RELEASE, V158, P148, DOI 10.1016/j.jconrel.2011.10.021; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; Winter PM, 2003, CANCER RES, V63, P5838; Wu M, 2013, J THEOR BIOL, V320, P131, DOI 10.1016/j.jtbi.2012.11.031	40	80	82	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56876	10.1371/journal.pone.0056876	http://dx.doi.org/10.1371/journal.pone.0056876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468887	Green Published, gold			2022-12-27	WOS:000315524900042
J	Quek, GL; Finkbeiner, M				Quek, Genevieve L.; Finkbeiner, Matthew			Spatial and Temporal Attention Modulate the Early Stages of Face Processing: Behavioural Evidence from a Reaching Paradigm	PLOS ONE			English	Article							MASKED REPETITION; VISUAL-ATTENTION; FACIAL EXPRESSION; CORTEX; TIME; DISCRIMINATION; BRAIN; IDENTIFICATION; ATTENUATION; RESPONSES	A presently unresolved question within the face perception literature is whether attending to the location of a face modulates face processing (i.e. spatial attention). Opinions on this matter diverge along methodological lines - where neuroimaging studies have observed that the allocation of spatial attention serves to enhance the neural response to a face, findings from behavioural paradigms suggest face processing is carried out independently of spatial attention. In the present study, we reconcile this divide by using a continuous behavioural response measure that indexes face processing at a temporal resolution not available in discrete behavioural measures (e.g. button press). Using reaching trajectories as our response measure, we observed that although participants were able to process faces both when attended and unattended (as others have found), face processing was not impervious to attentional modulation. Attending to the face conferred clear benefits on sex-classification processes at less than 350ms of stimulus processing time. These findings constitute the first reliable demonstration of the modulatory effects of both spatial and temporal attention on face processing within a behavioural paradigm.	[Quek, Genevieve L.; Finkbeiner, Matthew] Macquarie Univ, Dept Cognit Sci, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2109, Australia	Macquarie University	Quek, GL (corresponding author), Macquarie Univ, Dept Cognit Sci, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2109, Australia.	genevieve.quek@mq.edu.au	Quek, Genevieve L/T-2109-2018	Quek, Genevieve L/0000-0002-5905-8405	Australian Research Council [DP0880806]	Australian Research Council(Australian Research Council)	This research was supported in part by the Australian Research Council (DP0880806). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Awasthi B, 2011, NEUROPSYCHOLOGIA, V49, P2136, DOI 10.1016/j.neuropsychologia.2011.03.003; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D., 2011, LINEAR MIXED EFFECTS; Bates D., 2005, R R NEWS, V5, P27, DOI DOI 10.18637/JSS.V067.I01; Besner D, 2005, CAN J EXP PSYCHOL, V59, P99, DOI 10.1037/h0087465; Bruce V., 1998, EYE BEHOLDER; Chapman CS, 2010, COGNITION, V116, P168, DOI 10.1016/j.cognition.2010.04.008; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Clutterbuck R, 2004, PERCEPTION, V33, P159, DOI 10.1068/p5115; Correa A, 2006, BRAIN RES, V1076, P116, DOI 10.1016/j.brainres.2005.11.074; Correa A, 2005, PSYCHON B REV, V12, P328, DOI 10.3758/BF03196380; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Dale R, 2007, MEM COGNITION, V35, P15, DOI 10.3758/BF03195938; Dell'Acqua R, 1999, COGNITION, V73, pB1, DOI 10.1016/S0010-0277(99)00049-9; Dosher BA, 1998, J EXP PSYCHOL GEN, V127, P311, DOI 10.1037/0096-3445.127.3.311; Downing P, 2001, NEUROPSYCHOLOGIA, V39, P1329, DOI 10.1016/S0028-3932(01)00121-X; Esterman M, 2008, NEUROPSYCHOLOGIA, V46, P1032, DOI 10.1016/j.neuropsychologia.2007.11.014; Fabre L, 2007, COGNITION, V105, P513, DOI 10.1016/j.cognition.2006.10.011; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Finkbeiner M, 2009, PSYCHOL SCI, V20, P42, DOI 10.1111/j.1467-9280.2008.02256.x; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Harry B, 2012, CONSCIOUS COGN, V21, P573, DOI 10.1016/j.concog.2011.11.007; Henson RN, 2007, NEUROIMAGE, V35, P1317, DOI 10.1016/j.neuroimage.2007.01.019; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Jacques C, 2007, CEREB CORTEX, V17, P1055, DOI 10.1093/cercor/bhl015; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Karayanidis F, 2011, PSYCHOPHYSIOLOGY, V48, P559, DOI 10.1111/j.1469-8986.2010.01115.x; Kiefer M, 2006, J COGNITIVE NEUROSCI, V18, P184, DOI 10.1162/089892906775783688; Kliegl R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00238; Kliegl R, 2010, VIS COGN, V18, P655, DOI 10.1080/13506280902986058; Lachter J, 2004, PSYCHOL REV, V111, P880, DOI 10.1037/0033-295x.111.4.880; Langton SRH, 2008, COGNITION, V107, P330, DOI 10.1016/j.cognition.2007.07.012; Lien MC, 2010, ATTEN PERCEPT PSYCHO, V72, P973, DOI 10.3758/APP.72.4.973; Los SA, 2001, J EXP PSYCHOL HUMAN, V27, P370, DOI 10.1037/0096-1523.27.2.370; Lueschow A, 2004, PSYCHOPHYSIOLOGY, V41, P350, DOI 10.1111/j.1469-8986.2004.00159.x; Marzouki Y, 2008, PERCEPT PSYCHOPHYS, V70, P1393, DOI 10.3758/PP.70.7.1393; Marzouki Y, 2007, ACTA PSYCHOL, V126, P34, DOI 10.1016/j.actpsy.2006.11.002; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pratte MS, 2009, ATTEN PERCEPT PSYCHO, V71, P1276, DOI 10.3758/APP.71.6.1276; Puce A, 1996, J NEUROSCI, V16, P5205; Rahnev D, 2012, ATTEN PERCEPT PSYCHO, V74, P521, DOI 10.3758/s13414-011-0246-z; Reddy L, 2004, J VISION, V4, P106, DOI 10.1167/4.2.4; Reddy L, 2007, NEUROIMAGE, V38, P730, DOI 10.1016/j.neuroimage.2007.08.006; Reddy L, 2006, VISION RES, V46, P2336, DOI 10.1016/j.visres.2006.01.020; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Rolfs M., 2008, J EYE MOVEMENT RES, V1, P1; SCHILLER PH, 1990, VISUAL NEUROSCI, V5, P321, DOI 10.1017/S0952523800000420; Schyns PG, 2001, J VISION, V1, P339; Skottun BC, 2006, BRAIN COGNITION, V61, P172, DOI 10.1016/j.bandc.2005.12.004; Song JH, 2008, COGNITION, V106, P994, DOI 10.1016/j.cognition.2007.03.014; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; Sreenivasan KK, 2009, ATTEN PERCEPT PSYCHO, V71, P837, DOI 10.3758/APP.71.4.837; Staudte M, 2011, COGNITION, V120, P268, DOI 10.1016/j.cognition.2011.05.005; TREISMAN M, 1990, PERCEPTION, V19, P705, DOI 10.1068/p190705; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Waechter S, 2011, VIS COGN, V19, P171, DOI 10.1080/13506285.2010.517228; Westheimer G, 1996, J OPT SOC AM A, V13, P884, DOI 10.1364/JOSAA.13.000884; Wijers AA, 2012, CLIN NEUROPHYSIOL, V123, P513, DOI 10.1016/j.clinph.2011.07.040; Williams MA, 2005, NEUROIMAGE, V24, P417, DOI 10.1016/j.neuroimage.2004.08.017; WOESTENBURG JC, 1983, BIOL PSYCHOL, V16, P127, DOI 10.1016/0301-0511(83)90059-5; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Yi DJ, 2006, BRAIN RES, V1080, P53, DOI 10.1016/j.brainres.2006.01.090	71	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57365	10.1371/journal.pone.0057365	http://dx.doi.org/10.1371/journal.pone.0057365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23468977	Green Submitted, gold, Green Published			2022-12-27	WOS:000315524900078
J	Taira, Y; Hayashida, N; Tsuchiya, R; Yamaguchi, H; Takahashi, J; Kazlovsky, A; Urazalin, M; Rakhypbekov, T; Yamashita, S; Takamura, N				Taira, Yasuyuki; Hayashida, Naomi; Tsuchiya, Rimi; Yamaguchi, Hitoshi; Takahashi, Jumpei; Kazlovsky, Alexander; Urazalin, Marat; Rakhypbekov, Tolebay; Yamashita, Shunichi; Takamura, Noboru			Vertical Distribution and Estimated Doses from Artificial Radionuclides in Soil Samples around the Chernobyl Nuclear Power Plant and the Semipalatinsk Nuclear Testing Site	PLOS ONE			English	Article							CONTAMINATION; RADIOACTIVITY	For the current on-site evaluation of the environmental contamination and contributory external exposure after the accident at the Chernobyl Nuclear Power Plant (CNPP) and the nuclear tests at the Semipalatinsk Nuclear Testing Site (SNTS), the concentrations of artificial radionuclides in soil samples from each area were analyzed by gamma spectrometry. Four artificial radionuclides (Am-241, Cs-134, Cs-137, and Co-60) were detected in surface soil around CNPP, whereas seven artificial radionuclides (Am-241, Co-57, Cs-137, Zr-95, Nb-95, Co-58, and Co-60) were detected in surface soil around SNTS. Effective doses around CNPP were over the public dose limit of 1 mSv/y (International Commission on Radiological Protection, 1991). These levels in a contaminated area 12 km from Unit 4 were high, whereas levels in a decontaminated area 12 km from Unit 4 and another contaminated area 15 km from Unit 4 were comparatively low. On the other hand, the effective doses around SNTS were below the public dose limit. These findings suggest that the environmental contamination and effective doses on the ground definitely decrease with decontamination such as removing surface soil, although the effective doses of the sampling points around CNPP in the present study were all over the public dose limit. Thus, the remediation of soil as a countermeasure could be an extremely effective method not only for areas around CNPP and SNTS but also for areas around the Fukushima Dai-ichi Nuclear Power Plant (FNPP), and external exposure levels will be certainly reduced. Longterm follow-up of environmental monitoring around CNPP, SNTS, and FNPP, as well as evaluation of the health effects in the population residing around these areas, could contribute to radiation safety and reduce unnecessary exposure to the public.	[Taira, Yasuyuki; Hayashida, Naomi; Takamura, Noboru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Yamashita, Shunichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiat Med Sci, Nagasaki 852, Japan; [Yamaguchi, Hitoshi] Nagasaki Univ, Grad Sch Engn, Dept Ecomat Sci, Nagasaki 852, Japan; [Tsuchiya, Rimi] Nagasaki Univ, Sch Med, Nagasaki 852, Japan; [Takahashi, Jumpei] Nagasaki Univ, Ctr Int Collaborat Res, Nagasaki 852, Japan; [Kazlovsky, Alexander] Gomel State Med Univ, Dept Pediat, Gomel, BELARUS; [Yamaguchi, Hitoshi; Urazalin, Marat; Rakhypbekov, Tolebay] Semey State Med Acad, Dept Microbiol, Semey, Kazakhstan; [Taira, Yasuyuki] Nagasaki Prefectural Inst Environm Res & Publ Hlt, Omura, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Gomel State Medical University; Semey State Medical University	Takamura, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan.	takamura@nagasaki-u.ac.jp	Yamashita, Shunichi/GVS-9508-2022; Kozlovsky, Alexander/F-2829-2017	Kozlovsky, Alexander/0000-0002-2371-2305; Takamura, Noboru/0000-0002-5552-3234; Yamashita, Shunichi/0000-0001-6399-6261	Ministry of Education, Culture, Sports, Science and Technology of Japan through the Nagasaki University Global COE program	Ministry of Education, Culture, Sports, Science and Technology of Japan through the Nagasaki University Global COE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan through the Nagasaki University Global COE program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NATL DIET JAPAN, P37; Balonov MI, 2007, RADIAT PROT DOSIM, V127, P491, DOI 10.1093/rpd/ncm301; He Q, 1996, J ENVIRON RADIOACTIV, V30, P117, DOI 10.1016/0265-931X(96)89275-7; Howard BJ, 2004, RADIAT ENVIRON BIOPH, V43, P285, DOI 10.1007/s00411-004-0261-8; ICRP, 1991, ANN ICRP, V21, P1; International Atomic Energy Agency, 2000, IAEATECDOC1162; International Commission on Radiation Units and Measurements, 1994, 53 ICRU; International Committee on Radiological Protection, 1991, ICRP PUBL; Iwatani K, 1999, B HIROSHIMA PREFECTU, V4, P1; Jacob P, 2001, J ENVIRON RADIOACTIV, V56, P51, DOI 10.1016/S0265-931X(01)00047-9; Kashparov VA, 2003, SCI TOTAL ENVIRON, V317, P105, DOI 10.1016/S0048-9697(03)00336-X; Kato H, 2011, J ENV RADIOACT; Lehto J, 2006, SCI TOTAL ENVIRON, V366, P206, DOI 10.1016/j.scitotenv.2005.08.012; Ministry of Education Culture Sports Science and Technology, ENV RAD RAD JAP; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, SOURC EFF ION RAD 20; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, SOURC EFF ION RAD 20; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P5, DOI [10.1111/j.1749-6632.2009.04821.x, 10.1111/j.1749-6632.2009.04820.x]; Yamamoto M, 1996, HEALTH PHYS, V71, P142, DOI 10.1097/00004032-199608000-00004; Yamamoto M, 2002, J RADIOANAL NUCL CH, V252, P373, DOI 10.1023/A:1015738911028; Zhu YG, 2000, CHEMOSPHERE, V41, P121, DOI 10.1016/S0045-6535(99)00398-7	20	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57524	10.1371/journal.pone.0057524	http://dx.doi.org/10.1371/journal.pone.0057524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469013	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900113
J	Altenburg, TM; de Kroon, MLA; Renders, CM; HiraSing, R; Chinapaw, MJM				Altenburg, Teatske M.; de Kroon, Marlou L. A.; Renders, Carry M.; HiraSing, Remy; Chinapaw, Mai J. M.			TV Time but Not Computer Time Is Associated with Cardiometabolic Risk in Dutch Young Adults	PLOS ONE			English	Article							METABOLIC SYNDROME; SEDENTARY BEHAVIOR; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; HEALTH OUTCOMES; INACTIVITY PHYSIOLOGY; MEAL INTAKE; MORTALITY; ADOLESCENTS; EXERCISE	Background: TV time and total sedentary time have been positively related to biomarkers of cardiometabolic risk in adults. We aim to examine the association of TV time and computer time separately with cardiometabolic biomarkers in young adults. Additionally, the mediating role of waist circumference (WC) is studied. Methods and Findings: Data of 634 Dutch young adults (18-28 years; 39% male) were used. Cardiometabolic biomarkers included indicators of overweight, blood pressure, blood levels of fasting plasma insulin, cholesterol, glucose, triglycerides and a clustered cardiometabolic risk score. Linear regression analyses were used to assess the cross-sectional association of self-reported TV and computer time with cardiometabolic biomarkers, adjusting for demographic and lifestyle factors. Mediation by WC was checked using the product-of-coefficient method. TV time was significantly associated with triglycerides (B = 0.004; CI = [0.001;0.05]) and insulin (B = 0.10; CI = [0.01;0.20]). Computer time was not significantly associated with any of the cardiometabolic biomarkers. We found no evidence for WC to mediate the association of TV time or computer time with cardiometabolic biomarkers. Conclusions: We found a significantly positive association of TV time with cardiometabolic biomarkers. In addition, we found no evidence for WC as a mediator of this association. Our findings suggest a need to distinguish between TV time and computer time within future guidelines for screen time.	[Altenburg, Teatske M.; de Kroon, Marlou L. A.; HiraSing, Remy; Chinapaw, Mai J. M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Renders, Carry M.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Hlth Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Altenburg, TM (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	t.altenburg@vumc.nl	Paw, Mai Chin A/N-1665-2019; de Kroon, Marlou MLA/M-4040-2014; Altenburg, Teatske/S-2059-2016	Paw, Mai Chin A/0000-0001-6259-2441; de Kroon, Marlou/0000-0003-1730-4994; Altenburg, Teatske/0000-0002-8764-5631; Renders, Carry/0000-0001-6688-1312	Health Research and Development Council of the Netherlands (ZonMw) [2100.0092]	Health Research and Development Council of the Netherlands (ZonMw)(Netherlands Organization for Health Research and Development)	The Terneuzen Birth Cohort was funded by the Health Research and Development Council of the Netherlands (ZonMw Grants no.2100.0092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Bellisle F, 2004, APPETITE, V43, P175, DOI 10.1016/j.appet.2004.04.004; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Blass EM, 2006, PHYSIOL BEHAV, V88, P597, DOI 10.1016/j.physbeh.2006.05.035; Carson V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-274; de Jong E, 2011, INT J OBES LOND; de Kroon MLA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013966; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekelund U, 2009, DIABETES CARE, V32, P1081, DOI 10.2337/dc08-1895; Franks PW, 2004, DIABETES CARE, V27, P1187, DOI 10.2337/diacare.27.5.1187; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lanningham-Foster L, 2009, J PEDIATR-US, V154, P819, DOI 10.1016/j.jpeds.2009.01.009; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002; Pereira SMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031132; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Stamatakis E, 2012, OBESITY, V20, P229, DOI 10.1038/oby.2011.209; Stephens BR, 2011, METABOLISM, V60, P941, DOI 10.1016/j.metabol.2010.08.014; Sugiyama T, 2008, ANN BEHAV MED, V35, P245, DOI 10.1007/s12160-008-9017-z; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Wijndaele K, 2009, EUR J CLIN NUTR, V63, P421, DOI 10.1038/sj.ejcn.1602944; Williams DM, 2008, AM J LIFESTYLE MED, V2, P250, DOI 10.1177/1559827608314104	33	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57749	10.1371/journal.pone.0057749	http://dx.doi.org/10.1371/journal.pone.0057749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460900	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000155
J	Basu, S; Yoffe, P; Hills, N; Lustig, RH				Basu, Sanjay; Yoffe, Paula; Hills, Nancy; Lustig, Robert H.			The Relationship of Sugar to Population-Level Diabetes Prevalence: An Econometric Analysis of Repeated Cross-Sectional Data	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; LIFE-STYLE; FRUCTOSE; OBESITY; PATHOGENESIS; EPIDEMIC; GLUCOSE; RISK; BAD	While experimental and observational studies suggest that sugar intake is associated with the development of type 2 diabetes, independent of its role in obesity, it is unclear whether alterations in sugar intake can account for differences in diabetes prevalence among overall populations. Using econometric models of repeated cross-sectional data on diabetes and nutritional components of food from 175 countries, we found that every 150 kcal/person/day increase in sugar availability (about one can of soda/day) was associated with increased diabetes prevalence by 1.1% (p<0.001) after testing for potential selection biases and controlling for other food types (including fibers, meats, fruits, oils, cereals), total calories, overweight and obesity, period-effects, and several socioeconomic variables such as aging, urbanization and income. No other food types yielded significant individual associations with diabetes prevalence after controlling for obesity and other confounders. The impact of sugar on diabetes was independent of sedentary behavior and alcohol use, and the effect was modified but not confounded by obesity or overweight. Duration and degree of sugar exposure correlated significantly with diabetes prevalence in a dose-dependent manner, while declines in sugar exposure correlated with significant subsequent declines in diabetes rates independently of other socioeconomic, dietary and obesity prevalence changes. Differences in sugar availability statistically explain variations in diabetes prevalence rates at a population level that are not explained by physical activity, overweight or obesity.	[Basu, Sanjay] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA; [Yoffe, Paula] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Hills, Nancy] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Lustig, Robert H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Lustig, Robert H.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Basu, S (corresponding author), Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA.	basus@stanford.edu	Lustig, Robert/O-9380-2019	Lustig, Robert/0000-0001-6983-2639				Abbasi F, 2004, DIABETES, V53, P585, DOI 10.2337/diabetes.53.3.585; Bray GA, 2007, AM J CLIN NUTR, V86, P895, DOI 10.1093/ajcn/86.4.895; Bremer AA, 2012, PEDIATRICS, V129, P557, DOI 10.1542/peds.2011-2912; Bremer AA, 2011, CTS-CLIN TRANSL SCI, V4, P243, DOI 10.1111/j.1752-8062.2011.00298.x; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; DILLS WL, 1993, AM J CLIN NUTR, V58, P779, DOI 10.1093/ajcn/58.5.779S; Elobeld A, 2006, J AGR ECON, V57, P23, DOI 10.1111/j.1477-9552.2006.00030.x; FAOSTAT, 2011, FAOSTAT; Goran MI, 2012, HIGH FRUCTOSE CORN S; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hardin JW, 2012, GEN ESTIMATING EQUAT; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Heckman J, 2004, REV ECON STAT, V86, P30, DOI 10.1162/003465304323023660; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; International Diabetes Federation, 2011, IDF DIAB ATL; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Lee DC, 2012, AM J EPIDEMIOL, V176, P43, DOI 10.1093/aje/kwr471; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Malik VS, 2012, CURR DIABETES REP, V12, P195, DOI 10.1007/s11892-012-0259-6; Muth MK, 2011, USDA TECHNICAL B, V1927; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Schalkwijk CG, 2004, DIABETES-METAB RES, V20, P369, DOI 10.1002/dmrr.488; Siegel KR, 2012, DIABETES RES CLIN PR, V96, P76, DOI 10.1016/j.diabres.2011.11.014; Sung KC, 2011, J CLIN ENDOCR METAB, V96, P1093, DOI 10.1210/jc.2010-2190; Sung KCC, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-108; Teff KL, 2009, J CLIN ENDOCR METAB, V94, P1562, DOI 10.1210/jc.2008-2192; Viljoen A, 2011, MED CLIN N AM, V95, P615, DOI 10.1016/j.mcna.2011.02.003; Voulgari C, 2011, J AM COLL CARDIOL, V58, P1343, DOI 10.1016/j.jacc.2011.04.047; World Bank, 2022, WORLD DEV IND; World Health Organization, 2012, WHO GLOB INF; World Health Organization, 2012, GLOB HLTH OBS DAT RE; World Health Organization (WHO), 2012, GLOB DAT BOD MASS IN; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	44	214	216	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57873	10.1371/journal.pone.0057873	http://dx.doi.org/10.1371/journal.pone.0057873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460912	Green Published, gold			2022-12-27	WOS:000315519000167
J	Lombardi, MG; Negroni, MP; Pelegrina, LT; Castro, ME; Fiszman, GL; Azar, ME; Morgado, CC; Sales, ME				Gabriela Lombardi, Maria; Pia Negroni, Maria; Tatiana Pelegrina, Laura; Ester Castro, Maria; Fiszman, Gabriel L.; Eugenia Azar, Maria; Cresta Morgado, Carlos; Elena Sales, Maria			Autoantibodies against Muscarinic Receptors in Breast Cancer: Their Role in Tumor Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELLS PROLIFERATION; MCF-7 CELLS; ACTIVATION; PRINCIPLE; VEGF	The presence of autoantibodies in cancer has become relevant in recent years. We demonstrated that autoantibodies purified from the sera of breast cancer patients activate muscarinic acetylcholine receptors in tumor cells. Immunoglobulin G (IgG) from breast cancer patients in T1N0Mx stage (tumor size <= 2 cm, without lymph node metastasis) mimics the action of the muscarinic agonist carbachol stimulating MCF-7 cell proliferation, migration and invasion. Angiogenesis is a central step in tumor progression because it promotes tumor invasion and metastatic spread. Vascular endothelial growth factor-A (VEGF-A) is the main angiogenic mediator, and its levels have been correlated with poor prognosis in cancer. The aim of the present work was to investigate the effect of T1N0Mx-IgG on the expression of VEGF-A, and the in vivo neovascular response triggered by MCF-7 cells, via muscarinic receptor activation. We demonstrated that T1N0Mx-IgG (10(-8) M) and carbachol (10(-9) M) increased the constitutive expression of VEGF-A in tumor cells, effect that was reverted by the muscarinic antagonist atropine. We also observed that T1N0Mx-IgG and carbachol enhanced the neovascular response produced by MCF-7 cells in the skin of NUDE mice. The action of IgG or carbachol was reduced in the presence of atropine. In conclusion, T1N0Mx-IgG and carbachol may promote VEGF-A production and neovascularization induced by breast tumor cells via muscarinic receptors activation. These effects may be accelerating breast tumor progression.	[Gabriela Lombardi, Maria; Tatiana Pelegrina, Laura; Ester Castro, Maria; Elena Sales, Maria] UBA Buenos Aires, CONICET, Ctr Estudios Farmacol & Bot CEFYBO, Lab Inmunofarmacol Tumoral, Buenos Aires, DF, Argentina; [Pia Negroni, Maria] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Fiszman, Gabriel L.; Eugenia Azar, Maria; Cresta Morgado, Carlos] UBA, Inst Oncol AH Roffo, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Massachusetts System; University of Massachusetts Worcester; University of Buenos Aires	Sales, ME (corresponding author), UBA Buenos Aires, CONICET, Ctr Estudios Farmacol & Bot CEFYBO, Lab Inmunofarmacol Tumoral, Buenos Aires, DF, Argentina.	malegazpio@yahoo.com.ar			University of Buenos Aires [UBACYT MO064]; National Agency for Scientific and Technology Promotion [ANPCyT PICT 2006-485]	University of Buenos Aires(University of Buenos Aires); National Agency for Scientific and Technology Promotion	This work was supported by grants from University of Buenos Aires (UBACYT MO064) and from the National Agency for Scientific and Technology Promotion (ANPCyT PICT 2006-485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chapman C, 2007, ANN ONCOL, V18, P868, DOI 10.1093/annonc/mdm007; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; Davel Lilia E., 2004, Angiogenesis, V7, P45, DOI 10.1023/B:AGEN.0000037329.45326.a8; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Eglen RM, 2005, PROGR MED CHEM, V43, P105, DOI 10.1016/S0079-6468(05)43004-0; Espanol AJ, 2004, INT J MOL MED, V13, P311; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fiszman G, 2006, INT IMMUNOPHARMACOL, V6, P1323, DOI 10.1016/j.intimp.2006.04.007; Fiszman GL, 2007, CANCER BIOL THER, V6, P1106, DOI 10.4161/cbt.6.7.4330; Fiszman Gabriel L., 2008, Current Immunology Reviews, V4, P176, DOI 10.2174/157339508785160732; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; John Anitha, 2001, Pathology and Oncology Research, V7, P14; Kasukabe T, 2005, BREAST CANCER RES, V7, pR1097, DOI 10.1186/bcr1344; Madrid FF, 2005, AUTOIMMUN REV, V4, P230, DOI 10.1016/j.autrev.2004.11.004; Madrid MF, 2005, CANCER LETT, V230, P187, DOI 10.1016/j.canlet.2004.12.017; Monte M, 1997, EUR J CANCER, V33, P676, DOI 10.1016/S0959-8049(96)00506-0; Pelegrina LT, 2012, J CLIN IMMU IN PRESS; Negroni MP, 2010, J CLIN IMMUNOL, V30, P474, DOI 10.1007/s10875-010-9370-0; Rimmaudo LE, 2005, BIOCHEM BIOPH RES CO, V334, P1359, DOI 10.1016/j.bbrc.2005.07.031; Shah N, 2009, AM J PHYSIOL-CELL PH, V296, pC221, DOI 10.1152/ajpcell.00514.2008; Urtreger AJ, 1997, INT J ONCOL, V11, P489	24	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57572	10.1371/journal.pone.0057572	http://dx.doi.org/10.1371/journal.pone.0057572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460876	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000131
J	Song, F; Fan, CD; Wang, XJ; Goodrich, DW				Song, Fei; Fan, Chuandong; Wang, Xinjiang; Goodrich, David W.			The Thoc1 Encoded Ribonucleoprotein Is a Substrate for the NEDD4-1 E3 Ubiquitin Protein Ligase	PLOS ONE			English	Article							RNA-POLYMERASE-II; MESSENGER-RNA; EXPORT MACHINERY; NUCLEAR EXPORT; COMPLEX; TRANSCRIPTION; GENE; TREX; RECRUITMENT; BIOGENESIS	Ribonucleoprotein (RNP) complexes form around nascent RNA during transcription to facilitate proper transcriptional elongation, RNA processing, and nuclear export. RNPs are highly heterogeneous, and different types of RNPs tend to package functionally related transcripts. These observations have inspired the hypothesis that RNP mediated mechanisms help specify coordinated gene expression. This hypothesis is supported by the observation that mutations in RNP components can cause defects in specific developmental pathways. How RNP biogenesis itself is regulated, however, is not well understood. The evolutionarily conserved THO RNP complex functions early during transcription to package nascent transcripts and facilitate subsequent RNP biogenesis. THO deficiency compromises transcriptional elongation as well as RNP mediated events like 3' end formation nuclear export for some transcripts. Using molecularly manipulated cells and in vitro reconstituted biochemical reactions, we demonstrate that the essential THO protein component encoded by the Thoc1 gene is poly-ubiquitinated by the NEDD4-1 E3 ubiquitin ligase. Poly-ubiquitinated pThoc1 is degraded by the proteasome. These results indicate THO activity is regulated by the ubiquitin-proteasome pathway, and that this regulation is evolutionarily conserved between yeast and mammals. Manipulation of NEDD4-1 levels has modest effects on Thoc1 protein levels under steady state conditions, but destabilization of Thoc1 protein upon treatment with a transcriptional elongation inhibitor is dependent on NEDD4-1. This suggests NEDD4-1 functions in conjunction with other post-translational mechanisms to regulate Thoc1 protein and THO activity.	[Song, Fei; Fan, Chuandong; Wang, Xinjiang; Goodrich, David W.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Goodrich, DW (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	david.goodrich@roswellpark.org			NIH [R01 CA125665]; NATIONAL CANCER INSTITUTE [R01CA125665, P30CA016056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by a grant from the NIH (R01 CA125665 to D.W.G.), http://www.nih.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Dufu K, 2010, GENE DEV, V24, P2043, DOI 10.1101/gad.1898610; DURFEE T, 1994, J CELL BIOL, V127, P609, DOI 10.1083/jcb.127.3.609; Gasparri F, 2004, FEBS LETT, V574, P13, DOI 10.1016/j.febslet.2004.07.074; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Huertas P, 2006, MOL CELL BIOL, V26, P7451, DOI 10.1128/MCB.00684-06; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Li YL, 2007, CANCER RES, V67, P6657, DOI 10.1158/0008-5472.CAN-06-3234; Li YP, 2005, MOL CELL BIOL, V25, P4023, DOI 10.1128/MCB.25.10.4023-4033.2005; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Mancini A, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-1; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Saguez C, 2008, MOL CELL, V31, P91, DOI 10.1016/j.molcel.2008.04.030; Schneiter R, 1999, MOL CELL BIOL, V19, P3415; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002	32	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57995	10.1371/journal.pone.0057995	http://dx.doi.org/10.1371/journal.pone.0057995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460917	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000172
J	Tang, SW; Lv, XZ; Zhang, Y; Wu, SS; Yang, ZR; Xia, YY; Tu, DH; Deng, PY; Ma, Y; Chen, DF; Zhan, SY				Tang, Shaowen; Lv, Xiaozhen; Zhang, Yuan; Wu, Shanshan; Yang, Zhirong; Xia, Yinyin; Tu, Dehua; Deng, Peiyuan; Ma, Yu; Chen, Dafang; Zhan, Siyan			Cytochrome P450 2E1 Gene Polymorphisms/Haplotypes and Anti-Tuberculosis Drug-Induced Hepatitis in a Chinese Cohort	PLOS ONE			English	Article							INDUCED HEPATOTOXICITY; CYP2E1; LIVER; NAT2; SUSCEPTIBILITY; PYRAZINAMIDE; METABOLITES; GENOTYPE; ENZYMES	Objective: The pathogenic mechanism of anti-tuberculosis (anti-TB) drug-induced hepatitis is associated with drug metabolizing enzymes. No tagging single-nucleotide polymorphisms (tSNPs) of cytochrome P450 2E1(CYP2E1) in the risk of anti-TB drug-induced hepatitis have been reported. The present study was aimed at exploring the role of tSNPs in CYP2E1 gene in a population-based anti-TB treatment cohort. Methods and Design: A nested case-control study was designed. Each hepatitis case was 14 matched with controls by age, gender, treatment history, disease severity and drug dosage. The tSNPs were selected by using Haploview 4.2 based on the HapMap database of Han Chinese in Beijing, and detected by using TaqMan allelic discrimination technology. Results: Eighty-nine anti-TB drug-induced hepatitis cases and 356 controls were included in this study. 6 tSNPs (rs2031920, rs2070672, rs915908, rs8192775, rs2515641, rs2515644) were genotyped and minor allele frequencies of these tSNPs were 21.9%, 23.0%, 19.1%, 23.6%, 20.8% and 44.4% in the cases and 20.9%, 22.7%, 18.9%, 23.2%, 18.2% and 43.2% in the controls, respectively. No significant difference was observed in genotypes or allele frequencies of the 6 tSNPs between case group and control group, and neither of haplotypes in block 1 nor in block 2 was significantly associated with the development of hepatitis. Conclusion: Based on the Chinese anti-TB treatment cohort, we did not find a statistically significant association between genetic polymorphisms of CYP2E1 and the risk of anti-TB drug-induced hepatitis. None of the haplotypes showed a significant association with the development of hepatitis in Chinese TB population.	[Tang, Shaowen; Lv, Xiaozhen; Zhang, Yuan; Wu, Shanshan; Yang, Zhirong; Chen, Dafang; Zhan, Siyan] Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Tang, Shaowen] Nanjing Med Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Xia, Yinyin] Chinese Ctr Dis Control & Prevent, Ctr TB Control & Prevent, Beijing, Peoples R China; [Tu, Dehua] Beijing Inst TB Control, Dept TB Treatment, Beijing, Peoples R China; [Deng, Peiyuan] State Food & Drug Adm, Ctr Drug Reassessment, Beijing, Peoples R China; [Ma, Yu] Beijing TB & Thorac Tumor Res Inst, Dept TB Treatment, Beijing, Peoples R China	Peking University; Nanjing Medical University; Chinese Center for Disease Control & Prevention	Zhan, SY (corresponding author), Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China.	siyan-zhan@bjmu.edu.cn		Tang, Shaowen/0000-0001-5879-8594; Zhang, Yuan/0000-0002-4174-0641	National Natural Science Foundation of China [81072387]; Beijing Natural Science Foundation [7111006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study is funded by National Natural Science Foundation of China (NO. 81072387) and Beijing Natural Science Foundation (NO. 7111006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HR, 2012, CLIN EXP PHARMACOL P, V39, P535, DOI 10.1111/j.1440-1681.2012.05713.x; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; BENICHOU C, 1990, J HEPATOL, V11, P272; Bose PD, 2011, J GASTROEN HEPATOL, V26, P312, DOI 10.1111/j.1440-1746.2010.06355.x; Burman WJ, 2001, AM J RESP CRIT CARE, V164, P1112, DOI 10.1164/ajrccm.164.7.2109052; Cho HJ, 2007, TUBERCULOSIS, V87, P551, DOI 10.1016/j.tube.2007.05.012; Das Roy P, 2008, PHARMACOGENOMICS, V9, P311, DOI 10.2217/14622416.9.3.311; Teixeira RLD, 2011, MEM I OSWALDO CRUZ, V106, P716, DOI 10.1590/S0074-02762011000600011; De Rosa HJ, 2007, BIOPHARM DRUG DISPOS, V28, P291, DOI 10.1002/bdd.557; Devarbhavi Harshad, 2011, Trop Gastroenterol, V32, P167; Guo Mingruo, 2009, P1; HAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P559, DOI 10.1093/oxfordjournals.jbchem.a123619; Huang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040883; Huang YS, 2007, J HEPATOL, V47, P128, DOI 10.1016/j.jhep.2007.02.009; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Jana S, 2007, CURR PROTEIN PEPT SC, V8, P619, DOI 10.2174/138920307783018668; Kim SH, 2009, PHARMACOGENOMICS, V10, P1767, DOI 10.2217/PGS.09.100; Knowles SR, 2000, LANCET, V356, P1587, DOI 10.1016/S0140-6736(00)03137-8; Lee SW, 2010, INT J TUBERC LUNG D, V14, P622; Lv XZ, 2012, ANN HEPATOL, V11, P700, DOI 10.1016/S1665-2681(19)31446-2; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; Mohri T, 2010, BIOCHEM PHARMACOL, V79, P1045, DOI 10.1016/j.bcp.2009.11.015; Naisbitt DJ, 2001, CURR OPIN ALLERGY CL, V1, P317; NELSON SD, 1976, SCIENCE, V193, P901, DOI 10.1126/science.7838; Ormerod P, 1998, THORAX, V53, P536; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Roy B, 2006, J GASTROEN HEPATOL, V21, P784, DOI 10.1111/j.1440-1746.2006.04197.x; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Sotsuka T, 2011, IN VIVO, V25, P803; Teuber M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-81; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; TSUTSUMI M, 1994, GASTROENTEROLOGY, V107, P1430, DOI 10.1016/0016-5085(94)90546-0; Vieira I, 1996, EUR J BIOCHEM, V238, P476, DOI 10.1111/j.1432-1033.1996.0476z.x; Wang T, 2010, J INT MED RES, V38, P977, DOI 10.1177/147323001003800324; World Health Organization, 2005, USE WHO UMC SYST STA; Xia YY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-267; Yamada S, 2009, PHARMACOGENOMICS, V10, P1433, DOI [10.2217/pgs.09.66, 10.2217/PGS.09.66]; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Yew WW, 2006, RESPIROLOGY, V11, P699, DOI 10.1111/j.1440-1843.2006.00941.x	41	18	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57526	10.1371/journal.pone.0057526	http://dx.doi.org/10.1371/journal.pone.0057526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460870	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000125
J	Wang, YJ; Yang, YT; Hui, L; Tie, C; Li, F; Xu, ZQD; Wang, CY				Wang, Yongjun; Yang, Yutao; Hui, Li; Tie, Changle; Li, Feng; Xu, Zhi-Qing David; Wang, Chuanyue			A Neuropeptide Y Variant (rs16139) Associated with Major Depressive Disorder in Replicate Samples from Chinese Han Population	PLOS ONE			English	Article							RESTRAINT STRESS; NPY; POLYMORPHISM; BEHAVIOR; ANXIETY; WOMEN; RISK; TWIN	Objective: This study aimed to investigate the single nucleotide polymorphisms (SNPs) of neuropeptide Y (NPY) and major depressive disorder (MDD) in Chinese Han population. Design: Prospective and randomized studies were carried out. Patients: A total of 700 patients (324 male and 376 female; mean age = 406 +/- 14.9 years) with depression who met the diagnostic criteria of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) and 673 healthy controls (313 male and 360 female; mean age = 41.9 +/- 17.2 years) were used to investigate the relationship between SNPs of NPY and the pathogenesis of MDD. A total of 417 patients (195 male and 202 female; mean age = 36 +/- 14.2 years) diagnosed with MDD and 314 healthy controls (153 male and 161 female; mean age = 37.9 +/- 14.2 years) from Chinese Han population were used to verify the relationship between SNPs of NPY and the pathogenesis of MDD. Intervention and outcome: Ligase detection reactions were performed to detect the SNP sites of NPY. A series of statistical methods was carried out to investigate the correlation between the NPY gene SNP and MDD. Results: Statistical analysis showed a significant correlation between the SNP sites rs16139 in NPY and the morbidity of depression. Patients with MDD have a lower frequency of A-allele in rs16139 in replicate samples from Chinese Han population. However, the frequency varied between male and female patients. Conclusion: The gene polymorphism loci rs16139 was closely related to MDD in Chinese Han population.	[Wang, Yongjun; Wang, Chuanyue] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China; [Yang, Yutao; Hui, Li; Tie, Changle; Li, Feng; Xu, Zhi-Qing David] Capital Med Univ, Beijing Key Lab Brain Major Disorders, Beijing, Peoples R China; [Wang, Yongjun] Tianjin Anding Hosp, Tianjin, Peoples R China	Capital Medical University; Capital Medical University	Xu, ZQD (corresponding author), Capital Med Univ, Beijing Key Lab Brain Major Disorders, Beijing, Peoples R China.	zhiqingx@ccmu.edu.cn; chuanyuewang2012@163.com	Wang, Chuan-Yue/C-9369-2015; Xu, Zhi-Qing David/H-9757-2013	Wang, Chuan-Yue/0000-0001-6549-3713; Xu, Zhi-Qing David/0000-0002-0387-7559	Beijing Municipal Natural Science Foundation of China [7091002]; National Science and Technology Support Program of China [2007BAI17B05]	Beijing Municipal Natural Science Foundation of China; National Science and Technology Support Program of China	This work was funded by the Beijing Municipal Natural Science Foundation of China (7091002), and the National Science and Technology Support Program of China (2007BAI17B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews G, 2005, BRIT J PSYCHIAT, V187, P495, DOI 10.1192/bjp.187.6.495; Barlow DH, 2005, CENGAGE LEARNING; Bosker FJ, 2011, MOL PSYCHIATR, V16, P516, DOI 10.1038/mp.2010.38; Cizza G, 2008, BIOL PSYCHIAT, V64, P907, DOI 10.1016/j.biopsych.2008.05.035; Ding B, 2002, J CLIN PHARM THER, V27, P211, DOI 10.1046/j.1365-2710.2002.00409.x; Domschke K, 2010, EUR NEUROPSYCHOPHARM, V20, P301, DOI 10.1016/j.euroneuro.2009.09.006; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; Heilig M, 2004, J PSYCHIATR RES, V38, P113, DOI 10.1016/S0022-3956(03)00101-8; Hou CL, 2006, BRAIN RES, V1095, P154, DOI 10.1016/j.brainres.2006.04.026; Karl T, 2010, NEUROPEPTIDES, V44, P233, DOI 10.1016/j.npep.2009.12.008; Kendler KS, 1999, ARCH GEN PSYCHIAT, V56, P39, DOI 10.1001/archpsyc.56.1.39; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Madaan V, 2009, DRUG NEWS PERSPECT, V22, P319, DOI 10.1358/dnp.2009.22.6.1395255; Mickey BJ, 2011, ARCH GEN PSYCHIAT, V68, P158, DOI 10.1001/archgenpsychiatry.2010.197; Morales-Medina JC, 2010, BRAIN RES, V1314, P194, DOI 10.1016/j.brainres.2009.09.077; Moreno FA, 2010, EUR NEUROPSYCHOPHARM, V20, P18, DOI 10.1016/j.euroneuro.2009.10.003; Rhee SH, 2002, PSYCHOL BULL, V128, P490, DOI 10.1037//0033-2909.128.3.490; Sjoholm LK, 2009, J AFFECT DISORDERS, V118, P124, DOI 10.1016/j.jad.2009.02.009; Sommer WH, 2010, HUM MUTAT, V31, pE1594, DOI 10.1002/humu.21299; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Thorsell A, 2000, P NATL ACAD SCI USA, V97, P12852, DOI 10.1073/pnas.220232997; Thorsell A, 1998, REGUL PEPTIDES, V75-6, P247, DOI 10.1016/S0167-0115(98)00075-5; Weizman Shira, 2012, Neuropsychopharmacol Hung, V14, P87; Witt SH, 2011, PSYCHONEUROENDOCRINO, V36, P1010, DOI 10.1016/j.psyneuen.2010.12.015	24	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57042	10.1371/journal.pone.0057042	http://dx.doi.org/10.1371/journal.pone.0057042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468908	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000055
J	Rodriguez-Barreiro, R; Abendroth, C; Vilanova, C; Moya, A; Porcar, M				Rodriguez-Barreiro, Raul; Abendroth, Christian; Vilanova, Cristina; Moya, Andres; Porcar, Manuel			Towards a Microbial Thermoelectric Cell	PLOS ONE			English	Article							WASTE HEAT; FUEL-CELLS; ELECTRICITY; POWER	Microbial growth is an exothermic process. Biotechnological industries produce large amounts of heat, usually considered an undesirable by-product. In this work, we report the construction and characterization of the first microbial thermoelectric cell (MTC), in which the metabolic heat produced by a thermally insulated microbial culture is partially converted into electricity through a thermoelectric device optimized for low DT values. A temperature of 41 degrees C and net electric voltage of around 250-600 mV was achieved with 1.7 L baker's yeast culture. This is the first time microbial metabolic energy has been converted into electricity with an ad hoc thermoelectric device. These results might contribute towards developing a novel strategy to harvest excess heat in the biotechnology industry, in processes such as ethanol fermentation, auto thermal aerobic digestion (ATAD) or bioremediation, which could be coupled with MTCs in a single unit to produce electricity as a valuable by-product of the primary biotechnological product. Additionally, we propose that small portable MTCs could be conceived and inoculated with suitable thermophilic of hyperthermophilic starter cultures and used for powering small electric devices.	[Rodriguez-Barreiro, Raul; Abendroth, Christian; Vilanova, Cristina; Moya, Andres; Porcar, Manuel] Univ Valencia, Cavanilles Inst Biodivers & Evolut Biol, Valencia, Spain; [Moya, Andres] CSISP, Unidad Mixta Invest Genom & Salud, Valencia, Spain; [Porcar, Manuel] Univ Valencia, Fundacio Gen, Valencia, Spain	University of Valencia; University of Valencia	Porcar, M (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolut Biol, Valencia, Spain.	manuel.porcar@uv.es	Abendroth, Christian/E-2851-2015; Moya, Andrés/A-8190-2008; Porcar, Manuel/D-2503-2010; Abendroth, Christian/GLN-7432-2022	Moya, Andrés/0000-0002-2867-1119; Porcar, Manuel/0000-0002-7916-9479; Abendroth, Christian/0000-0002-3940-9124	Conselleria d'Educacio, Generalitat Valenciana, Spain [Prometeo/2009/092]	Conselleria d'Educacio, Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF))	Financial support was provided by grant Prometeo/2009/092 (Conselleria d'Educacio, Generalitat Valenciana, Spain) to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; Cheng SA, 2009, ENVIRON SCI TECHNOL, V43, P3953, DOI 10.1021/es803531g; Dauer LT, 2011, J NUCL MED, V52, P1423, DOI 10.2967/jnumed.111.091413; Delas J, 2009, NEW BIOTECHNOL, V26, P300, DOI 10.1016/j.nbt.2009.09.005; Ducommun R, 2010, YEAST, V27, P139, DOI 10.1002/yea.1738; Gross M, 2011, CURR BIOL, V21, pR379, DOI 10.1016/j.cub.2011.05.003; Gunawardena A, 2008, INT J MOL SCI, V9, P1893, DOI 10.3390/ijms9101893; Kim D, 2009, BIORESOURCE TECHNOL, V100, P4527, DOI 10.1016/j.biortech.2009.04.017; Larjola J, 1995, INT J PROD ECON, V41, P227, DOI 10.1016/0925-5273(94)00098-0; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Lineykin S, 2007, IEEE T IND APPL, V43, P505, DOI 10.1109/TIA.2006.889813; Liu H, 2005, ENVIRON SCI TECHNOL, V39, P4317, DOI 10.1021/es050244p; Logan BE, 2010, APPL MICROBIOL BIOT, V85, P1665, DOI 10.1007/s00253-009-2378-9; Rozendal RA, 2006, INT J HYDROGEN ENERG, V31, P1632, DOI 10.1016/j.ijhydene.2005.12.006; Saidur R, 2012, RENEW SUST ENERG REV, V16, P5649, DOI 10.1016/j.rser.2012.05.018; Song CS, 2002, CATAL TODAY, V77, P17, DOI 10.1016/S0920-5861(02)00231-6; Turker M, 2004, THERMOCHIM ACTA, V419, P73, DOI 10.1016/j.tca.2004.01.036; Ugwuanyi JO, 2008, J APPL MICROBIOL, V104, P79, DOI 10.1111/j.1365-2672.2007.03557.x; von Stockar U, 1997, J BIOTECHNOL, V59, P25, DOI 10.1016/S0168-1656(97)00167-3	19	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56358	10.1371/journal.pone.0056358	http://dx.doi.org/10.1371/journal.pone.0056358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468862	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400008
J	Brignani, D; Ruzzoli, M; Mauri, P; Miniussi, C				Brignani, Debora; Ruzzoli, Manuela; Mauri, Piercarlo; Miniussi, Carlo			Is Transcranial Alternating Current Stimulation Effective in Modulating Brain Oscillations?	PLOS ONE			English	Article							VISUAL-SPATIAL ATTENTION; ELECTRICAL-STIMULATION; THETA OSCILLATIONS; NEURONAL OSCILLATIONS; EEG ALPHA; HIPPOCAMPAL-FORMATION; CURRENT-DENSITY; PRIMATE RETINA; GANGLION-CELLS; CORTEX	Transcranial alternating current stimulation (tACS) is a promising tool for modulating brain oscillations, as well as a possible therapeutic intervention. However, the lack of conclusive evidence on whether tACS is able to effectively affect cortical activity continues to limit its application. The present study aims to address this issue by exploiting the well-known inhibitory alpha rhythm in the posterior parietal cortex during visual perception and attention orientation. Four groups of healthy volunteers were tested with a Gabor patch detection and discrimination task. All participants were tested at the baseline and selective frequencies of tACS, including Sham, 6 Hz, 10 Hz, and 25 Hz. Stimulation at 6 Hz and 10 Hz over the occipito-parietal area impaired performance in the detection task compared to the baseline. The lack of a retinotopically organised effect and marginal frequency-specificity modulation in the detection task force us to be cautious about the effectiveness of tACS in modulating brain oscillations. Therefore, the present study does not provide significant evidence for tACS reliably inducing direct modulations of brain oscillations that can influence performance in a visual task.	[Brignani, Debora; Mauri, Piercarlo; Miniussi, Carlo] IRCCS Ctr San Giovanni Dio Fatebenefratelli, Cognit Neurosci Sect, Brescia, Italy; [Ruzzoli, Manuela] Univ Pompeu Fabra, Dept Tecnol Informacio & Comunicac, Barcelona, Spain; [Miniussi, Carlo] Univ Brescia, Dept Clin & Expt Sci, Natl Inst Neurosci, Brescia, Italy	IRCCS Fatebenefratelli; Pompeu Fabra University; University of Brescia	Brignani, D (corresponding author), IRCCS Ctr San Giovanni Dio Fatebenefratelli, Cognit Neurosci Sect, Brescia, Italy.	debora.brignani@cognitiveneuroscience.it	Brignani, Debora/K-4495-2016; Miniussi, Carlo/P-5610-2019; Miniussi, Carlo/E-7602-2010; Ruzzoli, Manuela/B-6909-2012	Brignani, Debora/0000-0003-0848-5164; Miniussi, Carlo/0000-0002-5436-4745; Miniussi, Carlo/0000-0002-5436-4745; Ruzzoli, Manuela/0000-0002-1719-7140	Associazione Fatebenefratelli per la Ricerca (AFaR)	Associazione Fatebenefratelli per la Ricerca (AFaR)	The research was supported by a Project grant from Associazione Fatebenefratelli per la Ricerca (AFaR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2004, INVEST OPHTH VIS SCI, V45, P702, DOI 10.1167/iovs.03-0688; Antal A, 2010, J PAIN SYMPTOM MANAG, V39, P890, DOI 10.1016/j.jpainsymman.2009.09.023; Basar E., 2004, MEMORY BRAIN DYNAMIC; Basar E, 2008, BRAIN RES, V1235, P172, DOI 10.1016/j.brainres.2008.06.103; BASAREROGLU C, 1992, INT J PSYCHOPHYSIOL, V13, P161, DOI 10.1016/0167-8760(92)90055-G; Bastiaansen MCM, 2008, BRAIN LANG, V106, P15, DOI 10.1016/j.bandl.2007.10.006; Benardete EA, 1999, VISUAL NEUROSCI, V16, P355, DOI 10.1017/S0952523899162151; BENARDETE EA, 1992, VISUAL NEUROSCI, V8, P483, DOI 10.1017/S0952523800004995; Benninger DH, 2010, J NEUROL NEUROSUR PS, V81, P1105, DOI 10.1136/jnnp.2009.202556; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; Bikson M, 2010, CLIN NEUROPHYSIOL, V121, P1976, DOI 10.1016/j.clinph.2010.05.020; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Bolognini N, 2010, BRAIN RES, V1349, P76, DOI 10.1016/j.brainres.2010.06.053; Bolognini N, 2010, EUR J NEUROSCI, V31, P1800, DOI 10.1111/j.1460-9568.2010.07211.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRINDLEY GS, 1955, J PHYSIOL-LONDON, V127, P189, DOI 10.1113/jphysiol.1955.sp005248; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; Caplan JB, 2003, J NEUROSCI, V23, P4726; Cochran W.G., 1967, STAT METHODS; Darriba A, 2012, J COGNITIVE NEUROSCI, V24, P337, DOI 10.1162/jocn_a_00073; Datta A, 2008, J NEURAL ENG, V5, P163, DOI 10.1088/1741-2560/5/2/007; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Fenton BW, 2009, BRAIN STIMUL, V2, P103, DOI 10.1016/j.brs.2008.09.009; Fertonani A, 2010, BEHAV BRAIN RES, V208, P311, DOI 10.1016/j.bbr.2009.10.030; Feurra M, 2011, J NEUROSCI, V31, P12165, DOI 10.1523/JNEUROSCI.0978-11.2011; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; GARTSIDE IB, 1968, NATURE, V220, P383, DOI 10.1038/220383a0; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gould IC, 2011, J NEUROPHYSIOL, V105, P1318, DOI 10.1152/jn.00653.2010; Green JJ, 2008, PLOS BIOL, V6, P730, DOI 10.1371/journal.pbio.0060081; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; HAYES KJ, 1950, ARCH NEURO PSYCHIATR, V63, P102, DOI 10.1001/archneurpsyc.1950.02310190108008; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Joundi RA, 2012, CURR BIOL, V22, P403, DOI 10.1016/j.cub.2012.01.024; Kanai R, 2010, CLIN NEUROPHYSIOL, V121, P1551, DOI 10.1016/j.clinph.2010.03.022; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; Kaplan E., 1990, Progress in Retinal Research, V9, P273, DOI 10.1016/0278-4327(90)90009-7; Keeser D, 2011, NEUROIMAGE, V55, P644, DOI 10.1016/j.neuroimage.2010.12.004; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 2003, EUR J NEUROSCI, V17, P1129, DOI 10.1046/j.1460-9568.2003.02517.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; LEE BB, 1994, VISION RES, V34, P3081, DOI 10.1016/0042-6989(94)90074-4; LIPPOLD OCJ, 1964, BRIT J PSYCHIAT, V110, P768, DOI 10.1192/bjp.110.469.768; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Lorincz ML, 2009, NEURON, V63, P683, DOI 10.1016/j.neuron.2009.08.012; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Miniussi C, 2008, BRAIN STIMUL, V1, P326, DOI 10.1016/j.brs.2008.07.002; Miranda PC, 2009, CLIN NEUROPHYSIOL, V120, P1183, DOI 10.1016/j.clinph.2009.03.023; Moliadze V, 2010, CLIN NEUROPHYSIOL, V121, P2165, DOI 10.1016/j.clinph.2010.04.033; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; NATHAN SS, 1993, ELECTROEN CLIN NEURO, V86, P183, DOI 10.1016/0013-4694(93)90006-H; Neuling T, 2012, NEUROIMAGE; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; Polania R, 2012, CURR BIOL, V22, P1314, DOI 10.1016/j.cub.2012.05.021; Priori A, 2009, BRAIN STIMUL, V2, P241, DOI 10.1016/j.brs.2009.02.004; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Reato D, 2010, J NEUROSCI, V30, P15067, DOI 10.1523/JNEUROSCI.2059-10.2010; Romei V, 2011, CURR BIOL, V21, P334, DOI 10.1016/j.cub.2011.01.035; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sadleir RJ, 2010, NEUROIMAGE, V51, P1310, DOI 10.1016/j.neuroimage.2010.03.052; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Sauseng P, 2009, CURR BIOL, V19, P1846, DOI 10.1016/j.cub.2009.08.062; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Schutter DJLG, 2010, CLIN NEUROPHYSIOL, V121, P1080, DOI 10.1016/j.clinph.2009.10.038; Schwiedrzik CM, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.006.2009; Schyns PG, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001064; SHAPLEY R, 1986, TRENDS NEUROSCI, V9, P229, DOI 10.1016/0166-2236(86)90064-0; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Smitt JW, 1944, ACTA PSYCH NEUROL, V19, P529, DOI 10.1111/j.1600-0447.1944.tb04586.x; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919; Thut G, 2009, TRENDS COGN SCI; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Thut G, 2012, CURR BIOL, V22, pR658, DOI 10.1016/j.cub.2012.06.061; Thut G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00170; Thut G, 2011, CURR BIOL, V21, P1176, DOI 10.1016/j.cub.2011.05.049; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; VanRullen R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00060; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vines BW, 2006, NEUROREPORT, V17, P671, DOI 10.1097/00001756-200604240-00023; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Worden MS, 2000, J NEUROSCI, V20; Yamagishi N, 2008, BRAIN RES, V1197, P115, DOI 10.1016/j.brainres.2007.12.063; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0	112	73	74	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56589	10.1371/journal.pone.0056589	http://dx.doi.org/10.1371/journal.pone.0056589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457586	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000315602700082
J	Wargo, MJ				Wargo, Matthew J.			Choline Catabolism to Glycine Betaine Contributes to Pseudomonas aeruginosa Survival during Murine Lung Infection	PLOS ONE			English	Article							PHOSPHOLIPASE-C; CYSTIC-FIBROSIS; LISTERIA-MONOCYTOGENES; VIRULENCE FACTORS; ESCHERICHIA-COLI; 3 TRANSPORTERS; IN-VIVO; CARNITINE; IDENTIFICATION; GROWTH	Pseudomonas aeruginosa can acquire and metabolize a variety of molecules including choline, an abundant host-derived molecule. In P. aeruginosa, choline is oxidized to glycine betaine which can be used as an osmoprotectant, a sole source of carbon and nitrogen, and as an inducer of the virulence factor, hemolytic phospholipase C (PlcH) via the transcriptional regulator GbdR. The primary objective was to determine the contribution of choline conversion to glycine betaine to P. aeruginosa survival during mouse lung infection. A secondary objective was to gain insight into the relative contributions of the different roles of glycine betaine to P. aeruginosa survival during infection. Using a model of acute murine pneumonia, we determined that deletion of the choline oxidase system (encoded by betBA) decreased P. aeruginosa survival in the mouse lung. Deletion of the glycine betaine demethylase genes (gbcA-B), required for glycine betaine catabolism, did not impact P. aeruginosa survival in the lung. Thus, the defect of the betBA mutant was not due to a requirement for glycine betaine catabolism or dependence on a downstream metabolite. Deletion of betBA decreased the abundance of plcH transcript during infection, which suggested a role for PlcH in the betBA survival defect. To test the contribution of plcH to the betBA mutant phenotype a betBAplcHR double deletion mutant was generated. The betBA and betBAplcHR double mutant had a small but significant survival defect compared to the plcHR single mutant, suggesting that regulation of plcH expression is not the only role for glycine betaine during infection. The conclusion was that choline acquisition and its oxidation to glycine betaine contribute to P. aeruginosa survival in the mouse lung. While defective plcH induction can explain a portion of the betBA mutant phenotype, the exact mechanisms driving the betBA mutant survival defect remain unknown.	[Wargo, Matthew J.] Univ Vermont, Coll Med, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Wargo, Matthew J.] Univ Vermont, Coll Med, Vermont Lung Ctr, Burlington, VT USA	University of Vermont; University of Vermont	Wargo, MJ (corresponding author), Univ Vermont, Coll Med, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	mwargo@uvm.edu		Wargo, Matthew/0000-0001-5659-749X	National Center for Research Resources [5P20RR021905-07]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103496-07]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grants from the National Center for Research Resources (5P20RR021905-07) and the National Institute of General Medical Sciences (8 P20 GM103496-07) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelidis AS, 2003, APPL ENVIRON MICROB, V69, P1013, DOI 10.1128/AEM.69.2.1013-1022.2003; BERKA RM, 1982, J BACTERIOL, V152, P239; BODY DR, 1971, LIPIDS, V6, P625, DOI 10.1007/BF02531518; Boncompagni E, 1999, APPL ENVIRON MICROB, V65, P2072; Boulette ML, 2009, J BACTERIOL, V191, P6329, DOI 10.1128/JB.00817-09; BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955; Cattoir V, 2012, MBIO, V3, DOI 10.1128/mBio.00410-12; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chen C, 2008, J BACTERIOL, V190, P2717, DOI 10.1128/JB.01585-07; Chen CL, 2010, MOL MICROBIOL, V75, P29, DOI 10.1111/j.1365-2958.2009.06962.x; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Diab F, 2006, MICROBIOL-SGM, V152, P1395, DOI 10.1099/mic.0.28652-0; DOMENECH CE, 1991, FEMS MICROBIOL LETT, V82, P131, DOI 10.1111/j.1574-6968.1991.tb04853.x; Feinbaum RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002813; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Fitzsimmons LF, 2012, J BACTERIOL, V194, P4718, DOI 10.1128/JB.00596-12; Fitzsimmons LF, 2011, APPL ENVIRON MICROB, V77, P4383, DOI 10.1128/AEM.00504-11; GARBER ED, 1960, ANN NY ACAD SCI, V88, P1187, DOI 10.1111/j.1749-6632.1960.tb20108.x; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; GILLJAM H, 1988, CLIN CHIM ACTA, V176, P29, DOI 10.1016/0009-8981(88)90171-4; GRAY GL, 1981, J BACTERIOL, V147, P675, DOI 10.1128/JB.147.2.675-678.1981; GUTIERREZ JA, 1995, J BACTERIOL, V177, P390, DOI 10.1128/jb.177.2.390-400.1995; Kang PJ, 1997, MOL MICROBIOL, V24, P1249; Kim SH, 2008, INFECT IMMUN, V76, P4152, DOI 10.1128/IAI.01637-07; KORTSTEE GJ, 1970, ARCH MIKROBIOL, V71, P235, DOI 10.1007/BF00410157; KUNIN CM, 1992, J INFECT DIS, V166, P1311, DOI 10.1093/infdis/166.6.1311; Lanotte P, 2003, PEDIATR PULM, V36, P405, DOI 10.1002/ppul.10380; LINDSTED.G, 1967, BIOCHEMISTRY-US, V6, P1262, DOI 10.1021/bi00857a006; LISA TA, 1994, CURR MICROBIOL, V29, P193, DOI 10.1007/BF01570153; Mahajan-Miklos S, 2000, MOL MICROBIOL, V37, P981, DOI 10.1046/j.1365-2958.2000.02056.x; Malek AA, 2011, J BACTERIOL, V193, P3033, DOI 10.1128/JB.00160-11; Massimelli MJ, 2011, MICROBIOL RES, V166, P380, DOI 10.1016/j.micres.2010.07.004; Massimelli MJ, 2005, CURR MICROBIOL, V50, P251, DOI 10.1007/s00284-004-4499-9; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; MEYERS DJ, 1992, TOXICON, V30, P161, DOI 10.1016/0041-0101(92)90469-L; OSTROFF RM, 1989, INFECT IMMUN, V57, P1369, DOI 10.1128/IAI.57.5.1369-1373.1989; Price CTD, 2008, J BACTERIOL, V190, P3955, DOI 10.1128/JB.01476-07; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Rebouche CJ, 1998, ANNU REV NUTR, V18, P39, DOI 10.1146/annurev.nutr.18.1.39; Sage AE, 1997, MOL MICROBIOL, V23, P43, DOI 10.1046/j.1365-2958.1997.1681542.x; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Sleator RD, 2003, J APPL MICROBIOL, V95, P839, DOI 10.1046/j.1365-2672.2003.02056.x; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Vasil ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000420; VASIL ML, 1991, ANTIBIOT CHEMOTHER, V44, P34; Velasco-Garcia R, 2006, ARCH MICROBIOL, V185, P14, DOI 10.1007/s00203-005-0054-8; WANNER C, 1986, AM J NEPHROL, V6, P206, DOI 10.1159/000167119; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; Wargo MJ, 2011, AM J RESP CRIT CARE, V184, P345, DOI 10.1164/rccm.201103-0374OC; Wargo MJ, 2009, MICROBIOL-SGM, V155, P2411, DOI 10.1099/mic.0.028787-0; Wargo MJ, 2009, INFECT IMMUN, V77, P1103, DOI 10.1128/IAI.01008-08; Wieland CW, 2002, INFECT IMMUN, V70, P1352, DOI 10.1128/IAI.70.3.1352-1358.2002; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Zaldivar-Machorro VJ, 2011, BIOCHIMIE, V93, P286, DOI 10.1016/j.biochi.2010.09.022	60	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56850	10.1371/journal.pone.0056850	http://dx.doi.org/10.1371/journal.pone.0056850			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457628	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700099
J	Zhou, WW; Liang, QM; Xu, Y; Gurr, GM; Bao, YY; Zhou, XP; Zhang, CX; Cheng, J; Zhu, ZR				Zhou, Wen-Wu; Liang, Qing-Mei; Xu, Yi; Gurr, Geoff M.; Bao, Yan-Yuan; Zhou, Xue-Ping; Zhang, Chuan-Xi; Cheng, Jiaan; Zhu, Zeng-Rong			Genomic Insights into the Glutathione S-Transferase Gene Family of Two Rice Planthoppers, Nilaparvata lugens (Stal) and Sogatella furcifera (Horvath) (Hemiptera: Delphacidae)	PLOS ONE			English	Article							BROWN PLANTHOPPER; INSECTICIDE-RESISTANCE; EXPRESSION PROFILES; PHLOEM SAP; HETEROLOGOUS EXPRESSION; DETOXIFICATION ENZYMES; CHEMICAL-COMPOSITION; SUPERGENE FAMILY; RNA INTERFERENCE; IDENTIFICATION	Background: Glutathione S-transferase (GST) genes control crucial traits for the metabolism of various toxins encountered by insects in host plants and the wider environment, including insecticides. The planthoppers Nilaparvata lugens and Sogatella furcifera are serious specialist pests of rice throughout eastern Asia. Their capacity to rapidly adapt to resistant rice varieties and to develop resistance to various insecticides has led to severe outbreaks over the last decade. Methodology/Principal Findings: Using the genome sequence of N. lugens, we identified for the first time the complete GST gene family of a delphacid insect whilst nine GST gene orthologs were identified from the closely related species S. furcifera. Nilaparvata lugens has 11 GST genes belonging to six cytosolic subclasses and a microsomal class, many fewer than seen in other insects with known genomes. Sigma is the largest GST subclass, and the intron-exon pattern deviates significantly from that of other species. Higher GST gene expression in the N. lugens adult migratory form reflects the higher risk of this life stage in encountering the toxins of non-host plants. After exposure to a sub-lethal dose of four insecticides, chlorpyrifos, imidacloprid, buprofezin or beta-cypermethrin, more GST genes were upregulated in S. furcifera than in N. lugens. RNA interference targeting two N. lugens GST genes, NlGSTe1 and NlGSTm2, significantly increased the sensitivity of fourth instar nymphs to chlorpyrifos but not to beta-cypermethrin. Conclusions/Significance: This study provides the first elucidation of the nature of the GST gene family in a delphacid species, offering new insights into the evolution of metabolic enzyme genes in insects. Further, the use of RNA interference to identify the GST genes induced by insecticides illustrates likely mechanisms for the tolerance of these insects.	[Zhou, Wen-Wu; Liang, Qing-Mei; Gurr, Geoff M.; Bao, Yan-Yuan; Zhang, Chuan-Xi; Cheng, Jiaan; Zhu, Zeng-Rong] Zhejiang Univ, Minist Agr, Key Lab Agr Entomol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Wen-Wu; Liang, Qing-Mei; Gurr, Geoff M.; Bao, Yan-Yuan; Zhang, Chuan-Xi; Cheng, Jiaan; Zhu, Zeng-Rong] Zhejiang Univ, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Yi; Zhou, Xue-Ping] Zhejiang Univ, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Gurr, Geoff M.] Charles Sturt Univ, EH Graham Ctr Agr Innovat, Orange, NSW, Australia	Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University; Zhejiang University; Charles Sturt University	Zhu, ZR (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Agr Entomol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	zrzhu@zju.edu.cn	GURR, GEOFFREY M/F-3519-2011; Zhang, Chuan-Xi/K-7978-2019	Zhang, Chuan-Xi/0000-0002-7784-1188; Gurr, Geoff/0000-0001-5008-7966; Zhou, Wenwu/0000-0002-0727-8086	973 Programme [2010CB126200]; National Key Technology R&D Program of the Ministry of Science and Technology of China [2012BAD19B01]; National Natural Science Foundation of China [30971908]	973 Programme(National Basic Research Program of China); National Key Technology R&D Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the 973 Programme (2010CB126200) and National Key Technology R&D Program (2012BAD19B01) of the Ministry of Science and Technology of China and the National Natural Science Foundation of China (30971908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Asano K, 2011, P NATL ACAD SCI USA, V108, P11034, DOI 10.1073/pnas.1019490108; Bass C, 2012, INSECT SCI, V19, P1, DOI 10.1111/j.1744-7917.2011.01440.x; Catindig J. L., 2009, PLANTHOPPERS NEW THR, P191; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; Cheng J., 2009, PLANTHOPPERS NEW THR, P157; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Ding J.-H., 1981, J NANJING AGR COLL, V3, P78; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Fedorov A, 2003, GENOME RES, V13, P2236, DOI 10.1101/gr.1029803; Feng QL, 2001, J INSECT PHYSIOL, V47, P1, DOI 10.1016/S0022-1910(00)00093-7; Friedman R, 2011, MOL PHYLOGENET EVOL, V61, P924, DOI 10.1016/j.ympev.2011.08.027; FUKUMORITA T, 1982, PLANT CELL PHYSIOL, V23, P273; HAYASHI H, 1990, PLANT CELL PHYSIOL, V31, P247; HAYASHI H, 1985, PLANT CELL PHYSIOL, V26, P325; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hemingway J, 1999, INT J PEST MANAGE, V45, P215, DOI 10.1080/096708799227824; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; KAWABE S, 1980, PLANT CELL PHYSIOL, V21, P1319, DOI 10.1093/oxfordjournals.pcp.a076130; Kenmore P. E., 1991, INDONESIAS INTEGRATE; Ketterman AJ, 2011, DRUG METAB REV, V43, P253, DOI 10.3109/03602532.2011.552911; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Li XW, 2009, INSECT BIOCHEM MOLEC, V39, P745, DOI 10.1016/j.ibmb.2009.08.010; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Liu ZW, 2006, PEST MANAG SCI, V62, P279, DOI 10.1002/ps.1169; Lougarre A, 1999, INSECT MOL BIOL, V8, P141, DOI 10.1046/j.1365-2583.1999.810141.x; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Meng JY, 2009, J INSECT PHYSIOL, V55, P588, DOI 10.1016/j.jinsphys.2009.03.003; Morgenstern R, 2005, METHOD ENZYMOL, V401, P136, DOI 10.1016/S0076-6879(05)01008-6; NAGATA T, 1979, APPL ENTOMOL ZOOL, V14, P264, DOI 10.1303/aez.14.264; Nair PMG, 2011, AQUAT TOXICOL, V101, P550, DOI 10.1016/j.aquatox.2010.12.006; Nardini L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-113; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Otuka A, 2005, POPUL ECOL, V47, P143, DOI 10.1007/s10144-005-0216-1; PANNABECKER T, 1995, ANNU REV ENTOMOL, V40, P493, DOI 10.1146/annurev.en.40.010195.002425; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin GH, 2011, PEST MANAG SCI, V67, P697, DOI 10.1002/ps.2110; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Reddy BPN, 2011, PARASITOL RES, V109, P1165, DOI 10.1007/s00436-011-2364-x; Sezer M, 1998, HEREDITY, V80, P499, DOI 10.1046/j.1365-2540.1998.00316.x; Singh M, 2000, GENE, V247, P167, DOI 10.1016/S0378-1119(00)00102-5; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Skopelitou K, 2012, FUNCT INTEGR GENOMIC, V12, P157, DOI 10.1007/s10142-011-0248-x; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Tang J, 2010, PEST MANAG SCI, V66, P121, DOI 10.1002/ps.1836; Toba G, 2000, GENE, V253, P179, DOI 10.1016/S0378-1119(00)00246-8; Vit P, 2008, ARCH LATINOAM NUTR, V58, P411; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Vontas JG, 2002, BIOCHEM J, V362, P329, DOI 10.1042/bj3620329; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wongtrakul J, 2010, J MED ENTOMOL, V47, P162, DOI 10.1603/ME09132; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamamoto K, 2009, PESTIC BIOCHEM PHYS, V94, P30, DOI 10.1016/j.pestbp.2009.02.008; Yang ZF, 2005, ARCH INSECT BIOCHEM, V59, P59, DOI 10.1002/arch.20055; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yao HW, 2002, INSECT SCI, V9, P9; Yu QY, 2008, INSECT BIOCHEM MOLEC, V38, P1158, DOI 10.1016/j.ibmb.2008.08.002; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhou GH, 2008, CHINESE SCI BULL, V53, P3677, DOI 10.1007/s11434-008-0467-2; Zhou WW, 2012, PEST MANAG SCI, V68, P1296, DOI 10.1002/ps.3297; Zou FM, 2011, MOL BIOL REP, V38, P639, DOI 10.1007/s11033-010-0150-y; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	70	85	89	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56604	10.1371/journal.pone.0056604	http://dx.doi.org/10.1371/journal.pone.0056604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457591	Green Published, gold			2022-12-27	WOS:000315602700085
J	Pohlmann, A; Hentschel, J; Fechner, M; Hoff, U; Bubalo, G; Arakelyan, K; Cantow, K; Seeliger, E; Flemming, B; Waiczies, H; Waiczies, S; Schunck, WH; Dragun, D; Niendorf, T				Pohlmann, Andreas; Hentschel, Jan; Fechner, Mandy; Hoff, Uwe; Bubalo, Gordana; Arakelyan, Karen; Cantow, Kathleen; Seeliger, Erdmann; Flemming, Bert; Waiczies, Helmar; Waiczies, Sonia; Schunck, Wolf-Hagen; Dragun, Duska; Niendorf, Thoralf			High Temporal Resolution Parametric MRI Monitoring of the Initial Ischemia/Reperfusion Phase in Experimental Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; BOLD MRI; INTRARENAL OXYGENATION; RAT KIDNEYS; REPERFUSION; ISCHEMIA; PATHOPHYSIOLOGY; INHIBITION; HEMODYNAMICS; HYPOXIA	Ischemia/reperfusion (I/R) injury, a consequence of kidney hypoperfusion or temporary interruption of blood flow is a common cause of acute kidney injury (AKI). There is an unmet need to better understand the mechanisms operative during the initial phase of ischemic AKI. Non-invasive in vivo parametric magnetic resonance imaging (MRI) may elucidate spatio-temporal pathophysiological changes in the kidney by monitoring the MR relaxation parameters T-2* and T-2, which are known to be sensitive to blood oxygenation. The aim of our study was to establish the technical feasibility of fast continuous T-2*/T-2 mapping throughout renal I/R. MRI was combined with a remotely controlled I/R model and a segmentation model based semi-automated quantitative analysis. This technique enabled the detailed assessment of in vivo changes in all kidney regions during ischemia and early reperfusion. Significant changes in T-2* and T-2 were observed shortly after induction of renal ischemia and during the initial reperfusion phase. Our study demonstrated for the first time that continuous and high temporal resolution parametric MRI is feasible for in-vivo monitoring and characterization of I/R induced AKI in rats. This technique may help in the identification of the timeline of key events responsible for development of renal damage in hypoperfusion-induced AKI.	[Pohlmann, Andreas; Hentschel, Jan; Arakelyan, Karen; Waiczies, Helmar; Waiczies, Sonia; Niendorf, Thoralf] Max Delbruck Ctr Mol Med, Berlin Ultrahigh Field Facil, Berlin, Germany; [Fechner, Mandy; Hoff, Uwe; Bubalo, Gordana; Dragun, Duska] Charite Campus Virchow Klinikum, Berlin, Germany; [Fechner, Mandy; Hoff, Uwe; Bubalo, Gordana; Dragun, Duska] Cardiovasc Res Ctr, Charite, Berlin, Germany; [Arakelyan, Karen; Cantow, Kathleen; Seeliger, Erdmann; Flemming, Bert] Charite, Cardiovasc Res Ctr, Inst Physiol, D-13353 Berlin, Germany; [Waiczies, Helmar; Waiczies, Sonia; Niendorf, Thoralf] Charite Med Fac & Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Schunck, Wolf-Hagen] Max Delbruck Ctr Mol Med, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Pohlmann, A (corresponding author), Max Delbruck Ctr Mol Med, Berlin Ultrahigh Field Facil, Berlin, Germany.	andreas.pohlmann@mdc-berlin.de	Pohlmann, Andreas/K-7869-2016; Niendorf, Thoralf/H-7738-2013; Waiczies, Sonia/H-4181-2012	Pohlmann, Andreas/0000-0002-8572-2568; Niendorf, Thoralf/0000-0001-7584-6527; Waiczies, Sonia/0000-0002-9916-9572; Waiczies, Helmar/0000-0001-6651-4790; Dragun, Duska/0000-0002-0310-9269; Cantow, Kathleen/0000-0002-3907-6315	Deutsche Forschungsgemeinschaft [FOR 1368]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (FOR 1368). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; de Mendonca A, 2000, INTENS CARE MED, V26, P915, DOI 10.1007/s001340051281; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; dos Santos EA, 2007, INVEST RADIOL, V42, P157, DOI 10.1097/01.rli.0000252492.96709.36; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Haque M, 2011, J MAGN RESON IMAGING, V33, P898, DOI 10.1002/jmri.22509; Hoff U, 2011, KIDNEY INT, V79, P57, DOI 10.1038/ki.2010.377; Hoste EAJ, 2008, CRIT CARE MED, V36, pS146, DOI 10.1097/CCM.0b013e318168c590; Ji L, 2010, J MAGN RESON IMAGING, V32, P383, DOI 10.1002/jmri.22253; Kusakabe Y, 2010, MAGN RESON MED SCI, V9, P187, DOI 10.2463/mrms.9.187; Legrand M, 2008, MOL MED, V14, P502, DOI 10.2119/2008-00006.Legrand; Marinelli NL, 2009, SPINE, V34, P520, DOI 10.1097/BRS.0b013e318195dd44; MOFFAT DB, 1963, J ANAT, V97, P543; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Oostendorp M, 2011, NMR BIOMED, V24, P194, DOI 10.1002/nbm.1572; Pedersen M, 2005, KIDNEY INT, V67, P2305, DOI 10.1111/j.1523-1755.2005.00334.x; Prasad PV, 2006, NEPHRON CLIN PRACT, V103, pC58, DOI 10.1159/000090610; Reeder SB, 1998, MAGNET RESON MED, V39, P988, DOI 10.1002/mrm.1910390617; Ries M, 2003, J MAGN RESON IMAGING, V17, P104, DOI 10.1002/jmri.10224; Rognant N, 2011, NEPHROL DIAL TRANSPL, V26, P1205, DOI 10.1093/ndt/gfq538; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; SCHUREK HJ, 1988, KLIN WOCHENSCHR, V66, P828, DOI 10.1007/BF01728943; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Silvennoinen MJ, 2003, MAGNET RESON MED, V49, P47, DOI 10.1002/mrm.10355; TERRIER F, 1989, MAGNET RESON MED, V12, P114, DOI 10.1002/mrm.1910120114; TERRIER F, 1987, INVEST RADIOL, V22, P118, DOI 10.1097/00004424-198702000-00006; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; VEXLER VS, 1993, JMRI-J MAGN RESON IM, V3, P483, DOI 10.1002/jmri.1880030310; Whitehouse T, 2006, AM J PHYSIOL-RENAL, V291, pF647, DOI 10.1152/ajprenal.00475.2005; ZIMMERHACKL B, 1985, AM J PHYSIOL, V249, pF898, DOI 10.1152/ajprenal.1985.249.6.F898	33	44	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57411	10.1371/journal.pone.0057411	http://dx.doi.org/10.1371/journal.pone.0057411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468984	Green Published, Green Accepted, gold			2022-12-27	WOS:000315524900084
J	Granberg, F; Vicente-Rubiano, M; Rubio-Guerri, C; Karlsson, OE; Kukielka, D; Belak, S; Sanchez-Vizcaino, JM				Granberg, Fredrik; Vicente-Rubiano, Marina; Rubio-Guerri, Consuelo; Karlsson, Oskar E.; Kukielka, Deborah; Belak, Sandor; Manuel Sanchez-Vizcaino, Jose			Metagenomic Detection of Viral Pathogens in Spanish Honeybees: Co- Infection by Aphid Lethal Paralysis, Israel Acute Paralysis and Lake Sinai Viruses	PLOS ONE			English	Article							DEFORMED WING VIRUS; 1ST DETECTION; BEE VIRUSES; SHORT COMMUNICATION.; PREVALENCE; IAPV; APIARIES; KASHMIR; PUPAE	The situation in Europe concerning honeybees has in recent years become increasingly aggravated with steady decline in populations and/or catastrophic winter losses. This has largely been attributed to the occurrence of a variety of known and "unknown", emerging novel diseases. Previous studies have demonstrated that colonies often can harbour more than one pathogen, making identification of etiological agents with classical methods difficult. By employing an unbiased metagenomic approach, which allows the detection of both unexpected and previously unknown infectious agents, the detection of three viruses, Aphid Lethal Paralysis Virus (ALPV), Israel Acute Paralysis Virus (IAPV), and Lake Sinai Virus (LSV), in honeybees from Spain is reported in this article. The existence of a subgroup of ALPV with the ability to infect bees was only recently reported and this is the first identification of such a strain in Europe. Similarly, LSV appear to be a still unclassified group of viruses with unclear impact on colony health and these viruses have not previously been identified outside of the United States. Furthermore, our study also reveals that these bees carried a plant virus, Turnip Ringspot Virus (TuRSV), potentially serving as important vector organisms. Taken together, these results demonstrate the new possibilities opened up by high-throughput sequencing and metagenomic analysis to study emerging new diseases in domestic and wild animal populations, including honeybees.	[Granberg, Fredrik; Karlsson, Oskar E.; Belak, Sandor] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth BVF, Uppsala, Sweden; [Granberg, Fredrik; Karlsson, Oskar E.; Belak, Sandor] OIE Collaborating Ctr Biotechnol Based Diag Infec, Uppsala, Sweden; [Vicente-Rubiano, Marina; Rubio-Guerri, Consuelo; Kukielka, Deborah; Manuel Sanchez-Vizcaino, Jose] Univ Complutense Madrid, Fac Vet, Dept Anim Hlth, Madrid, Spain; [Karlsson, Oskar E.] SLU, Dept Anim Breeding & Genet HGEN, SLU Global Bioinformat Ctr, Uppsala, Sweden; [Belak, Sandor] Natl Vet Inst SVA, VIP, Dept Virol Immunobiol & Parasitol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Complutense University of Madrid; Swedish University of Agricultural Sciences; National Veterinary Institute SVA	Granberg, F (corresponding author), Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth BVF, Uppsala, Sweden.	fredrik.granberg@slu.se	Sánchez-Vizcaíno, José Manuel/G-6299-2015; Kukielka, Deborah/L-4667-2014; Belak, Sandor/AAP-4759-2021; Granberg, Fredrik/AAH-6330-2021	Sánchez-Vizcaíno, José Manuel/0000-0002-1502-8968; Kukielka, Deborah/0000-0002-3114-7377; Granberg, Fredrik/0000-0001-5497-9611; Karlsson Lindsjo, Oskar/0000-0003-1068-981X	Swedish University of Agricultural Sciences (SLU); Ministry of Education, Culture and Sports of Spain; EU-project AniBioThreat [Home/2009/ISEC/AG/191]; Prevention of and Fight against Crime Programme of the European Union, European Commission - Directorate General Home Affairs	Swedish University of Agricultural Sciences (SLU); Ministry of Education, Culture and Sports of Spain; EU-project AniBioThreat; Prevention of and Fight against Crime Programme of the European Union, European Commission - Directorate General Home Affairs	This work was mainly supported by the Award of Excellence (Excellensbidrag), provided to SB by the Swedish University of Agricultural Sciences (SLU), and an FPU grant from the Ministry of Education, Culture and Sports of Spain, which supported MVR and CRG. Special recognition is given to the Ministry of Education of Spain for the FPU grant of Consuelo Rubio-Guerri and Marina Vicente-Rubiano. The work was also partly supported by/executed in the framework of the EU-project AniBioThreat (Grant Agreement: Home/2009/ISEC/AG/191) with the financial support from the Prevention of and Fight against Crime Programme of the European Union, European Commission - Directorate General Home Affairs. This publication reflects the views only of the authors, and the European Commission cannot be held responsible for any use, which may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allen M, 1996, BEE WORLD, V77, P141, DOI 10.1080/0005772X.1996.11099306; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON DL, 1988, J GEN VIROL, V69, P1617, DOI 10.1099/0022-1317-69-7-1617; ANDERSON DL, 1991, AM BEE J, V131, P767; BAILEY L, 1983, ANN APPL BIOL, V103, P13, DOI 10.1111/j.1744-7348.1983.tb02735.x; BALL BV, 1988, ANN APPL BIOL, V113, P237, DOI 10.1111/j.1744-7348.1988.tb03300.x; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Blanchard P, 2008, J INVERTEBR PATHOL, V99, P348, DOI 10.1016/j.jip.2008.07.006; Blomstrom AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/j.virusres.2009.09.006; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; Blomstrom AL, 2010, VIRUS RES, V152, P59, DOI 10.1016/j.virusres.2010.06.004; Brodsgaard CJ, 2000, APIDOLOGIE, V31, P543, DOI 10.1051/apido:2000145; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; DALL DJ, 1985, ANN APPL BIOL, V106, P461, DOI 10.1111/j.1744-7348.1985.tb03136.x; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; Di Prisco G, 2011, VIRUSES-BASEL, V3, P2425, DOI 10.3390/v3122425; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forgach P, 2008, J INVERTEBR PATHOL, V98, P235, DOI 10.1016/j.jip.2007.11.002; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garrido-Bailon E, 2010, SPAN J AGRIC RES, V8, P658, DOI 10.5424/sjar/2010083-1262; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kukielka D, 2010, SPAN J AGRIC RES, V8, P308, DOI 10.5424/sjar/2010082-1218; Kukielka D, 2008, J VIROL METHODS, V147, P275, DOI 10.1016/j.jviromet.2007.09.008; Kukielka D, 2009, J VIROL METHODS, V161, P240, DOI 10.1016/j.jviromet.2009.06.014; Lipkin WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10; MORAN NA, 2012, PLOS ONE, V7; Nakamura S, 2011, EXP BIOL MED, V236, P968, DOI 10.1258/ebm.2011.010378; [NRC] National Research Council, 2006, STAT POLL N AM; Palacios G, 2008, J VIROL, V82, P6209, DOI 10.1128/JVI.00251-08; Reynaldi FJ, 2011, REV ARGENT MICROBIOL, V43, P84, DOI 10.1590/S0325-75412011000200003; Ribiere M, 2002, APIDOLOGIE, V33, P339, DOI 10.1051/apido:2002020; Rozen S, 2000, Methods Mol Biol, V132, P365; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Segundo E., 2003, Plant Disease, V87, P103, DOI 10.1094/PDIS.2003.87.1.103; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Munster M, 2002, J GEN VIROL, V83, P3131, DOI 10.1099/0022-1317-83-12-3131; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Ward L, 2007, APIDOLOGIE, V38, P181, DOI 10.1051/apido:2006072; Weiss RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-124	55	75	81	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57459	10.1371/journal.pone.0057459	http://dx.doi.org/10.1371/journal.pone.0057459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460860	gold, Green Accepted, Green Published			2022-12-27	WOS:000315519000114
J	Joppa, LN; Williams, R				Joppa, Lucas N.; Williams, Rich			Modeling the Building Blocks of Biodiversity	PLOS ONE			English	Article							NETWORK STRUCTURE; FOOD WEBS; NESTEDNESS; ARCHITECTURE; LINKAGE; RULES	Background: Networks of single interaction types, such as plant-pollinator mutualisms, are biodiversity's "building blocks". Yet, the structure of mutualistic and antagonistic networks differs, leaving no unified modeling framework across biodiversity's component pieces. Methods/Principal Findings: We use a one-dimensional "niche model" to predict antagonistic and mutualistic species interactions, finding that accuracy decreases with the size of the network. We show that properties of the modeled network structure closely approximate empirical properties even where individual interactions are poorly predicted. Further, some aspects of the structure of the niche space were consistently different between network classes. Conclusions/Significance: These novel results reveal fundamental differences between the ability to predict ecologically important features of the overall structure of a network and the ability to predict pair-wise species interactions.	[Joppa, Lucas N.] Microsoft Res, Computat Ecol & Environm Sci, Cambridge, England; [Williams, Rich] Quid Com, San Francisco, CA USA	Microsoft; QUID INC.	Joppa, LN (corresponding author), Microsoft Res, Computat Ecol & Environm Sci, Cambridge, England.	lujoppa@microsoft.com	Williams, Richard J/B-8344-2011	Williams, Richard J/0000-0001-8847-3213				Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Belgrano A, 2005, AQUATIC FOOD WEBS EC; Brose U, 2005, ECOL LETT, V8, P1317, DOI 10.1111/j.1461-0248.2005.00838.x; Campbell C, 2011, P NATL ACAD SCI USA, V108, P197, DOI 10.1073/pnas.1008204108; Cohen J.E., 1990, COMMUNITY FOOD WEBS; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Grant V., 1965, FLOWER POLLINATION P; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Jabot F, 2012, P NATL ACAD SCI USA, V109, P4521, DOI 10.1073/pnas.1107004109; Joppa LN, 2011, METHODS ECOL EVOL, V2, P541, DOI 10.1111/j.2041-210X.2011.00101.x; Joppa LN, 2010, EVOL ECOL RES, V12, P35; Joppa LN, 2009, ECOL LETT, V12, P961, DOI 10.1111/j.1461-0248.2009.01341.x; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Martinez ND, 2006, SFI S SCI C, P163; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; PAINE RT, 1980, J ANIM ECOL, V49, P667; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Petchey OL, 2008, P NATL ACAD SCI USA, V105, P4191, DOI 10.1073/pnas.0710672105; PIMM SL, 1982, FOOD WEBS; Pires MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027280; Ruiter de PC, 2006, THEORETICAL ECOLOGY; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Srinivasan UT, 2007, ECOLOGY, V88, P671, DOI 10.1890/06-0971; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Williams RJ, 2008, J ANIM ECOL, V77, P512, DOI 10.1111/j.1365-2656.2008.01362.x; Williams RJ, 2011, ECOLOGY, V92, P1849, DOI 10.1890/11-0200.1; Williams RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012092; Williams RJ, 2010, THEOR ECOL-NETH, V3, P45, DOI 10.1007/s12080-009-0052-6; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	40	9	9	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56277	10.1371/journal.pone.0056277	http://dx.doi.org/10.1371/journal.pone.0056277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460797	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000020
J	Kong, Y; Xu, XY; Zhu, L				Kong, Yun; Xu, Xiangyang; Zhu, Liang			Cyanobactericidal Effect of Streptomyces sp HJC-D1 on Microcystis auruginosa	PLOS ONE			English	Article							2-METHYL ACETOACETATE EMA; CHLORELLA-VULGARIS; ANTIOXIDANT ENZYMES; OXIDATIVE DAMAGE; GENE-EXPRESSION; GREEN-ALGAE; AERUGINOSA; INHIBITION; STRESS; MECHANISM	An isolated strain Streptomyces sp. HJC-D1 was applied to inhibit the growth of cyanobacterium Microcystis aeruginosa FACHB-905. The effect of Streptomyces sp. HJC-D1 culture broth on the cell integrity and physiological characteristics of M. aeruginosa FACHB-905 was investigated using the ow cytometry (FCM), enzyme activity and transmission electron microscopy (TEM) methods. Results showed that the growth of M. aeruginosa FACHB-905 was significantly inhibited, and the percentage of live cells depended on the culture broth concentration and exposure time. The activities of antioxidant enzymes including superoxide dismutase (SOD), peroxidase (POD) and catalase (CAT) increased with exposure concentration and exposure time, and the significant increase of reactive oxygen species (ROS) led to the disruption of the subcellular structure of M. aeruginosa FACHB-905, and caused the increase of malondialdehyde (MDA). Furthermore, TEM observation suggested the presence of three stages (cell breakage, organelle release and cell death) for the cyanobactericidal process of Streptomyces sp. HJC-D1. Therefore, Streptomyces sp. HJC-D1 not only affected antioxidant enzyme activities and ROS level, but also destroyed the subcellular structure of M. aeruginosa FACHB-905, demonstrating excellent cyanobactericidal properties.	[Kong, Yun; Xu, Xiangyang; Zhu, Liang] Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Xiangyang] ZJU UWA Joint Ctr Integrated Water Management & P, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhu, L (corresponding author), Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China.	felix79cn@zju.edu.cn	Kong, Yun/M-5848-2014		National Key Technology RD Program [2006BAJ08B01/2012BAJ25B07]; Department of Education of Zhejiang Province [Y200909172]	National Key Technology RD Program(National Key Technology R&D Program); Department of Education of Zhejiang Province	This work was supported by the National Key Technology R&D Program (No. 2006BAJ08B01/2012BAJ25B07), and Research Projects of the Department of Education of Zhejiang Province (No. Y200909172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bonekamp NA, 2009, BIOFACTORS, V35, P346, DOI 10.1002/biof.48; Chang DW, 2011, J HAZARD MATER, V185, P1214, DOI 10.1016/j.jhazmat.2010.10.033; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; Daly RI, 2007, ENVIRON SCI TECHNOL, V41, P4447, DOI 10.1021/es070318s; Dogru MK, 2008, J APPL TOXICOL, V28, P140, DOI 10.1002/jat.1259; Henderson RK, 2008, WATER RES, V42, P3435, DOI 10.1016/j.watres.2007.10.032; Hong HC, 2009, ARCH ENVIRON CON TOX, V56, P638, DOI 10.1007/s00244-008-9216-4; Hong Y, 2008, ECOTOX ENVIRON SAFE, V71, P527, DOI 10.1016/j.ecoenv.2007.10.010; Hong Y, 2008, J PLANT PHYSIOL, V165, P1264, DOI 10.1016/j.jplph.2007.10.007; Hong Y, 2009, AQUAT TOXICOL, V91, P262, DOI 10.1016/j.aquatox.2008.11.014; Hua XH, 2009, BIOTECHNOL LETT, V31, P1531, DOI 10.1007/s10529-009-0051-0; Huang HL, 2008, INT BIODETER BIODEGR, V61, P331, DOI 10.1016/j.ibiod.2007.06.014; Jia Y, 2010, J HAZARD MATER, V183, P176, DOI 10.1016/j.jhazmat.2010.07.009; Kim MJ, 2008, J APPL PHYCOL, V20, P1069, DOI 10.1007/s10811-008-9312-x; Liu ZQ, 2011, WATER RES, V45, P6489, DOI 10.1016/j.watres.2011.09.043; Lovejoy C, 1998, APPL ENVIRON MICROB, V64, P2806; MYKLESTAD SM, 1995, SCI TOTAL ENVIRON, V165, P155, DOI 10.1016/0048-9697(95)04549-G; Prado R, 2012, ECOTOXICOLOGY, V21, P409, DOI 10.1007/s10646-011-0801-3; Qian HF, 2008, AQUAT TOXICOL, V88, P301, DOI 10.1016/j.aquatox.2008.05.009; Qian HF, 2008, ENVIRON TOXICOL CHEM, V27, P182, DOI 10.1897/07-163.1; Qian HF, 2012, ENVIRON TOXICOL, V27, P229, DOI 10.1002/tox.20636; Qian HF, 2009, ECOTOXICOLOGY, V18, P537, DOI 10.1007/s10646-009-0311-8; Qian HF, 2009, CHEMOSPHERE, V75, P368, DOI 10.1016/j.chemosphere.2008.12.040; Qin BQ, 2006, CHINESE SCI BULL, V51, P2401, DOI 10.1007/s11434-006-2096-y; Qu JH, 2010, CRIT REV ENV SCI TEC, V40, P519, DOI 10.1080/10643380802451953; Rioboo C, 2009, AQUAT TOXICOL, V94, P229, DOI 10.1016/j.aquatox.2009.07.009; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Shao JH, 2011, AQUAT TOXICOL, V104, P48, DOI 10.1016/j.aquatox.2011.03.014; Shao JH, 2009, CHEMOSPHERE, V75, P924, DOI 10.1016/j.chemosphere.2009.01.021; Shi SY, 2006, BIOL CONTROL, V39, P345, DOI 10.1016/j.biocontrol.2006.06.011; Tang XQ, 2012, WATER AIR SOIL POLL, V223, P723, DOI 10.1007/s11270-011-0897-3; Trenzado C, 2006, AQUACULTURE, V254, P758, DOI 10.1016/j.aquaculture.2005.11.020; Wang J, 2011, CHEMOSPHERE, V85, P977, DOI 10.1016/j.chemosphere.2011.06.076; Xiao X, 2010, CHEMOSPHERE, V81, P1118, DOI 10.1016/j.chemosphere.2010.09.001; Yang CY, 2011, PESTIC BIOCHEM PHYS, V100, P93, DOI 10.1016/j.pestbp.2011.02.014; Zhang H, 2011, LIMNOLOGICA, V41, P70, DOI 10.1016/j.limno.2010.08.001	38	49	49	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57654	10.1371/journal.pone.0057654	http://dx.doi.org/10.1371/journal.pone.0057654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460891	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000146
J	Choi, J; Park, SY; Kim, BR; Roh, JH; Oh, IS; Han, SS; Lee, YH				Choi, Jaehyuk; Park, Sook-Young; Kim, Byung-Ryun; Roh, Jae-Hwan; Oh, In-Seok; Han, Seong-Sook; Lee, Yong-Hwan			Comparative Analysis of Pathogenicity and Phylogenetic Relationship in Magnaporthe grisea Species Complex	PLOS ONE			English	Article							RICE BLAST FUNGUS; PYRICULARIA-GRISEA; NONHOST RESISTANCE; MODEL SYSTEM; PRIMER SETS; SEQUENCE; DNA; POPULATIONS; DIVERSITY; ORYZAE	Outbreaks of rice blast have been a threat to the global production of rice. Members of the Magnaporthe grisea species complex cause blast disease on a wide range of gramineous hosts, including cultivated rice and other grass species. Recently, based on phylogenetic analyses and mating tests, isolates from crabgrass were separated from the species complex and named M. grisea. Then other isolates from grasses including rice were named as M. oryzae. Here, we collected 103 isolates from 11 different species of grasses in Korea and analyzed their phylogenetic relationships and pathogenicity. Phylogenetic analyses of multilocus sequences and DNA fingerprinting revealed that the haplotypes of most isolates were associated with their hosts. However, six isolates had different haplotypes from the expectation, suggesting potential host shift in nature. Results of pathogenicity tests demonstrated that 42 isolates from crabgrass and 19 isolates from rice and other grasses showed cross-infectivity on rice and crabgrass, respectively. Interestingly, we also found that the isolates from rice had a distinct deletion in the calmodulin that can be used as a probe.	[Choi, Jaehyuk; Park, Sook-Young; Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea; [Kim, Byung-Ryun; Roh, Jae-Hwan; Oh, In-Seok; Han, Seong-Sook] Rural Dev Adm, Natl Inst Crop Sci, Crop Environm Div, Suwon, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Dept Agr Biotechnol, Ctr Fungal Genet Resources, Plant Genom & Breeding Inst, Seoul, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Seoul National University (SNU); Seoul National University (SNU)	Lee, YH (corresponding author), Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea.	yonglee@snu.ac.kr			National Research Foundation of Korea; Korea government [2012-0001149, 2012-0000141]; TDPAF [309015-04-SB020]; Next-Generation BioGreen 21 Program of Rural Development Administration in Korea [PJ00821201]; Brain Korea 21 Program	National Research Foundation of Korea(National Research Foundation of Korea); Korea government(Korean Government); TDPAF; Next-Generation BioGreen 21 Program of Rural Development Administration in Korea; Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government (2012-0001149 and 2012-0000141), the TDPAF (309015-04-SB020) and the Next-Generation BioGreen 21 Program of Rural Development Administration in Korea (PJ00821201). J. Choi is grateful for a graduate fellowship through the Brain Korea 21 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARR ME, 1977, MYCOLOGIA, V69, P952, DOI 10.2307/3758778; Besi MI, 2009, MAGNAPORTHE ITS RELA, P1; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; CHEN DH, 1995, PHYTOPATHOLOGY, V85, P1011, DOI 10.1094/Phyto-85-1011; Chen QH, 2006, GENOME, V49, P873, DOI 10.1139/G06-043; Choi WooBong, 1996, Korean Journal of Plant Pathology, V12, P453; Couch BC, 2005, GENETICS, V170, P613, DOI 10.1534/genetics.105.041780; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; DOBINSON KF, 1993, MOL PLANT MICROBE IN, V6, P114, DOI 10.1094/MPMI-6-114; Faivre-Rampant O, 2008, NEW PHYTOL, V180, P899, DOI 10.1111/j.1469-8137.2008.02621.x; Farman ML, 1996, MOL GEN GENET, V251, P665, DOI 10.1007/BF02174115; Farman ML, 2002, PHYTOPATHOLOGY, V92, P245, DOI 10.1094/PHYTO.2002.92.3.245; FARR D.F., 2009, FUNGAL DATABASES; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Gnanamanickam SS, 2009, PROG BIOL CONTROL, V8, P1, DOI 10.1007/978-90-481-2465-7_1; HAMER JE, 1989, P NATL ACAD SCI USA, V86, P9981, DOI 10.1073/pnas.86.24.9981; Harrington TC, 1999, STRUCTURE DYNAMICS F, V43, P71, DOI DOI 10.1007/978-94-011-4423-0_3; Hemmi T, 1949, ANN PHYTOPATHOL SOC, V13, P23; Hirata K, 2007, MYCOL RES, V111, P799, DOI 10.1016/j.mycres.2007.05.014; Hori S, 1898, BLAST DIS RICE PLANT, P1; Kato Hajime, 2000, Journal of General Plant Pathology, V66, P30, DOI 10.1007/PL00012919; Kawakami T, 1902, J SAPPRO AGRIC SOC, V3, P1; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; KRAUSE RA, 1972, MYCOLOGIA, V64, P103, DOI 10.2307/3758018; Leslie J. F., 2007, FUSARIUM LAB MANUAL, P87; LEVY M, 1991, PLANT CELL, V3, P95, DOI 10.1105/tpc.3.1.95; LEVY M, 1993, PHYTOPATHOLOGY, V83, P1427, DOI 10.1094/Phyto-83-1427; McRae W, 1922, REPORT IMPERIAL MYCO, P44; Nisikado, 1926, B BUREAUX AGR MINIST, V15, P1; NOTTEGHEM JL, 1992, PHYTOPATHOLOGY, V82, P421, DOI 10.1094/Phyto-82-421; Oh HS, 2002, CAN J BOT, V80, P1088, DOI [10.1139/B02-101, 10.1139/b02-101]; Ou S. H, 1985, RICE DIS; Park SY, 2003, PHYTOPATHOLOGY, V93, P1378, DOI 10.1094/PHYTO.2003.93.11.1378; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; ROSSMAN AY, 1990, MYCOLOGIA, V82, P509, DOI 10.2307/3760024; SACCARDO PA, 1880, MICHELIA, V2, P1; Sawada K, 1917, SPECIAL B TAIWAN AGR, V16; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Sprague R., 1950, DIS CEREALS GRASSES, P414; Suzuki H, 1953, ANN PHYTOPATHOL SOC, V17, P94; SWOFFORD DL, 1993, J GEN PHYSIOL, V102, pA9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor J, 2003, COGN LINGUIST RES, V23, P1, DOI 10.1515/9783110219074.1; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tosa Y, 2004, PHYTOPATHOLOGY, V94, P454, DOI 10.1094/PHYTO.2004.94.5.454; Tsurushima T, 2005, MOL PLANT PATHOL, V6, P605, DOI 10.1111/J.1364-3703.2005.00309.X; VALENT B, 1990, PHYTOPATHOLOGY, V80, P33, DOI 10.1094/Phyto-80-33; VALENT B, 1991, GENETICS, V127, P87; YAEGASHI H, 1978, CAN J BOT, V56, P180, DOI 10.1139/b78-023; Zeigler RS, 1998, ANNU REV PHYTOPATHOL, V36, P249, DOI 10.1146/annurev.phyto.36.1.249; ZEIGLER RS, 1995, PHYTOPATHOLOGY, V85, P443, DOI 10.1094/Phyto-85-443; Zellerhoff N, 2006, MOL PLANT MICROBE IN, V19, P1014, DOI 10.1094/MPMI-19-1014; Zhang N, 2011, MYCOLOGIA, V103, P1267, DOI 10.3852/11-022	56	40	48	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57196	10.1371/journal.pone.0057196	http://dx.doi.org/10.1371/journal.pone.0057196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468934	gold, Green Published, Green Submitted			2022-12-27	WOS:000315561400029
J	Lu, YM; Chen, X; Wu, YX; Wang, YP; He, YQ; Wu, Y				Lu, Yuming; Chen, Xi; Wu, Yuxuan; Wang, Yanping; He, Yuqing; Wu, Yan			Directly Transforming PCR-Amplified DNA Fragments into Plant Cells Is a Versatile System That Facilitates the Transient Expression Assay	PLOS ONE			English	Article							ABSCISIC-ACID; ARABIDOPSIS-THALIANA; PROTEIN LOCALIZATION; GENE-EXPRESSION; IN-VIVO; DROUGHT; VARIABILITY; SEQUENCES; KINASES; TISSUES	A circular plasmid containing a gene coding sequence has been broadly used for studying gene regulation in cells. However, to accommodate a quick screen plasmid construction and preparation can be time consuming. Here we report a PCR amplified dsDNA fragments (PCR-fragments) based transient expression system (PCR-TES) for suiting in the study of gene regulation in plant cells. Instead of transforming plasmids into plant cells, transient expression of PCR-fragments can be applicable. The transformation efficiency and expression property of PCR-fragments are comparable to transformation using plasmids. We analyzed the transformation efficiency in PCR-TES at transcription and protein levels. Our results indicate that the PCR-TES is as versatile as the conventional transformation system using plasmid DNA. Through reconstituting PYR1-mediated ABA signaling pathway in Arabidopsis mesophyll protoplasts, we were not only validating the practicality of PCR-TES but also screening potential candidates of CDPK family members which might be involved in the ABA signaling. Moreover, we determined that phosphorylation of ABF2 by CPK4 could be mediated by ABA-induced PYR1 and ABI1, demonstrating a crucial role of CDPKs in the ABA signaling. In summary, PCR-TES can be applicable to facilitate analyzing gene regulation and for the screen of putative regulatory molecules at the high throughput level in plant cells.	[Lu, Yuming; Chen, Xi; Wu, Yuxuan; Wang, Yanping; He, Yuqing; Wu, Yan] Wuhan Univ, State Key Lab Hybrid Rice, Dept Cell & Dev Biol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Wu, Y (corresponding author), Wuhan Univ, State Key Lab Hybrid Rice, Dept Cell & Dev Biol, Coll Life Sci, Wuhan 430072, Peoples R China.	wuy@whu.edu.cn	Lu, Yuming/AIF-4429-2022	Lu, Yuming/0000-0002-0183-5574; Wang, Yanping/0000-0003-4391-0883	National Natural Science Foundation of China [30770459, 90817013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm) to Y. Wu (30770459, 90817013). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Chen Y, 2003, DIFFERENTIATION, V71, P528, DOI 10.1111/j.1432-0436.2003.07109007.x; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Choi HI, 2005, PLANT PHYSIOL, V139, P1750, DOI 10.1104/pp.105.069757; DEAN C, 1988, NUCLEIC ACIDS RES, V16, P9267, DOI 10.1093/nar/16.19.9267; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Isalan M, 2005, NAT METHODS, V2, P113, DOI 10.1038/NMETH732; KOBAYASHI M, 1991, APPL BIOCHEM BIOTECH, V27, P145, DOI 10.1007/BF02921523; Koroleva OA, 2005, PLANT J, V41, P162, DOI 10.1111/j.1365-313X.2004.02281.x; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Li S, 1997, GENE THER, V4, P449, DOI 10.1038/sj.gt.3300413; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; PEACH C, 1991, PLANT MOL BIOL, V17, P49, DOI 10.1007/BF00036805; Periasamy A, 2001, J BIOMED OPT, V6, P287, DOI 10.1117/1.1383063; Russell D. W., 2006, COLD SPRING HARB PRO; Saida F, 2006, CURR PROTEIN PEPT SC, V7, P47, DOI 10.2174/138920306775474095; Seki M, 1999, MOL BIOTECHNOL, V11, P251, DOI 10.1007/BF02788683; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Ueki S, 2009, NAT PROTOC, V4, P71, DOI 10.1038/nprot.2008.217; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wehner N, 2011, PLANT J, V68, P560, DOI 10.1111/j.1365-313X.2011.04704.x; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao R, 2011, PLANT SIGNAL BEHAV, V6, P1687, DOI 10.4161/psb.6.11.17954; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545	35	29	35	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57171	10.1371/journal.pone.0057171	http://dx.doi.org/10.1371/journal.pone.0057171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468926	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400027
J	Peng, YY; Shi, KK; Wang, LT; Lu, JL; Li, HW; Pan, SY; Ma, CY				Peng, Yanyan; Shi, Kaikai; Wang, Lintao; Lu, Jianlei; Li, Hongwei; Pan, Shiyang; Ma, Changyan			Characterization of Osterix Protein Stability and Physiological Role in Osteoblast Differentiation	PLOS ONE			English	Article							BONE-FORMATION; PROTEASOME SYSTEM; TRANSCRIPTION; UBIQUITIN; DEGRADATION; INHIBITORS; PATHWAY	Osterix (Osx/SP7) is a C2H2 zinc finger-containing transcription factor of the SP gene family. Osx knockout mice indicate that the gene plays an essential role in osteoblast differentiation and bone formation. However, the mechanisms involved in the regulation of Osx are still poorly understood. Here, we report a novel post-translational mechanism for the regulation of Osx in mammalian cells. We found that the stability of endogenous and exogenous Osx reduced after cycloheximide treatment. In cells treated with the proteasome inhibitors MG-132 or lactacystin, both endogenous and exogenous Osx protein expression increased in a time-dependent manner. Co-immunoprecipitation (Co-IP) assays showed that both endogenous and exogenous Osx were ubiquitinated. Six lysine residues of Osx were identified as candidate ubiquitination sites by construction of point mutant plasmids and luciferase reporter assays. Furthermore, we confirmed that K58 and K230 are the ubiquitination sites of Osx by Co-IP assays and protein stability assays. Moreover, the Osx K58R and K230R mutations promoted the expression of osteoblast differentiation markers (alkaline phosphatase, collagen I and osteocalcin) and enhanced osteogenic differentiation in C2C12 cells. Taken together, our data indicate that Osx is an unstable protein, and that the ubiquitin-proteasome pathway is involved in the regulation of Osx and thereby regulates osteoblast differentiation.	[Peng, Yanyan; Shi, Kaikai; Lu, Jianlei; Ma, Changyan] Nanjing Med Univ, Dept Dev Genet, Nanjing, Jiangsu, Peoples R China; [Wang, Lintao] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China; [Li, Hongwei] Nanjing Med Univ, Dept Oral & Maxillofacial Surg, Affiliated Hosp Stomatol, Nanjing, Jiangsu, Peoples R China; [Pan, Shiyang] Nanjing Med Univ, Dept Lab Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Pan, Shiyang] Natl Key Clin Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Ma, Changyan] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Ma, CY (corresponding author), Nanjing Med Univ, Dept Dev Genet, Nanjing, Jiangsu, Peoples R China.	cyma@njmu.edu.cn	Peng, Yanyan/I-1515-2019	Peng, Yanyan/0000-0002-1176-4837	National Natural Science Foundation of China [81071525]; Key Laboratory for Laboratory Medicine of Jiangsu Province of China [XK201114]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory for Laboratory Medicine of Jiangsu Province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by grants from the National Natural Science Foundation of China (81071525); Key Laboratory for Laboratory Medicine of Jiangsu Province of China (No. XK201114); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions; The Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek WY, 2010, BONE, V46, P920, DOI 10.1016/j.bone.2009.12.007; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012636; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Ciechanover A, 2005, PROTEIN DEGRADATION: UBIQUITIN AND THE CHEMISTRY OF LIFE, VOL 1, pXIII; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Heino TJ, 2008, CURR STEM CELL RES T, V3, P131, DOI 10.2174/157488808784223032; Hobler SC, 1999, AM J PHYSIOL-REG I, V276, pR468, DOI 10.1152/ajpregu.1999.276.2.R468; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kim MY, 2012, EXP DIABETES RES, DOI 10.1155/2012/716425; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mayer R.J., 2008, PROTEIN DEGRADATION; Mayer RJ, 2006, PROTEIN DEGRADATION; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Shi Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002089; Sorokin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1411, DOI 10.1134/S000629790913001X; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Voutsadakis IA, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-67; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37; Zhao X, 2012, J PHYSIOL BIOCHEM, V68, P129, DOI 10.1007/s13105-011-0126-y; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	29	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56451	10.1371/journal.pone.0056451	http://dx.doi.org/10.1371/journal.pone.0056451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457570	gold, Green Submitted, Green Published			2022-12-27	WOS:000315603700055
J	Xing, B; Bachstetter, AD; Van Eldik, LJ				Xing, Bin; Bachstetter, Adam D.; Van Eldik, Linda J.			Deficiency in p38 beta MAPK Fails to Inhibit Cytokine Production or Protect Neurons against Inflammatory Insult in In Vitro and In Vivo Mouse Models	PLOS ONE			English	Article							MICROGLIAL P38-ALPHA MAPK; DELAYED INDUCTION; CARBON-MONOXIDE; UP-REGULATION; BRAIN; ASTROCYTES; CYTOPROTECTION; CELLS	The p38 MAPK pathway plays a key role in regulating the production of proinflammatory cytokines, such as TNF alpha and IL-1 beta, in peripheral inflammatory disorders. There are four major isoforms of p38 MAPK (p38 alpha, beta, delta, gamma), with p38 alpha and p38 beta the targets of most p38 MAPK inhibitor drugs. Our previous studies demonstrated that the p38 alpha MAPK isoform is an important contributor to stressor-induced proinflammatory cytokine up-regulation and neurotoxicity in the brain. However, the potential role of the p38 beta MAPK isoform in CNS proinflammatory cytokine overproduction and neurotoxicity is poorly understood. In the current studies, we used primary microglia from wild type (WT) and p38 beta knockout (KO) mice in co-culture with WT neurons, and measured proinflammatory cytokines and neuron death after LPS insult. We also measured neuroinflammatory responses in vivo in WT and p38 beta KO mice after administration of LPS by intraperitoneal or intracerebroventricular injection. WT and p38 beta KO microglia/neuron co-cultures showed similar levels of TNF alpha and IL-1 beta production in response to LPS treatment, and no differences in LPS-induced neurotoxicity. The in vitro results were confirmed in vivo, where levels of TNF alpha and IL-1 beta in the CNS were not significantly different between WT or p38 beta KO mice after LPS insult. Our results suggest that, similar to peripheral inflammation, p38 alpha is critical but p38 beta MAPK is dispensable in the brain in regards to proinflammatory cytokine production and neurotoxicity induced by LPS inflammatory insult.	[Xing, Bin; Bachstetter, Adam D.; Van Eldik, Linda J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Van Eldik, Linda J.] Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Van Eldik, LJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.	linda.vaneldik@uky.edu		Bachstetter, Adam/0000-0003-4646-6757	Alzheimer's Association [ZEN-09-134506];  [NIH R01 NS064247];  [NIH F32 AG037280]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG037280] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH R01 NS064247; NIH F32 AG037280; Alzheimer's Association ZEN-09-134506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachstetter AD, 2010, AGING DIS, V1, P199; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Che YZ, 2001, MOL BRAIN RES, V94, P157, DOI 10.1016/S0169-328X(01)00233-9; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Fitzsimmons BL, 2010, NEUROREPORT, V21, P313, DOI 10.1097/WNR.0b013e32833774bf; Guo YL, 2001, J CELL BIOCHEM, V82, P556, DOI 10.1002/jcb.1180; Kaminska B, 2009, ANAT REC, V292, P1902, DOI 10.1002/ar.21047; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kim HP, 2005, J IMMUNOL, V175, P2622, DOI 10.4049/jimmunol.175.4.2622; Kim SW, 2004, BRAIN RES, V1007, P188, DOI 10.1016/j.brainres.2004.02.009; Lee SH, 2000, J NEUROSCI RES, V60, P623, DOI 10.1002/(SICI)1097-4547(20000601)60:5<623::AID-JNR7>3.0.CO;2-4; Loy B, 2011, J NEUROSCI, V31, P12059, DOI 10.1523/JNEUROSCI.0448-11.2011; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; O'Keefe SJ, 2007, J BIOL CHEM, V282, P34663, DOI 10.1074/jbc.M704236200; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Piao CS, 2003, BRAIN RES, V976, P120, DOI 10.1016/S0006-8993(03)02579-4; Piao CS, 2002, MOL BRAIN RES, V107, P137, DOI 10.1016/S0169-328X(02)00456-4; Risco A., 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/520289; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Schallner N, 2011, EUR J PHARMACOL, V670, P58, DOI 10.1016/j.ejphar.2011.08.028; Shin JH, 2011, NEUROSCI LETT, V501, P132, DOI 10.1016/j.neulet.2011.06.061; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xie Z, 2004, GLIA, V45, P170, DOI 10.1002/glia.10314; Xing B, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-84	26	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56852	10.1371/journal.pone.0056852	http://dx.doi.org/10.1371/journal.pone.0056852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457629	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700089
J	Chen, B; Yi, B; Mao, R; Liu, HT; Wang, JH; Sharma, A; Peiper, S; Leonard, WJ; She, JX				Chen, Bo; Yi, Bing; Mao, Rui; Liu, Haitao; Wang, Jinhua; Sharma, Ashok; Peiper, Stephen; Leonard, Warren J.; She, Jin-Xiong			Enhanced T Cell Lymphoma in NOD.Stat5b Transgenic Mice Is Caused by Hyperactivation of Stat5b in CD8(+) Thymocytes	PLOS ONE			English	Article							CONSTITUTIVE ACTIVATION; UP-REGULATION; JANUS KINASE; DNA-BINDING; EXPRESSION; CANCER; PATHWAY; EXPANSION; LEUKEMIA; RECEPTOR	Activation of signal transducers and activators of transcription (STAT) proteins may be critical to their oncogenic functions as demonstrated by the development of B-cell lymphoma/leukemia in transgenic (TG) mice overexpressing a constitutively activated form of Stat5b. However, low incidence of CD8(+) T cell lymphoma was observed in B6 transgenic mice overexpressing a wild-type Stat5b (B6.Stat5b(Tg)) despite of undetectable Stat5b phosphorylation and the rate of lymphomagenesis was markedly enhanced by immunization or the introduction of TCR transgenes [1]. Here, we report that the wild-type Stat5b transgene leads to the acceleration and high incidence (74%) of CD8(+) T cell lymphoblastic lymphomas in the non-obese-diabetic (NOD) background. In contrast to the B6.Stat5b(Tg) mice, Stat5b in transgenic NOD (NOD.Stat5b(Tg)) mice is selectively and progressively phosphorylated in CD8(+) thymocytes. Stat5 phosphorylation also leads to up-regulation of many genes putatively relevant to tumorigenesis. Treatment of NOD.Stat5b(Tg) mice with cancer chemopreventive agents Apigenin and Xanthohumol efficiently blocked lymphomagenesis through reduction of Stat5 phosphorylation and genes up-regulated in the NOD.Stat5b(Tg) mice. These results suggest that NOD genetic background is critical to the Stat5b-mediated lymphomagenesis through regulation of Stat5 hyperactivation. NOD.Stat5b(Tg) mouse is an excellent model for studying the molecular mechanisms underlying lymphomagenesis and testing novel chemoprevention strategies.	[Chen, Bo; Yi, Bing; Mao, Rui; Liu, Haitao; Wang, Jinhua; Sharma, Ashok; She, Jin-Xiong] Georgia Regents Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Chen, Bo; Wang, Jinhua; She, Jin-Xiong] Nanjing Univ Technol, Sinoamer Inst Translat Med, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Peiper, Stephen] Jefferson Univ, Dept Pathol, Philadelphia, PA USA; [Leonard, Warren J.] NHLBI, NIH, Bethesda, MD 20892 USA	University System of Georgia; Augusta University; Nanjing Tech University; Nanjing Medical University; Jefferson University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	She, JX (corresponding author), Georgia Regents Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA USA.	jshe@georgiahealth.edu	Leonard, Warren/AAA-1397-2022; chen, bo/G-4522-2014	Sharma, Ashok/0000-0001-9597-4374	Georgia Health Sciences University; National Natural Science Foundation of China [81272244]; GRA endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005402] Funding Source: NIH RePORTER	Georgia Health Sciences University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); GRA endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by funds from the Georgia Health Sciences University and National Natural Science Foundation of China(81272244). J.X.S. is a Georgia Research Alliance (GRA) Eminent Scholar and supported by a GRA endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsberg J, 2010, J BIOL CHEM, V285, P36275, DOI 10.1074/jbc.M110.155531; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Bessette K, 2008, BLOOD, V111, P344, DOI 10.1182/blood-2007-04-084707; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Carron C, 2000, BLOOD, V95, P3891; Chen E, 2012, IMMUNITY, V36, P529, DOI 10.1016/j.immuni.2012.03.017; Davoodi-Semiromi A, 2004, J BIOL CHEM, V279, P11553, DOI 10.1074/jbc.M312110200; Davoodi-Semiromi A, 2007, BIOCHEM BIOPH RES CO, V356, P655, DOI 10.1016/j.bbrc.2007.03.028; dos Santos NR, 2007, BLOOD, V109, P3972, DOI 10.1182/blood-2006-09-048801; Ermakova O, 2011, EMBO MOL MED, V3, P50, DOI 10.1002/emmm.201000112; Fantin VR, 2008, CANCER RES, V68, P3785, DOI 10.1158/0008-5472.CAN-07-6091; Gerhauser C, 2002, MOL CANCER THER, V1, P959; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Jin YL, 2012, BIOCHEM BIOPH RES CO, V424, P669, DOI 10.1016/j.bbrc.2012.06.162; Joliot V, 2006, ONCOGENE, V25, P4573, DOI 10.1038/sj.onc.1209480; Kelly J, 2003, J IMMUNOL, V170, P210, DOI 10.4049/jimmunol.170.1.210; Kelly JA, 2003, J EXP MED, V198, P79, DOI 10.1084/jem.20021548; Kerr KF, 2009, BIOINFORMATICS, V25, P2035, DOI 10.1093/bioinformatics/btp363; Klinger MB, 2005, ONCOGENE, V24, P2695, DOI 10.1038/sj.onc.1208334; Laloraya M, 2006, DIABETES, V55, P734, DOI 10.2337/diabetes.55.03.06.db05-1059; Lebigot I, 2003, BLOOD, V102, P4555, DOI 10.1182/blood-2003-06-2077; Litherland SA, 2005, J IMMUNOL, V175, P4561, DOI 10.4049/jimmunol.175.7.4561; Liu Yongbo, 2012, J Exp Ther Oncol, V10, P1; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nikitakis NG, 2004, CURR CANCER DRUG TAR, V4, P637, DOI 10.2174/1568009043332736; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Peck AR, 2011, J CLIN ONCOL, V29, P2448, DOI 10.1200/JCO.2010.30.3552; Pecquet C, 2010, BLOOD, V115, P1037, DOI 10.1182/blood-2008-10-183558; PRATT JA, 1988, J CLIN EPIDEMIOL, V41, P367, DOI 10.1016/0895-4356(88)90144-8; Rouet V, 2010, P NATL ACAD SCI USA, V107, P15199, DOI 10.1073/pnas.0911651107; Ruela-de-Sousa RR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.18; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Serwold T, 2010, P NATL ACAD SCI USA, V107, P18939, DOI 10.1073/pnas.1013230107; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Tan AHM, 2010, J IMMUNOL, V184, P1849, DOI 10.4049/jimmunol.0901509; Tang JZ, 2010, ENDOCRINOLOGY, V151, P43, DOI 10.1210/en.2009-0651; Tweardy D, 2011, J CLIN ONCOL, V29, P2443, DOI 10.1200/JCO.2010.34.2014; Wang N, 2006, AM J RESP CELL MOL, V35, P206, DOI 10.1165/rcmb.2005-0294OC; Wang Y, 2007, BLOOD, V109, P2147, DOI 10.1182/blood-2006-08-040022; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yu CL, 1997, J IMMUNOL, V159, P5206; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012	49	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56600	10.1371/journal.pone.0056600	http://dx.doi.org/10.1371/journal.pone.0056600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457589	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700084
J	Huveldt, D; Lewis-Tuffin, LJ; Carlson, BL; Schroeder, MA; Rodriguez, F; Giannini, C; Galanis, E; Sarkaria, JN; Anastasiadis, PZ				Huveldt, Deborah; Lewis-Tuffin, Laura J.; Carlson, Brett L.; Schroeder, Mark A.; Rodriguez, Fausto; Giannini, Caterina; Galanis, Evanthia; Sarkaria, Jann N.; Anastasiadis, Panos Z.			Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion	PLOS ONE			English	Article							FACTOR-KAPPA-B; P120 CATENIN; DASATINIB BMS-354825; TUMOR ANGIOGENESIS; MALIGNANT GLIOMAS; TYROSINE KINASES; PROSTATE-CANCER; XENOGRAFT MODEL; RHO-GTPASES; IN-VIVO	Anti-VEGF antibody therapy with bevacizumab provides significant clinical benefit in patients with recurrent glioblastoma multiforme (GBM). Unfortunately, progression on bevacizumab therapy is often associated with a diffuse disease recurrence pattern, which limits subsequent therapeutic options. Therefore, there is an urgent need to understand bevacizumab's influence on glioma biology and block it's actions towards cell invasion. To explore the mechanism(s) of GBM cell invasion we have examined a panel of serially transplanted human GBM lines grown either in short-term culture, as xenografts in mouse flank, or injected orthotopically in mouse brain. Using an orthotopic xenograft model that exhibits increased invasiveness upon bevacizumab treatment, we also tested the effect of dasatinib, a broad spectrum SFK inhibitor, on bevacizumab-induced invasion. We show that 1) activation of Src family kinases (SFKs) is common in GBM, 2) the relative invasiveness of 17 serially transplanted GBM xenografts correlates strongly with p120 catenin phosphorylation at Y228, a Src kinase site, and 3) SFK activation assessed immunohistochemically in orthotopic xenografts, as well as the phosphorylation of downstream substrates occurs specifically at the invasive tumor edge. Further, we show that SFK signaling is markedly elevated at the invasive tumor front upon bevacizumab administration, and that dasatinib treatment effectively blocked the increased invasion induced by bevacizumab. Our data are consistent with the hypothesis that the increased invasiveness associated with anti-VEGF therapy is due to increased SFK signaling, and support testing the combination of dasatinib with bevacizumab in the clinic.	[Huveldt, Deborah; Lewis-Tuffin, Laura J.; Anastasiadis, Panos Z.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Rodriguez, Fausto; Giannini, Caterina] Mayo Clin, Dept Pathol, Rochester, MN USA; [Galanis, Evanthia] Mayo Clin, Dept Oncol, Rochester, MN USA; [Carlson, Brett L.; Schroeder, Mark A.; Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Anastasiadis, PZ (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	panos@mayo.edu	Ramos, Joe W./L-6189-2013; Giannini, Caterina/AAB-7551-2022	Ramos, Joe W./0000-0002-9708-2115; 	National Institutes of Health [R01 CA100467, R01 NS069753, P50 CA108961]; NATIONAL CANCER INSTITUTE [P50CA108961, R01CA100467, R01CA154348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by National Institutes of Health R01 CA100467, R01 NS069753, and a career development project P50 CA108961 (PZA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SA, 2008, J NEUROSURG, V109, P268, DOI 10.3171/JNS/2008/109/8/0268; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Angers-Loustau A, 2004, MOL CANCER RES, V2, P595; Bible KC, 1999, ANAL BIOCHEM, V267, P217, DOI 10.1006/abio.1998.2980; Bokstein F, 2008, CANCER-AM CANCER SOC, V112, P2267, DOI 10.1002/cncr.23401; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Carlson Brett L, 2011, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1416s52; Christopher LJ, 2008, DRUG METAB DISPOS, V36, P1357, DOI 10.1124/dmd.107.018267; Cloughesy TF, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.2010b; Coluccia AML, 2006, CANCER RES, V66, P2279, DOI 10.1158/0008-5472.CAN-05-2057; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Fong TAT, 1999, CANCER RES, V59, P99; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Golas JM, 2005, CANCER RES, V65, P5358, DOI 10.1158/0008-5472.CAN-04-2484; Goldbrunner RH, 2004, NEUROSURGERY, V55, P426, DOI 10.1227/01.NEU.0000129551.64651.74; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Jallal H, 2007, CANCER RES, V67, P1580, DOI 10.1158/0008-5472.CAN-06-2027; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Kunkel P, 2001, CANCER RES, V61, P6624; Laird AD, 2000, CANCER RES, V60, P4152; Lewis-Tuffin LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013665; Li LM, 2003, MOL CELL BIOL, V23, P2883, DOI 10.1128/MCB.23.8.2883-2892.2003; Li Q, 2008, BIOCHEM J, V411, P531, DOI 10.1042/BJ20071534; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Lund CV, 2006, J NEURO-ONCOL, V78, P19, DOI 10.1007/s11060-005-9068-y; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Narayana A, 2012, J NEUROSURG, V116, P341, DOI 10.3171/2011.9.JNS11656; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Plate KH, 2012, ACTA NEUROPATHOL, V124, P763, DOI 10.1007/s00401-012-1066-5; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Serrels A, 2006, MOL CANCER THER, V5, P3014, DOI 10.1158/1535-7163.MCT-06-0382; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; Theurillat JP, 1999, AM J PATHOL, V154, P581, DOI 10.1016/S0002-9440(10)65303-5; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Vultur A, 2008, MOL CANCER THER, V7, P1185, DOI 10.1158/1535-7163.MCT-08-0126; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wick A, 2011, ANN NEUROL, V69, P586, DOI 10.1002/ana.22336; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yang L, 2008, CLIN CANCER RES, V14, P3993, DOI 10.1158/1078-0432.CCR-07-4152; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zagzag D, 2000, PEDIATR NEUROSURG, V33, P49, DOI 10.1159/000028975	68	62	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56505	10.1371/journal.pone.0056505	http://dx.doi.org/10.1371/journal.pone.0056505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457577	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700077
J	Hu, WT; Shelnutt, M; Wilson, A; Yarab, N; Kelly, C; Grossman, M; Libon, DJ; Khan, J; Lah, JJ; Levey, AI; Glass, J				Hu, William T.; Shelnutt, Matthew; Wilson, Ashley; Yarab, Nicole; Kelly, Crystal; Grossman, Murray; Libon, David J.; Khan, Jaffar; Lah, James J.; Levey, Allan I.; Glass, Jonathan			Behavior Matters-Cognitive Predictors of Survival in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; PHILADELPHIA BRIEF ASSESSMENT; FRONTAL ASSESSMENT BATTERY; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; EXECUTIVE FUNCTION; DEMENTIA; ALS; IMPAIRMENT; DYSFUNCTION	Background: It is difficult to longitudinally characterize cognitive impairment in amyotrophic lateral sclerosis (ALS) due to motor deficits, and existing instruments aren't comparable with assessments in other dementias. Methods: The ALS Brief Cognitive Assessment (ALS-BCA) was validated in 70 subjects (37 with ALS) who also underwent detailed neuropsychological analysis. Cognitive predictors for poor survival were then analyzed in a longitudinal cohort of 171 ALS patients. Results: The ALS-BCA was highly sensitive (90%) and specific (85%) for ALS-dementia (ALS-D). ALS-D patients had shorter overall survival, primarily due to the poor survival among ALS-D patients with disinhibited or apathetic behaviors after adjusting for demographic variables, ALS site of onset, medications, and supportive measures. ALS-D without behavioral changes was not a predictor of poor survival. Conclusion: ALS-D can present with or without prominent behavioral changes. Cognitive screening in ALS patients should focus on behavioral changes for prognosis, while non-behavioral cognitive impairments may impact quality of life without impacting survival.	[Hu, William T.; Shelnutt, Matthew; Wilson, Ashley; Yarab, Nicole; Kelly, Crystal; Khan, Jaffar; Lah, James J.; Levey, Allan I.; Glass, Jonathan] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Hu, William T.; Lah, James J.; Levey, Allan I.; Glass, Jonathan] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA USA; [Hu, William T.; Shelnutt, Matthew; Lah, James J.; Levey, Allan I.; Glass, Jonathan] Emory Univ, Sch Med, Alzheimers Dis Res Ctr, Atlanta, GA USA; [Grossman, Murray] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Libon, David J.] Drexel Univ, Dept Neurol, Philadelphia, PA 19104 USA	Emory University; Emory University; Emory University; University of Pennsylvania; Drexel University	Hu, WT (corresponding author), Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.	william.hu@emory.edu	Levey, Allan/F-2104-2011	Levey, Allan/0000-0002-3153-502X; Hu, William/0000-0003-4862-6777	Viretta Brady Discovery Fund at Emory University School of Medicine; NIH [AG025688]; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	Viretta Brady Discovery Fund at Emory University School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the Viretta Brady Discovery Fund at Emory University School of Medicine, and NIH AG025688. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenzato M, 2010, NEUROPSYCHOLOGIA, V48, P2, DOI 10.1016/j.neuropsychologia.2009.08.001; Ahn SW, 2011, CAN J NEUROL SCI, V38, P242, DOI 10.1017/S0317167100011409; Armitage SG, 1946, PSYCHOL MONOGR, V60, P1; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton A.L., 1994, CONTRIBUTIONS NEUROP; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cavallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025948; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Elamin M, 2011, NEUROLOGY, V76, P1263, DOI 10.1212/WNL.0b013e318214359f; Eslinger PJ, 2007, J NEUROL NEUROSUR PS, V78, P457, DOI 10.1136/jnnp.2006.098228; Fernandez-Duque D, 2010, J CLIN EXP NEUROPSYC, V32, P289, DOI 10.1080/13803390903002191; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Goodglass H., 1983, ASSESSMENT APHASIA R, V2nd; Gordon PH, 2007, AMYOTROPH LATERAL SC, V8, P362, DOI 10.1080/17482960701500817; Gordon PH, 2010, AMYOTROPH LATERAL SC, V11, P312, DOI 10.3109/17482961003622585; Grossman M, 2008, NEUROLOGY, V70, P2036, DOI 10.1212/01.wnl.0000303816.25065.bc; Hu WT, 2009, ARCH NEUROL-CHICAGO, V66, P1359, DOI 10.1001/archneurol.2009.253; Josephs KA, 2006, NEUROLOGY, V66, P41, DOI 10.1212/01.wnl.0000191307.69661.c3; Kertesz A, 1997, CAN J NEUROL SCI, V24, P29, DOI 10.1017/S0317167100021053; Kertesz A, 2000, J INT NEUROPSYCH SOC, V6, P460, DOI 10.1017/S1355617700644041; Libon DJ, 2007, DEMENT GERIATR COGN, V24, P441, DOI 10.1159/000110577; Libon DJ, 2011, CLIN NEUROPSYCHOL, V25, P1314, DOI 10.1080/13854046.2011.631585; Lillo P, 2011, AMYOTROPH LATERAL SC, V12, P45, DOI 10.3109/17482968.2010.520718; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1076/neur.7.2.123.16266; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Collaborative Group for the Revision of the Wechsler Adult Intelligence Scale, 1983, MANUAL WECHSLER ADUL, V03, P362; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Olney RK, 2005, NEUROLOGY, V65, P1774, DOI 10.1212/01.wnl.0000188759.87240.8b; Oskarsson B, 2010, AMYOTROPH LATERAL SC, V11, P244, DOI 10.3109/17482960903059588; Rascovsky K, 2007, ALZ DIS ASSOC DIS, V21, pS14, DOI 10.1097/WAD.0b013e31815c3445; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ricker, 1994, Assessment, V1, P47, DOI 10.1177/1073191194001001007; Rippon GA, 2006, ARCH NEUROL-CHICAGO, V63, P345, DOI 10.1001/archneur.63.3.345; Rusina R, 2010, EUR J NEUROL, V17, P23, DOI 10.1111/j.1468-1331.2009.02717.x; Snowden J, 2007, ACTA NEUROPATHOL, V114, P31, DOI 10.1007/s00401-007-0236-3; Spreen O, 1990, COMPENDIUM NEUROPSYC; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Strong MJ, 1999, NEUROLOGY, V53, P1665, DOI 10.1212/WNL.53.8.1665; Wechsler D, 1973, MANUAL WECHSLER MEMO; Woolley SC, 2010, AMYOTROPH LATERAL SC, V11, P303, DOI 10.3109/17482961003727954	46	56	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57584	10.1371/journal.pone.0057584	http://dx.doi.org/10.1371/journal.pone.0057584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460879	Green Published, gold			2022-12-27	WOS:000315519000134
J	Quintens, R; Singh, S; Lemaire, K; De Bock, K; Granvik, M; Schraenen, A; Vroegrijk, IOCM; Costa, V; Van Noten, P; Lambrechts, D; Lehnert, S; Van Lommel, L; Thorrez, L; De Faudeur, G; Romijn, JA; Shelton, JM; Scorrano, L; Lijnen, HR; Voshol, PJ; Carmeliet, P; Mammen, PPA; Schuit, F				Quintens, Roel; Singh, Sarvjeet; Lemaire, Katleen; De Bock, Katrien; Granvik, Mikaela; Schraenen, Anica; Vroegrijk, Irene Olga Cornelia Maria; Costa, Veronica; Van Noten, Pieter; Lambrechts, Dennis; Lehnert, Stefan; Van Lommel, Leentje; Thorrez, Lieven; De Faudeur, Geoffroy; Romijn, Johannes Anthonius; Shelton, John Michael; Scorrano, Luca; Lijnen, Henri Roger; Voshol, Peter Jacobus; Carmeliet, Peter; Mammen, Pradeep Puthenveetil Abraham; Schuit, Frans			Mice Deficient in the Respiratory Chain Gene Cox6a2 Are Protected against High-Fat Diet-Induced Obesity and Insulin Resistance	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL OXIDATIVE-PHOSPHORYLATION; TISSUE-SPECIFIC REGULATION; SKELETAL-MUSCLE; UNCOUPLING PROTEIN-2; ENERGY-METABOLISM; NUCLEAR RECEPTOR; ADIPOSE-TISSUE; UP-REGULATION; BOVINE HEART	Oxidative phosphorylation in mitochondria is responsible for 90% of ATP synthesis in most cells. This essential housekeeping function is mediated by nuclear and mitochondrial genes encoding subunits of complex I to V of the respiratory chain. Although complex IV is the best studied of these complexes, the exact function of the striated muscle-specific subunit COX6A2 is still poorly understood. In this study, we show that Cox6a2-deficient mice are protected against high-fat diet-induced obesity, insulin resistance and glucose intolerance. This phenotype results from elevated energy expenditure and a skeletal muscle fiber type switch towards more oxidative fibers. At the molecular level we observe increased formation of reactive oxygen species, constitutive activation of AMP-activated protein kinase, and enhanced expression of uncoupling proteins. Our data indicate that COX6A2 is a regulator of respiratory uncoupling in muscle and we demonstrate that a novel and direct link exists between muscle respiratory chain activity and diet-induced obesity/insulin resistance.	[Quintens, Roel; Lemaire, Katleen; Granvik, Mikaela; Schraenen, Anica; Lehnert, Stefan; Van Lommel, Leentje; Thorrez, Lieven; De Faudeur, Geoffroy; Schuit, Frans] Katholieke Univ Leuven, Gene Express Unit, Dept Mol & Cellular Med, Louvain, Belgium; [Singh, Sarvjeet; Shelton, John Michael; Mammen, Pradeep Puthenveetil Abraham] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA; [De Bock, Katrien; Carmeliet, Peter] Katholieke Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [De Bock, Katrien; Carmeliet, Peter] Catholic Univ Louvain VIB, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Vroegrijk, Irene Olga Cornelia Maria; Romijn, Johannes Anthonius; Voshol, Peter Jacobus] Leiden Univ, Dept Endocrinol & Metab Dis, Med Ctr, Leiden, Netherlands; [Costa, Veronica; Scorrano, Luca] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [Van Noten, Pieter] Katholieke Univ Leuven, Phys Act & Hlth Lab, Biomed Kinesiol Dept, Louvain, Belgium; [Lambrechts, Dennis] Katholieke Univ Leuven, Dept Met & Mat Engn, Louvain, Belgium; [Lijnen, Henri Roger] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium	KU Leuven; University of Texas System; University of Texas Southwestern Medical Center Dallas; KU Leuven; Flanders Institute for Biotechnology (VIB); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Geneva; KU Leuven; KU Leuven; KU Leuven	Schuit, F (corresponding author), Katholieke Univ Leuven, Gene Express Unit, Dept Mol & Cellular Med, Louvain, Belgium.	Frans.Schuit@med.kuleuven.be	Carmeliet, Peter/AAQ-5140-2020; Scorrano, Luca/A-6652-2008; Scorrano, Luca/K-3967-2019; Thorrez, Lieven/A-2583-2011; De Bock, Katrien/L-2273-2013; singh, sarvjeet/F-1569-2015; Lijnen, Roger/AAA-4085-2020; Quintens, Roel/G-5339-2017	Carmeliet, Peter/0000-0001-7961-1821; Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928; Thorrez, Lieven/0000-0002-5896-6823; De Bock, Katrien/0000-0001-8232-4663; Quintens, Roel/0000-0002-4359-3403; Lambrechts, Dennis/0000-0002-2373-2795	KU Leuven [GOA 2008/16]; Flanders Fund for Scientific Research (FWO) [G.0733-09, G.0672-12]; National Institutes of Health (USA) [HL-076440]; MRC [G0600717, MC_UU_12012/5] Funding Source: UKRI; Medical Research Council [MC_UU_12012/5/B, MC_UU_12012/5, G0600717B, G0600717] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102478, K08HL076440] Funding Source: NIH RePORTER	KU Leuven(KU Leuven); Flanders Fund for Scientific Research (FWO)(FWO); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was financially supported by grants of the KU Leuven (GOA 2008/16 to FS), the Flanders Fund for Scientific Research (FWO grants G.0733-09 and G.0672-12 to FS) and the National Institutes of Health (USA, HL-076440 to PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY G, 1993, P NATL ACAD SCI USA, V90, P1652, DOI 10.1073/pnas.90.5.1652; ANTHONY G, 1990, FEBS LETT, V277, P97, DOI 10.1016/0014-5793(90)80817-3; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bal NC, 2012, NAT MED; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Chemello F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016807; Chen W, 2010, P NATL ACAD SCI USA, V107, P10196, DOI 10.1073/pnas.1005626107; Chida D, 2008, DIABETOLOGIA, V51, P1698, DOI 10.1007/s00125-008-1075-z; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Crawford D, 2000, INT J OBESITY, V24, P1107, DOI 10.1038/sj.ijo.0801374; Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fornuskova D, 2010, BIOCHEM J, V428, P363, DOI 10.1042/BJ20091714; Frank V, 1996, FEBS LETT, V382, P121, DOI 10.1016/0014-5793(96)00096-8; Fritah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032520; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hoeks J, 2012, TRENDS ENDOCRIN MET, V23, P444, DOI 10.1016/j.tem.2012.05.007; Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519; Horvath TL, 2003, INT J OBESITY, V27, P433, DOI 10.1038/sj.ijo.0802257; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Irrcher I, 2009, AM J PHYSIOL-CELL PH, V296, pC116, DOI 10.1152/ajpcell.00267.2007; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; KADENBACH B, 1995, BBA-MOL BASIS DIS, V1271, P103, DOI 10.1016/0925-4439(95)00016-W; KADENBACH B, 1990, BIOCHIM BIOPHYS ACTA, V1015, P368, DOI 10.1016/0005-2728(90)90042-3; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Klaus S, 2011, GENES NUTR; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lee FYJ, 1999, HEPATOLOGY, V29, P677, DOI 10.1002/hep.510290320; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Lijnen HR, 2006, DIABETES, V55, P2698, DOI 10.2337/db06-0526; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakai Y, 2008, BIOSCI BIOTECH BIOCH, V72, P139, DOI 10.1271/bbb.70508; Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Papa S, 1997, BIOSCIENCE REP, V17, P23, DOI 10.1023/A:1027331116866; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Radford NB, 2002, AM J PHYSIOL-HEART C, V282, pH726, DOI 10.1152/ajpheart.00308.2001; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; ROHDICH F, 1993, BIOCHEMISTRY-US, V32, P8499, DOI 10.1021/bi00084a015; Rufini A, 2012, GENE DEV, V26, P2009, DOI 10.1101/gad.197640.112; Sadler NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047996; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sokolovic M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-361; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061; TAANMAN JW, 1993, BIOCHIM BIOPHYS ACTA, V1225, P95, DOI 10.1016/0925-4439(93)90128-N; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wamil M, 2011, DIABETES, V60, P1158, DOI 10.2337/db10-0830; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zanetti M, 2005, METH MOLEC MED, V108, P65	79	41	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56719	10.1371/journal.pone.0056719	http://dx.doi.org/10.1371/journal.pone.0056719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460811	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000034
J	Tan, SC; Yao, XH; Gao, HW; Shi, GY; Yue, X				Tan, Sai-Chun; Yao, Xiaohong; Gao, Hui-Wang; Shi, Guang-Yu; Yue, Xu			Variability in the Correlation between Asian Dust Storms and Chlorophyll a Concentration from the North to Equatorial Pacific	PLOS ONE			English	Article							EXPORT PRODUCTION; DISSOLVED IRON; CLIMATE-CHANGE; TRANSPORT; AEROSOLS; IMPACTS; MODEL; SEA	A long-term record of Asian dust storms showed seven high-occurrence-frequency centers in China. The intrusion of Asian dust into the downwind seas, including the China seas, the Sea of Japan, the subarctic North Pacific, the North Pacific subtropical gyre, and the western and eastern Equatorial Pacific, has been shown to add nutrients to ocean ecosystems and enhance their biological activities. To explore the relationship between the transported dust from various sources to the six seas and oceanic biological activities with different nutrient conditions, the correlation between monthly chlorophyll a concentration in each sea and monthly dust storm occurrence frequencies reaching the sea during 1997-2007 was examined in this study. No correlations were observed between dust and chlorophyll a concentration in the <50 m China seas because atmospheric deposition is commonly believed to exert less impact on coastal seas. Significant correlations existed between dust sources and many sea areas, suggesting a link between dust and chlorophyll a concentration in those seas. However, the correlation coefficients were highly variable. In general, the correlation coefficients (0.54-0.63) for the Sea of Japan were highest, except for that between the subarctic Pacific and the Taklimakan Desert, where it was as high as 0.7. For the >50 m China seas and the North Pacific subtropical gyre, the correlation coefficients were in the range 0.32-0.57. The correlation coefficients for the western and eastern Equatorial Pacific were relatively low (<0.36). These correlation coefficients were further interpreted in terms of the geographical distributions of dust sources, the transport pathways, the dust deposition, the nutrient conditions of oceans, and the probability of dust storms reaching the seas.	[Tan, Sai-Chun; Shi, Guang-Yu] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Numer Modeling Atmospher Sci & Geop, Beijing, Peoples R China; [Yao, Xiaohong; Gao, Hui-Wang] Ocean Univ China, Minist Educ China, Key Lab Marine Environm & Ecol, Qingdao, Peoples R China; [Yue, Xu] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Ministry of Education, China; Ocean University of China; Harvard University	Tan, SC (corresponding author), Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Numer Modeling Atmospher Sci & Geop, Beijing, Peoples R China.	sctan@mail.iap.ac.cn; hwgao@ouc.edu.cn	Yue, Xu/ABD-9066-2021; Tan, Saichun/D-1984-2015	Tan, Saichun/0000-0003-3089-3439; Yue, Xu/0000-0002-8861-8192	National Natural Science Foundation of China [41005080, 40976063, 41130104]; Ministry of Science and Technology of China [2010DFA22770, 2010DFA91350]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China (Grants No. 41005080, 40976063 and 41130104) and the Ministry of Science and Technology of China (Grant nos. 2010DFA22770 and 2010DFA91350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AR, 2010, MAR CHEM, V120, P4, DOI 10.1016/j.marchem.2008.09.003; Bishop JKB, 2002, SCIENCE, V298, P817, DOI 10.1126/science.1074961; Boyd PW, 2010, MAR CHEM, V120, P128, DOI 10.1016/j.marchem.2009.01.008; Calil PHR, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006704; Chan CK, 2008, ATMOS ENVIRON, V42, P1, DOI 10.1016/j.atmosenv.2007.09.003; Coale KH, 1996, NATURE, V379, P621, DOI 10.1038/379621a0; Draxler RR, 2010, HYSPLIT HYBRID SINGL; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Furutani H, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041367; Han YX, 2011, ATMOS ENVIRON, V45, P4291, DOI 10.1016/j.atmosenv.2011.04.078; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Jo CO, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027395; Kai Z, 2007, ATMOS ENVIRON, V41, P9136, DOI 10.1016/j.atmosenv.2007.08.007; Liu XH, 2007, THEOR APPL CLIMATOL, V88, P71, DOI 10.1007/s00704-006-0231-y; Longhurst A, 1995, PROG OCEANOGR, V36, P77, DOI 10.1016/0079-6611(95)00015-1; Matsuki A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003266; Mikami M, 2006, GLOBAL PLANET CHANGE, V52, P142, DOI 10.1016/j.gloplacha.2006.03.001; Nohara D, 2006, J HYDROMETEOROL, V7, P1076, DOI 10.1175/JHM531.1; Paytan A, 2009, P NATL ACAD SCI USA, V106, P4601, DOI 10.1073/pnas.0811486106; Qian ZA, 2006, CHINESE J GEOPHYS-CH, V49, P83; Shi JH, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013238; Takata H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031794; Tan SC, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001456; Tang YH, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003806; Uematsu M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016645; Wang BD, 2003, ESTUAR COAST SHELF S, V58, P127, DOI 10.1016/S0272-7714(03)00067-2; Wu JF, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001924; Yuan W, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025174; Yue X, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010995; Zhang XY, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018206; Zhao TL, 2006, J CLIMATE, V19, P88, DOI 10.1175/JCLI3605.1	31	45	48	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57656	10.1371/journal.pone.0057656	http://dx.doi.org/10.1371/journal.pone.0057656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460892	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000147
J	van der Werf, CS; Hsiao, NH; Conroy, S; Paredes, J; Ribeiro, AS; Sribudiani, Y; Seruca, R; Hofstra, RMW; Westers, H; van IJzendoorn, SCD				van der Werf, Christine S.; Hsiao, Nai-Hua; Conroy, Siobhan; Paredes, Joana; Ribeiro, Ana S.; Sribudiani, Yunia; Seruca, Raquel; Hofstra, Robert M. W.; Westers, Helga; van IJzendoorn, Sven C. D.			CLMP Is Essential for Intestinal Development, but Does Not Play a Key Role in Cellular Processes Involved in Intestinal Epithelial Development	PLOS ONE			English	Article							TIGHT JUNCTION PROTEIN; ADHERENS JUNCTIONS; FAMILY; EXPRESSION; CELLS	Loss-of-function mutations in CLMP have been found in patients with Congenital Short Bowel Syndrome (CSBS), suggesting that its encoded protein plays a major role in intestinal development. CLMP is a membrane protein that co-localizes with tight junction proteins, but its function is largely unknown. We expressed wild-type (WT)-CLMP and a mutant-CLMP (associated with CSBS) in human intestinal epithelial T84 cells that, as we show here, do not produce endogenous CLMP. We investigated the effects of WT-CLMP and mutant-CLMP proteins on key cellular processes that are important for intestinal epithelial development, including migration, proliferation, viability and transepithelial resistance. Our data showed that expression of WT-CLMP or mutant-CLMP does not affect any of these processes. Moreover, our aggregation assays in CHO cells show that CLMP does not act as a strong adhesion molecule. Thus, our data suggest that, in the in vitro model systems we used, the key processes involved in intestinal epithelial development appear to be unaffected by WT-CLMP or mutant-CLMP. Further research is needed to determine the role of CLMP in the development of the intestine.	[van der Werf, Christine S.; Conroy, Siobhan; Sribudiani, Yunia; Hofstra, Robert M. W.; Westers, Helga] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Hsiao, Nai-Hua; van IJzendoorn, Sven C. D.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Paredes, Joana; Ribeiro, Ana S.; Seruca, Raquel] Univ Porto, Canc Genet Grp, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Sribudiani, Yunia; Hofstra, Robert M. W.] Erasmus Univ, Dept Clin Genet, Erasmus Med Ctr, Rotterdam, Netherlands	University of Groningen; University of Groningen; Universidade do Porto; Erasmus University Rotterdam; Erasmus MC	Hofstra, RMW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	r.hofstra@erasmus.nl	Paredes, Joana/F-8224-2011; Ribeiro, Ana/J-7334-2013; Sribudiani, Yunia/I-2972-2019; seruca, raquel/F-8187-2011	Paredes, Joana/0000-0002-1076-1343; Ribeiro, Ana/0000-0002-9698-9233; Sribudiani, Yunia/0000-0003-1985-3292; Seruca, Raquel/0000-0002-8851-4166; Hofstra, Robert/0000-0001-7498-3829	Junior Scientific Masterclass (University of Groningen); J.K. de Cockstichting	Junior Scientific Masterclass (University of Groningen); J.K. de Cockstichting	This study was financially supported by the Junior Scientific Masterclass (University of Groningen) and the J.K. de Cockstichting. The funders had no role in study desing, data collection and analysis, decision to publish, or preparation of the manuscript.	Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; Bazzoni G, 2003, CURR OPIN CELL BIOL, V15, P525, DOI 10.1016/S0955-0674(03)00104-2; Boterberg T, 2001, Methods Mol Med, V58, P33, DOI 10.1385/1-59259-137-X:033; Clark E, 2005, GASTROENTEROLOGY, V128, P1258, DOI 10.1053/j.gastro.2005.01.046; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; Eguchi J, 2005, BIOCHEM J, V387, P343, DOI 10.1042/BJ20041709; Juuti-Uusitalo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022967; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Naydenov NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034320; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Raschperger E, 2004, J BIOL CHEM, V279, P796, DOI 10.1074/jbc.M308249200; Sze KL, 2008, BIOCHEM J, V410, P575, DOI 10.1042/BJ20070901; Sze KL, 2008, J CELL PHYSIOL, V214, P334, DOI 10.1002/jcp.21201; Van Der Werf CS, 2012, GASTROENTEROLOGY, V142, P453, DOI 10.1053/j.gastro.2011.11.038; Young P, 2003, EMBO J, V22, P5723, DOI 10.1093/emboj/cdg560	15	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e54649	10.1371/journal.pone.0054649	http://dx.doi.org/10.1371/journal.pone.0054649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460781	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000004
J	Carniglia, L; Durand, D; Caruso, C; Lasaga, M				Carniglia, Lila; Durand, Daniela; Caruso, Carla; Lasaga, Mercedes			Effect of NDP-alpha-MSH on PPAR-gamma and -beta Expression and Anti-Inflammatory Cytokine Release in Rat Astrocytes and Microglia	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; ACTIVATED RECEPTOR-GAMMA; PEPTIDES INHIBIT PRODUCTION; MELANOCORTIN 4 RECEPTOR; NITRIC-OXIDE; GENE-EXPRESSION; TGF-BETA; IN-VITRO; AGONISTS INHIBIT; MAP KINASE	Brain inflammation plays a central role in numerous brain pathologies. Microglia and astrocytes are the main effector cells that become activated when an inflammatory process takes place within the central nervous system. alpha-melanocyte-stimulating hormone (alpha-MSH) is a neuropeptide with proven anti-inflammatory properties. It binds with highest affinity to the melanocortin receptor 4 (MC4R), which is present in astrocytes and upon activation triggers anti-inflammatory pathways. The aim of this research was to identify anti-inflammatory mediators that may participate in the immunomodulatory effects of melanocortins in glial cells. Since peroxisome proliferator-activated receptors (PPARs) have recently been implicated in the modulation of inflammation, we investigated the effect of an alpha-MSH analog, [Nle(4), D-Phe(7)]-alpha-MSH (NDP-alpha-MSH), on PPAR-beta and PPAR-gamma gene and protein expression in rat primary astrocytes and microglia. We initially demonstrated that rat primary microglia express MC4R and showed that treatment with NDP-alpha-MSH increases PPAR-gamma protein levels and strongly decreases PPAR-beta levels in both astrocytes and microglia. We also showed that extracellular signal-regulated kinase 1/2 (ERK1/2)-mediated signaling is partially involved in these effects in a cell-specific fashion. Finally, we showed that NDP-alpha-MSH stimulates the release of the anti-inflammatory cytokines IL-10 and TGF-beta from microglia and astrocytes, respectively. The presented data suggest a role for IL-10 and TGF-beta in the protective action of melanocortins and a connection between MC4R pathway and that of the nuclear receptor PPAR-gamma. This is the first report providing evidence that MC4R is expressed in rat primary microglia and that melanocortins modulate PPAR levels in glial cells. Our findings provide new insights into the mechanisms underlying the activation of glial MC4R and open perspectives for new therapeutic strategies for the treatment of inflammation-mediated brain diseases.	[Carniglia, Lila; Durand, Daniela; Caruso, Carla; Lasaga, Mercedes] Univ Buenos Aires, Sch Med, CONICET, Inst Invest Biomed, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Lasaga, M (corresponding author), Univ Buenos Aires, Sch Med, CONICET, Inst Invest Biomed, Buenos Aires, DF, Argentina.	mlasaga@fmed.uba.ar	Caruso, Carla/AAR-5914-2020	Caruso, Carla/0000-0002-0889-0293; Lasaga, Mercedes/0000-0001-9916-3712; Carniglia, Lila/0000-0002-9354-8037	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 0894]; Universidad de Buenos Aires [W129]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 779]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) PICT 0894 (www.agencia.mincyt.gov.ar), Universidad de Buenos Aires W129 (www.uba.ar), and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)PIP 779 (www.conicet.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner L, 2008, CELL TISSUE RES, V331, P225, DOI 10.1007/s00441-007-0466-7; Al-Rasheed NM, 2004, J BIOL CHEM, V279, P49747, DOI 10.1074/jbc.M408268200; Aleshin S, 2009, MOL PHARMACOL, V76, P414, DOI 10.1124/mol.109.056010; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Arsenijevic D, 2006, J CEREBR BLOOD F MET, V26, P433, DOI 10.1038/sj.jcbfm.9600200; BENVENISTE EN, 1995, INT J DEV NEUROSCI, V13, P341, DOI 10.1016/0736-5748(94)00061-7; Bertolini A, 2009, PHARMACOL RES, V59, P13, DOI 10.1016/j.phrs.2008.10.005; Bhardwaj RS, 1996, J IMMUNOL, V156, P2517; Bitto A, 2012, CRIT CARE MED, V40, P945, DOI 10.1097/CCM.0b013e318236efde; Breit A, 2011, MOL CELL ENDOCRINOL, V331, P232, DOI 10.1016/j.mce.2010.07.007; Bright JJ, 2008, PPAR RES, V2008, DOI 10.1155/2008/658520; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Caruso C, 2004, NEUROENDOCRINOLOGY, V79, P278, DOI 10.1159/000079321; Caruso C, 2007, ENDOCRINOLOGY, V148, P4918, DOI 10.1210/en.2007-0366; Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036; Catania A, 2004, PHARMACOL REV, V56, P1, DOI 10.1124/pr.56.1.1; Catania A, 2008, TRENDS NEUROSCI, V31, P353, DOI 10.1016/j.tins.2008.04.002; Chai BX, 2007, REGUL PEPTIDES, V139, P115, DOI 10.1016/j.regpep.2006.11.003; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Cragnolini AB, 2004, REGUL PEPTIDES, V122, P185, DOI 10.1016/j.regpep.2004.06.011; Daniels D, 2003, BRAIN RES, V986, P1, DOI 10.1016/S0006-8993(03)03162-7; Delgado R, 1998, J LEUKOCYTE BIOL, V63, P740, DOI 10.1002/jlb.63.6.740; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Galimberti D, 1999, BIOCHEM BIOPH RES CO, V263, P251, DOI 10.1006/bbrc.1999.1276; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; Giaume C, 2007, CELL DEATH DIFFER, V14, P1324, DOI 10.1038/sj.cdd.4402144; Giuliani D, 2007, BRIT J PHARMACOL, V150, P595, DOI 10.1038/sj.bjp.0707115; Giuliani D, 2006, ENDOCRINOLOGY, V147, P1126, DOI 10.1210/en.2005-0692; Gray E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-63; Guntur KVP, 2010, J BIOL CHEM, V285, P6595, DOI 10.1074/jbc.M109.068502; Han D, 2007, GENE THER, V14, P383, DOI 10.1038/sj.gt.3302862; Herz RCG, 1996, EUR J PHARMACOL, V306, P113, DOI 10.1016/0014-2999(96)00220-8; Jana M, 2012, NEUROCHEM RES, V37, P1718, DOI 10.1007/s11064-012-0781-6; Kask A, 1998, ENDOCRINOLOGY, V139, P5006, DOI 10.1210/en.139.12.5006; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Krogsdam AM, 2002, BIOCHEM J, V363, P157, DOI 10.1042/0264-6021:3630157; Lam CW, 2006, PEPTIDES, V27, P404, DOI 10.1016/j.peptides.2005.01.031; Lasaga M, 2008, PEPTIDES, V29, P1825, DOI 10.1016/j.peptides.2008.06.009; Ledeboer A, 2000, GLIA, V30, P134, DOI 10.1002/(SICI)1098-1136(200004)30:2<134::AID-GLIA3>3.0.CO;2-3; Lee CH, 2008, PPAR RES, V2008, DOI 10.1155/2008/762398; Lindberg C, 2005, NEUROTOX RES, V8, P267, DOI 10.1007/BF03033980; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodge PA, 1996, J LEUKOCYTE BIOL, V60, P502, DOI 10.1002/jlb.60.4.502; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; Malik IA, 2012, HISTOCHEM CELL BIOL, V137, P279, DOI 10.1007/s00418-011-0899-7; Maresca V, 2012, PIGMENT CELL MELANOM; McClelland S, 2009, PPAR RES, V2009, DOI 10.1155/2009/193413; Mynatt RL, 2003, ANN NY ACAD SCI, V994, P141, DOI 10.1111/j.1749-6632.2003.tb03173.x; Natarajan C, 2002, GENES IMMUN, V3, P59, DOI 10.1038/sj.gene.6363832; Polak PE, 2005, J NEUROIMMUNOL, V168, P65, DOI 10.1016/j.jneuroim.2005.07.006; Poritsanos NJ, 2008, BIOCHEM BIOPH RES CO, V376, P384, DOI 10.1016/j.bbrc.2008.08.162; Qian L, 2008, J IMMUNOL, V181, P660, DOI 10.4049/jimmunol.181.1.660; Rodrigues AR, 2009, MOL CELL ENDOCRINOL, V303, P74, DOI 10.1016/j.mce.2009.01.014; Rodriguez-Calvo R, 2008, DIABETES, V57, P2149, DOI 10.2337/db08-0176; SAWYER TK, 1980, P NATL ACAD SCI-BIOL, V77, P5754, DOI 10.1073/pnas.77.10.5754; Schioth HB, 1998, BRIT J PHARMACOL, V124, P75, DOI 10.1038/sj.bjp.0701804; Selkirk JV, 2007, NEUROPHARMACOLOGY, V52, P459, DOI 10.1016/j.neuropharm.2006.08.015; Serrano-Marco L, 2011, DIABETES, V60, P1990, DOI 10.2337/db10-0704; Storer PD, 2005, J NEUROIMMUNOL, V161, P113, DOI 10.1016/j.jneuroim.2004.12.015; Thompson PW, 2007, CYTOKINE, V39, P184, DOI 10.1016/j.cyto.2007.07.191; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Vongs A, 2004, REGUL PEPTIDES, V120, P113, DOI 10.1016/j.regpep.2004.02.018; Yin P, 2003, GENE THER, V10, P348, DOI 10.1038/sj.gt.3301902; Zapata-Gonzalez F, 2008, J LEUKOCYTE BIOL, V84, P1172, DOI 10.1189/jlb.1007688; Zhong YH, 2005, J CONTROL RELEASE, V106, P309, DOI 10.1016/j.jconrel.2005.05.012	66	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57313	10.1371/journal.pone.0057313	http://dx.doi.org/10.1371/journal.pone.0057313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468969	Green Published, gold			2022-12-27	WOS:000315561400039
J	Czapla, L; Grosner, MA; Swigon, D; Olson, WK				Czapla, Luke; Grosner, Michael A.; Swigon, David; Olson, Wilma K.			Interplay of Protein and DNA Structure Revealed in Simulations of the lac Operon	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; LENGTH DEPENDENCE; LOOP FORMATION; MONTE-CARLO; REPRESSOR; HU; CONFORMATION; FLEXIBILITY; SEQUENCE; BINDING	The E. coli Lac repressor is the classic textbook example of a protein that attaches to widely spaced sites along a genome and forces the intervening DNA into a loop. The short loops implicated in the regulation of the lac operon suggest the involvement of factors other than DNA and repressor in gene control. The molecular simulations presented here examine two likely structural contributions to the in-vivo looping of bacterial DNA: the distortions of the double helix introduced upon association of the highly abundant, nonspecific nucleoid protein HU and the large-scale deformations of the repressor detected in low-resolution experiments. The computations take account of the three-dimensional arrangements of nucleotides and amino acids found in crystal structures of DNA with the two proteins, the natural rest state and deformational properties of protein-free DNA, and the constraints on looping imposed by the conformation of the repressor and the orientation of bound DNA. The predicted looping propensities capture the complex, chain-length-dependent variation in repression efficacy extracted from gene expression studies and in vitro experiments and reveal unexpected chain-length-dependent variations in the uptake of HU, the deformation of repressor, and the folding of DNA. Both the opening of repressor and the presence of HU, at levels approximating those found in vivo, enhance the probability of loop formation. HU affects the global organization of the repressor and the opening of repressor influences the levels of HU binding to DNA. The length of the loop determines whether the DNA adopts antiparallel or parallel orientations on the repressor, whether the repressor is opened or closed, and how many HU molecules bind to the loop. The collective behavior of proteins and DNA is greater than the sum of the parts and hints of ways in which multiple proteins may coordinate the packaging and processing of genetic information.	[Czapla, Luke; Grosner, Michael A.; Olson, Wilma K.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08855 USA; [Olson, Wilma K.] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ USA; [Swigon, David] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Olson, WK (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08855 USA.	wilma.olson@rutgers.edu			National Institutes of Health [2 R01 GM034809 25]; Human Frontiers in Science Program [RGP0051/2009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers in Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding came from the National Institutes of Health 2 R01 GM034809 25 URL: grants.nih.gov/, Human Frontiers in Science Program RGP0051/2009, URL: www.hfsp.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki T, 1997, EMBO J, V16, P3666, DOI 10.1093/emboj/16.12.3666; ALEXANDR.Z, 1969, J CHEM PHYS, V51, P561, DOI 10.1063/1.1672034; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Balaeff A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031919; Balaeff A, 2004, STRUCTURE, V12, P123, DOI 10.1016/j.str.2003.12.004; Becker NA, 2005, J MOL BIOL, V349, P716, DOI 10.1016/j.jmb.2005.04.035; Becker NA, 2007, NUCLEIC ACIDS RES, V35, P3988, DOI 10.1093/nar/gkm419; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Berger M, 2010, EMBO REP, V11, P59, DOI 10.1038/embor.2009.232; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOLSHOY A, 1991, P NATL ACAD SCI USA, V88, P2312, DOI 10.1073/pnas.88.6.2312; Bond LM, 2010, NUCLEIC ACIDS RES, V38, P8072, DOI 10.1093/nar/gkq755; Clauvelin N, 2013, VIBRATIONAL MO UNPUB; Clauvelin N, 2012, J CHEM THEORY COMPUT, V8, P1092, DOI 10.1021/ct200657e; Coleman BD, 2003, J CHEM PHYS, V118, P7127, DOI 10.1063/1.1559690; Cordeiro TN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002380; Czapla L, 2008, J MOL BIOL, V382, P353, DOI 10.1016/j.jmb.2008.05.088; Czapla L, 2006, J CHEM THEORY COMPUT, V2, P685, DOI 10.1021/ct060025+; Czapla L, 2011, J MOL BIOL, V409, P278, DOI 10.1016/j.jmb.2011.03.050; DIEKMANN S, 1989, J MOL BIOL, V205, P787, DOI 10.1016/0022-2836(89)90324-0; Edelman LM, 2003, BIOPHYS J, V84, P1131, DOI 10.1016/S0006-3495(03)74929-7; ELHASSAN MA, 1995, J MOL BIOL, V251, P648, DOI 10.1006/jmbi.1995.0462; FINZI L, 1995, SCIENCE, V267, P378, DOI 10.1126/science.7824935; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Geanacopoulos M, 2001, NAT STRUCT BIOL, V8, P432, DOI 10.1038/87595; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Goyal S, 2007, BIOPHYS J, V93, P4342, DOI 10.1529/biophysj.107.112268; Haeusler AR, 2012, NUCLEIC ACIDS RES, V40, P4432, DOI 10.1093/nar/gks019; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005621; Heath PJ, 1996, J MOL BIOL, V260, P718, DOI 10.1006/jmbi.1996.0432; Hirsh AD, 2011, BIOPHYS J, V101, P718, DOI 10.1016/j.bpj.2011.06.040; HODGESGARCIA Y, 1989, J BIOL CHEM, V264, P14621; HOROWITZ DS, 1984, J MOL BIOL, V173, P75, DOI 10.1016/0022-2836(84)90404-2; JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547; La Penna G, 2010, BIOPHYS J, V98, P2964, DOI 10.1016/j.bpj.2010.03.024; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Lillian TD, 2008, BIOPHYS J, V95, P5832, DOI 10.1529/biophysj.108.142471; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mehta RA, 1999, J MOL BIOL, V294, P67, DOI 10.1006/jmbi.1999.3244; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Olson WK, 2012, BIOCH SOC T IN PRESS; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Press W. H., 1992, NUMERICAL RECIPES C, P288; Romanuka J, 2009, J MOL BIOL, V390, P478, DOI 10.1016/j.jmb.2009.05.022; Ruben GC, 1997, MICROSC RES TECHNIQ, V36, P400, DOI 10.1002/(SICI)1097-0029(19970301)36:5<400::AID-JEMT10>3.0.CO;2-W; SADLER JR, 1965, J MOL BIOL, V12, P305, DOI 10.1016/S0022-2836(65)80255-8; Sagi D, 2004, J MOL BIOL, V341, P419, DOI 10.1016/j.jmb.2004.06.023; Saiz L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000355; Semsey S, 2005, TRENDS BIOCHEM SCI, V30, P334, DOI 10.1016/j.tibs.2005.04.009; Skoko D, 2006, J MOL BIOL, V364, P777, DOI 10.1016/j.jmb.2006.09.043; Spronk CAEM, 1999, STRUCT FOLD DES, V7, P1483, DOI 10.1016/S0969-2126(00)88339-2; Stella S, 2010, GENE DEV, V24, P814, DOI 10.1101/gad.1900610; Stenberg KAE, 2009, PROTEINS, V75, P748, DOI 10.1002/prot.22284; Sundararaj S, 2004, NUCLEIC ACIDS RES, V32, pD293, DOI 10.1093/nar/gkh108; Swigon D, 2006, P NATL ACAD SCI USA, V103, P9879, DOI 10.1073/pnas.0603557103; Swigon D, 2008, INT J NONLIN MECH, V43, P1082, DOI 10.1016/j.ijnonlinmec.2008.07.003; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Taraban M, 2008, J MOL BIOL, V376, P466, DOI 10.1016/j.jmb.2007.11.067; Towles KB, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025001; Vanzi F, 2006, NUCLEIC ACIDS RES, V34, P3409, DOI 10.1093/nar/gkl393; Villa E, 2005, P NATL ACAD SCI USA, V102, P6783, DOI 10.1073/pnas.0409387102; Virnik K, 2003, J MOL BIOL, V334, P53, DOI 10.1016/j.jmb.2003.09.030; Vreede J, 2012, BIOPHYS J, V103, P89, DOI 10.1016/j.bpj.2012.05.040; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Wong OK, 2008, PLOS BIOL, V6, P2028, DOI 10.1371/journal.pbio.0060232; Zhang Y, 2006, BIOPHYS J, V90, P1903, DOI 10.1529/biophysj.105.070490; Zhang YL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000136; ZHURKIN VB, 1979, NUCLEIC ACIDS RES, V6, P1081, DOI 10.1093/nar/6.3.1081	73	21	21	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56548	10.1371/journal.pone.0056548	http://dx.doi.org/10.1371/journal.pone.0056548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457581	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000315602700078
J	Onuma, Y; Tateno, H; Tsuji, S; Hirabayashi, J; Ito, Y; Asashima, M				Onuma, Yasuko; Tateno, Hiroaki; Tsuji, Shingo; Hirabayashi, Jun; Ito, Yuzuru; Asashima, Makoto			A Lectin-Based Glycomic Approach to Identify Characteristic Features of Xenopus Embryogenesis	PLOS ONE			English	Article							CELL-CELL ADHESION; MICROARRAY; INVOLVEMENT; BLASTULA; STRATEGY	Cell surface glycans show dynamic changes during cell differentiation. Several glycans are useful biomarkers of tumors, stem cells, and embryogenesis. Glycomic studies have been performed using liquid chromatography and mass spectrometry, which are powerful tools for glycan structural analysis but are difficult to use for small sample sizes. Recently, a lectin microarray system was developed for profiling cell surface glycome changes to terminal carbohydrate chains and branch types, using sample sizes of a few micrograms. In this study, we used the lectin microarray system for the first time to investigate stage-specific glycomes in Xenopus laevis embryos. Unsupervised cluster analysis of lectin microarray data indicated that glycan profiles changed sequentially during development. Nine lectin probes showed significantly different signals between early and the late-stage embryos: 4 showed higher signals in the early stages, and 5 exhibited higher signals in the late stages. The gene expression profiles of relevant glycosyltransferase genes support the lectin microarray data. Therefore, we have shown that lectin microarray is an effective tool for high-throughput glycan analysis in Xenopus embryogenesis, allowing glycan profiling of early embryos and small biopsy specimens.	[Onuma, Yasuko; Tateno, Hiroaki; Hirabayashi, Jun; Ito, Yuzuru; Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki, Japan; [Tsuji, Shingo] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Ito, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba Cent 4, Tsukuba, Ibaraki, Japan.	yuzu-itou@aist.go.jp	Tateno, Hiroaki/M-2706-2018; Hirabayashi, Jun/M-3998-2018; Onuma, Yasuko/L-7083-2018; Ito, Yuzuru/M-1085-2018; Asashima, Makoto/O-8389-2018	Tateno, Hiroaki/0000-0003-3006-1659; Hirabayashi, Jun/0000-0002-8571-359X; Onuma, Yasuko/0000-0002-9330-194X; Ito, Yuzuru/0000-0001-7923-865X; Asashima, Makoto/0000-0002-0012-026X	JSPS KAKENHI Grant [23770267]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 23770267 (http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowes JB, 2008, NUCLEIC ACIDS RES, V36, pD761, DOI 10.1093/nar/gkm826; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Narimatsu H, 2004, GLYCOCONJUGATE J, V21, P17, DOI 10.1023/B:GLYC.0000043742.99482.01; Narimatsu H, 2010, FEBS J, V277, P95, DOI 10.1111/j.1742-4658.2009.07430.x; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; NOMURA K, 1995, BIOCHEM J, V306, P821, DOI 10.1042/bj3060821; Nomura KH, 1998, DEV GENES EVOL, V208, P9, DOI 10.1007/s004270050148; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Tateno H, 2010, METHOD ENZYMOL, V478, P181, DOI 10.1016/S0076-6879(10)78008-3; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Tsuboi S, 2012, TRENDS MOL MED, V18, P224, DOI 10.1016/j.molmed.2012.02.001; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0	14	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56581	10.1371/journal.pone.0056581	http://dx.doi.org/10.1371/journal.pone.0056581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457585	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700081
J	Batista, MD; Tincati, C; Milush, JM; Ho, EL; Ndhlovu, LC; York, VA; Kallas, EG; Kalil, J; Keating, SM; Norris, PJ; Chang, D; Unemori, P; Leslie, KS; Maurer, T; Liao, W; Nixon, DF				Batista, Mariana D.; Tincati, Camilla; Milush, Jeffrey M.; Ho, Emily L.; Ndhlovu, Lishomwa C.; York, Vanessa A.; Kallas, Esper G.; Kalil, Jorge; Keating, Sheila M.; Norris, Philip J.; Chang, David; Unemori, Patrick; Leslie, Kieron S.; Maurer, Toby; Liao, Wilson; Nixon, Douglas F.			CD57 Expression and Cytokine Production by T Cells in Lesional and Unaffected Skin from Patients with Psoriasis	PLOS ONE			English	Article							HUMAN KERATINOCYTES; ATOPIC-DERMATITIS; GENE-EXPRESSION; IL-22; DIFFERENTIATION; LYMPHOCYTES; IMMUNOPATHOGENESIS; ACTIVATION; IMMUNITY; SUBSET	Background: The immunopathogenic mechanisms leading to psoriasis remain unresolved. CD57 is a marker of replicative inability and immunosenescence on CD8+ T cells and the proportion of CD57 expressing CD8+ T cells is increased in a number of inflammatory conditions. Methodology: We examined the expression of CD57 on T cells in the skin of patients affected with psoriasis, comparing lesional and unaffected skin. We also assessed functionality of the T cells by evaluating the secretion of several inflammatory cytokines (IL-17A, IFN-gamma, IL-2, IL-33, TNF-alpha, IL-21, IL-22, and IL-27), from cell-sorted purified CD4+ and CD8+ T cells isolated from lesional and unaffected skin biopsies of psoriasis patients. Principal Findings: We observed that the frequency of CD57+CD4+ and CD57+CD8+ T cells was significantly higher in unaffected skin of psoriasis patients compared to lesional skin. Sorted CD4+ T cells from psoriatic lesional skin produced higher levels of IL-17A, IL-22, and IFN-gamma compared to unaffected skin, while sorted CD8+ T cells from lesional skin produced higher levels of IL-17, IL-22, IFN-gamma, TNF-alpha, and IL-2 compared to unaffected skin. Conclusions/Significance: These findings suggest that T cells in unaffected skin from psoriasis patients exhibit a phenotype compatible with replicative inability. As they have a lower replicative capacity, CD57+ T cells are less frequent in lesional tissue due to the high cellular turnover.	[Batista, Mariana D.; Tincati, Camilla; Milush, Jeffrey M.; Ho, Emily L.; Ndhlovu, Lishomwa C.; York, Vanessa A.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Batista, Mariana D.; Kallas, Esper G.; Kalil, Jorge] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Kallas, Esper G.; Kalil, Jorge] Univ Sao Paulo, Inst Invest Imunol, Sao Paulo, Brazil; [Keating, Sheila M.; Norris, Philip J.] Blood Syst Res Inst, San Francisco, CA USA; [Keating, Sheila M.; Norris, Philip J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Chang, David] Calif Pacific Med Ctr, San Francisco, CA USA; [Unemori, Patrick; Leslie, Kieron S.; Maurer, Toby; Liao, Wilson] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Universidade de Sao Paulo; Universidade de Sao Paulo; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California Pacific Medical Center; University of California System; University of California San Francisco	Batista, MD (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	maridiasbatista@gmail.com	n, l/AAX-3992-2020; Ho, Emily Lin/AAR-4815-2021; KALIL, JORGE/C-8029-2012; Nixon, Douglas/AAU-5734-2020; TINCATI, CAMILLA/K-4501-2018	KALIL, JORGE/0000-0001-8415-4274; Nixon, Douglas/0000-0002-2801-1786; Ndhlovu, Lishomwa/0000-0001-5427-4187; TINCATI, CAMILLA/0000-0002-3083-2962; Keating, Sheila/0000-0002-8324-3694; Kallas, Esper/0000-0003-2026-6925; Milush, Jeffrey M./0000-0002-0773-6411	National Institutes of Health [AI64520, 5T32HL007185]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/15856-9/Kallas, 2010/05845-0/Kallas]; Peter and Shelagh Godsoe Family Foundation; UCSF REAC [37710/521717]; American Academy of Neurology Clinical Research Training Fellowship; National Institute of Musculoskeletal and Skin Diseases [5K08AR057763]; International AIDS Society; U.S. National Institutes of Health; UW Institute of Translational Health Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI064520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR057763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Peter and Shelagh Godsoe Family Foundation; UCSF REAC; American Academy of Neurology Clinical Research Training Fellowship; National Institute of Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); International AIDS Society; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW Institute of Translational Health Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by the National Institutes of Health (grants AI64520), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (04/15856-9/Kallas and 2010/05845-0/Kallas and Nixon), and the Peter and Shelagh Godsoe Family Foundation. DN was supported in part by UCSF REAC grant no. 37710/521717. ELH was a recipient of the American Academy of Neurology Clinical Research Training Fellowship. JMM was supported in part by the National Institutes of Health (grant 5T32HL007185). WL was supported in part by grants from the National Institute of Musculoskeletal and Skin Diseases (5K08AR057763) and the International AIDS Society in collaboration with the NIH-funded Centers for AIDS Research, U.S. National Institutes of Health, and the UW Institute of Translational Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 1998, CLIN EXP IMMUNOL, V111, P345; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Cameron AL, 2002, ARCH DERMATOL RES, V294, P363, DOI 10.1007/s00403-002-0349-4; Caruso R, 2009, NAT MED, V15, P1013, DOI 10.1038/nm.1995; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; Clark RA, 2011, J INVEST DERMATOL, V131, P283, DOI 10.1038/jid.2010.374; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Evans TG, 1999, AIDS, V13, P1139, DOI 10.1097/00002030-199906180-00019; Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Iking-Konert C, 2009, CLIN EXP RHEUMATOL, V27, pS19; Le Priol Y, 2006, J IMMUNOL, V177, P5145, DOI 10.4049/jimmunol.177.8.5145; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Mak RKH, 2009, ACTAS DERMO-SIFILOGR, V100, P2, DOI 10.1016/S0001-7310(09)73372-1; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Palmer BE, 2005, J IMMUNOL, V175, P8415, DOI 10.4049/jimmunol.175.12.8415; Plant D, 2006, EXP DERMATOL, V15, P900, DOI 10.1111/j.1600-0625.2006.00486.x; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x; Shibata S, J INVEST DERMATOL, V130, P1034; Simpson RJ, 2008, BRAIN BEHAV IMMUN, V22, P544, DOI 10.1016/j.bbi.2007.11.002; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124; Suarez-Farinas M, 2011, J INVEST DERMATOL, V131, P391, DOI 10.1038/jid.2010.280; Tarazona R, 2000, MECH AGEING DEV, V121, P77; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Theoharides TC, P NATL ACAD SCI US, V107, P4448; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	37	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e52144	10.1371/journal.pone.0052144	http://dx.doi.org/10.1371/journal.pone.0052144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468834	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900002
J	Deboux, C; Ladraa, S; Cazaubon, S; Ghribi-Mallah, S; Weiss, N; Chaverot, N; Couraud, PO; Evercooren, ABV				Deboux, Cyrille; Ladraa, Sophia; Cazaubon, Sylvie; Ghribi-Mallah, Siham; Weiss, Nicolas; Chaverot, Nathalie; Couraud, Pierre Olivier; Baron-Van Evercooren, Anne			Overexpression of CD44 in Neural Precursor Cells Improves Trans- Endothelial Migration and Facilitates Their Invasion of Perivascular Tissues In Vivo	PLOS ONE			English	Article							BREAST-CANCER CELLS; MULTIPLE-SCLEROSIS; UP-REGULATION; STEM-CELLS; TRANSENDOTHELIAL MIGRATION; FIRM ADHESION; SPINAL-CORD; TRANSPLANTATION; EXTRAVASATION; MECHANISM	Neural precursor (NPC) based therapies are used to restore neurons or oligodendrocytes and/or provide neuroprotection in a large variety of neurological diseases. In multiple sclerosis models, intravenously (i.v) -delivered NPCs reduced clinical signs via immunomodulation. We demonstrated recently that NPCs were able to cross cerebral endothelial cells in vitro and that the multifunctional signalling molecule, CD44 involved in trans-endothelial migration of lymphocytes to sites of inflammation, plays a crucial role in extravasation of syngeneic NPCs. In view of the role of CD44 in NPCs trans-endothelial migration in vitro, we questioned presently the benefit of CD44 overexpression by NPCs in vitro and in vivo, in EAE mice. We show that overexpression of CD44 by NPCs enhanced over 2 folds their trans-endothelial migration in vitro, without impinging on the proliferation or differentiation potential of the transduced cells. Moreover, CD44 overexpression by NPCs improved significantly their elongation, spreading and number of filopodia over the extracellular matrix protein laminin in vitro. We then tested the effect of CD44 overexpression after i. v. delivery in the tail vein of EAE mice. CD44 overexpression was functional in vivo as it accelerated trans-endothelial migration and facilitated invasion of HA expressing perivascular sites. These in vitro and in vivo data suggest that CD44 may be crucial not only for NPC crossing the endothelial layer but also for facilitating invasion of extravascular tissues.	[Deboux, Cyrille; Ladraa, Sophia; Ghribi-Mallah, Siham; Baron-Van Evercooren, Anne] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Deboux, Cyrille; Ladraa, Sophia; Ghribi-Mallah, Siham; Baron-Van Evercooren, Anne] INSERM, U975, Paris, France; [Deboux, Cyrille; Ladraa, Sophia; Ghribi-Mallah, Siham; Baron-Van Evercooren, Anne] CNRS, UMR 7225, Paris, France; [Baron-Van Evercooren, Anne] Hop La Pitie Salpetriere, AP HP, Paris, France; [Cazaubon, Sylvie; Weiss, Nicolas; Chaverot, Nathalie; Couraud, Pierre Olivier] Inst Cochin, INSERM, U1016, Paris, France; [Cazaubon, Sylvie; Weiss, Nicolas; Chaverot, Nathalie; Couraud, Pierre Olivier] CNRS, UMR8104, Paris Descartes, France; [Cazaubon, Sylvie; Weiss, Nicolas; Chaverot, Nathalie; Couraud, Pierre Olivier] Univ Paris 05, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Evercooren, ABV (corresponding author), Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France.	anne.baron@upmc.fr	Evercooren, Anne S Baron-Van/G-3632-2013; Weiss, Nicolas/E-7345-2011	Weiss, Nicolas/0000-0001-5155-196X; Baron-Van Evercooren, Anne/0000-0002-4150-2205	ARSEP (Association pour la Recherche sur la Sclerose En Plaques) Foundation; INSERM (Institut National de la Sante et de la Recherche Medicale)	ARSEP (Association pour la Recherche sur la Sclerose En Plaques) Foundation; INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This study was supported by a grant from ARSEP (Association pour la Recherche sur la Sclerose En Plaques) Foundation shared by Pierre-Olivier Couraud and Anne Baron-Van Evercooren, and INSERM (Institut National de la Sante et de la Recherche Medicale). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonowiz M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003145; BENNETT KL, 1995, J CELL BIOL, V131, P1623, DOI 10.1083/jcb.131.6.1623; Bourguignon LYW, 2007, J BIOL CHEM, V282, P1265, DOI 10.1074/jbc.M604672200; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Chu K, 2004, BRAIN RES, V1023, P213, DOI 10.1016/j.brainres.2004.07.045; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Kim BG, 2007, CELL TRANSPLANT, V16, P355, DOI 10.3727/000000007783464885; Laschinger M, 2000, J NEUROIMMUNOL, V102, P32, DOI 10.1016/S0165-5728(99)00156-3; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Lee ST, 2005, NEUROSCI RES, V52, P243, DOI 10.1016/j.neures.2005.03.016; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Martino G, 2010, NAT REV NEUROL, V6, P247, DOI 10.1038/nrneurol.2010.35; Mine S, 2003, EXP CELL RES, V288, P189, DOI 10.1016/S0014-4827(03)00184-8; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; Piao J.H, 2012, GLIA IN PRESS; Pluchino S, 2005, J NEUROL SCI, V233, P117, DOI 10.1016/j.jns.2005.03.026; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005959; Pusch A, 2010, BBA-MOL CELL RES, V1803, P261, DOI 10.1016/j.bbamcr.2009.12.003; Rampon C, 2008, STEM CELLS, V26, P1673, DOI 10.1634/stemcells.2008-0122; Siegelman MH, 2000, J CLIN INVEST, V105, P683, DOI 10.1172/JCI8692; Stoop R, 2002, EUR J IMMUNOL, V32, P2532, DOI 10.1002/1521-4141(200209)32:9<2532::AID-IMMU2532>3.0.CO;2-A; Takeuchi H, 2007, NEUROSCI LETT, V426, P69, DOI 10.1016/j.neulet.2007.08.048; Wang HS, 2005, EXP CELL RES, V304, P116, DOI 10.1016/j.yexcr.2004.10.015; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509	29	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57430	10.1371/journal.pone.0057430	http://dx.doi.org/10.1371/journal.pone.0057430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468987	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900087
J	Hu, SJ; Ning, T; Fu, DY; Haack, RA; Zhang, Z; Chen, DD; Ma, XY; Ye, H				Hu, Shao-ji; Ning, Tiao; Fu, Da-ying; Haack, Robert A.; Zhang, Zhen; Chen, De-dao; Ma, Xue-yu; Ye, Hui			Dispersal of the Japanese Pine Sawyer, Monochamus alternatus (Coleoptera: Cerambycidae), in Mainland China as Inferred from Molecular Data and Associations to Indices of Human Activity	PLOS ONE			English	Article							TOMICUS-PINIPERDA COLEOPTERA; HOPE COLEOPTERA; WILT DISEASE; MITOCHONDRIAL-DNA; LONGHORNED BEETLE; SOFTWARE PACKAGE; POPULATIONS; NEMATODE; HISTORY; BIOLOGY	The Japanese pine sawyer, Monochamus alternatus Hope (Coleoptera: Cerambycidae), is an important forest pest as well as the principal vector of the pinewood nematode (PWN), Bursaphelenchus xylophilus (Steiner et Buhrer), in mainland China. Despite the economic importance of this insect-disease complex, only a few studies are available on the population genetic structure of M. alternatus and the relationship between its historic dispersal pattern and various human activities. The aim of the present study was to further explore aspects of human activity on the population genetic structure of M. alternatus in mainland China. The molecular data based on the combined mitochondrial cox1 and cox2 gene fragments from 140 individuals representing 14 Chinese populations yielded 54 haplotypes. Overall, a historical (natural) expansion that originated from China's eastern coast to the western interior was revealed by the haplotype network, as well as several recent, long-distant population exchanges. Correlation analysis suggested that regional economic status and proximity to marine ports significantly influenced the population genetic structure of M. alternatus as indicated by both the ratio of shared haplotypes and the haplotype diversity, however, the PWN distribution in China was significantly correlated with only the ratio of shared haplotypes. Our results suggested that the modern logistical network (i.e., the transportation system) in China is a key medium by which humans have brought about population exchange of M. alternatus in mainland China, likely through inadvertent movement of infested wood packaging material associated with trade, and that this genetic exchange was primarily from the economically well-developed east coast of China, westward, to the less-developed interior. In addition, this study demonstrated the existence of non-local M. alternatus in new PWN-infested localities in China, but not all sites with non-local M. alternatus were infested with PWN.	[Hu, Shao-ji; Fu, Da-ying; Chen, De-dao; Ma, Xue-yu; Ye, Hui] Yunnan Univ, Lab Biol Invas & Ecosecur, Kunming, Peoples R China; [Hu, Shao-ji; Fu, Da-ying; Chen, De-dao; Ma, Xue-yu; Ye, Hui] Yunnan Univ, Yunnan Key Lab Int Rivers & Transboundary Ecosec, Kunming, Peoples R China; [Ning, Tiao] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Minist Educ, Kunming, Peoples R China; [Ning, Tiao] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Peoples R China; [Ning, Tiao] Yunnan Univ, Lab Anim Genet Div & Evolut Higher Educ Yunnan Pr, Kunming, Peoples R China; [Ning, Tiao] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Haack, Robert A.] US Forest Serv, USDA, No Res Stn, E Lansing, MI USA; [Zhang, Zhen] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Zhang, Zhen] State Forestry Adm, Key Lab Forest Ecol & Environm, Beijing, Peoples R China	Yunnan University; Yunnan University; Yunnan University; Yunnan University; Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; United States Department of Agriculture (USDA); United States Forest Service; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Ye, H (corresponding author), Yunnan Univ, Lab Biol Invas & Ecosecur, Kunming, Peoples R China.	yehui@ynu.edu.cn	Hu, Shao-Ji/AAO-6247-2021	Hu, Shao-Ji/0000-0002-1615-9601	"Special Research Program for Non-profit Forestry" of State Forestry Administration [200904061]; "The Graduate Student Researching Program" of Yunnan Provincial Department of Education [2010J024]; "The Forestry Science and Technology Support Plan" of Chinese Academy of Forestry [2006BAD08A19105]; The International Technological Cooperation Research [2006DFA31790]	"Special Research Program for Non-profit Forestry" of State Forestry Administration; "The Graduate Student Researching Program" of Yunnan Provincial Department of Education; "The Forestry Science and Technology Support Plan" of Chinese Academy of Forestry; The International Technological Cooperation Research	This research was supported by "Special Research Program for Non-profit Forestry" of State Forestry Administration (200904061), "The Graduate Student Researching Program" of Yunnan Provincial Department of Education (2010J024), "The Forestry Science and Technology Support Plan" of Chinese Academy of Forestry (2006BAD08A19105), and "The International Technological Cooperation Research" (2006DFA31790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbulut S, 2012, FOREST PATHOL, V42, P89, DOI 10.1111/j.1439-0329.2011.00733.x; Bray AM, 2011, BIOL INVASIONS, V13, P2869, DOI 10.1007/s10530-011-9970-5; Cao ZJ, 2012, RES DEV, V161, P157; Carter MCA, 1996, J ECON ENTOMOL, V89, P1345, DOI 10.1093/jee/89.6.1345; Chen S, 1959, EC INSECT FAUNA CHIN, P120; Colunga-Garcia M, 2009, J ECON ENTOMOL, V102, P237, DOI 10.1603/029.102.0133; Demurger S., 2002, NBER WORKING PAPER S, V1, P1; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu DY, 2010, INSECT SCI, V17, P439, DOI 10.1111/j.1744-7917.2010.01329.x; Fujioka H., 1993, B AKITA PREFECTURE F, V2, P40; Gu J, 2006, FOREST PATHOL, V36, P323, DOI 10.1111/j.1439-0329.2006.00462.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huang JS, 2005, J FUJIAN FOR SCI TEC, V32, P1; Jiang B., 2015, INT J PHYS DISTR LOG, V32, P783, DOI DOI 10.1108/09600030210452459; Kawai M, 2006, ENVIRON ENTOMOL, V35, P569, DOI 10.1603/0046-225X-35.2.569; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kendall MG, 1962, RANK CORRELATION MET, P199; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOBAYASHI F, 1984, ANNU REV ENTOMOL, V29, P115, DOI 10.1146/annurev.en.29.010184.000555; Koutroumpa FA, 2009, J ZOOL SYST EVOL RES, V47, P141, DOI 10.1111/j.1439-0469.2008.00492.x; Lai YanXue, 1998, Journal of Zhejiang Forestry College, V15, P320; Lan L, 2012, TRANSPOWORLD, V19, P22; LESSA EP, 1990, SYST ZOOL, V39, P242, DOI 10.2307/2992184; Liang X, 2011, LOGIST TECHNOL, V30; MAMIYA Y, 1988, J NEMATOL, V20, P219; MAMIYA Y, 1972, NEMATOLOGICA, V18, P159, DOI 10.1163/187529272X00395; Marini L, 2011, BIOL INVASIONS, V13, P2275, DOI 10.1007/s10530-011-0039-2; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; National Bureau of Statistics of China (NBSC), 2003, CHIN STAT YB REG EC; National Bureau of Statistics of China (NBSC), 2001, CHIN STAT YB REG EC; National Bureau of Statistics of China (NBSC), 2010, CHIN STAT YB REG EC; National Bureau of Statistics of China (NBSC), 2006, CHIN STAT YB REG EC; NBSC, 2011, CHIN STAT YB REG EC; NBSC (National Bureau of Statistics of China), 2005, CHIN STAT YB REG EC; NBSC (National Bureau of Statistics of China), 2007, CHIN STAT YB REG EC; NBSC (National Bureau of Statistics of China), 2004, CHIN STAT YB REG EC; NBSC (National Bureau of Statistics of China), 2002, CHIN STAT YB REG EC; NBSC (National Bureau of Statistics of China), 2009, CHIN STAT YB REG EC; NBSC (National Bureau of Statistics of China), 2008, CHIN STAT YB REG EC; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ning Tiao, 2004, Entomological Knowledge, V41, P97; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ritzerow S, 2004, EUR J ENTOMOL, V101, P13, DOI 10.14411/eje.2004.003; Robinet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004646; Roehrdanz R.L., 1993, Insect Molecular Biology, V2, P89, DOI 10.1111/j.1365-2583.1993.tb00129.x; SFA (State Forestry Administration), 2005, B STAT FOR ADM P R C; SFA (State Forestry Administration), 2012, B STAT FOR ADM P R C; SFA (State Forestry Administration), 2011, B STAT FOR ADM P R C; Shi W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037083; Shi W, 2010, GENETICA, V138, P377, DOI 10.1007/s10709-009-9429-0; SHIBATA E, 1986, APPL ENTOMOL ZOOL, V21, P184, DOI 10.1303/aez.21.184; Shoda-Kagaya E, 2007, B ENTOMOL RES, V97, P167, DOI 10.1017/S000748530700483X; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOGASHI K, 1989, JPN J APPL ENTOMOL Z, V33, P1, DOI 10.1303/jjaez.33.1; TOGASHI K, 1981, APPL ENTOMOL ZOOL, V16, P351, DOI 10.1303/aez.16.351; Wan FH, 2009, RES BIOL INVASIONS C, P312; [王成金 WANG Chengjin], 2007, [地理学报, Acta Geographica Sinica], V62, P809; Wang LP, 2004, J FUJIAN FORESTRY SC, V31, P23; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2000, DATA ANAL MOL BIOL E, P280; Zhao Jin-nian, 2000, Forest Research, V13, P262; Zhao Jin-nian, 2001, Forest Research, V14, P523; [No title captured]	70	21	23	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57568	10.1371/journal.pone.0057568	http://dx.doi.org/10.1371/journal.pone.0057568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469026	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900125
J	Tsai, VWW; Macia, L; Johnen, H; Kuffner, T; Manadhar, R; Jorgensen, SB; Lee-Ng, KKM; Zhang, HP; Wu, LY; Marquis, CP; Jiang, LL; Husaini, Y; Lin, S; Herzog, H; Brown, DA; Sainsbury, A; Breit, SN				Tsai, Vicky Wang-Wei; Macia, Laurence; Johnen, Heiko; Kuffner, Tamara; Manadhar, Rakesh; Jorgensen, Sebastian Beck; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Wu, Liyun; Marquis, Christopher Peter; Jiang, Lele; Husaini, Yasmin; Lin, Shu; Herzog, Herbert; Brown, David A.; Sainsbury, Amanda; Breit, Samuel N.			TGF-b Superfamily Cytokine MIC-1/GDF15 Is a Physiological Appetite and Body Weight Regulator	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; GROWTH-DIFFERENTIATION FACTOR-15; BONE MORPHOGENETIC PROTEIN-7; FACTOR-BETA SUPERFAMILY; DIET-INDUCED OBESITY; BROWN ADIPOGENESIS; SERUM; MIC-1; INDIVIDUALS; DIAGNOSIS	The TGF-b superfamily cytokine MIC-1/GDF15 circulates in all humans and when overproduced in cancer leads to anorexia/cachexia, by direct action on brain feeding centres. In these studies we have examined the role of physiologically relevant levels of MIC-1/GDF15 in the regulation of appetite, body weight and basal metabolic rate. MIC-1/GDF15 gene knockout mice (MIC-1(-/-)) weighed more and had increased adiposity, which was associated with increased spontaneous food intake. Female MIC-1(-/-) mice exhibited some additional alterations in reduced basal energy expenditure and physical activity, possibly owing to the associated decrease in total lean mass. Further, infusion of human recombinant MIC-1/GDF15 sufficient to raise serum levels in MIC-1(-/-) mice to within the normal human range reduced body weight and food intake. Taken together, our findings suggest that MIC-1/GDF15 is involved in the physiological regulation of appetite and energy storage.	[Tsai, Vicky Wang-Wei; Johnen, Heiko; Kuffner, Tamara; Manadhar, Rakesh; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Wu, Liyun; Jiang, Lele; Husaini, Yasmin; Brown, David A.; Breit, Samuel N.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Tsai, Vicky Wang-Wei; Johnen, Heiko; Kuffner, Tamara; Manadhar, Rakesh; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Wu, Liyun; Jiang, Lele; Husaini, Yasmin; Brown, David A.; Breit, Samuel N.] Univ New S Wales, Sydney, NSW, Australia; [Macia, Laurence; Lin, Shu; Herzog, Herbert; Sainsbury, Amanda] Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia; [Jorgensen, Sebastian Beck] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark; [Marquis, Christopher Peter] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney; Garvan Institute of Medical Research; Novo Nordisk; University of New South Wales Sydney	Breit, SN (corresponding author), St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia.	s.breit@amr.org.au	Macia, laurence/D-5983-2016; Herzog, Herbert/B-8294-2008; Salis, Amanda/A-3187-2011; Marquis, Christopher P/E-3847-2013	Macia, laurence/0000-0003-0835-851X; Salis, Amanda/0000-0001-9176-1574; Marquis, Christopher P/0000-0003-1656-7215; , Herbert/0000-0002-1713-1029; Brown, David/0000-0003-1382-9419; Jiang, Lele/0000-0002-1326-5871; lin, shu/0000-0002-4239-2028	National Health and Medical Research Council of Australia (NHMRC); NHMRC	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC). AS, DAB and HH are all recipients of NHMRC Career Development Awards or Fellowships. The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Breit SN, 2011, NEPHROL DIAL TRANSPL; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, BIOTECHNIQUES, V33, P118, DOI 10.2144/02331rr03; Brown WJ, 2005, OBES RES, V13, P1431, DOI 10.1038/oby.2005.173; Carstensen M, 2010, EUR J ENDOCRINOL, V162, P913, DOI 10.1530/EJE-09-1066; Cegla J, 2010, CURR OPIN CLIN NUTR, V13, P588, DOI 10.1097/MCO.0b013e32833b64a3; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Dani C, 2012, INT J OBES LOND; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Fournier B, 2012, MOL CELL BIOL, V32, P2871, DOI 10.1128/MCB.06575-11; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Huang HY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002691; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kempf T, 2007, J AM COLL CARDIOL, V50, P1054, DOI 10.1016/j.jacc.2007.04.091; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Lenth RV, 2007, J ANIM SCI, V85, pE24, DOI 10.2527/jas.2006-449; Lind L, 2009, EUR HEART J, V30, P2346, DOI 10.1093/eurheartj/ehp261; Luo X, 2012, DIABETES, V61, P124, DOI 10.2337/db11-0998; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; Magee TR, 2006, J GENE MED, V8, P1171, DOI 10.1002/jgm.946; Moore AG, 2000, J CLIN ENDOCR METAB, V85, P4781, DOI 10.1210/jc.85.12.4781; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Shen JJ, 2009, MOL ENDOCRINOL, V23, P113, DOI 10.1210/me.2007-0322; Sun FY, 2009, BIOCHEM GENET, V47, P789, DOI 10.1007/s10528-009-9277-8; Suzuki K, 2011, J OBES, V2011, DOI 10.1155/2011/528401; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Toth MJ, 2001, CURR OPIN CLIN NUTR, V4, P391, DOI 10.1097/00075197-200109000-00009; Townsend KL, 2012, FASEB J, V26, P2187, DOI 10.1096/fj.11-199067; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Zac-Varghese S, 2010, DISCOV MED, V10, P543	42	109	123	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e55174	10.1371/journal.pone.0055174	http://dx.doi.org/10.1371/journal.pone.0055174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468844	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900011
J	Fragaszy, DM; Liu, Q; Wright, BW; Allen, A; Brown, CW; Visalberghi, E				Fragaszy, Dorothy M.; Liu, Qing; Wright, Barth W.; Allen, Angellica; Brown, Callie Welch; Visalberghi, Elisabetta			Wild Bearded Capuchin Monkeys (Sapajus libidinosus) Strategically Place Nuts in a Stable Position during Nut-Cracking	PLOS ONE			English	Article							TOOL USE	Humans can use hand tools smoothly and effectively in varying circumstances; in other words, skillfully. A few other species of primates crack encased foods using hammer tools and anvils. Are they skilled? Positioning the food on the anvil so that it does not fall off when struck is a component of skilled cracking. We discovered that bearded capuchin monkeys deliberately place palm nuts in a relatively stable position on the anvil before striking them. In the first experiment, we marked the meridians of palm nuts where they stopped when rolled on a flat surface ("Stop meridian"). We videotaped monkeys as they cracked these nuts on an anvil. In playback we coded the position of the Stop meridian prior to each strike. Monkeys typically knocked the nuts on the anvil a few times before releasing them in a pit. They positioned the nuts so that the Stop meridian was within 30 degrees of vertical with respect to gravity more often than expected, and the nuts rarely moved after the monkeys released them. In the second experiment, 14 blindfolded people (7 men) asked to position marked nuts on an anvil as if to crack them reliably placed them with the Stop meridian in the same position as the monkeys did. In the third experiment, two people judged that palm nuts are most bilaterally symmetric along a meridian on, or close to, the Stop meridian. Thus the monkeys reliably placed the more symmetrical side of the nuts against the side of the pit, and the nuts reliably remained stationary when released. Monkeys apparently used information gained from knocking the nut to achieve this position. Thus, monkeys place the nuts skillfully, strategically managing the fit between the variable nuts and pits in the anvil, and skilled placement depends upon information generated by manual action.	[Fragaszy, Dorothy M.; Liu, Qing; Allen, Angellica; Brown, Callie Welch] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Wright, Barth W.] Kansas City Univ Med & Biosci, Dept Anat, Kansas City, MO USA; [Visalberghi, Elisabetta] CNR, Unit Cognit Primatol, Inst Sci & Technol Cognit, Rome, Italy	University System of Georgia; University of Georgia; Kansas City University of Medicine & Biosciences; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Fragaszy, DM (corresponding author), Univ Georgia, Dept Psychol, Athens, GA 30602 USA.	doree@uga.edu	Liu, Qing/C-5620-2014; , Doree/HCI-4354-2022	Visalberghi, Elisabetta/0000-0001-7407-5468	National Geographic Society; LSB Leakey Foundation; University of Georgia	National Geographic Society(National Geographic Society); LSB Leakey Foundation; University of Georgia	This study was funded by the National Geographic Society, The LSB Leakey Foundation, and The University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett TM, 2007, DEV PSYCHOL, V43, P352, DOI 10.1037/0012-1649.43.2.352; Bernstein N.A., 1996, RES ECOL PS; Bril B, 2010, J EXP PSYCHOL HUMAN, V36, P825, DOI 10.1037/a0018171; Carello C, 2005, MOVING IMAGE THEORY, P79; Chemero A, 2009, BRADFORD BOOKS, P1; ELLIOTT JM, 1984, DEV MED CHILD NEUROL, V26, P283, DOI 10.1111/j.1469-8749.1984.tb04445.x; Fobes J.L., 1982, P245; Fragaszy D, 2010, ANIM BEHAV, V79, P321, DOI 10.1016/j.anbehav.2009.11.004; Fragaszy D. M., 2004, COMPLETE CAPUCHIN; FRAGASZY DM, 1991, J COMP PSYCHOL, V105, P387, DOI 10.1037/0735-7036.105.4.387; Fragaszy Dorothy M, 2005, Behav Cogn Neurosci Rev, V4, P282, DOI 10.1177/1534582306286573; Fragaszy DM, 2010, ANIM BEHAV, V80, P205, DOI 10.1016/j.anbehav.2010.04.018; Hoffmann JN, 2004, ANAT REC PART A, V281A, P1138, DOI 10.1002/ar.a.20119; Humle T., 2010, PRIMATES PERSPECTIVE, P637; Jones L.A., 2006, HUMAN HAND FUNCTION; KAAS JH, 1993, ANN ANAT, V175, P509, DOI 10.1016/S0940-9602(11)80212-8; Khanna S.M., 1978, P23; Klatzky RL, 2005, INFANT BEHAV DEV, V28, P240, DOI 10.1016/j.infbeh.2005.05.002; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Liu Q, 2011, THESIS U GEORGIA; Liu Q, 2011, ANIM BEHAV, V81, P297, DOI 10.1016/j.anbehav.2010.10.021; McCarty ME, 2001, INFANCY, V2, P233, DOI 10.1207/S15327078IN0202_8; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Richardson M. J., 2008, HDB COGNITIVE SCI EM, P161, DOI [DOI 10.1016/B978-0-08-046616-3.00009-8, 10.1016/B978-0-08-046616-3.00009-8]; Sirianni G, 2010, PROCESSAMENTO CIBO P; Spagnoletti N, 2011, J HUM EVOL, V61, P97, DOI 10.1016/j.jhevol.2011.02.010; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Turvey MT, 1996, AM PSYCHOL, V51, P1134, DOI 10.1037/0003-066X.51.11.1134; Visalberghi E, 2008, AM J PRIMATOL, V70, P884, DOI 10.1002/ajp.20578; Visalberghi E, 2012, COMP COGNITION, P529; Visalberghi E, 2009, CURR BIOL, V19, P213, DOI 10.1016/j.cub.2008.11.064	31	29	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56182	10.1371/journal.pone.0056182	http://dx.doi.org/10.1371/journal.pone.0056182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460793	Green Published, gold			2022-12-27	WOS:000315519000016
J	Ibarrola-Jurado, N; Bullo, M; Guasch-Ferre, M; Ros, E; Martinez-Gonzalez, MA; Corella, D; Fiol, M; Warnberg, J; Estruch, R; Roman, P; Aros, F; Vinyoles, E; Serra-Majem, L; Pinto, X; Covas, MI; Basora, J; Salas-Salvado, J				Ibarrola-Jurado, Nuria; Bullo, Monica; Guasch-Ferre, Marta; Ros, Emilio; Martinez-Gonzalez, Miguel A.; Corella, Dolores; Fiol, Miquel; Waernberg, Julia; Estruch, Ramon; Roman, Pilar; Aros, Fernando; Vinyoles, Ernest; Serra-Majem, Lluis; Pinto, Xavier; Covas, Maria-Isabel; Basora, Josep; Salas-Salvado, Jordi		PREDIMED Study Investigators	Cross-Sectional Assessment of Nut Consumption and Obesity, Metabolic Syndrome and Other Cardiometabolic Risk Factors: The PREDIMED Study	PLOS ONE			English	Article							BODY-WEIGHT; MEDITERRANEAN DIET; COMPONENTS; COHORT; MARKERS	Introduction: Prospective studies have consistently suggested that nut consumption is inversely related to fatal and non-fatal coronary heart disease. Limited data are available on the epidemiological associations between nut intake and cardiometabolic risk factors. Objective: To evaluate associations between frequency of nut consumption and prevalence of cardiometabolic risk factors [obesity, metabolic syndrome (MetS), type-2 diabetes, hypertension, and dyslipidemia] in a Mediterranean population at high cardiovascular risk. Materials and Methods: Cross-sectional study of 7,210 men and women (mean age, 67 y) recruited into the PREDIMED study. MetS was defined by the harmonized ATPIII and IDF criteria. Diabetes and hypertension were assessed by clinical diagnosis and dyslipidemia (high triglycerides, low HDL-cholesterol, and hypercholesterolemia) by lipid analyses. Nut consumption was assessed using a validated food frequency questionnaire and categorized as <1, 1-3, and >3 servings/wk. Control of confounding was done with multivariate logistic regression. Results: Compared to participants consuming <1 serving/wk of nuts, those consuming >3 servings/wk had lower adjusted odds ratios (OR) for obesity (0.61, 95% confidence interval 0.54 to 0.68; P-trend <0.001), MetS (0.74, 0.65 to 0.85; P-trend<0.001), and diabetes (0.87, 0.78 to 0.99; P-trend = 0.043). Higher nut consumption was also associated with lower risk of the abdominal obesity MetS criterion (OR 0.68, 0.60 to 0.79; P-trend<0.001). No significant associations were observed for the MetS components high blood pressure, dyslipidemia, or elevated fasting glucose. Conclusions: Nut consumption was inversely associated with the prevalence of general obesity, central obesity, MetS, and diabetes in subjects at high cardiovascular risk.	[Ibarrola-Jurado, Nuria; Bullo, Monica; Guasch-Ferre, Marta; Basora, Josep; Salas-Salvado, Jordi] Univ Rovira & Virgili, Human Nutr Unit, Hosp Univ St Joan Reus, IISPV, E-43201 Reus, Spain; [Ibarrola-Jurado, Nuria; Bullo, Monica; Guasch-Ferre, Marta; Ros, Emilio; Corella, Dolores; Fiol, Miquel; Estruch, Ramon; Roman, Pilar; Covas, Maria-Isabel; Basora, Josep; Salas-Salvado, Jordi] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Ros, Emilio] Hosp Clin Barcelona, Lipid Clin, Endocrinol & Nutr Serv, Inst Invest Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain; [Martinez-Gonzalez, Miguel A.] Univ Navarra, Dept Prevent Med & Publ Hlth, Med Sch Clin, E-31080 Pamplona, Spain; [Corella, Dolores] Univ Valencia, Dept Prevent Med & Publ Hlth, Valencia, Spain; [Fiol, Miquel] Univ Inst Hlth Sci Invest, Palma de Mallorca, Spain; [Waernberg, Julia] Univ Malaga, Dept Prevent Med, E-29071 Malaga, Spain; [Estruch, Ramon] Hosp Clin Barcelona, Dept Internal Med, Inst Invest Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain; [Roman, Pilar] Mercedes Navarro Hlth Ctr, Dept Family Med, Primary Care Div Sevilla, Seville, Spain; [Aros, Fernando] Hosp Txangorritxu, Clin Trial Unit, Vitoria, Spain; [Vinyoles, Ernest] Univ Barcelona, La Mina Primary Care Ctr, IDIAP Jordi Gol, Barcelona, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Pinto, Xavier] Bellvitge Hosp, Internal Med Serv, Lhospitalet De Llobregat, Spain; [Covas, Maria-Isabel] Hosp del Mar, Cardiovasc Risk & Nutr Res Grp, IMIM Inst Recerca, Barcelona, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Navarra; University of Valencia; Universidad de Malaga; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Universidad de Las Palmas de Gran Canaria; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Salas-Salvado, J (corresponding author), Univ Rovira & Virgili, Human Nutr Unit, Hosp Univ St Joan Reus, IISPV, C St Llorenc 21, E-43201 Reus, Spain.	jordi.salas@urv.cat	Bulló, Mònica/F-2925-2016; IBIS, ATENCION PRIMARIA/I-3524-2016; Guasch-Ferre, Marta/H-6680-2019; Pintó, Xavier/AGI-4297-2022; Serra-Majem, Lluis/I-6708-2019; Salas-Salvado, Jordi/C-7229-2017; Estruch, Ramon/AAZ-3723-2020; Fiol, Miguel/F-6793-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Warnberg, Julia/G-1390-2011; Vinyoles, Ernest/GRX-4615-2022; Lapetra, Jose/F-2552-2015; Babio, Nancy/AAN-2715-2020; Toledo, Estefania/H-6211-2014; Lamuela-Raventos, Rosa M/F-3986-2016	Bulló, Mònica/0000-0002-0218-7046; Guasch-Ferre, Marta/0000-0001-8525-1404; Pintó, Xavier/0000-0002-2216-2444; Serra-Majem, Lluis/0000-0002-9658-9061; Salas-Salvado, Jordi/0000-0003-2700-7459; Fiol, Miguel/0000-0002-5370-1391; Warnberg, Julia/0000-0002-8408-316X; Babio, Nancy/0000-0003-3527-5277; Fernandez-Ballart, Joan D./0000-0002-1320-6484; Toledo, Estefania/0000-0002-6263-4434; Basora, Josep/0000-0003-0278-1149; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808; Ros, Emilio/0000-0002-2573-1294; Sorli, Jose V/0000-0002-0130-2006; Lamuela-Raventos, Rosa M/0000-0002-1287-4560; Vinyoles, Ernest/0000-0002-8725-9431	Spanish Ministry of Health (ISCIII) [PI1001407]; Thematic Network [G03/140, RD06/0045]; FEDER (Fondo Europeo de Desarrollo Regional); Centre Catala de la Nutricio de l'Institut d'Estudis Catalans	Spanish Ministry of Health (ISCIII)(Instituto de Salud Carlos IIISpanish Government); Thematic Network; FEDER (Fondo Europeo de Desarrollo Regional)(European Commission); Centre Catala de la Nutricio de l'Institut d'Estudis Catalans	This study was funded, in part, by the Spanish Ministry of Health (ISCIII), PI1001407, Thematic Network G03/140, RD06/0045, FEDER (Fondo Europeo de Desarrollo Regional), and the Centre Catala de la Nutricio de l'Institut d'Estudis Catalans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2011, NUTR METAB CARDIOVAS, V21, pB1, DOI 10.1016/j.numecd.2011.05.001; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Bes-Rastrollo M, 2007, OBESITY, V15, P107, DOI 10.1038/oby.2007.507; Bes-Rastrollo M, 2009, AM J CLIN NUTR, V89, P1913, DOI 10.3945/ajcn.2008.27276; Blomhoff R, 2006, BRIT J NUTR, V96, pS52, DOI 10.1017/BJN20061864; Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, P518, DOI 10.1016/j.numecd.2009.11.010; Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, pS21, DOI 10.1016/j.numecd.2011.01.009; Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, P126, DOI 10.1016/j.numecd.2009.08.005; Casas-Agustench P, 2009, CLIN NUTR, V28, P39, DOI 10.1016/j.clnu.2008.10.008; Casas-Agustench P, 2010, ASIA PAC J CLIN NUTR, V19, P124; Chen CYO, 2008, ASIA PAC J CLIN NUTR, V17, P329; Djousse L, 2009, CLIN NUTR, V28, P10, DOI 10.1016/j.clnu.2008.08.005; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Fernandez-Montero A, 2012, PUBLIC HEALTH NUTR, V23, P1; Garcia-Lorda P, 2003, EUR J CLIN NUTR, V57, pS8, DOI 10.1038/sj.ejcn.1601802; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Jenkins DJA, 2011, DIABETES CARE, V34, P1706, DOI 10.2337/dc11-0338; Jiang R, 2002, JAMA-J AM MED ASSOC, V288, P2554, DOI 10.1001/jama.288.20.2554; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Kendall CWC, 2010, BRIT J NUTR, V104, P465, DOI 10.1017/S0007114510001546; King JG, 2008, J NUTR, V138, p1736S, DOI 10.1093/jn/138.9.1736S; Lopez-Uriarte P, 2010, CLIN NUTR, V29, P373, DOI 10.1016/j.clnu.2009.12.008; Lopez-Uriarte P, 2009, NUTR REV, V67, P497, DOI 10.1111/j.1753-4887.2009.00223.x; Martinez-Gonzalez MA, 2011, NUTR METAB CARDIOVAS, V21, pS40, DOI 10.1016/j.numecd.2010.11.005; Martinez-Lapiscina EH, 2010, NUTR METAB CARDIOVAS, V20, P359, DOI 10.1016/j.numecd.2009.04.013; Mattes RD, 2010, ASIA PAC J CLIN NUTR, V19, P137; Mukuddem-Petersen J, 2007, BRIT J NUTR, V97, P1144, DOI 10.1017/S0007114507682944; O'Neil CE, 2011, J AM COLL NUTR, V30, P502, DOI 10.1080/07315724.2011.10719996; Parker ED, 2003, JAMA-J AM MED ASSOC, V290, P38, DOI 10.1001/jama.290.1.38; Ros E, 2006, BRIT J NUTR, V96, pS29, DOI 10.1017/BJN20061861; Ros E, 2010, CURR ATHEROSCLER REP, V12, P397, DOI 10.1007/s11883-010-0132-5; Sabate J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79; Salas-Salvado J, 2011, NUTR METAB CARDIOVAS, V21, pB32, DOI 10.1016/j.numecd.2011.03.009; Salas-Salvado J, 2008, ARCH INTERN MED, V168, P2449, DOI 10.1001/archinte.168.22.2449; Salas-Salvado J, 2006, BRIT J NUTR, V96, pS45, DOI 10.1017/BJN20061863; Sanchez-Tainta A, 2008, EUR J CARDIOV PREV R, V15, P589, DOI 10.1097/HJR.0b013e328308ba61; Segura R, 2006, BRIT J NUTR, V96, pS36, DOI 10.1017/BJN20061862; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; US Food and Drug Administration. Center for Food Safety and Applied Nutrition, QUAL HLTH CLAIMS SUB; Villegas R, 2008, AM J CLIN NUTR, V87, P162, DOI 10.1093/ajcn/87.1.162; Wang X, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-20	43	84	85	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57367	10.1371/journal.pone.0057367	http://dx.doi.org/10.1371/journal.pone.0057367			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460844	Green Published, gold			2022-12-27	WOS:000315519000098
J	Ling, JL; Pan, HZ; Gao, QQ; Xiong, LP; Zhou, YF; Zhang, DB; Gao, S; Liu, XF				Ling, Jielu; Pan, Haizhu; Gao, Qingqing; Xiong, Liping; Zhou, Yefei; Zhang, Debao; Gao, Song; Liu, Xiufan			Aerobactin Synthesis Genes iucA and iucC Contribute to the Pathogenicity of Avian Pathogenic Escherichia coli O2 Strain E058	PLOS ONE			English	Article							IRON UPTAKE SYSTEM; VIRULENCE FACTORS; INVASIVE STRAINS; PLASMID COLV-K30; TRANSPORT GENES; OPERON; IDENTIFICATION; CHROMOSOME; EXPRESSION; RESISTANCE	Aerobactin genes are known to be present in virulent strains and absent from avirulent strains, but contributions of iucC and iucA, which are involved in aerobactin synthesis, to the pathogenicity of avian pathogenic Escherichia coli (APEC) have not been clarified. In this study, effects of double mutants (iucA/iutA or iucC/iutA) compared to those of single mutants (iucA, iucC or iutA) of aerobactin genes on the virulence of APEC strain E058 were examined both in vitro (aerobactin production, ingestion into HD-11 cells, survival in chicken serum) and in vivo (competitive growth against parental strain, colonization and persistence). In competitive co-infection assays, compared to the E058 parental strain, the E058 Delta iucA mutant was significantly reduced in the liver, kidney, spleen (all P<0.01), heart and lung (both P<0.001). The E058 Delta iutA mutant also was significantly reduced in the liver, lung, kidney (all P<0.01), heart and spleen (both P<0.001). The E058 Delta iucC mutant was significantly attenuated in the heart and kidney (both P<0.05) and showed a remarkable reduction in the liver, spleen and lung (P<0.01); meanwhile, both E058 Delta iucA Delta iutA and E058 Delta iucC Delta iutA double mutants were sharply reduced as well (P<0.001). In colonization and persistence assays, compared with E058, recovered colonies of E058 Delta iucA were significantly reduced from the lung, liver, spleen and kidney (P<0.01) and significantly reduced in the heart (P<0.001). E058 Delta iutA was significantly reduced from the heart, lung, liver, spleen and kidney (P<0.01). E058 Delta iucC, E058 Delta iucA Delta iutA and E058 Delta iucC Delta iutA were significantly decreased in all organs tested (P<0.001). These results suggest that iutA, iucA and iucC play important roles in the pathogenicity of APEC E058.	[Ling, Jielu; Pan, Haizhu; Gao, Qingqing; Xiong, Liping; Zhou, Yefei; Zhang, Debao; Gao, Song; Liu, Xiufan] Yangzhou Univ, Coll Vet Med, Minist Agr, Anim Infect Dis Lab, Yangzhou, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Yangzhou University	Gao, S (corresponding author), Yangzhou Univ, Coll Vet Med, Minist Agr, Anim Infect Dis Lab, Yangzhou, Jiangsu, Peoples R China.	gsong@yzu.edu.cn			National Natural Science Foundation of China [30972196, 30771604, 30471281]; National Program for High Technology Research and Development in China [2003 AA222141]; program for Changjiang Scholars and Innovative Research Team in University [PCSIRT0978]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for High Technology Research and Development in China; program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China Grant 30972196, 30771604 and 30471281, and National Program for High Technology Research and Development in China Grant 2003 AA222141 to Song Gao. This study was also supported by the program for Changjiang Scholars and Innovative Research Team in University (PCSIRT0978) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; BINDEREIF A, 1985, J BACTERIOL, V161, P727, DOI 10.1128/JB.161.2.727-735.1985; BINDEREIF A, 1983, J BACTERIOL, V153, P1111, DOI 10.1128/JB.153.2.1111-1113.1983; BULLEN JJ, 1981, REV INFECT DIS, V3, P1127; CARBONETTI NH, 1984, INFECT IMMUN, V46, P7, DOI 10.1128/IAI.46.1.7-12.1984; COLONNA B, 1985, J BACTERIOL, V162, P307, DOI 10.1128/JB.162.1.307-316.1985; DELORENZO V, 1986, J BACTERIOL, V167, P350, DOI 10.1128/jb.167.1.350-355.1986; DELORENZO V, 1986, J BACTERIOL, V165, P570, DOI 10.1128/jb.165.2.570-578.1986; DERVARTANIAN M, 1988, INFECT IMMUN, V56, P413, DOI 10.1128/IAI.56.2.413-418.1988; DHO M, 1984, AVIAN DIS, V28, P1016, DOI 10.2307/1590278; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Escolar L, 2000, J BIOL CHEM, V275, P24709, DOI 10.1074/jbc.M002839200; FINKELSTEIN RA, 1983, REV INFECT DIS, V5, pS759; Forman S, 2007, MICROBIOL-SGM, V153, P2332, DOI 10.1099/mic.0.2006/004275-0; Gao Song, 1999, Acta Veterinaria et Zootechnica Sinica, V30, P164; GIBSON F, 1969, BIOCHIM BIOPHYS ACTA, V192, P175, DOI 10.1016/0304-4165(69)90353-5; GRIFFITHS E, 1985, INFECT IMMUN, V49, P67, DOI 10.1128/IAI.49.1.67-71.1985; GROSS R, 1984, MOL GEN GENET, V196, P74, DOI 10.1007/BF00334095; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kariyawasam S, 2006, INFECT IMMUN, V74, P744, DOI 10.1128/IAI.74.1.744-749.2006; Knobl T, 2001, VET MICROBIOL, V83, P71, DOI 10.1016/S0378-1135(01)00403-5; KONOPKA K, 1982, BIOCHEMISTRY-US, V21, P6503, DOI 10.1021/bi00268a028; LAFONT JP, 1987, INFECT IMMUN, V55, P193, DOI 10.1128/IAI.55.1.193-197.1987; LAWLOR KM, 1984, J BACTERIOL, V160, P266, DOI 10.1128/JB.160.1.266-272.1984; Li G, 2008, MICROBIOL-SGM, V154, P1082, DOI 10.1099/mic.0.2007/015784-0; Li GW, 2005, INFECT IMMUN, V73, P2818, DOI 10.1128/IAI.73.5.2818-2827.2005; MCDOUGALL S, 1984, J BACTERIOL, V159, P300, DOI 10.1128/JB.159.1.300-305.1984; Ngeleka M, 2002, AVIAN DIS, V46, P143, DOI 10.1637/0005-2086(2002)046[0143:POAECA]2.0.CO;2; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; Sabri M, 2008, INFECT IMMUN, V76, P601, DOI 10.1128/IAI.00789-07; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; Skyberg JA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-24; Tivendale KA, 2004, INFECT IMMUN, V72, P6554, DOI 10.1128/IAI.72.11.6554-6560.2004; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; VALVANO MA, 1984, INFECT IMMUN, V46, P159, DOI 10.1128/IAI.46.1.159-167.1984; Van LP, 1996, BIOCHEM J, V313, P39; VIDOTTO MC, 1990, AVIAN DIS, V34, P531, DOI 10.2307/1591241; WARNER PJ, 1981, INFECT IMMUN, V33, P540, DOI 10.1128/IAI.33.2.540-545.1981; Watson RJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-177; WEINBERG ED, 1984, PHYSIOL REV, V64, P65, DOI 10.1152/physrev.1984.64.1.65; WILLIAMS PH, 1979, INFECT IMMUN, V26, P925, DOI 10.1128/IAI.26.3.925-932.1979; Xiong LP, 2012, VET MICROBIOL, V159, P420, DOI 10.1016/j.vetmic.2012.04.024; Zaleski A, 2000, INFECT IMMUN, V68, P5261, DOI 10.1128/IAI.68.9.5261-5268.2000; Zhao LX, 2009, MICROBIOL-SGM, V155, P1634, DOI 10.1099/mic.0.024869-0	45	24	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57794	10.1371/journal.pone.0057794	http://dx.doi.org/10.1371/journal.pone.0057794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460907	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000162
J	Liu, K; Sun, Y; Liu, DJ; Yin, JM; Qiao, LX; Shi, Y; Dong, YW; Li, N; Zhang, FJ; Chen, DX				Liu, Kai; Sun, Yu; Liu, Daojie; Yin, Jiming; Qiao, Luxin; Shi, Ying; Dong, Yaowu; Li, Ning; Zhang, Fujie; Chen, Dexi			Mitochondrial Toxicity Studied with the PBMC of Children from the Chinese National Pediatric Highly Active Antiretroviral Therapy Cohort	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE; THYMIDINE KINASE; MTDNA DEPLETION; NUCLEOSIDE; MECHANISMS; MUTATION; DYSFUNCTION; RESISTANCE; INHIBITORS; LACTATE	As the backbone of highly active antiretroviral therapy (HAART), nucleoside reverse transcriptase inhibitors (NRTIs) have effectively improved outcomes for HIV-infected patients. However, long-term treatment with NRTIs can cause a series of pathologies associated with mitochondrial toxicity. To date, the status and mechanism of mitochondrial toxicity induced by NRTIs are still not clear, especially in HIV-infected children. As part of the national pediatric HAART program in China, our study focused on mitochondrial toxicity and its potential mechanism in HIV-1-infected children who were divided into two groups based on their duration of treatment with NRTIs: one group received treatment for less than 36 months and one group was treated for 36 to 72 months. The control group comprised age-matched non-HIV-infected children. Blood lactic acid and ATP levels in peripheral blood mononuclear cells (PBMCs) were measured to evaluate mitochondrial function, and mtDNA copies and mutations in PBMCs were determined for detecting mtDNA lesions. Simultaneously, TK2 and P53R2 gene expression in PBMC was measured. As compared with the control group, blood lactic acid levels in both NRTI treatment groups were significantly higher, whereas ATP levels and mtDNA mutation rates in PBMCs did not differ between the control and the two NRTI treatment groups. Both NRTI treatment groups exhibited significant mtDNA loss. N Moreover, we found that P53R2 mRNA expression and protein levels were significantly reduced in both treatment groups and that TK2 mRNA expression and protein levels were induced in the long-term NRTI treatment group. These results suggest that mitochondrial toxicity occurs in long-term HAART patients and that P53R2 and TK2 levels in PBMCs are useful biomarkers for detecting mitochondrial toxicity in patients on long-term treatment with NRTIs.	[Liu, Kai; Sun, Yu; Liu, Daojie; Yin, Jiming; Shi, Ying; Li, Ning; Chen, Dexi] Capital Med Univ, Beijing YouAn Hosp, Dept Med, Beijing, Peoples R China; [Liu, Kai; Liu, Daojie; Yin, Jiming; Qiao, Luxin; Li, Ning; Chen, Dexi] Beijing Inst Hepatol, Beijing, Peoples R China; [Zhang, Fujie] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Div Treatment & Care, Beijing, Peoples R China	Capital Medical University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Zhang, FJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Div Treatment & Care, Beijing, Peoples R China.	zhang.fujie.t@gmail.com; dexi0963@yahoo.com			Twelve-fifth Key Science and Technology Five Year Plan of China [2012ZX10001003-003-002, 2012ZX10001004-002, 2012BAI15B08]; National Natural Science Foundation of China [81272266, 30910103915]	Twelve-fifth Key Science and Technology Five Year Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is sponsored by Twelve-fifth Key Science and Technology Five Year Plan of China (2012ZX10001003-003-002, 2012ZX10001004-002 and 2012BAI15B08) and the National Natural Science Foundation of China (81272266 and 30910103915). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barret B, 2003, AIDS, V17, P1769, DOI 10.1097/00002030-200308150-00006; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Brinkman K, 2000, CURR OPIN INFECT DIS, V13, P5, DOI 10.1097/00001432-200002000-00002; Cossarizza A, 2002, J INFECT DIS, V185, P299, DOI 10.1086/338564; ERIKSSON S, 1995, J BIOL CHEM, V270, P18929, DOI 10.1074/jbc.270.32.18929; Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796; Gotz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236; Herman JS, 2001, INT J STD AIDS, V12, P555, DOI 10.1258/0956462011923714; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; Kohler JJ, 2007, ENVIRON MOL MUTAGEN, V48, P166, DOI 10.1002/em.20223; Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014; La Rovere, 2004, AIDS, V18, P1443, DOI 10.1097/01.aids.0000131334.38172.01; Lewis W, 2001, LAB INVEST, V81, P777, DOI 10.1038/labinvest.3780288; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Lo JC, 2005, CLIN INFECT DIS, V41, P1335, DOI 10.1086/496981; Mambo E, 2003, P NATL ACAD SCI USA, V100, P1838, DOI 10.1073/pnas.0437910100; Nolan D, 2004, ANTIVIR THER, V9, P849; Papp E, 2008, J ANTIMICROB CHEMOTH, V61, P1048, DOI 10.1093/jac/dkn067; Perez-Perez MJ, 2008, MED RES REV, V28, P797, DOI 10.1002/med.20124; Pinti M, 2006, BBA-BIOENERGETICS, V1757, P700, DOI 10.1016/j.bbabio.2006.05.001; Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200; Scruggs ER, 2008, PHARMACOLOGY, V82, P83, DOI 10.1159/000134943; Sun R, 2010, NUCLEOS NUCLEOT NUCL, V29, P382, DOI 10.1080/15257771003741018; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; ter Hofstede HJM, 2004, J CLIN VIROL, V29, P44, DOI 10.1016/S1386-6532(03)00085-4; Thelander L, 2007, NAT GENET, V39, P703, DOI 10.1038/ng0607-703; Vila MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47; Wester CW, 2007, JAIDS-J ACQ IMM DEF, V46, P318, DOI 10.1097/QAI.0b013e3181568e3f; Wong LJC, 2003, J MED GENET, V40; Wu YS, 2009, MUTAT RES-FUND MOL M, V664, P28, DOI 10.1016/j.mrfmmm.2009.02.006; Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872; Zhou ST, 2010, JAIDS-J ACQ IMM DEF, V54, P191, DOI 10.1097/QAI.0b013e3181c99226	33	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57223	10.1371/journal.pone.0057223	http://dx.doi.org/10.1371/journal.pone.0057223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468942	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000080
J	Manunza, A; Zidi, A; Yeghoyan, S; Balteanu, VA; Carsai, TC; Scherbakov, O; Ramirez, O; Eghbalsaied, S; Castello, A; Mercade, A; Amills, M				Manunza, Arianna; Zidi, Ali; Yeghoyan, Seryozha; Balteanu, Valentin Adrian; Carsai, Teodora Crina; Scherbakov, Oleg; Ramirez, Oscar; Eghbalsaied, Shahin; Castello, Anna; Mercade, Anna; Amills, Marcel			A High Throughput Genotyping Approach Reveals Distinctive Autosomal Genetic Signatures for European and Near Eastern Wild Boar	PLOS ONE			English	Article							PIG BREEDS; DOMESTIC PIG; DIVERSITY; MITOCHONDRIAL; POPULATION; DNA; ORIGIN; MULTIPLE; NUMBER	The lack of a Near Eastern genetic signature in modern European porcine breeds indicates that, although domestic pigs from the Fertile Crescent entered Europe during the Neolithic, they were completely replaced by their European counterparts in a short window of time. Whilst the absence of such genetic signature has been convincingly demonstrated at the mitochondrial level, variation at the autosomal genomes of European and Near Eastern Sus scrofa has not been compared yet. Herewith, we have explored the genetic relationships among 43 wild boar from Europe (N = 21), Near East (N = 19) and Korea (N = 3), and 40 Iberian (N = 16), Canarian (N = 4) and Mangalitza (N = 20) pigs by using a high throughput SNP genotyping platform. After data filtering, 37,167 autosomal SNPs were used to perform population genetics analyses. A multidimensional scaling plot based on genome-wide identity-by-state pairwise distances inferred with PLINK showed that Near Eastern and European wild boar populations are genetically differentiated. Maximum likelihood trees built with TreeMix supported this conclusion i.e. an early population split between Near Eastern and European Sus scrofa was observed. Moreover, analysis of the data with Structure evidenced that the sampled Iberian, Canarian and Mangalitza pigs did not carry any autosomal signature compatible with a Near Eastern ancestry, a finding that agrees well with previous mitochondrial studies.	[Manunza, Arianna; Zidi, Ali; Castello, Anna; Amills, Marcel] Univ Autonoma Barcelona, Dept Anim Genet, Ctr Res Agr Genom, CSIC,IRTA,UB, Bellaterra, Spain; [Yeghoyan, Seryozha; Scherbakov, Oleg] Armenian State Agr Univ, Yerevan, Armenia; [Balteanu, Valentin Adrian; Carsai, Teodora Crina] Univ Agr Sci & Vet Med Cluj Napoca, Fac Anim Husb & Biotechnol, Dept Biotechnol, Reg Lab Anim Genotyping, Cluj Napoca, Cluj County, Romania; [Ramirez, Oscar] Univ Pompeu Fabra, Inst Biol Evolut, CSIC, CEXS,PRBB, Barcelona, Spain; [Eghbalsaied, Shahin] Islamic Azad Univ, Dept Anim Sci, Khorasgan Isfahan Branch, Esfahan, Iran; [Mercade, Anna; Amills, Marcel] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Bellaterra, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Armenian National Agrarian University; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; Islamic Azad University; Autonomous University of Barcelona	Amills, M (corresponding author), Univ Autonoma Barcelona, Dept Anim Genet, Ctr Res Agr Genom, CSIC,IRTA,UB, Bellaterra, Spain.	Marcel.Amills@uab.cat	Amills, Marcel/D-4908-2019; Eghbalsaied, Shahin/AAC-8686-2019; Farré, Anna Castelló/K-9637-2015; Amills, Marcel/C-7156-2008; Ramirez, Oscar/E-7293-2012; Zidi, Ali/Q-6806-2016	Amills, Marcel/0000-0002-8999-0770; Eghbalsaied, Shahin/0000-0002-9030-8679; Farré, Anna Castelló/0000-0001-8497-6251; Ramirez, Oscar/0000-0001-5164-6790; Zidi, Ali/0000-0002-2314-4336; Mercade, Anna/0000-0002-4714-3565	Ministerio de Ciencia e Innovacion [AGL2010-22208-C02-02, CSD 2007-00036]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work has been funded by grants AGL2010-22208-C02-02 (Ministerio de Ciencia e Innovacion) and CSD 2007-00036 (Ministerio de Ciencia e Innovacion, Consolider Ingenio 2010 Program). A. Zidi received a contractual grant under the framework of CSD 2007-00036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alexandri P, 2012, J BIOGEOGR, V39, P713, DOI 10.1111/j.1365-2699.2011.02636.x; Alves E, 2009, ANIMAL, V3, P1216, DOI 10.1017/S1751731109004819; Amills M, 2010, ENCY LIFE SCI, P1, DOI [10.1002/9780470015902.a0022884, DOI 10.1002/9780470015902.A0022884]; Bruford MW, 2005, WORLD POULTR SCI ASS; Burgos-Paz W, 2013, ANIM GENET, V44, P130, DOI 10.1111/j.1365-2052.2012.02374.x; Capote JF, 1982, CERDO NEGRO CANARIO; Ciobanu DC, 2001, GENET SEL EVOL, V33, P417, DOI 10.1051/gse:2001125; Clop A, 2004, GENET SEL EVOL, V36, P97, DOI 10.1051/gse:2003053; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fabuel E, 2004, HEREDITY, V93, P104, DOI 10.1038/sj.hdy.6800488; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; Fernandez AI, 2011, ANIM GENET, V42, P86, DOI 10.1111/j.1365-2052.2010.02068.x; Georgescu SE, 2012, INT J MOL SCI, V13, P8467, DOI 10.3390/ijms13078467; Giuffra E, 2000, GENETICS, V154, P1785; Goedbloed DJ, 2013, MOL ECOL, V22, P856, DOI 10.1111/j.1365-294X.2012.05670.x; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Ji YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026416; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; Kim TH, 2005, J ANIM SCI, V83, P2255; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Li SJ, 2004, J ANIM SCI, V82, P368; Martinez AM, 2000, ANIM GENET, V31, P295, DOI 10.1046/j.1365-2052.2000.00645.x; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez O, 2009, MOL BIOL EVOL, V26, P2061, DOI 10.1093/molbev/msp118; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Scandura M, 2008, MOL ECOL, V17, P1745, DOI 10.1111/j.1365-294X.2008.03703.x; Scandura M, 2011, HEREDITY, V106, P1012, DOI 10.1038/hdy.2010.155; van Asch B, 2012, ANIM GENET, V43, P35, DOI 10.1111/j.1365-2052.2011.02222.x; Vila C, 2005, TRENDS GENET, V21, P214, DOI 10.1016/j.tig.2005.02.004; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; White S, 2011, ENVIRON HIST-US, V16, P94, DOI 10.1093/envhis/emq143; Zhang CY, 2011, CURR GENOMICS, V12, P138, DOI 10.2174/138920211795564386	40	24	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55891	10.1371/journal.pone.0055891	http://dx.doi.org/10.1371/journal.pone.0055891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460788	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000011
J	Shen, CC; Hu, YW; Hu, LY; Hung, MH; Su, TP; Huang, MW; Tsai, CF; Ou, SM; Yen, SH; Tzeng, CH; Chiou, TJ; Chen, TJ; Liu, CJ				Shen, Cheng-Che; Hu, Yu-Wen; Hu, Li-Yu; Hung, Man-Hsin; Su, Tung-Ping; Huang, Min-Wei; Tsai, Chia-Fen; Ou, Shuo-Ming; Yen, Sang-Hue; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Chen, Tzeng-Ji; Liu, Chia-Jen			The Risk of Cancer in Patients with Generalized Anxiety Disorder: A Nationwide Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; BREAST-CANCER; TUBERCULOSIS PATIENTS; GENDER-DIFFERENCES; PROSTATE-CANCER; UNITED-STATES; LUNG-CANCER; STRESS; DEPRESSION; COMORBIDITY	Objective: To evaluate the risk of cancer among patients with generalized anxiety disorder (GAD) in a nationwide population-based dataset. Methods: We recruited newly-diagnosed GAD patients aged 20 years or older without antecedent cancer from the Taiwan National Health Insurance Research database between 2000-2010. Standardized incidence ratios (SIRs) of cancers were calculated in GAD patients, and the subgroup of GAD patients diagnosed by psychiatric specialists. Results: A total of 559 cancers developed among 19,793 GAD patients with a follow-up of 89,485 person-years (median follow-up of 4.34 years), leading to a significantly increased SIR of 1.14 [95% confidence interval (CI) 1.05-1.24]. Male GAD patients had a significantly increased SIR overall (1.30, 95% CI 1.15-1.46) and for lung and prostate cancer (1.77, 95% CI 1.33-2.30 and 2.17, 95% CI 1.56-2.93, respectively). Patients over 80 years of age also had a significantly increased SIR (1.56, 95% CI 1.25-1.92), especially in males. However, psychiatrist-diagnosed GAD patients did not show increased cancer risk relative to the general population, perhaps due to having fewer physical comorbidities than non-psychiatrist-diagnosed GAD patients. Conclusion: This study found that overall cancer risk is elevated among patients with GAD. The risk of lung and prostate cancer also increased in male patients with GAD. This increased cancer risk may be due to physical comorbidities and surveillance bias. Further prospective study is necessary to confirm these findings.	[Shen, Cheng-Che; Huang, Min-Wei] Taichung Vet Gen Hosp, Dept Psychiat, Chiayi Branch, Chiayi, Taiwan; [Hu, Yu-Wen; Su, Tung-Ping; Tsai, Chia-Fen; Yen, Sang-Hue; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hu, Yu-Wen; Yen, Sang-Hue] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Hu, Yu-Wen; Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Hu, Li-Yu] Yuli Vet Hosp, Dept Psychiat, Hualien, Taiwan; [Hung, Man-Hsin; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Liu, Chia-Jen] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Su, Tung-Ping; Tsai, Chia-Fen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Ou, Shuo-Ming] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Yen, Sang-Hue] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ Hosp, Dept Internal Med, Yilan, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Liu, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.	chiajenliu@gmail.com	Chen, TJ/AAH-8430-2021	Shen, Cheng-Che/0000-0003-1587-5590; Hu, Yu-Wen/0000-0002-7983-415X				Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Aro AR, 2005, PSYCHOL MED, V35, P1515, DOI 10.1017/S0033291705005313; Biesalski HK, 1998, CA-CANCER J CLIN, V48, P167, DOI 10.3322/canjclin.48.3.167; Brenner DR, 2012, AM J EPIDEMIOL, V176, P573, DOI 10.1093/aje/kws151; BRESLOW N, 1977, INT J CANCER, V20, P680, DOI 10.1002/ijc.2910200506; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carter RM, 2001, DEPRESS ANXIETY, V13, P78, DOI 10.1002/da.1020; Chen YH, 2011, J AFFECT DISORDERS, V131, P200, DOI 10.1016/j.jad.2010.12.006; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Cougle JR, 2010, NICOTINE TOB RES, V12, P355, DOI 10.1093/ntr/ntq006; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; Feng JY, 2012, CLIN MICROBIOL INFEC, V18, pE331, DOI 10.1111/j.1469-0691.2012.03931.x; Friedenreich CM, 2010, EUR J CANCER, V46, P2593, DOI 10.1016/j.ejca.2010.07.028; Goldacre MJ, 2007, SOC PSYCH PSYCH EPID, V42, P683, DOI 10.1007/s00127-007-0211-2; Gonzalez AV, 2011, THORAX, V66, P38, DOI 10.1136/thx.2010.141978; Gross AL, 2010, CANCER CAUSE CONTROL, V21, P191, DOI 10.1007/s10552-009-9449-1; Gudmundsson G, 2006, RESP MED, V100, P87, DOI 10.1016/j.rmed.2005.04.003; Hamer M, 2009, J PSYCHOSOM RES, V66, P255, DOI 10.1016/j.jpsychores.2008.11.002; Hankey BF, 1999, JNCI-J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Hidalgo RB, 2012, HAND CLINIC, V106, P343, DOI 10.1016/B978-0-444-52002-9.00019-X; Hornstein Cecilia, 2004, Vertex, V15 Suppl 1, P21; Hsueh PR, 2006, J INFECTION, V52, P77, DOI 10.1016/j.jinf.2005.08.008; Jaeckle KA, 1996, PARANEOPLASTIC NEURO, P361; Kao CH, 2012, J CLIN PSYCHIAT, V73, P1264, DOI [10.4088/JCP.11m07333, 10.4088/JCP.12lr07984a]; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; Kayano H, 2012, CIRC J, V76, P1670, DOI 10.1253/circj.CJ-11-1085; Kayser MS, 2010, AM J PSYCHIAT, V167, P1039, DOI 10.1176/appi.ajp.2010.09101547; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kruk J, 2004, CANCER DETECT PREV, V28, P399, DOI 10.1016/j.cdp.2004.07.009; Liang JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036370; Lichtermann D, 2001, ARCH GEN PSYCHIAT, V58, P573, DOI 10.1001/archpsyc.58.6.573; Lillberg K, 2003, AM J EPIDEMIOL, V157, P415, DOI 10.1093/aje/kwg002; Lin HP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-55; Lykouras L, 2011, Psychiatriki, V22, P307; Martin RM, 2010, CANCER CAUSE CONTROL, V21, P463, DOI 10.1007/s10552-009-9477-x; MASSION AO, 1993, AM J PSYCHIAT, V150, P600; Moussas Georgios, 2008, Ann Gen Psychiatry, V7, P7, DOI 10.1186/1744-859X-7-7; Nielsen NR, 2006, NAT CLIN PRACT ONCOL, V3, P612, DOI 10.1038/ncponc0652; Ou SM, 2013, NEUROEPIDEMIOLOGY, V40, P42, DOI 10.1159/000341411; Reiche EMV, 2006, INT REV PSYCHIATR, V17, P515, DOI 10.1080/02646830500382102; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Rovira J, 2012, COMMUNITY MENT HLT J, V48, P372, DOI 10.1007/s10597-012-9503-4; Sabourin Brigitte C., 2011, Cognitive Behaviour Therapy, V40, P206, DOI 10.1080/16506073.2011.573572; Schraub S, 2009, REV EPIDEMIOL SANTE, V57, P113, DOI 10.1016/j.respe.2008.12.012; Schwarz S, 2007, MED KLIN, V102, P967, DOI 10.1007/s00063-007-1128-y; Sephton S, 2003, BRAIN BEHAV IMMUN, V17, P321, DOI 10.1016/S0889-1591(03)00078-3; Shikata K, 2012, CANC SCI; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Tseng CH, 2012, EXP DIABETES RES, DOI 10.1155/2012/101802; Wittchen HU, 2000, INT CLIN PSYCHOPHARM, V15, P319, DOI 10.1097/00004850-200015060-00002; Wittchen HU, 2002, DEPRESS ANXIETY, V16, P162, DOI 10.1002/da.10065; Yang EV, 2003, BRAIN BEHAV IMMUN, V17, pS37	53	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57399	10.1371/journal.pone.0057399	http://dx.doi.org/10.1371/journal.pone.0057399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460851	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000105
J	Sanchez, S; Dupret, V; Tafforeau, P; Trinajstic, KM; Ryll, B; Gouttenoire, PJ; Wretman, L; Zylberberg, L; Peyrin, F; Ahlberg, PE				Sanchez, Sophie; Dupret, Vincent; Tafforeau, Paul; Trinajstic, Katherine M.; Ryll, Bettina; Gouttenoire, Pierre-Jean; Wretman, Lovisa; Zylberberg, Louise; Peyrin, Francoise; Ahlberg, Per E.			3D Microstructural Architecture of Muscle Attachments in Extant and Fossil Vertebrates Revealed by Synchrotron Microtomography	PLOS ONE			English	Article							LIGAMENT INSERTION; JAWED VERTEBRATES; WESTERN-AUSTRALIA; PHASE TOMOGRAPHY; TENDON ENTHESES; BONE; EVOLUTION; HISTOLOGY; PALEOHISTOLOGY; TETRAPODS	Background: Firm attachments binding muscles to skeleton are crucial mechanical components of the vertebrate body. These attachments (entheses) are complex three-dimensional structures, containing distinctive arrangements of cells and fibre systems embedded in the bone, which can be modified during ontogeny. Until recently it has only been possible to obtain 2D surface and thin section images of entheses, leaving their 3D histology largely unstudied except by extrapolation from 2D data. Entheses are frequently preserved in fossil bones, but sectioning is inappropriate for rare or unique fossil material. Methodology/Principal Findings: Here we present the first non-destructive 3D investigation, by propagation phase contrast synchrotron microtomography (PPC-SR mu CT), of enthesis histology in extant and fossil vertebrates. We are able to identify entheses in the humerus of the salamander Desmognathus from the organization of bone-cell lacunae and extrinsic fibres. Statistical analysis of the lacunae differentiates types of attachments, and the orientation of the fibres, reflect the approximate alignment of the muscle. Similar histological structures, including ontogenetically related pattern changes, are perfectly preserved in two 380 million year old fossil vertebrates, the placoderm Compagopiscis croucheri and the sarcopterygian fish Eusthenopteron foordi. Conclusions/Significance: We are able to determine the position of entheses in fossil vertebrates, the approximate orientation of the attached muscles, and aspects of their ontogenetic histories, from PPC-SRmCT data. Sub-micron microtomography thus provides a powerful tool for studying the structure, development, evolution and palaeobiology of muscle attachments.	[Sanchez, Sophie; Tafforeau, Paul; Gouttenoire, Pierre-Jean; Peyrin, Francoise] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Sanchez, Sophie; Dupret, Vincent; Ryll, Bettina; Wretman, Lovisa; Ahlberg, Per E.] Uppsala Univ, Dept Organismal Biol, Uppsala, Sweden; [Trinajstic, Katherine M.] Curtin Univ Technol, Dept Chem, Perth, WA, Australia; [Trinajstic, Katherine M.] Western Australian Museum, Dept Earth & Planetary Sci, Perth, WA 6000, Australia; [Zylberberg, Louise] Univ Paris 06, UMR 7193, CNRS, Inst Sci Terre Paris, Paris, France; [Gouttenoire, Pierre-Jean; Peyrin, Francoise] Univ Lyon, INSERM, CNRS, UMR 5220,U1044, Lyon, France	European Synchrotron Radiation Facility (ESRF); Uppsala University; Curtin University; Western Australian Museum; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Ahlberg, PE (corresponding author), Uppsala Univ, Dept Organismal Biol, Uppsala, Sweden.	per.ahlberg@ebc.uu.se	Peyrin, Francoise/G-2823-2013; Ahlberg, Per/E-8086-2013; Sanchez, Sophie/AAE-1168-2022; Dupret, Vincent/L-2306-2015	Peyrin, Francoise/0000-0002-1988-3435; Sanchez, Sophie/0000-0002-3611-6836; Tafforeau, Paul/0000-0002-5962-1683; Ahlberg, Per/0000-0001-9054-2900; Dupret, Vincent/0000-0002-6859-1041; Trinajstic, Kate/0000-0002-6519-6396	European Synchrotron Radiation Facility (ESRF) in Grenoble, France [EC203, EC519]; ESRF; ERC [233111]; Wallenberg Scholarship from Knut och Alice Wallenbergs Stiftelse; Uppsala University; ARC QEII Fellowship;  [DP110101127]	European Synchrotron Radiation Facility (ESRF) in Grenoble, France; ESRF; ERC(European Research Council (ERC)European Commission); Wallenberg Scholarship from Knut och Alice Wallenbergs Stiftelse; Uppsala University; ARC QEII Fellowship(Australian Research Council); 	All scans were performed at the European Synchrotron Radiation Facility (ESRF) in Grenoble	Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Benjamin M, 2006, J ANAT, V208, P471, DOI 10.1111/j.1469-7580.2006.00540.x; Benjamin M, 2002, COMP BIOCHEM PHYS A, V133, P931, DOI 10.1016/S1095-6433(02)00138-1; Boyde A., 1972, BIOCH PHYSL BONE, V1, P259; Bromage TG, 2003, SCI TECHNOLOGY ED MI, P742; Bruce RC, 2002, HERPETOLOGICA, V58, P181, DOI 10.1655/0018-0831(2002)058[0181:SAOVIA]2.0.CO;2; Carr RK, 2009, J MORPHOL, V270, P775, DOI 10.1002/jmor.10719; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; COOPER RR, 1970, J BONE JOINT SURG AM, VA 52, P1; De Ricqles AJ, 2003, J VERTEBR PALEONTOL, V23, P373, DOI 10.1671/0272-4634(2003)023[0373:OOCSTA]2.0.CO;2; Diogo R, 2009, J ANAT, V214, P694, DOI 10.1111/j.1469-7580.2009.01067.x; Doschak M. R., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P35; Gabe M., 1968, TECHNIQUES HISTOLOGI; GARDINER BG, 1994, ZOOL J LINN SOC-LOND, V112, P443, DOI 10.1006/zjls.1994.1053; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; Graham A, 1996, MOL CELL NEUROSCI, V8, P76, DOI 10.1006/mcne.1996.0046; Hems T, 2000, ANAT EMBRYOL, V202, P201, DOI 10.1007/s004290000107; Hieronymus TL, 2006, J MORPHOL, V267, P954, DOI 10.1002/jmor.10450; HUGHES DR, 1994, ANAT EMBRYOL, V190, P163; Jarvik E., 1980, BASIC STRUCTURE EVOL; Johanson Z, 2003, J VERTEBR PALEONTOL, V23, P735, DOI 10.1671/2; JONES SJ, 1974, CELL TISSUE RES, V148, P83; Kawamoto T, 1992, Kokubyo Gakkai Zasshi, V59, P351; Langer M, 2008, MED PHYS, V35, P4556, DOI 10.1118/1.2975224; Long JA, 2010, ANNU REV EARTH PL SC, V38, P255, DOI 10.1146/annurev-earth-040809-152416; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; MATYAS JR, 1990, J ORTHOP RES, V8, P412, DOI 10.1002/jor.1100080313; Millot J., 1958, ANATOMIE LATIMERIA C; MOTTA PJ, 1995, J MORPHOL, V226, P309, DOI 10.1002/jmor.1052260307; Organ CL, 2011, J EVOLUTION BIOL, V24, P372, DOI 10.1111/j.1420-9101.2010.02176.x; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Renous S, 1986, ANATOMIE PHYSL COMP, P225; Sanchez S, 2008, BIOL LETTERS, V4, P411, DOI 10.1098/rsbl.2008.0159; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; Soda Y, 2003, ACTA ORTHOP SCAND, V74, P322, DOI 10.1080/00016470310014256; Staszyk C, 2001, EUR J MORPHOL, V39, P319, DOI 10.1076/ejom.39.5.319.7382; Suzuki D, 2002, ANN ANAT, V184, P363, DOI 10.1016/S0940-9602(02)80057-7; Tafforeau P, 2008, J HUM EVOL, V54, P272, DOI 10.1016/j.jhevol.2007.09.018; Walthall JC, 2006, ANAT REC PART A, V288A, P46, DOI 10.1002/ar.a.20279; Wilga CD, 2000, BIOL J LINN SOC, V71, P165; Witzmann Florian, 2009, Palaeodiversity, P233	42	52	54	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56992	10.1371/journal.pone.0056992	http://dx.doi.org/10.1371/journal.pone.0056992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468901	Green Published, gold			2022-12-27	WOS:000315561400020
J	Szasz, AM; Li, QY; Eklund, AC; Sztupinszki, Z; Rowan, A; Tokes, AM; Szekely, B; Kiss, A; Szendroi, M; Gyorffy, B; Szallasi, Z; Swanton, C; Kulka, J				Szasz, Attila Marcell; Li, Qiyuan; Eklund, Aron C.; Sztupinszki, Zsofia; Rowan, Andrew; Tokes, Anna-Maria; Szekely, Borbala; Kiss, Andras; Szendroi, Miklos; Gyorffy, Balazs; Szallasi, Zoltan; Swanton, Charles; Kulka, Janina			The CIN4 Chromosomal Instability qPCR Classifier Defines Tumor Aneuploidy and Stratifies Outcome in Grade 2 Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; HISTOLOGIC GRADE; GENOMIC GRADE; SURVIVAL; PROGNOSIS; SIGNATURE; DIAGNOSIS; SUBTYPES; LEVEL; INDEX	Purpose: Quantifying chromosomal instability (CIN) has both prognostic and predictive clinical utility in breast cancer. In order to establish a robust and clinically applicable gene expression-based measure of CIN, we assessed the ability of four qPCR quantified genes selected from the 70-gene Chromosomal Instability (CIN70) expression signature to stratify outcome in patients with grade 2 breast cancer. Methods: AURKA, FOXM1, TOP2A and TPX2 (CIN4), were selected from the CIN70 signature due to their high level of correlation with histological grade and mean CIN70 signature expression in silico. We assessed the ability of CIN4 to stratify outcome in an independent cohort of patients diagnosed between 1999 and 2002. 185 formalin-fixed, paraffin-embedded (FFPE) samples were included in the qPCR measurement of CIN4 expression. In parallel, ploidy status of tumors was assessed by flow cytometry. We investigated whether the categorical CIN4 score derived from the CIN4 signature was correlated with recurrence-free survival (RFS) and ploidy status in this cohort. Results: We observed a significant association of tumor proliferation, defined by Ki67 and mitotic index (MI), with both CIN4 expression and aneuploidy. The CIN4 score stratified grade 2 carcinomas into good and poor prognostic cohorts (mean RFS: 83.8+/-4.9 and 69.4+/-8.2 months, respectively, p = 0.016) and its predictive power was confirmed by multivariate analysis outperforming MI and Ki67 expression. Conclusions: The first clinically applicable qPCR derived measure of tumor aneuploidy from FFPE tissue, stratifies grade 2 tumors into good and poor prognosis groups.	[Szasz, Attila Marcell; Tokes, Anna-Maria; Szekely, Borbala; Kiss, Andras; Kulka, Janina] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Li, Qiyuan; Eklund, Aron C.; Szallasi, Zoltan] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Sztupinszki, Zsofia; Gyorffy, Balazs] Semmelweis Univ, Dept Pediat 1, Hungarian Acad Sci, Res Lab Pediat & Nephrol, H-1085 Budapest, Hungary; [Rowan, Andrew; Swanton, Charles] Canc Res UK, London Res Inst, Translat Canc Therapeut Lab, London, England; [Tokes, Anna-Maria] Semmelweis Univ, Hungarian Acad Sci, MTA SE Tumour Progress Res Grp, Dept Pathol 2, H-1085 Budapest, Hungary; [Szendroi, Miklos] Semmelweis Univ, Dept Orthopaed, H-1085 Budapest, Hungary; [Szallasi, Zoltan] Harvard Univ, Sch Med, Informat Program, Childrens Hosp Boston, Boston, MA USA; [Swanton, Charles] UCL, Inst Canc, London, England; [Kulka, Janina] Buda MAV Hosp, Dept Pathol, Budapest, Hungary	Semmelweis University; Technical University of Denmark; Hungarian Academy of Sciences; Semmelweis University; Cancer Research UK; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Harvard University; Boston Children's Hospital; Harvard Medical School; University of London; University College London	Szallasi, Z (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	zszallasi@chip.org; Charles.Swanton@cancer.org.uk; kj@korb2.sote.hu	Kiss, András/K-5649-2017; Kulka, Janina/K-5703-2017; Gyorffy, Balazs/AAA-9135-2021; Tokes, Anna-Maria/S-5713-2017	Kiss, András/0000-0002-7453-3163; Kulka, Janina/0000-0003-1530-6646; Gyorffy, Balazs/0000-0002-5772-3766; Sztupinszki, Zsofia/0000-0002-8691-4086; Szallasi, Zoltan/0000-0001-5395-7509; Swanton, Charles/0000-0002-4299-3018; Eklund, Aron Charles/0000-0003-0861-1001; Tokes, Anna-Maria/0000-0002-9581-7536; Szasz, Attila Marcell/0000-0003-2739-4196; Kulka, Janina/0000-0001-8884-8337	Legacy of Szollos Andras Peterne; Egeszsegugyi Tudomanyos Tanacs [(ETT)-029/2009, ETT-088/2009]; Tarsadalmi Megujulas Operativ Program [(TaMOP)-4.2.1.B-09/1/KMR2010-0001, TaMOP-4.2.2/B-10/1-2010-0013]; Medical Research Council [G0701935] Funding Source: researchfish; MRC [G0701935] Funding Source: UKRI	Legacy of Szollos Andras Peterne; Egeszsegugyi Tudomanyos Tanacs; Tarsadalmi Megujulas Operativ Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Legacy of Szollos Andras Peterne, Egeszsegugyi Tudomanyos Tanacs (ETT)-029/2009, ETT-088/2009, Tarsadalmi Megujulas Operativ Program(TaMOP)-4.2.1.B-09/1/KMR2010-0001 and the TaMOP-4.2.2/B-10/1-2010-0013 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhoum SF, 2011, CLIN CANCER RES, V17, P7704, DOI 10.1158/1078-0432.CCR-11-2049; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chassevent A, 2001, CLIN CANCER RES, V7, P909; Colleoni M, 2004, ANN ONCOL, V15, P1633, DOI 10.1093/annonc/mdh434; Dalton LW, 2000, MODERN PATHOL, V13, P730, DOI 10.1038/modpathol.3880126; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Ellsworth RE, 2008, BREAST CANCER RES TR, V107, P259, DOI 10.1007/s10549-007-9547-2; Fiegler H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1030; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Habermann JK, 2009, INT J CANCER, V124, P1552, DOI 10.1002/ijc.24017; Heselmeyer-Haddad K, 2002, CANCER RES, V62, P2365; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Ma XJ, 2008, CLIN CANCER RES, V14, P2601, DOI 10.1158/1078-0432.CCR-07-5026; McClelland SE, 2009, CELL CYCLE, V8, P3262, DOI 10.4161/cc.8.20.9690; Nakamura H, 2003, CLIN CANCER RES, V9, P2294; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Toussaint J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-424; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967	31	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56707	10.1371/journal.pone.0056707	http://dx.doi.org/10.1371/journal.pone.0056707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468873	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000315561400014
J	March, C; Cano, V; Moranta, D; Llobet, E; Perez-Gutierrez, C; Tomas, JM; Suarez, T; Garmendia, J; Bengoechea, JA				March, Catalina; Cano, Victoria; Moranta, David; Llobet, Enrique; Perez-Gutierrez, Camino; Tomas, Juan M.; Suarez, Teresa; Garmendia, Junkal; Bengoechea, Jose A.			Role of Bacterial Surface Structures on the Interaction of Klebsiella pneumoniae with Phagocytes	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE RESISTANCE; O SIDE-CHAIN; DICTYOSTELIUM-DISCOIDEUM; CAPSULAR POLYSACCHARIDE; CORE LIPOPOLYSACCHARIDE; ALVEOLAR MACROPHAGES; HOST MODEL; OUTER-CORE; LIPID-A; VIRULENCE	Phagocytosis is a key process of the immune system. The human pathogen Klebsiella pneumoniae is a well known example of a pathogen highly resistant to phagocytosis. A wealth of evidence demonstrates that the capsule polysaccharide (CPS) plays a crucial role in resistance to phagocytosis. The amoeba Dictyostelium discoideum shares with mammalian macrophages the ability to phagocytose and kill bacteria. The fact that K. pneumoniae is ubiquitous in nature and, therefore, should avoid predation by amoebae, poses the question whether K. pneumoniae employs similar means to counteract amoebae and mammalian phagocytes. Here we developed an assay to evaluate K. pneumoniae-D. discoideum interaction. The richness of the growth medium affected the threshold at which the cps mutant was permissive for Dictyostelium and only at lower nutrient concentrations the cps mutant was susceptible to predation by amoebae. Given the critical role of bacterial surface elements on host-pathogen interactions, we explored the possible contribution of the lipopolysaccharide (LPS) and outer membrane proteins (OMPs) to combat phagoyctosis by D. discoideum. We uncover that, in addition to the CPS, the LPS O-polysaccharide and the first core sugar participate in Klebsiella resistance to predation by D. discoideum. K. pneumoniae LPS lipid A decorations are also necessary to avoid predation by amoebae although PagP-dependent palmitoylation plays a more important role than the lipid A modification with aminoarabinose. Mutants lacking OMPs OmpA or OmpK36 were also permissive for D. discoideium growth. Except the LPS O-polysaccharide mutants, all mutants were more susceptible to phagocytosis by mouse alveolar macrophages. Finally, we found a correlation between virulence, using the pneumonia mouse model, and resistance to phagocytosis. Altogether, this work reveals novel K. pneumoniae determinants involved in resistance to phagocytosis and supports the notion that Dictyostelium amoebae might be useful as host model to measure K. pneumoniae virulence and not only phagocytosis.	[March, Catalina; Cano, Victoria; Moranta, David; Llobet, Enrique; Perez-Gutierrez, Camino; Garmendia, Junkal; Bengoechea, Jose A.] Fundacio Invest Sanitaria Illes Balears FISIB, Lab Microbial Pathogenesis, Bunyola, Spain; [March, Catalina; Cano, Victoria; Moranta, David; Llobet, Enrique; Perez-Gutierrez, Camino; Garmendia, Junkal; Bengoechea, Jose A.] Ctr Invest Biomed Red Enfermedades Resp CibeRes, Program Host Pathogen Interact, Bunyola, Spain; [Tomas, Juan M.] Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain; [Suarez, Teresa] Ctr Invest Biol CSIC, Dept Med Celular & Mol, Madrid, Spain; [Garmendia, Junkal] CSIC Univ Publ Navarra Gobierno Navarra, Inst Agrobiotecnol, Mutilva, Spain; [Bengoechea, Jose A.] CSIC, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Consejo Superior de Investigaciones Cientificas (CSIC)	Bengoechea, JA (corresponding author), Fundacio Invest Sanitaria Illes Balears FISIB, Lab Microbial Pathogenesis, Bunyola, Spain.	bengoechea@caubet-cimera.es	Cano, Victoria/GRO-4093-2022; Tomas, Juan M/L-1398-2015; Cano García, Victoria/E-1861-2017; Garmendia, Juncal/G-4360-2011; Suarez, Teresa/M-9126-2016; Mesquida, David Moranta/H-4958-2012	Tomas, Juan M/0000-0002-3575-7113; Cano García, Victoria/0000-0002-2537-4063; Garmendia, Juncal/0000-0002-7440-2737; Suarez, Teresa/0000-0002-4553-3818; Mesquida, David Moranta/0000-0001-9528-4920; Bengoechea, Jose/0000-0002-9677-8751	Ministerio de Economia y Competitividad (Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia); Biomedicine Program [SAF2009-07885]; SEPAR (Sociedad Espanola de Neumologia) [068/2011]; Govern Illes Balears [46/2011]; European Regional Development Fund	Ministerio de Economia y Competitividad (Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)(Generalitat de Catalunya); Biomedicine Program; SEPAR (Sociedad Espanola de Neumologia); Govern Illes Balears; European Regional Development Fund(European Commission)	Part of this work was supported by Ministerio de Economia y Competitividad (Spain) and from Generalitat de Catalunya (Centre de Referencia en Biotecnologia) grants to J.M.T.; by grants from Biomedicine Program (SAF2009-07885; Ministerio de Economia y Competitividad) and SEPAR (Sociedad Espanola de Neumologia, project reference 068/2011) to J.A.B. The laboratory of Microbial Pathogenesis is supported by a grant to Competitive groups (project reference 46/2011) from Govern Illes Balears (co-funded by European Regional Development Fund). CIBERES is an initiative from Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez D, 2000, INFECT IMMUN, V68, P953, DOI 10.1128/IAI.68.2.953-955.2000; APPLEYARD RK, 1954, GENETICS, V39, P440; BAGLEY ST, 1985, INFECT CONT HOSP EP, V6, P52, DOI 10.1017/S0195941700062603; Benghezal M, 2006, CELL MICROBIOL, V8, P139, DOI 10.1111/j.1462-5822.2005.00607.x; Bozzaro S, 2008, INT REV CEL MOL BIO, V271, P253, DOI 10.1016/S1937-6448(08)01206-9; BrougHolub E, 1997, INFECT IMMUN, V65, P1139, DOI 10.1128/IAI.65.4.1139-1146.1997; CAMPRUBI S, 1993, FEMS MICROBIOL LETT, V111, P9; Cardelli J, 2001, TRAFFIC, V2, P311, DOI 10.1034/j.1600-0854.2001.002005311.x; Cheung DOY, 2000, INFECT IMMUN, V68, P4585, DOI 10.1128/IAI.68.8.4585-4592.2000; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; de Astorza B, 2004, INFECT IMMUN, V72, P1767, DOI 10.1128/IAI.72.3.1767-1774.2004; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Evrard B, 2010, INFECT IMMUN, V78, P210, DOI 10.1128/IAI.00864-09; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Fresno S, 2006, MICROBIOL-SGM, V152, P1807, DOI 10.1099/mic.0.28611-0; Froquet R, 2007, APPL ENVIRON MICROB, V73, P5657, DOI 10.1128/AEM.00908-07; Froquet R, 2009, NAT PROTOC, V4, P25, DOI 10.1038/nprot.2008.212; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; Hernandez-Alles S, 1999, MICROBIOL-UK, V145, P673, DOI 10.1099/13500872-145-3-673; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Hsieh PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033155; Izquierdo L, 2003, J BACTERIOL, V185, P7213, DOI 10.1128/JB.185.24.7213-7221.2003; KABHA K, 1995, INFECT IMMUN, V63, P847, DOI 10.1128/IAI.63.3.847-852.1995; Lawlor MS, 2005, MOL MICROBIOL, V58, P1054, DOI 10.1111/j.1365-2958.2005.04918.x; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Lelong E, 2011, CELL MICROBIOL, V13, P246, DOI 10.1111/j.1462-5822.2010.01532.x; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Llobet E, 2011, INFECT IMMUN, V79, P3718, DOI 10.1128/IAI.05226-11; Llobet E, 2009, ANTIMICROB AGENTS CH, V53, P298, DOI 10.1128/AAC.00657-08; Lugo JZ, 2007, SHOCK, V27, P186, DOI 10.1097/01.shk.0000238058.23837.21; March C, 2011, J BIOL CHEM, V286, P9956, DOI 10.1074/jbc.M110.181008; Marolda Cristina L., 2006, V347, P237; Marti-Lliteras P, 2009, INFECT IMMUN; Moranta D, 2010, INFECT IMMUN, V78, P1135, DOI 10.1128/IAI.00940-09; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Pan YJ, 2011, INFECT IMMUN, V79, P997, DOI 10.1128/IAI.00906-10; Perez-Gutierrez C, 2010, INFECT IMMUN, V78, P2768, DOI 10.1128/IAI.01417-09; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Ravanel K, 2001, EUR J CELL BIOL, V80, P754, DOI 10.1078/0171-9335-00215; Regue M, 2005, J BACTERIOL, V187, P4198, DOI 10.1128/JB.187.12.4198-4206.2005; Regue M, 2001, J BACTERIOL, V183, P3564, DOI 10.1128/JB.183.12.3564-3573.2001; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Robey M, 2001, INFECT IMMUN, V69, P4276, DOI 10.1128/IAI.69.7.4276-4286.2001; Sahly H, 1997, CLIN DIAGN LAB IMMUN, V4, P393, DOI 10.1128/CDLI.4.4.393-399.1997; Shankar-Sinha S, 2004, INFECT IMMUN, V72, P1423, DOI 10.1128/IAI.72.3.1423-1430.2004; Skurnik M, 1999, MOL MICROBIOL, V31, P1443, DOI 10.1046/j.1365-2958.1999.01285.x; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Struve C, 2004, ENVIRON MICROBIOL, V6, P584, DOI 10.1111/j.1462-2920.2004.00590.x; SUSSMAN R, 1967, BIOCHEM BIOPH RES CO, V29, P53, DOI 10.1016/0006-291X(67)90539-6; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007	63	85	87	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56847	10.1371/journal.pone.0056847	http://dx.doi.org/10.1371/journal.pone.0056847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457627	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700088
J	Song, XC; Sturgis, EM; Liu, J; Jin, L; Wang, ZQ; Zhang, CY; Wei, QY; Li, GJ				Song, Xicheng; Sturgis, Erich M.; Liu, Jun; Jin, Lei; Wang, Zhongqiu; Zhang, Caiyun; Wei, Qingyi; Li, Guojun			MicroRNA Variants Increase the Risk of HPV-Associated Squamous Cell Carcinoma of the Oropharynx in Never Smokers	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; NECK-CANCER; ORAL-CANCER; EXPRESSION PROFILES; ANIMAL DEVELOPMENT; GENETIC-VARIANTS; UNITED-STATES; HEAD; PROGNOSIS; TRENDS	Background: Both microRNAs and human papillomavirus (HPV) infection play an important role in the development and progression of oral squamous cell carcinoma (OSCC). In addition, microRNAs affect all facets of the immune/inflammation responses to infection, which may control HPV clearance. We thus hypothesized that microRNA polymorphisms modify the association between HPV16 seropositivity and OSCC risk. Methods: Four single-nucleotide polymorphisms in microRNAs were genotyped and HPV16 serology was determined in 325 cases and 335 matched controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using univariate and multivariable logistic regression models. Results: Overall, each polymorphism had no significant main effect on OSCC risk. Compared with the risk among individuals with both miR146 rs2910164 GG genotype and HPV16 seronegativity, risk of OSCC was increased among those with CG or CC genotype and HPV16 seronegativity (OR, 1.2; 95% CI, 0.9-1.8), GG genotype and HPV16 seropositivity (OR, 3.0; 95% CI, 1.8-5.0), and CG or CC genotype and HPV16 seropositivity (OR, 4.7; 95% CI, 2.3-9.4). Similar results were found for miR149 rs2292832, miR196 rs11614913, and miR499 rs3746444. Analyses stratified by tumor sites and smoking status showed that each polymorphism significantly increased the risk of HPV16-associated squamous cell carcinoma of the oropharynx (SCCOP), and such effect modification was particularly prominent in never smokers. Conclusions: Our results indicate that microRNA polymorphisms modify the risk of OSCC associated with HPV16 seropositivity, particularly in patients with SCCOP and never smokers. Larger studies are needed to verify our findings.	[Song, Xicheng; Sturgis, Erich M.; Liu, Jun; Jin, Lei; Wang, Zhongqiu; Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Song, Xicheng] Qingdao Univ, Yuhuangding Hosp, Dept Otorhinolaryngol & Head & Neck Surg, Yantai, Peoples R China; [Sturgis, Erich M.; Wei, Qingyi; Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Liu, Jun] Sichuan Univ, Dept Otolaryngol Head & Neck Surg, West China Hosp, Chengdu 610064, Peoples R China; [Jin, Lei] Southern Med Univ, Sch Med, Jinling Hosp, Dept Stomatol, Nanjing, Jiangsu, Peoples R China; [Wang, Zhongqiu] Tongji Univ, East Hosp, Sch Med, Dept Radiol, Shanghai 200092, Peoples R China; [Zhang, Caiyun] Second Mil Med Univ, Changhai Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Qingdao University; University of Texas System; UTMD Anderson Cancer Center; Sichuan University; Southern Medical University - China; Tongji University; Naval Medical University	Li, GJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA.	gli@mdanderson.org			National Institute of Environmental Health Sciences [R01 ES-11740]; National Institutes of Health (NIH) [P-30 CA 16672]; NIH [CA 135679, CA133099]; NATIONAL CANCER INSTITUTE [R03CA135679, K07CA133099, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences Grant R01 ES-11740 (to Q. W.); National Institutes of Health (NIH) Grant P-30 CA 16672 (to the University of Texas M. D. Anderson Cancer Center); and NIH grants CA 135679 (to G. L.) and CA133099 (to G. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Carvalho AL, 2005, INT J CANCER, V114, P806, DOI 10.1002/ijc.20740; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chen XM, 2010, CANCER RES, V70, P7199, DOI 10.1158/0008-5472.CAN-09-4733; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Dahlstrom KR, 2003, CLIN CANCER RES, V9, P2620; Ernster JA, 2007, LARYNGOSCOPE, V117, P2115, DOI 10.1097/MLG.0b013e31813e5fbb; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fakhry C, 2006, J CLIN ONCOL, V24, P2606, DOI 10.1200/JCO.2006.06.1291; Gillison ML, 2007, HEAD NECK-J SCI SPEC, V29, P779, DOI 10.1002/hed.20573; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo Y, 2012, ONCOL REP, V27, P1097, DOI 10.3892/or.2011.1571; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; KIRNBAUER R, 1994, JNCI-J NATL CANCER I, V86, P494, DOI 10.1093/jnci/86.7.494; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Pedersen I, 2008, CYTOKINE, V43, P391, DOI 10.1016/j.cyto.2008.07.016; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	42	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56622	10.1371/journal.pone.0056622	http://dx.doi.org/10.1371/journal.pone.0056622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457596	Green Submitted, gold, Green Published			2022-12-27	WOS:000315603700069
J	Fields, J; Cisneros, IE; Borgmann, K; Ghorpade, A				Fields, Jerel; Cisneros, Irma E.; Borgmann, Kathleen; Ghorpade, Anuja			Extracellular Regulated Kinase 1/2 Signaling Is a Critical Regulator of Interleukin-1 beta-Mediated Astrocyte Tissue Inhibitor of Metalloproteinase-1 Expression	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MATRIX-METALLOPROTEINASE; DOWN-REGULATION; TUMOR-GROWTH; TGF-BETA; TIMP-1; BRAIN; GENE; PHOSPHORYLATION; CONTRIBUTES	Astrocytes are essential for proper central nervous system (CNS) function and are intricately involved in neuroinflammation. Despite evidence that immune-activated astrocytes contribute to many CNS pathologies, little is known about the inflammatory pathways controlling gene expression. Our laboratory identified altered levels of tissue inhibitor of metalloproteinase (TIMP)-1 in brain lysates from human immunodeficiency virus (HIV)-1 infected patients, compared to age-matched controls, and interleukin (IL)-1 beta as a key regulator of astrocyte TIMP-1. Additionally, CCAAT enhancer binding protein (C/EBP)beta levels are elevated in brain specimens from HIV-1 patients and the transcription factor contributes to astrocyte TIMP-1 expression. In this report we sought to identify key signaling pathways necessary for IL-1 beta-mediated astrocyte TIMP-1 expression and their interaction with C/EBP beta. Primary human astrocytes were cultured and treated with mitogen activated protein kinase-selective small molecule inhibitors, and IL-1 beta. TIMP-1 and C/EBP beta mRNA and protein expression were evaluated at 12 and 24 h post-treatment, respectively. TIMP-1 promoter-driven luciferase plasmids were used to evaluate TIMP-1 promoter activity in inhibitor-treated astrocytes. These data show that extracellular regulated kinase (ERK) 1/2-selective inhibitors block IL-1 beta-induced astrocyte TIMP-1 expression, but did not decrease C/EBP beta expression in parallel. The p38 kinase (p38K) inhibitors partially blocked both IL-1 beta-induced astrocyte TIMP-1 expression and C/EBP beta expression. The ERK1/2-selective inhibitor abrogated IL-1 beta-mediated increases in TIMP-1 promoter activity. Our data demonstrate that ERK1/2 activation is critical for IL-1 beta-mediated astrocyte TIMP-1 expression. ERK1/2-selective inhibition may elicit a compensatory response in the form of enhanced IL-1 beta-mediated astrocyte C/EBP beta expression, or, alternatively, ERK1/2 signaling may function to moderate IL-1 beta-mediated astrocyte C/EBP beta expression. Furthermore, p38K activation contributes to IL-1 beta-induced astrocyte TIMP-1 and C/EBP beta expression. These data suggest that ERK1/2 signals downstream of C/EBP beta to facilitate IL-1 beta-induced astrocyte TIMP-1 expression. Astrocyte ERK1/2 and p38K signaling may serve as therapeutic targets for manipulating CNS TIMP-1 and C/EBP beta levels, respectively.	[Fields, Jerel; Cisneros, Irma E.; Borgmann, Kathleen; Ghorpade, Anuja] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center	Ghorpade, A (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA.	anuja.ghorpade@unthsc.edu	Borgmann, Kathleen/ABU-3329-2022	Borgmann, Kathleen/0000-0003-0897-390X	National Institute of Neurological Disorders and Stroke (NINDS) [2R01NS048837]; National Institute on Aging (NIA) [T32 AG020494, 1F31NS072006-01A1]; National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [5R24HD0008836]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048837, F31NS072006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020494] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by 2R01NS048837 from National Institute of Neurological Disorders and Stroke (NINDS) to A. Ghorpade; a fellowship from National Institute on Aging (NIA) T32 AG020494 and 1F31NS072006-01A1 to J. Fields. The authors appreciate the assistance of the Laboratory of Developmental Biology for providing them with human brain tissues; also supported by National Institutes of Health award number 5R24HD0008836 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 1999, CAN J PHYSIOL PHARM, V77, P699, DOI 10.1139/cjpp-77-9-699; ARTHUR FE, 1987, DEV BRAIN RES, V36, P155, DOI 10.1016/0165-3806(87)90075-7; Aschner M, 1998, TOXICOL LETT, V103, P283, DOI 10.1016/S0378-4274(98)00324-5; Ashutosh, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.54; Barter MJ, 2010, MATRIX BIOL, V29, P602, DOI 10.1016/j.matbio.2010.05.002; Bloomston M, 2002, J SURG RES, V102, P39, DOI 10.1006/jsre.2001.6318; BLUMBERG BM, 1994, VIRUS RES, V32, P253, DOI 10.1016/0168-1702(94)90044-2; Boisse L, 2008, NEUROL CLIN, V26, P799, DOI 10.1016/j.ncl.2008.04.002; Bugno M, 1999, FEBS LETT, V448, P9, DOI 10.1016/S0014-5793(99)00323-3; Chen XM, 2002, KIDNEY INT, V61, P1377, DOI 10.1046/j.1523-1755.2002.00283.x; Ferrari CC, 2006, NEUROBIOL DIS, V24, P183, DOI 10.1016/j.nbd.2006.06.013; Clark IM, 1997, BIOCHEM J, V324, P611, DOI 10.1042/bj3240611; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dhar A, 2006, J NEUROSCI RES, V83, P1271, DOI 10.1002/jnr.20787; Dou H, 2006, GLIA; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016/S0002-9440(10)63438-4; Fields J, 2011, J NEUROCHEM, V118, P93, DOI 10.1111/j.1471-4159.2011.07203.x; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Fu ZY, 2011, BIOMED PHARMACOTHER, V65, P163, DOI 10.1016/j.biopha.2011.02.004; Gardner J, 2003, J NEUROSCI RES, V74, P801, DOI 10.1002/jnr.10835; Gardner J, 2006, J NEUROSCI RES, V83, P1281, DOI 10.1002/jnr.20823; Hall MC, 2003, J BIOL CHEM, V278, P10304, DOI 10.1074/jbc.M212334200; Hornebeck W, 2003, PATHOL BIOL, V51, P569, DOI 10.1016/j.patbio.2003.09.003; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Ikenaka Y, 2003, INT J CANCER, V105, P340, DOI 10.1002/ijc.11094; Itoh Y, 1998, J BIOL CHEM, V273, P24360, DOI 10.1074/jbc.273.38.24360; Jaworski DM, 2000, GLIA, V30, P199, DOI 10.1002/(SICI)1098-1136(200004)30:2<199::AID-GLIA9>3.0.CO;2-#; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kettlun AM, 2003, LIFE SCI, V72, P2863, DOI 10.1016/S0024-3205(03)00146-2; Lambert E, 2003, BIOCHEM J, V372, P767, DOI 10.1042/BJ20030187; Li FX, 2009, ENDOCRINOLOGY, V150, P3903, DOI 10.1210/en.2008-1141; Li RY, 2011, J NEUROCHEM, V118, P354, DOI 10.1111/j.1471-4159.2011.07317.x; Lorenzl S, 2002, EXP NEUROL, V178, P13, DOI 10.1006/exnr.2002.8019; Magnoni S, 2007, GENE THER, V14, P621, DOI 10.1038/sj.gt.3302894; MANTHORPE M, 1986, DEV BRAIN RES, V25, P191, DOI 10.1016/0165-3806(86)90208-7; Neary JT, 2004, NEUROCHEM RES, V29, P2037, DOI 10.1007/s11064-004-6876-y; Ould-yahoui A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008289; Pagenstecher A, 1998, AM J PATHOL, V152, P729; Rivera S, 1997, J NEUROSCI, V17, P4223; Rossi JL, 2011, J NEUROSCI RES, V89, P852, DOI 10.1002/jnr.22600; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Suryadevara R, 2003, GLIA, V44, P47, DOI 10.1002/glia.10266; Tong L, 2004, CELL SIGNAL, V16, P1123, DOI 10.1016/j.cellsig.2004.03.003; Wilczynska KM, 2006, J BIOL CHEM, V281, P34955, DOI 10.1074/jbc.M604616200; Young DA, 2005, FEBS J, V272, P1912, DOI 10.1111/j.1742-4658.2005.04622.x	50	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56891	10.1371/journal.pone.0056891	http://dx.doi.org/10.1371/journal.pone.0056891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457635	gold, Green Published, Green Submitted			2022-12-27	WOS:000315602700100
J	Mohiyeddini, C; Bauer, S; Semple, S				Mohiyeddini, Changiz; Bauer, Stephanie; Semple, Stuart			Displacement Behaviour Is Associated with Reduced Stress Levels among Men but Not Women	PLOS ONE			English	Article							EMOTION REGULATION STRATEGIES; GENDER-DIFFERENCES; SELF-CONSCIOUSNESS; NONVERBAL BEHAVIOR; CARDIOVASCULAR REACTIVITY; IMPRESSION MANAGEMENT; SEX-DIFFERENCES; PSYCHOLOGICAL STRESS; SOCIAL STRESS; AGE	Sex differences in the ability to cope with stress may contribute to the higher prevalence of stress-related disorders among women compared to men. We recently provided evidence that displacement behaviour - activities such as scratching and face touching - represents an important strategy for coping with stressful situations: in a healthy population of men, displacement behaviour during a social stress test attenuated the relationship between anxiety experienced prior to this test, and the subsequent self-reported experience of stress. Here, we extend this work to look at physiological and cognitive (in addition to self-reported) measures of stress, and study both men and women in order to investigate whether sex moderates the link between displacement behaviour and the response to stress. In a healthy study population, we quantified displacement behaviour, heart rate and cognitive performance during the Trier Social Stress Test, and used self-report questionnaires to assess the experience of stress afterwards. Men engaged in displacement behaviour about twice as often as women, and subsequently reported lower levels of stress. Bivariate correlations revealed that for men, higher rates of displacement behaviour were associated with decreased self-reported stress, fewer mistakes in the cognitive task and a trend towards lower heart rate; no relationships between displacement behaviour and stress measures were found for women. Moreover, moderation analyses revealed that high rates of displacement behaviour were associated with lower stress levels in men but not in women, and that high displacement behaviour rates were associated with poorer cognitive performance in women, but not men. These results point to an important sex difference in coping strategies, and highlight new avenues for research into sex biases in stress-related disorders.	[Mohiyeddini, Changiz] Univ Roehampton, Dept Psychol, London, England; [Bauer, Stephanie] Univ Heidelberg Hosp, Ctr Psychotherapy Res, Heidelberg, Germany; [Semple, Stuart] Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England	Roehampton University; Ruprecht Karls University Heidelberg; Roehampton University	Mohiyeddini, C (corresponding author), Univ Roehampton, Dept Psychol, London, England.	c.mohiyeddini@roehampton.ac.uk	Bauer, Stephanie/AAY-4610-2020	Semple, Stuart/0000-0003-0452-8104; Bauer, Stephanie/0000-0001-7508-6521	University of Roehampton	University of Roehampton	The authors thank the University of Roehampton for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Allen MT, 2011, INT J PSYCHOPHYSIOL, V81, P209, DOI 10.1016/j.ijpsycho.2011.06.013; Balanos GM, 2010, BIOL PSYCHOL, V85, P104, DOI 10.1016/j.biopsycho.2010.06.001; Bandura A, 2004, PSYCHOL BULL, V130, P691, DOI 10.1037/0033-2909.130.5.691; Bardi M, 2011, STRESS, V14, P557, DOI 10.3109/10253890.2011.571322; BAUMEISTER RF, 1982, J PERS, V50, P29, DOI 10.1111/j.1467-6494.1982.tb00743.x; BEYER S, 1990, J PERS SOC PSYCHOL, V59, P960, DOI 10.1037//0022-3514.59.5.960; Bolino MC, 2003, J MANAGE, V29, P141, DOI 10.1177/014920630302900202; Bolino MC, 2003, J ORGAN BEHAV, V24, P237, DOI 10.1002/job.185; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Brune M, 2008, J NERV MENT DIS, V196, P282, DOI 10.1097/NMD.0b013e31816a4922; Bussey K, 1999, PSYCHOL REV, V106, P676, DOI 10.1037/0033-295X.106.4.676; CARTER DB, 1982, DEV PSYCHOL, V18, P812, DOI 10.1037/0012-1649.18.6.812; CARVER CS, 1981, J RES PERS, V15, P16, DOI 10.1016/0092-6566(81)90003-9; Chance M. R. A., 1962, Symposia of the Zoological Society of London, VNo. 8, P71; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Davis MC, 1999, ANN BEHAV MED, V21, P83, DOI 10.1007/BF02895038; DEAUX E, 1976, PHYSIOL PSYCHOL, V4, P400; Diehl M, 2010, DEV PSYCHOL, V46, P1132, DOI 10.1037/a0019937; DIENER E, 1976, J RES PERS, V10, P107, DOI 10.1016/0092-6566(76)90088-X; DUNLAP WP, 1987, PSYCHOL BULL, V102, P418, DOI 10.1037/0033-2909.102.3.418; Else-Quest NM, 2006, PSYCHOL BULL, V132, P33, DOI 10.1037/0033-2909.132.1.33; ERDMANN G, 1978, BIOL PSYCHOL, V6, P61, DOI 10.1016/0301-0511(78)90007-8; Evers C, 2011, EMOTION REGULATION AND WELL-BEING, P211, DOI 10.1007/978-1-4419-6953-8_13; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FENIGSTEIN A, 1975, J CONSULT CLIN PSYCH, V43, P522, DOI 10.1037/h0076760; Fivush R., 1993, CHILD VICTIMS CHILD, P1; Fuglestad PT, 2009, HDB INDIVIDUAL DIFFE, P574, DOI DOI 10.1037/0033-2909.126.4.530; Garnefski N, 2004, PERS INDIV DIFFER, V36, P267, DOI 10.1016/S0191-8869(03)00083-7; Georgiades I, 1997, ACCULTURATION GENDER; Gross JJ, 2005, J PERS SOC PSYCHOL, V85, P348; Huflejt-Lukasik M, 2006, STRESS HEALTH, V22, P153, DOI 10.1002/smi.1090; IEDEMA J, 1994, J SOC PSYCHOL, V134, P771, DOI 10.1080/00224545.1994.9923012; Iversen S., 2000, PRINCIPLES NEURAL SC, V4, P982; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; KAMARCK TW, 1994, HEALTH PSYCHOL, V13, P471, DOI 10.1037/0278-6133.13.6.471; KEMPER S, 1984, SEX ROLES, V10, P435, DOI 10.1007/BF00287560; Kennedy DK, 2004, PSYCHOL REC, V54, P373, DOI 10.1007/BF03395480; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; KRANTZ DS, 1984, PSYCHOL BULL, V96, P435, DOI 10.1037/0033-2909.96.3.435; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; LEARY MR, 1994, J PERS SOC PSYCHOL, V67, P664, DOI 10.1037/0022-3514.67.4.664; LEARY MR, 1990, PSYCHOL BULL, V107, P34, DOI 10.1037/0033-2909.107.1.34; Lee SJ, 1999, PERS INDIV DIFFER, V26, P701, DOI 10.1016/S0191-8869(98)00178-0; LIPPA R, 1976, J PERS, V44, P541, DOI 10.1111/j.1467-6494.1976.tb00137.x; Maes M, 1998, CYTOKINE, V10, P313, DOI 10.1006/cyto.1997.0290; Maes M, 1998, PSYCHIAT RES, V80, P201, DOI 10.1016/S0165-1781(98)00059-6; Marcus-Newhall A, 2000, J PERS SOC PSYCHOL, V78, P670, DOI 10.1037/0022-3514.78.4.670; Martin P., 2007, MEASURING BEHAV INTR, V3; Maslow AH, 1937, PSYCHOL REV, V44, P404, DOI 10.1037/h0056714; Mcrae K, 2008, GROUP PROCESS INTERG, V11, P143, DOI 10.1177/1368430207088035; Mian R, 2003, STRESS, V6, P41, DOI 10.1080/1025389031000101349; Mohiyeddini C, STRESS IN PRESS; NISBETT RE, 1966, J EXP SOC PSYCHOL, V2, P227, DOI 10.1016/0022-1031(66)90081-3; Nolen-Hoeksema S, 2011, PERS INDIV DIFFER, V51, P704, DOI 10.1016/j.paid.2011.06.012; Obrist P.A., 1986, BIOL PSYCHOL FACTORS, P406, DOI [10.1007/978-3-642-71234-0_25, DOI 10.1007/978-3-642-71234-0_25]; Pico-Alfonso MA, 2007, PSYCHONEUROENDOCRINO, V32, P451, DOI 10.1016/j.psyneuen.2007.02.009; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Rankin JL, 2004, J RES ADOLESCENCE, V14, P1, DOI 10.1111/j.1532-7795.2004.01401001.x; Reips UD, 2008, BEHAV RES METHODS, V40, P699, DOI 10.3758/BRM.40.3.699; Rohleder N, 2003, PSYCHONEUROENDOCRINO, V28, P261, DOI 10.1016/S0306-4530(02)00019-7; ROSS M, 1989, PSYCHOL REV, V96, P341, DOI 10.1037/0033-295X.96.2.341; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Schlenker BR, 2003, HANDBOOK OF SELF AND IDENTITY, P492; SCHLENKER BR, 1980, J PERS SOC PSYCHOL, V39, P553, DOI 10.1037/0022-3514.39.4.553; Sgoifo A, 2003, NEUROSCI BIOBEHAV R, V27, P179, DOI 10.1016/S0149-7634(03)00019-8; Shih JH, 2010, J SOC CLIN PSYCHOL, V29, P243, DOI 10.1521/jscp.2010.29.3.243; Smith LL, 1998, J PERS SOC PSYCHOL, V75, P1350, DOI 10.1037/0022-3514.75.5.1350; SNYDER M, 1974, J PERS SOC PSYCHOL, V30, P526, DOI 10.1037/h0037039; Snyder M., 1987, PUBLIC APPEARANCES P; SQUIRE LR, 1989, J EXP PSYCHOL LEARN, V15, P241, DOI 10.1037/0278-7393.15.2.241; Stawski RS, 2008, PSYCHOL AGING, V23, P52, DOI 10.1037/0882-7974.23.1.52; Tamres LK, 2002, PERS SOC PSYCHOL REV, V6, P2, DOI 10.1207/S15327957PSPR0601_1; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; THOITS PA, 1995, J HEALTH SOC BEHAV, V36, P72, DOI 10.2307/2137288; Thoits PA, 2010, J HEALTH SOC BEHAV, V51, pS41, DOI 10.1177/0022146510383499; Treiber FA, 2003, PSYCHOSOM MED, V65, P46, DOI 10.1097/00006842-200301000-00007; Troisi A, 2001, PHYSIOL BEHAV, V73, P443, DOI 10.1016/S0031-9384(01)00459-0; Troisi A, 1996, J NERV MENT DIS, V184, P561, DOI 10.1097/00005053-199609000-00008; Troisi A, 2000, J NERV MENT DIS, V188, P13, DOI 10.1097/00005053-200001000-00003; Troisi A, 1999, J PSYCHIAT RES, V33, P243, DOI 10.1016/S0022-3956(98)00064-8; Troisi A, 1999, NEUROSCI BIOBEHAV R, V23, P905, DOI 10.1016/S0149-7634(99)00024-X; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; van Middendorp H, 2005, WOMEN HEALTH, V42, P75, DOI 10.1300/J013v42n01_05; VINGERHOETS AJJM, 1990, PSYCHOL MED, V20, P125, DOI 10.1017/S0033291700013301; von Hippel W, 2005, J PERS SOC PSYCHOL, V89, P22, DOI 10.1037/0022-3514.89.1.22; Wirtz PH, 2006, J CLIN ENDOCR METAB, V91, P3857, DOI 10.1210/jc.2005-2586; Wolf OT, 2001, PSYCHONEUROENDOCRINO, V26, P711, DOI 10.1016/S0306-4530(01)00025-7; Workman JE, 2011, INT J CONSUM STUD, V35, P307, DOI 10.1111/j.1470-6431.2010.00934.x	90	21	21	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56355	10.1371/journal.pone.0056355	http://dx.doi.org/10.1371/journal.pone.0056355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457555	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700070
J	Granlund, AV; Flatberg, A; Ostvik, AE; Drozdov, I; Gustafsson, BI; Kidd, M; Beisvag, V; Torp, SH; Waldum, HL; Martinsen, TC; Damas, JK; Espevik, T; Sandvik, AK				Granlund, Atle van Beelen; Flatberg, Arnar; Ostvik, Ann E.; Drozdov, Ignat; Gustafsson, Bjorn I.; Kidd, Mark; Beisvag, Vidar; Torp, Sverre H.; Waldum, Helge L.; Martinsen, Tom Christian; Damas, Jan Kristian; Espevik, Terje; Sandvik, Arne K.			Whole Genome Gene Expression Meta-Analysis of Inflammatory Bowel Disease Colon Mucosa Demonstrates Lack of Major Differences between Crohn's Disease and Ulcerative Colitis	PLOS ONE			English	Article							ALPHA-DEFENSIN EXPRESSION; ANTIMICROBIAL PEPTIDES; NETWORK ANALYSIS; TH17 CELLS; T-BET; PATHOGENESIS; ACTIVATION; PROFILES; IMMUNITY; DIFFERENTIATION	Background: In inflammatory bowel disease (IBD), genetic susceptibility together with environmental factors disturbs gut homeostasis producing chronic inflammation. The two main IBD subtypes are Ulcerative colitis (UC) and Crohn's disease (CD). We present the to-date largest microarray gene expression study on IBD encompassing both inflamed and un-inflamed colonic tissue. A meta-analysis including all available, comparable data was used to explore important aspects of IBD inflammation, thereby validating consistent gene expression patterns. Methods: Colon pinch biopsies from IBD patients were analysed using Illumina whole genome gene expression technology. Differential expression (DE) was identified using LIMMA linear model in the R statistical computing environment. Results were enriched for gene ontology (GO) categories. Sets of genes encoding antimicrobial proteins (AMP) and proteins involved in T helper (Th) cell differentiation were used in the interpretation of the results. All available data sets were analysed using the same methods, and results were compared on a global and focused level as t-scores. Results: Gene expression in inflamed mucosa from UC and CD are remarkably similar. The meta-analysis confirmed this. The patterns of AMP and Th cell-related gene expression were also very similar, except for IL23A which was consistently higher expressed in UC than in CD. Un-inflamed tissue from patients demonstrated minimal differences from healthy controls. Conclusions: There is no difference in the Th subgroup involvement between UC and CD. Th1/Th17 related expression, with little Th2 differentiation, dominated both diseases. The different IL23A expression between UC and CD suggests an IBD subtype specific role. AMPs, previously little studied, are strongly overexpressed in IBD. The presented meta-analysis provides a sound background for further research on IBD pathobiology.	[Granlund, Atle van Beelen; Flatberg, Arnar; Ostvik, Ann E.; Espevik, Terje; Sandvik, Arne K.] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7034 Trondheim, Norway; [Granlund, Atle van Beelen; Ostvik, Ann E.; Gustafsson, Bjorn I.; Beisvag, Vidar; Waldum, Helge L.; Martinsen, Tom Christian; Damas, Jan Kristian; Espevik, Terje; Sandvik, Arne K.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Torp, Sverre H.] Norwegian Univ Sci & Technol, Dept Lab Med, N-7034 Trondheim, Norway; [Ostvik, Ann E.; Gustafsson, Bjorn I.; Waldum, Helge L.; Martinsen, Tom Christian; Sandvik, Arne K.] St Olavs Univ Hosp, Dept Gastroenterol & Hepatol, Trondheim, Norway; [Torp, Sverre H.] St Olavs Univ Hosp, Dept Pathol, Trondheim, Norway; [Damas, Jan Kristian] St Olavs Univ Hosp, Dept Infect Dis, Trondheim, Norway; [Drozdov, Ignat] Bering Ltd, Richmond, Surrey, England; [Kidd, Mark] Yale Univ, Sch Med, Dept Surg, Gastroenterol Sect, New Haven, CT 06510 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Yale University	Sandvik, AK (corresponding author), Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7034 Trondheim, Norway.	arne.sandvik@ntnu.no	St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Torp, Sverre Helge/AAN-4229-2020	Torp, Sverre Helge/0000-0001-8345-6852; Waldum, Helge/0000-0002-3137-0843; Drozdov, Ignat/0000-0001-6727-4688; Granlund, Atle van Beelen/0000-0001-8117-2637	Norwegian University of Science and Technology (NTNU); Liaison Committee; National Institutes of Health (NIH) [R01DK080871]; National Technology Microarray Platform (Norwegian Microarray Consortium); Functional Genomics Programme (FUGE) of the Norwegian Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080871] Funding Source: NIH RePORTER	Norwegian University of Science and Technology (NTNU); Liaison Committee; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Technology Microarray Platform (Norwegian Microarray Consortium); Functional Genomics Programme (FUGE) of the Norwegian Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Atle van Beelen Granlund is the recipient of a PhD grant from the Norwegian University of Science and Technology (NTNU), Ann Elisabeth Ostvik of a PhD grant from The Liaison Committee between the Central Norway Regional Health Authority (RHA) and NTNU. This work was also supported by a research grant from The Liaison Committee between St. Olav's University Hospital and the Faculty of Medicine, NTNU. Mark Kidd is supported by National Institutes of Health (NIH) R01DK080871. BjOrn Munkvold, Kari SlOrdahl and Britt Schulze provided excellent technical assistance. The microarray work was carried out with support from the National Technology Microarray Platform (Norwegian Microarray Consortium) funded by the Functional Genomics Programme (FUGE) of the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Ahrens R, 2008, J IMMUNOL, V181, P7390, DOI 10.4049/jimmunol.181.10.7390; Arijs I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007984; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bjerrum JT, 2010, INFLAMM BOWEL DIS, V16, P999, DOI 10.1002/ibd.21142; Boulesteix AL, 2009, BRIEF BIOINFORM, V10, P556, DOI 10.1093/bib/bbp034; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Buisine MP, 2001, GUT, V49, P544, DOI 10.1136/gut.49.4.544; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Carey R, 2008, INFLAMM BOWEL DIS, V14, P446, DOI 10.1002/ibd.20342; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Di Sabatino A, 2012, INFLAMM BOWEL DIS, V18, P368, DOI 10.1002/ibd.21735; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Granlund AVB, 2012, GASTROENTEROLOGY, V46, P1316; Heimerl S, 2006, BBA-MOL BASIS DIS, V1762, P341, DOI 10.1016/j.bbadis.2005.12.006; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Koutroubakis IE, 2006, INFLAMM BOWEL DIS, V12, P515, DOI 10.1097/00054725-200606000-00012; Kugathasan S, 2008, NAT GENET, V40, P5; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LaPointe LC, 2008, PHYSIOL GENOMICS, V33, P50, DOI 10.1152/physiolgenomics.00185.2006; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Li Y, 2012, CYTOKINE GROWTH F R, V23, P127, DOI 10.1016/j.cytogfr.2012.04.005; Lovato P, 2003, J BIOL CHEM, V278, P16777, DOI 10.1074/jbc.M207999200; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Nutsch KM, 2012, CURR OPIN IMMUNOL, V24, P385, DOI 10.1016/j.coi.2012.04.009; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Olsen J, 2009, INFLAMM BOWEL DIS, V15, P1032, DOI 10.1002/ibd.20879; Ostvik AE, 2012, INFLAMMATORY BOWEL D; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107; Planell N, 2012, GUT; R Core Team, 2018, R LANG ENV STAT COMP; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Shale M, 2008, GUT, V57, P1349, DOI 10.1136/gut.2008.151563; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2007, CURR OPIN GASTROEN, V23, P370, DOI 10.1097/MOG.0b013e328136c580; White GE, 2011, J MOL HISTOL, V42, P137, DOI 10.1007/s10735-011-9317-7; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yu CR, 2003, J BIOL CHEM, V278, P29752, DOI 10.1074/jbc.M300489200; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	61	88	91	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56818	10.1371/journal.pone.0056818	http://dx.doi.org/10.1371/journal.pone.0056818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23468882	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300197
J	Calabrese, F; Kipar, A; Lunardi, F; Balestro, E; Perissinotto, E; Rossi, E; Nannini, N; Marulli, G; Stewart, JP; Rea, F				Calabrese, Fiorella; Kipar, Anja; Lunardi, Francesca; Balestro, Elisabetta; Perissinotto, Egle; Rossi, Emanuela; Nannini, Nazarena; Marulli, Giuseppe; Stewart, James P.; Rea, Federico			Herpes Virus Infection Is Associated with Vascular Remodeling and Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MEMBRANE-PROTEIN 1; LUNG FIBROSIS; DNA; CELLS; PREVALENCE; ACTIVATION; APOPTOSIS; SURVIVAL; EBV	Background: Pulmonary hypertension (PH) represents an important complication of idiopathic pulmonary fibrosis (IPF) with a negative impact on patient survival. Herpes viruses are thought to play an etiological role in the development and/or progression of IPF. The influence of viruses on PH associated with IPF is unknown. We aimed to investigate the influence of viruses in IPF patients focusing on aspects related to PH. A laboratory mouse model of gamma-herpesvirus (MHV-68) induced pulmonary fibrosis was also assessed. Methods: Lung tissue samples from 55 IPF patients and 41 controls were studied by molecular analysis to detect various viral genomes. Viral molecular data obtained were correlated with mean pulmonary arterial pressure (mPAP) and arterial remodelling. Different clinical and morphological variables were studied by univariate and multivariate analyses at time of transplant and in the early post-transplant period. The same lung tissue analyses were performed in MHV-68 infected mice. Results: A higher frequency of virus positive cases was found in IPF patients than in controls (p=0.0003) and only herpes virus genomes were detected. Viral cases showed higher mPAP (p=0.01), poorer performance in the six minute walking test (6MWT; p=0.002) and higher frequency of primary graft (PGD) dysfunction after lung transplant (p = 0.02). Increased arterial thickening, particularly of the intimal layer (p=0.002 and p=0.004) and higher TGF-beta expression (p=0.002) were demonstrated in viral cases. The remodelled vessels showed increased vessel cell proliferation (Ki-67 positive cells) in the proximity to metaplastic epithelial cells and macrophages. Viral infection was associated with higher mPAP (p=0.03), poorer performance in the 6MWT (p=0.008) and PGD (p = 0.02) after adjusting for other covariates/intermediate factors. In MHV-68 infected mice, morphological features were similar to those of patients. Conclusion: Herpesviral infections may contribute to the development of PH in IPF patients.	[Calabrese, Fiorella; Lunardi, Francesca; Balestro, Elisabetta; Perissinotto, Egle; Rossi, Emanuela; Nannini, Nazarena; Marulli, Giuseppe; Rea, Federico] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Kipar, Anja; Stewart, James P.] Univ Liverpool, Dept Infect Biol, Liverpool L69 3BX, Merseyside, England; [Kipar, Anja; Stewart, James P.] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England; [Kipar, Anja] Univ Helsinki, Dept Vet Basic Sci, Fac Vet Med, Helsinki, Finland	University of Padua; University of Liverpool; University of Liverpool; University of Helsinki	Calabrese, F (corresponding author), Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy.	fiorella.calabrese@unipd.it	Kipar, Anja/L-7214-2014	Kipar, Anja/0000-0001-7289-3459; MARULLI, GIUSEPPE/0000-0001-6570-615X; Lunardi, Francesca/0000-0001-5792-4683; Balestro, Elisabetta/0000-0003-1373-8197; Stewart, James/0000-0002-8928-2037	Italian Ministry of Instruction, University and Research [prot. 60A07-0959/11]	Italian Ministry of Instruction, University and Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Italian Ministry of Instruction, University and Research (prot. 60A07-0959/11). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277; Arase Y, 2008, WORLD J GASTROENTERO, V14, P5880, DOI 10.3748/wjg.14.5880; Calabrese F, 2008, THORAX, V63, P795, DOI 10.1136/thx.2007.088583; Calabrese F, 2000, J CLIN PATHOL, V53, P382, DOI 10.1136/jcp.53.5.382; Calabrese F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-14; Calabrese F, 2008, PEDIATR PULM, V43, P690, DOI 10.1002/ppul.20841; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Christie JD, 2005, J HEART LUNG TRANSPL, V24, P1454, DOI 10.1016/j.healun.2004.11.049; Cool CD, 2003, NEW ENGL J MED, V349, P1113, DOI 10.1056/NEJMoa035115; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Delgado JF, 2005, EUR J HEART FAIL, V7, P1011, DOI 10.1016/j.ejheart.2004.10.021; Ebina M, 2004, AM J RESP CRIT CARE, V169, P1203, DOI 10.1164/rccm.200308-1111OC; EGAN J, 1994, LANCET, V343, P481, DOI 10.1016/S0140-6736(94)92726-X; Egan JJ, 2011, PULM MED, V2011, DOI 10.1155/2011/240805; EGAN JJ, 1995, THORAX, V50, P1234, DOI 10.1136/thx.50.12.1234; ERCOLANI L, 1988, J BIOL CHEM, V263, P15335; Farkas L, 2011, AM J RESP CELL MOL, V45, P1, DOI 10.1165/rcmb.2010-0365TR; Farkas L, 2009, J CLIN INVEST, V119, P1298, DOI 10.1172/JCI36136; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Kelly BG, 2002, AM J RESP CRIT CARE, V166, P510, DOI 10.1164/rccm.2103058; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kuwano K, 1997, EUR RESPIR J, V10, P1445, DOI 10.1183/09031936.97.10071445; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Lettieri CJ, 2006, CHEST, V129, P746, DOI 10.1378/chest.129.3.746; Leuchte HH, 2004, AM J RESP CRIT CARE, V170, P360, DOI 10.1164/rccm.200308-1142OC; Lok SS, 2002, EUR RESPIR J, V20, P1228, DOI 10.1183/09031936.02.00272902; Lunardi F, 2011, CLIN KIDNEY J, V4, P49, DOI 10.1093/ndtplus/sfq197; LUNG ML, 1985, LANCET, V1, P889; Malizia AP, 2008, AM J PHYSIOL-LUNG C, V295, pL451, DOI 10.1152/ajplung.00376.2007; Malizia AP, 2009, EXP CELL RES, V315, P1819, DOI 10.1016/j.yexcr.2009.04.001; Malizia AP, 2009, MOL IMMUNOL, V46, P1905, DOI 10.1016/j.molimm.2009.01.002; McMillan TR, 2008, AM J RESP CRIT CARE, V177, P771, DOI 10.1164/rccm.200708-1184OC; Mihira H, 2012, J BIOCHEM, V151, P145, DOI 10.1093/jb/mvr121; Mora AL, 2005, AM J PHYSIOL-LUNG C, V289, pL711, DOI 10.1152/ajplung.00007.2005; Mora AL, 2007, AM J RESP CRIT CARE, V175, P1139, DOI 10.1164/rccm.200610-1426OC; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Nadrous HF, 2005, CHEST, V128, p616S, DOI 10.1378/chest.128.6_suppl.616S-a; Nathan SD, 2007, AM J RESP CRIT CARE, V175, P875, DOI 10.1164/rccm.200608-1153CC; Patel NM, 2007, CHEST, V132, P998, DOI 10.1378/chest.06-3087; Payne CM, 2001, J VIROL, V75, P10467, DOI 10.1128/JVI.75.21.10467-10471.2001; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Pulkkinen V, 2012, ANN MED, V44, P178, DOI 10.3109/07853890.2010.532151; Pulkkinen V, 2010, FASEB J, V24, P1167, DOI 10.1096/fj.09-138545; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sides MD, 2011, AM J RESP CELL MOL, V44, P852, DOI 10.1165/rcmb.2009-0232OC; Stewart JP, 1999, AM J RESP CRIT CARE, V159, P1336, DOI 10.1164/ajrccm.159.4.9807077; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; Suarez AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000152; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; Tsukamoto K, 2000, THORAX, V55, P958, DOI 10.1136/thorax.55.11.958; Vannella KM, 2010, AM J RESP CRIT CARE, V181, P465, DOI 10.1164/rccm.200905-0798OC; Whelan TPM, 2005, J HEART LUNG TRANSPL, V24, P1269, DOI 10.1016/j.healun.2004.10.014; Williams KJ, 2007, VET PATHOL, V44, P849, DOI 10.1354/vp.44-6-849; Zamo A, 2005, SARCOIDOSIS VASC DIF, V22, P123; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zisman DA, 2007, CHEST, V132, P773, DOI 10.1378/chest.07-0116	58	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e55715	10.1371/journal.pone.0055715	http://dx.doi.org/10.1371/journal.pone.0055715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468849	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000315524900013
J	Don-Salu-Hewage, AS; Chan, SY; McAndrews, KM; Chetram, MA; Dawson, MR; Bethea, DA; Hinton, CV				Don-Salu-Hewage, Ayesha S.; Chan, Siu Yuen; McAndrews, Kathleen M.; Chetram, Mahandranauth A.; Dawson, Michelle R.; Bethea, Danaya A.; Hinton, Cimona V.			Cysteine (C)-X-C Receptor 4 Undergoes Transportin 1-Dependent Nuclear Localization and Remains Functional at the Nucleus of Metastatic Prostate Cancer Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; HETEROTRIMERIC G-PROTEIN; LYMPH-NODE METASTASIS; CXCR4 EXPRESSION; VENTRICULAR MYOCYTES; BREAST-CANCER; GROWTH-FACTOR; SUBCELLULAR-DISTRIBUTION; CHEMOKINE RECEPTORS; CARDIAC MYOCYTES	The G-protein coupled receptor (GPCR), Cysteine (C)-X-C Receptor 4 (CXCR4), plays an important role in prostate cancer metastasis. CXCR4 is generally regarded as a plasma membrane receptor where it transmits signals that support transformation, progression and eventual metastasis. Due to the central role of CXCR4 in tumorigenesis, therapeutics approaches such as antagonist and monoclonal antibodies have focused on receptors that exist on the plasma membrane. An emerging concept for G-protein coupled receptors is that they may localize to and associate with the nucleus where they retain function and mediate nuclear signaling. Herein, we demonstrate that CXCR4 associated with the nucleus of malignant prostate cancer tissues. Likewise, expression of CXCR4 was detected in nuclear fractions among several prostate cancer cell lines, compared to normal prostate epithelial cells. Our studies identified a nuclear pool of CXCR4 and we defined a nuclear transport pathway for CXCR4. We reveal a putative nuclear localization sequence (NLS), 'RPRK', within CXCR4 that contributed to nuclear localization. Additionally, nuclear CXCR4 interacted with Transportin beta 1 and Transportin beta 1-binding to CXCR4 promoted its nuclear translocation. Importantly, G(alpha i) immunoprecipitation and calcium mobilization studies indicated that nuclear CXCR4 was functional and participated in G-protein signaling, revealing that the nuclear pool of CXCR4 retained function. Given the suggestion that functional, nuclear CXCR4 may be a mechanism underlying prostate cancer recurrence, increased metastatic ability and poorer prognosis after tumors have been treated with therapy that targets plasma membrane CXCR4, these studies addresses a novel mechanism of nuclear signaling for CXCR4, a novel mechanism of clinical targeting, and demonstrate an active nuclear pool that provides important new information to illuminate what has been primarily clinical reports of nuclear CXCR4.	[Don-Salu-Hewage, Ayesha S.; Chetram, Mahandranauth A.; Bethea, Danaya A.; Hinton, Cimona V.] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA; [Don-Salu-Hewage, Ayesha S.; Chetram, Mahandranauth A.] Clark Atlanta Univ, Dept Biol Sci, Atlanta, GA 30314 USA; [Chan, Siu Yuen; McAndrews, Kathleen M.] Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Dawson, Michelle R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	Clark Atlanta University; Clark Atlanta University; University of Hong Kong; University System of Georgia; Georgia Institute of Technology	Hinton, CV (corresponding author), Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA.	chinton@cau.edu	Dawson, Michelle R/Q-7217-2019; Jain, Rakesh K/I-1384-2017	Dawson, Michelle R/0000-0002-2122-4711; Jain, Rakesh K/0000-0001-7571-3548; Hinton, Cimona/0000-0002-5724-1804; Chan, Siu Yuen/0000-0001-7262-1293; McAndrews, Kathleen/0000-0002-4092-4991	National Institutes of Health [2R25GM060414, P201MD002285, F31CA153908, 2G12RR003062-22]; AAAS Women's International Research Collaboration (WIRC) for Minority Serving Institutions (MSI); National Science Foundation; NATIONAL CANCER INSTITUTE [F31CA153908] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060414] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD002285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AAAS Women's International Research Collaboration (WIRC) for Minority Serving Institutions (MSI); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in part, by National Institutes of Health grants 2R25GM060414, P201MD002285 (CVH), F31CA153908 (MAC), 2G12RR003062-22 (CVH) and AAAS Women's International Research Collaboration (WIRC) for Minority Serving Institutions (MSI), a National Science Foundation grant (CVH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.~	Akashi T, 2008, CANCER SCI, V99, P539, DOI 10.1111/j.1349-7006.2007.00712.x; Alonso MT, 2006, CELL CALCIUM, V40, P513, DOI 10.1016/j.ceca.2006.08.013; Audigier Y, 1998, J BIOL CHEM; Bai ST, 2011, ARCH PATHOL LAB MED, V135, P753, DOI 10.1043/2009-0230-OA.1; Baldassare JJ, 1997, J BIOL CHEM, V272, P4911, DOI 10.1074/jbc.272.8.4911; Barker BL, 2011, BIOCHEMISTRY-US, V50, P6933, DOI 10.1021/bi2005202; Berridge MJ, 2001, NOVART FDN SYMP, V239, P52; Bhattacharya M, 1999, J BIOL CHEM, V274, P15719, DOI 10.1074/jbc.274.22.15719; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Boivin B, 2005, J MOL CELL CARDIOL, V38, P665, DOI 10.1016/j.yjmcc.2005.02.011; Boivin B, 2003, J BIOL CHEM, V278, P29153, DOI 10.1074/jbc.M301738200; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Boivin B, 2006, CARDIOVASC RES, V71, P69, DOI 10.1016/j.cardiores.2006.03.015; BRIDGER GJ, 1995, J MED CHEM, V38, P366, DOI 10.1021/jm00002a019; Burgess A, 2006, J GEN VIROL, V87, P789, DOI 10.1099/vir.0.81640-0; BUU NT, 1993, J MOL CELL CARDIOL, V25, P1037, DOI 10.1006/jmcc.1993.1116; Cancer IN, 2009, SURV RES PROGR CANC; CARLSON KE, 1986, MOL PHARMACOL, V30, P463; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Chetram M, 2011, MOL CANCER RES, V9, P89; Chetram MA, 2011, BIOCHEM BIOPH RES CO, V410, P195, DOI 10.1016/j.bbrc.2011.05.074; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Chinni SR, 2008, MOL CANCER RES, V6, P446, DOI 10.1158/1541-7786.MCR-07-0117; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; CROUCH MF, 1991, FASEB J, V5, P200, DOI 10.1096/fasebj.5.2.1900794; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Dessein AF, 2010, CANCER RES, V70, P4644, DOI 10.1158/0008-5472.CAN-09-3828; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Favre N, 2008, PROTEOMICS, V8, P4560, DOI 10.1002/pmic.200800211; Ferguson SSG, 1998, SEMIN CELL DEV BIOL, V9, P119, DOI 10.1006/scdb.1997.0216; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gobeil F, 2003, J BIOL CHEM, V278, P38875, DOI 10.1074/jbc.M212481200; Gobeil F, 2002, CIRC RES, V90, P682, DOI 10.1161/01.RES.0000013303.17964.7A; Gobeil F, 2006, CAN J PHYSIOL PHARM, V84, P287, DOI 10.1139/Y05-127; Gobeil F, 2006, J BIOL CHEM, V281, P16058, DOI 10.1074/jbc.M602219200; HALL MN, 1990, P NATL ACAD SCI USA, V87, P6954, DOI 10.1073/pnas.87.18.6954; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hinton CV, 2007, EXP CELL RES, V313, P1735, DOI 10.1016/j.yexcr.2007.03.008; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Humbert JP, 1996, J BIOL CHEM, V271, P478, DOI 10.1074/jbc.271.1.478; Ishidate T, 1997, FEBS LETT, V409, P237, DOI 10.1016/S0014-5793(97)00455-9; Janowski M, 2011, ACTA NEUROBIOL EXP, V71, P24; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Kato M, 2003, BREAST CANCER RES, V5, pR144, DOI 10.1186/bcr627; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Kumar V, 2008, J BIOL CHEM, V283, P14072, DOI 10.1074/jbc.M708551200; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee SH, 2003, ADV DRUG DELIVER REV, V55, P717, DOI 10.1016/S0169-409X(03)00052-8; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; LEPRETRE N, 1994, J BIOL CHEM, V269, P29546; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; LIND GJ, 1995, INVEST OPHTH VIS SCI, V36, P1492; Lu D, 1998, ENDOCRINOLOGY, V139, P365, DOI 10.1210/en.139.1.365; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Malviya AN, 1998, CELL, V92, P17, DOI 10.1016/S0092-8674(00)80895-8; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marrache AM, 2002, J IMMUNOL, V169, P6474, DOI 10.4049/jimmunol.169.11.6474; McLane LM, 2009, IUBMB LIFE, V61, P697, DOI 10.1002/iub.194; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Miguel BG, 2001, PROSTAG OTH LIPID M, V65, P159, DOI 10.1016/S0090-6980(01)00124-1; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nielsen CK, 2005, CANCER RES, V65, P732; O'Malley KL, 2003, J BIOL CHEM, V278, P28210, DOI 10.1074/jbc.M300792200; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Patel TB, 2004, PHARMACOL REV, V56, P371, DOI 10.1124/pr.56.3.4; Pelchen-Matthews A, 1999, IMMUNOL REV, V168, P33, DOI 10.1111/j.1600-065X.1999.tb01281.x; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Power JM, 2002, J NEUROSCI, V22, P3454; Premack BA, 1996, NAT MED, V2, P1174, DOI 10.1038/nm1196-1174; Quimby BB, 2001, CELL MOL LIFE SCI, V58, P1766, DOI 10.1007/PL00000816; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Re M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011489; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Ren MZ, 2011, PLANT PHYSIOL, V155, P1367, DOI 10.1104/pp.110.169045; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Schoneberg T, 1999, MOL CELL ENDOCRINOL, V151, P181, DOI 10.1016/S0303-7207(99)00017-9; Shibuta K, 2002, JPN J CANCER RES, V93, P789, DOI 10.1111/j.1349-7006.2002.tb01321.x; Singh RK, 2011, CANCER RES, V71, P3268, DOI 10.1158/0008-5472.CAN-10-2769; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Sneyd MJ, 2008, CANCER CAUSE CONTROL, V19, P993, DOI 10.1007/s10552-008-9166-1; Spano JP, 2004, ANN ONCOL, V15, P613, DOI 10.1093/annonc/mdh136; Speetjens FM, 2009, CANCER MICROENVIRON, V2, P1, DOI 10.1007/s12307-008-0016-1; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Sun YX, 2003, J CELL BIOCHEM, V89, P462, DOI 10.1002/jcb.10522; Tadevosyan A, 2012, J PHYSIOL-LONDON, V590, P1313, DOI 10.1113/jphysiol.2011.222794; Taichman RS, 2002, CANCER RES, V62, P1832; Takei Y, 1999, FEBS LETT, V447, P292, DOI 10.1016/S0014-5793(99)00306-3; Tao MF, 2003, J VIROL, V77, P13232, DOI 10.1128/JVI.77.24.13232-13247.2003; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Uchida D, 2007, MOL CANCER RES, V5, P685, DOI 10.1158/1541-7786.MCR-06-0368; Valdehita A, 2010, PEPTIDES, V31, P2035, DOI 10.1016/j.peptides.2010.07.024; Vindrieux D, 2009, ENDOCR-RELAT CANCER, V16, P663, DOI 10.1677/ERC-09-0109; Wang LH, 2010, PLASMID, V63, P68, DOI 10.1016/j.plasmid.2009.09.004; Wang N, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-26; Wang SC, 2010, INT J COLORECTAL DIS, V25, P1185, DOI 10.1007/s00384-010-0999-1; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Woo SU, 2008, ANN SURG ONCOL, V15, P281, DOI 10.1245/s10434-007-9595-1; Wright CD, 2008, CIRC RES, V103, P992, DOI 10.1161/CIRCRESAHA.108.176024; Wright CD, 2012, CELL SIGNAL, V24, P794, DOI 10.1016/j.cellsig.2011.11.014; Yoshitake N, 2008, BRIT J CANCER, V98, P1682, DOI 10.1038/sj.bjc.6604363; Zagon IS, 2005, ANAT REC PART A, V282A, P24, DOI 10.1002/ar.a.20161; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015	121	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57194	10.1371/journal.pone.0057194	http://dx.doi.org/10.1371/journal.pone.0057194			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468933	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900057
J	Hao, JW; Shi, FD; Abdelwahab, M; Shi, SX; Simard, A; Whiteaker, P; Lukas, R; Zhou, QH				Hao, Junwei; Shi, Fu-Dong; Abdelwahab, Mohammed; Shi, Samuel X.; Simard, Alain; Whiteaker, Paul; Lukas, Ronald; Zhou, Qinghua			Nicotinic Receptor beta 2 Determines NK Cell-Dependent Metastasis in a Murine Model of Metastatic Lung Cancer	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; CIGARETTE-SMOKE; STIMULATION; ACTIVATION; RELEASE; MII	Cigarette smoke exposure markedly compromises the ability of the immune system to protect against invading pathogens and tumorigenesis. Nicotine is a psychoactive component of tobacco products that acts as does the natural neurotransmitter, acetylcholine, on nicotinic receptors (nAChRs). Here we demonstrate that natural killer (NK) cells strongly express nAChR beta 2. Nicotine exposure impairs the ability of NK cells to kill target cells and release cytokines, a process that is largely abrogated by nAChR beta 2 deficiency. Further, nicotinic suppression of NF-kappa B-induced transcriptional activity in NK cells is dependent on nAChR beta 2. This nAChR subtype also plays a large role in the NK cell-mediated control of melanoma lung metastasis, in a murine lung metastasis model exposed to nicotine. Our findings suggest nAChR beta 2 as a prominent pathway for nicotine induced impairment of NK cell functions which contributes to the occurrence of smoking-related pathologies.	[Zhou, Qinghua] Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin, Peoples R China; [Hao, Junwei; Shi, Fu-Dong] Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China; [Shi, Fu-Dong; Abdelwahab, Mohammed; Shi, Samuel X.; Lukas, Ronald] St Josephs Hosp, Dept Neurol, Barrow Neurol Inst, Phoenix, AZ USA; [Simard, Alain] Univ Moncton, Dept Chem & Biochem, Moncton, NB E1A 3E9, Canada	Tianjin Medical University; Tianjin Medical University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Moncton	Hao, JW (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China.	jhao0216@gmail.com; zhouqh1016@yahoo.com.cn	Zhou, Qinghua/A-4184-2008; Simard, Alain/E-1493-2013	Simard, Alain/0000-0002-3499-6235; Hao, Junwei/0000-0002-3075-5434	International Science Cooperative Project of China [2006DFB32330]; National Basic Research Program of China [2013CB966900]; Program for New Century Excellent Talents in University of China [NCET 111067]; NFSC [2010CB529405, 81100887, 81273287]; US National Institute of Health [R01AI083294]; Key Project of Natural Science Foundation of Tianjin Province [12JCZDJC24200]; Key Project of Chinese Ministry of Education [212005]	International Science Cooperative Project of China; National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); NFSC(National Natural Science Foundation of China (NSFC)); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Key Project of Natural Science Foundation of Tianjin Province; Key Project of Chinese Ministry of Education(Ministry of Education, China)	This study is supported in part by International Science Cooperative Project of China 2006DFB32330 to QHZ; National Basic Research Program of China 2013CB966900 to FDS; Program for New Century Excellent Talents in University of China (NCET 111067 to JWH); NFSC 2010CB529405 to QHZ, 81100887 and 81273287 to JWH; the US National Institute of Health (R01AI083294 to FDS); the Key Project of Natural Science Foundation of Tianjin Province 12JCZDJC24200 to JWH, and the Key Project of Chinese Ministry of Education (212005 to JWH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Hao J, 2010, EXP NEUROL; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lu LM, 2007, J IMMUNOL, V178, P936, DOI 10.4049/jimmunol.178.2.936; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Marks MJ, 1998, J PHARMACOL EXP THER, V285, P377; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; Mian MF, 2008, J LEUKOCYTE BIOL, V83, P774, DOI 10.1189/jlb.0707481; Ng AK, 2008, CANCER J, V14, P429, DOI 10.1097/PPO.0b013e31818d8779; Owens JC, 2003, ALCOHOL CLIN EXP RES, V27, P1867, DOI 10.1097/01.ALC.0000102700.72447.0F; Piao WH, 2009, ACTA PHARMACOL SIN, V30, P715, DOI 10.1038/aps.2009.67; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Robbins CS, 2004, AM J RESP CELL MOL, V30, P202, DOI 10.1165/rcmb.2003-0259OC; Shi FD, 2009, J IMMUNOL, V182, P1730, DOI 10.4049/jimmunol.182.3.1730; Smyth MJ, 2000, J IMMUNOL, V165, P2665, DOI 10.4049/jimmunol.165.5.2665; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; TOLLERUD DJ, 1989, AM REV RESPIR DIS, V139, P194, DOI 10.1164/ajrccm/139.1.194; van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P114, DOI 10.1002/art.24177; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Werneck MBF, 2008, J IMMUNOL, V180, P8004, DOI 10.4049/jimmunol.180.12.8004; Whiteaker P, 2000, BRIT J PHARMACOL, V131, P729, DOI 10.1038/sj.bjp.0703616; Whiteaker P, 2000, MOL PHARMACOL, V57, P913	27	27	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57495	10.1371/journal.pone.0057495	http://dx.doi.org/10.1371/journal.pone.0057495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469004	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900103
J	Jones, P; Peters, MJ; da Costa, NP; Kurth, T; Alberti, C; Kessous, K; Lode, N; Dauger, S				Jones, Peter; Peters, Mark J.; da Costa, Nathalia Pinto; Kurth, Tobias; Alberti, Corinne; Kessous, Katia; Lode, Noella; Dauger, Stephane			Atropine for Critical Care Intubation in a Cohort of 264 Children and Reduced Mortality Unrelated to Effects on Bradycardia	PLOS ONE			English	Article							CLINICAL-PRACTICE; COMPLICATIONS; INFANTS; PREMEDICATION; VARIABILITY; PARAMETERS; DEATH	Background: Atropine has is currently recommended to facilitate haemodynamic stability during critical care intubation. Our objective was to determine whether atropine use at induction influences ICU mortality. Methodology/Principal Findings: A 2-year prospective, observational study of all first non-planned intubations, September 2007-9 in PICU and Intensive Care Transport team of Hopital Robert Debre, Paris, 4 other PICUs and 5 NICUs in the Paris Region, France. Follow-up was from intubation to ICU discharge. A propensity score was used to adjust for patient specific characteristics influencing atropine prescription. 264/333 (79%) intubations were included. The unadjusted ICU mortality was 7.2% (9/124) for those who received atropine compared to 15.7% (22/140) for those who did not (OR 0.42, 95% CI 0.19-0.95, p = 0.04). One child died during intubation (1/264, 0.4%). Two age sub-groups of neonates (# 28 days) and older children (>28 days, <8 years) were examined. This difference in mortality arose from the higher mortality in children aged over one month when atropine was not used (propensity score adjusted OR 0.22, 95% CI 0.06-0.85, p = 0.028). No effect was seen in neonates (propensity score adjusted OR 1.3, 95% CI 0.31-5.1 p = 0.74). Using the propensity score, atropine maintained the mean heart rate 45.9 bpm above that observed when no atropine was used in neonates (95% CI 34.3-57.5, p, 0.001) and 43.5 bpm for older children (95% CI 25.5-61.5 bpm, p<0.001). Conclusions/Significance: Atropine use during induction was associated with a reduction in ICU mortality in children over one month. This effect is independent of atropine's capacity to attenuate bradycardia during intubation which occurred similarly in neonates and older children. This result needs to be confirmed in a study using randomised methodology.	[Jones, Peter; Peters, Mark J.] UCL, Inst Child Hlth, Crit Care Grp, Portex Unit, London, England; [Jones, Peter; da Costa, Nathalia Pinto; Kessous, Katia; Lode, Noella; Dauger, Stephane] Hop Robert Debre, AP HP, F-75019 Paris, France; [Kurth, Tobias] Inst Natl Sante & Rech Med, Bordeaux, France; [Kurth, Tobias] Univ Bordeaux, Bordeaux, France; [Kurth, Tobias] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med, Boston, MA 02115 USA; [Alberti, Corinne] Hop Robert Debre, AP HP, Clin Epidemiol Unit, F-75019 Paris, France; [Alberti, Corinne] Hop Robert Debre, Inst Natl Sante & Rech Med CIE 5, F-75019 Paris, France; [Alberti, Corinne; Dauger, Stephane] Univ Paris Diderot, Paris, France	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Jones, P (corresponding author), UCL, Inst Child Hlth, Crit Care Grp, Portex Unit, London, England.	sejjprj@live.ucl.ac.uk	Dauger, Stéphane/AAX-9669-2021; Kurth, Tobias/A-9243-2012; Peters, Mark/AAD-7518-2019	Kurth, Tobias/0000-0001-7169-2620; Peters, Mark/0000-0003-3653-4808	Merck	Merck(Merck & Company)	The authors have the following interests. Tobias Kurth has received within the last 2 years investigator-initiated research funding from Merck. He is a consultant to World Health Information Science Consultants, LLC; he has received honoraria Merck for educational lectures and from MAP Pharmaceutical for contributing to a scientific advisory panel. The authors are grateful to Welch Allwyn for the generous donation of the ECG paper used by the ICT team. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andriessen P, 2004, PEDIATR RES, V56, P939, DOI 10.1203/01.PDR.0000145257.75072.BB; [Anonymous], 2007, ANN REP PAED INT CAR, P115; Brady AR, 2006, PEDIATRICS, V117, pE733, DOI 10.1542/peds.2005-1853; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Carroll CL, 2010, PEDIATR CRIT CARE ME, V11, P343, DOI 10.1097/PCC.0b013e3181c51426; Chow LTC, 2001, ANAT RECORD, V264, P169, DOI 10.1002/ar.1158; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Fastle RK, 2004, PEDIATR EMERG CARE, V20, P651, DOI 10.1097/01.pec.0000142947.35394.81; Gayat E, 2010, INTENS CARE MED, V36, P1993, DOI 10.1007/s00134-010-1991-5; Ghanta S, 2007, PEDIATRICS, V119, pE1248, DOI 10.1542/peds.2006-2708; Jaber S, 2006, CRIT CARE MED, V34, P2355, DOI 10.1097/01.CCM.0000233879.58720.87; Jones P, 2012, J INTENSIVE CARE SOC, V13, P2; Jones P, 2012, ARCH DIS CHILD, V97, P139, DOI 10.1136/adc.2010.210518; Kleinman ME, 2010, CIRCULATION, V122, P8466, DOI [10.1161/CIRCULATIONAHA.110.971093, 10.1542/peds.2010-2972A]; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; LEIGH MD, 1957, ANESTHESIOLOGY, V18, P698, DOI 10.1097/00000542-195709000-00004; Oei J, 2002, J PAEDIATR CHILD H, V38, P146, DOI 10.1046/j.1440-1754.2002.00726.x; PARNIS SJ, 1994, ANAESTH INTENS CARE, V22, P61, DOI 10.1177/0310057X9402200110; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; SAARNIVAARA L, 1985, ACTA ANAESTH SCAND, V29, P529, DOI 10.1111/j.1399-6576.1985.tb02248.x; Salata JJ, 2007, REFLEX CONTROL CIRCU, P67; SCHWARTZ DE, 1995, ANESTHESIOLOGY, V82, P367, DOI 10.1097/00000542-199502000-00007; Shaw CA, 2000, BRIT J ANAESTH, V84, P174, DOI 10.1093/oxfordjournals.bja.a013399; SHORTEN GD, 1995, CAN J ANAESTH, V42, P8, DOI 10.1007/BF03010563; Simon L, 2004, CRIT CARE MED, V32, P565, DOI 10.1097/01.CCM.0000108883.58081.E3; Taha S, 2005, CAN J ANAESTH, V52, P249, DOI 10.1007/BF03016058; Thomsen MB, 2005, BASIC RES CARDIOL, V100, P279, DOI 10.1007/s00395-005-0519-6; Tirel O, 2005, ANAESTHESIA, V60, P982, DOI 10.1111/j.1365-2044.2005.04298.x; Venkatesh V, 2009, EUROPEAN J PEDIAT, V170, P223; VIRTANEN R, 1982, ACTA ANAESTH SCAND, V26, P297, DOI 10.1111/j.1399-6576.1982.tb01770.x; WALSH CK, 1983, AM J CARDIOL, V51, P557, DOI 10.1016/S0002-9149(83)80096-4; Wyllie JP, 2008, ARCH DIS CHILDHOOD-E, V93, P44, DOI 10.1136/adc.2007.121160	32	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57478	10.1371/journal.pone.0057478	http://dx.doi.org/10.1371/journal.pone.0057478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468997	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900096
J	Hao, GY; Du, Y; Zhou, XJ; Guo, JF; Sun, XK; Mohan, C; Oz, OK				Hao, Guiyang; Du, Yong; Zhou, Xin J.; Guo, Jianfei; Sun, Xiankai; Mohan, Chandra; Oez, Orhan K.			Serial Non-Invasive Assessment of Antibody Induced Nephritis in Mice Using Positron Emission Tomography	PLOS ONE			English	Article							GA-67 SCINTIGRAPHY; F-18-FDG PET; FDG-PET; LUPUS; KIDNEY; TOOL	Mouse models of experimental anti-glomerular basement membrane (anti-GBM) nephritis provide an analytical tool for studying spontaneous lupus nephritis. The potential of Positron Emission Tomography (PET) was evaluated using 2-deoxy-2-[F-18]fluoro-d-glucose (FDG) as a probe to monitor the progression of anti-GBM induced nephritis in a mouse model. The imaging results were compared to conventional measures of renal function and pathological changes. Serum and urinary vascular cell adhesion molecule-1 (VCAM-1) levels were used as measures of endothelial cell activation and inflammation. Following a challenge with anti-glomerular antibodies, mice exhibited peak changes in serum creatinine, proteinuria, and glomerulonephritis score at 14 days post-challenge (p.c.). In contrast, VCAM levels peaked at day 7 p.c. On dynamic PET images (0-60 min) of day 7, kidneys of the anti-GBM nephritis mice demonstrated a unique pattern of FDG uptake. Compared to the time activity curve (TAC) prior to challenge, a rightward shift was observed after the challenge. By day 10 p.c., kidney FDG uptake was lower than baseline and remained so until the study ended at 21 days p.c. During this time frame measures of renal dysfunction remained high but VCAM-1 levels declined. These changes were accompanied by an increase in kidney volume as measured by Computed Tomography (CT) and intra-abdominal fluid collection. Our results suggest that FDG-PET-CT can be used as a non-invasive imaging tool to longitudinally monitor the progression of renal disease activity in antibody mediated nephritis and the magnitude of renal FDG retention correlates better with early markers of renal inflammation than renal dysfunction.	[Hao, Guiyang; Guo, Jianfei; Sun, Xiankai; Oez, Orhan K.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Du, Yong; Mohan, Chandra] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Zhou, Xin J.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Sun, Xiankai] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sun, XK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA.	xiankai.sun@utsouthwestern.edu; chandra.mohan@utsouthwestern.edu; orhan.oz@utsouthwestern.edu	Hao, Guiyang/D-5312-2011; Mohan, Chandra/GPX-8233-2022; DU, YONG/B-9964-2011; Oz, Orhan/GVT-7264-2022	Hao, Guiyang/0000-0001-6695-5123; DU, YONG/0000-0003-1687-9024	National Institutes of Health [R01 DK092163, R01 DK081872]; Cain Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081872, R01DK092163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cain Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (R01 DK092163 and R01 DK081872) and the Cain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aten J, 2000, J AM SOC NEPHROL, V11, P1426, DOI 10.1681/ASN.V1181426; BAKIR AA, 1985, AM J MED, V79, P175, DOI 10.1016/0002-9343(85)90007-5; Bleeker-Rovers CP, 2003, AM J KIDNEY DIS, V41, DOI 10.1016/S0272-6386(03)00368-8; Davidson A, 2010, NAT REV RHEUMATOL, V6, P13, DOI 10.1038/nrrheum.2009.240; Du Y, 2008, ARCH IMMUNOL THER EX, V56, P31, DOI 10.1007/s00005-008-0007-4; Du Y, 2011, SYSTEMIC LUPUS ERYTHEMATOSUS, 5TH EDITION, P453; Du Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043941; Fu YY, 2007, CLIN IMMUNOL, V124, P109, DOI 10.1016/j.clim.2007.05.007; Karadeli E, 2010, RHEUMATOL INT, V30, P1177, DOI 10.1007/s00296-009-1124-z; Kobayashi M, 2010, NUCL MED COMMUN, V31, P141, DOI 10.1097/MNM.0b013e328333bcf5; Kosuda S, 1997, Ann Nucl Med, V11, P213; Lin WY, 2000, EUR J NUCL MED, V27, P1626, DOI 10.1007/s002590000350; Lin WY, 1998, J NUCL MED, V39, P2137; Love C, 2005, RADIOGRAPHICS, V25, P1357, DOI 10.1148/rg.255045122; Meller J, 2007, J NUCL MED, V48, P35; Minamimoto R, 2007, ANN NUCL MED, V21, P217, DOI 10.1007/s12149-007-0012-4; MUNK ZM, 1979, CLIN EXP IMMUNOL, V36, P244; O'Keefe DS, 1998, BBA-GENE STRUCT EXPR, V1443, P113; OZBEK SS, 1995, J CLIN ULTRASOUND, V23, P17, DOI 10.1002/jcu.1870230104; Panopalis P, 2008, ARTHRIT RHEUM-ARTHR, V59, P1788, DOI 10.1002/art.24063; Peters AM, 2000, RHEUMATOLOGY, V39, P463, DOI 10.1093/rheumatology/39.5.463; Reuter S, 2010, J NUCL MED, V51, P1644, DOI 10.2967/jnumed.110.078550; Serkova NJ, 2010, RADIOLOGY, V255, P517, DOI 10.1148/radiol.09091134; STANLEY JH, 1984, AM J ROENTGENOL, V142, P1165, DOI 10.2214/ajr.142.6.1165; WILSON CB, 1973, KIDNEY INT, V3, P74, DOI 10.1038/ki.1973.14; Wu TF, 2007, ARTHRITIS RHEUM-US, V56, P949, DOI 10.1002/art.22556; WUTHRICH RP, 1992, KIDNEY INT, V42, P903, DOI 10.1038/ki.1992.367; Xie C, 2004, J IMMUNOL, V172, P5047, DOI 10.4049/jimmunol.172.8.5047	28	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57418	10.1371/journal.pone.0057418	http://dx.doi.org/10.1371/journal.pone.0057418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460853	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000107
J	Link, A; Balaguer, F; Shen, Y; Lozano, JJ; Leung, HCE; Boland, CR; Goel, A				Link, Alexander; Balaguer, Francesc; Shen, Yan; Lozano, Juan Jose; Leung, Hon-Chiu E.; Boland, C. Richard; Goel, Ajay			Curcumin Modulates DNA Methylation in Colorectal Cancer Cells	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; CPG-ISLAND; METHYLTRANSFERASE INHIBITORS; PROSTATE-CANCER; IN-VITRO; HYPERMETHYLATION; DIETARY; CHEMOPREVENTION; TUMORIGENESIS; DEMETHYLATION	Aim: Recent evidence suggests that several dietary polyphenols may exert their chemopreventive effect through epigenetic modifications. Curcumin is one of the most widely studied dietary chemopreventive agents for colon cancer prevention, however, its effects on epigenetic alterations, particularly DNA methylation, remain unclear. Using systematic genome-wide approaches, we aimed to elucidate the effect of curcumin on DNA methylation alterations in colorectal cancer cells. Materials and Methods: To evaluate the effect of curcumin on DNA methylation, three CRC cell lines, HCT116, HT29 and RKO, were treated with curcumin. 5-aza-2'-deoxycytidine (5-aza-CdR) and trichostatin A treated cells were used as positive and negative controls for DNA methylation changes, respectively. Methylation status of LINE-1 repeat elements, DNA promoter methylation microarrays and gene expression arrays were used to assess global methylation and gene expression changes. Validation was performed using independent microarrays, quantitative bisulfite pyrosequencing, and qPCR. Results: As expected, genome-wide methylation microarrays revealed significant DNA hypomethylation in 5-aza-CdR-treated cells (mean beta-values of 0.12), however, non-significant changes in mean beta-values were observed in curcumin-treated cells. In comparison to mock-treated cells, curcumin-induced DNA methylation alterations occurred in a time-dependent manner. In contrast to the generalized, non-specific global hypomethylation observed with 5-aza-CdR, curcumin treatment resulted in methylation changes at selected, partially-methylated loci, instead of fully-methylated CpG sites. DNA methylation alterations were supported by corresponding changes in gene expression at both up- and down-regulated genes in various CRC cell lines. Conclusions: Our data provide previously unrecognized evidence for curcumin-mediated DNA methylation alterations as a potential mechanism of colon cancer chemoprevention. In contrast to non-specific global hypomethylation induced by 5-aza-CdR, curcumin-induced methylation changes occurred only in a subset of partially-methylated genes, which provides additional mechanistic insights into the potent chemopreventive effect of this dietary nutraceutical.	[Link, Alexander; Balaguer, Francesc; Shen, Yan; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Div Gastroenterol, Gastrointestinal Canc Res Lab, Dallas, TX USA; [Link, Alexander] Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Balaguer, Francesc; Lozano, Juan Jose] Univ Barcelona, Dept Gastroenterol, Hosp Clin,IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Leung, Hon-Chiu E.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor University; Baylor University Medical Center; Otto von Guericke University; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Baylor College of Medicine	Goel, A (corresponding author), Baylor Univ, Med Ctr, Div Gastroenterol, Gastrointestinal Canc Res Lab, Dallas, TX USA.	ajay.goel@baylorhealth.edu	BALAGUER, FRANCESC/G-2389-2016; Balaguer, Francesc/GPX-7801-2022	Link, Alexander/0000-0002-9514-4562; Lozano, Juan Jose/0000-0001-7613-3908; Balaguer, Francesc/0000-0002-0206-0539; Goel, Ajay/0000-0003-1396-6341	National Cancer Institute, National Institutes of Health [R01 CA72851, CA129286]; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA129286, R01CA072851] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grants R01 CA72851 and CA129286 from the National Cancer Institute, National Institutes of Health, and funds from the Baylor Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Chuang JC, 2005, MOL CANCER THER, V4, P1515, DOI 10.1158/1535-7163.MCT-05-0172; Costello JF, 2009, NAT BIOTECHNOL, V27, P1130, DOI 10.1038/nbt1209-1130; Davis CD, 2002, J NUTR, V132, P292, DOI 10.1093/jn/132.2.292; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Eads CA, 2002, CANCER RES, V62, P1296; Fang MZ, 2005, CLIN CANCER RES, V11, P7033, DOI 10.1158/1078-0432.CCR-05-0406; Fang MZ, 2003, CANCER RES, V63, P7563; Feinberg AP, 2008, JAMA-J AM MED ASSOC, V299, P1345, DOI 10.1001/jama.299.11.1345; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Gunderson Kevin L., 2009, V529, P197, DOI 10.1007/978-1-59745-538-1_13; Hamm CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008340; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Issa JPJ, 1996, CANCER RES, V56, P3655; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jha AK, 2010, FOLIA BIOL-PRAGUE, V56, P195; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Kristensen LS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn113; Kuck D, 2010, BIOORGAN MED CHEM, V18, P822, DOI 10.1016/j.bmc.2009.11.050; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; Link A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008146; Liu ZF, 2009, BIOORG MED CHEM LETT, V19, P706, DOI 10.1016/j.bmcl.2008.12.041; Majid S, 2010, CANCER-AM CANCER SOC, V116, P66, DOI 10.1002/cncr.24662; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Nagasaka T, 2008, INT J CANCER, V122, P2429, DOI 10.1002/ijc.23398; Patel K, 2010, NUCLEIC ACIDS RES, V38, P4313, DOI 10.1093/nar/gkq187; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Prasanna P, 1995, CLIN CANCER RES, V1, P865; Rabbani SA, 2008, NEOPLASIA, V10, P266, DOI 10.1593/neo.07947; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Schermelleh L, 2005, NAT METHODS, V2, P751, DOI 10.1038/NMETH794; Shen Y, 2012, CANCER BIOL THER, V13, P542, DOI 10.4161/cbt.19604; Shukeir N, 2006, CANCER RES, V66, P9202, DOI 10.1158/0008-5472.CAN-06-1954; Sporn MB, 2002, NAT REV CANCER, V2, P537, DOI 10.1038/nrc844; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Wong JJL, 2007, GUT, V56, P140, DOI 10.1136/gut.2005.088799; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	48	110	116	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57709	10.1371/journal.pone.0057709	http://dx.doi.org/10.1371/journal.pone.0057709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460897	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000152
J	Sun, Y; Xu, CC; Li, J; Guan, XY; Gao, L; Ma, LX; Li, RX; Peng, YW; Zhu, GP				Sun, Yan; Xu, Chong-Chong; Li, Jin; Guan, Xi-Yin; Gao, Lu; Ma, Li-Xiang; Li, Rui-Xi; Peng, Yu-Wen; Zhu, Guo-Pei			Transplantation of Oligodendrocyte Precursor Cells Improves Locomotion Deficits in Rats with Spinal Cord Irradiation Injury	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; RADIATION MYELOPATHY; SCHWANN-CELLS; IN-VITRO; NEUROTROPHIC FACTOR; NEURONAL SURVIVAL; GENE-EXPRESSION; INDUCED DAMAGE; WHITE-MATTER	Demyelination contributes to the functional impairment of irradiation injured spinal cord. One potential therapeutic strategy involves replacing the myelin-forming cells. Here, we asked whether transplantation of Olig2(+)-GFP(+)-oligodendrocyte precursor cells (OPCs), which are derived from Olig2-GFP-mouse embryonic stem cells (mESCs), could enhance remyelination and functional recovery after spinal cord irradiation injury. We differentiated Olig2-GFP-mESCs into purified Olig2(+)-GFP(+)-OPCs and transplanted them into the rats' cervical 4-5 dorsal spinal cord level at 4 months after irradiation injury. Eight weeks after transplantation, the Olig2(+)-GFP(+)-OPCs survived and integrated into the injured spinal cord. Immunofluorescence analysis showed that the grafted Olig2(+)-GFP(+)-OPCs primarily differentiated into adenomatous polyposis coli (APC(+)) oligodendrocytes (54.6+/-10.5%). The staining with luxol fast blue, hematoxylin & eosin (LFB/H&E) and electron microscopy demonstrated that the engrafted Olig2(+)-GFP(+)-OPCs attenuated the demyelination resulted from the irradiation. More importantly, the recovery of forelimb locomotor function was enhanced in animals receiving grafts of Olig2(+)-GFP(+)-OPCs. We concluded that OPC transplantation is a feasible therapy to repair the irradiated lesions in the central nervous system (CNS).	[Sun, Yan; Xu, Chong-Chong; Gao, Lu; Ma, Li-Xiang; Li, Rui-Xi; Peng, Yu-Wen] Fudan Univ, Shanghai Med Coll, Dept Anat Histol & Embryol, Shanghai 200433, Peoples R China; [Li, Jin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Guan, Xi-Yin; Zhu, Guo-Pei] Fudan Univ, Shanghai Canc Hosp, Dept Radiat Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Peng, YW (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Anat Histol & Embryol, Shanghai 200433, Peoples R China.	ywpeng@fudan.edu.cn; antica@gmail.com		ma, lixiang/0000-0001-9399-155X	National Natural Science Foundation of China [30770637, 30901615, 81201029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported the by the National Natural Science Foundation of China (No. 30770637, 30901615 and 81201029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson S, 2003, INT J RADIAT ONCOL, V57, P1093, DOI 10.1016/S0360-3016(03)00735-1; AvellanaAdalid V, 1996, J NEUROSCI RES, V45, P558, DOI 10.1002/(SICI)1097-4547(19960901)45:5<558::AID-JNR6>3.0.CO;2-B; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bijl HP, 2003, INT J RADIAT ONCOL, V57, P274, DOI [10.1016/S0360-3016(03)00529-7, 10.1016/s0360-3016(03)00529-7]; Billon N, 2002, J CELL SCI, V115, P3657, DOI 10.1242/jcs.00049; Bruce CC, 2010, HORM BEHAV, V57, P56, DOI 10.1016/j.yhbeh.2009.06.004; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Cao Q, J NEUROSCI, V30, P2989; Cao QL, 2010, J NEUROSCI, V30, P2989, DOI 10.1523/JNEUROSCI.3174-09.2010; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; Chari DM, 2006, EXP NEUROL, V198, P145, DOI 10.1016/j.expneurol.2005.11.023; Chari DM, 2003, J NEUROSCI RES, V73, P787, DOI 10.1002/jnr.10700; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Dai XD, 2003, J NEUROSCI, V23, P5846; DELATTRE JY, 1988, BRAIN, V111, P1319, DOI 10.1093/brain/111.6.1319; Du YZ, 2002, J NEUROSCI RES, V68, P647, DOI 10.1002/jnr.10245; Du ZW, 2006, MOL CELL NEUROSCI, V33, P371, DOI 10.1016/j.mcn.2006.08.007; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Fowler JF, 2000, RADIOTHER ONCOL, V55, P295, DOI 10.1016/S0167-8140(99)00133-4; Franklin RJM, 1996, EXP NEUROL, V137, P263, DOI 10.1006/exnr.1996.0025; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-1004-6; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hopewell JW, 1999, FRONT RADIAT THER ON, V33, P265; Iwashita Y, 2000, EXP NEUROL, V164, P292, DOI 10.1006/exnr.2000.7440; Jadasz JJ, 2012, CELL TISSUE RES; Jeffery ND, 1999, EUR J NEUROSCI, V11, P1508, DOI 10.1046/j.1460-9568.1999.00564.x; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Lankford KL, 2008, GLIA, V56, P1664, DOI 10.1002/glia.20718; Li YQ, 1996, CANCER RES, V56, P5417; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; Mitsui T, 2005, J NEUROSCI, V25, P9624, DOI 10.1523/JNEUROSCI.2175-05.2005; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Mothe AJ, 2008, EXP NEUROL, V213, P176, DOI 10.1016/j.expneurol.2008.05.024; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Okada S, 2001, NEUROPATHOLOGY, V21, P247, DOI 10.1046/j.1440-1789.2001.00408.x; Rezvani M, 2001, RADIAT RES, V156, P408, DOI 10.1667/0033-7587(2001)156[0408:MORMBT]2.0.CO;2; SCHULTHEISS TE, 1986, INT J RADIAT ONCOL, V12, P1765, DOI 10.1016/0360-3016(86)90317-2; SCHULTHEISS TE, 1992, BRIT J RADIOL, V65, P737, DOI 10.1259/0007-1285-65-777-737; SCHULTHEISS TE, 1995, INT J RADIAT ONCOL, V31, P1093, DOI 10.1016/0360-3016(94)00655-5; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; Talbott JF, 2006, GLIA, V54, P147, DOI 10.1002/glia.20369; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; USHIO Y, 1977, NEUROLOGY, V27, P422, DOI 10.1212/WNL.27.5.422; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Wong CS, 2004, MOL INTERV, V4, P273, DOI 10.1124/mi.4.5.7; Zhang SC, 1998, J NEUROCYTOL, V27, P475, DOI 10.1023/A:1006953023845; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	52	44	47	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57534	10.1371/journal.pone.0057534	http://dx.doi.org/10.1371/journal.pone.0057534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460872	gold, Green Submitted, Green Published			2022-12-27	WOS:000315519000127
J	Tsai, TH; Wong, AMK; Hsu, CL; Tseng, KC				Tsai, Tsai-Hsuan; Wong, Alice May-Kuen; Hsu, Chien-Lung; Tseng, Kevin C.			Research on a Community-based Platform for Promoting Health and Physical Fitness in the Elderly Community	PLOS ONE			English	Article							OLDER-ADULTS; FRAILTY; TESTS	This study aims to assess the acceptability of a fitness testing platform (iFit) for installation in an assisted living community with the aim of promoting fitness and slowing the onset of frailty. The iFit platform develops a means of testing Bureau of Health Promotion mandated health assessment items for the elderly (including flexibility tests, grip strength tests, balance tests, and reaction time tests) and integrates wireless remote sensors in a game-like environment to capture and store subject response data, thus providing individuals in elderly care contexts with a greater awareness of their own physical condition. In this study, we specifically evaluated the users' intention of using the iFit using a technology acceptance model (TAM). A total of 101 elderly subjects (27 males and 74 females) were recruited. A survey was conducted to measure technology acceptance, to verify that the platform could be used as intended to promote fitness among the elderly. Results indicate that perceived usefulness, perceived ease of use and usage attitude positively impact behavioral intention to use the platform. The iFit platform can offer user-friendly solutions for a community-based fitness care and monitoring of elderly subjects. In summary, iFit was determined by three key drivers and discussed as follows: risk factors among the frail elderly, mechanism for slowing the advance frailty, and technology acceptance and support for promoting physical fitness.	[Tsai, Tsai-Hsuan; Tseng, Kevin C.] Chang Gung Univ, Res Ctr Ind Innovat Senior Citizens, Tao Yuan, Taiwan; [Wong, Alice May-Kuen] Chang Gung Med Fdn, Dept Phys Med & Rehabil, Tao Yuan, Taiwan; [Hsu, Chien-Lung] Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Tseng, KC (corresponding author), Chang Gung Univ, Res Ctr Ind Innovat Senior Citizens, Tao Yuan, Taiwan.	ktseng@pddlab.org	Wong, Alice M. K./ABI-1000-2020	Wong, Alice M. K./0000-0003-3586-1292	National Science Council, Taiwan, ROC [NSC 100-2410-H-182-023-MY2, NSC100-2321-B-182A-003-]; Chang Gung University [UARPD3B0081]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Chang Gung University	This work was supported in part by the National Science Council, Taiwan, ROC under Contracts NSC 100-2410-H-182-023-MY2, NSC100-2321-B-182A-003- and the Chang Gung University under Contract UARPD3B0081. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggar C, 2011, ARCH GERONTOL GERIAT, V53, pE138, DOI 10.1016/j.archger.2010.07.010; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; Bartlett MS, 1951, B J PSYCHOL-STAT SEC, V4, P1, DOI 10.1111/j.2044-8317.1951.tb00299.x; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Black J.T, 1992, MULTIVARIATE DATA AN; [Bureau of Health Promotion Department of Health], 2006, GUID HLTH FITN MAK P, P1; Campbell AJ, 1997, AGE AGEING, V26, P315, DOI 10.1093/ageing/26.4.315; Chan M, 2009, MATURITAS, V64, P90, DOI 10.1016/j.maturitas.2009.07.014; Chen CY, 2010, ARCH GERONTOL GERIAT, V50, pS43, DOI 10.1016/S0167-4943(10)70012-1; Chen ML, 2011, AFR J BUS MANAGE, V5, P7099; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; de Vries NM, 2010, AGEING RES IN PRESS; Department of Health, 2007, HLTH STAT TAIW 2007; Espinoza S, 2005, CLEV CLIN J MED, V72, P1105, DOI 10.3949/ccjm.72.12.1105; Faber MJ, 2006, ARCH PHYS MED REHAB, V87, P885, DOI 10.1016/j.apmr.2006.04.005; Ferrucci L, 2003, CRIT REV ONCOL HEMAT, V46, P127, DOI 10.1016/S1040-8428(02)00177-4; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Gobbens RJ, 2010, NURS OUTLOOK, V58, P76, DOI 10.1016/j.outlook.2009.09.005; Goodman J, 2003, AGE OLD QUESTION NAI; Hayduk L. A., 1987, STRUCTURAL EQUATION; Hilgenkamp TIM, 2010, RES DEV DISABIL, V31, P1027, DOI 10.1016/j.ridd.2010.04.012; Hirpara KM, 2008, INJURY EXTRA, V39, P86; Holzinger A, 2011, UNIVERSAL ACCESS INF, V10, P245, DOI 10.1007/s10209-010-0212-x; [HsinChu City Government HsinChu], 2010, HLTH IOH CIT; Hubbard RE, 2010, BIOGERONTOLOGY, V11, P635, DOI 10.1007/s10522-010-9292-5; Jarvenpaa SL, 1999, J COMPUTER MEDIATED, V5, P0; Jones DM, 2004, J AM GERIATR SOC, V52, P1929, DOI 10.1111/j.1532-5415.2004.52521.x; Klein BEK, 2005, ARCH GERONTOL GERIAT, V41, P141, DOI 10.1016/j.archger.2005.01.002; Levers MJ, 2006, J ADV NURS, V56, P282, DOI 10.1111/j.1365-2648.2006.04021.x; Lin CC, 2009, EPIDEMIOLOGIC STUDY; Marks A, 2009, COMPLETE GUIDE GAME, P343; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Puts MTE, 2009, J AGING STUD, V23, P258, DOI 10.1016/j.jaging.2008.03.002; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Shih CH, 2010, RES DEV DISABIL, V31, P281, DOI 10.1016/j.ridd.2009.09.013; Sparks Dorothy, 2009, Inform Prim Care, V17, P55; Theng YL, 2010, IFIP ADV INF COMM TE, V332, P152; Walsh K, 2011, AGEING INT, V36, P102, DOI 10.1007/s12126-010-9075-y; Wong AMK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040591; Xynos K, 2010, DIGIT INVEST, V6, P104, DOI 10.1016/j.diin.2010.02.004	44	12	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57452	10.1371/journal.pone.0057452	http://dx.doi.org/10.1371/journal.pone.0057452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460859	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000113
J	Kattoor, J; Gizewski, ER; Kotsis, V; Benson, S; Gramsch, C; Theysohn, N; Maderwald, S; Forsting, M; Schedlowski, M; Elsenbruch, S				Kattoor, Joswin; Gizewski, Elke R.; Kotsis, Vassilios; Benson, Sven; Gramsch, Carolin; Theysohn, Nina; Maderwald, Stefan; Forsting, Michael; Schedlowski, Manfred; Elsenbruch, Sigrid			Fear Conditioning in an Abdominal Pain Model: Neural Responses during Associative Learning and Extinction in Healthy Subjects	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; AMYGDALA ACTIVATION; MUSCULAR RESPONSES; BRAIN ACTIVATION; VISCERAL STIMULI; REINSTATEMENT; MECHANISMS; EXPOSURE; CORTEX; HYPERSENSITIVITY	Fear conditioning is relevant for elucidating the pathophysiology of anxiety, but may also be useful in the context of chronic pain syndromes which often overlap with anxiety. Thus far, no fear conditioning studies have employed aversive visceral stimuli from the lower gastrointestinal tract. Therefore, we implemented a fear conditioning paradigm to analyze the conditioned response to rectal pain stimuli using fMRI during associative learning, extinction and reinstatement. In N = 21 healthy humans, visual conditioned stimuli (CS+) were paired with painful rectal distensions as unconditioned stimuli (US), while different visual stimuli (CS-) were presented without US. During extinction, all CSs were presented without US, whereas during reinstatement, a single, unpaired US was presented. In region-of-interest analyses, conditioned anticipatory neural activation was assessed along with perceived CS-US contingency and CS unpleasantness. Fear conditioning resulted in significant contingency awareness and valence change, i.e., learned unpleasantness of a previously neutral stimulus. This was paralleled by anticipatory activation of the anterior cingulate cortex, the somatosensory cortex and precuneus (all during early acquisition) and the amygdala (late acquisition) in response to the CS+. During extinction, anticipatory activation of the dorsolateral prefrontal cortex to the CS- was observed. In the reinstatement phase, a tendency for parahippocampal activation was found. Fear conditioning with rectal pain stimuli is feasible and leads to learned unpleasantness of previously neutral stimuli. Within the brain, conditioned anticipatory activations are seen in core areas of the central fear network including the amygdala and the anterior cingulate cortex. During extinction, conditioned responses quickly disappear, and learning of new predictive cue properties is paralleled by prefrontal activation. A tendency for parahippocampal activation during reinstatement could indicate a reactivation of the old memory trace. Together, these findings contribute to our understanding of aversive visceral learning and memory processes relevant to the pathophysiology of chronic abdominal pain.	[Kattoor, Joswin; Kotsis, Vassilios; Benson, Sven; Schedlowski, Manfred; Elsenbruch, Sigrid] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany; [Gizewski, Elke R.] Med Univ Innsbruck, Clin Neuroradiol, A-6020 Innsbruck, Austria; [Gramsch, Carolin; Theysohn, Nina; Forsting, Michael] Univ Duisburg Essen, Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Maderwald, Stefan] Univ Duisburg Essen, Erwin L Hahn Inst Resonance Imaging, Essen, Germany	University of Duisburg Essen; Medical University of Innsbruck; University of Duisburg Essen; University of Duisburg Essen	Elsenbruch, S (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany.	sigrid.elsenbruch@uk-essen.de	Benson, Sven/O-7201-2019; Maderwald, Stefan/B-4241-2011; Benson, Sven/I-1981-2014; Forsting, Michael/C-6925-2013	Benson, Sven/0000-0002-4487-4258; Benson, Sven/0000-0002-4487-4258; Elsenbruch, Sigrid/0000-0002-6528-2665; KOTSIS, VASILIOS/0000-0002-3755-8097; Gizewski, Elke Ruth/0000-0001-6859-8377	German Research Foundation [DFG EL 236/9-1]	German Research Foundation(German Research Foundation (DFG))	This work was funded by the German Research Foundation (DFG EL 236/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Benson S, 2012, EUR J PAIN, V16, P349, DOI 10.1002/j.1532-2149.2011.00027.x; Berman SM, 2008, J NEUROSCI, V28, P349, DOI 10.1523/JNEUROSCI.2500-07.2008; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Coen SJ, 2011, GASTROENTEROLOGY, V141, P909, DOI 10.1053/j.gastro.2011.06.008; Craske MG, 2011, BEHAV RES THER, V49, P413, DOI 10.1016/j.brat.2011.04.001; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; De Peuter S, 2011, EUR J PAIN, V15, P889, DOI 10.1016/j.ejpain.2011.03.002; Dunsmoor JE, 2008, NEUROIMAGE, V40, P811, DOI 10.1016/j.neuroimage.2007.11.042; Dunsmoor JE, 2007, BEHAV NEUROSCI, V121, P635, DOI 10.1037/0735-7044.121.4.635; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Elsenbruch S, 2012, PAIN, V153, P382, DOI 10.1016/j.pain.2011.10.036; Elsenbruch S, 2011, BRAIN BEHAV IMMUN, V25, P386, DOI 10.1016/j.bbi.2010.11.010; Elsenbruch S, 2010, GASTROENTEROLOGY, V139, P1310, DOI 10.1053/j.gastro.2010.06.054; Fiddick L, 2011, NEUROSCI BIOBEHAV R, V35, P1007, DOI 10.1016/j.neubiorev.2010.09.014; Flor H, 2002, PAIN, V95, P111, DOI 10.1016/S0304-3959(01)00385-2; Giovanello KS, 2009, HIPPOCAMPUS, V19, P111, DOI 10.1002/hipo.20491; Hermans D, 2005, BEHAV RES THER, V43, P533, DOI 10.1016/j.brat.2004.03.013; Hermans D, 2006, BIOL PSYCHIAT, V60, P361, DOI 10.1016/j.biopsych.2005.10.006; Herrmann-Lingen C., 2005, HADS D HOSP ANXIETY; Hubbard CS, 2011, J NEUROSCI, V31, P12491, DOI 10.1523/JNEUROSCI.1860-11.2011; Klinger R, 2010, PAIN, V150, P66, DOI 10.1016/j.pain.2010.03.036; Klosterhalfen S, 2000, PSYCHOSOM MED, V62, P671, DOI 10.1097/00006842-200009000-00011; LaBar KS, 2005, BEHAV NEUROSCI, V119, P677, DOI 10.1037/0735-7044.119.3.677; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Labus JS, 2009, NEUROIMAGE, V47, P952, DOI 10.1016/j.neuroimage.2009.05.078; Lembo T, 1999, AM J GASTROENTEROL, V94, P1320, DOI 10.1111/j.1572-0241.1999.01009.x; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Lissek S, 2009, BEHAV RES THER, V47, P111, DOI 10.1016/j.brat.2008.10.017; Ljotsson B, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-110; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Nees F, 2010, PSYCHOSOM MED, V72, P412, DOI 10.1097/PSY.0b013e3181d2bbef; Norberg MM, 2008, BIOL PSYCHIAT, V63, P1118, DOI 10.1016/j.biopsych.2008.01.012; North CS, 2007, WORLD J GASTROENTERO, V13, P2020, DOI 10.3748/wjg.v13.i14.2020; Nozu T, 2006, J GASTROENTEROL, V41, P217, DOI 10.1007/s00535-005-1748-z; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Quirk GJ, 2010, J NEUROSCI, V30, P14993, DOI 10.1523/JNEUROSCI.4268-10.2010; Rosenberger C, 2009, NEUROGASTROENT MOTIL, V21, P740, DOI 10.1111/j.1365-2982.2009.01295.x; Schmajuk NA, 2007, BEHAV BRAIN RES, V177, P242, DOI 10.1016/j.bbr.2006.11.026; Schneider C, 2004, PAIN, V112, P239, DOI 10.1016/j.pain.2004.08.025; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Stockhorst U, 2007, WORLD J GASTROENTERO, V13, P3430, DOI 10.3748/wjg.v13.i25.3430; Straube T, 2007, NEUROIMAGE, V34, P462, DOI 10.1016/j.neuroimage.2006.08.021; Tabbert K, 2005, INT J PSYCHOPHYSIOL, V57, P15, DOI 10.1016/j.ijpsycho.2005.01.007; Tyler K, 2007, NEUROGASTROENT MOTIL, V19, P761, DOI 10.1111/j.1365-2982.2007.00955.x; Van Damme S, 2006, J PAIN, V7, P346, DOI 10.1016/j.jpain.2005.12.006; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vouimba RM, 2011, NEUROPSYCHOPHARMACOL, V36, P2276, DOI 10.1038/npp.2011.115; Wang Z, 2011, PAIN, V152, P2746, DOI 10.1016/j.pain.2011.08.022; Worthen SF, 2011, EUR J NEUROSCI, V33, P946, DOI 10.1111/j.1460-9568.2010.07575.x; Yaguez L, 2005, GASTROENTEROLOGY, V128, P1819, DOI 10.1053/j.gastro.2005.02.068	56	66	67	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e51149	10.1371/journal.pone.0051149	http://dx.doi.org/10.1371/journal.pone.0051149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468832	gold, Green Submitted, Green Published			2022-12-27	WOS:000315561400002
J	Kim, JH; An, HJ; Garrido, D; German, JB; Lebrilla, CB; Mills, DA				Kim, Jae-Han; An, Hyun Joo; Garrido, Daniel; German, J. Bruce; Lebrilla, Carlito B.; Mills, David A.			Proteomic Analysis of Bifidobacterium longum subsp infantis Reveals the Metabolic Insight on Consumption of Prebiotics and Host Glycans	PLOS ONE			English	Article							HUMAN-MILK OLIGOSACCHARIDES; SURFACE-PROTEINS; BETA-GALACTOSIDASES; STATISTICAL-MODEL; POLYSACCHARIDES; IDENTIFICATION; FERMENTATION; GEL; QUANTITATION; MICROBIOTA	Bifidobacterium longum subsp. infantis is a common member of the intestinal microbiota in breast-fed infants and capable of metabolizing human milk oligosaccharides (HMO). To investigate the bacterial response to different prebiotics, we analyzed both cell wall associated and whole cell proteins in B. infantis. Proteins were identified by LC-MS/MS followed by comparative proteomics to deduce the protein localization within the cell. Enzymes involved in the metabolism of lactose, glucose, galactooligosaccharides, fructooligosaccharides and HMO were constitutively expressed exhibiting less than twofold change regardless of the sugar used. In contrast, enzymes in N-Acetylglucosamine and sucrose catabolism were induced by HMO and fructans, respectively. Galactose-metabolizing enzymes phosphoglucomutase, UDP-glucose 4-epimerase and UTP glucose-1-P uridylytransferase were expressed constitutively, while galactokinase and galactose-1-phosphate uridylyltransferase, increased their expression three fold when HMO and lactose were used as substrates for cell growth. Cell wall-associated proteomics also revealed ATP-dependent sugar transport systems associated with consumption of different prebiotics. In addition, the expression of 16 glycosyl hydrolases revealed the complete metabolic route for each substrate. Mucin, which possesses O-glycans that are structurally similar to HMO did not induced the expression of transport proteins, hydrolysis or sugar metabolic pathway indicating B. infantis do not utilize these glycoconjugates.	[Kim, Jae-Han] Chungnam Natl Univ, Dept Food Nutr, Taejon, South Korea; [An, Hyun Joo] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon, South Korea; [Garrido, Daniel; Mills, David A.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA; [Garrido, Daniel; German, J. Bruce; Lebrilla, Carlito B.; Mills, David A.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA; [German, J. Bruce; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Lebrilla, Carlito B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	Chungnam National University; Chungnam National University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Mills, DA (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA.	damills@ucdavis.edu	Lebrilla, Carlito Bangeles/ABE-6369-2020; Mills, David Andrew/G-2282-2011; Garrido, Daniel/F-8229-2013; Mills, David/GXF-1821-2022	Mills, David Andrew/0000-0003-1913-9865; Garrido, Daniel/0000-0002-4982-134X; An, Hyun Joo/0000-0001-5847-7483; kim, Jaehan/0000-0001-9719-9957	University of California Discovery Grant Program; California Dairy Research Foundation; National Institute of Health [R01HD061923, R01AT007079]; Converging Research Center Program through the Ministry of Education, Science and Technology [2011K000985]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061923] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT007079] Funding Source: NIH RePORTER	University of California Discovery Grant Program(University of California System); California Dairy Research Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Converging Research Center Program through the Ministry of Education, Science and Technology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the University of California Discovery Grant Program, the California Dairy Research Foundation, and National Institute of Health Awards R01HD061923 (C.B.L.) and R01AT007079 (D.A.M.). The research was also supported by the Converging Research Center Program through the Ministry of Education, Science and Technology (2011K000985 for J.H.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDALOUSSI SA, 1995, APPL MICROBIOL BIOT, V43, P995, DOI 10.1007/BF00166915; Cole JN, 2005, INFECT IMMUN, V73, P3137, DOI 10.1128/IAI.73.5.3137-3146.2005; Elschenbroich S, 2010, EXPERT REV PROTEOMIC, V7, P141, DOI 10.1586/EPR.09.97; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Garrido D, 2013, FOOD MICROBIOL, V33, P262, DOI 10.1016/j.fm.2012.10.003; Garrido D, 2012, MOL CELL PROTEOMICS, V11, P775, DOI 10.1074/mcp.M112.018119; Garrido D, 2012, ANAEROBE, V18, P430, DOI 10.1016/j.anaerobe.2012.04.012; Garrido D, 2012, ADV NUTR, V3, p415S, DOI 10.3945/an.111.001586; Garrido D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017315; Gosling A, 2010, FOOD CHEM, V121, P307, DOI 10.1016/j.foodchem.2009.12.063; HABU Y, 1987, J BIOCHEM-TOKYO, V102, P1423, DOI 10.1093/oxfordjournals.jbchem.a122188; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kohno M, 2009, CARBOHYD POLYM, V77, P351, DOI 10.1016/j.carbpol.2009.01.013; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Lane JI, 2010, TEMPORAL BONE, P1, DOI 10.1007/978-3-642-02210-4_1; Lee HW, 2002, ANAEROBE, V8, P319, DOI 10.1016/S1075-9964(03)00030-1; Liu CT, 2009, WORLD J MICROB BIOT, V25, P883, DOI 10.1007/s11274-009-9965-x; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Mujahid S, 2007, ELECTROPHORESIS, V28, P3998, DOI 10.1002/elps.200600858; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; Ninonuevo MR, 2007, ANAL BIOCHEM, V361, P15, DOI 10.1016/j.ab.2006.11.010; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; Novik GI, 2002, MICROBIOLOGY+, V71, P173, DOI 10.1023/A:1015194020327; Pocsfalvi G, 2008, PROTEOMICS, V8, P2462, DOI 10.1002/pmic.200700965; Rabiu BA, 2001, APPL ENVIRON MICROB, V67, P2526, DOI 10.1128/AEM.67.6.2526-2530.2001; Roger LC, 2010, MICROBIOL-SGM, V156, P3317, DOI 10.1099/mic.0.041913-0; Insenser MR, 2010, J PROTEOMICS, V73, P1183, DOI 10.1016/j.jprot.2010.02.005; Rudloff S, 2012, ADV NUTR, V3, p398S, DOI 10.3945/an.111.001594; Ruiz L, 2009, MICROBIOL-SGM, V155, P957, DOI 10.1099/mic.0.024273-0; Sabarth N, 2002, J BIOL CHEM, V277, P27896, DOI 10.1074/jbc.M204473200; Salazar N, 2009, INT J FOOD MICROBIOL, V135, P260, DOI 10.1016/j.ijfoodmicro.2009.08.017; Seipert RR, 2008, ANAL CHEM, V80, P159, DOI 10.1021/ac7017298; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2012, APPL ENVIRON MICROB, V78, P795, DOI 10.1128/AEM.06762-11; Sela DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193359; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Severin A, 2007, J BACTERIOL, V189, P1514, DOI 10.1128/JB.01132-06; Solis N, 2011, PROTEOMICS, V11, P3169, DOI 10.1002/pmic.201000808; Solis N, 2010, PROTEOMICS, V10, P2037, DOI 10.1002/pmic.200900564; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tao N, 2008, J DAIRY SCI, V91, P3768, DOI 10.3168/jds.2008-1305; Tjalsma H, 2008, PROTEOMICS, V8, P1415, DOI 10.1002/pmic.200700550; ToneShimokawa Y, 1996, J BACTERIOL, V178, P317, DOI 10.1128/jb.178.1.317-320.1996; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05; Washburn MP, 2002, ANAL CHEM, V74, P1650, DOI 10.1021/ac015704l; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoshida E, 2012, GLYCOBIOLOGY, V22, P361, DOI 10.1093/glycob/cwr116; Zdorovenko EL, 2009, CARBOHYD RES, V344, P2417, DOI 10.1016/j.carres.2009.08.039	55	47	47	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57535	10.1371/journal.pone.0057535	http://dx.doi.org/10.1371/journal.pone.0057535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23469017	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400044
J	Zhao, KJ; Zhang, YW; Xu, Y; Hong, B; Huang, QH; Zhao, WY; Yang, PF; Liu, JM				Zhao, Kai-Jun; Zhang, Yong-Wei; Xu, Yi; Hong, Bo; Huang, Qing-Hai; Zhao, Wen-Yuan; Yang, Peng-Fei; Liu, Jian-Min			Reconstruction of Saccular and Dissected Intracranial Aneurysms Using Solitaire (TM) AB Stents	PLOS ONE			English	Article							ASSISTED COIL EMBOLIZATION; ENDOVASCULAR TREATMENT; PLACEMENT; TRIAL; ISAT	Introduction: We aimed to evaluate the feasibility, safety, efficacy, and predictors for outcome of reconstructive treatment with Solitaire (TM) AB stent(s) based on 54 cases of saccular aneurysms and 14 of acute symptomatic dissecting aneurysms. Methods: Fifty-eight consecutive patients (M/F = 28/30; median age, 53 years) harbouring 68 aneurysms (ruptured/unruptured = 12/56) underwent treatment with Solitaire (TM) AB stent(s) implantation between April 2010 and August 2011 in our institution. The data were retrospectively reviewed and analysed. Results: The technical success rate of Solitaire (TM) AB stenting was 100%. The rates of the overall and the treatment-related adverse events were 9% (6/68) and 6% (4/68), respectively, and the recurrent rate was 1% (1/68). All of the adverse events (n = 6) occurred in tiny (n = 1, <= 3 mm) or small (n = 5, >3 to <= 10 mm) aneurysms. The majority (75%, 3/4) of thromboembolic events (thrombus, n = 2; infarction, n = 2) occurred in ruptured lesions, and 2 intraprocedural aneurysm ruptures occurred in the course of coiling when the stent(s) was/were applied within 6 months. Subarachnoid haemorrhages (SAH, p<0.05) and immediate occlusion grades (p<0.05) were predictors for overall adverse events by univariate analysis. Compared with the immediate post-treatment angiographic results, the follow-up angiographic imaging (mean, 13 months; range, 6-25 months) revealed that stent(s) implantation enhanced the rate of class I occlusion from 34% (23/68) to 93% (63/68). SAH was the only predictor for unfavourable outcomes (the modified Rankin Scale score [mRS], 2-6) during the mean 19-month (range, 12-27 months) of clinical follow-ups (p<0.05). Conclusions: Although the complete obliteration of tiny and small aneurysms without complications remains a challenge, stent(s) implantation could lead to further occlusion of incompletely coiled aneurysms. SAH and the occlusion grade were the primary predictors for adverse events. SAH was the only predictor for unfavourable outcomes by univariate analysis.	[Zhao, Kai-Jun; Xu, Yi; Hong, Bo; Huang, Qing-Hai; Zhao, Wen-Yuan; Yang, Peng-Fei; Liu, Jian-Min] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Zhang, Yong-Wei] Second Mil Med Univ, Changhai Hosp, Dept Neurol & Neurosurg, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Liu, JM (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.	chstroke@163.com			National Natural Science Foundation of China [81171093/H0906]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (grant No. 81171093/H0906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks NP, 2008, J NEUROSURG, V108, P1095, DOI 10.3171/JNS/2008/108/6/1095; Byrne JV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012492; Fargen KM, 2012, NEUROSURGERY; Fiorella D, 2008, NEUROSURGERY, V62, P1115, DOI 10.1227/01.neu.0000325873.44881.6e; Hong B, 2011, J CLIN NEUROSCI, V18, P655, DOI 10.1016/j.jocn.2010.09.013; Hong B, 2009, NEUROSURGERY, V65, P1131, DOI 10.1227/01.NEU.0000356983.23189.16; Huang QH, 2011, AM J NEURORADIOL, V32, P1721, DOI 10.3174/ajnr.A2597; Izar B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024875; Janssen PM, 2010, CEREBROVASC DIS, V29, P137, DOI 10.1159/000262309; Kallmes DF, 2007, STROKE, V38, P2346, DOI 10.1161/STROKEAHA.106.479576; Kim BM, 2011, NEUROLOGY, V76, P1735, DOI 10.1212/WNL.0b013e31821a7d94; Kim BM, 2011, STROKE, V42, P2425, DOI 10.1161/STROKEAHA.111.617381; Kim M, 2007, NEUROSURGERY, V61, P1305, DOI 10.1227/01.NEU.0000280168.25968.49; Klisch J, 2010, NEURORADIOLOGY, V52, P349, DOI 10.1007/s00234-009-0568-x; Klisch J, 2009, NEUROSURGERY, V65, P258, DOI 10.1227/01.NEU.0000348295.44970.C8; Krischek O, 2011, MINIM INVAS NEUROSUR, V54, P21, DOI 10.1055/s-0031-1271681; Larsen CC, 2010, ACTA NEUROCHIR, V152, P1577, DOI 10.1007/s00701-010-0699-1; Lawson MF, 2011, NEUROSURGERY, V69, P598, DOI 10.1227/NEU.0b013e3182181c2b; Lee JM, 2010, ACTA NEUROCHIR, V152, P1455, DOI 10.1007/s00701-010-0683-9; Lopes D, 2005, NEUROSURGERY, V56, P416, DOI 10.1227/01.NEU.0000145867.25167.CF; Maldonado IL, 2011, AM J NEURORADIOL, V32, P131, DOI 10.3174/ajnr.A2245; Meng H, 2006, AM J NEURORADIOL, V27, P1861; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Park SI, 2009, AM J NEURORADIOL, V30, P1351, DOI 10.3174/ajnr.A1561; Pierot L, 2011, RADIOLOGY, V258, P546, DOI 10.1148/radiol.10100894; Pierot L, 2010, RADIOLOGY, V256, P916, DOI 10.1148/radiol.10092209; Raymond J, 2003, STROKE, V34, P1398, DOI 10.1161/01.STR.0000073841.88563.E9; Santillan A, 2012, NEUROSURGERY, V70, P1232, DOI 10.1227/NEU.0b013e3182422a68; Schuette AJ, 2011, NEUROSURGERY, V68, P731, DOI 10.1227/NEU.0b013e3182077373; Suh SH, 2009, J NEUROSURG, V111, P48, DOI 10.3171/2009.2.JNS081418; Tahtinen OI, 2009, RADIOLOGY, V253, P199, DOI 10.1148/radiol.2531081923; Wakhloo AK, 2008, STROKE, V39, P3288, DOI 10.1161/STROKEAHA.107.512996	33	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57253	10.1371/journal.pone.0057253	http://dx.doi.org/10.1371/journal.pone.0057253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468947	Green Published, gold, Green Submitted			2022-12-27	WOS:000315561400033
J	Gandhapudi, SK; Chilton, PM; Mitchell, TC				Gandhapudi, Siva K.; Chilton, Paula M.; Mitchell, Thomas C.			TRIF Is Required for TLR4 Mediated Adjuvant Effects on T Cell Clonal Expansion	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; TOLL-LIKE RECEPTORS; CUTTING EDGE; LIPOPOLYSACCHARIDE; CD4; EXPRESSION; AGONISTS; IDENTIFICATION; COSTIMULATION; ACCUMULATION	Toll like receptor 4 (TLR4) is an important pattern recognition receptor with the ability to drive potent innate immune responses and also to modulate adaptive immune responses needed for long term protection. Activation of TLR4 by its ligands is mediated by engagement of the adapter proteins MyD88 (myeloid differentiation factor 88) and TRIF (Toll-interleukin 1 receptor domain-containing adapter inducing interferon-beta). Previously, we showed that TRIF, but not MyD88, plays an important role in allowing TLR4 agonists to adjuvant early T cell responses. In this study, we investigated the T cell priming events that are regulated specifically by the TRIF signaling branch of TLR4. We found that TRIF deficiency prevented the TLR4 agonist lipid A from enhancing T cell proliferation and survival in an adoptive transfer model of T cell priming. TRIF deficient DC showed defective maturation as evidenced by their failure to upregulate co-stimulatory molecules in response to lipid A stimulation. Importantly, TRIF alone caused CD86 and CD40 upregulation on splenic DC, but both TRIF and MyD88 were required for CD80 upregulation. The impairment of T cell adjuvant effects and defective DC maturation in TRIF (lps/lps) mice after TLR4 stimulation was mainly due to loss of type I IFN production, indicating that type I interferons are central to TLR4's adjuvant effects. These results are useful for the continued development of TLR4 based vaccine adjuvants that avoid inflammatory risks while retaining beneficial immune response.	[Gandhapudi, Siva K.; Chilton, Paula M.; Mitchell, Thomas C.] Univ Louisville, Sch Med, Inst Cellular Therapeut, Louisville, KY 40292 USA; [Mitchell, Thomas C.] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Mitchell, TC (corresponding author), Univ Louisville, Sch Med, Inst Cellular Therapeut, Louisville, KY 40292 USA.	tom.mitchell@louisville.edu	Mitchell, Thomas C/B-4193-2013	Chilton, Paula/0000-0002-8749-0975	National Institute of Health [RO1-AI071047]; Barnstable Brown research foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071047] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnstable Brown research foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by National Institute of Health grant awarded to Thomas C Mitchell (grant RO1-AI071047) and the Barnstable Brown research foundation. The funders had no role in study desing, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Alderson MR, 2006, J ENDOTOXIN RES, V12, P313, DOI 10.1179/096805106X118753; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Durand V, 2004, IMMUNOL CELL BIOL, V82, P596, DOI 10.1111/j.0818-9641.2004.01285.x; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Eri R, 2008, INFLAMM BOWEL DIS, V14, P458, DOI 10.1002/ibd.20344; Fang WF, 2007, AM J PHYSIOL-LUNG C, V293, pL336, DOI 10.1152/ajplung.00011.2007; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Fox CB, 2010, SUBCELL BIOCHEM, V53, P303, DOI 10.1007/978-90-481-9078-2_14; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Johnson DA, 2008, CURR TOP MED CHEM, V8, P64, DOI 10.2174/156802608783378882; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; MacKenzie SA, 2010, MOL IMMUNOL, V47, P1450, DOI 10.1016/j.molimm.2010.02.009; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Maxwell JR, 2002, J IMMUNOL, V168, P4372, DOI 10.4049/jimmunol.168.9.4372; McAleer JP, 2008, CRIT REV IMMUNOL, V28, P281; McAleer JP, 2007, J IMMUNOL, V179, P6524, DOI 10.4049/jimmunol.179.10.6524; McAleer JP, 2009, J IMMUNOL, V182, P5322, DOI 10.4049/jimmunol.0803616; Mitchell TC, 2002, ANN NY ACAD SCI, V975, P114, DOI 10.1111/j.1749-6632.2002.tb05946.x; Nolan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006600; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Saibil SD, 2007, J IMMUNOL, V178, P2932, DOI 10.4049/jimmunol.178.5.2932; Sathe P, 2008, MUCOSAL IMMUNOL, V1, P425, DOI 10.1038/mi.2008.56; Sengupta S, 2005, IMMUNOBIOLOGY, V210, P647, DOI 10.1016/j.imbio.2005.06.003; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Thompson BS, 2005, EUR J IMMUNOL, V35, P3196, DOI 10.1002/eji.200526132; Thompson BS, 2004, J IMMUNOL METHODS, V295, P79, DOI 10.1016/j.jim.2004.09.008; Ulrich J T, 1995, Pharm Biotechnol, V6, P495; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; Weighardt H, 2004, EUR J IMMUNOL, V34, P558, DOI 10.1002/eji.200324714; Yamamoto M, 2009, ADV EXP MED BIOL, V667, P59, DOI 10.1007/978-1-4419-1603-7_6; Yang D, 2012, J EXP MED, V209, P157, DOI 10.1084/jem.20101354; Yoneyama H, 2002, J EXP MED, V195, P1257, DOI 10.1084/jem.20011983	59	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56855	10.1371/journal.pone.0056855	http://dx.doi.org/10.1371/journal.pone.0056855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457630	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700090
J	Unuma, K; Aki, T; Funakoshi, T; Yoshida, K; Uemura, K				Unuma, Kana; Aki, Toshihiko; Funakoshi, Takeshi; Yoshida, Ken-ichi; Uemura, Koichi			Cobalt Protoporphyrin Accelerates TFEB Activation and Lysosome Reformation during LPS-Induced Septic Insults in the Rat Heart	PLOS ONE			English	Article							CARDIAC MITOCHONDRIAL BIOGENESIS; HEME OXYGENASE-1 GENE; RESPIRATORY FACTOR-I; TOLL-LIKE RECEPTOR; NF-KAPPA-B; INFLAMMATORY RESPONSE; CELL-DEATH; AUTOPHAGY; MONOXIDE; MICE	Lipopolysaccharide (LPS)-induced myocardial dysfunction is caused, at least in part, by mitochondrial dysfunction. Mitochondrial dysfunction and the oxidative damage associated with it are scavenged through various cellular defense systems such as autophagy to prevent harmful effects. Our recent study has demonstrated that cobalt protoporphyrin IX (CoPPIX), a potent inducer of heme oxygenase-1 (HO-1), ameliorates septic liver injuries by enhancing mitochondrial autophagy in rats. In our current study, we show that CoPPIX (5 mg/kg s.c.) not only accelerates the autophagic response but also promotes lysosome reformation in the rat heart treated with LPS (15 mg/kg i.p.). Lysosomal membrane-associated protein-2 (LAMP2), which is essential to the maintenance of lysosomal functions in the heart, is depleted transiently but restored rapidly during LPS administration in the rat. Activation of transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy, was also observed, indicating a hyper consumption and subsequent reformation of the lysosome to meet the increased demand for autophagosome cleaning. CoPPIX was found to promote these processes and tended to restore the LPS-induced suppression of cardiac performances whilst chloroquine (CQ; 20 mg/kg i.p.), an inhibitor of lysosomes and autophagic protein degradation, abrogates these beneficial effects. The cardioprotective effect of CoPPIX against LPS toxicity was also observed via decreased levels of cardiac releasing enzymes in the plasma. Taken together, our current data indicate that lysosome reformation mediated by TFEB may be involved in cardioprotection against LPS-induced septic insults, and serve as a novel mechanism by which CoPPIX protects the heart against oxidative stress.	[Unuma, Kana; Aki, Toshihiko; Funakoshi, Takeshi; Uemura, Koichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Forens Med, Tokyo, Japan; [Yoshida, Ken-ichi] Univ Tokyo, Dept Forens Med, Grad Sch Med, Tokyo, Japan; [Yoshida, Ken-ichi] Univ Tokyo, Fac Med, Tokyo 113, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo	Aki, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Forens Med, Tokyo, Japan.	aki.legm@tmd.ac.jp			Japan Society for the Promotion of Science [24790639, 22590629, 30586425]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in Aid from the Japan Society for the Promotion of Science (Grant 24790639 to K. Unuma, Grant 22590629 to TA and Grant 30586425 to K. Uemura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrades M, 2011, J SURG RES, V167, pE307, DOI 10.1016/j.jss.2009.08.005; Avlas O, 2011, ANTIOXID REDOX SIGN, V15, P1895, DOI 10.1089/ars.2010.3728; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Chen B, 2009, AM J PATHOL, V175, P422, DOI 10.2353/ajpath.2009.081033; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dare AJ, 2009, FREE RADICAL BIO MED, V47, P1517, DOI 10.1016/j.freeradbiomed.2009.08.019; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Fortunato F, 2009, GASTROENTEROLOGY, V137, P350, DOI 10.1053/j.gastro.2009.04.003; GALBRAITH RA, 1989, P NATL ACAD SCI USA, V86, P7653, DOI 10.1073/pnas.86.19.7653; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Hickson-Bick DLM, 2008, J MOL CELL CARDIOL, V44, P411, DOI 10.1016/j.yjmcc.2007.10.013; Hsieh CH, 2011, ANN SURG, V253, P1190, DOI 10.1097/SLA.0b013e318214b67e; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Lee SJ, 2011, AM J RESP CELL MOL, V45, P867, DOI 10.1165/rcmb.2010-0352OC; Lin WJ, 2005, SHOCK, V24, P206, DOI 10.1097/01.shk.0000180074.69143.77; Ma X., 2012, CIRCULATION; Ma X, 2012, AUTOPHAGY, V8, P3, DOI DOI 10.4161/AUT0.18658; Minutoli L, 2008, EUR J PHARMACOL, V589, P272, DOI 10.1016/j.ejphar.2008.04.005; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; O'Brien PJ, 2008, TOXICOLOGY, V245, P206, DOI 10.1016/j.tox.2007.12.006; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Ruivo R, 2009, BBA-MOL CELL RES, V1793, P636, DOI 10.1016/j.bbamcr.2008.12.008; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Schmidt R, 2004, J HEPATOL, V41, P706, DOI 10.1016/j.jhep.2004.07.004; Sehmidt R, 2007, ANN SURG, V245, P931, DOI 10.1097/01.sla.0000256891.45790.4d; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shan Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P219, DOI 10.1006/abbi.2000.1921; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; SMITH TJ, 1987, PHARMACOLOGY, V34, P9, DOI 10.1159/000138242; Srigley JR, 2009, MODERN PATHOL, V22, pS2, DOI 10.1038/modpathol.2009.70; Suliman HB, 2010, J CELL SCI, V123, P2565, DOI 10.1242/jcs.064089; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Unuma K, 2012, HEPATOL RES, DOI 10.1111/j.1872-034X.2012.01049.x; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	43	33	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56526	10.1371/journal.pone.0056526	http://dx.doi.org/10.1371/journal.pone.0056526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457579	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700060
J	Wang, LH; Cao, HL; Lu, N; Liu, LP; Wang, BM; Hu, TH; Israel, DA; Peek, RM; Polk, DB; Yan, F				Wang, Lihong; Cao, Hailong; Lu, Ning; Liu, Liping; Wang, Bangmao; Hu, Tianhui; Israel, Dawn A.; Peek, Richard M., Jr.; Polk, D. Brent; Yan, Fang			Berberine Inhibits Proliferation and Down-Regulates Epidermal Growth Factor Receptor through Activation of Cbl in Colon Tumor Cells	PLOS ONE			English	Article							CANCER-CELLS; COLORECTAL-CANCER; GENOTOXIC STRESS; EGF RECEPTOR; APOPTOSIS; PATHWAYS; MECHANISM; ADENOMAS; ARREST; DEATH	Berberine, an isoquinoline alkaloid, is an active component of Ranunculaceae and Papaveraceae plant families. Berberine has been found to suppress growth of several tumor cell lines in vitro through the cell-type-dependent mechanism. Expression and activation of epidermal growth factor receptor (EGFR) is increased in colonic precancerous lesions and tumours, thus EGFR is considered a tumour promoter. The aim of this study was to investigate the effects and mechanisms of berberine on regulation of EGFR activity and proliferation in colonic tumor cell lines and in vivo. We reported that berberine significantly inhibited basal level and EGF-stimulated EGFR activation and proliferation in the immorto Min mouse colonic epithelial (IMCE) cells carrying the APC(min) mutation and human colonic carcinoma cell line, HT-29 cells. Berberine acted to inhibit proliferation through inducing G1/S and G2/M cell cycle arrest, which correlated with regulation of the checkpoint protein expression. In this study, we also showed that berberine stimulated ubiquitin ligase Cbl activation and Cbl's interaction with EGFR, and EGFR ubiquitinylation and down-regulation in these two cell lines in the presence or absence of EGF treatment. Knock-down Cbl expression blocked the effects of berberine on down-regulation of EGFR and inhibition of proliferation. Furthermore, berberine suppressed tumor growth in the HT-29 cell xenograft model. Cell proliferation and EGFR expression level was decreased by berberine treatment in this xenograft model and in colon epithelial cells of APC(min/+) mice. Taken together, these data indicate that berberine enhances Cbl activity, resulting in downregulation of EGFR expression and inhibition of proliferation in colon tumor cells.	[Wang, Lihong; Hu, Tianhui] Xiamen Univ, Coll Med, Ctr Canc, Xiamen, Peoples R China; [Wang, Lihong; Cao, Hailong; Lu, Ning; Liu, Liping; Yan, Fang] Vanderbilt Univ, Med Ctr, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Nashville, TN 37235 USA; [Cao, Hailong; Wang, Bangmao] Tianjin Med Univ, Gen Hosp, Dept Med, Tianjin, Peoples R China; [Lu, Ning; Yan, Fang] Tianjin Med Univ, Canc Inst & Hosp, Dept Breast Canc Med Oncol, Key Lab Breast Canc Prevent & Therapy, Tianjin, Peoples R China; [Israel, Dawn A.; Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Polk, D. Brent] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Polk, D. Brent] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Polk, D. Brent] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA	Xiamen University; Vanderbilt University; Tianjin Medical University; Tianjin Medical University; Vanderbilt University; Vanderbilt University; University of Southern California; University of Southern California; Children's Hospital Los Angeles	Yan, F (corresponding author), Vanderbilt Univ, Med Ctr, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Nashville, TN 37235 USA.	fang.yan@vanderbilt.edu	liu, li/HGC-0900-2022		National Institutes of Health [R01DK081134, R01DK56008]; National Nature Science Foundation of China [81070283, 30971524, 81172284]; NIH grant [P30DK058404]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056008, P30DK058404, R01DK081134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01DK081134 (F.Y.), R01DK56008 (D.B.P.), National Nature Science Foundation of China grants 81070283 (B.W.), 30971524 and 81172284 (T.H.), core services performed through Vanderbilt University Medical Center's Digestive Disease Research Center supported by NIH grant P30DK058404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alferez D, 2008, MOL CANCER THER, V7, P590, DOI 10.1158/1535-7163.MCT-07-0433; Bucci M, 2000, BRIT J PHARMACOL, V131, P13, DOI 10.1038/sj.bjp.0703549; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Cohen G, 2006, CANCER RES, V66, P5656, DOI 10.1158/0008-5472.CAN-05-0308; de Melker AA, 2004, J CELL SCI, V117, P5001, DOI 10.1242/jcs.01354; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Fayolle C, 2006, CELL CYCLE, V5, P1859, DOI 10.4161/cc.5.16.3119; Goel GA, 2011, AM J GASTROENTEROL, V106, P719, DOI 10.1038/ajg.2011.51; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; Gu LL, 2011, J INFECT DIS, V203, P1602, DOI 10.1093/infdis/jir147; Hogel H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027112; Jauhiainen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033208; Liebermann Dan A., 2011, Critical Reviews in Oncogenesis, V16, P129; Malynn BA, 2000, GENE DEV, V14, P1390; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Murthy KNC, 2012, EUR J PHARMACOL, V688, P14, DOI 10.1016/j.ejphar.2012.05.004; Oksvold MP, 2003, ONCOGENE, V22, P8509, DOI 10.1038/sj.onc.1207117; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Sun YY, 2009, ANTI-CANCER DRUG, V20, P757, DOI 10.1097/CAD.0b013e328330d95b; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Tillhon M, 2012, BIOCHEM PHARMACOL, V84, P1260, DOI 10.1016/j.bcp.2012.07.018; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Wang N, 2010, J CELL BIOCHEM, V111, P1426, DOI 10.1002/jcb.22869; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; WHITEHEAD RH, 1994, EPITHELIAL CELL BIOL, V3, P119; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Zhang XL, 2010, CANCER RES, V70, P9895, DOI 10.1158/0008-5472.CAN-10-1546	35	50	58	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56666	10.1371/journal.pone.0056666	http://dx.doi.org/10.1371/journal.pone.0056666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457600	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700089
J	Merlet, I; Birot, G; Salvador, R; Molaee-Ardekani, B; Mekonnen, A; Soria-Frish, A; Ruffini, G; Miranda, PC; Wendling, F				Merlet, Isabelle; Birot, Gwenael; Salvador, Ricardo; Molaee-Ardekani, Behnam; Mekonnen, Abeye; Soria-Frish, Aureli; Ruffini, Giulio; Miranda, Pedro C.; Wendling, Fabrice			From Oscillatory Transcranial Current Stimulation to Scalp EEG Changes: A Biophysical and Physiological Modeling Study	PLOS ONE			English	Article							MAGNETIC STIMULATION; BRAIN-STIMULATION; BASIC MECHANISMS; ELECTRIC-FIELDS; CEREBRAL-CORTEX; MEMORY; EXCITABILITY; DYNAMICS; SEIZURES; RHYTHMS	Both biophysical and neurophysiological aspects need to be considered to assess the impact of electric fields induced by transcranial current stimulation (tCS) on the cerebral cortex and the subsequent effects occurring on scalp EEG. The objective of this work was to elaborate a global model allowing for the simulation of scalp EEG signals under tCS. In our integrated modeling approach, realistic meshes of the head tissues and of the stimulation electrodes were first built to map the generated electric field distribution on the cortical surface. Secondly, source activities at various cortical macro-regions were generated by means of a computational model of neuronal populations. The model parameters were adjusted so that populations generated an oscillating activity around 10 Hz resembling typical EEG alpha activity. In order to account for tCS effects and following current biophysical models, the calculated component of the electric field normal to the cortex was used to locally influence the activity of neuronal populations. Lastly, EEG under both spontaneous and tACS-stimulated (transcranial sinunoidal tCS from 4 to 16 Hz) brain activity was simulated at the level of scalp electrodes by solving the forward problem in the aforementioned realistic head model. Under the 10 Hz-tACS condition, a significant increase in alpha power occurred in simulated scalp EEG signals as compared to the no-stimulation condition. This increase involved most channels bilaterally, was more pronounced on posterior electrodes and was only significant for tACS frequencies from 8 to 12 Hz. The immediate effects of tACS in the model agreed with the post-tACS results previously reported in real subjects. Moreover, additional information was also brought by the model at other electrode positions or stimulation frequency. This suggests that our modeling approach can be used to compare, interpret and predict changes occurring on EEG with respect to parameters used in specific stimulation configurations.	[Merlet, Isabelle; Birot, Gwenael; Molaee-Ardekani, Behnam; Wendling, Fabrice] INSERM, U1099, Rennes, France; [Merlet, Isabelle; Birot, Gwenael; Molaee-Ardekani, Behnam; Wendling, Fabrice] Univ Rennes 1, LTSI, Rennes, France; [Salvador, Ricardo; Mekonnen, Abeye; Miranda, Pedro C.] Univ Lisbon, Inst Biophys & Biomed Engn, Fac Sci, P-1699 Lisbon, Portugal; [Soria-Frish, Aureli; Ruffini, Giulio] Starlab Barcelona, Barcelona, Spain; [Miranda, Pedro C.] Neuroelect Barcelona, Barcelona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universidade de Lisboa	Merlet, I (corresponding author), INSERM, U1099, Rennes, France.	isabelle.merlet@univ-rennes1.fr	Miranda, Pedro C/A-5643-2013; Merlet, Isabelle/M-6572-2016; WENDLING, Fabrice/P-9574-2019; Merlet, Isabelle/O-3752-2019; Salvador, Ricardo/K-2301-2015; Wendling, Fabrice/F-8924-2013	Miranda, Pedro C/0000-0002-6793-8111; Merlet, Isabelle/0000-0003-2590-6848; WENDLING, Fabrice/0000-0003-2428-9665; Merlet, Isabelle/0000-0003-2590-6848; Salvador, Ricardo/0000-0003-1235-6533; Ruffini, Giulio/0000-0003-3084-0177; Soria-Frisch, Aureli/0000-0002-4704-927X	Seventh Framework Program for Research of the European Commission, Future and Emerging Technologies (FET) program, FET-Open [222079]	Seventh Framework Program for Research of the European Commission, Future and Emerging Technologies (FET) program, FET-Open	This work was supported by the Seventh Framework Program for Research of the European Commission, Future and Emerging Technologies (FET) program, FET-Open grant number: 222079 (http://hive-eu.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann SB, 1997, IEEE T BIO-MED ENG, V44, P220, DOI 10.1109/10.554770; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Breakspear M, 2006, CEREB CORTEX, V16, P1296, DOI 10.1093/cercor/bhj072; Chen CC, 2009, NEUROIMAGE, V45, P453, DOI 10.1016/j.neuroimage.2008.12.041; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Cosandier-Rimele D, 2008, NEUROIMAGE, V42, P135, DOI 10.1016/j.neuroimage.2008.04.185; Cosandier-Rimele D, 2007, IEEE T BIO-MED ENG, V54, P380, DOI 10.1109/TBME.2006.890489; Cosandier-Rimele D, 2010, J CLIN NEUROPHYSIOL, V27, P465, DOI 10.1097/WNP.0b013e3182005dcd; David O, 2003, NEUROIMAGE, V20, P1743, DOI 10.1016/j.neuroimage.2003.07.015; Demanuele C, 2013, CLIN NEUROPHYSIOL, V124, P247, DOI 10.1016/j.clinph.2012.07.021; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dogdas B, 2005, HUM BRAIN MAPP, V26, P273, DOI 10.1002/hbm.20159; Esser SK, 2005, J NEUROPHYSIOL, V94, P622, DOI 10.1152/jn.01230.2004; Fell J, 2002, INT J NEUROSCI, V112, P893, DOI 10.1080/00207450290025905; Freeman W J, 1978, Electroencephalogr Clin Neurophysiol Suppl, P9; FREEMAN WJ, 1987, BIOL CYBERN, V56, P139, DOI 10.1007/BF00317988; Fregni F, 2006, EPILEPSIA, V47, P335, DOI 10.1111/j.1528-1167.2006.00426.x; Fregni F, 2006, DEPRESS ANXIETY, V23, P482, DOI 10.1002/da.20201; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Goncalves SI, 2003, IEEE T BIO-MED ENG, V50, P754, DOI 10.1109/TBME.2003.812164; Goodfellow M, 2011, NEUROIMAGE, V55, P920, DOI 10.1016/j.neuroimage.2010.12.074; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; JEFFERYS JGR, 1981, J PHYSIOL-LONDON, V319, P143, DOI 10.1113/jphysiol.1981.sp013897; Kim JW, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031907; Kirov R, 2009, P NATL ACAD SCI USA, V106, P15460, DOI 10.1073/pnas.0904438106; Knock SA, 2009, J NEUROSCI METH, V183, P86, DOI 10.1016/j.jneumeth.2009.07.007; LOPESDAS.FH, 1974, KYBERNETIK, V15, P27, DOI 10.1007/BF00270757; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Molaee-Ardekani B, 2012, BRAIN STIMU IN PRESS; Molaee-Ardekani B, 2010, NEUROIMAGE, V52, P1109, DOI 10.1016/j.neuroimage.2009.12.049; NICHOLSON PW, 1965, EXP NEUROL, V13, P386, DOI 10.1016/0014-4886(65)90126-3; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Parazzini M, 2011, IEEE T BIO-MED ENG, V58, P1773, DOI 10.1109/TBME.2011.2116019; Pinotsis DA, 2013, NEUROIMAGE, V66, P563, DOI 10.1016/j.neuroimage.2012.10.078; Pinotsis DA, 2012, NEUROIMAGE, V59, P1261, DOI [10.1016/j.neuroimage.2011.08.020, 10.1016/j.neuroimage.2010.12.039]; PLONSEY R, 1967, B MATH BIOPHYS, V29, P657, DOI 10.1007/BF02476917; Reis J, 2008, BRAIN STIMUL, V1, P363, DOI 10.1016/j.brs.2008.08.001; Roberts JA, 2008, J THEOR BIOL, V253, P189, DOI 10.1016/j.jtbi.2008.03.005; Robinson PA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011904; Rushton WAH, 1927, J PHYSIOL-LONDON, V63, P357, DOI 10.1113/jphysiol.1927.sp002409; Sabel BA, 2011, RESTOR NEUROL NEUROS, V29, P493, DOI 10.3233/RNN-2011-0624; Salvador R, 2010, IEEE ENG MED BIO, P2073, DOI 10.1109/IEMBS.2010.5626315; Schurmann M, 2000, NEUROSCI LETT, V292, P175, DOI 10.1016/S0304-3940(00)01456-7; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Shattuck DW, 2001, IEEE T MED IMAGING, V20, P1167, DOI 10.1109/42.963819; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; STERIADE M, 1990, ELECTROEN CLIN NEURO, V76, P481, DOI 10.1016/0013-4694(90)90001-Z; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Suffczynski P, 2001, INT J PSYCHOPHYSIOL, V43, P25, DOI 10.1016/S0167-8760(01)00177-5; Touboul J, 2011, NEURAL COMPUT, V23, P3232, DOI 10.1162/NECO_a_00206; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Wendling F, 2000, BIOL CYBERN, V83, P367, DOI 10.1007/s004220000160; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766	58	45	45	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57330	10.1371/journal.pone.0057330	http://dx.doi.org/10.1371/journal.pone.0057330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468970	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900072
J	Pe'er, T; Lahmi, R; Sharaby, Y; Chorni, E; Noach, M; Vecsler, M; Zlotorynski, E; Steen, H; Steen, JA; Tzur, A				Pe'er, Tal; Lahmi, Roxane; Sharaby, Yaara; Chorni, Evelin; Noach, Meirav; Vecsler, Manuela; Zlotorynski, Eitan; Steen, Hanno; Steen, Judith A.; Tzur, Amit			Gas2l3, a Novel Constriction Site-Associated Protein Whose Regulation Is Mediated by the APC/C Cdh1 Complex	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; CHROMATID SEPARATION; GROWTH ARREST; CYTOKINESIS; SPECTRAPLAKINS; ABSCISSION; SUBSTRATE; CELLS; COMPLEX/CYCLOSOME; DEGRADATION	Growth arrest-specific 2-like protein 3 (Gas2l3) was recently identified as an Actin/Tubulin cross-linker protein that regulates cytokinesis. Using cell-free systems from both frog eggs and human cells, we show that the Gas2l3 protein is targeted for ubiquitin-mediated proteolysis by the APC/C-Cdh1 complex, but not by the APC/C-Cdc20 complex, and is phosphorylated by Cdk1 in mitosis. Moreover, late in cytokinesis, Gas2l3 is exclusively localized to the constriction sites, which are the narrowest parts of the intercellular bridge connecting the two daughter cells. Overexpression of Gas2l3 specifically interferes with cell abscission, which is the final stage of cell division, when the cutting of the intercellular bridge at the constriction sites occurs. We therefore suggest that Gas2l3 is part of the cellular mechanism that terminates cell division.	[Pe'er, Tal; Lahmi, Roxane; Sharaby, Yaara; Chorni, Evelin; Noach, Meirav; Vecsler, Manuela; Zlotorynski, Eitan; Tzur, Amit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Pe'er, Tal; Lahmi, Roxane; Sharaby, Yaara; Chorni, Evelin; Noach, Meirav; Vecsler, Manuela; Tzur, Amit] Bar Ilan Univ, Inst Nanotechnol & Adv Mat, Ramat Gan, Israel; [Steen, Hanno; Steen, Judith A.] Boston Childrens Hosp, Prote Ctr, Boston, MA USA; [Steen, Hanno] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Steen, Hanno] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Steen, Judith A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Steen, Judith A.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA USA	Bar Ilan University; Bar Ilan University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Tzur, A (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	amit.tzur@biu.ac.il			Marie Curie International Reintegration Grant [PIRG-GA-2010-277062]; Israeli Centers of Research Excellence (I-CORE); Gene Regulation in Complex Human Disease, Center [41/11]; Israel Cancer Association [20120067]; German-Israeli Foundation (GIF) [2294-2269.2/2011]; NIH [R01GM094844, R01NS066973]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066973] Funding Source: NIH RePORTER	Marie Curie International Reintegration Grant(European Commission); Israeli Centers of Research Excellence (I-CORE); Gene Regulation in Complex Human Disease, Center; Israel Cancer Association; German-Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially funded by the Marie Curie International Reintegration Grant PIRG-GA-2010-277062 (AT), and by the Israeli Centers of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease, Center No. 41/11 (AT), the Israel Cancer Association Grant 20120067 (AT), the German-Israeli Foundation (GIF), No. 2294-2269.2/2011 (AT), and the NIH: R01GM094844 (HS) and R01NS066973 (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Bastos RN, 2010, J CELL BIOL, V191, P751, DOI 10.1083/jcb.201008108; BRANCOLINI C, 1992, J CELL BIOL, V117, P1251, DOI 10.1083/jcb.117.6.1251; Brown NH, 2008, CELL, V135, P16, DOI 10.1016/j.cell.2008.09.023; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Ferrell J E Jr, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.52.pe1; Goriounov D, 2003, J CELL SCI, V116, P1045, DOI 10.1242/jcs.00272; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Lee KKH, 1999, DEV BIOL, V207, P14; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Lui C, 2012, IUBMB LIFE, V64, P209, DOI 10.1002/iub.599; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Raiborg C, 2011, SCIENCE, V331, P1533, DOI 10.1126/science.1204208; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sharp DJ, 2012, J CELL SCI, V125, P2561, DOI 10.1242/jcs.101139; Stroud MJ, 2011, J BIOL CHEM, V286, P24987, DOI 10.1074/jbc.M111.242263; Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008; Wolter P, 2012, J CELL SCI, V125, P2393, DOI 10.1242/jcs.097253; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024698; Zhao WM, 2005, J BIOL CHEM, V280, P33516, DOI 10.1074/jbc.M504657200; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	33	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57532	10.1371/journal.pone.0057532	http://dx.doi.org/10.1371/journal.pone.0057532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469016	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900116
J	Shames, DS; Carbon, J; Walter, K; Jubb, AM; Kozlowski, C; Januario, T; AnDo; Fu, L; Xiao, YY; Raja, R; Jiang, B; Malekafzali, A; Stern, H; Settleman, J; Wilson, TR; Hampton, GM; Yauch, RL; Pirzkall, A; Amler, LC				Shames, David S.; Carbon, Juliet; Walter, Kim; Jubb, Adrian M.; Kozlowski, Cleopatra; Januario, Tom; AnDo; Fu, Ling; Xiao, Yuanyuan; Raja, Rajiv; Jiang, Brittany; Malekafzali, Ashi; Stern, Howard; Settleman, Jeff; Wilson, Timothy R.; Hampton, Garret M.; Yauch, Robert L.; Pirzkall, Andrea; Amler, Lukas C.			High Heregulin Expression Is Associated with Activated HER3 and May Define an Actionable Biomarker in Patients with Squamous Cell Carcinomas of the Head and Neck	PLOS ONE			English	Article							LUNG-CANCER; BIOLOGY; ERBB3; RECURRENT; RECEPTOR	Purpose: Tumors with oncogenic dependencies on the HER family of receptor tyrosine kinases (RTKs) often respond well to targeted inhibition. Our previous work suggested that many cell lines derived from squamous cell carcinomas of the head and neck (SCCHNs) depend on autocrine signaling driven by HER2/3 dimerization and high-level co-expression of HRG. Additionally, results from a Phase I trial of MEHD7495A, a dual-action antibody that blocks ligand binding to EGFR and HER3, suggest that high-level HRG expression was associated with clinical response in SCCHN patients. Here we explore the hypothesis that high-level HRG expression defines a subpopulation of SCCHNs with activated HER3. Experimental Design: qRT-PCR expression profiling was performed on >750 tumors of diverse origin, including >150 therapy-naive, primary, and recurrent SCCHNs. Activated HER3, defined by immunoprecipitation of phospho-HER3, was compared to HRG expression in SCCHN samples. Paracrine versus autocrine expression was evaluated using RNA-in situ hybridization. Results: SCCHN tumors express the highest levels of HRG compared to a diverse collection of other tumor types. We show that high HRG expression is associated with activated HER3, whereas low HRG expression is associated with low HER3 activation in SCCHN tumors. Furthermore, HRG expression is higher in recurrent SCCHN compared to patient-matched therapy naive specimens. Conclusions: HRG expression levels define a biologically distinct subset of SCCHN patients. We propose that high-level expression of HRG is associated with constitutive activation of HER3 in SCCHN and thus defines an actionable biomarker for interventions targeting HER3.	[Shames, David S.; Carbon, Juliet; Walter, Kim; Januario, Tom; AnDo; Fu, Ling; Raja, Rajiv; Jiang, Brittany; Malekafzali, Ashi; Wilson, Timothy R.; Hampton, Garret M.; Yauch, Robert L.; Amler, Lukas C.] Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Jubb, Adrian M.; Stern, Howard] Genentech Inc, Res Pathol, San Francisco, CA 94080 USA; [Pirzkall, Andrea] Genentech Inc, Early Clin Dev, San Francisco, CA 94080 USA; [Xiao, Yuanyuan] Genentech Inc, Biostat, San Francisco, CA 94080 USA; [Kozlowski, Cleopatra] Genentech Inc, Safety Assessment Pathol, San Francisco, CA 94080 USA; [Settleman, Jeff] Genentech Inc, Mol Diagnost & Canc Cell Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Shames, DS (corresponding author), Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA.	shames.david@gene.com; Amler.Lukas@gene.com			Genentech	Genentech(Roche HoldingGenentech)	This study was funded by Genentech (www.gene.com). All authors are employees of Genentech and Genentech played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cervantes-Ruiperez A, 2012, ASCO M, V30, P2568; Cohen EEW, 2009, LANCET ONCOL, V10, P247, DOI 10.1016/S1470-2045(09)70002-6; del Campo JM, 2011, BRIT J CANCER, V105, P618, DOI 10.1038/bjc.2011.237; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; LEFEBVRE JL, 2005, ANN ONCOL S, V16, P7; Morgan S, 2009, EXP CELL RES, V315, P572, DOI 10.1016/j.yexcr.2008.08.009; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Stewart JSW, 2009, J CLIN ONCOL, V27, P1864, DOI 10.1200/JCO.2008.17.0530; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Walter K, 2012, CLIN CANCER RES, V18, P2360, DOI 10.1158/1078-0432.CCR-11-2635-T; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011	20	59	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56765	10.1371/journal.pone.0056765	http://dx.doi.org/10.1371/journal.pone.0056765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468880	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900037
J	O'Haire, ME; McKenzie, SJ; Beck, AM; Slaughter, V				O'Haire, Marguerite E.; McKenzie, Samantha J.; Beck, Alan M.; Slaughter, Virginia			Social Behaviors Increase in Children with Autism in the Presence of Animals Compared to Toys	PLOS ONE			English	Article							SPECTRUM DISORDER; COMMUNICATION QUESTIONNAIRE; YOUNG-CHILDREN; HUMAN HEALTH; TEACHERS; STUDENTS; THERAPY; FRIENDSHIP; EFFICACY; SKILLS	Background: Previous research has demonstrated the capacity of animal presence to stimulate social interaction among humans. The purpose of this study was to examine the interactions of children with autism spectrum disorder (ASD) with an adult and their typically-developing peers in the presence of animals (two guinea pigs) compared to toys. Methods: Ninety-nine children from 15 classrooms in 4 schools met the inclusion criteria and participated in groups of three (1 child with ASD and 2 typically-developing peers). Each group was video-recorded during three 10-minute, free-play sessions with toys and three 10-minute, free-play sessions with two guinea pigs. Two blinded observers coded the behavior of children with ASD and their peers. To account for the nested study design, data were analyzed using hierarchical generalized linear modeling. Results: Participants with ASD demonstrated more social approach behaviors (including talking, looking at faces, and making tactile contact) and received more social approaches from their peers in the presence of animals compared to toys. They also displayed more prosocial behaviors and positive affect (i.e., smiling and laughing) as well as less self-focused behaviors and negative affect (i.e., frowning, crying, and whining) in the presence of animals compared to toys. Conclusions: These results suggest that the presence of an animal can significantly increase positive social behaviors among children with ASD.	[O'Haire, Marguerite E.; Slaughter, Virginia] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [McKenzie, Samantha J.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Beck, Alan M.] Purdue Univ, Ctr Human Anim Bond, Coll Vet Med, W Lafayette, IN 47907 USA	University of Queensland; University of Queensland; Purdue University System; Purdue University; Purdue University West Lafayette Campus	O'Haire, ME (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	maggie.ohaire@gmail.com	Slaughter, Virginia/I-6370-2015; McKenzie, Samantha/A-2516-2010	Slaughter, Virginia/0000-0001-9315-1497; McKenzie, Samantha/0000-0003-1328-4527	Thomas Meloy Foundation; Eunice Kennedy Shriver National Institute of Child Health & Human Development [R03HD070683]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD070683] Funding Source: NIH RePORTER	Thomas Meloy Foundation; Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by funding from the Thomas Meloy Foundation and Grant Number R03HD070683 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Atkins DC, 2007, J FAM PSYCHOL, V21, P726, DOI 10.1037/0893-3200.21.4.726; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Burrows KE, 2008, QUAL HEALTH RES, V18, P1642, DOI 10.1177/1049732308327088; Cappadocia MC, 2012, J AUTISM DEV DISORD, V42, P266, DOI 10.1007/s10803-011-1241-x; Chandler S, 2007, J AM ACAD CHILD PSY, V46, P1324, DOI 10.1097/chi.0b013e31812f7d8d; Clifford S, 2010, RES AUTISM SPECT DIS, V4, P509, DOI 10.1016/j.rasd.2009.11.008; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen J.E., 1988, STAT POWER ANAL BEHA; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Esposito L, 2011, CHILD DEV PERSPECT, V5, P205, DOI 10.1111/j.1750-8606.2011.00175.x; Fine AH, 2010, HANDBOOK ON ANIMAL-ASSISTED THERAPY: THEORETICAL FOUNDATIONS AND GUIDELINES FOR PRACTICE, 3RD EDITION, P1; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Friedmann E, 2009, VET CLIN N AM-SMALL, V39, P293, DOI 10.1016/j.cvsm.2008.10.015; Goin-Kochel RP, 2008, FOCUS AUTISM DEV DIS, V23, P148, DOI 10.1177/1088357608316270; Grandgeorge M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041739; Gresham F.M., 1990, SOCIAL SKILLS RATING; HUNT SJ, 1992, J SOC PSYCHOL, V132, P245, DOI 10.1080/00224545.1992.9922976; IBM Corp, 2011, IBM SPSS STAT WIND V; Jennett HK, 2003, J AUTISM DEV DISORD, V33, P583, DOI 10.1023/B:JADD.0000005996.19417.57; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Koning C, 2001, AUTISM, V5, P23, DOI 10.1177/1362361301005001003; Krskova L, 2010, SOC ANIM, V18, P139, DOI 10.1163/156853010X491999; Kruger KA, 2010, HANDBOOK ON ANIMAL-ASSISTED THERAPY: THEORETICAL FOUNDATIONS AND GUIDELINES FOR PRACTICE, 3RD EDITION, P33, DOI 10.1016/B978-0-12-381453-1.10003-0; Lockwood R., 1983, NEW PERSPECTIVES OUR, P64; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MacDonald R, 2007, RES DEV DISABIL, V28, P266, DOI 10.1016/j.ridd.2006.01.004; Macintosh K, 2006, J AUTISM DEV DISORD, V36, P1065, DOI 10.1007/s10803-006-0139-5; Marino L, 2012, ANTHROZOOS, V25, pS139, DOI 10.2752/175303712X13353430377219; Martin F, 2002, WESTERN J NURS RES, V24, P657, DOI 10.1177/019394502320555403; Martin P., 1993, MEASURING BEHAV INTR; Matson JL, 2011, RES AUTISM SPECT DIS, V5, P418, DOI 10.1016/j.rasd.2010.06.004; Mazurek MO, 2010, J AUTISM DEV DISORD, V40, P1512, DOI 10.1007/s10803-010-1014-y; McConnell SR, 2002, J AUTISM DEV DISORD, V32, P351, DOI 10.1023/A:1020537805154; Mcduffie AS, 2012, AUTISM, V16, P398, DOI 10.1177/1362361309360983; McGee GG, 1997, J AUTISM DEV DISORD, V27, P353, DOI 10.1023/A:1025849220209; McNicholas J, 2000, BRIT J PSYCHOL, V91, P61, DOI 10.1348/000712600161673; Melson G. F., 2009, WHY WILD THINGS ARE; Melson GF, 2006, HDB ANIMAL ASSISTED, P207; Norris M, 2010, AUTISM, V14, P263, DOI 10.1177/1362361309348071; O'Haire M, 2010, J VET BEHAV, V5, P226, DOI 10.1016/j.jveb.2010.02.002; O'Haire ME, 2013, J AUTISM DEV DISORD, V43, P1606, DOI 10.1007/s10803-012-1707-5; Pasco G, 2008, J AUTISM DEV DISORD, V38, P1807, DOI 10.1007/s10803-008-0569-3; PORESKY RH, 1990, PSYCHOL REP, V67, P51, DOI 10.2466/PR0.67.5.51-54; Raudenbush S. W., 2002, HIERARCHICAL LINEAR, V1; REDEFER LA, 1989, J AUTISM DEV DISORD, V19, P461, DOI 10.1007/BF02212943; Remington A, 2012, AUTISM, V16, P59, DOI 10.1177/1362361311409257; Robertson K, 2003, J AUTISM DEV DISORD, V33, P123, DOI 10.1023/A:1022979108096; Rowley E, 2012, RES AUTISM SPECT DIS, V6, P1126, DOI 10.1016/j.rasd.2012.03.004; Ruble LA, 2011, FOCUS AUTISM DEV DIS, V26, P67, DOI 10.1177/1088357610397345; Rutter M., 2003, SOCIAL COMMUNICATION; Sams MJ, 2006, AM J OCCUP THER, V60, P268, DOI 10.5014/ajot.60.3.268; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Silva K, 2011, J ALTERN COMPLEM MED, V17, P655, DOI 10.1089/acm.2010.0436; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Thompson KL, 2003, AUST PSYCHOL, V38, P175, DOI 10.1080/00050060310001707187; Viau R, 2010, PSYCHONEUROENDOCRINO, V35, P1187, DOI 10.1016/j.psyneuen.2010.02.004; Wells DL, 2009, J SOC ISSUES, V65, P523, DOI 10.1111/j.1540-4560.2009.01612.x; Wells M, 2001, ANTHROZOOS, V14, P161, DOI 10.2752/089279301786999472; White SW, 2009, J AUTISM DEV DISORD, V39, P1006, DOI 10.1007/s10803-009-0713-8; White SW, 2009, CLIN PSYCHOL REV, V29, P216, DOI 10.1016/j.cpr.2009.01.003; Witwer AN, 2007, J INTELLECT DEV DIS, V32, P179, DOI 10.1080/13668250701604776	62	75	75	5	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57010	10.1371/journal.pone.0057010	http://dx.doi.org/10.1371/journal.pone.0057010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23468902	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000054
J	Rong, JJ; Wang, QH; Liu, KJ; Tan, LW; Ran, X; Zhang, SX; Li, QY; Han, YL				Rong, Jingjing; Wang, Qinghua; Liu, Kaijun; Tan, Liwen; Ran, Xu; Zhang, Shaoxiang; Li, Qiyu; Han, Yaling			A New Atlas Localization Approach for Subthalamic Nucleus Utilizing Chinese Visible Human Head Datasets	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; BASAL GANGLIA; VALIDATION; ELECTRODES; DISEASE; TARGET	Objective: To study the possibility of Chinese visible human (CVH) head datasets as brain atlas for locating the subthalamic nucleus (STN) before deep brain stimulation (DBS) surgery. Methods: Optimal head axial and coronal 3.0T, T2-weighted magnetic resonance images (MRI) of 30 patients were obtained. Cross-sectional head images of four CVH head datasets were chosen to establish an average CVH model. All MRI sequences were registered to the CVH model via fiducials in X-, Y-, and Z-direction, respectively, within the same stereotactic space. The correlations between red nucleus (RN) and fiducials, the accuracy of MRI-to-CVH registration, and the coordinate value differences of RN gravity center between MRI and CVH were tested. Results: The mean gravity center coordinate values and ranges of STN in CVH were measured; The X coordinate value of RN positively correlates with the most anterior point of putamen(PU-A), the lateral edges of putamens (PU-L), and width of the third ventricle, negatively correlated with the patients' age; The minimal mean errors were when no fiducials were used when locating RN between the MRI and the CVH average model; There were no significant differences of RN in X- and Y-direction between MRI sequences and CVH. Conclusion: CVH head datasets can be used as brain atlas for Chinese STN localization. Moreover, average coordinate values of the gravity center and the ranges of STN in CVH can be considered as references for locating STN.	[Rong, Jingjing; Liu, Kaijun; Tan, Liwen; Zhang, Shaoxiang; Li, Qiyu] Third Mil Med Univ, Chongqing Inst Comp Med, Dept Anat, Coll Basic Med Sci, Chongqing, Peoples R China; [Wang, Qinghua] Third Mil Med Univ, Dept Neurol, Daping Hosp, Chongqing, Peoples R China; [Wang, Qinghua] Third Mil Med Univ, Ctr Clin Neurosci, Daping Hosp, Chongqing, Peoples R China; [Ran, Xu] Chongqing Commun Coll, Network Informat Ctr, Training Dept, Chongqing, Peoples R China; [Han, Yaling] Shenyang Mil Gen Hosp, Dept Cardiol, Shenyang, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Li, QY (corresponding author), Third Mil Med Univ, Chongqing Inst Comp Med, Dept Anat, Coll Basic Med Sci, Chongqing, Peoples R China.	liqiyu_99@163.com; hanyaling@263.net	Wang, Qinghua/GVT-3252-2022		National Natural Science Foundation of China [30872659, 30870696]; Major Program of the National Natural Science Foundation of China [61190122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 30872659 and 30870696). This work was also supported by the Major Program of the National Natural Science Foundation of China (No. 61190122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Acar F, 2007, STEREOT FUNCT NEUROS, V85, P287, DOI 10.1159/000107361; Bardinet E, 2009, J NEUROSURG, V110, P208, DOI 10.3171/2008.3.17469; Brunenberg EJL, 2011, J NEUROSURG, V115, P971, DOI 10.3171/2011.6.JNS101571; Castro FJS, 2006, IEEE T MED IMAGING, V25, P1440, DOI 10.1109/TMI.2006.882129; Coenen VA, 2008, ACTA NEUROCHIR, V150, P1163, DOI 10.1007/s00701-008-0136-x; Daniluk S, 2010, ACTA NEUROCHIR, V152, P201, DOI 10.1007/s00701-009-0514-z; Dormont D, 2004, AM J NEURORADIOL, V25, P1516; Duay V, 2008, LECT NOTES COMPUT SC, V5242, P980, DOI 10.1007/978-3-540-85990-1_118; Guehl D, 2007, J NEUROSURG, V106, P101, DOI 10.3171/jns.2007.106.1.101; Lemaire JJ, 2007, INT J COMPUT ASS RAD, V2, P75, DOI 10.1007/s11548-007-0124-2; Mai J.K., 1997, ATLAS HUMAN BRAIN; McClelland S, 2005, NEUROSURG FOCUS, V19, P1, DOI DOI 10.3171/; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Patel NK, 2008, STEREOT FUNCT NEUROS, V86, P153, DOI 10.1159/000120427; Richter EO, 2004, J NEUROSURG, V100, P541, DOI 10.3171/jns.2004.100.3.0541; Saint-Cyr JA, 2002, J NEUROSURG, V97, P1152, DOI 10.3171/jns.2002.97.5.1152; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; Schlaier J, 2005, ACTA NEUROCHIR, V147, P1175, DOI 10.1007/s00701-005-0606-3; Standring S, 2008, GRAYS ANATOMY; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; Videen TO, 2008, J NEUROSCI METH, V168, P275, DOI 10.1016/j.jneumeth.2007.10.007; Vitek JL, 2010, MOVEMENT DISORD, V25, P1530, DOI 10.1002/mds.23151; Yelnik J, 2003, J NEUROSURG, V99, P89, DOI 10.3171/jns.2003.99.1.0089; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026; Zaidel A, 2009, MOVEMENT DISORD, V24, P1785, DOI 10.1002/mds.22674; Zhang SX, 2006, CLIN ANAT, V19, P204, DOI 10.1002/ca.20273; Zhu XL, 2002, ACTA NEUROCHIR, V144, P959, DOI 10.1007/s00701-002-0982-x	27	3	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57264	10.1371/journal.pone.0057264	http://dx.doi.org/10.1371/journal.pone.0057264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460836	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000086
J	Rossi, PG; Benevolo, M; Vocaturo, A; Caraceni, D; Ciccocioppo, L; Frega, A; Terrenato, I; Zappacosta, R; French, D; Rosini, S				Rossi, Paolo Giorgi; Benevolo, Maria; Vocaturo, Amina; Caraceni, Donatella; Ciccocioppo, Lucia; Frega, Antonio; Terrenato, Irene; Zappacosta, Roberta; French, Deborah; Rosini, Sandra			Prognostic Value of HPV E6/E7 mRNA Assay in Women with Negative Colposcopy or CIN1 Histology Result: A Follow-Up Study	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS INFECTION; CLINICAL-PERFORMANCE; GRADE 3; CANCER; DNA; CYTOLOGY; RISK; PROOFER; TRIAGE	Pap test, and especially HPV DNA test, identify a large group of women who do not have any clinically relevant lesions, i.e., CIN2+ (Cervical Intraepithelial Neoplasia grade 2 or worse), but who are at greater risk of getting lesions in the future. The follow up of these women needs new biomarkers with prognostic value. The objective of this study is to evaluate the prognostic value of E6/E7 mRNA over-expression assay (PreTect HPV-Proofer, Norchip) for 5 HR-HPV types (16, 18, 31, 33, and 45) for progression to CIN2+ after a negative colposcopy. This prospective study, conducted at four Italian centres, enrolled 673 women with either a negative colposcopy or a negative or CIN1 histology. The clinical end-point was histological confirmation of CIN2+. Women were classified at baseline according to mRNA results and managed according to local colposcopy protocols. At least one conclusive follow-up test was obtained for 347 women (25 months average lapse since recruitment, range 5-74). Only seven CIN2+ were detected during follow up, three among the 82 women positive for mRNA at baseline, two among the 250 negative (Fisher exact test, p = 0.02), and two among the 12 with an invalid test. Absolute CIN2+ risk was 6.7/1,000 person/years in the whole cohort. The absolute CIN2+ risk was 18.4/1,000 person/years and 3.6/1,000 person/years in mRNA-positive and mRNA-negative women, respectively. In conclusion, E6/E7 mRNA overexpression appears to be a good candidate as a prognostic biomarker to manage HR-HPV DNA-positive women with negative colposcopy or histology, particularly in order to decrease follow-up intensity in those who are negative.	[Rossi, Paolo Giorgi] Agcy Publ Hlth Lazio Sanita, Rome, Italy; [Rossi, Paolo Giorgi] AUSL Reggio Emilia, Epidemiol Unit, Reggio Emilia, Italy; [Benevolo, Maria; Vocaturo, Amina] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [Caraceni, Donatella; Ciccocioppo, Lucia] F Renzetti Hosp, Cytopathol Unit, Chieti, Italy; [Frega, Antonio] Univ Roma La Sapienza, Dept Gynecol, Fac Med 2, St Andrea Hosp, Rome, Italy; [Terrenato, Irene] Regina Elena Inst Canc Res, Dept Epidemiol, Rome, Italy; [Zappacosta, Roberta; Rosini, Sandra] Univ G DAnnunzio, Oncol & Neurosci Dept, Cytopathol Sect, Pescara, Italy; [French, Deborah] Univ Roma La Sapienza, Clin & Mol Med Dept, Fac Med 2, St Andrea Hosp, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; G d'Annunzio University of Chieti-Pescara; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Benevolo, M (corresponding author), Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy.	benevolo@ifo.it	Rossi, Paolo Giorgi/K-6367-2016; Terrenato, Irene/B-1308-2017; Benevolo, Maria/J-8491-2018	Rossi, Paolo Giorgi/0000-0001-9703-2460; Terrenato, Irene/0000-0002-0187-9323; Benevolo, Maria/0000-0003-1994-0935	Italian Ministry of Health through grant "Progetto finalizzato Screening'' of the Agenzia Sanitaria Abruzzo; Italian Ministry of Health through "Programma Integrato Oncologia''	Italian Ministry of Health through grant "Progetto finalizzato Screening'' of the Agenzia Sanitaria Abruzzo; Italian Ministry of Health through "Programma Integrato Oncologia''	This study was partially supported by the Italian Ministry of Health, through a grant "Progetto finalizzato Screening'' of the Agenzia Sanitaria Abruzzo, and through the "Programma Integrato Oncologia''. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1804; Arbyn M, 2008, EUROPEAN GUIDELINES; Arbyn M, 2013, INT J CANCER, V132, P101, DOI 10.1002/ijc.27636; Benevolo M, 2011, J CLIN MICROBIOL, V49, P2643, DOI 10.1128/JCM.02570-10; Benevolo M, 2011, CANCER CAUSE CONTROL, V22, P869, DOI 10.1007/s10552-011-9757-0; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Carozzi F, 2008, LANCET ONCOL, V9, P937, DOI 10.1016/S1470-2045(08)70208-0; Castle PE, 2007, CLIN CANCER RES, V13, P2599, DOI 10.1158/1078-0432.CCR-06-2881; Castle PE, 2012, AM J CLIN PATHOL, V138, P241, DOI 10.1309/AJCPNTK6G2PXWHOO; Castle PE, 2011, OBSTET GYNECOL, V118, P1222, DOI 10.1097/AOG.0b013e318237caf4; Castle PE, 2010, LANCET ONCOL, V11, P214, DOI 10.1016/S1470-2045(09)70385-7; Castle PE, 2009, INT J CANCER, V125, P1649, DOI 10.1002/ijc.24525; Cuschieri K, 2008, CANCER EPIDEM BIOMAR, V17, P2536, DOI 10.1158/1055-9965.EPI-08-0306; Cuzick J, 2006, VACCINE, V24, P90, DOI 10.1016/j.vaccine.2006.05.122; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Dockter J, 2009, J CLIN VIROL, V45, pS55, DOI 10.1016/S1386-6532(09)70009-5; Doeberitz MV, 2002, EUR J CANCER, V38, P2229, DOI 10.1016/S0959-8049(02)00462-8; Dona MG, 2012, GYNECOL ONCOL, V126, P198, DOI 10.1016/j.ygyno.2012.05.004; Halfon P, 2010, J CLIN VIROL, V47, P177, DOI 10.1016/j.jcv.2009.11.011; International Agency for Research on Cancer (IARC), 2005, IARC HDB CANC PREV, V10, P45; Kitchener HC, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13510; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Koliopoulos G, 2012, ACTA OBSTET GYN SCAN, V91, P794, DOI 10.1111/j.1600-0412.2012.01414.x; Lie AK, 2008, EXPERT REV MOL DIAGN, V8, P405, DOI 10.1586/14737159.8.4.405; Lie AK, 2005, GYNECOL ONCOL, V97, P908, DOI 10.1016/j.ygyno.2005.02.026; Massad LS, 2009, J LOW GENIT TRACT DI, V13, P137, DOI 10.1097/LGT.0b013e31819308d4; Mitchell MF, 1998, OBSTET GYNECOL, V91, P626, DOI 10.1016/S0029-7844(98)00006-4; Molden T, 2005, INT J CANCER, V114, P973, DOI 10.1002/ijc.20839; Moyer VA., 2012, ANN INTERN MED; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Pretorius RG, 2011, J LOW GENIT TRACT DI, V15, P180, DOI 10.1097/LGT.0b013e3181fb4547; Ratnam S, 2010, J CLIN MICROBIOL, V48, P2779, DOI 10.1128/JCM.00382-10; Rijkaart DC, 2012, J CLIN MICROBIOL, V50, P2390, DOI 10.1128/JCM.06587-11; Ronco G., 2012, EPIDEMIOL PREV, V36, P1; Ronco G, 2008, J NATL CANCER I, V100, P492, DOI 10.1093/jnci/djn065; Ronco G, 2010, EPIDEMIOL PREV, V34, P35; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Rosini S, 2007, INT J IMMUNOPATH PH, V20, P341, DOI 10.1177/039463200702000214; Rossi PG, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-71, 10.1186/1471-2407-9-69]; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Sorbye SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026022; Sorbye SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012724; Stoler MH, 2011, INT J CANCER, V128, P1354, DOI 10.1002/ijc.25470; Szarewski A, 2008, CANCER EPIDEM BIOMAR, V17, P3033, DOI 10.1158/1055-9965.EPI-08-0508; Szarewski A, 2012, J CLIN MICROBIOL, V50, P1867, DOI 10.1128/JCM.00181-12; The NHS Information Centre, 2010, PUBL HLTH IND POP ST; Zuchna C, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.033	49	16	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57600	10.1371/journal.pone.0057600	http://dx.doi.org/10.1371/journal.pone.0057600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460880	gold, Green Submitted, Green Published			2022-12-27	WOS:000315519000135
J	Soloviev, M; Esteves, MP; Amiri, F; Crompton, MR; Rider, CC				Soloviev, Mikhail; Esteves, Michelle P.; Amiri, Fakhria; Crompton, Mark R.; Rider, Christopher C.			Elevated Transcription of the Gene QSOX1 Encoding Quiescin Q6 Sulfhydryl Oxidase 1 in Breast Cancer	PLOS ONE			English	Article							HUMAN URINARY PROTEOME; CANDIDATE GENES; EXPRESSION; IDENTIFICATION; THIOREDOXIN; PROGRESSION; FAMILY; CELLS; MICROARRAY; ESTROGEN	The q arm of chromosome 1 is frequently amplified at the gene level in breast cancer. Since the significance of this is unclear we investigated whether 1q genes are overexpressed in this disease. The cDNA levels of 1q-located genes were analysed in a search for overexpressed genes. 26 genes mapping to the 1q arm show highly significant (P <= 0.01) overexpression of transcripts in breast cancer compared to normal breast tissue. Amongst those showing the highest levels of overexpression in both expressed sequence tag (EST) and serial analysis of gene expression (SAGE) databases was enzyme quiescin Q6 sulfhydryl oxidase 1 (QSOX1). We investigated QSOX1 cDNA derived from T47D breast carcinoma cells by RT-PCR and 3'-RACE PCR and identified a novel extended form of QSOX1 transcript, containing a long 3'UTR, nearly double the size of the previously reported QSOX1 cDNA, and confirmed its 3' end nucleotide sequence using RACE-PCR. We also used quantitative real-time PCR to analyse a panel of cDNAs derived from 50 clinically-graded normal and malignant breast tissue samples for the expression of QSOX1 mRNAs. QSOX1 transcription was elevated in an increasing proportion in the grade 2 and grade 3 tumours (graded according to the Nottingham prognostic index), with 10 of the 15 grade 3 tumours (67%) examined exceeding the normal range. There was a significant correlation between relative transcript level and clinical grade (P <= 0.01) for all qPCR primer sets tested. QSOX1 mRNA levels, based on SAGE expression data, did not correlate with either Estrogen Receptor (ER) or Epidermal Growth Factor Receptor 2 (ErbB-2 or HER2/neu) expression. Our data indicate that QSOX1 is a potential new prognostic marker which may prove of use in the staging of breast tumours and the stratification of breast cancer patients.	[Soloviev, Mikhail; Esteves, Michelle P.; Amiri, Fakhria; Crompton, Mark R.; Rider, Christopher C.] Royal Holloway Univ London, Sch Biol Sci, Ctr Biomed Sci, London, England	University of London; Royal Holloway University London	Soloviev, M (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Ctr Biomed Sci, London, England.	mikhail.soloviev@rhul.ac.uk		Soloviev, Mikhail/0000-0002-3235-1134				Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; ALLRED DC, 1992, HUM PATHOL, V23, P974, DOI 10.1016/0046-8177(92)90257-4; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Antwi K, 2009, J PROTEOME RES, V8, P4722, DOI 10.1021/pr900414f; Castagna A, 2005, J PROTEOME RES, V4, P1917, DOI 10.1021/pr050153r; Chang XZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1789; Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605; de Andrade CR, 2011, IN VITRO CELL DEV-AN, V47, P716, DOI 10.1007/s11626-011-9461-0; Fabre-Lafay S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-73; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Grzybowska EA, 2001, BIOCHEM BIOPH RES CO, V288, P291, DOI 10.1006/bbrc.2001.5738; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; He J, 2007, CANCER BIOL THER, V6, P76, DOI 10.4161/cbt.6.1.3551; Heckler EJ, 2008, BBA-MOL CELL RES, V1783, P567, DOI 10.1016/j.bbamcr.2007.10.002; Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q; Hill JJ, 2011, J PROTEOME RES, V10, P2479, DOI 10.1021/pr101267k; Hyman E, 1962, CANCER RES, V62, P6240; Inoue A, 2002, J MOL ENDOCRINOL, V29, P175, DOI 10.1677/jme.0.0290175; Katchman BA, 2011, MOL CANCER RES, V9, P1621, DOI 10.1158/1541-7786.MCR-11-0018; Kodali VK, 2010, BIOCHEMISTRY-US, V49, P2075, DOI 10.1021/bi902222s; Kulasingam V, 2007, MOL CELL PROTEOMICS, V6, P1997, DOI 10.1074/mcp.M600465-MCP200; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Leth-Larsen R, 2012, MOL MED, V18, P1109, DOI 10.2119/molmed.2012.00091; Li ZG, 2008, CLIN EXP METASTAS, V25, P389, DOI 10.1007/s10585-007-9117-3; Lopez de Silanes I, 2007, CELL ONCOL, V29, P1; Lucci A, 2009, BREAST CANCER RES TR, V117, P61, DOI 10.1007/s10549-008-0135-x; Mairet-Coello G, 2004, J COMP NEUROL, V473, P334, DOI 10.1002/cne.20126; Moggs JG, 2005, J MOL ENDOCRINOL, V34, P535, DOI 10.1677/jme.1.01677; Morel C, 2007, EXP CELL RES, V313, P3971, DOI 10.1016/j.yexcr.2007.09.003; Nessling M, 2005, CANCER RES, V65, P439; Orsetti B, 2006, BRIT J CANCER, V95, P1439, DOI 10.1038/sj.bjc.6603433; Porter S, 2004, CLIN CANCER RES, V10, P2429, DOI 10.1158/1078-0432.CCR-0398-3; Radom J, 2006, BBA-GENE STRUCT EXPR, V1759, P225, DOI 10.1016/j.bbaexp.2006.04.008; Raje S, 2003, BIOCHEMISTRY-US, V42, P4560, DOI 10.1021/bi030003z; Salh B, 2002, INT J CANCER, V98, P148, DOI 10.1002/ijc.10147; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; Stange DE, 2006, CLIN CANCER RES, V12, P345, DOI 10.1158/1078-0432.CCR-05-1633; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; Tirkkonen M, 1998, GENE CHROMOSOME CANC, V21, P177, DOI 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.3.CO;2-C; Tury A, 2004, J ENDOCRINOL, V183, P353, DOI 10.1677/joe.1.05842; Witkiewicz AK, 2009, CANCER BIOL THER, V8, P1071, DOI 10.4161/cbt.8.11.8874; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873; Wittke I, 2003, CANCER RES, V63, P7742; Zheng WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040935; Zheng WY, 2011, J BIOCHEM, V149, P293, DOI 10.1093/jb/mvq143	46	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57327	10.1371/journal.pone.0057327	http://dx.doi.org/10.1371/journal.pone.0057327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460839	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000093
J	Sunami, Y; Araki, M; Hironaka, Y; Morishita, S; Kobayashi, M; Liew, EL; Edahiro, Y; Tsutsui, M; Ohsaka, A; Komatsu, N				Sunami, Yoshitaka; Araki, Marito; Hironaka, Yumi; Morishita, Soji; Kobayashi, Masaki; Liew, Ei Leen; Edahiro, Yoko; Tsutsui, Miyuki; Ohsaka, Akimichi; Komatsu, Norio			Inhibition of the NAD-Dependent Protein Deacetylase SIRT2 Induces Granulocytic Differentiation in Human Leukemia Cells	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE; DOWN-REGULATION; TUMOR-SUPPRESSOR; DNA-DAMAGE; CANCER; TUMORIGENESIS; ONCOPROTEIN	Sirtuins, NAD-dependent protein deacetylases, play important roles in cellular functions such as metabolism and differentiation. Whether sirtuins function in tumorigenesis is still controversial, but sirtuins are aberrantly expressed in tumors, which may keep cancerous cells undifferentiated. Therefore, we investigated whether the inhibition of sirtuin family proteins induces cellular differentiation in leukemic cells. The sirtuin inhibitors tenovin-6 and BML-266 induce granulocytic differentiation in the acute promyelocytic leukemia (APL) cell line NB4. This differentiation is likely caused by an inhibition of SIRT2 deacetylase activity, judging from the accumulation of acetylated alpha-tubulin, a major SIRT2 substrate. Unlike the clinically used differentiation inducer all-trans retinoic acid, tenovin-6 shows limited effects on promyelocytic leukemia-retinoic acid receptor alpha (PML-RAR-alpha) stability and promyelocytic leukemia nuclear body formation in NB4 cells, suggesting that tenovin-6 does not directly target PML-RAR-alpha activity. In agreement with this, tenovin-6 induces cellular differentiation in the non-APL cell line HL-60, where PML-RAR-alpha does not exist. Knocking down SIRT2 by shRNA induces granulocytic differentiation in NB4 cells, which demonstrates that the inhibition of SIRT2 activity is sufficient to induce cell differentiation in NB4 cells. The overexpression of SIRT2 in NB4 cells decreases the level of granulocytic differentiation induced by tenovin-6, which indicates that tenovin-6 induces granulocytic differentiation by inhibiting SIRT2 activity. Taken together, our data suggest that targeting SIRT2 is a viable strategy to induce leukemic cell differentiation.	[Sunami, Yoshitaka; Hironaka, Yumi; Kobayashi, Masaki; Liew, Ei Leen; Edahiro, Yoko; Tsutsui, Miyuki; Komatsu, Norio] Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan; [Araki, Marito; Morishita, Soji; Ohsaka, Akimichi] Juntendo Univ, Sch Med, Dept Transfus Med & Stem Cell Regulat, Tokyo 113, Japan; [Kobayashi, Masaki] Sysmex Corp, Cent Res Labs, Hyogo, Japan; [Liew, Ei Leen] Otsuka Pharmaceut Co Ltd, Fujii Mem Res Inst, Shiga, Japan	Juntendo University; Juntendo University; Sysmex Corporation; Otsuka Pharmaceutical	Komatsu, N (corresponding author), Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan.	komatsun@juntendo.ac.jp	Araki, Marito/T-4283-2019	Araki, Marito/0000-0002-3502-5000	JSPS KAKENHI [23800055, 23118528]; Japan Leukemia Research Fund; Grants-in-Aid for Scientific Research [25118725] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Leukemia Research Fund(Japan Leukemia Research Fund (JLRF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded in part by JSPS KAKENHI grants #23800055 (MA) and #23118528 (NK) and a grant from the Japan Leukemia Research Fund (NK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablain J, 2011, BLOOD, V117, P5795, DOI 10.1182/blood-2011-02-329367; Amin HM, 2001, BRIT J HAEMATOL, V115, P287, DOI 10.1046/j.1365-2141.2001.03123.x; Andersen JL, 2011, MOL CELL, V43, P834, DOI 10.1016/j.molcel.2011.07.028; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bosch-Presegue Laia, 2011, Genes Cancer, V2, P648, DOI 10.1177/1947601911417862; COLLINS SJ, 1987, BLOOD, V70, P1233; Cote S, 2002, BLOOD, V100, P2586, DOI 10.1182/blood-2002-02-0614; Dan L, 2012, HAEMATOL-HEMATOL J, V97, P551, DOI 10.3324/haematol.2011.055236; DANIEL MT, 1993, BLOOD, V82, P1858; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Derouazi M, 2004, BIOTECHNOL BIOENG, V87, P537, DOI 10.1002/bit.20161; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Grimwade D, 2002, LEUKEMIA, V16, P1959, DOI 10.1038/sj.leu.2402721; Harris MN, 2004, BLOOD, V104, P1314, DOI 10.1182/blood-2004-01-0046; He LZ, 2001, J CLIN INVEST, V108, P1321, DOI 10.1172/JCI200111537; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Inoue T, 2007, CELL CYCLE, V6, P1011, DOI 10.4161/cc.6.9.4219; Isakson P, 2010, BLOOD, V116, P2324, DOI 10.1182/blood-2010-01-261040; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kitamura K, 1997, LEUKEMIA, V11, P1950, DOI 10.1038/sj.leu.2400837; Kiviranta PH, 2006, J MED CHEM, V49, P7907, DOI 10.1021/jm060566j; Kosugi H, 2001, JPN J CANCER RES, V92, P529, DOI 10.1111/j.1349-7006.2001.tb01126.x; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; LANOTTE M, 1991, BLOOD, V77, P1080; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Li YZ, 2011, GENES CELLS, V16, P34, DOI 10.1111/j.1365-2443.2010.01460.x; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Minucci S, 2001, ONCOGENE, V20, P3110, DOI 10.1038/sj.onc.1204336; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Myatt SS, 2011, ANTIOXID REDOX SIGN, V14, P675, DOI 10.1089/ars.2010.3383; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; NEWBURGER PE, 1979, J CELL BIOL, V82, P315, DOI 10.1083/jcb.82.2.315; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Skokowa J, 2009, NAT MED, V15, P151, DOI 10.1038/nm.1913; Van Meter M, 2011, CELL CYCLE, V10, P3153, DOI 10.4161/cc.10.18.17435; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wang Z, 2013, ONCOGENE, V32, P589, DOI 10.1038/onc.2012.83; Warrell RP, 1998, JNCI-J NATL CANCER I, V90, P1621, DOI 10.1093/jnci/90.21.1621; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yoshida H, 1996, CANCER RES, V56, P2945; Yuan HF, 2012, BLOOD, V119, P1904, DOI 10.1182/blood-2011-06-361691; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	54	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57633	10.1371/journal.pone.0057633	http://dx.doi.org/10.1371/journal.pone.0057633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460888	gold, Green Submitted, Green Published			2022-12-27	WOS:000315519000143
J	Lai, YH; Xu, M; Zhang, ZZ; Liu, Y				Lai, Yanhao; Xu, Meng; Zhang, Zunzhen; Liu, Yuan			Instability of CTG Repeats Is Governed by the Position of a DNA Base Lesion through Base Excision Repair	PLOS ONE			English	Article							FLAP ENDONUCLEASE-1; GENETIC INSTABILITY; MYOTONIC-DYSTROPHY; CAG REPEATS; IN-VITRO; EXPANSION; DAMAGE; MECHANISMS; DELETION; BROMATE	Trinucleotide repeat (TNR) expansions and deletions are associated with human neurodegeneration and cancer. However, their underlying mechanisms remain to be elucidated. Recent studies have demonstrated that CAG repeat expansions can be initiated by oxidative DNA base damage and fulfilled by base excision repair (BER), suggesting active roles for oxidative DNA damage and BER in TNR instability. Here, we provide the first evidence that oxidative DNA damage can induce CTG repeat deletions along with limited expansions in human cells. Biochemical characterization of BER in the context of (CTG)(20) repeats further revealed that repeat instability correlated with the position of a base lesion in the repeat tract. A lesion located at the 5'-end of CTG repeats resulted in expansion, whereas a lesion located either in the middle or the 3'-end of the repeats led to deletions only. The positioning effects appeared to be determined by the formation of hairpins at various locations on the template and the damaged strands that were bypassed by DNA polymerase beta and processed by flap endonuclease 1 with different efficiency. Our study indicates that the position of a DNA base lesion governs whether TNR is expanded or deleted through BER.	[Lai, Yanhao; Xu, Meng; Liu, Yuan] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Lai, Yanhao; Zhang, Zunzhen] Sichuan Univ, Dept Environm & Occupat Hlth, West China Sch Publ Hlth, Chengdu 610064, Peoples R China	State University System of Florida; Florida International University; Sichuan University	Liu, Y (corresponding author), Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA.	yualiu@fiu.edu	Lai, Yanhao/AAD-3392-2019		NIH [ES017476]; National Natural Science Foundation of China [81172632]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES017476] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant ES017476 to Y.L.(http://www.nih.gov/) and partially was supported by the grant No. 81172632 from the National Natural Science Foundation of China to Z.Z.(http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Braithwaite EK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012229; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Entezam A, 2010, HUM MUTAT, V31, P611, DOI 10.1002/humu.21237; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gomes-Pereira M, 2004, NUCLEIC ACIDS RES, V32, P2865, DOI 10.1093/nar/gkh612; Goula AV, 2012, BIOCHEMISTRY-US, V51, P3919, DOI 10.1021/bi300410d; Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749; Hashem VI, 2002, MUTAT RES-FUND MOL M, V508, P107, DOI 10.1016/S0027-5107(02)00190-2; Jackson AL, 2000, MUTAT RES-FUND MOL M, V447, P187, DOI 10.1016/S0027-5107(99)00206-7; Jakupciak JP, 2000, IUBMB LIFE, V50, P355, DOI 10.1080/152165400300089358; Jarem DA, 2011, DNA REPAIR, V10, P887, DOI 10.1016/j.dnarep.2011.06.003; Jarem DA, 2009, BIOCHEMISTRY-US, V48, P6655, DOI 10.1021/bi9007403; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Kawanishi S, 2006, TOXICOLOGY, V221, P172, DOI 10.1016/j.tox.2006.01.002; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lahue RS, 2003, FRONT BIOSCI-LANDMRK, V8, pS653, DOI 10.2741/1107; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Liu Y, 2003, J BIOL CHEM, V278, P13728, DOI 10.1074/jbc.M212061200; Liu Y, 2012, TRENDS BIOCHEM SCI, V37, P162, DOI 10.1016/j.tibs.2011.12.002; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Messer J, 2006, FREE RADICAL BIO MED, V40, P1981, DOI 10.1016/j.freeradbiomed.2006.01.028; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Nakamori M, 2011, HUM MOL GENET, V20, P580, DOI 10.1093/hmg/ddq501; Nelson KA, 2002, AM J EPIDEMIOL, V155, P883, DOI 10.1093/aje/155.10.883; Oussatcheva E.A., 2001, J MOL BIOL, V279, P1101; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Panigrahi GB, 2010, P NATL ACAD SCI USA, V107, P12593, DOI 10.1073/pnas.0909087107; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pelletier R, 2005, NUCLEIC ACIDS RES, V33, P5667, DOI 10.1093/nar/gki880; Pineiro E, 2003, NUCLEIC ACIDS RES, V31, P6733, DOI 10.1093/nar/gkg898; Pluciennik A, 2002, J BIOL CHEM, V277, P34074, DOI 10.1074/jbc.M202127200; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Schildkraut JM, 2007, CANCER EPIDEM BIOMAR, V16, P473, DOI 10.1158/1055-9965.EPI-06-0868; Vallur AC, 2010, J BIOL CHEM, V285, P28514, DOI 10.1074/jbc.M110.132738; Volle CB, 2012, BIOCHEMISTRY-US, V51, P52, DOI 10.1021/bi201552s; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; Wilson SH, 2010, CELL MOL LIFE SCI, V67, P3633, DOI 10.1007/s00018-010-0489-1; Xu Meng, 2013, Nucleic Acids Res, V41, P1684, DOI 10.1093/nar/gks1306	45	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56960	10.1371/journal.pone.0056960	http://dx.doi.org/10.1371/journal.pone.0056960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468897	Green Published, gold			2022-12-27	WOS:000315561400018
J	Prokosch, V; Schallenberg, M; Thanos, S				Prokosch, Verena; Schallenberg, Maurice; Thanos, Solon			Crystallins Are Regulated Biomarkers for Monitoring Topical Therapy of Glaucomatous Optic Neuropathy	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; RETINAL GANGLION-CELLS; HEAT-SHOCK PROTEINS; ELEVATED INTRAOCULAR-PRESSURE; BETA-ADRENOCEPTOR ANTAGONISTS; OPEN-ANGLE GLAUCOMA; 2-DIMENSIONAL ELECTROPHORESIS; STRESS PROTEINS; RAT MODEL; BETA(1)-ADRENOCEPTOR ANTAGONIST	Optic nerve atrophy caused by abnormal intraocular pressure (IOP) remains the most common cause of irreversible loss of vision worldwide. The aim of this study was to determine whether topically applied IOP-lowering eye drugs affect retinal ganglion cells (RGCs) and retinal metabolism in a rat model of optic neuropathy. IOP was elevated through cauterization of episcleral veins, and then lowered either by the daily topical application of timolol, timolol/travoprost, timolol/dorzolamide, or timolol/brimonidine, or surgically with sectorial iridectomy. RGCs were retrogradely labeled 4 days prior to enucleation, and counted. Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE), matrix-assisted laser desorption ionization mass spectrometry, Western blotting, and immunohistochemistry allowed the identification of IOP-dependent proteomic changes. Genomic changes were scrutinized using microarrays and qRT-PCR. The significant increase in IOP induced by episcleral vein cauterization that persisted until 8 weeks of follow-up in control animals (p<0.05) was effectively lowered by the eye drops (p<0.05). As anticipated, the number of RGCs decreased significantly following 8 weeks of elevated IOP (p<0.05), while treatment with combination compounds markedly improved RGC survival (p<0.05). 2D-PAGE and Western blot analyses revealed an IOP-dependent expression of crystallin cry-bb2. Microarray and qRT-PCR analyses verified the results at the mRNA level. IHC demonstrated that crystallins were expressed mainly in the ganglion cell layer. The data suggest that IOP and either topically applied antiglaucomatous drugs influence crystallin expression within the retina. Neuronal crystallins are thus suitable biomarkers for monitoring the progression of neuropathy and evaluating any neuroprotective effects.	[Prokosch, Verena; Schallenberg, Maurice; Thanos, Solon] Univ Munster, Sch Med, Inst Expt Ophthalmol, D-48149 Munster, Germany; [Thanos, Solon] Interdisciplinary Ctr Clin Res, Munster, Germany	University of Munster	Thanos, S (corresponding author), Univ Munster, Sch Med, Inst Expt Ophthalmol, Albert Schweitzer Campus 1, D-48149 Munster, Germany.	solon@uni-muenster.de			Deutsche Forschungsgemeinschaft (DFG) [Th386 18-1]; IZKF [Tha3/002/09]; Medical Faculty of the University of Munster	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); IZKF; Medical Faculty of the University of Munster	The work was supported by the Deutsche Forschungsgemeinschaft (DFG, grant Th386 18-1 to S. T.), the IZKF (grant Tha3/002/09 to S. T.), and the Medical Faculty of the University of Munster. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; Berman Elaine R., 1994, P533; Caprioli J, 1996, INVEST OPHTH VIS SCI, V37, P2376; Chauhan BC, 2002, INVEST OPHTH VIS SCI, V43, P2969; Chidlow G, 2000, BRIT J PHARMACOL, V130, P759, DOI 10.1038/sj.bjp.0703369; CLAYTON RM, 1979, NATURE, V282, P628, DOI 10.1038/282628a0; COCKBURN DM, 1983, AM J OPTOM PHYS OPT, V60, P705; Davis TL, 1999, J OCUL PHARMACOL TH, V15, P323, DOI 10.1089/jop.1999.15.323; Donello JE, 2001, J PHARMACOL EXP THER, V296, P216; Dreyer EB, 1996, ARCH OPHTHALMOL-CHIC, V114, P299, DOI 10.1001/archopht.1996.01100130295012; Furuyoshi N, 2000, OPHTHALMOLOGICA, V214, P24, DOI 10.1159/000027470; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Graw J, 1997, BIOL CHEM, V378, P1331; Grus FH, 2010, KLIN MONATSBL AUGENH, V227, P114, DOI 10.1055/s-0029-1245150; HEAD MW, 1993, AM J PATHOL, V143, P1743; Hitchings R A, 1995, Curr Opin Ophthalmol, V6, P67; Hoyng PFJ, 2000, DRUGS, V59, P411, DOI 10.2165/00003495-200059030-00003; IWAKI T, 1992, AM J PATHOL, V140, P345; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; Kumar PA, 2005, ARCH BIOCHEM BIOPHYS, V444, P77, DOI 10.1016/j.abb.2005.09.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai RK, 2002, VISUAL NEUROSCI, V19, P175, DOI 10.1017/S0952523802191152; Levkovitch-Verbin H, 2002, INVEST OPHTH VIS SCI, V43, P402; Liedtke T, 2007, MOL CELL PROTEOMICS, V6, P895, DOI 10.1074/mcp.M600245-MCP200; Liu SQ, 2007, CELL MOL IMMUNOL, V4, P65; Martinez A, 2009, J OCUL PHARMACOL TH, V25, P239, DOI 10.1089/jop.2008.0114; Melena J, 1999, EUR J PHARMACOL, V378, P317, DOI 10.1016/S0014-2999(99)00459-8; Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451; MOORE CG, 1995, CURR EYE RES, V14, P711, DOI 10.3109/02713689508998499; Nakanishi Y, 2006, EXP EYE RES, V83, P1108, DOI 10.1016/j.exer.2006.05.018; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Naskar R, 2006, MOL VIS, V12, P1199; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Osborne NN, 1999, BRIT J OPHTHALMOL, V83, P980, DOI 10.1136/bjo.83.8.980; Park HY, 2008, J OCUL PHARMACOL TH, V24, P563, DOI 10.1089/jop.2008.0039; Piri N, 2007, BRAIN RES, V1141, P1, DOI 10.1016/j.brainres.2006.11.095; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; RENKAWEK K, 1992, ACTA NEUROPATHOL, V83, P324, DOI 10.1007/BF00296796; Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X; Salvador-Silva M, 2001, J NEUROSCI RES, V66, P59, DOI 10.1002/jnr.1197; Sax C M, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P155; Saylor M, 2009, ARCH OPHTHALMOL-CHIC, V127, P402, DOI 10.1001/archophthalmol.2009.9; Schwartz M, 2000, INVEST OPHTH VIS SCI, V41, P349; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tezel G, 2004, BRAIN RES BULL, V62, P473, DOI 10.1016/S0361-9230(03)00074-1; Tezel G, 1998, INVEST OPHTH VIS SCI, V39, P2277; Thanos S, 1997, EXP BRAIN RES, V114, P483, DOI 10.1007/PL00005657; Vazquez-Chona F, 2004, INVEST OPHTH VIS SCI, V45, P2737, DOI 10.1167/iovs.03-1047; Wang YD, 2007, CURR EYE RES, V32, P891, DOI 10.1080/02713680701593702; Wood JPM, 2003, EXP EYE RES, V76, P505, DOI 10.1016/S0014-4835(02)00335-4; Yoshimura N, 2003, INVEST OPHTH VIS SCI, V44, P2211, DOI 10.1167/iovs.02-0704; YOUNG DB, 1990, ANTON LEEUW INT J G, V58, P203, DOI 10.1007/BF00548934; YOUNG RA, 1989, CELL, V59, P5, DOI 10.1016/0092-8674(89)90861-1; ZIMMERMAN TJ, 1993, J OCUL PHARMACOL, V9, P373, DOI 10.1089/jop.1993.9.373	56	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e49730	10.1371/journal.pone.0049730	http://dx.doi.org/10.1371/journal.pone.0049730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468831	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400001
J	Kolu, P; Raitanen, J; Rissanen, P; Luoto, R				Kolu, Paivi; Raitanen, Jani; Rissanen, Pekka; Luoto, Riitta			Cost-Effectiveness of Lifestyle Counselling as Primary Prevention of Gestational Diabetes Mellitus: Findings from a Cluster-Randomised Trial	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PREGNANCY; PREVALENCE; OBESITY; COMPLICATIONS; RISK	Aims: The aim was to evaluate the cost-effectiveness of primary prevention of gestational diabetes mellitus (GDM) through intensified counselling on physical activity, diet, and appropriate weight gain among the risk group. Materials and Methods: The cost-effectiveness analysis was based on data from a cluster-randomised controlled GDM prevention trial carried out in primary health-care maternity clinics in Finland. Women (n = 399) with at least one risk factor for GDM were included. The incremental cost-effectiveness ratio (ICER) was calculated in terms of birth weight, 15D, and perceived health as measured with a visual analogue scale (VAS). A bootstrap technique for cluster-randomised samples was used to estimate uncertainty around a cost-effectiveness acceptability curve. Results: The mean total cost in the intervention group was (sic)7,763 (standard deviation (SD): (sic)4,511) and in the usual-care group was (sic)6,994 (SD: (sic)4,326, p = 0.14). The mean intervention cost was (sic)141. The difference for costs in the birth-weight group was (sic)753 (95% CI: 2250 to 1,818) and in effects for birth weight was 115 g (95% CI: 15 to 222). The ICER for birth weight was almost (sic)7, with 86.7% of bootstrap pairs located in the north-east quadrant, indicating that the intervention was more effective and more expensive in birth weight terms than the usual care was. The data show an 86.7% probability that each gram of birth weight avoided requires an additional cost of (sic)7. Conclusions: Intervention was effective for birth weight but was not cost-effective for birth weight, 15D, or VAS when compared to the usual care.	[Kolu, Paivi; Raitanen, Jani; Luoto, Riitta] UKK Inst Hlth Promot, Tampere, Finland; [Raitanen, Jani; Rissanen, Pekka] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Luoto, Riitta] Natl Inst Hlth & Welf, Dept Children Young People & Families, Helsinki, Finland	UKK Institute; Tampere University; Finland National Institute for Health & Welfare	Kolu, P (corresponding author), UKK Inst Hlth Promot, Tampere, Finland.	paivi.kolu@uta.fi	Raitanen, Jani/AAW-9233-2021	Raitanen, Jani/0000-0001-7674-0978	Juho Vainio Foundation; Yrjo Jahnsson Foundation; Pirkanmaa hospital district (EVO/TAYS) [9M053]	Juho Vainio Foundation; Yrjo Jahnsson Foundation; Pirkanmaa hospital district (EVO/TAYS)	The article was funded by Juho Vainio Foundation, Yrjo Jahnsson Foundation and competitive research funding from Pirkanmaa hospital district (EVO/TAYS, 9M053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2002, OBSTET GYNECOL, V99, P869; Aittasalo M, 2008, BMC WOMENS HEALTH, P14, DOI DOI 10.1186/1472-6874-8-14; Aittasalo M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-104; American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; [Anonymous], 2009, PIRK HOSP DISTR PROD; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; Bener A, 2011, INT J WOMENS HEALTH, V3, P367, DOI 10.2147/IJWH.S26094; Chen YZ, 2009, POPUL HEALTH MANAG, V12, P165, DOI 10.1089/pop.2009.12303; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Dalfra MG, 2012, QUAL LIFE RES, V21, P291, DOI 10.1007/s11136-011-9940-5; Davenport MH, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-85; Davison A, 1997, BOOTSTRAP METHODS TH, P102; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Galtier-Dereure Florence, 2000, American Journal of Clinical Nutrition, V71, p1242S; GALTIERDEREURE F, 1995, INT J OBESITY, V19, P443; Gomes M, 2012, MED DECIS MAKING, V32, P350, DOI 10.1177/0272989X11418372; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Halkoaho A, 2010, EUR J OBSTET GYN R B, V148, P40, DOI 10.1016/j.ejogrb.2009.09.025; Hujanen T, 2008, TERVEYDENHUOLLON YKS; Kim C, 2010, INT J WOMENS HEALTH, V2, P339, DOI 10.2147/IJWH.S13333; Kinnunen Tarja I, 2008, BMC Pregnancy Childbirth, V8, P37, DOI 10.1186/1471-2393-8-37; Kinnunen TI, 2014, MATERN CHILD NUTR, V10, P184, DOI 10.1111/j.1740-8709.2012.00426.x; Kolu P, 2011, PRIM CARE DIABETES, V5, P139, DOI 10.1016/j.pcd.2011.01.001; Lamberg S, 2012, EUR J PUBLIC HEALTH, V22, P278, DOI 10.1093/eurpub/ckq193; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Luoto R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001036; Luoto RM, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-39; McIntyre HD, 2012, MED J AUSTRALIA, V196, P184, DOI 10.5694/mja11.11120; Moss John R, 2007, BMC Pregnancy Childbirth, V7, P27, DOI 10.1186/1471-2393-7-27; Mudd LM, 2012, MED SC IN PRESS 0814; Ohno MS, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.051; Oostdam N, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-64; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Reece EA, 2009, LANCET, V373, P1789, DOI 10.1016/S0140-6736(09)60515-8; SCHEFFLER RM, 1992, AM J PUBLIC HEALTH, V82, P168, DOI 10.2105/AJPH.82.2.168; SINTONEN H, 1993, QUALITY OF LIFE ASSESSMENT : KEY ISSUES IN THE 1990S, P185; Sintonen H., REPLACING MISSING DA; Statistics Finland, 2010, WAG SAL LAB COSTS; Teh WT, 2011, AUST NZ J OBSTET GYN, V51, P26, DOI 10.1111/j.1479-828X.2011.01292.x; Tobias DK, 2011, DIABETES CARE, V34, P223, DOI 10.2337/dc10-1368; Viisainen K, 1999, GUMMERUS JYVASKYLA F, P34; Wendland EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-23	44	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56392	10.1371/journal.pone.0056392	http://dx.doi.org/10.1371/journal.pone.0056392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457562	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700049
J	Soong, RS; Trieu, J; Lee, SY; He, LM; Tsai, YC; Wu, TC; Hung, CF				Soong, Ruey-Shyang; Trieu, Janson; Lee, Sung Yong; He, Liangmei; Tsai, Ya-Chea; Wu, T. -C.; Hung, Chien-Fu			Xenogeneic Human p53 DNA Vaccination by Electroporation Breaks Immune Tolerance to Control Murine Tumors Expressing Mouse p53	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; CANCER-IMMUNOTHERAPY; CELLS; ANTIGEN	The pivotal role of p53 as a tumor suppressor protein is illustrated by the fact that this protein is found mutated in more than 50% of human cancers. In most cases, mutations in p53 greatly increase the otherwise short half-life of this protein in normal tissue and cause it to accumulate in the cytoplasm of tumors. The overexpression of mutated p53 in tumor cells makes p53 a potentially desirable target for the development of cancer immunotherapy. However, p53 protein represents an endogenous tumor-associated antigen (TAA). Immunization against a self-antigen is challenging because an antigen-specific immune response likely generates only low affinity antigen-specific CD8(+) T-cells. This represents a bottleneck of tumor immunotherapy when targeting endogenous TAAs expressed by tumors. The objective of the current study is to develop a safe cancer immunotherapy using a naked DNA vaccine. The vaccine employs a xenogeneic p53 gene to break immune tolerance resulting in a potent therapeutic antitumor effect against tumors expressing mutated p53. Our study assessed the therapeutic antitumor effect after immunization with DNA encoding human p53 (hp53) or mouse p53 (mp53). Mice immunized with xenogeneic full length hp53 DNA plasmid intramuscularly followed by electroporation were protected against challenge with murine colon cancer MC38 while those immunized with mp53 DNA were not. In a therapeutic model, established MC38 tumors were also well controlled by treatment with hp53 DNA therapy in tumor bearing mice compared to mp53 DNA. Mice vaccinated with hp53 DNA plasmid also exhibited an increase in mp53-specific CD8(+) T-cell precursors compared to vaccination with mp53 DNA. Antibody depletion experiments also demonstrated that CD8(+) T-cells play crucial roles in the antitumor effects. This study showed intramuscular vaccination with xenogeneic p53 DNA vaccine followed by electroporation is capable of inducing potent antitumor effects against tumors expressing mutated p53 through CD8(+) T cells.	[Soong, Ruey-Shyang; Lee, Sung Yong; He, Liangmei; Tsai, Ya-Chea; Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Soong, Ruey-Shyang] Chang Gung Mem Hosp Keelung, Dept Gen Surg, Keelung, Taiwan; [Soong, Ruey-Shyang] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Trieu, Janson] Johns Hopkins Univ, Baltimore, MD USA; [Lee, Sung Yong] Korea Univ, Dept Internal Med, Med Ctr, Seoul, South Korea	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Chang Gung Memorial Hospital; Chang Gung University; Johns Hopkins University; Korea University; Korea University Medicine (KU Medicine)	Hung, CF (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	chung2@jhmi.edu		LEE, SUNG YONG/0000-0002-8693-5792	United States National Institutes of Health (NIH)/NCI cervical cancer SPORE grant [P50CA098252]; Chang Gung Memorial Hospital at Keelung, Taiwan [CMRPG2B0381]; NATIONAL CANCER INSTITUTE [P50CA098252] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)/NCI cervical cancer SPORE grant; Chang Gung Memorial Hospital at Keelung, Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States National Institutes of Health (NIH)/NCI cervical cancer SPORE grant P50CA098252 and CMRPG2B0381 from Chang Gung Memorial Hospital at Keelung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adotevi O, 2010, BLOOD, V115, P3025, DOI 10.1182/blood-2009-11-253641; Bergman PJ, 2006, VACCINE, V24, P4582, DOI 10.1016/j.vaccine.2005.08.027; Best SR, 2009, VACCINE, V27, P5450, DOI 10.1016/j.vaccine.2009.07.005; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Chang CL, 2007, GENE THER, V14, P1189, DOI 10.1038/sj.gt.3302974; Cheng WF, 2001, J CLIN INVEST, V108, P669, DOI 10.1172/JCI200112346; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Dahl AM, 1996, J IMMUNOL, V157, P239; Fong L, 2001, J IMMUNOL, V167, P7150, DOI 10.4049/jimmunol.167.12.7150; FOX BA, 1990, J BIOL RESP MODIF, V9, P499; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hung CF, 2007, GENE THER, V14, P921, DOI 10.1038/sj.gt.3302913; Hung CF, 2001, CANCER RES, V61, P3698; Kang TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035141; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Luxembourg A, 2006, VACCINE, V24, P4490, DOI 10.1016/j.vaccine.2005.08.014; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Ruan ZH, 2009, J IMMUNOTHER, V32, P486, DOI 10.1097/CJI.0b013e3181a1d134; Ryan MH, 2001, CANCER IMMUNOL IMMUN, V49, P603, DOI 10.1007/s002620000156; Tu CF, 2007, VACCINE, V25, P719, DOI 10.1016/j.vaccine.2006.08.009; Turner MJ, 2008, J EXP MED, V205, P1859, DOI 10.1084/jem.20072390; Vierboom MPM, 2000, CANCER RES, V60, P5508; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701	23	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56912	10.1371/journal.pone.0056912	http://dx.doi.org/10.1371/journal.pone.0056912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457640	Green Submitted, gold, Green Published			2022-12-27	WOS:000315603700098
J	Mandel, K; Seidl, D; Rades, D; Lehnert, H; Gieseler, F; Hass, R; Ungefroren, H				Mandel, Katharina; Seidl, Daniel; Rades, Dirk; Lehnert, Hendrik; Gieseler, Frank; Hass, Ralf; Ungefroren, Hendrik			Characterization of Spontaneous and TGF-beta-Induced Cell Motility of Primary Human Normal and Neoplastic Mammary Cells In Vitro Using Novel Real-Time Technology	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PANCREATIC DUCTAL ADENOCARCINOMA; MESENCHYMAL STEM-CELLS; CANCER TISSUE-EXTRACTS; BREAST-CANCER; EPITHELIAL-CELLS; PLASMINOGEN-ACTIVATOR; DIFFERENTIAL ROLES; UMBILICAL-CORD; TUMOR-CELLS	The clinical complications derived from metastatic disease are responsible for the majority of all breast cancer related deaths. Since cell migration and invasion are a prerequisite for metastasis their assessment in patient cancer cells in vitro may have prognostic value for the tumor's metastatic capacity. We employed real-time cell analysis (RTCA) on the xCELLigence DP system to determine in vitro motility of patient-derived primary human breast cancer epithelial cells (HBCEC). Initially, the RTCA assay was validated using established human breast cancer cell lines with either an invasive (MDA-MB-231, MDA-MB-435s) or a non-invasive phenotype (MCF-7, MDA-MB-468), and primary NSCLC cells (Tu459). Previous standard assays of cell migration/invasion revealed that only MDA-MB-231, -435s, and Tu459 cells exhibited spontaneous and TGF-beta 1-stimulated migration and invasion through a Matrigel barrier. In the present study, the TGF-beta 1-stimulated activities could be blocked by SB431542, a potent kinase inhibitor of the TGF-beta type I receptor ALK5. Application of the RTCA assay to patient-derived tumor cells showed that 4/4 primary HBCEC and primary NSCLC cells, but not normal human mammary epithelial cells (HMEC), displayed high spontaneous migratory and invasive activity which correlated with higher MMP-2 expression and uPA protein levels in HBCEC compared to HMEC. Upon treatment with TGF-beta 1, HBCEC exhibited morphologic and gene regulatory alterations indicative of epithelial-to-mesenchymal transition. However, exclusively the invasive but not the migratory activity of HBCEC was further enhanced by TGF-beta 1. This indicates the requirement for molecular, e.g. integrin interactions with Matrigel components in HBCEC in order to become responsive to pro-invasive TGF-beta effects. Together, these results show for the first time that tumorigenic HBCEC but not normal HMEC possess a strong basal migratory as well as a basal and TGF-beta 1-inducible invasive potential. These findings qualify the RTCA assay as an in vitro migration/invasion testing system for patient-specific primary breast cancer cells.	[Mandel, Katharina; Hass, Ralf] Med Univ, Dept Gynecol & Obstet, Gynecol Res Unit, Biochem & Tumor Biol Lab, Hannover, Germany; [Seidl, Daniel; Lehnert, Hendrik; Gieseler, Frank; Ungefroren, Hendrik] Univ Hosp Schleswig Holstein UKSH, Dept Med 1, Lubeck, Germany; [Seidl, Daniel; Rades, Dirk] Univ Hosp Schleswig Holstein UKSH, Dept Radiat Oncol, Lubeck, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Ungefroren, H (corresponding author), Univ Hosp Schleswig Holstein UKSH, Dept Med 1, Campus Lubeck, Lubeck, Germany.	hendrik.ungefroren@uksh.de	Gieseler, Frank/L-4668-2013; Hass, Ralf/F-3197-2012; Gieseler, Frank/E-8386-2012	Hass, Ralf/0000-0002-2481-7547; Gieseler, Frank/0000-0001-6409-3822	Niedersachsische Krebshilfe	Niedersachsische Krebshilfe	This work was sponsored in part by the Niedersachsische Krebshilfe (awarded to Ralf Hass). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 2012, TRENDS MOL MED, V18, P13, DOI 10.1016/j.molmed.2011.11.003; Bartsch JE, 2003, J SURG RES, V110, P383, DOI 10.1016/S0022-4804(03)00007-6; Bartscht T, 2012, CANCER CHEMOTH PHARM, V70, P221, DOI 10.1007/s00280-012-1904-0; Bertram C, 2009, MECH AGEING DEV, V130, P657, DOI 10.1016/j.mad.2009.08.001; Brabek J, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-22; Calorini L, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-24; Chaturvedi S, 2011, MECH AGEING DEV, V132, P213, DOI 10.1016/j.mad.2011.04.002; Drabsch Y, 2011, J MAMMARY GLAND BIOL, V16, P97, DOI 10.1007/s10911-011-9217-1; Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gieseler F, 2007, Hamostaseologie, V27, P273; Guillot E, 2011, BREAST J, V17, P129, DOI 10.1111/j.1524-4741.2010.01045.x; Harbeck N, 2002, J CLIN ONCOL, V20, P1000, DOI 10.1200/JCO.20.4.1000; Hass R, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-26; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hass R, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-127; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jezierska A, 2009, MED SCI MONITOR, V15, pRA32; Keese CR, 2002, BIOTECHNIQUES, V33, P842, DOI 10.2144/02334rr01; Klein CA, 2008, SCIENCE, V321, P1785, DOI 10.1126/science.1164853; Lavrentieva A, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-18; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Lv ZD, 2013, ONCOL REP, V29, P219, DOI 10.3892/or.2012.2111; Majore I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-6; McSherry EA, 2007, CELL MOL LIFE SCI, V64, P3201, DOI 10.1007/s00018-007-7388-0; Porter PL, 2009, SALUD PUBLICA MEXICO, V51, pS141, DOI 10.1590/s0036-36342009000800003; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Schmitt M, 2006, METH MOLEC MED, V120, P245; Schniewind B, 2007, ONCOGENE, V26, P4850, DOI 10.1038/sj.onc.1210272; Sweep CGJ, 1998, BRIT J CANCER, V78, P1434, DOI 10.1038/bjc.1998.704; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Ungefroren H, 1996, J BIOL CHEM, V271, P15787, DOI 10.1074/jbc.271.26.15787; Ungefroren H, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-18; Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67; Ungefroren H, 2011, INT J ONCOL, V38, P797, DOI 10.3892/ijo.2011.897; Wang SJ, 2004, EXP CELL RES, V300, P180, DOI 10.1016/j.yexcr.2004.06.030; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x	38	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56591	10.1371/journal.pone.0056591	http://dx.doi.org/10.1371/journal.pone.0056591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457587	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700083
J	Chen, CCV; Ku, MC; Jayaseema, DM; Lai, JS; Hueng, DY; Chang, C				Chen, Chiao-Chi V.; Ku, Min-Chi; Jayaseema, D. M.; Lai, Jiann-Shiun; Hueng, Dueng-Yuan; Chang, Chen			Simple SPION Incubation as an Efficient Intracellular Labeling Method for Tracking Neural Progenitor Cells Using MRI	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; STEM-CELLS; TRANSFERRIN RECEPTOR; TRANSFECTION AGENT; CONTRAST AGENTS; IN-VIVO; FERUMOXIDES; TRANSPLANTATION; METABOLISM	Cellular magnetic resonance imaging (MRI) has been well-established for tracking neural progenitor cells (NPC). Superparamagnetic iron oxide nanoparticles (SPIONs) approved for clinical application are the most common agents used for labeling. Conventionally, transfection agents (TAs) were added with SPIONs to facilitate cell labeling because SPIONs in the native unmodified form were deemed inefficient for intracellular labeling. However, compelling evidence also shows that simple SPION incubation is not invariably ineffective. The labeling efficiency can be improved by prolonged incubation and elevated iron doses. The goal of the present study was to establish simple SPION incubation as an efficient intracellular labeling method. To this end, NPCs derived from the neonatal subventricular zone were incubated with SPIONs (FeridexH) and then evaluated in vitro with regard to the labeling efficiency and biological functions. The results showed that, following 48 hours of incubation at 75 mu g/ml, nearly all NPCs exhibited visible SPION intake. Evidence from light microscopy, electron microscopy, chemical analysis, and magnetic resonance imaging confirmed the effectiveness of the labeling. Additionally, biological assays showed that the labeled NPCs exhibited unaffected viability, oxidative stress, apoptosis and differentiation. In the demonstrated in vivo cellular MRI experiment, the hypointensities representing the SPION labeled NPCs remained observable throughout the entire tracking period. The findings indicate that simple SPION incubation without the addition of TAs is an efficient intracellular magnetic labeling method. This simple approach may be considered as an alternative approach to the mainstream labeling method that involves the use of TAs.	[Chen, Chiao-Chi V.; Ku, Min-Chi; Jayaseema, D. M.; Chang, Chen] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Chiao-Chi V.; Ku, Min-Chi; Jayaseema, D. M.; Chang, Chen] Acad Sinica, Funct & Micromagnet Resonance Imaging Ctr, Taipei 115, Taiwan; [Lai, Jiann-Shiun] Dev Ctr Biotechnol, New Taipei, Taiwan; [Hueng, Dueng-Yuan] Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan; [Hueng, Dueng-Yuan] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Tri-Service General Hospital; National Defense Medical Center	Hueng, DY (corresponding author), Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan.	hondy2195@yahoo.com.tw; bmcchen@ibms.sinica.edu.tw	Hueng, Dueng-Yuan/AAM-7807-2021; Chang, Chen/B-5079-2009	Hueng, Dueng-Yuan/0000-0001-7868-3161; Ku, Min-Chi/0000-0003-0963-2461	National Research Program for Genomic Medicine, National Science Council, Taiwan [NSC100-3112-B-001-009]	National Research Program for Genomic Medicine, National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by funding from National Research Program for Genomic Medicine, National Science Council, Taiwan, NSC100-3112-B-001-009. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Montet K, 2005, MOL IMAGING, V4, P165; Andreas K, 2012, BIOMATERIALS, V33, P4515, DOI 10.1016/j.biomaterials.2012.02.064; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Arbab AS, 2003, TRANSPLANTATION, V76, P1123, DOI 10.1097/01.TP.0000089237.39220.83; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Berman SMC, 2011, METHODS MOL BIOL, V711, P435, DOI 10.1007/978-1-61737-992-5_22; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Dokka S, 2000, PHARMACEUT RES, V17, P521, DOI 10.1023/A:1007504613351; Dunning MD, 2004, J NEUROSCI, V24, P9799, DOI 10.1523/JNEUROSCI.3126-04.2004; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Ferrari Daniela, 2010, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02d06s15; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008; Jing Y, 2008, FASEB J, V22, P4239, DOI 10.1096/fj.07-105544; Kalish H, 2003, MAGN RESON MED, V50, P275, DOI 10.1002/mrm.10556; Kohno RI, 2006, BRAIN RES, V1093, P54, DOI 10.1016/j.brainres.2006.03.093; Kunzmann A, 2011, TOXICOL APPL PHARM, V253, P81, DOI 10.1016/j.taap.2011.03.011; Miyoshi S, 2005, MOL IMAGING BIOL, V7, P286, DOI 10.1007/s11307-005-0008-1; Neri M, 2008, STEM CELLS, V26, P505, DOI 10.1634/stemcells.2007-0251; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Schafer R, 2007, RADIOLOGY, V244, P514, DOI 10.1148/radiol.2442060599; Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358; Sipe JC, 1999, MAGN RESON IMAGING, V17, P1521, DOI 10.1016/S0730-725X(99)00085-5; Suzuki Y, 2007, MAGN RESON MED, V57, P1173, DOI 10.1002/mrm.21219; Weinstein JS, 2010, J CEREBR BLOOD F MET, V30, P15, DOI 10.1038/jcbfm.2009.192	27	33	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56125	10.1371/journal.pone.0056125	http://dx.doi.org/10.1371/journal.pone.0056125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468856	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900018
J	Ea, HK; Chobaz, V; Nguyen, C; Nasi, S; van Lent, P; Daudon, M; Dessombz, A; Bazin, D; McCarthy, G; Jolles-Haeberli, B; Ives, A; Van Linthoudt, D; So, A; Liote, F; Busso, N				Ea, Hang-Korng; Chobaz, Veronique; Christelle Nguyen; Nasi, Sonia; van Lent, Peter; Daudon, Michel; Dessombz, Arnaud; Bazin, Dominique; McCarthy, Geraldine; Jolles-Haeberli, Brigitte; Ives, Annette; Van Linthoudt, Daniel; So, Alexander; Liote, Frederic; Busso, Nathalie			Pathogenic Role of Basic Calcium Phosphate Crystals in Destructive Arthropathies	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; MILWAUKEE SHOULDER; URIC-ACID; OSTEOARTHRITIS; MINERALIZATION; CALCIFICATION; ACTIVATION; IDENTIFICATION; INFLAMMASOME; ASSOCIATION	Background: basic calcium phosphate (BCP) crystals are commonly found in osteoarthritis (OA) and are associated with cartilage destruction. BCP crystals induce in vitro catabolic responses with the production of metalloproteases and inflammatory cytokines such as interleukin-1 (IL-1). In vivo, IL-1 production induced by BCP crystals is both dependant and independent of NLRP3 inflammasome. We aimed to clarify 1/the role of BCP crystals in cartilage destruction and 2/the role of IL-1 and NLRP3 inflammasome in cartilage degradation related to BCP crystals. Methodology/Principal Findings: synovial membranes isolated from OA knees were analysed by alizarin Red and FTIR. Pyrogen free BCP crystals were injected into right knees of WT, NLRP3 -/-, ASC -/-, IL-1 alpha -/- and IL-1 beta-/-mice and PBS was injected into left knees. To assess the role of IL-1, WT mice were treated by intra-peritoneal injections of anakinra, the IL-1Ra recombinant protein, or PBS. Articular destruction was studied at d4, d17 and d30 assessing synovial inflammation, proteoglycan loss and chondrocyte apoptosis. BCP crystals were frequently found in OA synovial membranes including low grade OA. BCP crystals injected into murine knee joints provoked synovial inflammation characterized by synovial macrophage infiltration that persisted at day 30, cartilage degradation as evidenced by loss of proteoglycan staining by Safranin-O and concomitant expression of VDIPEN epitopes, and increased chondrocyte apoptosis. BCP crystal-induced synovitis was totally independent of IL-1 alpha and IL-1 beta signalling and no alterations of inflammation were observed in mice deficient for components of the NLRP3-inflammasome, IL-1 alpha or IL-1 beta. Similarly, treatment with anakinra did not prevent BCP crystal effects. In vitro, BCP crystals elicited enhanced transcription of matrix degrading and pro-inflammatory genes in macrophages. Conclusions/Significance: intra-articular BCP crystals can elicit synovial inflammation and cartilage degradation suggesting that BCP crystals have a direct pathogenic role in OA. The effects are independent of IL-1 and NLRP3 inflammasome.	[Ea, Hang-Korng; Christelle Nguyen; Liote, Frederic] Hosp Lariboisiere, INSERM, UMR S 606, Paris, France; [Ea, Hang-Korng; Liote, Frederic] Univ Paris Diderot, UFR Med, Paris, France; [Chobaz, Veronique; Nasi, Sonia; Ives, Annette; Van Linthoudt, Daniel; So, Alexander; Busso, Nathalie] CHU Vaudois, Dept Musculoskeletal Med, Serv Rheumatol, Lausanne, Switzerland; [Chobaz, Veronique; Nasi, Sonia; Jolles-Haeberli, Brigitte; Ives, Annette; Van Linthoudt, Daniel; So, Alexander; Busso, Nathalie] Univ Lausanne, Lausanne, Switzerland; [van Lent, Peter] Radboud Univ Nijmegen, Dept Rheumatol Rheumatol Res & Adv Therapeut, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Daudon, Michel] Hop Tenon, AP HP, Serv Explorat Fonct, F-75970 Paris, France; [Dessombz, Arnaud; Bazin, Dominique] Univ Paris 11, Phys Solides Lab, F-91405 Orsay, France; [McCarthy, Geraldine] Mater Misericordiae Univ Hosp, Dublin, Ireland; [Jolles-Haeberli, Brigitte] CHU Vaudois, Serv Chirurg Orthoped & Traumatol Appareil Moteur, Dept Musculoskeletal Med, Lausanne, Switzerland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Mater Misericordiae University Hospital; University College Dublin; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Busso, N (corresponding author), CHU Vaudois, Dept Musculoskeletal Med, Serv Rheumatol, Lausanne, Switzerland.	Nathalie.Busso@chuv.ch	Liote, Frederic/AAD-6926-2020; , Bazin/C-6306-2014; van Lent, Peter/A-4269-2014; McCarthy, Geraldine/AFQ-5733-2022; van Lent, Peter/A-4047-2014; Dessombz, Arnaud/B-7149-2016; Ea, HK/P-5527-2016	, Bazin/0000-0002-5112-9061; Dessombz, Arnaud/0000-0002-6610-4879; Ea, HK/0000-0002-2393-7475; Nasi, Sonia/0000-0002-6625-8309; Liote, Frederic/0000-0003-4419-0726; Ives, Annette/0000-0002-7407-960X; Nguyen, MD, PhD, Christelle/0000-0001-7141-3230; McCarthy, Geraldine/0000-0003-4078-8499	Fonds national suisse de la recherche scientifique [310030-130085/1]; Fondation Jean; Linette Warnery; Fondation pour la Recherche Medicale [FRM DV020081013483]; INSERM; University Paris Diderot; Faculty of Medicine (Institut Claude Bernard); Societe Francaise de Rhumatologie; Association pour la Recherche en Pathologie Synoviale (ARPS); Prevention et Traitement des Decalcifications - Cristaux et Cartilage; Rhumatisme et Travail	Fonds national suisse de la recherche scientifique; Fondation Jean; Linette Warnery; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Diderot; Faculty of Medicine (Institut Claude Bernard); Societe Francaise de Rhumatologie; Association pour la Recherche en Pathologie Synoviale (ARPS); Prevention et Traitement des Decalcifications - Cristaux et Cartilage; Rhumatisme et Travail	This work was supported by the Fonds national suisse de la recherche scientifique (grant 310030-130085/1), from the Fondation Jean and Linette Warnery, from the Fondation pour la Recherche Medicale (FRM DV020081013483, call for bids Vieillissement, 2008-2011), INSERM, University Paris Diderot, Faculty of Medicine (Institut Claude Bernard), the Societe Francaise de Rhumatologie, the Association pour la Recherche en Pathologie Synoviale (ARPS), Prevention et Traitement des Decalcifications - Cristaux et Cartilage, and Rhumatisme et Travail. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacconnier L, 2009, ANN RHEUM DIS, V68, P1078, DOI 10.1136/ard.2008.094284; Bougault C, 2012, ARTHRITIS RHEUM; Busso N, 1998, J CLIN INVEST, V102, P41, DOI 10.1172/JCI2312; Chevalier X, 2009, ARTHRIT RHEUM-ARTHR, V61, P344, DOI 10.1002/art.24096; Cunningham CC, 2012, CLIN IMMUNOL, V144, P228, DOI 10.1016/j.clim.2012.06.007; Ea HK, 2008, ANN RHEUM DIS, V67, P1617, DOI 10.1136/ard.2008.087718; Ea HK, 2011, ARTHRITIS RHEUM-US, V63, P10, DOI 10.1002/art.27761; Ea HK, 2009, CURR OPIN RHEUMATOL, V21, P150, DOI 10.1097/BOR.0b013e3283257ba9; Ea HK, 2005, ARTHRITIS RES THER, V7, pR915, DOI 10.1186/ar1763; EstepaMaurice L, 1996, AM J CLIN PATHOL, V105, P576; FAM AG, 1995, ARTHRITIS RHEUM-US, V38, P201, DOI 10.1002/art.1780380208; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Fuerst M, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-166; HALVERSON PB, 1984, ANN RHEUM DIS, V43, P734, DOI 10.1136/ard.43.5.734; HALVERSON PB, 1981, ARTHRITIS RHEUM-US, V24, P474, DOI 10.1002/art.1780240304; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Horn DA, 2004, BIOTECH HISTOCHEM, V79, P151, DOI 10.1080/10520290400004708; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MCCARTY DJ, 1966, J EXP MED, V124, P99, DOI 10.1084/jem.124.1.99; Mitsuyama H, 2007, OSTEOARTHR CARTILAGE, V15, P559, DOI 10.1016/j.joca.2006.10.017; Molloy ES, 2009, OSTEOARTHR CARTILAGE, V17, P686, DOI 10.1016/j.joca.2008.09.014; Narayan S, 2011, ARTHRITIS RHEUM-US, V63, P422, DOI 10.1002/art.30147; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Nguyen C, 2011, J SYNCHROTRON RADIAT, V18, P475, DOI 10.1107/S0909049511006984; Pazar B, 2011, J IMMUNOL, V186, P2495, DOI 10.4049/jimmunol.1001284; Prudhommeaux F, 1996, ARTHRITIS RHEUM, V39, P1319, DOI 10.1002/art.1780390809; Roemhildt ML, 2012, OSTEOARTHR CARTILAGE, V20, P796, DOI 10.1016/j.joca.2012.04.011; SCOTCHFORD CA, 1992, J ANAT, V181, P293; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Sun YB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2968; van Lent P, 2011, ARTHRITIS RHEUM; vanLinthoudt D, 1997, CLIN EXP RHEUMATOL, V15, P493	35	60	61	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57352	10.1371/journal.pone.0057352	http://dx.doi.org/10.1371/journal.pone.0057352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468973	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900075
J	Guo, LH; Hu, W; He, XS; Lux, R; McLean, J; Shi, WY				Guo, Lihong; Hu, Wei; He, Xuesong; Lux, Renate; McLean, Jeff; Shi, Wenyuan			Investigating Acid Production by Streptococcus mutans with a Surface-Displayed pH-Sensitive Green Fluorescent Protein	PLOS ONE			English	Article							MICROBIAL BIOFILMS; ESCHERICHIA-COLI; ORAL BIOFILMS; IN-SITU; PHLUORIN; BACTERIA; PLAQUE; CELLS; MICROENVIRONMENTS; CARIOGENICITY	Acidogenicity and aciduricity are the main virulence factors of the cavity-causing bacterium Streptococcus mutans. Monitoring at the individual cell level the temporal and spatial distribution of acid produced by this important oral pathogen is central for our understanding of these key virulence factors especially when S. mutans resides in multi-species microbial communities. In this study, we explored the application of pH-sensitive green fluorescent proteins (pHluorins) to investigate these important features. Ecliptic pHluorin was functionally displayed on the cell surface of S. mutans as a fusion protein with SpaP. The resulting strain (O87) was used to monitor temporal and spatial pH changes in the microenvironment of S. mutans cells under both planktonic and biofilm conditions. Using strain O87, we revealed a rapid pH drop in the microenviroment of S. mutans microcolonies prior to the decrease in the macro-environment pH following sucrose fermentation. Meanwhile, a non-uniform pH distribution was observed within S. mutans biofilms, reflecting differences in microbial metabolic activity. Furthermore, strain O87 was successfully used to monitor the S. mutans acid production profiles within dual-and multispecies oral biofilms. Based on these findings, the ecliptic pHluorin allows us to investigate in vivo and in situ acid production and distribution by the cariogenic species S. mutans.	[Guo, Lihong; Hu, Wei; He, Xuesong; Lux, Renate; Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Hu, Wei] Shandong Univ, Coll Life Sci, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [McLean, Jeff] J Craig Venter Inst, San Diego, CA USA	University of California System; University of California Los Angeles; Shandong University; J. Craig Venter Institute	Shi, WY (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	wenyuan@ucla.edu	SHI, wen/GPW-9531-2022; He, Xuesong/GXN-2297-2022; McLean, Jeffrey S/A-8014-2012	McLean, Jeffrey S/0000-0001-9934-5137	National Institute of Health [NIH-1-R01-DE020102]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020102] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the National Institute of Health (NIH-1-R01-DE020102) to WS, RL and JML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Banas JA, 2004, FRONT BIOSCI-LANDMRK, V9, P1267, DOI 10.2741/1305; Barker WW, 1998, AM MINERAL, V83, P1551, DOI 10.2138/am-1998-11-1243; Bhagwat SP, 2001, FEMS MICROBIOL LETT, V205, P225, DOI 10.1016/S0378-1097(01)00471-2; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; de los Rios A, 2003, ENVIRON MICROBIOL, V5, P231; DIBDIN GH, 1990, J DENT RES, V69, P1324, DOI 10.1177/00220345900690062001; DIBDIN GH, 1988, J DENT RES, V67, P890, DOI 10.1177/00220345880670060101; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FERRIS FG, 1989, APPL ENVIRON MICROB, V55, P1249, DOI 10.1128/AEM.55.5.1249-1257.1989; Gu F, 2005, J MICROBIOL METH, V62, P145, DOI 10.1016/j.mimet.2005.02.013; Haagensen JAJ, 2007, J BACTERIOL, V189, P28, DOI 10.1128/JB.00720-06; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; Hegler F, 2010, FEMS MICROBIOL ECOL, V74, P592, DOI 10.1111/j.1574-6941.2010.00975.x; Hidalgo G, 2009, APPL ENVIRON MICROB, V75, P7426, DOI 10.1128/AEM.01220-09; Hunter RC, 2005, APPL ENVIRON MICROB, V71, P2501, DOI 10.1128/AEM.71.5.2501-2510.2005; Karagiannis J, 2001, J CELL SCI, V114, P2929; KELLY C, 1989, FEBS LETT, V258, P127, DOI 10.1016/0014-5793(89)81632-1; Khiroug SS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-141; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Lawrence JR, 2007, CAN J MICROBIOL, V53, P450, DOI 10.1139/W06-146; Lemme A, 2011, J BACTERIOL, V193, P1863, DOI 10.1128/JB.01363-10; Li LN, 2010, INT J ORAL SCI, V2, P66, DOI 10.4248/IJOS10024; Liermann LJ, 2000, CHEM GEOL, V171, P1, DOI 10.1016/S0009-2541(00)00202-3; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Marsh P D, 1994, Adv Dent Res, V8, P263; Martinez-Munoz GA, 2007, J BIO CHEM, V29, P20309; Matsui R, 2010, FUTURE MICROBIOL, V5, P403, DOI 10.2217/FMB.09.129; Merritt J, 2005, MOL MICROBIOL, V57, P960, DOI 10.1111/j.1365-2958.2005.04733.x; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Ohara-Imaizumi M, 2002, BIOCHEM J, V363, P73, DOI 10.1042/0264-6021:3630073; Padmanabhan S, 2009, FEBS LETT, V583, P107, DOI 10.1016/j.febslet.2008.11.033; PEARCE E I F, 1991, Proceedings of the Finnish Dental Society, V87, P527; PENA A, 1995, J BACTERIOL, V177, P1017, DOI 10.1128/jb.177.4.1017-1022.1995; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Qi FX, 2001, APPL ENVIRON MICROB, V67, P15, DOI 10.1128/AEM.67.1.15-21.2001; Roorda RD, 2004, J NEUROPHYSIOL, V92, P609, DOI 10.1152/jn.00087.2004; SCHEIE AA, 1992, CARIES RES, V26, P44, DOI 10.1159/000261426; Schuster S, 2005, ANAL CHEM, V77, P2727, DOI 10.1021/ac0486692; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SISSONS CH, 1994, ARCH ORAL BIOL, V39, P507, DOI 10.1016/0003-9969(94)90147-3; SLONCZEWSKI JL, 1982, J BACTERIOL, V152, P384; Smit A, 1997, CARIES RES, V31, P55, DOI 10.1159/000262375; Sobota JA, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-32; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Ullrich S, 1996, APPL ENVIRON MICROB, V62, P4587, DOI 10.1128/AEM.62.12.4587-4593.1996; Varshney M, 2008, TALANTA, V74, P518, DOI 10.1016/j.talanta.2007.06.027; Vroom JM, 1999, APPL ENVIRON MICROB, V65, P3502; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Yamashita Y, 1998, MICROBIOL-SGM, V144, P1235, DOI 10.1099/00221287-144-5-1235	55	31	34	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57182	10.1371/journal.pone.0057182	http://dx.doi.org/10.1371/journal.pone.0057182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468929	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900055
J	Huang, JG; Bergeron, Y; Berninger, F; Zhai, LH; Tardif, JC; Denneler, B				Huang, Jian-Guo; Bergeron, Yves; Berninger, Frank; Zhai, Lihong; Tardif, Jacques C.; Denneler, Bernhard			Impact of Future Climate on Radial Growth of Four Major Boreal Tree Species in the Eastern Canadian Boreal Forest	PLOS ONE			English	Article							PREDICT OPTIMAL-GROWTH; JACK PINE POPULATIONS; LATITUDINAL GRADIENT; STATISTICAL-MODEL; WESTERN QUEBEC; COUPLED MODEL; PICEA-MARIANA; RESPONSES; NORTH; DENDROCLIMATOLOGY	Immediate phenotypic variation and the lagged effect of evolutionary adaptation to climate change appear to be two key processes in tree responses to climate warming. This study examines these components in two types of growth models for predicting the 2010-2099 diameter growth change of four major boreal species Betula papyrifera, Pinus banksiana, Picea mariana, and Populus tremuloides along a broad latitudinal gradient in eastern Canada under future climate projections. Climate-growth response models for 34 stands over nine latitudes were calibrated and cross-validated. An adaptive response model (A-model), in which the climate-growth relationship varies over time, and a fixed response model (F-model), in which the relationship is constant over time, were constructed to predict future growth. For the former, we examined how future growth of stands in northern latitudes could be forecasted using growth-climate equations derived from stands currently growing in southern latitudes assuming that current climate in southern locations provide an analogue for future conditions in the north. For the latter, we tested if future growth of stands would be maximally predicted using the growthclimate equation obtained from the given local stand assuming a lagged response to climate due to genetic constraints. Both models predicted a large growth increase in northern stands due to more benign temperatures, whereas there was a minimal growth change in southern stands due to potentially warm-temperature induced drought-stress. The A-model demonstrates a changing environment whereas the F-model highlights a constant growth response to future warming. As time elapses we can predict a gradual transition between a response to climate associated with the current conditions (F-model) to a more adapted response to future climate (A-model). Our modeling approach provides a template to predict tree growth response to climate warming at mid-high latitudes of the Northern Hemisphere.	[Huang, Jian-Guo; Bergeron, Yves; Denneler, Bernhard] Univ Quebec Abitibi Temiscamingue, Chaire Ind CRSNG UQAT UQAM Amenagement Forestier, Rouyn Noranda, PQ, Canada; [Berninger, Frank; Zhai, Lihong] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Tardif, Jacques C.] Univ Winnipeg, C FIR, Winnipeg, MB R3B 2E9, Canada	University of Quebec; University of Quebec Montreal; University Quebec Abitibi-Temiscamingue; University of Quebec; University of Quebec Montreal; University of Winnipeg	Huang, JG (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	huang500@purdue.edu	Berninger, Frank/A-8891-2010	Berninger, Frank/0000-0001-7718-1661	Natural Science and Engineering Research Council of Canada; Ouranos Consortium; Canada Research Chair programs	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ouranos Consortium; Canada Research Chair programs(Canada Research Chairs)	This project was financially supported by the Natural Science and Engineering Research Council of Canada, Ouranos Consortium, and Canada Research Chair programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andalo C, 2005, FOREST ECOL MANAG, V205, P169, DOI 10.1016/j.foreco.2004.10.045; [Anonymous], 1979, PHYSL WOODY PLANTS; Berninger F, 1997, FUNCT ECOL, V11, P146, DOI 10.1046/j.1365-2435.1997.00067.x; Chhin S, 2008, FOREST ECOL MANAG, V256, P1692, DOI 10.1016/j.foreco.2008.02.046; Collins M, 2001, CLIM DYNAM, V17, P61, DOI 10.1007/s003820000094; Cook E.R., 2013, METHODS DENDROCHRONO; COOK ER, 1994, INT J CLIMATOL, V14, P379, DOI 10.1002/joc.3370140404; Drobyshev I, 2010, ECOSYSTEMS, V13, P556, DOI 10.1007/s10021-010-9340-7; Eggers J, 2008, GLOBAL CHANGE BIOL, V14, P2288, DOI 10.1111/j.1365-2486.2008.01653.x; Flato GM, 2000, CLIM DYNAM, V16, P451, DOI 10.1007/s003820050339; Fritts H. C., 1976, TREE RINGS CLIMATE; Futuyma DJ, 1979, EVOLUTIONARY BIOL; Gauthier S, 2000, J VEG SCI, V11, P781, DOI 10.2307/3236548; GAUTHIER S, 1992, CAN J FOREST RES, V22, P1958, DOI 10.1139/x92-255; Girardin MP, 2008, ECOL MODEL, V213, P209, DOI 10.1016/j.ecolmodel.2007.12.010; Girardin MP, 2009, J APPL METEOROL CLIM, V48, P517, DOI 10.1175/2008JAMC1996.1; Goldblum D, 2005, CAN J FOREST RES, V35, P2709, DOI 10.1139/X05-185; Hofgaard A, 1999, CAN J FOREST RES, V29, P1333, DOI 10.1139/cjfr-29-9-1333; Holmes R.L., 1999, DENDROCHRONOLOGICAL; Huang JG, 2008, CAN J FOREST RES, V38, P2535, DOI 10.1139/X08-080; Huang JG, 2007, CRIT REV PLANT SCI, V26, P265, DOI 10.1080/07352680701626978; Huang JG, 2011, AM J BOT, V98, P792, DOI 10.3732/ajb.1000074; Huang JG, 2010, GLOBAL CHANGE BIOL, V16, P711, DOI 10.1111/j.1365-2486.2009.01990.x; Hutchinson M.F., 2004, ANUSPLIN VERSION 4 3; Kochy M, 2001, J ECOL, V89, P807, DOI 10.1046/j.0022-0477.2001.00600.x; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lapointe-Garant MP, 2010, GLOBAL CHANGE BIOL, V16, P2039, DOI 10.1111/j.1365-2486.2009.02048.x; Laroque CP, 2003, FOREST ECOL MANAG, V183, P313, DOI 10.1016/S0378-1127(03)00110-5; Lawler JJ, 2006, CONDOR, V108, P47, DOI 10.1650/0010-5422(2006)108[0047:AVATIM]2.0.CO;2; Ledig FT, 2010, AM J BOT, V97, P970, DOI 10.3732/ajb.0900329; Ma ZH, 2012, P NATL ACAD SCI USA, V109, P2423, DOI 10.1073/pnas.1111576109; MATYAS C, 1994, TREE PHYSIOL, V14, P797, DOI 10.1093/treephys/14.7-8-9.797; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Ramirez-Villegas J., 2010, DOWNSCALING GLOBAL C; Rathgeber C, 2000, GLOBAL PLANET CHANGE, V26, P405, DOI 10.1016/S0921-8181(00)00053-9; Rehfeldt G. E., 2003, Eurasian Journal of Forest Research, V6-2, P83; Rehfeldt GE, 1999, ECOL MONOGR, V69, P375, DOI 10.1890/0012-9615(1999)069[0375:GRTCIP]2.0.CO;2; Rehfeldt GE, 2002, GLOBAL CHANGE BIOL, V8, P912, DOI 10.1046/j.1365-2486.2002.00516.x; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Roeckner E., 1996, 218 M PLANCK I MET; RUNNING SW, 1988, ECOL MODEL, V42, P125, DOI 10.1016/0304-3800(88)90112-3; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Savva Y, 2007, FOREST ECOL MANAG, V242, P636, DOI 10.1016/j.foreco.2007.01.073; Sheridan SC, 2002, INT J CLIMATOL, V22, P51, DOI 10.1002/joc.709; Stadt KJ, 2007, ANN FOREST SCI, V64, P477, DOI 10.1051/forest:2007025; Thomson AM, 2008, CAN J FOREST RES, V38, P157, DOI 10.1139/X07-122; Thomson AM, 2009, CAN J FOREST RES, V39, P143, DOI 10.1139/X08-167; Welsch R, 1980, REGRESSION DIAGNOSTI; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Zhai LH, 2012, AM J BOT, V99, P827, DOI 10.3732/ajb.1100235	55	37	40	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56758	10.1371/journal.pone.0056758	http://dx.doi.org/10.1371/journal.pone.0056758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468879	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000315524900036
J	Peng, YF; Shi, YH; Ding, ZB; Zhou, J; Qiu, SJ; Hui, B; Gu, CY; Yang, H; Liu, WR; Fan, J				Peng, Yuan-Fei; Shi, Ying-Hong; Ding, Zhen-Bin; Zhou, Jian; Qiu, Shuang-Jian; Hui, Bo; Gu, Cheng-Yu; Yang, Hua; Liu, Wei-Ren; Fan, Jia			Alpha-Fetoprotein Promoter-Driven Cre/LoxP-Switched RNA Interference for Hepatocellular Carcinoma Tissue-Specific Target Therapy	PLOS ONE			English	Article							IN-VIVO SELECTION; GENE-THERAPY; METASTATIC CHARACTERISTICS; CELL-LINE; ADENOVIRUS; SIRNA; ESTABLISHMENT; THERAPEUTICS; CHALLENGES; APOPTOSIS	Backgroud: RNA interference (RNAi) has recently emerged as a potential treatment modality for hepatocellular carcinoma (HCC) therapy, but the lack of cellular targets and sustained efficacy limits its application. The purpose of this study is to develop an HCC tissue-specific RNAi system and investigate its possibility for HCC treatment. Methods: Two different HCC-specific RNAi systems in which therapeutic miRNA or shRNA against target gene (Beclin 1) was directly or indirectly driven by alpha-fetoprotein promoter (AFP-miRNA and AFP-Cre/LoxP-shRNA) were constructed. Human HCC cell lines (HepG2, Hep3B and HCCLM3) and non-HCC cell lines (L-02, Hela and SW1116) were infected with the systems. The effectiveness and tissue-specificity of the systems were examined by Q-PCR and western blot analysis. The efficacy of the systems was further tested in mouse model of HCC by intravenous or intratumoral administration. The feasibility of the system for HCC treatment was evaluated by applying the system as adjuvant therapy to enhance sorafenib treatment. An AFP-Cre/LoxP-shRNA system targeting Atg5 gene (AFP-Cre/LoxP-shRNA-Atg5) was constructed and its efficacy in sensitizing HCC cells (MHCC97L/PLC) to sorafenib treatment was examined by apoptosis assay in vitro and tumorigenesis assay in vivo. Results: The AFP-miRNA system could silence target gene (Beclin 1) but required a high titer which was lethal to target cells. The AFP-Cre/LoxP-shRNA system could efficiently knockdown target gene while maintain high HCC specificity. Intratumoral injection of the AFP-Cre/LoxP-shRNA system could efficiently silence target gene (Beclin 1) in vivo while intravenous administration could not. The AFP-Cre/LoxP-shRNA system target Atg5 gene could significantly sensitize MHCC97L/PLC cells to sorafenib-induced apoptosis in vitro and tumor growth suppression in vivo. Conclusions: An efficient HCC tissue-specific RNAi system (AFP-Cre/LoxP-shRNA) was successfully established. The system provides a usable tool for HCC-specific RNAi therapy, which may serve as a new treatment modality for HCC.	[Peng, Yuan-Fei; Shi, Ying-Hong; Ding, Zhen-Bin; Zhou, Jian; Qiu, Shuang-Jian; Hui, Bo; Gu, Cheng-Yu; Yang, Hua; Liu, Wei-Ren; Fan, Jia] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg, Shanghai 200433, Peoples R China; [Peng, Yuan-Fei; Shi, Ying-Hong; Ding, Zhen-Bin; Zhou, Jian; Qiu, Shuang-Jian; Hui, Bo; Gu, Cheng-Yu; Yang, Hua; Liu, Wei-Ren; Fan, Jia] Minist Educ Res, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China; [Fan, Jia] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Fan, J (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg, Shanghai 200433, Peoples R China.	fan.jia@zs-hosptal.sh.cn	Shi, Ying-Hong/B-7063-2017; Fan, Jia/C-6689-2017	Zhou, Jian/0000-0002-7650-7540	National Natural Science Foundation of China [81030038, 81001060, 81272389]; National Key Sci-Tech Project [2012ZX10002011-002]; China Postdoctoral Science Foundation [20100470639, 201104240]; Shanghai Postdoctoral Science Foundation [11R21410300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the grants from National Natural Science Foundation of China (81030038, 81001060, 81272389), National Key Sci-Tech Project (2012ZX10002011-002), China Postdoctoral Science Foundation (20100470639, 201104240), and Shanghai Postdoctoral Science Foundation (11R21410300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bora RS, 2012, MOL MED REP, V6, P9, DOI 10.3892/mmr.2012.871; Chen SH, 2011, EUR J CLIN INVEST, V41, P221, DOI 10.1111/j.1365-2362.2010.02400.x; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gilmore Ian R., 2006, Current Drug Delivery, V3, P147, DOI 10.2174/156720106776359159; Hirano T, 2001, GENE THER, V8, P80, DOI 10.1038/sj.gt.3301355; IDO A, 1995, CANCER RES, V55, P3105; Johnson PJ, 1999, J GASTROEN HEPATOL, V14, pS32, DOI 10.1046/j.1440-1746.1999.01873.x; Kanai F, 1997, CANCER RES, V57, P461; Kaneko S, 2001, MOL BIOTECHNOL, V19, P323, DOI 10.1385/MB:19:3:323; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Mao CY, 2009, HEPATOB PANCREAT DIS, V8, P282; Marquardt JU, 2012, J HEPATOL, V56, P267, DOI 10.1016/j.jhep.2011.07.007; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Peng YF, 2008, ONCOL REP, V19, P73; Petrocca F, 2011, J CLIN ONCOL, V29, P747, DOI 10.1200/JCO.2009.27.6287; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Takahashi M, 2002, MOL THER, V5, P627, DOI 10.1006/mthe.2002.0589; Xu CR, 2011, RECENT PAT ANTI-CANC, V6, P106, DOI 10.2174/157489211793980097; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210	26	18	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e53072	10.1371/journal.pone.0053072	http://dx.doi.org/10.1371/journal.pone.0053072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468839	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900007
J	Schreiber, C; Kuch, V; Umansky, V; Sleeman, JP				Schreiber, Caroline; Kuch, Vanessa; Umansky, Viktor; Sleeman, Jonathan P.			Autochthonous Mouse Melanoma and Mammary Tumors do not Express the Pluripotency Genes Oct4 and Nanog	PLOS ONE			English	Article							CANCER STEM-CELLS; INITIATING CELLS; SELF-RENEWAL; TRANSCRIPTION FACTOR; TRANSGENIC MICE; ADENOCARCINOMA; MARKER; DIFFERENTIATION; SUBPOPULATION; MAINTENANCE	The homeodomain transcription factors Oct4 and Nanog maintain pluripotency and self-renewal in embryonic stem cells. In somatic cells, inappropriate expression of these genes has been associated with loss of differentiation, malignant transformation, and the acquisition of cancer stem cell-like properties. As cancer stem cells have been suggested to underlie the growth and malignancy of tumors, Oct4 and Nanog may represent therapeutic targets. Their expression could also act as a marker of the cancer stem cell population, permitting its isolation and characterisation. Nevertheless, the existence of multiple pseudogenes and isoforms of these genes has complicated the interpretation of the data that supports a role for Oct4 and Nanog in the cancer context. Here we addressed this issue using knockin mice in which IRES elements are used to allow GFP expression under the control of the endogenous Oct4 or Nanog promoters, while maintaining correct expression of the Oct4 or Nanog gene. These mice were crossed with MT/ret mice that develop melanomas, and with MMTV-PyMT mice and MMTV-Neu mice that develop mammary adenocarcinomas. We analysed the tumors that developed in these compound mice for GFP expression. In this way we could assess transcription of Oct4 and Nanog in autochthonous cancers without the complication of factors such as pseudogene expression, alternative splicing and antibody specificity. Both the Oct4 and Nanog knockin tumor-bearing mice expressed GFP in blastocysts and testes as expected. However, we could find no evidence for expression of the GFP reporter above background levels in tumors using FACS, qPCR and immunohistochemistry. Furthermore, cultivation of Oct4GFP and NanogGFP MMTV-PyMT tumor cells either adherently or as spheroids had no effect on the expression of the GFP reporter. Together these data suggest that Oct4 and Nanog are not expressed in tumor cells that arise in the autochthonous cancer models studied here.	[Schreiber, Caroline; Kuch, Vanessa; Sleeman, Jonathan P.] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Mannheim, Germany; [Sleeman, Jonathan P.] Inst Toxicol & Genet, Karlsruhe, Germany; [Umansky, Viktor] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany; [Umansky, Viktor] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Schreiber, C (corresponding author), Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Mannheim, Germany.	caroline.schreiber@medma.uni-heidelberg.de	Sleeman, Jonathan P/H-2515-2013	Sleeman, Jonathan P/0000-0003-1718-7687	European Union [HEALTH-F2-2008-201662]; Klinikum Mannheim GmbH	European Union(European Commission); Klinikum Mannheim GmbH	This work was supported by the European Union under the auspices of the FP7 collaborative project TuMIC, contract no. HEALTH-F2-2008-201662. J.P.S. gratefully acknowledges funding from the Klinikum Mannheim GmbH for the "Franz-Volhard-Stiftungsprofessur fur Mikrovaskulare Biologie und Pathobiologie". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambady S, 2010, INT J DEV BIOL, V54, P1743, DOI 10.1387/ijdb.103192sa; Beltran AS, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3019; Bernhardt M, 2012, BIOTECHNOL J, V7, P810, DOI 10.1002/biot.201100347; Booth HAF, 2004, GENOMICS, V84, P229, DOI 10.1016/j.ygeno.2004.02.014; Bortolomai I, 2010, CELL CYCLE, V9, P1194, DOI 10.4161/cc.9.6.11108; Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang CJ, 2011, BIOCHEM BIOPH RES CO, V415, P245, DOI 10.1016/j.bbrc.2011.10.024; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; de Jong Jeroen, 2006, Critical Reviews in Oncogenesis, V12, P171; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Gazouli M, 2012, MOL CARCINOGEN, V51, P165, DOI 10.1002/mc.20773; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; IWAMOTO T, 1991, EMBO J, V10, P3167, DOI 10.1002/j.1460-2075.1991.tb04878.x; Karoubi G, 2010, J SURG ONCOL, V102, P689, DOI 10.1002/jso.21665; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Kuch V, 2012, INT J CANC; Kuijk EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010987; Kumar SM, 2012, ONCOGENE; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Lin H, 2007, BIOCHEM BIOPH RES CO, V355, P111, DOI 10.1016/j.bbrc.2007.01.106; Lin YL, 2011, MOL CELL BIOCHEM, V351, P109, DOI 10.1007/s11010-011-0717-5; Linn Douglas E, 2010, Genes Cancer, V1, P908, DOI 10.1177/1947601910388271; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Ma YL, 2010, J CELL MOL MED, V14, P2697, DOI 10.1111/j.1582-4934.2010.01191.x; Maenhaut C, 2010, CARCINOGENESIS, V31, P149, DOI 10.1093/carcin/bgp259; Mimeault M, 2011, MOL MED, V17, P949, DOI 10.2119/molmed.2011.00115; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mizuno N, 2008, J BIOL CHEM, V283, P30997, DOI 10.1074/jbc.M802992200; Moon JH, 2011, BIOCHEM BIOPH RES CO, V412, P175, DOI 10.1016/j.bbrc.2011.07.070; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nagata T, 2012, BREAST CANC; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Prud'homme GJ, 2012, CURR PHARM DESIGN, V18, P2838; Ramgolam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018784; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Santini R, 2012, STEM CELLS, V30, P1808, DOI 10.1002/stem.1160; Sheikine Y, 2012, AM J CANCER RES, V2, P153; SHIMAZAKI T, 1993, EMBO J, V12, P4489, DOI 10.1002/j.1460-2075.1993.tb06138.x; Shimizu Y, 2006, INT J MOL MED, V17, P21; Sotomayor P, 2009, PROSTATE, V69, P401, DOI 10.1002/pros.20895; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang PX, 2003, BIOCHEM J, V375, P199, DOI 10.1042/BJ20030579; Warthemann R, 2012, MOL HUM REPROD, V18, P605, DOI 10.1093/molehr/gas032; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zhao SD, 2011, J PATHOL, V223, P672, DOI 10.1002/path.2827; Zhou X, 2011, INT J GYNECOL PATHOL, V30, P262, DOI 10.1097/PGP.0b013e3182055a1f; Zuk PA, 2009, J CELL BIOCHEM, V106, P867, DOI 10.1002/jcb.22054	61	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57465	10.1371/journal.pone.0057465	http://dx.doi.org/10.1371/journal.pone.0057465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468991	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900091
J	Zhang, S; Yan, H; Li, CZ; Chen, YH; Yuan, FH; Chen, YG; Weng, SP; He, JG				Zhang, Shuang; Yan, Hui; Li, Chao-Zheng; Chen, Yi-Hong; Yuan, Feng-hua; Chen, Yong-gui; Weng, Shao-Ping; He, Jian-Guo			Identification and Function of Leucine-Rich Repeat Flightless-I-Interacting Protein 2 (LRRFIP2) in Litopenaeus vannamei	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; FLI-I; SHRIMP; RECOGNITION; INTERFERON; INFECTION; IMMUNITY; DISEASES; DEFENSE; FAMILY	Leucine-rich repeat flightless-I-interacting protein 2 (LRRFIP2) is a myeloid differentiation factor 88-interacting protein with a positive regulatory function in toll-like receptor signaling. In this study, seven LRRFIP2 protein variants (LvLRRFIP2A-G) were identified in Litopenaeus vannamei. All the seven LvLRRFIP2 protein variants encode proteins with a DUF2051 domain. LvLRRFIP2s were upregulated in hemocytes after challenged with lipopolysaccharide, poly I:C, CpG-ODN2006, Vibrio parahaemolyticus, Staphylococcus aureus, and white spot syndrome virus (WSSV). Dual-luciferase reporter assays in Drosophila Schneider 2 cells revealed that LvLRRFIP2 activates the promoters of Drosophila and shrimp AMP genes. The knockdown of LvLRRFIP2 by RNA interference resulted in higher cumulative mortality of L. vannamei upon V. parahaemolyticus but not S. aureus and WSSV infections. The expression of L. vannamei AMP genes were reduced by dsLvLRRFIP2 interference. These results indicate that LvLRRFIP2 has an important function in antibacterials via the regulation of AMP gene expression.	[Zhang, Shuang; Yan, Hui; Li, Chao-Zheng; Yuan, Feng-hua; Weng, Shao-Ping; He, Jian-Guo] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Aquat Prod Safety,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yi-Hong; Chen, Yong-gui; He, Jian-Guo] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	He, JG (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Aquat Prod Safety,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	lsshjg@mail.sysu.edu.cn	Chaozheng, Li/E-4632-2016	Li, Chaozheng/0000-0001-7639-7831	National Natural Science Foundation of China [U1131002]; National High Technology Research and Development Program of China (973 Program) [2012CB114401]; China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest [201103034]; Foundation of Administration of Ocean and Fisheries of Guangdong Province [A201101B02]; State Key Laboratory of Biocontrol [SKLBC09K04]; Foundation of Science and Technology Bureau of Guangdong Province [2011A020102002, 2009A020102002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (973 Program)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest; Foundation of Administration of Ocean and Fisheries of Guangdong Province; State Key Laboratory of Biocontrol; Foundation of Science and Technology Bureau of Guangdong Province	This research was supported by the National Natural Science Foundation of China under Grant No. U1131002, the National High Technology Research and Development Program of China (973 Program) 2012CB114401, the China Agriculture Research System, the Special Fund for Agro-scientific Research in the Public Interest 201103034, the Foundation of Administration of Ocean and Fisheries of Guangdong Province A201101B02, the Open Project of the State Key Laboratory of Biocontrol (SKLBC09K04) and the Foundation of Science and Technology Bureau of Guangdong Province (2011A020102002 and 2009A020102002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arakawa R, 2010, BIOCHEM CELL BIOL, V88, P899, DOI 10.1139/O10-014; Bachere E, 2000, AQUACULTURE, V191, P3, DOI 10.1016/S0044-8486(00)00413-0; Bagashev A, 2010, J INTERF CYTOK RES, V30, P843, DOI 10.1089/jir.2010.0017; Dai PG, 2009, J IMMUNOL, V182, P3450, DOI 10.4049/jimmunol.0802260; DUNNE A, 2003, SCI STKE, V25, pRE3; Fong KSK, 1999, GENOMICS, V58, P146, DOI 10.1006/geno.1999.5817; Fouzi M, 2010, J FISH DIS, V33, P931, DOI 10.1111/j.1365-2761.2010.01200.x; Hatao F, 2008, FEMS IMMUNOL MED MIC, V53, P260, DOI 10.1111/j.1574-695X.2008.00425.x; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Huang XD, 2009, FISH SHELLFISH IMMUN, V27, P230, DOI 10.1016/j.fsi.2009.05.003; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Labreuche Y, 2009, DEV COMP IMMUNOL, V33, P806, DOI 10.1016/j.dci.2009.02.005; Lee YH, 2006, NUCLEIC ACIDS RES, V34, P5052, DOI 10.1093/nar/gkl652; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lightner DV, 2007, DEV BIOLOGICALS, V129, P137; Lightner DV, 2006, DEV BIOLOGICALS, V126, P117; Lin YR, 2011, J VIROL, V85, P3517, DOI 10.1128/JVI.01973-10; Liu J, 2005, P NATL ACAD SCI USA, V102, P1927, DOI 10.1073/pnas.0409472102; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; O'Leary NA, 2006, GENE, V371, P75, DOI 10.1016/j.gene.2005.11.028; O'Neill LAJ, 2003, BIOCHEM SOC T, V31, P643, DOI 10.1042/BST0310643; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Suriano AR, 2005, MOL CELL BIOL, V25, P9073, DOI 10.1128/MCB.25.20.9073-9081.2005; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Yang LS, 2007, MOL IMMUNOL, V44, P1999, DOI 10.1016/j.molimm.2006.09.021; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876	33	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57456	10.1371/journal.pone.0057456	http://dx.doi.org/10.1371/journal.pone.0057456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468989	Green Submitted, gold, Green Published			2022-12-27	WOS:000315524900089
J	Zhou, Y; Dong, N; Hu, LY; Shao, F				Zhou, Yan; Dong, Na; Hu, Liyan; Shao, Feng			The Shigella Type Three Secretion System Effector OspG Directly and Specifically Binds to Host Ubiquitin for Activation	PLOS ONE			English	Article							PROTEIN-KINASE; PATHOGENESIS; INHIBITORS; INVASION; YERSINIA; DEFINES; GTPASE; INNATE; FAMILY; IPGB1	The genus Shigella infects human gut epithelial cells to cause diarrhea and gastrointestinal disorders. Like many other Gram-negative bacterial pathogens, the virulence of Shigella spp. relies on a conserved type three secretion system that delivers a handful of effector proteins into host cells to manipulate various host cell physiology. However, many of the Shigella type III effectors remain functionally uncharacterized. Here we observe that OspG, one of the Shigella effectors, interacted with ubiquitin conjugates and poly-ubiquitin chains of either K48 or K63 linkage in eukaryotic host cells. Purified OspG protein formed a stable complex with ubiquitin but showed no interactions with other ubiquitin-like proteins. OspG binding to ubiquitin required the carboxyl terminal helical region in OspG and the canonical I44-centered hydrophobic surface in ubiquitin. OspG and OspG-homologous effectors, NleH1/2 from enteropathogenic E coli (EPEC), contain sub-domains I-VII of eukaryotic serine/threonine kinase. GST-tagged OspG and NleH1/2 could undergo autophosphorylation, the former of which was significantly stimulated by ubiquitin binding. Ubiquitin binding was also required for OspG functioning in attenuating host NF-kappa B signaling. Our data illustrate a new mechanism that bacterial pathogen like Shigella exploits ubiquitin binding to activate its secreted virulence effector for its functioning in host eukaryotic cells.	[Zhou, Yan] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Zhou, Yan; Dong, Na; Hu, Liyan; Shao, Feng] Natl Inst Biol Sci, Beijing, Peoples R China	Beijing Normal University; National Institute of Biological Sciences, Beijing	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	shaofeng@nibs.ac.cn			National Basic Research Program of China (973 Programs) [2010CB835400, 2012CB518700]	National Basic Research Program of China (973 Programs)(National Basic Research Program of China)	This research was supported by the National Basic Research Program of China (973 Programs 2010CB835400 and 2012CB518700) to FS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Chen GJ, 2000, BIOCHEMISTRY-US, V39, P2079, DOI 10.1021/bi9919495; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Handa Y, 2007, NAT CELL BIOL, V9, P121, DOI 10.1038/ncb1526; Hemrajani C, 2010, P NATL ACAD SCI USA, V107, P3129, DOI 10.1073/pnas.0911609106; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kramer RW, 2007, PLOS PATHOG, V3, P179, DOI 10.1371/journal.ppat.0030021; Le Gall T, 2005, MICROBIOL-SGM, V151, P951, DOI 10.1099/mic.0.27639-0; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; MENDELOW M, 1993, J BIOL CHEM, V268, P12289; Mittal R, 2010, J BIOL CHEM, V285, P19927, DOI 10.1074/jbc.M110.126581; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Ohya K, 2005, J BIOL CHEM, V280, P24022, DOI 10.1074/jbc.M502509200; Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb7100025; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Rytkonen A, 2007, CELL HOST MICROBE, V1, P13, DOI 10.1016/j.chom.2007.02.003; Sanada T, 2012, NATURE, V483, P623, DOI 10.1038/nature10894; Sansonetti PJ, 1998, JPN J MED SCI BIOL, V51, pS69, DOI 10.7883/yoken1952.51.Supplement1_S69; SASAKAWA C, 1992, CURR TOP MICROBIOL, V180, P21; Schwartz AL, 1999, ANNU REV MED, V50, P57; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; WARD NE, 1992, BIOCHEMISTRY-US, V31, P5905, DOI 10.1021/bi00140a029; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	38	32	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57558	10.1371/journal.pone.0057558	http://dx.doi.org/10.1371/journal.pone.0057558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469023	Green Published, gold			2022-12-27	WOS:000315524900122
J	Colman, BP; Arnaout, CL; Anciaux, S; Gunsch, CK; Hochella, MF; Kim, B; Lowry, GV; McGill, BM; Reinsch, BC; Richardson, CJ; Unrine, JM; Wright, JP; Yin, LY; Bernhardt, ES				Colman, Benjamin P.; Arnaout, Christina L.; Anciaux, Sarah; Gunsch, Claudia K.; Hochella, Michael F., Jr.; Kim, Bojeong; Lowry, Gregory V.; McGill, Bonnie M.; Reinsch, Brian C.; Richardson, Curtis J.; Unrine, Jason M.; Wright, Justin P.; Yin, Liyan; Bernhardt, Emily S.			Low Concentrations of Silver Nanoparticles in Biosolids Cause Adverse Ecosystem Responses under Realistic Field Scenario	PLOS ONE			English	Article							ENZYME-ACTIVITY; COMMUNITY STRUCTURE; SEWAGE-SLUDGE; SOIL; NANOMATERIALS; SULFIDATION; BACTERIA; NITROGEN; BEHAVIOR; IMPACT	A large fraction of engineered nanomaterials in consumer and commercial products will reach natural ecosystems. To date, research on the biological impacts of environmental nanomaterial exposures has largely focused on high-concentration exposures in mechanistic lab studies with single strains of model organisms. These results are difficult to extrapolate to ecosystems, where exposures will likely be at low-concentrations and which are inhabited by a diversity of organisms. Here we show adverse responses of plants and microorganisms in a replicated long-term terrestrial mesocosm field experiment following a single low dose of silver nanoparticles (0.14 mg Ag kg(-1) soil) applied via a likely route of exposure, sewage biosolid application. While total aboveground plant biomass did not differ between treatments receiving biosolids, one plant species, Microstegium vimeneum, had 32 % less biomass in the Slurry+AgNP treatment relative to the Slurry only treatment. Microorganisms were also affected by AgNP treatment, which gave a significantly different community composition of bacteria in the Slurry+AgNPs as opposed to the Slurry treatment one day after addition as analyzed by T-RFLP analysis of 16S-rRNA genes. After eight days, N2O flux was 4.5 fold higher in the Slurry+AgNPs treatment than the Slurry treatment. After fifty days, community composition and N2O flux of the Slurry+AgNPs treatment converged with the Slurry. However, the soil microbial extracellular enzymes leucine amino peptidase and phosphatase had 52 and 27% lower activities, respectively, while microbial biomass was 35% lower than the Slurry. We also show that the magnitude of these responses was in all cases as large as or larger than the positive control, AgNO3, added at 4-fold the Ag concentration of the silver nanoparticles.	[Colman, Benjamin P.; McGill, Bonnie M.; Wright, Justin P.; Bernhardt, Emily S.] Duke Univ, Dept Biol, Durham, NC 27706 USA; [Arnaout, Christina L.; Gunsch, Claudia K.] Duke Univ, Civil & Environm Engn Dept, Durham, NC 27706 USA; [Anciaux, Sarah] Coe Coll, Dept Chem, Cedar Rapids, IA 52402 USA; [Hochella, Michael F., Jr.; Kim, Bojeong] Virginia Tech, Dept Geosci, Blacksburg, VA USA; [Lowry, Gregory V.; Reinsch, Brian C.] Carnegie Mellon Univ, Dept Civil & Environm Engn, Pittsburgh, PA 15213 USA; [Richardson, Curtis J.] Duke Univ, Nicholas Sch Environm, Duke Wetland Ctr, Durham, NC 27706 USA; [Unrine, Jason M.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA; [Yin, Liyan] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China; [Colman, Benjamin P.; Arnaout, Christina L.; Anciaux, Sarah; Gunsch, Claudia K.; Hochella, Michael F., Jr.; Kim, Bojeong; Lowry, Gregory V.; Reinsch, Brian C.; Richardson, Curtis J.; Unrine, Jason M.; Yin, Liyan; Bernhardt, Emily S.] Duke Univ, Ctr Environm Implicat Nanotechnol CEINT, Durham, NC 27706 USA	Duke University; Duke University; Virginia Polytechnic Institute & State University; Carnegie Mellon University; Duke University; University of Kentucky; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Duke University	Colman, BP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	benjamin.colman@duke.edu	Colman, Benjamin P./AGJ-4864-2022; Bernhardt, Emily/B-4541-2010; Wright, Justin/AAG-6461-2019; Lowry, Gregory V/B-9846-2008; McGill, Bonnie/AAT-7426-2020; Richardson, Curtis J/A-8202-2009; Bernhardt, Emily S/D-9940-2011; Kim, Bojeong/AAE-9658-2021; Colman, Benjamin/B-5704-2009; Richardson, Curt/P-5905-2019	Colman, Benjamin P./0000-0001-6290-3705; Wright, Justin/0000-0002-9102-5347; McGill, Bonnie/0000-0002-5417-3519; Bernhardt, Emily S/0000-0003-3031-621X; Colman, Benjamin/0000-0001-6290-3705; Unrine, Jason/0000-0003-3012-5261; Gunsch, Claudia/0000-0002-8555-0313; Kim, Bojeong/0000-0001-5614-3287	National Science Foundation (NSF); Environmental Protection Agency (EPA) under NSF [EF-0830093]; Center for the Environmental Implications of Nanotechnology (CEINT); Bertucci Graduate Fellowship at Carnegie Mellon University	National Science Foundation (NSF)(National Science Foundation (NSF)); Environmental Protection Agency (EPA) under NSF(United States Environmental Protection Agency); Center for the Environmental Implications of Nanotechnology (CEINT); Bertucci Graduate Fellowship at Carnegie Mellon University	This study was supported by the National Science Foundation (NSF) and the Environmental Protection Agency (EPA) under NSF Cooperative Agreement EF-0830093, and the Center for the Environmental Implications of Nanotechnology (CEINT). Any opinions, findings, conclusions, or recommendations expressed in this paper are those of the authors and do not necessarily reflect the views of the NSF or the EPA. This work has not been subjected to EPA review and no official endorsement should be inferred. Funding was also provided for BCR by the Bertucci Graduate Fellowship at Carnegie Mellon University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benn TM, 2008, ENVIRON SCI TECHNOL, V42, P4133, DOI 10.1021/es7032718; Blaser SA, 2008, SCI TOTAL ENVIRON, V390, P396, DOI 10.1016/j.scitotenv.2007.10.010; Bradford A, 2009, ENVIRON SCI TECHNOL, V43, P4530, DOI 10.1021/es9001949; BURNS RG, 1982, SOIL BIOL BIOCHEM, V14, P423, DOI 10.1016/0038-0717(82)90099-2; CLARHOLM M, 1985, SOIL BIOL BIOCHEM, V17, P181, DOI 10.1016/0038-0717(85)90113-0; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Colman BP, 2012, ECOTOXICOLOGY, V21, P1867, DOI 10.1007/s10646-012-0920-5; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; EPA, 2009, TARG NAT SEW SLUDG S; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hansch M, 2010, J PLANT NUTR SOIL SC, V173, P554, DOI 10.1002/jpln.200900358; Hwang ET, 2008, SMALL, V4, P746, DOI 10.1002/smll.200700954; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; Kaegi R, 2011, ENVIRON SCI TECHNOL, V45, P3902, DOI 10.1021/es1041892; Kim B, 2012, J ENVIRON MONITOR, V14, P1129, DOI 10.1039/c2em10809g; Kim B, 2010, ENVIRON SCI TECHNOL, V44, P7509, DOI 10.1021/es101565j; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Levard C, 2011, ENVIRON SCI TECHNOL, V45, P5260, DOI 10.1021/es2007758; Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079; Lowry GV, 2012, ENV SCI TECHNOLOGY; Lukow T, 2000, FEMS MICROBIOL ECOL, V32, P241, DOI 10.1111/j.1574-6941.2000.tb00717.x; Luoma S.N., 2008, SILVER NANOTECHNOLOG; McCune B, 1999, MULTIVARIATE ANAL EC; Meyer JN, 2010, AQUAT TOXICOL, V100, P140, DOI 10.1016/j.aquatox.2010.07.016; Min JS, 2009, PLANT PATHOLOGY J, V25, P376, DOI 10.5423/PPJ.2009.25.4.376; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; *NAT RES COUNC COM, 2002, BIOS APPL LAND ADV S; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Pradhan A, 2011, MICROB ECOL, V62, P58, DOI 10.1007/s00248-011-9861-4; Pregitzer KS, 2000, ECOL APPL, V10, P18, DOI 10.1890/1051-0761(2000)010[0018:IEOACA]2.0.CO;2; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Reinsch BC, 2012, ENVIRON SCI TECHNOL, V46, P6992, DOI 10.1021/es203732x; Robichaud CO, 2005, ENVIRON SCI TECHNOL, V39, P8985, DOI 10.1021/es0506509; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Shoults-Wilson WA, 2011, SOIL SCI SOC AM J, V75, P365, DOI 10.2136/sssaj2010.0127nps; Stein L., 1995, PROCESS DESIGN MANUA; Systat Software Inc, 2008, SIGM; Unghire JM, 2010, RESTORATION ECOLOGY, V19, P738; US EPA, 1996, 3050B USEPA; US-EPA, 1996, SW 846 TEST METHOD 3; Yin LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047674; Yin LY, 2011, ENVIRON SCI TECHNOL, V45, P2360, DOI 10.1021/es103995x	46	219	227	2	254	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57189	10.1371/journal.pone.0057189	http://dx.doi.org/10.1371/journal.pone.0057189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468930	gold, Green Published			2022-12-27	WOS:000315519000072
J	Honsell, G; Bonifacio, A; De Bortoli, M; Penna, A; Battocchi, C; Ciminiello, P; Dell'Aversano, C; Fattorusso, E; Sosa, S; Yasumoto, T; Tubaro, A				Honsell, Giorgio; Bonifacio, Alois; De Bortoli, Marco; Penna, Antonella; Battocchi, Cecilia; Ciminiello, Patrizia; Dell'Aversano, Carmela; Fattorusso, Ernesto; Sosa, Silvio; Yasumoto, Takeshi; Tubaro, Aurelia			New Insights on Cytological and Metabolic Features of Ostreopsis cf. ovata Fukuyo (Dinophyceae): A Multidisciplinary Approach	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY; BENTHIC DINOFLAGELLATE; OVATOXIN-A; PUTATIVE PALYTOXIN; PROROCENTRUM-LIMA; TOXIN PRODUCTION; NUTRIENT STATUS; FINE-STRUCTURE; LC-MS; TEMPERATURE	The harmful dinoflagellate Ostreopsis cf. ovata has been causing toxic events along the Mediterranean coasts and other temperate and tropical areas, with increasing frequency during the last decade. Despite many studies, important biological features of this species are still poorly known. An integrated study, using different microscopy and molecular techniques, Raman microspectroscopy and high resolution liquid chromatography-mass spectrometry (HR LC-MS), was undertaken to elucidate cytological aspects, and identify main metabolites including toxins. The species was genetically identified as O. cf. ovata, Atlantic-Mediterranean clade. The ultrastructural results show unique features of the mucilage network abundantly produced by this species to colonize benthic substrates, with a new role of trichocysts, never described before. The amorphous polysaccharidic component of mucilage appears to derive from pusule fibrous material and mucocysts. In all stages of growth, the cells show an abundant production of lipids. Different developmental stages of chloroplasts are found in the peripheral cytoplasm and in the centre of cell. In vivo Raman microspectroscopy confirms the presence of the carotenoid peridinin in O. cf. ovata, and detects in several specimen the abundant presence of unsaturated lipids structurally related to docosahexaenoic acid. The HR LC-MS analysis reveals that ovatoxin-a is the predominant toxin, together with decreasing amounts of ovatoxin-b, -d/e, -c and putative palytoxin. Toxins concentration on a per cell basis increases from exponential to senescent phase. The results suggest that benthic blooms of this species are probably related to features such as the ability to create a unique mucilaginous sheath covering the sea bottom, associated with the production of potent toxins as palytoxin-like compounds. In this way, O. cf. ovata may be able to rapidly colonize benthic substrates outcompeting other species.	[Honsell, Giorgio] Univ Udine, Dept Agr & Environm Sci, I-33100 Udine, Italy; [Bonifacio, Alois] Univ Trieste, Dept Engn & Architecture, Trieste, Italy; [De Bortoli, Marco; Sosa, Silvio; Tubaro, Aurelia] Univ Trieste, Dept Life Sci, Trieste, Italy; [Penna, Antonella; Battocchi, Cecilia] Univ Urbino, Dept Biomol Sci, Lab Environm Biol, Pesaro, Italy; [Ciminiello, Patrizia; Dell'Aversano, Carmela; Fattorusso, Ernesto] Univ Naples Federico II, Dept Nat Prod Chem, Naples, Italy; [Yasumoto, Takeshi] Tama Lab, Japan Food Res Labs, Tokyo, Japan	University of Udine; University of Trieste; University of Trieste; University of Urbino; University of Naples Federico II	Tubaro, A (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	tubaro@units.it	Bonifacio, Alois/C-6311-2008; Tubaro, Aurelia/AAB-2601-2022; Dell'Aversano, Carmela/H-1803-2013; Honsell, Giorgio/B-2946-2009	Bonifacio, Alois/0000-0002-2251-7786; Dell'Aversano, Carmela/0000-0001-8337-3029; Honsell, Giorgio/0000-0003-3425-5952; SOSA, SILVIO/0000-0002-2909-6603	Italian Ministry of Education, University and Research [PRIN 2007FXSCL2_005]; Regione Autonoma Friuli-Venezia Giulia, Direzione Risorse Rurali, Agroalimentari e Forestali	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Autonoma Friuli-Venezia Giulia, Direzione Risorse Rurali, Agroalimentari e Forestali	The work was supported by the Italian Ministry of Education, University and Research (www.miur.it; PRIN 2007FXSCL2_005) and by Regione Autonoma Friuli-Venezia Giulia, Direzione Risorse Rurali, Agroalimentari e Forestali (www.regione.fvg.it/rafvg/cms/RAFVG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2011, CHEMOMETR INTELL LAB, V107, P174, DOI 10.1016/j.chemolab.2011.03.004; Accoroni S, 2011, MAR POLLUT BULL, V62, P2512, DOI 10.1016/j.marpolbul.2011.08.003; ALLDREDGE AL, 1993, DEEP-SEA RES PT I, V40, P1131, DOI 10.1016/0967-0637(93)90129-Q; Alldredge AL, 1998, J PLANKTON RES, V20, P393, DOI 10.1093/plankt/20.3.393; Almeida MR, 2010, ANAL BIOANAL CHEM, V397, P2693, DOI 10.1007/s00216-010-3566-2; [Anonymous], 2010, R LANG ENV STAT COMP; Barone R., 2007, Harmful Algae News, V33, P1; Barone Rossella, 2006, Naturalista Siciliano, V30, P401; Beattie JR, 2004, LIPIDS, V39, P407, DOI 10.1007/s11745-004-1245-z; Beleites C., 2012, HYPERSPEC PACKAGE HA; BESADA EG, 1982, B MAR SCI, V32, P723; Blossom HE, 2012, HARMFUL ALGAE, V17, P40, DOI 10.1016/j.hal.2012.02.010; BOUCK GB, 1966, PROTOPLASMA, V61, P205, DOI 10.1007/BF01247920; Cachon J, 1974, ANN STATION BIOL BES, V9, P177; Ciminiello P, 2008, J AM SOC MASS SPECTR, V19, P111, DOI 10.1016/j.jasms.2007.11.001; Ciminiello P, 2006, ANAL CHEM, V78, P6153, DOI 10.1021/ac060250j; Ciminiello P, 2012, CHEM RES TOXICOL, V25, P1243, DOI 10.1021/tx300085e; Ciminiello P, 2012, J AM SOC MASS SPECTR, V23, P952, DOI 10.1007/s13361-012-0345-7; Ciminiello P, 2012, J AM CHEM SOC, V134, P1869, DOI 10.1021/ja210784u; Ciminiello P, 2011, TOXICON, V57, P376, DOI 10.1016/j.toxicon.2010.11.002; Ciminiello P, 2010, RAPID COMMUN MASS SP, V24, P2735, DOI 10.1002/rcm.4696; Claquin P, 2008, AQUAT MICROB ECOL, V51, P1, DOI 10.3354/ame01187; De Gelder J, 2007, J RAMAN SPECTROSC, V38, P1133, DOI 10.1002/jrs.1734; Dietzek B, 2010, CHEM PHYS, V373, P129, DOI 10.1016/j.chemphys.2010.02.028; DURAND M, 1986, BIOL CELL, V56, P171; DURAND M, 1985, PHYCOLOGIA, V24, P217, DOI 10.2216/i0031-8884-24-2-217.1; Durando P., 2007, EUROSURVEILLANCE, V12, P1, DOI DOI 10.2807/ESW.12.23.03212-EN; Fraga S, 2008, J PHYCOL, V44, P1060, DOI 10.1111/j.1529-8817.2008.00555.x; FRITZ L, 1985, J PHYCOL, V21, P662, DOI 10.1111/j.0022-3646.1985.00662.x; Fuentes-Grunewald C, 2009, J IND MICROBIOL BIOT, V36, P1215, DOI 10.1007/s10295-009-0602-3; Gallitelli M, 2005, JAMA-J AM MED ASSOC, V293, P2599, DOI 10.1001/jama.293.21.2599-c; Gedaria AI, 2007, TOXICON, V50, P518, DOI 10.1016/j.toxicon.2007.04.021; Graneli E, 2011, HARMFUL ALGAE, V10, P165, DOI 10.1016/j.hal.2010.09.002; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Guerrini F, 2010, TOXICON, V55, P211, DOI 10.1016/j.toxicon.2009.07.019; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; HARRINGT.GW, 1968, BIOCHIM BIOPHYS ACTA, V164, P137, DOI 10.1016/0005-2760(68)90083-0; Heraud P, 2006, J CHEMOMETR, V20, P193, DOI 10.1002/cem.990; Heraud P, 2007, FEMS MICROBIOL LETT, V275, P24, DOI 10.1111/j.1574-6968.2007.00861.x; Honsell G, 2004, BOT MAR, V47, P152, DOI 10.1515/BOT.2004.016; Honsell G, 1992, G BOT, V126, P749; Honsell G, 2011, ENVIRON SCI TECHNOL, V45, P7051, DOI 10.1021/es201373e; Huang YY, 2010, BIOTECHNOL BIOENG, V105, P889, DOI 10.1002/bit.22617; Kaczor A, 2011, ANALYST, V136, P1109, DOI 10.1039/c0an00553c; Kim E., 2008, CHLOROPLAST INTERACT, P1; Kwok ACM, 2005, PLANT CELL PHYSIOL, V46, P1973, DOI 10.1093/pcp/pci213; LARSEN J, 1988, PHYCOLOGIA, V27, P366, DOI 10.2216/i0031-8884-27-3-366.1; Lemee R, 2012, CRYPTOGAMIE ALGOL, V33, P137, DOI 10.7872/crya.v33.iss2.2011.137; LIVOLANT F, 1982, BIOL CELL, V43, P201; MacKenzie L, 2002, HARMFUL ALGAE, V1, P295, DOI 10.1016/S1568-9883(02)00006-9; Mangialajo L, 2011, TOXICON, V57, P408, DOI 10.1016/j.toxicon.2010.11.019; Mayo D. W., 2004, COURSE NOTES INTERPR; MESSER G, 1972, Phycologia, V11, P291, DOI 10.2216/i0031-8884-11-3-291.1; Miyagishima S, 2011, PLANT PHYSIOL, V155, P1533, DOI 10.1104/pp.110.170688; MOORE RE, 1981, J AM CHEM SOC, V103, P2491, DOI 10.1021/ja00399a093; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Navarro JM, 2006, HARMFUL ALGAE, V5, P762, DOI 10.1016/j.hal.2006.04.001; Parker B. C., 1966, PHYCOLOGIA, V6, P37, DOI DOI 10.2216/I0031-8884-6-1-37.1; Parsons ML, 2012, HARMFUL ALGAE, V14, P107, DOI 10.1016/j.hal.2011.10.017; Penna A, 2005, J PHYCOL, V41, P212, DOI 10.1111/j.1529-8817.2005.04011.x; Penna A, 2008, EUR J PHYCOL, V43, P163, DOI 10.1080/09670260701783730; Penna A, 2010, J BIOGEOGR, V37, P830, DOI 10.1111/j.1365-2699.2009.02265.x; Perini F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017699; Pezzolesi L, 2012, WATER RES, V46, P82, DOI 10.1016/j.watres.2011.10.029; Pfannkuchen M, 2012, ENVIRON SCI TECHNOL, V46, P5574, DOI 10.1021/es300189h; Pickett-Heaps JD, 2006, KINGDOM PROTISTA DAZ; Pistocchi R, 2011, TOXICON, V57, P421, DOI 10.1016/j.toxicon.2010.09.013; Pompei M, 2003, HARMFUL ALGAE, V2, P301, DOI 10.1016/S1568-9883(03)00059-3; Privitera D, 2012, HARMFUL ALGAE, V18, P16, DOI 10.1016/j.hal.2012.03.009; Quintarelli G, 1964, HISTOCHEM CELL BIOL, V4, P86; Reynolds CS, 2007, HYDROBIOLOGIA, V578, P37, DOI 10.1007/s10750-006-0431-6; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Rhodes L, 2011, TOXICON, V57, P400, DOI 10.1016/j.toxicon.2010.05.010; Robert B, 1999, ADV PHOTOSYNTH, V8, P189; Robert B, 2009, PHOTOSYNTH RES, V101, P147, DOI 10.1007/s11120-009-9440-4; Rossi R, 2010, TOXICON, V56, P1381, DOI 10.1016/j.toxicon.2010.08.003; Sansoni G., 2003, BIOL AMBIENT, V17, P17, DOI DOI 10.1021/AC060250J; SCHMITTER RE, 1971, J CELL SCI, V9, P147; SCHMITTER RE, 1981, J CELL SCI, V51, P15; Schnepf E, 1999, GRANA, V38, P81, DOI 10.1080/00173139908559217; Schultz ZD, 2011, AUST J CHEM, V64, P611, DOI 10.1071/CH11019; Shears NT, 2010, ECOL LETT, V13, P1149, DOI 10.1111/j.1461-0248.2010.01512.x; Shears NT, 2009, HARMFUL ALGAE, V8, P916, DOI 10.1016/j.hal.2009.05.003; Simonini R, 2011, MAR ENVIRON RES, V72, P230, DOI 10.1016/j.marenvres.2011.08.009; Smith E, 2005, MODERN RAMAN SPECTROSCOPY: A PRACTICAL APPROACH, P1; Socrates G., 2004, INFRARED RAMAN CHARA; Throndsen J., 1978, PHYTOPLANKTON MANUAL, P69; Tischendorf G, 2007, EUR J PHYCOL, V42, P243, DOI 10.1080/09670260701437642; Totti C, 2010, HARMFUL ALGAE, V9, P233, DOI 10.1016/j.hal.2009.10.006; Tubaro A, 2011, TOXICON, V57, P478, DOI 10.1016/j.toxicon.2011.01.005; Turrell G., 1996, RAMAN MICROSCOPY DEV; UEMURA D, 1985, TETRAHEDRON, V41, P1007, DOI 10.1016/S0040-4020(01)96468-3; Urban PL, 2011, ANAL CHEM, V83, P1843, DOI 10.1021/ac102702m; Usup G, 2008, PHYCOLOGIA, V47, P105, DOI 10.2216/07-55.1; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; Vanucci S, 2012, HARMFUL ALGAE, V15, P78, DOI 10.1016/j.hal.2011.12.003; Vidyarathna NK, 2012, AQUAT MICROB ECOL, V65, P261, DOI 10.3354/ame01555; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Wood BR, 2005, ANAL CHEM, V77, P4955, DOI 10.1021/ac050281z; Wu HW, 2011, P NATL ACAD SCI USA, V108, P3809, DOI 10.1073/pnas.1009043108; Zhang J, 2009, THESIS RUTGERS U NEW; ZHOU J, 1993, PHYCOLOGIA, V32, P444, DOI 10.2216/i0031-8884-32-6-444.1; ZHOU J, 1994, J PHYCOL, V30, P39, DOI 10.1111/j.0022-3646.1994.00039.x	104	53	56	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57291	10.1371/journal.pone.0057291	http://dx.doi.org/10.1371/journal.pone.0057291			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460837	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000088
J	Kavcic, A; Cokl, A; Laumann, RA; Blassioli-Moraes, MC; Borges, M				Kavcic, Andreja; Cokl, Andrej; Laumann, Raul A.; Blassioli-Moraes, Maria Carolina; Borges, Miguel			Tremulatory and Abdomen Vibration Signals Enable Communication through Air in the Stink Bug Euschistus heros	PLOS ONE			English	Article							NEZARA-VIRIDULA HETEROPTERA; SUBSTRATE-BORNE SIGNALS; FUNCTIONAL-PROPERTIES; MATE LOCATION; HOST PLANTS; TRICHOBOTHRIA; PENTATOMIDAE; TRANSMISSION; BEHAVIOR	Communication by substrate-borne mechanical signals is widespread among animals but remains one of their least understood communication channels. Past studies of vibrational communication in insects have been oriented predominantly to communication during mating, showing that species-and sex-specific vibrational signals enable recognition and localization of potential mates on continuous solid substrates. No special attention has been paid to vibrational signals with less obvious specificity as well as to the possibility of vibrational communication across substrates that are not in physical contact. We aimed to reinvestigate emission of the aforementioned vibrational signals transmitted through a plant in the stink bug Euschistus heros (Pentatomidae: Pentatominae) and to check whether individuals are able to communicate across adjecent, physically separated substrates. We used laser vibrometry for registration of substrateborne vibrational signals on a bean plant. Using two bean plants separated for 3 to 7 cm between two most adjacent leaves, we investigated the possibility of transmission of these signals through air. Our study showed that males and females of E. heros communicate using tremulatory, percussion and buzzing signals in addition to the previously described signals produced by vibrations of the abdomen. Contrary to the latter, the first three signal types did not differ between sexes or between pentatomid species. Experiments with two physically separated plants showed significant searching behaviour and localization of vibrational signals of an E. heros male or a female, in response to abdominal vibration produced signals of a pair duetting on the neighbouring plant, in comparison to control where no animals were on the neighbouring plant. We also confirmed that transmission through air causes amplitude and frequency decay of vibrational signals, which suggests high-amplitude, low-frequency tremulatory signals of these stink bugs their most plausible way of communication across discontinuous substrates.	[Kavcic, Andreja; Cokl, Andrej] Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia; [Laumann, Raul A.; Blassioli-Moraes, Maria Carolina; Borges, Miguel] Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil	National Institute of Biology - Slovenia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Kavcic, A (corresponding author), Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia.	andreja.kavcic@nib.si	Laumann, Raul/C-4026-2013; Blassioli-Moraes, Maria carolina/C-6072-2013; laumann, raul/AAC-4416-2019; Kavčič, Andreja/AAC-5694-2022; Borges, Miguel/C-6937-2013; Borges, Miguel/K-9918-2019	Laumann, Raul/0000-0003-3531-2613; Blassioli-Moraes, Maria carolina/0000-0001-7569-9985; laumann, raul/0000-0003-3531-2613; Borges, Miguel/0000-0003-3364-9677	Brazilian Council for Scientific and Technological Development (CNPq); Distrito Federal Research Foundation (FAP-DF); Brazilian Corporation of Agricultural Research (EMBRAPA); Slovenian National Research Agency [1000-10-310036, P1-0255-105, BI-BR/10-12-003]	Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Distrito Federal Research Foundation (FAP-DF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Corporation of Agricultural Research (EMBRAPA); Slovenian National Research Agency(Slovenian Research Agency - Slovenia)	This work received financial support from the Brazilian Council for Scientific and Technological Development (CNPq), Distrito Federal Research Foundation (FAP-DF), Brazilian Corporation of Agricultural Research (EMBRAPA) and the Slovenian National Research Agency (PhD Fellowship 1000-10-310036, Research Program P1-0255-105 and Project BI-BR/10-12-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich Jeffrey R., 1995, P318; ALDRICH JR, 1987, J EXP ZOOL, V244, P171, DOI 10.1002/jez.1402440121; Amon T, 1999, SCOPOLIA S1, V1, P133; Barth FG, 1999, PHILOS T R SOC B, V354, P183, DOI 10.1098/rstb.1999.0370; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; BORGES M, 1987, ENTOMOL EXP APPL, V44, P205, DOI 10.1007/BF00369180; Borges M, 2006, EMBRAPA RESURSOS GEN, V182; BRENNAN BM, 1977, ENVIRON ENTOMOL, V6, P169, DOI 10.1093/ee/6.1.169; Broughton W. B., 1963, ACOUSTIC BEHAVIOUR A, P3; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cokl A, 2005, J EXP BIOL, V208, P1481, DOI 10.1242/jeb.01557; Cokl A, 2003, ANNU REV ENTOMOL, V48, P29, DOI 10.1146/annurev.ento.48.091801.112605; COKL A, 1983, J COMP PHYSIOL, V150, P261; Cokl A, 1999, ANIM BEHAV, V58, P1277, DOI 10.1006/anbe.1999.1272; Cokl AJ, 2006, PHYSIOL ENTOMOL, V31, P371, DOI 10.1111/j.1365-3032.2006.00530.x; Cokl A, 2008, J INSECT PHYSIOL, V54, P1113, DOI 10.1016/j.jinsphys.2008.06.004; Cokl A, 2011, CENT EUR J BIOL, V6, P431, DOI 10.2478/s11535-011-0015-y; Cokl A, 2009, CENT EUR J BIOL, V4, P585, DOI 10.2478/s11535-009-0043-z; Costa Maria L. M., 1998, Anais da Sociedade Entomologica do Brasil, V27, P559, DOI 10.1590/S0301-80591998000400008; de Groot M, 2011, BEHAV ECOL, V22, P1209, DOI 10.1093/beheco/arr115; de Groot M, 2011, CENT EUR J BIOL, V6, P756, DOI 10.2478/s11535-011-0056-2; de Groot M, 2010, J EXP BIOL, V213, P3213, DOI 10.1242/jeb.044024; De Luca PA, 1998, BEHAVIOUR, V135, P777, DOI 10.1163/156853998792640422; DRASLAR K, 1973, J COMP PHYSIOL, V84, P175, DOI 10.1007/BF00697605; Eriksson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019692; Hill P.S., 2008, VIBRATIONAL COMMUNIC, DOI DOI 10.4159/9780674273825; Markl H., 1983, P332; McBrien HL, 1999, PHEROMONES OF NON-LEPIDOPTERAN INSECTS ASSOCIATED WITH AGRICULTURAL PLANTS, P277; Moraes MCB, 2005, PHYSIOL ENTOMOL, V30, P175, DOI 10.1111/j.1365-3032.2005.00446.x; OTA D, 1991, J INSECT BEHAV, V4, P441, DOI 10.1007/BF01049329; Polajnar J, 2012, J R SOC INTERFACE, V9, P1898, DOI 10.1098/rsif.2011.0770; Romer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013325; STADDON BW, 1994, J NAT HIST, V28, P353, DOI 10.1080/00222939400770141; Zunic A, 2008, ANN ENTOMOL SOC AM, V101, P1169, DOI 10.1603/0013-8746-101.6.1169; Zunic A, 2011, J INSECT BEHAV, V24, P468, DOI 10.1007/s10905-011-9272-x	35	18	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56503	10.1371/journal.pone.0056503	http://dx.doi.org/10.1371/journal.pone.0056503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460803	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000026
J	Masaeli, E; Morshed, M; Nasr-Esfahani, MH; Sadri, S; Hilderink, J; van Apeldoorn, A; van Blitterswijk, CA; Moroni, L				Masaeli, Elahe; Morshed, Mohammad; Nasr-Esfahani, Mohammad Hossein; Sadri, Saeid; Hilderink, Janneke; van Apeldoorn, Aart; van Blitterswijk, Clemens A.; Moroni, Lorenzo			Fabrication, Characterization and Cellular Compatibility of Poly(Hydroxy Alkanoate) Composite Nanofibrous Scaffolds for Nerve Tissue Engineering	PLOS ONE			English	Article							IN-VITRO BIOCOMPATIBILITY; ELECTROSPUN FIBER MATS; NEURAL STEM-CELLS; SCHWANN-CELLS; PERIPHERAL-NERVE; POLY 3-HYDROXYBUTYRATE; NEURITE OUTGROWTH; MELTING BEHAVIOR; REGENERATION; BLENDS	Tissue engineering techniques using a combination of polymeric scaffolds and cells represent a promising approach for nerve regeneration. We fabricated electrospun scaffolds by blending of Poly (3-hydroxybutyrate) (PHB) and Poly (3-hydroxy butyrate-co-3-hydroxyvalerate) (PHBV) in different compositions in order to investigate their potential for the regeneration of the myelinic membrane. The thermal properties of the nanofibrous blends was analyzed by differential scanning calorimetry (DSC), which indicated that the melting and glass temperatures, and crystallization degree of the blends decreased as the PHBV weight ratio increased. Raman spectroscopy also revealed that the full width at half height of the band centered at 1725 cm(-1) can be used to estimate the crystalline degree of the electrospun meshes. Random and aligned nanofibrous scaffolds were also fabricated by electrospinning of PHB and PHBV with or without type I collagen. The influence of blend composition, fiber alignment and collagen incorporation on Schwann cell (SCs) organization and function was investigated. SCs attached and proliferated over all scaffolds formulations up to 14 days. SCs grown on aligned PHB/PHBV/collagen fibers exhibited a bipolar morphology that oriented along the fiber direction, while SCs grown on the randomly oriented fibers had a multipolar morphology. Incorporation of collagen within nanofibers increased SCs proliferation on day 14, GDNF gene expression on day 7 and NGF secretion on day 6. The results of this study demonstrate that aligned PHB/PHBV electrospun nanofibers could find potential use as scaffolds for nerve tissue engineering applications and that the presence of type I collagen in the nanofibers improves cell differentiation.	[Masaeli, Elahe; Morshed, Mohammad] Isfahan Univ Technol, Dept Text Engn, Esfahan, Iran; [Masaeli, Elahe; Nasr-Esfahani, Mohammad Hossein] ACECR, Royan Inst Biotechnol, Cell Sci Res Ctr, Dept Cell & Mol Biol, Esfahan, Iran; [Masaeli, Elahe; Hilderink, Janneke; van Apeldoorn, Aart; van Blitterswijk, Clemens A.; Moroni, Lorenzo] Univ Twente, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands	Isfahan University of Technology; Academic Center for Education, Culture & Research (ACECR); University of Twente	Moroni, L (corresponding author), Univ Twente, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.	l.moroni@utwente.nl	, Nasr-Esfahani/AAR-2434-2021; van Apeldoorn, Aart/AAP-5433-2021; Moroni, Lorenzo/D-2826-2014; Nasr-Esfahani, Mohammad Hossein/AAN-2577-2020	van Apeldoorn, Aart/0000-0002-2940-5699; Moroni, Lorenzo/0000-0003-1298-6025; Nasr-Esfahani, Mohammad Hossein/0000-0003-1983-3435; van Blitterswijk, Clemens/0000-0003-2371-4615	Isfahan University of Technology; Ministry of Science, Research and Technology (Iran)	Isfahan University of Technology; Ministry of Science, Research and Technology (Iran)	EM wishes to acknowledge Isfahan University of Technology and Ministry of Science, Research and Technology (Iran) for the scholarship and financial supports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SJ, 2007, TISSUE ENG, V13, P2863, DOI 10.1089/ten.2007.0055; Avella M, 2000, J MATER SCI, V35, P523, DOI 10.1023/A:1004740522751; Ayres CE, 2010, WIRES NANOMED NANOBI, V2, P20, DOI 10.1002/wnan.55; Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018; Cao D, 2011, COLLOID SURFACE B, V84, P26, DOI 10.1016/j.colsurfb.2010.12.005; Chan CH, 2004, MACROMOL CHEM PHYS, V205, P664, DOI 10.1002/macp.200300062; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036; Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025; Cooper A, 2011, CARBOHYD POLYM, V85, P149, DOI 10.1016/j.carbpol.2011.02.008; Feng SQ, 2011, J MACROMOL SCI B, V50, P1705, DOI 10.1080/00222348.2010.541002; Friedman HCH, 1996, J NEUROSCI, V16, P5344; Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007; Ghasemi-Mobarakeh L, 2010, MAT SCI ENG C-MATER, V30, P1129, DOI 10.1016/j.msec.2010.06.004; Griffin J, 2011, J BIOMED MATER RES A, V97A, P230, DOI 10.1002/jbm.a.33049; Gunaratne LMWK, 2005, THERMOCHIM ACTA, V430, P183, DOI 10.1016/j.tca.2005.01.060; Gupta D, 2009, ACTA BIOMATER, V5, P2560, DOI 10.1016/j.actbio.2009.01.039; Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002; Izumi CMS, 2010, VIB SPECTROSC, V54, P127, DOI 10.1016/j.vibspec.2010.07.011; Johnson EO, 2008, INJURY, V39, pS30, DOI 10.1016/j.injury.2008.05.018; Kalbermatten DF, 2008, J HAND SURG-EUR VOL, V33E, P587, DOI 10.1177/1753193408090755; Kim DY, 2007, J MICROBIOL, V45, P87; Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014; Lee H, 2011, J BIOMED MATER RES B, V97B, P263, DOI 10.1002/jbm.b.31809; Lee IS, 2004, MACROMOL RES, V12, P374, DOI 10.1007/BF03218414; Leong MF, 2009, J BIOMED MATER RES A, V89A, P1040, DOI 10.1002/jbm.a.32061; Li QF, 2006, MICROSURG, V26, P116, DOI 10.1002/micr.20192; Li WS, 2008, J MATER SCI-MATER M, V19, P847, DOI 10.1007/s10856-007-3087-5; Masaeli E, 2012, J BIOMED MATER RES A, V100A, P1907, DOI 10.1002/jbm.a.34131; Meng W, 2007, J BIOMAT SCI-POLYM E, V18, P81, DOI 10.1163/156856207779146114; Mey J, 2012, ADV POLYM SCI, V246, P131, DOI 10.1007/12_2011_122; Mohanna PN, 2003, J ANAT, V203, P553, DOI 10.1046/j.1469-7580.2003.00243.x; Nandakumar A, 2010, MACROMOL BIOSCI, V10, P1365, DOI 10.1002/mabi.201000145; Ndreu A, 2008, NANOMEDICINE-UK, V3, P45, DOI 10.2217/17435889.3.1.45; Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073; Niapour A, 2010, BIOTECHNOL LETT, V32, P781, DOI 10.1007/s10529-010-0230-z; Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033; Piirsoo M, 2010, NEUROSCI LETT, V469, P135, DOI 10.1016/j.neulet.2009.11.060; Pompe T, 2007, BIOMATERIALS, V28, P28, DOI 10.1016/j.biomaterials.2006.08.028; Prabhakaran MP, 2008, TISSUE ENG PT A, V14, P1787, DOI 10.1089/ten.tea.2007.0393; Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057; Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028; Rentsch C, 2010, J BIOMED MATER RES A, V92A, P185, DOI 10.1002/jbm.a.32314; Ribeiro-Resende VT, 2009, BIOMATERIALS, V30, P5251, DOI 10.1016/j.biomaterials.2009.07.007; Saito M, 2001, POLYMER, V42, P5573, DOI 10.1016/S0032-3861(01)00011-8; Sangsanoh P, 2007, BIOMACROMOLECULES, V8, P1587, DOI 10.1021/bm061152a; Schiffman JD, 2008, POLYM REV, V48, P317, DOI 10.1080/15583720802022182; Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009; Shakhbazau A, 2012, MOL CELL NEUROSCI, V50, P103, DOI 10.1016/j.mcn.2012.04.004; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Sombatmankhong K, 2007, POLYMER, V48, P1419, DOI 10.1016/j.polymer.2007.01.014; Sombatmankhong K, 2006, J POLYM SCI POL PHYS, V44, P2923, DOI 10.1002/polb.20915; Suwantong O, 2007, INT J BIOL MACROMOL, V40, P217, DOI 10.1016/j.ijbiomac.2006.07.006; Tan SM, 2006, J APPL POLYM SCI, V101, P2776, DOI 10.1002/app.21921; Tong HW, 2011, J MACROMOL SCI B, V50, P1535, DOI 10.1080/00222348.2010.541008; Valmikinathan CM, 2011, MAT SCI ENG C-MATER, V31, P22, DOI 10.1016/j.msec.2010.04.001; Wang W, 2009, J BIOMED MATER RES A, V91A, P994, DOI 10.1002/jbm.a.32329; Wang YY, 2011, BIOMACROMOLECULES, V12, P551, DOI 10.1021/bm100886w; Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3; Xu XY, 2010, BIOMATERIALS, V31, P3967, DOI 10.1016/j.biomaterials.2010.01.132; You SJ, 1997, GLIA, V20, P87, DOI 10.1002/(SICI)1098-1136(199706)20:2<87::AID-GLIA1>3.0.CO;2-1; Yu W, 2010, POLYMER, V51, P2403, DOI 10.1016/j.polymer.2010.03.024; Yu WW, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-68; Zonari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035422; Zorick TS, 1996, CURR OPIN CELL BIOL, V8, P870, DOI 10.1016/S0955-0674(96)80090-1	65	88	90	3	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57157	10.1371/journal.pone.0057157	http://dx.doi.org/10.1371/journal.pone.0057157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468923	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000069
J	Rodrigues, RJ; Antony, J; Krishnamurthy, S; Shet, A; De Costa, A				Rodrigues, Rashmi J.; Antony, Jimmy; Krishnamurthy, Shubha; Shet, Anita; De Costa, Ayesha			'What Do I Know? Should I Participate?' Considerations on Participation in HIV Related Research among HIV Infected Adults in Bangalore, South India	PLOS ONE			English	Article							CLINICAL-TRIALS; INFORMED-CONSENT; VACCINE TRIALS; WILLINGNESS	Background: India has the highest number of HIV infected persons in the world after South Africa. Much HIV related behavioral, clinical and laboratory based research is ongoing in India. Yet little is known on Indian HIV patients' knowledge of research, their processes of decision making and motives for participation. We aimed to explore these areas among HIV infected individuals to understand their reasons for participating in research. Methodology/Principal Findings: This is a cross sectional survey among 173 HIV infected adults at a tertiary level hospital in Bangalore, India, done between October 2010 and January 2011. A pre-tested questionnaire was administered to the participants by trained research assistants to assess their knowledge regarding research, willingness to participate, decision making and determinants of participation. Participants were presented with five hypothetical HIV research studies. Each study had a different level of intervention and time commitment. Of respondents, 103(60%), said that research meant 'to discover something new' and 138(80%) were willing to participate in research. A third of the respondents were unaware of their right to refuse participation. Willingness to participate in research varied with level of intervention. It was the lowest for the hypothetical study involving sensitive questions followed by the hypothetical drug trial; and was the highest for the hypothetical cross sectional questionnaire based study (p<0.0015). Individual health benefits and altruism were the primary motives for participation in research and indicate the presence of therapeutic misconception. Women were less likely to make autonomous decisions for participation in interventional studies. Conclusions/Significance: Despite a majority willing to participate, over a third of respondents did not have any knowledge of research or the voluntary nature of participation. This has ethical implications. Researchers need to focus on enabling potential research participants understand the concepts of research, promote autonomous decisions, especially by women and restrict therapeutic misconception.	[Rodrigues, Rashmi J.; Shet, Anita; De Costa, Ayesha] Karolinska Inst, Div Global Hlth, Stockholm, Sweden; [Rodrigues, Rashmi J.; Antony, Jimmy; Krishnamurthy, Shubha; Shet, Anita] St Johns Natl Acad Hlth Sci, Bangalore, Karnataka, India	Karolinska Institutet; St. John's National Academy of Health Sciences	Rodrigues, RJ (corresponding author), Karolinska Inst, Div Global Hlth, Stockholm, Sweden.	rashmijr@gmail.com	Rodrigues, Rashmi J/H-1901-2012	Rodrigues, Rashmi J/0000-0002-0656-0178; Shet, Anita/0000-0002-7204-8164; De Costa, Ayesha/0000-0003-1869-5990	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	European Commission's Seventh Framework Program Grant for the HIVIND project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi OF, 2009, AIDS PATIENT CARE ST, V23, P859, DOI 10.1089/apc.2009.0008; Annas GJ, 2009, NEW ENGL J MED, V360, P2050, DOI 10.1056/NEJMp0901474; Appelbaum Paul S, 2004, IRB, V26, P1, DOI 10.2307/3564231; Ballantyne A, 2007, HARVARD HLTH POLICY, V8, P29; BARRY M, 1988, NEW ENGL J MED, V319, P1083, DOI 10.1056/NEJM198810203191609; de la Gorgendiere L, 2005, HUM ORGAN, V64, P166, DOI 10.17730/humo.64.2.qywa96br4laj9k18; Ding EL, 2007, ARCH INTERN MED, V167, P905, DOI 10.1001/archinte.167.9.905; Edwards SJL, 2005, BIOETHICS, V19, P112, DOI 10.1111/j.1467-8519.2005.00429.x; Faden R, 1998, AM J PUBLIC HEALTH, V88, P548, DOI 10.2105/AJPH.88.4.548; Gifford AL, 2002, NEW ENGL J MED, V346, P1373, DOI 10.1056/NEJMsa011565; Gitanjali B, 2003, J Postgrad Med, V49, P109; Gucciardi E, 2010, J AMBUL CARE MANAG, V33, P272, DOI 10.1097/JAC.0b013e3181e62d3c; Hill Z, 2008, J MED ETHICS, V34, P48, DOI 10.1136/jme.2006.019059; Indian Council of Medical Research (ICMR), 2006, ETH GUID BIOM RES HU; Jayant K, 2005, TALKING SEXUALITY CO; Jejeebhoy SJ, 2001, POPUL DEV REV, V27, P687, DOI 10.1111/j.1728-4457.2001.00687.x; Karim QA, 1998, AM J PUBLIC HEALTH, V88, P637, DOI 10.2105/AJPH.88.4.637; Khalil Susan S, 2007, BMC Med Ethics, V8, P9, DOI 10.1186/1472-6939-8-9; Krishnan Suneeta, 2007, Indian J Med Ethics, V4, P121; Mason S, 2003, BRIT MED J, V326, P1244, DOI 10.1136/bmj.326.7401.1244; Muthuswamy V, 2005, INDIAN J MED RES, V121, P601; Mystakidou K, 2009, SAHARA J-J SOC ASP H, V6, P46, DOI 10.1080/17290376.2009.9724930; NACO, 2008, ETH GUID OP RES HIV; NACO, 2012, ANN REPORT; Nyamathi AM, 2007, AIDS BEHAV, V11, P619, DOI 10.1007/s10461-006-9173-8; Paradis C, 2010, J MED ETHICS, V36, P580, DOI 10.1136/jme.2009.032904; Pranati, 2010, Perspect Clin Res, V1, P124, DOI 10.4103/2229-3485.71769; Riessman CK, 2005, HEALTH-LONDON, V9, P473, DOI 10.1177/1363459305056414; Sastry J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-28; Shah JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010730; Shavers VL, 2000, J NATL MED ASSOC, V92, P563; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Suhadev M, 2009, AIDS RES HUM RETROV, V25, P217, DOI 10.1089/aid.2007.0312; Sumathipala A, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-7; Tharawan K, 2001, J ACQ IMMUN DEF SYND, V28, P180; van Herk H, 2004, J CROSS CULT PSYCHOL, V35, P346, DOI 10.1177/0022022104264126; Wazaify M, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-7; Wendler D, 2008, ARCH INTERN MED, V168, P1294, DOI 10.1001/archinte.168.12.1294; Yousuf RM, 2009, SINGAP MED J, V48, P559; Zukelwa N, 2009, CONCEPTIONS RES ATTI, P122	40	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e53054	10.1371/journal.pone.0053054	http://dx.doi.org/10.1371/journal.pone.0053054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460780	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000003
J	Shabaneh, TB; Downey, SL; Goddard, AL; Screen, M; Lucas, MM; Eastman, A; Kisselev, AF				Shabaneh, Tamer B.; Downey, Sondra L.; Goddard, Ayrton L.; Screen, Michael; Lucas, Marcella M.; Eastman, Alan; Kisselev, Alexei F.			Molecular Basis of Differential Sensitivity of Myeloma Cells to Clinically Relevant Bolus Treatment with Bortezomib	PLOS ONE			English	Article							PHASE-I TRIAL; ACTIVE PROTEASOME INHIBITOR; OVERCOMES DRUG-RESISTANCE; ADVANCED SOLID TUMORS; MULTIPLE-MYELOMA; PS-341; APOPTOSIS; MICROENVIRONMENT; ESTABLISHMENT; SPECIFICITY	The proteasome inhibitor bortezomib (Velcade) is prescribed for the treatment of multiple myeloma. Clinically achievable concentrations of bortezomib cause less than 85% inhibition of the chymotrypsin-like activity of the proteasome, but little attention has been paid as to whether in vitro studies are representative of this level of inhibition. Patients receive bortezomib as an intravenous or subcutaneous bolus injection, resulting in maximum proteasome inhibition within one hour followed by a gradual recovery of activity. In contrast, most in vitro studies use continuous treatment so that activity never recovers. Replacing continuous treatment with 1 h-pulse treatment increases differences in sensitivity in a panel of 7 multiple myeloma cell lines from 5.3-fold to 18-fold, and reveals that the more sensitive cell lines undergo apoptosis at faster rates. Clinically achievable inhibition of active sites was sufficient to induce cytotoxicity only in one cell line. At concentrations of bortezomib that produced similar inhibition of peptidase activities a different extent of inhibition of protein degradation was observed, providing an explanation for the differential sensitivity. The amount of protein degraded per number of active proteasomes correlated with sensitivity to bortezomib. Thus, (i) in vitro studies of proteasome inhibitors should be conducted at pharmacologically achievable concentrations and duration of treatment; (ii) a similar level of inhibition of active sites results in a different extent of inhibition of protein breakdown in different cell lines, and hence a difference in sensitivity.	[Shabaneh, Tamer B.; Downey, Sondra L.; Goddard, Ayrton L.; Screen, Michael; Lucas, Marcella M.; Eastman, Alan; Kisselev, Alexei F.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA; [Shabaneh, Tamer B.; Downey, Sondra L.; Goddard, Ayrton L.; Screen, Michael; Lucas, Marcella M.; Eastman, Alan; Kisselev, Alexei F.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Lebanon, NH USA; [Goddard, Ayrton L.; Screen, Michael; Lucas, Marcella M.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; University of Bath	Kisselev, AF (corresponding author), Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA.	Alexei.F.Kisselev@Dartmouth.edu		Downey, Sondra/0000-0003-4203-3583	NCI [R01CA124634]; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA124634] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by grant R01CA124634 from the NCI, by the American Recovery and Reinvestment Act supplement to this grant, and by a grant from the Multiple Myeloma Research Foundation (http://www.themmrf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adams J, 1999, CANCER RES, V59, P2615; Aghajanian C, 2002, CLIN CANCER RES, V8, P2505; Altun M, 2005, CANCER RES, V65, P7896, DOI 10.1158/0008-5472.CAN-05-0506; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Britton M, 2009, CHEM BIOL, V16, P1278, DOI 10.1016/j.chembiol.2009.11.015; Cenci S., 2012, J LEUKOC BIOL; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Edwards CM, 2009, AM J HEMATOL, V84, P268, DOI 10.1002/ajh.21374; Fuertes G, 2003, INT J BIOCHEM CELL B, V35, P651, DOI 10.1016/S1357-2725(02)00382-5; Greenstein S, 2003, EXP HEMATOL, V31, P271, DOI 10.1016/S0301-472X(03)00023-7; Groll M, 2000, J AM CHEM SOC, V122, P1237, DOI 10.1021/ja993588m; Gu JL, 2012, BIOCHEM BIOPH RES CO, V420, P644, DOI 10.1016/j.bbrc.2012.03.056; Hamilton AL, 2005, J CLIN ONCOL, V23, P6107, DOI 10.1200/JCO.2005.01.136; Hao M, 2011, LEUKEMIA LYMPHOMA, V52, P1787, DOI 10.3109/10428194.2011.576791; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Hideshima T, 2001, CANCER RES, V61, P3071; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kupperman E, 2010, CANCER RES, V70, P1970, DOI 10.1158/0008-5472.CAN-09-2766; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; Mirabella AC, 2011, CHEM BIOL, V18, P608, DOI 10.1016/j.chembiol.2011.02.015; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; NAMBA M, 1989, IN VITRO CELL DEV B, V25, P723; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Otsuki T, 1998, INT J ONCOL, V12, P545; Papandreou CN, 2004, J CLIN ONCOL, V22, P2108, DOI 10.1200/JCO.2004.02.106; Piva R, 2008, BLOOD, V111, P2765, DOI 10.1182/blood-2007-07-100651; Reece DE, 2011, CANCER CHEMOTH PHARM, V67, P57, DOI 10.1007/s00280-010-1283-3; Richardson PG, 2009, J CLIN ONCOL, V27, P3518, DOI 10.1200/JCO.2008.18.3087; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Screen M, 2010, J BIOL CHEM, V285, P40125, DOI 10.1074/jbc.M110.160606; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Venkatakrishnan K, 2009, CLIN THER, V31, P2444, DOI 10.1016/j.clinthera.2009.11.012; Zhou HJ, 2009, J MED CHEM, V52, P3028, DOI 10.1021/jm801329v	38	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56132	10.1371/journal.pone.0056132	http://dx.doi.org/10.1371/journal.pone.0056132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460792	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000015
J	Shigdar, S; Qian, C; Lv, L; Pu, CW; Li, Y; Li, LH; Marappan, M; Lin, J; Wang, LF; Duan, W				Shigdar, Sarah; Qian, Christine; Lv, Li; Pu, Chunwen; Li, Yong; Li, Lianhong; Marappan, Manju; Lin, Jia; Wang, Lifen; Duan, Wei			The Use of Sensitive Chemical Antibodies for Diagnosis: Detection of Low Levels of Epcam in Breast Cancer	PLOS ONE			English	Article							EP-CAM; EXPRESSION; HYBRIDIZATION; MOLECULE; APTAMERS; ENRICHMENT; THERAPY	EpCAM is expressed at low levels in a variety of normal human epithelial tissues, but is overexpressed in 70-90% of carcinomas. From a clinico-pathological point of view, this has both prognostic and therapeutic significance. EpCAM was first suggested as a therapeutic target for the treatment of epithelial cancers in the 1990s. However, following several immunotherapy trials, the results have been mixed. It has been suggested that this is due, at least in part, to an unknown level of EpCAM expression in the tumors being targeted. Thus, selection of patients who would benefit from EpCAM immunotherapy by determining EpCAM status in the tumor biopsies is currently undergoing vigorous evaluation. However, current EpCAM antibodies are not robust enough to be able to detect EpCAM expression in all pathological tissues. Here we report a newly developed EpCAM RNA aptamer, also known as a chemical antibody, which is not only specific but also more sensitive than current antibodies for the detection of EpCAM in formalin-fixed paraffin-embedded primary breast cancers. This new aptamer, together with our previously described aptamer, showed no non-specific staining or cross-reactivity with tissues that do not express EpCAM. They were able to reliably detect target proteins in breast cancer xenograft where an anti-EpCAM antibody (323/A3) showed limited or no reactivity. Our results demonstrated a more robust detection of EpCAM using RNA aptamers over antibodies in clinical samples with chromogenic staining. This shows the potential of aptamers in the future of histopathological diagnosis and as a tool to guide targeted immunotherapy.	[Shigdar, Sarah; Qian, Christine; Marappan, Manju; Lin, Jia; Duan, Wei] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [Lv, Li; Wang, Lifen] Dalian Med Univ, Affiliated Hosp 2, Dalian, Peoples R China; [Pu, Chunwen] Dalian Sixth Peoples Hosp, Dalian, Peoples R China; [Li, Yong] Univ New S Wales, St George Hosp, Canc Care Ctr, Kensington, NSW 2033, Australia; [Li, Yong] Univ New S Wales, Fac Med, St George Clin Sch, Kensington, NSW 2033, Australia; [Li, Lianhong] Dalian Med Univ, Dept Pathol & Forens Sci, Dalian, Peoples R China; [Qian, Christine] St John God Pathol, Dept Histopathol, Geelong, Vic, Australia	Deakin University; Dalian Medical University; St George Hospital; University of New South Wales Sydney; University of New South Wales Sydney; Dalian Medical University; St John of God Health Care	Wang, LF (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dalian, Peoples R China.	wduan@deakin.edu.au; lifen_w@163.com	Shigdar, Sarah/AFR-0438-2022; Duan, Wei/A-5181-2015	Duan, Wei/0000-0001-5782-9184; Li, Yong/0000-0002-8910-9787; Shigdar, Sarah/0000-0001-8084-8447	Royal College of Pathologists of Australasia; National Health & Medical Research Council, Australia (NH MRC); Australia-India Strategic Research Fund; Victorian Cancer Agency	Royal College of Pathologists of Australasia; National Health & Medical Research Council, Australia (NH MRC)(National Health and Medical Research Council (NHMRC) of Australia); Australia-India Strategic Research Fund(Australian GovernmentDepartment of Industry, Innovation and Science); Victorian Cancer Agency	This work was supported by grants from the Royal College of Pathologists of Australasia, National Health & Medical Research Council, Australia (NH & MRC); Australia-India Strategic Research Fund and Victorian Cancer Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolovic D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-35; Arora R, 2011, CYTOJOURNAL, V8, DOI 10.4103/1742-6413.83233; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Baird GS, 2010, AM J CLIN PATHOL, V134, P529, DOI 10.1309/AJCPFU4CG2WGJJKS; Bhatt AN, 2010, INDIAN J MED RES, V132, P129; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Cimino A, 2010, BREAST CANCER RES TR, V123, P701, DOI 10.1007/s10549-009-0671-z; Das M, 2009, EXPERT OPIN DRUG DEL, V6, P285, DOI 10.1517/17425240902780166; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Fritschy JM, 2008, EUR J NEUROSCI, V28, P2365, DOI 10.1111/j.1460-9568.2008.06552.x; Gires O, 2010, J CLIN ONCOL, V28, pE239, DOI 10.1200/JCO.2009.26.8540; Gown AM, 2008, MODERN PATHOL, V21, pS8, DOI 10.1038/modpathol.2008.34; Gupta S, 2011, APPL IMMUNOHISTO M M, V19, P273, DOI 10.1097/PAI.0b013e3182008c29; Heine M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036258; Hough CD, 2000, CANCER RES, V60, P6281; Idikio HA, 2010, INT J CLIN EXP PATHO, V3, P169; Kataria S, 2011, IJPBA, V2, P1346; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Lassalle H. P., 2012, CURR DRUG METAB; Lindblom A, 2000, BMJ-BRIT MED J, V320, P424, DOI 10.1136/bmj.320.7232.424; Patriarca C, 2012, CANCER TREAT REV, V38, P68, DOI 10.1016/j.ctrv.2011.04.002; Prang N, 2005, BRIT J CANCER, V92, P342, DOI 10.1038/sj.bjc.6602310; Rayburn ER, 2008, DRUG DISCOV TODAY, V13, P513, DOI 10.1016/j.drudis.2008.03.014; Rhodes A, 2000, J CLIN PATHOL, V53, P292, DOI 10.1136/jcp.53.4.292; Rodriguez-Canales J, 2011, BIOESSAYS, V33, P490, DOI 10.1002/bies.201100017; Sankpal NV, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3070; Schmidt M, 2008, CLIN CANCER RES, V14, P5849, DOI 10.1158/1078-0432.CCR-08-0669; Sharma S, 2009, INDIAN J MED PAEDIAT, V30, P1, DOI 10.4103/0971-5851.56328; Shigdar S, 2011, BRIT J HAEMATOL, V155, P3, DOI 10.1111/j.1365-2141.2011.08807.x; Shigdar S, 2011, CANCER SCI, V102, P991, DOI 10.1111/j.1349-7006.2011.01897.x; SINGH L, 1984, NUCLEIC ACIDS RES, V12, P5627, DOI 10.1093/nar/12.14.5627; Songun I, 2005, BRIT J CANCER, V92, P1767, DOI 10.1038/sj.bjc.6602519; Spizzo G, 2011, J CLIN PATHOL, V64, P415, DOI 10.1136/jcp.2011.090274; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Stone Marvin J, 2003, Proc (Bayl Univ Med Cent), V16, P30; Thurber GM, 2011, MOL IMAGING BIOL, V13, P623, DOI 10.1007/s11307-010-0397-7; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; vanGijlswijk RPM, 1996, J HISTOCHEM CYTOCHEM, V44, P389, DOI 10.1177/44.4.8601698; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; Winter MJ, 2003, AM J PATHOL, V163, P2139, DOI 10.1016/S0002-9440(10)63570-5; Yeong SS, 2006, J BIOL CHEM, V281, P30768, DOI 10.1074/jbc.M511278200; Zeng ZH, 2010, MODERN PATHOL, V23, P1553, DOI 10.1038/modpathol.2010.151	45	36	38	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57613	10.1371/journal.pone.0057613	http://dx.doi.org/10.1371/journal.pone.0057613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460885	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000140
J	Dorfer, C; Kuhn, P; Baumann, F; He, JS; Scholten, T				Doerfer, Corina; Kuehn, Peter; Baumann, Frank; He, Jin-Sheng; Scholten, Thomas			Soil Organic Carbon Pools and Stocks in Permafrost-Affected Soils on the Tibetan Plateau	PLOS ONE			English	Article							DENSITY FRACTIONS; TEMPERATURE-DEPENDENCE; MATTER DECOMPOSITION; NMR-SPECTROSCOPY; CLIMATIC-CHANGE; ALPINE MEADOW; TUNDRA SOILS; FOREST SOILS; STORAGE; DEGRADATION	The Tibetan Plateau reacts particularly sensitively to possible effects of climate change. Approximately two thirds of the total area is affected by permafrost. To get a better understanding of the role of permafrost on soil organic carbon pools and stocks, investigations were carried out including both discontinuous (site Huashixia, HUA) and continuous permafrost (site Wudaoliang, WUD). Three organic carbon fractions were isolated using density separation combined with ultrasonic dispersion: the light fractions (<1.6 g cm(-3)) of free particulate organic matter (FPOM) and occluded particulate organic matter (OPOM), plus a heavy fraction (>1.6 g cm(-3)) of mineral associated organic matter (MOM). The fractions were analyzed for C, N, and their portion of organic C. FPOM contained an average SOC content of 252 g kg(-1). Higher SOC contents (320 g kg(-1)) were found in OPOM while MOM had the lowest SOC contents (29 g kg(-1)). Due to their lower density the easily decomposable fractions FPOM and OPOM contribute 27% (HUA) and 22% (WUD) to the total SOC stocks. In HUA mean SOC stocks (0-30 cm depth) account for 10.4 kg m(-2), compared to 3.4 kg m(-2) in WUD. 53% of the SOC is stored in the upper 10 cm in WUD, in HUA only 39%. Highest POM values of 36% occurred in profiles with high soil moisture content. SOC stocks, soil moisture and active layer thickness correlated strongly in discontinuous permafrost while no correlation between SOC stocks and active layer thickness and only a weak relation between soil moisture and SOC stocks could be found in continuous permafrost. Consequently, permafrost-affected soils in discontinuous permafrost environments are susceptible to soil moisture changes due to alterations in quantity and seasonal distribution of precipitation, increasing temperature and therefore evaporation.	[Doerfer, Corina; Kuehn, Peter; Baumann, Frank; Scholten, Thomas] Univ Tubingen, Dept Geosci Phys Geog & Soil Sci, Tubingen, Germany; [He, Jin-Sheng] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China	Eberhard Karls University of Tubingen; Peking University	Dorfer, C (corresponding author), Univ Tubingen, Dept Geosci Phys Geog & Soil Sci, Tubingen, Germany.	corina.doerfer@uni-tuebingen.de	He, Jin-Sheng/A-4053-2009; Scholten, Thomas/E-4024-2012; Kühn, Peter/A-9146-2009	He, Jin-Sheng/0000-0001-5081-3569; Scholten, Thomas/0000-0002-4875-2602; Kühn, Peter/0000-0002-4417-5633	Federal Ministry of Education and Research (BMBF) [03G0810A]; German Academic Exchange Service (DAAD); National Natural Science Foundation of China [31025005, 31021001]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Federal Ministry of Education and Research (BMBF, 03G0810A, http://www.bmbf.de/en), the German Academic Exchange Service (DAAD, http://www.daad.de) and the National Natural Science Foundation of China (31025005 and 31021001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann F, 2009, GLOBAL CHANGE BIOL, V15, P3001, DOI 10.1111/j.1365-2486.2009.01953.x; Bockheim JG, 2003, SOIL SCI SOC AM J, V67, P948, DOI 10.2136/sssaj2003.0948; Callesen I, 2003, GLOBAL CHANGE BIOL, V9, P358, DOI 10.1046/j.1365-2486.2003.00587.x; Callesen I, 2007, BOREAL ENVIRON RES, V12, P681; Cheng GD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000631; Christensen B.T., 1992, ADV SOIL SCI, V20, P1, DOI [10.1007/978-1-4612-2930-8_1, DOI 10.1007/978-1-4612-2930-8_1]; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Du Zheng, 2000, MOUNTAIN GEOECOLOGY; Geng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034968; Geng Y, 2012, GLOBAL ECOL BIOGEOGR, V21, P416, DOI 10.1111/j.1466-8238.2011.00692.x; GOLCHIN A, 1994, AUST J SOIL RES, V32, P285, DOI 10.1071/SR9940285; GOLCHIN A, 1995, AUST J SOIL RES, V33, P59, DOI 10.1071/SR9950059; Grosse G., 2011, EOS T AM GEOPHYS UN, V92, P73, DOI [10.1002/ppp.689.Rowland, DOI 10.1029/2011EO090001, 10.1029/2011EO090001]; Grunewald G, 2006, ORG GEOCHEM, V37, P1573, DOI 10.1016/j.orggeochem.2006.05.002; Gundelwein A, 2007, EUR J SOIL SCI, V58, P1164, DOI 10.1111/j.1365-2389.2007.00908.x; IUSS Working Group WRB, 2007, WORLD SOIL RESOURCES; Jin HJ, 2000, GLOBAL PLANET CHANGE, V26, P387, DOI 10.1016/S0921-8181(00)00051-5; Jin HJ, 2006, SCI CHINA SER D, V49, P1170, DOI 10.1007/s11430-006-2003-z; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; John B, 2005, GEODERMA, V128, P63, DOI 10.1016/j.geoderma.2004.12.013; Kadono A, 2008, SOIL BIOL BIOCHEM, V40, P947, DOI 10.1016/j.soilbio.2007.11.015; Kaiser K, 2008, CATENA, V73, P300, DOI 10.1016/j.catena.2007.12.001; Kang SC, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/015101; Kato T, 2004, AGR FOREST METEOROL, V124, P121, DOI 10.1016/j.agrformet.2003.12.008; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kolbl A, 2004, J PLANT NUTR SOIL SC, V167, P45, DOI 10.1002/jpln.200321185; Luo TX, 2002, ECOL APPL, V12, P980, DOI 10.1890/1051-0761(2002)012[0980:EBAPON]2.0.CO;2; Nan ZT, 2005, SCI CHINA SER D, V48, P797, DOI 10.1360/03yd0258; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Ohtsuka T., 2008, POLAR SCI, V2, P277, DOI [10.1016/j.polar.2008.08.003, DOI 10.1016/J.POLAR.2008.08.003]; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Roscoe R, 2000, EUR J SOIL SCI, V51, P445, DOI 10.1046/j.1365-2389.2000.00321.x; Saito M, 2009, GLOBAL CHANGE BIOL, V15, P221, DOI 10.1111/j.1365-2486.2008.01713.x; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Six J, 1999, SOIL BIOL BIOCHEM, V31, P1193, DOI 10.1016/S0038-0717(99)00023-1; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Torn MS, 1997, NATURE, V389, P170, DOI 10.1038/38260; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; Uhlirova E, 2007, SOIL BIOL BIOCHEM, V39, P1978, DOI 10.1016/j.soilbio.2007.02.018; von Lutzow M, 2007, SOIL BIOL BIOCHEM, V39, P2183, DOI 10.1016/j.soilbio.2007.03.007; Wagner D., 2009, SOIL BIOL, P219; Wagner D, 2009, CAN J MICROBIOL, V55, P73, DOI 10.1139/W08-121; WANG BL, 1995, QUATERNARY SCI REV, V14, P255, DOI 10.1016/0277-3791(95)00006-B; Wang GX, 2008, HYDROL PROCESS, V22, P3310, DOI 10.1002/hyp.6913; Wang GX, 2008, GEODERMA, V143, P143, DOI 10.1016/j.geoderma.2007.10.023; Wang GX, 2007, CATENA, V70, P506, DOI 10.1016/j.catena.2007.01.001; Wang GX, 2006, MT RES DEV, V26, P153, DOI 10.1659/0276-4741(2006)26[153:LCCAII]2.0.CO;2; Wang GX, 2002, SCI TOTAL ENVIRON, V291, P207, DOI 10.1016/S0048-9697(01)01100-7; Wang W, 2009, SCI CHINA SER D, V52, P660, DOI 10.1007/s11430-009-0056-5; Weischet W., 2000, REGIONALE KLIMATOL 2; Yang MX, 2010, EARTH-SCI REV, V103, P31, DOI 10.1016/j.earscirev.2010.07.002; Yang MX, 2004, COLD REG SCI TECHNOL, V39, P47, DOI 10.1016/j.coldregions.2004.01.002; Yang Y.H., 2010, BIOGEOSCI DISCUSS, V7, P1, DOI [10.5194/bgd-7-1-2010, DOI 10.5194/BGD-7-1-2010]; Yang YH, 2008, GLOBAL CHANGE BIOL, V14, P1592, DOI 10.1111/j.1365-2486.2008.01591.x; Zhang TJ, 2005, PHYS GEOGR, V26, P279, DOI 10.2747/0272-3646.26.4.279; Zhang YQ, 2007, SCI CHINA SER D, V50, P113, DOI 10.1007/s11430-007-2032-2; Zhao L, 2000, CHINESE SCI BULL, V45, P2181, DOI 10.1007/BF02886326; Zhou HK, 2005, JAPANESE J GRASSLAND, V51, P191	59	51	53	18	169	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57024	10.1371/journal.pone.0057024	http://dx.doi.org/10.1371/journal.pone.0057024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468904	gold, Green Published, Green Submitted			2022-12-27	WOS:000315561400022
J	Hsu, YH; Li, HH; Sung, JM; Chen, WT; Hou, YC; Chang, MS				Hsu, Yu-Hsiang; Li, Hsing-Hui; Sung, Junne-Ming; Chen, Wei-Ting; Hou, Ya-Chin; Chang, Ming-Shi			Interleukin-19 Mediates Tissue Damage in Murine Ischemic Acute Kidney Injury	PLOS ONE			English	Article							RENAL EPITHELIAL-CELLS; INDUCED APOPTOSIS; TNF-ALPHA; ISCHEMIA/REPERFUSION INJURY; MESANGIAL CELLS; HIGH GLUCOSE; ACTIVATION; IL-19; FAILURE; CYTOKINES	Inflammation and renal tubular injury are major features of acute kidney injury (AKI). Many cytokines and chemokines are released from injured tubular cells and acts as proinflammatory mediators. However, the role of IL-19 in the pathogenesis of AKI is not defined yet. In bilateral renal ischemia/reperfusion injury (IRI)-induced and HgCl2-induced AKI animal models, real-time quantitative (RTQ)-PCR showed that the kidneys, livers, and lungs of AKI mice expressed significantly higher IL-19 and its receptors than did sham control mice. Immunohistochemical staining showed that IL-19 and its receptors were strongly stained in the kidney, liver, and lung tissue of AKI mice. In vitro, IL-19 upregulated MCP-1, TGF-beta 1, and IL-19, and induced mitochondria-dependent apoptosis in murine renal tubular epithelial M-1 cells. IL-19 upregulated TNF-alpha and IL-10 in cultured HepG2 cells, and it increased IL-1 beta and TNF-alpha expression in cultured A549 cells. In vivo, after renal IRI or a nephrotoxic dose of HgCl2 treatment, IL-20R1-deficient mice (the deficiency blocks IL-19 signaling) showed lower levels of blood urea nitrogen (BUN) in serum and less tubular damage than did wild-type mice. Therefore, we conclude that IL-19 mediates kidney, liver, and lung tissue damage in murine AKI and that blocking IL-19 signaling may provide a potent therapeutic strategy for treating AKI.	[Hsu, Yu-Hsiang; Chen, Wei-Ting; Chang, Ming-Shi] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Li, Hsing-Hui] Natl Museum Marine Biol & Aquarium, Dept Planning & Res, Pingtung, Taiwan; [Sung, Junne-Ming] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70101, Taiwan; [Hou, Ya-Chin; Chang, Ming-Shi] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan	National Cheng Kung University; National Museum of Marine Biology & Aquarium; National Cheng Kung University; National Cheng Kung University	Chang, MS (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan.	mschang@mail.ncku.edu.tw		Sung, Junne-Ming/0000-0003-1916-7815				Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Amiri F, 2002, KIDNEY INT, V61, P1605, DOI 10.1046/j.1523-1755.2002.00311.x; Azuma YT, 2010, INFLAMM BOWEL DIS, V16, P1017, DOI 10.1002/ibd.21151; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Dai CS, 2003, J BIOL CHEM, V278, P12537, DOI 10.1074/jbc.M300777200; Deng JP, 2004, AM J RESP CRIT CARE, V169, P749, DOI 10.1164/rccm.200303-372OC; Deng JP, 2001, KIDNEY INT, V60, P2118, DOI 10.1046/j.1523-1755.2001.00043.x; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gabunia K, 2011, AM J PHYSIOL-CELL PH, V300, pC896, DOI 10.1152/ajpcell.00439.2010; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Golab F, 2009, KIDNEY INT, V75, P783, DOI 10.1038/ki.2008.683; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Hoke TS, 2007, J AM SOC NEPHROL, V18, P155, DOI 10.1681/ASN.2006050494; Hsing CH, 2008, SHOCK, V29, P7, DOI 10.1097/shk.0b013e318067de40; Hsing CH, 2006, ANN THORAC SURG, V81, P2196, DOI 10.1016/j.athoracsur.2006.01.092; Hsu YH, 2012, RHEUMATOLOGY, V51, P434, DOI 10.1093/rheumatology/ker127; Hsu YH, 2011, J EXP MED, V208, P1849, DOI 10.1084/jem.20102234; Jiang J, 2004, TOXICOL SCI, V80, P170, DOI 10.1093/toxsci/kfh143; Jordan WJ, 2005, EUR J IMMUNOL, V35, P1576, DOI 10.1002/eji.200425317; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Kramer AA, 1999, KIDNEY INT, V55, P2362, DOI 10.1046/j.1523-1755.1999.00460.x; Kunduzova OR, 2002, FASEB J, V16, P1129, DOI 10.1096/fj.01-1008fje; Lee DW, 2011, CLIN NEPHROL, V76, P165, DOI 10.5414/CN106921; Li HH, 2008, GENES IMMUN, V9, P395, DOI 10.1038/gene.2008.28; Li HH, 2005, BRIT J DERMATOL, V153, P591, DOI 10.1111/j.1365-2133.2005.06665.x; Liao SC, 2004, J IMMUNOL, V173, P6712, DOI 10.4049/jimmunol.173.11.6712; Liao YC, 2002, J IMMUNOL, V169, P4288, DOI 10.4049/jimmunol.169.8.4288; Nguyen HT, 2006, NEPHRON EXP NEPHROL, V102, P49, DOI 10.1159/000088401; Okusa MD, 2002, NEPHRON, V90, P133, DOI 10.1159/000049032; Pecoits R, 2005, PEDIATR NEPHROL, V20, P714, DOI 10.1007/s00467-005-1891-z; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Rabb H, 2003, KIDNEY INT, V63, P600, DOI 10.1046/j.1523-1755.2003.00753.x; Rana A, 2001, APOPTOSIS, V6, P83, DOI 10.1023/A:1009680229931; Saperstein S, 2009, J INTERF CYTOK RES, V29, P273, DOI 10.1089/jir.2008.0076; Serteser M, 2002, J SURG RES, V107, P234, DOI 10.1006/jsre.2002.6513; Wang XD, 2002, DIABETES, V51, P3505, DOI 10.2337/diabetes.51.12.3505; Wei CC, 2008, BIOCHEM BIOPH RES CO, V374, P448, DOI 10.1016/j.bbrc.2008.07.039; Wong VY, 2001, EUR J PHARMACOL, V433, P135, DOI 10.1016/S0014-2999(01)01517-5; Yadav N, 2012, INDIAN J MED RES, V136, P211; Zhuang SG, 2007, AM J PHYSIOL-RENAL, V292, pF440, DOI 10.1152/ajprenal.00170.2006	43	24	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56028	10.1371/journal.pone.0056028	http://dx.doi.org/10.1371/journal.pone.0056028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468852	Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400006
J	Faucher, CP; Hilker, M; de Bruyne, M				Faucher, Cecile P.; Hilker, Monika; de Bruyne, Marien			Interactions of Carbon Dioxide and Food Odours in Drosophila: Olfactory Hedonics and Sensory Neuron Properties	PLOS ONE			English	Article							AVOIDANCE-BEHAVIOR; RECEPTOR NEURONS; SEX-PHEROMONE; FLORAL CO2; RESPONSES; MELANOGASTER; ATTRACTION; MODULATION; CHEMICALS; SENSILLA	Behavioural responses of animals to volatiles in their environment are generally dependent on context. Most natural odours are mixtures of components that can each induce different behaviours when presented on their own. We have investigated how a complex of two olfactory stimuli is evaluated by Drosophila flies in a free-flying two-trap choice assay and how these stimuli are encoded in olfactory receptor neurons. We first observed that volatiles from apple cider vinegar attracted flies while carbon dioxide (CO2) was avoided, confirming their inherent positive and negative values. In contradiction with previous results obtained from walking flies in a four-field olfactometer, in the present assay the addition of CO2 to vinegar increased rather than decreased the attractiveness of vinegar. This effect was female-specific even though males and females responded similarly to CO2 and vinegar on their own. To test whether the female-specific behavioural response to the mixture correlated with a sexual dimorphism at the peripheral level we recorded from olfactory receptor neurons stimulated with vinegar, CO2 and their combination. Responses to vinegar were obtained from three neuron classes, two of them housed with the CO2-responsive neuron in ab1 sensilla. Sensitivity of these neurons to both CO2 and vinegar per se did not differ between males and females and responses from female neurons did not change when CO2 and vinegar were presented simultaneously. We also found that CO2-sensitive neurons are particularly well adapted to respond rapidly to small concentration changes irrespective of background CO2 levels. The ability to encode temporal properties of stimulations differs considerably between CO2- and vinegar-sensitive neurons. These properties may have important implications for in-flight navigation when rapid responses to fragmented odour plumes are crucial to locate odour sources. However, the flies' sex-specific response to the CO2-vinegar combination and the context-dependent hedonics most likely originate from central rather than peripheral processing.	[Faucher, Cecile P.; de Bruyne, Marien] Free Univ Berlin, Inst Biol Neurobiol, Berlin, Germany; [Hilker, Monika] Free Univ Berlin, Inst Biol Appl Zool, Berlin, Germany	Free University of Berlin; Free University of Berlin	de Bruyne, M (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	Marien.DeBruijne@monash.au	Faucher, Cecile P/E-6908-2010		German Research Foundation DFG Graduiertenkolleg [837]	German Research Foundation DFG Graduiertenkolleg(German Research Foundation (DFG))	Funding was provided by the German Research Foundation (www.dfg.de) DFG Graduiertenkolleg 837. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher PG, 2010, J CHEM ECOL, V36, P599, DOI 10.1007/s10886-010-9794-2; BELL WJ, 1990, ANNU REV ENTOMOL, V35, P447, DOI 10.1146/annurev.en.35.010190.002311; Bhandawat V, 2010, J EXP BIOL, V213, P3625, DOI 10.1242/jeb.040402; Bodin A, 2008, J INSECT PHYSIOL, V54, P1343, DOI 10.1016/j.jinsphys.2008.07.004; Bodin A, 2009, J EXP BIOL, V212, P2386, DOI 10.1242/jeb.030668; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; DETHIER VG, 1960, J ECON ENTOMOL, V53, P134, DOI 10.1093/jee/53.1.134; Devaud JM, 2003, BEHAV PROCESS, V64, P177, DOI 10.1016/S0376-6357(03)00134-7; Duistermars BJ, 2009, CURR BIOL, V19, P1301, DOI 10.1016/j.cub.2009.06.022; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Furukawa S, 2004, ADV EXP MED BIOL, V542, P251; Goyret J, 2008, P NATL ACAD SCI USA, V105, P4565, DOI 10.1073/pnas.0708629105; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Guerenstein PG, 2008, ANNU REV ENTOMOL, V53, P161, DOI 10.1146/annurev.ento.53.103106.093402; HOFFMANN AA, 1985, AUST J ZOOL, V33, P451, DOI 10.1071/ZO9850451; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Krishnan P, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-62; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lebreton S, 2012, J INSECT PHYSIOL, V58, P125, DOI 10.1016/j.jinsphys.2011.10.009; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Nikonov AA, 2002, J CHEM ECOL, V28, P1075, DOI 10.1023/A:1015274104626; Ochieng SA, 2002, J COMP PHYSIOL A, V188, P325, DOI 10.1007/s00359-002-0308-8; Park SK, 2002, J NEUROBIOL, V51, P248, DOI 10.1002/neu.10057; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Poon PC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000356; Riffell JA, 2012, CURR OPIN NEUROBIOL, V22, P236, DOI 10.1016/j.conb.2012.02.013; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Ruebenbauer A, 2008, CURR BIOL, V18, P1438, DOI 10.1016/j.cub.2008.08.062; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; STANGE G, 1995, OECOLOGIA, V102, P341, DOI 10.1007/BF00329801; Stange G., 1996, Advances in Bioclimatology, V4, P223; Steck K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00361; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; Tinette S, 2004, GENES BRAIN BEHAV, V3, P39, DOI 10.1046/j.1601-183x.2003.0046.x; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; WILLIS ER, 1952, J EXP ZOOL, V121, P149, DOI 10.1002/jez.1401210107; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351; Zollner GE, 2004, PHYSIOL ENTOMOL, V29, P381, DOI 10.1111/j.0307-6962.2004.00399.x	58	37	38	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56361	10.1371/journal.pone.0056361	http://dx.doi.org/10.1371/journal.pone.0056361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457557	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700045
J	Baronchelli, S; Bentivegna, A; Redaelli, S; Riva, G; Butta, V; Paoletta, L; Isimbaldi, G; Miozzo, M; Tabano, S; Daga, A; Marubbi, D; Cattaneo, M; Biunno, I; Dalpra, L				Baronchelli, Simona; Bentivegna, Angela; Redaelli, Serena; Riva, Gabriele; Butta, Valentina; Paoletta, Laura; Isimbaldi, Giuseppe; Miozzo, Monica; Tabano, Silvia; Daga, Antonio; Marubbi, Daniela; Cattaneo, Monica; Biunno, Ida; Dalpra, Leda			Delineating the Cytogenomic and Epigenomic Landscapes of Glioma Stem Cell Lines	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; DNA METHYLATION; HUMAN GLIOBLASTOMAS; ASTROCYTIC TUMORS; MALIGNANT GLIOMA; CANCER; HETEROGENEITY; HYPERMETHYLATION; IDENTIFICATION	Glioblastoma multiforme (GBM), the most common and malignant type of glioma, is characterized by a poor prognosis and the lack of an effective treatment, which are due to a small sub-population of cells with stem-like properties, termed glioma stem cells (GSCs). The term "multiforme" describes the histological features of this tumor, that is, the cellular and morphological heterogeneity. At the molecular level multiple layers of alterations may reflect this heterogeneity providing together the driving force for tumor initiation and development. In order to decipher the common "signature" of the ancestral GSC population, we examined six already characterized GSC lines evaluating their cytogenomic and epigenomic profiles through a multilevel approach (conventional cytogenetic, FISH, aCGH, MeDIP-Chip and functional bioinformatic analysis). We found several canonical cytogenetic alterations associated with GBM and a common minimal deleted region (MDR) at 1p36.31, including CAMTA1 gene, a putative tumor suppressor gene, specific for the GSC population. Therefore, on one hand our data confirm a role of driver mutations for copy number alterations (CNAs) included in the GBM genomicsignature (gain of chromosome 7-EGFR gene, loss of chromosome 13-RB1 gene, loss of chromosome 10-PTEN gene); on the other, it is not obvious that the new identified CNAs are passenger mutations, as they may be necessary for tumor progression specific for the individual patient. Through our approach, we were able to demonstrate that not only individual genes into a pathway can be perturbed through multiple mechanisms and at different levels, but also that different combinations of perturbed genes can incapacitate functional modules within a cellular networks. Therefore, beyond the differences that can create apparent heterogeneity of alterations among GSC lines, there's a sort of selective force acting on them in order to converge towards the impairment of cell development and differentiation processes. This new overview could have a huge importance in therapy.	[Baronchelli, Simona; Bentivegna, Angela; Redaelli, Serena; Riva, Gabriele; Butta, Valentina; Paoletta, Laura; Dalpra, Leda] Univ Milano Bicocca, Dept Surg & Translat Med, Monza, Italy; [Baronchelli, Simona; Cattaneo, Monica] Ist Ricovero & Cura Carattere Sci IRCCS MultiMed, Milan, Italy; [Isimbaldi, Giuseppe] S Gerardo Hosp, Dept Surg Pathol, Monza, Italy; [Miozzo, Monica; Tabano, Silvia] Univ Milan, Dept Pathophysiol & Organ Transplant, Milan, Italy; [Miozzo, Monica; Tabano, Silvia] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Pathol Unit, Milan, Italy; [Daga, Antonio; Marubbi, Daniela] Univ San Martino, Azienda Osped, IRCCS, Dept Hematol Oncol,IST,Ist Nazl Ric Canc, Genoa, Italy; [Marubbi, Daniela] Univ Genoa, Dept Expt Med, Genoa, Italy; [Biunno, Ida] CNR, Inst Genet & Biomed Res, Milan, Italy	University of Milano-Bicocca; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)	Dalpra, L (corresponding author), Univ Milano Bicocca, Dept Surg & Translat Med, Monza, Italy.	leda.dalpra@unimib.it	Miozzo, Monica Rosa/AAC-6401-2022; Bentivegna, Angela/J-3478-2018; Baronchelli, Simona/G-6771-2016; Daga, Antonio/Z-2417-2019; Tabano, Silvia/P-1498-2017	Miozzo, Monica Rosa/0000-0002-6523-4575; Bentivegna, Angela/0000-0001-7535-846X; Baronchelli, Simona/0000-0002-1857-1472; Daga, Antonio/0000-0001-5845-8530; , IDA_2/0000-0002-1068-4763; /0000-0002-1866-5866; Riva, Gabriele/0000-0002-5894-9556; Tabano, Silvia Maria/0000-0002-5260-6691	European Community [222943]	European Community(European Commission)	Part of the research leading to these results has received funding from the European Community's Seventh Framework Programme NeuroStemcell, under grant agreement nr. 222943. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aronica E, 2008, NEUROSCIENCE, V151, P272, DOI 10.1016/j.neuroscience.2007.10.036; Barbashina V, 2005, CLIN CANCER RES, V11, P1119; Bauer A, 2001, GENE CHROMOSOME CANC, V31, P228, DOI 10.1002/gcc.1139; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bentivegna A, 2010, CANCER SCI, V101, P416, DOI 10.1111/j.1349-7006.2009.01414.x; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547; Caren H, 2013, MOL ASPECTS MED, V34, P849, DOI 10.1016/j.mam.2012.06.007; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chan TA, 2008, PLOS MED, V5, P823, DOI 10.1371/journal.pmed.0050114; Chari R, 2010, CANCER METAST REV, V29, P73, DOI 10.1007/s10555-010-9199-2; Cheung SW, 2007, AM J MED GENET A, V143A, P1679, DOI 10.1002/ajmg.a.31740; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clark PA, 2012, NEOPLASIA, V14, P420, DOI 10.1596/neo.12432; Dahl JA, 2008, INT J DEV BIOL, V52, P1033, DOI 10.1387/ijdb.082663jd; de Tayrac M, 2009, GENE CHROMOSOME CANC, V48, P55, DOI 10.1002/gcc.20618; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrich M, 2008, P NATL ACAD SCI USA, V105, P4844, DOI 10.1073/pnas.0712251105; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gorlia T, 2012, EUR J CANCER, V48, P1176, DOI 10.1016/j.ejca.2012.02.004; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Griffero F, 2009, J BIOL CHEM, V284, P7138, DOI 10.1074/jbc.M807111200; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Hegi ME, 2012, ACTA NEUROPATHOL, V123, P841, DOI 10.1007/s00401-011-0938-4; Huang Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-304; Huang Y, 2010, CANCER BIOL THER, V9, P204, DOI 10.4161/cbt.9.3.10960; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Ichimura K, 2008, ONCOGENE, V27, P2097, DOI 10.1038/sj.onc.1210848; Ichimura K, 2006, ONCOGENE, V25, P1261, DOI 10.1038/sj.onc.1209156; Ichimura K, 2004, J NEURO-ONCOL, V70, P137, DOI 10.1007/s11060-004-2747-2; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; IZUMOTO S, 1995, CANCER LETT, V97, P241, DOI 10.1016/0304-3835(95)03981-2; Jeon HM, 2008, GENE DEV, V22, P2028, DOI 10.1101/gad.1668708; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li AG, 2008, MOL CANCER RES, V6, P21, DOI 10.1158/1541-7786.MCR-07-0280; Li YQ, 2007, MOL BIOL REP, V34, P19, DOI 10.1007/s11033-006-9003-0; Liu WM, 2010, MOL BIOL REP, V37, P1801, DOI 10.1007/s11033-009-9614-3; Lo KC, 2007, GENE CHROMOSOME CANC, V46, P875, DOI 10.1002/gcc.20474; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Martinez R, 2010, NEUROBIOL DIS, V39, P40, DOI 10.1016/j.nbd.2009.12.030; Martinez R, 2009, EPIGENETICS-US, V4, P255, DOI 10.4161/epi.9130; Nord H, 2009, NEURO-ONCOLOGY, V11, P803, DOI 10.1215/15228517-2009-013; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Okada T, 2010, GENE CHROMOSOME CANC, V49, P452, DOI 10.1002/gcc.20755; Pack SD, 2004, CANCER RES, V64, P789, DOI 10.1158/0008-5472.CAN-03-1982; Panzeri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024237; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piccirillo SGM, 2009, ONCOGENE, V28, P1807, DOI 10.1038/onc.2009.27; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rahman M, 2011, NEUROSURGERY, V68, P531, DOI 10.1227/NEU.0b013e3181ff9eb5; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Regenbrecht CRA, 2008, STEM CELL REV, V4, P319, DOI 10.1007/s12015-008-9034-0; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ropolo M, 2009, MOL CANCER RES, V7, P383, DOI 10.1158/1541-7786.MCR-08-0409; Sadikovic B, 2008, CURR GENOMICS, V9, P394, DOI 10.2174/138920208785699580; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Schuebel K, 2006, NAT GENET, V38, P738, DOI 10.1038/ng0706-738; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Singh SK, 2003, CANCER RES, V63, P5821; Smith J.D.H., 1999, PUR AP M-WI; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631; Yuki K, 2009, CANCER LETT, V284, P71, DOI 10.1016/j.canlet.2009.04.020	85	31	33	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57462	10.1371/journal.pone.0057462	http://dx.doi.org/10.1371/journal.pone.0057462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468990	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900090
J	Cao, XC; Zhang, WR; Cao, WF; Liu, BW; Zhang, F; Zhao, HM; Meng, R; Zhang, L; Niu, RF; Hao, XS; Zhang, B				Cao, Xu-Chen; Zhang, Wei-Ran; Cao, Wen-Feng; Liu, Bo-Wen; Zhang, Fei; Zhao, Hong-Meng; Meng, Ran; Zhang, Lin; Niu, Rui-Fang; Hao, Xi-Shan; Zhang, Bin			Aquaporin3 Is Required for FGF-2-Induced Migration of Human Breast Cancers	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; CELL-MIGRATION; WATER CHANNELS; MOLECULAR-MECHANISMS; EXPRESSION; RECEPTOR; METASTASIS; PATHWAY; PLAYERS; ROLES	Purpose: The aquaporin (AQP) family consists of a number of small integral membrane proteins that transport water and glycerol. AQPs are critical for trans-epithelial fluid transport. Recent reports demonstrated that AQPs, particularly AQP1 and AQP5, are expressed in high grade tumor cells of a variety of tissue origins, and that AQPs are involved in cell migration and metastasis. Based on this background, we examined whether AQP3, another important member of the AQP family, could facilitate cell migration in human breast cancers. Methods: Potential role of AQP3 was examined using two representative breast cancer cell lines (MDA-MB-231 and Bcap-37). Briefly, AQP3 expression was inhibited with a lentivirus construct that stably expressed shRNA against the AQP3 mRNA. AQP3 expression inhibition was verified with Western blot. Cell migration was examined using a wound scratch assay in the presence of fibroblast growth factor-2 (FGF-2). In additional experiments, AQP3 was inhibited by CuSO4. Fibroblast growth factor receptor (FGFR) kinase inhibitor PD173074, PI3K inhibitor LY294002, and MEK1/2 inhibitor PD98059 were used to dissect the molecular mechanism of FGF-2 induced AQP3 expression. Results: FGF-2 treatment increased AQP3 expression and induced cell migration in a dose dependent manner. Silencing AQP3 expression by a lentiviral shRNA inhibited FGF-2 induced cell migration. CuSO4, a water transport inhibitor selective for AQP3, also suppressed FGF-2-induced cell migration. The FGFR kinase inhibitor PD173074, significantly inhibited FGF-2-induced AQP3 expression and cell migration. The PI3K inhibitor LY294002 and MEK1/2 inhibitor PD98059 inhibited, but not fully blocked, FGF-2-induced AQP3 expression and cell migration. Conclusions: AQP3 is required for FGF-2-induced cell migration in cultured human breast cancer cells. Our findings also suggest the importance of FGFR-PI3K and FGFR-ERK signaling in FGF-2-induced AQP3 expression. In summary, our findings suggest a novel function of AQP3 in cell migration and metastasis of breast cancers.	[Cao, Xu-Chen; Zhang, Wei-Ran; Liu, Bo-Wen; Zhao, Hong-Meng; Meng, Ran; Hao, Xi-Shan; Zhang, Bin] Canc Inst & Hosp, Natl Key Lab Breast Canc Prevent & Treatment, Tianjin, Peoples R China; [Cao, Xu-Chen; Zhang, Wei-Ran; Liu, Bo-Wen; Zhao, Hong-Meng; Meng, Ran; Hao, Xi-Shan; Zhang, Bin] Canc Inst & Hosp, Dept Breast Canc Surg, Tianjin, Peoples R China; [Cao, Wen-Feng] Canc Inst & Hosp, Dept Pathol, Tianjin, Peoples R China; [Zhang, Fei; Zhang, Lin; Niu, Rui-Fang] Tianjin Med Univ, Tianjin Key Lab Canc Prevent & Treatment, Tianjin, Peoples R China	Tianjin Medical University	Zhang, B (corresponding author), Canc Inst & Hosp, Natl Key Lab Breast Canc Prevent & Treatment, Tianjin, Peoples R China.	eeflying@163.com	Niu, Ruifang/AAJ-8017-2020	Niu, Ruifang/0000-0002-1905-7408; Zhang, Fei/0000-0001-7434-7339	National Natural Science Foundation of China [81001186]; Tianjin Municipal Natural Science Foundation [10JCYBJC14100, 11JCZDJC28000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Natural Science Foundation(Natural Science Foundation of Tianjin)	This work was supported by the National Natural Science Foundation of China (Grant no. 81001186) and the Tianjin Municipal Natural Science Foundation (Grant no. 10JCYBJC14100, 11JCZDJC28000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Cavallaro U, 1998, FASEB J, V12, P1027, DOI 10.1096/fasebj.12.11.1027; Ding T, 2010, J CLIN NEUROSCI, V17, P1359, DOI 10.1016/j.jocn.2010.02.014; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; Itoh T, 2005, BIOCHEM BIOPH RES CO, V330, P832, DOI 10.1016/j.bbrc.2005.03.046; Ji C, 2008, CANCER CHEMOTH PHARM, V62, P857, DOI 10.1007/s00280-007-0674-6; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Kasimir-Bauer S, 2009, MOL MED REP, V2, P645, DOI 10.3892/mmr_00000151; Khurana A, 2011, CANCER RES, V71, P2152, DOI 10.1158/0008-5472.CAN-10-3059; Li HP, 2005, BIOL CELL, V97, P823, DOI 10.1042/BC20040091; Liu JF, 2002, BIOCHEM BIOPH RES CO, V293, P1174, DOI 10.1016/S0006-291X(02)00350-9; Mazal PR, 2005, MODERN PATHOL, V18, P535, DOI 10.1038/modpathol.3800320; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Okada-Ban M, 2000, INT J BIOCHEM CELL B, V32, P263, DOI 10.1016/S1357-2725(99)00133-8; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Otterbach F, 2010, BREAST CANCER RES TR, V120, P67, DOI 10.1007/s10549-009-0370-9; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Procino G, 2008, SEMIN NEPHROL, V28, P297, DOI 10.1016/j.semnephrol.2008.03.007; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Shi ZH, 2012, J SURG ONCOL, V106, P267, DOI 10.1002/jso.22155; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tan G, 2008, J INT MED RES, V36, P777, DOI 10.1177/147323000803600420; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702	28	53	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56735	10.1371/journal.pone.0056735	http://dx.doi.org/10.1371/journal.pone.0056735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468877	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900034
J	Ding, LC; Song, T; Yi, CR; Huang, Y; Yu, W; Ling, L; Dai, YT; Wei, ZQ				Ding, Liucheng; Song, Tao; Yi, Chaoran; Huang, Yi; Yu, Wen; Ling, Lin; Dai, Yutian; Wei, Zhongqing			Transcutaneous Electrical Nerve Stimulation (TENS) Improves the Diabetic Cytopathy (DCP) via Up-Regulation of CGRP and cAMP	PLOS ONE			English	Article							PRIMARY SENSORY NEURONS; BLADDER DYSFUNCTION; SACRAL NEUROMODULATION; VOIDING DYSFUNCTION; PEPTIDE; RATS; EXPRESSION; DETRUSOR	The objective of this study was to investigate the effects and mechanism of Transcutaneous Electrical Nerve Stimulation (TENS) on the diabetic cytopathy (DCP) in the diabetic bladder. A total of 45 rats were randomly divided into diabetes mellitus (DM)/TENS group (n = 15), DM group (n = 15) and control group (n = 15). The rats in the DM/TENS and TENS groups were electronically stimulated (stimulating parameters: intensity-31 V, frequency-31 Hz, and duration of stimulation of 15 min) for three weeks. Bladder histology, urodynamics and contractile responses to field stimulation and carbachol were determined. The expression of calcitonin gene-related peptide (CGRP) was analyzed by RT-PCR and Western blotting. The results showed that contractile responses of the DM rats were ameliorated after 3 weeks of TENS. Furthermore, TENS significantly increased bladder wet weight, volume threshold for micturition and reduced PVR, V% and cAMP content of the bladder. The mRNA and protein levels of CGRP in dorsal root ganglion (DRG) in the DM/TENS group were higher than those in the DM group. TENS also significantly up-regulated the cAMP content in the bladder body and base compared with diabetic rats. We conclude that TENS can significantly improve the urine contractility and ameliorate the feeling of bladder fullness in DM rats possibly via up-regulation of cAMP and CGRP in DRG.	[Ding, Liucheng; Huang, Yi; Wei, Zhongqing] Nanjing Med Univ, Affiliated Hosp 2, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Yi, Chaoran; Yu, Wen; Ling, Lin; Dai, Yutian] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Urol, Nanjing 210008, Jiangsu, Peoples R China; [Song, Tao] Chinese PLA 454 Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University	Wei, ZQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Dept Urol, Nanjing, Jiangsu, Peoples R China.	weizq1@163.com		Huang, Yi/0000-0002-1245-6764	Natural Science Foundation of Jiangsu [SBK201123829]	Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province)	This work was supported in part by grants from the Natural Science Foundation of Jiangsu (SBK201123829). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudreau-Lariviere C, 1999, FEBS LETT, V444, P22, DOI 10.1016/S0014-5793(99)00015-0; CAMILLERI M, 1984, AM J PHYSIOL, V247, pG703, DOI 10.1152/ajpgi.1984.247.6.G703; Daneshgari F, 2006, J UROLOGY, V176, P380, DOI 10.1016/S0022-5347(06)00582-9; FALL M, 1980, J UROLOGY, V123, P192, DOI 10.1016/S0022-5347(17)55850-4; Feifer A, 2008, NEUROUROL URODYNAM, V27, P475, DOI 10.1002/nau.20569; Gladh G, 2003, NEUROUROL URODYNAM, V22, P233, DOI 10.1002/nau.10078; Horvath EE, 2010, NEUROUROL URODYNAM, V29, P401, DOI 10.1002/nau.20766; Jezernik S, 2002, NEUROL RES, V24, P413, DOI 10.1179/016164102101200294; Kessler TM, 2008, NAT CLIN PRACT UROL, V5, P657, DOI 10.1038/ncpuro1251; Leiria LOS, 2011, BRIT J PHARMACOL, V163, P1276, DOI 10.1111/j.1476-5381.2011.01311.x; Li XQ, 2004, J NEUROPATH EXP NEUR, V63, P1092, DOI 10.1093/jnen/63.10.1092; Lin ZY, 2004, DIABETES CARE, V27, P1071, DOI 10.2337/diacare.27.5.1071; LUHESHI GN, 1990, BRIT J PHARMACOL, V101, P411, DOI 10.1111/j.1476-5381.1990.tb12723.x; Martens FMJ, 2011, SPINAL CORD, V49, P566, DOI 10.1038/sc.2010.134; Martens FMJ, 2011, J UROLOGY, V186, P798, DOI 10.1016/j.juro.2011.02.2696; MCCARTHY PW, 1990, NEUROSCIENCE, V34, P623, DOI 10.1016/0306-4522(90)90169-5; Mumtaz FH, 1999, UROL RES, V27, P470, DOI 10.1007/s002400050137; Ruiz G, 2005, BRAIN RES, V1042, P44, DOI 10.1016/j.brainres.2005.02.009; Sasaki K, 2003, UROL CLIN N AM, V30, P1, DOI 10.1016/S0094-0143(02)00116-7; Tian XY, 2006, BRAIN RES, V1088, P101, DOI 10.1016/j.brainres.2006.03.014; van Balken MR, 2004, J UROLOGY, V172, P846, DOI 10.1097/01.ju.0000134418.21959.98; van Kerrebroeck PEV, 2007, J UROLOGY, V178, P2029, DOI 10.1016/j.juro.2007.07.032; Van Rey FS, 2008, UROL INT, V81, P373, DOI 10.1159/000167831; Wang XM, 2010, J DIABETES COMPLICAT, V24, P121, DOI 10.1016/j.jdiacomp.2009.06.002; Yi CR, 2006, ACTA PHARMACOL SIN, V27, P1037, DOI 10.1111/j.1745-7254.2006.00333.x; Yokozuka M, 2004, CLIN REHABIL, V18, P899, DOI 10.1191/0269215504cr803oa; Zhang Sui-Yang, 2001, Shengli Xuebao, V53, P219	27	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57477	10.1371/journal.pone.0057477	http://dx.doi.org/10.1371/journal.pone.0057477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468996	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900095
J	Fabian, AK; Marz, A; Neimanis, S; Biondi, RM; Kozany, C; Hausch, F				Fabian, Anne-Katrin; Maerz, Andreas; Neimanis, Sonja; Biondi, Ricardo M.; Kozany, Christian; Hausch, Felix			InterAKTions with FKBPs - Mutational and Pharmacological Exploration	PLOS ONE			English	Article							PROTEIN-KINASE-B; CYTOSOLIC-BINDING-PROTEIN; FK506-BINDING PROTEINS; IMMUNOPHILIN LIGANDS; CRYSTAL-STRUCTURE; CYCLOSPORINE-A; PI3K PATHWAY; CELL-GROWTH; AKT; PHOSPHORYLATION	The FK506-binding protein 51 (FKBP51) is an Hsp90-associated co-chaperone which regulates steroid receptors and kinases. In pancreatic cancer cell lines, FKBP51 was shown to recruit the phosphatase PHLPP to facilitate dephosphorylation of the kinase Akt, which was associated with reduced chemoresistance. Here we show that in addition to FKBP51 several other members of the FKBP family bind directly to Akt. FKBP51 can also form complexes with other AGC kinases and mapping studies revealed that FKBP51 interacts with Akt via multiple domains independent of their activation or phosphorylation status. The FKBP51-Akt1 interaction was not affected by FK506 analogs or Akt active site inhibitors, but was abolished by the allosteric Akt inhibitor VIII. None of the FKBP51 inhibitors affected AktS473 phosphorylation or downstream targets of Akt. In summary, we show that FKBP51 binds to Akt directly as well as via Hsp90. The FKBP51-Akt interaction is sensitive to the conformation of Akt1, but does not depend on the FK506-binding pocket of FKBP51. Therefore, FKBP inhibitors are unlikely to inhibit the Akt-FKBP-PHLPP network.	[Fabian, Anne-Katrin; Maerz, Andreas; Kozany, Christian; Hausch, Felix] Max Planck Inst Psychiat, Res Grp Chem Genom, Munich, Germany; [Neimanis, Sonja; Biondi, Ricardo M.] Univ Frankfurt Klinikum, Med Klin 1, Res Grp PhosphoSites, Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Hausch, F (corresponding author), Max Planck Inst Psychiat, Res Grp Chem Genom, Munich, Germany.	hausch@mpipsykl.mpg.de		Biondi, Ricardo/0000-0002-8873-7167	Max Planck Society	Max Planck Society(Max Planck Society)	This work was supported by the Max Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Belova L, 2008, J BIOL CHEM, V283, P18821, DOI 10.1074/jbc.M803289200; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Blackburn EA, 2011, CURR OPIN PHARMACOL, V11, P365, DOI 10.1016/j.coph.2011.04.007; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Gaali S, 2011, CURR MED CHEM, V18, P5355, DOI 10.2174/092986711798194342; Gaali S, 2010, ACS MED CHEM LETT, V1, P536, DOI 10.1021/ml1001272; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hou JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036252; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Jiang W, 2008, NEOPLASIA, V10, P235, DOI 10.1593/neo.07929; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Kozany C, 2009, CHEMBIOCHEM, V10, P1402, DOI 10.1002/cbic.200800806; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Liao Y, 2010, AM J TRANSL RES, V2, P19; Lin K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002618; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Marz AM, 2013, MOL CELL BIOL, V33, P1357, DOI 10.1128/MCB.00678-12; Ni L, 2010, MOL CELL BIOL, V30, P1243, DOI 10.1128/MCB.01891-08; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Periyasamy S, 2010, ONCOGENE, V29, P1691, DOI 10.1038/onc.2009.458; Periyasamy S, 2007, ENDOCRINOLOGY, V148, P4716, DOI 10.1210/en.2007-0145; Price RD, 2005, EUR J PHARMACOL, V509, P11, DOI 10.1016/j.ejphar.2004.12.023; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Romano S, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.32; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Saxty G, 2007, J MED CHEM, V50, P2293, DOI 10.1021/jm070091b; Schmidt MV, 2012, CHEMMEDCHEM; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SIEKIERKA JJ, 1990, J BIOL CHEM, V265, P21011; SMITH DF, 1993, J BIOL CHEM, V268, P18365; Somarelli JA, 2008, PROTEINS, V72, P197, DOI 10.1002/prot.21908; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	49	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57508	10.1371/journal.pone.0057508	http://dx.doi.org/10.1371/journal.pone.0057508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469007	gold, Green Published			2022-12-27	WOS:000315524900107
J	Ji, Y; Lu, XD; Zhong, QP; Liu, P; An, Y; Zhang, YT; Zhang, SJ; Jia, RR; Tesfamariam, IG; Kahsay, AG; Zhang, LQ; Zhu, WS; Zheng, YW				Ji, Yan; Lu, Xiaodan; Zhong, Qingping; Liu, Peng; An, Yao; Zhang, Yuntao; Zhang, Shujie; Jia, Ruirui; Tesfamariam, Isaias G.; Kahsay, Abraha G.; Zhang, Luqing; Zhu, Wensheng; Zheng, Yaowu			Transcriptional Profiling of Mouse Uterus at Pre-Implantation Stage under VEGF Repression	PLOS ONE			English	Article							GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; ENDOMETRIAL CARCINOMA; CELL-SURVIVAL; RNA; GROWTH; IMPLANTATION; FOLLISTATIN; MECHANISMS; POPULATION	Uterus development during pre-implantation stage affects implantation process and embryo growth. Aberrant uterus development is associated with many human reproductive diseases. Among the factors regulating uterus development, vascular remodeling promoters are critical for uterus function and fertility. Vascular endothelial growth factor (VEGF), as one of the major members, has been found to be important in endothelial cell growth and blood vessel development, as well as in non-endothelial cells. VEGF mediation in reproduction has been broadly studied, but VEGF-induced transcriptional machinery during implantation window has not been systematically studied. In this study, a genetically repressed VEGF mouse model was used to analyze uterus transcriptome at gestation 2.5 (G2.5) by Solexa/Illumina's digital gene expression (DGE) system. A number of 831 uterus-specific and 2398 VEGF-regulated genes were identified. Gene ontology (GO) analysis indicated that genes actively involved in uterus development were members of collagen biosynthesis, cell proliferation and cell apoptosis. Uterus-specific genes were enriched in activities of phosphatidyl inositol phosphate kinase, histone H3-K36 demethylation and protein acetylation. Among VEGF-regulated genes, up-regulated were associated with RNA polymerase III activity while down-regulated were strongly related with muscle development. Comparable numbers of antisense transcripts were identified. Expression levels of the antisense transcripts were found tightly correlated with their sense expression levels, an indication of possibly non-specific transcripts generated around the active promoters and enhancers. The antisense transcripts with exceptionally high or low expression levels and the antisense transcripts under VEGF regulation were also identified. These transcripts may be important candidates in regulation of uterus development. This study provides a global survey on genes and antisense transcripts regulated by VEGF in the pre-implantation stage. Results will contribute to further study the candidate genes and pathways in regulating implantation process and related diseases.	[Ji, Yan; Lu, Xiaodan; Liu, Peng; An, Yao; Zhang, Yuntao; Zhang, Shujie; Jia, Ruirui; Tesfamariam, Isaias G.; Kahsay, Abraha G.; Zhang, Luqing; Zheng, Yaowu] NE Normal Univ, Sch Life Sci, Transgen Res Ctr, Changchun, Peoples R China; [Zhong, Qingping; Zhu, Wensheng] NE Normal Univ, KLAS, Changchun, Peoples R China; [Zhong, Qingping; Zhu, Wensheng] NE Normal Univ, Sch Math & Stat, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China	Zhang, LQ (corresponding author), NE Normal Univ, Sch Life Sci, Transgen Res Ctr, Changchun, Peoples R China.	zhanglq479@nenu.edu.cn; wszhu@nenu.edu.cn; zhengyw442@nenu.edu.cn	Zhang, Luqing/A-1200-2019	Zhang, Luqing/0000-0001-7252-643X	National Natural Science Foundation of China [81270953/H0720]; joint foundation of Northeast Normal university [10JCXK001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); joint foundation of Northeast Normal university	This research was supported by National Natural Science Foundation of China (Grant No. 81270953/H0720) and the joint foundation of Northeast Normal university (Grant No. 10JCXK001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arase T, 2009, J IMMUNOL, V182, P7074, DOI 10.4049/jimmunol.0900001; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benson GV, 1996, DEVELOPMENT, V122, P2687; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; Boer JM, 2002, NEUROMUSCULAR DISORD, V12, pS118, DOI 10.1016/S0960-8966(02)00092-5; Burghardt RC, 2002, CELLS TISSUES ORGANS, V172, P202, DOI 10.1159/000066969; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Chau YM, 2002, J CLIN ENDOCR METAB, V87, P2674, DOI 10.1210/jc.87.6.2674; Cohen JE, 2010, P AM PHILOS SOC, V154, P158; Crambert Gilles, 2003, Sci STKE, V2003, pRE1, DOI 10.1126/stke.2003.166.re1; Daikoku T, 2003, J BIOL CHEM, V278, P7683, DOI 10.1074/jbc.M211390200; de Kretser DM, 2002, HUM REPROD UPDATE, V8, P529, DOI 10.1093/humupd/8.6.529; Diskin MG, 2006, ANIM REPROD SCI, V96, P297, DOI 10.1016/j.anireprosci.2006.08.008; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ferrara N, 1996, EUR J CANCER, V32A, P2413, DOI 10.1016/S0959-8049(96)00387-5; Fox SB, 1996, J PATHOL, V179, P232, DOI 10.1002/(SICI)1096-9896(199607)179:3<232::AID-PATH505>3.0.CO;2-A; Geering K, 2005, J BIOENERG BIOMEMBR, V37, P387, DOI 10.1007/s10863-005-9476-x; Gendron RL, 1997, BIOL REPROD, V56, P1097, DOI 10.1095/biolreprod56.5.1097; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; GREEN PJ, 1986, ANNU REV BIOCHEM, V55, P569, DOI 10.1146/annurev.bi.55.070186.003033; Gupta A, 1996, BIOL REPROD, V55, P796, DOI 10.1095/biolreprod55.4.796; Haigh JJ, 2000, DEVELOPMENT, V127, P1445; Halder JB, 2000, GENESIS, V26, P213, DOI 10.1002/(SICI)1526-968X(200003)26:3<213::AID-GENE7>3.0.CO;2-M; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones RL, 2002, TRENDS ENDOCRIN MET, V13, P144, DOI 10.1016/S1043-2760(01)00559-8; Kim KH, 2009, HISTOL HISTOPATHOL, V24, P309, DOI 10.14670/HH-24.309; KING GJ, 1982, J REPROD FERTIL, P17; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lin HH, 2011, INT J BIOL SCI, V7, P74, DOI 10.7150/ijbs.7.74; Liu XA, 2010, IUBMB LIFE, V62, P819, DOI 10.1002/iub.389; Lu XD, 2012, ENDOCRINOLOGY, V153, P3123, DOI 10.1210/en.2012-1151; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller C, 1998, DEVELOPMENT, V125, P3201; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Ohno T, 2008, ENDOCR J, V55, P83, DOI 10.1507/endocrj.K07-082; Porter JD, 2003, FASEB J, V17, P893, DOI 10.1096/fj.02-0810fje; Prifti E, 2008, BIOINFORMATICS, V24, P2636, DOI 10.1093/bioinformatics/btn492; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reiss K, 2011, EXP DERMATOL, V20, P905, DOI 10.1111/j.1600-0625.2011.01355.x; Shimomura Y, 2010, J INVEST DERMATOL, V130, P892, DOI 10.1038/jid.2009.341; Shooner C, 2005, REPROD BIOL ENDOCRIN, V3, P1, DOI 10.1186/1477-7827-3-20; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Soufla G, 2005, CANCER LETT, V221, P105, DOI 10.1016/j.canlet.2004.08.021; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Velculescu VE, 2007, NAT BIOTECHNOL, V25, P878, DOI 10.1038/nbt0807-878; Vogel P, 2010, VET PATHOL, V47, P120, DOI 10.1177/0300985809353553; WILMUT I, 1986, J REPROD FERTIL, V76, P851, DOI 10.1530/jrf.0.0760851; Yang CH, 2012, J NEUROSCI, V32, P7550, DOI 10.1523/JNEUROSCI.5902-11.2012; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; Zhang SZ, 2010, IUBMB LIFE, V62, P677, DOI 10.1002/iub.368; Zingg HH, 2003, TRENDS ENDOCRIN MET, V14, P222, DOI 10.1016/S1043-2760(03)00080-8	54	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57287	10.1371/journal.pone.0057287	http://dx.doi.org/10.1371/journal.pone.0057287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468957	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900066
J	Nagy, B; Farmer, JD; Bui, QM; Trancik, JE				Nagy, Bela; Farmer, J. Doyne; Bui, Quan M.; Trancik, Jessika E.			Statistical Basis for Predicting Technological Progress	PLOS ONE			English	Article							INFORMATION-TECHNOLOGY; FUNCTIONAL-APPROACH; LEARNING-CURVE; COSTS	Forecasting technological progress is of great interest to engineers, policy makers, and private investors. Several models have been proposed for predicting technological improvement, but how well do these models perform? An early hypothesis made by Theodore Wright in 1936 is that cost decreases as a power law of cumulative production. An alternative hypothesis is Moore's law, which can be generalized to say that technologies improve exponentially with time. Other alternatives were proposed by Goddard, Sinclair et al., and Nordhaus. These hypotheses have not previously been rigorously tested. Using a new database on the cost and production of 62 different technologies, which is the most expansive of its kind, we test the ability of six different postulated laws to predict future costs. Our approach involves hindcasting and developing a statistical model to rank the performance of the postulated laws. Wright's law produces the best forecasts, but Moore's law is not far behind. We discover a previously unobserved regularity that production tends to increase exponentially. A combination of an exponential decrease in cost and an exponential increase in production would make Moore's law and Wright's law indistinguishable, as originally pointed out by Sahal. We show for the first time that these regularities are observed in data to such a degree that the performance of these two laws is nearly the same. Our results show that technological progress is forecastable, with the square root of the logarithmic error growing linearly with the forecasting horizon at a typical rate of 2.5% per year. These results have implications for theories of technological change, and assessments of candidate technologies and policies for climate change mitigation.	[Nagy, Bela; Farmer, J. Doyne; Bui, Quan M.; Trancik, Jessika E.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Bui, Quan M.] St Johns Coll, Santa Fe, NM USA; [Trancik, Jessika E.] MIT, Engn Syst Div, Cambridge, MA 02139 USA	The Santa Fe Institute; Massachusetts Institute of Technology (MIT)	Trancik, JE (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	trancik@mit.edu		Bui, Quan M./0000-0003-2648-0586	National Science Foundation [NSF-0738187]; Boeing Company	National Science Foundation(National Science Foundation (NSF)); Boeing Company	This work was funded under National Science Foundation grant NSF-0738187. http://www.nsf.gov/. Partial funding for this work was provided by The Boeing Company. http://www.boeing.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNATHY WJ, 1974, HARVARD BUS REV, V52, P109; Alberth S, 2008, TECHNOL FORECAST SOC, V75, P952, DOI 10.1016/j.techfore.2007.09.003; Amaya M. A, 2008, PROGR WIRELESS DATA; ARGOTE L, 1990, SCIENCE, V247, P920, DOI 10.1126/science.247.4945.920; Dosi G, 2010, HDB EC INNOVATION; DUTTON JM, 1984, ACAD MANAGE REV, V9, P235, DOI 10.2307/258437; Fried I., 2010, CNET NEWS; Gillingham K, 2008, ENERG ECON, V30, P2734, DOI 10.1016/j.eneco.2008.03.001; GODDARD CT, 1982, IEEE T COMPON HYBR, V5, P328, DOI 10.1109/TCHMT.1982.1136009; IEA, 2000, EXP CURV EN TECHN PO; Koh H, 2008, TECHNOL FORECAST SOC, V75, P735, DOI 10.1016/j.techfore.2007.05.007; Koh H, 2006, TECHNOL FORECAST SOC, V73, P1061, DOI 10.1016/j.techfore.2006.06.001; Kurzweil R., 2005, SINGULARITY IS NEAR; McDonald A, 2001, ENERG POLICY, V29, P255, DOI 10.1016/S0301-4215(00)00122-1; McNerney J, 2011, ENERG POLICY, V39, P3042, DOI 10.1016/j.enpol.2011.01.037; Moore G., 1965, ELECT MAGAZINE, V38; Moore G. E., 1965, IEDM, V38, P11; Nagy B, 2011, TECHNOL FORECAST SOC, V78, P1356, DOI 10.1016/j.techfore.2011.07.006; Nordhaus W.D., 2009, TECHNICAL REPORT; Nordhaus WD, 2007, J ECON HIST, V67, P128, DOI 10.1017/S0022050707000058; SAHAL D, 1979, AIIE T, V11, P23, DOI 10.1080/05695557908974396; Sinclair G, 2000, MANAGE SCI, V46, P28, DOI 10.1287/mnsc.46.1.28.15133; Thompson P, 2010, HDB EC INNOVATION; Wright TP, 1936, J AERONAUT SCI, V10, P302	24	134	134	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e52669	10.1371/journal.pone.0052669	http://dx.doi.org/10.1371/journal.pone.0052669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23468837	Green Submitted, gold, Green Published			2022-12-27	WOS:000315524900005
J	Bishop, L; Bailes, F; Dean, RT				Bishop, Laura; Bailes, Freya; Dean, Roger T.			Musical Expertise and the Ability to Imagine Loudness	PLOS ONE			English	Article							AUDITORY IMAGERY; WORKING-MEMORY; PITCH; PERFORMANCE; PERCEPTION; EMOTION; COMMUNICATION; INTENSITY; MUSICIANS; TIME	Most perceived parameters of sound (e. g. pitch, duration, timbre) can also be imagined in the absence of sound. These parameters are imagined more veridically by expert musicians than non-experts. Evidence for whether loudness is imagined, however, is conflicting. In music, the question of whether loudness is imagined is particularly relevant due to its role as a principal parameter of performance expression. This study addressed the hypothesis that the veridicality of imagined loudness improves with increasing musical expertise. Experts, novices and non-musicians imagined short passages of well-known classical music under two counterbalanced conditions: 1) while adjusting a slider to indicate imagined loudness of the music and 2) while tapping out the rhythm to indicate imagined timing. Subtests assessed music listening abilities and working memory span to determine whether these factors, also hypothesised to improve with increasing musical expertise, could account for imagery task performance. Similarity between each participant's imagined and listening loudness profiles and reference recording intensity profiles was assessed using time series analysis and dynamic time warping. The results suggest a widespread ability to imagine the loudness of familiar music. The veridicality of imagined loudness tended to be greatest for the expert musicians, supporting the predicted relationship between musical expertise and musical imagery ability.	[Bishop, Laura; Bailes, Freya; Dean, Roger T.] Univ Western Sydney, MARCS Inst, Penrith, NSW 1797, Australia; [Bailes, Freya] Univ Hull, Mus Dept, Kingston Upon Hull HU6 7RX, N Humberside, England	Western Sydney University; University of Hull	Bishop, L (corresponding author), Univ Western Sydney, MARCS Inst, Penrith, NSW 1797, Australia.	L.Bishop@uws.edu.au		Dean, Roger Thornton/0000-0002-8859-8902; Bishop, Laura/0000-0002-0656-3969; Bailes, Freya/0000-0003-2723-3579	University of Western Sydney International Postgraduate Research Scholarship	University of Western Sydney International Postgraduate Research Scholarship	This research was funded by a University of Western Sydney International Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2000, NEUROPSYCHOLOGIA, V38, P1664, DOI 10.1016/S0028-3932(00)00079-8; Aleman A., 2004, COGNITIVE PROCESSING, V5, P228, DOI [DOI 10.1007/S10339-004-0034-Y, 10.1007/s10339-004-0034-y]; Baddeley AD, 2000, J EXP PSYCHOL GEN, V129, P126, DOI 10.1037//0096-3445.129.1.126; Bailes F, 2012, FRONTIERS PERCEPTION, P3; Bailes F, 2004, 8 INT C MUS PERC COG; Bailes F, 2007, EMPIR MUSICOL REV, V2, P21, DOI 10.18061/1811/24476; Besson M, 2007, RESTOR NEUROL NEUROS, V25, P399; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; Bishop L, MUSICAL IMA IN PRESS; Brodsky W, 2003, PERCEPT PSYCHOPHYS, V65, P602, DOI 10.3758/BF03194586; Chaffin R., 2006, ADV COGN PSYCHOL, V2, P113, DOI [10.2478/vl0053-008-0050-z, DOI 10.2478/V10053-008-0050-Z]; Chaffin R, 2010, PSYCHOL MUSIC, V38, P3, DOI 10.1177/0305735608100377; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Clark T, 2011, IMAGINE MUSIC CONTEX; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Dean RT, 2010, EMPIR MUSICOL REV, V5, P152, DOI 10.18061/1811/48550; Dean RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018591; Dean RT, 2010, ORGAN SOUND, V15, P147, DOI 10.1017/S1355771810000142; Drake C, 2000, MUSIC PERCEPT, V18, P1; Dyson BJ, 2010, ATTEN PERCEPT PSYCHO, V72, P1676, DOI 10.3758/APP.72.6.1676; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Franklin MS, 2008, PSYCHOL MUSIC, V36, P353, DOI 10.1177/0305735607086044; GERINGER JM, 1995, J RES MUSIC EDUC, V43, P22, DOI 10.2307/3345789; Gingras B, 2011, PERCEPTION, V40, P1206, DOI 10.1068/p6891; Giovagnoli AR, 2011, PERCEPT MOTOR SKILL, V113, P563, DOI 10.2466/04.11.22.23.PMS.113.5.563-569; Gordon E. E., 1979, PSYCHOL MUSIC, V7, P42, DOI [10.1177/030573567971005, DOI 10.1177/030573567971005]; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Halpern AR, 2012, ANN NY ACAD SCI, V1252, P200, DOI 10.1111/j.1749-6632.2011.06442.x; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; HALPERN AR, 1988, J EXP PSYCHOL LEARN, V14, P434, DOI 10.1037/0278-7393.14.3.434; HALPERN AR, 1982, AM J PSYCHOL, V95, P31, DOI 10.2307/1422658; Helmbold N., 2005, J INDIVID DIFFER, V26, P74, DOI [10.1027/1614-0001.26.2.74, DOI 10.1027/1614-0001.26.2.74]; Highben Z, 2004, B COUN RES MUSIC ED, P58; Hill NM, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P653; Hubbard TL, 2010, PSYCHOL BULL, V136, P302, DOI 10.1037/a0018436; Huron D., 1991, PSYCHOL MUSIC, V19, P33, DOI 10.1177/0305735691191003; Ilie G, 2006, MUSIC PERCEPT, V23, P319, DOI 10.1525/mp.2006.23.4.319; INTONSPETERSON MJ, 1980, MEM COGNITION, V8, P385, DOI 10.3758/BF03211134; Janata P, 2006, PERCEPT PSYCHOPHYS, V68, P829, DOI 10.3758/BF03193705; Juslin P.N., 2003, PSYCHOL MUSIC, V31, P273, DOI [10.1177/03057356030313003, DOI 10.1177/03057356030313003]; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kamenetsky S.B., 1997, PSYCHOL MUSIC, V25, P149, DOI 10.1177/ 0305735697252005.; Keller PE, 2010, J EXP PSYCHOL HUMAN, V36, P508, DOI 10.1037/a0017604; Knecht M.G., 2003, MUSIC EDUC RES, V5, P227; Kosslyn S. M., 1980, IMAGE MIND; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; Levitin DJ, 1996, PERCEPT PSYCHOPHYS, V58, P927, DOI 10.3758/BF03205494; Livingstone S, 2009, INT S PERF SCI AUCKL, P445; Lucas BJ, 2010, MUSIC PERCEPT, V27, P399, DOI 10.1525/mp.2010.27.5.399; Madison G, 2000, J NEW MUSIC RES, V29, P335, DOI 10.1080/09298210008565466; MCADAMS S, 1995, PSYCHOL RES-PSYCH FO, V58, P177, DOI 10.1007/BF00419633; Neuhoff JG, 1999, J EXP PSYCHOL HUMAN, V25, P1050, DOI 10.1037/0096-1523.25.4.1050; Ollen J, 2009, SOC MUS PERC COGN C; Ollen J.E., 2006, THESIS OHIO STATE U; Olsen KN, 2010, PERCEPTION, V39, P695, DOI 10.1068/p6592; Palmer C, 1997, ANNU REV PSYCHOL, V48, P115, DOI 10.1146/annurev.psych.48.1.115; Palmer C, 2003, PSYCHOL REV, V110, P683, DOI 10.1037/0033-295X.110.4.683; Pecenka N, 2009, ANN NY ACAD SCI, V1169, P282, DOI 10.1111/j.1749-6632.2009.04785.x; Penel A, 2004, PERCEPT PSYCHOPHYS, V66, P545, DOI 10.3758/BF03194900; PITT MA, 1992, J EXP PSYCHOL HUMAN, V18, P728, DOI 10.1037/0096-1523.18.3.728; PYLYSHYN ZW, 1981, PSYCHOL REV, V88, P16, DOI 10.1037/0033-295X.88.1.16; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rammsayer T, 2006, MUSIC PERCEPT, V24, P37, DOI 10.1525/mp.2006.24.1.37; Repp B. H., 1997, MUSIC SCI, V1, P257, DOI DOI 10.1177/102986499700100206; Repp BH, 1999, MUSIC PERCEPT, V16, P409; Rosenberg HS, 1990, IMAGERY CURRENT PERS, P55; Schubert E, 2004, MUSIC PERCEPT, V21, P561, DOI 10.1525/mp.2004.21.4.561; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sloboda JA, 2001, MUSIC PERCEPT, V19, P87, DOI 10.1525/mp.2001.19.1.87; Sloboda JA, 2000, TRENDS COGN SCI, V4, P397, DOI 10.1016/S1364-6613(00)01531-X; Snyder J, 2001, MUSIC PERCEPT, V18, P455, DOI 10.1525/mp.2001.18.4.455; Snyder JS, 2006, MUSIC PERCEPT, V24, P135, DOI 10.1525/mp.2006.24.2.135; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Thompson WL, 2008, MEM COGNITION, V36, P1024, DOI 10.3758/MC.36.5.1024; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; WEBER RJ, 1986, MUSIC PERCEPT, V3, P411; Williamson A, 2002, COGNITIVE PSYCHOL, V44, P1, DOI 10.1006/cogp.2001.0759; Wollner C, 2007, RES STUD MUSIC EDUC, V29, P39; Wu JH, 2011, PSYCHOPHYSIOLOGY, V48, P415, DOI 10.1111/j.1469-8986.2010.01070.x; Zatorre RJ, 2005, NEURON, V47, P9, DOI 10.1016/j.neuron.2005.06.013	82	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56052	10.1371/journal.pone.0056052	http://dx.doi.org/10.1371/journal.pone.0056052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	098BN	23460791	Green Published, gold			2022-12-27	WOS:000315519000014
J	Fassbinder-Orth, CA; Barak, VA; Brown, CR				Fassbinder-Orth, Carol A.; Barak, Virginia A.; Brown, Charles R.			Immune Responses of a Native and an Invasive Bird to Buggy Creek Virus (Togaviridae: Alphavirus) and Its Arthropod Vector, the Swallow Bug (Oeciacus vicarius)	PLOS ONE			English	Article							WEST NILE VIRUS; ANTIBODY-RESPONSE; HOUSE SPARROWS; PASSER-DOMESTICUS; ANOPHELES-GAMBIAE; SALIVARY PROTEINS; MIGRATORY BIRDS; CLIFF SWALLOWS; UNITED-STATES; AEDES-AEGYPTI	Invasive species often display different patterns of parasite burden and virulence compared to their native counterparts. These differences may be the result of variability in host-parasite co-evolutionary relationships, the occurrence of novel host-parasite encounters, or possibly innate differences in physiological responses to infection between invasive and native hosts. Here we examine the adaptive, humoral immune responses of a resistant, native bird and a susceptible, invasive bird to an arbovirus (Buggy Creek virus; Togaviridae: Alphavirus) and its ectoparasitic arthropod vector (the swallow bug; Oeciacus vicarius). Swallow bugs parasitize the native, colonially nesting cliff swallow (Petrochelidon pyrrhonota) and the introduced house sparrow (Passer domesticus) that occupies nests in cliff swallow colonies. We measured levels of BCRV-specific and swallow bug-specific IgY levels before nesting (prior to swallow bug exposure) and after nesting (after swallow bug exposure) in house sparrows and cliff swallows in western Nebraska. Levels of BCRV-specific IgY increased significantly following nesting in the house sparrow but not in the cliff swallow. Additionally, house sparrows displayed consistently higher levels of swallow bug-specific antibodies both before and after nesting compared to cliff swallows. The higher levels of BCRV and swallow bug specific antibodies detected in house sparrows may be reflective of significant differences in both antiviral and anti-ectoparasite immune responses that exist between these two avian species. To our knowledge, this is the first study to compare the macro-and microparasite-specific immune responses of an invasive and a native avian host exposed to the same parasites.	[Fassbinder-Orth, Carol A.; Barak, Virginia A.] Creighton Univ, Dept Biol, Omaha, NE 68178 USA; [Brown, Charles R.] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA	Creighton University; University of Tulsa	Fassbinder-Orth, CA (corresponding author), Creighton Univ, Dept Biol, Omaha, NE 68178 USA.	carolfassbinder-orth@creighton.edu			Creighton College of Arts and Sciences Faculty Summer Research Fellowship; Creighton College of Arts and Sciences Undergraduate Summer Research Scholarship; National Science Foundation [DEB-1019423]	Creighton College of Arts and Sciences Faculty Summer Research Fellowship; Creighton College of Arts and Sciences Undergraduate Summer Research Scholarship; National Science Foundation(National Science Foundation (NSF))	This work was funded by Creighton College of Arts and Sciences Faculty Summer Research Fellowship to CFO and Creighton College of Arts and Sciences Undergraduate Summer Research Scholarship to VAB (www.creighton.edu), and National Science Foundation grant DEB-1019423 to CRB (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR., 2006, BIOL UBIQUITOUS HOUS; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Boppana VD, 2009, PARASITE IMMUNOL, V31, P287, DOI 10.1111/j.1365-3024.2009.01096.x; Brown C. R., 1996, COLONIALITY CLIFF SW; Brown C.R., 2011, ORNITHOL MONOGR, V71, P1, DOI [DOI 10.1525/0M.2011.71.1.1, 10.1525/om.2011.71.1.1.1, DOI 10.1525/OM.2011.71.1.1.1]; Brown CR, 2012, VECTOR-BORNE ZOONOT, V12, P34, DOI 10.1089/vbz.2011.0677; Brown CR, 2010, J MED ENTOMOL, V47, P436, DOI 10.1603/ME09288; Brown CR, 2010, VECTOR-BORNE ZOONOT, V10, P355, DOI 10.1089/vbz.2009.0031; Brown CR, 2009, ECOLOGY, V90, P3168, DOI 10.1890/08-1731.1; BROWN CR, 1986, ECOLOGY, V67, P1206, DOI 10.2307/1938676; Brown CR, 2004, ECOLOGY, V85, P1619, DOI 10.1890/03-0206; Brown CR, 2001, P ROY SOC B-BIOL SCI, V268, P1833, DOI 10.1098/rspb.2001.1749; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; CALISHER CH, 1980, AM J TROP MED HYG, V29, P1428, DOI 10.4269/ajtmh.1980.29.1428; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Dusek RJ, 2009, AM J TROP MED HYG, V81, P1151, DOI 10.4269/ajtmh.2009.09-0106; Fitze PS, 2004, J ANIM ECOL, V73, P216, DOI 10.1111/j.0021-8790.2004.00799.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HAYES RO, 1977, J MED ENTOMOL, V14, P257, DOI 10.1093/jmedent/14.3.257; HOPLA CE, 1993, J MED ENTOMOL, V30, P267, DOI 10.1093/jmedent/30.1.267; Hostomska J, 2008, VECTOR-BORNE ZOONOT, V8, P443, DOI 10.1089/vbz.2007.0214; Huber SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008605; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; King MO, 2011, AUK, V128, P340, DOI 10.1525/auk.2011.10253; Lee KA, 2005, OECOLOGIA, V145, P244, DOI 10.1007/s00442-005-0113-5; Lee KA, 2004, TRENDS ECOL EVOL, V19, P523, DOI 10.1016/j.tree.2004.07.012; Lee KA, 2006, OECOLOGIA, V150, P383, DOI 10.1007/s00442-006-0537-6; LOWTHER PE, 1992, BIRDS N AM; Machain-Williams C, 2012, PARASITE IMMUNOL, V34, P15, DOI 10.1111/j.1365-3024.2011.01339.x; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; MOLLER AP, 1993, J ANIM ECOL, V62, P309, DOI 10.2307/5362; Moore AT, 2007, J MED ENTOMOL, V44, P42, DOI 10.1603/0022-2585(2007)44[42:ECOBCV]2.0.CO;2; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; O'Brien VA, 2012, J WILDLIFE DIS, V48, P138, DOI 10.7589/0090-3558-48.1.138; O'Brien VA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025521; O'Brien VA, 2011, P ROY SOC B-BIOL SCI, V278, P239, DOI 10.1098/rspb.2010.1098; O'Brien VA, 2010, AM J TROP MED HYG, V82, P937, DOI 10.4269/ajtmh.2010.09-0515; O'Brien VA, 2010, J WILDLIFE DIS, V46, P23, DOI 10.7589/0090-3558-46.1.23; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Peng ZK, 2004, J ALLERGY CLIN IMMUN, V114, P1189, DOI 10.1016/j.jaci.2004.08.014; Pfeffer M, 2006, APPL ENVIRON MICROB, V72, P6886, DOI 10.1128/AEM.00868-06; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Proctor H, 2000, TRENDS ECOL EVOL, V15, P358, DOI 10.1016/S0169-5347(00)01924-8; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Reisen WK, 2010, AM J TROP MED HYG, V83, P808, DOI 10.4269/ajtmh.2010.10-0200; Reisen WK, 2003, J MED ENTOMOL, V40, P968, DOI 10.1603/0022-2585-40.6.968; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; Rizzo C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-206; Robbins C.S., 1973, Ornithological Monographs, VNo. 14, P3; Sanders ML, 1998, AM J TROP MED HYG, V59, P279, DOI 10.4269/ajtmh.1998.59.279; Schneider BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001171; Schneider BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011704; Schwarz A, 2009, INT J PARASITOL, V39, P1021, DOI 10.1016/j.ijpara.2009.01.010; Tsujimoto H, 2010, PARASITE IMMUNOL, V32, P275, DOI 10.1111/j.1365-3024.2009.01186.x; Wikel SK, 1999, INT J PARASITOL, V29, P851, DOI 10.1016/S0020-7519(99)00042-9; Wilkinson L, 1999, SYSTAT; Zeidner NS, 1999, PARASITE IMMUNOL, V21, P35, DOI 10.1046/j.1365-3024.1999.00199.x; [No title captured]	59	18	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58045	10.1371/journal.pone.0058045	http://dx.doi.org/10.1371/journal.pone.0058045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460922	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000177
J	Han, C; Yin, XJ; He, DL; Yang, PF				Han, Chao; Yin, Xiaojian; He, Dongli; Yang, Pingfang			Analysis of Proteome Profile in Germinating Soybean Seed, and Its Comparison with Rice Showing the Styles of Reserves Mobilization in Different Crops	PLOS ONE			English	Article							ARABIDOPSIS SEEDS; DORMANCY; LIGHT; ABA; LIPOXYGENASES; INTEGRATION; OXIDATION; STRESS; L.	Background: Seed germination is a complex physiological process during which mobilization of nutrient reserves happens. In different crops, this event might be mediated by different regulatory and metabolic pathways. Proteome profiling has been proved to be an efficient way that can help us to construct these pathways. However, no such studies have been performed in soybean germinating seeds up to date. Results: Proteome profiling was conducted through one-dimensional gel electrophoresis followed by liquid chromatography and tandem mass spectrometry strategy in the germinating seeds of soybean (glycine max). Comprehensive comparisons were also carried out between rice and soybean germinating seeds. 764 proteins belonging to 14 functional groups were identified and metabolism related proteins were the largest group. Deep analyses of the proteins and pathways showed that lipids were degraded through lipoxygenase dependent pathway and proteins were degraded through both protease and 26S proteosome system, and the lipoxygenase could also help to remove the reactive oxygen species during the rapid mobilization of reserves of soybean germinating seeds. The differences between rice and soybean germinating seeds proteome profiles indicate that each crop species has distinct mechanism for reserves mobilization during germination. Different reserves could be converted into starches before they are totally utilized during the germination in different crops seeds. Conclusions: This study is the first comprehensive analysis of proteome profile in germinating soybean seeds to date. The data presented in this paper will improve our understanding of the physiological and biochemical status in the imbibed soybean seeds just prior to germination. Comparison of the protein profile with that of germinating rice seeds gives us new insights on mobilization of nutrient reserves during the germination of crops seeds.	[Han, Chao; Yin, Xiaojian; He, Dongli; Yang, Pingfang] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan Bot Garden, Wuhan, Peoples R China; [Han, Chao; Yin, Xiaojian] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, PF (corresponding author), Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan Bot Garden, Wuhan, Peoples R China.	yangpf@wbgcas.cn			Chinese Academy of Sciences	Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the 100 talents program of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2008, PLANT PHYSIOL, V148, P504, DOI 10.1104/pp.108.119222; Assmann Sarah M, 2005, Sci STKE, V2005, pcm12, DOI 10.1126/stke.3102005cm12; Baginsky S, 2010, PLANT PHYSIOL, V152, P402, DOI 10.1104/pp.109.150433; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Chen H, 2008, P NATL ACAD SCI USA, V105, P4495, DOI 10.1073/pnas.0710778105; DANDOY E, 1987, MUTAT RES, V181, P57, DOI 10.1016/0027-5107(87)90287-9; Dinkova TD, 2011, SEED SCI RES, V21, P85, DOI 10.1017/S0960258511000043; Eastmond PJ, 2000, P NATL ACAD SCI USA, V97, P5669, DOI 10.1073/pnas.97.10.5669; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; FEUSSNER I, 1995, P NATL ACAD SCI USA, V92, P11849, DOI 10.1073/pnas.92.25.11849; Feussner I, 2001, TRENDS PLANT SCI, V6, P268, DOI 10.1016/S1360-1385(01)01950-1; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Gubler F, 2005, CURR OPIN PLANT BIOL, V8, P183, DOI 10.1016/j.pbi.2005.01.011; He DL, 2011, PROTEOMICS, V11, P2693, DOI 10.1002/pmic.201000598; He FL, 2007, J EXP BOT, V58, P1059, DOI 10.1093/jxb/erl267; Howell KA, 2006, PLANT MOL BIOL, V60, P201, DOI 10.1007/s11103-005-3688-7; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Kim HT, 2011, BBA-PROTEINS PROTEOM, V1814, P1178, DOI 10.1016/j.bbapap.2011.05.004; Kim SG, 2008, PLANT J, V55, P77, DOI 10.1111/j.1365-313X.2008.03493.x; Kim ST, 2008, PROTEOMICS, V8, P3577, DOI 10.1002/pmic.200800183; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Linkies A, 2010, NEW PHYTOL, V186, P817, DOI 10.1111/j.1469-8137.2010.03249.x; Lu TC, 2008, PLANTA, V228, P1029, DOI 10.1007/s00425-008-0805-2; Macovei A, 2011, PLANT PHYSIOL BIOCH, V49, P1040, DOI 10.1016/j.plaphy.2011.05.007; Meyer LJ, 2012, PLANT PHYSIOL, V159, P517, DOI 10.1104/pp.111.191700; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Ning ZB, 2008, J PROTEOME RES, V7, P4525, DOI 10.1021/pr800318j; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Ohyanagi H, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00110; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Park J, 2011, PLANT PHYSIOL, V156, P537, DOI 10.1104/pp.111.177071; Pawlowski TA, 2007, PROTEOMICS, V7, P2246, DOI 10.1002/pmic.200600912; Penfield S, 2005, CURR BIOL, V15, P1998, DOI 10.1016/j.cub.2005.11.010; Pinfield-Wells H, 2005, PLANT J, V43, P861, DOI 10.1111/j.1365-313X.2005.02498.x; Piskurewicz U, 2009, EMBO J, V28, P2259, DOI 10.1038/emboj.2009.170; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Weber H, 2005, ANNU REV PLANT BIOL, V56, P253, DOI 10.1146/annurev.arplant.56.032604.144201; Xu XY, 2011, J ZHEJIANG UNIV-SC B, V12, P507, DOI 10.1631/jzus.B1100061; Yang MF, 2009, J PROTEOME RES, V8, P1441, DOI 10.1021/pr800799s; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Yi B, 2010, PLANT J, V63, P925, DOI 10.1111/j.1365-313X.2010.04289.x; Zafra A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-36	49	66	70	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56947	10.1371/journal.pone.0056947	http://dx.doi.org/10.1371/journal.pone.0056947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460823	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000050
J	Liu, JG; Folberth, C; Yang, H; Rockstrom, J; Abbaspour, K; Zehnder, AJB				Liu, Junguo; Folberth, Christian; Yang, Hong; Rockstrom, Johan; Abbaspour, Karim; Zehnder, Alexander J. B.			A Global and Spatially Explicit Assessment of Climate Change Impacts on Crop Production and Consumptive Water Use	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; FOOD SECURITY; HIGH-RESOLUTION; SRES EMISSIONS; WHEAT YIELD; EPIC MODEL; AGRICULTURE; ADAPTATION; MAIZE; AVAILABILITY	Food security and water scarcity have become two major concerns for future human's sustainable development, particularly in the context of climate change. Here we present a comprehensive assessment of climate change impacts on the production and water use of major cereal crops on a global scale with a spatial resolution of 30 arc-minutes for the 2030s (short term) and the 2090s (long term), respectively. Our findings show that impact uncertainties are higher on larger spatial scales (e.g., global and continental) but lower on smaller spatial scales (e.g., national and grid cell). Such patterns allow decision makers and investors to take adaptive measures without being puzzled by a highly uncertain future at the global level. Short-term gains in crop production from climate change are projected for many regions, particularly in African countries, but the gains will mostly vanish and turn to losses in the long run. Irrigation dependence in crop production is projected to increase in general. However, several water poor regions will rely less heavily on irrigation, conducive to alleviating regional water scarcity. The heterogeneity of spatial patterns and the non-linearity of temporal changes of the impacts call for site-specific adaptive measures with perspectives of reducing short-and long-term risks of future food and water security.	[Liu, Junguo] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Liu, Junguo] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, A-2361 Laxenburg, Austria; [Folberth, Christian; Yang, Hong; Abbaspour, Karim] Swiss Fed Inst Aquat Sci & Technol, SIAM, Dubendorf, Switzerland; [Rockstrom, Johan] Stockholm Environm Inst, Stockholm, Sweden; [Zehnder, Alexander J. B.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Zehnder, Alexander J. B.] Alberta Water Res Inst, Edmonton, AB, Canada	Beijing Forestry University; International Institute for Applied Systems Analysis (IIASA); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Stockholm Environment Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Liu, JG (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	junguo.liu@gmail.com	Liu, Junguo/B-3021-2012; Yang, Hong/AAA-5152-2020	Liu, Junguo/0000-0002-5745-6311; Folberth, Christian/0000-0002-6738-5238; Rockstrom, Johan/0000-0001-8988-2983	National Natural Science Foundation of China [91025009]; Projects of International Cooperation and Exchanges NSFC [41161140353]; New Century Excellent Talents in University [NCET-09-0222]; Special Fund for Forestry Scientific Research in the Public Interest [201204204]; International S&T Cooperation Program from the Ministry of Science and Technology of China [2012DFA91530]; Fundamental Research Funds for the Central Universities [HJ2010-1]; Swiss National Science Foundation [K-21K0_122479]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of International Cooperation and Exchanges NSFC; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Special Fund for Forestry Scientific Research in the Public Interest; International S&T Cooperation Program from the Ministry of Science and Technology of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the National Natural Science Foundation of China (91025009) and Projects of International Cooperation and Exchanges NSFC (41161140353), New Century Excellent Talents in University (NCET-09-0222), the Special Fund for Forestry Scientific Research in the Public Interest (No. 201204204), International S&T Cooperation Program from the Ministry of Science and Technology of China (2012DFA91530), Fundamental Research Funds for the Central Universities (HJ2010-1), and the Swiss National Science Foundation (K-21K0_122479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejuwon JO, 2006, CLIM RES, V32, P229, DOI 10.3354/cr032229; Aggarwal PK, 2008, INDIAN J AGR SCI, V78, P911; Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P31, DOI 10.1016/j.gloenvcha.2003.10.006; Babel MS, 2011, CLIM RES, V46, P137, DOI 10.3354/cr00978; Bernardos JN, 2001, AGR SYST, V69, P215, DOI 10.1016/S0308-521X(01)00027-0; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Brown ME, 2008, SCIENCE, V319, P580, DOI 10.1126/science.1154102; Chavas DR, 2009, AGR FOREST METEOROL, V149, P1118, DOI 10.1016/j.agrformet.2009.02.001; Deryng D, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003765; Easterling WE, 1996, CLIMATE RES, V6, P263, DOI 10.3354/cr006263; Faramarzi M, 2013, J HYDROL, V480, P85, DOI 10.1016/j.jhydrol.2012.12.016; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; Folberth C, 2012, ECOL MODEL, V235, P8, DOI 10.1016/j.ecolmodel.2012.03.035; Folberth C, 2012, AGR ECOSYST ENVIRON, V151, P21, DOI 10.1016/j.agee.2012.01.026; Gaiser T, 2011, AGR FOREST METEOROL, V151, P1120, DOI 10.1016/j.agrformet.2011.03.015; Gassman PW, 2005, HIST DEV APPL EPIC A; Gedney N, 2006, NATURE, V439, P835, DOI 10.1038/nature04504; Ghosh S, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005351; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gordon HB, 1997, MON WEATHER REV, V125, P875, DOI 10.1175/1520-0493(1997)125<0875:TCCITC>2.0.CO;2; GWSP Digital Water Atlas, 2008, MAP 7 WAT STRESS V1; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Heijmans MMPD, 2001, GLOBAL CHANGE BIOL, V7, P817, DOI 10.1046/j.1354-1013.2001.00440.x; Intergovernmental Panel on Climate Change { IPCC, 2007, GENEBRA SUICA; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; Liu J, 2007, IRRIGATION SCI, V26, P21, DOI 10.1007/s00271-007-0069-9; Liu JG, 2007, AGR SYST, V94, P478, DOI 10.1016/j.agsy.2006.11.019; Liu JG, 2010, J HYDROL, V384, P187, DOI 10.1016/j.jhydrol.2009.11.024; Liu JG, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006051; Liu J, 2009, ENVIRON MODELL SOFTW, V24, P655, DOI 10.1016/j.envsoft.2008.10.008; Liu JG, 2008, GLOBAL PLANET CHANGE, V64, P222, DOI 10.1016/j.gloplacha.2008.09.007; Liu JG, 2009, ENVIRON MODELL SOFTW, V24, P411, DOI 10.1016/j.envsoft.2008.08.004; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; MITCHELL JFB, 1998, 2 HADL CTR; Mitchell T. D., 2004, TYNDALL CTR CLIMATE, V55, P25; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Muller C, 2011, P NATL ACAD SCI USA, V108, P4313, DOI 10.1073/pnas.1015078108; Nakicenovic N., 2000, SPECIAL REPORT EMISS; PARRY M, 1999, GLOBAL ENVIRON CHANG, V9, pS51, DOI DOI 10.1016/S0959-3780(99)00018-7; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Pierson ST, 2001, J ENVIRON QUAL, V30, P1790, DOI 10.2134/jeq2001.3051790x; Portmann F., 2008, GLOBAL DATA SET MONT; Priya S, 2001, ECOL MODEL, V136, P113, DOI 10.1016/S0304-3800(00)00364-1; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Reilly J, 2000, CLIMATIC CHANGE, V45, P253, DOI 10.1023/A:1005669807945; Rinaldi M, 2001, AGR WATER MANAGE, V49, P185, DOI 10.1016/S0378-3774(00)00148-7; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Siebert S, 2010, J HYDROL, V384, P198, DOI 10.1016/j.jhydrol.2009.07.031; Tao F, 2008, AGR FOREST METEOROL, V148, P94, DOI 10.1016/j.agrformet.2007.09.012; Thornton PK, 2010, AGR SYST, V103, P73, DOI 10.1016/j.agsy.2009.09.003; Valmir da Silva R, HYDROLOGICAL PROCESS, V25, P2715; van der Velde M, 2012, CLIMATIC CHANGE, V113, P751, DOI 10.1007/s10584-011-0368-2; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; WILLIAMS JR, 1989, T ASAE, V32, P497; Xiong W, 2009, GLOBAL ENVIRON CHANG, V19, P34, DOI 10.1016/j.gloenvcha.2008.10.006; Zwart SJ, 2010, AGR WATER MANAGE, V97, P1617, DOI 10.1016/j.agwat.2010.05.018; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	62	65	69	4	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57750	10.1371/journal.pone.0057750	http://dx.doi.org/10.1371/journal.pone.0057750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460901	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000315519000156
J	Schouten, B; Davila, A; Verfaillie, K				Schouten, Ben; Davila, Alex; Verfaillie, Karl			Further Explorations of the Facing Bias in Biological Motion Perception: Perspective Cues, Observer Sex, and Response Times	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; POINT; GENDER; IDENTIFICATION; EMOTION; PEOPLE; DEPTH	The human visual system has evolved to be highly sensitive to visual information about other persons and their movements as is illustrated by the effortless perception of point-light figures or 'biological motion'. When presented orthographically, a point-light walker is interpreted in two anatomically plausible ways: As 'facing the viewer' or as 'facing away' from the viewer. However, human observers show a 'facing bias': They perceive such a point-light walker as facing towards them in about 70-80% of the cases. In studies exploring the role of social and biological relevance as a possible account for the facing bias, we found a 'figure gender effect': Male point-light figures elicit a stronger facing bias than female point-light figures. Moreover, we also found an 'observer gender effect': The 'figure gender effect' was stronger for male than for female observers. In the present study we presented to 11 males and 11 females point-light walkers of which, very subtly, the perspective information was manipulated by modifying the earlier reported 'perspective technique'. Proportions of 'facing the viewer' responses and reaction times were recorded. Results show that human observers, even in the absence of local shape or size cues, easily pick up on perspective cues, confirming recent demonstrations of high visual sensitivity to cues on whether another person is potentially approaching. We also found a consistent difference in how male and female observers respond to stimulus variations (figure gender or perspective cues) that cause variations in the perceived in-depth orientation of a point-light walker. Thus, the 'figure gender effect' is possibly caused by changes in the relative locations and motions of the dots that the perceptual system tends to interpret as perspective cues. Third, reaction time measures confirmed the existence of the facing bias and recent research showing faster detection of approaching than receding biological motion.	[Schouten, Ben; Davila, Alex; Verfaillie, Karl] Katholieke Univ Leuven, Expt Psychol Lab, Louvain, Belgium	KU Leuven	Schouten, B (corresponding author), Katholieke Univ Leuven, Expt Psychol Lab, Louvain, Belgium.	Ben.Schouten@ppw.kuleuven.be	Davila, Alex/AAJ-5086-2020		FWO [G.0810.13]; Research Fund K.U. Leuven [PDM K/11/057];  [3H090031]	FWO(FWO); Research Fund K.U. Leuven(KU Leuven); 	This research was supported by FWO grant (G.0810.13) to Karl Verfaillie. Ben Schouten is a postdoctoral research fellow of the Research Fund K.U. Leuven (PDM K/11/057). Alex Davila is supported by Phd Project 3H090031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; de Lussanet MHE, 2012, J VISION, V12, DOI 10.1167/12.11.14; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Doi H, 2012, PSYCHON B REV, V19, P858, DOI 10.3758/s13423-012-0284-0; Grassi M, 2010, PERCEPTION, V39, P1424, DOI 10.1068/p6810; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Johnson KL, 2011, COGNITION, V119, P265, DOI 10.1016/j.cognition.2011.01.016; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; Loula F, 2005, J EXP PSYCHOL HUMAN, V31, P210, DOI 10.1037/0096-1523.31.1.210; Manera V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037514; Manera V, 2010, BEHAV RES METHODS, V42, P168, DOI 10.3758/BRM.42.1.168; MONTEPARE JM, 1987, J NONVERBAL BEHAV, V11, P33, DOI 10.1007/BF00999605; MONTEPARE JM, 1988, J PERS SOC PSYCHOL, V55, P547, DOI 10.1037/0022-3514.55.4.547; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Neuhoff JG, 2009, J EXP PSYCHOL HUMAN, V35, P225, DOI 10.1037/a0013159; Pollick FE, 2005, J EXP PSYCHOL HUMAN, V31, P1247, DOI 10.1037/0096-1523.31.6.1247; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Ross PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044815; Schouten B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014725; Schouten B, 2011, ATTEN PERCEPT PSYCHO, V73, P130, DOI 10.3758/s13414-010-0018-1; Schouten B, 2010, ATTEN PERCEPT PSYCHO, V72, P1256, DOI 10.3758/APP.72.5.1256; Schouten B, 2010, BEHAV RES METHODS, V42, P161, DOI 10.3758/BRM.42.1.161; Sweeny TD, 2012, VISION RES, V64, P26, DOI 10.1016/j.visres.2012.05.008; Takei S, 2010, J VISION, V10, DOI 10.1167/10.4.23; Troje NF, 2005, PERCEPT PSYCHOPHYS, V67, P667, DOI 10.3758/BF03193523; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Vanrie J, 2004, PERCEPTION, V33, P547, DOI 10.1068/p5004; Vanrie J, 2008, VIS COGN, V16, P585, DOI 10.1080/13506280701269334; Vanrie J, 2006, PERCEPT PSYCHOPHYS, V68, P601, DOI 10.3758/BF03208762; Vanrie J, 2011, VIS COGN, V19, P1158, DOI 10.1080/13506285.2011.614381; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	34	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56978	10.1371/journal.pone.0056978	http://dx.doi.org/10.1371/journal.pone.0056978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23468898	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000051
J	Turroni, S; Tolomeo, M; Mamone, G; Picariello, G; Giacomini, E; Brigidi, P; Roberti, M; Grimaudo, S; Pipitone, RM; Di Cristina, A; Recanatini, M				Turroni, Silvia; Tolomeo, Manlio; Mamone, Gianfranco; Picariello, Gianluca; Giacomini, Elisa; Brigidi, Patrizia; Roberti, Marinella; Grimaudo, Stefania; Pipitone, Rosaria Maria; Di Cristina, Antonietta; Recanatini, Maurizio			A Natural-Like Synthetic Small Molecule Impairs Bcr-Abl Signaling Cascades and Induces Megakaryocyte Differentiation in Erythroleukemia Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ERYTHROID-DIFFERENTIATION; TYROSINE KINASE; MYC; THERAPY; OVEREXPRESSION; RESISTANCE; INDUCTION; APOPTOSIS; BIOLOGY	Over the past years, we synthesized a series of new molecules that are hybrids of spirocyclic ketones as complexity-bearing cores with bi- and ter-phenyls as privileged fragments. Some of these newly-shaped small molecules showed antiproliferative, pro-apoptotic and differentiating activity in leukemia cell lines. In the present study, to investigate more in depth the mechanisms of action of these molecules, the protein expression profiles of K562 cells treated with or without the compounds IND_S1, MEL_T1, IND_S7 and MEL_S3 were analyzed using two-dimensional gel electrophoresis coupled with mass spectrometry. Proteome comparisons revealed several differentially expressed proteins, mainly related to cellular metabolism, chaperone activity, cytoskeletal organization and RNA biogenesis. The major results were validated by Western blot and qPCR. To attempt integrating findings into a cellular signaling context, proteomic data were explored using MetaCore. Network analysis highlighted relevant relationships between the identified proteins and additional potential effectors. Notably, qPCR validation of central hubs showed that the compound MEL_S3 induced high mRNA levels of the transcriptional factors EGR1 and HNF4-alpha; the latter to our knowledge is reported here for the first time to be present in K562 cells. Consistently with the known EGR1 involvement in the regulation of differentiation along megakaryocyte lineage, MEL_S3-treated leukemia cells showed a marked expression of glycoprotein IIb/IIIa (CD41) and glycoprotein Ib (CD42), two important cell markers in megakaryocytic differentiation, together with morphological aspects of megakaryoblasts and megakaryocytes.	[Turroni, Silvia; Giacomini, Elisa; Brigidi, Patrizia; Roberti, Marinella; Recanatini, Maurizio] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Tolomeo, Manlio; Grimaudo, Stefania; Pipitone, Rosaria Maria; Di Cristina, Antonietta] Univ Palermo, Interdept Ctr Res Clin Oncol, Palermo, Italy; [Tolomeo, Manlio; Grimaudo, Stefania; Pipitone, Rosaria Maria; Di Cristina, Antonietta] Univ Palermo, Dept Infect Dis, Palermo, Italy; [Mamone, Gianfranco; Picariello, Gianluca] CNR, Inst Food Sci, Avellino, Italy	University of Bologna; University of Palermo; University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Roberti, M (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.	marinella.roberti@unibo.it	Mamone, Gianfranco/AAX-8690-2020; Recanatini, Maurizio/AAU-3319-2021; Turroni, Silvia/J-7195-2016; Roberti, Marinella/R-1996-2016; Recanatini, Maurizio/GXH-1338-2022	Mamone, Gianfranco/0000-0002-0394-7617; Recanatini, Maurizio/0000-0002-0039-0518; Turroni, Silvia/0000-0003-2345-9482; Tolomeo, Manlio/0000-0002-7974-2319; PICARIELLO, Gianluca/0000-0003-1290-1239; PIPITONE, Rosaria Maria/0000-0002-6721-3962; Brigidi, Patrizia/0000-0001-8375-6150; Grimaudo, Stefania/0000-0003-3225-4112	MIUR, Italy	MIUR, Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by a PRIN2009 Project Grant from MIUR, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 2010, LEUKEMIA RES, V34, P1255, DOI 10.1016/j.leukres.2010.04.016; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bantscheff M, 2011, BIOORG MED CHEM; Branford S, 2011, CURR OPIN HEMATOL, V18, P111, DOI 10.1097/MOH.0b013e32834399ef; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Buchi F, 2011, LEUKEMIA RES, V35, P921, DOI 10.1016/j.leukres.2011.01.033; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; CHENG T, 1994, J BIOL CHEM, V269, P30848; Cornelison A Megan, 2011, Clin Lymphoma Myeloma Leuk, V11 Suppl 1, pS101, DOI 10.1016/j.clml.2011.02.009; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Du QF, 2010, MED ONCOL, V27, P673, DOI 10.1007/s12032-009-9267-z; Eiring AM, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-99; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Galluzzi L, 2006, ONCOGENE, V25, P4812, DOI 10.1038/sj.onc.1209598; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Goehe RW, 2010, J CLIN INVEST, V120, P3923, DOI 10.1172/JCI43552; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Hong Y, 1996, BLOOD, V87, P123, DOI 10.1182/blood.V87.1.123.bloodjournal871123; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; KANZ L, 1987, KLIN WOCHENSCHR, V65, P297, DOI 10.1007/BF01745383; Khalil AA, 2011, BBA-REV CANCER, V1816, P89, DOI 10.1016/j.bbcan.2011.05.001; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Leps J, 2003, MULTIVARIATE ANAL EC; LONG MW, 1990, J CLIN INVEST, V85, P1072, DOI 10.1172/JCI114538; Mazzoni C, 2009, YEAST, V26, P31, DOI 10.1002/yea.1647; Meunier B, 2007, J PROTEOME RES, V6, P358, DOI 10.1021/pr060343h; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Munoz-Alonso MJ, 2012, J CELL PHYSIOL, V227, P2069, DOI 10.1002/jcp.22935; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Osti F, 1997, HAEMATOLOGICA, V82, P395; Perrotti D, 2007, CLIN CANCER RES, V13, P1638, DOI 10.1158/1078-0432.CCR-06-2320; Perrotti D, 2011, LEUKEMIA LYMPHOMA, V52, P30, DOI 10.3109/10428194.2010.546914; Pizzirani D, 2007, TETRAHEDRON LETT, V48, P7120, DOI 10.1016/j.tetlet.2007.07.214; Pizzirani D, 2009, J MED CHEM, V52, P6936, DOI 10.1021/jm900907s; Pocaly M, 2007, LEUKEMIA, V21, P93, DOI 10.1038/sj.leu.2404463; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Romanov V, 2011, APOPTOSIS, V16, P1217, DOI 10.1007/s10495-011-0646-5; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Tolomeo M, 2009, ANTI-CANCER AGENT ME, V9, P853, DOI 10.2174/187152009789124637; Turroni S, 2010, WORLD J GASTROENTERO, V16, P30, DOI 10.3748/wjg.v16.i1.30; Valledor AF, 1998, J LEUKOCYTE BIOL, V63, P405, DOI 10.1002/jlb.63.4.405; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walz C, 2006, CRIT REV ONCOL HEMAT, V57, P145, DOI 10.1016/j.critrevonc.2005.06.007; Wei Q, 2006, FRONT BIOSCI-LANDMRK, V11, P977, DOI 10.2741/1854; Wierzba K, 2011, CURR OPIN CHEM BIOL, V15, P57, DOI 10.1016/j.cbpa.2010.10.009	54	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57650	10.1371/journal.pone.0057650	http://dx.doi.org/10.1371/journal.pone.0057650			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460890	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000145
J	Willemink, MJ; Borstlap, J; Takx, RAP; Schilham, AMR; Leiner, T; Budde, RPJ; de Jong, PA				Willemink, Martin J.; Borstlap, Jaap; Takx, Richard A. P.; Schilham, Arnold M. R.; Leiner, Tim; Budde, Ricardo P. J.; de Jong, Pim A.			The Effects of Computed Tomography with Iterative Reconstruction on Solid Pulmonary Nodule Volume Quantification	PLOS ONE			English	Article							DOSE CT; CHEST; VARIABILITY; PERFORMANCE; ALGORITHM; GROWTH	Background: The objectives of this study were to evaluate the influence of iterative reconstruction (IR) on pulmonary nodule volumetry with chest computed tomography (CT). Methods: Twenty patients (12 women and 8 men, mean age 61.9, range 32-87) underwent evaluation of pulmonary nodules with a 64-slice CT-scanner. Data were reconstructed using filtered back projection (FBP) and IR (Philips Healthcare, iDose(4)-levels 2, 4 and 6) at similar radiation dose. Volumetric nodule measurements were performed with semi-automatic software on thin slice reconstructions. Only solid pulmonary nodules were measured, no additional selection criteria were used for the nature of nodules. For intra-observer and inter-observer variability, measurements were performed once by one observer and twice by another observer. Algorithms were compared using the concordance correlation-coefficient (p(c)) and Friedman-test, and post-hoc analysis with the Wilcoxon-signed ranks-test with Bonferroni-correction (significance-level p<0.017). Results: Seventy-eight nodules were present including 56 small nodules (volume<200 mm(3), diameter<8 mm) and 22 large nodules (volume >= 200 mm(3), diameter >= 8 mm). No significant differences in measured pulmonary nodule volumes between FBP, iDose 4 -levels 2, 4 and 6 were found in both small nodules and large nodules. FBP and iDose 4 -levels 2, 4 and 6 were correlated with p(c)-values of 0.98 or higher for both small and large nodules. P-c-values of intra-observer and inter-observer variability were 0.98 or higher. Conclusions: Measurements of solid pulmonary nodule volume measured with standard-FBP were comparable with IR, regardless of the IR-level and no significant differences between measured volumes of both small and large solid nodules were found.	[Willemink, Martin J.; Borstlap, Jaap; Takx, Richard A. P.; Schilham, Arnold M. R.; Leiner, Tim; Budde, Ricardo P. J.; de Jong, Pim A.] Univ Utrecht, Med Ctr, Utrecht, Netherlands; [Budde, Ricardo P. J.] Gelre Hosp, Dept Radiol, Apeldoorn, Netherlands	Utrecht University; Gelre Hospitals	Willemink, MJ (corresponding author), Univ Utrecht, Med Ctr, Utrecht, Netherlands.	m.willemink@umcutrecht.nl	de Jong, Pim A/G-7220-2014; Willemink, Martin/GRX-4798-2022; Takx, Richard/T-2852-2019; Willemink, Martin/M-3650-2013; Budde, Ricardo/E-4252-2015	de Jong, Pim A/0000-0003-4840-6854; Willemink, Martin/0000-0002-6991-6557; Takx, Richard/0000-0003-2252-3040; Willemink, Martin/0000-0002-6991-6557; 				Ahn MI, 2010, RADIOLOGY, V254, P949, DOI 10.1148/radiol.09090031; Beister M, 2012, PHYS MEDICA, V28, P94, DOI 10.1016/j.ejmp.2012.01.003; de Hoop B, 2009, EUR RADIOL, V19, P800, DOI 10.1007/s00330-008-1229-x; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Funama Y, 2011, J COMPUT ASSIST TOMO, V35, P480, DOI 10.1097/RCT.0b013e31821fee94; Gervaise A, 2012, EUR RADIOL, V22, P295, DOI 10.1007/s00330-011-2271-7; Gietema HA, 2006, RADIOLOGY, V241, P251, DOI 10.1148/radiol.2411050860; Habets J, 2012, INT J CARDIOVAS IMAG, V28, P1567, DOI 10.1007/s10554-011-9954-7; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hein PA, 2009, ROFO-FORTSCHR RONTG, V181, P24, DOI 10.1055/s-2008-1027874; Hein PA, 2010, J DIGIT IMAGING, V23, P8, DOI 10.1007/s10278-008-9157-5; Hu XH, 2011, CLIN RADIOL, V66, P1023, DOI 10.1016/j.crad.2011.04.008; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; McBride GB, 2005, HAM2005062 NIWA; Noel PB, 2011, AM J ROENTGENOL, V197, P1404, DOI 10.2214/AJR.11.6907; Ost D, 2003, NEW ENGL J MED, V348, P2535, DOI 10.1056/NEJMcp012290; Pontana F, 2011, EUR RADIOL, V21, P636, DOI 10.1007/s00330-010-1991-4; Prakash P, 2010, RADIOLOGY, V256, P261, DOI 10.1148/radiol.10091487; Prakash P, 2010, J COMPUT ASSIST TOMO, V34, P40, DOI 10.1097/RCT.0b013e3181b26c67; Revel MP, 2004, RADIOLOGY, V231, P459, DOI 10.1148/radiol.2312030241; Scibelli A, 2011, IDOSE ITERATIVE RECO; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Utsunomiya D, 2012, EUR RADIOL, V22, P1287, DOI 10.1007/s00330-011-2361-6; Willemink MJ, 2013, EUR RADIOL, V23, P1623, DOI 10.1007/s00330-012-2765-y; Willemink MJ, 2013, EUR RADIOL, V23, P1632, DOI 10.1007/s00330-012-2764-z; Willemink MJ, 2012, AM J ROENTGENOL, V199, P1241, DOI 10.2214/AJR.12.8727; Wormanns D, 2004, EUR RADIOL, V14, P86, DOI 10.1007/s00330-003-2132-0; Xu DM, 2009, RADIOLOGY, V250, P264, DOI 10.1148/radiol.2493070847; Yanagawa M, 2012, EUR J RADIOL, V81, P2877, DOI 10.1016/j.ejrad.2011.09.011; Yanagawa M, 2010, ACAD RADIOL, V17, P1259, DOI 10.1016/j.acra.2010.05.014; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251	32	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58053	10.1371/journal.pone.0058053	http://dx.doi.org/10.1371/journal.pone.0058053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460924	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000179
J	Cruz, SM; Hooten, M; Huyvaert, KP; Proano, CB; Anderson, DJ; Afanasyev, V; Wikelski, M				Cruz, Sebastian M.; Hooten, Mevin; Huyvaert, Kathryn P.; Proano, Carolina B.; Anderson, David J.; Afanasyev, Vsevolod; Wikelski, Martin			At-Sea Behavior Varies with Lunar Phase in a Nocturnal Pelagic Seabird, the Swallow-Tailed Gull	PLOS ONE			English	Article							VERTICAL MIGRATION; FORAGING ACTIVITY; ACTIVITY PATTERN; CYCLES; MOONLIGHT; PREDATION; AVOIDANCE; ALBATROSS; NIGHT; LIGHT	Strong and predictable environmental variability can reward flexible behaviors among animals. We used long-term records of activity data that cover several lunar cycles to investigate whether behavior at-sea of swallow-tailed gulls Creagrus furcatus, a nocturnal pelagic seabird, varied with lunar phase in the Galapagos Islands. A Bayesian hierarchical model showed that nighttime at-sea activity of 37 breeding swallow-tailed gulls was clearly associated with changes in moon phase. Proportion of nighttime spent on water was highest during darker periods of the lunar cycle, coinciding with the cycle of the diel vertical migration (DVM) that brings prey to the sea surface at night. Our data show that at-sea behavior of a tropical seabird can vary with environmental changes, including lunar phase.	[Cruz, Sebastian M.; Proano, Carolina B.; Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Baden Wurttembe, Germany; [Hooten, Mevin] US Geol Survey, Colorado Cooperat Fish & Wildlife Res Unit, Ft Collins, CO USA; [Hooten, Mevin; Huyvaert, Kathryn P.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Anderson, David J.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Afanasyev, Vsevolod] British Antarctic Survey, Nat Environm Res Council, Cambridge, England; [Wikelski, Martin] Univ Konstanz, Constance, Baden Wurttembe, Germany	Max Planck Society; United States Department of the Interior; United States Geological Survey; Colorado State University; Wake Forest University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Konstanz	Cruz, SM (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Baden Wurttembe, Germany.	cruz.seb@gmail.com	Callahan, Charles D/L-1641-2013; Huyvaert, Kathryn P/A-2710-2009	Huyvaert, Kathryn P/0000-0003-3302-030X	Max Planck Society; National Science Foundation [DEB 0842199]; NERC [bas010011] Funding Source: UKRI; Natural Environment Research Council [bas010011] Funding Source: researchfish	Max Planck Society(Max Planck SocietyFoundation CELLEX); National Science Foundation(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work had the support from the Max Planck Society (http://www.orn.mpg.de/) and National Science Foundation (http://www.nsf.gov/) Grant No. DEB 0842199. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awkerman JA, 2005, MAR ECOL PROG SER, V291, P289, DOI 10.3354/meps291289; Ballance L. T., 1999, P INT ORN C, P2057; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Ballance Lisa T., 2007, Marine Ornithology, V35, P127; BRINTON E, 1967, LIMNOL OCEANOGR, V12, P451, DOI 10.4319/lo.1967.12.3.0451; Castro P., 2009, MARINE BIOL; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Cubaynes S, 2011, BIOL LETTERS, V7, P303, DOI 10.1098/rsbl.2010.0778; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; DALY M, 1992, ANIM BEHAV, V44, P1, DOI 10.1016/S0003-3472(05)80748-1; deBruyn AMH, 2001, MAR ECOL PROG SER, V214, P307, DOI 10.3354/meps214307; Fernandez P, 2000, CONDOR, V102, P577, DOI 10.1650/0010-5422(2000)102[0577:NADFAO]2.0.CO;2; Fernandez-Duque E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012572; FINGERMAN M, 1957, AM NAT, V91, P167, DOI 10.1086/281976; Fraser NHC, 1997, FUNCT ECOL, V11, P385, DOI 10.1046/j.1365-2435.1997.00098.x; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Gelman A., 2003, BAYESIAN DATA ANAL; GLIWICZ MZ, 1986, NATURE, V320, P746, DOI 10.1038/320746a0; GLIWICZ ZM, 1986, ECOLOGY, V67, P883, DOI 10.2307/1939811; HAILMAN JACK P., 1964, WILSON BULL, V76, P347; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; Harris MP., 1977, P65; HARRIS MP, 1970, AUK, V87, P215, DOI 10.2307/4083917; Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753; Irons DB, 1998, ECOLOGY, V79, P647, DOI 10.2307/176960; Jetz W, 2003, OIKOS, V103, P627, DOI 10.1034/j.1600-0706.2003.12856.x; Lang AB, 2006, OECOLOGIA, V146, P659, DOI 10.1007/s00442-005-0131-3; Longhurst AR, 1987, ECOLOGY TROPICAL OCE; Lowry M, 2007, FISH RES, V88, P15, DOI 10.1016/j.fishres.2007.07.011; LUECKE C, 1993, T AM FISH SOC, V122, P112, DOI 10.1577/1548-8659(1993)122<0112:EOMADO>2.3.CO;2; Meyer CFJ, 2004, J TROP ECOL, V20, P397, DOI 10.1017/S0266467404001373; Naylor E, 2001, EARTH MOON PLANETS, V85-6, P291, DOI 10.1023/A:1017088504226; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Pinet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027663; Regular PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026763; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; SNOW BK, 1968, CONDOR, V70, P252, DOI 10.2307/1366698; Tessmar-Raible K, 2011, BIOESSAYS, V33, P165, DOI 10.1002/bies.201000096; TRILLMICH F, 1981, OECOLOGIA, V48, P85, DOI 10.1007/BF00346992; van Gils Jan, 1999, Wader Study Group Bulletin, V89, P36; Weimerskirch H, 1997, MAR ECOL PROG SER, V151, P245, DOI 10.3354/meps151245; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wikelski M, 2006, J ORNITHOL, V147, P107, DOI 10.1007/s10336-005-0018-4; Yamamoto T, 2008, ANIM BEHAV, V76, P1647, DOI 10.1016/j.anbehav.2008.07.019; Zuyev G, 2002, B MAR SCI, V71, P1091	45	17	17	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56889	10.1371/journal.pone.0056889	http://dx.doi.org/10.1371/journal.pone.0056889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468889	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000315561400016
J	Velghe, K; Gregory-Eaves, I				Velghe, Katherine; Gregory-Eaves, Irene			Body Size Is a Significant Predictor of Congruency in Species Richness Patterns: A Meta-Analysis of Aquatic Studies	PLOS ONE			English	Article							CROSS-TAXON CONGRUENCE; BIODIVERSITY LOSS; DIVERSITY; CONCORDANCE; MACROINVERTEBRATES; ASSEMBLAGES; INDICATORS; EVOLUTION; ABUNDANCE; STRENGTH	Biodiversity losses over the next century are predicted to result in alterations of ecosystem functions that are on par with other major drivers of global change. Given the seriousness of this issue, there is a need to effectively monitor global biodiversity. Because performing biodiversity censuses of all taxonomic groups is prohibitively costly, indicator groups have been studied to estimate the biodiversity of different taxonomic groups. Quantifying cross-taxon congruence is a method of evaluating the assumption that the diversity of one taxonomic group can be used to predict the diversity of another. To improve the predictive ability of cross-taxon congruence in aquatic ecosystems, we evaluated whether body size, measured as the ratio of average body length between organismal groups, is a significant predictor of their cross-taxon biodiversity congruence. To test this hypothesis, we searched the published literature and screened for studies that used species richness correlations as their metric of cross-taxon congruence. We extracted 96 correlation coefficients from 16 studies, which encompassed 784 inland water bodies. With these correlation coefficients, we conducted a categorical meta-analysis, grouping data based on the body size ratio of organisms. Our results showed that cross-taxon congruence is variable among sites and between different groups (r values ranging between -0.53 to 0.88). In addition, our quantitative meta-analysis demonstrated that organisms most similar in body size showed stronger species richness correlations than organisms which differed increasingly in size (r(adj)(2) = 0.94, p = 0.02). We propose that future studies applying biodiversity indicators in aquatic ecosystems consider functional traits such as body size, so as to increase their success at predicting the biodiversity of taxonomic groups where cost-effective conservation tools are needed.	[Velghe, Katherine; Gregory-Eaves, Irene] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Velghe, Katherine; Gregory-Eaves, Irene] Grp Rech Interuniv Limnol & Environm Aquat GRIL, Montreal, PQ, Canada	McGill University	Velghe, K (corresponding author), Univ Quebec Montreal UQAM, Dept Sci Biol, Montreal, PQ, Canada.	velghe.katherine@uqam.ca	Gregory-Eaves, Irene/U-9325-2019	Gregory-Eaves, Irene/0000-0002-0380-5061	NSERC; FQRNT; Quebec Centre for Biodiversity Science; McGill University; NSERC (CGS M)	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FQRNT(FQRNT); Quebec Centre for Biodiversity Science; McGill University; NSERC (CGS M)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this project was provided by NSERC (discovery grant "The Ecology and Paleoecology of Shallow lakes" awarded to IGE, CGS M awarded to KV), FQRNT (B1 awarded to KV), the Quebec Centre for Biodiversity Science (www.qcbs.ca) and McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 1999, CAN J FISH AQUAT SCI, V56, P2029, DOI 10.1139/cjfas-56-11-2029; Allen AP, 1999, CAN J FISH AQUAT SCI, V56, P739, DOI 10.1139/cjfas-56-5-739; ARNQVIST G, 1995, TRENDS ECOL EVOL, V10, P236, DOI 10.1016/S0169-5347(00)89073-4; Atkinson David, 2007, P33, DOI 10.1017/CBO9780511611223.004; Bagella S, 2011, COMMUNITY ECOL, V12, P40, DOI 10.1556/ComEc.12.2011.1.6; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Barnett A, 2007, ECOLOGY, V88, P1675, DOI 10.1890/06-1056.1; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bhargava RP, 1946, SANKHYA, V7, P435; Bilton DT, 2006, FRESHWATER BIOL, V51, P578, DOI 10.1111/j.1365-2427.2006.01505.x; Borer ET, 2005, ECOLOGY, V86, P528, DOI 10.1890/03-0816; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brown James H., 2007, P1; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Certain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018930; Christensen Deditors., 1993, TROPHIC MODELS AQUAT; Clifford H. F, 1991, AQUATIC INVERTEBRATE; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cooper JE, 1998, ESTUARIES, V21, P307, DOI 10.2307/1352477; Cote IM, 2012, EVOL ECOL, V26, P1237, DOI 10.1007/s10682-012-9568-0; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Gaston K, 1996, ASPECTS GENESIS MAIN, P123; Gaston KJ, 1996, PROG PHYS GEOG, V20, P105, DOI 10.1177/030913339602000108; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gates S, 2002, J ANIM ECOL, V71, P547, DOI 10.1046/j.1365-2656.2002.00634.x; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Gioria M, 2011, ACTA OECOL, V37, P187, DOI 10.1016/j.actao.2011.02.001; Haxton TJ, 2008, CAN J FISH AQUAT SCI, V65, P437, DOI 10.1139/F07-175; Heino J, 2002, BIODIVERS CONSERV, V11, P137, DOI 10.1023/A:1014075901605; Heino J, 2005, BIODIVERS CONSERV, V14, P415, DOI 10.1007/s10531-004-5064-z; Heino J, 2003, CAN J FISH AQUAT SCI, V60, P1039, DOI 10.1139/F03-081; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; Heino J, 2009, BIODIVERS CONSERV, V18, P3085, DOI 10.1007/s10531-009-9626-2; Heino J, 2009, ECOL INDIC, V9, P1179, DOI 10.1016/j.ecolind.2009.02.003; Hildrew Alan G., 2007, P326; Hillebrand H, 2010, ECOLOGY, V91, P2545, DOI 10.1890/09-0070.1; Holm E, 2009, FRESHWATER FISHES ON; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hoyt, 2010, MAC METAANALYSIS COR, V1, P1; King W, 1979, AUDUBON SOC FIELD GU; Kirkman LK, 2012, ECOL INDIC, V18, P131, DOI 10.1016/j.ecolind.2011.10.015; Korhonen JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022041; Krammer K., 1986, SUSSWASERFLORA MITTE; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; Lindenmayer DB, 2011, ECOSYSTEMS, V14, P47, DOI 10.1007/s10021-010-9394-6; Longmuir A, 2007, ECOLOGY, V88, P1663, DOI 10.1890/06-1448.1; Lopes PM, 2011, ECOL INDIC, V11, P1171, DOI 10.1016/j.ecolind.2010.12.017; Magurran A.E, 2004, MEASURING BIOL DIVER; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Nascimbene J, 2011, J LIMNOL, V70, P3, DOI 10.4081/jlimnol.2011.s1.3; Pennak RW, 1989, FRESHWATER INVERTEBR; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Core Team, 2021, R LANGUAGE ENV STAT; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; ROSEN RA, 1981, J FRESHWATER ECOL, V1, P225, DOI 10.1080/02705060.1981.9664034; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanchez-Fernandez D, 2006, BIODIVERS CONSERV, V15, P4507, DOI 10.1007/s10531-005-5101-x; Shurin JB, 2006, P ROY SOC B-BIOL SCI, V273, P1, DOI 10.1098/rspb.2005.3377; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; SMOCK LA, 1980, FRESHWATER BIOL, V10, P375, DOI 10.1111/j.1365-2427.1980.tb01211.x; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Tolonen KT, 2005, BIODIVERS CONSERV, V14, P961, DOI 10.1007/s10531-004-8414-2; Toranza Carolina, 2010, BMC Ecology, V10, P18, DOI 10.1186/1472-6785-10-18; Tornblom J, 2011, FUND APPL LIMNOL, V178, P287, DOI 10.1127/1863-9135/2011/0178-0287; Townsend C., 2008, ESSENTIALS ECOLOGY, P281; Velghe K, 2012, QUANTIFYING BIODIVER; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Wolters V, 2006, ECOLOGY, V87, P1886, DOI 10.1890/0012-9658(2006)87[1886:RATSRO]2.0.CO;2; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Woodward G, 2002, J ANIM ECOL, V71, P1063, DOI 10.1046/j.1365-2656.2002.00669.x; Woodward Guy, 2007, P98, DOI 10.1017/CBO9780511611223.007	81	15	15	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57019	10.1371/journal.pone.0057019	http://dx.doi.org/10.1371/journal.pone.0057019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468903	Green Submitted, Green Published, gold			2022-12-27	WOS:000315561400021
J	Hamano, T; Kawakami, N; Li, XJ; Sundquist, K				Hamano, Tsuyoshi; Kawakami, Naomi; Li, Xinjun; Sundquist, Kristina			Neighbourhood Environment and Stroke: A Follow-Up Study in Sweden	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; FAST-FOOD; HEALTH; RISK; DEPRIVATION; WOMEN; CONSUMPTION; MULTILEVEL; PEOPLE; COHORT	Background: In recent years, research on the association between physical environments and cardiovascular disease outcomes has gained momentum with growing attention being paid to Geographic Information Systems (GIS). This nationwide study is the first to examine the effect of neighbourhood physical environments on individual-level stroke, using GIS-based measures of neighbourhood availability of potentially health-damaging (fast food restaurants and pubs/bars) and health-promoting (physical activity and healthcare) resources. Methods: The study population comprised a nationwide sample of 2,115,974 men and 2,193,700 women aged 35-80 years who were followed between 1 December 2005 and 31 December 2007 in Sweden. Totally 42,270 first-ever strokes (both morbidity and mortality) were identified. Multilevel logistic regression models were used to estimate the association between neighbourhood availability of four different resources (fast food restaurants, pubs/bars, physical activity and healthcare) and individual-level stroke. Principal Findings: There were significant associations between neighbourhood availability of the four types of neighbourhood resources and individual-level stroke. The significant odds ratios varied between 1.06 and 1.12 for men and 1.07 and 1.24 for women. After adjustment for age, income, and neighbourhood-level deprivation, the increased odds remained statistically significant for neighbourhood availability of fast food restaurants in both men and women. Conclusions: Specific neighbourhood availability of resources were associated with individual-level stroke but most of these associations were explained by individual-level sociodemographic factors and neighbourhood-level deprivation.	[Hamano, Tsuyoshi] Shimane Univ, Org Promot Project Res, Ctr Community Based Hlth Res & Educ, Izumo, Shimane, Japan; [Hamano, Tsuyoshi] Shimane Univ, Sch Med, Dept Environm & Prevent Med, Izumo, Shimane, Japan; [Kawakami, Naomi] Waseda Univ, Waseda Inst Sport Sci, Tokorozawa, Saitama, Japan; [Li, Xinjun; Sundquist, Kristina] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Sundquist, Kristina] Stanford Univ, Stanford Sch Med, SPRC, Stanford, CA 94305 USA	Shimane University; Shimane University; Waseda University; Lund University; Stanford University	Hamano, T (corresponding author), Shimane Univ, Org Promot Project Res, Ctr Community Based Hlth Res & Educ, Izumo, Shimane, Japan.	thamano@med.shimane-u.ac.jp		Hamano, Tsuyoshi/0000-0002-6755-9138; Li, Xinjun/0000-0002-5559-4657	ALF; Swedish Research Council	ALF; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by ALF funding awarded to Kristina Sundquist and by grants from the Swedish Research Council (awarded to Kristina Sundquist). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG HEALTHC RES QU, NAT HEALTHC DISP REP; Babisch W, 1999, ARCH ENVIRON HEALTH, V54, P210, DOI 10.1080/00039899909602261; Callas PW, 1998, AM J IND MED, V33, P33; Chuang YC, 2005, J EPIDEMIOL COMMUN H, V59, P568, DOI 10.1136/jech.2004.029041; Clark CJ, 2011, STROKE, V42, P1212, DOI 10.1161/STROKEAHA.110.609164; ESRI, 2006, ARCGIS ARCINFO 9 2 S; Gilthorpe MS, 1995, J EPIDEMIOL COMMUN H, V49, pS45, DOI 10.1136/jech.49.Suppl_2.S45; Hiscock R, 2008, HEALTH SERV RES, V43, P2183, DOI 10.1111/j.1475-6773.2008.00877.x; Kawachi I., 2003, NEIGHBORHOODS HLTH; Kawakami N, 2011, J EPIDEMIOL COMMUN H, V65, P866, DOI 10.1136/jech.2010.117580; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Morgenstern LB, 2009, ANN NEUROL, V66, P165, DOI 10.1002/ana.21726; Pollack CE, 2005, INT J EPIDEMIOL, V34, P772, DOI 10.1093/ije/dyi026; RASBASH J, 2000, USERS GUIDE MLWIN VE; Rosenheck R, 2008, OBES REV, V9, P535, DOI 10.1111/j.1467-789X.2008.00477.x; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Rushton G, 2003, ANNU REV PUBL HEALTH, V24, P43, DOI 10.1146/annurev.publhealth.24.012902.140843; Schmidt M, 2005, ARCH PEDIAT ADOL MED, V159, P626, DOI 10.1001/archpedi.159.7.626; Sundquist J, 2006, SOC SCI MED, V62, P954, DOI 10.1016/j.socscimed.2005.06.049; Sundquist K, 2006, SOC SCI MED, V62, P2061, DOI 10.1016/j.socscimed.2005.08.051; Sundquist K, 2004, J EPIDEMIOL COMMUN H, V58, P71, DOI 10.1136/jech.58.1.71; Sundquist K, 2004, AM J EPIDEMIOL, V159, P655, DOI 10.1093/aje/kwh096; Winkleby M, 2007, AM J PREV MED, V32, P97, DOI 10.1016/j.amepre.2006.10.002; World Health Organization, 1992, INT STAT CLASS DIS R	24	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56680	10.1371/journal.pone.0056680	http://dx.doi.org/10.1371/journal.pone.0056680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457603	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700072
J	Xu, B; Xu, WJ; Yang, FY; Li, JJ; Yang, YJ; Tang, XH; Mu, YL; Zhou, JP; Huang, ZX				Xu, Bo; Xu, Weijiang; Yang, Fuya; Li, Junjun; Yang, Yunjuan; Tang, Xianghua; Mu, Yuelin; Zhou, Junpei; Huang, Zunxi			Metagenomic Analysis of the Pygmy Loris Fecal Microbiome Reveals Unique Functional Capacity Related to Metabolism of Aromatic Compounds	PLOS ONE			English	Article							GENE-CENTRIC METAGENOMICS; HUMAN GUT MICROBIOTA; INTESTINAL MICROBIOTA; BACTERIAL DIVERSITY; COMMUNITY; BENZOATE; WILD; OBESITY; DEGRADATION; POPULATIONS	The animal gastrointestinal tract contains a complex community of microbes, whose composition ultimately reflects the co-evolution of microorganisms with their animal host. An analysis of 78,619 pyrosequencing reads generated from pygmy loris fecal DNA extracts was performed to help better understand the microbial diversity and functional capacity of the pygmy loris gut microbiome. The taxonomic analysis of the metagenomic reads indicated that pygmy loris fecal microbiomes were dominated by Bacteroidetes and Proteobacteria phyla. The hierarchical clustering of several gastrointestinal metagenomes demonstrated the similarities of the microbial community structures of pygmy loris and mouse gut systems despite their differences in functional capacity. The comparative analysis of function classification revealed that the metagenome of the pygmy loris was characterized by an overrepresentation of those sequences involved in aromatic compound metabolism compared with humans and other animals. The key enzymes related to the benzoate degradation pathway were identified based on the Kyoto Encyclopedia of Genes and Genomes pathway assignment. These results would contribute to the limited body of primate metagenome studies and provide a framework for comparative metagenomic analysis between human and non-human primates, as well as a comparative understanding of the evolution of humans and their microbiome. However, future studies on the metagenome sequencing of pygmy loris and other prosimians regarding the effects of age, genetics, and environment on the composition and activity of the metagenomes are required.	[Xu, Bo; Xu, Weijiang; Yang, Fuya; Li, Junjun; Yang, Yunjuan; Tang, Xianghua; Mu, Yuelin; Zhou, Junpei; Huang, Zunxi] Yunnan Normal Univ, Sch Life Sci, Kunming, Peoples R China; [Xu, Bo; Xu, Weijiang; Li, Junjun; Yang, Yunjuan; Tang, Xianghua; Mu, Yuelin; Zhou, Junpei; Huang, Zunxi] Minist Educ, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Kunming, Peoples R China; [Xu, Bo; Xu, Weijiang; Li, Junjun; Yang, Yunjuan; Tang, Xianghua; Mu, Yuelin; Zhou, Junpei; Huang, Zunxi] Key Lab Yunnan Biomass Energy & Biotechnol Enviro, Kunming, Peoples R China; [Xu, Bo; Xu, Weijiang; Yang, Fuya; Li, Junjun; Yang, Yunjuan; Tang, Xianghua; Mu, Yuelin; Zhou, Junpei; Huang, Zunxi] Yunnan Normal Univ, Key Lab Enzyme Engn, Kunming, Peoples R China	Yunnan Normal University; Yunnan Normal University	Huang, ZX (corresponding author), Yunnan Normal Univ, Sch Life Sci, Kunming, Peoples R China.	huangzunxi@163.com			National Natural Science Foundation of China [30960165, 31160229]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (30960165 and 31160229). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnous K, 2009, J NUTR, V139, P2024, DOI 10.3945/jn.109.109470; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Valderrama JA, 2012, J BIOL CHEM, V287, P10494, DOI 10.1074/jbc.M111.309005; BOTTA GA, 1994, CLIN INFECT DIS, V18, pS260, DOI 10.1093/clinids/18.Supplement_4.S260; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chandler DP, 1997, MOL ECOL, V6, P475, DOI 10.1046/j.1365-294X.1997.00205.x; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; de Macario EC, 2009, INT J MED MICROBIOL, V299, P99, DOI 10.1016/j.ijmm.2008.06.011; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Frey JC, 2006, APPL ENVIRON MICROB, V72, P3788, DOI 10.1128/AEM.72.5.3788-3792.2006; GIBSON DT, 1968, SCIENCE, V161, P1093, DOI 10.1126/science.161.3846.1093; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gorski A, 2005, CELL MOL LIFE SCI, V62, P511, DOI 10.1007/s00018-004-4403-6; Griswold KE, 1999, CURR MICROBIOL, V39, P187, DOI 10.1007/s002849900443; Hackstein J. H. P., 2010, ENDOSYMBIOTIC METHAN; HARAYAMA S, 1991, J BACTERIOL, V173, P7540, DOI 10.1128/jb.173.23.7540-7548.1991; Harvey AJ, 2000, PROTEINS, V41, P257, DOI 10.1002/1097-0134(20001101)41:2<257::AID-PROT100>3.0.CO;2-C; HOBSON PN, 1982, CRC CR REV MICROBIOL, V9, P165, DOI 10.3109/10408418209104490; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Kaufman L., 1990, FINDING GROUPS DATA; KIM MK, 1991, FEMS MICROBIOL LETT, V83, P199, DOI 10.1016/0378-1097(91)90354-D; Kisidayova S, 2009, AM J PRIMATOL, V71, P548, DOI 10.1002/ajp.20687; KOTTURI G, 1991, APPL MICROBIOL BIOT, V34, P539, DOI 10.1007/BF00180585; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; Lee RC, 2003, J BIOL CHEM, V278, P5377, DOI 10.1074/jbc.M210627200; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li F, 2009, J NUTR, V139, P1685, DOI 10.3945/jn.109.108191; Lubbs DC, 2009, J ANIM PHYSIOL AN N, V93, P113, DOI 10.1111/j.1439-0396.2007.00788.x; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; MARQUES S, 1993, MOL MICROBIOL, V9, P923, DOI 10.1111/j.1365-2958.1993.tb01222.x; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Oboirien B.O., 2005, BIOTECHNOLOGY, V4, P56, DOI DOI 10.3923/biotech.2005.56.61; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pandey PK, 2012, J BIOSCIENCES, V37, P221, DOI 10.1007/s12038-012-9197-3; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Ratajszczak R, 1998, FOLIA PRIMATOL, V69, P171, DOI 10.1159/000052710; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; SAHASRABUDHE SR, 1985, BIOCHEM INT, V10, P525; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; SIEBER R, 1995, INT DAIRY J, V5, P227, DOI 10.1016/0958-6946(94)00005-A; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Szekely BA, 2010, AM J PRIMATOL, V72, P566, DOI 10.1002/ajp.20809; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Ten Hove RJ, 2009, J EUKARYOT MICROBIOL, V56, P388, DOI 10.1111/j.1550-7408.2009.00393.x; Tun HM, 2012, J MICROBIOL METH, V88, P369, DOI 10.1016/j.mimet.2012.01.001; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uenishi G, 2007, AM J PRIMATOL, V69, P367, DOI 10.1002/ajp.20351; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei B, 2002, INFECT IMMUN, V70, P6567, DOI 10.1128/IAI.70.12.6567-6575.2002; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Xu B, 2010, AM J PRIMATOL, V72, P699, DOI 10.1002/ajp.20826; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	71	35	40	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56565	10.1371/journal.pone.0056565	http://dx.doi.org/10.1371/journal.pone.0056565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457582	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700062
J	Mrakovcic, M; Absenger, M; Riedl, R; Smole, C; Roblegg, E; Frohlich, LF; Frohlich, E				Mrakovcic, Maria; Absenger, Markus; Riedl, Regina; Smole, Claudia; Roblegg, Eva; Froehlich, Leopold F.; Froehlich, Eleonore			Assessment of Long-Term Effects of Nanoparticles in a Microcarrier Cell Culture System	PLOS ONE			English	Article							INCREASED PULMONARY TOXICITY; IN-VITRO; ULTRAFINE PARTICLES; VERO CELLS; CYTOTOXICITY; GROWTH; RECOMMENDATIONS; BIOREACTOR; METABOLISM; CHEMICALS	Nano-sized materials could find multiple applications in medical diagnosis and therapy. One main concern is that engineered nanoparticles, similar to combustion-derived nanoparticles, may cause adverse effects on human health by accumulation of entire particles or their degradation products. Chronic cytotoxicity must therefore be evaluated. In order to perform chronic cytotoxicity testing of plain polystyrene nanoparticles on the endothelial cell line EAhy 926, we established a microcarrier cell culture system for anchorage-dependent cells (BioLevitator (TM)). Cells were cultured for four weeks and exposed to doses, which were not cytotoxic upon 24 hours of exposure. For comparison, these particles were also studied in regularly sub-cultured cells, a method that has traditionally been used to assess chronic cellular effects. Culturing on basal membrane coated microcarriers produced very high cell densities. Fluorescent particles were mainly localized in the lysosomes of the exposed cells. After four weeks of exposure, the number of cells exposed to 20 nm polystyrene particles decreased by 60% as compared to untreated controls. When tested in sub-cultured cells, the same particles decreased cell numbers to 80% of the untreated controls. Dose-dependent decreases in cell numbers were also noted after exposure of microcarrier cultured cells to 50 nm short multi-walled carbon nanotubes. Our findings support that necrosis, but not apoptosis, contributed to cell death of the exposed cells in the microcarrier culture system. In conclusion, the established microcarrier model appears to be more sensitive for the identification of cellular effects upon prolonged and repeated exposure to nanoparticles than traditional sub-culturing.	[Mrakovcic, Maria; Absenger, Markus; Froehlich, Eleonore] Med Univ Graz, Med Res Ctr, Graz, Austria; [Riedl, Regina] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Smole, Claudia; Froehlich, Leopold F.] Med Univ Graz, Inst Pathol, Graz, Austria; [Roblegg, Eva] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Dept Pharmaceut Technol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Graz	Frohlich, E (corresponding author), Med Univ Graz, Med Res Ctr, Graz, Austria.	eleonore.froehlich@medunigraz.at	Fröhlich, Eleonore/M-8943-2014	Fröhlich, Eleonore/0000-0002-6056-6829; Roblegg, Eva/0000-0002-5553-5147	Austrian Funding Foundation (FWF) [P22576-B18]; Austrian Research Promotion Agency (FFG) Research and Technology Development in Project Cluster NANO-HEALTH; Austrian Science Fund (FWF) [P 22576] Funding Source: researchfish	Austrian Funding Foundation (FWF); Austrian Research Promotion Agency (FFG) Research and Technology Development in Project Cluster NANO-HEALTH; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Funding Foundation (FWF) grant number P22576-B18 and by the Austrian Research Promotion Agency (FFG) Research and Technology Development in Project Cluster NANO-HEALTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Jafar, 2011, Int J Nanomedicine, V6, P1117, DOI 10.2147/IJN.S16603; Alves PM, 1996, BIOTECHNOL BIOENG, V52, P429, DOI 10.1002/(SICI)1097-0290(19961105)52:3<429::AID-BIT9>3.0.CO;2-M; Anderson N, 2006, FEBS LETT, V580, P5533, DOI 10.1016/j.febslet.2006.08.061; Bihari P, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-14; Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x; Butler M, 2000, BIOTECHNOL PROGR, V16, P854, DOI 10.1021/bp000110+; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Donaldson K, 2000, PHILOS T ROY SOC A, V358, P2741, DOI 10.1098/rsta.2000.0681; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; European Commission E., 2011, **NON-TRADITIONAL**; FERIN J, 1990, J AEROSOL SCI, V21, P381, DOI 10.1016/0021-8502(90)90064-5; Frohlich E, 2009, J TOXICOL SCI, V34, P363; Gebhardt R, 2003, DRUG METAB REV, V35, P145, DOI 10.1081/DMR-120023684; Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003; Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006; Kishore AS, 2009, TOXICOL LETT, V191, P268, DOI 10.1016/j.toxlet.2009.09.007; Kwon JT, 2009, J OCCUP HEALTH, V51, P423, DOI 10.1539/joh.L8159; Larson B, 2010, BIOTECH INT, V22, P10; Lasagna-Reeves C, 2010, BIOCHEM BIOPH RES CO, V393, P649, DOI 10.1016/j.bbrc.2010.02.046; Lee J, 2009, SMALL, V5, P1213, DOI 10.1002/smll.200801788; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; Li CL, 2008, ONCOL REP, V20, P1465, DOI 10.3892/or_00000167; Lindl T, 2005, ATLA-ALTERN LAB ANIM, V33, P591, DOI 10.1177/026119290503300614; Lison D, 1997, ARCH TOXICOL, V71, P725, DOI 10.1007/s002040050453; Lock LT, 2009, TISSUE ENG PT A, V15, P2051, DOI 10.1089/ten.tea.2008.0455; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster C, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-8; OBERDORSTER G, 1995, INHAL TOXICOL, V7, P111, DOI 10.3109/08958379509014275; OBERDORSTER G, 1990, J AEROSOL SCI, V21, P384, DOI 10.1016/0021-8502(90)90065-6; Pazos P, 2002, ATLA-ALTERN LAB ANIM, V30, P515, DOI 10.1177/026119290203000505; Renwick LC, 2001, TOXICOL APPL PHARM, V172, P119, DOI 10.1006/taap.2001.9128; Rodriguez-Yanez Y, 2013, TOXICOL MECH METHOD, V23, P178, DOI 10.3109/15376516.2012.754534; Rourou S, 2007, VACCINE, V25, P3879, DOI 10.1016/j.vaccine.2007.01.086; Sadauskas E, 2009, CHEM CENT J, V3, DOI 10.1186/1752-153X-3-16; Seaton A, 2010, J R SOC INTERFACE, V7, pS119, DOI 10.1098/rsif.2009.0252.focus; Seibert H, 1996, ATLA-ALTERN LAB ANIM, V24, P499; Serra M, 2009, ANN ANAT, V191, P104, DOI 10.1016/j.aanat.2008.09.005; Swiech K, 2007, ELECTRON J BIOTECHN, V10, P200, DOI 10.2225/vol10-issue2-fulltext-15; Thurnherr T, 2011, TOXICOL LETT, V200, P176, DOI 10.1016/j.toxlet.2010.11.012; van Nieuwenhuijze AEM, 2003, ANN RHEUM DIS, V62, P10, DOI 10.1136/ard.62.1.10; Varani J, 1998, CYTOTECHNOLOGY, V28, P101, DOI 10.1023/A:1008029715765; Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872; Wu JH, 2009, TOXICOL LETT, V191, P1, DOI 10.1016/j.toxlet.2009.05.020; Xiao CZ, 1999, CYTOTECHNOLOGY, V30, P143, DOI 10.1023/A:1008038609967; Yang H, 2009, J APPL TOXICOL, V29, P69, DOI 10.1002/jat.1385	46	43	44	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56791	10.1371/journal.pone.0056791	http://dx.doi.org/10.1371/journal.pone.0056791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457616	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700094
J	Wang, ZY; Wang, DM; Han, SW; Wang, N; Mo, FZ; Loo, TY; Shen, JG; Huang, H; Chen, JP				Wang, Zhiyu; Wang, Dongmei; Han, Shouwei; Wang, Neng; Mo, Feizhi; Loo, Tjing Yung; Shen, Jiangang; Huang, Hui; Chen, Jianping			Bioactivity-Guided Identification and Cell Signaling Technology to Delineate the Lactate Dehydrogenase A Inhibition Effects of Spatholobus suberectus on Breast Cancer	PLOS ONE			English	Article							GLYCOLYSIS; (-)-EPIGALLOCATECHIN; METABOLISM; ACTIVATION; EXPRESSION; FLAVONOIDS; CARCINOMA; ESTROGEN; STRATEGY; HSP90	Aerobic glycolysis is an important feature of cancer cells. In recent years, lactate dehydrogenase A (LDH-A) is emerging as a novel therapeutic target for cancer treatment. Seeking LDH-A inhibitors from natural resources has been paid much attention for drug discovery. Spatholobus suberectus (SS) is a common herbal medicine used in China for treating blood-stasis related diseases such as cancer. This study aims to explore the potential medicinal application of SS for LDH-A inhibition on breast cancer and to determine its bioactive compounds. We found that SS manifested apoptosis-inducing, cell cycle arresting and anti-LDH-A activities in both estrogen-dependent human MCF-7 cells and estrogen-independent MDA-MB-231 cell. Oral herbal extracts (1 g/kg/d) administration attenuated tumor growth and LDH-A expression in both breast cancer xenografts. Bioactivity-guided fractionation finally identified epigallocatechin as a key compound in SS inhibiting LDH-A activity. Further studies revealed that LDH-A plays a critical role in mediating the apoptosis-induction effects of epigallocatechin. The inhibited LDH-A activities by epigallocatechin is attributed to disassociation of Hsp90 from HIF-1 alpha and subsequent accelerated HIF-1 alpha proteasome degradation. In vivo study also demonstrated that epigallocatechin could significantly inhibit breast cancer growth, HIF-1 alpha/LDH-A expression and trigger apoptosis without bringing toxic effects. The preclinical study thus suggests that the potential medicinal application of SS for inhibiting cancer LDH-A activity and the possibility to consider epigallocatechin as a lead compound to develop LDH-A inhibitors. Future studies of SS for chemoprevention or chemosensitization against breast cancer are thus warranted.	[Wang, Zhiyu; Wang, Neng; Mo, Feizhi; Loo, Tjing Yung; Shen, Jiangang; Chen, Jianping] Univ Hong Kong, Sch Chinese Med, Pokfulam, Hong Kong, Peoples R China; [Wang, Dongmei] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Han, Shouwei] Univ Guangzhou Tradit Chinese Med, Clin Med Collage 2, Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [Huang, Hui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China	University of Hong Kong; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Sun Yat Sen University	Chen, JP (corresponding author), Univ Hong Kong, Sch Chinese Med, Pokfulam, Hong Kong, Peoples R China.	jpjpchen@yahoo.com	wang, zhiyu/K-5255-2016	wang, zhiyu/0000-0002-5299-8410	Hong Kong Innovation and Technology Support Programme ITF funding [ITS/073/11FP]; National Natural Science Foundation of China [81170647]; Projects of International Cooperation program, Guangdong Province [2012B050300014]	Hong Kong Innovation and Technology Support Programme ITF funding; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of International Cooperation program, Guangdong Province	The work was supported by the Hong Kong Innovation and Technology Support Programme ITF funding (ITS/073/11FP), National Natural Science Foundation of China (81170647) and Projects of International Cooperation program, Guangdong Province 2012B050300014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENTANI MM, 1983, CANCER DETECT PREV, V6, P241; BURKE RE, 1978, CANCER RES, V38, P2773; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen Dong-hui, 2004, Zhongguo Zhong Yao Za Zhi, V29, P352; Cheng XL, 2011, J CHROMATOGR A, V1218, P5774, DOI 10.1016/j.chroma.2011.06.091; Clark AS, 2002, MOL CANCER THER, V1, P707; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; Gu LW, 2003, J AGR FOOD CHEM, V51, P7513, DOI 10.1021/jf034815d; Guo WM, 2009, NUTR CANCER, V61, P807, DOI 10.1080/01635580903285098; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Kushima Y, 2009, BIOL PHARM BULL, V32, P899, DOI 10.1248/bpb.32.899; Kuzuhara T, 2008, CANCER LETT, V261, P12, DOI 10.1016/j.canlet.2007.10.037; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Ocana A, 2011, NAT REV CLIN ONCOL, V8, P200, DOI 10.1038/nrclinonc.2010.194; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shi HS, 2010, CANCER SCI, V101, P1447, DOI 10.1111/j.1349-7006.2010.01562.x; TAKAHASHI Y, 1995, INTERNAL MED, V34, P326, DOI 10.2169/internalmedicine.34.326; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vergote D, 2002, BREAST CANCER RES TR, V76, P195, DOI 10.1023/A:1020833410523; Wang Z, 2012, EVID-BASED COMPL ALT, V2012; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; Wang ZY, 2011, J ETHNOPHARMACOL, V133, P751, DOI 10.1016/j.jep.2010.11.004; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yoon JS, 2004, ARCH PHARM RES, V27, P589, DOI 10.1007/BF02980154; 杨德明, 2003, [中医杂志, Journal of Traditional Chinese Medicine], V44, P730	37	52	54	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56631	10.1371/journal.pone.0056631	http://dx.doi.org/10.1371/journal.pone.0056631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457597	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700087
J	Dowell, KG; Simons, AK; Wang, ZZ; Yun, K; Hibbs, MA				Dowell, Karen G.; Simons, Allen K.; Wang, Zack Z.; Yun, Kyuson; Hibbs, Matthew A.			Cell-Type-Specific Predictive Network Yields Novel Insights into Mouse Embryonic Stem Cell Self-Renewal and Cell Fate	PLOS ONE			English	Article							GENE-FUNCTION PREDICTION; SIGNALING PATHWAYS; SYSTEMS BIOLOGY; PLURIPOTENCY; EXPRESSION; NORMALIZATION; INTEGRATION; GENOME; GBX2	Self-renewal, the ability of a stem cell to divide repeatedly while maintaining an undifferentiated state, is a defining characteristic of all stem cells. Here, we clarify the molecular foundations of mouse embryonic stem cell (mESC) self-renewal by applying a proven Bayesian network machine learning approach to integrate high-throughput data for protein function discovery. By focusing on a single stem-cell system, at a specific developmental stage, within the context of well-defined biological processes known to be active in that cell type, we produce a consensus predictive network that reflects biological reality more closely than those made by prior efforts using more generalized, context-independent methods. In addition, we show how machine learning efforts may be misled if the tissue specific role of mammalian proteins is not defined in the training set and circumscribed in the evidential data. For this study, we assembled an extensive compendium of mESC data: similar to 2.2 million data points, collected from 60 different studies, under 992 conditions. We then integrated these data into a consensus mESC functional relationship network focused on biological processes associated with embryonic stem cell self-renewal and cell fate determination. Computational evaluations, literature validation, and analyses of predicted functional linkages show that our results are highly accurate and biologically relevant. Our mESC network predicts many novel players involved in self-renewal and serves as the foundation for future pluripotent stem cell studies. This network can be used by stem cell researchers (at http://StemSight.org) to explore hypotheses about gene function in the context of self-renewal and to prioritize genes of interest for experimental validation.	[Dowell, Karen G.; Simons, Allen K.; Yun, Kyuson; Hibbs, Matthew A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Dowell, Karen G.; Wang, Zack Z.; Yun, Kyuson; Hibbs, Matthew A.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME USA; [Wang, Zack Z.] Johns Hopkins Univ, Baltimore, MD USA; [Hibbs, Matthew A.] Trinity Univ, Dept Comp Sci, San Antonio, TX USA	Jackson Laboratory; University of Maine System; University of Maine Orono; Johns Hopkins University; Trinity University	Hibbs, MA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	mhibbs@trinity.edu			Jackson Laboratory; Pharmaceutical Researchers and Manufacturers of America (PhRMA) Foundation; University of Maine Graduate School of Biomedical Sciences; National Science Foundation [0221625]; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin (NIH/NIAMS) [R21 AR069981-01]; NIH [P50 GM076468-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER	Jackson Laboratory; Pharmaceutical Researchers and Manufacturers of America (PhRMA) Foundation; University of Maine Graduate School of Biomedical Sciences; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin (NIH/NIAMS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was partially funded by The Jackson Laboratory. KGD is supported by a Pharmaceutical Researchers and Manufacturers of America (PhRMA) Foundation Fellowship in Informatics, and has received funding from the University of Maine Graduate School of Biomedical Sciences and the National Science Foundation Integrated Graduate Education and Research Traineeship (IGERT) program grant 0221625 to conduct this work. MAH is an Ellison Medical Foundation New Scholar in Aging; he is partially supported by National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin (NIH/NIAMS) grant R21 AR069981-01 (Hibbs, Ackert-Bicknell), and NIH Grant P50 GM076468-06 (Churchill). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Bult CJ, 2010, NUCLEIC ACIDS RES, V38, pD586, DOI 10.1093/nar/gkp880; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chapman G, 1997, GENOMICS, V46, P223, DOI 10.1006/geno.1997.4969; CHARNIAK E, 1991, AI MAG, V12, P50; Chen X, 2008, COLD SH Q B, V73, P203, DOI 10.1101/sqb.2008.73.026; Chikina MD, 2012, BIOINFORMATICS, V28, P607, DOI 10.1093/bioinformatics/bts009; Darwiche A, 2009, MODELING AND REASONING WITH BAYESIAN NETWORKS, P1, DOI 10.1017/CBO9780511811357; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Druzdzel MJ, 1999, SIXTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-99)/ELEVENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE (IAAI-99), P902; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gillis J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002444; Guan YF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s3; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Hampton T, 2011, JAMA-J AM MED ASSOC, V306, P1968, DOI 10.1001/jama.2011.1625; Hibbs MA, 2010, PRINCIPLES PRACTICES, V3; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Hibbs MA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000322; Hill DP, 2009, MOL REPROD DEV; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huttenhower C, 2008, BIOINFORMATICS, V24, P1559, DOI 10.1093/bioinformatics/btn237; Huttenhower C, 2006, BIOINFORMATICS, V22, P2890, DOI 10.1093/bioinformatics/btl492; Huttenhower C, 2009, BIOINFORMATICS, V25, P2404, DOI 10.1093/bioinformatics/btp397; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jones A, 2010, PROTEIN CELL, V1, P1056, DOI 10.1007/s13238-010-0142-7; Joshi Trupti, 2008, V439, P369, DOI 10.1007/978-1-59745-188-8_25; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lanza R., 2006, ESSENTIALS STEM CELL; Li B, 2009, DEVELOPMENT, V136, P3267, DOI 10.1242/dev.036954; MacArthur BD, 2008, COLD SH Q B, V73, P211, DOI 10.1101/sqb.2008.73.061; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Miki T, 2011, STEM CELL REV; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Myers CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r114; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Obozinski G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s6; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Quackenbush J, 2007, J EXP BIOL, V210, P1507, DOI 10.1242/jeb.004432; Russell S, 2009, ARTIFICAL INTELLIGEN; Ryu JM, 2011, J BIOL CHEM, V286, P23667, DOI 10.1074/jbc.M110.216283; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Sealfon RSG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-443; Shannon C. E., 1993, CE SHANNON COLLECTED; Shigekawa M, 2011, BIOCHEM BIOPH RES CO, V406, P614, DOI 10.1016/j.bbrc.2011.02.105; Steck H, 2002, DIRICHLET PRIOR BAYE; Tasan M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s8; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamanaka S, 2008, CELL TISSUE RES, V331, P5, DOI 10.1007/s00441-007-0520-5; Yoshida Y, 2010, CIRCULATION, V122, P80, DOI 10.1161/CIRCULATIONAHA.109.881433	70	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56810	10.1371/journal.pone.0056810	http://dx.doi.org/10.1371/journal.pone.0056810			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468881	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900038
J	Ren, YF; Li, GL; Xue, YF; Zhang, XJ; Song, YJ; Lv, L; Wu, JM; Fang, YX; Wang, YQ; Shi, KQ; Chen, YP; Tang, KF				Ren, Yong-Feng; Li, Guiling; Xue, Yong-Feng; Zhang, Xue-Jiao; Song, Yi-Jiang; Lv, Lu; Wu, Jianmin; Fang, Yu-Xiao; Wang, Yu-Qun; Shi, Ke-Qing; Chen, Yong-ping; Tang, Kai-Fu			Decreased Dicer Expression Enhances SRP-Mediated Protein Targeting	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; VIRUS-LIKE PARTICLES; 7SL RNA; ENDOPLASMIC-RETICULUM; UP-REGULATION; CELLS; HIV-1; MECHANISM; TRANSPORT; APOBEC3G	We have shown that Dicer processes 7SL RNA into different fragments ranging from similar to 20 to more than 200 nucleotides. Here we addressed the molecular functions of these 7SL RNA fragments and found that some of them functioned as dominant-negative regulators of the full-length 7SL RNA, interfering with signal recognition particle (SRP) complex formation. Transfection of these 7SL RNA fragments inhibited the expression of cell surface glycoproteins, the targeting of a reporter protein to the endoplasmic reticulum, and the secretion of secreted alkaline phosphatase. These results suggest that some Dicer-processed 7SL RNA fragments interfered with SRP-mediated protein targeting. Moreover, we showed that Dicer knockdown enhanced SRP-mediated protein targeting and that transfection of a mixture of the 7SL RNA fragments partially restored this effect. Our data indicate that Dicer can fine-tune the efficiency of SRP-mediated protein targeting via processing a proportion of 7SL RNA into fragments of different lengths.	[Ren, Yong-Feng; Li, Guiling; Xue, Yong-Feng; Zhang, Xue-Jiao; Song, Yi-Jiang; Lv, Lu; Wu, Jianmin; Fang, Yu-Xiao; Tang, Kai-Fu] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China; [Wang, Yu-Qun; Shi, Ke-Qing; Chen, Yong-ping] Wenzhou Med Coll, Liver Res Ctr, Dept Infect & Liver Dis, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Tang, KF (corresponding author), Wenzhou Med Coll, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China.	tangkaifu@hotmail.com	Shi, KeQing/A-3411-2009; Shi, Keqing/GZK-5146-2022	Shi, KeQing/0000-0002-5070-3834; Shi, Keqing/0000-0002-5070-3834; Tang, Kai-Fu/0000-0002-2657-4163; Tang, Kai-Fu/0000-0002-6892-1207; Wu, Jianmin/0000-0002-8223-1667	National Natural Science Foundation of China [30971612, 81171967, 31271383, 30700708]; Zhejiang Provincial Natural Science Foundation [R2110503, Y2101210]; Wenzhou Science and Technology Foundation [Y20100202, Y20100203]; Chongqing Medical Science Foundation [09-1-17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Wenzhou Science and Technology Foundation; Chongqing Medical Science Foundation	This work was supported by National Natural Science Foundation of China (30971612, 81171967, 31271383 and 30700708 to KFT); Zhejiang Provincial Natural Science Foundation (R2110503 to KFT, Y2101210 to JW); Wenzhou Science and Technology Foundation (Y20100202 to KFT, Y20100203 to JW) and the key project of Chongqing Medical Science Foundation (09-1-17 to KFT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; BISHOP JM, 1970, VIROLOGY, V42, P927, DOI 10.1016/0042-6822(70)90341-7; BOVIA F, 1995, MOL BIOL CELL, V6, P471, DOI 10.1091/mbc.6.4.471; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Keene SE, 2010, J VIROL, V84, P9070, DOI 10.1128/JVI.00714-10; Lakkaraju AKK, 2007, EXP CELL RES, V313, P834, DOI 10.1016/j.yexcr.2006.12.003; LOWE ME, 1992, J CELL BIOL, V116, P799, DOI 10.1083/jcb.116.3.799; Misra S, 2005, J BIOL CHEM, V280, P29364, DOI 10.1074/jbc.M504162200; Onafuwa-Nuga AA, 2006, RNA, V12, P542, DOI 10.1261/rna.2306306; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Ren YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040705; Saraogi I, 2011, TRAFFIC, V12, P535, DOI 10.1111/j.1600-0854.2011.01171.x; Schwartz TU, 2007, ADV EXP MED BIOL, V607, P52; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Tang KF, 2008, J CELL BIOL, V182, P233, DOI 10.1083/jcb.200801169; Tang KF, 2007, BBA-GEN SUBJECTS, V1770, P820, DOI 10.1016/j.bbagen.2007.01.004; Tang KF, 2010, BBA-GEN SUBJECTS, V1800, P380, DOI 10.1016/j.bbagen.2009.11.009; Tijsterman M, 2004, CELL, V117, P1, DOI 10.1016/S0092-8674(04)00293-4; Wang T, 2008, J MOL BIOL, V375, P1098, DOI 10.1016/j.jmb.2007.11.017; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07	22	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56950	10.1371/journal.pone.0056950	http://dx.doi.org/10.1371/journal.pone.0056950			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468895	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900045
J	Wang, H; Zhang, F; Meng, YF; Zhang, T; Willis, P; Le, T; Soriano, S; Ray, E; Valji, K; Zhang, GX; Yang, XM				Wang, Han; Zhang, Feng; Meng, Yanfeng; Zhang, Tong; Willis, Patrick; Le, Thomas; Soriano, Stephanie; Ray, Erik; Valji, Karim; Zhang, Guixiang; Yang, Xiaoming			MRI-Monitored Intra-Shunt Local Agent Delivery of Motexafin Gadolinium: Towards Improving Long-Term Patency of TIPS	PLOS ONE			English	Article							INTRAHEPATIC PORTOSYSTEMIC SHUNTS; ORTHOTOPIC LIVER-TRANSPLANTATION; PORTASYSTEMIC SHUNTS; PORTAL-HYPERTENSION; COVERED STENTS; CIRRHOSIS; PIGS; FEASIBILITY; PIGGYBACK; CATHETER	Background: Transjugular intrahepatic portosystemic shunt (TIPS) has become an important and effective interventional procedure in treatment of the complications related to portal hypertension. Although the primary patency of TIPS has been greatly improved due to the clinical application of cover stent-grafts, the long-term patency is still suboptimal. This study was to investigate the feasibility of using magnetic resonance imaging (MRI)-monitored intra-shunt local agent delivery of motexafin gadolinium (MGd) into shunt-vein walls of TIPS. This new technique aimed to ultimately inhibit shuntstenosis of TIPS. Methodology: Human umbilical vein smooth muscle cells (SMCs) were incubated with various concentrations of MGd, and then examed by confocal microscopy and T1-map MRI. In addition, the proliferation of MGd-treated cells was evaluated. For in vivo validation, seventeen pigs underwent TIPS. Before placement of the stent, an MGd/trypan-blue mixture was locally delivered, via a microporous balloon, into eleven shunt-hepatic vein walls under dynamic MRI monitoring, while trypan-blue only was locally delivered into six shunt-hepatic vein walls as serve as controls. T1-weighted MRI of the shunt-vein walls was achieved before-and at different time points after agent injections. Contrast-to-noise ratio (CNR) of the shunt-vein wall at each time-point was measured. Shunts were harvested for subsequent histology confirmation. Principal Findings: In vitro studies confirmed the capability of SMCs in uptaking MGds in a concentration-dependent fashion, and demonstrated the suppression of cell proliferation by MGds as well. Dynamic MRI displayed MGd/blue penetration into the shunt-vein walls, showing significantly higher CNR of shunt-vein walls on post-delivery images than on pre-delivery images (49.5 +/- 9.4 vs 11.2 +/- 1.6, P<0.01), which was confirmed by histology. Conclusion: Results of this study indicate that MRI-monitored intra-shunt local MGd delivery is feasible and MGd functions as a potential therapeutic agent to inhibit the proliferation of SMCs, which may open alternative avenues to improve the long-term patency of TIPS.	[Wang, Han; Zhang, Guixiang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Radiol, Shanghai 200030, Peoples R China; [Wang, Han; Zhang, Feng; Meng, Yanfeng; Zhang, Tong; Willis, Patrick; Le, Thomas; Soriano, Stephanie; Ray, Erik; Valji, Karim; Yang, Xiaoming] Univ Washington, Sch Med, Dept Radiol, Image Guided Biomol Intervent Sect,Inst Stem Cell, Seattle, WA 98195 USA; [Yang, Xiaoming] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China	Shanghai Jiao Tong University; University of Washington; University of Washington Seattle; Zhejiang University	Yang, XM (corresponding author), Univ Washington, Sch Med, Dept Radiol, Image Guided Biomol Intervent Sect,Inst Stem Cell, Seattle, WA 98195 USA.	xmyang@u.washington.edu	Wang, Han/AAU-3579-2020; Meng, Yanfeng/AAS-4532-2021	Wang, Han/0000-0001-8042-1232; 	Radiological Society of North America [ESCH1101]; National Institutes of Health [RO1EBO12467]	Radiological Society of North America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Radiological Society of North America (grant ESCH1101) and the National Institutes of Health (grant RO1EBO12467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni S, 2004, AM J GASTROENTEROL, V99, P280, DOI 10.1111/j.1572-0241.2004.04056.x; Avval FZ, 2009, BIOCHEM BIOPH RES CO, V379, P775, DOI 10.1016/j.bbrc.2008.12.128; Boyer TD, 2010, HEPATOLOGY, V51, P306, DOI 10.1002/hep.23383; Brushett C, 2008, J MAGN RESON IMAGING, V27, P246, DOI 10.1002/jmri.21174; Garcia-Pagan JC, 2010, NEW ENGL J MED, V362, P2370, DOI 10.1056/NEJMoa0910102; Clark TWI, 2008, TECH VASC INTERV RAD, V11, P212, DOI 10.1053/j.tvir.2009.04.003; Clark W, 2011, AM J SURG, V202, P561, DOI 10.1016/j.amjsurg.2011.06.021; Clark W, 2010, AM SURGEON, V76, P857; COLAPINTO RF, 1983, AM J ROENTGENOL, V140, P709, DOI 10.2214/ajr.140.4.709; Cura M, 2008, AM J ROENTGENOL, V191, P1751, DOI 10.2214/AJR.07.3534; Du XY, 2005, RADIOLOGY, V236, P939, DOI 10.1148/radiol.2363041021; Ducoin H, 1997, HEPATOLOGY, V25, P1064, DOI 10.1002/hep.510250503; Gurusamy KS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008258.pub2; Haskal ZJ, 1999, RADIOLOGY, V213, P853, DOI 10.1148/radiology.213.3.r99dc24853; Jovine E, 1997, TRANSPLANT INT, V10, P109, DOI 10.1007/PL00003824; Jung HS, 2009, J VASC INTERV RADIOL, V20, P180, DOI 10.1016/j.jvir.2008.11.005; Latimer J, 1998, CARDIOVASC INTER RAD, V21, P234, DOI 10.1007/s002709900251; Magda D, 2006, SEMIN CANCER BIOL, V16, P466, DOI 10.1016/j.semcancer.2006.09.002; Maleux G, 2004, CARDIOVASC INTER RAD, V27, P140, DOI 10.1007/s00270-003-0085-y; Micol C, 2012, ABDOM IMAGING, V37, P252, DOI 10.1007/s00261-011-9763-4; Murad SD, 2008, LIVER INT, V28, P249, DOI 10.1111/j.1478-3231.2007.01649.x; Roberts JH, 2011, J CLIN IMAG SCI, V1, DOI 10.4103/2156-7514.86665; Sanyal AJ, 1998, HEPATOLOGY, V28, P22, DOI 10.1002/hep.510280105; Sanyal AJ, 1999, HEPATOLOGY, V29, P710, DOI 10.1002/hep.510290323; Saugel B, 2012, RADIOLOGY, V262, P343, DOI 10.1148/radiol.11110043; de Melo PSV, 2011, TRANSPL P, V43, P1327, DOI 10.1016/j.transproceed.2011.03.061; Woodburn KW, 2001, J PHARMACOL EXP THER, V297, P888; Wroblewski T, 2006, TRANSPLANT P, V38, P204, DOI 10.1016/j.transproceed.2005.12.019; Wrolewski T, 2008, ANN TRANSPL, V13, P42; Yang XM, 2001, CIRCULATION, V104, P1588, DOI 10.1161/hc3901.097505; Zhang F, 2012, RADIOLOGY, V262, P846, DOI 10.1148/radiol.11110723	31	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57419	10.1371/journal.pone.0057419	http://dx.doi.org/10.1371/journal.pone.0057419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468986	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900086
J	Deaner, RO; Lowen, A; Cobley, S				Deaner, Robert O.; Lowen, Aaron; Cobley, Stephen			Born at the Wrong Time: Selection Bias in the NHL Draft	PLOS ONE			English	Article							RELATIVE AGE; BIRTH DATES; TEAM SPORTS; LEAGUE; SOCCER; HOCKEY; SUCCESS; DISCRIMINATION; PERFORMANCE; MATURITY	Relative age effects (RAEs) occur when those who are relatively older for their age group are more likely to succeed. RAEs occur reliably in some educational and athletic contexts, yet the causal mechanisms remain unclear. Here we provide the first direct test of one mechanism, selection bias, which can be defined as evaluators granting fewer opportunities to relatively younger individuals than is warranted by their latent ability. Because RAEs are well-established in hockey, we analyzed National Hockey League (NHL) drafts from 1980 to 2006. Compared to those born in the first quarter (i.e., January-March), those born in the third and fourth quarters were drafted more than 40 slots later than their productivity warranted, and they were roughly twice as likely to reach career benchmarks, such as 400 games played or 200 points scored. This selection bias in drafting did not decrease over time, apparently continues to occur, and reduces the playing opportunities of relatively younger players. This bias is remarkable because it is exhibited by professional decision makers evaluating adults in a context where RAEs have been widely publicized. Thus, selection bias based on relative age may be pervasive.	[Deaner, Robert O.] Grand Valley State Univ, Dept Psychol, Allendale, MI 49401 USA; [Lowen, Aaron] Grand Valley State Univ, Dept Econ, Grand Rapids, MI USA; [Cobley, Stephen] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia	Grand Valley State University; Grand Valley State University; University of Sydney	Deaner, RO (corresponding author), Grand Valley State Univ, Dept Psychol, Allendale, MI 49401 USA.	deanerr@gvsu.edu	Cobley, Stephen P/I-5686-2017	Cobley, Stephen P/0000-0001-6099-392X; Lowen, Aaron/0000-0002-1769-9693	Grand Valley State University	Grand Valley State University	Grand Valley State University supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonna V, 2010, J QUANT ANAL SPORT, V6, P1, DOI [10.2202/1559-0410.1227, DOI 10.2202/1559-0410.1227]; [Anonymous], 2012, NAT HOCK LE IN PRESS; Ashworth J, 2007, J SPORT ECON, V8, P355, DOI 10.1177/1527002506287695; Baker J, 2007, BRIT J SPORT MED, V41, P515, DOI 10.1136/bjsm.2006.033977; Barnsley R. H., 1985, CANADIAN ASS HLTH PH, V51, P23, DOI [10.1177/1012690210371560, DOI 10.1177/1012690210371560]; BARNSLEY RH, 1988, CAN J BEHAV SCI, V20, P167, DOI 10.1037/h0079927; Bedard K, 2006, Q J ECON, V121, P1437, DOI 10.1162/qjec.121.4.1437; Black SE, 2011, REV ECON STAT, V93, P455, DOI 10.1162/REST_a_00081; Burger JD, 2009, J SPORT ECON, V10, P485, DOI 10.1177/1527002509332350; Camerer CF, 1999, J ECON BEHAV ORGAN, V39, P59, DOI 10.1016/S0167-2681(99)00026-8; Cobley S, 2009, SPORTS MED, V39, P235, DOI 10.2165/00007256-200939030-00005; Crawford C, 2007, ARE YOU BORN MATTERS; Delorme N, 2010, EUR J SPORT SCI, V10, P91, DOI 10.1080/17461390903271584; Dhuey E, 2008, ECON EDUC REV, V27, P173, DOI 10.1016/j.econedurev.2006.08.005; Duckworth AL, 2011, SOC PSYCHOL PERS SCI, V2, P174, DOI 10.1177/1948550610385872; Elder TE, 2010, J HEALTH ECON, V29, P641, DOI 10.1016/j.jhealeco.2010.06.003; Elder TE, 2009, J HUM RESOUR, V44, P641; Fischler S, 1999, CRACKED ICE INSIDERS; Ford PR, 2011, RES Q EXERCISE SPORT, V82, P570, DOI 10.1080/02701367.2011.10599790; Gibbs BG, 2012, INT REV SOCIOL SPORT, V47, P644, DOI 10.1177/1012690211414343; Gladwell Malcolm, 2008, OUTLIERS; Grondin S., 1984, APPRENT SOCIAL, V16, P169, DOI DOI 10.1234/12345678; Hendricks W, 2003, J LABOR ECON, V21, P857, DOI 10.1086/377025; Joyce G., 2007, FUTURE GREATS HEARTB; Jurges H, 2011, GER ECON REV, V12, P371, DOI 10.1111/j.1468-0475.2011.00533.x; Koz D, 2012, SCAND J MED SCI SPOR, V22, pE64, DOI 10.1111/j.1600-0838.2011.01408.x; Malloy S, 2011, ART SCOUTING HOCKEY; Massey C., 2010, LOSERS CURSE OVERCON; Meylan C, 2010, INT J SPORTS SCI COA, V5, P571, DOI 10.1260/1747-9541.5.4.571; Mitchell H, 2011, J SPORT ECON, V12, P36, DOI 10.1177/1527002510365051; Muhlenweg AM, 2010, J HUM RESOUR, V45, P407; Musch J, 2001, DEV REV, V21, P147, DOI 10.1006/drev.2000.0516; National Hockey League, 2005, COLL BARG AGR NAT HO; Nolan JE, 2010, INT REV SOCIOL SPORT, V45, P507, DOI 10.1177/1012690210371560; Pedace R, 2008, J SPORT ECON, V9, P115, DOI 10.1177/1527002507301422; Pellizzari M, 2012, J POPUL ECON, V25, P697, DOI 10.1007/s00148-011-0379-3; Petersen AM, 2011, P NATL ACAD SCI USA, V108, P18, DOI 10.1073/pnas.1016733108; STAW BM, 1995, ADMIN SCI QUART, V40, P474, DOI 10.2307/2393794; Thompson AH, 2004, EDUC RES-UK, V46, P313, DOI 10.1080/0013188042000277368; Till K, 2010, SCAND J MED SCI SPOR, V20, P320, DOI 10.1111/j.1600-0838.2009.00884.x; Vaeyens R, 2005, J SPORT SCI, V23, P747, DOI 10.1080/02640410400022052; Wattie N, 2007, INT J SPORT PSYCHOL, V38, P178	42	55	55	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57753	10.1371/journal.pone.0057753	http://dx.doi.org/10.1371/journal.pone.0057753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460902	gold, Green Published			2022-12-27	WOS:000315519000157
J	Hsu, PH; Wei, KC; Huang, CY; Wen, CJ; Yen, TC; Liu, CL; Lin, YT; Chen, JC; Shen, CR; Liu, HL				Hsu, Po-Hung; Wei, Kuo-Chen; Huang, Chiung-Yin; Wen, Chih-Jen; Yen, Tzu-Chen; Liu, Chao-Lin; Lin, Ya-Tin; Chen, Jin-Chung; Shen, Chia-Rui; Liu, Hao-Li			Noninvasive and Targeted Gene Delivery into the Brain Using Microbubble-Facilitated Focused Ultrasound	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; CENTRAL-NERVOUS-SYSTEM; TRANSGENE EXPRESSION; AAV SEROTYPES; PARKINSONS-DISEASE; BARRIER DISRUPTION; VIRAL VECTORS; MOUSE-BRAIN; IN-VITRO; PHASE-I	Recombinant adeno-associated viral (rAAV) vectors are potentially powerful tools for gene therapy of CNS diseases, but their penetration into brain parenchyma is severely limited by the blood-brain barrier (BBB) and current delivery relies on invasive stereotactic injection. Here we evaluate the local, targeted delivery of rAAV vectors into the brains of mice by noninvasive, reversible, microbubble-facilitated focused ultrasound (FUS), resulting in BBB opening that can be monitored and controlled by magnetic resonance imaging (MRI). Using this method, we found that IV-administered AAV2-GFP (green fluorescence protein) with a low viral vector titer (1x10(9) vg/g) can successfully penetrate the BBB-opened brain regions to express GFP. We show that MRI monitoring of BBB-opening could serve as an indicator of the scale and distribution of AAV transduction. Transduction peaked at 3 weeks and neurons and astrocytes were affected. This novel, noninvasive delivery approach could significantly broaden the application of AAV-viral-vector-based genes for treatment of CNS diseases.	[Hsu, Po-Hung; Liu, Hao-Li] Chang Gung Univ, Dept Elect Engn, Tao Yuan, Taiwan; [Wei, Kuo-Chen; Huang, Chiung-Yin] Chang Gung Univ, Dept Neurosurg, Tao Yuan, Taiwan; [Wei, Kuo-Chen; Huang, Chiung-Yin; Wen, Chih-Jen; Yen, Tzu-Chen] Mem Hosp, Tao Yuan, Taiwan; [Wen, Chih-Jen; Yen, Tzu-Chen] Chang Gung Univ, Mol Imaging Ctr, Tao Yuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Univ, Dept Nucl Med, Tao Yuan, Taiwan; [Liu, Chao-Lin] Min Chi Univ Technol, Dept Chem Engn, Taipei, Taiwan; [Lin, Ya-Tin; Chen, Jin-Chung] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Shen, Chia-Rui] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University	Shen, CR (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Tao Yuan, Taiwan.	crshen@mail.cgu.edu.tw; haoliliu@mail.cgu.edu.tw	Lin, Ya-Tin/AAM-2733-2021	Lin, Ya-Tin/0000-0001-7910-1223; Shen, Chia-Rui/0000-0002-8386-3965; Wei, Kuochen/0000-0003-3505-2196; Chen, Jin-Chung/0000-0003-2996-5781; Hsu, Pohung/0000-0002-2941-4712	National Science Council (Taiwan) [NSC-100-2321-B-182-010]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Council (Taiwan) Grants NSC-100-2321-B-182-010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisky JM, 2000, NEUROREPORT, V11, P2669, DOI 10.1097/00001756-200008210-00013; [Anonymous], HUM GENE THER; Bankiewicz KS, 2000, EXP NEUROL, V164, P2, DOI 10.1006/exnr.2000.7408; Bennett J, 1999, P NATL ACAD SCI USA, V96, P9920, DOI 10.1073/pnas.96.17.9920; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Carty N, J NEUROSCI METHODS, V194, P144; Carty N, 2010, J NEUROSCI METH, V194, P144, DOI 10.1016/j.jneumeth.2010.10.010; Chen H, 1999, J NEUROSCI RES, V55, P504, DOI 10.1002/(SICI)1097-4547(19990215)55:4<504::AID-JNR10>3.0.CO;2-0; Chen H, 1998, GENE THER, V5, P50, DOI 10.1038/sj.gt.3300547; Chen PY, 2010, NEURO-ONCOLOGY, V12, P1050, DOI 10.1093/neuonc/noq054; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; DORAN SE, 1995, NEUROSURGERY, V36, P965, DOI 10.1227/00006123-199505000-00012; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Favre D, 2001, MOL THER, V4, P559, DOI 10.1006/mthe.2001.0494; Fu HY, 2003, MOL THER, V8, P911, DOI 10.1016/j.ymthe.2003.08.021; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; Hu CH, 2010, J GENE MED, V12, P766, DOI 10.1002/jgm.1496; Huang Q, 2012, EXP NEUROL, V233, P350, DOI 10.1016/j.expneurol.2011.10.027; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Hynynen K, 2006, J NEUROSURG, V105, P445, DOI 10.3171/jns.2006.105.3.445; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kinoshita M, 2006, BIOCHEM BIOPH RES CO, V340, P1085, DOI 10.1016/j.bbrc.2005.12.112; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; Klein RL, 2008, EUR J NEUROSCI, V27, P1615, DOI 10.1111/j.1460-9568.2008.06161.x; Lawlor PA, 2009, MOL THER, V17, P1692, DOI 10.1038/mt.2009.170; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Liu HL, 2008, ULTRASOUND MED BIOL, V34, P598, DOI 10.1016/j.ultrasmedbio.2008.01.011; Liu HL, 2010, P NATL ACAD SCI USA, V107, P15205, DOI 10.1073/pnas.1003388107; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; McCown TJ, 1996, BRAIN RES, V713, P99, DOI 10.1016/0006-8993(95)01488-8; McDannold N, 2010, NEUROSURGERY, V66, P323, DOI 10.1227/01.NEU.0000360379.95800.2F; McPhee SWJ, 2006, J GENE MED, V8, P577, DOI 10.1002/jgm.885; Meijer DH, 2009, CANCER GENE THER, V16, P664, DOI 10.1038/cgt.2009.8; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Ponnazhagan S, 1997, GENE, V190, P203, DOI 10.1016/S0378-1119(96)00576-8; Properzi F, 2008, EUR J NEUROSCI, V27, P593, DOI 10.1111/j.1460-9568.2008.06042.x; Rapoport SI, 1976, BLOOD BRAIN BARRIER; Royo NC, 2008, BRAIN RES, V1190, P15, DOI 10.1016/j.brainres.2007.11.015; Ryals RC, 2011, MOL VIS, V17, P1090; Sarra GM, 2002, VISION RES, V42, P541, DOI 10.1016/S0042-6989(01)00230-9; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Toromanoff A, 2008, MOL THER, V16, P1291, DOI 10.1038/mt.2008.87; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Wu CJ, 2012, HUM GENE THER; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Xing X, 1998, GENE THER, V5, P1538, DOI 10.1038/sj.gt.3300771; Yang CJ, 2009, HUM GENE THER, V20, P1597, DOI 10.1089/hum.2008.092	55	94	100	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57682	10.1371/journal.pone.0057682	http://dx.doi.org/10.1371/journal.pone.0057682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460893	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000148
J	Oakley, BB; Morales, CA; Line, J; Berrang, ME; Meinersmann, RJ; Tillman, GE; Wise, MG; Siragusa, GR; Hiett, KL; Seal, BS				Oakley, Brian B.; Morales, Cesar A.; Line, J.; Berrang, Mark E.; Meinersmann, Richard J.; Tillman, Glenn E.; Wise, Mark G.; Siragusa, Gregory R.; Hiett, Kelli L.; Seal, Bruce S.			The Poultry-Associated Microbiome: Network Analysis and Farm-to-Fork Characterizations	PLOS ONE			English	Article							INTESTINAL BACTERIAL COMMUNITY; CAMPYLOBACTER SPP.; FOODBORNE ILLNESS; FAECALIBACTERIUM-PRAUSNITZII; COMPETITIVE-EXCLUSION; BROILER CARCASSES; SAMPLING METHODS; RARE BIOSPHERE; JEJUNI; DIVERSITY	Microbial communities associated with agricultural animals are important for animal health, food safety, and public health. Here we combine high-throughput sequencing (HTS), quantitative-PCR assays, and network analysis to profile the poultry-associated microbiome and important pathogens at various stages of commercial poultry production from the farm to the consumer. Analysis of longitudinal data following two flocks from the farm through processing showed a core microbiome containing multiple sequence types most closely related to genera known to be pathogenic for animals and/or humans, including Campylobacter, Clostridium, and Shigella. After the final stage of commercial poultry processing, taxonomic richness was ca. 2-4 times lower than the richness of fecal samples from the same flocks and Campylobacter abundance was significantly reduced. Interestingly, however, carcasses sampled at 48 hr after processing harboured the greatest proportion of unique taxa (those not encountered in other samples), significantly more than expected by chance. Among these were anaerobes such as Prevotella, Veillonella, Leptrotrichia, and multiple Campylobacter sequence types. Retail products were dominated by Pseudomonas, but also contained 27 other genera, most of which were potentially metabolically active and encountered in on-farm samples. Network analysis was focused on the foodborne pathogen Campylobacter and revealed a majority of sequence types with no significant interactions with other taxa, perhaps explaining the limited efficacy of previous attempts at competitive exclusion of Campylobacter. These data represent the first use of HTS to characterize the poultry microbiome across a series of farm-to-fork samples and demonstrate the utility of HTS in monitoring the food supply chain and identifying sources of potential zoonoses and interactions among taxa in complex communities.	[Oakley, Brian B.; Morales, Cesar A.; Line, J.; Tillman, Glenn E.; Wise, Mark G.; Siragusa, Gregory R.; Hiett, Kelli L.; Seal, Bruce S.] ARS, USDA, Richard B Russell Agr Res Ctr, Athens, GA USA; [Berrang, Mark E.; Meinersmann, Richard J.] ARS, Bacterial Epidemiol & Antibiot Resistance Res Uni, USDA, Richard B Russell Agr Res Ctr, Athens, GA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Oakley, BB (corresponding author), ARS, USDA, Richard B Russell Agr Res Ctr, Athens, GA USA.	brian.oakley@ars.usda.gov	Oakley, Brian Oakley B/AAG-4015-2019	Wise, Mark/0000-0001-7356-1851; Oakley, Brian/0000-0003-2098-6439	USDA ARS CRIS [6612-32000-059, 6612-32000-060, 6612-41420-004]	USDA ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding was provided by the USDA ARS CRIS project 6612-32000-059, Molecular Characterization and Gastrointestinal Tract Ecology of Commensal Human Food-Borne Bacterial Pathogens in the Chicken, 6612-32000-060, Interventions and Methodologies to Reduce Human Food-Borne Bacterial? Pathogens in Chickens, and 6612-41420-004, Microbial Ecology of Human Pathogens Relative to Poultry Processing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamian FM, 2011, CLIN MICROBIOL REV, V24, P231, DOI 10.1128/CMR.00041-10; Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Alter T, 2011, VET MICROBIOL, V147, P90, DOI 10.1016/j.vetmic.2010.06.005; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Berrang ME, 2000, J APPL POULTRY RES, V9, P43, DOI 10.1093/japr/9.1.43; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bojesen AM, 2004, AVIAN PATHOL, V33, P145, DOI 10.1080/03079450310001652059; Bradshaw DJ, 1996, MICROBIOL-UK, V142, P623, DOI 10.1099/13500872-142-3-623; Callicott KA, 2008, APPL ENVIRON MICROB, V74, P6483, DOI 10.1128/AEM.01129-08; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cox NA, 2001, J FOOD PROTECT, V64, P252, DOI 10.4315/0362-028X-64.2.252; Damjanova I, 2011, INT J FOOD MICROBIOL, V150, P95, DOI 10.1016/j.ijfoodmicro.2011.07.011; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; DICKENS JA, 1985, POULTRY SCI, V64, P1116, DOI 10.3382/ps.0641116; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Foster James A, 2008, Interdiscip Perspect Infect Dis, V2008, P839501, DOI 10.1155/2008/839501; Gabriel I, 2006, WORLD POULTRY SCI J, V62, P499, DOI 10.1017/S0043933906001115; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hald B, 2004, EMERG INFECT DIS, V10, P1490, DOI 10.3201/eid1008.040129; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Hiett KL, 2002, APPL ENVIRON MICROB, V68, P6220, DOI 10.1128/AEM.68.12.6220-6236.2002; Hume ME, 2011, FOODBORNE PATHOG DIS, V8, P1159, DOI 10.1089/fpd.2011.0863; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jacobs-Reitsma W., 2000, CAMPYLOBACTER, P467; JACOBSREITSMA WF, 1995, EPIDEMIOL INFECT, V114, P413, DOI 10.1017/S0950268800052122; Jay J M, 2000, MODERN FOOD MICROBIO, V2nd; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Khan MT, 2012, ISME J, V6, P1578, DOI 10.1038/ismej.2012.5; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kwan PSL, 2008, APPL ENVIRON MICROB, V74, P5130, DOI 10.1128/AEM.02198-07; Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1; Li JR, 2003, APPL ENVIRON MICROB, V69, P901, DOI 10.1128/AEM.69.2.901-908.2003; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LILLARD HS, 1989, J FOOD PROTECT, V52, P829, DOI 10.4315/0362-028X-52.11.829; LILLARD HS, 1993, J FOOD PROTECT, V56, P716, DOI 10.4315/0362-028X-56.8.716; Line JE, 2013, POULTRY SCI, V92, P218, DOI 10.3382/ps.2012-02217; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lund M, 2010, POULTRY SCI, V89, P1217, DOI 10.3382/ps.2010-00653; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mavromatis K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007979; Mead G.C., 2000, MICROBIOLOGICAL SAFE, P445; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Oakley B.B., 2011, ISME J, P1; Oakley BB, 2012, DIAGN MICR INFEC DIS, V72, P131, DOI 10.1016/j.diagmicrobio.2011.11.001; Oakley BB, 2012, FEMS MICROBIOL ECOL, V79, P327, DOI 10.1111/j.1574-6941.2011.01219.x; Oakley BB, 2011, FEMS MICROBIOL ECOL, V77, P17, DOI 10.1111/j.1574-6941.2011.01079.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; R DCT, 2010, R LANG ENV STAT COMP; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rittenberry Ronnie, 2011, Occup Health Saf, V80, P66; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scharff RL, 2012, J FOOD PROTECT, V75, P123, DOI 10.4315/0362-028X.JFP-11-058; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scupham AJ, 2010, APPL ENVIRON MICROB, V76, P8026, DOI 10.1128/AEM.00678-10; Sekelja M, 2012, APPL ENVIRON MICROB, V78, P2941, DOI 10.1128/AEM.05391-11; Shreeve JE, 2000, AVIAN DIS, V44, P983, DOI 10.2307/1593076; Simmons M, 2008, J MICROBIOL METH, V74, P89, DOI 10.1016/j.mimet.2008.03.007; Simmons M, 2003, J FOOD PROTECT, V66, P1768, DOI 10.4315/0362-028X-66.10.1768; Skov MN, 2004, AVIAN DIS, V48, P9, DOI 10.1637/5698; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; SOERJADI AS, 1982, AVIAN DIS, V26, P520, DOI 10.2307/1589897; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; STERN NJ, 1994, POULTRY SCI, V73, P402, DOI 10.3382/ps.0730402; Stern NJ, 2001, J FOOD PROTECT, V64, P1705, DOI 10.4315/0362-028X-64.11.1705; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tillman GE, 2011, FEMS MICROBIOL ECOL; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002; Zweifel C, 2008, INT J FOOD MICROBIOL, V125, P182, DOI 10.1016/j.ijfoodmicro.2008.03.038	82	88	88	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57190	10.1371/journal.pone.0057190	http://dx.doi.org/10.1371/journal.pone.0057190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468931	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000073
J	Stevens, SG; Brown, CM				Stevens, Stewart G.; Brown, Chris M.			In Silico Estimation of Translation Efficiency in Human Cell Lines: Potential Evidence for Widespread Translational Control	PLOS ONE			English	Article							MESSENGER-RNA; TRANSCRIPTOME; REVEALS; QUANTIFICATION; NORMALIZATION; PROTEOME; DETERMINANTS; DYNAMICS; GENES; SILAC	Recently large scale transcriptome and proteome datasets for human cells have become available. A striking finding from these studies is that the level of an mRNA typically predicts no more than 40% of the abundance of protein. This correlation represents the overall figure for all genes. We present here a bioinformatic analysis of translation efficiency - the rate at which mRNA is translated into protein. We have analysed those human datasets that include genome wide mRNA and protein levels determined in the same study. The analysis comprises five distinct human cell lines that together provide comparable data for 8,170 genes. For each gene we have used levels of mRNA and protein combined with protein stability data from the HeLa cell line to estimate translation efficiency. This was possible for 3,990 genes in one or more cell lines and 1,807 genes in all five cell lines. Interestingly, our analysis and modelling shows that for many genes this estimated translation efficiency has considerable consistency between cell lines. Some deviations from this consistency likely result from the regulation of protein degradation. Others are likely due to known translational control mechanisms. These findings suggest it will be possible to build improved models for the interpretation of mRNA expression data. The results we present here provide a view of translation efficiency for many genes. We provide an online resource allowing the exploration of translation efficiency in genes of interest within different cell lines (http://bioanalysis.otago.ac.nz/TranslationEfficiency).	[Stevens, Stewart G.; Brown, Chris M.] Univ Otago, Dunedin, New Zealand	University of Otago	Brown, CM (corresponding author), Univ Otago, Dunedin, New Zealand.	chris.brown@otago.ac.nz		Brown, Chris M/0000-0003-0079-7067	Human Frontier Science Foundation Research Grant [RGP0031 2009]; University of Otago	Human Frontier Science Foundation Research Grant; University of Otago	Partially funded by a Human Frontier Science Foundation Research Grant[RGP0031 2009 to Ian Macara, Anne Spang and C. M. B.]; University of Otago Research Grant to C. M. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman F, 2012, INT J MOL SCI, V13, P16223, DOI 10.3390/ijms131216223; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Bermano G, 2001, FEBS LETT, V497, P77, DOI 10.1016/S0014-5793(01)02438-3; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Chepelev NL, 2011, FREE RADICAL BIO MED, V50, P645, DOI 10.1016/j.freeradbiomed.2010.12.023; Dressaire C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000606; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Hinkson IV, 2011, TRENDS CELL BIOL, V21, P293, DOI 10.1016/j.tcb.2011.02.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jacobs GH, 2009, NUCLEIC ACIDS RES, V37, pD72, DOI 10.1093/nar/gkn763; Kleffmann T, 2007, PLANT PHYSIOL, V143, P912, DOI 10.1104/pp.106.090738; Law GL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r111; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Mahlab S, 2012, RNA; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Song XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027836; Stevens SG, 2011, RNA BIOL, V8, P792, DOI 10.4161/rna.8.5.16037; Sury MD, 2010, MOL CELL PROTEOMICS, V9, P2173, DOI 10.1074/mcp.M110.000323; Szostak E, 2012, BRIEF FUNCT GENOMICS; Tebaldi T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-220; Thellin O, 2009, BIOTECHNOL ADV, V27, P323, DOI 10.1016/j.biotechadv.2009.01.010; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuller T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r110; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tunbridge EM, 2011, BIOL PSYCHIAT, V69, P173, DOI 10.1016/j.biopsych.2010.05.023; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Waldman YY, 2010, NUCLEIC ACIDS RES, V38, P2964, DOI 10.1093/nar/gkq009; Walther DM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004523; Wilkins MR, 1999, METH MOL B, V112, P531	46	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57625	10.1371/journal.pone.0057625	http://dx.doi.org/10.1371/journal.pone.0057625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460887	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000142
J	Wang, M; Sun, DF; Wang, S; Qing, Y; Chen, S; Wu, D; Lin, YM; Luo, JZ; Li, YQ				Wang, Min; Sun, De-Feng; Wang, Shuai; Qing, Ying; Chen, Shuo; Wu, Dong; Lin, Ying-Min; Luo, Ji-Zhuang; Li, Yan-Qing			Polymorphic Expression of UDP-Glucuronosyltransferase UGTlA Gene in Human Colorectal Cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; HUMAN PLACENTA; JAPANESE PATIENTS; GILBERTS-SYNDROME; SERUM BILIRUBIN; UGT1A LOCUS; HUMAN COLON; 1A7; RISK; GLUCURONIDATION	Background: Polymorphism of genes encoding drug-metabolizing enzymes is known to play an important role in increased susceptibility of colorectal cancer. UGT1A gene locus has been suggested to define tissue-specific glucuronidation activity. Reduced capacity of glucuronidation is correlated with the development of colorectal cancer. Therefore, we sought to explore polymorphism of UGTlA gene in human colorectal cancer. Methods: Cancerous and healthy tissues were obtained from selectedpatients. Blood samples were collected and UGTlA mRNA transcriptions were analyzed. Genomic DNA was prepared and UGTlA8 exon-1 sequences were amplified, visualized and purified. The extracted DNA was subcloned and sequenced. Two-tailed Fisher's exact test, Odds ratios (ORs), confidence interval (CIs) and Logistics Regression Analysis were used for statistical analysis. Results: UGTlA mRNA expression was reduced in cancerous tissues compared with healthy tissues from the same patient. The UGTlA mRNA expression of healthy tissue in study patients was lower than control. The mRNA expression of cancerous tissue was down-regulated in UGTlAl, 1A3, 1A4, lA6, 1A9 and up-regulated in UGTlA8 and UGTlAl0 UGT1A5 and UGT1A7 were not expressed in colonic tissue of either group. The allele frequency of WT UGTlA8*1 was higher (p = 0.000), frequency of UGTlA8*3 was lowered in control group (p = 0.000). The expression of homozygous UGTlA8*1 was higher in control group (p = 0.000). Higher frequency of both heterozygous UGTlA8*1/*3 and UGTlA8*2/*3 were found in study group (p = 0.000; p = 0.000). The occurrence of colorectal cancer was mainly related to the presence of polymorphic UGTlA8*3 alleles (p = 0.000). Conclusion: Regulation of human UGT1A genes is tissue-specific. Individual variation in polymorphic expressions of UGTlA gene locus was noted in all types of colonic tissue tested, whereas hepatic tissue expression was uniform. The high incidence of UGTlA8 polymorphism exists in colorectal cancer patients. UGTlA8*1 allele is a protective factor and UGTlA8*3 allele is a risk factor.	[Wang, Min; Wang, Shuai; Qing, Ying; Chen, Shuo; Lin, Ying-Min] Shandong Univ, Qi Lu Hosp, Key Lab Prote Shandong Prov, Dept Geriatr & Gastroenterol, Jinan 250100, Shandong, Peoples R China; [Sun, De-Feng] Shandong Med Sch, Dept Biochem & Mol Biol, Jinan, Shandong, Peoples R China; [Wu, Dong] Shandong Univ, Qi Lu Hosp, Dept Gen Surg, Jinan 250100, Shandong, Peoples R China; [Luo, Ji-Zhuang] Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Li, Yan-Qing] Shandong Univ, Qi Lu Hosp, Dept Gastroenterol, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Wang, M (corresponding author), Shandong Univ, Qi Lu Hosp, Key Lab Prote Shandong Prov, Dept Geriatr & Gastroenterol, Jinan 250100, Shandong, Peoples R China.	doctorminmin@163.com		Qing, Ying/0000-0001-6763-6204	Science and Technology Key Project of Shandong Province [2006GG3202050]; Science Bonus Funds for Young Scientists of Shandong Province [2007BS03017]; Natural Science Foundation of Shandong Province [Y2008C115]	Science and Technology Key Project of Shandong Province; Science Bonus Funds for Young Scientists of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by grants from Science and Technology Key Project of Shandong Province (No. 2006GG3202050), Science Bonus Funds for Young Scientists of Shandong Province (NO. 2007BS03017, no URL link), and Natural Science Foundation of Shandong Province (No. Y2008C115, no URL link). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello M, 2011, MOL MED REP, V4, P203, DOI 10.3892/mmr.2010.408; Bernard O, 2004, DRUG METAB DISPOS, V32, P775, DOI 10.1124/dmd.32.8.775; Bock KW, 2012, BIOCHEM PHARMACOL, V84, P1000, DOI 10.1016/j.bcp.2012.07.009; Bock KW, 2010, BIOCHEM PHARMACOL, V80, P771, DOI 10.1016/j.bcp.2010.04.034; Butler LM, 2005, CANCER EPIDEM BIOMAR, V14, P1626, DOI 10.1158/1055-9965.EPI-04-0682; Caillier B, 2007, PHARMACOGENET GENOM, V17, P481, DOI 10.1097/FPC.0b013e32806d87a4; Chen K, 2006, J GASTROEN HEPATOL, V21, P1036, DOI 10.1111/j.1440-1746.2005.04032.x; Cheng ZQ, 1998, ARCH BIOCHEM BIOPHYS, V356, P301, DOI 10.1006/abbi.1998.0781; Dura P, 2012, INT J ONCOL, V40, P1789, DOI 10.3892/ijo.2012.1385; Ehmer U, 2004, HEPATOLOGY, V39, P970, DOI 10.1002/hep.20131; Farheen S, 2006, WORLD J GASTROENTERO, V12, P2269, DOI 10.3748/wjg.v12.i14.2269; Gong QH, 2001, PHARMACOGENETICS, V11, P357, DOI 10.1097/00008571-200106000-00011; Guillemette C, 2000, PHARMACOGENETICS, V10, P629, DOI 10.1097/00008571-200010000-00006; Huang YH, 2002, PHARMACOGENETICS, V12, P287, DOI 10.1097/00008571-200206000-00004; Ishii Y, 2010, DRUG METAB PHARMACOK, V25, P134, DOI 10.2133/dmpk.25.134; Iwai M, 2004, J HUM GENET, V49, P123, DOI 10.1007/s10038-003-0119-y; Kong SY, 2008, CANCER SCI, V99, P340, DOI 10.1111/j.1349-7006.2007.00693.x; Lampe JW, 1999, PHARMACOGENETICS, V9, P341, DOI 10.1097/00008571-199906000-00009; Lankisch TO, 2008, CANCER EPIDEM BIOMAR, V17, P695, DOI 10.1158/1055-9965.EPI-07-2517; Lankisch TO, 2006, HEPATOLOGY, V44, P1324, DOI 10.1002/hep.21361; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Maitland ML, 2006, PHARMACOGENOMICS J, V6, P52, DOI 10.1038/sj.tpj.6500351; Mojarrabi B, 1998, BIOCHEM BIOPH RES CO, V247, P704, DOI 10.1006/bbrc.1998.8843; Myllynen P, 2005, PLACENTA, V26, P361, DOI 10.1016/j.placenta.2004.09.006; Myllynen P, 2007, EXPERT OPIN DRUG MET, V3, P331, DOI 10.1517/17425255.3.3.331; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Osawa K, 2012, ASIAN PAC J CANCER P, V13, P2311, DOI 10.7314/APJCP.2012.13.5.2311; Saeki M, 2006, PHARMACOGENOMICS J, V6, P63, DOI 10.1038/sj.tpj.6500335; Saeki Mayumi, 2005, Drug Metab Pharmacokinet, V20, P144, DOI 10.2133/dmpk.20.144; Sai K, 2004, CLIN PHARMACOL THER, V75, P501, DOI 10.1016/j.clpt.2004.01.010; Strassburg CP, 1997, MOL PHARMACOL, V52, P212, DOI 10.1124/mol.52.2.212; Strassburg CP, 2002, GUT, V50, P851, DOI 10.1136/gut.50.6.851; Strassburg CP, 1998, J BIOL CHEM, V273, P8719, DOI 10.1074/jbc.273.15.8719; Stucker I, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-214; Syme MR, 2004, CLIN PHARMACOKINET, V43, P487, DOI 10.2165/00003088-200443080-00001; Tang KS, 2005, WORLD J GASTROENTERO, V11, P3250, DOI 10.3748/wjg.v11.i21.3250; Thomas SS, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9432; Tseng CS, 2005, AM J GASTROENTEROL, V100, P1758, DOI 10.1111/j.1572-0241.2005.41857.x; Udomuksorn W, 2007, PHARMACOGENET GENOM, V17, P1017, DOI 10.1097/FPC.0b013e328256b1b6; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Wan De-Sen, 2009, Ai Zheng, V28, P897; [王敏 Wang Min], 2006, [中华消化杂志, Chinese Journal of Digestion], V26, P96; [王敏 Wang Min], 2005, [中国病理生理杂志, Chinese Journal of Pathophysiology], V21, P1315; Wang Y, 2004, CLIN CANCER RES, V10, P2441, DOI 10.1158/1078-0432.CCR-1187-3	44	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57045	10.1371/journal.pone.0057045	http://dx.doi.org/10.1371/journal.pone.0057045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468910	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000056
J	Stockel, J; Elvitigala, TR; Liberton, M; Pakrasi, HB				Stoeckel, Jana; Elvitigala, Thanura R.; Liberton, Michelle; Pakrasi, Himadri B.			Carbon Availability Affects Diurnally Controlled Processes and Cell Morphology of Cyanothece 51142	PLOS ONE			English	Article							GENE-EXPRESSION; N-2 FIXATION; AMINO-ACIDS; ANABAENA SP; WILD-TYPE; CYANOBACTERIUM; CO2; LIMITATION; GROWTH; TRICHODESMIUM	Cyanobacteria are oxygenic photoautotrophs notable for their ability to utilize atmospheric CO2 as the major source of carbon. The prospect of using cyanobacteria to convert solar energy and high concentrations of CO2 efficiently into biomass and renewable energy sources has sparked substantial interest in using flue gas from coal-burning power plants as a source of inorganic carbon. However, in order to guide further advances in this area, a better understanding of the metabolic changes that occur under conditions of high CO2 is needed. To determine the effect of high CO2 on cell physiology and growth, we analyzed the global transcriptional changes in the unicellular diazotrophic cyanobacterium Cyanothece 51142 grown in 8% CO2-enriched air. We found a concerted response of genes related to photosynthesis, carbon metabolism, respiration, nitrogen fixation, ribosome biosynthesis, and the synthesis of nucleotides and structural cell wall polysaccharides. The overall response to 8% CO2 in Cyanothece 51142 involves different strategies, to compensate for the high C/N ratio during both phases of the diurnal cycle. Our analyses show that high CO2 conditions trigger the production of carbon-rich compounds and stimulate processes such as respiration and nitrogen fixation. In addition, we observed that high levels of CO2 affect fundamental cellular processes such as cell growth and dramatically alter the intracellular morphology. This study provides novel insights on how diurnal and developmental rhythms are integrated to facilitate adaptation to high CO2 in Cyanothece 51142.	[Stoeckel, Jana; Elvitigala, Thanura R.; Liberton, Michelle; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	pakrasi@wustl.edu			Office of Science (BER), U.S. Department of Energy; Consortium for Clean Coal Utilization at Washington University; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC 0001035]	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); Consortium for Clean Coal Utilization at Washington University; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This research was supported by funding from the Office of Science (BER), U.S. Department of Energy and from the Consortium for Clean Coal Utilization at Washington University. Electron microscopy imaging was performed as part of the Photosynthetic Antenna Research Center, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Award Number DE-SC 0001035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2006, PLANT PHYSIOL, V142, P135, DOI 10.1104/pp.106.086256; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Bandyopadhyay A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1139; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Battchikova N, 2010, J PROTEOME RES, V9, P5896, DOI 10.1021/pr100651w; Carr NG, 1988, NITROGEN RESERVES DY; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; Eisenhut M, 2008, PLANT PHYSIOL, V148, P2109, DOI 10.1104/pp.108.129403; FLYNN KJ, 1990, ARCH MICROBIOL, V153, P574, DOI 10.1007/BF00245267; Fu FX, 2008, LIMNOL OCEANOGR, V53, P2472, DOI 10.4319/lo.2008.53.6.2472; Lopez CVG, 2009, BIORESOURCE TECHNOL, V100, P5904, DOI 10.1016/j.biortech.2009.04.070; Hacham Y, 2002, PLANT PHYSIOL, V128, P454, DOI 10.1104/pp.010819; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; KALLAS T, 1983, J BACTERIOL, V155, P427, DOI 10.1128/JB.155.1.427-431.1983; Karradt A, 2008, J BIOL CHEM, V283, P32394, DOI 10.1074/jbc.M805823200; Kranz SA, 2010, PLANT PHYSIOL, V154, P334, DOI 10.1104/pp.110.159145; Kranz SA, 2009, LIMNOL OCEANOGR, V54, P548, DOI 10.4319/lo.2009.54.2.0548; LANG NJ, 1987, J BACTERIOL, V169, P920, DOI 10.1128/jb.169.2.920-923.1987; Leakey ADB, 2009, P NATL ACAD SCI USA, V106, P3597, DOI 10.1073/pnas.0810955106; Levitan O, 2007, GLOBAL CHANGE BIOL, V13, P531, DOI 10.1111/j.1365-2486.2006.01314.x; Liberton M, 2011, PLANT PHYSIOL, V155, P1656, DOI 10.1104/pp.110.165332; Long BM, 2001, APPL ENVIRON MICROB, V67, P278, DOI 10.1128/AEM.67.1.278-283.2001; Paul MJ, 2003, J EXP BOT, V54, P539, DOI 10.1093/jxb/erg052; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; SCHRADER M, 1981, FEMS MICROBIOL LETT, V11, P37; SEBER GAF, 1984, MULTIVARIATE OBSERVA; SINGH S, 1993, J BASIC MICROB, V33, P41, DOI 10.1002/jobm.3620330109; Smith PMC, 2002, PLANT PHYSIOL, V128, P793, DOI 10.1104/pp.010912; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Stockel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016680; Summerfield TC, 2011, MICROBIOL-SGM, V157, P301, DOI 10.1099/mic.0.041053-0; Tapia MI, 1996, PLANTA, V198, P526, DOI 10.1007/BF00262638; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; VERMAAS WFJ, 2001, PHOTOSYNTHESIS RESP, P1; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Woodger FJ, 2003, PLANT PHYSIOL, V133, P2069, DOI 10.1104/pp.103.029728; Worrell E, 2001, ANNU REV ENERG ENV, V26, P303, DOI 10.1146/annurev.energy.26.1.303; Ziegler K, 2001, FEMS MICROBIOL LETT, V196, P13, DOI 10.1111/j.1574-6968.2001.tb10533.x	43	13	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56887	10.1371/journal.pone.0056887	http://dx.doi.org/10.1371/journal.pone.0056887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457634	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700094
J	Turner, A; Li, LC; Pilli, T; Qian, LX; Wiley, EL; Setty, S; Christov, K; Ganesh, L; Maker, AV; Li, PF; Kanteti, P; Gupta, TKD; Prabhakar, BS				Turner, Andrea; Li, Liang-Cheng; Pilli, Tania; Qian, Lixia; Wiley, Elizabeth Louise; Setty, Suman; Christov, Konstantin; Ganesh, Lakshmy; Maker, Ajay V.; Li, Peifeng; Kanteti, Prasad; Gupta, Tapas K. Das; Prabhakar, Bellur S.			MADD Knock-Down Enhances Doxorubicin and TRAIL Induced Apoptosis in Breast Cancer Cells	PLOS ONE			English	Article							MADD/DENN SPLICE VARIANT; CYTOTOXIC LIGAND TRAIL; DEATH RECEPTORS 4; IG20 GENE; DENN-SV; CASPASE-8; EXPRESSION; RESISTANCE; ACTIVATION; FADD	The Map kinase Activating Death Domain containing protein (MADD) isoform of the IG20 gene is over-expressed in different types of cancer tissues and cell lines and it functions as a negative regulator of apoptosis. Therefore, we speculated that MADD might be over-expressed in human breast cancer tissues and that MADD knock-down might synergize with chemotherapeutic or TRAIL-induced apoptosis of breast cancer cells. Analyses of breast tissue microarrays revealed overexpression of MADD in ductal and invasive carcinomas relative to benign tissues. MADD knockdown resulted in enhanced spontaneous apoptosis in human breast cancer cell lines. Moreover, MADD knockdown followed by treatment with TRAIL or doxorubicin resulted in increased cell death compared to either treatment alone. Enhanced cell death was found to be secondary to increased caspase-8 activation. These data indicate that strategies to decrease MADD expression or function in breast cancer may be utilized to increase tumor cell sensitivity to TRAIL and doxorubicin induced apoptosis.	[Turner, Andrea; Li, Liang-Cheng; Pilli, Tania; Qian, Lixia; Ganesh, Lakshmy; Maker, Ajay V.; Li, Peifeng; Kanteti, Prasad; Prabhakar, Bellur S.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Wiley, Elizabeth Louise; Setty, Suman] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA; [Christov, Konstantin; Gupta, Tapas K. Das] Univ Illinois, Coll Med, Dept Surg Oncol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Prabhakar, BS (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	bprabhak@uic.edu	Li, Peifeng/AHE-6906-2022; Li, Peifeng/ABD-5663-2021	Li, Peifeng/0000-0002-0969-9407; Das Gupta, Tapas K./0000-0001-6437-6320	National Institutes of Health, Bethesda, Maryland [RO1 CA107506]; Elsa U. Pardee Foundation; NATIONAL CANCER INSTITUTE [R01CA107506] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elsa U. Pardee Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the grant RO1 CA107506 to B.S.P. from the National Institutes of Health, Bethesda, Maryland, and by a grant from Elsa U. Pardee Foundation to L-C.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zoubi AM, 2001, J BIOL CHEM, V276, P47202, DOI 10.1074/jbc.M104835200; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Efimova E, 2003, CANCER RES, V63, P8768; Efimova EV, 2004, ONCOGENE, V23, P1076, DOI 10.1038/sj.onc.1207210; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Geisler S, 2001, CANCER RES, V61, P2505; Guseva NV, 2008, BREAST CANCER RES TR, V107, P349, DOI 10.1007/s10549-007-9563-2; Keane MM, 1999, CANCER RES, V59, P734; Kim KH, 2000, CLIN CANCER RES, V6, P335; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Li LC, 2011, AM J OBSTET GYNECOL, V205; Li LC, 2008, CANCER RES, V68, P7352, DOI 10.1158/0008-5472.CAN-07-6311; Li PF, 2010, J BIOL CHEM, V285, P22713, DOI 10.1074/jbc.M110.105692; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Liang K, 2006, MOL PHARMACOL, V70, P1045, DOI 10.1124/mol.106.023333; Lim KM, 2002, MOL CARCINOGEN, V35, P110, DOI 10.1002/mc.10082; Lin TY, 2002, ONCOGENE, V21, P8020, DOI 10.1038/sj.onc.1205926; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Mulherkar N, 2006, ONCOGENE, V25, P6252, DOI 10.1038/sj.onc.1209650; Mulherkar N, 2007, J BIOL CHEM, V282, P11715, DOI 10.1074/jbc.M701085200; Navarro R, 2006, ANN NY ACAD SCI, V1090, P408, DOI 10.1196/annals.1378.044; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Prabhakar BS, 2008, CLIN CANCER RES, V14, P347, DOI 10.1158/1078-0432.CCR-07-0493; Ramaswamy M, 2004, ONCOGENE, V23, P6083, DOI 10.1038/sj.onc.1207804; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Subramanian M, 2009, J CLIN ENDOCR METAB, V94, P1467, DOI 10.1210/jc.2008-2378; Ta HQ, 2008, CANCER RES, V68, P8796, DOI 10.1158/0008-5472.CAN-08-2426; Tari AM, 2001, J CHEMOTHERAPY, V13, P334, DOI 10.1179/joc.2001.13.3.334; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Wu XX, 2007, CANCER SCI, V98, P1969, DOI 10.1111/j.1349-7006.2007.00632.x; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313; Zhao YB, 2008, ACTA BIOCH BIOPH SIN, V40, P304, DOI 10.1111/j.1745-7270.2008.00402.x	36	20	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56817	10.1371/journal.pone.0056817	http://dx.doi.org/10.1371/journal.pone.0056817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457619	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700083
J	Nakagawa, S; Sugiura, M; Akitsuki, Y; Hosseini, SMH; Kotozaki, Y; Miyauchi, CM; Yomogida, Y; Yokoyama, R; Takeuchi, H; Kawashima, R				Nakagawa, Seishu; Sugiura, Motoaki; Akitsuki, Yuko; Hosseini, S. M. Hadi; Kotozaki, Yuka; Miyauchi, Carlos Makoto; Yomogida, Yukihito; Yokoyama, Ryoichi; Takeuchi, Hikaru; Kawashima, Ryuta			Compensatory Effort Parallels Midbrain Deactivation during Mental Fatigue: An fMRI Study	PLOS ONE			English	Article							DOPAMINERGIC MIDBRAIN; INVOLVEMENT; QUESTIONNAIRE; ACTIVATION; ATTENTION; WORKLOAD; EXERCISE	Fatigue reflects the functioning of our physiological negative feedback system, which prevents us from overworking. When fatigued, however, we often try to suppress this system in an effort to compensate for the resulting deterioration in performance. Previous studies have suggested that the effect of fatigue on neurovascular demand may be influenced by this compensatory effort. The primary goal of the present study was to isolate the effect of compensatory effort on neurovascular demand. Healthy male volunteers participated in a series of visual and auditory divided attention tasks that steadily increased fatigue levels for 2 hours. Functional magnetic resonance imaging scans were performed during the first and last quarter of the study (Pre and Post sessions, respectively). Tasks with low and high attentional load (Low and High conditions, respectively) were administrated in alternating blocks. We assumed that compensatory effort would be greater under the High-attentional-load condition compared with the Low-load condition. The difference was assessed during the two sessions. The effect of compensatory effort on neurovascular demand was evaluated by examining the interaction between load (High vs. Low) and time (Pre vs. Post). Significant fatigue-induced deactivation (i.e., Pre>Post) was observed in the frontal, temporal, occipital, and parietal cortices, in the cerebellum, and in the midbrain in both the High and Low conditions. The interaction was significantly greater in the High than in the Low condition in the midbrain. Neither significant fatigue-induced activation (i.e., Pre<Post), nor its interaction with factor Load, was identified. The observed midbrain deactivation ([PreH - PostH]>[PreE- PostE]) may reflect suppression of the negative feedback system that normally triggers recuperative rest to maintain homeostasis.	[Nakagawa, Seishu; Sugiura, Motoaki; Hosseini, S. M. Hadi; Miyauchi, Carlos Makoto; Yomogida, Yukihito; Yokoyama, Ryoichi; Kawashima, Ryuta] Tohoku Univ, IDAC, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan; [Sugiura, Motoaki] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan; [Akitsuki, Yuko; Kotozaki, Yuka; Takeuchi, Hikaru; Kawashima, Ryuta] Tohoku Univ, IDAC, Smart Ageing Ctr, Sendai, Miyagi 980, Japan; [Hosseini, S. M. Hadi] Stanford Univ, Dept Psychiat & Behav Sci, Ctr Interdisciplinary Brain Sci Res, Sch Med, Stanford, CA 94305 USA; [Yomogida, Yukihito] Japan Soc Promot Sci, Tokyo, Japan	Tohoku University; Tohoku University; Tohoku University; Stanford University; Japan Society for the Promotion of Science	Nakagawa, S (corresponding author), Tohoku Univ, IDAC, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan.	seishu@idac.tohoku.ac.jp	Kotozaki, Yuka/ABA-2922-2020; Hosseini, Hadi/AAF-7095-2020; Kotozaki, Yuka/ABA-2267-2020; Takeuchi, Hikaru/D-1057-2011	Kotozaki, Yuka/0000-0002-4659-1200; Takeuchi, Hikaru/0000-0002-8022-9694; Yomogida, Yukihito/0000-0001-5026-4440; Hosseini, Hadi/0000-0001-5186-7008	JSPS	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by JSPS (there are no particular numbers). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2008, J PHYSIOL-LONDON, V586, P161, DOI 10.1113/jphysiol.2007.141838; Amann M, 2011, MED SCI SPORT EXER, V43, P2039, DOI 10.1249/MSS.0b013e31821f59ab; Aratake Y, 2007, J OCCUP HEALTH, V49, P453, DOI 10.1539/joh.49.453; Ashburner J, 2008, SPM5 MANUAL; Barnden LR, 2011, NMR BIOMED, V24, P1302, DOI 10.1002/nbm.1692; Beurskens AJHM, 2000, OCCUP ENVIRON MED, V57, P353, DOI 10.1136/oem.57.5.353; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Boehler CN, 2011, J NEUROSCI, V31, P4955, DOI 10.1523/JNEUROSCI.4845-10.2011; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; BRUNO RL, 1995, ANN NY ACAD SCI, V753, P257, DOI 10.1111/j.1749-6632.1995.tb27552.x; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Dorland WAN, 2007, DORLANDS ILLUSTRATED, Vxxxi, P695; Gao Q, 2008, FEBS LETT, V582, P132, DOI 10.1016/j.febslet.2007.11.063; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; Klaassen EB, 2012, NEUROPHARMACOLOGY, P160; Kondo N, 2010, J EPIDEMIOL COMMUN H, V64, P649, DOI 10.1136/jech.2009.090787; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; LEMOAL M, 1991, PHYSIOL REV, V71, P155, DOI 10.1152/physrev.1991.71.1.155; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Meeusen R, 2006, SPORTS MED, V36, P881, DOI 10.2165/00007256-200636100-00006; Mulert C, 2008, NEUROIMAGE, V42, P158, DOI 10.1016/j.neuroimage.2008.04.236; Naidich T., 2009, DUVERNOYS ATLAS BRAI; Napadow V, 2006, NEUROIMAGE, V32, P1113, DOI 10.1016/j.neuroimage.2006.05.050; Nater UM, 2008, J CLIN ENDOCR METAB, V93, P703, DOI 10.1210/jc.2007-1747; Rahman S, 2001, J NEUROCHEM, V77, P1248, DOI 10.1046/j.1471-4159.2001.00326.x; Roberts ADL, 2004, BRIT J PSYCHIAT, V184, P136, DOI 10.1192/bjp.184.2.136; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Suda M, 2009, BRAIN RES, V1252, P152, DOI 10.1016/j.brainres.2008.11.077; Tajima S, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/671421; Tanaka M, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-9; Tolentino NJ, 2011, ALCOHOL CLIN EXP RES, V35, P1034, DOI 10.1111/j.1530-0277.2011.01435.x; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X	41	26	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56606	10.1371/journal.pone.0056606	http://dx.doi.org/10.1371/journal.pone.0056606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457592	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700086
J	Chen, KY; Xia, Y; Wang, HN; Xiao, FL; Xiang, G; Shen, F				Chen, Kaiyun; Xia, Yong; Wang, Hanning; Xiao, Fanglian; Xiang, Guoan; Shen, Feng			Adjuvant Iodine-125 Brachytherapy for Hepatocellular Carcinoma after Complete Hepatectomy: A Randomized Controlled Trial	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CURATIVE RESECTION; RECURRENCE; THERAPY; IRRADIATION; CHEMOTHERAPY; MANAGEMENT; RADIATION	Background: Tumor recurrence is a major problem after curative resection of hepatocellular carcinoma (HCC). The current study evaluated the effects of adjuvant iodine-125 (I-125) brachytherapy on postoperative recurrence of HCC. Methodology/Principal Findings: From July 2000 to June 2004, 68 HCC patients undergoing curative hepatectomy were randomly assigned into a I-125 adjuvant brachytherapy group (n = 34) and a group of best care (n = 34). Patients in the I-125 adjuvant brachytherapy group received I-125 seed implantation on the raw surface of resection. Patients in the best care control group received identical treatments except for the I-125 seed implantation. Time to recurrence (TTR) and 1-, 3- and 5-year overall survival (OS) were compared between the two groups. The follow-up ended in January 2010, and lasted for 7.7-106.4 months with a median of 47.6 months. TTR was significantly longer in the I-125 group (mean of 60.0 months vs. 36.7 months in the control). The 1-, 3-and 5-year recurrence-free rates of the I-125 group were 94.12%, 76.42%, and 73.65% vs. 88.24%, 50.00%, and 29.41% compared with the control group, respectively. The 1-, 3-and 5-year OS rates of the I-125 group were 94.12%, 73.53%, and 55.88% vs. 88.24%, 52.94%, and 29.41% compared with the control group, respectively. The I-125 brachytherapy decreased the risk of recurrence (HR = 0.310) and the risk of death (HR = 0.364). Most frequent adverse events in the I-125 group included nausea, vomiting, arrhythmia, decreased white blood cell and/or platelet counts, and were generally mild and manageable. Conclusions/Significance: Adjuvant I-125 brachytherapy significantly prolonged TTR and increased the OS rate after curative resection of HCC.	[Chen, Kaiyun; Wang, Hanning; Xiao, Fanglian; Xiang, Guoan] Second Prov Peoples Hosp Guangdong Prov, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Xia, Yong; Shen, Feng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai, Peoples R China	Naval Medical University	Xiang, G (corresponding author), Second Prov Peoples Hosp Guangdong Prov, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China.	guoanxiang@yahoo.cn; shenfengdfgd@yahoo.com.cn	Shen, Feng/GSD-2508-2022		State Key Project on Infectious Diseases of China [2008ZX10002-025, 2012ZX10002-016]; Guangdong Natural Science Fund [9151012001000009]; National Natural Science Foundation of China [81071990, 81172190]; Science and Technology Planning Project of Guangdong [2011B031800184]	State Key Project on Infectious Diseases of China; Guangdong Natural Science Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong	This study was supported by State Key Project on Infectious Diseases of China (grant no. 2008ZX10002-025, 2012ZX10002-016), Guangdong Natural Science Fund (grant no. 9151012001000009), the National Natural Science Foundation of China (grant no. 81071990, 81172190), and Science and Technology Planning Project of Guangdong (grant no. 2011B031800184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JG, 1994, CANCER-AM CANCER SOC, V73, P1800, DOI 10.1002/1097-0142(19940401)73:7<1800::AID-CNCR2820730705>3.0.CO;2-E; Aronowitz Jesse N, 2002, Brachytherapy, V1, P167; Cha C, 2003, J AM COLL SURGEONS, V197, P753, DOI 10.1016/j.jamcollsurg.2003.07.003; Chang CH, 2004, ARCH SURG-CHICAGO, V139, P320, DOI 10.1001/archsurg.139.3.320; Covey AM, 2006, CANCER-AM CANCER SOC, V106, P2181, DOI 10.1002/cncr.21883; Goertz S R, 1990, Clin Oncol (R Coll Radiol), V2, P22, DOI 10.1016/S0936-6555(05)80214-6; Heysek Randy V, 2007, Cancer Control, V14, P238; Horwitz EM, 1997, HEAD NECK-J SCI SPEC, V19, P219, DOI 10.1002/(SICI)1097-0347(199705)19:3<219::AID-HED10>3.0.CO;2-6; Horwitz EM, 1996, CANCER, V78, P948, DOI 10.1002/(SICI)1097-0142(19960901)78:5<948::AID-CNCR3>3.0.CO;2-8; Huang K, 2009, J NEURO-ONCOL, V91, P83, DOI 10.1007/s11060-008-9686-2; JOYCE F, 1990, INT J RADIAT ONCOL, V19, P1049, DOI 10.1016/0360-3016(90)90032-F; Lai ECS, 1998, ARCH SURG-CHICAGO, V133, P183, DOI 10.1001/archsurg.133.2.183; Lau WY, 1999, LANCET, V353, P797, DOI 10.1016/S0140-6736(98)06475-7; Li CX, 2011, CANCER BIOL THER, V12, P865, DOI 10.4161/cbt.12.10.17676; Lo CM, 2007, ANN SURG, V245, P831, DOI 10.1097/01.sla.0000245829.00977.45; Lopez PM, 2006, ALIMENT PHARM THER, V23, P1535, DOI 10.1111/j.1365-2036.2006.02932.x; Luo JJ, 2011, J VASC INTERV RADIOL, V22, P479, DOI 10.1016/j.jvir.2010.11.029; Martinez-Monge R, 1999, CANCER, V85, P1218, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1218::AID-CNCR2>3.0.CO;2-F; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; Nag S, 2006, INT J RADIAT ONCOL, V64, P736, DOI 10.1016/j.ijrobp.2005.08.029; NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458; Ono T, 2001, CANCER, V91, P2378, DOI 10.1002/1097-0142(20010615)91:12<2378::AID-CNCR1271>3.3.CO;2-U; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X; Samuel M, 2009, COCHRANE DB SYST REV, pD1199; Schwartz JD, 2002, LANCET ONCOL, V3, P593, DOI 10.1016/S1470-2045(02)00873-2; SON YH, 1985, AM J SURG, V150, P480, DOI 10.1016/0002-9610(85)90158-8; Strasser-Wozak EMC, 1998, CELL DEATH DIFFER, V5, P687, DOI 10.1038/sj.cdd.4400402; Sun HC, 2006, J CANCER RES CLIN, V132, P458, DOI 10.1007/s00432-006-0091-y; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; TAKENAKA K, 1995, AM J SURG, V169, P400, DOI 10.1016/S0002-9610(99)80184-6; Wuu CS, 1996, INT J RADIAT ONCOL, V36, P689, DOI 10.1016/S0360-3016(96)00374-4; Xiang Guo-an, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P292; Zhang Fu-Jun, 2007, Zhonghua Yi Xue Za Zhi, V87, P3272; Zhuang HQ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-12	35	32	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57397	10.1371/journal.pone.0057397	http://dx.doi.org/10.1371/journal.pone.0057397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468980	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900081
J	Fatima, SS; Bozaoglu, K; Rehman, R; Alam, F; Memon, AS				Fatima, Syeda Sadia; Bozaoglu, Kiymet; Rehman, Rehana; Alam, Faiza; Memon, Abdul Shakoor			Elevated Chemerin Levels in Pakistani Men: An Interrelation with Metabolic Syndrome Phenotypes	PLOS ONE			English	Article							ADIPOSE-TISSUE; DIABETES-MELLITUS; BODY-WEIGHT; OBESITY; ADIPOKINE; INFLAMMATION; INSULIN; PREVALENCE; ADIPOGENESIS; ASSOCIATION	Chemerin is a novel protein linked to adipocyte differentiation and the development of metabolic imbalances. We sought to examine the relationship of chemerin with metabolic syndrome disturbances including body fat percentage, serum lipid, glucose, insulin levels and body fat percentage in lean and obese volunteers. A cross-sectional study of 90 randomly selected healthy males from Pakistan were divided into three groups as per Body Mass Index (BMI) criteria for South Asian Population. Anthropometric measurements were taken for BMI, waist circumference, hip circumference and body fat percentage, while serum analyses were performed for fasting blood glucose, fasting insulin, fasting lipid profile and serum chemerin. Associations between serum chemerin levels and body fat and other metabolic syndrome parameters were performed using ANOVA and multiple regression analyses. Data was presented as Mean +/- SD. In all statistical analyses p-values <0.05 were considered significant. Circulating chemerin levels were significantly higher in obese subjects with BMI greater than 25 kg/m(2) compared with those with a BMI below 25 kg/m(2) (P = 0.001). Serum chemerin levels were found to be independently and significantly associated with serum levels of cholesterol (P = 0.0160; r = 0.255), fasting glucose (P = 0.002; r = 0.323), HOMA-IR (P = 0.004; r = 0.300) and hip circumference (P = 0.021; r = 0.246). This demonstrates that chemerin levels are associated with obesity and dyslipidemia and may play a role in the development of insulin resistance. This data suggests that chemerin may serve as an independent marker in diagnosing these conditions even before they become clinically symptomatic.	[Fatima, Syeda Sadia] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Bozaoglu, Kiymet] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Rehman, Rehana] Bahria Univ Med & Dent Coll, Dept Physiol, Karachi, Pakistan; [Alam, Faiza; Memon, Abdul Shakoor] Jinnah Postgrad Med Ctr, Inst Basic Med Sci, Dept Physiol, Karachi, Pakistan	Aga Khan University; Baker Heart and Diabetes Institute	Fatima, SS (corresponding author), Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan.	sadia.fatima@aku.edu	Alam, Faiza/AAG-5297-2022; Bozaoglu, Kiymet/AAB-2513-2019; Alam, Faiza/P-4978-2016; Alam, Faiza/AFK-6964-2022; Rehman, Rehana/AAG-1473-2020	Bozaoglu, Kiymet/0000-0002-0807-2813; Fatima, Syeda Sadia/0000-0002-3164-0225; Alam, Faiza/0000-0002-4131-129X				Becker M, 2010, DIABETES, V59, P2898, DOI 10.2337/db10-0362; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Bozaoglu K, 2010, J CLIN ENDOCR METAB, V95, P2476, DOI 10.1210/jc.2010-0042; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Chakaroun R, 2012, METABOLISM, V61, P706, DOI 10.1016/j.metabol.2011.10.008; Conde J, 2011, ANN RHEUM DIS, V70, P551, DOI 10.1136/ard.2010.132399; Corson Marshall A, 2009, Curr Cardiol Rep, V11, P452, DOI 10.1007/s11886-009-0065-1; Dong BK, 2011, INTERNAL MED, V50, P1093, DOI 10.2169/internalmedicine.50.5025; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GARROW JS, 1985, INT J OBESITY, V9, P147; Gomez R, 2011, NAT REV RHEUMATOL, V7, P528, DOI 10.1038/nrrheum.2011.107; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Hah YJ, 2011, DIABETES METAB J, V35, P248, DOI 10.4093/dmj.2011.35.3.248; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Kukla M, 2011, POL J PATHOL, V62, P218; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Landgraf K, 2012, J CLIN ENDOCR METAB, V97, pE556, DOI 10.1210/jc.2011-2937; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; National health survey of Pakistan 1990-94, 1997, NAT HLTH SURV PAK 19, P181; Pfau D, 2010, HORM RES PAEDIAT, V74, P56, DOI 10.1159/000282114; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenbaum M, 1998, PEDIATRICS, V101, P525; Saremi Abbas, 2010, Asian J Sports Med, V1, P151; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Snehalatha C, 2003, DIABETES CARE, V26, P1380, DOI 10.2337/diacare.26.5.1380; Sorensen TIA, 2000, DIABETES CARE, V23, pB1; Stejskal D, 2008, BIOMED PAP, V152, P217, DOI 10.5507/bp.2008.033; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Tan BK, 2009, DIABETES, V58, P1971, DOI 10.2337/db08-1528; Tonjes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013911; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; Weigert J, 2010, CLIN ENDOCRINOL, V72, P342, DOI 10.1111/j.1365-2265.2009.03664.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WHO, 2008, WAIST CIRCUMFERENCE; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yajnik CS, 2004, LANCET, V363, P163, DOI 10.1016/S0140-6736(03)15269-5; Yang ML, 2010, J INVEST MED, V58, P883, DOI 10.231/JIM.0b013e3181ec5db2; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003	52	35	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57113	10.1371/journal.pone.0057113	http://dx.doi.org/10.1371/journal.pone.0057113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468920	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900053
J	Shanley, DK; Kiely, PA; Golla, K; Allen, S; Martin, K; O'Riordan, RT; Ball, M; Aplin, JD; Singer, BB; Caplice, N; Moran, N; Moore, T				Shanley, Daniel K.; Kiely, Patrick A.; Golla, Kalyan; Allen, Seamus; Martin, Kenneth; O'Riordan, Ronan T.; Ball, Melanie; Aplin, John D.; Singer, Bernhard B.; Caplice, Noel; Moran, Niamh; Moore, Tom			Pregnancy-Specific Glycoproteins Bind Integrin alpha IIb beta 3 and Inhibit the Platelet-Fibrinogen Interaction	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; EXPRESSION; PREECLAMPSIA; COAGULATION; SECRETION; PROTEINS; MARKERS; PSG; BETA-1-GLYCOPROTEIN; FIBRINOLYSIS	Pregnancy-specific glycoproteins (PSGs) are immunoglobulin superfamily members encoded by multigene families in rodents and primates. In human pregnancy, PSGs are secreted by the syncytiotrophoblast, a fetal tissue, and reach a concentration of up to 400 mu g/ml in the maternal bloodstream at term. Human and mouse PSGs induce release of anti-inflammatory cytokines such as IL-10 and TGF beta 1 from monocytes, macrophages, and other cell types, suggesting an immunoregulatory function. RGD tri-peptide motifs in the majority of human PSGs suggest that they may function like snake venom disintegrins, which bind integrins and inhibit interactions with ligands. We noted that human PSG1 has a KGD, rather than an RGD motif. The presence of a KGD in barbourin, a platelet integrin alpha IIb beta 3 antagonist found in snake venom, suggested that PSG1 may be a selective alpha IIb beta 3 ligand. Here we show that human PSG1 binds alpha IIb beta 3 and inhibits the platelet - fibrinogen interaction. Unexpectedly, however, the KGD is not critical as multiple PSG1 domains independently bind and inhibit alpha IIb beta 3 function. Human PSG9 and mouse Psg23 are also inhibitory suggesting conservation of this function across primate and rodent PSG families. Our results suggest that in species with haemochorial placentation, in which maternal blood is in direct contact with fetal trophoblast, the high expression level of PSGs reflects a requirement to antagonise abundant (3 mg/ml) fibrinogen in the maternal circulation, which may be necessary to prevent platelet aggregation and thrombosis in the prothrombotic maternal environment of pregnancy.	[Shanley, Daniel K.; O'Riordan, Ronan T.; Ball, Melanie; Moore, Tom] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cork, Ireland; [Martin, Kenneth; Caplice, Noel] Natl Univ Ireland Univ Coll Cork, Vasc Biol Res Ctr, Cork, Ireland; [Kiely, Patrick A.] Univ Limerick, Dept Life Sci, Limerick, Ireland; [Kiely, Patrick A.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland; [Golla, Kalyan; Allen, Seamus; Moran, Niamh] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Aplin, John D.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Singer, Bernhard B.] Univ Hosp Essen, Inst Anat, Essen, Germany	University College Cork; University College Cork; University of Limerick; University of Limerick; Royal College of Surgeons - Ireland; University of Manchester; University of Duisburg Essen	Moran, N (corresponding author), Royal Coll Surgeons Ireland, Dublin 2, Ireland.	nmoran@rcsi.ie; t.moore@ucc.ie	Moore, Tom/B-1471-2015; Singer, Bernhard B./AAP-9999-2020; Aplin, John/AET-4363-2022	Caplice, Noel/0000-0001-5445-1016; Moore, Tom/0000-0001-9712-9625; Aplin, John/0000-0001-8777-9261	Science Foundation Ireland; National Development Plan; Irish Higher Education Authority Program for Research in Third Level Institutions 3 (HEA-PRTLI3) Program in Integrative Reproduction	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Development Plan; Irish Higher Education Authority Program for Research in Third Level Institutions 3 (HEA-PRTLI3) Program in Integrative Reproduction	This study was funded by a Science Foundation Ireland (www.sfi.ie) Principal Investigator Award to T. Moore and by the Irish Higher Education Authority (www.hea.ie) Program for Research in Third Level Institutions 3 (HEA-PRTLI3) Program in Integrative Reproduction funded under the National Development Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylward K, 2006, J THROMB HAEMOST, V4, P1804, DOI 10.1111/j.1538-7836.2006.02041.x; Bates SM, 2008, CHEST, V133, p844S, DOI 10.1378/chest.08-0761; Bebo Bruce F. Jr, 2005, Current Drug Targets - Inflammation and Allergy, V4, P231; Bernard E, 2009, ACS CHEM BIOL, V4, P457, DOI 10.1021/cb8002623; Bersinger NA, 2004, ACTA OBSTET GYN SCAN, V83, P37, DOI 10.1111/j.1600-0412.2004.00277.x; Blumenstein M, 2009, PROTEOMICS, V9, P2929, DOI 10.1002/pmic.200800625; Bonnar J, 1976, Perspect Nephrol Hypertens, V5, P85; CADROY Y, 1993, BRIT J OBSTET GYNAEC, V100, P416, DOI 10.1111/j.1471-0528.1993.tb15264.x; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V11, P362, DOI 10.1080/713605565; DEBOER K, 1989, AM J OBSTET GYNECOL, V160, P95, DOI 10.1016/0002-9378(89)90096-3; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Dusse LM, 2011, CLIN CHIM ACTA, V412, P17, DOI 10.1016/j.cca.2010.09.030; Edstrom CS, 2000, EARLY HUM DEV, V59, P77, DOI 10.1016/S0378-3782(00)00084-0; Edwards RJ, 2007, NAT CHEM BIOL, V3, P108, DOI 10.1038/nchembio854; Fialova L, 1991, Cesk Gynekol, V56, P166; Ha CT, 2008, AM J REPROD IMMUNOL, V59, P251, DOI 10.1111/j.1600-0897.2007.00573.x; Ha CT, 2010, BIOL REPROD, V83, P27, DOI 10.1095/biolreprod.109.082412; Ha CT, 2005, J LEUKOCYTE BIOL, V77, P948, DOI 10.1189/jlb.0804453; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; HARRIS SJ, 1984, J REPROD IMMUNOL, V6, P267, DOI 10.1016/0165-0378(84)90015-9; James AH, 2010, CRIT CARE MED, V38, pS57, DOI 10.1097/CCM.0b013e3181c9e2bb; Jurisicova A, 1999, HUM REPROD, V14, P1852, DOI 10.1093/humrep/14.7.1852; Kammerer R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-12; Kazmi RS, 2011, BRIT J CLIN PHARMACO, V72, P593, DOI 10.1111/j.1365-2125.2011.04060.x; Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-115; Li M, 2009, THROMB RES, V124, P656, DOI 10.1016/j.thromres.2009.07.012; Li WH, 2005, BLOOD, V106, P2716, DOI 10.1182/blood-2005-01-0406; LIN TM, 1974, AM J OBSTET GYNECOL, V118, P223, DOI 10.1016/0002-9378(74)90553-5; Lisboa FA, 2011, J BIOL CHEM, V286, P7577, DOI 10.1074/jbc.M110.161810; MAJUMDAR S, 1982, INT J FERTIL, V27, P66; Mamanova L, 2010, NAT METHODS, V7, P130, DOI [10.1038/NMETH.1417, 10.1038/nmeth.1417]; Martinez FF, 2012, EUR J IMMUNOL, V42, P1573, DOI 10.1002/eji.201142140; McLellan AS, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-39; MENDELSOHN ME, 1991, P NATL ACAD SCI USA, V88, P11212, DOI 10.1073/pnas.88.24.11212; Motran CC, 2003, EUR J IMMUNOL, V33, P3007, DOI 10.1002/eji.200323993; Motran CC, 2002, J LEUKOCYTE BIOL, V72, P512; Pihl K, 2009, PRENATAL DIAG, V29, P1256, DOI 10.1002/pd.2408; Previtali E, 2011, BLOOD TRANSFUS-ITALY, V9, P120, DOI 10.2450/2010.0066-10; Ren QS, 2008, CURR OPIN HEMATOL, V15, P537, DOI 10.1097/MOH.0b013e328309ec74; SCARBOROUGH RM, 1991, J BIOL CHEM, V266, P9359; Schjetlein R, 1997, ACTA OBSTET GYN SCAN, V76, P541, DOI 10.3109/00016349709024580; Snyder SK, 2001, AM J REPROD IMMUNOL, V45, P205, DOI 10.1111/j.8755-8920.2001.450403.x; Sood R, 2006, BLOOD, V107, P3173, DOI 10.1182/blood-2005-10-4111; Sulkowski GN, 2011, PLACENTA, V32, P603, DOI 10.1016/j.placenta.2011.05.008; Tanjung MT, 2005, CLIN APPL THROMB-HEM, V11, P467, DOI 10.1177/107602960501100415; TEGLUND S, 1995, BIOCHEM BIOPH RES CO, V211, P656, DOI 10.1006/bbrc.1995.1862; TOWLER CM, 1976, BRIT J OBSTET GYNAEC, V83, P775, DOI 10.1111/j.1471-0528.1976.tb00743.x; Valera MC, 2010, PLATELETS, V21, P587, DOI 10.3109/09537104.2010.509828; WeilerGuettler H, 1996, DEVELOPMENT, V122, P2271; Wu JA, 2008, BIOL REPROD, V79, P1054, DOI 10.1095/biolreprod.108.070268; Wynne F, 2006, REPRODUCTION, V131, P721, DOI 10.1530/rep.1.00869; Zhou GQ, 1997, PLACENTA, V18, P491, DOI 10.1016/0143-4004(77)90002-9; Zhou GQ, 2001, BIOL REPROD, V64, P90, DOI 10.1095/biolreprod64.1.90; ZIMMERMANN W, 1989, BIOCHEM BIOPH RES CO, V163, P1197, DOI 10.1016/0006-291X(89)91105-4	55	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57491	10.1371/journal.pone.0057491	http://dx.doi.org/10.1371/journal.pone.0057491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469002	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900101
J	Simonato, F; Ventura, L; Sartori, N; Cappellesso, R; Fassan, M; Busund, LT; Fassina, A				Simonato, Francesca; Ventura, Laura; Sartori, Nicola; Cappellesso, Rocco; Fassan, Matteo; Busund, Lill-Tove; Fassina, Ambrogio			Detection of MicroRNAs in Archival Cytology Urine Smears	PLOS ONE			English	Article							BLADDER-CANCER; CELL-DEATH; EXPRESSION; CARCINOMA	MicroRNAs' dysregulation and profiling have been demonstrated to be clinically relevant in urothelial carcinoma (UC). Urine cytology is commonly used as the mainstay non-invasive test for secondary prevention and follow-up of UC patients. Ancillary tools are needed to support cytopathologists in the diagnosis of low-grade UC. The feasibility and reliability of microRNAs profiling by qRT-PCR analysis (miR-145 and miR-205) in archival routine urine cytology smears (affected by fixation/staining [Papanicolau] and room temperature storage) was tested in a series of 15 non-neoplastic and 10 UC urine specimens. Only samples with >5,000 urothelial cells and with <50% of inflammatory cells/red blood cells clusters were considered. Overall, a satisfactory amount of total RNA was obtained from all the considered samples (mean 1.27 +/- 1.43 mu g, range 0.06-4.60 mu g). Twenty nanograms of total RNA have been calculated to be the minimal total RNA concentration for reliable and reproducible miRNAs expression profiling analysis of archival cytological smears (slope = -3.4084; Rsquared = 0.99; efficiency = 1.94). miR-145 and miR-205 were significantly downregulated in UC samples in comparison to non-tumor controls. These findings demonstrate that urine archival cytology smears are suitable for obtaining high-quality RNA to be used in microRNAs expression profiling. Further studies should investigate if miRNAs profiling can be successfully translated into clinical practice as diagnostic or prognostic markers.	[Simonato, Francesca; Cappellesso, Rocco; Fassina, Ambrogio] Univ Padua, Dept Med DIMED, Surg Pathol & Cytopathol Unit, Padua, Italy; [Ventura, Laura; Sartori, Nicola] Univ Padua, Dept Stat, Padua, Italy; [Fassan, Matteo] Univ Verona, Dept Pathol & Diagnost, Surg Pathol & Cytopathol Unit, I-37100 Verona, Italy; [Busund, Lill-Tove] Univ Tromso, Inst Med Biol, Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway	University of Padua; University of Padua; University of Verona; UiT The Arctic University of Tromso; University Hospital of North Norway	Fassina, A (corresponding author), Univ Padua, Dept Med DIMED, Surg Pathol & Cytopathol Unit, Padua, Italy.	ambrogio.fassina@unipd.it	Cappellesso, Rocco/L-5463-2016; Fassan, Matteo/F-5152-2012	Cappellesso, Rocco/0000-0002-0480-3412; Fassan, Matteo/0000-0001-6515-5482; Sartori, Nicola/0000-0002-3063-8385	Veneto Region; University of Padova; Cariparo Foundation	Veneto Region(Regione Veneto); University of Padova; Cariparo Foundation(Fondazione Cariparo)	This work was supported by a grant from the Veneto Region (Ricerca Finalizzata 2006), by a grant from the University of Padova (Progetti di Ricerca di Ateneo 2011) and by the Cariparo Foundation Excellence-grant 2011/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almallah YZ, 2000, UROLOGY, V56, P37, DOI 10.1016/S0090-4295(00)00555-0; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Banos JLG, 2001, UROLOGY, V57, P685, DOI 10.1016/S0090-4295(00)01090-6; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bastacky S, 1999, CANCER CYTOPATHOL, V87, P118, DOI 10.1002/(SICI)1097-0142(19990625)87:3<118::AID-CNCR4>3.0.CO;2-N; Brown FM, 2000, UROL CLIN N AM, V27, P25, DOI 10.1016/S0094-0143(05)70231-7; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Daniely M, 2007, CANCER CYTOPATHOL, V111, P517, DOI 10.1002/cncr.23119; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Eble JN, 2004, PATHOLOGY GENETICS T; Fassan M, 2007, BIOL-TARGETS THER, V1, P393; Fassina A, 2012, CYTOPATHOLOGY, V23, P213, DOI 10.1111/j.1365-2303.2012.01005.x; Fassina A, 2012, LAB INVEST, V92, P1574, DOI 10.1038/labinvest.2012.129; Fassina A, 2012, MODERN PATHOL, V25, P86, DOI 10.1038/modpathol.2011.144; Fassina A, 2011, CHEST, V140, P1305, DOI 10.1378/chest.11-0708; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Hwang EC, 2011, UROLOGY, V77, P154, DOI 10.1016/j.urology.2010.04.059; Kenney PA, 2011, BJU INT, V107, P656, DOI 10.1111/j.1464-410X.2010.09489.x; Kocjan G., 2010, DIAGN CYTOPATHOL, V27; KOSS LG, 1985, ACTA CYTOL, V29, P810; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Neely LA, 2010, UROL ONCOL-SEMIN ORI, V28, P39, DOI 10.1016/j.urolonc.2008.06.006; Ostenfeld MS, 2010, ONCOGENE, V29, P1073, DOI 10.1038/onc.2009.395; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Tilki D, 2011, EUR UROL, V60, P484, DOI 10.1016/j.eururo.2011.05.053; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang G, 2012, CLIN GENITOURIN CANC, V10, P106, DOI 10.1016/j.clgc.2012.01.001; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Witjes JA, 2008, EUR UROL, V53, P45, DOI 10.1016/j.eururo.2007.08.015; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Zhou H, 2010, J MOL MED, V88, P709, DOI 10.1007/s00109-010-0617-2	34	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57490	10.1371/journal.pone.0057490	http://dx.doi.org/10.1371/journal.pone.0057490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469001	Green Published, gold			2022-12-27	WOS:000315524900100
J	Stiver, KA; Wolff, SH; Alonzo, SH				Stiver, Kelly A.; Wolff, Stephen H.; Alonzo, Suzanne H.			Sharing of Potential Nest Sites by Etheostoma olmstedi Males Suggests Mutual Tolerance in an Alloparental Species	PLOS ONE			English	Article							ECOLOGICAL CONSTRAINTS; PIMEPHALES-PROMELAS; FATHEAD MINNOW; COALITION-FORMATION; TESSELLATED DARTER; KIN SELECTION; NEOLAMPROLOGUS-PULCHER; GENETIC RELATEDNESS; PRISONERS-DILEMMA; ALLOPATERNAL CARE	When reproductive competitors tolerate or cooperate with one another, they may gain particular benefits, such as collectively guarding resources or attracting mates. Shared resources may be those essential to reproduction, such as a breeding site or nest. Using the tessellated darter, a species where males but not females compete over potential nest sites, we examined site use and sharing under controlled conditions of differing competitor density. Sharing was observed even when competitor density was low and individuals could have each occupied a potential nest site without same-sex sharing. Males were more likely to share a nest site with one other when the difference in size between them was larger rather than smaller. There was no evidence that female sharing was dependent on their relative size. Fish were generally more likely to use and share larger sites, in accordance with the greater relative surface area they offered. We discuss how one or both sharing males may potentially benefit, and how male sharing of potential nest sites could relate to female mating preferences. Tessellated darter males are known to provide alloparental care for eggs but this occurs without any social contact between the alloparent and the genetic father of the young. Thus, the suggestion that they may also share sites and maintain social contact with reproductive competitors highlights the importance of increased focus on the potential complexity of reproductive systems.	[Stiver, Kelly A.] So Connecticut State Univ, Dept Psychol, New Haven, CT 06515 USA; [Stiver, Kelly A.; Alonzo, Suzanne H.] Yale Univ, Sch Med, Dept Ecol & Evolut Biol, New Haven, CT USA; [Wolff, Stephen H.] Rice Univ, Dept Econ, Houston, TX USA	Connecticut State University System; Southern Connecticut State University; Yale University; Rice University	Stiver, KA (corresponding author), So Connecticut State Univ, Dept Psychol, New Haven, CT 06515 USA.	stiverk1@southernct.edu		Stiver, Kelly/0000-0002-0650-8281	Yale University; National Science Foundation [IOB-0450807]; Natural Sciences and Engineering Research Council of Canada (NSERC)	Yale University; National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding support was courtesy of Yale University, a grant from the National Science Foundation (IOB-0450807) to S. H. A., and a Natural Sciences and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship to K. A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awata S, 2005, BEHAV ECOL SOCIOBIOL, V58, P506, DOI 10.1007/s00265-005-0934-6; Backwell PRY, 2004, NATURE, V430, P417, DOI 10.1038/430417a; Balshine Sigal, 2008, P437; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Bergmuller R, 2005, P ROY SOC B-BIOL SCI, V272, P325, DOI 10.1098/rspb.2004.2960; Bessert ML, 2007, J HERED, V98, P716, DOI 10.1093/jhered/esm092; BROWN JL, 1978, ANNU REV ECOL SYST, V9, P123, DOI 10.1146/annurev.es.09.110178.001011; Buston PM, 2007, BEHAV PROCESS, V76, P152, DOI 10.1016/j.beproc.2007.01.020; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; CONNOR RC, 1995, TRENDS ECOL EVOL, V10, P84, DOI 10.1016/S0169-5347(00)88988-0; Connor R, 2007, BEHAV PROCESS, V76, P109, DOI 10.1016/j.beproc.2007.01.014; CONSTANTZ GD, 1985, ENVIRON BIOL FISH, V14, P175, DOI 10.1007/BF00000824; Constantz GD, 1979, P ACAD NAT SCI PHILI, V313, P131; Detto T, 2010, AM NAT, V175, pE119, DOI 10.1086/651588; DeWoody JA, 2000, COPEIA, P740; Dierkes P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1581, DOI 10.1007/s00265-008-0587-3; Dierkes P, 2005, ECOL LETT, V8, P968, DOI 10.1111/j.1461-0248.2005.00801.x; Dugatkin LA, 1998, P ROY SOC B-BIOL SCI, V265, P2121, DOI 10.1098/rspb.1998.0548; Duval EH, 2007, AM NAT, V169, P423, DOI 10.1086/512137; EMLEN ST, 1982, AM NAT, V119, P29, DOI 10.1086/283888; FAHY WILLIAM E., 1954, JOUR ELISHA MITCHELL SCI SOC, V70, P139; GALE WF, 1985, T AM FISH SOC, V114, P220, DOI 10.1577/1548-8659(1985)114<220:FASFOC>2.0.CO;2; HARCOURT AH, 1992, POLIT LIFE SCI, V11, P251, DOI 10.1017/S0730938400015252; Harcourt AH., 1992, COALITIONS ALLIANCES; Hatchwell BJ, 2000, ANIM BEHAV, V59, P1079, DOI 10.1006/anbe.2000.1394; Heg D, 2008, ENVIRON BIOL FISH, V83, P191, DOI 10.1007/s10641-007-9317-3; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, P2367, DOI 10.1098/rspb.2004.2855; Heg D, 2011, BEHAV ECOL, V22, P82, DOI 10.1093/beheco/arq170; Hoglund J, 1999, P ROY SOC B-BIOL SCI, V266, P813; Hoglund J, 2003, ANN ZOOL FENN, V40, P249; Hoglund J., 1995, LEKS, DOI DOI 10.1515/9781400864157; Jadwiszczak P., 2009, RUNDOM PRO 3 14 SOFT; Johnstone RA, 2000, P ROY SOC B-BIOL SCI, V267, P17, DOI 10.1098/rspb.2000.0960; Koenig W.D., 1981, P261; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P919, DOI 10.1098/rspb.1996.0136; MCDONALD DB, 1994, SCIENCE, V266, P1030, DOI 10.1126/science.7973654; Mesterton-Gibbons M, 2007, BEHAV ECOL, V18, P277, DOI 10.1093/beheco/arl084; NOE R, 1990, ANIM BEHAV, V39, P78, DOI 10.1016/S0003-3472(05)80728-6; Olson LE, 2009, BEHAV ECOL, V20, P624, DOI 10.1093/beheco/arp040; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; Page L.M., 1983, HDB DARTERS; Petrie M, 1999, NATURE, V401, P155, DOI 10.1038/43651; POPE TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P439, DOI 10.1007/BF00164071; RADABAUGH DC, 1989, J FISH BIOL, V34, P679, DOI 10.1111/j.1095-8649.1989.tb03349.x; Riehl C, 2011, P ROY SOC B-BIOL SCI, V278, P1728, DOI 10.1098/rspb.2010.1752; SARGENT RC, 1988, BEHAV ECOL SOCIOBIOL, V23, P33, DOI 10.1007/BF00303055; Schoepf I, 2012, J ANIM ECOL, V81, P649, DOI 10.1111/j.1365-2656.2011.01939.x; Shorey L, 2000, NATURE, V408, P352, DOI 10.1038/35042562; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Stiver KA, 2008, BEHAV ECOL, V19, P816, DOI 10.1093/beheco/arn031; Stiver KA, 2009, J FISH BIOL, V74, P1129, DOI 10.1111/j.1095-8649.2009.02173.x; Stiver KA, 2005, P ROY SOC B-BIOL SCI, V272, P1593, DOI 10.1098/rspb.2005.3123; Stiver KA, 2012, BEHAV ECOL SOCIOBIOL, V66, P855, DOI 10.1007/s00265-012-1334-3; Stiver KA, 2011, BEHAV ECOL, V22, P206, DOI 10.1093/beheco/arq186; Stiver KA, 2010, CURR ZOOL, V56, P1; TABORSKY M, 1987, BEHAVIOUR, V102, P82, DOI 10.1163/156853986X00063; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; Taborsky M, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P251, DOI 10.1017/CBO9780511542602.011; UNGER LM, 1983, BEHAV ECOL SOCIOBIOL, V13, P125, DOI 10.1007/BF00293802; UNGER LM, 1988, BEHAV ECOL SOCIOBIOL, V23, P27, DOI 10.1007/BF00303054; Vehrencamp SL, 2000, BEHAV ECOL, V11, P334, DOI 10.1093/beheco/11.3.334; WARNER RR, 1985, MAR BIOL, V87, P89, DOI 10.1007/BF00397010; WISENDEN BD, 1995, J CHEM ECOL, V21, P1469, DOI 10.1007/BF02035146; Wong MYL, 2007, P ROY SOC B-BIOL SCI, V274, P1093, DOI 10.1098/rspb.2006.0284; Woolfenden G.E., 1984, FLORIDA SCRUB JAY DE	66	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56041	10.1371/journal.pone.0056041	http://dx.doi.org/10.1371/journal.pone.0056041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468853	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900016
J	Uddin, S; Hossain, L; Rasmussen, K				Uddin, Shahadat; Hossain, Liaquat; Rasmussen, Kim			Network Effects on Scientific Collaborations	PLOS ONE			English	Article							CO-AUTHORSHIP; COAUTHORSHIP NETWORKS; PATTERNS; IMPACT; SCIENCE	Background: The analysis of co-authorship network aims at exploring the impact of network structure on the outcome of scientific collaborations and research publications. However, little is known about what network properties are associated with authors who have increased number of joint publications and are being cited highly. Methodology/Principal Findings: Measures of social network analysis, for example network centrality and tie strength, have been utilized extensively in current co-authorship literature to explore different behavioural patterns of co-authorship networks. Using three SNA measures (i.e., degree centrality, closeness centrality and betweenness centrality), we explore scientific collaboration networks to understand factors influencing performance (i.e., citation count) and formation (tie strength between authors) of such networks. A citation count is the number of times an article is cited by other articles. We use co-authorship dataset of the research field of 'steel structure' for the year 2005 to 2009. To measure the strength of scientific collaboration between two authors, we consider the number of articles co-authored by them. In this study, we examine how citation count of a scientific publication is influenced by different centrality measures of its co-author(s) in a co-authorship network. We further analyze the impact of the network positions of authors on the strength of their scientific collaborations. We use both correlation and regression methods for data analysis leading to statistical validation. We identify that citation count of a research article is positively correlated with the degree centrality and betweenness centrality values of its co-author(s). Also, we reveal that degree centrality and betweenness centrality values of authors in a co-authorship network are positively correlated with the strength of their scientific collaborations. Conclusions/Significance: Authors' network positions in co-authorship networks influence the performance (i.e., citation count) and formation (i.e., tie strength) of scientific collaborations.	[Uddin, Shahadat] Univ Sydney, Project Management Program, Sydney, NSW 2006, Australia; [Uddin, Shahadat] Univ Sydney, Ctr Complex Syst Res, Sydney, NSW 2006, Australia; [Hossain, Liaquat; Rasmussen, Kim] Univ Sydney, Fac Engn & IT, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Uddin, S (corresponding author), Univ Sydney, Project Management Program, Sydney, NSW 2006, Australia.	shahadat.uddin@sydney.edu.au	Rasmussen, Kim/F-7258-2013; Uddin, Shahadat/E-1963-2011; /E-7946-2010	Uddin, Shahadat/0000-0003-0091-6919; /0000-0002-7616-9182; Rasmussen, Kim J. R./0000-0002-8649-9257				Abbasi A, 2011, SCIENTOMETRICS, V89, P687, DOI 10.1007/s11192-011-0463-1; Acedo FJ, 2006, J MANAGE STUD, V43, P957, DOI 10.1111/j.1467-6486.2006.00625.x; BAVELAS A, 1950, J ACOUST SOC AM, V22, P723; Bosnjak L, 2012, SCIENTOMETRICS, P1; Cho CC, 2010, SCIENTOMETRICS, V85, P463, DOI 10.1007/s11192-010-0263-z; Eom YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024926; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gingras Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004048; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hamra J, 2011, SIGMIS CPR 2011: PROCEEDINGS OF THE 2011 ACM SIGMIS COMPUTER PERSONNEL RESEARCH CONFERENCE, P71; Hoekman J, 2010, RES POLICY, V39, P662, DOI 10.1016/j.respol.2010.01.012; Hoffman P, 1987, ATLANTIC MONTHLY, V260, P60; Hu MC, 2011, SCIENTOMETRICS, V88, P949, DOI 10.1007/s11192-011-0427-5; Inzelt A, 2009, SCIENTOMETRICS, V78, P37, DOI 10.1007/s11192-007-1957-8; KRETSCHMER H, 1994, SCIENTOMETRICS, V30, P363, DOI 10.1007/BF02017234; Liao CH, 2012, J INFORMETR, V6, P27, DOI 10.1016/j.joi.2011.09.003; Liu XM, 2005, INFORM PROCESS MANAG, V41, P1462, DOI 10.1016/j.ipm.2005.03.012; LUUKKONEN T, 1993, SCIENTOMETRICS, V28, P15, DOI 10.1007/BF02016282; LUUKKONEN T, 1992, SCI TECHNOL HUM VAL, V17, P101, DOI 10.1177/016224399201700106; Mazloumian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049246; Mazloumian A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018975; Meho LI, 2007, J AM SOC INF SCI TEC, V58, P2105, DOI 10.1002/asi.20677; Melin G, 1996, SCIENTOMETRICS, V36, P363, DOI 10.1007/BF02129600; Moray R, 1665, PHILOS T ROY SOC LON, V1, P82; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Oldenburg H, 1665, PHILOS T ROYAL SOC L, P1; Pan RK, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/18007; PERSSON O, 1995, SCIENTOMETRICS, V33, P351, DOI 10.1007/BF02017336; Petit M, 1665, PHILOS T, V1, P41; Radicchi F, 2012, UNDERST COMPLEX SYST, P233, DOI 10.1007/978-3-642-23068-4_7; Scott J., 2005, SOCIAL NETWORK ANAL; Uddin Mohammed Shahadat, 2011, J Healthc Qual, V33, P37, DOI 10.1111/j.1945-1474.2011.00118.x; Uddin S, 2012, SCIENTOMETRICS, V90, P687, DOI 10.1007/s11192-011-0511-x; Uddin S, 2011, PHYSICA A, V390, P2845, DOI 10.1016/j.physa.2011.03.028; Uddin S, 2011, COMPLEXITY, V16, P27, DOI 10.1002/cplx.20349; Wallace ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033339; Wasserman S., 2003, SOCIAL NETWORK ANAL; Yan EJ, 2009, J AM SOC INF SCI TEC, V60, P2107, DOI 10.1002/asi.21128; Zou GY, 2011, COMPUT MATH ORGAN TH, V17, P35, DOI 10.1007/s10588-010-9068-0	42	79	80	4	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57546	10.1371/journal.pone.0057546	http://dx.doi.org/10.1371/journal.pone.0057546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23469021	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900120
J	Xu, CX; Bai, RP; Zhang, DD; Li, ZL; Zhu, HH; Lai, MD; Zhu, YM				Xu, Chunxiao; Bai, Rongpan; Zhang, Dandan; Li, Zhenli; Zhu, Honghong; Lai, Maode; Zhu, Yimin			Effects of APOA5-1131T > C (rs662799) on Fasting Plasma Lipids and Risk of Metabolic Syndrome: Evidence from a Case-Control Study in China and a Meta-Analysis	PLOS ONE			English	Article							APOLIPOPROTEIN A5 GENE; CORONARY-ARTERY-DISEASE; APOA-V GENE; TRIGLYCERIDE LEVELS; HEART-DISEASE; VITAMIN-E; POLYMORPHISM; ASSOCIATION; VARIANTS; SUSCEPTIBILITY	The apolipoprotein A5 (APOA5) gene -1131T>C (rs662799) has been suggested to be involved in the pathway of lipid homeostasis and the development of metabolic syndrome (MetS). However, the findings are not consistent. To systematically evaluate the associations between -1131T>C polymorphism and fasting lipid parameters and the risk of MetS, we conducted a case-control study in a Chinese population and a meta-analysis. The findings from 1840 Chinese participants indicated that the C allele carriers had significantly higher fasting total cholesterol (TC), triglycerides (TG) and lower HDL-cholesterol (HDL-C) than the TT homozygotes carriers. The -1131C allele was also found to be significantly associated with increased risk of MetS (OR = 1.40, 95% confidence interval (CI) = 1.15, 1.69) compared to the TT homozygotes. In the meta-analysis of 51,868 participants from 46 East Asian studies, 26 European studies and 19 studies of other ethnic groups, the -1131C allele was associated with higher fasting TC (weighted mean difference (WMD) = 0.08 mmol/L, 95% CI = 0.05, 0.10, P = 1.74 x 10(-9)), TG (WMD = 0.30 mmol/L, 95% CI = 0.26, 0.33, P = 1.87 x 10(-55)), LDL-cholesterol (LDL-C) (WMD = 0.04 mmol/L, 95% CI = 0.02, 0.07, P = 0.002), and lower HDL-C (WMD = -0.05 mmol/L, 95% CI = -0.06, -0.04, P = 1.88 x 10(-21)), respectively. Based on 12 studies with 5,573 MetS cases and 8,290 controls from 5 East Asian studies, 5 European studies and 2 studies of other ethnic groups, the -1131C allele was associated with increased risk of MetS with an OR (95% CI) = 1.33 (1.16, 1.53) in the overall population, 1.43 (1.29, 1.58) in East Asian and 1.30 (0.94, 1.78) in European populations. In conclusion, the -1131C allele may be associated with elevated levels of fasting TG, TC, LDL-C and decreased HDL-C, and increased risk of MetS, especially in East Asians.	[Xu, Chunxiao; Zhu, Yimin] Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hangzhou 310003, Zhejiang, Peoples R China; [Bai, Rongpan] Zhejiang Univ, Sch Publ Hlth, Bioelectromagnet Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Dandan; Li, Zhenli; Lai, Maode] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Honghong] Western Kentucky Univ, Coll Hlth & Human Serv, Dept Publ Hlth, Bowling Green, KY 42101 USA	Zhejiang University; Zhejiang University; Zhejiang University; Western Kentucky University	Zhu, YM (corresponding author), Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hangzhou 310003, Zhejiang, Peoples R China.	zhuym@zju.edu.cn	Zhang, Dandan/ABA-9747-2020; Zhu, Yimin/D-6387-2017	Zhu, Yimin/0000-0001-8409-7636; zhang, dandan/0000-0001-5305-9856	National Natural Science Foundation of China [81172755]; National Key Technology R&D Program of China [2012BAI02B03, 2009BAI80B02]; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents; Fundamental Research Funds for the Central Universities; Program for Zhejiang Leading Team of Science and Technology Innovation [2010R50050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program); Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Zhejiang Leading Team of Science and Technology Innovation	Supported by the National Natural Science Foundation of China (81172755), National Key Technology R&D Program of China (2012BAI02B03, 2009BAI80B02), Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents, Fundamental Research Funds for the Central Universities, Program for Zhejiang Leading Team of Science and Technology Innovation (2010R50050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Aouizerat BE, 2003, J LIPID RES, V44, P1167, DOI 10.1194/jlr.M200480-JLR200; Baum L, 2003, CLIN GENET, V63, P377, DOI 10.1034/j.1399-0004.2003.00063.x; Baum L, 2007, J DIABETES COMPLICAT, V21, P158, DOI 10.1016/j.jdiacomp.2006.02.003; Beecham GW, 2010, ANN HUM GENET, V74, P189, DOI 10.1111/j.1469-1809.2010.00573.x; Bi N, 2004, MOL GENET METAB, V83, P280, DOI 10.1016/j.ymgme.2004.06.017; Chaaba Raja, 2005, Lipids Health Dis, V4, P1, DOI 10.1186/1476-511X-4-1; Chandak GR, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-76; Charriere S, 2008, CLIN CHIM ACTA, V394, P99, DOI 10.1016/j.cca.2008.04.013; Cheng YQ, 2007, MOL CARDIOLOGY CHINA, V7; Chien KL, 2008, CLIN CHIM ACTA, V390, P56, DOI 10.1016/j.cca.2007.12.014; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dai HY, 2011, J CHINESE PHYS, V13, P754; Dallongeville J, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-84; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dick DM, 2011, ANNU REV CLIN PSYCHO, V7, P383, DOI 10.1146/annurev-clinpsy-032210-104518; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Elosua R, 2006, J LIPID RES, V47, P990, DOI 10.1194/jlr.M500446-JLR200; Gao LB, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-117; Girona J, 2008, CLIN CHEM LAB MED, V46, P453, DOI 10.1515/CCLM.2008.110; Grallert H, 2007, J LIPID RES, V48, P2614, DOI 10.1194/jlr.M700011-JLR200; Hahne P, 2008, J INTERN MED, V264, P452, DOI 10.1111/j.1365-2796.2008.01987.x; Hodoglugil U, 2006, J LIPID RES, V47, P144, DOI 10.1194/jlr.M500343-JLR200; Hsu LA, 2006, ATHEROSCLEROSIS, V185, P143, DOI 10.1016/j.atherosclerosis.2005.05.031; Hsu LA, 2008, CLIN CHEM LAB MED, V46, P1714, DOI 10.1515/CCLM.2008.352; Huang MC, 2008, KAOHSIUNG J MED SCI, V24, P171, DOI 10.1016/S1607-551X(08)70114-1; Hubacek Jaroslav A, 2008, Exp Clin Cardiol, V13, P129; Jang Y, 2004, AM J CLIN NUTR, V80, P832; Jang Y, 2010, ATHEROSCLEROSIS, V211, P512, DOI 10.1016/j.atherosclerosis.2010.03.014; Jang Y, 2009, CLIN CHIM ACTA, V402, P83, DOI 10.1016/j.cca.2008.12.024; Jaromi L, 2010, J MOL NEUROSCI, V41, P121, DOI 10.1007/s12031-009-9301-9; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Ken-Dror G, 2010, J HUM GENET, V55, P300, DOI 10.1038/jhg.2010.27; Kisfali P, 2010, NUTR METAB CARDIOVAS, V20, P505, DOI 10.1016/j.numecd.2009.05.001; Komurcu-Bayrak E, 2008, CLIN CHEM LAB MED, V46, P778, DOI 10.1515/CCLM.2008.161; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Lai CQ, 2003, J LIPID RES, V44, P2365, DOI 10.1194/jlr.M300251-JLR200; Lee KWJ, 2004, ATHEROSCLEROSIS, V176, P165, DOI 10.1016/j.atherosclerosis.2004.04.024; Li GP, 2004, CLIN GENET, V65, P470, DOI 10.1111/j.1399-0004.2004.00251.x; Li XQ, 2011, EUR J INTERN MED, V22, P99, DOI 10.1016/j.ejim.2010.07.012; Li XP, 2007, CHINESE CIRCULATION, V22; Li XF, 2008, J HUAZHONG U SCI-MED, V28, P653, DOI 10.1007/s11596-008-0608-5; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin J, 2011, ANN NUTR METAB, V58, P150, DOI 10.1159/000327913; Liu HK, 2005, METABOLISM, V54, P568, DOI 10.1016/j.metabol.2004.11.009; Liu ZK, 2010, ATHEROSCLEROSIS, V208, P427, DOI 10.1016/j.atherosclerosis.2009.08.013; Maasz A, 2008, CIRC J, V72, P1065, DOI 10.1253/circj.72.1065; Maasz A, 2007, PATHOL ONCOL RES, V13, P243, DOI 10.1007/BF02893505; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martinelli N, 2007, ATHEROSCLEROSIS, V191, P409, DOI 10.1016/j.atherosclerosis.2006.04.009; Mattei J, 2009, J NUTR, V139, P2301, DOI 10.3945/jn.109.109900; Minelli C, 2008, INT J EPIDEMIOL, V37, P136, DOI 10.1093/ije/dym234; Niculescu LS, 2010, BIOCHEM BIOPH RES CO, V391, P587, DOI 10.1016/j.bbrc.2009.11.103; Olano-Martin E, 2008, J LIPID RES, V49, P945, DOI 10.1194/jlr.M700112-JLR200; Ong KL, 2011, CLIN ENDOCRINOL, V74, P206, DOI 10.1111/j.1365-2265.2010.03899.x; Palmen J, 2008, BBA-MOL BASIS DIS, V1782, P447, DOI 10.1016/j.bbadis.2008.03.003; Pennacchio LA, 2003, ARTERIOSCL THROM VAS, V23, P529, DOI 10.1161/01.ATV.0000054194.78240.45; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Povel CM, 2011, OBES REV, V12, P952, DOI 10.1111/j.1467-789X.2011.00907.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiao Y, 2008, J SICHUAN U MED SCI, V39; Qiu F, 2007, CHIN J ANERIOSCLER, V15; Saleheen D, 2010, CIRC-CARDIOVASC GENE, V3, P348, DOI 10.1161/CIRCGENETICS.109.906180; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Song KH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/598394; Sundl I, 2007, J LIPID RES, V48, P2506, DOI 10.1194/jlr.M700285-JLR200; Szalai C, 2004, ATHEROSCLEROSIS, V173, P109, DOI 10.1016/j.atherosclerosis.2003.12.003; Talmud PJ, 2004, J LIPID RES, V45, P750, DOI 10.1194/jlr.M300458-JLR200; Tang YB, 2005, CHIN J ARTERIOSCLER, V13; Vasilopoulos Y, 2011, GENET TEST MOL BIOMA, V15, P613, DOI 10.1089/gtmb.2010.0256; Wang Q, 2010, ANHUI MED J, V31; Yamada Y, 2007, GENOMICS, V90, P551, DOI 10.1016/j.ygeno.2007.08.001; Yamada Y, 2007, ATHEROSCLEROSIS, V191, P298, DOI 10.1016/j.atherosclerosis.2006.05.035; Yan SK, 2005, CLIN CHEM LAB MED, V43, P607, DOI 10.1515/CCLM.2005.105; Yang F, 2007, SHANDONG MED J, V47, P1; Yin RX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017954; Zhu M, 2007, CHIN J DIABETES, V15; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	81	32	33	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56216	10.1371/journal.pone.0056216	http://dx.doi.org/10.1371/journal.pone.0056216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468858	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900020
J	Foglia, E; Bonfanti, P; Rizzardini, G; Bonizzoni, E; Restelli, U; Ricci, E; Porazzi, E; Scolari, F; Croce, D				Foglia, Emanuela; Bonfanti, Paolo; Rizzardini, Giuliano; Bonizzoni, Erminio; Restelli, Umberto; Ricci, Elena; Porazzi, Emanuele; Scolari, Francesca; Croce, Davide			Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir plus Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World	PLOS ONE			English	Article							TWICE-DAILY LOPINAVIR/RITONAVIR; ONCE-DAILY ATAZANAVIR/RITONAVIR; NAIVE HIV-1-INFECTED PATIENTS; IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; ECONOMIC-EVALUATION; HEART-DISEASE; HEALTH-CARE; TENOFOVIR; CASTLE	Objective: To estimate the lifetime cost utility of two antiretroviral regimens (once-daily atazanavir plus ritonavir [ATV+r] versus twice-daily lopinavir/ ritonavir [LPV/r]) in Italian human immunodeficiency virus (HIV)-infected patients naive to treatment. Design: With this observational retrospective study we collected the clinical data of a cohort of HIV-infected patients receiving first-line treatment with LPV/r or ATV+r. Methodology: A Markov microsimulation model including direct costs and health outcomes of first- and second-line highly active retroviral therapy was developed from a third-party (Italian National Healthcare Service) payer's perspective. Health and monetary outcomes associated with the long-term use of ATV+r and LPV/r regimens were evaluated on the basis of eight health states, incidence of diarrhoea and hyperbilirubinemia, AIDS events, opportunistic infections, coronary heart disease events and, for the first time in an economic evaluation, chronic kidney disease (CKD) events. In order to account for possible deviations between real-life data and randomised controlled trial results, a second control arm (ATV+r 2) was created with differential transition probabilities taken from the literature. Results: The average survival was 24.061 years for patients receiving LPV/r, 24.081 and 24.084 for those receiving ATV+r 1 and 2 respectively. The mean quality-adjusted life-years (QALYs) were higher for the patients receiving LPV/r than those receiving ATV+r (13.322 vs. 13.060 and 13.261 for ATV+r 1 and 2). The cost-utility values were 15,310.56 for LPV/r, 15,902.99 and 15,524.85 for ATV+r 1 and 2. Conclusions: Using real-life data, the model produced significantly different results compared with other studies. With the innovative addition of an evaluation of CKD events, the model showed a cost-utility value advantage for twice-daily LPV/r over once-daily ATV+r, thus providing evidence for its continued use in the treatment of HIV.	[Foglia, Emanuela; Restelli, Umberto; Porazzi, Emanuele; Scolari, Francesca; Croce, Davide] Univ Carlo Cattaneo LIUC, CREMS Ctr Res Hlth Econ Social & Hlth Care Manage, Castellanza, Varese, Italy; [Bonfanti, Paolo] A Manzoni Hosp, Dept Infect & Trop Dis, Lecce, Italy; [Rizzardini, Giuliano; Ricci, Elena] L Sacco Hosp Author, Dept Infect Dis 1, Milan, Italy; [Rizzardini, Giuliano; Ricci, Elena] L Sacco Hosp Author, Dept Infect Dis 2, Milan, Italy; [Bonizzoni, Erminio] Univ Milan, Fac Med & Surg, Dept Occupat Hlth Clin L Devoto Labour, Sect Med Stat & Biometry GA Maccacaro, Milan, Italy; [Restelli, Umberto; Croce, Davide] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa	Universita Carlo Cattaneo - Liuc; University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; University of Milan; University of Witwatersrand	Restelli, U (corresponding author), Univ Carlo Cattaneo LIUC, CREMS Ctr Res Hlth Econ Social & Hlth Care Manage, Castellanza, Varese, Italy.	urestelli@liuc.it	Bonfanti, Paolo/AAK-9800-2020	Bonfanti, Paolo/0000-0001-7289-8823; Porazzi, Emanuele/0000-0002-9620-9209; Ricci, Elena/0000-0001-5279-0444; CROCE, Davide/0000-0002-9472-3431	Abbott Italy	Abbott Italy(Abbott Laboratories)	An unconditional grant was received by Abbott Italy, to cover the costs for the reprocessing of data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Heart Association, 2009, HEART DIS STROK STAT; Bowles H, 1999, NURS STAND, V13, P32; Broder Michael S, 2011, J Med Econ, V14, P167, DOI 10.3111/13696998.2011.554932; Buxton MJ, 1997, HEALTH ECON, V6, P217, DOI 10.1002/(SICI)1099-1050(199705)6:3<217::AID-HEC267>3.0.CO;2-W; Castiel D, 1992, Pharmacoeconomics, V1, P438; Creed F, 2001, ANN INTERN MED, V134, P860, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00010; Drummond MF, 2015, METHODS EC EVALUATIO; EUnetHTA, 2008, HTA COR MOD MED SURG; Ferrer-i-Carbonell A, 2001, 314 IZA; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; Fukui T, 2003, INT FORUM MACROECONO; Goeree R, 2005, GEN EC EVALUATIONS U; ISTAT, DEM CIFR; Italian Ministry of Health, 2010, LIN GUID IT SULLUTIL; Manca A, 2006, PHARMACOECONOMICS, V24, P1101, DOI 10.2165/00019053-200624110-00007; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Molina JM, 2010, JAIDS-J ACQ IMM DEF, V53, P323, DOI 10.1097/QAI.0b013e3181c990bf; O'Brien BJ, 1997, AM J MANAG CARE, V3, pS33; Obel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022698; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Rizzardini G, 2011, JAIDS-J ACQ IMM DEF, V57, P211, DOI 10.1097/QAI.0b013e31821fdee2; Rose DN, 1998, ANN INTERN MED, V129, P779, DOI 10.7326/0003-4819-129-10-199811150-00005; Sculpher MJ, 2004, HEALTH TECHNOL ASSES, V8, P1; Simpson KN, 2007, CLIN DRUG INVEST, V27, P807, DOI 10.2165/00044011-200727120-00002; Simpson KN, 2007, CLIN DRUG INVEST, V27, P67, DOI 10.2165/00044011-200727010-00006; Simpson KN, 2009, ADV THER, V26, P185, DOI 10.1007/s12325-008-0141-8; Simpson KN, 2004, HIV CLIN TRIALS, V5, P294, DOI 10.1310/WT81-MEM4-5C4L-CHPK; Whitehead WE, 1996, DIGEST DIS SCI, V41, P2248, DOI 10.1007/BF02071408; Worm SW, 2009, CIRCULATION, V119, P805, DOI 10.1161/CIRCULATIONAHA.108.790857; Young J, 2012, AIDS, V26, P567, DOI 10.1097/QAD.0b013e32834f337c	32	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57777	10.1371/journal.pone.0057777	http://dx.doi.org/10.1371/journal.pone.0057777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460905	gold, Green Published			2022-12-27	WOS:000315519000160
J	Majumder, P; Banerjee, A; Shandilya, J; Senapati, P; Chatterjee, S; Kundu, TK; Dasgupta, D				Majumder, Parijat; Banerjee, Amrita; Shandilya, Jayasha; Senapati, Parijat; Chatterjee, Snehajyoti; Kundu, Tapas K.; Dasgupta, Dipak			Minor Groove Binder Distamycin Remodels Chromatin but Inhibits Transcription	PLOS ONE			English	Article							RNA-POLYMERASE-II; IN-VITRO; SYNTHETIC ANALOGS; DNA-BINDING; NUCLEOSOMAL BARRIER; HISTONE OCTAMER; NETROPSIN; SPECIFICITY; DISPLACEMENT; ASSOCIATION	The condensed structure of chromatin limits access of cellular machinery towards template DNA. This in turn represses essential processes like transcription, replication, repair and recombination. The repression is alleviated by a variety of energy dependent processes, collectively known as "chromatin remodeling''. In a eukaryotic cell, a fine balance between condensed and de-condensed states of chromatin helps to maintain an optimum level of gene expression. DNA binding small molecules have the potential to perturb such equilibrium. We present herein the study of an oligopeptide antibiotic distamycin, which binds to the minor groove of B-DNA. Chromatin mobility assays and circular dichroism spectroscopy have been employed to study the effect of distamycin on chromatosomes, isolated from the liver of Sprague-Dawley rats. Our results show that distamycin is capable of remodeling both chromatosomes and reconstituted nucleosomes, and the remodeling takes place in an ATP-independent manner. Binding of distamycin to the linker and nucleosomal DNA culminates in eviction of the linker histone and the formation of a population of off-centered nucleosomes. This hints at a possible corkscrew type motion of the DNA with respect to the histone octamer. Our results indicate that distamycin in spite of remodeling chromatin, inhibits transcription from both DNA and chromatin templates. Therefore, the DNA that is made accessible due to remodeling is either structurally incompetent for transcription, or bound distamycin poses a roadblock for the transcription machinery to advance.	[Majumder, Parijat; Banerjee, Amrita; Dasgupta, Dipak] Saha Inst Nucl Phys, Div Biophys, Kolkata, W Bengal, India; [Shandilya, Jayasha; Senapati, Parijat; Chatterjee, Snehajyoti; Kundu, Tapas K.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India	Saha Institute of Nuclear Physics; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Dasgupta, D (corresponding author), Saha Inst Nucl Phys, Div Biophys, Kolkata, W Bengal, India.	dipak.dasgupta@saha.ac.in	Chatterjee, Snehajyoti/AAV-3919-2021; Senapati, Parijat/C-6300-2009	Chatterjee, Snehajyoti/0000-0002-4873-9416; Senapati, Parijat/0000-0002-7324-1230; Shandilya, Jayasha/0000-0001-9911-8065; Kundu, Tapas/0000-0001-7790-214X	intramural grant MMDDA, of the Department of Atomic Energy, India	intramural grant MMDDA, of the Department of Atomic Energy, India	This work was funded by the intramural grant MMDDA, of the Department of Atomic Energy, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagi M, 2010, BIOPHYS CHEM, V149, P34, DOI 10.1016/j.bpc.2010.03.014; B RS, 2009, CHEM BIOL, V16, P203, DOI 10.1016/j.chembiol.2008.12.006; Baron RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010656; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; BELLORINI M, 1995, NUCLEIC ACIDS RES, V23, P1657, DOI 10.1093/nar/23.10.1657; Blossey R, 2011, FEBS J, V278, P3619, DOI 10.1111/j.1742-4658.2011.08283.x; Brown PM, 1996, J MOL BIOL, V262, P671, DOI 10.1006/jmbi.1996.0544; Broyles SS, 2004, J VIROL, V78, P2137, DOI 10.1128/JVI.78.4.2137-2141.2004; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; DASGUPTA D, 1990, BIOPOLYMERS, V30, P223, DOI 10.1002/bip.360300124; DASGUPTA D, 1987, BIOCHEMISTRY-US, V26, P6381, DOI 10.1021/bi00394a011; DASGUPTA D, 1986, BIOCHEM BIOPH RES CO, V140, P626, DOI 10.1016/0006-291X(86)90777-1; DATTAGUPTA N, 1980, BIOCHEMISTRY-US, V19, P5998, DOI 10.1021/bi00567a009; Fasman G D, 1978, Methods Cell Biol, V18, P327; Fasman G.D., 1996, CIRCULAR DICHROISM C; FENG HP, 1993, BIOCHEMISTRY-US, V32, P7824, DOI 10.1021/bi00081a030; FISH EL, 1988, BIOCHEMISTRY-US, V27, P6026, DOI 10.1021/bi00416a030; Flaus A, 2001, CURR OPIN GENET DEV, V11, P148, DOI 10.1016/S0959-437X(00)00172-6; GARTENBERG MR, 1992, P NATL ACAD SCI USA, V89, P11461, DOI 10.1073/pnas.89.23.11461; Gottesfeld JM, 2002, J MOL BIOL, V321, P249, DOI 10.1016/S0022-2836(02)00598-3; Horn PJ, 2002, SCIENCE, V297, P1824, DOI 10.1126/science.1074200; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Joshi RS, 2010, EMBO J, V29, P740, DOI 10.1038/emboj.2009.391; KAS E, 1989, J MOL BIOL, V210, P587, DOI 10.1016/0022-2836(89)90134-4; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; KIROV N, 1992, EMBO J, V11, P1941, DOI 10.1002/j.1460-2075.1992.tb05247.x; KOPKA ML, 1985, P NATL ACAD SCI USA, V82, P1376, DOI 10.1073/pnas.82.5.1376; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; KUPPER HA, 1973, EUR J BIOCHEM, V38, P581, DOI 10.1111/j.1432-1033.1973.tb03093.x; Lah J, 2000, BIOCHEMISTRY-US, V39, P9317, DOI 10.1021/bi000748u; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LOW CML, 1986, NUCLEIC ACIDS RES, V14, P6785, DOI 10.1093/nar/14.17.6785; LUCK G, 1977, NUCLEIC ACIDS RES, V4, P2655, DOI 10.1093/nar/4.8.2655; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Majumder P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026486; Mir MA, 2003, BIOORGAN MED CHEM, V11, P2791, DOI 10.1016/S0968-0896(03)00211-6; Mir MA, 2001, BIOCHEMISTRY-US, V40, P11578, DOI 10.1021/bi010731r; Nelson SM, 2007, MUTAT RES-FUND MOL M, V623, P24, DOI 10.1016/j.mrfmmm.2007.03.012; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; PARRACK P, 1987, FEBS LETT, V212, P297, DOI 10.1016/0014-5793(87)81364-9; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Peterson CL, 2008, CSH PROTOC; Portugal J, 2001, METHOD ENZYMOL, V340, P503; PUSCHENDORF B, 1974, EUR J BIOCHEM, V49, P531, DOI 10.1111/j.1432-1033.1974.tb03857.x; RAO KE, 1988, BIOCHEMISTRY-US, V27, P3018, DOI 10.1021/bi00408a053; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Roca J, TRANSCRIPTION, V2, P82; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; STRANEY DC, 1987, BIOCHEMISTRY-US, V26, P1987, DOI 10.1021/bi00381a031; STUDITSKY VM, 1995, CELL, V83, P19, DOI 10.1016/0092-8674(95)90230-9; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; STUDITSKY VM, 1994, CELL, V76, P371, DOI 10.1016/0092-8674(94)90343-3; Taylor A, 1997, MOL CELL BIOCHEM, V169, P61, DOI 10.1023/A:1006898812618; Todd RC, 2010, CHEM BIOL, V17, P1334, DOI 10.1016/j.chembiol.2010.10.018; Todd RC, 2009, METALLOMICS, V1, P280, DOI 10.1039/b907567d; VANDYKE MW, 1982, P NATL ACAD SCI-BIOL, V79, P5470; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Wu B, 2008, CHEM BIOL, V15, P1023, DOI 10.1016/j.chembiol.2008.08.010; Zimmer C, 1975, Prog Nucleic Acid Res Mol Biol, V15, P285, DOI 10.1016/S0079-6603(08)60122-1	67	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57693	10.1371/journal.pone.0057693	http://dx.doi.org/10.1371/journal.pone.0057693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460895	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000150
J	Ragazzoni, A; Pirulli, C; Veniero, D; Feurra, M; Cincotta, M; Giovannelli, F; Chiaramonti, R; Lino, M; Rossi, S; Miniussi, C				Ragazzoni, Aldo; Pirulli, Cornelia; Veniero, Domenica; Feurra, Matteo; Cincotta, Massimo; Giovannelli, Fabio; Chiaramonti, Roberta; Lino, Mario; Rossi, Simone; Miniussi, Carlo			Vegetative versus Minimally Conscious States: A Study Using TMS-EEG, Sensory and Event-Related Potentials	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL EFFECTIVE CONNECTIVITY; SOMATOSENSORY-EVOKED POTENTIALS; BRAIN-DAMAGE; DISORDERS; RESPONSES; RECOVERY; CORTEX; MOTOR; NEUROPATHOLOGY	Differential diagnoses between vegetative and minimally conscious states (VS and MCS, respectively) are frequently incorrect. Hence, further research is necessary to improve the diagnostic accuracy at the bedside. The main neuropathological feature of VS is the diffuse damage of cortical and subcortical connections. Starting with this premise, we used electroencephalography (EEG) recordings to evaluate the cortical reactivity and effective connectivity during transcranial magnetic stimulation (TMS) in chronic VS or MCS patients. Moreover, the TMS-EEG data were compared with the results from standard somatosensory-evoked potentials (SEPs) and event-related potentials (ERPs). Thirteen patients with chronic consciousness disorders were examined at their bedsides. A group of healthy volunteers served as the control group. The amplitudes (reactivity) and scalp distributions (connectivity) of the cortical potentials evoked by TMS (TEPs) of the primary motor cortex were measured. Short-latency median nerve SEPs and auditory ERPs were also recorded. Reproducible TEPs were present in all control subjects in both the ipsilateral and the contralateral hemispheres relative to the site of the TMS. The amplitudes of the ipsilateral and contralateral TEPs were reduced in four of the five MCS patients, and the TEPs were bilaterally absent in one MCS patient. Among the VS patients, five did not manifest ipsilateral or contralateral TEPs, and three of the patients exhibited only ipsilateral TEPs with reduced amplitudes. The SEPs were altered in five VS and two MCS patients but did not correlate with the clinical diagnosis. The ERPs were impaired in all patients and did not correlate with the clinical diagnosis. These TEP results suggest that cortical reactivity and connectivity are severely impaired in all VS patients, whereas in most MCS patients, the TEPs are preserved but with abnormal features. Therefore, TEPs may add valuable information to the current clinical and neurophysiological assessment of chronic consciousness disorders.	[Ragazzoni, Aldo; Cincotta, Massimo; Giovannelli, Fabio; Chiaramonti, Roberta] San Giovanni di Dio Hosp, Azienda Sanitaria Firenze, Neurol Unit, Florence, Italy; [Pirulli, Cornelia; Veniero, Domenica; Miniussi, Carlo] IRCCS Ctr San Giovanni di Dio Fatebenefratelli, Cognit Neurosci Sect, Brescia, Italy; [Feurra, Matteo; Rossi, Simone] Azienda Osped Univ, Dept Neurol & Neurosensorial Sci, Neurol & Clin Neurophysiol Sect, Siena, Italy; [Lino, Mario] Rehab Ctr Villa Terme, Florence, Italy; [Miniussi, Carlo] Univ Brescia, Natl Inst Neurosci, Dept Clin & Expt Sci, Brescia, Italy	Azienda Sanitaria di Firenze; IRCCS Fatebenefratelli; University of Siena; University Hospital of Siena; University of Brescia	Ragazzoni, A (corresponding author), San Giovanni di Dio Hosp, Azienda Sanitaria Firenze, Neurol Unit, Florence, Italy.	ragazzoni@neuro.unifi.it; carlo.miniussi@cognitiveneuroscience.it	Giovannelli, Fabio/AAC-1571-2019; Feurra, Matteo/K-1524-2019; Cincotta, Massimo/AAA-7532-2019; Rossi, Simone/AAC-6067-2022; Miniussi, Carlo/E-7602-2010; Pirulli, Cornelia/K-1518-2016; Miniussi, Carlo/P-5610-2019	Giovannelli, Fabio/0000-0003-1059-9945; Feurra, Matteo/0000-0003-0934-6764; Cincotta, Massimo/0000-0001-5223-646X; Rossi, Simone/0000-0001-6697-9459; Miniussi, Carlo/0000-0002-5436-4745; Pirulli, Cornelia/0000-0003-1865-5833; Miniussi, Carlo/0000-0002-5436-4745; Ragazzoni, Roberto/0000-0002-7697-5555	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This study was supported by a grant from the Italian Ministry of Health to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Babiloni C, 2009, CLIN NEUROPHYSIOL, V120, P719, DOI 10.1016/j.clinph.2009.02.157; Bonato C, 2006, CLIN NEUROPHYSIOL, V117, P1699, DOI 10.1016/j.clinph.2006.05.006; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; Casarotto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010281; Cavinato M, 2011, CLIN NEUROPHYSIOL, V122, P719, DOI 10.1016/j.clinph.2010.08.024; Cavinato M, 2009, BRAIN INJURY, V23, P973, DOI 10.3109/02699050903373493; Cruccu G, 2008, CLIN NEUROPHYSIOL, V119, P1705, DOI 10.1016/j.clinph.2008.03.016; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Daskalakis ZJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2860, DOI 10.1038/npp.2008.22; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Faugeras F, 2011, NEUROLOGY, V77, P264, DOI 10.1212/WNL.0b013e3182217ee8; Faugeras F, 2012, NEUROPSYCHOLOGIA, V50, P403, DOI 10.1016/j.neuropsychologia.2011.12.015; Fellinger R, 2011, CLIN NEUROPHYSIOL, V122, P2177, DOI 10.1016/j.clinph.2011.03.004; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Ferreri F, 2011, NEUROIMAGE, V54, P90, DOI 10.1016/j.neuroimage.2010.07.056; Fingelkurts AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025967; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Friston KJ, 2002, ANNU REV NEUROSCI, V25, P221, DOI 10.1146/annurev.neuro.25.112701.142846; Giacino JT, 2006, ARCH PHYS MED REHAB, V87, pS67, DOI 10.1016/j.apmr.2006.07.272; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Harris IM, 2003, J COGNITIVE NEUROSCI, V15, P315, DOI 10.1162/089892903321593054; Ilmoniemi RJ, 2010, BRAIN TOPOGR, V22, P233, DOI 10.1007/s10548-009-0123-4; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; JENNETT B, 1972, LANCET, V1, P734; Jox RJ, 2012, LANCET NEUROL, V11, P732, DOI 10.1016/S1474-4422(12)70154-0; Kahkonen S, 2004, CLIN NEUROPHYSIOL, V115, P583, DOI 10.1016/j.clinph.2003.10.032; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; Komssi S, 2004, HUM BRAIN MAPP, V21, P154, DOI 10.1002/hbm.10159; Komssi S, 2006, BRAIN RES REV, V52, P183, DOI 10.1016/j.brainresrev.2006.01.008; Korhonen RJ, 2011, MED BIOL ENG COMPUT, V49, P397, DOI 10.1007/s11517-011-0748-9; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Leon-Carrion J, 2008, CLIN NEUROPHYSIOL, V119, P1506, DOI 10.1016/j.clinph.2008.03.030; Maki H, 2011, NEUROIMAGE, V54, P2706, DOI 10.1016/j.neuroimage.2010.11.041; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Miniussi C, 2005, CLIN NEUROPHYSIOL, V116, P1062, DOI 10.1016/j.clinph.2005.01.002; Miniussi C, 2010, BRAIN TOPOGR, V22, P249, DOI 10.1007/s10548-009-0083-8; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Racine E, 2008, NEUROLOGY, V71, P1027, DOI 10.1212/01.wnl.0000320507.64683.ee; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Rossi S, 2007, CLIN NEUROPHYSIOL, V118, P709, DOI 10.1016/j.clinph.2006.11.005; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Siebner HR, 2009, BRAIN STIMUL, V2, P58, DOI 10.1016/j.brs.2008.11.002; Tshibanda L, 2010, NEURORADIOLOGY, V52, P15, DOI 10.1007/s00234-009-0614-8; Veniero D, 2010, J NEUROPHYSIOL, V104, P1578, DOI 10.1152/jn.00172.2010; Veniero D, 2009, CLIN NEUROPHYSIOL, V120, P1392, DOI 10.1016/j.clinph.2009.04.023; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306	63	75	82	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57069	10.1371/journal.pone.0057069	http://dx.doi.org/10.1371/journal.pone.0057069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460826	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000058
J	Tripathi, AM; Tyagi, A; Kumar, A; Singh, A; Singh, S; Chaudhary, LB; Roy, S				Tripathi, Abhinandan Mani; Tyagi, Antariksh; Kumar, Anoop; Singh, Akanksha; Singh, Shivani; Chaudhary, Lal Babu; Roy, Sribash			The Internal Transcribed Spacer (ITS) Region and trnhH-psbA Are Suitable Candidate Loci for DNA Barcoding of Tropical Tree Species of India	PLOS ONE			English	Article							LAND PLANTS; BIOLOGICAL IDENTIFICATIONS; SEDGES CAREX; RBCL; L.; RESOLUTION; PROSPECTS; MARKERS; GENUS; COX1	Background: DNA barcoding as a tool for species identification has been successful in animals and other organisms, including certain groups of plants. The exploration of this new tool for species identification, particularly in tree species, is very scanty from biodiversity-rich countries like India. rbcL and matK are standard barcode loci while ITS, and trnH-psbA are considered as supplementary loci for plants. Methodology and Principal Findings: Plant barcode loci, namely, rbcL, matK, ITS, trnH-psbA, and the recently proposed ITS2, were tested for their efficacy as barcode loci using 300 accessions of tropical tree species. We tested these loci for PCR, sequencing success, and species discrimination ability using three methods. rbcL was the best locus as far as PCR and sequencing success rate were concerned, but not for the species discrimination ability of tropical tree species. ITS and trnH-psbA were the second best loci in PCR and sequencing success, respectively. The species discrimination ability of ITS ranged from 24.4 percent to 74.3 percent and that of trnH-psbA was 25.6 percent to 67.7 percent, depending upon the data set and the method used. matK provided the least PCR success, followed by ITS2 (59.0%). Species resolution by ITS2 and rbcL ranged from 9.0 percent to 48.7 percent and 13.2 percent to 43.6 percent, respectively. Further, we observed that the NCBI nucleotide database is poorly represented by the sequences of barcode loci studied here for tree species. Conclusion: Although a conservative approach of a success rate of 60-70 percent by both ITS and trnH-psbA may not be considered as highly successful but would certainly help in large-scale biodiversity inventorization, particularly for tropical tree species, considering the standard success rate of plant DNA barcode program reported so far. The recommended matK and rbcL primers combination may not work in tropical tree species as barcode markers.	[Tripathi, Abhinandan Mani; Tyagi, Antariksh; Singh, Akanksha; Singh, Shivani; Roy, Sribash] Natl Bot Res Inst, CSIR, Genet & Mol Biol Div, Lucknow 226001, Uttar Pradesh, India; [Kumar, Anoop; Chaudhary, Lal Babu] Natl Bot Res Inst, CSIR, Plant Divers Systemat & Herbarium Div, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Roy, S (corresponding author), Natl Bot Res Inst, CSIR, Genet & Mol Biol Div, Lucknow 226001, Uttar Pradesh, India.	sribashroy@nbri.res.in	Tripathi, Abhinandan/ABF-2608-2020; Tyagi, Antariksh/F-4367-2015	Tyagi, Antariksh/0000-0002-4662-077X	Department of Science and Technology, Government of India, New Delhi; CSIR, New Delhi; UGC, New Delhi	Department of Science and Technology, Government of India, New Delhi(Department of Science & Technology (India)); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); UGC, New Delhi(University Grants Commission, India)	The authors are thankful to the Director, CSIR-National Botanical Research Institute, Lucknow for facilities. The Department of Science and Technology, Government of India, New Delhi is duly acknowledged for partly sponsoring the work. The authors also acknowledge CSIR, New Delhi for fellowship provided to AT and AS and UGC, New Delhi, for AMT and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Arca M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034089; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Borek K, 2009, DNA BARCODING QUERCU; Campbell CS, 2005, MOL PHYLOGENET EVOL, V35, P165, DOI 10.1016/j.ympev.2004.11.010; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; DeSaille R, 2007, BIOESSAYS, V29, P1289, DOI 10.1002/bies.20667; Devey DS, 2009, TAXON, V58, P7, DOI 10.1002/tax.581003; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Gao T, 2010, J ETHNOPHARMACOL; Gao T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-324; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Gu J, 2011, J SYST EVOL, V49, P213, DOI 10.1111/j.1759-6831.2011.00136.x; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hubbell SP, 2008, P NATL ACAD SCI USA, V105, P11498, DOI 10.1073/pnas.0801915105; Jobes DV, 1997, PLANT MOL BIOL REP, V15, P326, DOI 10.1023/A:1007462330699; Kelly LJ, 2010, TAXON, V59, P251, DOI 10.1002/tax.591023; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Le Clerc-Blain J, 2010, MOL ECOL RESOUR, V10, P69, DOI 10.1111/j.1755-0998.2009.02725.x; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Liu J, 2011, MOL ECOL RESOUR, V11, P89, DOI 10.1111/j.1755-0998.2010.02907.x; Luo K, 2010, SCI CHINA LIFE SCI, V53, P701, DOI 10.1007/s11427-010-4009-1; Maia VH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029877; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Mort ME, 2010, TAXON, V59, P581, DOI 10.1002/tax.592022; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; Muellner AN, 2011, MOL ECOL RESOUR, V11, P450, DOI 10.1111/j.1755-0998.2011.02984.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Pang X, PLANT BIOL SUTTG; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Pang XH, 2010, PLANTA MED, V76, P1784, DOI 10.1055/s-0030-1249806; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Ragupathy S, 2009, MOL ECOL RESOUR, V9, P164, DOI 10.1111/j.1755-0998.2009.02641.x; Rao RR, 1994, BIODIVERSITY INDIA F; Robba L, 2006, AM J BOT, V93, P1101, DOI 10.3732/ajb.93.8.1101; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Singh Hemant Kumar, 2012, BMC Res Notes, V5, P42, DOI 10.1186/1756-0500-5-42; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Sun XQ, PLOS ONE, V7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Van De Wiel CCM, 2009, MOL ECOL RESOUR, V9, P1086, DOI 10.1111/j.1755-0998.2009.02547.x; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Wang WQ, 2010, BMC PLANT BIOL, V10, DOI [10.1186/1471-2229-10-205, 10.1186/1471-2229-10-14]; Wang YiHong, 2009, Acta Horticulturae Sinica, V36, P1651; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529	75	60	72	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57934	10.1371/journal.pone.0057934	http://dx.doi.org/10.1371/journal.pone.0057934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460915	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000170
J	Cuturi, LF; MacNeilage, PR				Cuturi, Luigi F.; MacNeilage, Paul R.			Systematic Biases in Human Heading Estimation	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; PERIPHERAL-VISION; OPTIC FLOW; 3-D SOUND; PERCEPTION; ORIENTATION; MOTION; AREA; DISCRIMINATION; DIRECTION	Heading estimation is vital to everyday navigation and locomotion. Despite extensive behavioral and physiological research on both visual and vestibular heading estimation over more than two decades, the accuracy of heading estimation has not yet been systematically evaluated. Therefore human visual and vestibular heading estimation was assessed in the horizontal plane using a motion platform and stereo visual display. Heading angle was overestimated during forward movements and underestimated during backward movements in response to both visual and vestibular stimuli, indicating an overall multimodal bias toward lateral directions. Lateral biases are consistent with the overrepresentation of lateral preferred directions observed in neural populations that carry visual and vestibular heading information, including MSTd and otolith afferent populations. Due to this overrepresentation, population vector decoding yields patterns of bias remarkably similar to those observed behaviorally. Lateral biases are inconsistent with standard Bayesian accounts which predict that estimates should be biased toward the most common straight forward heading direction. Nevertheless, lateral biases may be functionally relevant. They effectively constitute a perceptual scale expansion around straight ahead which could allow for more precise estimation and provide a high gain feedback signal to facilitate maintenance of straight-forward heading during everyday navigation and locomotion.	[Cuturi, Luigi F.; MacNeilage, Paul R.] Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Cuturi, Luigi F.] Univ Munich, Grad Sch Syst Neurosci, Munich, Germany	University of Munich; University of Munich	MacNeilage, PR (corresponding author), Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany.	p.macneilage@gmail.com	Cuturi, Luigi/N-1581-2016	Cuturi, Luigi/0000-0001-8144-3740	German Federal Ministry of Education and Research [01 EO 0901]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The work was supported by a grant from the German Federal Ministry of Education and Research under the Grant code 01 EO 0901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Arthur JC, 2008, ACTA PSYCHOL, V129, P72, DOI 10.1016/j.actpsy.2008.04.008; Bardy BG, 1999, PERCEPT PSYCHOPHYS, V61, P1356, DOI 10.3758/BF03206186; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; Chen AH, 2011, J NEUROSCI, V31, P11617, DOI 10.1523/JNEUROSCI.1266-11.2011; CROWELL JA, 1993, PERCEPT PSYCHOPHYS, V53, P325, DOI 10.3758/BF03205187; Cuturi LF, 2011, SOC NEUR M; DAvossa G, 1996, VISION RES, V36, P2915, DOI 10.1016/0042-6989(96)00010-7; De Vrijer M, 2008, J NEUROPHYSIOL, V99, P915, DOI 10.1152/jn.00921.2007; De Vrijer M, 2009, J VISION, V9, DOI 10.1167/9.2.9; Dokka K, 2011, J VISION, V11, DOI 10.1167/11.13.2; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; Durgin FH, 2011, ATTEN PERCEPT PSYCHO, V73, P1856, DOI 10.3758/s13414-011-0143-5; Durgin FH, 2011, J VISION, V11, DOI 10.1167/11.8.13; Feldman NH, 2009, PSYCHOL REV, V116, P752, DOI 10.1037/a0017196; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Fetsch CR, 2011, NAT NEUROSCI; Fischer BJ, 2011, NAT NEUROSCI, V14, P1061, DOI 10.1038/nn.2872; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gibson JJ, 1950, PERCEPTION VISUAL WO; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Karnath HO, 2006, BRAIN, V129, P293, DOI 10.1093/brain/awh698; Klatzky RL, 2003, EXP BRAIN RES, V149, P48, DOI 10.1007/s00221-002-1334-z; KOENDERINK JJ, 1987, BIOL CYBERN, V56, P247, DOI 10.1007/BF00365219; Lappe M, 1996, J NEUROSCI, V16, P6265; Li L, 2002, OPTOMETRY VISION SCI, V79, P581, DOI 10.1097/00006324-200209000-00009; Loomis JM, 2002, J EXP PSYCHOL LEARN, V28, P335, DOI 10.1037//0278-7393.28.2.335; MacNeilage PR, 2007, EXP BRAIN RES, V179, P263, DOI 10.1007/s00221-006-0792-0; MacNeilage PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040264; MacNeilage PR, 2010, J NEUROSCI, V30, P9084, DOI 10.1523/JNEUROSCI.1304-10.2010; MacNeilage PR, 2008, J NEUROPHYSIOL, V100, P2981, DOI 10.1152/jn.90677.2008; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; Telford L, 1996, PERCEPT PSYCHOPHYS, V58, P283, DOI 10.3758/BF03211881; TELFORD L, 1995, EXP BRAIN RES, V104, P502; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1992, PERCEPT PSYCHOPHYS, V51, P443, DOI 10.3758/BF03211640; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	45	41	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56862	10.1371/journal.pone.0056862	http://dx.doi.org/10.1371/journal.pone.0056862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457631	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700091
J	Gdalevitch, M; Kasaai, B; Alam, N; Dohin, B; Lauzier, D; Hamdy, RC				Gdalevitch, Marie; Kasaai, Bahar; Alam, Norine; Dohin, Bruno; Lauzier, Dominique; Hamdy, Reggie C.			The Effect of Heparan Sulfate Application on Bone Formation during Distraction Osteogenesis	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MORPHOGENETIC PROTEIN; CELL-SURFACE; MOUSE MODEL; PROTEOGLYCANS; BMP; DIFFERENTIATION; EXPRESSION; LOCALIZATION; REGENERATION	Bone morphogenetic proteins (BMPs) are recognized for their ability to induce bone formation in vivo and in vitro. Their osteogenic and osteoinductive properties are tightly regulated by the secretion of specific BMP antagonists, which have been shown to physically bind and sometimes be blocked by the extracellular proteoglycan heparan sulphate side chains (from hereon referred to as HS). The purpose of this study was to investigate if local application of 5 mu g of HS proteoglycan to a bone regenerate site in a mouse model of distraction osteogenesis (DO) can accelerate bone healing and affect the expression of key members of the BMP signaling pathway. DO was performed on the right tibia of 115 adult male wild-type mice. At mid-distraction (day 11), half the group was injected locally with 5 mu g of HS, while the other half was injected with saline. The mice were sacrificed at 2 time-points: mid-consolidation (34 days) and full consolidation (51 days). The distracted tibial zone was then collected for analysis by mu CT, radiology, biomechanical testing, immunohistochemistry, and histology. While mu CT data showed no statistically significant difference in bone formation, the results of biomechanical testing in stiffness and ultimate force were significantly lower in the HS-injected bones at 51 days, compared to controls. Immunohistochemistry results also suggested a decrease in expression of several key members of the BMP signaling pathway at 34 days. Furthermore, wound dehiscence and infection rates were significantly elevated in the HS group compared to the controls, which resulted in a higher rate of euthanasia in the treatment group. Our findings demonstrate that exogenous application of 5 mu g of HS in the distracted gap of a murine model had a negative impact on bone and wound healing.	[Gdalevitch, Marie; Kasaai, Bahar; Alam, Norine; Lauzier, Dominique; Hamdy, Reggie C.] Shriners Hosp Children, Div Orthoped, Montreal, PQ, Canada; [Dohin, Bruno] Univ St Etienne, Hop Femme Mere Enfant, Dept Pediat Orthoped Surg, Bron, France	McGill University; CHU Lyon; Universite Jean Monnet	Gdalevitch, M (corresponding author), Shriners Hosp Children, Div Orthoped, Montreal, PQ, Canada.	marie.gdalevitch@mail.mcgill.ca	dohin, bruno/AAS-2974-2021		Shriners of Canada [8700]	Shriners of Canada	This study was funded by Shriners of Canada under operating grant 8700. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation o the manuscript.	Alam N, 2009, CLIN ORTHOP RELAT R, V467, P3190, DOI 10.1007/s11999-009-1065-6; Borza DB, 1998, J BIOL CHEM, V273, P5493, DOI 10.1074/jbc.273.10.5493; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Colburn NT, 2009, ARTHRITIS RHEUM-US, V60, P1694, DOI 10.1002/art.24520; Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7; Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1; Eckert R, 2003, FEBS LETT, V541, P121, DOI 10.1016/S0014-5793(03)00322-3; Economides A, 2000, MODIFIED NOGGIN POLY; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fisher MC, 2006, MATRIX BIOL, V25, P27, DOI 10.1016/j.matbio.2005.07.008; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Giannoudis PV, 2007, OSTEOPOROSIS INT, V18, P1565, DOI 10.1007/s00198-007-0441-x; Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009; Haidar ZS, 2010, GROWTH FACTORS, V28, P44, DOI 10.3109/08977190903367788; Hamdy RC, 2003, BONE, V33, P248, DOI 10.1016/S8756-3282(03)00154-6; Hamdy RC, 1997, ANN CHIR, V51, P875; Haque T, 2007, HISTOL HISTOPATHOL, V22, P119, DOI 10.14670/HH-22.119; Haque T, 2006, J HISTOCHEM CYTOCHEM, V54, P407, DOI 10.1369/jhc.5A6738.2005; Haque T, 2008, BONE, V42, P1144, DOI 10.1016/j.bone.2008.01.028; Harwood Paul J, 2005, Expert Opin Drug Saf, V4, P75, DOI 10.1517/14740338.4.1.75; Hu J, 2007, J ORTHOP RES, V25, P241, DOI 10.1002/jor.20288; Hu J, 2002, INT J ORAL MAX SURG, V31, P185, DOI 10.1054/ijom.2001.0193; ILIZAROV GA, 1990, CLIN ORTHOP RELAT R, P8; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; Isefuku S, 2000, BONE, V27, P661, DOI 10.1016/S8756-3282(00)00385-9; Jackson R, 2006, J ORTHOPAEDIC RES, V24; Jasuja R, 2004, J BIOL CHEM, V279, P51289, DOI 10.1074/jbc.M408129200; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Kanzaki S, 2008, J CELLULAR PHYSL, V216; Kasaai B, 2012, J HISTOCHEM CYTOCHEM, V60, P219, DOI 10.1369/0022155411432010; Khan SA, 2008, AM J PHYSIOL-CELL PH, V294, pC1387, DOI 10.1152/ajpcell.00346.2007; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Krawczyk A, 2007, BONE, V40, P781, DOI 10.1016/j.bone.2006.10.002; Mandu-Hrit M, 2006, GROWTH FACTORS, V24, P172, DOI 10.1080/08977190600621362; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Okamoto M, 2006, J BONE MINER RES, V21, P1022, DOI 10.1359/JBMR.060411; OLWIN BB, 1992, J CELL BIOL, V118, P631, DOI 10.1083/jcb.118.3.631; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Rengachary S, 2002, NEUROSURG FOCUS, V13, P1; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Sailhan F, 2011, OSTEOPOROSIS INT, V22, P2011, DOI 10.1007/s00198-011-1613-2; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; Tavakoli K, 1999, BRIT J PLAST SURG, V52, P434, DOI 10.1054/bjps.1999.3157; Troulis MJ, 2003, J ORAL MAXIL SURG, V61, P1144, DOI 10.1016/S0278-2391(03)00672-4; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Woodruff MA, 2007, J MOL HISTOL, V38, P425, DOI 10.1007/s10735-007-9137-y; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yeung HY, 2001, CLIN ORTHOP RELAT R, P219	51	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56790	10.1371/journal.pone.0056790	http://dx.doi.org/10.1371/journal.pone.0056790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457615	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700081
J	Albright, R; Mason, B				Albright, Rebecca; Mason, Benjamin			Projected Near-Future Levels of Temperature and pCO(2) Reduce Coral Fertilization Success	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CLIMATE-CHANGE; ELEVATED-TEMPERATURE; SPERM LIMITATION; RECRUITMENT; SETTLEMENT; SURVIVORSHIP; MOTILITY; DECLINE; IMPACT	Increases in atmospheric carbon dioxide (pCO(2)) are projected to contribute to a 1.1-6.4 degrees C rise in global average surface temperatures and a 0.14-0.35 reduction in the average pH of the global surface ocean by 2100. If realized, these changes are expected to have negative consequences for reef-building corals including increased frequency and severity of coral bleaching and reduced rates of calcification and reef accretion. Much less is known regarding the independent and combined effects of temperature and pCO(2) on critical early life history processes such as fertilization. Here we show that increases in temperature (+3 degrees C) and pCO(2) (+400 mu atm) projected for this century negatively impact fertilization success of a common Indo-Pacific coral species, Acropora tenuis. While maximum fertilization did not differ among treatments, the sperm concentration required to obtain 50% of maximum fertilization increased 6- to 8- fold with the addition of a single factor (temperature or CO2) and nearly 50- fold when both factors interact. Our results indicate that near-future changes in temperature and pCO(2) narrow the range of sperm concentrations that are capable of yielding high fertilization success in A. tenuis. Increased sperm limitation, in conjunction with adult population decline, may have severe consequences for coral reproductive success. Impaired sexual reproduction will further challenge corals by inhibiting population recovery and adaptation potential.	[Albright, Rebecca; Mason, Benjamin] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	Albright, R (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	r.albright@aims.gov.au		Albright, Rebecca/0000-0003-3409-8766	Australian Research Council fellowship; Australian Institute of Marine Science	Australian Research Council fellowship(Australian Research Council); Australian Institute of Marine Science	This project was supported by an Australian Research Council fellowship awarded to RA and by the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R., 2011, J MAR BIOL, V2011, P1, DOI [10.1155/2011/473615, DOI 10.1155/2011/473615]; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Andersson A. J., 2011, OCEAN ACIDIFICATION, P122; Anlauf H, 2011, J EXP MAR BIOL ECOL, V397, P13, DOI 10.1016/j.jembe.2010.11.009; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2010, MAR BIOL, V157, P2061, DOI 10.1007/s00227-010-1474-9; Byrne M, 2010, MAR ENVIRON RES, V69, P234, DOI 10.1016/j.marenvres.2009.10.014; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Dickson A.G., 2007, GUIDE BEST PRACTICES; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Edmunds PJ, 2007, MAR ECOL PROG SER, V341, P1, DOI 10.3354/meps341001; Gattuso J-P, 2011, OCEAN ACIDIFICATION; Harrison P.L., 1990, P133; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Havenhand JN, 2009, BIOGEOSCIENCES, V6, P3009, DOI 10.5194/bg-6-3009-2009; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; Heyward AJ, 2010, CORAL REEFS, V29, P631, DOI 10.1007/s00338-009-0578-5; HEYWARD AJ, 1986, MAR BIOL, V90, P191, DOI 10.1007/BF00569127; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; Marshall DJ, 2006, MAR POLLUT BULL, V52, P734, DOI 10.1016/j.marpolbul.2006.05.005; Medina-Rosas P, 2012, INV REP DEV; Morita M, 2010, ZYGOTE, V18, P103, DOI 10.1017/S0967199409990177; Nakamura M, 2012, AQUAT BIOL, V15, P299, DOI 10.3354/ab00436; Nakamura M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014521; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; OLIVER J, 1992, BIOL BULL, V183, P409, DOI 10.2307/1542017; Omori M, 2001, LIMNOL OCEANOGR, V46, P704, DOI 10.4319/lo.2001.46.3.0704; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Randall CJ, 2009, BIOL BULL-US, V217, P269, DOI 10.1086/BBLv217n3p269; Reuter KE, 2011, GLOBAL CHANGE BIOL, V17, P163, DOI 10.1111/j.1365-2486.2010.02216.x; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Ross PM, 2011, WATER-SUI, V3, P1005, DOI 10.3390/w3041005; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242	45	65	66	0	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56468	10.1371/journal.pone.0056468	http://dx.doi.org/10.1371/journal.pone.0056468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457572	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000315602700074
J	Franceschini, M; Rampello, A; Agosti, M; Massucci, M; Bovolenta, F; Sale, P				Franceschini, Marco; Rampello, Anais; Agosti, Maurizio; Massucci, Maurizio; Bovolenta, Federica; Sale, Patrizio			Walking Performance: Correlation between Energy Cost of Walking and Walking Participation. New Statistical Approach Concerning Outcome Measurement	PLOS ONE			English	Article							COMMUNITY AMBULATION; STROKE PATIENTS; LEVEL WALKING; OLDER-ADULTS; GAIT; REHABILITATION; POPULATION; PARAMETERS; MOBILITY; INJURY	Walking ability, though important for quality of life and participation in social and economic activities, can be adversely affected by neurological disorders, such as Spinal Cord Injury, Stroke, Multiple Sclerosis or Traumatic Brain Injury. The aim of this study is to evaluate if the energy cost of walking (CW), in a mixed group of chronic patients with neurological diseases almost 6 months after discharge from rehabilitation wards, can predict the walking performance and any walking restriction on community activities, as indicated by Walking Handicap Scale categories (WHS). One hundred and seven subjects were included in the study, 31 suffering from Stroke, 26 from Spinal Cord Injury and 50 from Multiple Sclerosis. The multivariable binary logistical regression analysis has produced a statistical model with good characteristics of fit and good predictability. This model generated a cut-off value of. 40, which enabled us to classify correctly the cases with a percentage of 85.0%. Our research reveal that, in our subjects, CW is the only predictor of the walking performance of in the community, to be compared with the score of WHS. We have been also identifying a cut-off value of CW cost, which makes a distinction between those who can walk in the community and those who cannot do it. In particular, these values could be used to predict the ability to walk in the community when discharged from the rehabilitation units, and to adjust the rehabilitative treatment to improve the performance.	[Franceschini, Marco; Sale, Patrizio] IRCCS San Raffale, Dept NeuroRehabilitat, Rome, Italy; [Rampello, Anais; Agosti, Maurizio] Univ Hosp, Dept Rehabil, Parma, Italy; [Massucci, Maurizio] Hosp Passignano, Rehabil Unit, Perugia, Italy; [Bovolenta, Federica] Med Rehabil NOCSAE Hosp AUSL Modena, Modena, Italy	University of Parma; University Hospital of Parma	Sale, P (corresponding author), IRCCS San Raffale, Dept NeuroRehabilitat, Rome, Italy.	patrizio.sale@gmail.com	Sale, Patrizio/J-3276-2019; Sale, Patrizio/K-8757-2016	Sale, Patrizio/0000-0002-4850-3673; Sale, Patrizio/0000-0002-4850-3673; Agosti, Maurizio/0000-0003-2365-3488; Franceschini, Marco/0000-0002-2131-1583				BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; Barbeau H, 2001, CURR OPIN NEUROL, V14, P735, DOI 10.1097/00019052-200112000-00009; Bernardi M, 1999, J ELECTROMYOGR KINES, V9, P149, DOI 10.1016/S1050-6411(98)00046-7; Blessey R L, 1976, Phys Ther, V56, P1019; Bregman DJJ, 2010, PROSTHET ORTHOT INT, V34, P293, DOI 10.3109/03093646.2010.495969; Corrigan R, 2008, DISABIL REHABIL, V30, P1079, DOI 10.1080/09638280701623158; Cunha IT, 2002, AM J PHYS MED REHAB, V81, P848, DOI 10.1097/00002060-200211000-00008; Delextrat A, 2011, HUM MOVEMENT SCI, V30, P115, DOI 10.1016/j.humov.2010.10.004; Duffy CM, 1997, DEV MED CHILD NEUROL, V39, P234; Eriksson JS, 2012, EUR J APPL PHYSIOL, V112, P345, DOI 10.1007/s00421-011-1985-1; Finlayson ML, 2010, PHYS MED REH CLIN N, V21, P357, DOI 10.1016/j.pmr.2009.12.003; Franceschini M, 2003, CLIN REHABIL, V17, P368, DOI 10.1191/0269215503cr622oa; Ijzerman MJ, 2002, ARCH PHYS MED REHAB, V83, P1777, DOI 10.1053/apmr.2002.35655; Kelly JO, 2003, ARCH PHYS MED REHAB, V84, P1780, DOI 10.1016/S0003-9993(03)00376-9; Lapointe R, 2001, SPINAL CORD, V39, P327, DOI 10.1038/sj.sc.3101167; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; Maclean N, 2000, SOC SCI MED, V50, P495; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; Mudge S, 2009, ARCH PHYS MED REHAB, V90, P296, DOI 10.1016/j.apmr.2008.07.025; Pang MYC, 2007, PHYS THER, V87, P282, DOI 10.2522/ptj.20060142; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Peyrot N, 2009, J APPL PHYSIOL, V106, P1763, DOI 10.1152/japplphysiol.91240.2008; Rosdahl H, 2010, EUR J APPL PHYSIOL, V109, P159, DOI 10.1007/s00421-009-1326-9; SCHAFER H, 1989, STAT MED, V8, P1381, DOI 10.1002/sim.4780081110; Shumway-Cook A, 2002, PHYS THER, V82, P670, DOI 10.1093/ptj/82.7.670; Snook EM, 2009, NEUROREHAB NEURAL RE, V23, P108, DOI 10.1177/1545968308320641; van de Port IG, 2008, J REHABIL MED, V40, P23, DOI 10.2340/16501977-0114; van Hedel HJA, 2010, RESTOR NEUROL NEUROS, V28, P123, DOI 10.3233/RNN-2010-0508; WATERS R L, 1983, Journal of Orthopaedic Research, V1, P73, DOI 10.1002/jor.1100010110; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P756; Wevers L, 2009, STROKE, V40, P2450, DOI 10.1161/STROKEAHA.108.541946; World Health Organization/Regional Office for Europe. Vienna Declaration on Nutrition and Noncommunicable Diseases in the Context of Health, 2013, EUR MIN C NUTR NONC, P5, DOI [10.1136/bmj.f4417, DOI 10.1136/BMJ.F4417]; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zamparo P., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P348; Zamparo P, 1998, SCAND J MED SCI SPOR, V8, P222; ZWEIG MH, 1993, CLIN CHEM, V39, P561	37	42	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56669	10.1371/journal.pone.0056669	http://dx.doi.org/10.1371/journal.pone.0056669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468871	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900030
J	Hughes, J; Frago, S; Buhnemann, C; Carter, EJ; Hassan, AB				Hughes, Jennifer; Frago, Susana; Buehnemann, Claudia; Carter, Emma J.; Hassan, A. Bassim			Maternal Transmission of a Humanised Igf2r Allele Results in an Igf2 Dependent Hypomorphic and Non-Viable Growth Phenotype	PLOS ONE			English	Article							FACTOR-II GENE; IMPRINTED GENES; LIFE-SPAN; PERINATAL LETHALITY; M6P/IGF2 RECEPTOR; FETAL OVERGROWTH; TRANSGENIC MICE; CANCER RISK; MOUSE; EXPRESSION	The cation independent mannose 6-phosphate/insulin-like growth factor 2 receptor (IGF2R) functions in the transportation and regulation of insulin-like growth factor 2 (IGF2) and mannose 6-phosphate modified proteins. The relative and specific titration of IGF2 by high affinity binding of IGF2R represents a mechanism that supports the parental conflict theory of genomic imprinting. Imprinting of Igf2 (paternal allele expressed) and Igf2r (maternal allele expressed) arose to regulate the relative supply of both proteins. Experiments in the mouse have established that loss of the maternal allele of Igf2r results in disproportionate growth and peri-natal lethality. In order to systematically investigate the consequences of loss of function and of hypomorphic alleles of Igf2r on growth functions, we introduced a conditional human IGF2R exon 3-48 cDNA into the intron 2 region of murine Igf2r. Here we show that the knock-in construct resulted in over-growth when the humanised Igf2r allele was maternally transmitted, a phenotype that was rescued by either paternal transmission of the humanised allele, expression of a wild-type paternal allele or loss of function of Igf2. We also show that expression of IGF2R protein was reduced to less than 50% overall in tissues previously known to be Igf2 growth dependent. This occurred despite the detection of mouse derived peptides, suggesting that trans-splicing of the knock-in human cDNA with the endogenous maternal mouse Igf2r allele. The phenotype following maternal transmission of the humanised allele resulted in overgrowth of the embryo, heart and placenta with partial peri-natal lethality, suggesting that further generation of hypomorphic Igf2r alleles are likely to be at the borderline of maintaining Igf2 dependent viability.	[Hughes, Jennifer; Frago, Susana; Buehnemann, Claudia; Carter, Emma J.; Hassan, A. Bassim] Univ Oxford, Sir William Dunn Sch Pathol, Oxford Mol Pathol Inst, Canc Res UK Tumour Growth Grp, Oxford OX1 3RE, England	University of Oxford	Hassan, AB (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford Mol Pathol Inst, Canc Res UK Tumour Growth Grp, S Parks Rd, Oxford OX1 3RE, England.	bass.hassan@path.ox.ac.uk	Frago, Susana/L-1477-2017	Frago, Susana/0000-0002-1369-1328; Hassan, Andrew/0000-0002-2517-6681	 [C429/A9891]; Cancer Research UK [9891] Funding Source: researchfish	; Cancer Research UK(Cancer Research UK)	Funding came from C429/A9891, www.cancerresearchuk.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2010, PEDIATR RES, V68, P429, DOI 10.1203/PDR.0b013e3181f1ca99; Ahamed K, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-31; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Barlow DP, 2011, ANNU REV GENET, V45, P379, DOI 10.1146/annurev-genet-110410-132459; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Biong M, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-9; Bokov AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026891; Burns JL, 2001, DEVELOPMENT, V128, P3819; Cheng I, 2009, CANCER EPIDEM BIOMAR, V18, P1922, DOI 10.1158/1055-9965.EPI-09-0253; Church DN, 2012, ONCOGENE, V31, P3635, DOI 10.1038/onc.2011.526; de Wet B, 2011, J BIOL CHEM, V286, P4072, DOI 10.1074/jbc.M110.165415; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DESOUZA AT, 1995, NAT GENET, V11, P447, DOI 10.1038/ng1295-447; deSouza AT, 1997, FASEB J, V11, P60, DOI 10.1096/fasebj.11.1.9034167; Dong XQ, 2012, CANCER EPIDEMIOL, V36, P206, DOI 10.1016/j.canep.2011.05.013; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hagan JP, 2004, GENOMICS, V84, P836, DOI 10.1016/j.ygeno.2004.07.007; HAIG D, 1991, CELL, V64, P1045; Hankins GR, 1996, ONCOGENE, V12, P2003; Harper J, 2006, CANCER RES, V66, P1940, DOI 10.1158/0008-5472.CAN-05-2036; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hoyo C, 2012, DIS MARKERS, V32, P133, DOI [10.1155/2012/492068, 10.3233/DMA-2011-0865]; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jin CY, 2011, CELL METAB, V14, P161, DOI 10.1016/j.cmet.2011.07.001; Killian JK, 2001, HUM MUTAT, V18, P25, DOI 10.1002/humu.1146; Latos PA, 2009, DEVELOPMENT, V136, P437, DOI 10.1242/dev.032060; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; Mills JJ, 1998, ONCOGENE, V16, P2797, DOI 10.1038/sj.onc.1201801; Pehar M, 2010, AGING CELL, V9, P174, DOI 10.1111/j.1474-9726.2010.00547.x; Petry CJ, 2005, GROWTH HORM IGF RES, V15, P363, DOI 10.1016/j.ghir.2005.07.003; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pravtcheva DD, 2008, MOL REPROD DEV, V75, P1678, DOI 10.1002/mrd.20909; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Rezgui D, 2009, J MOL ENDOCRINOL, V42, P341, DOI 10.1677/JME-08-0154; Savage SA, 2007, CANCER EPIDEM BIOMAR, V16, P1667, DOI 10.1158/1055-9965.EPI-07-0214; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Stricker SH, 2008, EMBO J, V27, P3116, DOI 10.1038/emboj.2008.239; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Williams C, 2012, SCIENCE, V338, P1209, DOI 10.1126/science.1228633; Wutz A, 2001, DEVELOPMENT, V128, P1881; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Wylie AA, 2003, AM J PATHOL, V162, P321, DOI 10.1016/S0002-9440(10)63823-0; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Zaina S, 2002, J BIOL CHEM, V277, P4505, DOI 10.1074/jbc.M108061200; Zaina S, 1998, ENDOCRINOLOGY, V139, P3886, DOI 10.1210/en.139.9.3886	55	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57270	10.1371/journal.pone.0057270	http://dx.doi.org/10.1371/journal.pone.0057270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468951	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900063
J	Stella, EJ; Franceschelli, JJ; Tasselli, SE; Morbidoni, HR				Stella, Emma J.; Franceschelli, Jorgelina J.; Tasselli, Sabrina E.; Morbidoni, Hector R.			Analysis of Novel Mycobacteriophages Indicates the Existence of Different Strategies for Phage Inheritance in Mycobacteria	PLOS ONE			English	Article							COMPARATIVE GENOMIC ANALYSIS; DRUG-RESISTANT TUBERCULOSIS; LINEAR PLASMID-PROPHAGE; BOVIS BCG; DNA; DETERMINANTS; CONSTRUCTION; ACQUISITION; MUTAGENESIS; VIRULENCE	Mycobacteriophages have been essential in the development of mycobacterial genetics through their use in the construction of tools for genetic manipulation. Due to the simplicity of their isolation and variety of exploitable molecular features, we searched for and isolated 18 novel mycobacteriophages from environmental samples collected from several geographic locations. Characterization of these phages did not differ from most of the previously described ones in the predominant physical features (virion size in the 100-400 nm, genome size in the 50-70 kbp, morphological features compatible with those corresponding to the Siphoviridae family), however novel characteristics for propagation were noticed. Although all the mycobacteriophages propagated at 30 degrees C, eight of them failed to propagate at 37 degrees C. Since some of our phages yielded pinpoint plaques, we improved plaque detection by including sub-inhibitory concentrations of isoniazid or ampicillin-sulbactam in the culture medium. Thus, searches for novel mycobacteriophages at low temperature and in the presence of these drugs would allow for the isolation of novel members that would otherwise not be detected. Importantly, while eight phages lysogenized Mycobacterium smegmatis, four of them were also capable of lysogenizing Mycobacterium tuberculosis. Analysis of the complete genome sequence obtained for twelve mycobacteriophages (the remaining six rendered partial genomic sequences) allowed for the identification of a new singleton. Surprisingly, sequence analysis revealed the presence of parA or parA/parB genes in 7/18 phages including four that behaved as temperate in M. tuberculosis. In summary, we report here the isolation and preliminary characterization of mycobacteriophages that bring new information to the field.	[Stella, Emma J.; Franceschelli, Jorgelina J.; Tasselli, Sabrina E.; Morbidoni, Hector R.] Univ Nacl Rosario, Fac Ciencias Med, Catedra Microbiol, RA-2000 Rosario, Argentina	National University of Rosario	Morbidoni, HR (corresponding author), Univ Nacl Rosario, Fac Ciencias Med, Catedra Microbiol, RA-2000 Rosario, Argentina.	morbiatny@yahoo.com			National Agency for Science and Technology Promotion (ANPCyT), Argentina [PICT 02337]; Bill and Melinda Gates Foundation [OPP1045751]	National Agency for Science and Technology Promotion (ANPCyT), Argentina(ANPCyT); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by grants (PICT 02337) from the National Agency for Science and Technology Promotion (ANPCyT), Argentina, and the Bill and Melinda Gates Foundation (662 Grnad Challenges Explorations Grant OPP1045751). HRM is a career member of Consejo de Investigaciones de la Universidad Nacional de Rosario (CIUNR), EJS and JJF are Fellows of Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bardarov S, 1997, P NATL ACAD SCI USA, V94, P10961, DOI 10.1073/pnas.94.20.10961; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Bourhy P, 2005, J BACTERIOL, V187, P3931, DOI 10.1128/JB.187.12.3931-3940.2005; Braunstein M, 2002, METHOD ENZYMOL, V358, P67; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Casart Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-51; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Casjens SR, 2004, J BACTERIOL, V186, P1818, DOI 10.1128/JB.186.6.1818-1832.2004; Cresawn SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-395; ENGEL HWB, 1978, ANN INST PASTEUR MIC, VA129, P75; Fullner KJ, 1997, MOL MICROBIOL, V26, P755, DOI 10.1046/j.1365-2958.1997.6111984.x; Gao LY, 2003, INFECT IMMUN, V71, P922, DOI 10.1128/IAI.71.2.922-929.2003; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Grigoriev PS, 2001, MOL MICROBIOL, V42, P355, DOI 10.1046/j.1365-2958.2001.02632.x; GUILHOT C, 1994, J BACTERIOL, V176, P535, DOI 10.1128/JB.176.2.535-539.1994; Hatfull GF, 2008, RES MICROBIOL, V159, P332, DOI 10.1016/j.resmic.2008.04.008; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2012, J VIROL, V86, P2382, DOI 10.1128/JVI.06870-11; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Huff J, 2010, GENE, V468, P8, DOI 10.1016/j.gene.2010.07.012; Jacobs-Sera D, 2012, VIROLOGY; JONES WD, 1982, AM REV RESPIR DIS, V125, P640; JONES WD, 1988, TUBERCLE, V69, P43, DOI 10.1016/0041-3879(88)90039-6; Lee S, 2004, FEMS MICROBIOL LETT, V241, P271, DOI 10.1016/j.femsle.2004.10.032; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; Los JM, 2008, APPL ENVIRON MICROB, V74, P5113, DOI 10.1128/AEM.00306-08; LUDTKE DN, 1989, J MOL BIOL, V209, P393, DOI 10.1016/0022-2836(89)90005-3; Morris P, 2008, J BACTERIOL, V190, P2172, DOI 10.1128/JB.01657-07; MOTALLEBIVESHAREH M, 1990, MOL MICROBIOL, V4, P1455, DOI 10.1111/j.1365-2958.1990.tb02056.x; Parish T, 2001, TUBERCULOSIS, V81, P359, DOI 10.1054/tube.2001.0312; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Payne KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034052; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pham TT, 2007, MICROBIOL-SGM, V153, P2711, DOI 10.1099/mic.0.2007/008904-0; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Raviglione MC, 2008, NEW ENGL J MED, V359, P636, DOI 10.1056/NEJMe0804906; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Raviglione MC, 2006, INT J TUBERC LUNG D, V10, P238; Ravin NV, 2011, PLASMID, V65, P102, DOI 10.1016/j.plasmid.2010.12.004; Rybniker J, 2006, J MED MICROBIOL, V55, P37, DOI 10.1099/jmm.0.46238-0; Saint Girons I, 2000, J BACTERIOL, V182, P5700, DOI 10.1128/JB.182.20.5700-5705.2000; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sampson T, 2009, MICROBIOL-SGM, V155, P2962, DOI 10.1099/mic.0.030486-0; SARKIS GJ, 1995, MOL MICROBIOL, V15, P1055, DOI 10.1111/j.1365-2958.1995.tb02281.x; Schumacher MA, 2007, CURR OPIN STRUC BIOL, V17, P103, DOI 10.1016/j.sbi.2006.11.005; Smartt AE, 2011, ANAL BIOANAL CHEM, V400, P991, DOI 10.1007/s00216-010-4561-3; van Kessel Julia C., 2008, V435, P203, DOI 10.1007/978-1-59745-232-8_15; van Kessel JC, 2008, NAT REV MICROBIOL, V6, P851, DOI 10.1038/nrmicro2014; van Kessel JC, 2008, MOL MICROBIOL, V67, P1094, DOI 10.1111/j.1365-2958.2008.06109.x; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858	58	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56384	10.1371/journal.pone.0056384	http://dx.doi.org/10.1371/journal.pone.0056384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468864	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900024
J	Tan, M; Song, XL; Zhang, GL; Peng, AM; Li, X; Li, M; Liu, Y; Wang, CH				Tan, Min; Song, Xiaolian; Zhang, Guoliang; Peng, Aimei; Li, Xuan; Li, Ming; Liu, Yang; Wang, Changhui			Statins and the Risk of Lung Cancer: A Meta-Analysis	PLOS ONE			English	Article							FOLLOW-UP; REDUCTASE INHIBITORS; 11-YEAR MORTALITY; COLORECTAL-CANCER; CELL; SIMVASTATIN; LOVASTATIN; DISEASE; CHOLESTEROL; PRAVASTATIN	Purpose: Several epidemiologic studies have evaluated the association between statins and lung cancer risk, whereas randomized controlled trials (RCTs) on cardiovascular outcomes provide relevant data as a secondary end point. We conducted a meta-analysis of all relevant studies to examine this association. Methods: A systematic literature search up to March 2012 was performed in PubMed database. Study-specific risk estimates were pooled using a random-effects model. Results: Nineteen studies (5 RCTs and 14 observational studies) involving 38,013 lung cancer cases contributed to the analysis. They were grouped on the basis of study design, and separate meta-analyses were conducted. There was no evidence of an association between statin use and risk of lung cancer either among RCTs (relative risk [RR] 0.91, 95% confidence interval [CI] 0.76-1.09), among cohort studies (RR 0.94, 95% CI 0.82-1.07), or among case-control studies (RR 0.82, 95% CI 0.57-1.16). Low evidence of publication bias was found. However, statistically significant heterogeneity was found among cohort studies and among case-control studies. After excluding the studies contributing most to the heterogeneity, summary estimates were essentially unchanged. Conclusion: The results of our meta-analysis suggest that there is no association between statin use and the risk of lung cancer.	[Tan, Min; Song, Xiaolian; Zhang, Guoliang; Peng, Aimei; Li, Xuan; Li, Ming; Liu, Yang; Wang, Changhui] Tongji Univ, Dept Resp Med, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China	Tongji University	Wang, CH (corresponding author), Tongji Univ, Dept Resp Med, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	wangchanghui123@hotmail.com	Tan, Min/GQQ-2702-2022					Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; Bonovas S, 2007, J CLIN ONCOL, V25, P3462, DOI 10.1200/JCO.2007.10.8936; Bonovas S, 2010, EUR J EPIDEMIOL, V25, P29, DOI 10.1007/s10654-009-9396-x; Browning DRL, 2007, INT J CANCER, V120, P833, DOI 10.1002/ijc.22366; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Cheng MH, 2012, LUNG CANCER, V75, P275, DOI 10.1016/j.lungcan.2011.08.014; Coogan PF, 2007, EPIDEMIOLOGY, V18, P213, DOI 10.1097/01.ede.0000254694.03027.a1; Cui XB, 2012, CANCER CAUSE CONTROL, V23, P1099, DOI 10.1007/s10552-012-9979-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimitroulakos J, 2002, NEOPLASIA, V4, P337, DOI 10.1038/sj.neo.7900247; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Ezzati M, 2005, INT J CANCER, V116, P963, DOI 10.1002/ijc.21100; Farwell WR, 2008, JNCI-J NATL CANCER I, V100, P134, DOI 10.1093/jnci/djm286; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Friedman GD, 2008, PHARMACOEPIDEM DR S, V17, P27, DOI 10.1002/pds.1507; Friis S, 2005, INT J CANCER, V114, P643, DOI 10.1002/ijc.20758; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Han JY, 2011, CLIN CANCER RES, V17, P1553, DOI 10.1158/1078-0432.CCR-10-2525; Han JY, 2011, CANCER-AM CANCER SOC, V117, P2178, DOI 10.1002/cncr.25790; Haukka J, 2012, PHARMACOEPIDEM DR S, V21, P61, DOI 10.1002/pds.2255; Haukka J, 2010, INT J CANCER, V126, P279, DOI 10.1002/ijc.24536; Heart Protection Study Collaborative Group, 2011, Lancet, V378, P2013, DOI 10.1016/S0140-6736(11)61125-2; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Hippisley-Cox Julia, 2010, BMJ, V340, pc2197, DOI 10.1136/bmj.c2197; Jacobs EJ, 2011, CANCER RES, V71, P1763, DOI 10.1158/0008-5472.CAN-10-2953; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karp I, 2008, AM J MED, V121, P302, DOI 10.1016/j.amjmed.2007.12.011; Kaye JA, 2004, BRIT J CANCER, V90, P635, DOI 10.1038/sj.bjc.6601566; Khanzada UK, 2006, ONCOGENE, V25, P877, DOI 10.1038/sj.onc.1209117; Khurana V, 2007, CHEST, V131, P1282, DOI 10.1378/chest.06-0931; Kuoppala J, 2008, EUR J CANCER, V44, P2122, DOI 10.1016/j.ejca.2008.06.025; Maksimova E, 2008, LUNG, V186, P45, DOI 10.1007/s00408-007-9053-7; Marelli C, 2011, J AM COLL CARDIOL, V58, P530, DOI 10.1016/j.jacc.2011.04.015; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Newman TB, 1996, JAMA-J AM MED ASSOC, V275, P55, DOI 10.1001/jama.275.1.55; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Pfeffer MA, 2002, CIRCULATION, V105, P2341, DOI 10.1161/01.CIR.0000017634.00171.24; Rubins JB, 1998, AM J RESP CRIT CARE, V157, P1616, DOI 10.1164/ajrccm.157.5.9709020; Sato S, 2006, J EPIDEMIOL, V16, P201, DOI 10.2188/jea.16.201; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Setoguchi S, 2007, CIRCULATION, V115, P27, DOI 10.1161/CIRCULATIONAHA.106.650176; Sever PS, 2011, EUR HEART J, V32, P2525, DOI 10.1093/eurheartj/ehr333; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simes RJ, 2002, LANCET, V359, P1379; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Taylor ML, 2008, EUR J CANCER PREV, V17, P259, DOI 10.1097/CEJ.0b013e3282b721fe; Undela K, 2012, BREAST CANCER RES TR, V135, P261, DOI 10.1007/s10549-012-2154-x; Vinogradova Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-409; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Wen J, 2011, MODERN PATHOL, V24, P932, DOI 10.1038/modpathol.2011.46; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Yang XL, 2009, DIABETES CARE, V32, P1826, DOI 10.2337/dc09-0725	60	42	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57349	10.1371/journal.pone.0057349	http://dx.doi.org/10.1371/journal.pone.0057349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468972	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900074
J	Villacorta-Atienza, JA; Makarov, VA				Antonio Villacorta-Atienza, Jose; Makarov, Valeri A.			Wave-Processing of Long-Scale Information by Neuronal Chains	PLOS ONE			English	Article							FIELD POTENTIALS; BRAIN; PROPAGATION; OSCILLATIONS; COLLISIONS; SOLITONS	Investigation of mechanisms of information handling in neural assemblies involved in computational and cognitive tasks is a challenging problem. Synergetic cooperation of neurons in time domain, through synchronization of firing of multiple spatially distant neurons, has been widely spread as the main paradigm. Complementary, the brain may also employ information coding and processing in spatial dimension. Then, the result of computation depends also on the spatial distribution of long-scale information. The latter bi-dimensional alternative is notably less explored in the literature. Here, we propose and theoretically illustrate a concept of spatiotemporal representation and processing of long-scale information in laminar neural structures. We argue that relevant information may be hidden in self-sustained traveling waves of neuronal activity and then their nonlinear interaction yields efficient wave- processing of spatiotemporal information. Using as a testbed a chain of FitzHugh-Nagumo neurons, we show that the wave-processing can be achieved by incorporating into the single-neuron dynamics an additional voltage-gated membrane current. This local mechanism provides a chain of such neurons with new emergent network properties. In particular, nonlinear waves as a carrier of long-scale information exhibit a variety of functionally different regimes of interaction: from complete or asymmetric annihilation to transparent crossing. Thus neuronal chains can work as computational units performing different operations over spatiotemporal information. Exploiting complexity resonance these composite units can discard stimuli of too high or too low frequencies, while selectively compress those in the natural frequency range. We also show how neuronal chains can contextually interpret raw wave information. The same stimulus can be processed differently or identically according to the context set by a periodic wave train injected at the opposite end of the chain.	[Antonio Villacorta-Atienza, Jose; Makarov, Valeri A.] Univ Complutense, Fac Ciencias Matemat, Dept Appl Math, E-28040 Madrid, Spain	Complutense University of Madrid	Makarov, VA (corresponding author), Univ Complutense, Fac Ciencias Matemat, Dept Appl Math, E-28040 Madrid, Spain.	vmakarov@mat.ucm.es	Makarov, Valeri/AAF-4790-2019; Makarov, Valeri A/L-5031-2014; Villacorta-Atienza, José/L-1621-2017	Makarov, Valeri/0000-0001-8789-7532; Makarov, Valeri A/0000-0001-8789-7532; Villacorta-Atienza, José/0000-0002-9220-1226	Spanish Ministry of Science and Innovation [FIS2010-20054]; Russian Ministry of Education and Science [14.B37.21.1237]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This work has been supported by the Spanish Ministry of Science and Innovation (project FIS2010-20054) and by the Russian Ministry of Education and Science (contract14.B37.21.1237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon G, 1997, BRAIN, V120, P2259, DOI 10.1093/brain/120.12.2259; Villacorta-Atienza JA, 2010, BIOL CYBERN, V103, P285, DOI 10.1007/s00422-010-0398-2; Argentina M, 2000, J THEOR BIOL, V205, P47, DOI 10.1006/jtbi.2000.2044; Aslanidi OV, 1999, J BIOL PHYS, V25, P149, DOI 10.1023/A:1005119218136; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Dahlem MA, 1997, EXP BRAIN RES, V115, P319, DOI 10.1007/PL00005700; Ermakova EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004454; Fernandez-Ruiz A, 2012, J NEUROSCI, V32, P5165, DOI 10.1523/JNEUROSCI.4499-11.2012; Fuster J.M, 2003, CORTEX MIND UNIFYING; Gollo LL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000402; Grun S, 2010, SPR SER COMPUT NEURO, V7, P1, DOI 10.1007/978-1-4419-5675-0; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Koch Christof, 1999, P1; KOSEK J, 1995, PHYS REV LETT, V74, P2134, DOI 10.1103/PhysRevLett.74.2134; Kwaku KF, 1996, CIRC RES, V79, P957, DOI 10.1161/01.RES.79.5.957; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; Lu Y, 2011, NEURAL COMPUT, V23, P1248, DOI 10.1162/NECO_a_00111; Makarov V.A., 2011, RECURRENT NEURAL NET; Makarov VA, 2001, INT J BIFURCAT CHAOS, V11, P109, DOI 10.1142/S0218127401001931; Makarov VA, 2010, J COMPUT NEUROSCI, V29, P445, DOI 10.1007/s10827-009-0206-y; Makarov Valeri A, 2010, Comput Intell Neurosci, P340541, DOI 10.1155/2010/340541; Makarova J, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00077; Makarova J, 2010, J NEUROPHYSIOL, V103, P2446, DOI 10.1152/jn.01045.2009; Murray J. D., 2002, MATH BIOL, V2; NEKORKIN VI, 1995, PHYS REV LETT, V74, P4819, DOI 10.1103/PhysRevLett.74.4819; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Nunez PL, 2006, CLIN NEUROPHYSIOL, V117, P2424, DOI 10.1016/j.clinph.2006.06.754; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Rieke F., 1999, SPIKES EXPLORING NEU; ROTERMUND HH, 1991, PHYS REV LETT, V66, P3083, DOI 10.1103/PhysRevLett.66.3083; Royer AS, 2007, VISUAL NEUROSCI, V24, P619, DOI 10.1017/S0952523807070617; SantiagoRosanne M, 1997, J COLLOID INTERF SCI, V191, P65, DOI 10.1006/jcis.1997.4956; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Steuer R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061911; Tsyganov MA, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031901; Tsyganov MA, 2004, PHYSICA D, V197, P18, DOI 10.1016/j.phsyd.2004.06.004; TUCKWELL HC, 1981, INT J NEUROSCI, V12, P95, DOI 10.3109/00207458108985794; TUCKWELL HC, 1979, SCIENCE, V205, P493, DOI 10.1126/science.205.4405.493; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Wu JY, 2008, NEUROSCIENTIST, V14, P487, DOI 10.1177/1073858408317066; Wu JY, 1999, J NEUROSCI, V19, P5005; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038402; Zochowski MR, 2005, J NEUROPHYSIOL, V94, P2667, DOI 10.1152/jn.00328.2005	44	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57440	10.1371/journal.pone.0057440	http://dx.doi.org/10.1371/journal.pone.0057440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460856	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000110
J	Caldwell, N; Srebotnjak, T; Wang, T; Hsia, R				Caldwell, Nolan; Srebotnjak, Tanja; Wang, Tiffany; Hsia, Renee			"How Much Will I get Charged for This?" Patient Charges for Top Ten Diagnoses in the Emergency Department	PLOS ONE			English	Article							HEALTH-CARE; VISITS	Objectives: We examined the charges, their variability, and respective payer group for diagnosis and treatment of the ten most common outpatient conditions presenting to the Emergency department (ED). Methods: We conducted a cross-sectional study of the 2006-2008 Medical Expenditure Panel Survey. Analysis was limited to outpatient visits with non-elderly, adult (years 18-64) patients with a single discharge diagnosis. Results: We studied 8,303 ED encounters, representing 76.6 million visits. Median charges ranged from $740 (95% CI $651-$817) for an upper respiratory infection to $3437 (95% CI $2917-$3877) for a kidney stone. The median charge for all ten outpatient conditions in the ED was $1233 (95% CI $1199-$1268), with a high degree of charge variability. All diagnoses had an interquartile range (IQR) greater than $800 with 60% of IQRs greater than $1550. Conclusion: Emergency department charges for common conditions are expensive with high charge variability. Greater acute care charge transparency will at least allow patients and providers to be aware of the emergency department charges patients may face in the current health care system.	[Caldwell, Nolan] Stanford Univ, Dept Emergency Med, Stanford, CA 94305 USA; [Srebotnjak, Tanja] Inst Ecol, San Mateo, CA USA; [Wang, Tiffany] Univ Minnesota, Sch Med, St Paul, MN USA; [Hsia, Renee] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA	Stanford University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco	Hsia, R (corresponding author), Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA.	Renee.hsia@emergency.ucsf.edu			National Institutes of Health (NIH)/National Center for Research Resources (NCRR) University of California San Francisco-Clinical and Translational Science Institute (UCSF-CTSI) [UL1 RR024131 01]; Robert Wood Johnson Foundation Physician Faculty Scholars; UCSF Center for Healthcare Value; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Center for Research Resources (NCRR) University of California San Francisco-Clinical and Translational Science Institute (UCSF-CTSI); Robert Wood Johnson Foundation Physician Faculty Scholars; UCSF Center for Healthcare Value; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project is funded by National Institutes of Health (NIH)/National Center for Research Resources (NCRR) University of California San Francisco-Clinical and Translational Science Institute (UCSF-CTSI) Grant Number UL1 RR024131 01 (RYH), the Robert Wood Johnson Foundation Physician Faculty Scholars (RYH), and a grant from the UCSF Center for Healthcare Value (RYH). No other authors have funding sources to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2011, MED MONTHL HOUS COST; AHRQ, 2011, EM ROOM SERV MEAN ME; Alderman L, 2010, NY TIMES; Allan GM, 2008, INT J TECHNOL ASSESS, V24, P158, DOI 10.1017/S0266462308080227; Cohen S, 1999, 5 AHRQ; Cunningham P. J., 2008, FALLING AM ACCESS ME, V19; Emerman E, 2010, WATSON WYATT IDENTIF; GAO, 2003, HOSP PREP MOST URB H, P1; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012; Hsia RY, 2008, ANN EMERG MED, V51, P265, DOI 10.1016/j.annemergmed.2007.08.009; Hsu J, 2004, MED CARE, V42, P290, DOI 10.1097/01.mlr.0000114917.50457.52; Innes G, 2000, CJEM, V2, P95; Lagnado L, 2004, WALL STREET J; Machlin S, 2010, 24 AHRQ; Massachusetts Division of Health Care Finance and Policy, 2011, MASS HLTH CAR COST T; McCarron S, 2011, LATEST HEALTHCARE TR; National Center for Health Statistics, 2006, HLTH US 2006 CHARTB; Porter ME, 2004, HARVARD BUS REV, V82, P64; Reinhardt UE, 2006, HEALTH AFFAIR, V25, P57, DOI 10.1377/hlthaff.25.1.57; Richmond R, 2011, WALL STREET J; Robinson JC, 2008, HEALTH AFFAIR, V27, P1353, DOI 10.1377/hlthaff.27.5.1353; Sinaiko AD, 2011, NEW ENGL J MED, V364, P891, DOI 10.1056/NEJMp1100041; Stagnitti MN, 2008, DESIGN METHODS FIELD; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Truffer CJ, 2010, HEALTH AFFAIR, V29, P522, DOI 10.1377/hlthaff.2009.1074; Waldman P, 2010, WHY BABY COSTS LESS; Wielawski I, 2000, HEALTH AFFAIR, V19, P180, DOI 10.1377/hlthaff.19.5.180	27	79	79	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55491	10.1371/journal.pone.0055491	http://dx.doi.org/10.1371/journal.pone.0055491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460786	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000009
J	Vetrovsky, T; Baldrian, P				Vetrovsky, Tomas; Baldrian, Petr			The Variability of the 16S rRNA Gene in Bacterial Genomes and Its Consequences for Bacterial Community Analyses	PLOS ONE			English	Article							OPERON COPY NUMBER; MICROBIAL COMMUNITIES; MOLECULAR MARKERS; DISTINCT TYPES; DIVERSITY; PROTEIN	16S ribosomal RNA currently represents the most important target of study in bacterial ecology. Its use for the description of bacterial diversity is, however, limited by the presence of variable copy numbers in bacterial genomes and sequence variation within closely related taxa or within a genome. Here we use the information from sequenced bacterial genomes to explore the variability of 16S rRNA sequences and copy numbers at various taxonomic levels and apply it to estimate bacterial genome and DNA abundances. In total, 7,081 16S rRNA sequences were in silico extracted from 1,690 available bacterial genomes (1-15 per genome). While there are several phyla containing low 16S rRNA copy numbers, in certain taxa, e. g., the Firmicutes and Gammaproteobacteria, the variation is large. Genome sizes are more conserved at all tested taxonomic levels than 16S rRNA copy numbers. Only a minority of bacterial genomes harbors identical 16S rRNA gene copies, and sequence diversity increases with increasing copy numbers. While certain taxa harbor dissimilar 16S rRNA genes, others contain sequences common to multiple species. Sequence identity clusters (often termed operational taxonomic units) thus provide an imperfect representation of bacterial taxa of a certain phylogenetic rank. We have demonstrated that the information on 16S rRNA copy numbers and genome sizes of genome-sequenced bacteria may be used as an estimate for the closest related taxon in an environmental dataset to calculate alternative estimates of the relative abundance of individual bacterial taxa in environmental samples. Using an example from forest soil, this procedure would increase the abundance estimates of Acidobacteria and decrease these of Firmicutes. Using the currently available information, alternative estimates of bacterial community composition may be obtained in this way if the variation of 16S rRNA copy numbers among bacteria is considered.	[Vetrovsky, Tomas; Baldrian, Petr] Acad Sci Czech Republ, Inst Microbiol, Lab Environm Microbiol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Baldrian, P (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Lab Environm Microbiol, Prague, Czech Republic.	baldrian@biomed.cas.cz	Vetrovsky, Tomas/R-5817-2017; Baldrian, Petr/A-9170-2009	Baldrian, Petr/0000-0002-8983-2721	Ministry of Education, Youth and Sports of the Czech Republic [LD12048, LD12050]; research concept of the Institute of Microbiology of the Academy of Sciences of the Czech Republic [RVO61388971]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); research concept of the Institute of Microbiology of the Academy of Sciences of the Czech Republic	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic (LD12048, LD12050) and by the research concept of the Institute of Microbiology of the Academy of Sciences of the Czech Republic (RVO61388971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Baldrian P, 2013, FUNGAL ECOL, V6, P1, DOI 10.1016/j.funeco.2012.10.002; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Bresler V, 2003, MAR BIOL, V143, P17, DOI 10.1007/s00227-003-1055-2; Candela M, 2004, LETT APPL MICROBIOL, V38, P229, DOI 10.1111/j.1472-765X.2003.01475.x; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Dahllof I, 2000, APPL ENVIRON MICROB, V66, P3376, DOI 10.1128/AEM.66.8.3376-3380.2000; Daubin V, 2003, SCIENCE, V301, P829, DOI 10.1126/science.1086568; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eichorst SA, 2007, APPL ENVIRON MICROB, V73, P2708, DOI 10.1128/AEM.02140-06; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798, DOI 10.1128/AEM.61.7.2798-2801.1995; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Hashimoto JQ, 2003, J BACTERIOL, V185, P966, DOI 10.1128/JB.185.3.966-972.2003; Head IM, 1998, MICROB ECOL, V35, P1, DOI 10.1007/s002489900056; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Konstantinidis KT, 2006, APPL ENVIRON MICROB, V72, P7286, DOI 10.1128/AEM.01398-06; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lee CM, 2008, FEMS MICROBIOL LETT, V287, P136, DOI 10.1111/j.1574-6968.2008.01305.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ohtani N, 2010, J BACTERIOL, V192, P5499, DOI 10.1128/JB.00662-10; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Roux S, 2011, FEMS MICROBIOL ECOL, V78, P617, DOI 10.1111/j.1574-6941.2011.01190.x; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Schellenberg J, 2011, METHODS MOL BIOL, V733, P143, DOI 10.1007/978-1-61779-089-8_10; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Sukenik A, 2012, ISME J, V6, P670, DOI 10.1038/ismej.2011.128; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Vos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030600; Wang Y, 1997, J BACTERIOL, V179, P3270, DOI 10.1128/jb.179.10.3270-3276.1997; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999	37	604	652	13	192	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57923	10.1371/journal.pone.0057923	http://dx.doi.org/10.1371/journal.pone.0057923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460914	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000169
J	Zhang, CH; Awasthi, N; Schwarz, MA; Hinz, S; Schwarz, RE				Zhang, Changhua; Awasthi, Niranjan; Schwarz, Margaret A.; Hinz, Stefan; Schwarz, Roderich E.			Superior Antitumor Activity of Nanoparticle Albumin-Bound Paclitaxel in Experimental Gastric Cancer	PLOS ONE			English	Article							PHASE-III TRIAL; 1ST-LINE THERAPY; NAB-PACLITAXEL; BOLUS 5-FLUOROURACIL; PLUS; OXALIPLATIN; COMBINATION; STATHMIN; CAPECITABINE; FLUOROURACIL	Gastric cancer is the second common cause of cancer related death worldwide and lacks highly effective treatment for advanced disease. Nab-paclitaxel is a novel microtubule-inhibitory cytotoxic agent that has not been tested in gastric cancer as of yet. In this study, human gastric cancer cell lines AGS, NCI-N87 and SNU16 were studied. Nab-paclitaxel inhibited cell proliferation with an IC50 of 5 nM in SNU16, 23 nM in AGS and 49 nM in NCI-N87 cells after 72-hour treatment, which was lower than that of oxaliplatin (1.05 mu M to 1.51 mu M) and epirubicin (0.12 mu M to 0.25 mu M). Nab-paclitaxel treatment increased expression of the mitotic-spindle associated phospho-stathmin irrespective of the baseline total or phosphorylated stathmin level, and induced mitotic cell death as confirmed through increased expression of cleaved-PARP and caspase-3. After a two-week nab-paclitaxel, oxaliplatin or epirubicin treatment, the average in vivo local tumor growth inhibition rate was 77, 17.2 and 21.4 percent, respectively (p = 0.002). Effects of therapy on tumoral proliferative and apoptotic indices corresponded with tumor growth inhibition data, while expression of phospho-stathmin also increased in tissues. There was an increase in median animal survival after nab-paclitaxel treatment (93 days) compared to controls (31 days, p = 0.0007), oxaliplatin (40 days, p = 0.0007) or to docetaxel therapy (81 days, p = 0.0416). The strong antitumor activity of nab-paclitaxel in experimental gastric cancer supports such microtubule-inhibitory strategy for clinical application. Nab-paclitaxel benefits were observed independent from phosphorylated stathmin expression at baseline, putting into question the consideration of nab-paclitaxel use in gastric cancer based on this putative biomarker.	[Zhang, Changhua; Awasthi, Niranjan; Hinz, Stefan; Schwarz, Roderich E.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA; [Zhang, Changhua; Awasthi, Niranjan; Hinz, Stefan; Schwarz, Roderich E.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Zhang, Changhua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinopancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Schwarz, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sun Yat Sen University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Schwarz, RE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA.	Roderich.Schwarz@utsouthwestern.edu		Hinz, Stefan/0000-0003-3184-2983				Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382; [Anonymous], J GASTRIC CANC, V12, P3; Awasthi N, 2012, MOL CANCER THER, V11, P2644, DOI 10.1158/1535-7163.MCT-12-0447; Awasthi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038477; Awasthi N, 2009, LAB INVEST, V89, P38, DOI 10.1038/labinvest.2008.106; Belletti B, 2011, EXPERT OPIN THER TAR, V15, P1249, DOI 10.1517/14728222.2011.620951; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Choi YH, 2012, CANC CHEMOTHER PHARM; Coleman RL, 2011, GYNECOL ONCOL, V122, P111, DOI 10.1016/j.ygyno.2011.03.036; Crown J, 2004, ONCOLOGIST, V9, P24, DOI 10.1634/theoncologist.9-suppl_2-24; De Vita F, 2005, BRIT J CANCER, V92, P1644, DOI 10.1038/sj.bjc.6602573; De Vita F, 2012, EXPERT OPIN THER TAR, V16, pS29, DOI 10.1517/14728222.2011.652616; Elsadek B, 2012, J CONTROL RELEASE, V157, P4, DOI 10.1016/j.jconrel.2011.09.069; Gradishar WJ, 2006, EXPERT OPIN PHARMACO, V7, P1041, DOI 10.1517/14656566.7.8.1041; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Gradishar WJ, 2012, CLIN BREAST CANC; Hofheinz RD, 2009, INT J RADIAT ONCOL, V73, P142, DOI 10.1016/j.ijrobp.2008.04.033; Hou HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035665; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeon TY, 2010, BRIT J CANCER, V102, P710, DOI 10.1038/sj.bjc.6605537; Kang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033919; Kobunai T, 2011, ANTICANCER RES, V31, P3691; Kottschade LA, 2011, CANCER-AM CANCER SOC, V117, P1704, DOI 10.1002/cncr.25659; Li XD, 2011, WORLD J GASTROENTERO, V17, P1082, DOI 10.3748/wjg.v17.i8.1082; Mansilla S, 2006, CELL CYCLE, V5, P53, DOI 10.4161/cc.5.1.2267; Matsubara J, 2008, JPN J CLIN ONCOL, V38, P540, DOI 10.1093/jjco/hyn062; Matsubara J, 2011, ONCOLOGY-BASEL, V81, P291, DOI 10.1159/000334462; Mistry SJ, 2007, MOL CANCER RES, V5, P773, DOI 10.1158/1541-7786.MCR-06-0290; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; PYRHONEN S, 1995, BRIT J CANCER, V71, P587, DOI 10.1038/bjc.1995.114; Rao S, 2010, ANN ONCOL, V21, P2213, DOI 10.1093/annonc/mdq247; Risinger AL, 2009, CANCER TREAT REV, V35, P255, DOI 10.1016/j.ctrv.2008.11.001; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; Schwarz RE, 2002, ANN SURG ONCOL, V9, P394, DOI 10.1007/BF02573875; Schwarz RE, 2007, ANN SURG ONCOL, V14, P317, DOI 10.1245/s10434-006-9218-2; Socinski MA, 2012, J CLIN ONCOL, V30, P2055, DOI 10.1200/JCO.2011.39.5848; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Volk LD, 2011, NEOPLASIA, V13, P327, DOI 10.1593/neo.101490; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Wacheck V, 2001, J MOL MED-JMM, V79, P587, DOI 10.1007/s001090100251; Wosnitzer MS, 2011, J UROLOGY, V186, P2094, DOI 10.1016/j.juro.2011.06.051; Zhang C, 2012, J SURG RES; Zhang CH, 2007, ANN SURG ONCOL, V14, P1312, DOI 10.1245/s10434-006-9190-x; Zhao PX, 2012, CHEMMEDCHEM, V7, P952, DOI 10.1002/cmdc.201200052; Zhou QA, 2011, INT J ONCOL, V38, P721, DOI 10.3892/ijo.2011.902	48	20	21	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58037	10.1371/journal.pone.0058037	http://dx.doi.org/10.1371/journal.pone.0058037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460921	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000176
J	Fielding, JE; Bergeri, I; Higgins, N; Kelly, HA; Meagher, J; McBryde, ES; Moran, R; Hellard, ME; Lester, RA				Fielding, James E.; Bergeri, Isabel; Higgins, Nasra; Kelly, Heath A.; Meagher, Julian; McBryde, Emma S.; Moran, Rodney; Hellard, Margaret E.; Lester, Rosemary A.			The Spread of Influenza A(H1N1) pdm09 in Victorian School Children in 2009: Implications for Revised Pandemic Planning	PLOS ONE			English	Article							TRANSMISSION; CLOSURE	Background: Victoria was the first state in Australia to experience community transmission of influenza A(H1N1)pdm09. We undertook a descriptive epidemiological analysis of the first 1,000 notified cases to describe the epidemic associated with school children and explore implications for school closure and antiviral distribution policy in revised pandemic plans. Methods: Records of the first 1,000 laboratory-confirmed cases of influenza A(H1N1) pdm09 notified to the Victorian Government Department of Health between 20 May and 5 June 2009 were extracted from the state's notifiable infectious diseases database. Descriptive analyses were conducted on case demographics, symptoms, case treatment, prophylaxis of contacts and distribution of cases in schools. Results: Two-thirds of the first 1,000 cases were school-aged (5-17 years) with cases in 203 schools, particularly along the north and western peripheries of the metropolitan area. Cases in one school accounted for nearly 8% of all cases but the school was not closed until nine days after symptom onset of the first identified case. Amongst all cases, cough (85%) was the most commonly reported symptom followed by fever (68%) although this was significantly higher in primary school children (76%). The risk of hospitalisation was 2%. The median time between illness onset and notification of laboratory confirmation was four days, with only 10% of cases notified within two days of onset and thus eligible for oseltamivir treatment. Nearly 6,000 contacts were followed up for prophylaxis. Conclusions: With a generally mild clinical course and widespread transmission before its detection, limited and short-term school closures appeared to have minimal impact on influenza A(H1N1) pdm09 transmission. Antiviral treatment could rarely be delivered to cases within 48 hours of symptom onset. These scenarios and lessons learned from them need to be incorporated into revisions of pandemic plans.	[Fielding, James E.; Kelly, Heath A.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Fielding, James E.; Higgins, Nasra; Meagher, Julian; McBryde, Emma S.; Moran, Rodney; Lester, Rosemary A.] Victorian Govt Dept Hlth, Melbourne, Vic, Australia; [Fielding, James E.; Kelly, Heath A.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Bergeri, Isabel; Hellard, Margaret E.] Burnet Inst, Melbourne, Vic, Australia; [McBryde, Emma S.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [McBryde, Emma S.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Hellard, Margaret E.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Victorian Infectious Diseases Reference Laboratory; Australian National University; Burnet Institute; Royal Melbourne Hospital; University of Melbourne; Monash University	Fielding, JE (corresponding author), Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia.	james.fielding@mh.org.au	; McBryde, Emma/D-2220-2018	Fielding, James/0000-0003-2995-9576; McBryde, Emma/0000-0002-9570-9172	Australian Government National Health and Medical Research Council [603753]	Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was partly funded by an Australian Government National Health and Medical Research Council grant (application ID 603753) for research on H1N1 Influenza 09 to inform public policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P173; Australian Government Department of Health and Ageing, 2011, REV AUSTR HLTH SEC R; Australian Government Department of Health and Ageing, 2008, AUSTR HLTH MAN PLAN; Australian Government Department of Health and Ageing, 2009, 5 AUSTR GOV DEP HLTH; Australian Government Department of Health and Ageing, 2009, 4 AUSTR GOV DEP HLTH; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Chan M., 2009, WORLD NOW START 2009; Copeland DL, 2012, CLIN INFECT DIS; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Effler PV, 2010, EMERG INFECT DIS, V16, P205, DOI 10.3201/eid1602.091372; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fielding JE, 2009, EURO SURVEILL, V14; Glass K, 2007, EPIDEMIOLOGY, V18, P623, DOI 10.1097/EDE.0b013e31812713b4; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Kavanagh AM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-2; Kelly H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021828; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Lester R, 2009, VICTORIAN INFECT DIS, V12, P43; McBryde ES, 2009, EUROSURVEILLANCE, V14, P45; McVernon J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-257; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Victorian Government, 2007, VICT HLTH MAN PLAN P; Wilson L, 2009, AUSTRALIAN; World Health Organization, 2009, PAND INFL PREP RESP; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57265	10.1371/journal.pone.0057265	http://dx.doi.org/10.1371/journal.pone.0057265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468949	Green Published, gold, Green Accepted			2022-12-27	WOS:000315561400034
J	Hamaji, T; Smith, DR; Noguchi, H; Toyoda, A; Suzuki, M; Kawai-Toyooka, H; Fujiyama, A; Nishii, I; Marriage, T; Olson, BJSC; Nozaki, H				Hamaji, Takashi; Smith, David R.; Noguchi, Hideki; Toyoda, Atsushi; Suzuki, Masahiro; Kawai-Toyooka, Hiroko; Fujiyama, Asao; Nishii, Ichiro; Marriage, Tara; Olson, Bradley J. S. C.; Nozaki, Hisayoshi			Mitochondrial and Plastid Genomes of the Colonial Green Alga Gonium pectorale Give Insights into the Origins of Organelle DNA Architecture within the Volvocales	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; NUCLEOTIDE DIVERSITY; EVOLUTION; GENE; CHLOROPHYCEAE; PLEODORINA; MOLECULES; ALIGNMENT; MULTIPLE; INTRONS	Volvocalean green algae have among the most diverse mitochondrial and plastid DNAs (mtDNAs and ptDNAs) from the eukaryotic domain. However, nearly all of the organelle genome data from this group are restricted to unicellular species, like Chlamydomonas reinhardtii, and presently only one multicellular species, the similar to 4,000-celled Volvox carteri, has had its organelle DNAs sequenced. The V. carteri organelle genomes are repeat rich, and the ptDNA is the largest plastome ever sequenced. Here, we present the complete mtDNA and ptDNA of the colonial volvocalean Gonium pectorale, which is comprised of similar to 16 cells and occupies a phylogenetic position closer to that of V. carteri than C. reinhardtii within the volvocine line. The mtDNA and ptDNA of G. pectorale are circular-mapping AT-rich molecules with respective lengths and coding densities of 16 and 222.6 kilobases and 73 and 44%. They share some features with the organelle DNAs of V. carteri, including palindromic repeats within the plastid compartment, but show more similarities with those of C. reinhardtii, such as a compact mtDNA architecture and relatively low organelle DNA intron contents. Overall, the G. pectorale organelle genomes raise several interesting questions about the origin of linear mitochondrial chromosomes within the Volvocales and the relationship between multicellularity and organelle genome expansion.	[Hamaji, Takashi] Kyoto Univ, Dept Bot, Grad Sch Sci, Sakyo Ku, Kyoto, Japan; [Smith, David R.] Univ British Columbia, Dept Bot, Canadian Inst Adv Res, Vancouver, BC, Canada; [Noguchi, Hideki; Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Ctr Adv Genom, Mishima, Shizuoka 411, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Suzuki, Masahiro; Kawai-Toyooka, Hiroko] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo, Japan; [Nishii, Ichiro] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Marriage, Tara; Olson, Bradley J. S. C.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Kyoto University; Canadian Institute for Advanced Research (CIFAR); University of British Columbia; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo; National University of Singapore; Kansas State University	Nozaki, H (corresponding author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo, Japan.	nozaki@biol.s.u-tokyo.ac.jp	Smith, David Roy/AAR-1529-2020; NOZAKI, HISAYOSHI/G-4926-2014; Smith, David/L-7910-2015	Smith, David Roy/0000-0001-9560-5210; Smith, David/0000-0001-9560-5210; Hamaji, Takashi/0000-0002-2801-2148; Nozaki, Hisayoshi/0000-0002-9308-4498	Challenging Exploratory Research [24657045]; MEXT/JSPS KAKENHI [24247042];  [221S0002];  [23-5499]; Grants-in-Aid for Scientific Research [24657045] Funding Source: KAKEN	Challenging Exploratory Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas "Genome Science" (number 221S0002), JSPS Fellows (number 23-5499 to TH), Challenging Exploratory Research (number 24657045 to HNZ) and Scientific Research (A) (number 24247042 to HNZ) from MEXT/JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2009, Japanese Journal of Phycology, V57, P1; Belanger AS, 2006, MOL GENET GENOMICS, V276, P464, DOI 10.1007/s00438-006-0156-2; Daubin V, 2004, SCIENCE, V306; Fan J, 2002, MOL BIOL EVOL, V19, P999, DOI 10.1093/oxfordjournals.molbev.a004180; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamaji T, 2008, GENETICS, V178, P283, DOI 10.1534/genetics.107.078618; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Herron MD, 2009, P NATL ACAD SCI USA, V106, P3254, DOI 10.1073/pnas.0811205106; Kirk DL, 2005, BIOESSAYS, V27, P299, DOI 10.1002/bies.20197; Laflamme M, 2003, J PHYCOL, V39, P213, DOI 10.1046/j.1529-8817.2003.02045.x; Lee RW, 2012, ENCY MOL LI IN PRESS, V1; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lynch M, 2007, ORIGINS GENOME ARCHI; Maul JE, 2002, PLANT CELL, V14, P2659, DOI 10.1105/tpc.006155; MICHAELIS G, 1990, MOL GEN GENET, V223, P211, DOI 10.1007/BF00265056; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MILLER SM, 1993, PLANT CELL, V5, P1125, DOI 10.1105/tpc.5.9.1125; Mogi Y, 2012, J PHYCOL, V48, P670, DOI 10.1111/j.1529-8817.2012.01149.x; MOORE LJ, 1989, PLANT MOL BIOL, V13, P459, DOI 10.1007/BF00015557; Nakada T, 2008, MOL PHYLOGENET EVOL, V48, P281, DOI 10.1016/j.ympev.2008.03.016; Nakada T, 2010, J PLANT RES, V123, P67, DOI 10.1007/s10265-009-0266-0; Nozaki H, 2000, MOL PHYLOGENET EVOL, V17, P256, DOI 10.1006/mpev.2000.0831; Nozaki H, 2003, BIOLOGIA, V58, P425; Nozaki H, 2002, MOL PHYLOGENET EVOL, V23, P326, DOI 10.1016/S1055-7903(02)00030-1; NOZAKI H, 1989, PHYCOLOGIA, V28, P252, DOI 10.2216/i0031-8884-28-2-252.1; Popescu CE, 2007, GENETICS, V175, P819, DOI 10.1534/genetics.106.063156; Sachs JL, 2008, TRENDS ECOL EVOL, V23, P245, DOI 10.1016/j.tree.2008.02.003; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Smith DR, 2008, MOL BIOL EVOL, V25, P487, DOI 10.1093/molbev/msm245; Smith DR, 2010, MOL BIOL EVOL, V27, P2244, DOI 10.1093/molbev/msq110; Smith DR, 2010, CURR GENET, V56, P427, DOI 10.1007/s00294-010-0311-5; Smith DR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-83; Smith DR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-120; Smith DR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-132; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STEIN DB, 1986, CURR GENET, V10, P835, DOI 10.1007/BF00418530; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876	39	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57177	10.1371/journal.pone.0057177	http://dx.doi.org/10.1371/journal.pone.0057177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468928	Green Published, gold			2022-12-27	WOS:000315561400028
J	Taylor, EM; Hayman, R; Crawford, F; Jeffery, P; Smith, J				Taylor, Emma Michelle; Hayman, Rachel; Crawford, Fay; Jeffery, Patricia; Smith, James			The Impact of Official Development Aid on Maternal and Reproductive Health Outcomes: A Systematic Review	PLOS ONE			English	Review							RURAL BURKINA-FASO; SAFE MOTHERHOOD; CHILD HEALTH; CARE; INTERVENTIONS; PROGRAMS; HONDURAS	Background: Progress toward meeting Millennium Development Goal 5, which aims to improve maternal and reproductive health outcomes, is behind schedule. This is despite ever increasing volumes of official development aid targeting the goal, calling into question the distribution and efficacy of aid. The 2005 Paris Declaration on Aid Effectiveness represented a global commitment to reform aid practices in order to improve development outcomes, encouraging a shift toward collaborative aid arrangements which support the national plans of aid recipient countries (and discouraging unaligned donor projects). Methods and Findings: We conducted a systematic review to summarise the evidence of the impact on MDG 5 outcomes of official development aid delivered in line with Paris aid effectiveness principles and to compare this with the impact of aid in general on MDG 5 outcomes. Searches of electronic databases identified 30 studies reporting aid-funded interventions designed to improve maternal and reproductive health outcomes. Aid interventions appear to be associated with small improvements in the MDG indicators, although it is not clear whether changes are happening because of the manner in which aid is delivered. The data do not allow for a meaningful comparison between Paris style and general aid. The review identified discernible gaps in the evidence base on aid interventions targeting MDG 5, notably on indicators MDG 5.4 (adolescent birth rate) and 5.6 (unmet need for family planning). Discussion: This review presents the first systematic review of the impact of official development aid delivered according to the Paris principles and aid delivered outside this framework on MDG 5 outcomes. Its findings point to major gaps in the evidence base and should be used to inform new approaches and methodologies aimed at measuring the impact of official development aid.	[Taylor, Emma Michelle; Smith, James] Univ Edinburgh, Ctr African Studies, Edinburgh, Midlothian, Scotland; [Hayman, Rachel] Int NGO Training & Res Ctr, Oxford, England; [Crawford, Fay] Univ Edinburgh, Ctr Populat Hlth Serv, Edinburgh, Midlothian, Scotland; [Jeffery, Patricia] Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Taylor, EM (corresponding author), Univ Edinburgh, Ctr African Studies, Edinburgh, Midlothian, Scotland.	E.M.Taylor@ed.ac.uk	Smith, James/J-4631-2015	Smith, James/0000-0002-8827-2005; Crawford, Fay/0000-0002-0473-9959	United Kingdom's Department for International Development [PO 40031130]; ESRC [ES/F028180/1] Funding Source: UKRI; Economic and Social Research Council [ES/F028180/1] Funding Source: researchfish	United Kingdom's Department for International Development; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by the United Kingdom's Department for International Development (www.dfid.gov.uk) (grant number PO 40031130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accra High-Level Forum on Aid Effectiveness, 2008, ACCR AG ACT; Agha S, 2002, INT FAM PLAN PERSPEC, V28, P67, DOI 10.2307/3088237; Baird J, 2011, SOC SCI MED, V72, P1948, DOI 10.1016/j.socscimed.2010.04.038; Barbey A, 2001, DINAJPUR SAFE MOTHER; Barnett C, 2007, EVALUATION DFID COUN; Buckley C, 2006, STUD FAMILY PLANN, V37, P155, DOI 10.1111/j.1728-4465.2006.00095.x; Campbell C, 2005, B WORLD HEALTH ORGAN, V83, P462; Centre for Reviews and Dissemination, 2009, CRDS GUID UND REV EF; Cowi Goss Gilroy Inc and EPOS Health Consultants, 2007, JOINT EXT EV HLTH SE; Debay M, 2007, FAOA009800027002007; Edwards NC, 2006, CAN J PUBLIC HEALTH, V97, P45, DOI 10.1007/BF03405214; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Hayman R, 2011, IMPACT AID MATERNAL; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Hounton S, 2008, TROP MED INT HEALTH, V13, P53, DOI 10.1111/j.1365-3156.2008.02087.x; Hounton S, 2008, TROP MED INT HEALTH, V13, P14, DOI 10.1111/j.1365-3156.2008.02083.x; Magnani RJ, 1998, POPUL RES POLICY REV, V17, P305, DOI 10.1023/A:1005926905494; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Mansour M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-1; Mathur S., 2004, YOUTH REPROD HLTH NE; Meuwissen Liesbeth E, 2006, J Adolesc Health, V38, P56; Mize L, 2008, HLTH ALLIANCE INT IM; Mulay S, 1992, Artha Vijnana, V34, P209; OECD, 2007, 2006 SURV MON PAR DE, V2; OECD, 2008, 2008 SURV MON PAR DE, V1; Options Consultancy Ltd, 2010, SUPP SAF MOTH PROGR; Paris High-Level Forum, 2005, PAR DECL AID EFF; Perks C, 2006, B WORLD HEALTH ORGAN, V84, P132, DOI 10.2471/BLT.05.025403; Posner, 2007, EVALUATION AFRICAN Y; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Public Health Resource Unit, 2006, 10 QUEST HELP MAK SE; Rees R, 2009, CHILDRENS VIEWS OBES; Ronsmans C, 2001, TROP MED INT HEALTH, V6, P799, DOI 10.1046/j.1365-3156.2001.00780.x; SENLET P, 2008, MIDTERM EVALUATION U; Shiffman J, 2004, HEALTH POLICY PLANN, V19, P380, DOI 10.1093/heapol/czh053; Snyder L, 2003, METAANALYSIS EFFECTI; Stern E., 2008, THEMATIC STUDY PARIS; Stern E, 2012, BROADENING RANGE DES; Taylor EM, 2010, IMPACT AID MATERNAL; Thomas J., 2003, CHILDREN HLTH EATING; United Nations Development Programme, 2009, HUM DEV REP OV BARR; Waddington H., 2009, WATER SANITATION HYG; World Bank, 2006, 36564 WORLD BANK; World Bank, 1998, 181411998 WORLD BANK; World Bank, 2007, 39118 WORLD BANK; World Bank, 2003, 25239 WORLD BANK; World Bank, 2008, 44465 WORLD BANK	48	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56271	10.1371/journal.pone.0056271	http://dx.doi.org/10.1371/journal.pone.0056271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23468860	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800008
J	Hagen, SM; Lafranca, JA; Steyerberg, EW; IJzermans, JNM; Dor, FJMF				Hagen, Sander M.; Lafranca, Jeffrey A.; Steyerberg, Ewout W.; IJzermans, Jan N. M.; Dor, Frank J. M. F.			Laparoscopic versus Open Peritoneal Dialysis Catheter Insertion: A Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ADJUSTED MORTALITY-RATES; SINGLE-CENTER EXPERIENCE; TENCKHOFF CATHETERS; ASSISTED PLACEMENT; IMPLANTATION TECHNIQUE; SURGICAL PLACEMENT; DOUBLE-CUFF; ACCESS; HEMODIALYSIS	Background: Peritoneal dialysis is an effective treatment for end-stage renal disease. Key to successful peritoneal dialysis is a well-functioning catheter. The different insertion techniques may be of great importance. Mostly, the standard operative approach is the open technique; however, laparoscopic insertion is increasingly popular. Catheter malfunction is reported up to 35% for the open technique and up to 13% for the laparoscopic technique. However, evidence is lacking to definitely conclude that the laparoscopic approach is to be preferred. This review and meta-analysis was carried out to investigate if one of the techniques is superior to the other. Methods: Comprehensive searches were conducted in MEDLINE, Embase and CENTRAL (the Cochrane Library 2012, issue 10). Reference lists were searched manually. The methodology was in accordance with the Cochrane Handbook for interventional systematic reviews, and written based on the PRISMA-statement. Results: Three randomized controlled trials and eight cohort studies were identified. Nine postoperative outcome measures were meta-analyzed; of these, seven were not different between operation techniques. Based on the meta-analysis, the proportion of migrating catheters was lower (odds ratio (OR) 0.21, confidence interval (CI) 0.07 to 0.63; P = 0.006), and the one-year catheter survival was higher in the laparoscopic group (OR 3.93, CI 1.80 to 8.57; P = 0.0006). Conclusions: Based on these results there is some evidence in favour of the laparoscopic insertion technique for having a higher one-year catheter survival and less migration, which would be clinically relevant.	[Hagen, Sander M.; Lafranca, Jeffrey A.; IJzermans, Jan N. M.; Dor, Frank J. M. F.] Univ Med Ctr, Dept Surg, Erasmus MC, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Univ Med Ctr, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Dor, FJMF (corresponding author), Univ Med Ctr, Dept Surg, Erasmus MC, Rotterdam, Netherlands.	f.dor@erasmusmc.nl	Steyerberg, Ewout W/C-1509-2018	Steyerberg, Ewout W/0000-0002-7787-0122; Lafranca, Jeffrey/0000-0002-2727-0524				Ash SR, 2003, SEMIN DIALYSIS, V16, P323, DOI 10.1046/j.1525-139X.2003.16062.x; Ashegh H, 2008, PERITON DIALYSIS INT, V28, P622; Attaluri V, 2010, J AM COLL SURGEONS, V211, P699, DOI 10.1016/j.jamcollsurg.2010.08.010; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Batey CA, 2002, J ENDOUROL, V16, P681, DOI 10.1089/089277902761403041; Brozek J, GRADEPRO VERSION 3 2; Chen WM, 2007, PERITON DIALYSIS INT, V27, P554; Crabtree JH, 2005, AM SURGEON, V71, P135; Crabtree JH, 1999, SURG ENDOSC-ULTRAS, V13, P186, DOI 10.1007/s004649900936; Crabtree JH, 1999, SURG LAPARO ENDO PER, V9, P228, DOI 10.1097/00019509-199906000-00018; Crabtree JH, 2000, PERITON DIALYSIS INT, V20, P757; Crabtree JH, 2009, AM J SURG, V198, P135, DOI 10.1016/j.amjsurg.2008.10.019; DAVIS AS, 1983, SURG GYNECOL OBSTET, V157, P579; Draganic B, 1998, AUST NZ J SURG, V68, P735, DOI 10.1111/j.1445-2197.1998.tb04662.x; Eklund B, 1997, NEPHROL DIAL TRANSPL, V12, P2664, DOI 10.1093/ndt/12.12.2664; Fenton SSA, 1997, AM J KIDNEY DIS, V30, P334, DOI 10.1016/S0272-6386(97)90276-6; Figueiredo A, 2010, PERITON DIALYSIS INT, V30, P424, DOI 10.3747/pdi.2010.00087; Gadallah MF, 2000, AM J KIDNEY DIS, V36, P1014, DOI 10.1053/ajkd.2000.19104; Gadallah MF, 1999, AM J KIDNEY DIS, V33, P118, DOI 10.1016/S0272-6386(99)70266-0; Gajar AH, 2007, AM J SURG, V194, P872, DOI 10.1016/j.amjsurg.2007.08.038; Garcia MAV, 1997, PERITON DIALYSIS INT, V17, P194; Glasziou P, OXFORD 2011 LEVELS E; Hagen SM, 2011, BMC SURG, V20, P11; Heaf JG, 2002, NEPHROL DIAL TRANSPL, V17, P112, DOI 10.1093/ndt/17.1.112; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hwang SJ, 1998, PERITON DIALYSIS INT, V18, P433; Johnson DW, 2006, AM J KIDNEY DIS, V48, P812, DOI 10.1053/j.ajkd.2006.08.010; Jwo SC, 2010, J SURG RES, V159, P489, DOI 10.1016/j.jss.2008.09.008; Keus F, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006231; Keus F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008318; Klarenbeek BR, 2011, SURG ENDOSC, V25, P1121, DOI 10.1007/s00464-010-1327-0; Ko J, 2009, SURG TODAY, V39, P356, DOI 10.1007/s00595-008-3877-5; Kok NFM, 2006, BRIT MED J, V333, P221, DOI 10.1136/bmj.38886.618947.7C; Li JR, 2011, SURG LAPARO ENDO PER, V21, P106, DOI 10.1097/SLE.0b013e31820af4ad; Liu WJ, 2010, PERITON DIALYSIS INT, V30, P509, DOI 10.3747/pdi.2009.00083; Lo WK, 2003, PERITON DIALYSIS INT, V23, pS127; Lu CT, 2003, ANZ J SURG, V73, P109, DOI 10.1046/j.1445-2197.2003.02651.x; Lund L, 2007, INT UROL NEPHROL, V39, P625, DOI 10.1007/s11255-007-9193-y; MAIORCA R, 1991, PERITON DIALYSIS INT, V11, P118; Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873; Nessim SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2310, DOI 10.1093/ndt/gfq002; NIELSEN PK, 1995, PERITON DIALYSIS INT, V15, P18; Ogunc G, 2003, SURG ENDOSC, V17, P1749, DOI 10.1007/s00464-002-8586-3; Poole GH, 2000, AUST NZ J SURG, V70, P371, DOI 10.1046/j.1440-1622.2000.01830.x; Prischl FC, 1997, NEPHROL DIAL TRANSPL, V12, P1661, DOI 10.1093/ndt/12.8.1661; Ranganathan D, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-11; ROBISON RJ, 1984, SURGERY, V96, P723; Schmidt SC, 2007, J LAPAROENDOSC ADV S, V17, P596, DOI 10.1089/lap.2006.0162; Soontrapornchai P, 2005, SURG ENDOSC, V19, P137, DOI 10.1007/s00464-004-8156-y; Strippoli G.F., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004680.PUB2; Strippoli GFM, 2004, AM J KIDNEY DIS, V44, P591, DOI [10.1016/S0272-6386(04)00941-2, 10.1053/j.ajkd.2004.05.043]; SWARTZ R, 1990, PERITON DIALYSIS INT, V10, P231; Termorshuizen F, 2003, J AM SOC NEPHROL, V14, P2851, DOI 10.1097/01.ASN.0000091585.45723.9E; Tiong H. Y., 2006, SMJ Singapore Medical Journal, V47, P707; Tsimoyiannis ECT, 2000, SURG LAPARO ENDO PER, V10, P218, DOI 10.1097/00019509-200008000-00007; Wright MJ, 1999, PERITON DIALYSIS INT, V19, P372; Xie HY, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-69; Yan XA, 2010, SCAND J UROL NEPHROL, V44, P341, DOI 10.3109/00365591003733690; Yang PJ, 2010, PERITON DIALYSIS INT, V30, P513, DOI 10.3747/pdi.2009.00033	59	53	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56351	10.1371/journal.pone.0056351	http://dx.doi.org/10.1371/journal.pone.0056351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457554	Green Published, gold			2022-12-27	WOS:000315603700043
J	Kristensen, SL; Ahlehoff, O; Lindhardsen, J; Erichsen, R; Jensen, GV; Torp-Pedersen, C; Nielsen, OH; Gislason, GH; Hansen, PR				Kristensen, Soren Lund; Ahlehoff, Ole; Lindhardsen, Jesper; Erichsen, Rune; Jensen, Gunnar Vagn; Torp-Pedersen, Christian; Nielsen, Ole Haagen; Gislason, Gunnar Hilmar; Hansen, Peter Riis			Disease Activity in Inflammatory Bowel Disease Is Associated with Increased Risk of Myocardial Infarction, Stroke and Cardiovascular Death - A Danish Nationwide Cohort Study	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; RHEUMATOID-ARTHRITIS; ATRIAL-FIBRILLATION; ULCERATIVE-COLITIS; ISCHEMIC-STROKE; CROHNS-DISEASE; MORTALITY; ATHEROSCLEROSIS; MECHANISMS; THROMBOSIS	Purpose: Chronic inflammatory diseases have been linked to increased risk of atherothrombotic events, but the risk associated with inflammatory bowel disease (IBD) is unclear. We therefore examined the risk of myocardial infarction (MI), stroke, and cardiovascular death in patients with IBD. Methods: In a nationwide Danish population-based setting, a cohort of patients with incident IBD between 1996 and 2009 were identified in national registers. Hospitalizations with IBD as primary diagnosis, initiation of biological treatment and dispensed prescriptions of corticosteroids were all used as surrogate markers for disease activity, with flares classified as the first 120 days after diagnosis of IBD, and 120 days after a new corticosteroid prescription, biological treatment or IBD hospitalization, respectively. Continued corticosteroid prescriptions or IBD hospitalizations were defined as persistent activity, and periods free of such events were defined as remissions. Poisson regression was used to examine risk of MI, stroke, and cardiovascular death using a matched population-based comparison cohort as reference Results: We identified 20,795 IBD patients with a mean age of 40.3 years that were matched according to age and sex with 199,978 controls. During the study period, there were 365 patients with MI, 454 with stroke, and 778 with cardiovascular death. Patients with IBD had an overall increased risk of MI (rate ratio [RR] 1.17 [95% confidence interval 1.05-1.31]), stroke (RR 1.15 [1.04-1.27], and cardiovascular death (RR 1.35 [1.25-1.45]). During flares and persistent IBD activity the RRs of MI increased to 1.49 (1.16-1.93) and 2.05 (1.58-2.65), the RRs of stroke to 1.53 (1.22-1.92) and 1.55 (1.18-2.04) and for cardiovascular death 2.32 (2.01-2.68) and 2.50 (2.14-2.92). In remission periods, the risk of MI, stroke and cardiovascular death was similar to controls. Conclusion: Inflammatory bowel disease is associated with increased risk of MI, stroke, and cardiovascular death during periods with active disease.	[Kristensen, Soren Lund; Ahlehoff, Ole; Lindhardsen, Jesper; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar; Hansen, Peter Riis] Univ Copenhagen, Dept Cardiol, Gentofte Hosp, Hellerup, Denmark; [Kristensen, Soren Lund; Ahlehoff, Ole; Jensen, Gunnar Vagn] Univ Copenhagen, Dept Cardiol, Hosp Roskilde, Roskilde, Denmark; [Erichsen, Rune] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Nielsen, Ole Haagen] Univ Copenhagen, Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Aarhus University; University of Copenhagen; Herlev & Gentofte Hospital	Kristensen, SL (corresponding author), Univ Copenhagen, Dept Cardiol, Gentofte Hosp, Hellerup, Denmark.	slk@heart.dk	Hansen, Peter Riis/AAR-7659-2020; Gislason, Gunnar/B-7561-2009; Torp-Pedersen, Christian/E-5931-2013; Nielsen, Ole Haagen/AAK-2482-2021; Kristensen, Søren Lund/J-5267-2019	Gislason, Gunnar/0000-0002-0548-402X; Nielsen, Ole Haagen/0000-0003-4612-8635; Kristensen, Søren Lund/0000-0002-9759-7397; Erichsen, Rune/0000-0001-9398-9185; Hansen, Peter Riis/0000-0002-9056-535X	Department of Cardiology, Copenhagen University Hospital Gentofte, Denmark [DK-2900]; Department of Cardiology, Copenhagen University Roskilde, Denmark [DK-4000]	Department of Cardiology, Copenhagen University Hospital Gentofte, Denmark; Department of Cardiology, Copenhagen University Roskilde, Denmark	The study was supported by Department of Cardiology, Copenhagen University Hospital Gentofte, DK-2900, and Department of Cardiology, Copenhagen University Roskilde, DK-4000, Denmark. SL Kristensen has received donations from the foundations of Eva and Henry Frankel and Snedkermester Sophus Jacobsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageno W, 2008, THROMB HAEMOSTASIS, V100, P181, DOI 10.1160/TH08-06-0360; Ahlehoff O, 2011, J INTERN MED, V270, P147, DOI 10.1111/j.1365-2796.2010.02310.x; Ahlehoff O, 2012, EUR HEART J, V33, P2054, DOI 10.1093/eurheartj/ehr285; Andersohn F, 2010, INFLAMM BOWEL DIS, V16, P1387, DOI 10.1002/ibd.21187; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bernstein CN, 2008, CLIN GASTROENTEROL H, V6, P41, DOI 10.1016/j.cgh.2007.09.016; Dagli N, 2010, ANGIOLOGY, V61, P198, DOI 10.1177/0003319709333869; Dorn SD, 2007, AM J GASTROENTEROL, V102, P662, DOI 10.1111/j.1572-0241.2006.01018.x; Fonager K, 1996, SCAND J GASTROENTERO, V31, P154, DOI 10.3109/00365529609031980; Gaist D, 1997, DAN MED BULL, V44, P445; Gandhi S, 2012, AM J MED; Grainge MJ, 2010, LANCET, V375, P657, DOI 10.1016/S0140-6736(09)61963-2; Gresele P, 2010, THROMB HAEMOSTASIS, V103, P56, DOI 10.1160/TH09-08-0562; Ha C, 2009, AM J GASTROENTEROL, V104, P1445, DOI 10.1038/ajg.2009.81; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Irving PM, 2005, CLIN GASTROENTEROL H, V3, P617, DOI 10.1016/S1542-3565(05)00154-0; Kappelman MD, 2011, GUT, V60, P937, DOI 10.1136/gut.2010.228585; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Liuzzo G, 2001, Rays, V26, P221; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Meune C, 2009, RHEUMATOLOGY, V48, P1309, DOI 10.1093/rheumatology/kep252; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Osterman MT, 2011, CLIN GASTROENTEROL H, V9, P875, DOI 10.1016/j.cgh.2011.06.032; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Roifman I, 2009, CLIN GASTROENTEROL H, V7, P175, DOI 10.1016/j.cgh.2008.10.021; Rungoe C, 2012, GUT; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Solomon DH, 2010, ANN RHEUM DIS, V69, P1920, DOI 10.1136/ard.2009.122226; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; van Leuven SI, 2007, J LIPID RES, V48, P2640, DOI 10.1194/jlr.M700176-JLR200; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Yarur AJ, 2011, AM J GASTROENTEROL, V106, P741, DOI 10.1038/ajg.2011.63; Zitomersky NL, 2011, INFLAMM BOWEL DIS, V17, P458, DOI 10.1002/ibd.21334	40	134	140	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56944	10.1371/journal.pone.0056944	http://dx.doi.org/10.1371/journal.pone.0056944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457642	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700100
J	Pielstrom, S; Roces, F				Pielstroem, Steffen; Roces, Flavio			Sequential Soil Transport and Its Influence on the Spatial Organisation of Collective Digging in Leaf-Cutting Ants	PLOS ONE			English	Article							ATTA-VOLLENWEIDERI FOREL; INTERNAL STRUCTURE; NEST VENTILATION; INSECT SOCIETIES; 1893 HYM; HYMENOPTERA; FORMICIDAE; TERMITES; PATTERNS; DISTANCE	The Chaco leaf-cutting ant Atta vollenweideri (Forel) inhabits large and deep subterranean nests composed of a large number of fungus and refuse chambers. The ants dispose of the excavated soil by forming small pellets that are carried to the surface. For ants in general, the organisation of underground soil transport during nest building remains completely unknown. In the laboratory, we investigated how soil pellets are formed and transported, and whether their occurrence influences the spatial organisation of collective digging. Similar to leaf transport, we discovered size matching between soil pellet mass and carrier mass. Workers observed while digging excavated pellets at a rate of 26 per hour. Each excavator deposited its pellets in an individual cluster, independently of the preferred deposition sites of other excavators. Soil pellets were transported sequentially over 2 m, and the transport involved up to 12 workers belonging to three functionally distinct groups: excavators, several short-distance carriers that dropped the collected pellets after a few centimetres, and long-distance, last carriers that reached the final deposition site. When initiating a new excavation, the proportion of long-distance carriers increased from 18% to 45% within the first five hours, and remained unchanged over more than 20 hours. Accumulated, freshly-excavated pellets significantly influenced the workers' decision where to start digging in a choice experiment. Thus, pellets temporarily accumulated as a result of their sequential transport provide cues that spatially organise collective nest excavation.	[Pielstroem, Steffen; Roces, Flavio] Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany	University of Wurzburg	Pielstrom, S (corresponding author), Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany.	steffen.pielstroem@gmx.com	Pielström, Steffen/C-6878-2013	Roces, Flavio/0000-0001-9258-3079	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation (DFG) [SFB 554/TP E1]	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg, and by funds from the German Research Foundation (DFG, grant SFB 554/TP E1). The publication costs were covered by the Library of the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2000, INSECT SOC, V47, P198, DOI 10.1007/PL00001702; Anderson C, 2002, INSECT SOC, V49, P171, DOI 10.1007/s00040-002-8298-7; Autuori M., 1942, ARQ INST BIOL [SAO PAULO], V13, P137; BLUM MS, 1966, ANN ENTOMOL SOC AM, V59, P774, DOI 10.1093/aesa/59.4.774; BUCHER E H, 1967, Acta Zoologica Lilloana, V23, P83; Cosarinsky MI, 2007, GEODERMA, V141, P224, DOI 10.1016/j.geoderma.2007.06.006; Cosarinsky MI, 2012, J INSECT BEHAV, V25, P222, DOI 10.1007/s10905-011-9290-8; DELYE G, 1971, INSECT SOC, V18, P15, DOI 10.1007/BF02223160; Delye G., 1957, Insectes Sociaux Paris, V4, P77, DOI 10.1007/BF02224144; EMERSON ALFRED E., 1938, ECOL MONOGR, V8, P247, DOI 10.2307/1943251; FOWLER HG, 1979, ECOL ENTOMOL, V4, P239, DOI 10.1111/j.1365-2311.1979.tb00581.x; FREEDMAN DA, 1981, ANN STAT, V9, P1218, DOI 10.1214/aos/1176345638; Frohle K, 2009, THESIS JULIUS MAXIMI; Frohle K., 2009, INSECT NEST HUMAN AR, P95; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Hansell M., 2005, OXF ANIMAL BIOL SER; Hingston R.W.G., 1929, INSTINCT INTELLIGENC; HUBBELL SP, 1980, BIOTROPICA, V12, P210, DOI 10.2307/2387973; JARVIS JUM, 1971, J ZOOL, V163, P451; JEANNE RL, 1986, BEHAV ECOL SOCIOBIOL, V19, P333, DOI 10.1007/BF00295706; JEANNE RL, 1986, MONIT ZOOL ITAL, V20, P119; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P158; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P217; JONKMAN JCM, 1978, Z ANGEW ENTOMOL, V86, P25; JONKMAN JCM, 1976, Z ANGEW ENTOMOL, V81, P140; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; Kleineidam C, 2001, NATURWISSENSCHAFTEN, V88, P301, DOI 10.1007/s001140100235; Lee SH, 2008, BEHAV PROCESS, V78, P397, DOI 10.1016/j.beproc.2008.02.009; LIGHTON JRB, 1987, PHYSIOL ZOOL, V60, P524, DOI 10.1086/physzool.60.5.30156127; Pielstrom S, 2012, ANIM BEHAV, V84, P743, DOI 10.1016/j.anbehav.2012.07.008; Roces F, 2009, CONTEMP TOP ENTOMOL, P261; Roschard J, 2003, J TROP ECOL, V19, P647, DOI 10.1017/S0266467403006047; Roschard J, 2003, INSECT SOC, V50, P237, DOI 10.1007/s00040-003-0663-7; Roschard J, 2002, OECOLOGIA, V131, P319, DOI 10.1007/s00442-002-0882-z; Roschard Jacqueline, 2011, Psyche (Cambridge), V2011, P1, DOI 10.1155/2011/643127; SLEEMAN JR, 1972, PEDOBIOLOGIA, V12, P347; Sosa B, 2010, J VEG SCI, V21, P597, DOI 10.1111/j.1654-1103.2010.01170.x; SPANGLER HAYWARD G., 1966, J KANS ENTOMOL SOC, V39, P739; Sudd J. H., 1969, Zeitschrift fuer Tierpsychologie, V26, P257; Theraulaz G, 1999, ARTIF LIFE, V5, P97, DOI 10.1162/106454699568700; Weber N. A., 1972, GARDENING ANTS ATTIN; WILSON EDWARD O., 1958, PSYCHE, V65, P41, DOI 10.1155/1958/57483	43	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e57040	10.1371/journal.pone.0057040	http://dx.doi.org/10.1371/journal.pone.0057040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457648	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700102
J	Saleem, M; Prince, SM; Rigby, SEJ; Imran, M; Patel, H; Chan, H; Sanders, H; Maiden, MCJ; Feavers, IM; Derrick, JP				Saleem, Muhammad; Prince, Stephen M.; Rigby, Stephen E. J.; Imran, Muhammad; Patel, Hema; Chan, Hannah; Sanders, Holly; Maiden, Martin C. J.; Feavers, Ian M.; Derrick, Jeremy P.			Use of a Molecular Decoy to Segregate Transport from Antigenicity in the FrpB Iron Transporter from Neisseria meningitidis	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; FERRIC ENTEROBACTIN; STRUCTURAL BASIS; CLUSTAL-W; TONB; EVOLUTION; BINDING; FETA; FEPA; CRYSTALLOGRAPHY	FrpB is an outer membrane transporter from Neisseria meningitidis, the causative agent of meningococcal meningitis. It is a member of the TonB-dependent transporter (TBDT) family and is responsible for iron uptake into the periplasm. FrpB is subject to a high degree of antigenic variation, principally through a region of hypervariable sequence exposed at the cell surface. From the crystal structures of two FrpB antigenic variants, we identify a bound ferric ion within the structure which induces structural changes on binding which are consistent with it being the transported substrate. Binding experiments, followed by elemental analysis, verified that FrpB binds Fe3+ with high affinity. EPR spectra of the bound Fe3+ ion confirmed that its chemical environment was consistent with that observed in the crystal structure. Fe3+ binding was reduced or abolished on mutation of the Fe3+-chelating residues. FrpB orthologs were identified in other Gram-negative bacteria which showed absolute conservation of the coordinating residues, suggesting the existence of a specific TBDT sub-family dedicated to the transport of Fe3+. The region of antigenic hypervariability lies in a separate, external sub-domain, whose structure is conserved in both the F3-3 and F5-1 variants, despite their sequence divergence. We conclude that the antigenic sub-domain has arisen separately as a result of immune selection pressure to distract the immune response from the primary transport function. This would enable FrpB to function as a transporter independently of antibody binding, by using the antigenic sub-domain as a 'molecular decoy' to distract immune surveillance.	[Saleem, Muhammad; Imran, Muhammad; Derrick, Jeremy P.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Prince, Stephen M.; Rigby, Stephen E. J.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Patel, Hema; Chan, Hannah; Sanders, Holly; Feavers, Ian M.] Hlth Protect Agcy, Natl Inst Biol Stand & Control, Potters Bar, Herts, England; [Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Manchester; University of Manchester; Health Protection Agency; National Institute for Biological Standards & Control; University of Oxford	Derrick, JP (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester, Lancs, England.	Jeremy.Derrick@manchester.ac.uk	Maiden, Martin C J/C-5055-2014; Saleem, Muhammad/W-4014-2017; Maiden, Martin/N-6805-2019	Maiden, Martin C J/0000-0001-6321-5138; Saleem, Muhammad/0000-0002-0994-9701; Maiden, Martin/0000-0001-6321-5138; Prince, Stephen/0000-0003-0929-0254; Derrick, Jeremy/0000-0002-4350-5354	Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/E013007/1] Funding Source: researchfish; BBSRC [BB/E013007/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported with a Translation Award from the Wellcome Trust. Martin Maiden is a Wellcome Trust Senior Research Fellow. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Alexeev D, 2003, NAT STRUCT BIOL, V10, P297, DOI 10.1038/nsb903; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beernink PT, 2009, MICROBIOL-SGM, V155, P2873, DOI 10.1099/mic.0.029876-0; BEUCHER M, 1995, J BACTERIOL, V177, P2041, DOI 10.1128/jb.177.8.2041-2049.1995; Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bruns CM, 1997, NAT STRUCT BIOL, V4, P919, DOI 10.1038/nsb1197-919; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Buchanan SK, 2007, EMBO J, V26, P2594, DOI 10.1038/sj.emboj.7601693; Buckee CO, 2010, P ROY SOC B-BIOL SCI, V277, P1635, DOI 10.1098/rspb.2009.2033; Buckee CO, 2008, P NATL ACAD SCI USA, V105, P15082, DOI 10.1073/pnas.0712019105; Callaghan MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000020; Carson SDB, 1999, J BACTERIOL, V181, P2895, DOI 10.1128/JB.181.9.2895-2901.1999; Chimento DP, 2005, PROTEINS, V59, P240, DOI 10.1002/prot.20416; Cobessi D, 2010, PROTEINS, V78, P286, DOI 10.1002/prot.22539; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Devanathan S, 2007, MOL MICROBIOL, V65, P441, DOI 10.1111/j.1365-2958.2007.05808.x; DYER DW, 1988, INFECT IMMUN, V56, P977, DOI 10.1128/IAI.56.4.977-983.1988; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanucci GE, 2003, BIOCHEMISTRY-US, V42, P13106, DOI 10.1021/bi035439t; Fanucci GE, 2003, P NATL ACAD SCI USA, V100, P11382, DOI 10.1073/pnas.1932486100; Feavers IM, 2009, VACCINE, V27, pB42, DOI 10.1016/j.vaccine.2009.05.001; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Guo ML, 2003, J BIOL CHEM, V278, P2490, DOI 10.1074/jbc.M208776200; Gupta S, 2001, TRENDS MICROBIOL, V9, P181, DOI 10.1016/S0966-842X(01)01986-2; Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437; Hollander A, 2011, INFECT IMMUN, V79, P4764, DOI 10.1128/IAI.05806-11; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kortekaas J, 2007, VACCINE, V25, P72, DOI 10.1016/j.vaccine.2006.07.016; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V24, P946; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLuskey K, 2001, BIOCHEMISTRY-US, V40, P8783, DOI 10.1021/bi010309a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noinaj N, 2012, NATURE, V483, P53, DOI 10.1038/nature10823; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; PETTERSSON A, 1995, INFECT IMMUN, V63, P4181, DOI 10.1128/IAI.63.10.4181-4184.1995; PETTERSSON A, 1990, INFECT IMMUN, V58, P3036, DOI 10.1128/IAI.58.9.3036-3041.1990; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Saleem M, 2012, ACTA CRYSTALLOGR F, V68, P231, DOI 10.1107/S1744309111056028; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Smallwood CR, 2009, MOL MICROBIOL, V72, P1171, DOI 10.1111/j.1365-2958.2009.06715.x; SPARTALIAN K, 1975, J CHEM PHYS, V62, P3538, DOI 10.1063/1.430998; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zhu HZ, 2003, BIOCHEM J, V376, P35, DOI 10.1042/BJ20031283; Zollinger WD, 2011, EXPERT REV VACCINES, V10, P559, DOI [10.1586/erv.11.41, 10.1586/ERV.11.41]	62	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56746	10.1371/journal.pone.0056746	http://dx.doi.org/10.1371/journal.pone.0056746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457610	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700078
J	Hurwitz, BL; Sullivan, MB				Hurwitz, Bonnie L.; Sullivan, Matthew B.			The Pacific Ocean Virome (POV): A Marine Viral Metagenomic Dataset and Associated Protein Clusters for Quantitative Viral Ecology	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; TRANSFER AGENT GENES; MONTEREY BAY; POPULATION-STRUCTURE; MICROBIAL DIVERSITY; DEEP-SEA; VIRUSES; CYANOPHAGES; AMPLIFICATION; GENOMES	Bacteria and their viruses (phage) are fundamental drivers of many ecosystem processes including global biogeochemistry and horizontal gene transfer. While databases and resources for studying function in uncultured bacterial communities are relatively advanced, many fewer exist for their viral counterparts. The issue is largely technical in that the majority (often 90%) of viral sequences are functionally 'unknown' making viruses a virtually untapped resource of functional and physiological information. Here, we provide a community resource that organizes this unknown sequence space into 27 K high confidence protein clusters using 32 viral metagenomes from four biogeographic regions in the Pacific Ocean that vary by season, depth, and proximity to land, and include some of the first deep pelagic ocean viral metagenomes. These protein clusters more than double currently available viral protein clusters, including those from environmental datasets. Further, a protein cluster guided analysis of functional diversity revealed that richness decreased (i) from deep to surface waters, (ii) from winter to summer, (iii) and with distance from shore in surface waters only. These data provide a framework from which to draw on for future metadata-enabled functional inquiries of the vast viral unknown.	[Hurwitz, Bonnie L.; Sullivan, Matthew B.] Univ Arizona, Tucson, AZ 85721 USA	University of Arizona	Sullivan, MB (corresponding author), Univ Arizona, Tucson, AZ 85721 USA.	mbsulli@email.arizona.edu	Sullivan, Matthew B/H-3256-2011	Sullivan, Matthew B/0000-0003-4040-9831	Department of Energy; Gordon and Betty Moore Foundation Marine Microbial Initiative; National Science Foundation [DBI-0850105, OCE-0961947]; Biosphere 2; BIO5; Gordon and Betty Moore Foundation	Department of Energy(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation Marine Microbial Initiative; National Science Foundation(National Science Foundation (NSF)); Biosphere 2; BIO5; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Sequencing was provided by the Department of Energy Joint Genome Institute Community Sequencing Program and the Gordon and Betty Moore Foundation Marine Microbial Initiative, while funding was from National Science Foundation (DBI-0850105 and OCE-0961947), Biosphere 2, BIO5 and Gordon and Betty Moore Foundation grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017722; Allers E, 2013, ENVIRON MICROBIOL, V15, P2306, DOI 10.1111/1462-2920.12100; Allers E, 2013, ISME J, V7, P256, DOI 10.1038/ismej.2012.108; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews-Pfannkoch C, 2010, APPL ENVIRON MICROB, V76, P5039, DOI 10.1128/AEM.00204-10; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; Biers EJ, 2008, APPL ENVIRON MICROB, V74, P2933, DOI 10.1128/AEM.02129-07; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Breitbart M, 2007, OCEANOGRAPHY, V20, P135, DOI 10.5670/oceanog.2007.58; Caporaso JG, 2012, ISME J, V6, P1089, DOI 10.1038/ismej.2011.162; Council SNR, 2010, MAL EXP; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; Deng L, 2012, MBIO, V3, DOI 10.1128/mBio.00373-12; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Duhaime M, 2012, VIROLOGY; Duhaime Melissa B, 2012, Environ Microbiol, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Edwards RA, 2012, BIOINFORMATICS, V28, P3316, DOI 10.1093/bioinformatics/bts599; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fortunato CS, 2012, ISME J, V6, P554, DOI 10.1038/ismej.2011.135; Freeland H, 2007, PROG OCEANOGR, V75, P120, DOI 10.1016/j.pocean.2007.08.005; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Henn MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009083; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Holmfeldt K, 2012, APPL ENVIRON MICROB, V78, P892, DOI 10.1128/AEM.06580-11; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; John SG, 2011, ENV MICROBIOL REP, V3, P195, DOI 10.1111/j.1758-2229.2010.00208.x; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; Kim KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Lu J, 2001, APPL ENVIRON MICROB, V67, P3285, DOI 10.1128/AEM.67.7.3285-3290.2001; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; McDaniel L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003263; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pennington JT, 2000, DEEP-SEA RES PT II, V47, P947, DOI 10.1016/S0967-0645(99)00132-0; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rattei T, 2006, NUCLEIC ACIDS RES, V34, pD252, DOI 10.1093/nar/gkj106; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Roux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033641; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stanton TB, 2007, ANAEROBE, V13, P43, DOI 10.1016/j.anaerobe.2007.03.004; Steward GF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-287; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; SUTTLE CA, 1994, APPL ENVIRON MICROB, V60, P3167, DOI 10.1128/AEM.60.9.3167-3174.1994; Tadmor AD, 2011, SCIENCE, V333, P58, DOI 10.1126/science.1200758; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward BB, 2005, MAR ECOL PROG SER, V292, P97, DOI 10.3354/meps292097; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; Williamson SJ, 2008, ISME J, V2, P1112, DOI 10.1038/ismej.2008.73; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Wommack KE, 2012, STAND GENOMIC SCI, V6, P421, DOI 10.4056/sigs.2945050; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Yooseph S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-182; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao YL, 2013, NATURE, V494, P357, DOI 10.1038/nature11921	74	239	249	7	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57355	10.1371/journal.pone.0057355	http://dx.doi.org/10.1371/journal.pone.0057355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468974	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900076
J	Svendsen, AJ; Kyvik, KO; Houen, G; Junker, P; Christensen, K; Christiansen, L; Nielsen, C; Skytthe, A; Hjelmborg, JV				Svendsen, Anders J.; Kyvik, Kirsten O.; Houen, Gunnar; Junker, Peter; Christensen, Kaare; Christiansen, Lene; Nielsen, Christian; Skytthe, Axel; Hjelmborg, Jacob V.			On the Origin of Rheumatoid Arthritis: The Impact of Environment and Genes-A Population Based Twin Study	PLOS ONE			English	Article							PERINATAL CHARACTERISTICS; AUTOIMMUNE-DISEASES; RISK; CONCORDANCE; ASSOCIATIONS; SEVERITY; ETIOLOGY; VALIDITY; HLA-DR4; COHORT	Background: Rheumatoid arthritis (RA) is an autoimmune disease with a complex origin. Previous studies have reported heritability estimates on RA at about 60%. Only 16% of the genetic background of the disease has been disclosed so far. The purpose of the present investigation was to provide an optimized estimate on the heritability of RA and to study the recurrence risk in a nationwide Caucasian twin population. Methods and Findings: In a mail survey addressed to 56.707 twin individuals, RA was reported by 479 individuals, mean age 52 (range 16-73). Respondents underwent an interview and clinical examination. Ascertainment probability was 80%. RA was confirmed in 162 twin individuals yielding a prevalence at 0.37% (95% CI 0.31-0.43). The mean discordance time was 19 years (range 0-57). The concordance was 9.1% (95% CI 1.9 to 24.3) in MZ, 6.4% (95% CI 2.1 to 14.3) in DZss. The increased relative risk of attracting RA conditioned on having an affected cotwin compared to the background population risk was 24.6 to 35.4 in MZ twins and 17.3 to 31.6 in DZss twins. The correlation coefficients were 0.60 (0.33 to 0.78) in monozygotic (MZ) and 0.55 (0.33 to 0.72) in dizygotic same sexed (DZss) pairs. Twelve percent (95% CI 0-76%) of the phenotypic variance in the liability to RA was due to additive genetic effects, 50% (95% CI 0-72%) to shared environmental effects and 38% (95% CI 17-61%) to non-shared environmental effects. Conclusions: This study emphasizes that family factors are important for the development of RA. Although genetic effectors are important, shared and non-shared environmental triggers and/or epigenetic stochastic events seem to be even more significant. However, it should be borne in mind that the genetic and non-genetic components may not be the same across disease subsets.	[Svendsen, Anders J.; Christensen, Kaare; Christiansen, Lene; Skytthe, Axel] Univ Southern Denmark, Inst Publ Hlth, Danish Twin Registry, Odense, Denmark; [Kyvik, Kirsten O.] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Kyvik, Kirsten O.] Odense Univ Hosp, Odense Patient data Explorat Network OPEN, DK-5000 Odense, Denmark; [Houen, Gunnar] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Svendsen, Anders J.; Junker, Peter] Univ Southern Denmark, Dept Rheumatol, Odense Univ Hosp, Odense, Denmark; [Nielsen, Christian] Odense Univ Hosp, Dept Clin Immunol, DK-5000 Odense, Denmark; [Hjelmborg, Jacob V.] Univ Southern Denmark, Inst Publ Hlth, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Statens Serum Institut; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Svendsen, AJ (corresponding author), Univ Southern Denmark, Inst Publ Hlth, Danish Twin Registry, Odense, Denmark.	asvendsen@health.sdu.dk	Hjelmborg, Jacob/AAN-5966-2020; Christensen, Kaare/C-2360-2009; Kyvik, Kirsten O/K-5680-2016; Skytthe, Axel E/G-4820-2019	Hjelmborg, Jacob/0000-0001-9630-9149; Christensen, Kaare/0000-0002-5429-5292; Kyvik, Kirsten O/0000-0003-2981-0245; Skytthe, Axel E/0000-0002-8629-4913; Nielsen, Christian/0000-0002-5711-6595; Houen, Gunnar/0000-0002-5948-4156; Svendsen, Anders/0000-0002-3481-9001	Danish Rheumatism Association	Danish Rheumatism Association	This work was funded by The Danish Rheumatism Association. This is an investigator initiated study and the funding source had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	AHO K, 1986, J RHEUMATOL, V13, P899; ALLEBECK P, 1981, SCAND J RHEUMATOL, V10, P301, DOI 10.3109/03009748109095320; Bogdanos DP, 2012, J AUTOIMMUN, V38, pJ156, DOI 10.1016/j.jaut.2011.11.003; Bond C, 1996, SEMIN ARTHRITIS RHEU, V25, P308, DOI 10.1016/S0049-0172(96)80017-5; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlens C, 2009, ANN RHEUM DIS, V68, P1159, DOI 10.1136/ard.2008.089342; Christiansen L, 2003, TWIN RES, V6, P275, DOI 10.1375/136905203322296610; DEIGHTON CM, 1992, ANN RHEUM DIS, V51, P943, DOI 10.1136/ard.51.8.943; DELJUNCO DJ, 1984, AM J EPIDEMIOL, V119, P813; Falconer DS, 1965, ANNHUMGENET; Feitsma AL, 2007, P NATL ACAD SCI USA, V104, P19966, DOI 10.1073/pnas.0710260104; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010373; Harvald B, 1965, PUBLIC HLTH SERVICE, V1163, P61; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hemminki K, 2009, ARTHRITIS RHEUM, V60, P661, DOI 10.1002/art.24328; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Jaakkola JJ, 2005, INT J EPIDEMIOL, V34, P664, DOI 10.1093/ije/dyi006; Jacobsson LTH, 2003, BRIT MED J, V326, P1068, DOI 10.1136/bmj.326.7398.1068; Ji JD, 2010, MOL BIOL REP, V37, P141, DOI 10.1007/s11033-009-9553-z; Jones MA, 1996, ANN RHEUM DIS, V55, P89, DOI 10.1136/ard.55.2.89; Karlson EW, 2004, ARTHRITIS RHEUM-US, V50, P3458, DOI 10.1002/art.20621; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; LYKKEN DT, 1978, SOC BIOL, V25, P1, DOI 10.1080/19485565.1978.9988312; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; MACGREGOR A, 1995, J RHEUMATOL, V22, P1032; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; MACGREGOR AJ, 1994, J RHEUMATOL, V21, P1420; MCGUE M, 1992, SCHIZOPHRENIA BULL, V18, P171, DOI 10.1093/schbul/18.2.171; Michou L, 2008, J RHEUMATOL, V35, P790; NEALE MC, 1994, BEHAV GENET, V24, P239, DOI 10.1007/BF01067191; Neale MC, 2010, MX STAT MODELING; Neale MC, 1994, MX STAT MODELING; OLSEN NJ, 1988, AM J MED, V84, P257, DOI 10.1016/0002-9343(88)90422-6; Orozco G, 2010, EXPERT REV CLIN IMMU, V6, P61, DOI 10.1586/ECI.09.72; Pedersen Jens K, 2011, Open Rheumatol J, V5, P91, DOI 10.2174/1874312901105010091; Pedersen M, 2004, EUR J EPIDEMIOL, V19, P1097, DOI 10.1007/s10654-004-1025-0; Pedersen M, 2007, ARTHRITIS RHEUM-US, V56, P1446, DOI 10.1002/art.22597; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; REILLY PA, 1990, ANN RHEUM DIS, V49, P363, DOI 10.1136/ard.49.6.363; Scott David L, 2010, Lancet, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; SILMAN AJ, 1993, BRIT J RHEUMATOL, V32, P903; Skytthe A, 2006, TWIN RES HUM GENET, V9, P763; Skytthe A, 2011, SCAND J PUBLIC HEALT, V39, P75, DOI 10.1177/1403494810387966; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Svendsen AJ, 2011, ANN RHEUM DIS, V70, P708, DOI 10.1136/ard.2010.132860; Svendsen AJ, 2002, BRIT MED J, V324, P264, DOI 10.1136/bmj.324.7332.264; Svendsen AJ, 2013, J AUTOIMMUN IN PRESS; SYMMONS D P M, 1988, British Journal of Rheumatology, V27, P44; van der Woude D, 2009, ARTHRITIS RHEUM-US, V60, P916, DOI 10.1002/art.24385; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; WORDSWORTH P, 1992, AM J HUM GENET, V51, P585; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	57	58	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57304	10.1371/journal.pone.0057304	http://dx.doi.org/10.1371/journal.pone.0057304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468964	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900071
J	Zeng, DG; Chen, XL; Xie, DX; Zhao, YZ; Yang, CL; Li, YM; Ma, N; Peng, M; Yang, Q; Liao, ZP; Wang, H; Chen, XH				Zeng, Digang; Chen, Xiuli; Xie, Daxiang; Zhao, Yongzhen; Yang, Chunling; Li, Yongmei; Ma, Ning; Peng, Min; Yang, Qiong; Liao, Zhenping; Wang, Hui; Chen, Xiaohan			Transcriptome Analysis of Pacific White Shrimp (Litopenaeus vannamei) Hepatopancreas in Response to Taura Syndrome Virus (TSV) Experimental Infection	PLOS ONE			English	Article							SPOT-SYNDROME-VIRUS; DIFFERENTIALLY EXPRESSED GENES; C-TYPE LECTIN; PENAEUS-JAPONICUS; RNA-SEQ; WSSV; HEMOCYANIN; HEMOCYTES; IDENTIFICATION; RECOGNITION	Background: The Pacific white shrimp, Litopenaeus vannamei, is a worldwide cultured crustacean species with important commercial value. Over the last two decades, Taura syndrome virus (TSV) has seriously threatened the shrimp aquaculture industry in the Western Hemisphere. To better understand the interaction between shrimp immune and TSV, we performed a transcriptome analysis in the hepatopancreas of L. vannamei challenged with TSV, using the 454 pyrosequencing (Roche) technology. Methodology/Principal Findings: We obtained 126919 and 102181 high-quality reads from TSV-infected and non-infected (control) L. vannamei cDNA libraries, respectively. The overall de novo assembly of cDNA sequence data generated 15004 unigenes, with an average length of 507 bp. Based on BLASTX search (E-value,1025) against NR, Swissprot, GO, COG and KEGG databases, 10425 unigenes (69.50% of all unigenes) were annotated with gene descriptions, gene ontology terms, or metabolic pathways. In addition, we identified 770 microsatellites and designed 497 sets of primers. Comparative genomic analysis revealed that 1311 genes differentially expressed in the infected shrimp compared to the controls, including 559 up-and 752 down-regulated genes. Among the differentially expressed genes, several are involved in various animal immune functions, such as antiviral, antimicrobial, proteases, protease inhibitors, signal transduction, transcriptional control, cell death and cell adhesion. Conclusions/Significance: This study provides valuable information on shrimp gene activities against TSV infection. Results can contribute to the in-depth study of candidate genes in shrimp immunity, and improves our current understanding of this host-virus interaction. In addition, the large amount of transcripts reported in this study provide a rich source for identification of novel genes in shrimp.	[Zeng, Digang; Chen, Xiuli; Xie, Daxiang; Zhao, Yongzhen; Yang, Chunling; Li, Yongmei; Ma, Ning; Peng, Min; Yang, Qiong; Liao, Zhenping; Wang, Hui; Chen, Xiaohan] Guangxi Inst Fisheries, Guangxi Key Lab Aquat Genet Breeding & Hlth Aquac, Nanning, Peoples R China		Chen, XH (corresponding author), Guangxi Inst Fisheries, Guangxi Key Lab Aquat Genet Breeding & Hlth Aquac, Nanning, Peoples R China.	gxnnscs@126.com	li, yong/HDN-3885-2022; zhao, YZ/GXH-6401-2022; ZHAO, YUAN/HCI-5831-2022		National Natural Science Foundation of China [31160531]; Natural Science Foundation of Guangxi [2012GXNSFDA053015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province)	This work was supported by the National Natural Science Foundation of China (31160531) and the Natural Science Foundation of Guangxi (2012GXNSFDA053015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2004, INFECT IMMUN, V72, P4159, DOI 10.1128/IAI.72.7.4159-4171.2004; Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375; Aranguren LF, 2012, J INVERTEBR PATHOL; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Chen DD, 2012, DEV COMP IMMUNOL; COHEN JJ, 1993, HOSP PRACT, V28, P35, DOI 10.1080/21548331.1993.11442887; Cote I, 2009, J FISH DIS, V32, P989, DOI 10.1111/j.1365-2761.2009.01082.x; Dhar AK, 2003, ARCH VIROL, V148, P2381, DOI 10.1007/s00705-003-0172-z; Do JW, 2006, DIS AQUAT ORGAN, V70, P171, DOI 10.3354/dao070171; Ganz T, 2001, Semin Respir Infect, V16, P4; George SK, 2011, J VIROL METHODS, V172, P54, DOI 10.1016/j.jviromet.2010.12.020; Gomez-Anduro GA, 2012, COMP BIOCHEM PHYS B, V162, P120, DOI 10.1016/j.cbpb.2012.03.003; Goncalves-Soares D, 2012, COMP BIOCHEM PHYS D, V7, P73, DOI 10.1016/j.cbd.2011.11.002; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Guryev V, 2009, FEBS LETT, V583, P1668, DOI 10.1016/j.febslet.2009.04.020; Hasson KW, 1999, DIS AQUAT ORGAN, V36, P81, DOI 10.3354/dao036081; Havanapan PO, 2009, J PROTEOME RES, V8, P2476, DOI 10.1021/pr801067e; Huang XW, 2007, APPL MICROBIOL BIOT, V76, P753, DOI 10.1007/s00253-007-1076-8; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; James R, 2010, FISH SHELLFISH IMMUN, V29, P884, DOI 10.1016/j.fsi.2010.07.029; Lei KY, 2008, DEV COMP IMMUNOL, V32, P808, DOI 10.1016/j.dci.2007.11.010; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Lightner DV, 1997, REV SCI TECH OIE, V16, P146, DOI 10.20506/rst.16.1.1010; LINZEN B, 1989, NATURWISSENSCHAFTEN, V76, P206, DOI 10.1007/BF00627687; LITT M, 1989, AM J HUM GENET, V44, P397; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Lotz JM, 1997, DIS AQUAT ORGAN, V30, P45, DOI 10.3354/dao030045; Ma THT, 2007, FISH SHELLFISH IMMUN, V23, P430, DOI 10.1016/j.fsi.2006.12.005; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mari J, 2002, J GEN VIROL, V83, P915, DOI 10.1099/0022-1317-83-4-915; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Meehan D, 2003, MAR BIOTECHNOL, V5, P311, DOI 10.1007/s10126-002-0092-z; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moody D.E., 2001, J ANIM SCI, V79, pE128, DOI [10.2527/jas2001.79E-SupplE128x, DOI 10.2527/JAS2001.79E-SUPPLE128X]; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Nunan LM, 1998, DIS AQUAT ORGAN, V34, P87, DOI 10.3354/dao034087; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ongvarrasopone C, 2011, ARCH VIROL, V156, P1117, DOI 10.1007/s00705-011-0952-9; Overstreet RM, 1997, J INVERTEBR PATHOL, V69, P165, DOI 10.1006/jipa.1996.4654; Ozaki A, 2003, ANIM GENET, V34, P315, DOI 10.1046/j.1365-2052.2003.01031.x; Pan D, 2005, DEV COMP IMMUNOL, V29, P103, DOI 10.1016/j.dci.2004.07.001; Robalino J, 2007, PHYSIOL GENOMICS, V29, P44, DOI 10.1152/physiolgenomics.00165.2006; Rojtinnakorn J, 2002, FISH SHELLFISH IMMUN, V13, P69, DOI 10.1006/fsim.2001.0382; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Rozen S, 2000, Methods Mol Biol, V132, P365; RUBIN BY, 1980, J VIROL, V34, P446, DOI 10.1128/JVI.34.2.446-454.1980; Scherbaum S, 2010, J COMP PHYSIOL B, V180, P1235, DOI 10.1007/s00360-010-0495-5; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Song KK, 2010, FISH SHELLFISH IMMUN, V28, P596, DOI 10.1016/j.fsi.2009.12.015; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tassanakajon A, 2010, MAR BIOTECHNOL, V12, P487, DOI [10.1007/s10126-010-9288-9, 10.1007/s10126-011-9381-8]; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tu C, 1999, DIS AQUAT ORGAN, V38, P159, DOI 10.3354/dao038159; Valles-Jimenez R, 2004, MAR BIOTECHNOL, V6, P475, DOI 10.1007/s10126-004-3138-6; Wang B, 2008, MAR BIOTECHNOL, V10, P664, DOI 10.1007/s10126-008-9105-x; Wei XM, 2012, FISH SHELLFISH IMMUN, V32, P132, DOI 10.1016/j.fsi.2011.11.001; Yan F, 2010, ARCH VIROL, V155, P1077, DOI 10.1007/s00705-010-0686-0; Yang L, 2011, FISH SHELLFISH IMMUN, V30, P744, DOI 10.1016/j.fsi.2010.12.026; Yao BJ, 2012, BIOTECHNOL LETT, V34, P813, DOI 10.1007/s10529-011-0841-z; Zhang XB, 2004, ANTIVIR RES, V61, P93, DOI 10.1016/j.antiviral.2003.08.019; Zhao ZY, 2009, J VIROL, V83, P347, DOI 10.1128/JVI.00707-08	63	96	100	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57515	10.1371/journal.pone.0057515	http://dx.doi.org/10.1371/journal.pone.0057515			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469011	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900111
J	Bains, I; Yates, AJ; Callard, RE				Bains, Iren; Yates, Andrew J.; Callard, Robin E.			Heterogeneity in Thymic Emigrants: Implications for Thymectomy and Immunosenescence	PLOS ONE			English	Article							CD4(+) T-CELLS; EXCISION CIRCLE CONTENT; IMMUNE FUNCTION; AGED MICE; DEFECTS; ANTIGEN; LIFE; POOL; PROLIFERATION; COMPARTMENT	The development of mature, antigen-inexperienced (naive) T cells begins in the thymus and continues after export into the periphery. Post-thymic maturation of naive T cells, in humans, coincides with the progressive loss of markers such as protein tyrosine kinase 7 (PTK7) and platelet endothelial cell adhesion molecule-1 (CD31). As a consequence, subpopulations of naive T cells can be recognised raising questions about the processes that give rise to the loss of these markers and their exact relationship to recent thymic emigrants (RTE). Here, we combine a mathematical survival analysis approach and data from healthy and thymectomised humans to understand the apparent persistence of populations of 'veteran' PTK7(+)T cells in thymectomised individuals. We show that a model of heterogeneity in rates of maturation, possibly linked to natural variation in TCR signalling thresholds or affinity for self-antigens, can explain the data. This model of maturation predicts that the average post-thymic age of PTK7(+)T cells will increase linearly with the age of the host suggesting that, despite the immature phenotype, PTK7(+) cells do not necessarily represent a population of RTE. Further, the model predicts an accelerated increase in the average post-thymic age of residual PTK7(+) T cells following thymectomy and may also explain in part the prematurely aged phenotype of the naive T cell pool in individuals thymectomised early in life.	[Bains, Iren] Natl Inst Med Res, London NW7 1AA, England; [Bains, Iren; Yates, Andrew J.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Bains, Iren; Callard, Robin E.] UCL Inst Child Hlth, Immunobiol Unit, London, England; [Bains, Iren; Callard, Robin E.] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London, England; [Yates, Andrew J.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	MRC National Institute for Medical Research; Yeshiva University; Albert Einstein College of Medicine; University of London; University College London; University of London; University College London; Yeshiva University; Albert Einstein College of Medicine	Bains, I (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	ibains@nimr.mrc.ac.uk			NIH [R01 AI093870-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093870] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH (R01 AI093870-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo RI, 2009, BLOOD, V113, P2999, DOI 10.1182/blood-2008-07-166223; Bains I, 2009, J IMMUNOL, V183, P4329, DOI 10.4049/jimmunol.0900743; Bains I, 2009, BLOOD, V113, P5480, DOI 10.1182/blood-2008-10-184184; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; CALLARD RE, 1978, EUR J IMMUNOL, V8, P552, DOI 10.1002/eji.1830080803; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Chu YW, 2004, BLOOD, V104, P1110, DOI 10.1182/blood-2003-10-3635; Clise-Dwyer K, 2007, J IMMUNOL, V178, P1321, DOI 10.4049/jimmunol.178.3.1321; COOK JM, 1987, CELL IMMUNOL, V109, P89, DOI 10.1016/0008-8749(87)90294-2; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Haines CJ, 2009, J EXP MED, V206, P275, DOI 10.1084/jem.20080996; Haynes L, 2005, J EXP MED, V201, P845, DOI 10.1084/jem.20041933; Hazenberg MD, 2003, NAT IMMUNOL, V4, P97, DOI 10.1038/ni0203-97; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; HOSSEINZADEH H, 1993, J IMMUNOL, V150, P1670; Huenecke S, 2008, EUR J HAEMATOL, V80, P532, DOI 10.1111/j.1600-0609.2008.01052.x; HULSTAERT F, 1994, CLIN IMMUNOL IMMUNOP, V70, P152, DOI 10.1006/clin.1994.1023; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Jones SC, 2008, J IMMUNOL, V180, P4465, DOI 10.4049/jimmunol.180.7.4465; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kohler S, 2005, EUR J IMMUNOL, V35, P1987, DOI 10.1002/eji.200526181; Linton PJ, 1996, J EXP MED, V184, P1891, DOI 10.1084/jem.184.5.1891; Macallan DC, 2004, J EXP MED, V200, P255, DOI 10.1084/jem.20040341; Mancebo E, 2008, CLIN EXP IMMUNOL, V154, P375, DOI 10.1111/j.1365-2249.2008.03771.x; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Opiela SJ, 2009, BLOOD, V113, P5635, DOI 10.1182/blood-2008-08-173658; Palmer MJ, 2011, IMMUNOL CELL BIOL, V89, P581, DOI 10.1038/icb.2011.5; PHAIR J, 1978, J LAB CLIN MED, V92, P822; Prelog M, 2008, VACCINE, V26, P595, DOI 10.1016/j.vaccine.2007.11.074; Prelog M, 2009, CLIN IMMUNOL, V130, P123, DOI 10.1016/j.clim.2008.08.023; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Shigemura N, 2006, SURG ENDOSC, V20, P1614, DOI 10.1007/s00464-005-0614-7; STEINMANN GG, 1985, SCAND J IMMUNOL, V22, P563, DOI 10.1111/j.1365-3083.1985.tb01916.x; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Terszowski G, 2006, SCIENCE, V312, P284, DOI 10.1126/science.1123497; Tsukamoto H, 2009, P NATL ACAD SCI USA, V106, P18333, DOI 10.1073/pnas.0910139106; Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x; Zlamy M, 2009, REJUV RES, V12, P249, DOI 10.1089/rej.2009.0864	44	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e49554	10.1371/journal.pone.0049554	http://dx.doi.org/10.1371/journal.pone.0049554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468830	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000001
J	Edelmann, MN; Demers, CH; Auger, AP				Edelmann, Michelle N.; Demers, Catherine H.; Auger, Anthony P.			Maternal Touch Moderates Sex Differences in Juvenile Social Play Behavior	PLOS ONE			English	Article							TACTILE STIMULATION; PREPUBESCENT RATS; EXPRESSION; GENES; CARE; NORMALIZATION; TESTOSTERONE; ORGANIZATION; RECEPTORS; TISSUE	Additional somatosensory contact of preterm human infants improves a variety of developmental assessment scores, but less is known about its lasting consequences. In rodents, maternal contact may influence the programming of juvenile social play behavior. Therefore, we used a paradigm where we can control the levels of somatosensory contact associated with maternal care. We find that additional somatosensory contact of offspring can have lasting consequences on juvenile social play behavior in a sex-dependent manner. Specifically, additional somatosensory stimuli reduced male social play behavior, but did not change female play behavior. We then examined if this additional infant contact altered some neurobiological substrates associated with play within the juvenile amygdala. Control males had lower levels of 5HT2a receptor mRNA levels contrasted to females; however, similar to its sex-dependent effect on juvenile social play, males that received additional somatosensory contact had higher serotonin 5HT2a receptor mRNA levels than control males. No difference was found in females. As serotonin signaling typically opposes juvenile play behavior, these data suggest that maternal touch can program lasting differences in juvenile social play and 5HT2a receptors mRNA levels within the juvenile amygdala.	[Edelmann, Michelle N.; Auger, Anthony P.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Demers, Catherine H.; Auger, Anthony P.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Auger, AP (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA.	apauger@wisc.edu			National Institute of Mental Health grant [R01-MH072956]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072956] Funding Source: NIH RePORTER	National Institute of Mental Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grant R01-MH072956 to APA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiel EL, 2010, PAED CHILD HEALT-CAN, V15, P153, DOI 10.1093/pch/15.3.153; Auger AP, 2009, J NEUROENDOCRINOL, V21, P519, DOI 10.1111/j.1365-2826.2009.01871.x; BEATTY WW, 1984, PHARMACOL BIOCHEM BE, V20, P747, DOI 10.1016/0091-3057(84)90194-1; BEATTY WW, 1981, PHYSIOL BEHAV, V26, P241, DOI 10.1016/0031-9384(81)90017-2; BIRKE LIA, 1987, DEV PSYCHOBIOL, V20, P85, DOI 10.1002/dev.420200111; BLACKBURN JR, 1992, PROG NEUROBIOL, V39, P247, DOI 10.1016/0301-0082(92)90018-A; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; CASLER L, 1965, GENET PSYCHOL MONOGR, V71, P137; Casto JM, 2003, PHYSIOL BEHAV, V79, P633, DOI 10.1016/S0031-9384(03)00120-3; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; EVONIUK GE, 1979, COMMUN PSYCHOPHARMAC, V3, P363; Fairbanks LA, 2001, NEUROPSYCHOPHARMACOL, V24, P370, DOI 10.1016/S0893-133X(00)00211-6; FIELD TM, 1986, PEDIATRICS, V77, P654; Filby AL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-10; GERALL HD, 1967, ANIM BEHAV, V15, P54, DOI 10.1016/S0003-3472(67)80010-1; Higley JD, 1997, ANN NY ACAD SCI, V836, P39, DOI 10.1111/j.1749-6632.1997.tb52354.x; Homberg JR, 2007, PSYCHOPHARMACOLOGY, V195, P175, DOI 10.1007/s00213-007-0895-8; HUMPHREYS AP, 1981, ANIM BEHAV, V29, P259, DOI 10.1016/S0003-3472(81)80173-X; LE MM, 1991, PHYSIOL REV, V71, P155; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEANEY MJ, 1981, HORM BEHAV, V15, P197, DOI 10.1016/0018-506X(81)90028-3; MEANEY MJ, 1986, BRAIN RES, V398, P324, DOI 10.1016/0006-8993(86)91492-7; MOORE CL, 1979, J COMP PHYSIOL PSYCH, V93, P677, DOI 10.1037/h0077599; MOORE CL, 1992, DEV PSYCHOBIOL, V25, P165, DOI 10.1002/dev.420250303; MOORE CL, 1984, DEV PSYCHOBIOL, V17, P347, DOI 10.1002/dev.420170403; NIESINK RJM, 1989, NEUROPHARMACOLOGY, V28, P411, DOI 10.1016/0028-3908(89)90038-5; Olesen KM, 2005, ENDOCRINOLOGY, V146, P3705, DOI 10.1210/en.2005-0498; OLIOFF M, 1978, PHYSIOL BEHAV, V20, P113, DOI 10.1016/0031-9384(78)90060-4; PANKSEPP J, 1984, NEUROSCI BIOBEHAV R, V8, P465, DOI 10.1016/0149-7634(84)90005-8; Parent CI, 2008, DEV PSYCHOBIOL, V50, P767, DOI 10.1002/dev.20342; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; SPEAR LP, 1983, DEV PSYCHOBIOL, V16, P83, DOI 10.1002/dev.420160203; TAYLOR GT, 1980, J COMP PHYSIOL PSYCH, V94, P953, DOI 10.1037/h0077816; THOR DH, 1986, BEHAV NEUROSCI, V100, P275, DOI 10.1037/0735-7044.100.2.275; TONJES R, 1987, EXP CLIN ENDOCRINOL, V90, P257; Vanderschuren LJMJ, 1997, NEUROSCI BIOBEHAV R, V21, P309, DOI 10.1016/S0149-7634(96)00020-6; Veenema AH, 2009, PSYCHONEUROENDOCRINO, V34, P463, DOI 10.1016/j.psyneuen.2008.10.017	38	21	21	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57396	10.1371/journal.pone.0057396	http://dx.doi.org/10.1371/journal.pone.0057396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460849	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000103
J	James, MM; Laeyendecker, O; Sun, J; Hoover, DR; Mullis, CE; Cousins, MM; Coates, T; Moore, RD; Kelen, GD; Fowler, MG; Kumwenda, JJ; Mofenson, LM; Kumwenda, NI; Taha, TE; Eshleman, SH				James, Maria M.; Laeyendecker, Oliver; Sun, Jin; Hoover, Donald R.; Mullis, Caroline E.; Cousins, Matthew M.; Coates, Thomas; Moore, Richard D.; Kelen, Gabor D.; Fowler, Mary Glenn; Kumwenda, Johnstone J.; Mofenson, Lynne M.; Kumwenda, Newton I.; Taha, Taha E.; Eshleman, Susan H.			Antibody Maturation and Viral Diversification in HIV-Infected Women	PLOS ONE			English	Article							RESOLUTION MELTING ASSAY; ENZYME-IMMUNOASSAY; DRUG-RESISTANCE; SUBTYPE-C; DIVERSITY; MUTATIONS; SEX	Introduction: The Post-exposure Prophylaxis in Infants (PEPI)-Malawi trial evaluated infant antiretroviral regimens for prevention of post-natal HIV transmission. A multi-assay algorithm (MAA) that includes the BED capture immunoassay, an avidity assay, CD4 cell count, and viral load was used to identify women who were vs. were not recently infected at the time of enrollment (MAA recent, N = 73; MAA non-recent, N = 2,488); a subset of the women in the MAA non-recent group known to have been HIV infected for at least 2 years before enrollment (known non-recent, N = 54). Antibody maturation and viral diversification were examined in these women. Methods: Samples collected at enrollment (N = 2,561) and 12-24 months later (N = 1,306) were available for serologic analysis using the BED and avidity assays. A subset of those samples was used for analysis of viral diversity, which was performed using a high resolution melting (HRM) diversity assay. Viral diversity analysis was performed using all available samples from women in the MAA recent group (61 enrollment samples, 38 follow-up samples) and the known non-recent group (43 enrollment samples, 22 follow-up samples). Diversity data from PEPI-Malawi were also compared to similar data from 169 adults in the United States (US) with known recent infection (N = 102) and known non-recent infection (N = 67). Results: In PEPI-Malawi, results from the BED and avidity assays increased over time in the MAA recent group, but did not change significantly in the MAA non- recent group. At enrollment, HIV diversity was lower in the MAA recent group than in the known non- recent group. HRM diversity assay results from women in PEPI-Malawi were similar to those from adults in the US with known duration of HIV infection. Conclusions: Antibody maturation and HIV diversification patterns in African women provide additional support for use of the MAA to identify populations with recent HIV infection.	[James, Maria M.; Cousins, Matthew M.; Fowler, Mary Glenn; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Laeyendecker, Oliver] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Laeyendecker, Oliver; Mullis, Caroline E.; Moore, Richard D.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Sun, Jin; Kumwenda, Newton I.; Taha, Taha E.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ USA; [Hoover, Donald R.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, Piscataway, NJ USA; [Coates, Thomas] Univ Calif Los Angeles, Program Global Hlth, Los Angeles, CA USA; [Kelen, Gabor D.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Kumwenda, Johnstone J.] Univ Malawi, Dept Med, Coll Med, Blantyre, Malawi; [Mofenson, Lynne M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat Adolescent & Maternal AIDS Branch, NIH, Rockville, MD USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of California System; University of California Los Angeles; Johns Hopkins University; University of Malawi; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Eshleman, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	seshlem@jhmi.edu	Laeyendecker, Oliver B/B-9331-2009; Kumwenda, Newton/ADL-6890-2022; Mofenson, Lynne/P-9631-2019	Mofenson, Lynne/0000-0002-2818-9808; Cousins, Matthew/0000-0003-0067-9087; Taha, Taha/0000-0001-9814-4894; Laeyendecker, Oliver/0000-0002-6429-4760; Kelen, Gabor/0000-0002-3236-8286; Kumwenda, Newton/0000-0003-2622-4339	International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group, American Recovery and Reinvestment Act (ARRA) award [3U01AI068632-05S3]; National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); Office of AIDS Research, of the National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS) [U01AI068613, UM1AI068613]; Centers for Disease Control and Prevention [U50/CCU022061]; International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Group [U01-AI068632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068613, UM1AI068613, R01AI095068, ZIAAI000361, U01AI068632] Funding Source: NIH RePORTER	International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group, American Recovery and Reinvestment Act (ARRA) award; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research, of the National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Group; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funders for this work are as follows: (1) International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group, American Recovery and Reinvestment Act (ARRA) award (Cooperative Agreement 3U01AI068632-05S3); (2) The HIV Prevention Trials Network (HPTN) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health (NIMH), and the Office of AIDS Research, of the National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS) (U01AI068613, UM1AI068613); (3) The Centers for Disease Control and Prevention (Cooperative Agreement U50/CCU022061); and (4) The International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Group (U01-AI068632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Church JD, 2007, AIDS RES HUM RETROV, V23, P764, DOI 10.1089/aid.2006.0272; Coates T, 2013, 20 C RETR OPP INF AT; Cousins MM, 2012, J CLIN MICROBIOL, V50, P3054, DOI 10.1128/JCM.01460-12; Cousins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027211; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Eshleman SH, 2007, AIDS, V21, P1165, DOI 10.1097/QAD.0b013e32810fd72e; Eshleman SH, 2013, J INFECT DIS, V207, P223, DOI 10.1093/infdis/jis658; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; James MM, 2012, PEDIATR INFECT DIS J, V31, pE222, DOI 10.1097/INF.0b013e3182678c3f; James MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018642; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Laeyendecker O, 2013, 20 C RETR OPP INF AT; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P816, DOI [10.1089/aid.2011.0258, 10.1089/AID.2011.0258]; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Lihana RW, 2012, AIDS REV, V14, P83; Long EM, 2000, NAT MED, V6, P71; Masciotra S., 2010, 17 C RETR OPP INF 20; Murphy G, 2008, EURO SURVEILL, V13; Petch LA, 2005, AIDS RES HUM RETROV, V21, P799, DOI 10.1089/aid.2005.21.799; Ray SC, 2000, NAT MED, V6, P23, DOI 10.1038/71487; Taha TE, 2011, AIDS, V25, P1357, DOI 10.1097/QAD.0b013e3283489d45; Towler WI, 2010, AIDS RES HUM RETROV, V26, P913, DOI 10.1089/aid.2009.0259; *UNAIDS, 2005, UNAIDS REF GROUP EST; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wilson E, 2011, 18 C RETR OPP INF BO	28	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57350	10.1371/journal.pone.0057350	http://dx.doi.org/10.1371/journal.pone.0057350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460842	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000096
J	Kerlin, DH; Gatton, ML				Kerlin, Douglas H.; Gatton, Michelle L.			Preferential Invasion by Plasmodium Merozoites and the Self-Regulation of Parasite Burden	PLOS ONE			English	Article							ACUTE MALARIA INFECTIONS; RED-BLOOD-CELLS; HUMAN RETICULOCYTES; ANEMIA; VIVAX; FALCIPARUM; ERYTHROCYTES; DYNAMICS; SUSCEPTIBILITY; SELECTIVITY	The preferential invasion of particular red blood cell (RBC) age classes may offer a mechanism by which certain species of Plasmodia regulate their population growth. Asexual reproduction of the parasite within RBCs exponentially increases the number of circulating parasites; limiting this explosion in parasite density may be key to providing sufficient time for the parasite to reproduce, and for the host to develop a specific immune response. It is critical that the role of preferential invasion in infection is properly understood to model the within-host dynamics of different Plasmodia species. We develop a simulation model to show that limiting the range of RBC age classes available for invasion is a credible mechanism for restricting parasite density, one which is equally as important as the maximum parasite replication rate and the duration of the erythrocytic cycle. Different species of Plasmodia that regularly infect humans exhibit different preferences for RBC invasion, with all species except P. falciparum appearing to exhibit a combination of characteristics which are able to self-regulate parasite density.	[Kerlin, Douglas H.; Gatton, Michelle L.] Queensland Inst Med Res, Malaria Drug Resistance & Chemotherapy Lab, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute	Gatton, ML (corresponding author), Queensland Inst Med Res, Malaria Drug Resistance & Chemotherapy Lab, Brisbane, Qld 4006, Australia.	Michelle.Gatton@qimr.edu.au	Borrmann, Steffen/G-1838-2013; Gatton, Michelle/H-3139-2019	Borrmann, Steffen/0000-0001-9189-4393; Gatton, Michelle/0000-0003-1188-609X; Kerlin, Douglas/0000-0001-5898-1559	NHMRC grant [613648]; NHMRC CDA; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health	NHMRC grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC CDA(National Health and Medical Research Council (NHMRC) of Australia); Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by NHMRC grant #613648. MLG is supported by NHMRC CDA and the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA S, 1980, BRIT J HAEMATOL, V46, P171, DOI 10.1111/j.1365-2141.1980.tb05956.x; ABDALLA SH, 1990, BLOOD CELLS, V16, P401; Antia R, 2008, P ROY SOC B-BIOL SCI, V275, P1449, DOI 10.1098/rspb.2008.0198; BELAIR J, 1995, MATH BIOSCI, V128, P317, DOI 10.1016/0025-5564(94)00078-E; BERLIN NI, 1964, JAMA-J AM MED ASSOC, V188, P375; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Chang KH, 2004, BLOOD, V103, P3727, DOI 10.1182/blood-2003-08-2887; Collins WE, 2003, AM J TROP MED HYG, V68, P410, DOI 10.4269/ajtmh.2003.68.410; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Cromer D, 2006, INT J PARASITOL, V36, P1389, DOI 10.1016/j.ijpara.2006.07.009; Cromer D, 2009, J THEOR BIOL, V257, P533, DOI 10.1016/j.jtbi.2008.12.019; Deans AM, 2006, AM J TROP MED HYG, V74, P554, DOI 10.4269/ajtmh.2006.74.554; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; Garnham PCC., 1966, MALARIA PARASITES OT; Gotelli NJ, 2001, PRIMER ECOLOGY; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P289, DOI 10.1098/rspb.2002.2203; Hegner R, 1938, AM J HYG, V27, P690, DOI 10.1093/oxfordjournals.aje.a118422; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Jakeman GN, 1999, PARASITOLOGY, V119, P127, DOI 10.1017/S0031182099004564; McQueen Philip G, 2010, Biophys Rev, V2, P111; MONS B, 1990, BLOOD CELLS, V16, P299; Pacheco MA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-299; PASVOL G, 1980, BRIT J HAEMATOL, V45, P285, DOI 10.1111/j.1365-2141.1980.tb07148.x; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodriguez LE, 2002, VACCINE, V20, P1331, DOI 10.1016/S0264-410X(01)00472-8; ROTH RL, 1979, EXP PARASITOL, V47, P169, DOI 10.1016/0014-4894(79)90070-5; Russell B, 2011, BLOOD, V118, pE74, DOI 10.1182/blood-2011-04-348748; Sherwood L., 1997, HUMAN PHYSL CELLS SY; Silva JC, 2011, PARASITOLOGY, V138, P1737, DOI 10.1017/S0031182010001575; Simpson JA, 1999, T ROY SOC TROP MED H, V93, P165, DOI 10.1016/S0035-9203(99)90295-X; Tian LP, 1998, ACTA OBSTET GYN SCAN, V77, P717, DOI 10.1034/j.1600-0412.1998.770704.x; White NJ, 2009, MANSONS TROPICAL DIS; William T, 2011, EMERG INFECT DIS, V17, P1248, DOI 10.3201/eid1707.101017; World Health Organization, 2008, WORLD MAL REP	36	26	27	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57434	10.1371/journal.pone.0057434	http://dx.doi.org/10.1371/journal.pone.0057434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460855	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000109
J	Liu, Y; Huo, NX; Dong, LL; Wang, Y; Zhang, SX; Young, HA; Feng, XX; Gu, YQ				Liu, Yue; Huo, Naxin; Dong, Lingli; Wang, Yi; Zhang, Shuixian; Young, Hugh A.; Feng, Xiaoxiao; Gu, Yong Qiang			Complete Chloroplast Genome Sequences of Mongolia Medicine Artemisia frigida and Phylogenetic Relationships with Other Plants	PLOS ONE			English	Article							ANCIENT EVOLUTIONARY SPLIT; PLASTID GENOME; DNA INVERSION; MOLECULAR PHYLOGENY; HORDEUM-VULGARE; MAJOR CLADES; ASTERACEAE; GENE; MICROSATELLITES; REPEAT	Background: Artemisia frigida Willd. is an important Mongolian traditional medicinal plant with pharmacological functions of stanch and detumescence. However, there is little sequence and genomic information available for Artemisia frigida, which makes phylogenetic identification, evolutionary studies, and genetic improvement of its value very difficult. We report the complete chloroplast genome sequence of Artemisia frigida based on 454 pyrosequencing. Methodology/Principal Findings: The complete chloroplast genome of Artemisia frigida is 151,076 bp including a large single copy (LSC) region of 82,740 bp, a small single copy (SSC) region of 18,394 bp and a pair of inverted repeats (IRs) of 24,971 bp. The genome contains 114 unique genes and 18 duplicated genes. The chloroplast genome of Artemisia frigida contains a small 3.4 kb inversion within a large 23 kb inversion in the LSC region, a unique feature in Asteraceae. The gene order in the SSC region of Artemisia frigida is inverted compared with the other 6 Asteraceae species with the chloroplast genomes sequenced. This inversion is likely caused by an intramolecular recombination event only occurred in Artemisia frigida. The existence of rich SSR loci in the Artemisia frigida chloroplast genome provides a rare opportunity to study population genetics of this Mongolian medicinal plant. Phylogenetic analysis demonstrates a sister relationship between Artemisia frigida and four other species in Asteraceae, including Ageratina adenophora, Helianthus annuus, Guizotia abyssinica and Lactuca sativa, based on 61 protein-coding sequences. Furthermore, Artemisia frigida was placed in the tribe Anthemideae in the subfamily Asteroideae (Asteraceae) based on ndhF and trnL-F sequence comparisons. Conclusion: The chloroplast genome sequence of Artemisia frigida was assembled and analyzed in this study, representing the first plastid genome sequenced in the Anthemideae tribe. This complete chloroplast genome sequence will be useful for molecular ecology and molecular phylogeny studies within Artemisia species and also within the Asteraceae family.	[Liu, Yue; Zhang, Shuixian; Feng, Xiaoxiao] Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China; [Liu, Yue] China Acad Tradit Chinese Med, Inst Chinese Mat Med, Beijing, Peoples R China; [Liu, Yue; Huo, Naxin; Dong, Lingli; Wang, Yi; Young, Hugh A.; Gu, Yong Qiang] ARS, Western Reg Res Ctr, USDA, Albany, CA USA; [Liu, Yue] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Zhang, Shuixian; Feng, Xiaoxiao] Minzu Univ China, Grad Sch, Beijing, Peoples R China	Minzu University of China; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; United States Department of Agriculture (USDA); University of California System; University of California Davis; Minzu University of China	Liu, Y (corresponding author), Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China.	yueliu@caas.net.cn; yong.gu@ars.usda.gov		Wang, Yi/0000-0002-4706-8171	National Science Foundation of China [30801554, 81110108011]; China Postdoctoral Science Foundation [20110490556]; 111 Project [B08044]; 985 Project of Minzu University of China [MUC98504-14, MUC98507-08]; 211 Project of Minzu University of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 111 Project(Ministry of Education, China - 111 Project); 985 Project of Minzu University of China; 211 Project of Minzu University of China	This work was supported by National Science Foundation of China (30801554 and 81110108011), China Postdoctoral Science Foundation (20110490556), 111 Project (B08044), 985 Project of Minzu University of China (MUC98504-14 and MUC98507-08), and 211 Project of Minzu University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bremer K., 1994, ASTERACEAE CLADISTIC; Bryan GJ, 1999, THEOR APPL GENET, V99, P859, DOI 10.1007/s001220051306; Cai ZQ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-77; Catalan P, 1997, MOL PHYLOGENET EVOL, V8, P150, DOI 10.1006/mpev.1997.0416; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Cui J, 2006, J MINZU U CHINA NATU, V15, P149; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559; Dempewolf H, 2010, MOL ECOL RESOUR, V10, P1048, DOI 10.1111/j.1755-0998.2010.02859.x; Denda T, 1999, PLANT SYST EVOL, V217, P299, DOI 10.1007/BF00984372; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Doyle JJ, 1996, MOL PHYLOGENET EVOL, V5, P429, DOI 10.1006/mpev.1996.0038; DOYLE JJ, 1992, P NATL ACAD SCI USA, V89, P7722, DOI 10.1073/pnas.89.16.7722; Dufourmantel N, 2004, PLANT MOL BIOL, V55, P479, DOI 10.1007/s11103-004-0192-4; Ebert D, 2009, MOL ECOL RESOUR, V9, P673, DOI 10.1111/j.1755-0998.2008.02319.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fernandez IA, 2001, MOL PHYLOGENET EVOL, V20, P41, DOI 10.1006/mpev.2001.0954; Flannery ML, 2006, THEOR APPL GENET, V113, P1221, DOI 10.1007/s00122-006-0377-0; Frank DA, 2010, ECOLOGY, V91, P3201, DOI 10.1890/09-1831.1; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Garcia S, 2004, GENOME, V47, P1004, DOI 10.1139/G04-061; Garcia S, 2011, AM J BOT, V98, P638, DOI 10.3732/ajb.1000386; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Hagemann R, 2004, SEXUAL INHERITANCE P; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; Hiiesalu I, 2012, MOL ECOL, V21, P2004, DOI 10.1111/j.1365-294X.2011.05390.x; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Jakobsson M, 2007, THEOR APPL GENET, V114, P223, DOI 10.1007/s00122-006-0425-9; JANSEN RK, 1987, P NATL ACAD SCI USA, V84, P5818, DOI 10.1073/pnas.84.16.5818; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Kajita T, 1998, MOL PHYLOGENET EVOL, V10, P202, DOI 10.1006/mpev.1998.0516; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; KIM KJ, 1995, P NATL ACAD SCI USA, V92, P10379, DOI 10.1073/pnas.92.22.10379; Kumar S, 2004, PLANT MOL BIOL, V56, P203, DOI 10.1007/s11103-004-2907-y; Kumar S, 2004, PLANT PHYSIOL, V136, P2843, DOI 10.1104/pp.104.045187; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Lee JH, 2009, BIOL PHARM BULL, V32, P1912, DOI 10.1248/bpb.32.1912; Liu Y., 2008, STUD TRACE ELEM HLTH, V25, P55; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; NECKERMANN K, 1994, GENE, V146, P177, DOI 10.1016/0378-1119(94)90290-9; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; OGIHARA Y, 1988, P NATL ACAD SCI USA, V85, P8573, DOI 10.1073/pnas.85.22.8573; Palmer J. D, 1991, PLASTID CHROMOSOMES; PALMER JD, 1988, ANN MO BOT GARD, V75, P1180, DOI 10.2307/2399279; PALMER JD, 1987, P NATL ACAD SCI USA, V84, P769, DOI 10.1073/pnas.84.3.769; Panero JL, 2008, MOL PHYLOGENET EVOL, V47, P757, DOI 10.1016/j.ympev.2008.02.011; [朴香兰 PIAO Xiang-lan], 2009, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V20, P1848; Provan J, 1997, GENOME, V40, P104, DOI 10.1139/g97-014; Provan J, 1999, MOL ECOL, V8, P505, DOI 10.1046/j.1365-294X.1999.00545.x; Provan J, 2000, MOL ECOL, V9, P2183, DOI 10.1046/j.1365-294X.2000.105316.x; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Provan J, 1996, P ROY SOC B-BIOL SCI, V263, P1275, DOI 10.1098/rspb.1996.0187; Quesada-Vargas T, 2005, PLANT PHYSIOL, V138, P1746, DOI 10.1104/pp.105.063040; RAUBESON LA, 1992, SCIENCE, V255, P1697, DOI 10.1126/science.255.5052.1697; Riggins CW, 2012, MOL PHYLOGENET EVOL, V64, P471, DOI 10.1016/j.ympev.2012.05.003; Ruiz ON, 2003, PLANT PHYSIOL, V132, P1344, DOI 10.1104/pp.103.020958; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; Schulze-Menz G.K., 1964, ENGLERS SYLLABUS PFL; SCOTLAND RW, 1995, AM J BOT, V82, P266, DOI 10.2307/2445533; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Tangphatsornruang S, 2011, GENE, V475, P104, DOI 10.1016/j.gene.2011.01.002; Terry RG, 1997, AM J BOT, V84, P664, DOI 10.2307/2445903; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tian YH, 2000, CHINESE NATL MED PRO; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Tkach NV, 2008, EVOLUTION, V62, P184, DOI 10.1111/j.1558-5646.2007.00270.x; Wan Tao, 2011, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V31, P456; Wang QH, 2010, J ASIAN NAT PROD RES, V12, P950, DOI 10.1080/10286020.2010.510469; Wang WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024670; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Young HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023980; Zhang TW, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-38; Zhang W, 2008, LI SHIZHEN MED MATER, V19, P2952	85	18	23	7	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57533	10.1371/journal.pone.0057533	http://dx.doi.org/10.1371/journal.pone.0057533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460871	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000126
J	Pathai, S; Lawn, SD; Shiels, PG; Weiss, HA; Cook, C; Wood, R; Gilbert, CE				Pathai, Sophia; Lawn, Stephen D.; Shiels, Paul G.; Weiss, Helen A.; Cook, Colin; Wood, Robin; Gilbert, Clare E.			Corneal Endothelial Cells Provide Evidence of Accelerated Cellular Senescence Associated with HIV Infection: A Case-Control Study	PLOS ONE			English	Article							AGE-RELATED COMORBIDITIES; ANTIRETROVIRAL TREATMENT; PROLIFERATIVE CAPACITY; DIABETES-MELLITUS; EXPRESSION; DENSITY; INFLAMMATION; POPULATION; P16(INK4A); MORTALITY	Background: Cellular senescence may be a key factor in HIV-related premature biological aging. We assessed features of the corneal endothelium that are known to be associated with biological aging, and cellular senescence markers in HIV-infected adults. Methods: Case-control study of 242 HIV-infected adults and 249 matched controls. Using specular microscopy, the corneal endothelium was assessed for features of aging (low endothelial cell density [ECD], high variation in cell size, and low hexagonality index). Data were analysed by multivariable regression. CDKN2A expression (a cell senescence mediator) was measured in peripheral blood leukocytes and 8-hydroxy-2'-deoxyguanosine (8-OHDG; an oxidative DNA damage marker) levels were measured in plasma. Results: The median age of both groups was 40 years. Among HIV-infected adults, 88% were receiving antiretroviral therapy (ART); their median CD4 count was 468 cells/mu L. HIV infection was associated with increased odds of variation in cell size (OR = 1.67; 95% CI: 1.00-2.78, p = 0.04). Among HIV-infected participants, low ECD was independently associated with current CD4 count <200 cells/mu L (OR = 2.77; 95%CI: 1.12-6.81, p = 0.03). In participants on ART with undetectable viral load, CDKN2A expression and 8-OHDG levels were higher in those with accelerated aging, as reflected by lower ECD. Conclusions: The corneal endothelium shows features consistent with HIV-related accelerated senescence, especially among those with poor immune recovery.	[Pathai, Sophia; Gilbert, Clare E.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Int Ctr Eye Hlth, Dept Clin Res, London WC1, England; [Pathai, Sophia; Lawn, Stephen D.; Wood, Robin] Univ Cape Town, Fac Hlth Sci, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Lawn, Stephen D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Shiels, Paul G.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Glasgow, Lanark, Scotland; [Weiss, Helen A.] London Sch Hyg & Trop Med, Trop Epidemiol Grp, Fac Epidemiol & Populat Hlth, MRC, London WC1, England; [Cook, Colin] Univ Cape Town, Groote Schuur Hosp, Fac Hlth Sci, Dept Ophthalmol, ZA-7925 Cape Town, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; University of Glasgow; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Pathai, S (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Int Ctr Eye Hlth, Dept Clin Res, London WC1, England.	Sophia.pathai@lshtm.ac.uk	weiss, helen/ABC-7823-2021; Pathai, Sophia/GLU-7811-2022	weiss, helen/0000-0003-3547-7936; Pathai, Sophia/0000-0002-2835-4666; Shiels, Paul/0000-0002-7577-9843	Wellcome Trust [090354/Z/09/Z]; Wellcome Trust, London [088590]; International Epidemiologic Database to Evaluate Aids [5U01AI069924-02]; Cost-Effectiveness of Preventing AIDS Complications 5 [R01AI058736-02]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust, London(Wellcome Trust); International Epidemiologic Database to Evaluate Aids; Cost-Effectiveness of Preventing AIDS Complications 5; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Wellcome Trust grant awarded to SP (Grant number: 090354/Z/09/Z). SDL is funded by the Wellcome Trust, London (Grant # 088590). RW is supported by International Epidemiologic Database to Evaluate Aids (Grant no: 5U01AI069924-02) and Cost-Effectiveness of Preventing AIDS Complications 5 (R01AI058736-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann J, 2003, AM J OPHTHALMOL, V135, P584, DOI 10.1016/S0002-9394(02)02237-7; BERGMANSON JPG, 1992, CORNEA, V11, P133, DOI 10.1097/00003226-199203000-00007; Bourne WM, 2004, EXP EYE RES, V78, P561, DOI 10.1016/j.exer.2003.08.002; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Capeau J, 2011, CLIN INFECT DIS, V53, P1127, DOI 10.1093/cid/cir628; Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x; CHENG H, 1985, ARCH OPHTHALMOL-CHIC, V103, P1478; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deeks Steven G, 2009, Top HIV Med, V17, P118; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Fisher M, 2012, CURR OPIN INFECT DIS, V25, P1, DOI 10.1097/QCO.0b013e32834f14fa; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Higuchi A, 2011, FREE RADICAL BIO MED, V51, P2210, DOI 10.1016/j.freeradbiomed.2011.09.025; Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014; Joyce NC, 2009, INVEST OPHTH VIS SCI, V50, P2116, DOI 10.1167/iovs.08-3007; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; LAING RA, 1976, EXP EYE RES, V22, P587, DOI 10.1016/0014-4835(76)90003-8; Larsson LI, 1996, ARCH OPHTHALMOL-CHIC, V114, P9, DOI 10.1001/archopht.1996.01100130007001; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lee JS, 2006, EYE, V20, P315, DOI 10.1038/sj.eye.6701868; Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Martin J, 2010, ANN INTERN MED, V153, P477, DOI 10.7326/0003-4819-153-7-201010050-00013; McCarey BE, 2008, CORNEA, V27, P1, DOI 10.1097/ICO.0b013e31815892da; McGlynn LM, 2009, AGING CELL, V8, P45, DOI 10.1111/j.1474-9726.2008.00447.x; Newton R, 2001, INT J CANCER, V92, P622, DOI 10.1002/1097-0215(20010601)92:5&lt;622::AID-IJC1256&gt;3.0.CO;2-K; Ohguro N, 1999, AM J OPHTHALMOL, V128, P234, DOI 10.1016/S0002-9394(99)00086-0; Otiti-Sengeri J, 2008, CURR OPIN HIV AIDS, V3, P432, DOI 10.1097/COH.0b013e328302cc3d; PATHAI S, 2012, J ACQ IMMUN DEF SYND, V62, P43; Pathai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051405; Pathai S, 2011, TROP MED INT HEALTH, V16, P356, DOI 10.1111/j.1365-3156.2010.02712.x; Pathanapitoon K, 2011, AIDS, V25, P81, DOI 10.1097/QAD.0b013e328340fe91; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Rasmussen LD, 2011, AIDS, V25, P1637, DOI 10.1097/QAD.0b013e3283493fb0; Sanchis-Gimeno JA, 2005, HISTOL HISTOPATHOL, V20, P423, DOI 10.14670/HH-20.423; SCHULTZ RO, 1984, AM J OPHTHALMOL, V98, P401, DOI 10.1016/0002-9394(84)90120-X; Sheerin AN, 2012, AGING CELL, V11, P234, DOI 10.1111/j.1474-9726.2011.00776.x; Song ZH, 2008, MOL VIS, V14, P161; Tsygankov D, 2009, P NATL ACAD SCI USA, V106, P16562, DOI 10.1073/pnas.0904405106; Waddell K, 2010, INT J CANCER, V127, P427, DOI 10.1002/ijc.25040; Wang Y, 2012, MOL VIS, V18, P803; WILSON RS, 1982, BRIT J OPHTHALMOL, V66, P513, DOI 10.1136/bjo.66.8.513; Xiao X, 2009, MOL VIS, V15, P747; YEE RW, 1985, CURR EYE RES, V4, P671, DOI 10.3109/02713688509017661; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	49	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57422	10.1371/journal.pone.0057422	http://dx.doi.org/10.1371/journal.pone.0057422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460854	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000108
J	Lockhart, MM; Wirrig, EE; Phelps, AL; Ghatnekar, AV; Barth, JL; Norris, RA; Wessels, A				Lockhart, Marie M.; Wirrig, Elaine E.; Phelps, Aimee L.; Ghatnekar, Angela V.; Barth, Jeremy L.; Norris, Russell A.; Wessels, Andy			Mef2c Regulates Transcription of the Extracellular Matrix Protein Cartilage Link Protein 1 in the Developing Murine Heart	PLOS ONE			English	Article							ENHANCER-BINDING-FACTOR; CARDIAC MORPHOGENESIS; VALVE DEVELOPMENT; BONE-DEVELOPMENT; GENE; HYALURONAN; EXPRESSION; IDENTIFICATION; MESENCHYME; AGGRECAN	Cartilage Link Protein 1 (Crtl1) is an extracellular matrix (ECM) protein that stabilizes the interaction between hyaluronan and versican and is expressed in endocardial and endocardially-derived cells in the developing heart, including cells in the atrioventricular (AV) and outflow tract (OFT) cushions. Previous investigations into the transcriptional regulation of the Crtl1 gene have shown that Sox9 regulates Crtl1 expression in both cartilage and the AV valves. The cardiac transcription factor Mef2c is involved in the regulation of gene expression in cardiac and skeletal muscle cell lineages. In this study we have investigated the potential role of Mef2c in the regulation of ECM production in the endocardial and mesenchymal cell lineages of the developing heart. We demonstrate that the Crtl1 5' flanking region contains two highly conserved Mef2 binding sites and that Mef2c is able to bind to these sites in vivo during cardiovascular development. Additionally, we show that Crtl1 transcription is dependent on Mef2c expression in fetal mitral valve interstitial cells (VICs). Combined, these findings highlight a new role for Mef2c in cardiac development and the regulation of cardiac extracellular matrix protein expression.	[Lockhart, Marie M.; Phelps, Aimee L.; Barth, Jeremy L.; Norris, Russell A.; Wessels, Andy] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Wirrig, Elaine E.] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH USA; [Ghatnekar, Angela V.] Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA	Medical University of South Carolina; Cincinnati Children's Hospital Medical Center; Medical University of South Carolina	Wessels, A (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.	wesselsa@musc.edu			NCRR [C06 RR018823, C06 RR015455, P20-RR016434, P30 GM103342-01]; NIH-NHLBI [R01HL084285]; NIH [5T32 HL007260]; AHA Pre-doctoral fellowship [0715280U, 11SDG5270006]; Foundation Leducq (Paris, France) Transatlantic Mitral Network of Excellence grant [07CVD04]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823, C06RR015455, P20RR016434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084285, R01HL033756, T32HL007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103342] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Pre-doctoral fellowship(American Heart Association); Foundation Leducq (Paris, France) Transatlantic Mitral Network of Excellence grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge the financial support by the following grants: NCRR C06 RR018823 (A.W., R.A.N.), NCRR C06 RR015455 (A.W., R.A.N.), NCRR P20-RR016434 (A.W., R.A.N.), P30 GM103342-01 (A.W., R.A.N.), NIH-NHLBI R01HL084285 (A.W.), NIH 5T32 HL007260 (M.M.L), AHA Pre-doctoral fellowship 0715280U (E.W.), 11SDG5270006 (R.A.N.), and The Foundation Leducq (Paris, France) Transatlantic Mitral Network of Excellence grant 07CVD04 (R.A.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Azhar M, 2011, DEV DYNAM, V240, P2127, DOI 10.1002/dvdy.22702; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Camenisch T D, 2001, Exp Clin Cardiol, V6, P4; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; CATERSON B, 1985, FED PROC, V44, P386; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; Ghatnekar A, 2008, BBA-GENE REGUL MECH, V1779, P145, DOI 10.1016/j.bbagrm.2007.11.012; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Kou I, 2004, J BIOL CHEM, V279, P50942, DOI 10.1074/jbc.M406786200; Kruithof BPT, 2007, DEV BIOL, V302, P208, DOI 10.1016/j.ydbio.2006.09.024; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; Lee Y, 1997, MOL CELL BIOL, V17, P2745, DOI 10.1128/MCB.17.5.2745; Lemonnier M, 2004, J BIOL CHEM, V279, P55651, DOI 10.1074/jbc.M411082200; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; Lincoln J, 2006, DEV BIOL, V294, P292, DOI 10.1016/j.ydbio.2006.03.027; Matsumoto K, 2006, J BIOL CHEM, V281, P18257, DOI 10.1074/jbc.M510330200; Miwa HE, 2006, BBA-GEN SUBJECTS, V1760, P472, DOI 10.1016/j.bbagen.2005.12.003; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; NEAME PJ, 1986, J BIOL CHEM, V261, P3519; Norris RA, 2005, ANAT EMBRYOL, V210, P13, DOI 10.1007/s00429-005-0010-z; Peacock JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026769; Peacock JD, 2010, CIRC RES, V106, P712, DOI 10.1161/CIRCRESAHA.109.213702; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; RHODES C, 1995, NUCLEIC ACIDS RES, V23, P2305, DOI 10.1093/nar/23.12.2305; Rodriguez E, 2006, OSTEOARTHR CARTILAGE, V14, P823, DOI 10.1016/j.joca.2006.02.008; Seyfried NT, 2005, J BIOL CHEM, V280, P5435, DOI 10.1074/jbc.M411297200; Waller BR, 2000, METH MOL B, V135, P151; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Wirrig EE, 2007, DEV BIOL, V310, P291, DOI 10.1016/j.ydbio.2007.07.041	36	15	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57073	10.1371/journal.pone.0057073	http://dx.doi.org/10.1371/journal.pone.0057073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468913	Green Published, gold, Green Submitted			2022-12-27	WOS:000315561400026
J	Kidder, DP; Bachanas, P; Medley, A; Pals, S; Nuwagaba-Biribonwoha, H; Ackers, M; Howard, A; DeLuca, N; Mbatia, R; Sheriff, M; Arthur, G; Katuta, F; Cherutich, P; Somi, G				Kidder, Daniel P.; Bachanas, Pam; Medley, Amy; Pals, Sherri; Nuwagaba-Biribonwoha, Harriet; Ackers, Marta; Howard, Andrea; DeLuca, Nick; Mbatia, Redempta; Sheriff, Muhsin; Arthur, Gilly; Katuta, Frieda; Cherutich, Peter; Somi, Geoffrey		PwP Evaluation Study Team	HIV Prevention in Care and Treatment Settings: Baseline Risk Behaviors among HIV Patients in Kenya, Namibia, and Tanzania	PLOS ONE			English	Article							SELF-REPORTED ADHERENCE; ANTIRETROVIRAL THERAPY; ALCOHOL-CONSUMPTION; INFECTED ADULTS; VIRAL LOAD; TRANSMISSION; MEDICATIONS; DISCLOSURE; RETENTION; MORTALITY	HIV care and treatment settings provide an opportunity to reach people living with HIV/AIDS (PLHIV) with prevention messages and services. Population-based surveys in sub-Saharan Africa have identified HIV risk behaviors among PLHIV, yet data are limited regarding HIV risk behaviors of PLHIV in clinical care. This paper describes the baseline sociodemographic, HIV transmission risk behaviors, and clinical data of a study evaluating an HIV prevention intervention package for HIV care and treatment clinics in Africa. The study was a longitudinal group-randomized trial in 9 intervention clinics and 9 comparison clinics in Kenya, Namibia, and Tanzania (N = 3538). Baseline participants were mostly female, married, had less than a primary education, and were relatively recently diagnosed with HIV. Fifty-two percent of participants had a partner of negative or unknown status, 24% were not using condoms consistently, and 11% reported STI symptoms in the last 6 months. There were differences in demographic and HIV transmission risk variables by country, indicating the need to consider local context in designing studies and using caution when generalizing findings across African countries. Baseline data from this study indicate that participants were often engaging in HIV transmission risk behaviors, which supports the need for prevention with PLHIV (PwP).	[Kidder, Daniel P.; Bachanas, Pam; Medley, Amy; Pals, Sherri] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA 30329 USA; [Nuwagaba-Biribonwoha, Harriet; Howard, Andrea] ICAP Columbia Univ, New York, NY USA; [Ackers, Marta] Ctr Dis Control & Prevent, Nairobi, Kenya; [DeLuca, Nick] Ctr Dis Control & Prevent, Windhoek, Namibia; [Mbatia, Redempta] ICAP Columbia Univ, Dar Es Salaam, Tanzania; [Sheriff, Muhsin] ICAP Columbia Univ, Nairobi, Kenya; [Arthur, Gilly] Ctr Dis Control & Prevent, Dar Es Salaam, Tanzania; [Katuta, Frieda] Minist Hlth & Social Serv, Windhoek, Namibia; [Cherutich, Peter] Minist Hlth, Nairobi, Kenya; [Somi, Geoffrey] Minist Hlth, Dar Es Salaam, Tanzania	Centers for Disease Control & Prevention - USA	Kidder, DP (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA 30329 USA.	dkidder@cdc.gov		Sheriff, Muhsin/0000-0001-9130-5747; Kidder, Daniel/0000-0003-1693-4281	President's Emergency Plan for AIDS Relief (PEPFAR)	President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the President's Emergency Plan for AIDS Relief (PEPFAR), www.pepfar.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaynew Y, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-8; [Anonymous], 2011, LANCET, V377, P1719, DOI 10.1016/S0140-6736(11)60713-7; [Anonymous], 2004, GEND DIM HIV STAT DI; [Anonymous], 2008, NAM DEM HLTH SURV 20; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bhat VG, 2010, EUR J CLIN MICROBIOL, V29, P947, DOI 10.1007/s10096-010-0949-4; Bottegay M, 2007, ANTIVIR THER, V12, P841; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Chemaitelly H, 2012, SEX TRANSM INFECT, V88, P51, DOI 10.1136/sextrans-2011-050114; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohn SE, 2011, AIDS CARE, V23, P775, DOI 10.1080/09540121.2010.525617; Coldiron ME, 2008, AIDS BEHAV, V12, P594, DOI 10.1007/s10461-007-9304-x; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Do NT, 2010, AIDS RES HUM RETROV, V26, P685, DOI 10.1089/aid.2009.0222; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Gust DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018435; Hahn Judith A, 2010, Curr HIV/AIDS Rep, V7, P226, DOI 10.1007/s11904-010-0060-6; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; [KNBS] Kenya National Bureau of Statistics and ICF Macro, 2010, KENYA DEMOGRAPHIC HL; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Macro I, 2006, MEASURE DHS MODEL QU; Mellins CA, 2009, AIDS CARE, V21, P168, DOI 10.1080/09540120802001705; Mukherjee JS, 2006, JAIDS-J ACQ IMM DEF, V43, pS123, DOI 10.1097/01.qai.0000248348.25630.74; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Palepu A, 2004, ADDICTION, V99, P361, DOI 10.1111/j.1360-0443.2003.00670.x; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Reynolds NR, 2007, JAIDS-J ACQ IMM DEF, V46, P402, DOI 10.1097/QAI.0b013e318158a44f; Richardson JL, 2004, AIDS, V18, P1179, DOI 10.1097/00002030-200405210-00011; Samet JH, 2007, JAIDS-J ACQ IMM DEF, V46, P194, DOI 10.1097/QAI.0b013e318142aabb; Shuper PA, 2009, AIDS BEHAV, V13, P1021, DOI 10.1007/s10461-009-9589-z; STIGMA, 2019, GUID MAN SEX TRANSM; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNAIDS, 2011, UNAIDS DAT TABL 2011; World Health Organization, 2007, ESSENTIAL PREVENTION	48	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57215	10.1371/journal.pone.0057215	http://dx.doi.org/10.1371/journal.pone.0057215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115ZB	23459196	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500079
J	McFarland, R; Roebuck, H; Yan, Y; Majolo, B; Li, W; Guo, K				McFarland, Richard; Roebuck, Hettie; Yan, Yin; Majolo, Bonaventura; Li, Wu; Guo, Kun			Social Interactions through the Eyes of Macaques and Humans	PLOS ONE			English	Article							GAZE; MONKEYS; PATTERNS; VIEW; COMPETITION; ATTENTION; MOVEMENTS; IMAGES; FACES	Group-living primates frequently interact with each other to maintain social bonds as well as to compete for valuable resources. Observing such social interactions between group members provides individuals with essential information (e.g. on the fighting ability or altruistic attitude of group companions) to guide their social tactics and choice of social partners. This process requires individuals to selectively attend to the most informative content within a social scene. It is unclear how non-human primates allocate attention to social interactions in different contexts, and whether they share similar patterns of social attention to humans. Here we compared the gaze behaviour of rhesus macaques and humans when free-viewing the same set of naturalistic images. The images contained positive or negative social interactions between two conspecifics of different phylogenetic distance from the observer; i.e. affiliation or aggression exchanged by two humans, rhesus macaques, Barbary macaques, baboons or lions. Monkeys directed a variable amount of gaze at the two conspecific individuals in the images according to their roles in the interaction (i.e. giver or receiver of affiliation/aggression). Their gaze distribution to non-conspecific individuals was systematically varied according to the viewed species and the nature of interactions, suggesting a contribution of both prior experience and innate bias in guiding social attention. Furthermore, the monkeys' gaze behavior was qualitatively similar to that of humans, especially when viewing negative interactions. Detailed analysis revealed that both species directed more gaze at the face than the body region when inspecting individuals, and attended more to the body region in negative than in positive social interactions. Our study suggests that monkeys and humans share a similar pattern of role-sensitive, species- and context-dependent social attention, implying a homologous cognitive mechanism of social attention between rhesus macaques and humans.	[McFarland, Richard; Roebuck, Hettie; Majolo, Bonaventura; Guo, Kun] Lincoln Univ, Sch Psychol, Lincoln, England; [McFarland, Richard] Univ Witwatersrand, Sch Physiol, ZA-2050 Johannesburg, South Africa; [Yan, Yin; Li, Wu] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	University of Lincoln; University of Witwatersrand; Beijing Normal University	Majolo, B (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, England.	bmajolo@lincoln.ac.uk; liwu@bnu.edu.cn; kguo@lincoln.ac.uk	Li, Wu/G-9415-2011; Li, Wu/AHA-4320-2022	Li, Wu/0000-0002-2175-4579; McFarland, Richard/0000-0001-8245-9269; Majolo, Bonaventura/0000-0002-0235-3040; Roebuck, Hettie/0000-0002-5053-7274; Yan, Yin/0000-0001-5594-3020; Guo, Kun/0000-0001-6765-1957	National Basic Research Program of China Grant [2011CBA00405]; National Natural Science Foundation of China Grant [30970983, 31125014, 30930031]; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, China; Leverhulme Trust Grant [RF/2/RFG/2009/0152]	National Basic Research Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, China; Leverhulme Trust Grant(Leverhulme Trust)	This work was supported by National Basic Research Program of China Grant 2011CBA00405; National Natural Science Foundation of China Grant 30970983, 31125014 and 30930031; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, China; the Leverhulme Trust Grant No. RF/2/RFG/2009/0152. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg DJ, 2009, J VISION, V9, DOI 10.1167/9.5.19; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Birmingham E, 2008, VIS COGN, V16, P341, DOI 10.1080/13506280701434532; Cheney D.L., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; Colmenares F, 2002, BEHAVIOUR, V139, P1525, DOI 10.1163/15685390260514753; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; de Waal F.B.M., 2005, ANIMAL SOCIAL COMPLE; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Ghazanfar AA, 2006, COGNITION, V101, P515, DOI 10.1016/j.cognition.2005.12.007; Guo K, 1998, NEUROREPORT, V9, P3543, DOI 10.1097/00001756-199810260-00038; Guo K, 2003, EXP BRAIN RES, V150, P363, DOI 10.1007/s00221-003-1429-1; Guo K, 2007, EXP BRAIN RES, V181, P673, DOI 10.1007/s00221-007-1038-5; Guo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042585; Guo K, 2010, PERCEPTION, V39, P533, DOI 10.1068/p6517; Guo K, 2009, ANIM COGN, V12, P409, DOI 10.1007/s10071-008-0199-3; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Hoffman M.L., 2000, EMPATHY MORAL DEV IM, DOI DOI 10.1017/CBO9780511805851; Isaacowitz DM, 2006, CURR DIR PSYCHOL SCI, V15, P68, DOI 10.1111/j.0963-7214.2006.00409.x; Kano F, 2009, P R SOC B, V276, P1949, DOI 10.1098/rspb.2008.1811; KEATING CF, 1982, PERCEPTION, V11, P211, DOI 10.1068/p110211; Machado CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026598; Majolo B, 2012, ANIM BEHAV, V83, P763, DOI 10.1016/j.anbehav.2011.12.026; Maner JK, 2008, PERS SOC PSYCHOL B, V34, P488, DOI 10.1177/0146167207311910; McFarland R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026893; McGregor PK, 2005, ANIMAL COMMUNICATION; Mosher CP, 2011, BEHAV NEUROSCI, V125, P639, DOI 10.1037/a0024264; Nahm FKD, 1997, J COGNITIVE NEUROSCI, V9, P611, DOI 10.1162/jocn.1997.9.5.611; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Pinheiro J, 2001, MIXED EFFECTS MODELS; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rutte C, 2006, TRENDS ECOL EVOL, V21, P16, DOI 10.1016/j.tree.2005.10.014; Schaller GB, 1996, SERENGETI LION STUDY; Schino G, 2001, ANIM BEHAV, V62, P265, DOI 10.1006/anbe.2001.1750; Shepherd SV, 2010, CURR BIOL, V20, P649, DOI 10.1016/j.cub.2010.02.032; VAN HOOF J. A. R. A. M., 1967, P7	39	23	23	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56437	10.1371/journal.pone.0056437	http://dx.doi.org/10.1371/journal.pone.0056437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457569	Green Published, Green Accepted, gold			2022-12-27	WOS:000315603700054
J	Mortamais, M; Reynes, C; Brickman, AM; Provenzano, FA; Muraskin, J; Portet, F; Berr, C; Touchon, J; Bonafe, A; le Bars, E; Maller, JJ; Meslin, C; Sabatier, R; Ritchie, K; Artero, S				Mortamais, Marion; Reynes, Christelle; Brickman, Adam M.; Provenzano, Frank A.; Muraskin, Jordan; Portet, Florence; Berr, Claudine; Touchon, Jacques; Bonafe, Alain; le Bars, Emmanuelle; Maller, Jerome J.; Meslin, Chantal; Sabatier, Robert; Ritchie, Karen; Artero, Sylvaine			Spatial Distribution of Cerebral White Matter Lesions Predicts Progression to Mild Cognitive Impairment and Dementia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HYPERINTENSITIES; DEPRESSION; LEUKOARAIOSIS; PREVALENCE; DECLINE; MCI; AD	Context: White matter lesions (WML) increase the risk of dementia. The relevance of WML location is less clear. We sought to determine whether a particular WML profile, based on the density and location of lesions, could be associated with an increased risk of mild cognitive impairment (MCI) or dementia over the following 7 years. Methods: In 426 healthy subjects from a cohort of community-dwelling people aged 65 years and over (ESPRIT Project), standardized cognitive and neurological evaluations were repeated after 2, 4 and 7 years. Patterns of WML were computed with a supervised data mining approach (decision trees) using the regional WML volumes (frontal, parietal, temporal, and occipital regions) and the total WML volume estimated at baseline. Cox proportional hazard models were then constructed to study the association between WML patterns and risk of MCI/dementia. Results: Total WML volume and percentage of WML in the temporal region proved to be the best predictors of progression to MCI and dementia. Specifically, severe total WML load with a high proportion of lesions in the temporal region was significantly associated with the risk of developing MCI or dementia. Conclusions: Above a certain threshold of damage, a pattern of WML clustering in the temporal region identifies individuals at increased risk of MCI or dementia. As this WML pattern is observed before the onset of clinical symptoms, it may facilitate the detection of patients at risk of MCI/dementia.	[Mortamais, Marion; Portet, Florence; Berr, Claudine; Touchon, Jacques; Ritchie, Karen; Artero, Sylvaine] La Colombiere Hosp, INSERM, U1061, Montpellier, France; [Mortamais, Marion; Reynes, Christelle; Berr, Claudine; Touchon, Jacques; Bonafe, Alain; le Bars, Emmanuelle; Sabatier, Robert; Ritchie, Karen; Artero, Sylvaine] Univ Montpellier I, Montpellier, France; [Reynes, Christelle; Sabatier, Robert] Fac Pharm Montpellier, EA 2415, Montpellier, France; [Brickman, Adam M.; Provenzano, Frank A.; Muraskin, Jordan] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Portet, Florence] CHU Nimes, Ctr Ruffi, CHU Caremeau, Unite Transversale Troubles Neurol Sujet Age, Nimes, France; [Portet, Florence] CHU Montpellier, La Colombiere Hosp, Univ Dept Adult Psychiat, Montpellier Univ Hosp, Montpellier, France; [Bonafe, Alain; le Bars, Emmanuelle] CHRU Montpellier, Montpellier, France; [Maller, Jerome J.] Alfred & Monash Univ Cent Clin Sch, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; [Meslin, Chantal] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia; [Ritchie, Karen] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; Columbia University; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Monash University; Australian National University; Imperial College London	Artero, S (corresponding author), La Colombiere Hosp, INSERM, U1061, Montpellier, France.	sylvaine.artero@inserm.fr	Maller, Jerome J/H-4963-2014; Artero, Sylvaine/AAE-6059-2020; Ritchie, Karen/G-3571-2013; berr, Claudine/D-5238-2014	Maller, Jerome J/0000-0003-4685-1508; Ritchie, Karen/0000-0002-0688-8982; berr, Claudine/0000-0001-5254-7655; Artero, Sylvaine/0000-0002-1671-226X; Muraskin, Jordan/0000-0002-9913-4193; Sabatier, Robert/0000-0001-8685-6579; Mortamais, Marion/0000-0003-3983-9826; BONAFE, ALAIN/0000-0002-9187-1375	regional government of Languedoc-Roussillon; Agence Nationale de la Recherche (ANR); Novartis; France Alzheimer; NATIONAL INSTITUTE ON AGING [R01AG034189] Funding Source: NIH RePORTER	regional government of Languedoc-Roussillon(Region Occitanie); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Novartis(Novartis); France Alzheimer; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The ESPRIT Project is financed by the regional government of Languedoc-Roussillon (http://www.laregion.fr), the Agence Nationale de la Recherche (ANR: http://www.agence-nationale-recherche.fr) and an unconditional grant from Novartis (http://www.novartis.fr). This study is also supported by France Alzheimer (http://www.francealzheimer.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal-Behloul F., 2004, P INT SOC MAGN RES, P138; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Artero S, 2004, J NEUROL NEUROSUR PS, V75, P1304, DOI 10.1136/jnnp.2003.023713; Artero S, 2006, DEMENT GERIATR COGN, V22, P465, DOI 10.1159/000096287; Benton A, 1965, MANUEL APPL TEST RET; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Breiman L., 1984, CLASSIFICATION REGRE, P368, DOI DOI 10.1201/9781315139470-8; Brickman AM, 2011, PSYCHIAT RES-NEUROIM, V193, P101, DOI 10.1016/j.pscychresns.2011.03.007; Chen YF, 2006, DEMENT GERIATR COGN, V22, P177, DOI 10.1159/000094785; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; de Leeuw FE, 2000, J NEUROL, V247, P291, DOI 10.1007/s004150050586; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DeCarli C, 2005, STROKE, V36, P50, DOI 10.1161/01.STR.0000150668.58689.f2; Dubois B., 2001, NEUROLOGIE PSYCHIAT, V1, P40; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gao JL, 2011, J ALZHEIMERS DIS, V26, P47, DOI 10.3233/JAD-2011-101788; Gootjes L, 2004, DEMENT GERIATR COGN, V18, P180, DOI 10.1159/000079199; Greenwald BS, 2001, J AM GERIATR SOC, V49, P1218, DOI 10.1046/j.1532-5415.2001.49240.x; Gurol ME, 2006, NEUROLOGY, V66, P23, DOI 10.1212/01.wnl.0000191403.95453.6a; Herrmann LL, 2008, J NEUROL NEUROSUR PS, V79, P619, DOI 10.1136/jnnp.2007.124651; Holland CM, 2008, STROKE, V39, P1127, DOI 10.1161/STROKEAHA.107.497438; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; Lamarca R, 1998, J GERONTOL A-BIOL, V53, pM337, DOI 10.1093/gerona/53A.5.M337; Maller JJ, 2007, HIPPOCAMPUS, V17, P1023, DOI 10.1002/hipo.20339; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ritchie K, 2004, BRIT J PSYCHIAT, V184, P147, DOI 10.1192/bjp.184.2.147; Ritchie K, 2012, J AFFECT DISORDERS, V141, P294, DOI 10.1016/j.jad.2012.03.035; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Ross ED, 2005, COGN BEHAV NEUROL, V18, P89, DOI 10.1097/01.wnn.0000151859.19031.e8; Schmidt R, 2005, ANN NEUROL, V58, P610, DOI 10.1002/ana.20630; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa; Yoshita M, 2006, NEUROLOGY, V67, P2192, DOI 10.1212/01.wnl.0000249119.95747.1f	39	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56972	10.1371/journal.pone.0056972	http://dx.doi.org/10.1371/journal.pone.0056972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457645	Green Published, gold			2022-12-27	WOS:000315602700104
J	Bashir, MEH; Lui, JH; Palnivelu, R; Naclerio, RM; Preuss, D				Bashir, Mohamed Elfatih H.; Lui, Jan Hsi; Palnivelu, Ravishankar; Naclerio, Robert M.; Preuss, Daphne			Pollen Lipidomics: Lipid Profiling Exposes a Notable Diversity in 22 Allergenic Pollen and Potential Biomarkers of the Allergic Immune Response	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; BRASSICA-NAPUS; T-CELLS; KAPPA-B; CYTOKINE PRODUCTION; GENE-EXPRESSION; DENDRITIC CELLS; LINOLEIC-ACID; ASTHMA; ARABIDOPSIS	Background/Aim: Pollen grains are the male gametophytes that deliver sperm cells to female gametophytes during sexual reproduction of higher plants. Pollen is a major source of aeroallergens and environmental antigens. The pollen coat harbors a plethora of lipids that are required for pollen hydration, germination, and penetration of the stigma by pollen tubes. In addition to proteins, pollen displays a wide array of lipids that interact with the human immune system. Prior searches for pollen allergens have focused on the identification of intracellular allergenic proteins, but have largely overlooked much of the extracellular pollen matrix, a region where the majority of lipid molecules reside. Lipid antigens have attracted attention for their potent immunoregulatory effects. By being in close proximity to allergenic proteins on the pollen surface when they interact with host cells, lipids could modify the antigenic properties of proteins. Methodology/Principal Findings: We performed a comparative pollen lipid profiling of 22 commonly allergenic plant species by the use of gas chromatography-mass spectroscopy, followed by detailed data mining and statistical analysis. Three experiments compared pollen lipid profiles. We built a database library of the pollen lipids by matching acquired pollen-lipid mass spectra and retention times with the NIST/EPA/NIH mass-spectral library. We detected, identified, and relatively quantified more than 106 lipid molecular species including fatty acids, n-alkanes, fatty alcohols, and sterols. Pollen-derived lipids stimulation up-regulate cytokines expression of dendritic and natural killer T cells co-culture. Conclusions/Significance: Here we report on a lipidomic analysis of pollen lipids that can serve as a database for identifying potential lipid antigens and/or novel candidate molecules involved in allergy. The database provides a resource that facilitates studies on the role of lipids in the immunopathogenesis of allergy. Pollen lipids vary greatly among allergenic species and contain many molecules that have stimulatory or regulatory effects on immune responses.	[Bashir, Mohamed Elfatih H.; Naclerio, Robert M.] Univ Chicago, Dept Surg, Div Biol Sci, Sect Otolaryngol Head & Neck Surg, Chicago, IL 60637 USA; [Bashir, Mohamed Elfatih H.; Lui, Jan Hsi; Palnivelu, Ravishankar; Preuss, Daphne] Univ Chicago, Dept Mol Genet & Cell Biol, Div Biol Sci, Chicago, IL 60637 USA; [Palnivelu, Ravishankar] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Preuss, Daphne] Chromatin Inc, Chicago, IL USA	University of Chicago; University of Chicago; University of Arizona	Bashir, MEH (corresponding author), Univ Chicago, Dept Surg, Div Biol Sci, Sect Otolaryngol Head & Neck Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mbashir@surgery.bsd.uchicago.edu		Bashir, Mohamed Elfatih/0000-0003-0125-1648	Strategic Program for Asthma Research; National Science Foundation [MCB-0520283]; Department of Energy [DE-FG02-96ER20240]; Direct For Biological Sciences [1146090] Funding Source: National Science Foundation	Strategic Program for Asthma Research; National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the Strategic Program for Asthma Research (www.spar-aaf.org); National Science Foundation (http://www.nsf.gov/) "Arabidopsis 2010: Functional analysis of pollen exine assembly," MCB-0520283; Department of Energy (http://energy.gov/) "Cell-Cell Interaction during Pollen Tube Guidance in Arabidopsis," DE-FG02-96ER20240; The McHugh Otolaryngology Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVES M, 1991, J ALLERGY CLIN IMMUN, V88, P124, DOI 10.1016/0091-6749(91)90309-C; Agea E, 2005, J EXP MED, V202, P295, DOI 10.1084/jem.20050773; Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Allen Patricia L Jackson, 2006, Dermatol Nurs, V18, P236; August A, 2006, J NUTR, V136, P695, DOI 10.1093/jn/136.3.695; Bashir MEH, 2013, PLOS ONE; Beck JP, 2007, SCI TOTAL ENVIRON, V372, P440, DOI 10.1016/j.scitotenv.2006.10.009; Belvisi MG, 2004, BIODRUGS, V18, P211, DOI 10.2165/00063030-200418040-00001; Chang CCJ, 2000, J IMMUNOL, V165, P3584, DOI 10.4049/jimmunol.165.7.3584; Cincinelli A, 2007, CHEMOSPHERE, V68, P472, DOI 10.1016/j.chemosphere.2006.12.089; D'Amato Gennaro, 2006, Treat Respir Med, V5, P393, DOI 10.2165/00151829-200605060-00004; DICKINSON H, 1993, NATURE, V364, P573, DOI 10.1038/364573a0; Engel E, 1997, J BIOL CHEM, V272, P28630, DOI 10.1074/jbc.272.45.28630; EVANS DE, 1990, PLANT PHYSIOL, V93, P418, DOI 10.1104/pp.93.2.418; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; Fukanoki S, 2000, J VET MED SCI, V62, P917, DOI 10.1292/jvms.62.917; GAFNER F, 1988, CONTACT DERMATITIS, V19, P125, DOI 10.1111/j.1600-0536.1988.tb05509.x; HULSKAMP M, 1995, PLANT CELL, V7, P57, DOI 10.1105/tpc.7.1.57; Jakobsen MA, 2006, SCAND J IMMUNOL, V63, P330, DOI 10.1111/j.1365-3083.2006.01745.x; JOHNSON RA, 1972, J ALLERGY CLIN IMMUN, V49, P27, DOI 10.1016/0091-6749(72)90120-0; Joshi-Barve S, 2007, HEPATOLOGY; KARSTEN S, 1994, J CELL PHYSIOL, V161, P15, DOI 10.1002/jcp.1041610103; Kim JL, 2007, INDOOR AIR, V17, P153, DOI 10.1111/j.1600-0668.2006.00466.x; Kronenberg M, 2005, NATURE, V435, P598, DOI 10.1038/nature03725; Kuroda Y, 2006, TOXICOLOGY, V218, P186, DOI 10.1016/j.tox.2005.10.011; Kuroda Y, 2004, BIOMED PHARMACOTHER, V58, P325, DOI 10.1016/j.biopha.2004.04.009; Laine PS, 2007, BIOCHEM BIOPH RES CO, V358, P150, DOI 10.1016/j.bbrc.2007.04.092; Lee JY, 2006, MOL CELLS, V21, P174; Lee KS, 2006, J ALLERGY CLIN IMMUN, V118, P120, DOI 10.1016/j.jaci.2006.03.021; LERNHARDT W, 1990, BIOCHEM BIOPH RES CO, V166, P879, DOI 10.1016/0006-291X(90)90892-Q; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mayfield JA, 2000, NAT CELL BIOL, V2, P128, DOI 10.1038/35000084; Mayfield JA, 2001, SCIENCE, V292, P2482, DOI 10.1126/science.1060972; McEwan M, 1998, CLIN EXP ALLERGY, V28, P332; Nathan RA, 2007, ALLERGY ASTHMA PROC, V28, P3, DOI 10.2500/aap.2007.28.2934; Ogren TL., 2000, ALLERGY FREE GARDENI; Palmer CNA, 2007, CLIN PHARMACOL THER, V81, P713, DOI 10.1038/sj.clpt.6100119; Papa G, 1996, ALLERGY, V51, P833, DOI 10.1111/j.1398-9995.1996.tb00030.x; Piffanelli P, 1997, PLANT J, V11, P549, DOI 10.1046/j.1365-313X.1997.11030549.x; Pont F, 1997, Arch Bronconeumol, V33, P453; PREUSS D, 1993, GENE DEV, V7, P974, DOI 10.1101/gad.7.6.974; Ritchie GD, 2003, J TOXICOL ENV HEAL B, V6, P357, DOI 10.1080/10937400306473; Rodriguez-Garcia MI, 2003, PROTOPLASMA, V221, P237, DOI 10.1007/s00709-002-0076-x; Roth M, 2006, CURR DRUG TARGETS, V7, P589, DOI 10.2174/138945006776818638; Russano AM, 2006, J ALLERGY CLIN IMMUN, V117, P1178, DOI 10.1016/j.jaci.2006.01.001; Satoh M, 2003, J AUTOIMMUN, V21, P1, DOI 10.1016/S0896-8411(03)00083-0; Swoboda I, 2004, J IMMUNOL, V172, P6490, DOI 10.4049/jimmunol.172.10.6490; Szatmari I, 2004, IMMUNITY, V21, P95, DOI 10.1016/j.immuni.2004.06.003; Taylor PE, 2007, INT ARCH ALLERGY IMM, V144, P162, DOI 10.1159/000103230; Ting JTL, 1998, PLANT J, V16, P541, DOI 10.1046/j.1365-313x.1998.00325.x; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Traidl-Hoffmann C, 2003, INT ARCH ALLERGY IMM, V131, P1, DOI 10.1159/000070428; Traidl-Hoffmann C, 2002, J ALLERGY CLIN IMMUN, V109, P831, DOI 10.1067/mai.2002.124655; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; WOOTEN MW, 1988, BIOCHEM BIOPH RES CO, V153, P67, DOI 10.1016/S0006-291X(88)81190-2; WOOTEN RM, 1993, CELL IMMUNOL, V152, P35, DOI 10.1006/cimm.1993.1265	57	37	40	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57566	10.1371/journal.pone.0057566	http://dx.doi.org/10.1371/journal.pone.0057566			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469025	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900124
J	Price, GA; McFann, K; Holmes, RK				Price, Gregory A.; McFann, Kim; Holmes, Randall K.			Immunization with Cholera Toxin B Subunit Induces High-Level Protection in the Suckling Mouse Model of Cholera	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; VIBRIO-CHOLERAE; CELL RESPONSES; PARENTERAL IMMUNIZATION; ANTITOXIC IMMUNITY; BREAST-MILK; O1; MICE; BANGLADESH; ANTIBODIES	Cholera toxin (CT) is the primary virulence factor responsible for severe cholera. Vibrio cholerae strains unable to produce CT show severe attenuation of virulence in animals and humans. The pentameric B subunit of CT (CTB) contains the immunodominant epitopes recognized by antibodies that neutralize CT. Although CTB is a potent immunogen and a promising protective vaccine antigen in animal models, immunization of humans with detoxified CT failed to protect against cholera. We recently demonstrated however that pups reared from mice immunized intraperitoneally (IP) with 3 doses of recombinant CTB were well protected against a highly lethal challenge dose of V. cholerae N16961. The present study investigated how the route and number of immunizations with CTB could influence protective efficacy in the suckling mouse model of cholera. To this end female mice were immunized with CTB intranasally (IN), IP, and subcutaneously (SC). Serum and fecal extracts were analyzed for anti-CTB antibodies by quantitative ELISA, and pups born to immunized mothers were challenged orogastrically with a lethal dose of V. cholerae. Pups from all immunized groups were highly protected from death by 48 hours (64-100% survival). Cox regression showed that percent body weight loss at 24 hours predicted death by 48 hours, but we were unable to validate a specific amount of weight loss as a surrogate marker for protection. Although CTB was highly protective in all regimens, three parenteral immunizations showed trends toward higher survival and less weight loss at 24 hours post infection. These results demonstrate that immunization with CTB by any of several routes and dosing regimens can provide protection against live V. cholerae challenge in the suckling mouse model of cholera. Our data extend the results of previous studies and provide additional support for the inclusion of CTB in the development of a subunit vaccine against V. cholerae.	[Price, Gregory A.; Holmes, Randall K.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA; [McFann, Kim] Colorado Sch Publ Hlth, Colorado Biostat Consortium, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health	Holmes, RK (corresponding author), Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA.	randall.holmes@ucdenver.edu			NIH from National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01 AI31940]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031940] Funding Source: NIH RePORTER	NIH from National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH Grant R01 AI31940 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (http://www.nih.gov). No other research grant supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alam MM, 2011, CLIN VACCINE IMMUNOL, V18, P844, DOI 10.1128/CVI.00562-10; Aldinger KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004729; Ansaruzzaman M, 2004, EMERG INFECT DIS, V10, P2057, DOI 10.3201/eid1011.040682; APPLEBY P, 1983, J REPROD IMMUNOL, V5, P203, DOI 10.1016/0165-0378(83)90236-X; Bishop AL, 2011, EXPERT REV VACCINES, V10, P79, DOI [10.1586/erv.10.150, 10.1586/ERV.10.150]; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; CLEMENS JD, 1986, LANCET, V2, P124; Curlin GT, 1975, P 11 JOINT C CHOL US, P314; DUBEY RS, 1990, J GEN MICROBIOL, V136, P1839, DOI 10.1099/00221287-136-9-1839; Fazil MH, 2011, J MOL MODEL; FIELD M, 1972, J CLIN INVEST, V51, P796, DOI 10.1172/JCI106874; FUJITA K, 1972, J INFECT DIS, V125, P647, DOI 10.1093/infdis/125.6.647; GLASS RI, 1983, NEW ENGL J MED, V308, P1389, DOI 10.1056/NEJM198306093082304; GLASS RI, 1985, AM J EPIDEMIOL, V121, P791, DOI 10.1093/oxfordjournals.aje.a114050; GUENTZEL MN, 1974, INFECT IMMUN, V10, P167, DOI 10.1128/IAI.10.1.167-172.1974; Harris AM, 2009, INFECT IMMUN, V77, P3850, DOI 10.1128/IAI.00369-09; HOLMGREN J, 1975, INFECT IMMUN, V12, P1331, DOI 10.1128/IAI.12.6.1331-1340.1975; HOLMGREN J, 1973, Scandinavian Journal of Infectious Diseases, V5, P77, DOI 10.3109/inf.1973.5.issue-1.15; HOLMGREN J, 1977, NATURE, V269, P602, DOI 10.1038/269602a0; Jayasekera CR, 2008, J INFECT DIS, V198, P1055, DOI 10.1086/591500; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kundu J, 2009, FEMS IMMUNOL MED MIC, V56, P179, DOI 10.1111/j.1574-695X.2009.00563.x; LaRocque RC, 2009, GENES IMMUN, V10, P267, DOI 10.1038/gene.2009.2; LEVINE MM, 1979, T ROY SOC TROP MED H, V73, P3, DOI 10.1016/0035-9203(79)90119-6; MAJUMDAR AS, 1981, INFECT IMMUN, V32, P9, DOI 10.1128/IAI.32.1.9-14.1981; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; NEOH SH, 1972, J INFECT DIS, V126, P41, DOI 10.1093/infdis/126.1.41; Noriki H, 1976, P 12 JOINT C CHOL US, P302; OLSVIK O, 1993, J CLIN MICROBIOL, V31, P22, DOI 10.1128/JCM.31.1.22-25.1993; Patel SM, 2012, CLIN VACCINE IMMUNOL, V19, P842, DOI 10.1128/CVI.00037-12; PETERSON JW, 1979, INFECT IMMUN, V26, P594, DOI 10.1128/IAI.26.2.594-598.1979; Peterson JW, 1974, P 10 JOINT C US JAP, P89; PIERCE NF, 1974, J IMMUNOL, V113, P1017; PIERCE NF, 1982, INFECT IMMUN, V37, P687, DOI 10.1128/IAI.37.2.687-694.1982; Price GA, 2005, INFECT IMMUN, V73, P3945, DOI 10.1128/IAI.73.7.3945-3953.2005; Price GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042434; Qureshi K, 2006, PEDIATR INFECT DIS J, V25, P1163, DOI 10.1097/01.inf.0000246977.58697.a5; Raychoudhuri A, 2009, EMERG INFECT DIS, V15, P131, DOI 10.3201/eid1501.080543; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; SALETTI M, 1974, B WORLD HEALTH ORGAN, V51, P633; Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08; Schild S, 2008, INFECT IMMUN, V76, P4554, DOI 10.1128/IAI.00532-08; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; SRIVASTAVA R, 1979, INDIAN J MED RES, V70, P369; Stewart-Tull DES, 2004, VACCINE, V22, P2137, DOI 10.1016/j.vaccine.2003.12.004; Uddin T, 2011, CLIN VACCINE IMMUNOL, V18, P506, DOI 10.1128/CVI.00481-10; UJIIYE A, 1968, Tropical Medicine, V10, P65; Ujiye A, 1970, J INFECT DIS S121, V121, P1501; WALDMAN RH, 1972, J INFECT DIS, V126, P401, DOI 10.1093/infdis/126.4.401; WALDMAN RH, 1971, J INFECT DIS, V123, P579, DOI 10.1093/infdis/123.6.579; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	54	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57269	10.1371/journal.pone.0057269	http://dx.doi.org/10.1371/journal.pone.0057269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468950	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900062
J	Vadhvani, M; Schwedhelm-Domeyer, N; Mukherjee, C; Stegmuller, J				Vadhvani, Mayur; Schwedhelm-Domeyer, Nicola; Mukherjee, Chaitali; Stegmueller, Judith			The Centrosomal E3 Ubiquitin Ligase FBXO31-SCF Regulates Neuronal Morphogenesis and Migration	PLOS ONE			English	Article							F-BOX PROTEINS; CELL-POLARITY; AXONAL GROWTH; BETA-TRCP; COMPLEX; DEGRADATION; DIFFERENTIATION; MAINTENANCE; RECRUITMENT; CYCLE	Neuronal development requires proper migration, polarization and establishment of axons and dendrites. Growing evidence identifies the ubiquitin proteasome system (UPS) with its numerous components as an important regulator of various aspects of neuronal development. F-box proteins are interchangeable subunits of the Cullin-1 based E3 ubiquitin ligase, but only a few family members have been studied. Here, we report that the centrosomal E3 ligase FBXO31-SCF (Skp1/Cullin-1/F-box protein) regulates neuronal morphogenesis and axonal identity. In addition, we identified the polarity protein Par6c as a novel interaction partner and substrate targeted for proteasomal degradation in the control of axon but not dendrite growth. Finally, we ascribe a role for FBXO31 in dendrite growth and neuronal migration in the developing cerebellar cortex. Taken together, we uncovered the centrosomal E3 ligase FBXO31-SCF as a novel regulator of neuronal development.	[Vadhvani, Mayur; Schwedhelm-Domeyer, Nicola; Mukherjee, Chaitali; Stegmueller, Judith] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Vadhvani, Mayur; Mukherjee, Chaitali; Stegmueller, Judith] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany	Max Planck Society	Stegmuller, J (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	stegmueller@em.mpg.de			Max Planck Society; Deutsche Forschungsgemeinschaft (DFG); Gottingen Graduate Schools for Neurosciences, Biophysics and Molecular Biosciences (GGNB); Cluster of Excellence; DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain, Gottingen	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gottingen Graduate Schools for Neurosciences, Biophysics and Molecular Biosciences (GGNB); Cluster of Excellence; DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain, Gottingen	This work was supported by the Max Planck Society, the Deutsche Forschungsgemeinschaft (DFG), the Gottingen Graduate Schools for Neurosciences, Biophysics and Molecular Biosciences (GGNB) and the Cluster of Excellence and DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain, Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cheng PL, 2011, NEURON, V69, P231, DOI 10.1016/j.neuron.2010.12.021; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; Henrique D, 2003, CURR OPIN GENET DEV, V13, P341, DOI 10.1016/S0959-437X(03)00077-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jandke A, 2011, DEV BIOL, V358, P201, DOI 10.1016/j.ydbio.2011.07.030; Jiang Q, 2008, J NEUROSCI, V28, P12993, DOI 10.1523/JNEUROSCI.2860-08.2008; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kawabe H, 2011, NAT REV NEUROSCI, V12, P251, DOI 10.1038/nrn3009; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kodani A, 2010, MOL BIOL CELL, V21, P3376, DOI 10.1091/mbc.E10-05-0430; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kuijpers M, 2011, MOL CELL NEUROSCI, V48, P349, DOI 10.1016/j.mcn.2011.05.004; Kumar R, 2005, CANCER RES, V65, P11304, DOI 10.1158/0008-5472.CAN-05-0936; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007; Narayan S, 2008, BRAIN RES, V1239, P235, DOI 10.1016/j.brainres.2008.08.023; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Puram SV, 2011, NAT NEUROSCI; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Silverman JS, 2012, TRENDS BIOCHEM SCI, V37, P66, DOI 10.1016/j.tibs.2011.10.004; Sobotzik JM, 2009, P NATL ACAD SCI USA, V106, P17564, DOI 10.1073/pnas.0909267106; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Stegmuller J, 2010, F1000 BIOL REPORTS; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	51	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57530	10.1371/journal.pone.0057530	http://dx.doi.org/10.1371/journal.pone.0057530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469015	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900115
J	Boyd, CA; Drumheller, SK; Gates, TA				Boyd, Clint A.; Drumheller, Stephanie K.; Gates, Terry A.			Crocodyliform Feeding Traces on Juvenile Ornithischian Dinosaurs from the Upper Cretaceous (Campanian) Kaiparowits Formation, Utah	PLOS ONE			English	Article							TOOTH MARKS; CROCODILE; BONE; ONTOGENY; BEHAVIOR	Crocodyliforms serve as important taphonomic agents, accumulating and modifying vertebrate remains. Previous discussions of Mesozoic crocodyliform feeding in terrestrial and riverine ecosystems have often focused on larger taxa and their interactions with equally large dinosaurian prey. However, recent evidence suggests that the impact of smaller crocodyliforms on their environments should not be discounted. Here we present direct evidence of feeding by a small crocodyliform on juvenile specimens of a 'hypsilophodontid' dinosaur from the Upper Cretaceous (Campanian) Kaiparowits Formation of southern Utah. Diagnostic crocodyliform bite marks present on a left scapula and a right femur, as well as a partial probable crocodyliform tooth crown (ovoid in cross-section) preserved within a puncture on the right femur, comprise the bulk of the feeding evidence. Computed tomography scans of the femoral puncture reveal impact damage to the surrounding bone and that the distal tip of the embedded tooth was missing prior to the biting event. This is only the second reported incidence of a fossil crocodyliform tooth being found embedded directly into prey bone. These bite marks provide insight into the trophic interactions of the ecosystem preserved in the Kaiparowits Formation. The high diversity of crocodyliforms within this formation may have led to accentuated niche partitioning, which seems to have included juvenile dinosaurian prey.	[Boyd, Clint A.] S Dakota Sch Mines & Technol, Dept Geol & Geol Engn, Rapid City, SD USA; [Drumheller, Stephanie K.] Univ Iowa, Dept Geosci, Iowa City, IA USA; [Drumheller, Stephanie K.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA; [Gates, Terry A.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Gates, Terry A.] Nat Hist Museum Utah, Salt Lake City, UT USA	South Dakota School Mines & Technology; University of Iowa; University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; North Carolina State University	Boyd, CA (corresponding author), S Dakota Sch Mines & Technol, Dept Geol & Geol Engn, Rapid City, SD USA.	clintboyd@stratfit.org		Gates, Terry/0000-0001-6850-7455; Drumheller, Stephanie/0000-0001-9714-7153	Geological Society of America; Max and Lorraine Littlefield Geoscience fund; University of Iowa Department of Geoscience; Division Of Earth Sciences [0948842] Funding Source: National Science Foundation	Geological Society of America; Max and Lorraine Littlefield Geoscience fund; University of Iowa Department of Geoscience; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was funded in part by a Geological Society of America Graduate Student Research Grant (http://www.geosociety.org/grants/gradgrants.htm) to CAB. SKD received funding from the Max and Lorraine Littlefield Geoscience fund and the University of Iowa Department of Geoscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Bader KS, 2009, PALAIOS, V24, P140, DOI 10.2110/palo.2008.p08-058r; Binford L.R., 1981, BONES ANCIENT MEN MO; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; Boyd CA, 2009, J VERTEBR PALEONTOL, V29, P758, DOI 10.1671/039.029.0328; Brochu CA, 2003, PALAIOS, V18, P475, DOI 10.1669/0883-1351(2003)018<0475:LFATTA>2.0.CO;2; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brochu CA, 1997, PALAIOS, V18, P80; Brochu CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009333; Byers S., 2004, INTRO FORENSIC ANTHR, P254, DOI 10.4324/9781315642031; Carpenter Kenneth, 2000, Gaia (Lisboa), V15, P135; Chure Daniel J., 2000, Gaia (Lisboa), V15, P227; Cisneros Juan Carlos, 2005, Revista Brasileira de Paleontologia, V8, P239; D'Amore DC, 2009, PALEOBIOLOGY, V35, P525, DOI 10.1666/0094-8373-35.4.525; Davidson I., 1990, Tempus, V2, P197; DEBROIN F, 1966, CR ACAD SCI D NAT, V262, P2326; DRUMHELLER S. K., 2007, MICROSC MICROANAL, V13, p510CD; Drumheller-Horton SK, 2012, ACTUALISTIC PHYLOGEN; Eaton J.G., 1999, UTAH GEOLOGICAL SURV, V99-1, P345; Erickson GM, 1996, J VERTEBR PALEONTOL, V16, P175, DOI 10.1080/02724634.1996.10011297; Erickson GM, 2003, J ZOOL, V260, P317, DOI 10.1017/S0952836903003819; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Farlow J.O., 1991, Modern Geology, V16, P161; Farlow JO, 2002, HIST BIOL, V16, P21, DOI DOI 10.1080/0891296031000154687; FIORILLO AR, 1991, PALAEOGEOGR PALAEOCL, V88, P157, DOI 10.1016/0031-0182(91)90062-V; Forrest R, 2003, P GEOLOGIST ASSOC, V114, P363, DOI 10.1016/S0016-7878(03)80037-8; Fowler Denver W., 2006, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P127; Franzen Jens Lorenz, 1993, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V3, P113; Frey Eberhard, 2010, Palaeobiodiversity and Palaeoenvironments, V90, P65, DOI 10.1007/s12549-009-0021-5; Fuentes E. J., 2003, STUDIA GEOLOGICA SAL, V39, P11; Gates TA, 2010, PALAEOGEOGR PALAEOCL, V291, P371, DOI 10.1016/j.palaeo.2010.03.008; GEBO DL, 1984, AM J PHYS ANTHROPOL, V65, P31, DOI 10.1002/ajpa.1330650106; Haglund W., 1997, FORENSIC TAPHONOMY P, P405; Hiiemae Karen M., 2000, P411, DOI 10.1016/B978-012632590-4/50014-9; Horner J.R, 1993, COMPLETE T REX; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Hutchison JH, 2009, ADV W INTERIOR LATE, V1, P27; Hyslop DB, 2004, GEOLOGICAL SOC AM AB, V36, P381; Irmis RB, TOP GRAND STAIRCASE; Jacobsen A.R., 2001, P58; Lehman TM, 2010, J VERTEBR PALEONTOL, V30, P1709, DOI 10.1080/02724634.2010.520782; Longrich NR, 2010, PALAEONTOLOGY, V53, P703, DOI 10.1111/j.1475-4983.2010.00957.x; Mayr G, 2009, WATERBIRDS, V32, P468, DOI 10.1675/063.032.0315; MCILHENNY EA, 1935, ALLIGATORS LIFE HIST; Mead JI, 2006, STUD NEOTROP FAUNA E, V41, P1, DOI 10.1080/01650520500309917; Mikulas Radek, 2006, Ichnos, V13, P113, DOI 10.1080/10420940600850729; Milan J., 2010, NEW MEXICO MUSEUM NA, V51, P195; Njau JK, 2012, J HUM EVOL, V63, P408, DOI 10.1016/j.jhevol.2011.05.008; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; Noto CR, 2012, PALAIOS, V27, P105, DOI 10.2110/palo.2011.p11-052r; Platt SG, 2006, HERPETOL J, V16, P281; Rivera-Sylva HE, 2009, CARNETS GEOLOGIE LET, V2; Roberts EM, 2005, CRETACEOUS RES, V26, P307, DOI 10.1016/j.cretres.2005.01.002; Roberts EM, 2007, SEDIMENT GEOL, V197, P207, DOI 10.1016/j.sedgeo.2006.10.001; Schwimmer DR, 2010, GEOLOGICAL SOC AM AB, V42, P104; Schwimmer DR., 2002, KING CROCODYLIANS PA; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; Steadman DW, 2006, J FORENSIC SCI, V51, P11, DOI 10.1111/j.1556-4029.2005.00001.x; Subalusky AL, 2009, BIOL CONSERV, V142, P1507, DOI 10.1016/j.biocon.2009.02.019; Titus A.L., 2008, GEOLOGICAL SOC AM AB, V40, P58; Varricchio DJ, 2007, P ROY SOC B-BIOL SCI, V274, P1361, DOI 10.1098/rspb.2006.0443; von Nopsca F., 1902, Z DTSCH GEOLOGISCHEN, V54, P34; WEIGELT J, 1927, RECENT VERTEBRATE CA; Wiersma J, 2004, J VERTEBR PALEONTOL, V24, p129A; Xing LD, 2012, LETHAIA, V45, P500, DOI 10.1111/j.1502-3931.2012.00310.x	65	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57605	10.1371/journal.pone.0057605	http://dx.doi.org/10.1371/journal.pone.0057605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460882	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000137
J	Bromberg, Z; Goloubinoff, P; Saidi, Y; Weiss, YG				Bromberg, Zohar; Goloubinoff, Pierre; Saidi, Younousse; Weiss, Yoram George			The Membrane-Associated Transient Receptor Potential Vanilloid Channel Is the Central Heat Shock Receptor Controlling the Cellular Heat Shock Response in Epithelial Cells	PLOS ONE			English	Article							CAPSAICIN-RECEPTOR; PROTEIN DENATURATION; PULMONARY EPITHELIUM; CECAL LIGATION; MAMMALIAN-CELL; EXPRESSION; TRPV1; HEAT-SHOCK-PROTEIN-70; STRESS; INHIBITION	The heat shock response (HSR) is a highly conserved molecular response to various types of stresses, including heat shock, during which heat-shock proteins (Hsps) are produced to prevent and repair damages in labile proteins and membranes. In cells, protein unfolding in the cytoplasm is thought to directly enable the activation of the heat shock factor 1 (HSF-1), however, recent work supports the activation of the HSR via an increase in the fluidity of specific membrane domains, leading to activation of heat-shock genes. Our findings support the existence of a plasma membrane-dependent mechanism of HSF-1 activation in animal cells, which is initiated by a membrane-associated transient receptor potential vanilloid receptor (TRPV). We found in various non-cancerous and cancerous mammalian epithelial cells that the TRPV1 agonists, capsaicin and resiniferatoxin (RTX), upregulated the accumulation of Hsp70, Hsp90 and Hsp27 and Hsp70 and Hsp90 respectively, while the TRPV1 antagonists, capsazepine and AMG-9810, attenuated the accumulation of Hsp70, Hsp90 and Hsp27 and Hsp70, Hsp90, respectively. Capsaicin was also shown to activate HSF-1. These findings suggest that heat-sensing and signaling in mammalian cells is dependent on TRPV channels in the plasma membrane. Thus, TRPV channels may be important drug targets to inhibit or restore the cellular stress response in diseases with defective cellular proteins, such as cancer, inflammation and aging.	[Bromberg, Zohar; Weiss, Yoram George] Hadassah Hebrew Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Jerusalem, Israel; [Bromberg, Zohar; Weiss, Yoram George] Hadassah Hebrew Univ, Sch Med, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Goloubinoff, Pierre; Saidi, Younousse] Univ Lausanne, Dept Plant Mol Biol, Lausanne, Switzerland; [Weiss, Yoram George] Univ Penn, Sch Med, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Lausanne; University of Pennsylvania	Weiss, YG (corresponding author), Hadassah Hebrew Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Jerusalem, Israel.	weiss@hadassah.org.il		Goloubinoff, Pierre/0000-0002-4802-0807	Israel Science Foundation [529/08]; ESICM (European Society of Intensive Care Medicine) Basic Science Award; Hadassah Medical Organization; Zwahlen foundation from Lausanne University	Israel Science Foundation(Israel Science Foundation); ESICM (European Society of Intensive Care Medicine) Basic Science Award; Hadassah Medical Organization; Zwahlen foundation from Lausanne University	This work was supported in part by grants from the Israel Science Foundation (#529/08 - YGW), the ESICM (European Society of Intensive Care Medicine) Basic Science Award, the Hadassah Medical Organization internal research grant (YGW), the Hadassah Medical Organization internal research grant (YGW) and the Zwahlen foundation from Lausanne University (PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2007, ANN NY ACAD SCI, V13, P15; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Akiyama H, 2011, BBA-MOL CELL BIOL L, V1811, P314, DOI 10.1016/j.bbalip.2011.02.005; Aschkenasy G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026956; Balogh G, 2005, FEBS J, V272, P6077, DOI 10.1111/j.1742-4658.2005.04999.x; Balogh G, 2010, BBA-MOL CELL BIOL L, V1801, P1036, DOI 10.1016/j.bbalip.2010.04.011; Bromberg Z, 2008, CRIT CARE MED, V36, P246, DOI 10.1097/01.CCM.0000295473.56522.EF; Bromberg Z, 2005, J ANESTH, V19, P236, DOI 10.1007/s00540-005-0308-2; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Carratu L, 1996, P NATL ACAD SCI USA, V93, P3870, DOI 10.1073/pnas.93.9.3870; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Clark N, 2007, FASEB J, V21, P3747, DOI 10.1096/fj.06-7460com; Cui XB, 2012, INTEGR CANCER THER, V11, P61, DOI 10.1177/1534735411399900; Czifra G, 2009, J CANCER RES CLIN, V135, P507, DOI 10.1007/s00432-008-0482-3; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; FRANCOCERECEDA A, 1991, REGUL PEPTIDES, V32, P253, DOI 10.1016/0167-0115(91)90019-D; Gombos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028818; Han P, 2007, BIOCHEM PHARMACOL, V73, P1635, DOI 10.1016/j.bcp.2006.12.035; Hinault MP, 2011, NEURODEGENER DIS, V8, P397, DOI 10.1159/000324514; Hohfeld J, 1998, BIOL CHEM, V379, P269; Holzer P, 2008, BRIT J PHARMACOL, V155, P1145, DOI 10.1038/bjp.2008.351; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Kampinga HH, 2006, HANDB EXP PHARM, V172, P1; Kiang JG, 1999, MOL CELL BIOCHEM, V199, P179, DOI 10.1023/A:1006946329581; KIANG JG, 1994, EUR J PHARM-MOLEC PH, V267, P135, DOI 10.1016/0922-4106(94)90164-3; Klafke JZ, 2012, NEUROSCIENCE, V222, P136, DOI 10.1016/j.neuroscience.2012.07.022; Li WH, 2007, J INVEST DERMATOL, V127, P2328, DOI 10.1038/sj.jid.5700880; Liu AYC, 2011, J BIOL CHEM, V286, P2785, DOI 10.1074/jbc.M110.158220; Marincsak R, 2009, ORAL DIS, V15, P328, DOI 10.1111/j.1601-0825.2009.01526.x; MOSSER DD, 1990, P NATL ACAD SCI USA, V87, P3748, DOI 10.1073/pnas.87.10.3748; Mustafi SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008719; Nagy E, 2007, P NATL ACAD SCI USA, V104, P7945, DOI 10.1073/pnas.0702557104; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Roy A, 2012, J APPL PHYSIOL, V112, P212, DOI 10.1152/japplphysiol.01303.2010; Saidi Y, 2005, PLANT MOL BIOL, V59, P697, DOI 10.1007/s11103-005-0889-z; Saidi Y, 2010, PLANT SIGNAL BEHAV, V5, P1530, DOI 10.4161/psb.5.12.13163; Saidi Y, 2009, PLANT CELL, V21, P2829, DOI 10.1105/tpc.108.065318; Sanchez AM, 2006, APOPTOSIS, V11, P89, DOI 10.1007/s10495-005-3275-z; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Stangl S, 2011, P NATL ACAD SCI USA, V108, P733, DOI 10.1073/pnas.1016065108; Szallasi A, 2011, CURR TOP MED CHEM, V11, P2116, DOI 10.2174/156802611796904906; Tiligada E, 2006, ENDOCR-RELAT CANCER, V13, pS115, DOI 10.1677/erc.1.01272; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Torok Z, 2003, P NATL ACAD SCI USA, V100, P3131, DOI 10.1073/pnas.0438003100; Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Vigh L, 1998, TRENDS BIOCHEM SCI, V23, P369, DOI 10.1016/S0968-0004(98)01279-1; Vigh L, 2007, TRENDS BIOCHEM SCI, V32, P357, DOI 10.1016/j.tibs.2007.06.009; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Vos MH, 2006, J NEUROCHEM, V99, P1088, DOI 10.1111/j.1471-4159.2006.04145.x; Walton SP, 2010, FEBS J, V277, P4806, DOI 10.1111/j.1742-4658.2010.07903.x; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Weiss YG, 2000, SHOCK, V13, P19, DOI 10.1097/00024382-200013010-00004; Weiss YG, 2001, ANESTHESIOLOGY, V95, P974, DOI 10.1097/00000542-200110000-00029; Weiss YG, 2002, J CLIN INVEST, V110, P801, DOI 10.1172/JCI200215888; Weiss YG, 2007, CRIT CARE MED, V35, P2128, DOI 10.1097/01.CCM.0000278915.78030.74; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200	62	34	35	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57149	10.1371/journal.pone.0057149	http://dx.doi.org/10.1371/journal.pone.0057149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468922	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000068
J	Coskun, D; Britto, DT; Jean, YK; Kabir, I; Tolay, I; Torun, AA; Kronzucker, HJ				Coskun, Devrim; Britto, Dev T.; Jean, Yuel-Kai; Kabir, Imtiaz; Tolay, Inci; Torun, Ayfer A.; Kronzucker, Herbert J.			K+ Efflux and Retention in Response to NaCl Stress Do Not Predict Salt Tolerance in Contrasting Genotypes of Rice (Oryza sativa L.)	PLOS ONE			English	Article							HORDEUM-VULGARE L.; NITROGEN-SOURCE INCREASES; POTASSIUM-TRANSPORT; BARLEY ROOTS; COMPARTMENTAL ANALYSIS; SALINITY RESISTANCE; ION CONCENTRATIONS; SODIUM-TRANSPORT; PLASMA-MEMBRANE; EXCISED BARLEY	Sudden elevations in external sodium chloride (NaCl) accelerate potassium (K+) efflux across the plasma membrane of plant root cells. It has been proposed that the extent of this acceleration can predict salt tolerance among contrasting cultivars. However, this proposal has not been considered in the context of plant nutritional history, nor has it been explored in rice (Oryza sativa L.), which stands among the world's most important and salt-sensitive crop species. Using efflux analysis with 42 K, coupled with growth and tissue K+ analyses, we examined the short-and long-term effects of NaCl exposure to plant performance within a nutritional matrix that significantly altered tissue-K+ set points in three rice cultivars that differ in salt tolerance: IR29 (sensitive), IR72 (moderate), and Pokkali (tolerant). We show that total short-term K+ release from roots in response to NaCl stress is small (no more than 26% over 45 min) in rice. Despite strong varietal differences, the extent of efflux is shown to be a poor predictor of plant performance on long-term NaCl stress. In fact, no measure of K+ status was found to correlate with plant performance among cultivars either in the presence or absence of NaCl stress. By contrast, shoot Na+ accumulation showed the strongest correlation (a negative one) with biomass, under long-term salinity. Pharmacological evidence suggests that NaCl-induced K+ efflux is a result of membrane disintegrity, possibly as result of osmotic shock, and not due to ion-channel mediation. Taken together, we conclude that, in rice, K+ status (including efflux) is a poor predictor of salt tolerance and overall plant performance and, instead, shoot Na+ accumulation is the key factor in performance decline on NaCl stress.	[Coskun, Devrim; Britto, Dev T.; Jean, Yuel-Kai; Kabir, Imtiaz; Kronzucker, Herbert J.] Univ Toronto, Dept Biol Sci, Toronto, ON, Canada; [Tolay, Inci] Akdeniz Univ, Dept Agr, TR-07058 Antalya, Turkey; [Torun, Ayfer A.] Cukurova Univ, Dept Soil Sci & Plant Nutr, Adana, Turkey	University of Toronto; Akdeniz University; Cukurova University	Kronzucker, HJ (corresponding author), Univ Toronto, Dept Biol Sci, Toronto, ON, Canada.	herbertk@utsc.utoronto.ca	Kronzucker, Herbert J./HCH-4019-2022; Coskun, Devrim/E-4604-2010; Tolay, Inci/C-7582-2016; Coskun, Devrim/J-7084-2019; Alkan Torun, Ayfer/J-7235-2018	Coskun, Devrim/0000-0001-9598-2227; Kronzucker, Herbert/0000-0002-9358-0029	University of Toronto; Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair (CRC) program; Canadian Foundation for Innovation (CFI)	University of Toronto(University of Toronto); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair (CRC) program(Canada Research ChairsAustralian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	Funding for this work was provided by the University of Toronto, the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canada Research Chair (CRC) program, and the Canadian Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilea O, 2002, ACTA HORTIC, P43, DOI 10.17660/ActaHortic.2002.573.4; Anil VS, 2005, PHYSIOL PLANTARUM, V124, P451, DOI 10.1111/j.1399-3054.2005.00529.x; Balkos KD, 2010, PLANT CELL ENVIRON, V33, P23, DOI 10.1111/j.1365-3040.2009.02046.x; Bartholomew RP, 1929, SOIL SCI, V27, P189, DOI 10.1097/00010694-192903000-00002; BEHL R, 1982, J EXP BOT, V33, P584, DOI 10.1093/jxb/33.4.584; Botella MA, 1997, J PLANT NUTR, V20, P793, DOI 10.1080/01904169709365295; BOURGEAISCHAILLOU P, 1992, J EXP BOT, V43, P1225, DOI 10.1093/jxb/43.9.1225; Britto DT, 2008, PHYSIOL PLANTARUM, V133, P637, DOI 10.1111/j.1399-3054.2008.01067.x; Britto DT, 2010, NEW PHYTOL, V186, P373, DOI 10.1111/j.1469-8137.2009.03169.x; Cakmak I, 2005, J PLANT NUTR SOIL SC, V168, P521, DOI 10.1002/jpln.200420485; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen ZG, 2008, CROP SCI, V48, P1382, DOI 10.2135/cropsci2007.10.0557; Chen ZH, 2007, FUNCT PLANT BIOL, V34, P150, DOI 10.1071/FP06237; Coskun D, 2012, J EXP BOT, V63, P151, DOI 10.1093/jxb/err267; CRAMER GR, 1985, PLANT PHYSIOL, V79, P207, DOI 10.1104/pp.79.1.207; Cuin TA, 2008, J EXP BOT, V59, P2697, DOI 10.1093/jxb/ern128; Davenport RJ, 2000, PLANT PHYSIOL, V122, P823, DOI 10.1104/pp.122.3.823; EPSTEIN E, 1963, P NATL ACAD SCI USA, V49, P684, DOI 10.1073/pnas.49.5.684; Faiyue B, 2012, PLANT CELL ENVIRON, V35, P1099, DOI 10.1111/j.1365-3040.2011.02475.x; Flowers TJ, 1999, SCI HORTIC-AMSTERDAM, V78, P1; Frechilla S, 2001, PLANT GROWTH REGUL, V35, P171, DOI 10.1023/A:1014487908495; Garcia A, 1997, PLANT CELL ENVIRON, V20, P1167, DOI 10.1046/j.1365-3040.1997.d01-146.x; GARYBOBO CM, 1970, NATURE, V228, P1101, DOI 10.1038/2281101a0; Grattan SR, 1999, SCI HORTIC-AMSTERDAM, V78, P127, DOI 10.1016/S0304-4238(98)00192-7; HAJIBAGHERI MA, 1988, J EXP BOT, V39, P279, DOI 10.1093/jxb/39.3.279; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Hoagland DR, 1933, SOIL SCI, V36, P1; Ismail AM, 2007, PLANT MOL BIOL, V65, P547, DOI 10.1007/s11103-007-9215-2; Kinraide TB, 1999, J EXP BOT, V50, P1495, DOI 10.1093/jexbot/50.338.1495; KOCHIAN LV, 1985, PLANT PHYSIOL, V79, P771, DOI 10.1104/pp.79.3.771; Krishnamurthy P, 2011, J EXP BOT, V62, P4215, DOI 10.1093/jxb/err135; Krol E, 2000, ANN BOT-LONDON, V86, P449, DOI 10.1006/anbo.2000.1226; Kronzucker HJ, 2006, PLANT CELL ENVIRON, V29, P2228, DOI 10.1111/j.1365-3040.2006.01597.x; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; Kronzucker HJ, 2003, PLANTA, V217, P540, DOI 10.1007/s00425-003-1032-5; KRONZUCKER HJ, 1995, PLANT PHYSIOL, V109, P481, DOI 10.1104/pp.109.2.481; Lee KS, 2003, PLANTA, V216, P1043, DOI 10.1007/s00425-002-0958-3; LEE RB, 1986, J EXP BOT, V37, P1753, DOI 10.1093/jxb/37.12.1753; LEWIS OAM, 1989, NEW PHYTOL, V111, P155, DOI 10.1111/j.1469-8137.1989.tb00676.x; Lopez MV, 1996, PLANT SCI, V114, P19, DOI 10.1016/0168-9452(95)04300-4; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; MEMON AR, 1985, J EXP BOT, V36, P1860, DOI 10.1093/jxb/36.12.1860; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NASSERY H, 1979, NEW PHYTOL, V83, P23, DOI 10.1111/j.1469-8137.1979.tb00722.x; NASSERY H, 1975, NEW PHYTOL, V75, P63, DOI 10.1111/j.1469-8137.1975.tb01371.x; POOLE RJ, 1971, PLANT PHYSIOL, V47, P731, DOI 10.1104/pp.47.6.731; RAINS DW, 1967, PLANT PHYSIOL, V42, P319, DOI 10.1104/pp.42.3.319; RENGEL Z, 1992, PLANT CELL ENVIRON, V15, P625, DOI 10.1111/j.1365-3040.1992.tb01004.x; Roberts SK, 1997, J EXP BOT, V48, P431, DOI 10.1093/jxb/48.Special_Issue.431; Roberts SK, 1995, PLANT J, V8, P811, DOI 10.1046/j.1365-313X.1995.8060811.x; Schulze LM, 2012, J EXP BOT, V63, P2479, DOI 10.1093/jxb/err419; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Shabala S, 2007, FEBS LETT, V581, P1993, DOI 10.1016/j.febslet.2007.04.032; Shabala S, 2006, PLANT PHYSIOL, V141, P1653, DOI 10.1104/pp.106.082388; Shannon MC, 1998, CROP SCI, V38, P394, DOI 10.2135/cropsci1998.0011183X003800020021x; SIDDIQI MY, 1991, J EXP BOT, V42, P1455, DOI 10.1093/jxb/42.11.1455; Smethurst CF, 2008, FUNCT PLANT BIOL, V35, P640, DOI 10.1071/FP08030; SPEER M, 1994, PLANT CELL ENVIRON, V17, P1223, DOI 10.1111/j.1365-3040.1994.tb02020.x; SPEER M, 1994, PLANT CELL ENVIRON, V17, P1215, DOI 10.1111/j.1365-3040.1994.tb02019.x; Szczerba MW, 2009, J PLANT PHYSIOL, V166, P447, DOI 10.1016/j.jplph.2008.12.009; Tyerman SD, 1997, J EXP BOT, V48, P459, DOI 10.1093/jxb/48.Special_Issue.459; Walker DJ, 1996, P NATL ACAD SCI USA, V93, P10510, DOI 10.1073/pnas.93.19.10510; White PJ, 2000, NEW PHYTOL, V147, P241, DOI 10.1046/j.1469-8137.2000.00704.x; YEO AR, 1987, J EXP BOT, V38, P1141, DOI 10.1093/jxb/38.7.1141; YEO AR, 1982, PHYSIOL PLANTARUM, V56, P343, DOI 10.1111/j.1399-3054.1982.tb00350.x; YEO AR, 1990, THEOR APPL GENET, V79, P377, DOI 10.1007/BF01186082; YEO AR, 1983, PHYSIOL PLANTARUM, V59, P189, DOI 10.1111/j.1399-3054.1983.tb00756.x; Zhang JL, 2010, PLANT SOIL, V326, P45, DOI 10.1007/s11104-009-0076-0; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	72	38	40	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57767	10.1371/journal.pone.0057767	http://dx.doi.org/10.1371/journal.pone.0057767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460903	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000158
J	Espindola, CR; Blay, SL				Espindola, Cybele R.; Blay, Sergio L.			Long Term Remission of Anorexia Nervosa: Factors Involved in the Outcome of Female Patients	PLOS ONE			English	Article							10-YEAR FOLLOW-UP; EATING-DISORDERS; QUALITATIVE RESEARCH; INDIVIDUAL THERAPY; CLINICAL-TRIAL; MORTALITY; EPIDEMIOLOGY; ADOLESCENTS; PREDICTORS; INTERVIEWS	Background: Anorexia nervosa (AN) is usually marked by difficult recovery. Objective: To elicit, describe and characterize factors involved in successful AN remission for at least five years and post-recovery life. Methods: A qualitative study design using semi-structured interviews according to grounded theory methodology was used. An intentional sample of 15 information rich AN patients was selected using two sampling procedures: the criterion and "snowball" techniques. Qualitative interviews were audiotaped, transcribed, and entered into a content analysis. Researchers coded transcripts and developed themes. Results: Four core parameters were found to be associated with remission: (i) 'motivation to change/stimuli'; (ii) 'empowerment/autonomy'; (iii) 'media related factors'; (iv) 'treatment factors'. Clinical remission can be associated with residual symptoms. Conclusions: The recovery model involves not only one, but rather a set of inter-active variables, each one can partially explain remission. Media factors can take a new role on recovery. Remission, however, can be followed by remnants of the disease and functional limitations.	[Espindola, Cybele R.; Blay, Sergio L.] Univ Fed Sao Paulo, Dept Psychiat, Escola Paulista Med UNIFESP, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Blay, SL (corresponding author), Univ Fed Sao Paulo, Dept Psychiat, Escola Paulista Med UNIFESP, Sao Paulo, Brazil.	blay@uol.com.br			FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (The State of Sao Paulo Research Foundation) [07/50739]; National Council for Scientific and Technological Development (CNPq) [306156/2011-3]	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (The State of Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (The State of Sao Paulo Research Foundation), Grant 07/50739. Dr. Blay was partially supported by the National Council for Scientific and Technological Development (CNPq) for a Research Grant for Dr. Sergio L. Blay (Grant number 306156/2011-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Associagao Brasileira de Empresas de Pesquisa (ABEP), 2008, CRIT CLASS EC BRAS 2; Ben-Tovim DI, 2001, LANCET, V357, P1254, DOI 10.1016/S0140-6736(00)04406-8; Bjorck C, 2008, PSYCHOL PSYCHOTHER-T, V81, P95, DOI 10.1348/147608307X224547; Bjork T, 2008, HEALTH CARE WOMEN IN, V29, P926, DOI 10.1080/07399330802269543; Blay SL, 2008, AM J GERIAT PSYCHIAT, V16, P934, DOI 10.1097/JGP.0b013e3181871392; BRADLEY CP, 1992, BRIT MED J, V304, P294, DOI 10.1136/bmj.304.6822.294; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Button EJ, 2001, EUR EAT DISORD REV, V9, P74, DOI 10.1002/erv.400; Carei TR, 2010, J ADOLESCENT HEALTH, V46, P346, DOI 10.1016/j.jadohealth.2009.08.007; CRISP AH, 1992, BRIT J PSYCHIAT, V161, P104, DOI 10.1192/bjp.161.1.104; Eisler I, 1997, ARCH GEN PSYCHIAT, V54, P1025; Ernst E, 2004, J MED ETHICS, V30, P156, DOI 10.1136/jme.2003.007021; Espindola CR, 2009, ANN CLIN PSYCHIATRY, V21, P38; Fichter MM, 2006, INT J EAT DISORDER, V39, P87, DOI 10.1002/eat.20215; Gowers SG, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14150; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Hay PJ, 2012, AUST NZ J PSYCHIAT; Herpertz-Dahlmann B, 2001, J CHILD PSYCHOL PSYC, V42, P603, DOI 10.1111/1469-7610.00756; Hill PC, 2003, AM PSYCHOL, V58, P64, DOI 10.1037/0003-066X.58.1.64; Keel PK, 2010, INT J EAT DISORDER, V43, P195, DOI 10.1002/eat.20810; Keski-Rahkonen A, 2005, INT J EAT DISORDER, V37, pS80, DOI 10.1002/eat.20123; Keski-Rahkonen A, 2007, AM J PSYCHIAT, V164, P1259, DOI 10.1176/appi.ajp.2007.06081388; Lamoureux Mary M H, 2005, Health Care Women Int, V26, P170, DOI 10.1080/07399330590905602; Lock J, 2010, ARCH GEN PSYCHIAT, V67, P1025, DOI 10.1001/archgenpsychiatry.2010.128; Lowe B, 2001, PSYCHOL MED, V31, P881, DOI 10.1017/S003329170100407X; Mitchison D, 2012, QUAL LIFE RES; Nilsson K, 2005, EUR EAT DISORD REV, V13, P89, DOI 10.1002/erv.631; Nilsson Karin, 2006, Eat Disord, V14, P305, DOI 10.1080/10640260600796234; Noordenbos Greta, 2006, Eat Disord, V14, P41, DOI 10.1080/10640260500296756; Nordbo RHS, 2012, EUR EAT DISORD REV, V20, P60, DOI 10.1002/erv.1097; Patton M, 2015, UTILIZATION FOCUSED, VFourth; Pettersen Gunn, 2002, Eat Disord, V10, P61; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; RATNASURIYA RH, 1991, BRIT J PSYCHIAT, V158, P495, DOI 10.1192/bjp.158.4.495; Rigaud D, 2009, CLIN NUTR; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Steinhausen HC, 2002, AM J PSYCHIAT, V159, P1284, DOI 10.1176/appi.ajp.159.8.1284; Strauss A, 2008, BASICS QUALITATIVE R; Strober M, 1997, INT J EAT DISORDER, V22, P339, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;339::AID-EAT1&gt;3.0.CO;2-N; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vansteenkiste M, 2005, INT J EAT DISORDER, V37, P207, DOI 10.1002/eat.20099; Wentz E, 2001, J CHILD PSYCHOL PSYC, V42, P613, DOI 10.1111/1469-7610.00757; Williams S, 2010, PSYCHOL HEALTH, V25, P551, DOI 10.1080/08870440802617629; Zipfel S, 2000, LANCET, V355, P721, DOI 10.1016/S0140-6736(99)05363-5	44	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56275	10.1371/journal.pone.0056275	http://dx.doi.org/10.1371/journal.pone.0056275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23460796	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000019
J	Hosseini, A; Espona-Fiedler, M; Soto-Cerrato, V; Quesada, R; Perez-Tomas, R; Guallar, V				Hosseini, Ali; Espona-Fiedler, Margarita; Soto-Cerrato, Vanessa; Quesada, Roberto; Perez-Tomas, Ricardo; Guallar, Victor			Molecular Interactions of Prodiginines with the BH3 Domain of Anti-Apoptotic Bcl-2 Family Members	PLOS ONE			English	Article							MELANOMA-CELLS; MCL-1; PROTEIN; INHIBITORS; GX15-070; EXPLORATION; RESISTANCE; BCL-X(L); INSIGHTS; DOCKING	Prodigiosin and obatoclax, members of the prodiginines family, are small molecules with anti-cancer properties that are currently under preclinical and clinical trials. The molecular target(s) of these agents, however, is an open question. Combining experimental and computational techniques we find that prodigiosin binds to the BH3 domain in some BCL-2 protein families, which play an important role in the apoptotic programmed cell death. In particular, our results indicate a large affinity of prodigiosin for MCL-1, an anti-apoptotic member of the BCL-2 family. In melanoma cells, we demonstrate that prodigiosin activates the mitochondrial apoptotic pathway by disrupting MCL-1/BAK complexes. Computer simulations with the PELE software allow the description of the induced fit process, obtaining a detailed atomic view of the molecular interactions. These results provide new data to understand the mechanism of action of these molecules, and assist in the development of more specific inhibitors of anti-apoptotic BCL-2 proteins.	[Hosseini, Ali; Guallar, Victor] Joint BSC IRB Res Program Computat Biol, Barcelona, Spain; [Espona-Fiedler, Margarita; Soto-Cerrato, Vanessa; Perez-Tomas, Ricardo] Univ Barcelona, Canc Cell Biol Res Grp, Dept Pathol & Expt Therapeut, Barcelona, Spain; [Quesada, Roberto] Univ Burgos, Dept Chem, Burgos, Spain; [Guallar, Victor] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	University of Barcelona; Universidad de Burgos; ICREA	Guallar, V (corresponding author), Joint BSC IRB Res Program Computat Biol, Barcelona, Spain.	victor.guallar@bsc.es	Espona-Fiedler, Margarita/AAL-9280-2021; quesada, roberto/GSM-7910-2022; quesada, roberto/C-6965-2008; Soto-Cerrato, Vanessa/AAB-4392-2020; Guallar, Victor/B-1579-2013; quesada, roberto/AAX-8833-2021	quesada, roberto/0000-0003-2764-7157; quesada, roberto/0000-0003-2764-7157; Soto-Cerrato, Vanessa/0000-0001-5835-3595; Guallar, Victor/0000-0002-4580-1114; Espona-Fiedler, Margarita/0000-0001-7639-2299; Perez-Tomas, Ricardo/0000-0003-3226-1240	Spanish government; European Union [FIS-PI10/00338]; ERC-2009-Adg 25027-PELE European project; ICREA Funding Source: Custom	Spanish government(Spanish GovernmentEuropean Commission); European Union(European Commission); ERC-2009-Adg 25027-PELE European project; ICREA(ICREA)	This work was supported by a research grant from the Spanish government and the European Union (FIS-PI10/00338) and from the ERC-2009-Adg 25027-PELE European project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acoca S, 2011, PROTEINS, V79, P2624, DOI 10.1002/prot.23083; [Anonymous], 2011, PROT PREP WIZ EP VER; [Anonymous], 2010, GLID; [Anonymous], 2011, SITEMAP; Bernardo PH, 2010, J MED CHEM, V53, P2314, DOI 10.1021/jm901469p; Boersma MD, 2012, J AM CHEM SOC, V134, P315, DOI 10.1021/ja207148m; Borrelli KW, 2010, J COMPUT CHEM, V31, P1224, DOI 10.1002/jcc.21409; Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Cossins BP, 2012, J CHEM THEORY COMPUT, V8, P959, DOI 10.1021/ct200675g; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; de Grenu BD, 2011, CHEM-EUR J, V17, P14074, DOI 10.1002/chem.201101547; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Espona-Fiedler M, 2012, BIOCHEM PHARMACOL, V83, P489, DOI 10.1016/j.bcp.2011.11.027; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Ho TF, 2009, TOXICOL APPL PHARM, V235, P253, DOI 10.1016/j.taap.2008.12.009; Hsieh HY, 2012, BRIT J PHARMACOL, V166, P2095, DOI 10.1111/j.1476-5381.2012.01921.x; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Konopleva M, 2008, CANCER RES, V68, P3413, DOI 10.1158/0008-5472.CAN-07-1919; Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Li J, 2008, CANCER CHEMOTH PHARM, V61, P525, DOI 10.1007/s00280-007-0499-3; Lu CH, 2012, TOXICOL LETT, V212, P83, DOI 10.1016/j.toxlet.2012.05.002; Martin AP, 2009, MOL PHARMACOL, V76, P327, DOI 10.1124/mol.109.056309; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Parikh SA, 2010, CL LYMPH MYELOM LEUK, V10, P285, DOI 10.3816/CLML.2010.n.059; Perez-Tomas R, 2010, CURR MED CHEM, V17, P2222, DOI 10.2174/092986710791331103; Rahmani M, 2012, BLOOD, V119, P6089, DOI 10.1182/blood-2011-09-378141; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Soto-Cerrato V, 2004, BIOCHEM PHARMACOL, V68, P1345, DOI 10.1016/j.bcp.2004.05.056; Soto-Cerrato V, 2007, MOL CANCER THER, V6, P362, DOI 10.1158/1535-7163.MCT-06-0266; Trudel S, 2007, BLOOD, V109, P5430, DOI 10.1182/blood-2006-10-047951; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937	44	36	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57562	10.1371/journal.pone.0057562	http://dx.doi.org/10.1371/journal.pone.0057562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460874	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000129
J	Jobbings, CE; Sandig, H; Whittingham-Dowd, JK; Roberts, IS; Bulfone-Paus, S				Jobbings, Catherine E.; Sandig, Hilary; Whittingham-Dowd, Jayde K.; Roberts, Ian S.; Bulfone-Paus, Silvia			Listeria monocytogenes Alters Mast Cell Phenotype, Mediator and Osteopontin Secretion in a Listeriolysin-Dependent Manner	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; C-KIT; PHOSPHATIDYLINOSITOL 3-KINASE; ALPHA-2-BETA-1 INTEGRIN; INTRACELLULAR GROWTH; HOST-DEFENSE; MICE LACKING; E-CADHERIN; GM-CSF; RESPONSES	Whilst mast cells participate in the immune defence against the intracellular bacterium Listeria monocytogenes, there is conflicting evidence regarding the ability of L. monocytogenes to infect mast cells. It is known that the pore-forming toxin listeriolysin (LLO) is important for mast cell activation, degranulation and the release of pro-inflammatory cytokines. Mast cells, however, are a potential source of a wide range of cytokines, chemokines and other mediators including osteopontin, which contributes to the clearing of L. monocytogenes infections in vivo, although its source is unknown. We therefore aimed to resolve the controversy of mast cell infection by L. monocytogenes and investigated the extent of mediator release in response to the bacterium. In this paper we show that the infection of bone marrow-derived mast cells by L. monocytogenes is inefficient and LLO-independent. LLO, however, is required for calcium-independent mast cell degranulation as well as for the transient and selective downregulation of cell surface CD117 (c-kit) on mast cells. We demonstrate that in addition to the key pro-inflammatory cytokines TNF-alpha and IL-6, mast cells release a wide range of other mediators in response to L. monocytogenes. Osteopontin, IL-2, IL-4, IL-13 and granulocyte macrophage colony-stimulating factor (GM-CSF), and chemokines including CCL2, CCL3, CCL4 and CCL5 are released in a MyD88-dependent manner. The wide range of mediators released by mast cells in response to L. monocytogenes may play an important role in the recruitment and activation of a variety of immune cells in vivo. The cocktail of mediators, however, is unlikely to skew the immune response to a particular effector response. We propose that mast cells provide a hitherto unreported source of osteopontin, and may provide an important role in co-ordinating the immune response during Listeria infection.	[Jobbings, Catherine E.; Sandig, Hilary; Whittingham-Dowd, Jayde K.; Bulfone-Paus, Silvia] Univ Manchester, Fac Human & Med Sci, Manchester, Lancs, England; [Roberts, Ian S.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Bulfone-Paus, Silvia] Res Ctr Borstel, Borstel, Germany	University of Manchester; University of Manchester; Forschungszentrum Borstel	Bulfone-Paus, S (corresponding author), Univ Manchester, Fac Human & Med Sci, Manchester, Lancs, England.	Silvia.bulfone-paus@manchester.ac.uk		Whittingham-Dowd, Jayde/0000-0002-7939-6081	MRC [G0601205] Funding Source: UKRI; Medical Research Council [G0601205] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abel B, 2005, J IMMUNOL, V175, P6006, DOI 10.4049/jimmunol.175.9.6006; Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; BISCHOFF SC, 1992, J EXP MED, V175, P237, DOI 10.1084/jem.175.1.237; CHEERS C, 1978, INFECT IMMUN, V19, P755, DOI 10.1128/IAI.19.3.755-762.1978; Cruz AC, 2004, J BIOL CHEM, V279, P5612, DOI 10.1074/jbc.M312323200; Dietrich N, 2010, P NATL ACAD SCI USA, V107, P8748, DOI 10.1073/pnas.0912551107; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Edelson BT, 2006, BLOOD, V107, P143, DOI 10.1182/blood-2005-06-2218; Edelson BT, 2004, BLOOD, V103, P2214, DOI 10.1182/blood-2003-08-2978; Fuchs TM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00023; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; Gekara NO, 2008, CELL MICROBIOL, V10, P225, DOI 10.1111/j.1462-5822.2007.01033.x; Gekara NO, 2007, CELL MICROBIOL, V9, P2008, DOI 10.1111/j.1462-5822.2007.00932.x; Gekara NO, 2009, J INFECT DIS, V199, P124, DOI 10.1086/595562; Gommerman JL, 1997, J BIOL CHEM, V272, P30519, DOI 10.1074/jbc.272.48.30519; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Heo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020912; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lopez-Castejon G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035936; Lundequist A, 2011, CELL MOL LIFE SCI, V68, P965, DOI 10.1007/s00018-010-0587-0; MALAVIYA R, 1994, J IMMUNOL, V152, P1907; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Mccall-Culbreath KD, 2008, BLOOD, V111, P3562, DOI 10.1182/blood-2007-08-107664; McCall-Culbreath KD, 2011, J INNATE IMMUN, V3, P459, DOI 10.1159/000324832; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mirmonsef P, 1999, J IMMUNOL, V163, P2530; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nagasaka A, 2008, EUR J IMMUNOL, V38, P489, DOI 10.1002/eji.200737057; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Repp H, 2002, CELL MICROBIOL, V4, P483, DOI 10.1046/j.1462-5822.2002.00207.x; ROGERS HW, 1994, J IMMUNOL, V153, P2093; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Sandig H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00185; Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022; Tegoshi T, 2000, LAB INVEST, V80, P1571, DOI 10.1038/labinvest.3780167; Unanue ER, 1997, IMMUNOL REV, V158, P11, DOI 10.1111/j.1600-065X.1997.tb00988.x; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Westcott MM, 2007, CELL MICROBIOL, V9, P1397, DOI 10.1111/j.1462-5822.2006.00880.x; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Yamamoto K, 2005, CLIN EXP IMMUNOL, V142, P268, DOI 10.1111/j.1365-2249.2005.02922.x; YEE NS, 1994, J BIOL CHEM, V269, P31991; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869; Zhong MX, 2004, INFECT IMMUN, V72, P1057, DOI 10.1128/IAI.72.2.1057-1064.2004	54	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57102	10.1371/journal.pone.0057102	http://dx.doi.org/10.1371/journal.pone.0057102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460827	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000063
J	Isomura, N; Iwao, K; Fukami, H				Isomura, Naoko; Iwao, Kenji; Fukami, Hironobu			Possible Natural Hybridization of Two Morphologically Distinct Species of Acropora (Cnidaria, Scleractinia) in the Pacific: Fertilization and Larval Survival Rates	PLOS ONE			English	Article							MONTASTRAEA-ANNULARIS COMPLEX; CORAL GENUS ACROPORA; REPRODUCTIVE ISOLATION; RETICULATE EVOLUTION; BOUNDARIES; SETTLEMENT; MECHANISMS	Natural hybridization of corals in the Indo-Pacific has been considered rather rare. However, field studies have observed many corals with intermediate interspecific or unusual morphologies. Given that the existence of F1 hybrids with intermediate interspecific morphologies has been proven in the Caribbean, hybrids may also inhabit the Indo-Pacific and occur more frequently than expected. In this study, we focused on two morphologically different species, Acropora florida and A. intermedia, and performed crossing experiments at Akajima Island, Japan. Results showed that these species could hybridize in both directions via eggs and sperm, but that fertilization rates significantly differed according to which species provided eggs. These results are similar to those reported from the Caribbean. Although all embryos developed normally to the planular larval stage, the developmental processes of some hybrid embryos were delayed by approximately 1 h compared with conspecific embryos, suggesting that fertilization occurred 1 h later in interspecific crosses than in intraspecific crosses. More successful hybridization could occur under conditions with low numbers of conspecific colonies. Additionally, a comparison of survival rates between hybrid and intraspecific larvae revealed that intra- and interspecific larvae produced from eggs of A. florida survived for significantly longer than those produced from eggs of A. intermedia. Considering these data, under specific conditions, hybrids can be expected to be produced and survive in nature in the Pacific. Furthermore, we identified one colony with intermediate morphology between A. florida and A. intermedia in the field. This colony was fertilized only by eggs of A. florida, with high fertilization rates, suggesting that this colony would be a hybrid of these two species and might be backcrossed.	[Isomura, Naoko] Okinawa Natl Coll Technol, Dept Bioresources Engn, Nago City, Okinawa, Japan; [Iwao, Kenji] Akajima Marine Sci Lab, Zamamison, Okinawa, Japan; [Fukami, Hironobu] Miyazaki Univ, Fac Agr, Dept Marine Biol & Environm Sci, Miyazaki 88921, Japan	University of Miyazaki	Fukami, H (corresponding author), Miyazaki Univ, Fac Agr, Dept Marine Biol & Environm Sci, Miyazaki 88921, Japan.	hirofukami@cc.miyazaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [22370033, 20121002]; Grants-in-Aid for Scientific Research [20121002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (B) (Grant No. 22370033) to HF and Grant-in-Aid for Scientific Research on Innovative Areas "Coral reef science for symbiosis and coexistence of human and ecosystem under combined stresses'' (Grant No. 20121002) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan to NI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold ML, 2009, INT J MOL SCI, V10, P3836, DOI 10.3390/ijms10093836; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Cruz P, 1997, J EXP MAR BIOL ECOL, V212, P95, DOI 10.1016/S0022-0981(96)02742-6; Fogarty ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030486; Fujioka Y., 2002, GALAXEA JCRS, V4, P53, DOI DOI 10.3755/JCRS.2002.53; Fujioka Y., 1999, GALAXEA JCRS, V1, P41, DOI DOI 10.3755/jcrs.1999.41; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Fukami H, 2003, MAR BIOL, V142, P679, DOI 10.1007/s00227-002-1001-8; Gardner JPA, 1997, ADV MAR BIOL, V31, P1, DOI 10.1016/S0065-2881(08)60221-7; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; HAYASHIBARA T, 1993, MAR ECOL PROG SER, V101, P253, DOI 10.3354/meps101253; Isomura N, 2001, CORAL REEFS, V20, P309, DOI 10.1007/s003380100180; Isomura N, 2013, MAR BIOL RES, V9, P181, DOI 10.1080/17451000.2012.707321; Kenyon JC, 1997, EVOLUTION, V51, P756, DOI 10.1111/j.1558-5646.1997.tb03659.x; Knowlton N, 1997, MAR BIOL, V127, P705, DOI 10.1007/s002270050061; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Lopez JV, 1999, BIOL BULL-US, V196, P80, DOI 10.2307/1543170; Medina M, 1999, MAR BIOTECHNOL, V1, P89, DOI 10.1007/PL00011756; Miller DJ, 2003, MOL ECOL, V12, P805, DOI 10.1046/j.1365-294X.2003.01808.x; Miller K, 1997, BIOL BULL, V192, P98, DOI 10.2307/1542579; Morita M, 2006, J EXP BIOL, V209, P4574, DOI 10.1242/jeb.02500; Nishihira M., 1995, HERMATYPIC CORALS JA; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; Nozawa Y, 2008, MAR BIOL, V155, P347, DOI 10.1007/s00227-008-1034-8; Okubo N, 2007, ZOOL SCI, V24, P1169, DOI 10.2108/zsj.24.1169; Richards ZT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003240; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Scheer G., 1983, Zoologica (Stuttgart), P1; Sessa EB, 2012, MOL PHYLOGENET EVOL, V64, P563, DOI 10.1016/j.ympev.2012.05.009; Suzuki G, 2011, MAR ECOL PROG SER, V421, P131, DOI 10.3354/meps08896; Szmant AM, 1997, MAR BIOL, V129, P561, DOI 10.1007/s002270050197; Taniguchi H., 2012, Midoriishi, V23, P20; Taniguchi H, 2004, MIDORIISHI, P16; Taniguchi H, 1999, GALAXEA JCRS, V1, P59; Van Oppen MJH, 2000, MOL ECOL, V9, P1363, DOI 10.1046/j.1365-294x.2000.01010.x; Veron J, 1984, AUST I MAR SCI MONOG, V6, P485; Veron J. E., 2000, CORALS WORLD, V1; VERON JEN, 1995, CORALS SPACE TIME BI; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; WALLACE CC, 1994, ANNU REV ECOL SYST, V25, P237, DOI 10.1146/annurev.es.25.110194.001321; Wei NV, 2012, ZOOL STUD, V51, P85; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; Wolstenholme JK, 2004, MAR BIOL, V144, P567, DOI 10.1007/s00227-003-1209-2; Yamazato K, 1999, GALAXEA JCRS, V1999, P83, DOI DOI 10.3755/JCRS.1999.83	47	25	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56701	10.1371/journal.pone.0056701	http://dx.doi.org/10.1371/journal.pone.0056701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457605	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700091
J	Ali-Khan, SE; Ray, M; McMahon, DS; Thorsteinsdottir, H				Ali-Khan, Sarah E.; Ray, Monali; McMahon, Dominique S.; Thorsteinsdottir, Halla			Sino-Canadian Collaborations in Stem Cell Research: A Scientometric Analysis	PLOS ONE			English	Article							REGENERATIVE MEDICINE; INNOVATION; IMPACT	Background: International collaboration (IC) is essential for the advance of stem cell research, a field characterized by marked asymmetries in knowledge and capacity between nations. China is emerging as a global leader in the stem cell field. However, knowledge on the extent and characteristics of IC in stem cell science, particularly China's collaboration with developed economies, is lacking. Methods and Findings: We provide a scientometric analysis of the China-Canada collaboration in stem cell research, placing this in the context of other leading producers in the field. We analyze stem cell research published from 2006 to 2010 from the Scopus database, using co-authored papers as a proxy for collaboration. We examine IC levels, collaboration preferences, scientific impact, the collaborating institutions in China and Canada, areas of mutual interest, and funding sources. Our analysis shows rapid global expansion of the field with 48% increase in papers from 2006 to 2010. China now ranks second globally after the United States. China has the lowest IC rate of countries examined, while Canada has one of the highest. China-Canada collaboration is rising steadily, more than doubling during 2006-2010. China-Canada collaboration enhances impact compared to papers authored solely by China-based researchers This difference remained significant even when comparing only papers published in English. Conclusions: While China is increasingly courted in IC by developed countries as a partner in stem cell research, it is clear that it has reached its status in the field largely through domestic publications. Nevertheless, IC enhances the impact of stem cell research in China, and in the field in general. This study establishes an objective baseline for comparison with future studies, setting the stage for in-depth exploration of the dynamics and genesis of IC in stem cell research.	[Ali-Khan, Sarah E.; Thorsteinsdottir, Halla] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Ray, Monali] Univ Toronto, Mississauga Acad Med, Mississauga, ON L5L 1C6, Canada; [McMahon, Dominique S.] Univ Toronto, Munk Sch Global Affairs, Toronto, ON, Canada; [Thorsteinsdottir, Halla] Small Globe, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Mississauga; University of Toronto	Thorsteinsdottir, H (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	halla.thorsteins@utoronto.ca			Canadian Institutes of Health Research (CIHR); RMEthnet network [457569]; Dalla Lana School of Public Health, University of Toronto; McLaughlin-Rotman Centre for Global Health at the University Health Network; University of Toronto; CIHR New Investigator Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); RMEthnet network; Dalla Lana School of Public Health, University of Toronto; McLaughlin-Rotman Centre for Global Health at the University Health Network; University of Toronto(University of Toronto); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR))	This research was funded by a subgrant to HT from a Canadian Institutes of Health Research (CIHR-www.cihr-irsc.gc.ca) Net grant to the RMEthnet network led by Prof. Abdallah Daar (Fund number 457569). It was supported by the Dalla Lana School of Public Health, University of Toronto, as well as the McLaughlin-Rotman Centre for Global Health at the University Health Network and the University of Toronto. HT was supported by a CIHR New Investigator Award and finalized the paper while she was a Senior Visiting Scientist at the Institute of Policy and Management, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ECONOMIST; APCO, 2010, CHIN 12 5 YEAR PLAN; Bakkalbasi Nisa, 2006, Biomed Digit Libr, V3, P7, DOI 10.1186/1742-5581-3-7; Beaver DD, 2001, SCIENTOMETRICS, V52, P365, DOI 10.1023/A:1014254214337; Boekholt P., 2009, DRIVERS INT COLLABOR; Caulfield T, 2007, J OBSTET GYNAECOL CA, V29, P843, DOI 10.1016/S1701-2163(16)32632-9; Caulfield T, 2009, STEM CELL REV REP, V5, P82, DOI 10.1007/s12015-009-9071-3; Cookson C, 2005, FINANC TIMES, P17; Evans P, 2005, CANADA NATIONS 2005, V21, P150; Flynn JM, 2010, STEM CELL REV REP, V6, P143, DOI 10.1007/s12015-010-9133-6; FRAME JD, 1979, SOC STUD SCI, V9, P481; Glanzel W, 2001, SCIENTOMETRICS, V50, P199, DOI 10.1023/A:1010561321723; Glanzel W, 2008, SCIENTOMETRICS, V74, P71, DOI 10.1007/s11192-008-0104-5; Gorraiz J, 2012, SCIENTOMETRICS, V91, P417, DOI 10.1007/s11192-011-0579-3; Gunaha X, 2006, PUBL LECT 16 FEBR; Heinze T, 2008, RES POLICY, V37, P888, DOI 10.1016/j.respol.2008.01.009; Horvat M., 2008, REV SCI TECHNOLOGY C; Hsu JW, 2011, SCIENTOMETRICS, V86, P317, DOI 10.1007/s11192-010-0265-x; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Industry Canada, 2007, MOB SCI TECHN CAN AD; Kahler O, 2010, LEARN PUBL, V23, P336, DOI 10.1087/20100411; Katz JS, 1997, SCIENTOMETRICS, V40, P541, DOI 10.1007/BF02459299; Knoppers BM, 2010, REGEN MED, V5, P5, DOI 10.2217/RME.09.84; Lander B, 2008, CELL STEM CELL, V3, P11, DOI 10.1016/j.stem.2008.06.015; Lander B, 2011, SCI PUBL POLICY, V38, P767, DOI 10.1093/spp/38.10.767; Luo JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017684; LUUKKONEN T, 1993, SCIENTOMETRICS, V28, P15, DOI 10.1007/BF02016282; MaRS Advisory Services, 2009, REG MED IND BRIEF CO; McMahon Dominique S, 2011, Regen Med, V6, P163, DOI 10.2217/rme.11.67; McMahon DS, 2010, REGEN MED, V5, P863, DOI [10.2217/rme.10.76, 10.2217/RME.10.76]; McMahon DS, 2010, REGEN MED, V5, P35, DOI [10.2217/rme.09.78, 10.2217/RME.09.78]; Narin F., 1990, 12900 EUR; National Natural Science Foundation of China, 2011, GUID PROGR 2011 INT; National Science Board, 2018, SCI ENG IND; OECD, 2010, OECD SCI TECHN IND O; Persson O, 2010, SCIENTOMETRICS, V83, P397, DOI 10.1007/s11192-009-0007-0; Qiu S, 2010, CHINESE WORLD J DIGE, V18, P3905; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roberts G, 2012, INT PARTNERSHIPS RES; Salter B, 2006, REGEN MED, V1, P671, DOI 10.2217/17460751.1.5.671; Science-Metrix Noiseux M, 2004, POTENTIAL STEM CELLS; Seguin B, 2006, SCIENCE, V312, P1602, DOI 10.1126/science.1126325; Sipp D, 2011, NEURON, V70, P573, DOI 10.1016/j.neuron.2011.05.008; Sipp D, 2009, REGEN MED, V4, P911, DOI 10.2217/RME.09.60; Sipp D, 2009, J CELL BIOCHEM, V107, P853, DOI 10.1002/jcb.22160; Stem Cell Network, 2010, STEM CELL NETW ANN R; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Thorsteinsdottir H, 2012, S S COLLABORATION HL, P42; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Trounson A, 2012, STEM CELLS, V30, P357, DOI 10.1002/stem.1038; UKSCI, 2005, UK STEM CELL IN REP; *UNCTAD, 2005, WORLD INV REP 2005 T; UNESCO, 2010, UNESCO SCI REP 2010; Yuan WP, 2012, CELL STEM CELL, V10, P12, DOI 10.1016/j.stem.2011.12.002; Zheng J, 2012, SCIENTOMETRICS, V91, P65, DOI 10.1007/s11192-011-0529-0	57	6	6	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57176	10.1371/journal.pone.0057176	http://dx.doi.org/10.1371/journal.pone.0057176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	23468927	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900054
J	Ray, D; Shukla, S; Allam, US; Helman, A; Ramanand, SG; Tran, L; Bassetti, M; Krishnamurthy, PM; Rumschlag, M; Paulsen, M; Sun, L; Shanley, TP; Ljungman, M; Nyati, MK; Zhang, M; Lawrence, TS				Ray, Dipankar; Shukla, Shirish; Allam, Uday Sankar; Helman, Abigail; Ramanand, Susmita Gurjar; Linda Tran; Bassetti, Michael; Krishnamurthy, Pranathi Meda; Rumschlag, Matthew; Paulsen, Michelle; Sun, Lei; Shanley, Thomas P.; Ljungman, Mats; Nyati, Mukesh K.; Zhang, Ming; Lawrence, Theodore S.			Tristetraprolin Mediates Radiation-Induced TNF-alpha Production in Lung Macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-BETA; ACTIVATED PROTEIN-KINASE; MESSENGER-RNA DECAY; RHEUMATOID-ARTHRITIS; CANCER PATIENTS; FIBROSIS-PRONE; THERAPY; MICE; PNEUMONITIS	The efficacy of radiation therapy for lung cancer is limited by radiation-induced lung toxicity (RILT). Although tumor necrosis factor-alpha (TNF-alpha) signaling plays a critical role in RILT, the molecular regulators of radiation-induced TNF-alpha production remain unknown. We investigated the role of a major TNF-alpha regulator, Tristetraprolin (TTP), in radiation-induced TNFa production by macrophages. For in vitro studies we irradiated (4 Gy) either a mouse lung macrophage cell line, MH-S or macrophages isolated from TTP knockout mice, and studied the effects of radiation on TTP and TNF-alpha levels. To study the in vivo relevance, mouse lungs were irradiated with a single dose (15 Gy) and assessed at varying times for TTP alterations. Irradiation of MH-S cells caused TTP to undergo an inhibitory phosphorylation at Ser-178 and proteasome-mediated degradation, which resulted in increased TNF-alpha mRNA stabilization and secretion. Similarly, MH-S cells treated with TTP siRNA or macrophages isolated from ttp (2/2) mice had higher basal levels of TNF-alpha, which was increased minimally after irradiation. Conversely, cells overexpressing TTP mutants defective in undergoing phosphorylation released significantly lower levels of TNF-alpha. Inhibition of p38, a known kinase for TTP, by either siRNA or a small molecule inhibitor abrogated radiation-induced TNF-alpha release by MH-S cells. Lung irradiation induced TTP Ser178 phosphorylation and protein degradation and a simultaneous increase in TNF-alpha production in C57BL/6 mice starting 24 h post-radiation. In conclusion, irradiation of lung macrophages causes TTP inactivation via p38-mediated phosphorylation and proteasome-mediated degradation, leading to TNF-alpha production. These findings suggest that agents capable of blocking TTP phosphorylation or stabilizing TTP after irradiation could decrease RILT.	[Ray, Dipankar; Shukla, Shirish; Allam, Uday Sankar; Helman, Abigail; Ramanand, Susmita Gurjar; Linda Tran; Bassetti, Michael; Krishnamurthy, Pranathi Meda; Rumschlag, Matthew; Paulsen, Michelle; Ljungman, Mats; Nyati, Mukesh K.; Zhang, Ming; Lawrence, Theodore S.] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Sun, Lei; Shanley, Thomas P.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ray, D (corresponding author), Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA.	dipray@umich.edu	meda, Pranathi/J-7637-2019; Allam, Uday/HDN-4342-2022	Allam, Uday/0000-0003-4641-3903; Shanley, Thomas/0000-0001-8936-377X	National Cancer Institute [R01CA127477]; University of Michigan's Cancer Center Support Grant [5P30CA46592]; NATIONAL CANCER INSTITUTE [R01CA127477, R01CA160981, P30CA046592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885, T32ES007062] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Michigan's Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding I: National Cancer Institute, Grant# R01CA127477. Funding II: University of Michigan's Cancer Center Support Grant, Grant# 5P30CA46592. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Souhibani N, 2010, ONCOGENE, V29, P4205, DOI 10.1038/onc.2010.168; Andrisani G, 2012, EUR REV MED PHARMACO, V16, P890; Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101; Anscher MS, 1998, INT J RADIAT ONCOL, V41, P1029, DOI 10.1016/S0360-3016(98)00154-0; Anscher MS, 1997, INT J RADIAT ONCOL, V37, P253, DOI 10.1016/S0360-3016(96)00529-9; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Franko AJ, 1997, RADIAT RES, V147, P245, DOI 10.2307/3579426; Fu J, 2011, J PHARM EXP THER; GILLIES NE, 1987, BRIT MED J, V295, P1390, DOI 10.1136/bmj.295.6610.1390; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Inoue A, 2001, INT J RADIAT ONCOL, V49, P649, DOI 10.1016/S0360-3016(00)00783-5; Johnston CJ, 2002, RADIAT RES, V157, P256, DOI 10.1667/0033-7587(2002)157[0256:RIPFEO]2.0.CO;2; Killar L, 1999, ANN NY ACAD SCI, V878, P442, DOI 10.1111/j.1749-6632.1999.tb07701.x; Kong FM, 2005, SEMIN ONCOL, V32, pS42, DOI 10.1053/j.seminoncol.2005.03.009; Kouvaris JR, 2007, ONCOLOGIST, V12, P738, DOI 10.1634/theoncologist.12-6-738; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lee HH, 2010, INT J CANCER, V126, P1817, DOI 10.1002/ijc.24847; Manzanero S, 2012, METHODS MOL BIOL, V844, P177, DOI 10.1007/978-1-61779-527-5_12; Matsuno H, 2002, RHEUMATOLOGY, V41, P329, DOI 10.1093/rheumatology/41.3.329; Movsas B, 2005, J CLIN ONCOL, V23, P2145, DOI 10.1200/JCO.2005.07.167; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Pantelidis P, 2001, RESP RES, V2, P365, DOI 10.1186/rr87; Qiu LQ, 2012, J IMMUNOL, V188, P5150, DOI 10.4049/jimmunol.1103700; Ray D, 2011, NEOPLASIA, V13, P570, DOI 10.1593/neo.11632; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rube CE, 2004, STRAHLENTHER ONKOL, V180, P541, DOI 10.1007/s00066-004-1279-1; Rube CE, 2000, INT J RADIAT ONCOL, V47, P1033, DOI 10.1016/S0360-3016(00)00482-X; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Schindler JF, 2007, J DENT RES, V86, P800, DOI 10.1177/154405910708600902; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; Tobin AM, 2005, BIODRUGS, V19, P47, DOI 10.2165/00063030-200519010-00006; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Treggiari MM, 2004, CRIT CARE MED, V32, P327, DOI 10.1097/01.CCM.0000108870.09693.42; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Vujaskovic Z, 2000, SEMIN RADIAT ONCOL, V10, P296, DOI 10.1053/srao.2000.9424; Wang PY, 1996, J INFLAMM, V47, P126; Werner-Wasik M, 2005, SEMIN ONCOL, V32, pS105, DOI 10.1053/j.seminoncol.2005.03.018; Xie JL, 2007, J PLAST RECONSTR AES, V60, P983, DOI 10.1016/j.bjps.2005.12.062; Yanik G, 2002, BIOL BLOOD MARROW TR, V8, P395, DOI 10.1053/bbmt.2002.v8.pm12171486; Yoshino S, 2000, IMMUNOLOGY, V99, P607, DOI 10.1046/j.1365-2567.2000.00015.x; Zhang M, 2008, CLIN CANCER RES, V14, P1868, DOI 10.1158/1078-0432.CCR-07-1894	53	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57290	10.1371/journal.pone.0057290	http://dx.doi.org/10.1371/journal.pone.0057290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468959	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900068
J	Wibral, M; Pampu, N; Priesemann, V; Siebenhuhner, F; Seiwert, H; Lindner, M; Lizier, JT; Vicente, R				Wibral, Michael; Pampu, Nicolae; Priesemann, Viola; Siebenhuehner, Felix; Seiwert, Hannes; Lindner, Michael; Lizier, Joseph T.; Vicente, Raul			Measuring Information-Transfer Delays	PLOS ONE			English	Article							CAUSALITY	In complex networks such as gene networks, traffic systems or brain circuits it is important to understand how long it takes for the different parts of the network to effectively influence one another. In the brain, for example, axonal delays between brain areas can amount to several tens of milliseconds, adding an intrinsic component to any timing-based processing of information. Inferring neural interaction delays is thus needed to interpret the information transfer revealed by any analysis of directed interactions across brain structures. However, a robust estimation of interaction delays from neural activity faces several challenges if modeling assumptions on interaction mechanisms are wrong or cannot be made. Here, we propose a robust estimator for neuronal interaction delays rooted in an information-theoretic framework, which allows a model-free exploration of interactions. In particular, we extend transfer entropy to account for delayed source-target interactions, while crucially retaining the conditioning on the embedded target state at the immediately previous time step. We prove that this particular extension is indeed guaranteed to identify interaction delays between two coupled systems and is the only relevant option in keeping with Wiener's principle of causality. We demonstrate the performance of our approach in detecting interaction delays on finite data by numerical simulations of stochastic and deterministic processes, as well as on local field potential recordings. We also show the ability of the extended transfer entropy to detect the presence of multiple delays, as well as feedback loops. While evaluated on neuroscience data, we expect the estimator to be useful in other fields dealing with network dynamics.	[Wibral, Michael; Siebenhuehner, Felix; Seiwert, Hannes; Vicente, Raul] Goethe Univ Frankfurt, MEG Unit, Brain Imaging Ctr, D-60054 Frankfurt, Germany; [Pampu, Nicolae] Ctr Cognit & Neural Studies Coneural, Cluj Napoca, Romania; [Priesemann, Viola; Vicente, Raul] Goethe Univ Frankfurt, FIAS, D-60054 Frankfurt, Germany; [Siebenhuehner, Felix] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Lindner, Michael] Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany; [Lizier, Joseph T.] Max Planck Inst Math Sci, Leipzig, Germany; [Lizier, Joseph T.] CSIRO Informat & Commun Technol Ctr, Marsfield, NSW, Australia; [Vicente, Raul] Max Planck Inst Brain Res, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; University of California System; University of California Santa Barbara; University of Bonn; Max Planck Society; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Max Planck Society	Wibral, M (corresponding author), Goethe Univ Frankfurt, MEG Unit, Brain Imaging Ctr, D-60054 Frankfurt, Germany.	wibral@em.uni-frankfurt.de	Siebenhühner, Felix/A-4788-2019; Lizier, Joseph/B-8093-2008; Vicente, Raul/E-1566-2011; Priesemann, Viola/R-3042-2017; Siebenhühner, Felix/V-2935-2019; Wibral, Michael/H-5255-2019	Siebenhühner, Felix/0000-0002-2621-9145; Lizier, Joseph/0000-0002-9910-8972; Vicente, Raul/0000-0002-2497-0007; Priesemann, Viola/0000-0001-8905-5873; Siebenhühner, Felix/0000-0002-2621-9145; Wibral, Michael/0000-0001-8010-5862	LOEWE Grant "Neuronale Koordination Forschungsschwerpunkt Frankfurt(NeFF)"; Max Planck Society; Max Planck Institute for Mathematics in the Sciences	LOEWE Grant "Neuronale Koordination Forschungsschwerpunkt Frankfurt(NeFF)"; Max Planck Society(Max Planck Society); Max Planck Institute for Mathematics in the Sciences(Max Planck Society)	MW, RV, and VP received financial support from LOEWE Grant "Neuronale Koordination Forschungsschwerpunkt Frankfurt(NeFF)." VP received financial support from the Max Planck Society. MW thanks the Max Planck Institute for Mathematics in the Sciences for funding a visit which contributed to this work. JL thanks the LOEWE Grant "Neuronale Koordination Forschungsschwerpunkt Frankfurt(NeFF)" for funding a visit which contributed to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amblard PO, 2011, J COMPUT NEUROSCI, V30, P7, DOI 10.1007/s10827-010-0231-x; Ay N, 2008, ADV COMPLEX SYST, V11, P17, DOI 10.1142/S0219525908001465; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Besserve M, 2010, J COMPUT NEUROSCI, V29, P547, DOI 10.1007/s10827-010-0236-5; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buehlmann A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000934; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Chicharro D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032466; Csorgo M., 1998, LIMIT THEOREMS CHANG; Faes L, 2006, MED BIOL ENG COMPUT, V44, P383, DOI 10.1007/s11517-006-0043-3; Faes L, 2012, COMPUT BIOL MED, V42, P290, DOI 10.1016/j.compbiomed.2011.02.007; Faes L, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051112; Felts PA, 1997, J NEUROSCI, V17, P7267; Freiwald WA, 1999, J NEUROSCI METH, V94, P105, DOI 10.1016/S0165-0270(99)00129-6; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gomez-Herrero G., 2010, ARXIV10080539; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; Hadjipapas A, 2005, CLIN NEUROPHYSIOL, V116, P1300, DOI 10.1016/j.clinph.2005.01.014; Hahs DW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.128701; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Kantz H., 2003, NONLINEAR TIME SERIE; Kozachenko L, 1987, PROBL INFORM TRANSM, V23, P95; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Leistritz L, 2006, BIOMED TECH, V51, P64, DOI 10.1515/BMT.2006.012; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Lizier J., 2012, 252012 M PLANCK I MA; Lizier JT, 2010, EUR PHYS J B, V73, P605, DOI 10.1140/epjb/e2010-00034-5; Lizier JT, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026110; Lizier JT, 2012, INFORM SCIENCES, V208, P39, DOI 10.1016/j.ins.2012.04.016; Lizier JT, 2011, J COMPUT NEUROSCI, V30, P85, DOI 10.1007/s10827-010-0271-2; Lizier JT, 2010, CHAOS, V20, DOI 10.1063/1.3486801; LIZIER JT, 2012, JIDT INFORM THEORETI; Ludtke N, 2010, MAGN RESON IMAGING, V28, P1113, DOI 10.1016/j.mri.2010.03.028; MARIMONT RB, 1979, J I MATH APPL, V24, P59; Neymotin SA, 2011, J COMPUT NEUROSCI, V30, P69, DOI 10.1007/s10827-010-0253-4; Nichols JM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046217; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; Overbey LA, 2009, J SOUND VIB, V322, P438, DOI 10.1016/j.jsv.2008.11.025; Palus M, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.046211; Pecora L, 1996, BUILDING BRIDGE NATU, P49; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pompe B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051122; Ragwitz M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056201; ROSENBERG AF, 1990, J NEUROPHYSIOL, V63, P1033, DOI 10.1152/jn.1990.63.5.1033; Sabesan S, 2009, IEEE T NEUR SYS REH, V17, P244, DOI 10.1109/TNSRE.2009.2023291; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Soriano MC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.134101; Staniek M, 2009, BIOMED TECH, V54, P323, DOI 10.1515/BMT.2009.040; Sun LM, 2012, J NEUROSCI, V32, P9563, DOI 10.1523/JNEUROSCI.1073-12.2012; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Terry JR, 2003, BIOL CYBERN, V88, P129, DOI 10.1007/s00422-002-0368-4; Turi G, 2012, NEUROIMAGE, V59, P2607, DOI 10.1016/j.neuroimage.2011.08.078; Vakorin VA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00096; Vakorin VA, 2010, NEUROIMAGE, V49, P1593, DOI 10.1016/j.neuroimage.2009.08.027; Vakorin VA, 2009, J NEUROSCI METH, V184, P152, DOI 10.1016/j.jneumeth.2009.07.014; VANDERLO.H, 1972, BRAIN RES, V48, P355, DOI 10.1016/0006-8993(72)90189-8; Victor J, 2005, PHYS REV E, V72; Voss HU, 2000, PHYS REV E, V61, P5115, DOI 10.1103/PhysRevE.61.5115; Whitford TJ, 2012, SCHIZOPHRENIA BULL, V38, P486, DOI 10.1093/schbul/sbq105; Wibral M, 2008, INT J PSYCHOPHYSIOL, V67, P200, DOI 10.1016/j.ijpsycho.2007.06.009; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006	64	163	164	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e55809	10.1371/journal.pone.0055809	http://dx.doi.org/10.1371/journal.pone.0055809			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468850	Green Submitted, gold, Green Published			2022-12-27	WOS:000315524900014
J	Kashani-Sabet, M; Sagebiel, RW; Joensuu, H; Miller, JR				Kashani-Sabet, Mohammed; Sagebiel, Richard W.; Joensuu, Heikki; Miller, James R., III			A Patient-Centered Methodology That Improves the Accuracy of Prognostic Predictions in Cancer	PLOS ONE			English	Article							PRIMARY CUTANEOUS MELANOMA; AMERICAN JOINT COMMITTEE; DOSE INTERFERON-ALPHA-2B; CARDIOVASCULAR RISK; BREAST-CANCER; ROC CURVE; RECLASSIFICATION; MARKER; STATISTICS; VALIDATION	Individualized approaches to prognosis are crucial to effective management of cancer patients. We developed a methodology to assign individualized 5-year disease-specific death probabilities to 1,222 patients with melanoma and to 1,225 patients with breast cancer. For each cancer, three risk subgroups were identified by stratifying patients according to initial stage, and prediction probabilities were generated based on the factors most closely related to 5-year disease-specific death. Separate subgroup probabilities were merged to form a single composite index, and its predictive efficacy was assessed by several measures, including the area (AUC) under its receiver operating characteristic (ROC) curve. The patient-centered methodology achieved an AUC of 0.867 in the prediction of 5-year disease-specific death, compared with 0.787 using the AJCC staging classification alone. When applied to breast cancer patients, it achieved an AUC of 0.907, compared with 0.802 using the AJCC staging classification alone. A prognostic algorithm produced from a randomly selected training subsample of 800 melanoma patients preserved 92.5% of its prognostic efficacy (as measured by AUC) when the same algorithm was applied to a validation subsample containing the remaining patients. Finally, the tailored prognostic approach enhanced the identification of high-risk candidates for adjuvant therapy in melanoma. These results describe a novel patient-centered prognostic methodology with improved predictive efficacy when compared with AJCC stage alone in two distinct malignancies drawn from two separate populations.	[Kashani-Sabet, Mohammed; Sagebiel, Richard W.; Miller, James R., III] Calif Pacific Med Ctr & Res Inst, Ctr Melanoma Res & Treatment, San Francisco, CA USA; [Joensuu, Heikki] Univ Helsinki, Mol Canc Biol Program, Helsinki, Finland	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Helsinki	Kashani-Sabet, M (corresponding author), Calif Pacific Med Ctr & Res Inst, Ctr Melanoma Res & Treatment, San Francisco, CA USA.	kashani@cpmcri.org		Joensuu, Heikki/0000-0003-0281-2507	United States Public Health Service [CA114337, CA122947]; NATIONAL CANCER INSTITUTE [R01CA122947, R01CA114337] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States Public Health Service Grants CA114337 and CA122947 (to M. K. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Cochran AJ, 2000, HUM PATHOL, V31, P327, DOI 10.1016/S0046-8177(00)80246-4; Conway C, 2009, CLIN CANCER RES, V15, P6939, DOI 10.1158/1078-0432.CCR-09-1631; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; JOENSUU H, 1995, J CLIN ONCOL, V13, P62, DOI 10.1200/JCO.1995.13.1.62; Kashani-Sabet M, 2004, J CLIN ONCOL, V22, P617, DOI 10.1200/JCO.2004.06.047; Kashani-Sabet M, 2002, J CLIN ONCOL, V20, P1826, DOI 10.1200/JCO.2002.07.082; Kashani-Sabet M, 2001, ARCH DERMATOL, V137, P1169; Kashani-Sabet M, 2009, CLIN CANCER RES, V15, P6987, DOI 10.1158/1078-0432.CCR-09-1777; Kashani-Sabet M, 2009, P NATL ACAD SCI USA, V106, P6268, DOI 10.1073/pnas.0901185106; Kirkwood JM, 2000, J CLIN ONCOL, V18, P2444, DOI 10.1200/JCO.2000.18.12.2444; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Kirkwood JM, 2001, J CLIN ONCOL, V19, P2370, DOI 10.1200/JCO.2001.19.9.2370; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2008, STAT MED, V27, P173, DOI 10.1002/sim.2991; Rangel J, 2006, J CLIN ONCOL, V24, P4565, DOI 10.1200/JCO.2006.07.3833; Rothberg BEG, 2009, J CLIN ONCOL, V27, P5772, DOI 10.1200/JCO.2009.22.8239; Soong SJ, 2010, ANN SURG ONCOL, V17, P2006, DOI 10.1245/s10434-010-1050-z; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Zettersten E, 2003, SURG CLIN N AM, V83, P61, DOI 10.1016/S0039-6109(02)00094-4	25	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56435	10.1371/journal.pone.0056435	http://dx.doi.org/10.1371/journal.pone.0056435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460802	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000025
J	Van Sickle, D; Magzamen, S; Truelove, S; Morrison, T				Van Sickle, David; Magzamen, Sheryl; Truelove, Shaun; Morrison, Teresa			Remote Monitoring of Inhaled Bronchodilator Use and Weekly Feedback about Asthma Management: An Open-Group, Short-Term Pilot Study of the Impact on Asthma Control	PLOS ONE			English	Article							CHILDHOOD ASTHMA; TRIAL	Objective: Adequate symptom control is a problem for many people with asthma. We asked whether weekly email reports on monitored use of inhaled, short-acting bronchodilators might improve scores on composite asthma-control measures. Methods: Through an investigational electronic medication sensor attached to each participant's inhaler, we monitored 4 months' use of inhaled, short-acting bronchodilators. Participants completed surveys, including the Asthma Control Test (TM) (ACT), to assess asthma control at entry and monthly thereafter. After the first month, participants received weekly email reports for 3 months. The reports summarized inhaled bronchodilator use during the preceding week and provided suggestions derived from National Asthma Education and Prevention Program (NAEPP) guidelines. Paired t-tests and random-effects mixed models were implemented to assess changes in primary asthma endpoints. Results: Thirty individuals participated in the 4-month study; 29 provided complete asthma control information. Mean age was 36.8 years (range: 19-74 years); 52% of respondents were female. Mean ACT scores were 17.6 (Standard Deviation [SD] = 3.35) at entry and 18.4 (SD = 3.60) at completion of the first month. No significant difference appeared between ACT values at entry and completion of the first month (p = 0.66); however, after participants began receiving email reports and online information about their inhaler use, mean ACT scores increased 1.40 points (95% CI: 0.61, 2.18) for each subsequent study month. Significant decreases occurred in 2-week histories of daytime symptoms (beta = -1.35, 95% CI: -2.65, -0.04) and nighttime symptoms (beta = -0.84, 95% CI: -1.25, -0.44); no significant change in activity limitation (beta = -0.21, 95% CI: -0.69, 0.26) was observed. Participants reported increased awareness and understanding of asthma patterns, level of control, bronchodilator use (timing, location) and triggers, and improved preventive practices. Conclusions: Weekly email reports and access to online charts summarizing remote monitoring of inhaled bronchodilator frequency and location were associated with improved asthma control and a decline in day-to-day asthma symptoms.	[Van Sickle, David; Magzamen, Sheryl; Truelove, Shaun] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Morrison, Teresa] Ctr Dis Control & Prevent, Air Pollut & Resp Hlth Branch, Natl Ctr Environm Hlth, Atlanta, GA USA	University of Wisconsin System; University of Wisconsin Madison; Centers for Disease Control & Prevention - USA	Van Sickle, D (corresponding author), Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA.	dvansickle@gmail.com	Truelove, Shaun/D-4187-2018	Truelove, Shaun/0000-0003-0538-0607	Robert Wood Johnson Foundation Health and Society Scholars Program; US Centers for Disease Control and Prevention	Robert Wood Johnson Foundation Health and Society Scholars Program(Robert Wood Johnson Foundation (RWJF)); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The project was supported by the Robert Wood Johnson Foundation Health and Society Scholars Program (http://www.healthandsocietyscholars.org) and the US Centers for Disease Control and Prevention (http://cdc.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKINBAMI LJ, 2011, NATL HLTH STAT REPOR, V12, P1; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Bell B. A., 2010, P ANN SAS GLOB FOR; Chapman KR, 2008, EUR RESPIR J, V31, P320, DOI 10.1183/09031936.00039707; Clark NM, 1999, ENVIRON HEALTH PERSP, V107, P421, DOI 10.1289/ehp.99107s3421; Global Initiative for Asthma, 2006, GLOB STRAT ASTHM MAN; Jan RL, 2007, TELEMED J E-HEALTH, V13, P257, DOI 10.1089/tmj.2006.0053; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; National Asthma Education and Prevention Program, 2007, GUID DIAGN MAN ASTHM; Rasmussen LM, 2005, J ALLERGY CLIN IMMUN, V115, P1137, DOI 10.1016/j.jaci.2005.03.030; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Ryan Dermot, 2009, Prim Care Respir J, V18, P343, DOI 10.4104/pcrj.2009.00064; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; van der Meer V, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-74; van der Meer V, 2009, ANN INTERN MED, V151, P110, DOI 10.7326/0003-4819-151-2-200907210-00008	16	38	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55335	10.1371/journal.pone.0055335	http://dx.doi.org/10.1371/journal.pone.0055335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460785	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000008
J	Yu, Q; Shen, XH; Li, Y; Li, RJ; Li, J; Luo, YY; Liu, SF; Deng, MY; Pei, MF; Zhang, GS				Yu, Qian; Shen, Xiao-hui; Li, Ying; Li, Rui-juan; Li, Ji; Luo, Yun-ya; Liu, Su-fang; Deng, Ming-yang; Pei, Min-fei; Zhang, Guang-sen			An Intron Mutation in the ACVRL1 May Be Associated with a Transcriptional Regulation Defect in a Chinese Family with Hereditary Hemorrhagic Telangiectasia	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; GENETIC-HETEROGENEITY; JUVENILE POLYPOSIS; KINASE GENE; ENDOGLIN; LOCUS; EXPRESSION; TYPE-2; MAPS; PHENOTYPES	Purpose: To identify a novel pathogenic gene mutation present in a Chinese family with hereditary hemorrhagic telangiectasia (HHT) and to determine if an intron mutation may influence the transcriptional activity of the ACVRL1 gene. Methods: HHT family members were ascertained following the presentation of proband and involved subjects. All family members (n = 5) and 113 healthy individuals were genotyped for the variant in intron 6 c.772+27G>C of ACVRL1 gene. The genomic structure of ACVRL1 in affected HHT patients and healthy individuals was determined by long range PCR and sequencing. The expression of ACVRL1 mRNA and protein in patients with HHT was evaluated using real-time polymerase chain reaction and immunoblot analysis. Luciferase activity assay and electrophoretic mobility shift assay (EMSA) were performed to uncover the mechanism of intron-related transcriptional regulation. Results: Only one novel mutation in intron 6 (c.772+27G>C) of ACVRL1 gene, no other mutation, abnormal splice, gross genomic deletion or rearrangement was found in this HHT2 family. Compared with healthy individuals, ACVRL1 mRNA and protein were significantly decreased in affected HHT2 individuals. Luciferase activity assay demonstrated that the transcriptional activity of the mutated ACVRL1 was significantly lower than that of the wild-type of intron 6; EMSA results showed that intron 6 c.772+27G>C mutation was able to inhibit the binding of transcriptional factor Sp1. Conclusions: A novel intron mutation in ACVRL1 gene is associated with familial HHT2. The mechanisms may be involved in the down-regulation of ACVRL1 gene transcription.	[Yu, Qian; Shen, Xiao-hui; Li, Ying; Li, Rui-juan; Li, Ji; Luo, Yun-ya; Liu, Su-fang; Deng, Ming-yang; Pei, Min-fei; Zhang, Guang-sen] Cent S Univ, Xiang Ya Hosp 2, Inst Mol Hematol, Div Hematol, Changsha, Hunan, Peoples R China	Central South University	Zhang, GS (corresponding author), Cent S Univ, Xiang Ya Hosp 2, Inst Mol Hematol, Div Hematol, Changsha, Hunan, Peoples R China.	zgsllzy@163.com			Ministry of Health [2008-02031]; Scientific Research Program for Public Interests from The Health Ministry of China [201202017]; Health Ministry of China	Ministry of Health; Scientific Research Program for Public Interests from The Health Ministry of China; Health Ministry of China	This study was supported in part by public welfare and special-purpose fund (No: 2008-02031) from Ministry of Health; Scientific Research Program for Public Interests from The Health Ministry of China (No: 201202017), and Clinical Research Program from Health Ministry of China (key project 2011-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; Abdalla SA, 2003, J MED GENET, V40, P494, DOI 10.1136/jmg.40.7.494; Abdalla SA, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9312; Berg J, 2003, J MED GENET, V40, P585, DOI 10.1136/jmg.40.8.585; Berg JN, 1997, AM J HUM GENET, V61, P60, DOI 10.1086/513903; Berg JN, 1996, J MED GENET, V33, P256, DOI 10.1136/jmg.33.3.256; Cole SG, 2005, J MED GENET, V42, P577, DOI 10.1136/jmg.2004.028712; Cunnion KM, 2003, INFECT IMMUN, V71, P1321, DOI 10.1128/IAI.71.3.1321-1327.2003; Cymerman U, 2003, HUM MUTAT, V21, P482, DOI 10.1002/humu.10203; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Gallione CJ, 2006, J MED GENET, V43, P793, DOI 10.1136/jmg.2006.041517; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Garrido-Martin EM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-51; HAMANN L, 1994, MOL CELL BIOL, V14, P5786, DOI 10.1128/MCB.14.9.5786; HENKEL G, 1994, P NATL ACAD SCI USA, V91, P7737, DOI 10.1073/pnas.91.16.7737; HEUTINK P, 1994, J MED GENET, V31, P933, DOI 10.1136/jmg.31.12.933; Jiang LL, 2004, AM J PHYSIOL-GASTR L, V286, P922; Jo EK, 2001, J IMMUNOL, V167, P4038, DOI 10.4049/jimmunol.167.7.4038; JOHNSON DW, 1995, GENOME RES, V5, P21, DOI 10.1101/gr.5.1.21; Kuehl HKA, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9311; LASTRES P, 1992, EUR J IMMUNOL, V22, P393, DOI 10.1002/eji.1830220216; Letteboer TGW, 2005, HUM GENET, V116, P8, DOI 10.1007/s00439-004-1196-5; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MCALLISTER KA, 1994, J MED GENET, V31, P927, DOI 10.1136/jmg.31.12.927; McDonald J, 2009, J MOL DIAGN, V11, P569, DOI 10.2353/jmoldx.2009.080148; MCDONALD MT, 1994, NAT GENET, V6, P197, DOI 10.1038/ng0294-197; Olivieri C, 2007, J HUM GENET, V52, P820, DOI 10.1007/s10038-007-0187-5; PORTEOUS MEM, 1994, J MED GENET, V31, P925, DOI 10.1136/jmg.31.12.925; Pyatt RE, 2006, J MOL DIAGN, V8, P84, DOI 10.2353/jmoldx.2006.050072; ROTHENEDER H, 1991, NUCLEIC ACIDS RES, V19, P6805, DOI 10.1093/nar/19.24.6805; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Sanz-Rodriguez F, 2004, CLIN CHEM, V50, P2003, DOI 10.1373/clinchem.2004.035287; Schulte Claudia, 2005, Hum Mutat, V25, P595, DOI 10.1002/humu.9345; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; WAKABAYASHIITO N, 1994, J BIOL CHEM, V269, P29831; Yan K, 2008, GASTROINTEST ENDOSC, V18, P415; Zhang GS, 2004, CHINESE MED J-PEKING, V117, P808	38	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58031	10.1371/journal.pone.0058031	http://dx.doi.org/10.1371/journal.pone.0058031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460919	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000174
J	Cheng, T; Roth, B; Choi, W; Black, PC; Dinney, C; McConkey, DJ				Cheng, Tiewei; Roth, Beat; Choi, Woonyoung; Black, Peter C.; Dinney, Colin; McConkey, David J.			Fibroblast Growth Factor Receptors-1 and-3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting	PLOS ONE			English	Article							CELL-CARCINOMA; FGFR3; EXPRESSION; MUTATION; INHIBITOR; SENSITIVITY	Fibroblast growth factor receptors (FGFRs) are activated by mutation and overexpressed in bladder cancers (BCs), and FGFR inhibitors are currently being evaluated in clinical trials in BC patients. However, BC cells display marked heterogeneity in their responses to FGFR inhibitors, and the biological mechanisms underlying this heterogeneity are not well defined. Here we used a novel inhibitor of FGFRs 1-3 and RNAi to determine the effects of inhibiting FGFR1 or FGFR3 in a panel of human BC cell lines. We observed that FGFR1 was expressed in BC cells that also expressed the "mesenchymal" markers ZEB1 and vimentin, whereas FGFR3 expression was restricted to the E-cadherin- and p63-positive "epithelial" subset. Sensitivity to the growth-inhibitory effects of BGJ-398 was also restricted to the "epithelial" BC cells and it correlated directly with FGFR3 mRNA levels but not with the presence of activating FGFR3 mutations. In contrast, BGJ-398 did not strongly inhibit proliferation but did block invasion in the "mesenchymal" BC cells in vitro. Similarly, BGJ-398 did not inhibit primary tumor growth but blocked the production of circulating tumor cells (CTCs) and the formation of lymph node and distant metastases in mice bearing orthotopically implanted "mesenchymal" UM-UC3 cells. Together, our data demonstrate that FGFR1 and FGFR3 have largely non-overlapping roles in regulating invasion/metastasis and proliferation in distinct "mesenchymal" and "epithelial" subsets of human BC cells. The results suggest that the tumor EMT phenotype will be an important determinant of the biological effects of FGFR inhibitors in patients.	[Cheng, Tiewei; Roth, Beat; Choi, Woonyoung; Dinney, Colin; McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Cheng, Tiewei; Choi, Woonyoung; Dinney, Colin; McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Cheng, Tiewei; McConkey, David J.] Univ Texas Houston, Grad Sch Biomed Sci, Expt Therapeut Acad Program, Houston, TX USA; [Black, Peter C.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of British Columbia	McConkey, DJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA.	dmcconke@mdanderson.org	Black, Peter/AAE-8424-2020	Black, Peter/0000-0002-2919-7068; Dinney, Colin/0000-0002-8969-711X	MD Anderson Bladder SPORE [P50 CA91846]; MD Anderson CCSG [P30 016672]; NATIONAL CANCER INSTITUTE [P50CA091846, P30CA016672] Funding Source: NIH RePORTER	MD Anderson Bladder SPORE; MD Anderson CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by MD Anderson Bladder SPORE (P50 CA91846), The Baker Foundation, and the MD Anderson CCSG (P30 016672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard-Pierrot I, 2006, CARCINOGENESIS, V27, P740, DOI 10.1093/carcin/bgi290; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Black PC, 2008, CLIN CANCER RES, V14, P1478, DOI 10.1158/1078-0432.CCR-07-1593; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Choi W, 2012, PLOS ONE, V7, P453, DOI 10.1371/journal.pone.0030206; di Martino E, 2009, ONCOGENE, V28, P4306, DOI 10.1038/onc.2009.280; DINNEY CPN, 1995, J UROLOGY, V154, P1532, DOI 10.1016/S0022-5347(01)66923-4; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gozgit JM, 2012, MOL CANCER THER, V11, P690, DOI 10.1158/1535-7163.MCT-11-0450; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Hoff J, 2000, LAB ANIMAL, V29, P47; Knowles MA, 2007, WORLD J UROL, V25, P581, DOI 10.1007/s00345-007-0213-4; Knowles MA, 2008, FUTURE ONCOL, V4, P71, DOI 10.2217/14796694.4.1.71; Lamont FR, 2012, BRIT J CANCER, V104, P75; Lu C, 2007, CLIN CANCER RES, V13, P4209, DOI 10.1158/1078-0432.ccr-07-0197; Marquis L, 2012, CANCER BIOL THER, V13, P477, DOI 10.4161/cbt.19590; Miyake M, 2010, J PHARMACOL EXP THER, V332, P795, DOI 10.1124/jpet.109.162768; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qing J, 2009, J CLIN INVEST, V119, P1216, DOI 10.1172/JCI38017; Shah JB, 2011, CLIN CANCER RES, V17, P2608, DOI 10.1158/1078-0432.CCR-10-2770; Shrader M, 2007, MOL CANCER THER, V6, P277, DOI 10.1158/1535-7163.MCT-06-0513; Sibley K, 2001, ONCOGENE, V20, P4416, DOI 10.1038/sj.onc.1204543; Sibley K, 2001, ONCOGENE, V20, P686, DOI 10.1038/sj.onc.1204110; Tomlinson D, 2007, ONCOGENE, V26, P5889, DOI 10.1038/sj.onc.1210399; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Tomlinson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038972; Tomlinson DC, 2009, CANCER RES, V69, P4613, DOI 10.1158/0008-5472.CAN-08-2816; van Rhijn BWG, 2001, CANCER RES, V61, P1265; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345	30	53	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57284	10.1371/journal.pone.0057284	http://dx.doi.org/10.1371/journal.pone.0057284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468956	Green Submitted, Green Published, gold			2022-12-27	WOS:000315561400035
J	Jafari, Y; Peeling, RW; Shivkumar, S; Claessens, C; Joseph, L; Pai, NP				Jafari, Yalda; Peeling, Rosanna W.; Shivkumar, Sushmita; Claessens, Christiane; Joseph, Lawrence; Pai, Nitika Pant			Are Treponema pallidum Specific Rapid and Point-of-Care Tests for Syphilis Accurate Enough for Screening in Resource Limited Settings? Evidence from a Meta-Analysis	PLOS ONE			English	Article							CONGENITAL-SYPHILIS; DIAGNOSTIC-TESTS; ANTIBODIES	Background: Rapid and point-of-care (POC) tests for syphilis are an invaluable screening tool, yet inadequate evaluation of their diagnostic accuracy against best reference standards limits their widespread global uptake. To fill this gap, a systematic review and meta-analysis was conducted to evaluate the sensitivity and specificity of rapid and POC tests in blood and serum samples against Treponema pallidum (TP) specific reference standards. Methods: Five electronic databases (1980-2012) were searched, data was extracted from 33 articles, and Bayesian hierarchical models were fit. Results: In serum samples, against a TP specific reference standard point estimates with 95% credible intervals (CrI) for the sensitivities of popular tests were: i) Determine, 90.04% (80.45, 95.21), ii) SD Bioline, 87.06% (75.67, 94.50), iii) VisiTect, 85.13% (72.83, 92.57), and iv) Syphicheck, 74.48% (56.85, 88.44), while specificities were: i) Syphicheck, 99.14% (96.37, 100), ii) Visitect, 96.45% (91.92, 99.29), iii) SD Bioline, 95.85% (89.89, 99.53), and iv) Determine, 94.15% (89.26, 97.66). In whole blood samples, sensitivities were: i) Determine, 86.32% (77.26, 91.70), ii) SD Bioline, 84.50% (78.81, 92.61), iii) Syphicheck, 74.47% (63.94, 82.13), and iv) VisiTect, 74.26% (53.62, 83.68), while specificities were: i) Syphicheck, 99.58% (98.91, 99.96), ii) VisiTect, 99.43% (98.22, 99.98), iii) SD Bioline, 97.95% (92.54, 99.33), and iv) Determine, 95.85% (92.42, 97.74). Conclusions: Rapid and POC treponemal tests reported sensitivity and specificity estimates comparable to laboratory-based treponemal tests. In resource limited settings, where access to screening is limited and where risk of patients lost to follow up is high, the introduction of these tests has already been shown to improve access to screening and treatment to prevent stillbirths and neonatal mortality due to congenital syphilis. Based on the evidence, it is concluded that rapid and POC tests are useful in resource limited settings with poor access to laboratories or screening for syphilis.	[Jafari, Yalda; Shivkumar, Sushmita; Joseph, Lawrence] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Peeling, Rosanna W.] London Sch Hyg & Trop Med, London WC1, England; [Claessens, Christiane] Inst Natl Sante Publ INSPQ, Montreal, PQ, Canada; [Joseph, Lawrence; Pai, Nitika Pant] McGill Univ, Dept Med, Div Clin Epidemiol, Montreal, PQ, Canada; [Joseph, Lawrence; Pai, Nitika Pant] MUHC, Montreal, PQ, Canada	McGill University; University of London; London School of Hygiene & Tropical Medicine; Institut national de sante publique du Quebec (INSPQ); McGill University	Pai, NP (corresponding author), McGill Univ, Dept Med, Div Clin Epidemiol, Montreal, PQ, Canada.	nitika.pai@mcgill.ca		Pant Pai, Nitika/0000-0002-4672-0500; Jafari, Yalda/0000-0002-8922-3387	Canadian Institutes of Health Research (CIHR) Knowledge Synthesis Grant [CIHR KRS 102067]	Canadian Institutes of Health Research (CIHR) Knowledge Synthesis Grant(Canadian Institutes of Health Research (CIHR))	This study was supported by a Canadian Institutes of Health Research (CIHR) Knowledge Synthesis Grant (CIHR KRS 102067, 2010-2012) (URL: http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aledort Julia E, 2006, Nature, V444 Suppl 1, P59, DOI 10.1038/nature05447; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Bronzan RN, 2007, SEX TRANSM DIS, V34, pS55, DOI 10.1097/01.olq.0000245987.78067.0c; Bud Robert, 2007, PENICILLIN TRIUMPH T; Castro AR, 2010, SEX TRANSM INFECT, V86, P532, DOI 10.1136/sti.2010.042937; Castro AR, 2010, J CLIN MICROBIOL, V48, P4615, DOI 10.1128/JCM.00624-10; Centers for Disease Control and Prevention, 2007, CDC FACT SHEET SYPH; Creegan L, 2007, SEX TRANSM DIS, V34, P1016, DOI 10.1097/OLQ.0b013e3181124473; Herring A, 2006, NAT REV MICROBIOL, pS33, DOI 10.1038/nrmicro1563; Huang QJH, 1996, J CLIN MICROBIOL, V34, P2011, DOI 10.1128/JCM.34.8.2011-2013.1996; Jafari Y, 2011, SYNTHESIS EVIDENCE I; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Miranda Angélica Espinosa, 2012, An. Bras. Dermatol., V87, P76, DOI 10.1590/S0365-05962012000100009; Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x; Peeling RW, 2006, NAT REV MICROBIOL, V4, P909, DOI 10.1038/nrmicro1555; Peeling RW, 2004, B WORLD HEALTH ORGAN, V82, P439; Rotanov S. V., 2008, Klinicheskaya Laboratornaya Diagnostika, P42; Schiller I, HSROC JOINT METAANAL; Schmid G, 2004, B WORLD HEALTH ORGAN, V82, P402; Steinbrook R, 2007, NEW ENGL J MED, V356, P1089, DOI 10.1056/NEJMp078009; The Sexually Transmitted Diseases Diagnostics Initiative, 2006, US RAP SYPH TESTS; Tucker JD, 2010, LANCET INFECT DIS, V10, P381, DOI 10.1016/S1473-3099(10)70092-X; Vickerman P, 2006, SEX TRANSM INFECT, V82, pV38, DOI 10.1136/sti.2006.021824; Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Workowski Kimberly A., 2010, Morbidity and Mortality Weekly Report, V59, P1; Young H, 1998, DERMATOL CLIN, V16, P691, DOI 10.1016/S0733-8635(05)70034-6; Zarakolu P, 2002, J CLIN MICROBIOL, V40, P3064, DOI 10.1128/JCM.40.8.3064-3065.2002	30	83	87	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e54695	10.1371/journal.pone.0054695	http://dx.doi.org/10.1371/journal.pone.0054695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468842	Green Published, gold, Green Accepted			2022-12-27	WOS:000315561400003
J	Wisnowski, JL; Bluml, S; Paquette, L; Zelinski, E; Nelson, MD; Painter, MJ; Damasio, H; Gilles, F; Panigrahy, A				Wisnowski, Jessica L.; Blueml, Stefan; Paquette, Lisa; Zelinski, Elizabeth; Nelson, Marvin D., Jr.; Painter, Michael J.; Damasio, Hanna; Gilles, Floyd; Panigrahy, Ashok			Altered Glutamatergic Metabolism Associated with Punctate White Matter Lesions in Preterm Infants	PLOS ONE			English	Article							PERIVENTRICULAR LEUKOMALACIA; MITOCHONDRIAL GLUTAMINASE; N-ACETYLASPARTATE; MR SPECTROSCOPY; AMINO-ACIDS; HUMAN BRAIN; RESONANCE; INJURY; EXPRESSION; ISCHEMIA	Preterm infants (similar to 10% of all births) are at high-risk for long-term neurodevelopmental disabilities, most often resulting from white matter injury sustained during the neonatal period. Glutamate excitotoxicity is hypothesized to be a key mechanism in the pathogenesis of white matter injury; however, there has been no in vivo demonstration of glutamate excitotoxicity in preterm infants. Using magnetic resonance spectroscopy (MRS), we tested the hypothesis that glutamate and glutamine, i.e., markers of glutamatergic metabolism, are altered in association with punctate white matter lesions and "diffuse excessive high signal intensity" (DEHSI), the predominant patterns of preterm white matter injury. We reviewed all clinically-indicated MRS studies conducted on preterm infants at a single institution during a six-year period and determined the absolute concentration of glutamate, glutamine, and four other key metabolites in the parietal white matter in 108 of those infants after two investigators independently evaluated the studies for punctate white matter lesions and DEHSI. Punctate white matter lesions were associated with a 29% increase in glutamine concentration (p = 0.002). In contrast, there were no differences in glutamatergic metabolism in association with DEHSI. Severe DEHSI, however, was associated with increased lactate concentration (p = 0.001), a marker of tissue acidosis. Findings from this study support glutamate excitotoxicity in the pathogenesis of punctate white matter lesions, but not necessarily in DEHSI, and suggest that MRS provides a useful biomarker for determining the pathogenesis of white matter injury in preterm infants during a period when neuroprotective agents may be especially effective.	[Wisnowski, Jessica L.; Blueml, Stefan; Nelson, Marvin D., Jr.; Panigrahy, Ashok] Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA; [Wisnowski, Jessica L.; Damasio, Hanna] Univ So Calif, Brain & Creat Inst, Los Angeles, CA USA; [Paquette, Lisa] Childrens Hosp Los Angeles, Div Neonatol, Dept Pediat, Los Angeles, CA 90027 USA; [Zelinski, Elizabeth] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA USA; [Painter, Michael J.] UPMC, Childrens Hosp Pittsburgh, Div Neurol, Dept Pediat, Pittsburgh, PA USA; [Gilles, Floyd] Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Neuropathol Sect, Los Angeles, CA 90027 USA; [Panigrahy, Ashok] UPMC, Childrens Hosp Pittsburgh, Dept Radiol, Pittsburgh, PA USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Panigrahy, A (corresponding author), Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA.	panigrahya@upmc.edu		Bluml, Stefan/0000-0003-2124-797X	National Institutes of Health [K23NS063371, P50NS01962]; Rudi Schulte Foundation; USC-CHLA CTSI [1UL1RR031986]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS063371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rudi Schulte Foundation; USC-CHLA CTSI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: National Institutes of Health [K23NS063371 to AP, P50NS01962 to JLW and HD]; and the Rudi Schulte Foundation to SB; and USC-CHLA CTSI grant 1UL1RR031986 to AP, JLW, and LP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SA, 2007, STROKE, V38, P724, DOI 10.1161/01.STR.0000254729.27386.05; Back SA, 2007, J CEREBR BLOOD F MET, V27, P334, DOI 10.1038/sj.jcbfm.9600344; BANKER BQ, 1962, ARCH NEUROL-CHICAGO, V7, P386, DOI 10.1001/archneur.1962.04210050022004; Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Billiards SS, 2008, BRAIN PATHOL, V18, P153, DOI 10.1111/j.1750-3639.2007.00107.x; Bluml S, 2013, CEREB CORTEX, V23, P2944, DOI 10.1093/cercor/bhs283; Bluml S, 2001, MAGNET RESON MED, V45, P981, DOI 10.1002/mrm.1131; Braissant O, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-9; Chen J, 2012, PLOS ONE, V7; CHOI DW, 1988, J NEUROSCI, V8, P185; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Cornette LG, 2002, ARCH DIS CHILD-FETAL, V86, P171, DOI 10.1136/fn.86.3.F171; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Desilva TM, 2008, J COMP NEUROL, V508, P238, DOI 10.1002/cne.21667; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Follett PL, 2004, J NEUROSCI, V24, P4412, DOI 10.1523/JNEUROSCI.0477-04.2004; GILLES FH, 1969, J NEUROL NEUROSUR PS, V32, P404, DOI 10.1136/jnnp.32.5.404; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Haynes RL, 2008, PEDIATR RES, V63, P656, DOI 10.1203/PDR.0b013e31816c825c; Kidokoro H, 2011, AM J NEURORADIOL, V32, P2005, DOI 10.3174/ajnr.A2703; Kreis R, 2004, NMR BIOMED, V17, P361, DOI 10.1002/nbm.891; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; Lei HX, 2009, J CEREBR BLOOD F MET, V29, P811, DOI 10.1038/jcbfm.2009.8; Lentner C, 1981, GEIGY SCI TABLES, p[220, 222, 223]; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Manning SM, 2008, J NEUROSCI, V28, P6670, DOI 10.1523/JNEUROSCI.1702-08.2008; Matsumae M, 2001, MECH AGEING DEV, V122, P1281, DOI 10.1016/S0047-6374(01)00265-2; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Miller SP, 2009, TRENDS NEUROSCI, V32, P496, DOI 10.1016/j.tins.2009.05.010; Newcomb R, 1997, J BIOL CHEM, V272, P11276; Newcomb R, 1998, BRAIN RES, V813, P103, DOI 10.1016/S0006-8993(98)01006-3; Panigrahy Ashok, 2007, Top Magn Reson Imaging, V18, P3, DOI 10.1097/RMR.0b013e318093e6c7; Panigrahy A, 2010, PEDIATR RADIOL, V40, P3, DOI 10.1007/s00247-009-1450-z; PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; Robertson NJ, 2000, J CEREBR BLOOD F MET, V20, P1446, DOI 10.1097/00004647-200010000-00006; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Rutherford MA, 2010, NEURORADIOLOGY, V52, P505, DOI 10.1007/s00234-010-0700-y; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sanchez-Gomez MV, 2003, J NEUROSCI, V23, P9519; Skiold B, 2012, J PEDIATR-US, V160, P559, DOI 10.1016/j.jpeds.2011.09.053; SMART JL, 1973, J NUTR, V103, P1327, DOI 10.1093/jn/103.9.1327; Sulyok E, 2001, BIOL NEONATE, V79, P67, DOI 10.1159/000047068; TORP R, 1991, NEUROSCIENCE, V41, P433, DOI 10.1016/0306-4522(91)90339-P; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Volpe J.J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Xu DA, 2011, J MAGN RESON IMAGING, V33, P306, DOI 10.1002/jmri.22460	58	25	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56880	10.1371/journal.pone.0056880	http://dx.doi.org/10.1371/journal.pone.0056880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468888	Green Published, gold, Green Submitted			2022-12-27	WOS:000315561400015
J	Bhaduri, B; Wickland, D; Wang, R; Chan, V; Bashir, R; Popescu, G				Bhaduri, Basanta; Wickland, David; Wang, Ru; Chan, Vincent; Bashir, Rashid; Popescu, Gabriel			Cardiomyocyte Imaging Using Real-Time Spatial Light Interference Microscopy (SLIM)	PLOS ONE			English	Article							QUANTITATIVE PHASE; CELL; CONTRAST; SUBWAVELENGTH; TOMOGRAPHY	Spatial light interference microscopy (SLIM) is a highly sensitive quantitative phase imaging method, which is capable of unprecedented structure studies in biology and beyond. In addition to the pi/2 shift introduced in phase contrast between the scattered and unscattered light from the sample, 4 phase shifts are generated in SLIM, by increments of pi/2 using a reflective liquid crystal phase modulator (LCPM). As 4 phase shifted images are required to produce a quantitative phase image, the switching speed of the LCPM and the acquisition rate of the camera limit the acquisition rate and, thus, SLIM's applicability to highly dynamic samples. In this paper we present a fast SLIM setup which can image at a maximum rate of 50 frames per second and provide in real-time quantitative phase images at 50/4 = 12.5 frames per second. We use a fast LCPM for phase shifting and a fast scientific-grade complementary metal oxide semiconductor (sCMOS) camera (Andor) for imaging. We present the dispersion relation, i.e. decay rate vs. spatial mode, associated with dynamic beating cardiomyocyte cells from the quantitative phase images obtained with the real-time SLIM system.	[Bhaduri, Basanta; Wickland, David; Wang, Ru; Bashir, Rashid; Popescu, Gabriel] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL USA; [Chan, Vincent; Bashir, Rashid; Popescu, Gabriel] Univ Illinois, Dept Bioengn, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Popescu, G (corresponding author), Univ Illinois, Dept Elect & Comp Engn, Urbana, IL USA.	gpopescu@illinois.edu		Bhaduri, Basanta/0000-0001-9737-0996	National Science Foundation [CBET 08-46660 CAREER, CBET-1040462 MRI, CBET-0939511 EBICS]	National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Science Foundation (grants CBET 08-46660 CAREER, CBET-1040462 MRI, CBET-0939511 EBICS). For more information, visit http://light.ece.uiuc.edu/. BB acknowledges useful discussions with Mustafa Mir. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barty A, 1998, OPT LETT, V23, P817, DOI 10.1364/OL.23.000817; Charriere F, 2006, OPT LETT, V31, P178, DOI 10.1364/OL.31.000178; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; Ding HF, 2011, OPT LETT, V36, P2281, DOI 10.1364/OL.36.002281; Ding HF, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.238102; Dubois F, 1999, APPL OPTICS, V38, P7085, DOI 10.1364/AO.38.007085; Dunn GA, 1998, CELL BIOL LAB HDB; Fowler B, 2010, PROC SPIE, V7536, DOI 10.1117/12.846975; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; Ikeda T, 2005, OPT LETT, V30, P1165, DOI 10.1364/OL.30.001165; Maass Alexander H, 2007, Methods Mol Biol, V366, P321; Mann CJ, 2005, OPT EXPRESS, V13, P8693, DOI 10.1364/OPEX.13.008693; Marquet P, 2005, OPT LETT, V30, P468, DOI 10.1364/OL.30.000468; Mir M, 2012, PROG OPTICS, V57, P133, DOI 10.1016/B978-0-44-459422-8.00003-5; Mir M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039816; Mir M, 2011, BIOMED OPT EXPRESS, V2, P3259, DOI 10.1364/BOE.2.003259; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Mir M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3369965; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Pham H, 2012, OPT LETT, V37, P3438, DOI 10.1364/OL.37.003438; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Popescu G, 2004, OPT LETT, V29, P2503, DOI 10.1364/OL.29.002503; Popescu G., 2011, QUANTITATIVE PHASE I, P385; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Popescu G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218101; Saurabh S, 2012, OPT EXPRESS, V20, P7338, DOI 10.1364/OE.20.007338; Shaked NT, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3420179; Sridharan S, 2011, BIOMED OPT EXPRESS, V2, P2815, DOI 10.1364/BOE.2.002815; Wang R, 2011, OPT EXPRESS, V19, P20571, DOI 10.1364/OE.19.020571; Wang R, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/37/374107; Wang Z, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3656732; Wang Z, 2011, OPT EXPRESS, V19, P19907, DOI 10.1364/OE.19.019907; Wang Z, 2011, OPT LETT, V36, P1215, DOI 10.1364/OL.36.001215; Wang Z, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3549204; Wang Z, 2011, OPT EXPRESS, V19, P1016, DOI 10.1364/OE.19.001016; Yang CH, 2001, OPT LETT, V26, P1271, DOI 10.1364/OL.26.001271; Zernike F, 1942, PHYSICA, V9, P686, DOI 10.1016/S0031-8914(42)80035-X	37	18	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56930	10.1371/journal.pone.0056930	http://dx.doi.org/10.1371/journal.pone.0056930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457641	gold, Green Submitted, Green Published			2022-12-27	WOS:000315603700099
J	Junemann, AGM; Stopa, P; Michalke, B; Chaudhri, A; Reulbach, U; Huchzermeyer, C; Schlotzer-Schrehardt, U; Kruse, FE; Zrenner, E; Rejdak, R				Juenemann, Anselm G. M.; Stopa, Piotr; Michalke, Bernhard; Chaudhri, Anwar; Reulbach, Udo; Huchzermeyer, Cord; Schloetzer-Schrehardt, Ursula; Kruse, Friedrich E.; Zrenner, Eberhart; Rejdak, Robert			Levels of Aqueous Humor Trace Elements in Patients with Non-Exsudative Age-related Macular Degeneration: A Case-control Study	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; CADMIUM ACCUMULATION; GENE-EXPRESSION; PC12 CELLS; ZINC; COBALT; TOXICITY; HYPOXIA; PROTEIN; METALLOTHIONEIN	Trace elements might play a role in the complex multifactorial pathogenesis of age-related macular degeneration (AMD). The aim of this study was to measure alterations of trace elements levels in aqueous humor of patients with non-exsudative (dry) AMD. For this pilot study, aqueous humor samples were collected from patients undergoing cataract surgery. 12 patients with dry AMD (age 77.9 +/- 6.62, female 8, male 4) and 11 patients without AMD (age 66.6 +/- 16.7, female 7, male 4) were included. Aqueous levels of cadmium, cobalt, copper, iron, manganese, selenium, and zinc were measured by use of Flow-Injection-Inductively-Coupled-Plasma-Mass-Spectrometry (FI-ICP-MS), quality controlled with certified standards. Patients with AMD had significantly higher aqueous humor levels of cadmium (median: 0.70 mu mol/L, IQR: 0.40-0.84 vs. 0.06 mu mol/L; IQR: 0.01-.018; p = 0.002), cobalt (median: 3.1 mu mol/L, IQR: 2.62-3.15 vs. 1.17 mu mol/L; IQR: 0.95-1.27; p<0.001), iron (median: 311 mu mol/L, IQR: 289-329 vs. 129 mu mol/L; IQR: 111-145; p<0.001) and zinc (median: 23.1 mu mol/L, IQR: 12.9-32.6 vs. 5.1 mu mol/L; IQR: 4.4-9.4; p = 0.020) when compared with patients without AMD. Copper levels were significantly reduced in patients with AMD (median: 16.2 mu mol/L, IQR: 11.4-31.3 vs. 49.9 mu mol/L; IQR: 32.0-. 142.0; p = 0.022) when compared to those without. No significant differences were observed in aqueous humor levels of manganese and selenium between patients with and without AMD. After an adjustment for multiple testing, cadmium, cobalt, copper and iron remained a significant factor in GLM models (adjusted for age and gender of the patients) for AMD. Alterations of trace element levels support the hypothesis that cadmium, cobalt, iron, and copper are involved in the pathogenesis of AMD.	[Juenemann, Anselm G. M.; Huchzermeyer, Cord; Schloetzer-Schrehardt, Ursula; Kruse, Friedrich E.] Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany; [Stopa, Piotr; Rejdak, Robert] Med Univ Lublin, Dept Gen Ophthalmol, Lublin, Poland; [Michalke, Bernhard] Helmholtz Zentrum Munchen, Inst Ecol Chem, Neuherberg, Germany; [Chaudhri, Anwar] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Reulbach, Udo] Trinity Coll Dublin, Dept Publ Hlth & Primary Care, Dublin, Ireland; [Zrenner, Eberhart] Ctr Ophthalmol, Tubingen, Germany; [Rejdak, Robert] Polish Acad Sci, Med Res Ctr, Dept Expt Pharmacol, Warsaw, Poland	University of Erlangen Nuremberg; Medical University of Lublin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg; Trinity College Dublin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Polish Academy of Sciences	Junemann, AGM (corresponding author), Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany.	anselm.juenemann@uk-erlangen.de	Jünemann, Anselm Gerhard Maria/GPK-8482-2022; Reulbach, Udo/F-4239-2012; Schmuki, Patrik/B-9720-2008	Reulbach, Udo/0000-0002-9527-157X; Rejdak, Robert/0000-0003-3321-2723				Erie JC, 2007, AM J OPHTHALMOL, V144, P414, DOI 10.1016/j.ajo.2007.05.020; Erie JC, 2009, AM J OPHTHALMOL, V147, P276, DOI 10.1016/j.ajo.2008.08.014; Erie JC, 2005, AM J OPHTHALMOL, V139, P888, DOI 10.1016/j.ajo.2004.12.007; Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099; Karovic O, 2007, BIOCHEM PHARMACOL, V73, P694, DOI 10.1016/j.bcp.2006.11.008; Klein R, 2008, OPHTHALMOLOGY, V115, P1460, DOI 10.1016/j.ophtha.2008.01.026; Kowalski M, 2010, MED SCI MONITOR, V16, pCR190; Lengyel I, 2007, EXP EYE RES, V84, P772, DOI 10.1016/j.exer.2006.12.015; Montezuma Sandra R, 2007, Semin Ophthalmol, V22, P229, DOI 10.1080/08820530701745140; Moulis JM, 2010, BIOMETALS, V23, P877, DOI 10.1007/s10534-010-9336-y; Nicolas MG, 1996, EXP EYE RES, V62, P399, DOI 10.1006/exer.1996.0045; Olbryt M, 2006, GENE EXPRESSION, V13, P191, DOI 10.3727/000000006783991818; Ortega R, 2009, TOXICOL LETT, V188, P26, DOI 10.1016/j.toxlet.2009.02.024; Rousselet E, 2008, PROTEOMICS, V8, P2244, DOI 10.1002/pmic.200701067; Sabolic I, 2010, BIOMETALS, V23, P897, DOI 10.1007/s10534-010-9351-z; Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013; Ugarte M, 2001, PROG NEUROBIOL, V64, P219, DOI 10.1016/S0301-0082(00)00057-5; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wills NK, 2008, EXP EYE RES, V87, P80, DOI 10.1016/j.exer.2008.04.013; Wills NK, 2008, EXP EYE RES, V86, P41, DOI 10.1016/j.exer.2007.09.005; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zou WG, 2002, J NEUROSCI RES, V67, P837, DOI 10.1002/jnr.10168; Zou WG, 2001, J NEUROSCI RES, V64, P646, DOI 10.1002/jnr.1118; 2001, ARCH OPHTHALMOL, V119, P1417	24	43	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56734	10.1371/journal.pone.0056734	http://dx.doi.org/10.1371/journal.pone.0056734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457607	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700075
J	Moul, C; Dobson-Stone, C; Brennan, J; Hawes, D; Dadds, M				Moul, Caroline; Dobson-Stone, Carol; Brennan, John; Hawes, David; Dadds, Mark			An Exploration of the Serotonin System in Antisocial Boys with High Levels of Callous-Unemotional Traits	PLOS ONE			English	Article							WHOLE-BLOOD SEROTONIN; TRYPTOPHAN HYDROXYLASE-2 GENE; MESSENGER-RNA EXPRESSION; 1B RECEPTOR GENE; CONDUCT PROBLEMS; CANDIDATE GENES; MONOAMINE METABOLITES; PSYCHOPATHIC TRAITS; AGGRESSIVE-BEHAVIOR; CEREBROSPINAL-FLUID	Background: The serotonin system is thought to play a role in the aetiology of antisocial and aggressive behaviour in both adults and children however previous findings have been inconsistent. Recently, research has suggested that the function of the serotonin system may be specifically altered in a sub-set of antisocial populations - those with psychopathic (callous-unemotional) personality traits. We explored the relationships between callous-unemotional traits and functional polymorphisms of selected serotonin-system genes, and tested the association between callous-unemotional traits and serum serotonin levels independently of antisocial and aggressive behaviour. Method: Participants were boys with antisocial behaviour problems aged 3-16 years referred to University of New South Wales Child Behaviour Research Clinics. Participants volunteered either a blood or saliva sample from which levels of serum serotonin (N = 66) and/or serotonin-system single nucleotide polymorphisms (N = 157) were assayed. Results: Functional single nucleotide polymorphisms from the serotonin 1b receptor gene (HTR1B) and 2a receptor gene (HTR2A) were found to be associated with callous-unemotional traits. Serum serotonin level was a significant predictor of callous-unemotional traits; levels were significantly lower in boys with high callous-unemotional traits than in boys with low callous-unemotional traits. Conclusion: Results provide support to the emerging literature that argues for a genetically-driven system-wide alteration in serotonin function in the aetiology of callous-unemotional traits. The findings should be interpreted as preliminary and future research that aims to replicate and further investigate these results is required.	[Moul, Caroline; Brennan, John; Dadds, Mark] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Dobson-Stone, Carol] Neurosci Res Australia, Sydney, NSW, Australia; [Dobson-Stone, Carol] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Brennan, John] Sydney Childrens Hosp, Sydney, NSW, Australia; [Hawes, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	University of New South Wales Sydney; Neuroscience Research Australia; University of New South Wales Sydney; University of Sydney; University of Sydney	Moul, C (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	cmoul@psy.unsw.edu.au	Hawes, David/AAE-6800-2021	Dadds, Mark/0000-0002-2900-1715; Dobson-Stone, Carol/0000-0002-2211-0257; Moul, Caroline/0000-0003-2632-1067; Hawes, David/0000-0003-3260-1225	Australian Research Council [DP120102296, LP100200150]	Australian Research Council(Australian Research Council)	Prof. Dadds is supported by grants from the Australian Research Council (DP120102296 and LP100200150) (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PR, 2012, PHILOS T R SOC B, V367, P2402, DOI 10.1098/rstb.2011.0376; [Anonymous], 2001, INFORM PAPER CENSUS; [Anonymous], 2006, BIOL AGGRESSION, DOI DOI 10.1093/ACPROF:OSO/9780195168761.003.0004; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Attenburrow MJ, 2003, PSYCHOPHARMACOLOGY, V169, P104, DOI 10.1007/s00213-003-1479-x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; Brown SM, 2005, MOL PSYCHIATR, V10, P884, DOI 10.1038/sj.mp.4001716; Burt SA, 2008, AGGRESSIVE BEHAV, V34, P437, DOI 10.1002/ab.20251; CASTELLANOS FX, 1994, PSYCHIAT RES, V52, P305, DOI 10.1016/0165-1781(94)90076-0; Chen DY, 2012, J AFFECT DISORDERS, V138, P27, DOI 10.1016/j.jad.2011.04.018; Chen GL, 2008, HUM GENET, V122, P645, DOI 10.1007/s00439-007-0443-y; Clark M S, 2001, Psychopharmacol Bull, V35, P170; Clarke HF, 2005, J NEUROSCI, V25, P532, DOI 10.1523/JNEUROSCI.3690-04.2005; Conner TS, 2010, AM J MED GENET B, V153B, P67, DOI 10.1002/ajmg.b.30955; COOK EH, 1995, PSYCHIAT RES, V57, P13, DOI 10.1016/0165-1781(95)02596-O; Arias JMC, 2011, PSYCHIAT GENET, V21, P115, DOI 10.1097/YPG.0b013e3283437175; Dadds MR, 2008, J AM ACAD CHILD PSY, V47, P455, DOI 10.1097/CHI.0b013e31816407f1; Dadds MR, 2009, J CHILD PSYCHOL PSYC, V50, P599, DOI 10.1111/j.1469-7610.2008.02058.x; Dadds MR, 2005, J CONSULT CLIN PSYCH, V73, P400, DOI 10.1037/0022-006X.73.3.400; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Divers J, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-28; Drago A, 2010, EUR J CLIN PHARMACOL, V66, P5, DOI 10.1007/s00228-009-0724-6; Duan J, 2003, MOL PSYCHIATR, V8, P901, DOI 10.1038/sj.mp.4001403; Enoch MA, 2011, MOL PSYCHIATR, V16, P1139, DOI 10.1038/mp.2010.94; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Fowler T, 2009, PSYCHIAT GENET, V19, P312, DOI 10.1097/YPG.0b013e3283328df4; Frick PJ, 2003, J ABNORM CHILD PSYCH, V31, P457, DOI 10.1023/A:1023899703866; Frick PJ, 2005, J ABNORM CHILD PSYCH, V33, P471, DOI 10.1007/s10648-005-5728-9; Frick PJ., 2001, ANTISOCIAL PROCESS S; Frick PJ, 2010, PROPOSAL DSM 5 CHILD; Gao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036721; Gao XP, 2005, CHINESE J CLIN REHAB, V9, P221; Gaysina D, 2006, ANN GEN PSYCHIATR, V5, pS213; Giegling I, 2006, J AFFECT DISORDERS, V96, P75, DOI 10.1016/j.jad.2006.05.016; Glenn AL, 2008, PSYCHIAT CLIN N AM, V31, P463, DOI 10.1016/j.psc.2008.03.004; Glenn AL, 2011, NEUROSCI BIOBEHAV R, V35, P612, DOI 10.1016/j.neubiorev.2010.07.005; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gutknecht L, 2007, INT J NEUROPSYCHOPH, V10, P309, DOI 10.1017/S1461145706007437; Halperin JM, 2006, J AM ACAD CHILD PSY, V45, P833, DOI 10.1097/01.chi.0000220855.79144.ae; Halperin JM, 2003, PSYCHIAT RES, V119, P205, DOI 10.1016/S0165-1781(03)00136-7; Harmer CJ, 2003, NEUROPSYCHOPHARMACOL, V28, P148, DOI 10.1038/sj.npp.1300004; Heiser P, 2007, J NEURAL TRANSM, V114, P513, DOI 10.1007/s00702-006-0584-5; Hicks BM, 2010, PERSONAL DISORD, V1, P38, DOI 10.1037/a0018135; Holland D., 1997, DIAGNOSTIC INTERVIEW; Hughes CW, 1996, PSYCHIAT RES, V65, P79, DOI 10.1016/S0165-1781(96)02932-0; Jensen KP, 2009, MOL PSYCHIATR, V14, P381, DOI 10.1038/mp.2008.15; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Jonsson EG, 1997, EUR ARCH PSY CLIN N, V247, P297, DOI 10.1007/BF02922258; Keselman HJ, 1999, PSYCHOL METHODS, V4, P58, DOI 10.1037/1082-989X.4.1.58; Koglin U, 2012, KINDH ENTWICKL, V21, P141, DOI 10.1026/0942-5403/a000080; Krischer MK, 2008, INT J LAW PSYCHIAT, V31, P253, DOI 10.1016/j.ijlp.2008.04.008; Lim JE, 2007, MOL PSYCHIATR, V12, P491, DOI 10.1038/sj.mp.4001923; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Lynam DR, 2007, J ABNORM PSYCHOL, V116, P155, DOI 10.1037/0021-843X.116.1.155; Ma DQ, 2010, AM J MED GENET B, V153B, P477, DOI 10.1002/ajmg.b.31003; Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145; Mossner R, 2006, INT J NEUROPSYCHOPH, V9, P437, DOI 10.1017/S1461145705005997; Moffitt TE, 1998, BIOL PSYCHIAT, V43, P446, DOI 10.1016/S0006-3223(97)00340-5; Moffitt TE, 2003, CAUSES OF CONDUCT DISORDER AND JUVENILE DELINQUENCY, P49; Moore TM, 2002, AGGRESSIVE BEHAV, V28, P299, DOI 10.1002/ab.90027; MOSS HB, 1990, BIOL PSYCHIAT, V28, P325, DOI 10.1016/0006-3223(90)90660-T; Moul C, 2012, PSYCHOL REV; MULLER J, 2003, BIOL PSYCHIAT, V171, P54; Newman JP, 2010, BIOL PSYCHIAT, V67, P66, DOI 10.1016/j.biopsych.2009.07.035; OKEANE V, 1992, BRIT J PSYCHIAT, V160, P643, DOI 10.1192/bjp.160.5.643; Pasalich DS, 2012, J CHILD PSYCHOL PSYC; PATRICK CJ, 1994, PSYCHOPHYSIOLOGY, V31, P319, DOI 10.1111/j.1469-8986.1994.tb02440.x; Pine DS, 1997, ARCH GEN PSYCHIAT, V54, P839; Rey JM, 1997, ARCH GEN PSYCHIAT, V54, P817; Rowe R, 2010, J CHILD PSYCHOL PSYC, V51, P688, DOI 10.1111/j.1469-7610.2009.02199.x; Sadeh N, 2010, J ABNORM PSYCHOL, V119, P604, DOI 10.1037/a0019709; Scheuch K, 2007, BIOL PSYCHIAT, V62, P1288, DOI 10.1016/j.biopsych.2007.01.015; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; STOFF DM, 1992, PSYCHIAT RES, V43, P263, DOI 10.1016/0165-1781(92)90059-C; Szabo M, 2010, J ADOLESCENCE, V33, P1, DOI 10.1016/j.adolescence.2009.05.014; Turecki G, 1999, AM J PSYCHIAT, V156, P1456; Unis AS, 1997, BIOL PSYCHIAT, V42, P553, DOI 10.1016/S0006-3223(96)00465-9; van Goozen SHM, 1999, EUR NEUROPSYCHOPHARM, V9, P141, DOI 10.1016/S0924-977X(98)00019-4; Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x; Viding E, 2008, DEVELOPMENTAL SCI, V11, P17, DOI 10.1111/j.1467-7687.2007.00648.x; VIRKKUNEN M, 1995, J PSYCHIATR NEUROSCI, V20, P271; WALLER G, 1990, BRIT J PSYCHIAT, V156, P546, DOI 10.1192/bjp.156.4.546; Walrath CM, 2004, J PSYCHOEDUC ASSESS, V22, P209, DOI 10.1177/073428290402200302; Walstab J, 2008, PHARMACOGENET GENOM, V18, P793, DOI 10.1097/FPC.0b013e3283050117; Weiss LA, 2005, AM J HUM GENET, V76, P33, DOI 10.1086/426697; Willemsen J, 2012, INT J OFFENDER THER, V56, P505, DOI 10.1177/0306624X11407443; YAN D, 1993, LIFE SCI, V52, P745, DOI 10.1016/0024-3205(93)90237-W; Zill P, 2007, J PSYCHIATR RES, V41, P168, DOI 10.1016/j.jpsychires.2005.05.004; Zouk H, 2007, AM J MED GENET B, V144B, P996, DOI 10.1002/ajmg.b.30521	90	32	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56619	10.1371/journal.pone.0056619	http://dx.doi.org/10.1371/journal.pone.0056619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457595	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700067
J	Valenzuela, SM; Alkhamici, H; Brown, LJ; Almond, OC; Goodchild, SC; Carne, S; Curmi, PMG; Holt, SA; Cornell, BA				Valenzuela, Stella M.; Alkhamici, Heba; Brown, Louise J.; Almond, Oscar C.; Goodchild, Sophia C.; Carne, Sonia; Curmi, Paul M. G.; Holt, Stephen A.; Cornell, Bruce A.			Regulation of the Membrane Insertion and Conductance Activity of the Metamorphic Chloride Intracellular Channel Protein CLIC1 by Cholesterol	PLOS ONE			English	Article							STAPHYLOCOCCAL ALPHA-HEMOLYSIN; HEPTAMERIC TRANSMEMBRANE PORE; DEPENDENT CYTOLYSINS; CRYSTAL-STRUCTURE; LIPID-BILAYERS; SOLUBLE FORM; ION CHANNELS; NCC27; FLUORESCENCE; DOMAIN	The Chloride Intracellular ion channel protein CLIC1 has the ability to spontaneously insert into lipid membranes from a soluble, globular state. The precise mechanism of how this occurs and what regulates this insertion is still largely unknown, although factors such as pH and redox environment are known contributors. In the current study, we demonstrate that the presence and concentration of cholesterol in the membrane regulates the spontaneous insertion of CLIC1 into the membrane as well as its ion channel activity. The study employed pressure versus area change measurements of Langmuir lipid monolayer films; and impedance spectroscopy measurements using tethered bilayer membranes to monitor membrane conductance during and following the addition of CLIC1 protein. The observed cholesterol dependent behaviour of CLIC1 is highly reminiscent of the cholesterol-dependent-cytolysin family of bacterial pore-forming proteins, suggesting common regulatory mechanisms for spontaneous protein insertion into the membrane bilayer.	[Valenzuela, Stella M.; Alkhamici, Heba; Almond, Oscar C.; Carne, Sonia] Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia; [Brown, Louise J.; Goodchild, Sophia C.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Carne, Sonia; Cornell, Bruce A.] Surgical Diagnost Pty Ltd, Sydney, NSW, Australia; [Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW, Australia; [Curmi, Paul M. G.] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Holt, Stephen A.] Australian Nucl Sci & Technol Org, Bragg Inst, Sydney, NSW, Australia	University of Technology Sydney; Macquarie University; University of New South Wales Sydney; St Vincents Hospital Sydney; Australian Nuclear Science & Technology Organisation	Valenzuela, SM (corresponding author), Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia.	Stella.Valenzuela@uts.edu.au	Valenzuela, Stella/R-6387-2019; Goodchild, Sophia/AAB-1465-2021; Curmi, Paul/G-7185-2011; Holt, Stephen A/E-4662-2011	Valenzuela, Stella/0000-0001-5934-6047; Curmi, Paul/0000-0001-5762-7638; Holt, Stephen A/0000-0003-3189-8047; Brown, Louise/0000-0001-8592-2431; Goodchild, Sophia/0000-0002-5091-7576; cornell, bruce/0000-0003-4166-3241	Australian Research Council [LP0990084]; Australian Institute of Nuclear Science and Engineering (AINSE Award) [ALNGRA12018]	Australian Research Council(Australian Research Council); Australian Institute of Nuclear Science and Engineering (AINSE Award)	The authors thank the following organisations for financial support of this research: the Australian Research Council (grant LP0990084 to S.M.V. and B.A.C.) and the Australian Institute of Nuclear Science and Engineering (AINSE Award ALNGRA12018 to S.M.V., S.A.H., L.J.B.). ARC website URL: http://www.arc.gov. au/; AINSE website URL: http://www.ainse.edu.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, ESSENTIAL CELL BIOL; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Berryman M, 2004, J BIOL CHEM, V279, P34794, DOI 10.1074/jbc.M402835200; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Cornell BA, 1997, NATURE, V387, P580, DOI 10.1038/42432; Cromer BA, 2007, J MOL BIOL, V374, P719, DOI 10.1016/j.jmb.2007.09.041; Epand RF, 2002, BIOCHEM J, V367, P849, DOI 10.1042/BJ20020986; Epand RF, 2002, BIOCHEM BIOPH RES CO, V298, P744, DOI 10.1016/S0006-291X(02)02544-5; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Gilbert RJC, 2010, ADV EXP MED BIOL, V677, P56; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Goodchild SC, 2010, BIOCHEMISTRY-US, V49, P5278, DOI 10.1021/bi100111c; Goodchild SC, 2009, EUR BIOPHYS J BIOPHY, V39, P129, DOI 10.1007/s00249-009-0450-0; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Ishitsuka Y, 2010, ANAL CHEM, V82, P9694, DOI 10.1021/ac101714u; Littler DR, 2008, PROTEINS, V71, P364, DOI 10.1002/prot.21704; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; Posokhov YO, 2008, BIOCHEMISTRY-US, V47, P5078, DOI 10.1021/bi702223c; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Reshetnyak YK, 2007, BIOPHYS J, V93, P2363, DOI 10.1529/biophysj.107.109967; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Singh H, 2007, FEBS J, V274, P6306, DOI 10.1111/j.1742-4658.2007.06145.x; Singh H, 2006, BIOPHYS J, V90, P1628, DOI 10.1529/biophysj.105.072678; Singh H, 2007, MOL MEMBR BIOL, V24, P41, DOI 10.1080/09687860600927907; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Stoychev SH, 2009, BIOCHEMISTRY-US, V48, P8413, DOI 10.1021/bi9010607; Tulk BM, 2002, AM J PHYSIOL-CELL PH, V282, pC1103, DOI 10.1152/ajpcell.00402.2001; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Valenzuela S, 1996, J LEUKOCYTE BIOL, P106; Valenzuela SM, 2000, J PHYSIOL-LONDON, V529, P541, DOI 10.1111/j.1469-7793.2000.00541.x; Vijayvargia R, 2004, BIOCHEM BIOPH RES CO, V324, P1130, DOI 10.1016/j.bbrc.2004.09.164; Vockenroth IK, 2008, LANGMUIR, V24, P496, DOI 10.1021/la7030279; Warton K, 2002, J BIOL CHEM, V277, P26003, DOI 10.1074/jbc.M203666200	37	28	28	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56948	10.1371/journal.pone.0056948	http://dx.doi.org/10.1371/journal.pone.0056948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457643	gold, Green Published, Green Submitted			2022-12-27	WOS:000315602700102
J	Cornelissen, F; Asmawidjaja, PS; Mus, AMC; Corneth, O; Kikly, K; Lubberts, E				Cornelissen, Ferry; Asmawidjaja, Patrick S.; Mus, Adriana M. C.; Corneth, Odilia; Kikly, Kristine; Lubberts, Erik			IL-23 Dependent and Independent Stages of Experimental Arthritis: No Clinical Effect of Therapeutic IL-23p19 Inhibition in Collagen-induced Arthritis	PLOS ONE			English	Article							INFLAMMATION; CYTOKINE; ANTIBODY; DIFFERENTIATION; INTERLEUKIN-23; EXPRESSION; INDUCTION; RECEPTOR; SUBUNIT; MEMBERS	IL-23p19 deficient mice have revealed a critical role of IL-23 in the development of experimental autoimmune diseases, such as collagen-induced arthritis (CIA). Neutralizing IL-23 after onset of CIA in rats has been shown to reduce paw volume, but the effect on synovial inflammation and the immunological autoimmune response is not clear. In this study, we examined the role of IL-23 at different stages of CIA and during T cell memory mediated flare-up arthritis with focus on changes in B cell activity and Th1/Th17 modulation. Anti-IL-23p19 antibody (anti-IL23p19) treatment, starting 15 days after the type II collagen (CII)-immunization but before clinical signs of disease onset, significantly suppressed the severity of CIA. This was accompanied with significantly lower CII-specific IgG1 levels and lower IgG2a levels in the anti-IL-23p19 treated mice compared to the control group. Importantly, neutralizing IL-23 after the first signs of CIA did not ameliorate the disease. This was in contrast to arthritic mice that underwent an arthritis flare-up since a significantly lower disease score was observed in the IL-23p19 treated mice compared to the control group, accompanied by lower synovial IL-17A and IL-22 expression in the knee joints of these mice. These data show IL-23-dependent and IL-23-independent stages during autoimmune CIA. Furthermore, the memory T cell mediated flare-up arthritis is IL-23-mediated. These data suggest that specific neutralization of IL-23p19 after onset of autoimmune arthritis may not be beneficial as a therapeutic therapy for patients with rheumatoid arthritis (RA). However, T cell mediated arthritis relapses in patients with RA might be controlled by anti-IL-23p19 treatment.	[Cornelissen, Ferry; Asmawidjaja, Patrick S.; Mus, Adriana M. C.; Corneth, Odilia; Lubberts, Erik] Erasmus MC, Dept Rheumatol, Rotterdam, Netherlands; [Cornelissen, Ferry; Asmawidjaja, Patrick S.; Mus, Adriana M. C.; Corneth, Odilia; Lubberts, Erik] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Kikly, Kristine] Eli Lilly & Co, Indianapolis, IN 46285 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Eli Lilly	Lubberts, E (corresponding author), Erasmus MC, Dept Rheumatol, Rotterdam, Netherlands.	E.Lubberts@erasmusmc.nl	Cornelissen, Ferry/GOG-8103-2022; Lubberts, Erik/AAI-4657-2020; Cornelissen, Ferry/A-4568-2009		Erasmus MC research grant	Erasmus MC research grant	This study was supported by an Erasmus MC research grant to E. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Cornelissen F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2893; Croxford AL, 2012, EUR J IMMUNOL, V42, P2263, DOI 10.1002/eji.201242598; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Gyulveszi G, 2009, EUR J IMMUNOL, V39, P1864, DOI 10.1002/eji.200939305; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Krausz S, 2012, ARTHRITIS RHEUM-US, V64, P1750, DOI 10.1002/art.34339; Lemos HP, 2009, P NATL ACAD SCI USA, V106, P5954, DOI 10.1073/pnas.0812782106; LENS JW, 1984, CLIN EXP IMMUNOL, V57, P520; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Mangan PR, 2006, NATURE; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Mus AMC, 2010, ARTHRITIS RHEUM-US, V62, P1043, DOI 10.1002/art.27336; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Yago T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2297; Yanaba K, 2007, J IMMUNOL, V179, P1369, DOI 10.4049/jimmunol.179.2.1369	24	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57553	10.1371/journal.pone.0057553	http://dx.doi.org/10.1371/journal.pone.0057553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469022	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900121
J	Kapoor, A; Iqbal, M; Petropoulos, S; Ho, HL; Gibb, W; Matthews, SG				Kapoor, Amita; Iqbal, Majid; Petropoulos, Sophie; Ho, Hay Lam; Gibb, William; Matthews, Stephen G.			Effects of Sertraline and Fluoxetine on P-Glycoprotein at Barrier Sites: In Vivo and In Vitro Approaches	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; BLOOD-BRAIN; SUBSTRATE RECOGNITION; DIFFERENT EPITOPES; MOUSE PLACENTA; CANCER; TRANSPORTERS; EXPRESSION; MICE; MRP1	Background and Purpose: Retention of substances from systemic circulation in the brain and testes are limited due to high levels of P-glycoprotein (P-gp) in the luminal membranes of brain and testes capillary endothelial cells. From a clinical perspective, P-gp rapidly extrudes lipophilic therapeutic agents, which then fail to reach efficacious levels. Recent studies have demonstrated that acute administration of selective serotonin reuptake inhibitors (SSRI) can affect P-gp function, in vitro and in vivo. However, little is known concerning the time-course of these effects or the effects of different SSRI in vivo. Experimental Approach: The P-gp substrate, tritiated digoxin ([H-3] digoxin), was co-administered with fluoxetine or sertraline to determine if either compound increased drug accumulation within the brains and testes of mice due to inhibition of P-gp activity. We undertook parallel studies in endothelial cells derived from brain microvessels to determine the dose-response and time-course of effects. Key Results: In vitro, sertraline resulted in rapid and potent inhibition of P-gp function in brain endothelial cells, as determined by cellular calcein accumulation. In vivo, a biphasic effect was demonstrated. Brain accumulation of [H-3] digoxin was increased 5 minutes after treatment with sertraline, but by 60 minutes after sertraline treatment, brain accumulation of digoxin was reduced compared to control. By 240 minutes after sertraline treatment brain digoxin accumulation was elevated compared to control. A similar pattern of results was obtained in the testes. There was no significant effect of fluoxetine on P-gp function, in vitro or in vivo. Conclusions and Implications: Acute sertraline administration can modulate P-gp activity in the blood-brain barrier and blood-testes barrier. This clearly has implications for the ability of therapeutic agents that are P-gp substrates, to enter the brain when co-administered with SSRI.	[Kapoor, Amita] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Iqbal, Majid; Petropoulos, Sophie; Ho, Hay Lam; Matthews, Stephen G.] Univ Toronto, Fac Med, Dept Phys, Toronto, ON, Canada; [Iqbal, Majid; Petropoulos, Sophie; Ho, Hay Lam; Matthews, Stephen G.] Univ Toronto, Fac Med, Dept Obstet & Gynecol, Toronto, ON, Canada; [Iqbal, Majid; Petropoulos, Sophie; Ho, Hay Lam; Matthews, Stephen G.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; [Gibb, William] Univ Ottawa, Dept Obstet & Gynecol Cellular & Mol Med, Ottawa, ON, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Toronto; University of Toronto; University of Toronto; University of Ottawa	Kapoor, A (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.	akapoor@wisc.edu	Petropoulos, Sophie/D-6861-2016; Petropoulos, Sophie/M-3090-2017; Matthews, Stephen G/N-7555-2018; Matthews, Stephen/R-5147-2019	Petropoulos, Sophie/0000-0003-2293-8238; Matthews, Stephen G/0000-0002-9654-9940; Matthews, Stephen/0000-0002-9654-9940	Canadian Institutes for Health Research [452740]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes for Health Research 452740 to WG and SGM and Doctoral Research Award to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argov M, 2009, CANCER LETT, V274, P118, DOI 10.1016/j.canlet.2008.09.005; Bansal T, 2009, J PHARM PHARM SCI, V12, P46, DOI 10.18433/J3RC77; Bart J, 2004, EUR J CANCER, V40, P2064, DOI 10.1016/j.ejca.2004.05.010; Bhuiyan M, 2012, REPROD SCI, V19, P407, DOI 10.1177/1933719111424438; Carlson RW, 2006, CANCER INVEST, V24, P677, DOI 10.1080/07357900600981349; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Endres CJ, 2006, EUR J PHARM SCI, V27, P501, DOI 10.1016/j.ejps.2005.11.002; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; Iqbal M, 2011, ENDOCRINOLOGY, V152, P1067, DOI 10.1210/en.2010-1227; Kalabis GM, 2007, PLACENTA, V28, P1073, DOI 10.1016/j.placenta.2007.03.010; Lhomme C, 2008, J CLIN ONCOL, V26, P2674, DOI 10.1200/JCO.2007.14.9807; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Luna-Tortos C, 2010, NEUROPHARMACOLOGY, V58, P1019, DOI 10.1016/j.neuropharm.2010.01.007; Mayer U, 1997, J CLIN INVEST, V100, P2430, DOI 10.1172/JCI119784; Peer D, 2004, CANCER RES, V64, P7562, DOI 10.1158/0008-5472.CAN-03-4046; Petropoulos S, 2010, PLACENTA, V31, P803, DOI 10.1016/j.placenta.2010.06.014; Petropoulos S, 2007, REPROD SCI, V14, P321, DOI 10.1177/1933719107303856; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Seelig A, 2000, INT J CLIN PHARM TH, V38, P111; Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x; Solbach TF, 2006, TRENDS CARDIOVAS MED, V16, P7, DOI 10.1016/j.tcm.2005.10.001; Sun M, 2006, PLACENTA, V27, P602, DOI 10.1016/j.placenta.2005.05.007; THIEBAUT F, 1989, J HISTOCHEM CYTOCHEM, V37, P159, DOI 10.1177/37.2.2463300; TSUJI A, 1992, LIFE SCI, V51, P1427, DOI 10.1016/0024-3205(92)90537-Y; Uhr M, 2003, BIOL PSYCHIAT, V54, P840, DOI 10.1016/S0006-3223(03)00074-X; Uhr M, 2003, J PSYCHIAT RES, V37, P179, DOI 10.1016/S0022-3956(03)00022-0; VANDERVALK P, 1990, ANN ONCOL, V1, P56; Weiss J, 2003, J PHARMACOL EXP THER, V305, P197, DOI 10.1124/jpet.102.046532; Westholm DE, 2008, CURR TOP DEV BIOL, V80, P135, DOI 10.1016/S0070-2153(07)80004-4	30	29	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56525	10.1371/journal.pone.0056525	http://dx.doi.org/10.1371/journal.pone.0056525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468867	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900028
J	Lama, D; Modi, V; Sankararamakrishnan, R				Lama, Dilraj; Modi, Vivek; Sankararamakrishnan, Ramasubbu			Behavior of Solvent-Exposed Hydrophobic Groove in the Anti-Apoptotic Bcl-X-L Protein: Clues for Its Ability to Bind Diverse BH3 Ligands from MD Simulations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; EWALD BOUNDARY-CONDITIONS; CYTOCHROME-C RELEASE; PARTICLE MESH EWALD; INDUCED CELL-DEATH; FAMILY-MEMBERS; STRUCTURAL PLASTICITY; CANCER CELLS; ARTIFICIAL PERIODICITY; BCL-X(L) INHIBITORS	Bcl-X-L is a member of Bcl-2 family of proteins involved in the regulation of intrinsic pathway of apoptosis. Its overexpression in many human cancers makes it an important target for anti-cancer drugs. Bcl-X-L interacts with the BH3 domain of several pro-apoptotic Bcl-2 partners. This helical bundle protein has a pronounced hydrophobic groove which acts as a binding region for the BH3 domains. Eight independent molecular dynamics simulations of the apo/'holo forms of Bcl-X-L were carried out to investigate the behavior of solvent-exposed hydrophobic groove. The simulations used either a twin-range cut-off or particle mesh Ewald (PME) scheme to treat long-range interactions. Destabilization of the BH3 domain-containing helix H2 was observed in all four twin-range cut-off simulations. Most of the other major helices remained stable. The unwinding of H2 can be related to the ability of Bcl-X-L to bind diverse BH3 ligands. The loss of helical character can also be linked to the formation of homo-or hetero-dimers in Bcl-2 proteins. Several experimental studies have suggested that exposure of BH3 domain is a crucial event before they form dimers. Thus unwinding of H2 seems to be functionally very important. The four PME simulations, however, revealed a stable helix H2. It is possible that the H2 unfolding might occur in PME simulations at longer time scales. Hydrophobic residues in the hydrophobic groove are involved in stable interactions among themselves. The solvent accessible surface areas of bulky hydrophobic residues in the groove are significantly buried by the loop LB connecting the helix H2 and subsequent helix. These observations help to understand how the hydrophobic patch in Bcl-X-L remains stable in the solvent-exposed state. We suggest that both the destabilization of helix H2 and the conformational heterogeneity of loop LB are important factors for binding of diverse ligands in the hydrophobic groove of Bcl-X-L.	[Lama, Dilraj; Modi, Vivek; Sankararamakrishnan, Ramasubbu] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Sankararamakrishnan, R (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	rsankar@iitk.ac.in	Lama, Dilraj/ABG-9950-2020	Sankararamakrishnan, Ramasubbu/0000-0002-8527-5614; Modi, Vivek/0000-0002-9742-0559; Lama, Dilraj/0000-0001-8603-9368	IIT-Kanpur	IIT-Kanpur	RS is a USV Chair Professor of IIT-Kanpur. VM thanks IIT-Kanpur for a fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz A, 2012, BIOCHEMISTRY-US, V51, P715, DOI 10.1021/bi201211v; Almerico AM, 2010, EUR J MED CHEM, V45, P4774, DOI 10.1016/j.ejmech.2010.07.042; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barelier S, 2010, J MED CHEM, V53, P2577, DOI 10.1021/jm100009z; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bodur C, 2012, CURR MED CHEM, V19, P1804, DOI 10.2174/092986712800099839; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cordomi A, 2007, J COMPUT CHEM, V28, P1017, DOI 10.1002/jcc.20579; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1998, J COMPUT CHEM, V19, P535, DOI 10.1002/(SICI)1096-987X(19980415)19:5<535::AID-JCC6>3.0.CO;2-N; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Delaney CL, 2001, J NEUROPATH EXP NEUR, V60, P147, DOI 10.1093/jnen/60.2.147; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Diaz JL, 1997, J BIOL CHEM, V272, P11350; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Ernst JT, 2003, ANGEW CHEM INT EDIT, V42, P535, DOI 10.1002/anie.200390154; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Eswar N, 2000, PROTEIN ENG, V13, P227, DOI 10.1093/protein/13.4.227; Ezzoukhry Z, 2011, MOL PHARMACOL, V79, P997, DOI 10.1124/mol.110.070565; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Florova P, 2010, J CHEM THEORY COMPUT, V6, P3569, DOI 10.1021/ct1003687; Friess H, 1998, ANN SURG, V228, P780, DOI 10.1097/00000658-199812000-00009; Furse KE, 2009, J CHEM THEORY COMPUT, V5, P1959, DOI 10.1021/ct9001416; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hinds MG, 2003, EMBO J, V22, P1497, DOI 10.1093/emboj/cdg144; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunenberger PH, 1999, BIOPHYS CHEM, V78, P69, DOI 10.1016/S0301-4622(99)00007-1; Issack BB, 2012, PROTEINS, V80, P1847, DOI 10.1002/prot.24082; Karthik S, 2011, PROTEINS, V79, P1830, DOI 10.1002/prot.23008; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Lama D, 2008, PROTEINS, V73, P492, DOI 10.1002/prot.22075; Lama D, 2011, J COMPUT AID MOL DES, V25, P413, DOI 10.1007/s10822-011-9428-y; Lama D, 2010, BIOCHEMISTRY-US, V49, P2574, DOI 10.1021/bi100029k; Lebedeva I, 2000, CANCER RES, V60, P6052; Leber B, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001572; Lee EF, 2011, CHEMBIOCHEM, V12, P2025, DOI 10.1002/cbic.201100314; Lee EF, 2009, J BIOL CHEM, V284, P30508, DOI 10.1074/jbc.M109.040725; Leech SH, 2000, INT J CANCER, V86, P570, DOI 10.1002/(SICI)1097-0215(20000515)86:4<570::AID-IJC20>3.0.CO;2-T; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lins RD, 2006, J CHEM THEORY COMPUT, V2, P246, DOI 10.1021/ct0501699; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manion MK, 2004, J BIOL CHEM, V279, P2159, DOI 10.1074/jbc.M306021200; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Modi V, 2013, J BIOMOL STRUCT DYN, V31, P65, DOI 10.1080/07391102.2012.691363; Monticelli L, 2004, THEOR CHEM ACC, V112, P145, DOI 10.1007/s00214-004-0565-4; Monticelli L, 2006, J PHYS-CONDENS MAT, V18, pS329, DOI 10.1088/0953-8984/18/14/S15; MORTON A, 1995, BIOCHEMISTRY-US, V34, P8576, DOI 10.1021/bi00027a007; Mukherjee P, 2010, J CHEM INF MODEL, V50, P906, DOI 10.1021/ci1000373; Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Pinto M, 2011, J CHEM INF MODEL, V51, P1249, DOI 10.1021/ci100501d; Prakash P, 2010, J COMPUT CHEM, V31, P266, DOI 10.1002/jcc.21313; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schulz R, 2009, J CHEM THEORY COMPUT, V5, P2798, DOI 10.1021/ct900292r; Shangary S, 2002, BIOCHEMISTRY-US, V41, P9485, DOI 10.1021/bi025605h; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; Silva DA, 2011, PROTEINS, V79, P2097, DOI 10.1002/prot.23030; Simoes-Wust AP, 2000, INT J CANCER, V87, P582, DOI 10.1002/1097-0215(20000815)87:4<582::AID-IJC19>3.0.CO;2-P; Simonen M, 1997, EUR J BIOCHEM, V249, P85, DOI 10.1111/j.1432-1033.1997.t01-1-00085.x; Simonian PL, 1997, BLOOD, V90, P1208, DOI 10.1182/blood.V90.3.1208.1208_1208_1216; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Tieleman DP, 2002, BIOPHYS J, V83, P2393, DOI 10.1016/S0006-3495(02)75253-3; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W.F., 1996, BIOMOLECULAR SIMULAT, P1; Venken T, 2012, PROTEINS, V80, P1633, DOI 10.1002/prot.24057; Villarreal MA, 2005, J BIOMOL STRUCT DYN, V23, P135, DOI 10.1080/07391102.2005.10507054; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weber W, 2000, J PHYS CHEM B, V104, P3668, DOI 10.1021/jp9937757; Yang CY, 2011, ACS MED CHEM LETT, V2, P280, DOI 10.1021/ml100276b; Yap JL, 2012, ORG BIOMOL CHEM, V10, P2928, DOI 10.1039/c2ob07125h; Zhu HB, 2005, MOL CANCER THER, V4, P451	85	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e54397	10.1371/journal.pone.0054397	http://dx.doi.org/10.1371/journal.pone.0054397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468841	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900009
J	Song, C; Chen, GK; Millikan, RC; Ambrosone, CB; John, EM; Bernstein, L; Zheng, W; Hu, JJ; Ziegler, RG; Nyante, S; Bandera, EV; Ingles, SA; Press, MF; Deming, SL; Rodriguez-Gil, JL; Chanock, SJ; Wan, P; Sheng, X; Pooler, LC; Van Den Berg, DJ; Le Marchand, L; Kolonel, LN; Henderson, BE; Haiman, CA; Stram, DO				Song, Chi; Chen, Gary K.; Millikan, Robert C.; Ambrosone, Christine B.; John, Esther M.; Bernstein, Leslie; Zheng, Wei; Hu, Jennifer J.; Ziegler, Regina G.; Nyante, Sarah; Bandera, Elisa V.; Ingles, Sue A.; Press, Michael F.; Deming, Sandra L.; Rodriguez-Gil, Jorge L.; Chanock, Stephen J.; Wan, Peggy; Sheng, Xin; Pooler, Loreall C.; Van Den Berg, David J.; Le Marchand, Loic; Kolonel, Laurence N.; Henderson, Brian E.; Haiman, Chris A.; Stram, Daniel O.			A Genome-Wide Scan for Breast Cancer Risk Haplotypes among African American Women	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY LOCI; P-VALUES; UNRELATED INDIVIDUALS; INFERRED HAPLOTYPES; MAXIMUM-LIKELIHOOD; TRUNCATED PRODUCT; SCORE TESTS; ASSOCIATION; POPULATION	Genome-wide association studies (GWAS) simultaneously investigating hundreds of thousands of single nucleotide polymorphisms (SNP) have become a powerful tool in the investigation of new disease susceptibility loci. Haplotypes are sometimes thought to be superior to SNPs and are promising in genetic association analyses. The application of genome-wide haplotype analysis, however, is hindered by the complexity of haplotypes themselves and sophistication in computation. We systematically analyzed the haplotype effects for breast cancer risk among 5,761 African American women (3,016 cases and 2,745 controls) using a sliding window approach on the genome-wide scale. Three regions on chromosomes 1, 4 and 18 exhibited moderate haplotype effects. Furthermore, among 21 breast cancer susceptibility loci previously established in European populations, 10p15 and 14q24 are likely to harbor novel haplotype effects. We also proposed a heuristic of determining the significance level and the effective number of independent tests by the permutation analysis on chromosome 22 data. It suggests that the effective number was approximately half of the total (7,794 out of 15,645), thus the half number could serve as a quick reference to evaluating genome-wide significance if a similar sliding window approach of haplotype analysis is adopted in similar populations using similar genotype density.	[Song, Chi; Chen, Gary K.; Ingles, Sue A.; Wan, Peggy; Sheng, Xin; Pooler, Loreall C.; Van Den Berg, David J.; Henderson, Brian E.; Haiman, Chris A.; Stram, Daniel O.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Song, Chi; Chen, Gary K.; Ingles, Sue A.; Press, Michael F.; Wan, Peggy; Sheng, Xin; Pooler, Loreall C.; Van Den Berg, David J.; Henderson, Brian E.; Haiman, Chris A.; Stram, Daniel O.] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Chen, Gary K.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Millikan, Robert C.; Nyante, Sarah] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [John, Esther M.] Canc Prevent Inst Calif, Fremont, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [John, Esther M.] Stanford Canc Inst, Stanford, CA USA; [Bernstein, Leslie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Div Canc Etiol, Duarte, CA USA; [Zheng, Wei; Deming, Sandra L.] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Zheng, Wei; Deming, Sandra L.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Hu, Jennifer J.; Rodriguez-Gil, Jorge L.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Hu, Jennifer J.; Rodriguez-Gil, Jorge L.] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Ziegler, Regina G.; Chanock, Stephen J.] NCI, Epidemiol & Biostat Program, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Bandera, Elisa V.] Canc Inst New Jersey, New Brunswick, NJ USA; [Press, Michael F.] Univ So Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA 90089 USA; [Van Den Berg, David J.] Univ So Calif, Epigenome Ctr, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Le Marchand, Loic; Kolonel, Laurence N.] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA	University of Southern California; University of Southern California; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Roswell Park Cancer Institute; Cancer Prevention Institute of California; Stanford University; Stanford Cancer Institute; City of Hope; Beckman Research Institute of City of Hope; Vanderbilt University; Vanderbilt University; University of Miami; University of Miami; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of Southern California; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System	Stram, DO (corresponding author), Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA.	stram@usc.edu	Zheng, Wei/O-3351-2013; Jorge L. Rodriguez-Gil, D.Phil/AAD-3523-2020; Bandera, Elisa V/M-4169-2014; Van Den Berg, David J/G-8598-2017; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; Jorge L. Rodriguez-Gil, D.Phil/0000-0002-1125-1281; Bandera, Elisa V/0000-0002-8789-2755; Van Den Berg, David J/0000-0002-5404-5218; Nyante, Sarah/0000-0002-1770-5993	Department of Defense Breast Cancer Research Program Era of Hope Scholar Award; Norris Foundation; California Breast Cancer Research Program [15UB-8402]; MEC (National Institutes of Health) [R01-CA63464, R37-CA54281]; CARE (National Institute for Child Health and Development) [NO1-HD-3-3175, K05 CA136967]; WCHS (U.S. Army Medical Research and Material Command (USAMRMC) [DAMD-17-01-0-0334]; National Institutes of Health [R01-CA100598]; Breast Cancer Research Foundation; SFBCS (National Institutes of Health) [R01-CA77305]; SFBCS (United States Army Medical Research Program) [DAMD17-96-6071]; NC-BCFR (National Institutes of Health) [U01-CA69417]; CBCS (National Institutes of Health Specialized Program of Research Excellence in Breast Cancer) [P50-CA58223]; Center for Environmental Health and Susceptibility National Institute of Environmental Health Sciences, National Institutes of Health [P30-ES10126]; PLCO (Intramural Research Program, National Cancer Institute, National Institutes of Health); NBHS (National Institutes of Health) [R01-CA100374]; WFBC (National Institutes of Health) [R01-CA73629]; National Cancer Institute, National Institutes of Health [RFA-CA-06-503]; National Heart, Lung, and Blood Institute, NIH, U. S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD033175] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA063464, P50CA058223, R01CA100374, R01CA077305, R01CA073629, K05CA136967, R01CA100598, R37CA054281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032111, N01WH032118, N01WH032102, N01WH042109, N01WH032100, N01WH032119, N01WH042107, N01WH032106, N01WH022110, N01WH042130, N01WH032122, N01WH032113, N01WH032101, N01WH032112, N01WH042132, N01WH032108, N01WH032109, N01WH032105, N01WH032115, N01WH042131, N01WH042129] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program Era of Hope Scholar Award(United States Department of Defense); Norris Foundation; California Breast Cancer Research Program; MEC (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USASpanish Government); CARE (National Institute for Child Health and Development)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); WCHS (U.S. Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; SFBCS (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SFBCS (United States Army Medical Research Program); NC-BCFR (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CBCS (National Institutes of Health Specialized Program of Research Excellence in Breast Cancer)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Environmental Health and Susceptibility National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PLCO (Intramural Research Program, National Cancer Institute, National Institutes of Health); NBHS (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WFBC (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute, NIH, U. S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Department of Defense Breast Cancer Research Program Era of Hope Scholar Award to CAH and the Norris Foundation and by the California Breast Cancer Research Program (15UB-8402). Each of the participating studies was supported by the following grants: MEC (National Institutes of Health grants R01-CA63464 and R37-CA54281); CARE (National Institute for Child Health and Development grant NO1-HD-3-3175, K05 CA136967), WCHS (U.S. Army Medical Research and Material Command (USAMRMC) grant DAMD-17-01-0-0334, the National Institutes of Health grant R01-CA100598, and the Breast Cancer Research Foundation, SFBCS (National Institutes of Health grant R01-CA77305 and United States Army Medical Research Program grant DAMD17-96-6071), NC-BCFR (National Institutes of Health grant U01-CA69417), CBCS (National Institutes of Health Specialized Program of Research Excellence in Breast Cancer, grant number P50-CA58223, and Center for Environmental Health and Susceptibility National Institute of Environmental Health Sciences, National Institutes of Health, grant number P30-ES10126), PLCO (Intramural Research Program, National Cancer Institute, National Institutes of Health), NBHS (National Institutes of Health grantR01-CA100374), WFBC (National Institutes of Health grant R01-CA73629). The Breast Cancer Family Registry (BCFR) was supported by the National Cancer Institute, National Institutes of Health under RFA-CA-06-503 and through cooperative agreements with members of the Breast Cancer Family Registry and Principal Investigators. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the BCFR, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government or the BCFR. The WHI program is funded by the National Heart, Lung, and Blood Institute, NIH, U. S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119,32122, 42107-26, 42129-32, and 44221. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ambrosone CB, 2009, J ONCOL, V2009, DOI 10.1155/2009/871250; Amler LC, 2000, GENOMICS, V64, P195, DOI 10.1006/geno.1999.6097; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Chen F, 2013, HUM GENET, V132, P39, DOI 10.1007/s00439-012-1214-y; Chen F, 2011, HUM MOL GENET, V20, P4491, DOI 10.1093/hmg/ddr367; Chen F, 2011, EUR J HUM GENET, V19, P243, DOI 10.1038/ejhg.2010.185; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Costas J, 2005, GENE, V349, P219, DOI 10.1016/j.gene.2004.12.042; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Guo YF, 2009, EUR J HUM GENET, V17, P785, DOI 10.1038/ejhg.2008.244; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu YJ, 2010, GENET EPIDEMIOL, V34, P803, DOI 10.1002/gepi.20527; Huang L, 2008, ONCOGENE, V27, P6131, DOI 10.1038/onc.2008.208; Jia L, 2009, PLOS GENET, V5, P10; John EM, 2004, BREAST CANCER RES, V6, pR375, DOI 10.1186/bcr801; John EM, 2007, AM J EPIDEMIOL, V166, P1409, DOI 10.1093/aje/kwm259; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Kraft P, 2005, GENET EPIDEMIOL, V28, P261, DOI 10.1002/gepi.20061; Kraft P, 2007, AM J HUM GENET, V81, P863, DOI 10.1086/521371; Lambert JC, 2013, MOL PSYCHIATR, V18, P461, DOI 10.1038/mp.2012.14; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin DY, 2007, USE INFERRED HAPLOTY, V80, P2006; Liu NJ, 2008, ADV GENET, V60, P335, DOI 10.1016/S0065-2660(07)00414-2; Lorenz AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014079; Marchbanks PA, 2002, ANN EPIDEMIOL, V12, P213, DOI 10.1016/S1047-2797(01)00274-5; Mathias RA, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-38; Meng ZL, 2003, AM J HUM GENET, V73, P115, DOI 10.1086/376561; Methods MHA, 2012, STAT HUMAN GENETICS, V850, P423, DOI [10.1007/978-1-61779-555-8, DOI 10.1007/978-1-61779-555-8]; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; NEWMAN B, 1995, BREAST CANCER RES TR, V35, P51, DOI 10.1007/BF00694745; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Poduslo SE, 2010, AM J MED GENET B, V153B, P114, DOI 10.1002/ajmg.b.30963; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Prorok PC, 2000, DESIGN PROSTATE LUNG; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shim Heejung, 2009, BMC Proc, V3 Suppl 7, pS35; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Sung YJ, 2012, GENET EPIDEMIOL, V36, P508, DOI 10.1002/gepi.21647; Tang R, 2009, ANN HUM GENET, V73, P631, DOI 10.1111/j.1469-1809.2009.00543.x; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Wang XY, 2010, ADV MAT RES, V83-86, P1, DOI 10.4028/www.scientific.net/AMR.83-86.1; Wang Y, 2007, GENET MOL RES, V6, P1131; Xie RR, 2005, GENET EPIDEMIOL, V29, P166, DOI 10.1002/gepi.20087; Zaboli G, 2008, AM J MED GENET B, V147B, P301, DOI 10.1002/ajmg.b.30597; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhang C, 2006, BIOINFORMATICS, V22, P2122, DOI 10.1093/bioinformatics/btl365; Zhao HY, 2003, PHARMACOGENOMICS, V4, P171, DOI 10.1517/phgs.4.2.171.22636; Zheng W, 2009, CANCER EPIDEM BIOMAR, V18, P2761, DOI 10.1158/1055-9965.EPI-09-0624	70	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57298	10.1371/journal.pone.0057298	http://dx.doi.org/10.1371/journal.pone.0057298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468962	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900070
J	Braga, RF; Korasaki, V; Andresen, E; Louzada, J				Braga, Rodrigo F.; Korasaki, Vanesca; Andresen, Ellen; Louzada, Julio			Dung Beetle Community and Functions along a Habitat-Disturbance Gradient in the Amazon: A Rapid Assessment of Ecological Functions Associated to Biodiversity	PLOS ONE			English	Article							SECONDARY SEED DISPERSAL; ECOSYSTEM FUNCTION; RAIN-FOREST; CONSERVATION BIOLOGY; SCARABAEIDAE; FRAGMENTATION; COLEOPTERA; DIVERSITY; LAND; INTENSIFICATION	Although there is increasing interest in the effects of habitat disturbance on community attributes and the potential consequences for ecosystem functioning, objective approaches linking biodiversity loss to functional loss are uncommon. The objectives of this study were to implement simultaneous assessment of community attributes (richness, abundance and biomass, each calculated for total-beetle assemblages as well as small-and large-beetle assemblages) and three ecological functions of dung beetles (dung removal, soil perturbation and secondary seed dispersal), to compare the effects of habitat disturbance on both sets of response variables, and their relations. We studied dung beetle community attributes and functions in five land-use systems representing a disturbance gradient in the Brazilian Amazon: primary forest, secondary forest, agroforestry, agriculture and pasture. All response variables were affected negatively by the intensification of habitat disturbance regimes, but community attributes and ecological functions did not follow the same pattern of decline. A hierarchical partitioning analysis showed that, although all community attributes had a significant effect on the three ecological functions (except the abundance of small beetles on all three ecological functions and the biomass of small beetles on secondary dispersal of large seed mimics), species richness and abundance of large beetles were the community attributes with the highest explanatory value. Our results show the importance of measuring ecological function empirically instead of deducing it from community metrics.	[Braga, Rodrigo F.; Korasaki, Vanesca; Louzada, Julio] Univ Fed Lavras, Dept Biol, Setor Ecol & Conservacao, Lavras, MG, Brazil; [Andresen, Ellen] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico	Universidade Federal de Lavras; Universidad Nacional Autonoma de Mexico	Braga, RF (corresponding author), Univ Fed Lavras, Dept Biol, Setor Ecol & Conservacao, Campus Univ, Lavras, MG, Brazil.	rodrigo.fagundes@yahoo.com.br	Louzada, Julio/F-1265-2010; Andresen, Ellen/AFM-7145-2022	Louzada, Julio/0000-0002-1481-3112; Andresen, Ellen/0000-0001-8957-4454; Korasaki, Vanesca/0000-0001-6239-2976	Global Environmental Facility (GEF); CAPES [5081-11-4]	Global Environmental Facility (GEF); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank Conservation and Sustainable Management of Below-Ground Biodiversity (CSM-BGBD), coordinated by the Tropical Soil Biology and Fertility Institute of CIAT (TSBF-CIAT) with funding from the Global Environmental Facility (GEF) and implemented by the United Nations Environmental Program (UNEP), which is coordinated in Brazil by Dr. F.M.S. Moreira, Universidade Federal de Lavras (UFLA). RFB thanks CAPES for the scholarship granted (process 5081-11-4), and VK thanks Capes for the scholarship granted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida S, 2011, BIOTROPICA, V43, P704, DOI 10.1111/j.1744-7429.2011.00751.x; Altieri MA, 1993, BIODIVERSITY PEST MA; Amezquita S, 2010, ENVIRON ENTOMOL, V39, P328, DOI 10.1603/EN09182; Andresen E, 1999, BIOTROPICA, V31, P145, DOI 10.1111/j.1744-7429.1999.tb00125.x; Andresen E, 2002, ECOL ENTOMOL, V27, P257, DOI 10.1046/j.1365-2311.2002.00408.x; Andresen E, 2004, OECOLOGIA, V139, P45, DOI 10.1007/s00442-003-1480-4; Andresen E, 2003, ECOGRAPHY, V26, P87, DOI 10.1034/j.1600-0587.2003.03362.x; Andresen E, 2001, J TROP ECOL, V17, P61, DOI 10.1017/S0266467401001043; Andresen Ellen, 2005, P331, DOI 10.1079/9780851998060.0331; Anduaga S, 2004, ENVIRON ENTOMOL, V33, P1306, DOI 10.1603/0046-225X-33.5.1306; Bang HS, 2005, APPL SOIL ECOL, V29, P165, DOI 10.1016/j.apsoil.2004.11.001; Barragan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017976; BERGSTROM RC, 1976, P HELM SOC WASH, V43, P171; Braga RF, 2012, ECOSYSTEMS, V15, P1173, DOI 10.1007/s10021-012-9576-5; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Coelho MR, 2005, CONSERVATION SUSTAIN; Colwell RK, 2013, ESTIMATES STAT ESTIM; Crawley M. J, 2002, STAT COMPUTING INTRO; Culot L, 2011, BIOTROPICA, V43, P84, DOI 10.1111/j.1744-7429.2010.00655.x; Dangles O, 2012, ECOLOGY, V93, P2615, DOI 10.1890/12-0510.1; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Escobar F, 2008, J APPL ECOL, V45, P1584, DOI 10.1111/j.1365-2664.2008.01551.x; Feer F, 2005, CONSERV BIOL, V19, P1103, DOI 10.1111/j.1523-1739.2005.00087.x; Feer F, 1999, J TROP ECOL, V15, P129, DOI 10.1017/S0266467499000711; Fidalgo ECC, 2005, CONSERVATION SUSTAIN; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Halffer G, 1982, NESTING BEHAV DUNG B; Hanski I., 1991, P305; Hassan R., 2005, ECOSYSTEMS HUMAN WEL, V1, P297, DOI DOI 10.1021/JF020083Y; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horgan FG, 2005, FOREST ECOL MANAG, V216, P117, DOI 10.1016/j.foreco.2005.05.049; Jacobs CT, 2010, J INSECT CONSERV, V14, P389, DOI 10.1007/s10841-010-9270-x; Koike S, 2012, ACTA OECOL, V41, P74, DOI 10.1016/j.actao.2012.04.009; Korasaki V, 2012, INSECT SCI, V00, P1; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Lawson CR, 2012, BIOTROPICA, V44, P271, DOI 10.1111/j.1744-7429.2012.00871.x; Lewis OT, 2009, BASIC APPL ECOL, V10, P97, DOI 10.1016/j.baae.2008.08.010; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Louzada J, 2010, LANDSCAPE ECOL, V25, P631, DOI 10.1007/s10980-010-9448-3; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; MCKINNEY GT, 1975, J APPL ECOL, V12, P831; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; R Core Team, 2016, R FDN STAT COMP; SAMWAYS MJ, 1995, INSECT CONSERVATION; Santos-Heredia C, 2011, INTEGR ZOOL, V6, P399, DOI 10.1111/j.1749-4877.2011.00261.x; Santos-Heredia C, 2010, J TROP ECOL, V26, P355, DOI 10.1017/S0266467410000192; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Simelane TS, 2010, AFR J ECOL, V48, P490, DOI 10.1111/j.1365-2028.2009.01138.x; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Slade EM, 2011, BIOL CONSERV, V144, P166, DOI 10.1016/j.biocon.2010.08.011; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Tilman D, 1999, SCIENCE, V286, P1099, DOI 10.1126/science.286.5442.1099; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Vulinec K, 2002, BIOTROPICA, V34, P297, DOI 10.1111/j.1744-7429.2002.tb00541.x; Yamada Daigo, 2007, Grassland Science, V53, P121, DOI 10.1111/j.1744-697X.2007.00082.x	60	143	146	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57786	10.1371/journal.pone.0057786	http://dx.doi.org/10.1371/journal.pone.0057786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460906	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000315519000161
J	Del Coso, J; Fernandez, D; Abian-Vicen, J; Salinero, JJ; Gonzalez-Millan, C; Areces, F; Ruiz, D; Gallo, C; Calleja-Gonzalez, J; Perez-Gonzalez, B				Del Coso, Juan; Fernandez, David; Abian-Vicen, Javier; Jose Salinero, Juan; Gonzalez-Millan, Cristina; Areces, Francisco; Ruiz, Diana; Gallo, Cesar; Calleja-Gonzalez, Julio; Perez-Gonzalez, Benito			Running Pace Decrease during a Marathon Is Positively Related to Blood Markers of Muscle Damage	PLOS ONE			English	Article							PROLONGED STRENUOUS EXERCISE; HEAT ILLNESS; TEMPERATURE; HYDRATION; DEHYDRATION; PERFORMANCE; GLYCOGEN; FATIGUE; THERMOREGULATION; RUNNERS	Background: Completing a marathon is one of the most challenging sports activities, yet the source of running fatigue during this event is not completely understood. The aim of this investigation was to determine the cause(s) of running fatigue during a marathon in warm weather. Methodology/Principal Findings: We recruited 40 amateur runners (34 men and 6 women) for the study. Before the race, body core temperature, body mass, leg muscle power output during a countermovement jump, and blood samples were obtained. During the marathon (27 degrees C; 27% relative humidity) running fatigue was measured as the pace reduction from the first 5-km to the end of the race. Within 3 min after the marathon, the same pre-exercise variables were obtained. Results: Marathoners reduced their running pace from 3.5 +/- 0.4 m/s after 5-km to 2.9 +/- 0.6 m/s at the end of the race (P<0.05), although the running fatigue experienced by the marathoners was uneven. Marathoners with greater running fatigue (> 15% pace reduction) had elevated post-race myoglobin (1318 +/- 1411 v 623 +/- 391 mu g L-1; P<0.05), lactate dehydrogenase (687 +/- 151 v 583 +/- 117 U L-1; P<0.05), and creatine kinase (564 +/- 469 v 363 +/- 158 U L-1; P = 0.07) in comparison with marathoners that preserved their running pace reasonably well throughout the race. However, they did not differ in their body mass change (-3.1 +/- 1.0 v -3.0 +/- 1.0%; P = 0.60) or post-race body temperature (38.7 +/- 0.7 v 38.9 +/- 0.9 degrees C; P = 0.35). Conclusions/Significance: Running pace decline during a marathon was positively related with muscle breakdown blood markers. To elucidate if muscle damage during a marathon is related to mechanistic or metabolic factors requires further investigation.	[Del Coso, Juan; Abian-Vicen, Javier; Jose Salinero, Juan; Gonzalez-Millan, Cristina; Areces, Francisco; Ruiz, Diana; Gallo, Cesar; Perez-Gonzalez, Benito] Camilo Jose Cela Univ, Sports Sci Inst, Exercise Physiol Lab, Madrid, Spain; [Fernandez, David] Univ Complutense, Fac Med, E-28040 Madrid, Spain; [Calleja-Gonzalez, Julio] Univ Basque Country, Fac Sport Sci, Lab Anal Sport Performance, Sport & Phys Educ Dept, Vitoria, Spain	Camilo Jose Cela University; Complutense University of Madrid; University of Basque Country	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Sports Sci Inst, Exercise Physiol Lab, Madrid, Spain.	jdelcoso@ucjc.edu	Areces, Francisco/ABH-3023-2020; GALLO, CESAR/O-4823-2019; Abián-Vicén, Javier/I-8509-2012; Pérez-González, Benito/AAF-7128-2021; Salinero, Juan J./GLT-1243-2022; Calleja-Gonzalez, Julio/AAX-3058-2021; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012; Del Coso, Juan/AAC-7117-2020	Areces, Francisco/0000-0003-2996-4156; GALLO, CESAR/0000-0001-8676-4658; Abián-Vicén, Javier/0000-0001-9635-3289; Pérez-González, Benito/0000-0002-6191-2885; Salinero, Juan J./0000-0003-4153-5100; MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; Del Coso, Juan/0000-0002-5785-984X; CALLEJA GONZALEZ, JULIO MARIA/0000-0003-4878-0176; calleja-gonzalez, julio/0000-0003-2575-7168; Fernandez-de-Velasco, David/0000-0003-0889-8145; Gonzalez-Millan, Cristina/0000-0002-3371-9420				Armstrong LE, 2007, MED SCI SPORT EXER, V39, P556, DOI 10.1249/MSS.0b013e31802fa199; Beis LY, 2012, CLIN J SPORT MED, V22, P254, DOI 10.1097/JSM.0b013e31824a55d7; Blake JB, 1903, BOSTON MED SURG J, V148, P41; CALLOW M, 1986, EUR J APPL PHYSIOL O, V55, P654, DOI 10.1007/BF00423212; Casa DJ, 2010, J ATHL TRAINING, V45, P147, DOI 10.4085/1062-6050-45.2.147; Cheuvront SN, 2002, MED SCI SPORT EXER, V34, P1344, DOI 10.1097/00005768-200208000-00017; Cheuvront SN, 2001, SPORTS MED, V31, P743, DOI 10.2165/00007256-200131100-00004; Coso JD, 2012, APPL PHYSL IN PRESS; Coso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039558; Coyle EF, 2007, SPORTS MED, V37, P306, DOI 10.2165/00007256-200737040-00009; COYLE EF, 1986, J APPL PHYSIOL, V61, P165, DOI 10.1152/jappl.1986.61.1.165; Ely MR, 2008, MED SCI SPORT EXER, V40, P1675, DOI 10.1249/MSS.0b013e3181788da9; Finch CF, 2008, J SCI MED SPORT, V11, P48, DOI 10.1016/j.jsams.2007.08.008; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; Gonzalez-Alonso J, 2008, J PHYSIOL-LONDON, V586, P45, DOI 10.1113/jphysiol.2007.142158; Gonzalez-Alonso J, 2007, SPORTS MED, V37, P371, DOI 10.2165/00007256-200737040-00025; Gosztyla AE, 2006, J STRENGTH COND RES, V20, P882, DOI 10.1519/R-19275.1; Goulet EDB, 2011, BRIT J SPORT MED, V45, P1149, DOI 10.1136/bjsm.2010.077966; HIKIDA RS, 1983, J NEUROL SCI, V59, P185, DOI 10.1016/0022-510X(83)90037-0; Kratz A, 2002, AM J CLIN PATHOL, V118, P856, DOI 10.1092/BTWQ5YMYVQ67QK9L; Laursen PB, 2006, BRIT J SPORT MED, V40, P320, DOI 10.1136/bjsm.2005.022426; Maughan R J, 1985, Br J Sports Med, V19, P192; MAUGHAN RJ, 1985, INT J SPORTS MED, V6, P15, DOI 10.1055/s-2008-1025806; Maughan RJ, 2007, SPORTS MED, V37, P396, DOI 10.2165/00007256-200737040-00032; MCCARTHY DA, 1988, SPORTS MED, V6, P333, DOI 10.2165/00007256-198806060-00002; Meludu S C, 2005, Niger J Physiol Sci, V20, P43; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Mora-Rodriguez R, 2010, EUR J APPL PHYSIOL, V109, P973, DOI 10.1007/s00421-010-1436-4; Noakes TD, 2007, J SPORT SCI, V25, P781, DOI 10.1080/02640410600875036; NOAKES TD, 1991, MED SCI SPORT EXER, V23, P443; Noakes TD, 2007, SPORTS MED, V37, P463, DOI 10.2165/00007256-200737040-00050; Nybo L, 2003, MED SCI SPORT EXER, V35, P589, DOI 10.1249/01.MSS.0000058433.85789.66; Passe D, 2007, INT J SPORT NUTR EXE, V17, P284, DOI 10.1123/ijsnem.17.3.284; Pfeiffer B, 2012, MED SCI SPORT EXER, V44, P344, DOI 10.1249/MSS.0b013e31822dc809; PUGH LGC, 1967, J APPL PHYSIOL, V23, P347, DOI 10.1152/jappl.1967.23.3.347; Rapoport BI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000960; Rust CA, 2012, J STRENGTH COND RES, V26, P1505, DOI 10.1519/JSC.0b013e318231a7b5; Salinero JJ, 2012, ANN C SPAN OL COMM, P3; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; SCHIFF HB, 1978, Q J MED, V47, P463; SHERMAN WM, 1983, J APPL PHYSIOL, V55, P1219, DOI 10.1152/jappl.1983.55.4.1219; Shirreffs SM, 2000, J SPORT MED PHYS FIT, V40, P80; Smith JE, 2004, BRIT J SPORT MED, V38, P292, DOI 10.1136/bjsm.2002.002873; Tee JC, 2007, SPORTS MED, V37, P827, DOI 10.2165/00007256-200737100-00001; Vihma T, 2010, INT J BIOMETEOROL, V54, P297, DOI 10.1007/s00484-009-0280-x; Wyndham C H, 1969, S Afr Med J, V43, P893	46	67	69	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57602	10.1371/journal.pone.0057602	http://dx.doi.org/10.1371/journal.pone.0057602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460881	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000136
J	Geller, R; Andino, R; Frydman, J				Geller, Ron; Andino, Raul; Frydman, Judith			Hsp90 Inhibitors Exhibit Resistance-Free Antiviral Activity against Respiratory Syncytial Virus	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; SHOCK-PROTEIN 90; GENE NETWORKS; REPLICATION; PREVENTION; EVOLUTION; INFECTION	Respiratory syncytial virus (RSV) is a major cause of respiratory illness in young children, leading to significant morbidity and mortality worldwide. Despite its medical importance, no vaccine or effective therapeutic interventions are currently available. Therefore, there is a pressing need to identify novel antiviral drugs to combat RSV infections. Hsp90, a cellular protein-folding factor, has been shown to play an important role in the replication of numerous viruses. We here demonstrate that RSV requires Hsp90 for replication. Mechanistic studies reveal that inhibition of Hsp90 during RSV infection leads to the degradation of a viral protein similar in size to the RSV L protein, the viral RNA-dependent RNA polymerase, implicating it as an Hsp90 client protein. Accordingly, Hsp90 inhibitors exhibit antiviral activity against laboratory and clinical isolates of RSV in both immortalized as well as primary differentiated airway epithelial cells. Interestingly, we find a high barrier to the emergence of drug resistance to Hsp90 inhibitors, as extensive growth of RSV under conditions of Hsp90 inhibition did not yield mutants with reduced sensitivity to these drugs. Our results suggest that Hsp90 inhibitors may present attractive antiviral therapeutics for treatment of RSV infections and highlight the potential of chaperone inhibitors as antivirals exhibiting high barriers to development of drug resistance.	[Geller, Ron; Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Frydman, J (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Geller, Ron/D-2919-2017	Geller, Ron/0000-0002-7612-4611; , judith/0000-0003-2302-6943	NIH [GM56433, AI91575]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI091575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056433, R01GM056433] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by NIH grants GM56433 to JF and AI91575 to JF and RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco JCG, 2010, HUM VACCINES, V6, P482, DOI 10.4161/hv.6.6.11562; Brasier AR, 2004, J VIROL, V78, P11461, DOI 10.1128/JVI.78.21.11461-11476.2004; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Collins PL, 2007, FIELDS VIROLOGY, P1497; Connor JH, 2007, VIROLOGY, V362, P109, DOI 10.1016/j.virol.2006.12.026; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Empey KM, 2010, CLIN INFECT DIS, V50, P1258, DOI 10.1086/651603; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Geller R, 2012, BBA-MOL CELL RES, V1823, P698, DOI 10.1016/j.bbamcr.2011.11.007; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Lundin A, 2010, ANTIVIR RES, V88, P317, DOI 10.1016/j.antiviral.2010.10.004; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Murata Y, 2007, ANTIVIR THER, V12, P659; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nijhuis M., 2009, V189, P299, DOI 10.1007/978-3-540-79086-0_11; Pashtan I, 2008, CELL CYCLE, V7, P2936, DOI 10.4161/cc.7.18.6701; Radhakrishnan A, 2010, MOL CELL PROTEOMICS, V9, P1829, DOI 10.1074/mcp.M110.001651; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Taguwa S, 2008, J VIROL, V82, P2631, DOI 10.1128/JVI.02153-07; Taguwa S, 2009, J VIROL, V83, P10427, DOI 10.1128/JVI.01035-09; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Whitesell L, 2012, BBA-MOL CELL RES, V1823, P756, DOI 10.1016/j.bbamcr.2011.12.006; Wright M, 2011, PEDIATR PULM, V46, P324, DOI 10.1002/ppul.21377; Xiao A, 2010, ARCH VIROL, V155, P1021, DOI 10.1007/s00705-010-0691-3; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002; Zhang YH, 2001, J VIROL, V75, P9044, DOI 10.1128/JVI.75.19.9044-9058.2001; zur Wiesch PA, 2011, LANCET INFECT DIS, V11, P236, DOI 10.1016/S1473-3099(10)70264-4	35	45	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56762	10.1371/journal.pone.0056762	http://dx.doi.org/10.1371/journal.pone.0056762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460813	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000036
J	Giannotti, D; Patrizi, G; Di Rocco, G; Vestri, AR; Semproni, CP; Fiengo, L; Pontone, S; Palazzini, G; Redler, A				Giannotti, Domenico; Patrizi, Gregorio; Di Rocco, Giorgio; Vestri, Anna Rita; Semproni, Camilla Proietti; Fiengo, Leslie; Pontone, Stefano; Palazzini, Giorgio; Redler, Adriano			Play to Become a Surgeon: Impact of Nintendo WII Training on Laparoscopic Skills	PLOS ONE			English	Article							VIRTUAL-REALITY SIMULATOR; VIDEO GAMES; SURGICAL SKILLS; PERFORMANCE; FUNDAMENTALS; ACQUISITION; VALIDATION	Background: Video-games have become an integral part of the new multimedia culture. Several studies assessed video-gaming enhancement of spatial attention and eye-hand coordination. Considering the technical difficulty of laparoscopic procedures, legal issues and time limitations, the validation of appropriate training even outside of the operating rooms is ongoing. We investigated the influence of a four-week structured Nintendo (R) Wii (TM) training on laparoscopic skills by analyzing performance metrics with a validated simulator (Lap Mentor (TM), Simbionix (TM)). Methodology/Principal Findings: We performed a prospective randomized study on 42 post-graduate I-II year residents in General, Vascular and Endoscopic Surgery. All participants were tested on a validated laparoscopic simulator and then randomized to group 1 (Controls, no training with the Nintendo (R) Wii (TM)), and group 2 (training with the Nintendo (R) Wii (TM)) with 21 subjects in each group, according to a computer-generated list. After four weeks, all residents underwent a testing session on the laparoscopic simulator of the same tasks as in the first session. All 42 subjects in both groups improved significantly from session 1 to session 2. Compared to controls, the Wii group showed a significant improvement in performance (p<0.05) for 13 of the 16 considered performance metrics. Conclusions/Significance: The Nintendo (R) Wii (TM) might be helpful, inexpensive and entertaining part of the training of young laparoscopists, in addition to a standard surgical education based on simulators and the operating room.	[Giannotti, Domenico; Patrizi, Gregorio; Di Rocco, Giorgio; Fiengo, Leslie; Pontone, Stefano; Palazzini, Giorgio; Redler, Adriano] Univ Roma La Sapienza, Dept Surg Sci, Fac Med & Dent, Rome, Italy; [Vestri, Anna Rita] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Fac Pharm & Med, Rome, Italy; [Semproni, Camilla Proietti] Univ Roma La Sapienza, Dept Radiol Sci Oncol & Pathol, Fac Med & Dent, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Patrizi, G (corresponding author), Univ Roma La Sapienza, Dept Surg Sci, Fac Med & Dent, Rome, Italy.	g_patrizi@yahoo.com	Pontone, Stefano/H-7681-2019	Pontone, Stefano/0000-0001-7148-3220; Patrizi, Gregorio/0000-0002-3219-6242				Badurdeen S, 2010, SURG ENDOSC, V24, P1824, DOI 10.1007/s00464-009-0862-z; Boyle E, 2011, J SURG EDUC, V68, P148, DOI 10.1016/j.jsurg.2010.11.005; Chaudhry A, 1999, ANN ROY COLL SURG, V81, P281; Gallagher AG, 1998, ENDOSCOPY, V30, P617, DOI 10.1055/s-2007-1001366; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Grantcharov TP, 2003, AM J SURG, V185, P146, DOI 10.1016/S0002-9610(02)01213-8; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hafford ML, 2013, SURG ENDOSC, V27, P118, DOI 10.1007/s00464-012-2437-7; Hamdorf JM, 2000, BRIT J SURG, V87, P28, DOI 10.1046/j.1365-2168.2000.01327.x; Johannes F, 2003, GAME STUDIES, V3, P1; Jones DB, 1996, SURG LAPAROSC ENDOSC, V6, P191, DOI 10.1097/00019509-199606000-00005; Lynch J, 2010, J SURG EDUC, V67, P184, DOI 10.1016/j.jsurg.2010.02.010; Lynch PJ, 1999, PSYCHOSOM MED, V61, P113, DOI 10.1097/00006842-199901000-00157; Palter VN, 2013, ANN SURG, V257, P224, DOI 10.1097/SLA.0b013e31827051cd; Peters JH, 2004, SURGERY, V135, P21, DOI 10.1016/S0039-6060(03)00156-9; Rosenberg BH, 2005, J ENDOUROL, V19, P372, DOI 10.1089/end.2005.19.372; Rosser JC, 2007, ARCH SURG-CHICAGO, V142, P181, DOI 10.1001/archsurg.142.2.181; Schlickum MK, 2008, ST HEAL T, V132, P210; Schlickum MK, 2009, WORLD J SURG, V33, P2360, DOI 10.1007/s00268-009-0151-y; Strauss RS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e85; Wilson MR, 2011, SURG ENDOSC, V25, P2268, DOI 10.1007/s00464-010-1546-4	21	39	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57372	10.1371/journal.pone.0057372	http://dx.doi.org/10.1371/journal.pone.0057372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460845	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000099
J	Hadad, I; Veithen, A; Springael, JY; Sotiropoulou, PA; Da Costa, AM; Miot, F; Naeije, R; De Deken, X; Mc Entee, K				Hadad, Ielham; Veithen, Alex; Springael, Jean-Yves; Sotiropoulou, Panagiota A.; Da Costa, Agnes Mendes; Miot, Francoise; Naeije, Robert; De Deken, Xavier; Mc Entee, Kathleen			Stroma Cell-Derived Factor-1 alpha Signaling Enhances Calcium Transients and Beating Frequency in Rat Neonatal Cardiomyocytes	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; CA2+ TRANSIENTS; CXCR4; HEART; EXPRESSION; MYOCYTES; THERAPY	Stroma cell-derived factor-1 alpha (SDF-1 alpha) is a cardioprotective chemokine, acting through its G-protein coupled receptor CXCR4. In experimental acute myocardial infarction, administration of SDF-1 alpha induces an early improvement of systolic function which is difficult to explain solely by an anti-apoptotic and angiogenic effect. We wondered whether SDF-1 alpha signaling might have direct effects on calcium transients and beating frequency. Primary rat neonatal cardiomyocytes were culture-expanded and characterized by immunofluorescence staining. Calcium sparks were studied by fluorescence microscopy after calcium loading with the Fluo-4 acetoxymethyl ester sensor. The cardiomyocyte enriched cellular suspension expressed troponin I and CXCR4 but was vimentin negative. Addition of SDF-1 alpha in the medium increased cytoplasmic calcium release. The calcium response was completely abolished by using a neutralizing anti-CXCR4 antibody and partially suppressed and delayed by preincubation with an inositol triphosphate receptor (IP3R) blocker, but not with a ryanodine receptor (RyR) antagonist. Calcium fluxes induced by caffeine, a RyR agonist, were decreased by an IP3R blocker. Treatment with forskolin or SDF-1 alpha increased cardiomyocyte beating frequency and their effects were additive. In vivo, treatment with SDF-1 alpha increased left ventricular dP/dtmax. These results suggest that in rat neonatal cardiomyocytes, the SDF-1 alpha/CXCR4 signaling increases calcium transients in an IP3-gated fashion leading to a positive chronotropic and inotropic effect.	[Hadad, Ielham; Da Costa, Agnes Mendes; Naeije, Robert; Mc Entee, Kathleen] Univ Libre Brussels, Dept Physiopathol, Fac Med, Brussels, Belgium; [Springael, Jean-Yves; Sotiropoulou, Panagiota A.; Miot, Francoise; De Deken, Xavier] Univ Libre Brussels, Inst Rech Interdisciplinaire Biol Humaine & Mol, Fac Med, Brussels, Belgium; [Veithen, Alex] Chemcom SA, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Hadad, I (corresponding author), Univ Libre Brussels, Dept Physiopathol, Fac Med, Brussels, Belgium.	ielham.hadad@ulb.ac.be		Mc Entee, Kathleen/0000-0003-3521-9232	Foundation for Cardiac Surgery, Brussels, Belgium	Foundation for Cardiac Surgery, Brussels, Belgium	This work was supported by the Foundation for Cardiac Surgery, Brussels, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Chlopcikova Sarka, 2001, Biomedical Papers (Olomouc), V145, P49; GO LO, 1995, J CLIN INVEST, V95, P888, DOI 10.1172/JCI117739; HARARY I, 1973, ARCH BIOCHEM BIOPHYS, V156, P563, DOI 10.1016/0003-9861(73)90306-8; Harzheim D, 2009, P NATL ACAD SCI USA, V106, P11406, DOI 10.1073/pnas.0905485106; Hasenfuss G, 2011, EUR HEART J, V32, P1838, DOI 10.1093/eurheartj/ehr026; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Janowski E, 2010, AM J PHYSIOL-HEART C, V298, pH1939, DOI 10.1152/ajpheart.00607.2009; Kanki S, 2011, CIRC-HEART FAIL, V4, P509, DOI 10.1161/CIRCHEARTFAILURE.110.960302; LaRocca TJ, 2010, J CARDIOVASC PHARM, V56, P548, DOI 10.1097/FJC.0b013e3181f713fe; Lee BC, 2009, EUR J HEART FAIL, V11, P238, DOI 10.1093/eurjhf/hfn035; Leszek P, 2007, EUR J HEART FAIL, V9, P579, DOI 10.1016/j.ejheart.2007.01.011; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; Mathieu M, 2009, J THORAC CARDIOV SUR, V138, P646, DOI 10.1016/j.jtcvs.2008.12.031; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Pillarisetti K, 2001, INFLAMMATION, V25, P293, DOI 10.1023/A:1012808525370; Pyo RT, 2006, J MOL CELL CARDIOL, V41, P834, DOI 10.1016/j.yjmcc.2006.08.008; Rubin JB, 2009, SEMIN CANCER BIOL, V19, P116, DOI 10.1016/j.semcancer.2008.10.001; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Seki S, 2003, CARDIOVASC RES, V58, P535, DOI 10.1016/S0008-6363(03)00255-4; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Winship IR, 2007, J NEUROSCI, V27, P6268, DOI 10.1523/JNEUROSCI.4801-06.2007; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	27	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56007	10.1371/journal.pone.0056007	http://dx.doi.org/10.1371/journal.pone.0056007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460790	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000013
J	Hobson-Peters, J; Yam, AWY; Lu, JWF; Setoh, YX; May, FJ; Kurucz, N; Walsh, S; Prow, NA; Davis, SS; Weir, R; Melville, L; Hunt, N; Webb, RI; Blitvich, BJ; Whelan, P; Hall, RA				Hobson-Peters, Jody; Yam, Alice Wei Yee; Lu, Jennifer Wei Fei; Setoh, Yin Xiang; May, Fiona J.; Kurucz, Nina; Walsh, Susan; Prow, Natalie A.; Davis, Steven S.; Weir, Richard; Melville, Lorna; Hunt, Neville; Webb, Richard I.; Blitvich, Bradley J.; Whelan, Peter; Hall, Roy A.			A New Insect-Specific Flavivirus from Northern Australia Suppresses Replication of West Nile Virus and Murray Valley Encephalitis Virus in Co-infected Mosquito Cells	PLOS ONE			English	Article							CULEX FLAVIVIRUS; MONOCLONAL-ANTIBODIES; JAPANESE ENCEPHALITIS; GENETIC-CHARACTERIZATION; ENVELOPE PROTEIN; SEQUENCE; AEDES; INTERFERENCE; TRANSMISSION; STRAIN	Recent reports of a novel group of flaviviruses that replicate only in mosquitoes and appear to spread through insect populations via vertical transmission have emerged from around the globe. To date, there is no information on the presence or prevalence of these insect-specific flaviviruses (ISFs) in Australian mosquito species. To assess whether such viruses occur locally, we used reverse transcription-polymerase chain reaction (RT-PCR) and flavivirus universal primers that are specific to the NS5 gene to detect these viruses in mosquito pools collected from the Northern Territory. Of 94 pools of mosquitoes, 13 were RT-PCR positive, and of these, 6 flavivirus isolates were obtained by inoculation of mosquito cell culture. Sequence analysis of the NS5 gene revealed that these isolates are genetically and phylogenetically similar to ISFs reported from other parts of the world. The entire coding region of one isolate (designated 56) was sequenced and shown to have approximately 63.7% nucleotide identity and 66.6% amino acid identity with its closest known relative (Nakiwogo virus) indicating that the prototype Australian ISF represents a new species. All isolates were obtained from Coquillettidia xanthogaster mosquitoes. The new virus is tentatively named Palm Creek virus (PCV) after its place of isolation. We also demonstrated that prior infection of cultured mosquito cells with PCV suppressed subsequent replication of the medically significant West Nile and Murray Valley encephalitis viruses by 10-43 fold (1 to 1.63 log) at 48 hr post-infection, suggesting that superinfection exclusion can occur between ISFs and vertebrate-infecting flaviviruses despite their high level of genetic diversity. We also generated several monoclonal antibodies (mAbs) that are specific to the NS1 protein of PCV, and these represent the first ISF-specific mAbs reported to date.	[Hobson-Peters, Jody; Yam, Alice Wei Yee; Lu, Jennifer Wei Fei; Setoh, Yin Xiang; Prow, Natalie A.; Hall, Roy A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [May, Fiona J.] Univ Queensland, Australian Ctr Ecogen, Lucia, Qld, Australia; [Kurucz, Nina; Whelan, Peter] Northern Terr Dept Hlth, Ctr Dis Control, Hlth Protect Div, Darwin, NT, Australia; [Walsh, Susan; Davis, Steven S.; Weir, Richard; Melville, Lorna; Hunt, Neville] Dept Primary Ind & Fisheries, Berrimah Vet Labs, Darwin, NT, Australia; [Webb, Richard I.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld, Australia; [Blitvich, Bradley J.] Iowa State Univ, Dept Vet Microbiol & Preventat Med, Coll Vet Med, Ames, IA USA	University of Queensland; University of Queensland; University of Queensland; Iowa State University	Hall, RA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.	roy.hall@uq.edu.au	Lu, Jennifer WF/O-8473-2015; Blitvich, Brad/P-3168-2019; Setoh, Yin Xiang/K-4503-2012	Lu, Jennifer WF/0000-0002-1777-4788; Setoh, Yin Xiang/0000-0002-1683-3555; Prow, Natalie/0000-0001-7312-8767; May, Fiona/0000-0003-1306-0179	Australian Research Council [DP120103994]	Australian Research Council(Australian Research Council)	Funding for this study was provided by the Australian Research Council (DP120103994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2; Blitvich BJ, 2009, J MED ENTOMOL, V46, P934, DOI 10.1603/033.046.0428; Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474; Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Broom AK, 1998, PATHOLOGY, V30, P286, DOI 10.1080/00313029800169456; Calzolari M, 2012, J GEN VIROL, V93, P1215, DOI 10.1099/vir.0.040485-0; CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A; Chang GJJ, 2000, J VIROL, V74, P4244, DOI 10.1128/JVI.74.9.4244-4252.2000; Clark DC, 2007, J GEN VIROL, V88, P1175, DOI 10.1099/vir.0.82609-0; Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0; Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0; Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0; Crabtree MB, 2009, ARCH VIROL, V154, P857, DOI 10.1007/s00705-009-0373-1; Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; DITTMAR D, 1982, J GEN VIROL, V59, P273, DOI 10.1099/0022-1317-59-2-273; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999; Frost MJ, 2012, EMERG INFECT DIS, V18, P792, DOI 10.3201/eid1805.111720; GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548; GORMAN B. M., 1975, Aust. J. Med. Technol., V6, P65; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HALL RA, 1988, IMMUNOL CELL BIOL, V66, P51, DOI 10.1038/icb.1988.6; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harbach RE, 1998, SYST ENTOMOL, V23, P327, DOI 10.1046/j.1365-3113.1998.00072.x; Hobson-Peters J, 2008, J GEN VIROL, V89, P3063, DOI 10.1099/vir.0.2008/003731-0; Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039; Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025; Huhtamo E, 2009, J VIROL, V83, P9532, DOI 10.1128/JVI.00529-09; Junglen S, 2009, J VIROL, V83, P4462, DOI 10.1128/JVI.00014-09; Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lee YM, 2005, J VIROL, V79, P3231, DOI 10.1128/JVI.79.6.3231-3242.2005; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1101, DOI DOI 10.1016/0038-092X(88)90131-4; LOBIGS M, 1988, VIROLOGY, V165, P245, DOI 10.1016/0042-6822(88)90678-2; Lutomiah Joel J.L., 2007, Journal of Insect Science (Tucson), V7, P1, DOI 10.1673/031.007.5501; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074; May FJ, 2006, J GEN VIROL, V87, P329, DOI 10.1099/vir.0.81252-0; Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144; Parreira R, 2012, VIRUS RES, V167, P152, DOI 10.1016/j.virusres.2012.04.010; Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28; RANDOLPH VB, 1988, J GEN VIROL, V69, P2189, DOI 10.1099/0022-1317-69-9-2189; RANDOLPH VB, 1990, J GEN VIROL, V71, P1845, DOI 10.1099/0022-1317-71-8-1845; Ritchie SA, 1997, AM J TROP MED HYG, V56, P80, DOI 10.4269/ajtmh.1997.56.80; Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24; Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043; Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848; STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0; Tyler S, 2011, AM J TROP MED HYG, V85, P162, DOI 10.4269/ajtmh.2011.10-0469; Whelan P. L., 1993, ARBOVIRUS RES AUST, V6, P270; Zou G, 2009, J VIROL, V83, P11765, DOI 10.1128/JVI.01205-09	55	143	145	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56534	10.1371/journal.pone.0056534	http://dx.doi.org/10.1371/journal.pone.0056534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460804	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000027
J	Zhang, TZ; Qian, N; Zhu, XF; Chen, H; Wang, S; Mei, HX; Zhang, YM				Zhang, Tianzhen; Qian, Neng; Zhu, Xiefei; Chen, Hong; Wang, Sen; Mei, Hongxian; Zhang, Yuanming			Variations and Transmission of QTL Alleles for Yield and Fiber Qualities in Upland Cotton Cultivars Developed in China	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; ASSOCIATION; TRAITS; RESISTANCE; DIVERSITY; MAP	Cotton is the world's leading cash crop, and genetic improvement of fiber yield and quality is the primary objective of cotton breeding program. In this study, we used various approaches to identify QTLs related to fiber yield and quality. Firstly, we constructed a four-way cross (4WC) mapping population with four base core cultivars, Stoneville 2B, Foster 6, Deltapine 15 and Zhongmiansuo No.7 (CRI 7), as parents in Chinese cotton breeding history and identified 83 QTLs for 11 agronomic and fiber quality traits. Secondly, association mapping of agronomical and fiber quality traits was based on 121 simple sequence repeat (SSR) markers using a general linear model (GLM). For this, 81 Gossypium hirsutum L. accessions including the four core parents and their derived cultivars were grown in seven diverse environments. Using these approaches, we successfully identified 180 QTLs significantly associated with agronomic and fiber quality traits. Among them were 66 QTLs that were identified via linkage disequilibrium (LD) and 4WC family-based linkage (FBL) mapping and by previously published family-based linkage (FBL) mapping in modern Chinese cotton cultivars. Twenty eight and 44 consistent QTLs were identified by 4WC and LD mapping, and by FBL and LD mapping methods, respectively. Furthermore, transmission and variation of QTL-alleles mapped by LD association in the three breeding periods revealed that some could be detected in almost all Chinese cotton cultivars, suggesting their stable transmission and some identified only in the four base cultivars and not in the modern cultivars, suggesting they were missed in conventional breeding. These results will be useful to conduct genomics-assisted breeding effectively using these existing and novel QTL alleles to improve yield and fiber qualities in cotton.	[Zhang, Tianzhen; Qian, Neng; Zhu, Xiefei; Wang, Sen; Mei, Hongxian; Zhang, Yuanming] Nanjing Agr Univ, MOE Hybrid Cotton R&D Engn Res Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Chen, Hong] Xinjiang Acad Agr & Reclamat Sci, Cotton Res Inst, Xinjiang, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Zhang, TZ (corresponding author), Nanjing Agr Univ, MOE Hybrid Cotton R&D Engn Res Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	cotton@njau.edu.cn	Zhang, Yuan-Ming/AFQ-8637-2022; Zhang, Yuan-Ming/AAT-2899-2021		Major State Basic Research Development Program of China (973 Program) [2011CB109300]; National High Technology Research and Development Program of China (863 Program) [2011AA10A102]; Philosophy Doctoral Fund Program of Xinjiang BingTuan Group [2010JC01]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Philosophy Doctoral Fund Program of Xinjiang BingTuan Group; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was financially supported in part by grants from the Major State Basic Research Development Program of China (973 Program) (2011CB109300) and the National High Technology Research and Development Program of China (863 Program) (2011AA10A102), the Philosophy Doctoral Fund Program of Xinjiang BingTuan Group (2010JC01) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2008, GENOMICS, V92, P478, DOI 10.1016/j.ygeno.2008.07.013; Abdurakhmonov IY, 2007, P WORLD COTT RES C 4; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Chen Guang, 2006, Acta Genetica Sinica, V33, P733, DOI 10.1016/S0379-4172(06)60106-6; Chen Li, 2008, Acta Agronomica Sinica, V34, P1199, DOI 10.3724/SP.J.1006.2008.01199; CRI-CAAS, 2003, GEN BREED COTT CHIN, P29; Eizenga GC, 2006, CROP SCI, V46, P1870, DOI 10.2135/cropsci2006.0143; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Guo W.Z., 1997, ACTA GOSSYPII SINICA, V9, P19; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Han ZG, 2004, MOL GENET GENOMICS, V272, P308, DOI 10.1007/s00438-004-1059-8; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Huang ZK, 2007, CULTIVARS THEIR PEDI; Kloth KJ, 2012, TRENDS PLANT SCI, V17, P311, DOI 10.1016/j.tplants.2012.01.002; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Kraft T, 2000, THEOR APPL GENET, V101, P323, DOI 10.1007/s001220051486; Liang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-539; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; Nguyen TB, 2004, THEOR APPL GENET, V109, P167, DOI 10.1007/s00122-004-1612-1; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; PATERSON AH, 1999, COTTON ORIGIN HIST T; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2004, DOCUMENTATION STRUCT; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; [秦永生 QIN Yong-Sheng], 2009, [作物学报, Acta Agronomica Sinica], V35, P1812; Qin YongSheng, 2009, Scientia Agricultura Sinica, V42, P4145; Qureshi S. N., 2004, Journal of Cotton Science, V8, P112; Reddy O. U. K., 2001, Journal of Cotton Science, V5, P103; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Schulze TG, 2002, AM J MED GENET, V114, P1, DOI 10.1002/ajmg.10042; Shappley Z. W., 1998, Journal of Cotton Science, V2, P153; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Ulloa M., 2000, Journal of Cotton Science, V4, P161; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; Van Ooijen JW, 2001, JOINMAPR VERSION 3 0; VANOOIJEN JW, 2004, MAPQTL 5 0 SOFTWARE; Wang Baohua, 2007, Journal of Genetics and Genomics, V34, P35, DOI 10.1016/S1673-8527(07)60005-8; Wang BH, 2006, EUPHYTICA, V152, P367, DOI 10.1007/s10681-006-9224-2; Wang Juan, 2007, Acta Agronomica Sinica, V33, P1915; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Whitt Sr, 2003, METH MOL B, V236, P123; Xiao J, 2009, J COTTON SCI, V13, P75; YASUDA N, 1968, ANN HUM GENET, V31, P409, DOI 10.1111/j.1469-1809.1968.tb00574.x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zafar Mehboob-ur-Rahman Yusuf, 2009, V3, P101, DOI 10.1007/978-0-387-70810-2_5; Zhang J, 2000, COTTON SCI, V12, P267, DOI DOI 10.3969/J.ISSN.1002-7807.2000.05.012; Zhang JF, 2005, THEOR APPL GENET, V111, P1385, DOI 10.1007/s00122-005-0070-8; Zhang TZ, 2003, THEOR APPL GENET, V106, P262, DOI 10.1007/s00122-002-1101-3; Zhang ZS, 2005, EUPHYTICA, V144, P91, DOI 10.1007/s10681-005-4629-x; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	58	85	97	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57220	10.1371/journal.pone.0057220	http://dx.doi.org/10.1371/journal.pone.0057220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468939	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000078
J	Krueger, M; Hartig, W; Reichenbach, A; Bechmann, I; Michalski, D				Krueger, Martin; Haertig, Wolfgang; Reichenbach, Andreas; Bechmann, Ingo; Michalski, Dominik			Blood-Brain Barrier Breakdown after Embolic Stroke in Rats Occurs without Ultrastructural Evidence for Disrupting Tight Junctions	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NEURODEGENERATIVE DISORDERS; HEMORRHAGIC TRANSFORMATION; CLAUDIN-5 EXPRESSION; SYNAPTIC VESICLES; ENDOTHELIAL-CELLS; ARTERY OCCLUSION; L-GLUTAMATE; PERMEABILITY; PERICYTES	The term blood-brain barrier (BBB) relates to the ability of cerebral vessels to hold back hydrophilic and large molecules from entering the brain, thereby crucially contributing to brain homeostasis. In fact, experimental opening of endothelial tight junctions causes a breakdown of the BBB evidenced as for instance by albumin leakage. This and similar observations led to the conclusion that BBB breakdown is predominantly mediated by damage to tight junction complexes, but evidentiary ultrastructural data are rare. Since functional deficits of the BBB contribute to an increased risk of hemorrhagic transformation and brain edema after stroke, which both critically impact on the clinical outcome, we studied the mechanism of BBB breakdown using an embolic model of focal cerebral ischemia in Wistar rats to closely mimic the essential human pathophysiology. Ischemia-induced BBB breakdown was detected using intravenous injection of FITC-albumin and tight junctions in areas of FITC-albumin extravasation were subsequently studied using fluorescence and electron microscopy. Against our expectation, 25 hours after ischemia induction the morphology of tight junction complexes (identified ultrastructurally and using antibodies against the transcellular proteins occludin and claudin-5) appeared to be regularly maintained in regions where FITC-albumin massively leaked into the neuropil. Furthermore, occludin signals along pan-laminin-labeled vessels in the affected hemisphere equaled the non-affected contralateral side (ratio: 0.966 vs. 0.963; P = 0.500). Additional ultrastructural analyses at 5 and 25 h after ischemia induction clearly indicated FITC-albumin extravasation around vessels with intact tight junctions, while the endothelium exhibited enhanced transendothelial vesicle trafficking and signs of degeneration. Thus, BBB breakdown and leakage of FITC-albumin cannot be correlated with staining patterns for common tight junction proteins alone. Understanding the mechanisms causing functional endothelial alterations and endothelial damage is likely to provide novel protective targets in stroke.	[Krueger, Martin; Bechmann, Ingo] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Haertig, Wolfgang; Reichenbach, Andreas] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Michalski, Dominik] Univ Leipzig, Dept Neurol, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Krueger, M (corresponding author), Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany.	martin.krueger@medizin.uni-leipzig.de; dominik.michalski@medizin.uni-leipzig.de	Reichenbach, Andreas/B-2510-2017		Department of Neurology, University of Leipzig; DFG [FOR1336]	Department of Neurology, University of Leipzig; DFG(German Research Foundation (DFG))	Funding was provided for initial experiments by Prof. Dietmar Schneider and Dr. Carsten Hobohm (Department of Neurology, University of Leipzig) and then by the DFG (FOR1336) to Prof. Ingo Bechmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; ARTHUR FE, 1987, DEV BRAIN RES, V36, P155, DOI 10.1016/0165-3806(87)90075-7; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Braeuninger Stefan, 2009, Exp Transl Stroke Med, V1, P8, DOI 10.1186/2040-7378-1-8; Chen B, 2009, STROKE, V40, pE666, DOI 10.1161/STROKEAHA.109.551341; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; del Zoppo GJ, 2010, J INTERN MED, V267, P156, DOI 10.1111/j.1365-2796.2009.02199.x; Dente CJ, 2001, J SURG RES, V97, P85, DOI 10.1006/jsre.2001.6117; Diener HC, 2008, STROKE, V39, P1751, DOI 10.1161/STROKEAHA.107.503334; DIETRICH WD, 1987, ACTA NEUROPATHOL, V72, P326, DOI 10.1007/BF00687263; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Ehrlich P, 1885, FARBENANALYTISCHE ST; Endres M, 2008, CEREBROVASC DIS, V25, P268, DOI 10.1159/000118039; Endres Matthias, 2009, Handb Clin Neurol, V92, P31, DOI 10.1016/S0072-9752(08)01902-7; Engelhardt B, 2011, J CEREBR BLOOD F MET, V31, P1969, DOI 10.1038/jcbfm.2011.98; Fischer S, 2000, AM J PHYSIOL-CELL PH, V279, pC935, DOI 10.1152/ajpcell.2000.279.4.C935; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Hamm S, 2004, CELL TISSUE RES, V315, P157, DOI 10.1007/s00441-003-0825-y; Hang Y, 2012, J MOL NEUROSCI, V46, P236, DOI 10.1007/s12031-011-9584-5; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hom J, 2011, AM J NEURORADIOL, V32, P41, DOI 10.3174/ajnr.A2244; ITO U, 1980, STROKE, V11, P606, DOI 10.1161/01.STR.11.6.606; Ito U, 2011, J CEREBR BLOOD F MET, V31, P328, DOI 10.1038/jcbfm.2010.97; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jiang J, 2007, EUR J PHARMACOL, V561, P54, DOI 10.1016/j.ejphar.2006.12.028; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Lewandowsky M., 1909, KLIN MED, V40, P480; Liebner S, 2000, ACTA NEUROPATHOL, V100, P323, DOI 10.1007/s004010000180; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Liu WL, 2008, J NEUROCHEM, V107, P1196, DOI 10.1111/j.1471-4159.2008.05664.x; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Matsuzaki M, 2010, NEUROPEDIATRICS, V41, P72, DOI 10.1055/s-0030-1261886; McCaffrey G, 2009, J NEUROCHEM, V110, P58, DOI 10.1111/j.1471-4159.2009.06113.x; Meairs S, 2006, CEREBROVASC DIS, V22, P75, DOI 10.1159/000093098; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Michalski D, 2010, BRAIN RES, V1359, P186, DOI 10.1016/j.brainres.2010.08.045; Nagaraja TN, 2008, MICROCIRCULATION, V15, P1, DOI 10.1080/10739680701409811; Osada T, 2011, J CEREBR BLOOD F MET, V31, P1972, DOI 10.1038/jcbfm.2011.99; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Qin ZY, 2007, STROKE, V38, P1362, DOI 10.1161/01.STR.0000259660.62865.eb; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Roseth S, 1998, BIOCHEM PHARMACOL, V56, P1243, DOI 10.1016/S0006-2952(98)00200-7; ROSETH S, 1995, J NEUROCHEM, V65, P96; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Spirig R, 2008, MOL IMMUNOL, V45, P4084, DOI 10.1016/j.molimm.2008.07.024; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Tarawneh R, 2010, CLIN GERIATR MED, V26, P125, DOI 10.1016/j.cger.2009.12.003; Wang GM, 2009, BRAIN RES, V1294, P183, DOI 10.1016/j.brainres.2009.07.070; Wang Y, 2012, P NATL ACAD SCI USA, V109, P4892, DOI 10.1073/pnas.1112129109; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Young AR, 2007, J NEUROCHEM, V103, P1302, DOI 10.1111/j.1471-4159.2007.04866.x; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhao YJ, 2010, NEUROL RES, V32, P748, DOI 10.1179/016164109X12445616596562; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	67	123	127	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e56419	10.1371/journal.pone.0056419	http://dx.doi.org/10.1371/journal.pone.0056419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468865	Green Submitted, gold, Green Published			2022-12-27	WOS:000315561400010
J	Platzer, A				Platzer, Alexander			Visualization of SNPs with t-SNE	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GENETIC-VARIATION; VALIDATION	Background: Single Nucleotide Polymorphisms (SNPs) are one of the largest sources of new data in biology. In most papers, SNPs between individuals are visualized with Principal Component Analysis (PCA), an older method for this purpose. Principal Findings: We compare PCA, an aging method for this purpose, with a newer method, t-Distributed Stochastic Neighbor Embedding (t-SNE) for the visualization of large SNP datasets. We also propose a set of key figures for evaluating these visualizations; in all of these t-SNE performs better. Significance: To transform data PCA remains a reasonably good method, but for visualization it should be replaced by a method from the subfield of dimension reduction. To evaluate the performance of visualization, we propose key figures of cross-validation with machine learning methods, as well as indices of cluster validity.	Gregor Mendel Inst, Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Platzer, A (corresponding author), Gregor Mendel Inst, Vienna, Austria.	alexander.platzer@gmi.oeaw.ac.at		Platzer, Alexander/0000-0002-2318-8806	Austrian Academy of Science	Austrian Academy of Science	Funding was provided by the Austrian Academy of Science (http://www.oeaw.ac.at/english/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman M, 2009, CLUSTERABILITY THEOR; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], J STAT SOFTWARE; Asuncion A., 2010, UCI MACHINE LEARNING; Belkin M, 2002, ADV NEUR IN, V14, P585; Bellman R., 1961, ADAPTIVE CONTROL PRO; Brown P. F., 1992, Computational Linguistics, V18, P31; Christopher D, 2009, INTRO INFORM RETRIEV; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Frank E, 1998, GENERATING ACCURATE; Globerson A, 2003, Journal of Machine Learning Research, V3, P1307, DOI 10.1162/153244303322753689; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hurtado MA, 2012, COMP BIOCH PHYSL B; Jarzynska G, 2011, ENVIRON INT, V37, P882, DOI 10.1016/j.envint.2011.02.017; Khalilia M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-51; Laurens van der Maaten EP, 2009, DIMENSIONALITY REDUC; Lin W.J., 2012, BRIEF BIOINFORM; Lu HP, 2008, IEEE T NEURAL NETWOR, V19, P18, DOI 10.1109/TNN.2007.901277; Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198; Pau G, 2010, ITALY COMPUTATIONAL; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Sun ZF, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-84; Swingley WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038108; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; TORGERSON WS, 1952, PSYCHOMETRIKA, V17, P401; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Xie B, 2010, LECT NOTES COMPUT SC, V6443, P338, DOI 10.1007/978-3-642-17537-4_42; Yu ZZ, 2012, NEPHROL DIAL TRANSPL, V27, P4437, DOI 10.1093/ndt/gfs075; Zhang H, 2005, INT J PATTERN RECOGN, V19, P183, DOI 10.1142/S0218001405003983; Zhou H, 2012, J ZHEJIANG UNIV-SC B, V13, P438, DOI 10.1631/jzus.B1200003	41	46	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56883	10.1371/journal.pone.0056883	http://dx.doi.org/10.1371/journal.pone.0056883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457633	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700093
J	Seppala, EH; Reuser, AJJ; Lohi, H				Seppala, Eija H.; Reuser, Arnold J. J.; Lohi, Hannes			A Nonsense Mutation in the Acid alpha-Glucosidase Gene Causes Pompe Disease in Finnish and Swedish Lapphunds	PLOS ONE			English	Article							GLYCOGEN-STORAGE-DISEASE; ITALIAN PATIENTS; MODEL	Pompe disease is a recessively inherited and often fatal disorder caused by the deficiency of acid alpha-glucosidase, an enzyme encoded by the GAA gene and needed to break down glycogen in lysosomes. This glycogen storage disease type II has been reported also in Swedish Lapphund dogs. Here we describe the genetic defect in canine Pompe disease and show that three related breeds from Scandinavia carry the same mutation. The affected dogs are homozygous for the GAA c.2237G>A mutation leading to a premature stop codon at amino acid position 746. The corresponding mutation has previously been reported in humans and causes infantile Pompe disease in combination with a second fully deleterious mutation. The affected dogs from both the Finnish as well as the Swedish breed mimic infantile-onset Pompe disease genetically, but also clinico-pathologically. Therefore this canine model provides a valuable tool for preclinical studies aimed at the development of gene therapy in Pompe disease.	[Seppala, Eija H.; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Seppala, Eija H.; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Seppala, Eija H.; Lohi, Hannes] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Seppala, Eija H.; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Reuser, Arnold J. J.] Erasmus MC, Ctr Lysosomal & Metab Dis, Dept Clin Genet, Rotterdam, Netherlands; [Reuser, Arnold J. J.] Erasmus MC, Ctr Lysosomal & Metab Dis, Dept Paediat, Rotterdam, Netherlands	University of Helsinki; University of Helsinki; University of Helsinki; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Lohi, H (corresponding author), Univ Helsinki, Res Programs Unit, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532	Academy of Finland; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jane and Aatos Erkko Foundation	This study was funded by the Academy of Finland, the Sigrid Juselius Foundation and The Jane and Aatos Erkko Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bali DS, 2011, MUSCLE NERVE, V43, P665, DOI 10.1002/mus.21933; Beesley C E, 1998, Hum Mutat, V11, P413, DOI 10.1002/(SICI)1098-1004(1998)11:5<413::AID-HUMU16>3.0.CO;2-I; Chiara A, 2008, NEUROLOGY, V70, P617, DOI 10.1212/01.wnl.0000299892.81127.8e; Dennis JA, 2000, MAMM GENOME, V11, P206, DOI 10.1007/s003350010038; Hirschhorn R, 2001, METABOLIC MOL BASES, P3389; HUDGSON P, 1968, BRAIN, V91, P435, DOI 10.1093/brain/91.3.435; Jackson T, 2003, FINNISH LAPPHUND COM, P9; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kishnani PS, 2012, AM J MED GENET C, V160C, P1, DOI [10.1002/ajmc.31324, 10.1002/ajmg.c.31324]; Kroos M, 2012, AM J MED GENET C, V160C, P59, DOI [10.1002/ajmg.c.31318, 10.1002/ajmc.31318]; MANKTELOW BW, 1975, J COMP PATHOL, V85, P139, DOI 10.1016/0021-9975(75)90092-4; MATSUI T, 1983, VET PATHOL, V20, P312, DOI 10.1177/030098588302000307; Montalvo ALE, 2006, HUM MUTAT, V27, P999, DOI 10.1002/humu.20374; MOSTAFA IE, 1970, ACTA VET SCAND, V11, P197; OSULLIVAN BM, 1981, AUST VET J, V57, P227, DOI 10.1111/j.1751-0813.1981.tb02666.x; Pittis M G, 2008, Hum Mutat, V29, pE27, DOI 10.1002/humu.20753; Pittis MG, 2003, AM J MED GENET A, V121A, P225, DOI 10.1002/ajmg.a.20164; Pompe JC, 1932, NED TIJDSCHR GENEESK, V76, P304; SANDSTROM B, 1969, ACTA NEUROPATHOL, V14, P194, DOI 10.1007/BF00685299; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; WALVOORT HC, 1984, AM J MED GENET, V19, P589, DOI 10.1002/ajmg.1320190323; WALVOORT HC, 1985, J INHERIT METAB DIS, V8, P38, DOI 10.1007/BF01805484; WALVOORT HC, 1984, J AM ANIM HOSP ASSOC, V20, P279; WALVOORT HC, 1985, VET QUART, V7, P187, DOI 10.1080/01652176.1985.9693981; WALVOORT HC, 1982, BIOCHIM BIOPHYS ACTA, V715, P63, DOI 10.1016/0304-4165(82)90050-2; WALVOORT HC, 1981, BERL MUNCH TIERARZTL, V94, P39	26	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56825	10.1371/journal.pone.0056825	http://dx.doi.org/10.1371/journal.pone.0056825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457621	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700097
J	Grabher, D; Hofer, S; Ortner, D; Heufler, C				Grabher, Daniela; Hofer, Susanne; Ortner, Daniela; Heufler, Christine			In Human Monocyte Derived Dendritic Cells SOCS1 Interacting with CYTIP Induces the Degradation of CYTIP by the Proteasome	PLOS ONE			English	Article							LYMPH-NODES; PROTEIN; LYMPHOCYTES; GENERATION; ADHESION; DYNAMICS; IMMUNITY; BLOOD	CYTIP (cytohesin interacting protein) is an intracellular molecule induced in dendritic cells during maturation. CYTIP modulates the binding intensity of the adhesion molecule LFA-1. If dendritic cells are silenced for CYTIP they keep longer contacts with T-cells resulting in a lower T cell stimulation. We identified Suppressor of cytokine signaling-1 (SOCS-1) as a binding partner for CYTIP in human monocyte derived dendritic cells. In Western blot analyses we found that CYTIP expression is down regulated at later time points, starting at about 72 hours after induction of maturation. To investigate a possible role for SOCS-1 in taking CYTIP to the degradation machinery of the cell we measured endogenous CYTIP protein levels in mature dendritic cells transfected with SOCS-1 encoding plasmid in quantitative Western blot analyses. We observed lower amounts of endogenous CYTIP in mature dendritic cells transfected with SOCS-1 encoding plasmid compared with untransfected dendritic cells. Experiments with the proteasome-inhibitor Bortezomib/Velcade (R) show stable CYTIP expression levels in dendritic cells. In addition, we show that CYTIP in dendritic cells matured for 48 hours is ubiquitinated and thus ready for degradation. We here describe a newly identified binding partner of CYTIP, SOCS-1, and confirm its function in regulating the degradation of CYTIP by the proteasome.	[Grabher, Daniela; Ortner, Daniela; Heufler, Christine] Med Univ Innsbruck, Dept Dermatol, A-6020 Innsbruck, Austria; [Hofer, Susanne] Med Univ Innsbruck, Dept Gynecol Endocrinol & Reprod Med, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Heufler, C (corresponding author), Med Univ Innsbruck, Dept Dermatol, A-6020 Innsbruck, Austria.	christine.heufler@i-med.ac.at		Hofer, Susanne/0000-0002-0328-3945; Ortner-Tobider, Daniela Anna/0000-0002-9433-5367	Austrian science foundation (FWF) [20478]; Austrian Science Fund (FWF) [P 20478] Funding Source: researchfish	Austrian science foundation (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian science foundation (FWF) project number 20478 to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkow S, 2010, BLOOD, V116, P1885, DOI 10.1182/blood-2009-05-224428; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Ebner S, 2001, J IMMUNOL METHODS, V252, P93, DOI 10.1016/S0022-1759(01)00337-4; Hofer S, 2006, BLOOD, V107, P1003, DOI 10.1182/blood-2005-01-0425; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; MacNeil AJ, 2007, BIOCHEM BIOPH RES CO, V359, P848, DOI 10.1016/j.bbrc.2007.05.162; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Shen L, 2004, NAT BIOTECHNOL, V22, P1546, DOI 10.1038/nbt1035; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Tang PT, 2002, P NATL ACAD SCI USA, V99, P2625, DOI 10.1073/pnas.052712999; Theodoridis AA, 2011, BLOOD, V118, P107, DOI 10.1182/blood-2010-07-294363; Vuong BQ, 2004, MOL CELL BIOL, V24, P9092, DOI 10.1128/MCB.24.20.9092-9101.2004; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zinser E, 2009, IMMUNOBIOLOGY, V214, P843, DOI 10.1016/j.imbio.2009.06.018	19	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57538	10.1371/journal.pone.0057538	http://dx.doi.org/10.1371/journal.pone.0057538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23469018	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900117
J	Guarany, FC; Picon, PD; Guarany, NR; dos Santos, AC; Chiella, BPM; Barone, CR; Fendt, LCC; Schestatsky, P				Guarany, Fabio Coelho; Picon, Paulo Dornelles; Guarany, Nicole Ruas; dos Santos, Antonio Cardoso; Mentz Chiella, Bianca Paula; Barone, Carolina Rocha; Cabral Fendt, Lucia Costa; Schestatsky, Pedro			A Double-Blind, Randomised, Crossover Trial of Two Botulinum Toxin Type A in Patients with Spasticity	PLOS ONE			English	Article							UPPER-LIMB SPASTICITY; NEUROTOXIN; PROSIGNE; STROKE; BOTOX	Background: Botulinum toxin type A (btxA) is one of the main treatment choices for patients with spasticity. Prosigne (R) a new released botulinum toxin serotype A may have the same effectiveness as Botox (R) in focal dystonia. However, there are no randomized clinical trials comparing these formulations in spasticity treatment. The aim of our study was to compare the efficacy and safety of Prosigne (R) with Botox (R) in the treatment of spasticity. Methodology/Principal Findings: We performed a double-blind, randomized, crossover study consisting of 57 patients with clinically meaningful spasticity. The patients were assessed at baseline, 4 and 12 weeks after Prosigne (R) or Botox (R) administration. The main outcomes were changes in the patients' Modified Ashworth Scale (MAS), Functional Independence Measure (FIM) and Pediatric Evaluation of Disability Inventory (PEDI) scores and adverse effects related to the botulinum toxin. Both of the toxins were significantly effective in relieving the level of spasticity in adults and children. There were no significant differences found between the Prosigne (R) and Botox (R) treatments regarding their MAS, FIM and PEDI scores. Likewise, the incidence of adverse effects was similar between the two groups. Conclusion: Our results suggest that Prosigne (R) and Botox (R) are both efficient and comparable with respect to their efficacy and safety for the three month treatment of spasticity. Trial Registration: ClinicalTrials.gov NCT00819065.	[Guarany, Fabio Coelho; dos Santos, Antonio Cardoso] HCPA, Phys Med & Rehabil Serv, Porto Alegre, RS, Brazil; [Guarany, Fabio Coelho; Guarany, Nicole Ruas] Univ Fed Rio Grande do Sul, Grad Program Med Sci, Porto Alegre, RS, Brazil; [Picon, Paulo Dornelles; Schestatsky, Pedro] HCPA, Dept Internal Med, Porto Alegre, RS, Brazil; [Guarany, Nicole Ruas] Univ Fed Pelotas UFPel, Sch Occupat Therapy, Pelotas, RS, Brazil; [Mentz Chiella, Bianca Paula] HCPA, Dept Pharm, Porto Alegre, RS, Brazil; [Barone, Carolina Rocha; Cabral Fendt, Lucia Costa] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Schestatsky, Pedro] HCPA, Neurol Serv, EMG Unit, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal de Pelotas; Universidade Federal do Rio Grande do Sul	Guarany, FC (corresponding author), HCPA, Phys Med & Rehabil Serv, Porto Alegre, RS, Brazil.	fguarany@hotmail.com	Picon, Paulo/J-2448-2015		FIPE-HCPA (Research and Events Support Fund at Hospital de Clinicas de Porto Alegre); CAPES, Brazil	FIPE-HCPA (Research and Events Support Fund at Hospital de Clinicas de Porto Alegre); CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial support was provided by FIPE-HCPA (Research and Events Support Fund at Hospital de Clinicas de Porto Alegre). P. S. received funding support from CAPES, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Quagliato EMAB, 2010, CLIN NEUROPHARMACOL, V33, P22, DOI 10.1097/WNF.0b013e3181c46f48; Bakheit AMO, 2004, J NEUROL NEUROSUR PS, V75, P1558, DOI 10.1136/jnnp.2003.035139; Brashear A, 2008, NEUROLOGIST, V14, P289, DOI 10.1097/NRL.0b013e31816f2cdd; Cardoso E, 2005, ARQ NEURO-PSIQUIAT, V63, P30, DOI 10.1590/S0004-282X2005000100006; Childers MK, 2004, ARCH PHYS MED REHAB, V85, P1063, DOI 10.1016/j.apmr.2003.10.015; Guarany FC, 2010, PROTOCOLOS CLIN DIRE, V1, P291; Mayer NH, 1997, MUSCLE NERVE, pS21; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Picon PD, 2007, 4 HLTH TECHN ASS INT; Richardson D, 2000, J NEUROL NEUROSUR PS, V69, P499, DOI 10.1136/jnnp.69.4.499; Rieder CRM, 2007, CLIN NEUROPHARMACOL, V30, P39, DOI 10.1097/01.WNF.0000236771.77021.3C; Russman BS, 1997, MUSCLE NERVE, pS181; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4	14	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56479	10.1371/journal.pone.0056479	http://dx.doi.org/10.1371/journal.pone.0056479			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468866	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900027
J	Haggstrom, C; Rapp, K; Stocks, T; Manjer, J; Bjorge, T; Ulmer, H; Engeland, A; Almqvist, M; Concin, H; Selmer, R; Ljungberg, B; Tretli, S; Nagel, G; Hallmans, G; Jonsson, H; Stattin, P				Haggstrom, Christel; Rapp, Kilian; Stocks, Tanja; Manjer, Jonas; Bjorge, Tone; Ulmer, Hanno; Engeland, Anders; Almqvist, Martin; Concin, Hans; Selmer, Randi; Ljungberg, Borje; Tretli, Steinar; Nagel, Gabriele; Hallmans, Goran; Jonsson, Hakan; Stattin, Par			Metabolic Factors Associated with Risk of Renal Cell Carcinoma	PLOS ONE			English	Article							KIDNEY CANCER-RISK; BODY-MASS INDEX; REGRESSION DILUTION; METAANALYSIS; OBESITY; HYPERTENSION; ADULTS; MEN; EPIDEMIOLOGY; ETIOLOGY	Previous studies have shown that obesity and hypertension are associated with increased risk of renal cell carcinoma (RCC), but less is known about the association to other metabolic factors. In the Metabolic Syndrome and Cancer project (Me-Can) data on body mass index (BMI, kg/m2), blood pressure, and circulating levels of glucose, cholesterol, and triglycerides were collected from 560,388 men and women in cohorts from Norway, Austria, and Sweden. By use of Cox proportional hazard models, hazard ratios (HR) were calculated for separate and composite metabolic exposures. During a median follow-up of 10 years, 592 men and 263 women were diagnosed with RCC. Among men, we found an increased risk of RCC for BMI, highest vs. lowest quintile, (HR = 1.51, 95% CI 1.13-2.03), systolic blood pressure, (HR = 3.40, 95% CI 1.91-6.06), diastolic blood pressure, (HR = 3.33, 95% CI 1.85-5.99), glucose, (HR = 3.75, 95% CI 1.46-9.68), triglycerides, (HR = 1.79, 95% CI 1.00-3.21) and a composite score of these metabolic factors, (HR = 2.68, 95% CI 1.75-4.11). Among women we found an increased risk of RCC for BMI, highest vs. lowest quintile, (HR = 2.21, 95% CI 1.32-3.70) and the composite score, (HR = 2.29, 95% CI 1.12-4.68). High levels of the composite score were also associated with risk of death from RCC among both men and women. No multiplicative statistical or biological interactions between metabolic factors on risk of RCC were found. High levels of BMI, blood pressure, glucose and triglycerides among men and high BMI among women were associated with increased risk of RCC.	[Haggstrom, Christel; Stocks, Tanja; Ljungberg, Borje; Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Rapp, Kilian; Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Stocks, Tanja] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Manjer, Jonas; Almqvist, Martin] Lund Univ, Skane Univ Hosp, Dept Surg, Malmo, Sweden; [Bjorge, Tone; Engeland, Anders] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Bjorge, Tone; Engeland, Anders; Selmer, Randi] Norwegian Inst Publ Hlth, Oslo, Norway; [Ulmer, Hanno] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria; [Concin, Hans; Nagel, Gabriele] Agcy Prevent & Social Med, Bregenz, Australia; [Tretli, Steinar] Canc Registry Norway, Inst Populat Based Canc Res, Oslo, Norway; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Jonsson, Hakan] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Stattin, Par] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA	Umea University; Ulm University; University of Copenhagen; Lund University; Skane University Hospital; University of Bergen; Norwegian Institute of Public Health (NIPH); Medical University of Innsbruck; University of Oslo; Umea University; Umea University; Memorial Sloan Kettering Cancer Center	Haggstrom, C (corresponding author), Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden.	christel.haggstrom@urologi.umu.se	Ulmer, Hanno/S-6615-2019; Rapp, Kilian/AAJ-3370-2020; Engeland, Anders/AAG-7437-2021; vhmpp, aks/F-9756-2012; Nagel, Gabriele/C-3635-2012	Ulmer, Hanno/0000-0001-5911-1002; Rapp, Kilian/0000-0003-1625-2571; Nagel, Gabriele/0000-0001-6185-8535; Ljungberg, Borje/0000-0002-4121-3753; Bjorge, Tone/0000-0002-9096-5257	Lion's Cancer Research Foundation; Umea University, Sweden [LP 09-1799]; World Cancer Research Fund [2007/09, 2010/247]; Swedish Cancer Foundation [2010/628]	Lion's Cancer Research Foundation; Umea University, Sweden; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Swedish Cancer Foundation	This study was supported by grants from Lion's Cancer Research Foundation (http://www.cancerforskningsfond-umea.lions.se/), Umea University, Sweden (LP 09-1799). Funding for the Me-Can project was obtained from the World Cancer Research Fund (http://www.wcrf.org/) (2007/09 and 2010/247) and the Swedish Cancer Foundation (http://www.cancerfonden.se/sv/Information-in-English/)(2010/628). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2008, AM J EPIDEMIOL, V168, P268, DOI 10.1093/aje/kwn122; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Benichou J, 1998, AM J EPIDEMIOL, V148, P424; Bjorge T, 2004, AM J EPIDEMIOL, V160, P1168, DOI 10.1093/aje/kwh345; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Brock KE, 2007, OBES RES CLIN PRACT, V1, P147, DOI 10.1016/j.orcp.2007.02.004; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chow WH, 2000, NEW ENGL J MED, V343, P1305, DOI 10.1056/NEJM200011023431804; Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Emberson JR, 2004, EUR J CARDIOV PREV R, V11, P125, DOI 10.1097/01.hjr.0000114967.39211.e5; Eurostat, 1998, EUR SHORTL CAUS DEAT; Flaherty KT, 2005, CANCER CAUSE CONTROL, V16, P1099, DOI 10.1007/s10552-005-0349-8; Gago-Dominguez M, 2002, CANCER CAUSE CONTROL, V13, P287, DOI 10.1023/A:1015044518505; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Hunt JD, 2005, INT J CANCER, V114, P101, DOI 10.1002/ijc.20618; Ildaphonse G, 2009, ASIAN PAC J CANCER P, V10, P279; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Joh HK, 2011, DIABETES CARE, V34, P1552, DOI 10.2337/dc11-0132; Kitahara CM, 2011, J CLIN ONCOL, V29, P1592, DOI 10.1200/JCO.2010.31.5200; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; Lindblad P, 1999, DIABETOLOGIA, V42, P107, DOI 10.1007/s001250051122; Lipworth L, 2006, J UROLOGY, V176, P2353, DOI 10.1016/j.juro.2006.07.130; Mathew A, 2009, ASIAN PAC J CANCER P, V10, P471; Nicodemus KK, 2004, INT J CANCER, V108, P115, DOI 10.1002/ijc.11532; Rapp K, 2006, DIABETOLOGIA, V49, P945, DOI 10.1007/s00125-006-0207-6; Sandblom G, 2003, SCAND J UROL NEPHROL, V37, P112, DOI 10.1080/00365590310008839; Setiawan VW, 2007, AM J EPIDEMIOL, V166, P932, DOI 10.1093/aje/kwm170; Stocks T, 2010, INT J EPIDEMIOL, V39, P660, DOI 10.1093/ije/dyp186; Van Hemelrijck M, 2012, INT J CANCER, V130, P2118, DOI 10.1002/ijc.26212; Weikert S, 2010, WORLD J UROL, V28, P247, DOI 10.1007/s00345-010-0555-1; Whitlock G, 2001, EUR J EPIDEMIOL, V17, P907, DOI 10.1023/A:1016228410194; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233	37	66	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57475	10.1371/journal.pone.0057475	http://dx.doi.org/10.1371/journal.pone.0057475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468995	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900094
J	Sampei, Z; Igawa, T; Soeda, T; Okuyama-Nishida, Y; Moriyama, C; Wakabayashi, T; Tanaka, E; Muto, A; Kojima, T; Kitazawa, T; Yoshihashi, K; Harada, A; Funaki, M; Haraya, K; Tachibana, T; Suzuki, S; Esaki, K; Nabuchi, Y; Hattori, K				Sampei, Zenjiro; Igawa, Tomoyuki; Soeda, Tetsuhiro; Okuyama-Nishida, Yukiko; Moriyama, Chifumi; Wakabayashi, Tetsuya; Tanaka, Eriko; Muto, Atsushi; Kojima, Tetsuo; Kitazawa, Takehisa; Yoshihashi, Kazutaka; Harada, Aya; Funaki, Miho; Haraya, Kenta; Tachibana, Tatsuhiko; Suzuki, Sachiyo; Esaki, Keiko; Nabuchi, Yoshiaki; Hattori, Kunihiro			Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity	PLOS ONE			English	Article							HUMANIZED MONOCLONAL-ANTIBODY; THERAPEUTIC ANTIBODIES; VARIABLE REGION; BINDING-SITE; LIGHT-CHAIN; A1 SUBUNIT; A2 SUBUNIT; FACTOR IXA; HEMOPHILIA; PHARMACOKINETICS	In hemophilia A, routine prophylaxis with exogenous factor VIII (FVIII) requires frequent intravenous injections and can lead to the development of anti-FVIII alloantibodies (FVIII inhibitors). To overcome these drawbacks, we screened asymmetric bispecific IgG antibodies to factor IXa (FIXa) and factor X (FX), mimicking the FVIII cofactor function. Since the therapeutic potential of the lead bispecific antibody was marginal, FVIII-mimetic activity was improved by modifying its binding properties to FIXa and FX, and the pharmacokinetics was improved by engineering the charge properties of the variable region. Difficulties in manufacturing the bispecific antibody were overcome by identifying a common light chain for the anti-FIXa and anti-FX heavy chains through framework/complementarity determining region shuffling, and by pI engineering of the two heavy chains to facilitate ion exchange chromatographic purification of the bispecific antibody from the mixture of byproducts. Engineering to overcome low solubility and deamidation was also performed. The multidimensionally optimized bispecific antibody hBS910 exhibited potent FVIII-mimetic activity in human FVIII-deficient plasma, and had a half-life of 3 weeks and high subcutaneous bioavailability in cynomolgus monkeys. Importantly, the activity of hBS910 was not affected by FVIII inhibitors, while anti-hBS910 antibodies did not inhibit FVIII activity, allowing the use of hBS910 without considering the development or presence of FVIII inhibitors. Furthermore, hBS910 could be purified on a large manufacturing scale and formulated into a subcutaneously injectable liquid formulation for clinical use. These features of hBS910 enable routine prophylaxis by subcutaneous delivery at a long dosing interval without considering the development or presence of FVIII inhibitors. We expect that hBS910 (investigational drug name: ACE910) will provide significant benefit for severe hemophilia A patients.	[Sampei, Zenjiro; Igawa, Tomoyuki; Soeda, Tetsuhiro; Okuyama-Nishida, Yukiko; Moriyama, Chifumi; Wakabayashi, Tetsuya; Tanaka, Eriko; Muto, Atsushi; Kojima, Tetsuo; Kitazawa, Takehisa; Yoshihashi, Kazutaka; Harada, Aya; Funaki, Miho; Haraya, Kenta; Tachibana, Tatsuhiko; Suzuki, Sachiyo; Esaki, Keiko; Nabuchi, Yoshiaki; Hattori, Kunihiro] Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan	Chugai Pharmaceutical Co., Ltd.; Roche Holding	Igawa, T (corresponding author), Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan.	igawatmy@chugai-pharm.co.jp	HARAYA, KENTA/AAW-4267-2020	HARAYA, KENTA/0000-0002-9142-5607; Tachibana, Tatsuhiko/0000-0001-8339-3986; Sampei, Zenjiro/0000-0001-5343-4468	Chugai Pharmaceutical Co., Ltd.	Chugai Pharmaceutical Co., Ltd.	Chugai Pharmaceutical Co., Ltd. supported and funded the research described in this report. The funders authorized our decision to publish, but had no role in study design, data collection and analysis, or preparation of the manuscript.	Astermark J, 2007, BLOOD, V109, P546, DOI 10.1182/blood-2006-04-017988; Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Benincosa LJ, 2000, J PHARMACOL EXP THER, V292, P810; Berntorp E, 2012, LANCET, V379, P1447, DOI 10.1016/S0140-6736(11)61139-2; Bhaskar V, 2012, DIABETES, V61, P1263, DOI 10.2337/db11-1578; Bjorkman S, 2012, BLOOD, V119, P612, DOI 10.1182/blood-2011-07-360594; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; De Groot AS, 2008, CURR OPIN PHARMACOL, V8, P620, DOI 10.1016/j.coph.2008.08.002; Deng R, 2011, MABS-AUSTIN, V3, P61, DOI 10.4161/mabs.3.1.13799; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fischer K, 2012, HAEMOPHILIA, V18, pe241, DOI 10.1111/j.1365-2516.2011.02687.x; Geraghty S, 2006, HAEMOPHILIA, V12, P75, DOI 10.1111/j.1365-2516.2006.01189.x; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P385, DOI 10.1093/protein/gzq009; Igawa T, 2011, MABS-AUSTIN, V3, P243, DOI 10.4161/mabs.3.3.15234; Jackman J, 2010, J BIOL CHEM, V285, P20850, DOI 10.1074/jbc.M110.113910; Johnson S, 1999, J INFECT DIS, V180, P35, DOI 10.1086/314846; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kitazawa T, 2012, NAT MED, V18, P1570, DOI 10.1038/nm.2942; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Lacy SE, 2008, J IMMUNOL, V181, P1282, DOI 10.4049/jimmunol.181.2.1282; Lapan KA, 1997, J BIOL CHEM, V272, P2082; Lapan KA, 1998, THROMB HAEMOSTASIS, V80, P418, DOI 10.1055/s-0037-1615223; Leissinger C, 2011, NEW ENGL J MED, V365, P1684, DOI 10.1056/NEJMoa1104435; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; Lin YS, 1999, J PHARMACOL EXP THER, V288, P371; Liu ZH, 2007, BLOOD, V110, P2408, DOI 10.1182/blood-2007-04-083998; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Mason BD, 2011, J PHARM SCI-US, V100, P4587, DOI 10.1002/jps.22650; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; Mayorov AV, 2008, P NATL ACAD SCI USA, V105, P17487, DOI 10.1073/pnas.0711808105; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Okuda M, 2004, CLIN LAB HAEMATOL, V26, P215, DOI 10.1111/j.1365-2257.2004.00605.x; Pepinsky RB, 2010, PROTEIN SCI, V19, P954, DOI 10.1002/pro.372; Ragni MV, 2012, HAEMOPHILIA, V18, P63, DOI 10.1111/j.1365-2516.2011.02554.x; Richter WF, 2012, AAPS J, V14, P559, DOI 10.1208/s12248-012-9367-0; Shi Q, 2012, HAEMOPHILIA, V18, P639, DOI 10.1111/j.1365-2516.2011.02735.x; Shima M, 2008, HAEMOPHILIA, V14, P83, DOI 10.1111/j.1365-2516.2008.01737.x; Shire SJ, 2004, J PHARM SCI-US, V93, P1390, DOI 10.1002/jps.20079; SONGSIVILAI S, 1990, CLIN EXP IMMUNOL, V79, P315; Van Walle I, 2007, EXPERT OPIN BIOL TH, V7, P405, DOI 10.1517/14712598.7.3.405; Vlasak J, 2009, ANAL BIOCHEM, V392, P145, DOI 10.1016/j.ab.2009.05.043; Vugmeyster Yulia, 2012, World J Biol Chem, V3, P73, DOI 10.4331/wjbc.v3.i4.73; Weber CA, 2009, ADV DRUG DELIVER REV, V61, P965, DOI 10.1016/j.addr.2009.07.001; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744	48	189	221	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57479	10.1371/journal.pone.0057479	http://dx.doi.org/10.1371/journal.pone.0057479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468998	gold, Green Submitted, Green Published			2022-12-27	WOS:000315524900097
J	Vangala, RK; Ravindran, V; Ghatge, M; Shanker, J; Arvind, P; Bindu, H; Shekar, M; Rao, VS				Vangala, Rajani Kanth; Ravindran, Vandana; Ghatge, Madan; Shanker, Jayashree; Arvind, Prathima; Bindu, Hima; Shekar, Meghala; Rao, Veena S.			Integrative Bioinformatics Analysis of Genomic and Proteomic Approaches to Understand the Transcriptional Regulatory Program in Coronary Artery Disease Pathways	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS; EXPRESSION; BIOMARKERS; INFLAMMATION; ADIPONECTIN; CLUSTERIN	Patients with cardiovascular disease show a panel of differentially regulated serum biomarkers indicative of modulation of several pathways from disease onset to progression. Few of these biomarkers have been proposed for multimarker risk prediction methods. However, the underlying mechanism of the expression changes and modulation of the pathways is not yet addressed in entirety. Our present work focuses on understanding the regulatory mechanisms at transcriptional level by identifying the core and specific transcription factors that regulate the coronary artery disease associated pathways. Using the principles of systems biology we integrated the genomics and proteomics data with computational tools. We selected biomarkers from 7 different pathways based on their association with the disease and assayed 24 biomarkers along with gene expression studies and built network modules which are highly regulated by 5 core regulators PPARG, EGR1, ETV1, KLF7 and ESRRA. These network modules in turn comprise of biomarkers from different pathways showing that the core regulatory transcription factors may work together in differential regulation of several pathways potentially leading to the disease. This kind of analysis can enhance the elucidation of mechanisms in the disease and give better strategies of developing multimarker module based risk predictions.	[Vangala, Rajani Kanth; Ghatge, Madan; Bindu, Hima; Shekar, Meghala; Rao, Veena S.] Narayana Hrudayalaya Hosp, Thrombosis Res Inst, Tata Prote & Coagulat Dept, Bangalore, Karnataka, India; [Vangala, Rajani Kanth; Ravindran, Vandana] Narayana Hrudayalaya Hosp, Elizabeth & Emmanuel Kaye Bioinformat & Biostat D, Thrombosis Res Inst, Bangalore, Karnataka, India; [Shanker, Jayashree; Arvind, Prathima] Narayana Hrudayalaya Hosp, Thrombosis Res Inst, Mary & Garry Weston Funct Genom Unit, Bangalore, Karnataka, India		Vangala, RK (corresponding author), Narayana Hrudayalaya Hosp, Thrombosis Res Inst, Tata Prote & Coagulat Dept, Bangalore, Karnataka, India.	rajani@triindia.org.in	Ghatge, Madankumar/CAG-8432-2022	Ghatge, Madankumar/0000-0002-6606-0108; Ravindran, Vandana/0000-0002-6440-9433	Department of Biotechnology, Government of India [BT/01/COE/08/07]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India (grant no: BT/01/COE/08/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong EJ, 2006, CIRCULATION, V113, pE72, DOI 10.1161/CIRCULATIONAHA.105.595520; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Bhindi R, 2005, THROMB HAEMOSTASIS, V93, P172, DOI 10.1055/s-0037-1617410; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Brown Todd M, 2008, Curr Cardiol Rep, V10, P497, DOI 10.1007/s11886-008-0078-1; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Caiazzo M, 2011, EXP CELL RES, V317, P464, DOI 10.1016/j.yexcr.2010.11.006; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen JL, 2011, J AM MED INFORM ASSN, V18, P392, DOI 10.1136/amiajnl-2011-000178; Chen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024495; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; Connelly JJ, 2006, PLOS GENET, V2, P1265, DOI 10.1371/journal.pgen.0020139; Costa V, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/126917; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Das D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100067; Hamada N, 2011, J ATHEROSCLER THROMB, V18, P209, DOI 10.5551/jat.5819; Imai A, 2011, ATHEROSCLEROSIS, V218, P350, DOI 10.1016/j.atherosclerosis.2011.06.046; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Levula M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033787; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lie-Venema H, 2003, CIRC RES, V92, P749, DOI 10.1161/01.RES.0000066662.70010.DB; Liu PY, 2005, J CLIN ENDOCR METAB, V90, P1041, DOI 10.1210/jc.2004-1211; Lu X, 2010, CURR MED CHEM, V17, P957, DOI 10.2174/092986710790820688; Mackness B, 1997, ARTERIOSCL THROM VAS, V17, P1233, DOI 10.1161/01.ATV.17.7.1233; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Pagel JI, 2012, INT J MOL SCI, V13, P13104, DOI 10.3390/ijms131013104; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Satoh N, 2004, DIABETES CARE, V27, P2488, DOI 10.2337/diacare.27.10.2488; Shanker Jayashree, 2010, Indian Heart J, V62, P286; Shargorodsky M, 2009, INT J OBESITY, V33, P553, DOI 10.1038/ijo.2009.37; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Spagnoli LG, 2007, J NUCL MED, V48, P1800, DOI 10.2967/jnumed.107.038661; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Wang NP, 2011, CIRC J, V75, P528, DOI 10.1253/circj.CJ-11-0060; WILCOX JN, 1988, J CLIN INVEST, V82, P1134, DOI 10.1172/JCI113671; Zhan XH, 2010, J CEREBR BLOOD F MET, V30, P110, DOI 10.1038/jcbfm.2009.189	40	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57193	10.1371/journal.pone.0057193	http://dx.doi.org/10.1371/journal.pone.0057193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23468932	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900056
J	Edwards, M; Beaugrand, G; Helaouet, P; Alheit, J; Coombs, S				Edwards, Martin; Beaugrand, Gregory; Helaouet, Pierre; Alheit, Juergen; Coombs, Stephen			Marine Ecosystem Response to the Atlantic Multidecadal Oscillation	PLOS ONE			English	Article							NORTH-ATLANTIC; LONG-TERM; SUBPOLAR GYRE; REGIME SHIFT; CLIMATE; SEA; OCEAN; FLUCTUATIONS; BIODIVERSITY; VARIABILITY	Against the backdrop of warming of the Northern Hemisphere it has recently been acknowledged that North Atlantic temperature changes undergo considerable variability over multidecadal periods. The leading component of natural low-frequency temperature variability has been termed the Atlantic Multidecadal Oscillation (AMO). Presently, correlative studies on the biological impact of the AMO on marine ecosystems over the duration of a whole AMO cycle (similar to 60 years) is largely unknown due to the rarity of continuously sustained biological observations at the same time period. To test whether there is multidecadal cyclic behaviour in biological time-series in the North Atlantic we used one of the world's longest continuously sustained marine biological time-series in oceanic waters, long-term fisheries data and historical records over the last century and beyond. Our findings suggest that the AMO is far from a trivial presence against the backdrop of continued temperature warming in the North Atlantic and accounts for the second most important macro-trend in North Atlantic plankton records; responsible for habitat switching (abrupt ecosystem/regime shifts) over multidecadal scales and influences the fortunes of various fisheries over many centuries.	[Edwards, Martin; Helaouet, Pierre] Sir Alister Hardy Fdn Ocean Sci, The Laboratory, Plymouth, Devon, England; [Edwards, Martin] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England; [Beaugrand, Gregory] Univ Sci & Technol Lille 1, Stn Marine, CNRS, LOG,UMR 8187, Wimereux, France; [Alheit, Juergen] Univ Rostock, Balt Sea Res Inst, Warnemunde, Germany; [Coombs, Stephen] Marine Biol Assoc UK, The Laboratory, Plymouth, Devon, England	University of Plymouth; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Leibniz Institut fur Ostseeforschung Warnemunde; University of Rostock; Marine Biological Association United Kingdom	Edwards, M (corresponding author), Sir Alister Hardy Fdn Ocean Sci, The Laboratory, Citadel Hill, Plymouth, Devon, England.	maed@sahfos.ac.uk		BEAUGRAND, GREGORY/0000-0002-0712-5223; Helaouet, Pierre/0000-0001-6102-7379	Canada (Department of Fisheries and Oceans); United Kingdom (Department for Environment, Food and Rural Affairs and National Environmental Research Council); USA (National Science Foundation); UK DEFRA; UK NERC; German Federal Ministry for Education and Research through the ECODRIVE project; EU through the FACTS project; Norway (Institute of Marine Research); Division Of Ocean Sciences [1154661] Funding Source: National Science Foundation	Canada (Department of Fisheries and Oceans); United Kingdom (Department for Environment, Food and Rural Affairs and National Environmental Research Council); USA (National Science Foundation)(National Science Foundation (NSF)); UK DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); UK NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); German Federal Ministry for Education and Research through the ECODRIVE project; EU through the FACTS project; Norway (Institute of Marine Research); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	A funding consortium made up of governmental agencies from Canada (Department of Fisheries and Oceans), Norway (Institute of Marine Research), the United Kingdom (Department for Environment, Food and Rural Affairs and National Environmental Research Council) and the USA (National Science Foundation) financially supports the CPR survey. Main support for this work was provided by UK DEFRA and UK NERC. J.A. received funding from the German Federal Ministry for Education and Research through the ECODRIVE project and from the EU through the FACTS project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheit J, 1997, FISH OCEANOGR, V6, P130, DOI 10.1046/j.1365-2419.1997.00035.x; Beare D, 2004, GLOBAL CHANGE BIOL, V10, P1209, DOI 10.1111/j.1529-8817.2003.00790.x; Beaugrand G, 2000, MAR ECOL PROG SER, V204, P299, DOI 10.3354/meps204299; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Cannaby H, 2009, ICES J MAR SCI, V66, P1480, DOI 10.1093/icesjms/fsp062; Coombs Steve, 2011, Marine Biological Association of the United Kingdom Occasional Publication, V24, P1; Cushing D.H., 1976, Advances mar Biol, V14, P1; Dragesund O, 1997, SARSIA, V82, P97, DOI 10.1080/00364827.1997.10413643; Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; Edwards M, 2002, MAR ECOL PROG SER, V239, P1, DOI 10.3354/meps239001; Edwards M, 2001, ICES J MAR SCI, V58, P39, DOI 10.1006/jmsc.2000.0987; Edwards M, 2010, TRENDS ECOL EVOL, V25, P602, DOI 10.1016/j.tree.2010.07.007; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Fischer H, 2005, CLIM DYNAM, V25, P65, DOI 10.1007/s00382-005-0011-x; Gray ST, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019932; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Hatun H, 2009, CAN J FISH AQUAT SCI, V66, P759, DOI 10.1139/F09-037; Keenlyside NS, 2008, NATURE, V453, P84, DOI 10.1038/nature06921; Knight JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026242; Reid PC, 2001, FISH RES, V50, P163, DOI 10.1016/S0165-7836(00)00249-6; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; Reid PC, 2001, SENCK MARIT, V31, P107, DOI 10.1007/BF03043021; RUSSELL FS, 1971, NATURE, V234, P468, DOI 10.1038/234468a0; SOUTHWARD AJ, 1988, J MAR BIOL ASSOC UK, V68, P423, DOI 10.1017/S0025315400043320; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Ting MF, 2009, J CLIMATE, V22, P1469, DOI 10.1175/2008JCLI2561.1; Toresen R, 2000, FISH FISH, V1, P231, DOI 10.1111/j.1467-2979.2000.00022.x; WOODRUFF SD, 1987, B AM METEOROL SOC, V68, P1239, DOI 10.1175/1520-0477(1987)068<1239:ACOADS>2.0.CO;2; Zhang XD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035607	30	90	90	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57212	10.1371/journal.pone.0057212	http://dx.doi.org/10.1371/journal.pone.0057212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460832	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000076
J	Feldman, DE; Chen, CL; Punj, V; Machida, K				Feldman, Douglas E.; Chen, Chialin; Punj, Vasu; Machida, Keigo			The TBC1D15 Oncoprotein Controls Stem Cell Self-Renewal through Destabilization of the Numb-p53 Complex	PLOS ONE			English	Article							EMBRYONIC STEM; INITIATING CELLS; P53; AUTOPHAGY; PROTEIN; LIVER; PHOSPHORYLATION; GENES; SUPPRESSION; ONCOGENESIS	Stem cell populations are maintained through self-renewing divisions in which one daughter cell commits to a specific fate while the other retains the multipotent characteristics of its parent. The p53 tumor suppressor, in conjunction with its interacting partner protein Numb, preserves this asymmetry and functions as a vital barrier against the unchecked expansion of tumor stem cell pools; however, little is known about the biological control of the Numb-p53 interaction. We show here that Numb and p53 are the constituents of a high molecular mass complex, which is disintegrated upon activation of aPKC zeta, a Numb kinase. Using large-scale affinity purification and tandem mass spectrometry, we identify TBC1D15 as a Numb-associated protein and demonstrate that its amino-terminal domain disengages p53 from Numb, triggering p53 proteolysis and promoting self-renewal and pluripotency. Cellular levels of TBC1D15 are diminished upon acute nutrient deprivation through autophagy-mediated degradation, indicating that TBC1D15 serves as a conduit through which cellular metabolic status is linked to self-renewal. The profound deregulation of TBC1D15 expression exhibited in a diverse array of patient tumors underscores its proposed function as an oncoprotein.	[Feldman, Douglas E.; Chen, Chialin; Machida, Keigo] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Punj, Vasu] Univ So Calif, Bioinformat Core, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Punj, Vasu] Univ So Calif, Keck Sch Med, Div Hematol, Los Angeles, CA 90033 USA; [Machida, Keigo] Univ So Calif, Keck Sch Med, So Calif Res Ctr ALPD & Cirrhosis, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Feldman, DE (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	defeldma@usc.edu; kmachida@usc.edu	Chen, Chialin/M-9190-2017	Chen, Chialin/0000-0002-8832-0062; Machida, Keigo/0000-0002-9721-8553	National Cancer Institute [PO1 CA123228]; National Institute on Alcohol Abuse and Alcoholism [RO1 AA018857, P50 AA11999]; California Institute for Regenerative Medicine; Cell and Tissue Imaging Core of the USC Research Center for Liver Diseases, NIH [P30 DK048522, S10 RR022508]; NATIONAL CANCER INSTITUTE [R01CA123228] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, R01AA018857] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Cell and Tissue Imaging Core of the USC Research Center for Liver Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the National Cancer Institute (PO1 CA123228) and the National Institute on Alcohol Abuse and Alcoholism (RO1 AA018857, P50 AA11999). DF was supported by a postdoctoral scholarship from the California Institute for Regenerative Medicine. FACS analysis was performed by the Flow Cytometry Core at USC Keck Medical Center. Confocal microscopy services were provided by the Cell and Tissue Imaging Core of the USC Research Center for Liver Diseases, NIH grants P30 DK048522 and S10 RR022508. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bonizzi G, 2012, TRENDS MOL MED, V18, P6, DOI 10.1016/j.molmed.2011.08.002; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; CARLSSON G, 1983, J CANCER RES CLIN, V105, P20, DOI 10.1007/BF00391826; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Feldman DE, 2012, P NATL ACAD SCI USA, V109, P829, DOI 10.1073/pnas.1114438109; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gjoerup O, 2001, J VIROL, V75, P9142, DOI 10.1128/JVI.75.19.9142-9155.2001; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Ikushima H, 2011, J BIOL CHEM, V286, P41434, DOI 10.1074/jbc.M111.300863; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jellicoe MM, 2008, CARCINOGENESIS, V29, P1124, DOI 10.1093/carcin/bgn093; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Li M, 2012, MOL CELL; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Machida K, 2009, P NATL ACAD SCI USA, V106, P1548, DOI 10.1073/pnas.0807390106; Majumder M, 2003, FEBS LETT, V555, P528, DOI 10.1016/S0014-5793(03)01337-1; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Peralta ER, 2010, J BIOL CHEM, V285, P16814, DOI 10.1074/jbc.M110.111633; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Prigione A, 2011, STEM CELLS, V29, P1338, DOI 10.1002/stem.683; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shafee N, 2008, CANCER RES, V68, P3243, DOI 10.1158/0008-5472.CAN-07-5480; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shinmura K, 2007, ONCOGENE, V26, P2939, DOI 10.1038/sj.onc.1210085; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Speicher S, 2008, CURR BIOL, V18, P831, DOI 10.1016/j.cub.2008.04.072; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tokumitsu H, 2006, FEBS LETT, V580, P5797, DOI 10.1016/j.febslet.2006.09.043; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wee B, 2011, J CELL BIOL, V195, P369, DOI 10.1083/jcb.201102130; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Yang W, 2012, NAT CELL BIOL; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015; Zhu WH, 2011, J PROTEOME RES, V10, P2129, DOI 10.1021/pr101190f	63	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57312	10.1371/journal.pone.0057312	http://dx.doi.org/10.1371/journal.pone.0057312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23468968	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000091
J	Fernandez, E; Toledo, JR; Mendez, L; Gonzalez, N; Parra, F; Martin-Alonso, JM; Limonta, M; Sanchez, K; Cabrales, A; Estrada, MP; Rodriguez-Mallon, A; Farnos, O				Fernandez, Erlinda; Toledo, Jorge R.; Mendez, Lidice; Gonzalez, Nemecio; Parra, Francisco; Martin-Alonso, Jose M.; Limonta, Miladys; Sanchez, Kosara; Cabrales, Ania; Estrada, Mario P.; Rodriguez-Mallon, Alina; Farnos, Omar			Conformational and Thermal Stability Improvements for the Large-Scale Production of Yeast-Derived Rabbit Hemorrhagic Disease Virus-Like Particles as Multipurpose Vaccine	PLOS ONE			English	Article							CLASSICAL SWINE-FEVER; B SURFACE-ANTIGEN; PICHIA-PASTORIS; IMMUNOGENIC PROPERTIES; PROTECTS RABBITS; RHDV; VP60; IMMUNIZATION; CALICIVIRUS; EXPRESSION	Recombinant virus-like particles (VLP) antigenically similar to rabbit hemorrhagic disease virus (RHDV) were recently expressed at high levels inside Pichia pastoris cells. Based on the potential of RHDV VLP as platform for diverse vaccination purposes we undertook the design, development and scale-up of a production process. Conformational and stability issues were addressed to improve process control and optimization. Analyses on the structure, morphology and antigenicity of these multimers were carried out at different pH values during cell disruption and purification by size-exclusion chromatography. Process steps and environmental stresses in which aggregation or conformational instability can be detected were included. These analyses revealed higher stability and recoveries of properly assembled high-purity capsids at acidic and neutral pH in phosphate buffer. The use of stabilizers during long-term storage in solution showed that sucrose, sorbitol, trehalose and glycerol acted as useful aggregation-reducing agents. The VLP emulsified in an oil-based adjuvant were subjected to accelerated thermal stress treatments. None to slight variations were detected in the stability of formulations and in the structure of recovered capsids. A comprehensive analysis on scale-up strategies was accomplished and a nine steps large-scale production process was established. VLP produced after chromatographic separation protected rabbits against a lethal challenge. The minimum protective dose was identified. Stabilized particles were ultimately assayed as carriers of a foreign viral epitope from another pathogen affecting a larger animal species. For that purpose, a linear protective B-cell epitope from Classical Swine Fever Virus (CSFV) E2 envelope protein was chemically coupled to RHDV VLP. Conjugates were able to present the E2 peptide fragment for immune recognition and significantly enhanced the peptide-specific antibody response in vaccinated pigs. Overall these results allowed establishing improved conditions regarding conformational stability and recovery of these multimers for their production at large-scale and potential use on different animal species or humans.	[Fernandez, Erlinda; Mendez, Lidice; Estrada, Mario P.; Rodriguez-Mallon, Alina; Farnos, Omar] Ctr Genet Engn & Biotechnol, Div Anim Biotechnol, Havana, Cuba; [Toledo, Jorge R.] Univ Concepcion, Dept Physiopathol, Fac Biol Sci, Concepcion, Chile; [Gonzalez, Nemecio] Ctr Genet Engn & Biotechnol Camaguey, Dev Technol Dept, Camaguey, Cuba; [Parra, Francisco; Martin-Alonso, Jose M.] Univ Oviedo, Dept Biochem & Mol Biol, Inst Univ Biotecnol Asturias, Oviedo, Spain; [Limonta, Miladys] Ctr Genet Engn & Biotechnol, Technol Dev Div, Havana, Cuba; [Sanchez, Kosara] Ctr Genet Engn & Biotechnol, Div Dev Formulat, Havana, Cuba; [Cabrales, Ania] Ctr Genet Engn & Biotechnol, Peptide Synth Dept, Havana, Cuba	Centro de Ingenieria Genetica y Biotecnologia; Universidad de Concepcion; University of Oviedo; Centro de Ingenieria Genetica y Biotecnologia; Centro de Ingenieria Genetica y Biotecnologia; Centro de Ingenieria Genetica y Biotecnologia	Farnos, O (corresponding author), Ctr Genet Engn & Biotechnol, Div Anim Biotechnol, Havana, Cuba.	omar.farnos@yahoo.com	Rodriguez Mallon, Alina/GVU-0924-2022; Parra, Francisco/D-5401-2009	Parra, Francisco/0000-0002-1885-9521; Toledo, Jorge R./0000-0002-9879-7710; Farnos, Omar/0000-0003-1295-8323	Center for Genetic Engineering and Biotechnology (Ministry of Science, Technology and Environment of Cuba); Instituto Universitario de Biotecnologia de Asturias from the University of Oviedo, Spain	Center for Genetic Engineering and Biotechnology (Ministry of Science, Technology and Environment of Cuba); Instituto Universitario de Biotecnologia de Asturias from the University of Oviedo, Spain	This work was supported by research projects on Animal Health from the Center for Genetic Engineering and Biotechnology (Ministry of Science, Technology and Environment of Cuba) and the Instituto Universitario de Biotecnologia de Asturias from the University of Oviedo, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-12; Acosta-Rivero N, 2004, BIOCHEM BIOPH RES CO, V325, P68, DOI 10.1016/j.bbrc.2004.10.012; Acosta-Rivero N, 2004, BIOCHEM BIOPH RES CO, V323, P926, DOI 10.1016/j.bbrc.2004.08.189; Acosta-Rivero N, 2001, BIOCHEM BIOPH RES CO, V287, P122, DOI 10.1006/bbrc.2001.5561; Alvarez-Lajonchere L, 2009, J VIRAL HEPATITIS, V16, P156, DOI 10.1111/j.1365-2893.2008.01058.x; Ausar SF, 2006, J BIOL CHEM, V281, P19478, DOI 10.1074/jbc.M603313200; Barcena J, 2000, J VIROL, V74, P1114, DOI 10.1128/JVI.74.3.1114-1123.2000; Barrera M, 2010, VET IMMUNOL IMMUNOP, V133, P25, DOI 10.1016/j.vetimm.2009.06.015; Bertagnoli S, 1996, VACCINE, V14, P506, DOI 10.1016/0264-410X(95)00232-P; Bertagnoli S, 1996, J VIROL, V70, P5061, DOI 10.1128/JVI.70.8.5061-5066.1996; BOGA JA, 1994, J GEN VIROL, V75, P2409, DOI 10.1099/0022-1317-75-9-2409; Boga JA, 1997, J GEN VIROL, V78, P2315, DOI 10.1099/0022-1317-78-9-2315; Brun A, 2011, VIRUS RES, V157, P1, DOI 10.1016/j.virusres.2011.02.006; Canales M, 1997, VACCINE, V15, P414, DOI 10.1016/S0264-410X(96)00192-2; CAPUCCI L, 1995, VIRUS RES, V37, P221, DOI 10.1016/0168-1702(95)00033-M; Castanon S, 1999, J VIROL, V73, P4452; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Chang CY, 2012, VIRUS RES, V163, P190, DOI 10.1016/j.virusres.2011.09.019; Estevez ZC, 2007, BIOLOGICALS, V35, P115, DOI 10.1016/j.biologicals.2006.06.001; Cooke BD, 2002, REV SCI TECH OIE, V21, P347, DOI 10.20506/rst.21.2.1337; Crisci E, 2012, VACCINE, V30, P2427, DOI 10.1016/j.vaccine.2012.01.069; Crisci E, 2009, VIROLOGY, V387, P303, DOI 10.1016/j.virol.2009.02.045; de Arce HD, 2005, VIRUS RES, V112, P123, DOI 10.1016/j.virusres.2005.03.018; de la Fuente Jose, 2007, Animal Health Research Reviews, V8, P23, DOI 10.1017/S1466252307001193; Dong XN, 2007, VACCINE, V25, P205, DOI 10.1016/j.vaccine.2006.07.033; Dong XN, 2006, VACCINE, V24, P426, DOI 10.1016/j.vaccine.2005.08.002; Evans RK, 2004, J PHARM SCI-US, V93, P2458, DOI 10.1002/jps.20157; Farnos O, 2007, ARCH VIROL, V152, P1215, DOI 10.1007/s00705-006-0926-5; Farnos O, 2005, J BIOTECHNOL, V117, P215, DOI 10.1016/j.jbiotec.2005.01.013; Farnos O, 2009, ANTIVIR RES, V81, P25, DOI 10.1016/j.antiviral.2008.08.007; Fernandez E, 2011, VET IMMUNOL IMMUNOP, V142, P179, DOI 10.1016/j.vetimm.2011.05.007; Fernandez-Fernandez MR, 2001, VIROLOGY, V280, P283, DOI 10.1006/viro.2000.0762; Ferreira PG, 2006, RES VET SCI, V80, P218, DOI 10.1016/j.rvsc.2005.05.007; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fischer L, 1997, VACCINE, V15, P90, DOI 10.1016/S0264-410X(96)00102-8; Forrester NL, 2006, VIROLOGY, V344, P277, DOI 10.1016/j.virol.2005.10.006; Gil F, 2006, PLANT BIOTECHNOL J, V4, P135, DOI 10.1111/j.1467-7652.2005.00172.x; Gonzalez N, 2011, P INT C BIOT HAV 201; Gould EA, 2012, MOL ECOL, V21, P1042, DOI 10.1111/j.1365-294X.2012.05462.x; Hardy E, 2000, J BIOTECHNOL, V77, P157, DOI 10.1016/S0168-1656(99)00201-1; Jiang G, 2006, J PHARM SCI-US, V95, P80, DOI 10.1002/jps.20484; Kissmann J, 2008, J PHARM SCI-US, V97, P4208, DOI 10.1002/jps.21315; Krell T, 2005, BIOTECHNOL APPL BIOC, V41, P241, DOI 10.1042/BA20040113; LAURENT S, 1994, J VIROL, V68, P6794, DOI 10.1128/JVI.68.10.6794-6798.1994; LEE JC, 1981, J BIOL CHEM, V256, P7193; Lewis JD, 1997, J COLLOID INTERF SCI, V196, P170, DOI 10.1006/jcis.1997.5187; Li GX, 2012, VET MICROBIOL, V156, P200, DOI 10.1016/j.vetmic.2011.10.012; Liu FX, 2012, RES VET SCI, V93, P553, DOI 10.1016/j.rvsc.2011.10.018; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maa YF, 1997, BIOTECHNOL BIOENG, V54, P503, DOI 10.1002/(SICI)1097-0290(19970620)54:6<503::AID-BIT1>3.0.CO;2-N; Maddux NR, 2011, J PHARM SCI-US, V100, P4171, DOI 10.1002/jps.22618; Marin MS, 1995, VIRUS RES, V39, P119, DOI 10.1016/0168-1702(95)00074-7; McIntosh MT, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-96; Moennig V, 2000, VET MICROBIOL, V73, P93, DOI 10.1016/S0378-1135(00)00137-1; Monso M, 2011, J PEPT SCI, V17, P24, DOI 10.1002/psc.1292; PARRA F, 1993, VIRUS RES, V27, P219, DOI 10.1016/0168-1702(93)90034-K; PARRA F, 1990, J VIROL, V64, P4013, DOI 10.1128/JVI.64.8.4013-4015.1990; Peacey M, 2008, VACCINE, V26, P5334, DOI 10.1016/j.vaccine.2008.07.074; Peacey M, 2007, BIOTECHNOL BIOENG, V98, P968, DOI 10.1002/bit.21518; Peek LJ, 2007, J PHARM SCI-US, V96, P547, DOI 10.1002/jps.20762; Peek LJ, 2006, VACCINE, V24, P5839, DOI 10.1016/j.vaccine.2006.04.067; Perez-Filgueira DM, 2007, VIROLOGY, V364, P422, DOI 10.1016/j.virol.2007.03.016; Perez-Perez D, 2010, VET PARASITOL, V167, P321, DOI 10.1016/j.vetpar.2009.09.034; Rohde J, 2011, VACCINE, V29, P9256, DOI 10.1016/j.vaccine.2011.09.121; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Ruvoen-Clouet N, 2000, J VIROL, V74, P11950, DOI 10.1128/JVI.74.24.11950-11954.2000; Salnikova MS, 2008, J PHARM SCI-US, V97, P4194, DOI 10.1002/jps.21300; Smith JS, 1996, BIOCHEMISTRY-US, V35, P7292, DOI 10.1021/bi960341i; Suarez M, 2011, P INT C BIOT HAV 201; Tarradas J, 2011, VACCINE, V29, P4422, DOI 10.1016/j.vaccine.2011.03.095; Tleugabulova D, 1998, J CHROMATOGR B, V716, P209, DOI 10.1016/S0378-4347(98)00297-7; Toledo JR, 2008, J BIOTECHNOL, V133, P370, DOI 10.1016/j.jbiotec.2007.09.014; Toledo JR, 2010, VACCINE, V28, P7907, DOI 10.1016/j.vaccine.2010.09.073; Valdes I, 2007, MOL BIOTECHNOL, V35, P23, DOI 10.1385/MB:35:1:23; Vargas M, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-43; Yildiz I, 2011, CURR OPIN BIOTECH, V22, P901, DOI 10.1016/j.copbio.2011.04.020; Zheng T, 2011, VET MICROBIOL, V153, P387, DOI 10.1016/j.vetmic.2011.05.049; Zhou B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-378	78	14	14	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56417	10.1371/journal.pone.0056417	http://dx.doi.org/10.1371/journal.pone.0056417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460801	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000024
J	Leptidis, S; el Azzouzi, H; Lok, SI; de Weger, R; Olieslagers, S; Kisters, N; Silva, GJ; Heymans, S; Cuppen, E; Berezikov, E; De Windt, LJ; Martins, PD				Leptidis, Stefanos; el Azzouzi, Hamid; Lok, Sjoukje I.; de Weger, Roel; Olieslagers, Serv; Kisters, Natasja; Silva, Gustavo J.; Heymans, Stephane; Cuppen, Edwin; Berezikov, Eugene; De Windt, Leon J.; Martins, Paula da Costa			A Deep Sequencing Approach to Uncover the miRNOME in the Human Heart	PLOS ONE			English	Article							SMALL RNAS; CARDIAC-HYPERTROPHY; MICRORNA EXPRESSION; IDENTIFICATION; DISCOVERY; MIR-145; REVEALS; TARGETS; MIRNAS; CELLS	MicroRNAs (miRNAs) are a class of non-coding RNAs of similar to 22 nucleotides in length, and constitute a novel class of gene regulators by imperfect base-pairing to the 3'UTR of protein encoding messenger RNAs. Growing evidence indicates that miRNAs are implicated in several pathological processes in myocardial disease. The past years, we have witnessed several profiling attempts using high-density oligonucleotide array-based approaches to identify the complete miRNA content (miRNOME) in the healthy and diseased mammalian heart. These efforts have demonstrated that the failing heart displays differential expression of several dozens of miRNAs. While the total number of experimentally validated human miRNAs is roughly two thousand, the number of expressed miRNAs in the human myocardium remains elusive. Our objective was to perform an unbiased assay to identify the miRNOME of the human heart, both under physiological and pathophysiological conditions. We used deep sequencing and bioinformatics to annotate and quantify microRNA expression in healthy and diseased human heart (heart failure secondary to hypertrophic or dilated cardiomyopathy). Our results indicate that the human heart expresses >800 miRNAs, the majority of which not being annotated nor described so far and some of which being unique to primate species. Furthermore, >250 miRNAs show differential and etiology-dependent expression in human dilated cardiomyopathy (DCM) or hypertrophic cardiomyopathy (HCM). The human cardiac miRNOME still possesses a large number of miRNAs that remain virtually unexplored. The current study provides a starting point for a more comprehensive understanding of the role of miRNAs in regulating human heart disease.	[Leptidis, Stefanos; el Azzouzi, Hamid; Olieslagers, Serv; Kisters, Natasja; Silva, Gustavo J.; Heymans, Stephane; De Windt, Leon J.; Martins, Paula da Costa] Maastricht Univ, Fac Hlth Med & Life Sci, CARIM Sch Cardiovasc Dis, Dept Cardiol, Maastricht, Netherlands; [Lok, Sjoukje I.; de Weger, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Cuppen, Edwin; Berezikov, Eugene] Royal Netherlands Acad Sci, Hubrecht Inst, Utrecht, Netherlands	Maastricht University; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Martins, PD (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, CARIM Sch Cardiovasc Dis, Dept Cardiol, Maastricht, Netherlands.	p.dacostamartins@maastrichtuniversity.nl	Cuppen, Edwin/H-2389-2016; Leptidis, Stefanos/D-1455-2016; Berezikov, Eugene/D-3363-2013; de Windt, Leon/AAO-6395-2020; da Silva, Gustavo J Justo/H-5222-2011; Cuppen, Edwin/F-5696-2011	Cuppen, Edwin/0000-0002-0400-9542; Leptidis, Stefanos/0000-0003-0172-4193; Berezikov, Eugene/0000-0002-1145-2884; de Windt, Leon/0000-0002-7793-2856; da Silva, Gustavo J Justo/0000-0002-1651-7966; Cuppen, Edwin/0000-0002-0400-9542; Heymans, Stephane/0000-0001-9477-7803; el Azzouzi, Hamid/0000-0003-1242-9691	Netherlands Organization for Health Research and Development [917-863-72]; Netherlands Heart Foundation [NHS2007B167, NHS2010B261]; Foundation Leducq Transatlantic Network of Excellence program [08-CVD-03]; Foundation Leducq	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Heart Foundation(Netherlands Heart Foundation); Foundation Leducq Transatlantic Network of Excellence program(Leducq Foundation); Foundation Leducq(Leducq Foundation)	L.D.W. was supported by a VIDI award 917-863-72 from the Netherlands Organization for Health Research and Development, the Netherlands Heart Foundation program grant NHS2007B167, and by the Foundation Leducq Transatlantic Network of Excellence program 08-CVD-03. P.D.C.M. was supported by a Career Development Award from Foundation Leducq and by the Netherlands Heart Foundation program grant NHS2010B261. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Barringhaus KG, 2009, CIRCULATION, V119, P2217, DOI 10.1161/CIRCULATIONAHA.107.715839; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; de Wit E, 2009, GENOME RES, V19, P2064, DOI 10.1101/gr.093781.109; Dorn GW, 2011, TRANSL RES, V157, P226, DOI 10.1016/j.trsl.2010.12.013; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Gommans WM, 2012, METHODS MOL BIOL, V786, P167, DOI 10.1007/978-1-61779-292-2_10; Hata A, 2012, ANN REV PHYSL; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Mayorga ME, 2012, J CELL MOL MED, V16, P1106, DOI 10.1111/j.1582-4934.2011.01385.x; Meiri E, 2010, NUCLEIC ACIDS RES, V38, P6234, DOI 10.1093/nar/gkq376; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ryu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016403; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; van Empel VPM, 2012, CURR HYPERTENS REP, V14, P498, DOI 10.1007/s11906-012-0310-7; van Loosdregt J, 2006, CIRCULATION, V114, P1599, DOI 10.1161/CIRCULATIONAHA.105.597526; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Zhang Z, 1998, J COMPUT BIOL, V5, P197, DOI 10.1089/cmb.1998.5.197	57	73	75	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57800	10.1371/journal.pone.0057800	http://dx.doi.org/10.1371/journal.pone.0057800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460909	Green Published, Green Submitted, gold			2022-12-27	WOS:000315519000164
J	Munn, AJ; Dunne, C; Muller, DWH; Clauss, M				Munn, Adam J.; Dunne, Craig; Mueller, Dennis W. H.; Clauss, Marcus			Energy In-Equivalence in Australian Marsupials: Evidence for Disruption of the Continent's Mammal Assemblage, or Are Rules Meant to Be Broken?	PLOS ONE			English	Article							BASAL METABOLIC-RATE; BODY-SIZE; POPULATION-DENSITY; ABUNDANCE; ANIMALS; BIODIVERSITY; EXTINCTION; ALLOMETRY; VARIABLES; ECOLOGY	The energy equivalence rule (EER) is a macroecological hypothesis that posits that total population energy use (PEU) should be independent of species body mass, because population densities and energy metabolisms scale with body mass in a directly inverse manner. However, evidence supporting the EER is equivocal, and the use of basal metabolic rate (BMR) in such studies has been questioned; ecologically-relevant indices like field metabolic rate (FMR) are probably more appropriate. In this regard, Australian marsupials present a novel test for the EER because, unlike eutherians, marsupial BMRs and FMRs scale differently with body mass. Based on either FMR or BMR, Australian marsupial PEU did not obey an EER, and scaled positively with body mass based on ordinary least squares (OLS) regressions. Importantly, the scaling of marsupial population density with body mass had a slope of -0.37, significantly shallower than the expected slope of -0.75, and not directly inverse of body-mass scaling exponents for BMR (0.72) or FMR (0.62). The findings suggest that the EER may not be a causal, universal rule, or that for reasons not yet clear, it is not operating for Australia's unique native fauna.	[Munn, Adam J.; Dunne, Craig] Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia; [Mueller, Dennis W. H.; Clauss, Marcus] Univ Zurich, Clin Zoo Anim Exot Pets & Wildlife, Vetsuisse Fac, Zurich, Switzerland	University of Wollongong; University of Zurich	Munn, AJ (corresponding author), Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia.	amunn@uow.edu.au	Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/M-8702-2019; Clauss, Marcus/A-4710-2008	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207				Ackerman JL, 2004, OECOLOGIA, V139, P568, DOI 10.1007/s00442-004-1536-0; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; Blackburn TM, 1997, J ANIM ECOL, V66, P233, DOI 10.2307/6025; Brown JH, 2003, P NATL ACAD SCI USA, V100, P1467, DOI 10.1073/pnas.0630310100; Capellini I, 2010, ECOLOGY, V91, P2783, DOI 10.1890/09-0817.1; Carbone C, 2009, INT J ECOLOGY, V2009; Carbone C, 2007, AM NAT, V170, P479, DOI 10.1086/519858; Cardillo M, 2001, CONSERV BIOL, V15, P1435, DOI 10.1046/j.1523-1739.2001.00286.x; COTGREAVE P, 1993, TRENDS ECOL EVOL, V8, P244, DOI 10.1016/0169-5347(93)90199-Y; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; Damuth J, 1981, NATURE, V290; Dawson TJ, 2012, AUSTRAL NAT HIST SER, P1; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Gaston K. J., 2000, PATTERNS PROCESS MAC; Geiser F, 2009, NATURWISSENSCHAFTEN, V96, P1235, DOI 10.1007/s00114-009-0583-0; Happold D.C.D., 2008, MAMMALS AUSTR, P589; Isaac NJB, 2011, BIOL LETTERS, V7, P615, DOI 10.1098/rsbl.2011.0128; Isaac NJB, 2010, ECOL LETT, V13, P728, DOI 10.1111/j.1461-0248.2010.01461.x; Johnson C, 2006, AUSTR MAMMAL EXTINCT; Johnson CN, 2009, AUSTRAL ECOL, V34, P35, DOI 10.1111/j.1442-9993.2008.01878.x; Johnson CN, 1999, OIKOS, V85, P565, DOI 10.2307/3546706; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; MARQUET PA, 1995, J ANIM ECOL, V64, P325, DOI 10.2307/5894; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; NEE S, 1991, NATURE, V351, P312, DOI 10.1038/351312a0; Newsome AE, 2001, RANGELAND J, V23, P71, DOI 10.1071/RJ01015; Ozgul A, 2009, SCIENCE, V325, P464, DOI 10.1126/science.1173668; Russo SE, 2003, AM NAT, V161, P267, DOI 10.1086/345938; WESTOBY M, 1995, J ECOL, V83, P531, DOI 10.2307/2261605; White CR, 2005, J EXP BIOL, V208, P1611, DOI 10.1242/jeb.01501; White CR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P929, DOI 10.1086/425186; White CR, 2012, P ROY SOC B-BIOL SCI, V279, P3616, DOI 10.1098/rspb.2012.0884; White CR, 2011, COMP BIOCHEM PHYS A, V158, P346, DOI 10.1016/j.cbpa.2010.10.004; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Withers PC, 2006, PHYSIOL BIOCHEM ZOOL, V79, P437, DOI 10.1086/501063	38	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57449	10.1371/journal.pone.0057449	http://dx.doi.org/10.1371/journal.pone.0057449			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460858	Green Accepted, gold, Green Published			2022-12-27	WOS:000315519000112
J	Tiwari, A; Hadley, JA; Hendricks, GL; Elkin, RG; Cooper, T; Ramachandran, R				Tiwari, Anupama; Hadley, Jill A.; Hendricks, Gilbert L., III; Elkin, Robert G.; Cooper, Timothy; Ramachandran, Ramesh			Characterization of Ascites-Derived Ovarian Tumor Cells from Spontaneously Occurring Ovarian Tumors of the Chicken: Evidence for E-Cadherin Upregulation	PLOS ONE			English	Article							SURFACE EPITHELIAL-CELLS; ANTI-MULLERIAN HORMONE; IN-VITRO MODEL; GENE-EXPRESSION; CANCER CELLS; TRANSCRIPTION FACTOR; ADHESION MOLECULES; SKELETAL-MUSCLE; LAYING HENS; ADENOCARCINOMAS	Ovarian cancer, a highly metastatic disease, is the fifth leading cause of cancer-related deaths in women. Chickens are widely used as a model for human ovarian cancer as they spontaneously develop epithelial ovarian tumors similar to humans. The cellular and molecular biology of chicken ovarian cancer (COVCAR) cells, however, have not been studied. Our objectives were to culture COVCAR cells and to characterize their invasiveness and expression of genes and proteins associated with ovarian cancer. COVCAR cell lines (n = 13) were successfully maintained in culture for up to19 passages, cryopreserved and found to be viable upon thawing and replating. E-cadherin, cytokeratin and alpha-smooth muscle actin were localized in COVCAR cells by immunostaining. COVCAR cells were found to be invasive in extracellular matrix and exhibited anchorage-independent growth forming colonies, acini and tube-like structures in soft agar. Using RT-PCR, COVCAR cells were found to express E-cadherin, N-cadherin, cytokeratin, vimentin, mesothelin, EpCAM, steroidogenic enzymes/proteins, inhibin subunits-alpha, beta A, beta B, anti-mullerian hormone, estrogen receptor [ER]-alpha, ER-beta, progesterone receptor, androgen receptor, and activin receptors. Quantitative PCR analysis revealed greater N-cadherin, vimentin, and VEGF mRNA levels and lesser cytokeratin mRNA levels in COVCAR cells as compared with normal ovarian surface epithelial (NOSE) cells, which was suggestive of epithelial-mesenchymal transformation. Western blotting analyses revealed significantly greater E-cadherin levels in COVCAR cell lines compared with NOSE cells. Furthermore, cancerous ovaries and COVCAR cell lines expressed higher levels of an E-cadherin cleavage product when compared to normal ovaries and NOSE cells, respectively. Cancerous ovaries were found to express significantly higher ovalbumin levels whereas COVCAR cell lines did not express ovalbumin thus suggesting that the latter did not originate from oviduct. Taken together, COVCAR cell lines are likely to improve our understanding of the cellular and molecular biology of ovarian tumors and its metastasis.	[Tiwari, Anupama; Hadley, Jill A.; Hendricks, Gilbert L., III; Elkin, Robert G.; Ramachandran, Ramesh] Penn State Univ, Ctr Reprod Biol & Hlth, Dept Anim Sci, University Pk, PA 16802 USA; [Cooper, Timothy] Penn State Hershey Med Ctr, Penn State Coll Med, Dept Comparat Med, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ramachandran, R (corresponding author), Penn State Univ, Ctr Reprod Biol & Hlth, Dept Anim Sci, University Pk, PA 16802 USA.	RameshR@psu.edu			College of Agricultural Sciences, Pennsylvania State University	College of Agricultural Sciences, Pennsylvania State University	The authors acknowledge funding support from the College of Agricultural Sciences, Pennsylvania State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Ansenberger K, 2010, GYNECOL ONCOL, V117, P341, DOI 10.1016/j.ygyno.2010.01.021; Ansenberger K, 2009, GYNECOL ONCOL, V113, P362, DOI 10.1016/j.ygyno.2009.02.011; AUERSPERG N, 1994, LAB INVEST, V71, P510; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Barnes MN, 2002, GYNECOL ONCOL, V87, P57, DOI 10.1006/gyno.2002.6806; Barua A, 2009, INT J GYNECOL CANCER, V19, P531, DOI 10.1111/IGC.0b013e3181a41613; Bosquet JG, 2011, GYNECOL ONCOL, V120, P256, DOI 10.1016/j.ygyno.2010.10.030; CAMPBELL JG, 1951, BRIT J CANCER, V5, P69, DOI 10.1038/bjc.1951.7; Choi JW, 2011, ONCOL LETT, V2, P1047, DOI 10.3892/ol.2011.391; David JM, 2012, CANCER RES, V72, P2917, DOI 10.1158/0008-5472.CAN-11-3498; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Fishman DA, 1997, CANCER-AM CANCER SOC, V80, P1457, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1457::AID-CNCR13>3.0.CO;2-4; FREDRICKSON TN, 1987, ENVIRON HEALTH PERSP, V73, P35, DOI 10.2307/3430596; GALLIN WJ, 1983, P NATL ACAD SCI-BIOL, V80, P1038, DOI 10.1073/pnas.80.4.1038; Giles JR, 2006, EXP BIOL MED, V231, P1718, DOI 10.1177/153537020623101108; Giles JR, 2004, GYNECOL ONCOL, V95, P530, DOI 10.1016/j.ygyno.2004.07.061; Goodman MT, 2003, CANCER, V97, P2615, DOI 10.1002/cncr.11339; Graves LE, 2004, CANCER RES, V64, P7045, DOI 10.1158/0008-5472.CAN-04-1800; Hakim AA, 2009, CANCER PREV RES, V2, P114, DOI 10.1158/1940-6207.CAPR-08-0065; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; HOFFMAN AG, 1993, INT J CANCER, V54, P828, DOI 10.1002/ijc.2910540518; Hurt EM, 2008, MOL CELL BIOCHEM, V318, P89, DOI 10.1007/s11010-008-9860-z; Ito I, 2000, BRIT J CANCER, V82, P1415, DOI 10.1054/bjoc.1999.1127; Jackson E, 2007, GYNECOL ONCOL, V104, P192, DOI 10.1016/j.ygyno.2006.07.024; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson PA, 2008, BIOL REPROD, V78, P13, DOI 10.1095/biolreprod.107.061879; Johnson PA, 2009, REPRODUCTION, V137, P857, DOI 10.1530/REP-08-0406; KANEMOTO T, 1991, INVAS METAST, V11, P84; KARLAN BY, 1995, AM J OBSTET GYNECOL, V173, P97, DOI 10.1016/0002-9378(95)90176-0; Klar M, 2009, INT J GYNECOL CANCER, V19, P489, DOI 10.1111/IGC.0b013e3181a40561; Krzysik-Walker SM, 2008, ENDOCRINOLOGY, V149, P1543, DOI 10.1210/en.2007-1301; Krzysik-Walker SM, 2011, COMP BIOCHEM PHYS A, V159, P413, DOI 10.1016/j.cbpa.2011.04.007; Lau KM, 1999, P NATL ACAD SCI USA, V96, P5722, DOI 10.1073/pnas.96.10.5722; Lim W, 2012, EXP BIOL MED, V237, P150, DOI 10.1258/ebm.2011.011250; LINGEMAN CH, 1974, JNCI-J NATL CANCER I, V53, P1603; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meunier L, 2010, TRANSL ONCOL, V3, P230, DOI 10.1593/tlo.10103; Millimagg D, 2009, INT J ONCOL, V35, P1423, DOI 10.3892/ijo_00000460; Murdoch WJ, 2005, EXP BIOL MED, V230, P429, DOI 10.1177/15353702-0323006-11; OLSON TA, 1994, CANCER RES, V54, P276; Reddy P, 2005, MOL ENDOCRINOL, V19, P2564, DOI 10.1210/me.2004-0342; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; SHIRAYOSHI Y, 1986, EMBO J, V5, P2485, DOI 10.1002/j.1460-2075.1986.tb04525.x; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tingulstad S, 2003, OBSTET GYNECOL, V101, P885, DOI 10.1016/S0029-7844(03)00123-6; Trevino Lindsey S., 2010, Hormones & Cancer, V1, P177, DOI 10.1007/s12672-010-0024-8; Urick ME, 2008, GYNECOL ONCOL, V110, P418, DOI 10.1016/j.ygyno.2008.05.018; Urick ME, 2009, GYNECOL ONCOL, V112, P166, DOI 10.1016/j.ygyno.2008.09.032; VEATCH AL, 1994, INT J CANCER, V58, P393, DOI 10.1002/ijc.2910580315; Vergara D, 2010, CANCER LETT, V291, P59, DOI 10.1016/j.canlet.2009.09.017; Wright JW, 2011, HUM REPROD, V26, P1408, DOI 10.1093/humrep/der057	57	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57582	10.1371/journal.pone.0057582	http://dx.doi.org/10.1371/journal.pone.0057582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460878	Green Submitted, gold, Green Published			2022-12-27	WOS:000315519000133
J	Ullrich, S; Bremer, P; Neumann-Grutzeck, C; Otto, H; Ruther, C; von Seydewitz, CU; Meyer, GP; Ahmadi-Simab, K; Rother, J; Hogan, B; Schwenk, W; Fischbach, R; Caselitz, J; Puttfarcken, J; Huggett, S; Tiedeken, P; Pober, J; Kirkiles-Smith, NC; Hagenmuller, F				Ullrich, Sebastian; Bremer, Phillip; Neumann-Grutzeck, Christine; Otto, Helge; Ruether, Christoph; von Seydewitz, Cay Uwe; Meyer, Gerd Peter; Ahmadi-Simab, Keihan; Roether, Joachim; Hogan, Barbara; Schwenk, Wolfgang; Fischbach, Roman; Caselitz, Joerg; Puttfarcken, Jochen; Huggett, Susanne; Tiedeken, Petra; Pober, Jordan; Kirkiles-Smith, Nancy C.; Hagenmueller, Friedrich			Symptoms and Clinical Course of EHEC O104 Infection in Hospitalized Patients: A Prospective Single Center Study	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; THROMBOTIC THROMBOCYTOPENIC PURPURA; ESCHERICHIA-COLI; NEUROLOGICAL INVOLVEMENT; ANTIBIOTIC-TREATMENT; OUTBREAK; VEROTOXIN; RISK; HUS; ASSOCIATION	Objectives: Shiga-toxin producing O157:H7 Entero Haemorrhagic E. coli (STEC/EHEC) is one of the most common causes of Haemolytic Uraemic Syndrome (HUS) related to infectious haemorrhagic colitis. Nearly all recommendations on clinical management of EHEC infections refer to this strain. The 2011 outbreak in Northern Europe was the first to be caused by the serotype O104:H4. This EHEC strain was found to carry genetic features of Entero Aggregative E. coli (EAEC) and extended spectrum beta lactamase (ESBL). We report symptoms and complications in patients at one of the most affected centres of the 2011 EHEC O104 outbreak in Northern Germany. Methods: The courses of patients admitted to our hospital due to bloody diarrhoea with suspected EHEC O104 infection were recorded prospectively. These data include the patients' histories, clinical findings, and complications. Results: EHEC O104 infection was confirmed in 61 patients (female = 37; mean age: 44+/-2 years). The frequency of HUS was 59% (36/61) in our cohort. An enteric colonisation with co-pathogens was found in 57%. Thirty-one (51%) patients were treated with plasma-separation/plasmapheresis, 16 (26%) with haemodialysis, and 7 (11%) with Eculizumab. Patients receiving antibiotic treatment (n = 37; 61%) experienced no apparent change in their clinical course. Twenty-six (43%) patients suffered from neurological symptoms. One 83-year-old patient died due to comorbidities after HUS was successfully treated. Conclusions: EHEC O104: H4 infections differ markedly from earlier reports on O157: H7 induced enterocolitis in regard to epidemiology, symptomatology, and frequency of complications. We recommend a standard of practice for clinical monitoring and support the renaming of EHEC O104: H4 syndrome as "EAHEC disease".	[Ullrich, Sebastian; Bremer, Phillip; Neumann-Grutzeck, Christine; Otto, Helge; Ruether, Christoph; Hagenmueller, Friedrich] Asklepios Klin Altona, Dept Med Gastroenterol 1, Hamburg, Germany; [von Seydewitz, Cay Uwe] Asklepios Klin Altona, Dept Med Oncol & Haematol 2, Hamburg, Germany; [Meyer, Gerd Peter] Asklepios Klin Altona, Dept Med Cardiol Angiol & Pulmonol Intens Care 3, Hamburg, Germany; [Ahmadi-Simab, Keihan] Asklepios Klin Altona, Dept Med Rheumatol Immunol & Nephrol 4, Hamburg, Germany; [Roether, Joachim] Asklepios Klin Altona, Dept Neurol, Hamburg, Germany; [Hogan, Barbara] Asklepios Klin Altona, Emergency Dept, Hamburg, Germany; [Schwenk, Wolfgang] Asklepios Klin Altona, Dept Surg Gen & Visceral Surg 1, Hamburg, Germany; [Fischbach, Roman] Asklepios Klin Altona, Dept Radiol Neuroradiol & Nucl Med, Hamburg, Germany; [Caselitz, Joerg] Asklepios Klin Altona, Dept Pathol, Hamburg, Germany; [Puttfarcken, Jochen; Huggett, Susanne] Lab Gesell mbh, MEDILYS, Hamburg, Germany; [Tiedeken, Petra] Dialysezentrum Hamburg West, Hamburg, Germany; [Pober, Jordan] Yale Univ, Sch Med, Dept Immunobiol Pathol & Dermatol, New Haven, CT USA; [Kirkiles-Smith, Nancy C.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Asklepios Klinik Altona; Yale University; Yale University	Ullrich, S (corresponding author), Asklepios Klin Altona, Dept Med Gastroenterol 1, Hamburg, Germany.	mi.ullrich@asklepios.com	Schwenk, Wolfgamg/AAB-8515-2021; Bremer, Phillip/AAE-7842-2020	Fischbach, Roman/0000-0002-2125-6748				Ake JA, 2005, PEDIATRICS, V115, pE673, DOI 10.1542/peds.2004-2236; Aurass P, 2011, ENVIRON MICROBIOL, V13, P3139, DOI 10.1111/j.1462-2920.2011.02604.x; Bae WK, 2006, YONSEI MED J, V47, P437, DOI 10.3349/ymj.2006.47.3.437; Bettelheim KA, 1999, J DIARRHOEAL DIS RES, V17, P34; Bielaszewska M, 2012, ANTIMICROB AGENTS CH, V56, P3277, DOI 10.1128/AAC.06315-11; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Bitzan M, 2010, SEMIN THROMB HEMOST, V36, P594, DOI 10.1055/s-0030-1262881; Bitzan M, 2009, KIDNEY INT, V75, pS62, DOI 10.1038/ki.2008.624; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Chattaway MA, 2011, J INFECT DEV COUNTR, V5, P425, DOI 10.3855/jidc.2166; CIMOLAI N, 1992, PEDIATRICS, V90, P616; Deutsche Gesellschaft fur Infektiologie, 2011, EHEC ANT; Deutsche Gesellschaft fur Nephrologie, 2011, THER APH BEI EHEC AS; Dolgikh T. I., 2010, Klinicheskaya Laboratornaya Diagnostika, P52; Ducker C, 2011, DEUT MED WOCHENSCHR, V136, P1770, DOI 10.1055/s-0031-1286099; European Food Safety Authority, 2011, TRAC SEEDS PART FEN; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; GALLO GE, 1995, PEDIATR NEPHROL, V9, P117, DOI 10.1007/BF00858990; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; HAHN JS, 1989, J CHILD NEUROL, V4, P108, DOI 10.1177/088307388900400206; HUGHES DA, 1991, SCOT MED J, V36, P9, DOI 10.1177/003693309103600105; Iizuka S, 2005, JPN J INFECT DIS, V58, P329; Karpac CA, 2008, BRIT J HAEMATOL, V141, P696, DOI 10.1111/j.1365-2141.2008.07116.x; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Michael M, 2009, AM J KIDNEY DIS, V53, P259, DOI 10.1053/j.ajkd.2008.07.038; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Nathanson S, 2010, CLIN J AM SOC NEPHRO, V5, P1218, DOI 10.2215/CJN.08921209; Nayar Deepa M, 2006, J Infect, V52, pe103, DOI 10.1016/j.jinf.2005.07.029; Nitschke M, 2012, JAMA-J AM MED ASSOC, V307, P1046, DOI 10.1001/jama.2012.264; Ochoa TJ, 2007, ANTIMICROB AGENTS CH, V51, P2837, DOI 10.1128/AAC.01397-06; Panos GZ, 2006, ALIMENT PHARM THER, V24, P731, DOI 10.1111/j.1365-2036.2006.03036.x; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; PROULX F, 1992, J PEDIATR-US, V121, P299, DOI 10.1016/S0022-3476(05)81209-0; Robert Koch Institut, 2011, ABSCHL DARST BEW EP; Robert Koch-Institut, 2011, PRAV ENT EINZ WERN; Safdar N, 2002, JAMA-J AM MED ASSOC, V288, P996, DOI 10.1001/jama.288.8.996; SHETH KJ, 1986, ANN NEUROL, V19, P90, DOI 10.1002/ana.410190120; Steinborn M, 2004, PEDIATR RADIOL, V34, P805, DOI 10.1007/s00247-004-1289-2; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; TAYLOR CM, 1986, BRIT MED J, V292, P1513, DOI 10.1136/bmj.292.6534.1513; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Yoh M, 1999, CAN J MICROBIOL, V45, P732, DOI 10.1139/cjm-45-9-732	44	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e55278	10.1371/journal.pone.0055278	http://dx.doi.org/10.1371/journal.pone.0055278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460784	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000007
J	Kim, SR; Skerker, JM; Kang, W; Lesmana, A; Wei, N; Arkin, AP; Jin, YS				Kim, Soo Rin; Skerker, Jeffrey M.; Kang, Wei; Lesmana, Anastashia; Wei, Na; Arkin, Adam P.; Jin, Yong-Su			Rational and Evolutionary Engineering Approaches Uncover a Small Set of Genetic Changes Efficient for Rapid Xylose Fermentation in Saccharomyces cerevisiae	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; ETHANOL-PRODUCTION; XYLITOL DEHYDROGENASE; HEXOSE TRANSPORTERS; ACETIC-ACID; RECOMBINANT; REDUCTASE; EXPRESSION; GLUCOSE; STRAIN	Economic bioconversion of plant cell wall hydrolysates into fuels and chemicals has been hampered mainly due to the inability of microorganisms to efficiently co-ferment pentose and hexose sugars, especially glucose and xylose, which are the most abundant sugars in cellulosic hydrolysates. Saccharomyces cerevisiae cannot metabolize xylose due to a lack of xylose-metabolizing enzymes. We developed a rapid and efficient xylose-fermenting S. cerevisiae through rational and inverse metabolic engineering strategies, comprising the optimization of a heterologous xylose-assimilating pathway and evolutionary engineering. Strong and balanced expression levels of the XYL1, XYL2, and XYL3 genes constituting the xylose-assimilating pathway increased ethanol yields and the xylose consumption rates from a mixture of glucose and xylose with little xylitol accumulation. The engineered strain, however, still exhibited a long lag time when metabolizing xylose above 10 g/l as a sole carbon source, defined here as xylose toxicity. Through serial-subcultures on xylose, we isolated evolved strains which exhibited a shorter lag time and improved xylose-fermenting capabilities than the parental strain. Genome sequencing of the evolved strains revealed that mutations in PHO13 causing loss of the Pho13p function are associated with the improved phenotypes of the evolved strains. Crude extracts of a PHO13-overexpressing strain showed a higher phosphatase activity on xylulose-5-phosphate (X-5-P), suggesting that the dephosphorylation of X-5-P by Pho13p might generate a futile cycle with xylulokinase overexpression. While xylose consumption rates by the evolved strains improved substantially as compared to the parental strain, xylose metabolism was interrupted by accumulated acetate. Deletion of ALD6 coding for acetaldehyde dehydrogenase not only prevented acetate accumulation, but also enabled complete and efficient fermentation of xylose as well as a mixture of glucose and xylose by the evolved strain. These findings provide direct guidance for developing industrial strains to produce cellulosic fuels and chemicals.	[Kim, Soo Rin; Kang, Wei; Lesmana, Anastashia; Jin, Yong-Su] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA; [Kim, Soo Rin; Wei, Na; Jin, Yong-Su] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Skerker, Jeffrey M.; Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Skerker, Jeffrey M.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Jin, YS (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA.	ysjin@illinois.edu	Jin, Yong-Su/L-4530-2013; Arkin, Adam P/A-6751-2008; Kim, Soo Rin/X-2192-2019; Arkin, Adam/M-9941-2019; Wei, Na/C-9172-2014	Arkin, Adam P/0000-0002-4999-2931; Kim, Soo Rin/0000-0001-5855-643X; Arkin, Adam/0000-0002-4999-2931; Jin, Yong-Su/0000-0002-4464-9536	Energy Biosciences Institute	Energy Biosciences Institute	This work was funded by Energy Biosciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker B, 1998, INTERNET WORLD, V9, P14; Bellissimi E, 2009, FEMS YEAST RES, V9, P358, DOI 10.1111/j.1567-1364.2009.00487.x; Bengtsson O, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-9; Bengtsson O, 2008, YEAST, V25, P835, DOI 10.1002/yea.1638; Bera AK, 2011, J IND MICROBIOL BIOT, V38, P617, DOI 10.1007/s10295-010-0806-6; Bergdahl B, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-34; Brat D, 2009, APPL ENVIRON MICROB, V75, P2304, DOI 10.1128/AEM.02522-08; Cadiere A, 2011, METAB ENG, V13, P263, DOI 10.1016/j.ymben.2011.01.008; Cakar ZP, 2012, FEMS YEAST RES, V12, P171, DOI 10.1111/j.1567-1364.2011.00775.x; Eglinton JM, 2002, YEAST, V19, P295, DOI 10.1002/yea.834; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Fujitomi K, 2012, BIORESOURCE TECHNOL, V111, P161, DOI 10.1016/j.biortech.2012.01.161; Ha S-J, 2011, P NATL ACAD SCI US; Ha SJ, 2011, APPL MICROBIOL BIOT, V92, P77, DOI 10.1007/s00253-011-3345-9; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Hamacher T, 2002, MICROBIOL-SGM, V148, P2783, DOI 10.1099/00221287-148-9-2783; Hector RE, 2011, YEAST, V28, P645, DOI 10.1002/yea.1893; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Ho NWY, 1998, APPL ENVIRON MICROB, V64, P1852; Hong K-K, 2011, P NATL ACAD SCI US; HOSAKA K, 1992, J BIOCHEM-TOKYO, V111, P352, DOI 10.1093/oxfordjournals.jbchem.a123761; Jeppsson M, 2006, BIOTECHNOL BIOENG, V93, P665, DOI 10.1002/bit.20737; Jin YS, 2005, APPL ENVIRON MICROB, V71, P8249, DOI 10.1128/AEM.71.12.8249-8256.2005; Jin YS, 2003, APPL BIOCHEM BIOTECH, V105, P277; Jin YS, 2003, APPL ENVIRON MICROB, V69, P495, DOI 10.1128/AEM.69.1.495-503.2003; Johansson B, 2001, APPL ENVIRON MICROB, V67, P4249, DOI 10.1128/AEM.67.9.4249-4255.2001; Jojima T, 2010, APPL MICROBIOL BIOT, V85, P471, DOI 10.1007/s00253-009-2292-1; Karhumaa K, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-5; Karhumaa K, 2009, YEAST, V26, P371, DOI 10.1002/yea.1673; Kim SR, 2012, METAB ENG; Klimacek M, 2010, APPL ENVIRON MICROB, V76, P7566, DOI 10.1128/AEM.01787-10; KOTTER P, 1990, CURR GENET, V18, P493, DOI 10.1007/BF00327019; Krahulec S, 2012, J BIOTECHNOL, V158, P192, DOI 10.1016/j.jbiotec.2011.08.026; Krahulec S, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-16; Kuyper M, 2005, FEMS YEAST RES, V5, P399, DOI 10.1016/j.femsyr.2004.09.010; Kuyper M, 2005, FEMS YEAST RES, V5, P925, DOI 10.1016/j.femsyr.2005.04.004; Kuznetsova E, 2009, THESIS U TORONTO; Lee SH, 2012, J BIOTECHNOL, V158, P184, DOI 10.1016/j.jbiotec.2011.06.005; Lee WJ, 2000, PROCESS BIOCHEM, V35, P1199, DOI 10.1016/S0032-9592(00)00165-5; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Madhavan A, 2009, APPL MICROBIOL BIOT, V82, P1037, DOI 10.1007/s00253-008-1818-2; Matsushika A, 2012, ENZYME MICROB TECH, V51, P16, DOI 10.1016/j.enzmictec.2012.03.008; Matsushika A, 2009, APPL ENVIRON MICROB, V75, P3818, DOI 10.1128/AEM.02636-08; McMillan JD, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-29; Meinander NQ, 1997, APPL ENVIRON MICROB, V63, P1959, DOI 10.1128/AEM.63.5.1959-1964.1997; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Ni HY, 2007, APPL ENVIRON MICROB, V73, P2061, DOI 10.1128/AEM.02564-06; Oh EJ, 2012, METAB ENG IN PRESS; Oud B, 2012, FEMS YEAST RES, V12, P183, DOI 10.1111/j.1567-1364.2011.00776.x; Peng BY, 2012, METAB ENG, V14, P9, DOI 10.1016/j.ymben.2011.12.001; Petschacher B, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-9; Puts RA, 2010, THESIS ROCHESTER I T; Roca C, 2003, APPL ENVIRON MICROB, V69, P4732, DOI 10.1128/AEM.69.8.4732-4736.2003; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Runquist D, 2010, J BIOTECHNOL, V150, pS137, DOI 10.1016/j.jbiotec.2010.08.359; Runquist D, 2010, APPL ENVIRON MICROB, V76, P7796, DOI 10.1128/AEM.01505-10; Saloheimo A, 2007, APPL MICROBIOL BIOT, V74, P1041, DOI 10.1007/s00253-006-0747-1; Sedlak M, 2004, YEAST, V21, P671, DOI 10.1002/yea.1060; Somerville C, 2007, CURR BIOL, V17, pR115, DOI 10.1016/j.cub.2007.01.010; Sonderegger M, 2004, APPL ENVIRON MICROB, V70, P2892, DOI 10.1128/AEM.70.5.2892-2897.2004; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Suga H, 2012, APPL MICROBIOL BIOT, P1; Tanino T, 2012, J BIOSCI BIOENG; TANTIRUNGKIJ M, 1993, J FERMENT BIOENG, V75, P83, DOI 10.1016/0922-338X(93)90214-S; Toivari MH, 2001, METAB ENG, V3, P236, DOI 10.1006/mben.2000.0191; Tuleva B, 1998, FEMS MICROBIOL LETT, V161, P139; Usher J, 2011, G3-GENES GENOM GENET, V1, P247, DOI 10.1534/g3.111.000695; Van Vleet JH, 2008, METAB ENG, V10, P360, DOI 10.1016/j.ymben.2007.12.002; Verho R, 2003, APPL ENVIRON MICROB, V69, P5892, DOI 10.1128/AEM.69.10.5892-5897.2003; Wahlbom CF, 2003, FEMS YEAST RES, V3, P319, DOI 10.1016/S1567-1356(02)00206-4; Wahlbom F, 2007, US Patent, Patent No. [8,138,371, 8138371]; Walfridsson M, 1997, APPL MICROBIOL BIOT, V48, P218, DOI 10.1007/s002530051041; WALFRIDSSON M, 1995, APPL ENVIRON MICROB, V61, P4184, DOI 10.1128/AEM.61.12.4184-4190.1995; Walfridsson M, 1996, APPL ENVIRON MICROB, V62, P4648, DOI 10.1128/AEM.62.12.4648-4651.1996; Watanabe S, 2007, MICROBIOL-SGM, V153, P3044, DOI 10.1099/mic.0.2007/007856-0; Watanabe S, 2007, J BIOTECHNOL, V130, P316, DOI 10.1016/j.jbiotec.2007.04.019; Wisselink HW, 2009, APPL ENVIRON MICROB, V75, P907, DOI 10.1128/AEM.02268-08; Young EM, 2012, METAB ENG; Young E, 2011, APPL ENVIRON MICROB, V77, P3311, DOI 10.1128/AEM.02651-10; Young E, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-24; Zaldivar J, 2001, APPL MICROBIOL BIOT, V56, P17, DOI 10.1007/s002530100624; Zhang GC, 2012, APPL ENVIRON MICROB, V78, P1081, DOI 10.1128/AEM.06635-11; Zhou H, 2012, METAB ENG IN PRESS	84	146	154	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57048	10.1371/journal.pone.0057048	http://dx.doi.org/10.1371/journal.pone.0057048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23468911	Green Published, gold, Green Submitted			2022-12-27	WOS:000315561400024
J	Chen, L; Lu, J; Zhang, J; Feng, KR; Zheng, MY; Cai, YD				Chen, Lei; Lu, Jing; Zhang, Jian; Feng, Kai-Rui; Zheng, Ming-Yue; Cai, Yu-Dong			Predicting Chemical Toxicity Effects Based on Chemical-Chemical Interactions	PLOS ONE			English	Article							PROTEIN STRUCTURAL CLASSES; AMINO-ACID-COMPOSITION; INTERACTION NETWORK; LUNG-CANCER; CARCINOGENICITY; LOCATIONS; BIOMARKER; MACHINE; DISEASE; SMOKERS	Toxicity is a major contributor to high attrition rates of new chemical entities in drug discoveries. In this study, an order-classifier was built to predict a series of toxic effects based on data concerning chemical-chemical interactions under the assumption that interactive compounds are more likely to share similar toxicity profiles. According to their interaction confidence scores, the order from the most likely toxicity to the least was obtained for each compound. Ten test groups, each of them containing one training dataset and one test dataset, were constructed from a benchmark dataset consisting of 17,233 compounds. By a Jackknife test on each of these test groups, the 1st order prediction accuracies of the training dataset and the test dataset were all approximately 79.50%, substantially higher than the rate of 25.43% achieved by random guesses. Encouraged by the promising results, we expect that our method will become a useful tool in screening out drugs with high toxicity.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Lu, Jing; Zheng, Ming-Yue] Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China; [Feng, Kai-Rui] Simcyp Ltd, Blades Enterprise Ctr, Sheffield, S Yorkshire, England	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Jiao Tong University; Simcyp	Zheng, MY (corresponding author), Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai, Peoples R China.	myzheng@mail.shcnc.ac.cn; cai_yud@yahoo.com.cn	Chen, Lei/A-2275-2011; Zheng, Mingyue/AAJ-8027-2020; Zheng, Mingyue/B-4860-2010; Zheng, Mingyue/HHZ-4062-2022; Zheng, Mingyue/Z-3582-2019	Chen, Lei/0000-0003-3068-1583; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; National Natural Science Foundation of China [61202021, 81001399]; National ST Major Project [2012ZX09301-001-002]; Hi-TECH Research and Development Program of China [2012AA020308]; Innovation Program of Shanghai Municipal Education Commission [12YZ120, 12ZZ087]; Shanghai Educational Development Foundation [12CG55]; Science and Technology Program of Shanghai Maritime University [20120105]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National ST Major Project; Hi-TECH Research and Development Program of China(National High Technology Research and Development Program of China); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Educational Development Foundation; Science and Technology Program of Shanghai Maritime University	This work was supported by National Basic Research Program of China (2011CB510102, 2011CB510101), National Natural Science Foundation of China (61202021, 81001399), National S&T Major Project (2012ZX09301-001-002), Hi-TECH Research and Development Program of China (2012AA020308), Innovation Program of Shanghai Municipal Education Commission (12YZ120, 12ZZ087), Shanghai Educational Development Foundation (12CG55), and Science and Technology Program of Shanghai Maritime University (No. 20120105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ACC TOX DAT 2011 4; Arcos JC, 1995, MULTIFACTOR INTERACT, P1; Benigni R, 2008, MUTAT RES-REV MUTAT, V659, P248, DOI 10.1016/j.mrrev.2008.05.003; Benigni R, 2011, CHEM REV, V111, P2507, DOI 10.1021/cr100222q; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Cai YD, 2010, MOL DIVERS, V14, P551, DOI 10.1007/s11030-009-9182-4; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen L, 2012, PROTEIN PEPTIDE LETT, V19, P99, DOI 10.2174/092986612798472857; Church TR, 2009, CANCER EPIDEM BIOMAR, V18, P260, DOI 10.1158/1055-9965.EPI-08-0718; Crammer K., 2001, J MACHINE LEARNING R, V2, P265; Dietterich T. G., 1995, Journal of Artificial Intelligence Research, V2, P263; Du PF, 2011, EXPERT REV PROTEOMIC, V8, P391, DOI [10.1586/EPR.11.20, 10.1586/epr.11.20]; DUBACH UC, 1991, NEW ENGL J MED, V324, P155, DOI 10.1056/NEJM199101173240304; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Gao P, 2012, PROTEIN PEPTIDE LETT, V19, P910, DOI 10.2174/092986612802084528; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Hu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017668; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Ivanciuc O, 2008, CURR TOP MED CHEM, V8, P1691, DOI 10.2174/156802608786786589; Jin LX, 2003, COMPUT BIOL CHEM, V27, P373, DOI 10.1016/S1476-9271(02)00087-7; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Kuhn M, 2010, NUCLEIC ACIDS RES, V38, pD552, DOI 10.1093/nar/gkp937; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Patlewicz GY, 2002, CONTACT DERMATITIS, V47, P219, DOI 10.1034/j.1600-0536.2002.470406.x; Plaimas K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-67; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Shao XJ, 2009, J THEOR BIOL, V258, P289, DOI 10.1016/j.jtbi.2009.01.024; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sun XD, 2006, AMINO ACIDS, V30, P469, DOI 10.1007/s00726-005-0239-0; Wang Wei-bin, 2011, Chinese Medical Sciences Journal, V26, P168; Wang Y, 2012, J CHEM INF MODEL, V52, P1994, DOI 10.1021/ci300266p; Woo Y. T., 2003, QUANTITATIVE STRUCTU, P41; Yuan JM, 2009, CANCER RES, V69, P2990, DOI 10.1158/0008-5472.CAN-08-4330; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zheng MY, 2006, BIOINFORMATICS, V22, P2099, DOI 10.1093/bioinformatics/btl352	37	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56517	10.1371/journal.pone.0056517	http://dx.doi.org/10.1371/journal.pone.0056517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457578	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700059
J	Hsu, MF; Yu, TF; Chou, CC; Fu, HY; Yang, CS; Wang, AHJ				Hsu, Min-Feng; Yu, Tsung-Fu; Chou, Chia-Cheng; Fu, Hsu-Yuan; Yang, Chii-Shen; Wang, Andrew H. J.			Using Haloarcula marismortui Bacteriorhodopsin as a Fusion Tag for Enhancing and Visible Expression of Integral Membrane Proteins in Escherichia coli	PLOS ONE			English	Article							UNDECAPRENYL PYROPHOSPHATE PHOSPHATASE; GENOME SEQUENCE; CARNITINE TRANSPORTER; ANGSTROM RESOLUTION; NMR STRUCTURE; OVEREXPRESSION; PURIFICATION; ARCHAEON; TEMPERATURE; MECHANISM	Membrane proteins are key targets for pharmacological intervention because of their vital functions. Structural and functional studies of membrane proteins have been severely hampered because of the difficulties in producing sufficient quantities of properly folded and biologically active proteins. Here we generate a high-level expression system of integral membrane proteins in Escherichia coli by using a mutated bacteriorhodopsin (BR) from Haloarcula marismortui (HmBRI/D94N) as a fusion partner. A purification strategy was designed by incorporating a His-tag on the target membrane protein for affinity purification and an appropriate protease cleavage site to generate the final products. The fusion system can be used to detect the intended target membrane proteins during overexpression and purification either with the naked eye or by directly monitoring their characteristic optical absorption. In this study, we applied this approach to produce two functional integral membrane proteins, undecaprenyl pyrophosphate phosphatase and carnitine/butyrobetaine antiporter with significant yield enhancement. This technology could facilitate the development of a high-throughput strategy to screen for conditions that improve the yield of correctly folded target membrane proteins. Other robust BRs can also be incorporated in this system.	[Hsu, Min-Feng; Yu, Tsung-Fu; Chou, Chia-Cheng; Wang, Andrew H. J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Hsu, Min-Feng; Chou, Chia-Cheng; Wang, Andrew H. J.] Acad Sinica, Core Facil Prot Struct Anal, Taipei 115, Taiwan; [Yu, Tsung-Fu] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Fu, Hsu-Yuan; Yang, Chii-Shen] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Wang, Andrew H. J.] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Tsing Hua University; National Taiwan University; National Taiwan University	Yang, CS (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan.	chiishen@ntu.edu.tw; ahjwang@gate.sinica.edu.tw	Hsiao, Wei-Hung/B-9931-2013	YANG, CHII-SHEN/0000-0002-2792-6247; Fu, Hsu-Yuan/0000-0002-5327-2208	National Science Council [NSC100-2325-B-001-029]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants from National Science Council NSC100-2325-B-001-029 to AHJW for core facilities for protein structural analysis at Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; BRAIMAN MS, 1987, J BIOL CHEM, V262, P9271; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Daggett V, 2009, CURR OPIN STRUC BIOL, V19, P1, DOI 10.1016/j.sbi.2009.01.006; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; DUNN RJ, 1987, J BIOL CHEM, V262, P9246; El Ghachi M, 2004, J BIOL CHEM, V279, P30106, DOI 10.1074/jbc.M401701200; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Finn RD, 2005, BIOTECHNIQUES, V38, P387, DOI 10.2144/05383ST01; Fu HY, 2010, J BACTERIOL, V192, P5866, DOI 10.1128/JB.00642-10; Jung H, 2002, J BIOL CHEM, V277, P39251, DOI 10.1074/jbc.M206319200; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Katzen F, 2009, TRENDS BIOTECHNOL, V27, P455, DOI 10.1016/j.tibtech.2009.05.005; Lu T, 1998, J CHEM SOC FARADAY T, V94, P79, DOI 10.1039/a701858d; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Lundstrom K, 2004, CURR OPIN DRUG DISC, V7, P342; Manley DM, 2000, BIOCHEMISTRY-US, V39, P12303, DOI 10.1021/bi000703t; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MOGI T, 1988, P NATL ACAD SCI USA, V85, P4148, DOI 10.1073/pnas.85.12.4148; Neophytou I, 2007, APPL MICROBIOL BIOT, V77, P375, DOI 10.1007/s00253-007-1174-7; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Schmies G, 2000, FEBS LETT, V466, P67, DOI 10.1016/S0014-5793(99)01760-3; Shih YP, 2002, PROTEIN SCI, V11, P1714, DOI 10.1110/ps.0205202; Tang L, 2010, NAT STRUCT MOL BIOL, V17, P492, DOI 10.1038/nsmb.1788; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Touze T, 2008, J BIOL CHEM, V283, P16573, DOI 10.1074/jbc.M800394200; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Yokoyama Y, 2002, J BIOCHEM, V131, P785, DOI 10.1093/oxfordjournals.jbchem.a003166; Yokoyama Y, 2007, J BIOCHEM, V142, P325, DOI 10.1093/jb/mvm135	41	32	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56363	10.1371/journal.pone.0056363	http://dx.doi.org/10.1371/journal.pone.0056363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457558	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700046
J	Ledeganck, KJ; Boulet, GA; Bogers, JJ; Verpooten, GA; De Winter, BY				Ledeganck, Kristien J.; Boulet, Gaelle A.; Bogers, Johannes J.; Verpooten, Gert A.; De Winter, Benedicte Y.			The TRPM6/EGF Pathway Is Downregulated in a Rat Model of Cisplatin Nephrotoxicity	PLOS ONE			English	Article							SECONDARY HYPOCALCEMIA; INDUCED HYPOMAGNESEMIA; MAGNESIUM DEPLETION; EXPRESSION; CETUXIMAB; CHANNELS; CA2+	Cisplatin-induced hypomagnesemia is described in humans and rats, but the underlying mechanisms are still unclear. Recent studies have shown that epidermal growth factor (EGF) stimulates Mg2+ re-absorption in the distal convoluted tubule via the Mg2+ channel TRPM6. This study investigates the role of TRPM Mg2+ channels, claudines, and EGF in the Mg2+ homeostasis in a rat model of cisplatin-induced nephrotoxicity. Wistar rats were given 2.5 mg/kg cisplatin per week for 3 weeks and were euthanized 4 or 9 weeks after the first administration. The cisplatin treatment significantly increased the fractional excretion of Mg2+. Real-time RT-PCR and/or Western blots were performed to assess the renal expression TRPM6, TRPM7, claudin-16, claudin-19, EGF, EGF receptor (EGFR) and EGFR-pathway components. The renal mRNA expression of TRPM6 and EGF showed a significant decrease after cisplatin treatment, while the TRPM7, claudin-16 and EGFR expressions remained stable. The claudin-19 mRNA expression was significantly upregulated after cisplatin treatment. Western blotting confirmed the mRNA expression data for the claudins, but an showed upregulation of EGFR only at week 9. The role of the EGFR pathway, involving Pi3-AKT-Rac1, in cisplatin-induced nephropathy, could not be substantiated in further detail. This study shows that cisplatin treatment results in EGF and TRPM6 downregulation in the rat kidney, causing renal Mg2+ loss. Our results are in line with the hypothesis that EGF influences the renal expression or activation of TRPM6 and plays a significant role in Mg2+ loss in medication-induced nephropathy.	[Ledeganck, Kristien J.; Verpooten, Gert A.; De Winter, Benedicte Y.] Univ Antwerp, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium; [Boulet, Gaelle A.; Bogers, Johannes J.] Univ Antwerp, Appl Mol Biol Res Grp, B-2020 Antwerp, Belgium; [Verpooten, Gert A.] Univ Antwerp Hosp, Dept Nephrol Hypertens, Edegem, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	De Winter, BY (corresponding author), Univ Antwerp, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium.	benedicte.dewinter@ua.ac.be	Ledeganck, Kristien/AAY-1428-2020; De Winter, Benedicte Y/G-2616-2011; Bogers, John-Paul/E-2596-2017	Ledeganck, Kristien/0000-0003-4377-7648; De Winter, Benedicte Y/0000-0003-0327-6304; Bogers, John-Paul/0000-0001-9107-132X	University of Antwerp	University of Antwerp	This study was supported by a research grant for KJL from the University of Antwerp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussieres L, 1990, Magnes Res, V3, P179; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cao YF, 2010, CHEMOTHERAPY, V56, P459, DOI 10.1159/000321011; Choi Dae Eun, 2009, Korean Journal of Internal Medicine, V24, P238, DOI 10.3904/kjim.2009.24.3.238; Chubanov V, 2007, J BIOL CHEM, V282, P7656, DOI 10.1074/jbc.M611117200; Dimke H, 2010, J AM SOC NEPHROL, V21, P1309, DOI 10.1681/ASN.2009111153; Duymelinck C, 1998, KIDNEY INT, V54, P804, DOI 10.1046/j.1523-1755.1998.00050.x; Fakih MG, 2006, CLIN COLORECTAL CANC, V6, P152, DOI 10.3816/CCC.2006.n.033; Gamba G, 2009, AM J PHYSIOL-RENAL, V297, pF838, DOI 10.1152/ajprenal.00159.2009; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Hodgkinson E, 2006, CLIN ONCOL-UK, V18, P710, DOI 10.1016/j.clon.2006.06.011; Hoenderop JGJ, 2005, J AM SOC NEPHROL, V16, P15, DOI 10.1681/ASN.2004070523; Hou JH, 2010, CURR OPIN NEPHROL HY, V19, P483, DOI 10.1097/MNH.0b013e32833b7125; Ikari A, 2007, ARCH PHARM, V377, P333; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Lajer H, 2005, CANCER CHEMOTH PHARM, V56, P535, DOI 10.1007/s00280-005-1010-7; LAM M, 1986, AM J KIDNEY DIS, V8, P164, DOI 10.1016/S0272-6386(86)80020-8; Ledeganck KJ, 2011, AM J PHYSIOL-RENAL, V301, pF486, DOI 10.1152/ajprenal.00116.2011; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; MAVICHAK V, 1985, KIDNEY INT, V28, P914, DOI 10.1038/ki.1985.217; Meier M, 2008, CELL PHYSIOL BIOCHEM, V21, P279, DOI 10.1159/000129386; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nijenhuis T, 2004, J AM SOC NEPHROL, V15, P549, DOI 10.1097/01.ASN.0000113318.56023.B6; Perez-Rojas JM, 2009, FREE RADICAL RES, V43, P1122, DOI 10.1080/10715760903214447; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; SAFIRSTEIN R, 1989, KIDNEY INT, V36, P810, DOI 10.1038/ki.1989.266; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Seo JY, 2009, AM J NEPHROL, V30, P481, DOI 10.1159/000242477; Shimamura H, 2003, J AM SOC NEPHROL, V14, P1427, DOI 10.1097/01.ASN.0000066140.99610.32; Tejpar S, 2007, LANCET ONCOL, V8, P387, DOI 10.1016/S1470-2045(07)70108-0; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Touyz RM, 2008, AM J PHYSIOL-HEART C, V294, pH1103, DOI 10.1152/ajpheart.00903.2007; van Angelen AA, 2012, NEPHROL DIAL TRANSPL; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Wang ZF, 2003, J AM SOC NEPHROL, V14, P3147, DOI 10.1097/01.ASN.0000098681.56240.1A	35	40	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e57016	10.1371/journal.pone.0057016	http://dx.doi.org/10.1371/journal.pone.0057016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457647	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700101
J	Maestro, B; Galan, B; Alfonso, C; Rivas, G; Prieto, MA; Sanz, JM				Maestro, Beatriz; Galan, Beatriz; Alfonso, Carlos; Rivas, German; Prieto, Maria A.; Sanz, Jesus M.			A New Family of Intrinsically Disordered Proteins: Structural Characterization of the Major Phasin PhaF from Pseudomonas putida KT2440	PLOS ONE			English	Article							POLYHYDROXYALKANOIC ACID GRANULES; SECONDARY STRUCTURE PREDICTION; CIRCULAR-DICHROISM; RALSTONIA-EUTROPHA; BACILLUS-MEGATERIUM; LEUCINE-ZIPPER; HEAT-CAPACITY; COILED COILS; BACTERIAL; IDENTIFICATION	Phasins are intracellular polyhydroxyalkanoat4e ( PHA)-associated proteins involved in the stabilization of these bacterial carbon storage granules. Despite its importance in PHA metabolism and regulation, only few reports have focused so far on the structure of these proteins. In this work we have investigated the structure and stability of the PhaF phasin from Pseudomonas putida KT2440, a protein that is involved in PHA granule stabilization and distribution to daughter cells upon cell division. A structural, three-dimensional model of the protein was built from homology modeling procedures and consensus secondary structure predictions. The model predicts that PhaF is an elongated protein, with a long, amphipathic N-terminal helix with PHA binding capacity, followed by a short leucine zipper involved in protein oligomerization and a superhelical C-terminal domain wrapped around the chromosomal DNA. Hydrodynamic, spectroscopical and thermodynamic experiments validated the model and confirmed both that free PhaF is a tetramer in solution and that most part of the protein is intrinsically disordered in the absence of its ligands. The results lay a molecular basis for the explanation of the biological role of PhaF and, along with an exhaustive analysis of phasin sequence databases, suggest that intrinsic disorder and oligomerization through coiled-coils may be a widespread mechanism among these proteins.	[Maestro, Beatriz; Sanz, Jesus M.] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain; [Galan, Beatriz; Alfonso, Carlos; Rivas, German; Prieto, Maria A.] CSIC, Ctr Invest Biol, Madrid, Spain	Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Sanz, JM (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain.	jmsanz@umh.es	Rivas, German/AAG-7458-2022; Alfonso, Carlos/K-1316-2014; Sanz, Jesus M/B-2244-2008; Maestro, Beatriz/F-3857-2016; Rivas, German/AFL-7528-2022; Prieto, María Auxiliadora/I-8092-2015	Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Sanz, Jesus M/0000-0002-4421-9376; Maestro, Beatriz/0000-0001-5317-650X; Rivas, German/0000-0003-3450-7478; Galan, Beatriz/0000-0002-2596-6034; Prieto Jimenez, M. Auxiliadora/0000-0002-8038-1223	Spanish Ministry of Economy and Competitiveness [BFU2010-17824, BIO2010-21049, BIO2007-67304-C02]; Valencian Government, Spain [FPA/2010/055]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Valencian Government, Spain	This work was supported by grants BFU2010-17824, BIO2010-21049, BIO2007-67304-C02 (Spanish Ministry of Economy and Competitiveness, http://www.mineco.gob.es/portal/site/mineco?lang_choosen=en) and FPA/2010/055 (Valencian Government, Spain, http://www.gva.es/en/inicio/presentacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backmann J, 1998, J MOL BIOL, V284, P817, DOI 10.1006/jmbi.1998.2216; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; DESMET MJ, 1983, J BACTERIOL, V154, P870, DOI 10.1128/JB.154.2.870-878.1983; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Durr E, 1999, BIOCHEMISTRY-US, V38, P870, DOI 10.1021/bi981891e; Fairman R, 1996, BIOCHEMISTRY-US, V35, P2824, DOI 10.1021/bi952784c; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FINDLAY RH, 1983, APPL ENVIRON MICROB, V45, P71, DOI 10.1128/AEM.45.1.71-78.1983; FREIRE E, 1990, ANNU REV BIOPHYS BIO, V19, P159; Galan B, 2011, MOL MICROBIOL, V79, P402, DOI 10.1111/j.1365-2958.2010.07450.x; Gao X, 2011, CURR OPIN BIOTECH, V22, P768, DOI 10.1016/j.copbio.2011.06.005; Garcia B, 1999, J BIOL CHEM, V274, P29228, DOI 10.1074/jbc.274.41.29228; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Jendrossek D, 2009, J BACTERIOL, V191, P3195, DOI 10.1128/JB.01723-08; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kuchta K, 2007, BIOMACROMOLECULES, V8, P657, DOI 10.1021/bm060912e; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lewitzky M, 2004, J BIOL CHEM, V279, P28724, DOI 10.1074/jbc.M402745200; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Luengo JM, 2003, CURR OPIN MICROBIOL, V6, P251, DOI 10.1016/S1369-5274(03)00040-7; LUMRY R, 1954, J PHYS CHEM-US, V58, P110, DOI 10.1021/j150512a005; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Maehara A, 1999, J BACTERIOL, V181, P2914, DOI 10.1128/JB.181.9.2914-2921.1999; Mayer F, 1996, J GEN APPL MICROBIOL, V42, P445, DOI 10.2323/jgam.42.445; McCool GJ, 1999, J BACTERIOL, V181, P585, DOI 10.1128/JB.181.2.585-592.1999; MEDVEDKIN VN, 1995, PROTEIN ENG, V8, P63, DOI 10.1093/protein/8.1.63; Minton A.P., 1994, MODERN ANAL ULTRACEN, P81; Moldes C, 2004, APPL ENVIRON MICROB, V70, P3205, DOI 10.1128/AEM.70.6.3205-3212.2004; Moldes C, 2006, APPL MICROBIOL BIOT, V72, P88, DOI 10.1007/s00253-005-0257-6; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Peng ZL, 2012, MOL BIOSYST, V8, P1886, DOI 10.1039/c2mb25102g; Phelan P, 2002, BIOCHEMISTRY-US, V41, P2998, DOI 10.1021/bi011920c; PIEPERFURST U, 1994, J BACTERIOL, V176, P4328, DOI 10.1128/jb.176.14.4328-4337.1994; Prieto M, 2007, PSEUDOMONAS MODEL SY, P397, DOI [10.1007/978-1-4020-6097-7_14, DOI 10.1007/978-1-4020-6097-7_14]; Prieto MA, 1999, J BACTERIOL, V181, P858, DOI 10.1128/JB.181.3.858-868.1999; PRIVALOV PL, 1989, J MOL BIOL, V205, P737, DOI 10.1016/0022-2836(89)90318-5; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Qi Q, 2000, APPL MICROBIOL BIOT, V54, P37, DOI 10.1007/s002530000357; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Sandoval A, 2007, ENVIRON MICROBIOL, V9, P737, DOI 10.1111/j.1462-2920.2006.01196.x; SCHEMBRI MA, 1995, FEMS MICROBIOL LETT, V133, P277, DOI 10.1016/0378-1097(95)00374-E; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SREERAMA N, 1994, BIOCHEMISTRY-US, V33, P10022, DOI 10.1021/bi00199a028; Steinbuchel A, 1998, TRENDS BIOTECHNOL, V16, P419, DOI 10.1016/S0167-7799(98)01194-9; STEINBUCHEL A, 1995, CAN J MICROBIOL, V41, P94, DOI 10.1139/m95-175; SWINT L, 1993, PROTEIN SCI, V2, P2037, DOI 10.1002/pro.5560021205; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; van Holde KE, 1986, PHYSICAL BIOCH, P3; VENTURI V, 1995, GENE, V155, P83, DOI 10.1016/0378-1119(94)00868-S; Wang ZH, 2008, LAB CHIP, V8, P1957, DOI 10.1039/b807762b; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WIECZOREK R, 1995, J BACTERIOL, V177, P2425, DOI 10.1128/jb.177.9.2425-2435.1995; Williams S.F., 2002, BIOPOLYMERS POLYESTE, V4, P91; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; York GM, 2002, J BACTERIOL, V184, P59, DOI 10.1128/JB.184.1.59-66.2002; York GM, 2001, J BACTERIOL, V183, P4217, DOI 10.1128/JB.183.14.4217-4226.2001; Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6	68	40	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56904	10.1371/journal.pone.0056904	http://dx.doi.org/10.1371/journal.pone.0056904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457638	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700096
J	Goto, R; Okamoto, T; Ishikawa, H; Hamamura, Y; Kato, M				Goto, Ryutaro; Okamoto, Tomoko; Ishikawa, Hiroshi; Hamamura, Yoichi; Kato, Makoto			Molecular Phylogeny of Echiuran Worms (Phylum: Annelida) Reveals Evolutionary Pattern of Feeding Mode and Sexual Dimorphism	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; CLASSIFICATION; SEAVIEW	The Echiura, or spoon worms, are a group of marine worms, most of which live in burrows in soft sediments. This annelid-like animal group was once considered as a separate phylum because of the absence of segmentation, although recent molecular analyses have placed it within the annelids. In this study, we elucidate the interfamily relationships of echiuran worms and their evolutionary pattern of feeding mode and sexual dimorphism, by performing molecular phylogenetic analyses using four genes (18S, 28S, H3, and COI) of representatives of all extant echiuran families. Our results suggest that Echiura is monophyletic and comprises two unexpected groups: [Echiuridae+Urechidae+Thalassematidae] and [Bonelliidae+Ikedidae]. This grouping agrees with the presence/absence of marked sexual dimorphism involving dwarf males and the paired/non-paired configuration of the gonoducts (genital sacs). Furthermore, the data supports the sister group relationship of Echiuridae and Urechidae. These two families share the character of having anal chaetae rings around the posterior trunk as a synapomorphy. The analyses also suggest that deposit feeding is a basal feeding mode in echiurans and that filter feeding originated once in the common ancestor of Urechidae. Overall, our results contradict the currently accepted order-level classification, especially in that Echiuroinea is polyphyletic, and provide novel insights into the evolution of echiuran worms.	[Goto, Ryutaro] Univ Tokyo, Dept Marine Ecosyst Dynam, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Goto, Ryutaro; Okamoto, Tomoko; Kato, Makoto] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	University of Tokyo; Kyoto University	Goto, R (corresponding author), Univ Tokyo, Dept Marine Ecosyst Dynam, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan.	gotoryutaro@gmail.com	Okamoto, Tomoko/L-8550-2013	Okamoto, Tomoko/0000-0001-8135-481X	Japan Society for the Promotion of Science Grant; Japan Society for the Promotion of Science Research Fellowships for Young Scientists Grant	Japan Society for the Promotion of Science Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science Research Fellowships for Young Scientists Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by a Japan Society for the Promotion of Science Grant to MK and a Japan Society for the Promotion of Science Research Fellowships for Young Scientists Grant to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biseswar R, 2010, ZOOTAXA, P21; Biseswar R, 2009, ZOOTAXA, P17, DOI 10.11646/zootaxa.2222.1.2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edmonds S.J., 2000, POLYCHAETES ALLIES A, P353; Fisher Walter Kenrick, 1946, PROC U S NATION MUS, V96, P215; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gislen T., 1940, Lunds Universitets Arsskrift, V36, P1; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Lehrke J, 2012, THESIS RHEINISCHEN F; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Nishikawa T, 2002, ZOOL SCI, V19, P1175, DOI 10.2108/zsj.19.1175; Pietsch TW, 2005, ICHTHYOL RES, V52, P207, DOI 10.1007/s10228-005-0286-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Rouse GW, 2001, POLYCHAETES, P42, DOI DOI 10.1111/J.1439-0469.2004.00263.X; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; SAXENA R, 1983, J ZOOL, V199, P149; Sokolov EP, 2000, J MOLLUS STUD, V66, P573, DOI 10.1093/mollus/66.4.573; Stephen A. C., 1972, PHYLA SIPUNCULA ECHI; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Yusa Y, 2012, P ROY SOC B-BIOL SCI, V279, P959, DOI 10.1098/rspb.2011.1554	24	22	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56809	10.1371/journal.pone.0056809	http://dx.doi.org/10.1371/journal.pone.0056809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457618	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700095
J	Cao, HL; Auguet, JC; Gu, JD				Cao, Huiluo; Auguet, Jean-Christophe; Gu, Ji-Dong			Global Ecological Pattern of Ammonia-Oxidizing Archaea	PLOS ONE			English	Article							AUSTRIAN CENTRAL ALPS; NITROSOPUMILUS-MARITIMUS; COMMUNITY STRUCTURE; RELATIVE ABUNDANCE; HOT-SPRINGS; AMOA GENES; SOIL-PH; DIVERSITY; BACTERIA; CRENARCHAEOTA	Background: The global distribution of ammonia-oxidizing archaea (AOA), which play a pivotal role in the nitrification process, has been confirmed through numerous ecological studies. Though newly available amoA (ammonia monooxygenase subunit A) gene sequences from new environments are accumulating rapidly in public repositories, a lack of information on the ecological and evolutionary factors shaping community assembly of AOA on the global scale is apparent. Methodology and Results: We conducted a meta-analysis on uncultured AOA using over ca. 6,200 archaeal amoA gene sequences, so as to reveal their community distribution patterns along a wide spectrum of physicochemical conditions and habitat types. The sequences were dereplicated at 95% identity level resulting in a dataset containing 1,476 archaeal amoA gene sequences from eight habitat types: namely soil, freshwater, freshwater sediment, estuarine sediment, marine water, marine sediment, geothermal system, and symbiosis. The updated comprehensive amoA phylogeny was composed of three major monophyletic clusters (i.e. Nitrosopumilus, Nitrosotalea, Nitrosocaldus) and a non-monophyletic cluster constituted mostly by soil and sediment sequences that we named Nitrososphaera. Diversity measurements indicated that marine and estuarine sediments as well as symbionts might be the largest reservoirs of AOA diversity. Phylogenetic analyses were further carried out using macroevolutionary analyses to explore the diversification pattern and rates of nitrifying archaea. In contrast to other habitats that displayed constant diversification rates, marine planktonic AOA interestingly exhibit a very recent and accelerating diversification rate congruent with the lowest phylogenetic diversity observed in their habitats. This result suggested the existence of AOA communities with different evolutionary history in the different habitats. Conclusion and Significance: Based on an up-to-date amoA phylogeny, this analysis provided insights into the possible evolutionary mechanisms and environmental parameters that shape AOA community assembly at global scale.	[Cao, Huiluo; Gu, Ji-Dong] Univ Hong Kong, Sch Biol Sci, Lab Environm Microbiol & Toxicol, Hong Kong, Hong Kong, Peoples R China; [Auguet, Jean-Christophe] Univ Pau & Pays Adour, UMR CNRS IPREM 5254, Equipe Environm Microbiol, Pau, France; [Gu, Ji-Dong] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Universite de Pau et des Pays de l'Adour; University of Hong Kong	Gu, JD (corresponding author), Univ Hong Kong, Sch Biol Sci, Lab Environm Microbiol & Toxicol, Hong Kong, Hong Kong, Peoples R China.	jdgu@hkucc.hku.hk	Auguet, Jean-Christophe/H-5697-2015; Gu, Ji-Dong/AAF-2291-2019; Gu, Ji-Dong/AAO-7851-2020; Cao, Heping/AAC-1666-2021	Auguet, Jean-Christophe/0000-0003-4340-7161; Klasson, K. Thomas/0000-0003-3358-3081; Cao, Heping/0000-0002-0958-1468; Scheffler, Brian/0000-0003-1968-8952; Shockey, Jay/0000-0002-5057-5457	University of Hong Kong	University of Hong Kong(University of Hong Kong)	PhD studentship (HC) from The University of Hong Kong supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguet JC, 2012, ISME J, V6, P1786, DOI 10.1038/ismej.2012.33; Auguet JC, 2011, APPL ENVIRON MICROB, V77, P1937, DOI 10.1128/AEM.01213-10; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Barberan A, 2011, MOL ECOL, V20, P1988, DOI 10.1111/j.1365-294X.2011.05057.x; Barberan A, 2010, AQUAT MICROB ECOL, V59, P1, DOI 10.3354/ame01389; Bernhard AE, 2010, APPL ENVIRON MICROB, V76, P1285, DOI 10.1128/AEM.02018-09; Biller SJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00252; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Cao HL, 2011, METHOD ENZYMOL, V496, P35, DOI 10.1016/B978-0-12-386489-5.00002-6; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Enwall K, 2005, APPL ENVIRON MICROB, V71, P8335, DOI 10.1128/AEM.71.12.8335-8343.2005; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fernandez-Guerra A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047330; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Helmus MR, 2007, ECOL LETT, V10, P917, DOI 10.1111/j.1461-0248.2007.01083.x; Jiang HC, 2010, APPL ENVIRON MICROB, V76, P4538, DOI 10.1128/AEM.00143-10; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Junier P, 2010, APPL MICROBIOL BIOT, V85, P425, DOI 10.1007/s00253-009-2228-9; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kim JG, 2012, ENV MICROBIOL; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Labrenz M, 2010, ISME J, V4, P1496, DOI 10.1038/ismej.2010.78; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu ZH, 2011, MICROBIOL RES, V166, P337, DOI 10.1016/j.micres.2010.08.002; Lliros M, 2008, FEMS MICROBIOL ECOL, V66, P331, DOI 10.1111/j.1574-6941.2008.00583.x; Lliros M, 2010, APPL ENVIRON MICROB, V76, P6853, DOI 10.1128/AEM.02864-09; Logares R, 2009, TRENDS MICROBIOL, V17, P414, DOI 10.1016/j.tim.2009.05.010; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Martin AP, 2004, EVOLUTION, V58, P946; Molina V, 2010, ENVIRON MICROBIOL, V12, P2450, DOI 10.1111/j.1462-2920.2010.02218.x; Mosier AC, 2008, ENVIRON MICROBIOL, V10, P3002, DOI 10.1111/j.1462-2920.2008.01764.x; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rogers DR, 2010, APPL ENVIRON MICROB, V76, P7938, DOI 10.1128/AEM.02056-09; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Santoro AE, 2008, ENVIRON MICROBIOL, V10, P1068, DOI 10.1111/j.1462-2920.2007.01547.x; Schleper C, 2010, ADV MICROB PHYSIOL, V57, P1, DOI 10.1016/B978-0-12-381045-8.00001-1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; van der Wielen PWJJ, 2009, APPL ENVIRON MICROB, V75, P4687, DOI 10.1128/AEM.00387-09; VANDEGRAAF AA, 1995, APPL ENVIRON MICROB, V61, P1246, DOI 10.1128/AEM.61.4.1246-1251.1995; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027597; Weidler GW, 2008, APPL ENVIRON MICROB, V74, P5934, DOI 10.1128/AEM.02602-07; Weidler GW, 2007, APPL ENVIRON MICROB, V73, P259, DOI 10.1128/AEM.01570-06; Wessen E, 2011, ISME J, V5, P1213, DOI 10.1038/ismej.2010.206; Zhang CL, 2008, APPL ENVIRON MICROB, V74, P6417, DOI 10.1128/AEM.00843-08	69	184	195	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e52853	10.1371/journal.pone.0052853	http://dx.doi.org/10.1371/journal.pone.0052853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	24146944	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900006
J	Ji, LN; Li, HM; Guo, XH; Li, Y; Hu, RM; Zhu, ZY				Ji, Linong; Li, Hongmei; Guo, Xiaohui; Li, Yan; Hu, Renming; Zhu, Zhengying			Impact of Baseline BMI on Glycemic Control and Weight Change with Metformin Monotherapy in Chinese Type 2 Diabetes Patients: Phase IV Open-Label Trial	PLOS ONE			English	Article							BODY-MASS INDEX; NONOBESE PATIENTS; RISK-FACTORS; THERAPY; HYPERGLYCEMIA; EFFICACY; ADULTS	Background: Differences exist between treatment recommendations regarding the choice of metformin as first-line therapy for type 2 diabetes patients according to body mass index (BMI). This study compared the efficacy of metformin monotherapy among normal-weight, overweight, and obese patients with newly diagnosed type 2 diabetes. Methods: In this prospective, multicenter, open-label study in China, patients aged 23-77 years were enrolled 1: 1: 1 according to baseline BMI: normal-weight (BMI 18.5-23.9 kg/m(2); n = 125); overweight (BMI 24.0-27.9 kg/m(2); n = 122) or obese (BMI >= 28 kg/m(2); n = 124). Extended-release metformin was administered for 16 weeks (500 mg/day, up-titrated weekly to a maximum 2,000 mg/day). The primary efficacy endpoint was the effect of baseline BMI on glycemic control with metformin monotherapy, measured as the change from baseline in glycosylated hemoglobin (HbA(1c)) at week 16 compared among BMI groups using ANCOVA. Other endpoints included comparisons of metformin's effects on fasting plasma glucose (FPG), lipid levels and body weight. Results: Mean HbA1c decreases at week 16, adjusted for baseline values, were -1.84%, -1.78% and -1.78% in normal-weight, overweight and obese patients, (P = 0.664); body weight decreased by 2.4%, 3.9% and 3.5%, respectively. FPG levels decreased similarly over time in all BMI groups (P = 0.461) and changes from baseline in high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) did not differ significantly among BMI groups at week 16 (P = 0.143 and 0.451, respectively). Conclusions: Baseline BMI had no impact on glycemic control, weight change or other efficacy measures with metformin monotherapy. These data suggest that normal-weight type 2 diabetes patients would derive the same benefits from first-line treatment with metformin as overweight and obese patients, and are not at increased risk of excess weight loss.	[Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China; [Li, Hongmei] Sino Amer Shanghai Squibb Pharmaceut Ltd, Clin Res, China Res & Dev, Shanghai, Peoples R China; [Guo, Xiaohui] Peking Univ, Peoples Hosp, Dept Endocrinol, Beijing 100871, Peoples R China; [Li, Yan] Sun Yat Sen Univ, Dept Endocrinol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Renming] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Zhu, Zhengying] Bristol Myers Squibb, China Res & Dev, Clin Res, Shanghai, Peoples R China	Peking University; Peking University; Sun Yat Sen University; Fudan University; Bristol-Myers Squibb	Ji, LN (corresponding author), Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China.	jiln@bjmu.edu.cn	Linong, Ji/AAB-6543-2020		Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	This study was funded by Bristol-Myers Squibb. Statistical analyses were performed by Mei Ji and Xianyi Kong of Pharmaceutical Product Development, Inc., paid for by Bristol-Myers Squibb. Editorial assistance with preparation of the manuscript was provided by Samantha Santangelo, PhD, of MediTech Media Asia Pacific Pte Ltd, paid for by Bristol-Myers Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors LJ, XG and RH have received honoraria for attending Advisory Board meetings for Bristol-Myers Squibb and have received payment for lectures. LJ and XG are investigators in clinical trials of other compounds under development by Bristol-Myers Squibb. ZZ is an employee of Bristol-Myers Squibb and has received stock/stock options from Bristol-Myers Squibb. This study was funded by Bristol-Myers Squibb. Statistical analyses were performed by MJ and XK of Pharmaceutical Product Development, Inc., paid for by Bristol-Myers Squibb. Editorial assistance with preparation of the manuscript was provided by Samantha Santangelo, PhD, of MediTech Media Asia Pacific Pte Ltd, paid for by Bristol-Myers Squibb. HL is an employee of Sino-American Shanghai Squibb Pharmaceutical Ltd. Metformin which was used in this study is a product of Bristol-Myers Squibb. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Asian-Pacific Type 2 Diabetes Policy Group, 2005, TYP 2 DIAB PRACT TAR; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Blonde L, 2004, CURR MED RES OPIN, V20, P565, DOI 10.1185/030079904125003278; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Chan WB, 2004, DIABETIC MED, V21, P349, DOI 10.1111/j.1464-5491.2004.01158.x; Chinese Diabetes Society, 2010, CHIN INV CORP ANN RE, P1; Consoli A, 2004, DIABETES METAB, V30, P509, DOI 10.1016/S1262-3636(07)70148-9; Donnelly LA, 2006, DIABETIC MED, V23, P128, DOI 10.1111/j.1464-5491.2005.01755.x; Garber A, 2003, DIABETES OBES METAB, V5, P171, DOI 10.1046/j.1463-1326.2003.00259.x; Home P, 2006, DIABETIC MED, V23, P579; Ito H, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-83; Lund SS, 2007, DIABETES OBES METAB, V9, P394, DOI 10.1111/j.1463-1326.2007.00713.x; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Ong CR, 2006, DIABETES CARE, V29, P2361, DOI 10.2337/dc06-0827; Sambol NC, 1996, J CLIN PHARMACOL, V36, P1012, DOI 10.1177/009127009603601105; Scarpello JHB, 2008, DIABETES VASC DIS RE, V5, P157, DOI 10.3132/dvdr.2008.027; West DS, 2008, OBESITY, V16, P1413, DOI 10.1038/oby.2008.224; Xu H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-683	21	39	58	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57222	10.1371/journal.pone.0057222	http://dx.doi.org/10.1371/journal.pone.0057222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23667609	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900060
J	Cao, HP; Shockey, JM; Klasson, KT; Chapital, DC; Mason, CB; Scheffler, BE				Cao, Heping; Shockey, Jay M.; Klasson, K. Thomas; Chapital, Dorselyn C.; Mason, Catherine B.; Scheffler, Brian E.			Developmental Regulation of Diacylglycerol Acyltransferase Family Gene Expression in Tung Tree Tissues	PLOS ONE			English	Article							TRIACYLGLYCEROL BIOSYNTHESIS; TRIGLYCERIDE SYNTHESIS; ARABIDOPSIS-THALIANA; QUANTITATIVE PCR; SKELETAL-MUSCLE; MESSENGER-RNA; CLUSTAL-W; RT-PCR; OIL; CLONING	Diacylglycerol acyltransferases (DGAT) catalyze the final and rate-limiting step of triacylglycerol (TAG) biosynthesis in eukaryotic organisms. DGAT genes have been identified in numerous organisms. Multiple isoforms of DGAT are present in eukaryotes. We previously cloned DGAT1 and DGAT2 genes of tung tree (Vernicia fordii), whose novel seed TAGs are useful in a wide range of industrial applications. The objective of this study was to understand the developmental regulation of DGAT family gene expression in tung tree. To this end, we first cloned a tung tree gene encoding DGAT3, a putatively soluble form of DGAT that possesses 11 completely conserved amino acid residues shared among 27 DGAT3s from 19 plant species. Unlike DGAT1 and DGAT2 subfamilies, DGAT3 is absent from animals. We then used TaqMan and SYBR Green quantitative real-time PCR, along with northern and western blotting, to study the expression patterns of the three DGAT genes in tung tree tissues. Expression results demonstrate that 1) all three isoforms of DGAT genes are expressed in developing seeds, leaves and flowers; 2) DGAT2 is the major DGAT mRNA in tung seeds, whose expression profile is well-coordinated with the oil profile in developing tung seeds; and 3) DGAT3 is the major form of DGAT mRNA in tung leaves, flowers and immature seeds prior to active tung oil biosynthesis. These results suggest that DGAT2 is probably the major TAG biosynthetic isoform in tung seeds and that DGAT3 gene likely plays a significant role in TAG metabolism in other tissues. Therefore, DGAT2 should be a primary target for tung oil engineering in transgenic organisms.	[Cao, Heping; Shockey, Jay M.; Klasson, K. Thomas; Chapital, Dorselyn C.; Mason, Catherine B.] ARS, USDA, So Reg Res Ctr, Commod Utilizat Res Unit, New Orleans, LA USA; [Scheffler, Brian E.] ARS, USDA, Genom & Bioinformat Res Unit, Stoneville, MS USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Cao, HP (corresponding author), ARS, USDA, So Reg Res Ctr, Commod Utilizat Res Unit, New Orleans, LA USA.	Heping.Cao@ars.usda.gov	Auguet, Jean-Christophe/H-5697-2015; Gu, Ji-Dong/AAF-2291-2019; Gu, Ji-Dong/AAO-7851-2020; Cao, Heping/AAC-1666-2021	Auguet, Jean-Christophe/0000-0003-4340-7161; Klasson, K. Thomas/0000-0003-3358-3081; Cao, Heping/0000-0002-0958-1468; Scheffler, Brian/0000-0003-1968-8952; Shockey, Jay/0000-0002-5057-5457	USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS [6435-41000-106-00D]	USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS	This work was supported by the USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS 6435-41000-106-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CE, 1929, J AGRIC RES, V38, P0679; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrianov V, 2010, PLANT BIOTECHNOL J, V8, P277, DOI 10.1111/j.1467-7652.2009.00458.x; Aranguren MI, 2012, POLYM TEST, V31, P7, DOI 10.1016/j.polymertesting.2011.09.001; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao HP, 2007, ARCH BIOCHEM BIOPHYS, V459, P214, DOI 10.1016/j.abb.2006.12.034; Cao HP, 2013, IN VITRO CELL DEV-AN, V49, P759, DOI 10.1007/s11626-013-9671-8; Cao HP, 2013, IND CROP PROD, V50, P248, DOI 10.1016/j.indcrop.2013.07.030; Cao HP, 2012, J AGR FOOD CHEM, V60, P12296, DOI 10.1021/jf304690e; Cao HP, 2012, APPL MICROBIOL BIOT, V96, P711, DOI 10.1007/s00253-012-3869-7; Cao Heping, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-249; Cao HP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-73; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Cao HP, 1999, PLANT PHYSIOL, V120, P205, DOI 10.1104/pp.120.1.205; CAO HP, 1995, PHYSIOL PLANTARUM, V95, P176, DOI 10.1111/j.1399-3054.1995.tb00825.x; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2004, DIABETES, V53, P1445, DOI 10.2337/diabetes.53.6.1445; Chen YH, 2012, RENEW ENERG, V44, P305, DOI 10.1016/j.renene.2012.01.098; Chen YH, 2010, BIORESOURCE TECHNOL, V101, P9521, DOI 10.1016/j.biortech.2010.06.117; Chen YC, 2010, IND CROP PROD, V32, P684, DOI 10.1016/j.indcrop.2010.06.009; Manh DV, 2012, ENERGY, V48, P519, DOI 10.1016/j.energy.2012.09.065; Durrett TP, 2010, P NATL ACAD SCI USA, V107, P9464, DOI 10.1073/pnas.1001707107; Dyer JM, 2004, J AM OIL CHEM SOC, V81, P647, DOI 10.1007/s11746-004-956-x; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; Gidda SK, 2009, PLANT PHYSIOL BIOCH, V47, P867, DOI 10.1016/j.plaphy.2009.05.008; Haas JT, 2012, J CLIN INVEST, V122, P4680, DOI 10.1172/JCI64873; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Hwang YT, 2004, PLANT CELL, V16, P3002, DOI 10.1105/tpc.104.026039; ICHIHARA K, 1988, BIOCHIM BIOPHYS ACTA, V958, P125, DOI 10.1016/0005-2760(88)90253-6; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; Kamisaka Y, 2007, BIOCHEM J, V408, P61, DOI 10.1042/BJ20070449; Kamisaka Y, 2010, APPL MICROBIOL BIOT, V88, P105, DOI 10.1007/s00253-010-2725-x; KOPACZ BM, 1968, J AM OIL CHEM SOC, V45, P285, DOI 10.1007/BF02652428; Kwiatkowska M, 2012, FOLIA HISTOCHEM CYTO, V50, P427, DOI [10.5603/19752, 10.5603/FHC.2012.0058]; Lardizabal K, 2008, PLANT PHYSIOL, V148, P89, DOI 10.1104/pp.108.123042; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin JT, 1998, LIPIDS, V33, P59, DOI 10.1007/s11745-998-0180-3; Liu CG, 2013, IND CROP PROD, V43, P677, DOI 10.1016/j.indcrop.2012.07.072; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Liu L, 2009, J BIOL CHEM, V284, P36312, DOI 10.1074/jbc.M109.049817; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Liu Q, 2011, J BIOL CHEM, V286, P13115, DOI 10.1074/jbc.M110.204412; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Park JY, 2008, APPL BIOCHEM BIOTECH, V148, P109, DOI 10.1007/s12010-007-8082-2; Pastor S, 2013, PLANT SCI, V203, P79, DOI 10.1016/j.plantsci.2012.12.009; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Peng ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061363; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POTTER GF, 1968, J AM OIL CHEM SOC, V45, P281, DOI 10.1007/BF02652427; PRYDE EH, 1979, J AM OIL CHEM SOC, V56, pA719, DOI 10.1007/BF02667427; Rani SH, 2013, MICROBIOL-SGM, V159, P155, DOI 10.1099/mic.0.063156-0; Rani SH, 2010, J BIOL CHEM, V285, P38337, DOI 10.1074/jbc.M110.133116; Roorda BD, 2005, J LIPID RES, V46, P230, DOI 10.1194/jlr.M400416-JLR200; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samadzadeh M, 2011, PROG ORG COAT, V70, P383, DOI 10.1016/j.porgcoat.2010.08.017; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHNEEBERGER C, 1995, PCR METH APPL, V4, P234; Schneider UV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038451; Shang Q, 2012, APPL BIOCHEM BIOTECH, V168, P106, DOI 10.1007/s12010-011-9364-2; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Shockey JM, 2005, PLANT SCI, V169, P375, DOI 10.1016/j.plantsci.2005.03.023; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Sonntag N.O.V., 1979, BAILEYS IND OIL FAT, V1, P289; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Tang F, 1998, PLANT PHYSIOL, V117, P717; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Weselake Randall J., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-24; Xu JY, 2008, PLANT BIOTECHNOL J, V6, P799, DOI 10.1111/j.1467-7652.2008.00358.x; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x	88	184	195	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76946	10.1371/journal.pone.0076946	http://dx.doi.org/10.1371/journal.pone.0076946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146944	Green Submitted, gold, Green Published			2022-12-27	WOS:000325819400090
J	Wu, CL; Zhang, ZF; Lu, Z; Liao, M; Zhang, YJ; Xie, YL; Guo, XF; Yu, XX; Yang, XB; Gao, Y; Tan, AH; Mo, ZN				Wu, Chunlei; Zhang, Zhifu; Lu, Zheng; Liao, Ming; Zhang, Youjie; Xie, Yuanliang; Guo, Xuefeng; Yu, Xiaoxiang; Yang, Xiaobo; Gao, Yong; Tan, Aihua; Mo, Zengnan			Prevalence of and Risk Factors for Asymptomatic Inammatory (NIH-IV) Prostatitis in Chinese Men	PLOS ONE			English	Article							FANGCHENGGANG AREA; HEALTH; SYMPTOMS; POPULATION; ASSOCIATION; PAIN	Background: While many investigators have studied symptomatic prostatitis, little research has been done with regard to asymptomatic (NIH-IV) prostatitis. Purpose: To describe the prevalence of and risk factors for NIH-IV prostatitis among a large male population. Methods: The study population was comprised of 1,868 men at the second phase recruitment of a population-based cohort in China. Asymptomatic and symptomatic men were defined by the National Institutes of Health Chronic Prostatitis (CP) Symptom Index. Meanwhile, EPS specimens and their leukocyte count were collected. Lifestyle and demographic characteristics were obtained through a questionnaire. Results: Prevalence of NIH-IV prostatitis was 21.1% among 1,868 asymptomatic men aged 19-78 years and increased with age. After adjusteing for potential confounding variables (age, smoking habits, alcohol drinking habits, education, physical activity, hypertension, dyslipidemia, obesity and diabetes), age remained a significant factor for NIH-IV prostatitis (OR = 1.35; 95% CI = 1.06-1.71; P = 0.01) and the risk of NIH-IV prostatitis was significantly higher in smokers >= 15 pack/years than nonsmokers (OR = 1.33; 95% CI = 1.01-1.75; P = 0.03). In addition, compared with non-drinkers, the OR of NIH-IV prostatitis in drinkers >= 1 drinks/week was 1.35 (95% CI = 1.03, 1.77, p = 0.02) after adjusting for the other variables above. In addition, having less than a college education may be a risk factor for NIH-IV prostatitis, although a statistically significant difference did not exist in our data (OR = 1.22; 95% CI = 0.97-1.52; P = 0.08). Conclusions: Our findings suggest that NIH-IV prostatitis is prevalent in China. Age, smoking, drinking and lower education levels were associated with an increased risk of NIH-IV prostatitis. The prevalence of NIH-IV prostatitis should be taken into account when estimating the total prevalence of CP in future studies.	[Wu, Chunlei; Zhang, Zhifu; Lu, Zheng; Liao, Ming; Zhang, Youjie; Xie, Yuanliang; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China; [Zhang, Zhifu; Lu, Zheng; Liao, Ming; Zhang, Youjie; Xie, Yuanliang; Guo, Xuefeng; Yu, Xiaoxiang; Gao, Yong; Tan, Aihua] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Yang, Xiaobo] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi Zhuang, Peoples R China; [Yu, Xiaoxiang] 303rd Hosp Chinese Peoples Liberat Army, Dept Urol, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Mo, ZN (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China.	zengnanmo@hotmail.com	Zhang, Youjie/F-7346-2016; Sun, Yuelian/AFF-2622-2022; Olsen, Jørn/F-8801-2015; Yang, Xiaobo/G-3854-2016	Zhang, Youjie/0000-0002-6035-8536; Sun, Yuelian/0000-0002-6905-0503; Olsen, Jørn/0000-0001-7462-5140; mo, zengnan/0000-0002-3047-3138; Miller, Jessica/0000-0002-1806-1894	National Natural Science Foundation of China [30945204]; Provincial Department of Finance, Guangxi Zhuang Autonomous Region, China [2009GJCJ150]; Provincial Department of Education, Guangxi Zhuang Autonomous Region, China [2009GJCJ150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Department of Finance, Guangxi Zhuang Autonomous Region, China; Provincial Department of Education, Guangxi Zhuang Autonomous Region, China	The work described in this article is supported by grants from the National Natural Science Foundation of China (grant number 30945204) and the Provincial Departments of Finance and Education, Guangxi Zhuang Autonomous Region, China (grant number 2009GJCJ150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Bozeman CB, 2002, J UROLOGY, V167, P1723, DOI 10.1016/S0022-5347(05)65186-5; Carver BS, 2003, J UROLOGY, V169, P589, DOI 10.1016/S0022-5347(05)63959-6; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; De Nunzio C, 2011, EUR UROL, V60, P106, DOI 10.1016/j.eururo.2011.03.055; Ejike CECC, 2008, INT J UROL, V15, P340, DOI 10.1111/j.1442-2042.2008.02003.x; Ferris JA, 2010, BJU INT, V105, P373, DOI 10.1111/j.1464-410X.2009.08708.x; Gavin JR, 1999, DIABETES CARE, V22, pS5; Korrovits P, 2008, UROLOGY, V71, P1010, DOI 10.1016/j.urology.2007.12.082; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Ku JH, 2005, INT J ANDROL, V28, P317, DOI 10.1111/j.1365-2605.2005.00560.x; Kunishima Y, 2006, INT J UROL, V13, P1286, DOI 10.1111/j.1442-2042.2004.01556.x; Li GZ, 2011, INT UROL NEPHROL, V43, P295, DOI 10.1007/s11255-010-9825-5; Liang CZ, 2009, J UROLOGY, V182, P558, DOI 10.1016/j.juro.2009.04.011; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; MEARES EM, 1991, MED CLIN N AM, V75, P405, DOI 10.1016/S0025-7125(16)30462-X; Mehik A, 2000, BJU INT, V86, P443, DOI 10.1046/j.1464-410X.2000.00836.x; Mi H, 2012, UROLOGY, V79, P403, DOI 10.1016/j.urology.2011.09.032; Muller CH, 2001, J UROLOGY, V166, P2518, DOI 10.1016/S0022-5347(05)65627-3; Nickel JC, 2003, J UROLOGY, V170, P818, DOI 10.1097/01.ju.0000082252.49374.e9; Nickel JC, 2001, J UROLOGY, V165, P842, DOI 10.1016/S0022-5347(05)66541-X; Pontari MA, 2007, J UROLOGY, V177, P2050, DOI 10.1016/j.juro.2007.01.128; Sharma RK, 2001, J ANDROL, V22, P575; Shimomura Tatsuya, 2003, Kansenshogaku Zasshi, V77, P611; Simardi LH, 2004, UROLOGY, V64, P1098, DOI 10.1016/j.urology.2004.08.060; Stancik I, 2004, EUR UROL, V46, P760, DOI 10.1016/j.eururo.2004.08.003; Tripp DA, 2009, BJU INT, V103, P1080, DOI 10.1111/j.1464-410X.2008.08157.x; Wu CL, 2011, J ANDROL, V33, P59, DOI 10.2164/jandrol.110.012542	28	24	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71298	10.1371/journal.pone.0071298	http://dx.doi.org/10.1371/journal.pone.0071298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967188	Green Submitted, Green Published, gold			2022-12-27	WOS:000323115800048
J	Zhou, L; Zhang, N; Song, WJ; You, N; Li, QJ; Sun, W; Zhang, Y; Wang, DS; Dou, KF				Zhou, Liang; Zhang, Ning; Song, Wenjie; You, Nan; Li, Qingjun; Sun, Wei; Zhang, Yong; Wang, Desheng; Dou, Kefeng			The Significance of Notch1 Compared with Notch3 in High Metastasis and Poor Overall Survival in Hepatocellular Carcinoma	PLOS ONE			English	Article							HUMAN BREAST-CANCER; ACTIVATED PROTEIN-KINASE; E-CADHERIN; TISSUE MICROARRAY; SIGNALING PATHWAY; DOWN-REGULATION; MESSENGER-RNA; CROSS-TALK; CELL; EXPRESSION	Background: The prognosis for patients with hepatocellular carcinoma (HCC) is poor, and the mechanisms underlying the development of HCC remain unclear. Notch1 and Notch3 may be involved in malignant transformation, although their roles remain unknown. Materials and Methods: HCC tissues were stained with anti-Notch1 or -Notch3 antibody. The migration and invasion capacities of the cells were measured with transwell cell culture chambers. RT-PCR was used to measure the expression of Notch1 and Notch3 mRNA. Additionally, western blot analysis was used to assess the protein expression of Notch1, Notch3, CD44v6, E-cadherin, matrix metalloproteinase-2 (MMP-2), MMP-9, and urokinase-type plasminogen activator (uPA). RNA interference was used to down-regulate the expression of Notch1 and Notch3. Cell viability was assessed using MTT. Results: Based on immunohistochemistry, high Notch1 expression was correlated with tumor size, tumor grade, metastasis, venous invasion and AJCC TNM stage. High Notch3 expression was only strongly correlated with metastasis, venous invasion and satellite lesions. Kaplan-Meier curves demonstrated that patients with high Notch1 or Notch3 expression were at a significantly increased risk for shortened survival time. In vitro, the down-regulation of Notch1 decreased the migration and invasion capacities of HCC cells by regulating CD44v6, E-cadherin, MMP-2, MMP-9, and uPA via the COX-2 and ERK1/2 pathways. Down-regulation of Notch3 only decreased the invasion capacity of HCC cells by regulating MMP-2 and MMP-9 via the ERK1/2 pathway. Conclusions: Based on the migration and invasion of HCC, we hypothesize that targeting Notch1 may be more useful than Notch3 for designing novel preventive and therapeutic strategies for HCC in the near future.	[Zhou, Liang; Zhang, Ning; Song, Wenjie; You, Nan; Li, Qingjun; Sun, Wei; Zhang, Yong; Wang, Desheng; Dou, Kefeng] Fourth Mil Med Univ, Dept Hepatobiliary Surg, Xijing Hosp, Xian 710032, Shannxi, Peoples R China	Air Force Military Medical University	Dou, KF (corresponding author), Fourth Mil Med Univ, Dept Hepatobiliary Surg, Xijing Hosp, Xian 710032, Shannxi, Peoples R China.	Kefengdou@126.com			National Natural Science Foundation of China [30872480, 81030010/H0318]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Grants No. 30872480) and the Major Program of the National Natural Science Foundation of China (Grants No. 81030010/H0318). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2003, GLIA, V43, P254, DOI 10.1002/glia.10255; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bellavia D, 2002, P NATL ACAD SCI USA, V99, P3788, DOI 10.1073/pnas.062050599; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Chan-Hui PY, 1998, BIOCHEM J, V336, P599, DOI 10.1042/bj3360599; Cheng YC, 2009, MOL CELL BIOCHEM, V325, P15, DOI 10.1007/s11010-008-0016-y; Chu D, 2011, ANN ONCOL, V22, P2440, DOI 10.1093/annonc/mdq776; Chu D, 2010, ANN SURG ONCOL, V17, P1337, DOI 10.1245/s10434-009-0893-7; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Dickson BC, 2007, MODERN PATHOL, V20, P685, DOI 10.1038/modpathol.3800785; Dohadwala M, 2002, J BIOL CHEM, V277, P50828, DOI 10.1074/jbc.M210707200; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dubinett SM, 2003, PROG EXP TUMOR RES, V37, P138; Gallahan D, 1996, CANCER RES, V56, P1775; Gao J, 2008, DIGEST LIVER DIS, V40, P114, DOI 10.1016/j.dld.2007.08.001; Giovannini C, 2006, ANTICANCER RES, V26, P2123; Giovannini C, 2009, J HEPATOL, V50, P969, DOI 10.1016/j.jhep.2008.12.032; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Indraccolo S, 2009, CANCER RES, V69, P1314, DOI 10.1158/0008-5472.CAN-08-2791; Itoh Y, 2002, ESSAYS BIOCHEM, V38, P21, DOI 10.1042/bse0380021; Jang MS, 2000, CURR OPIN MOL THER, V2, P55; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Kamstrup MR, 2010, BLOOD, V116, P2504, DOI 10.1182/blood-2009-12-260216; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Komatsu Kyoko, 2004, Brain Tumor Pathol, V21, P105, DOI 10.1007/BF02482184; Lim SO, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-83; Liu DG, 2001, ANN THORAC SURG, V71, P949, DOI 10.1016/S0003-4975(00)02545-5; Liu YJ, 2005, WORLD J GASTROENTERO, V11, P6601, DOI 10.3748/wjg.v11.i42.6601; Mann CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051119; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Ning L, 2009, AM J TRANSL RES, V1, P358; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Park JT, 2010, AM J PATHOL, V177, P1087, DOI 10.2353/ajpath.2010.100316; Park K, 2006, EJSO-EUR J SURG ONC, V32, P1093, DOI 10.1016/j.ejso.2006.05.010; Parr C, 2004, INT J MOL MED, V14, P779; Qi RZ, 2003, CANCER RES, V63, P8323; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Shimizu M, 2011, CANCER RES, V71, P277, DOI 10.1158/0008-5472.CAN-10-2523; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Wang J, 2011, ONCOL REP, V26, P1295, DOI 10.3892/or.2011.1399; Wang Xiaodong, 2011, Proceedings of the 2011 International Conference on Business Management and Electronic Information (BMEI 20111), P1, DOI 10.1109/ICBMEI.2011.5918026; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Yeasmin S, 2010, GYNECOL ONCOL, V117, P409, DOI 10.1016/j.ygyno.2010.03.004; Yeh TS, 2009, CANCER RES, V69, P5039, DOI 10.1158/0008-5472.CAN-08-4021; Yu B, 2012, ONCOL REP, V27, P547, DOI 10.3892/or.2011.1492; Zeng ZS, 1999, CARCINOGENESIS, V20, P749, DOI 10.1093/carcin/20.5.749; Zhang ZY, 2010, AM J PATHOL, V177, P1459, DOI 10.2353/ajpath.2010.090476; Zlobin A., 2000, Current Pharmaceutical Biotechnology, V1, P83, DOI 10.2174/1389201003379013	57	92	100	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57382	10.1371/journal.pone.0057382	http://dx.doi.org/10.1371/journal.pone.0057382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	24040041	Green Published, gold, Green Submitted			2022-12-27	WOS:000315524900079
J	Zhang, XL; Ge, XH; Shao, YJ; Sun, GL; Li, ZY				Zhang, Xueli; Ge, Xianhong; Shao, Yujiao; Sun, Genlou; Li, Zaiyun			Genomic Change, Retrotransposon Mobilization and Extensive Cytosine Methylation Alteration in Brassica napus Introgressions from Two Intertribal Hybridizations	PLOS ONE			English	Article							PARTIAL HYBRIDS; CHROMOSOME ELIMINATION; INTERGENERIC HYBRIDS; DNA METHYLATION; TRANSCRIPTIONAL ACTIVATION; HOMEOLOGOUS RECOMBINATION; ORYCHOPHRAGMUS-VIOLACEUS; HELIANTHUS-ANNUUS; GENE-EXPRESSION; MAJOR ROLE	Hybridization and introgression represent important means for the transfer and/or de novo origination of traits and play an important role in facilitating speciation and plant breeding. Two sets of introgression lines in Brassica napus L. were previously established by its intertribal hybridizations with two wild species and long-term selection. In this study, the methods of amplified fragment length polymorphisms (AFLP), sequence-specific amplification polymorphism (SSAP) and methylation-sensitive amplified polymorphism (MSAP) were used to determine their genomic change, retrotransposon mobilization and cytosine methylation alteration in these lines. The genomic change revealed by the loss or gain of AFLP bands occurred for similar to 10% of the total bands amplified in the two sets of introgressions, while no bands specific for wild species were detected. The new and absent SSAP bands appeared for 9 out of 11 retrotransposons analyzed, with low frequency of new bands and their total percentage of about 5% in both sets. MSAP analysis indicated that methylation changes were common in these lines (33.4-39.8%) and the hypermethylation was more frequent than hypomethylation. Our results suggested that certain extents of genetic and epigenetic alterations were induced by hybridization and alien DNA introgression. The cryptic mechanism of these changes and potential application of these lines in breeding were also discussed.	[Zhang, Xueli; Ge, Xianhong; Li, Zaiyun] Huazhong Agr Univ, Natl Ctr Oil Crop Improvement Wuhan, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement,Natl Ctr Crop, Wuhan, Peoples R China; [Shao, Yujiao] Hubei Univ Educ, Coll Chem & Life Sci, Wuhan, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Huazhong Agricultural University; Hubei University Education; Saint Marys University - Canada	Ge, XH (corresponding author), Huazhong Agr Univ, Natl Ctr Oil Crop Improvement Wuhan, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement,Natl Ctr Crop, Wuhan, Peoples R China.	gexianhong@gmail.com; lizaiyun@mail.hzau.edu.cn	; Zeng, Qingdong/H-7208-2014	Wu, Jianhui/0000-0001-8154-1199; Zeng, Qingdong/0000-0002-7856-2340; Kang, Zhensheng/0000-0001-5575-0122	Agricultural Ministry of China [201103016]	Agricultural Ministry of China(Ministry of Agriculture & Rural Affairs)	The work was supported by the grant from Agricultural Ministry of China (201103016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Alix K, 2008, PLANT J, V56, P1030, DOI 10.1111/j.1365-313X.2008.03660.x; ANDERSON E., 1949, Introgressive hybridization.; Arnold ML, 2004, PLANT CELL, V16, P562, DOI 10.1105/tpc.160370; Beaulieu J, 2009, MOL GENET GENOMICS, V281, P421, DOI 10.1007/s00438-008-0421-7; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chen HF, 2007, PLANT CELL REP, V26, P1791, DOI 10.1007/s00299-007-0392-x; Cheng BF, 2002, GENOME, V45, P110, DOI 10.1139/g01-131; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; Du XZ, 2008, PLANT CELL REP, V27, P261, DOI 10.1007/s00299-007-0452-2; Faure N, 2002, THEOR APPL GENET, V104, P652, DOI 10.1007/s001220100746; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Ha M, 2011, GENOME RES, V21, P590, DOI 10.1101/gr.116467.110; Ha M, 2009, P NATL ACAD SCI USA, V106, P17835, DOI 10.1073/pnas.0907003106; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hua YW, 2006, ANN BOT-LONDON, V97, P993, DOI 10.1093/aob/mcl073; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kashkush K, 2007, GENETICS, V177, P1975, DOI 10.1534/genetics.107.080234; Kidwell Kimberlee K., 1992, P1; Kraitshtein Z, 2010, GENETICS, V186, P801, DOI 10.1534/genetics.110.120790; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lashermes P, 2000, THEOR APPL GENET, V100, P139, DOI 10.1007/s001220050019; Leflon M, 2006, THEOR APPL GENET, V113, P1467, DOI 10.1007/s00122-006-0393-0; LI Z, 1995, THEOR APPL GENET, V91, P131, DOI 10.1007/BF00220869; Li ZY, 2007, PLANT CELL REP, V26, P701, DOI 10.1007/s00299-006-0290-7; Liu B., 1999, Journal of Genetics and Breeding, V53, P279; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Liu H.L., 2000, GENETICS BREEDING RA; Liu M, 2007, GENOME, V50, P985, DOI 10.1139/G07-071; LUO P, 1994, PLANT BREEDING, V113, P83, DOI 10.1111/j.1439-0523.1994.tb00707.x; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Ma N, 2007, EUPHYTICA, V157, P231, DOI 10.1007/s10681-007-9416-4; Ma N, 2006, PLANT CELL REP, V25, P1089, DOI 10.1007/s00299-006-0171-0; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Melayah D, 2001, PLANT J, V28, P159, DOI 10.1046/j.1365-313X.2001.01141.x; Nicolas SD, 2007, GENETICS, V175, P487, DOI 10.1534/genetics.106.062968; Okamoto H, 2001, TRENDS PLANT SCI, V6, P527, DOI 10.1016/S1360-1385(01)02105-7; Osborn TC, 2003, GENETICS, V165, P1569; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Parisod C, 2010, NEW PHYTOL, V186, P37, DOI 10.1111/j.1469-8137.2009.03096.x; Petit M, 2010, NEW PHYTOL, V186, P135, DOI 10.1111/j.1469-8137.2009.03140.x; Petit M, 2007, MOL GENET GENOMICS, V278, P1, DOI 10.1007/s00438-007-0226-0; Pires JC, 2004, BIOL J LINN SOC, V82, P675, DOI 10.1111/j.1095-8312.2004.00350.x; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Scascitelli M, 2010, MOL ECOL, V19, P521, DOI 10.1111/j.1365-294X.2009.04504.x; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Tate Jennifer A., 2005, P371, DOI 10.1016/B978-012301463-4/50009-7; Tu YQ, 2009, ANN BOT-LONDON, V103, P1039, DOI 10.1093/aob/mcp045; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang NN, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-190; Wang YM, 2005, GENETICS, V170, P1945, DOI 10.1534/genetics.105.040964; Waugh R, 1997, MOL GEN GENET, V253, P687, DOI 10.1007/s004380050372; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu YH, 2009, PLANTA, V229, P471, DOI 10.1007/s00425-008-0844-8; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zhao N, 2011, GENETICS, V188, P499, DOI 10.1534/genetics.111.127688; Zhao ZG, 2007, GENOME, V50, P226, DOI 10.1139/G06-146; Zou J, 2011, PLANT J, V68, P212, DOI 10.1111/j.1365-313X.2011.04679.x	74	38	46	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56346	10.1371/journal.pone.0056346	http://dx.doi.org/10.1371/journal.pone.0056346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23526955	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900023
J	Shen, HM; Wu, XM; Zhu, YZ; Sun, HL				Shen, Hongmei; Wu, Xinmin; Zhu, Yuzhong; Sun, Hualing			Intravenous Administration of Achyranthes Bidentata Polypeptides Supports Recovery from Experimental Ischemic Stroke in Vivo	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; NEURONAL DAMAGE; NEUROPROTECTION; CALCIUM; SENSORIMOTOR; GLUTAMATE; NMDA; APOPTOSIS; CELLS; PATHOPHYSIOLOGY	Background: Achyranthes bidentata Blume (A. bidentata) is a commonly prescribed Chinese medicinal herb. A. bidentata polypeptides (ABPP) is an active composite constituent, separated from the aqueous extract of A. bidentata. Our previous studies have found that ABPP have the neuroprotective function in vitro and in rat middle cerebral artery occlusion (MCAO) model in attenuating the brain infract area induced by focal ischemia-reperfusion. However, the ultimate goal of the stroke treatment is the restoration of behavioral function. Identifying behavioral deficits and therapeutic treatments in animal models of ischemic stroke is essential for potential translational applications. Methodology and Principal Findings: The effect of ABPP on motor, sensory, and cognitive function in an ischemic stroke model with MCAO was investigated up to day 30. The function recovery monitored by the neurological deficit score, grip test, body asymmetry, beam-balancing task, and the Morris Water Maze. In this study, systemic administration of ABPP by i.v after MCAO decreased the neurological deficit score, ameliorated the forepaw muscle strength, and diminished the motor and sensory asymmetry on 7th and 30th day after MCAO. MCAO has been observed to cause prolonged disturbance of spatial learning and memory in rats using the MWM, and ABPP treatment could improve the spatial learning and memory function, which is impaired by MCAO in rats, on 30th day after MCAO. Then, the viable cells in CA1 region of hippocampus were counted by Nissl staining, and the neuronal cell death were significantly suppressed in the ABPP treated group. Conclusion: ABPP could improve the recovery of sensory, motor and coordination, and cognitive function in MCAO-induced ischemic rats. And this recovery had a good correlation to the less of neuronal injury in brain.	[Shen, Hongmei] Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China; Nantong Univ, Inst Naut Med, Nantong, Peoples R China	Nantong University; Nantong University	Shen, HM (corresponding author), Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China.	hmshen1971@gmail.com	sun, hualin/AAX-6391-2021		National Natural Science Foundation of China [81073079, K2009013]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The National Natural Science Foundation of China (Grant No. 81073079, K2009013) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) supported Hongmei Shen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blandini F, 1996, FUNCT NEUROL, V11, P3; Borlongan CV, 1998, NEUROREPORT, V9, P3615, DOI 10.1097/00001756-199811160-00012; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; BUCHAN A, 1990, J NEUROSCI, V10, P311; Buckmaster PS, 2002, EPILEPSY RES, V48, P43, DOI 10.1016/S0920-1211(01)00318-7; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Cespedes-Rubio A, 2010, J NEUROSCI RES, V88, P3621, DOI 10.1002/jnr.22511; CHOI DW, 1989, ANN NY ACAD SCI, V568, P219; Dhar-Mascareno M, 2005, FREE RADICAL BIO MED, V38, P1311, DOI 10.1016/j.freeradbiomed.2005.01.017; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; EIMERL S, 1994, J NEUROCHEM, V62, P1223; Feigin VL, 2007, STROKE, V38, P1734, DOI 10.1161/STROKEAHA.107.487132; Gagliardi RJ, 2000, ARQ NEURO-PSIQUIAT, V58, P583, DOI 10.1590/S0004-282X2000000300030; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; Gerriets T, 2003, J NEUROSCI METH, V122, P201, DOI 10.1016/S0165-0270(02)00322-9; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; GOLDSTEIN LB, 1993, J NEUROSCI METH, V48, P35, DOI 10.1016/S0165-0270(05)80005-6; Gong X, 2002, PHYTOMEDICINE, V9, P478, DOI 10.1078/09447110260571760; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; Harvey AL, 1999, TRENDS PHARMACOL SCI, V20, P196, DOI 10.1016/S0165-6147(99)01346-2; Hossmann KA, 2009, FOLIA NEUROPATHOL, V47, P213; Joshi CN, 2004, BRAIN RES PROTOC, V13, P11, DOI 10.1016/j.brainresprot.2003.12.001; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kirino T, 1986, No To Shinkei, V38, P1157; Kitagawa K, 1998, STROKE, V29, P2616, DOI 10.1161/01.STR.29.12.2616; Liu HT, 1999, P NATL ACAD SCI USA, V96, P12096, DOI 10.1073/pnas.96.21.12096; Lo EH, 2005, STROKE, V36, P189, DOI 10.1161/01.STR.0000153069.96296.fd; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; MARKGRAF CG, 1992, BRAIN RES, V575, P238, DOI 10.1016/0006-8993(92)90085-N; MORAN PM, 1995, P NATL ACAD SCI USA, V92, P5341, DOI 10.1073/pnas.92.12.5341; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Reglodi D, 2003, BRAIN RES BULL, V59, P459, DOI 10.1016/S0361-9230(02)00962-0; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Savitz SI, 2007, ANN NEUROL, V61, P396, DOI 10.1002/ana.21127; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Shen HM, 2010, J NEUROSCI RES, V88, P669, DOI 10.1002/jnr.22221; Shen HM, 2008, BRAIN RES BULL, V77, P274, DOI 10.1016/j.brainresbull.2008.08.002; Shen YT, 2011, NEUROCHEM RES, V36, P2186, DOI 10.1007/s11064-011-0543-x; Thomalla G, 2006, STROKE, V37, P852, DOI 10.1161/01.STR.0000204120.79399.72; Yonemori F, 1996, J CEREBR BLOOD F MET, V16, P973, DOI 10.1097/00004647-199609000-00022	44	61	65	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2013	8	2							e57055	10.1371/journal.pone.0057055	http://dx.doi.org/10.1371/journal.pone.0057055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098PO	23469228	Green Submitted, gold, Green Published			2022-12-27	WOS:000315561400025
J	Li, HZ; Hou, S; Wu, X; Nandagopal, S; Lin, F; Kung, S; Marshall, AJ				Li, Hongzhao; Hou, Sen; Wu, Xun; Nandagopal, Saravanan; Lin, Francis; Kung, Sam; Marshall, Aaron James			The Tandem PH Domain-Containing Protein 2 (TAPP2) Regulates Chemokine-Induced Cytoskeletal Reorganization and Malignant B Cell Migration	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; DYSTROPHIN-GLYCOPROTEIN COMPLEX; PHOSPHOINOSITIDE 3-KINASES; ACTIN; CHEMOTAXIS; POLARITY; MOTILITY; CXCR4; RECEPTOR; RECRUITMENT	The intracellular signaling processes controlling malignant B cell migration and tissue localization remain largely undefined. Tandem PH domain-containing proteins TAPP1 and TAPP2 are adaptor proteins that specifically bind to phosphatidylinositol-3,4-bisphosphate, or PI(3,4) P2, a product of phosphoinositide 3-kinases (PI3K). While PI3K enzymes have a number of functions in cell biology, including cell migration, the functions of PI(3,4) P2 and its binding proteins are not well understood. Previously we found that TAPP2 is highly expressed in primary leukemic B cells that have strong migratory capacity. Here we find that SDF-1-dependent migration of human malignant B cells requires both PI3K signaling and TAPP2. Migration in a transwell assay is significantly impaired by pan-PI3K and isoform-selective PI3K inhibitors, or by TAPP2 shRNA knockdown (KD). Strikingly, TAPP2 KD in combination with PI3K inhibitor treatment nearly abolished the migration response, suggesting that TAPP2 may contribute some functions independent of the PI3K pathway. In microfluidic chamber cell tracking assays, TAPP2 KD cells show reduction in percentage of migrating cells, migration velocity and directionality. TAPP2 KD led to alterations in chemokine-induced rearrangement of the actin cytoskeleton and failure to form polarized morphology. TAPP2 co-localized with the stable F-actin-binding protein utrophin, with both molecules reciprocally localizing against F-actin accumulated at the leading edge upon SDF-1 stimulation. In TAPP2 KD cells, Rac was over-activated and localized to multiple membrane protrusions, suggesting that TAPP2 may act in concert with utrophin and stable F-actin to spatially restrict Rac activation and reduce formation of multiple membrane protrusions. TAPP2 function in cell migration is also apparent in the more complex context of B cell migration into stromal cell layers - a process that is only partially dependent on PI3K and SDF-1. In summary, this study identified TAPP2 as a novel regulator of malignant B cell migration and a potential therapeutic intervention target.	[Li, Hongzhao; Hou, Sen; Wu, Xun; Lin, Francis; Kung, Sam; Marshall, Aaron James] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Nandagopal, Saravanan; Lin, Francis] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB, Canada; [Marshall, Aaron James] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba	Marshall, AJ (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	marshall@ms.umanitoba.ca		Lin, Francis/0000-0003-1736-193X; Wu, Xun/0000-0001-7549-5464; Andalur Nandagopal, Saravanan/0000-0002-1787-3356; Marshall, Aaron/0000-0002-1175-5498; Pei, Zhen-Ming/0000-0003-1473-696X	Canadian Cancer Society [2011-700981]; Canadian Institutes of Health Research; Manitoba Health Research Council	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council	This research was funded by the Canadian Cancer Society (grant #2011-700981). HL was supported by studentship awards from the Canadian Institutes of Health Research and Manitoba Health Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso PV, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002019; Allam A, 2004, J BIOL CHEM, V279, P39775, DOI 10.1074/jbc.M403367200; Allikian MJ, 2007, TRAFFIC, V8, P177, DOI 10.1111/j.1600-0854.2006.00519.x; Barber Mark A, 2006, Bull Cancer, V93, pE44; Bradstock KF, 2000, LEUKEMIA, V14, P882, DOI 10.1038/sj.leu.2401729; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Burger JA, 2007, BRIT J HAEMATOL, V137, P288, DOI 10.1111/j.1365-2141.2007.06590.x; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Cernuda-Morollon E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012393; Cheung SMS, 2007, CELL SIGNAL, V19, P902, DOI 10.1016/j.cellsig.2006.10.013; Cooper KM, 2008, MOL BIOL CELL, V19, P3180, DOI 10.1091/mbc.E08-02-0225; Costantini JL, 2009, BLOOD; Del Principe MI, 2006, BLOOD, V108, P853, DOI 10.1182/blood-2005-12-4986; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Haenggi T, 2006, CELL MOL LIFE SCI, V63, P1614, DOI 10.1007/s00018-005-5461-0; HENDERSON AJ, 1990, J IMMUNOL, V145, P423; Hogan A, 2004, J BIOL CHEM, V279, P53717, DOI 10.1074/jbc.M410654200; Jiang P, 2009, CANCER LETT, V284, P122, DOI 10.1016/j.canlet.2009.02.034; Konopleva M, 2009, DRUG RESIST UPDATE, V12, P103, DOI 10.1016/j.drup.2009.06.001; Landego I, 2012, EUR J IMMUNOL; Lin F, 2006, LAB CHIP, V6, P1462, DOI 10.1039/b607071j; Marshall AJ, 2002, MOL CELL BIOL, V22, P5479, DOI 10.1128/MCB.22.15.5479-5491.2002; Mehes E, 2005, GLIA, V49, P492, DOI 10.1002/glia.20135; Narang A, 2006, J THEOR BIOL, V240, P538, DOI 10.1016/j.jtbi.2005.10.022; Niedermeier M, 2009, BLOOD, V113, P5549, DOI 10.1182/blood-2008-06-165068; Nishioka T, 2008, MOL BIOL CELL, V19, P4213, DOI 10.1091/mbc.E08-03-0315; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pauls SD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00224; Richardson SJ, 2006, BLOOD, V107, P3584, DOI 10.1182/blood-2005-04-1718; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tai YT, 2003, BLOOD, V101, P2762, DOI 10.1182/blood-2002-09-2813; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Vicente-Manzanares M, 2011, J CELL BIOL, V193, P381, DOI 10.1083/jcb.201012159; Ward SG, 2004, TRENDS IMMUNOL, V25, P67, DOI 10.1016/j.it.2003.12.003; Wong D, 2008, CLIN CANCER RES, V14, P7975, DOI 10.1158/1078-0432.CCR-07-4846; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015; Zhang TT, 2009, IMMUNOL REV, V232, P255, DOI 10.1111/j.1600-065X.2009.00838.x	43	50	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57809	10.1371/journal.pone.0057809	http://dx.doi.org/10.1371/journal.pone.0057809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23460911	gold, Green Submitted, Green Published			2022-12-27	WOS:000315519000166
J	Chan, CM; Chang, HH; Wang, VC; Huang, CL; Hung, CF				Chan, Chi-Ming; Chang, Hsun-Hsien; Wang, Vin-Chi; Huang, Chuen-Lin; Hung, Chi-Feng			Inhibitory Effects of Resveratrol on PDGF-BB-Induced Retinal Pigment Epithelial Cell Migration via PDGFR beta, PI3K/Akt and MAPK pathways	PLOS ONE			English	Article							EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY; EXTRACELLULAR-MATRIX PROTEINS; VASCULAR SMOOTH-MUSCLE; GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; IN-VIVO; (-)-EPIGALLOCATECHIN GALLATE; DIABETIC-RETINOPATHY; ADJUNCTIVE TREATMENT; ARPE19 CELLS	Purpose: In diseases such as proliferative vitreoretinopathy (PVR), proliferative diabetic retinopathy, and age-related macular degeneration, retinal pigment epithelial (RPE) cells proliferate and migrate. Moreover, platelet-derived growth factor (PDGF) has been shown to enhance proliferation and migration of RPE cells in PVR. Even resveratrol can suppress the migration and adhesion of many cell types, its effects on RPE cell migration and adhesion remain unknown. In this study, we investigated the inhibitory effects of resveratrol on RPE cell migration induced by PDGF-BB, an isoform of PDGF, and adhesion to fibronectin, a major ECM component of PVR tissue. Methods: The migration of RPE cells was assessed by an electric cell-substrate impedance sensing migration assay and a Transwell migration assay. A cell viability assay was used to determine the viability of resveratrol treated-cells. The cell adhesion to fibronectin was examined by an adhesion assay. The interactions of resveratrol with PDGF-BB were analyzed by a dot binding assay. The PDGF-BB-induced signaling pathways were determined by western blotting and scratch wound healing assay. Results: Resveratrol inhibited PDGF-BB-induced RPE cell migration in a dose-dependent manner, but showed no effects on ARPE19 cell adhesion to fibronectin. The cell viability assay showed no cytotoxicity of resveratrol on RPE cells and the dot binding assay revealed no direct interactions of resveratrol with PDGF-BB. Inhibitory effects of resveratrol on PDGF-BB-induced platelet-derived growth factor receptor beta (PDGFR beta) and tyrosine phosphorylation and the underlying pathways of PI3K/Akt, ERK and p38 activation were found; however, resveratrol and PDGF-BB showed no effects on PDGFR alpha and JNK activation. Scratch wound healing assay demonstrated resveratrol and the specific inhibitors of PDGFR, PI3K, MEK or p38 suppressed PDGF-BB-induced cell migration. Conclusions: These results indicate that resveratrol is an effective inhibitor of PDGF-BB-induced RPE cell migration via PDGFRb, PI3K/Akt and MAPK pathways, but has no effects on the RPE cell adhesion to fibronectin.	[Chan, Chi-Ming] Cardinal Tien Hosp, Dept Ophthalmol, New Taipei City, Taiwan; [Chan, Chi-Ming; Wang, Vin-Chi; Hung, Chi-Feng] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Chang, Hsun-Hsien; Hung, Chi-Feng] Harvard Univ, Childrens Hosp Informat Program, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol,Med Sch, Boston, MA USA; [Wang, Vin-Chi] Cardinal Tien Hosp, Neurol Ctr, New Taipei City, Taiwan; [Huang, Chuen-Lin] Cardinal Tien Hosp, Med Res Ctr, New Taipei City, Taiwan; [Huang, Chuen-Lin] Natl Def Med Ctr, Dept Physiol & Biophys, Grad Inst Physiol, Taipei, Taiwan	Cardinal Tien Hospital; Fu Jen Catholic University; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Cardinal Tien Hospital; Cardinal Tien Hospital; National Defense Medical Center	Hung, CF (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan.	054317@gmail.com	Hung, Chi-Feng/AAL-4977-2021; Chan, Chi-Ming/GWZ-3612-2022	Hung, Chi-Feng/0000-0003-3478-5451; Troughton, Richard/0000-0001-7484-4036	National Science Council, Taipei, Taiwan [NSC97-2320-B-030-001-MY3]; Cardinal Tien Hospital, Taipei, Taiwan [FU10008]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Cardinal Tien Hospital, Taipei, Taiwan	This work was supported by the research grants from the National Science Council (NSC97-2320-B-030-001-MY3) and from Cardinal Tien Hospital (FU10008), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akiyama H, 2006, J CELL PHYSIOL, V207, P407, DOI 10.1002/jcp.20583; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Campochiaro PA, 1997, ARCH OPHTHALMOL-CHIC, V115, P237, DOI 10.1001/archopht.1997.01100150239014; CAMPOCHIARO PA, 1994, J CELL SCI, V107, P2459; Cao LM, 2010, INVEST OPHTH VIS SCI, V51, P6658, DOI 10.1167/iovs.10-5524; Cardillo JA, 1997, OPHTHALMOLOGY, V104, P1166, DOI 10.1016/S0161-6420(97)30167-5; Chan CM, 2010, MOL VIS, V16, P586; Chan CM, 2009, BIOCHEM BIOPH RES CO, V388, P172, DOI 10.1016/j.bbrc.2009.07.155; Chan CM, 2008, MOL VIS, V14, P2528; CHARTERIS DG, 1995, BRIT J OPHTHALMOL, V79, P953, DOI 10.1136/bjo.79.10.953; Charteris DG, 2002, EYE, V16, P369, DOI 10.1038/sj.eye.6700194; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Cicha I, 2011, J ATHEROSCLER THROMB, V18, P1031, DOI 10.5551/jat.8136; Csiszar A, 2011, ANN NY ACAD SCI, V1215, P117, DOI 10.1111/j.1749-6632.2010.05848.x; de Silva DJ, 2008, BRIT J OPHTHALMOL, V92, P954, DOI 10.1136/bjo.2007.131540; Frombaum M, 2012, BIOCHIMIE, V94, P269, DOI 10.1016/j.biochi.2011.11.001; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; HAMILTON CW, 1982, AM J OPHTHALMOL, V94, P473, DOI 10.1016/0002-9394(82)90241-0; Haugland HK, 1997, ANTICANCER RES, V17, P1035; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hinton DR, 1998, EXP CELL RES, V239, P11, DOI 10.1006/excr.1997.3873; HISCOTT P, 1994, BRIT J OPHTHALMOL, V78, P219, DOI 10.1136/bjo.78.3.219; Ho J, 2011, OPHTHALMOLOGY, V118, P687, DOI 10.1016/j.ophtha.2010.08.010; Hughes AD, 1996, GEN PHARMACOL-VASC S, V27, P1079, DOI 10.1016/S0306-3623(96)00060-2; Ikuno Y, 2000, INVEST OPHTH VIS SCI, V41, P3107; Ikuno Y, 2002, INVEST OPHTH VIS SCI, V43, P2406; Kim Dong Shoo, 2007, Nutr Res Pract, V1, P285, DOI 10.4162/nrp.2007.1.4.285; Kiselev KV, 2011, APPL MICROBIOL BIOT, V90, P417, DOI 10.1007/s00253-011-3184-8; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; Lee MF, 2011, J AGR FOOD CHEM, V59, P11853, DOI 10.1021/jf202426k; Lei HT, 2011, INVEST OPHTH VIS SCI, V52, P5016, DOI 10.1167/iovs.11-7442; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Li XR, 2003, CYTOKINE GROWTH F R, V14, P91, DOI 10.1016/S1359-6101(02)00090-4; Lubbers J, 2011, CELL BIOL TOXICOL, V27, P95, DOI 10.1007/s10565-010-9173-3; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P2001; Ong ET, 2011, TOXICOL APPL PHARM, V256, P198, DOI 10.1016/j.taap.2011.08.013; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Penumathsa SV, 2009, CAN J PHYSIOL PHARM, V87, P275, DOI 10.1139/Y09-013; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Powell RJ, 1996, J VASC SURG, V24, P51, DOI 10.1016/S0741-5214(96)70144-1; Praidou A, 2009, CURR EYE RES, V34, P152, DOI 10.1080/02713680802585920; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3649; Rosenkranz S, 1999, GROWTH FACTORS, V16, P201, DOI 10.3109/08977199909002130; Saishin Y, 2003, INVEST OPHTH VIS SCI, V44, P3656, DOI 10.1167/iovs.02-1143; SCHEIFFARTH OF, 1988, GRAEF ARCH CLIN EXP, V226, P357, DOI 10.1007/BF02172967; Seo MS, 2000, AM J PATHOL, V157, P995, DOI 10.1016/S0002-9440(10)64612-3; SmithThomas L, 1996, CURR EYE RES, V15, P739, DOI 10.3109/02713689609003457; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Szekeres T, 2011, ANN NY ACAD SCI, V1215, P89, DOI 10.1111/j.1749-6632.2010.05864.x; Tang FY, 2008, MOL NUTR FOOD RES, V52, P683, DOI 10.1002/mnfr.200700325; Venkatesan B, 2009, AM J PHYSIOL-HEART C, V297, pH874, DOI 10.1152/ajpheart.00311.2009; VINORES SA, 1995, EXP EYE RES, V60, P607, DOI 10.1016/S0014-4835(05)80003-X; WAGNER M, 1995, CURR EYE RES, V14, P373, DOI 10.3109/02713689508999935; WALTMAN SR, 1978, DIABETES, V27, P85, DOI 10.2337/diabetes.27.2.85; Wang KT, 2011, J AGR FOOD CHEM, V59, P3649, DOI 10.1021/jf104718g; Xianfeng-Huang, 2011, ANTI-CANCER AGENT ME, V11, P479; Yu W, 2012, J CELL BIOCHEM, V113, P752, DOI 10.1002/jcb.23431; Zheng YP, 2003, JPN J OPHTHALMOL, V47, P158, DOI 10.1016/S0021-5155(02)00698-6	64	70	78	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56819	10.1371/journal.pone.0056819	http://dx.doi.org/10.1371/journal.pone.0056819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457620	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700096
J	Caraiani, P; Haven, E				Caraiani, Petre; Haven, Emmanuel			The Role of Recurrence Plots in Characterizing the Output-Unemployment Relationship: An Analysis	PLOS ONE			English	Article							INFLATION; BUSINESS; EXPECTATIONS; DYNAMICS; CYCLES; STATES; RATES	We analyse the output-unemployment relationship using an approach based on cross-recurrence plots and quantitative recurrence analysis. We use post-war period quarterly U. S. data. The results obtained show the emergence of a complex and interesting relationship.	[Caraiani, Petre] Romanian Acad, Inst Econ Forecasting, Bucharest, Romania; [Haven, Emmanuel] Univ Leicester, Sch Management, Leicester, Leics, England; [Haven, Emmanuel] Univ Leicester, Inst Finance, Leicester, Leics, England	Romanian Academy of Sciences; University of Leicester; University of Leicester	Haven, E (corresponding author), Univ Leicester, Sch Management, Leicester, Leics, England.	eh76@le.ac.uk	Caraiani, Petre/A-2963-2009; Haven, E./AAC-2273-2022; Caraiani, Petre/E-9082-2018	Caraiani, Petre/0000-0002-7526-580X; Caraiani, Petre/0000-0002-7526-580X	Sectorial Operational Programme Human Resources Development (SOP HRD); European Social Fund; Romanian Government [SOP HRD/89/1.5/S/62988]	Sectorial Operational Programme Human Resources Development (SOP HRD); European Social Fund(European Social Fund (ESF)); Romanian Government(Romanian Government)	This paper is supported by the Sectorial Operational Programme Human Resources Development (SOP HRD), financed from the European Social Fund and by the Romanian Government under the contract number SOP HRD/89/1.5/S/62988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belaire-Franch J, 2002, PHYSICA D, V171, P249, DOI 10.1016/S0167-2789(02)00625-5; BLANCHARD OJ, 1989, AM ECON REV, V79, P655; Casdagli MC, 1997, PHYSICA D, V108, P12, DOI 10.1016/S0167-2789(97)82003-9; Chen WS, 2011, PHYSICA A, V390, P1332, DOI 10.1016/j.physa.2010.12.020; Clarida R, 1999, J ECON LIT, V37, P1661, DOI 10.1257/jel.37.4.1661; Crowley PM, 2008, EUR PHYS J-SPEC TOP, V164, P67, DOI 10.1140/epjst/e2008-00835-3; CROWLEY P.M., 2007, ANAL VISUALIZATION S; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; EVANS GW, 1989, J APPL ECONOMET, V4, P213, DOI 10.1002/jae.3950040302; FRIEDMAN BM, 1974, REV ECON STAT, V56, P167, DOI 10.2307/1924436; FRIEDMAN M, 1968, AM ECON REV, V58, P1; GORDON RJ, 1984, BROOKINGS PAP ECO AC, P537; Karagianni S, 2011, STUD NONLINEAR DYN E, V15; Lo Cascio I, 2013, MANCH SCH, V81, P226, DOI 10.1111/j.1467-9957.2011.02273.x; Marwan N, 2002, PHYS LETT A, V302, P299, DOI 10.1016/S0375-9601(02)01170-2; MARWAN N, 2003, THESIS U POTSDAM; Marwan N, 2011, INT J BIFURCAT CHAOS, V21, P1003, DOI 10.1142/S0218127411029008; Nalewaik JJ, 2010, BROOKINGS PAP ECO AC, P71; Okun A. M., 1962, P BUS EC STAT SECT A, P98, DOI DOI 10.1016/0167-2231(79)90009-5; Palley TI., 1993, INT REV APPL ECON, V7, P144, DOI DOI 10.1080/758530144; PHELPS ES, 1967, ECONOMICA, V34, P254, DOI 10.2307/2552025; Roberts JM, 1995, J MONEY CREDIT BANK, V27, P975, DOI 10.2307/2077783; Romer CD, 1999, J ECON PERSPECT, V13, P23, DOI 10.1257/jep.13.2.23; ROSE H, 1967, REV ECON STUD, V34, P153, DOI 10.2307/2296806; Rothman PA, 2008, STUD NONLINEAR DYN E, V12; Silvapulle P, 2004, CAN J ECON, V37, P353, DOI 10.1111/j.0008-4085.2004.00006.x; Stock JH, 2003, NBER MACROEC ANN-SER, V17, P159; Swamy PAVB, 2007, ECON THEOR, V31, P293, DOI 10.1007/s00199-006-0100-z; TAKANAMI T, 1991, ANN I STAT MATH, V43, P407, DOI 10.1007/BF00053364; Viren M, 2001, ECON LETT, V70, P253, DOI 10.1016/S0165-1765(00)00370-0; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; WEBER CE, 1995, J APPL ECONOMET, V10, P433, DOI 10.1002/jae.3950100407; Zbilut JP, 2005, NEW ECON WINDOWS, P91, DOI 10.1007/88-470-0344-X_5; ZBILUT JP, 1992, PHYS LETT A, V171, P199, DOI 10.1016/0375-9601(92)90426-M; Zbilut JP, 1998, PHYS LETT A, V246, P122, DOI 10.1016/S0375-9601(98)00457-5	37	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56767	10.1371/journal.pone.0056767	http://dx.doi.org/10.1371/journal.pone.0056767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23483979	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000037
J	Wu, CS; Pedersen, LH; Miller, JE; Sun, YL; Streja, E; Uldall, P; Olsen, J				Wu, Chun S.; Pedersen, Lars H.; Miller, Jessica E.; Sun, Yuelian; Streja, Elani; Uldall, Peter; Olsen, Jorn			Risk of Cerebral Palsy and Childhood Epilepsy Related to Infections before or during Pregnancy	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; MATERNAL GENITOURINARY INFECTION; POPULATION-BASED COHORT; INTRAUTERINE INFECTION; PRENATAL INFECTION; EXPOSURE; SCHIZOPHRENIA; INFLUENZA; WOMEN; BIRTH	Background and Aim: Maternal infections during pregnancy have been associated with several neurological disorders in the offspring. However, given the lack of specificity for both the exposures and the outcomes, other factors related to infection such as impaired maternal immune function may be involved in the causal pathway. If impaired maternal immune function plays a role, we would expect infection before pregnancy to be associated with these neurological outcomes. Methods/Principal Findings: The study population included all first-born singletons in Denmark between January 1 1982 and December 31 2004. We identified women who had hospital-recorded infections within the 5 year period before pregnancy, and women who had hospital-recorded infections during pregnancy. We grouped infections into either infections of the genitourinary system, or any other infections. Cox models were used to estimate adjusted hazard ratios (aHRs) with 95% confidence interval (CI). Maternal infection of the genitourinary system during pregnancy was associated with an increased risk of cerebral palsy (aHR = 1.63, 95% CI: 1.34-1.98) and epilepsy (aHR = 1.27, 95% CI: 1.13-1.42) in the children, compared to children of women without infections during pregnancy. Among women without hospital-recorded infections during pregnancy, maternal infection before pregnancy was associated with an increased risk of epilepsy (aHR = 1.35, 95% CI: 1.21-1.50 for infections of the genitourinary system, and HR = 1.12, 95% CI: 1.03-1.22 for any other infections) and a slightly higher risk of cerebral palsy (aHR = 1.20, 95% CI: 0.96-1.49 for infections of the genitourinary system, and HR = 1.23, 95% CI: 1.06-1.43 for any other infections) in the children, compared to children of women without infections before (and during) pregnancy. Conclusions: These findings indicate that the maternal immune system, maternal infections, or factors related to maternal immune function play a role in the observed associations between maternal infections before pregnancy and cerebral diseases in the offspring.	[Wu, Chun S.; Pedersen, Lars H.; Sun, Yuelian; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Pedersen, Lars H.] Aarhus Univ Hosp, Dept Obstet & Gynecol, Inst Clin Med, DK-8000 Aarhus, Denmark; [Miller, Jessica E.; Streja, Elani; Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Uldall, Peter] Univ Southern Denmark, Natl Inst Publ Hlth, Cerebral Palsy Registry Denmark, Odense, Denmark; [Uldall, Peter] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Paediat Clin, Copenhagen, Denmark	Aarhus University; Aarhus University; University of California System; University of California Los Angeles; University of Southern Denmark; Rigshospitalet; University of Copenhagen	Wu, CS (corresponding author), Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark.	cw@soci.au.dk	Zhang, Youjie/F-7346-2016; Sun, Yuelian/AFF-2622-2022; Olsen, Jørn/F-8801-2015; Yang, Xiaobo/G-3854-2016	Zhang, Youjie/0000-0002-6035-8536; Sun, Yuelian/0000-0002-6905-0503; Olsen, Jørn/0000-0001-7462-5140; mo, zengnan/0000-0002-3047-3138; Miller, Jessica/0000-0002-1806-1894	Danish Medical Research Council (FSS)	Danish Medical Research Council (FSS)(Danish Medical Research Council)	The study was supported by the Danish Medical Research Council (FSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2008, IMMUNOL INVEST, V37, P427, DOI 10.1080/08820130802191599; Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001; Andersen TF, 1999, DAN MED BULL, V46, P263; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Atladottir HO, 2009, PEDIATRICS, V124, P687, DOI 10.1542/peds.2008-2445; Atladottir HO, 2010, ARCH PEDIAT ADOL MED, V164, P470, DOI 10.1001/archpediatrics.2010.9; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Crump C, 2011, NEUROLOGY, V77, P1376, DOI 10.1212/WNL.0b013e318231528f; DEYKIN EY, 1979, AM J EPIDEMIOL, V109, P628, DOI 10.1093/oxfordjournals.aje.a112726; Genc MR, 2011, BJOG-INT J OBSTET GY, V118, P154, DOI 10.1111/j.1471-0528.2010.02772.x; Genc MR, 2007, BEST PRACT RES CL OB, V21, P491, DOI 10.1016/j.bpobgyn.2007.01.009; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Knudsen LB, 1998, DAN MED BULL, V45, P320; Koman LA, 2004, LANCET, V363, P1619, DOI 10.1016/S0140-6736(04)16207-7; Krageloh-Mann I, 2009, BRAIN DEV-JPN, V31, P537, DOI 10.1016/j.braindev.2009.03.009; Libbey JE, 2005, J NEUROVIROL, V11, P1, DOI 10.1080/13550280590900553; Mann JR, 2009, AM J PERINAT, V26, P667, DOI 10.1055/s-0029-1220792; Mann JR, 2009, DEV MED CHILD NEUROL, V51, P282, DOI 10.1111/j.1469-8749.2008.03226.x; McDermott S, 2010, NEUROEPIDEMIOLOGY, V34, P117, DOI 10.1159/000268824; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Miller JE, 2012, PAEDIATR PERINAT EP, V26, P589, DOI 10.1111/j.1365-3016.2012.01317.x; Nelson KB, 2008, CLIN OBSTET GYNECOL, V51, P749, DOI 10.1097/GRF.0b013e318187087c; Nelson KB, 2009, DEV MED CHILD NEUROL, V51, P253, DOI 10.1111/j.1469-8749.2008.03256.x; Norgaard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030850; Norgaard M, 2011, AM J EPIDEMIOL, V174, P945, DOI 10.1093/aje/kwr201; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Silva MJPMD, 2011, BRAZ J INFECT DIS, V15, P533, DOI 10.1590/S1413-86702011000600006; Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068; Schendel D E, 2001, J Am Med Womens Assoc (1972), V56, P105; Sun Y, 2008, PEDIATRICS, V121, pE1100, DOI 10.1542/peds.2007-2316; Sun YL, 2011, PAEDIATR PERINAT EP, V25, P53, DOI 10.1111/j.1365-3016.2010.01143.x; Takei N, 1996, BIOL PSYCHIAT, V40, P817, DOI 10.1016/0006-3223(95)00592-7; Uldall P, 2001, DAN MED BULL, V48, P161; VanderWeele TJ, 2012, EPIDEMIOLOGY, V23, P1, DOI 10.1097/EDE.0b013e31823aca5d; Westergaard T, 1999, ARCH GEN PSYCHIAT, V56, P993, DOI 10.1001/archpsyc.56.11.993; Wilcox AJ, 2011, AM J EPIDEMIOL, V174, P1062, DOI 10.1093/aje/kwr230; Yoon BH, 2003, BJOG-INT J OBSTET GY, V110, P124, DOI 10.1016/S1470-0328(03)00063-6; Zanardo V, 2010, OBSTET GYNECOL, V116, P1454, DOI 10.1097/AOG.0b013e3181fd343a	42	24	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57552	10.1371/journal.pone.0057552	http://dx.doi.org/10.1371/journal.pone.0057552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23967188	gold, Green Published			2022-12-27	WOS:000315519000128
J	Yu, CC; Huang, SP; Lee, YC; Huang, CY; Liu, CC; Hour, TC; Huang, CN; You, BJ; Chang, TY; Huang, CH; Bao, BY				Yu, Chia-Cheng; Huang, Shu-Pin; Lee, Yung-Chin; Huang, Chao-Yuan; Liu, Chia-Chu; Hour, Tzyh-Chyuan; Huang, Chun-Nung; You, Bang-Jau; Chang, Ta-Yuan; Huang, Chun-Hsiung; Bao, Bo-Ying			Molecular Markers in Sex Hormone Pathway Genes Associated with the Efficacy of Androgen-Deprivation Therapy for Prostate Cancer	PLOS ONE			English	Article							CAG REPEAT LENGTH; RECEPTOR GENE; ENDOCRINE-THERAPY; ANTIGEN NADIR; SURVIVAL; POLYMORPHISMS; TESTOSTERONE; LEVEL; RISK; TIME	Although most advanced prostate cancer patients respond to androgen-deprivation therapy (ADT), the efficacy is widely variable. We investigated whether the host genetic variations in sex hormone pathway genes are associated with the efficacy of ADT. A cohort of 645 patients with advanced prostate cancer treated with ADT was genotyped for 18 polymorphisms across 12 key genes involved in androgen and estrogen metabolism. We found that after adjusting for known risk factors in multivariate Cox regression models, AKR1C3 rs12529 and AR-CAG repeat length remained significantly associated with prostate cancer-specific mortality (PCSM) after ADT (P <= 0.041). Furthermore, individuals carrying two unfavorable genotypes at these loci presented a 13.7-fold increased risk of PCSM compared with individuals carrying zero (P<0.001). Our results identify two candidate molecular markers in key genes of androgen and estrogen pathways associated with PCSM after ADT, establishing the role of pharmacogenomics in this therapy.	[Yu, Chia-Cheng] Kaohsiung Vet Gen Hosp, Div Urol, Dept Surg, Kaohsiung, Taiwan; [Yu, Chia-Cheng] Tajen Univ, Dept Pharm, Pingtung, Taiwan; [Yu, Chia-Cheng] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Shu-Pin; Lee, Yung-Chin; Liu, Chia-Chu; Huang, Chun-Nung; Huang, Chun-Hsiung] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Huang, Shu-Pin; Lee, Yung-Chin; Liu, Chia-Chu; Huang, Chun-Nung; Huang, Chun-Hsiung] Kaohsiung Med Univ, Dept Urol, Fac Med, Coll Med, Kaohsiung, Taiwan; [Huang, Shu-Pin] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ, Dept Urol, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan; [Hour, Tzyh-Chyuan] Kaohsiung Med Univ, Inst Biochem, Kaohsiung, Taiwan; [You, Bang-Jau] China Med Univ, Dept Chinese Med Resources, Taichung, Taiwan; [Chang, Ta-Yuan] China Med Univ, Dept Occupat Safety & Hlth, Taichung, Taiwan; [Bao, Bo-Ying] China Med Univ, Dept Pharm, Taichung, Taiwan; [Bao, Bo-Ying] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Bao, BY (corresponding author), China Med Univ, Dept Pharm, Taichung, Taiwan.	bao@mail.cmu.edu.tw	Chang, Ta-Yuan/P-3126-2015; LIU, CHIA CHU/T-2880-2019; Bao, Bo-Ying/D-1789-2012; Bao, Bo-Ying/H-4589-2019	Chang, Ta-Yuan/0000-0001-5664-4559; Bao, Bo-Ying/0000-0001-5510-6513; Bao, Bo-Ying/0000-0001-5510-6513; CHOW, LU-PING/0000-0002-4420-211X; LIN, CHUNG-WU/0000-0001-5042-0503; HUANG, CHAO-YUAN/0000-0002-9322-6062; YANG, JYH-CHIN/0000-0003-4219-0685; Wu, Ming-Shiang/0000-0002-1940-6428; Yu, Cheng-Ping/0000-0002-0693-5056; Ho, Jar-Yi/0000-0001-6933-041X	National Science Council (NSC), Taiwan [NSC-98-2320-B-039-019-MY3, NSC-100-2314-B-039-009-MY3]; China Medical University [CMU98-N1-21, CMU98-C-12]; Kaohsiung Medical University Hospital [KMUH100-0R42]; Kaohsiung Veterans General Hospital [VGHKS97-048, VGHKS101-112]	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Kaohsiung Medical University Hospital; Kaohsiung Veterans General Hospital	This work was supported by the National Science Council (NSC), Taiwan (grant numbers: NSC-98-2320-B-039-019-MY3 and NSC-100-2314-B-039-009-MY3), China Medical University (grant number: CMU98-N1-21 and CMU98-C-12), Kaohsiung Medical University Hospital (grant number: KMUH100-0R42), and Kaohsiung Veterans General Hospital (grant number: VGHKS97-048 and VGHKS101-112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab M, 2006, AM J CLIN ONCOL-CANC, V29, P14, DOI 10.1097/01.coc.0000195085.34162.88; Bao BY, 2012, INT J CANCER, V130, P876, DOI 10.1002/ijc.26091; Bao BY, 2011, CLIN CANCER RES, V17, P928, DOI 10.1158/1078-0432.CCR-10-2648; Bratt O, 1999, BRIT J CANCER, V81, P672, DOI 10.1038/sj.bjc.6690746; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Choueiri TK, 2009, CANCER, V115, P981, DOI 10.1002/cncr.24064; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; Edwards SM, 1999, INT J CANCER, V84, P458, DOI 10.1002/(SICI)1097-0215(19991022)84:5<458::AID-IJC2>3.0.CO;2-Y; Figueroa JD, 2008, CARCINOGENESIS, V29, P1955, DOI 10.1093/carcin/bgn163; GELLER J, 1984, J UROLOGY, V132, P693, DOI 10.1016/S0022-5347(17)49829-6; Gregory CW, 2001, CANCER RES, V61, P4315; Hakimi JM, 1997, CLIN CANCER RES, V3, P1599; Hardy DO, 1996, J CLIN ENDOCR METAB, V81, P4400, DOI 10.1210/jc.81.12.4400; Huang CN, 2012, J INTERN MED, V271, P499, DOI 10.1111/j.1365-2796.2011.02449.x; Huang CN, 2012, ANN ONCOL, V23, P707, DOI 10.1093/annonc/mdr264; Huang SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041219; Hussain M, 2006, J CLIN ONCOL, V24, P3984, DOI 10.1200/JCO.2006.06.4246; Imamoto T, 2001, ENDOCR J, V48, P573, DOI 10.1507/endocrj.48.573; Klotz L, 2005, PROSTATE CANCER P D, V8, P179, DOI 10.1038/sj.pcan.4500792; Kwak C, 2002, J UROLOGY, V168, P995, DOI 10.1016/S0022-5347(05)64559-4; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Lin HK, 1997, MOL ENDOCRINOL, V11, P1971, DOI 10.1210/me.11.13.1971; Lindstrom S, 2006, PROSTATE, V66, P1729, DOI 10.1002/pros.20489; Misra D, 2011, BJU INT, V108, P1086, DOI 10.1111/j.1464-410X.2010.10037.x; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Palmberg C, 2000, J UROLOGY, V164, P1992, DOI 10.1016/S0022-5347(05)66935-2; Pao JB, 2013, WORLD J UROL, V31, P281, DOI 10.1007/s00345-011-0813-x; Penning TM, 2008, MOL CELL ENDOCRINOL, V281, P1, DOI 10.1016/j.mce.2007.10.008; Pfeiffer MJ, 2011, MOL MED, V17, P657, DOI 10.2119/molmed.2010.00143; Ross RW, 2008, J CLIN ONCOL, V26, P842, DOI 10.1200/JCO.2007.13.6804; Shimbo M, 2005, EUR UROL, V47, P557, DOI 10.1016/j.eururo.2004.10.016; Sircar K, 2007, PROSTATE CANCER P D, V10, P360, DOI 10.1038/sj.pcan.4500967; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Stewart AJ, 2005, J CLIN ONCOL, V23, P6556, DOI 10.1200/JCO.2005.20.966; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suzuki H, 2002, PROSTATE, V51, P219, DOI 10.1002/pros.10080; Takeda H, 1996, CANCER, V77, P934, DOI 10.1002/(SICI)1097-0142(19960301)77:5<934::AID-CNCR20>3.3.CO;2-Q; Taplin ME, 1999, CANCER RES, V59, P2511; VANDERKWAST TH, 1991, INT J CANCER, V48, P189, DOI 10.1002/ijc.2910480206; Yang M, 2011, J CLIN ONCOL, V29, P2565, DOI 10.1200/JCO.2010.31.2405; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1	42	149	150	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54627	10.1371/journal.pone.0054627	http://dx.doi.org/10.1371/journal.pone.0054627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23460808	Green Submitted, gold, Green Published			2022-12-27	WOS:000314023600080
J	Liu, JY				Liu, J. Y.			Status of Marine Biodiversity of the China Seas	PLOS ONE			English	Review								China's seas cover nearly 5 million square kilometers extending from the tropical to the temperate climate zones and bordering on 32,000 km of coastline, including islands. Comprehensive systematic study of the marine biodiversity within this region began in the early 1950s with the establishment of the Qingdao Marine Biological Laboratory of the Chinese Academy of Sciences. Since that time scientists have carried out intensive multidisciplinary research on marine life in the China seas and have recorded 22,629 species belonging to 46 phyla. The marine flora and fauna of the China seas are characterized by high biodiversity, including tropical and subtropical elements of the Indo-West Pacific warm-water fauna in the South and East China seas, and temperate elements of North Pacific temperate fauna mainly in the Yellow Sea. The southern South China Sea fauna is characterized by typical tropical elements paralleled with the Philippine-New Guinea-Indonesia Coral triangle typical tropical faunal center. This paper summarizes advances in studies of marine biodiversity in China's seas and discusses current research mainly on characteristics and changes in marine biodiversity, including the monitoring, assessment, and conservation of endangered species and particularly the strengthening of effective management. Studies of (1) a tidal flat in a semi-enclosed embayment, (2) the impact of global climate change on a cold-water ecosystem, (3) coral reefs of Hainan Island and Xisha-Nansha atolls, (4) mangrove forests of the South China Sea, (5) a threatened seagrass field, and (6) an example of stock enhancement practices of the Chinese shrimp fishery are briefly introduced. Besides the overexploitation of living resources (more than 12.4 million tons yielded in 2007), the major threat to the biodiversity of the China seas is environmental deterioration (pollution, coastal construction), particularly in the brackish waters of estuarine environments, which are characterized by high productivity and represent spawning and nursery areas for several economically important species. In the long term, climate change is also a major threat. Finally, challenges in marine biodiversity studies are briefly discussed along with suggestions to strengthen the field. Since 2004, China has participated in the Census of Marine Life, through which advances in the study of zooplankton and zoobenthos biodiversity were finally summarized.	Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Liu, JY (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	pmilos@usb.ve		Pedrosa Domellof, Fatima/0000-0002-0648-4996	External Cooperation Program of the Chinese Academy of Sciences [GJHZ200808]; Main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences [KZCX2-YW-417, KSCX2-EW-Z-5]; Special funds for science infrastructure of the Ministry of Science and Technology of the People's Republic of China [2006FY110500-4]; Alfred P. Sloan Foundation	External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Special funds for science infrastructure of the Ministry of Science and Technology of the People's Republic of China; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Dr. Liu received funding for this study from the following organizations: The External Cooperation Program of the Chinese Academy of Sciences (GJHZ200808); Main Direction Program of Knowledge Innovation of the Chinese Academy of Sciences (KZCX2-YW-417), (KSCX2-EW-Z-5); Special funds for science infrastructure of the Ministry of Science and Technology of the People's Republic of China (2006FY110500-4); and The Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, DIVERSITY SPECIES XI; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Bureau of Fisheries Ministry of Agriculture of China, 2007, CHIN FISH STAT YB; Bureau of Fisheries Ministry of Agriculture of China, 2009, CHIN FISH STAT YB; Chen Q, 2003, LATIN CHINESE NAMES; Cheng J, 2003, LIVING RESOURCES OCE; Department of Marine Geology Institute of Oceanology Chinese Academy of Sciences, 1982, GEOL YELL E CHIN SEA; Fang J, 1996, MAR FISH RES, V17, P95; FUJIAN Marine Environment and Fishery Resources Monitor Center, 2010, MAR BIOD SURV REP QU; Guan BX, 2006, J OCEANOGR, V62, P1, DOI 10.1007/s10872-006-0028-8; Gurjanova E. F., 1958, Bull Inst mar Biol Peking, V1, P1; Huang X, 2007, STUDY SEAGRASS S CHI; HUANG Z, 1994, MARINE SPECIES THEIR; Huang Z. G, 2004, BIODIVERSITY MARINE; Jia X, 2004, FISHERY ECOLOGICAL E; Jin X, 2005, LIVING RESOURCES HAB; Lee YC, 1998, YELLOW SEA ATLAS; Li G, 2004, MARINE ECOLOGY; Li J. J., 2011, J ZHEJIANG OCEAN U N, V30, P381; Liao K., 1999, NATL PHYS ATLAS CHIN; Lin AK, 2008, SATELLITE REMOTE SEN; LIN P, 1999, MANGROVE ECOSYSTEM C; Liu R, 1983, P INT S SED CONT SHE; Liu R, 1991, P 2 INT S MAR SCI YE, P240; Liu R, 2006, J MARINE SCI BIOTECH, V1, P40; Liu R, 1998, P EUR AS WORKSH INV, P351; Liu R. Y., 1963, OCEANOLOGIA LIMNOLOG, V5, P306; Liu R.Y., 1992, ECOLOGY LIVING RESOU, P2; Liu RuiYu, 2011, Biodiversity Science, V19, P614, DOI 10.3724/SP.J.1003.2011.13185; Liu Ruiyu, 2007, P103; Liu RY., 2008, CHECKLIST MARINE BIO; Ng PKL, 2000, RAFFLES B ZOOL, P3; Ning X, 2002, RES EVALUATION AQUAC; Qi Y, 2003, RED TIDES CHINESE CO; SHAW PT, 1994, DEEP-SEA RES PT I, V41, P1663, DOI 10.1016/0967-0637(94)90067-1; Song Haitang, 2003, ACTA OCEANOLOGICA S, V1, P8; Song Haitang, 2006, EC SHRIMP CRAB SPECI, P1; Sun S, 2007, P WORKSH BIOD MARG S, P97; Tang Q, 2006, MARINE BIOL RESOURCE; Ushakov PV, 1955, VESTN AN SSSR+, V56, P14; WANG S., 2005, CHINA SPECIES RED LI, VIII; Wang S, 2009, CHINA SPECIES RED A, V2; Wang S, 1999, CHINA RED DATA BOOK; Wang S, 2009, CHINA SPECIES RED B, V2; Wang S, 2004, CHINA SPECIES RED LI, VI; Wang WQ, 2007, MANGROVES CHINA; WANG Y, 1987, CONT SHELF RES, V7, P329, DOI 10.1016/0278-4343(87)90104-X; Wang Y. S. J., 2012, OCEANOGRAPHY CHINA; Xu G.Z., 1989, ENV RESOURCES DAYA B; Yu Cun-gen, 2009, Marine Fisheries, V31, P27; Yue P. Q., 1998, CHINA RED DATA BOOK; Zhang S., 2007, ECOLOGICAL ENV BIORE; Zheng Q.N., 2006, J GEOPHYS RES OCEANS, V111; Zheng T, 1982, GEOLOGY HUANGHAI DON, P198; Zheng Y., 2003, BIOL RESOURCES ENV E; Zhong Zhenru, 1986, MARINE FIEHERIES, V3, P99; ZHOU D, 1994, OCEANOLOGY CHINA SEA; Zhou M, 2012, OCEANOGRAPHY CHINA; Zhou MJ, 2008, CONT SHELF RES, V28, P1483, DOI 10.1016/j.csr.2007.02.009; Zhuang Q, 1984, STUDIA MARINA SINICA, V22, P79; Zhuang Q., 1981, OCEANOLOGIA LIMNOLOG, V12, P341; Zou R, 1966, OCEANOLOGIA LIMNOLOG, V2, P153; Zuo T., 2003, COMMUNITY STRUCTURE	63	232	256	27	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e50719	10.1371/journal.pone.0050719	http://dx.doi.org/10.1371/journal.pone.0050719			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23468993	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800005
J	Wang, H; Chen, K; Pan, YF; Jing, FY; Liu, H				Wang, Hui; Chen, Kun; Pan, Yifeng; Jing, Fangyuan; Liu, He			Associations and Impact Factors between Living Arrangements and Functional Disability among Older Chinese Adults	PLOS ONE			English	Article							SOCIAL SUPPORT; MARITAL-STATUS; DEPRESSIVE SYMPTOMS; HEALTH-STATUS; MORTALITY; GENDER; INTEGRATION; PREDICTORS; CANCER; STAGE	Objectives: To examine the association of living arrangements with functional disability among older persons and explore the mediation of impact factors on the relationship. Design: Cross-sectional analysis using data from Healthy Aging study in Zhejiang Province. Participants: Analyzed sample was drawn from a representative rural population of older persons in Wuyi County, Zhejiang Province, including 1542 participants aged 60 and over in the second wave of the study. Measurements: Living arrangements, background, functional disability, self-rated health, number of diseases, along with contemporaneous circumstances including income, social support (physical assistance and emotional support). Instrument was Activities of Daily Living (ADL) scale, including Basic Activities Daily Living (BADL) and Instrumental Activities of Daily Living (IADL). Results: Living arrangements were significantly associated with BADL, IADL and ADL disability. Married persons living with or without children were more advantaged on all three dimensions of functional disability. Unmarried older adults living with children only had the worst functional status, even after controlling for background, social support, income and health status variables (compared with the unmarried living alone, beta for BADL: -1.262, beta for IADL: -2.112, beta for ADL: -3.388; compared with the married living with children only, beta for BADL: -1.166, beta for IADL: -2.723, beta for ADL: -3.902). In addition, older adults without difficulty in receiving emotional support, in excellent health and with advanced age had significantly better BADL, IADL and ADL function. However, a statistically significant association between physical assistance and functional disability was not found. Conclusion: Functional disabilities vary by living arrangements with different patterns and other factors. Our results highlight the association of unmarried elders living with children only and functioning decline comparing with other types. Our study implies policy makers should pay closer attention to unmarried elders living with children in community. Community service especially emotional support such as psychological counseling is important social support and should be improved.	[Wang, Hui; Chen, Kun; Pan, Yifeng; Jing, Fangyuan; Liu, He] Zhejiang Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hui] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Provincial Center for Disease Control & Prevention	Chen, K (corresponding author), Zhejiang Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	ck@zju.edu.cn	wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022	YANG, CHIEN-MING/0000-0001-8144-8496; wang, huaizhou/0000-0002-4126-100X	Zhejiang Research Center on Aging	Zhejiang Research Center on Aging	The source of funding that has supported our research is from Zhejiang Research Center on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWIN DF, 1985, J MARRIAGE FAM, V47, P319, DOI 10.2307/352132; AUSLANDER GK, 1991, J AGING HEALTH, V3, P493, DOI [DOI 10.1177/089826439100300404, DOI 10.1177/089826439100.300404]; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Beydoun MA, 2005, SOC SCI MED, V60, P2045, DOI 10.1016/j.socscimed.2004.08.063; BLAZER DG, 1982, AM J EPIDEMIOL, V115, P684, DOI 10.1093/oxfordjournals.aje.a113351; BROADHEAD WE, 1983, AM J EPIDEMIOL, V117, P521, DOI 10.1093/oxfordjournals.aje.a113575; Chen FN, 2008, J FAM ISSUES, V29, P1379, DOI 10.1177/0192513X07313602; Cheng Ching-Yu, 2006, J Gerontol Nurs, V32, P16, DOI 10.3928/00989134-20060901-05; Cheng CY, 2006, J GERONTOLOGICAL NUR, V9, P24; Chou KL, 2006, AGING MENT HEALTH, V10, P583, DOI 10.1080/13607860600641150; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Davis MA, 1997, AM J PUBLIC HEALTH, V87, P371, DOI 10.2105/AJPH.87.3.371; Denton M, 1999, SOC SCI MED, V48, P1221, DOI 10.1016/S0277-9536(98)00421-3; GOODWIN JS, 1987, JAMA-J AM MED ASSOC, V258, P3125, DOI 10.1001/jama.258.21.3125; GRIMBY G, 1988, SCAND J REHABIL MED, V20, P93; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; House JS, 1981, WORK STRESS SOCIAL S; HUGHES M, 1981, AM J SOCIOL, V87, P48, DOI 10.1086/227419; Hughes ME, 2002, J SOCIOL, V87, P48; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; Hupcey JE, 1998, J ADV NURS, V27, P1231, DOI 10.1046/j.1365-2648.1998.01231.x; Jefferson AL, 2008, AM J GERIAT PSYCHIAT, V16, P375, DOI 10.1097/JGP.0b013e318162f197; JOUNG IMA, 1994, INT J EPIDEMIOL, V23, P91, DOI 10.1093/ije/23.1.91; Kharicha K, 2007, BRIT J GEN PRACT, V57, P271; Knodel J, 2002, PATTERNS DETERMINANT, P143; Koskinen S, 2007, INT J EPIDEMIOL, V36, P1255, DOI 10.1093/ije/dym212; LAWTON MP, 1984, RES AGING, V6, P323, DOI 10.1177/0164027584006003002; Lawton MP, 1976, HDB PSYCHOL AGING; Lennartsson C, 1999, RES AGING, V21, P657, DOI 10.1177/0164027599215002; Li LW, 2009, SOC SCI MED, V68, P220, DOI 10.1016/j.socscimed.2008.10.013; Litwin H, 2012, J AGING HEALTH, V24, P846, DOI 10.1177/0898264312436714; Lund R, 2002, SOC SCI MED, V55, P673, DOI 10.1016/S0277-9536(01)00219-2; Macran S, 1996, SOC SCI MED, V42, P1203, DOI 10.1016/0277-9536(95)00432-7; MOEN P, 1989, AM SOCIOL REV, V54, P635, DOI 10.2307/2095884; Mor-Barak M E, 1991, J Appl Gerontol, V10, P293, DOI 10.1177/073346489101000305; MORITZ DJ, 1993, J CLIN EPIDEMIOL, V46, P443, DOI 10.1016/0895-4356(93)90021-R; Russell D, 2009, J GERONTOL B-PSYCHOL, V64, P95, DOI 10.1093/geronb/gbn002; Sarwari AR, 1998, AM J EPIDEMIOL, V147, P370; Sereny M, 2011, RES AGING, V33, P172, DOI 10.1177/0164027510392387; Shin JK, 2008, PSYCHIAT INVEST, V5, P155, DOI 10.4306/pi.2008.5.3.155; Taylor MG, 2004, J GERONTOL B-PSYCHOL, V59, pS238, DOI 10.1093/geronb/59.4.S238; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Vanderhorst RK, 2005, AGING MENT HEALTH, V9, P517, DOI 10.1080/13607860500193062; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Waite LJ, 1999, J GERONTOL B-PSYCHOL, V54, pS136, DOI 10.1093/geronb/54B.3.S136; Wang JJ, 2001, INT J NURS STUD, V38, P339, DOI 10.1016/S0020-7489(00)00072-9; Wong YS, 2009, J CROSS-CULT GERONTO, V24, P209, DOI 10.1007/s10823-008-9081-7; Wu Z, 2008, SPRINGER SERIES DEMO, V20, P197; Yeh SCJ, 2004, SOC BEHAV PERSONAL, V32, P129, DOI 10.2224/sbp.2004.32.2.129; You KS, 2009, ARCH PSYCHIAT NURS, V23, P309, DOI 10.1016/j.apnu.2008.07.003; Zhang H, 2004, FILIAL PIETY PRACTIC, P63; Zunzunegui MV, 2001, INT J EPIDEMIOL, V30, P1090, DOI 10.1093/ije/30.5.1090; Zyzanski S J, 1989, Fam Med, V21, P199	54	90	99	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53879	10.1371/journal.pone.0053879	http://dx.doi.org/10.1371/journal.pone.0053879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23843989	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400094
J	Liu, AH; Gao, F; Kanno, Y; Jordan, MC; Kamiya, Y; Seo, M; Ayele, BT				Liu, Aihua; Gao, Feng; Kanno, Yuri; Jordan, Mark C.; Kamiya, Yuji; Seo, Mitsunori; Ayele, Belay T.			Regulation of Wheat Seed Dormancy by After-Ripening Is Mediated by Specific Transcriptional Switches That Induce Changes in Seed Hormone Metabolism and Signaling	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA SEEDS; ACTIVATED PROTEIN-KINASES; ABSCISIC-ACID; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; GIBBERELLIN METABOLISM; CONJUGATE HYDROLASES; FLORAL DEVELOPMENT; JASMONIC ACID; CROSS-TALK	Treatments that promote dormancy release are often correlated with changes in seed hormone content and/or sensitivity. To understand the molecular mechanisms underlying the role of after-ripening (seed dry storage) in triggering hormone related changes and dormancy decay in wheat (Triticum aestivum), temporal expression patterns of genes related to abscisic acid (ABA), gibberellin (GA), jasmonate and indole acetic acid (IAA) metabolism and signaling, and levels of the respective hormones were examined in dormant and after-ripened seeds in both dry and imbibed states. After-ripening mediated developmental switch from dormancy to germination appears to be associated with declines in seed sensitivity to ABA and IAA, which are mediated by transcriptional repressions of PROTEIN PHOSPHATASE 2C, SNF1-RELATED PROTEIN KINASE2, ABA INSENSITIVE5 and LIPID PHOSPHATE PHOSPHTASE2, and AUXIN RESPONSE FACTOR and RELATED TO UBIQUITIN1 genes. Transcriptomic analysis of wheat seed responsiveness to ABA suggests that ABA inhibits the germination of wheat seeds partly by repressing the transcription of genes related to chromatin assembly and cell wall modification, and activating that of GA catabolic genes. After-ripening induced seed dormancy decay in wheat is also associated with the modulation of seed IAA and jasmonate contents. Transcriptional control of members of the ALLENE OXIDE SYNTHASE, 3-KETOACYL COENZYME A THIOLASE, LIPOXYGENASE and 12-OXOPHYTODIENOATE REDUCTASE gene families appears to regulate seed jasmonate levels. Changes in the expression of GA biosynthesis genes, GA 20-OXIDASE and GA 3-OXIDASE, in response to after-ripening implicate this hormone in enhancing dormancy release and germination. These findings have important implications in the dissection of molecular mechanisms underlying regulation of seed dormancy in cereals.	[Liu, Aihua; Gao, Feng; Ayele, Belay T.] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Jordan, Mark C.] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada; [Kanno, Yuri; Kamiya, Yuji; Seo, Mitsunori] RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan	University of Manitoba; Agriculture & Agri Food Canada; RIKEN	Ayele, BT (corresponding author), Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada.	b_ayele@umanitoba.ca	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada to BTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YQ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-105; Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Ayele BT, 2012, J PLANT GROWTH REGUL, V31, P235, DOI 10.1007/s00344-011-9234-8; Barrero JM, 2012, NEW PHYTOL, V193, P376, DOI 10.1111/j.1469-8137.2011.03938.x; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; BERESTETZKY V, 1991, BIOCHEM PHYSIOL PFL, V187, P13, DOI 10.1016/S0015-3796(11)80178-2; Berger S, 1996, PLANT PHYSIOL, V111, P525, DOI 10.1104/pp.111.2.525; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BIALEK K, 1989, PLANT PHYSIOL, V91, P775, DOI 10.1104/pp.91.2.775; BIALEK K, 1992, PLANT PHYSIOL, V100, P509, DOI 10.1104/pp.100.1.509; BIALEK K, 1992, PLANT PHYSIOL, V100, P2002, DOI 10.1104/pp.100.4.2002; Blazejczyk M, 2007, FLEXARRAY VERSION 1; Brady SM, 2003, PLANT J, V34, P67, DOI 10.1046/j.1365-313X.2003.01707.x; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; Chen KG, 2010, ACTA PHYSIOL PLANT, V32, P789, DOI 10.1007/s11738-010-0464-3; Chibani K, 2006, PLANT PHYSIOL, V142, P1493, DOI 10.1104/pp.106.087452; Chono M, 2006, J EXP BOT, V57, P2421, DOI 10.1093/jxb/erj215; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Gao F, 2012, PLANT BIOTECHNOL J, V10, P465, DOI 10.1111/j.1467-7652.2012.00682.x; Gomez-Cadenas A, 1999, P NATL ACAD SCI USA, V96, P1767, DOI 10.1073/pnas.96.4.1767; Gubler F, 2005, CURR OPIN PLANT BIOL, V8, P183, DOI 10.1016/j.pbi.2005.01.011; Gubler F, 2008, PLANT PHYSIOL, V147, P886, DOI 10.1104/pp.107.115469; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Henderson JT, 2004, PLANT PHYSIOL, V134, P995, DOI 10.1104/pp.103.030148; HILHORST HWM, 1995, SEED SCI RES, V5, P61, DOI 10.1017/S0960258500002634; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Jacobsen JV, 2002, PHYSIOL PLANTARUM, V115, P428, DOI 10.1034/j.1399-3054.2002.1150313.x; JACOBSEN SE, 1993, PLANT CELL, V5, P887, DOI 10.1105/tpc.5.8.887; Jones HD, 1997, PLANT J, V12, P911, DOI 10.1046/j.1365-313X.1997.12040911.x; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Kanno Y, 2010, PLANT CELL PHYSIOL, V51, P1988, DOI 10.1093/pcp/pcq158; Katagiri T, 2005, PLANT J, V43, P107, DOI 10.1111/j.1365-313X.2005.02431.x; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kermode AR, 2005, J PLANT GROWTH REGUL, V24, P319, DOI 10.1007/s00344-005-0110-2; Kline KG, 2010, PLANT PHYSIOL, V154, P479, DOI 10.1104/pp.110.160846; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Lackman P, 2011, P NATL ACAD SCI USA, V108, P5891, DOI 10.1073/pnas.1103010108; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; Li CJ, 2012, PLANT CELL ENVIRON, V35, P952, DOI 10.1111/j.1365-3040.2011.02464.x; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; LIU YQ, 1994, PLANTA, V194, P368, DOI 10.1007/BF00197537; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; MCCARTY DR, 1989, PLANT CELL, V1, P523, DOI 10.1105/tpc.1.5.523; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; McKibbin RS, 2002, P NATL ACAD SCI USA, V99, P10203, DOI 10.1073/pnas.152318599; MORRIS CF, 1989, PLANT PHYSIOL, V90, P643, DOI 10.1104/pp.90.2.643; Nag R, 2005, PLANT MOL BIOL, V59, P821, DOI 10.1007/s11103-005-1387-z; Nakamura S, 2001, J EXP BOT, V52, P875, DOI 10.1093/jexbot/52.357.875; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Nambara E, 2010, SEED SCI RES, V20, P55, DOI 10.1017/S0960258510000012; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Penfield S, 2006, CURR BIOL, V16, P2366, DOI 10.1016/j.cub.2006.10.057; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Preston J, 2009, PLANT CELL PHYSIOL, V50, P1786, DOI 10.1093/pcp/pcp121; Rampey RA, 2004, PLANT PHYSIOL, V135, P978, DOI 10.1104/pp.104.039677; Rikiishi K, 2010, J CEREAL SCI, V51, P292, DOI 10.1016/j.jcs.2010.01.003; ROUSSELIN P, 1992, THEOR APPL GENET, V85, P213, DOI 10.1007/BF00222862; Saavedra L, 2009, PLANT CELL PHYSIOL, V50, P595, DOI 10.1093/pcp/pcp018; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Seo M, 2006, PLANT J, V48, P354, DOI 10.1111/j.1365-313X.2006.02881.x; Simpson G. M., 1990, SEED DORMANCY GRASSE; Steber CM, 1998, GENETICS, V149, P509; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Tanaka M, 2008, PLANT PHYSIOL, V146, P149, DOI 10.1104/pp.107.111674; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Townley-Smith TF, 2008, CAN J PLANT SCI, V88, P347, DOI 10.4141/CJPS07004; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Rodriguez MV, 2009, ANN BOT-LONDON, V104, P975, DOI 10.1093/aob/mcp184; WALKERSIMMONS M, 1987, PLANT PHYSIOL, V84, P61, DOI 10.1104/pp.84.1.61; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yao Z, 2012, J PLANT PHYSIOL, V169, P1477, DOI 10.1016/j.jplph.2012.06.001; Yildiz K, 2007, ASIAN J CHEM, V19, P1098; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705	104	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56570	10.1371/journal.pone.0056570	http://dx.doi.org/10.1371/journal.pone.0056570			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23468976	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200108
J	Liu, EK; Yan, CR; Mei, XR; Zhang, YQ; Fan, TL				Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing; Fan, Tinglu			Long-Term Effect of Manure and Fertilizer on Soil Organic Carbon Pools in Dryland Farming in Northwest China	PLOS ONE			English	Article							DIFFERENT CROPPING SYSTEMS; SEQUESTRATION RATES; DEPTH DISTRIBUTION; LOESS PLATEAU; MATTER; TILLAGE; MANAGEMENT; FRACTIONS; DYNAMICS; QUALITY	An understanding of the dynamics of soil organic carbon (SOC) as affected by farming practices is imperative for maintaining soil productivity and mitigating global warming. The objectives of this study were to investigate the effects of long-term fertilization on SOC and SOC fractions for the whole soil profile (0-100 cm) in northwest China. The study was initiated in 1979 in Gansu, China and included six treatments: unfertilized control (CK), nitrogen fertilizer (N), nitrogen and phosphorus (P) fertilizers (NP), straw plus N and P fertilizers (NP+S), farmyard manure (FYM), and farmyard manure plus N and P fertilizers (NP+FYM). Results showed that SOC concentration in the 0-20 cm soil layer increased with time except in the CK and N treatments. Long-term fertilization significantly influenced SOC concentrations and storage to 60 cm depth. Below 60 cm, SOC concentrations and storages were statistically not significant between all treatments. The concentration of SOC at different depths in 0-60 cm soil profile was higher under NP+FYM follow by under NP+S, compared to under CK. The SOC storage in 0-60 cm in NP+FYM, NP+S, FYM and NP treatments were increased by 41.3%, 32.9%, 28.1% and 17.9%, respectively, as compared to the CK treatment. Organic manure plus inorganic fertilizer application also increased labile soil organic carbon pools in 0-60 cm depth. The average concentration of particulate organic carbon (POC), dissolved organic carbon (DOC) and microbial biomass carbon (MBC) in organic manure plus inorganic fertilizer treatments (NP+S and NP+FYM) in 0-60 cm depth were increased by 64.9-91.9%, 42.5-56.9%, and 74.7-99.4%, respectively, over the CK treatment. The POC, MBC and DOC concentrations increased linearly with increasing SOC content. These results indicate that long-term additions of organic manure have the most beneficial effects in building carbon pools among the investigated types of fertilization.	[Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing] Minist Agr Peoples Republ China MOA, Key Lab Dryland Farming g Agr, Beijing, Peoples R China; [Fan, Tinglu] Gansu Acad Agr Sci, Dryland Agr Inst, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs	Yan, CR (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	yancr@ieda.org.cn; zhangyq@ieda.org.cn	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	National Basic Research Program of China (973 Program) [2012CB955904]; Chinese National Scientific Foundation [31000253, 31170490]; National Key Technologies RD Program [2012BAD09B01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Scientific Foundation; National Key Technologies RD Program(National Key Technology R&D Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Basic Research Program of China (973 Program) (No.2012CB955904), the Chinese National Scientific Foundation (No. 31000253, 31170490), the 12th five-year plan of the National Key Technologies R&D Program (No. 2012BAD09B01). The authors declare that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black C.A, 1965, AM SOC AGRON MADISON, P482; Blair N, 2006, SOIL TILL RES, V91, P39, DOI 10.1016/j.still.2005.11.001; Bronson KF, 1998, ADV SOIL S, P35; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Chakraborty A, 2011, BIOL FERT SOILS, V47, P227, DOI 10.1007/s00374-010-0509-1; Chan KY, 1997, SOIL SCI SOC AM J, V61, P1376, DOI 10.2136/sssaj1997.03615995006100050013x; Chapman H.D., 1965, METHODS SOIL ANAL 2, P891; Doran JW, 1996, ADV AGRON, V56, P1, DOI 10.1016/S0065-2113(08)60178-9; Dou F, 2008, SOIL SCI SOC AM J, V72, P1445, DOI 10.2136/sssaj2007.0230; Dou F, 2007, SOIL TILL RES, V94, P530, DOI 10.1016/j.still.2006.10.001; FAO-UNESCO, 1988, SOIL MAP WORLD; Gami SK, 2009, SOIL TILL RES, V106, P95, DOI 10.1016/j.still.2009.10.003; Gong W, 2009, GEODERMA, V149, P318, DOI 10.1016/j.geoderma.2008.12.010; GOYAL S, 1992, SOIL BIOL BIOCHEM, V24, P1081, DOI 10.1016/0038-0717(92)90056-4; GREGORICH EG, 1994, CAN J SOIL SCI, V74, P367, DOI 10.4141/cjss94-051; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; Janzen HH, 1997, DEV SOIL SCI, V25, P277; Jiang PK, 2006, FOREST ECOL MANAG, V236, P30, DOI 10.1016/j.foreco.2006.06.010; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kanchikerimath M, 2001, AGR ECOSYST ENVIRON, V86, P155, DOI 10.1016/S0167-8809(00)00280-2; Liang BC, 1998, BIOL FERT SOILS, V26, P88, DOI 10.1007/s003740050348; Liang Q, 2012, NUTR CYCL AGROECOSYS, V92, P21, DOI 10.1007/s10705-011-9469-6; Lorenz K, 2005, ADV AGRON, V88, P35, DOI 10.1016/S0065-2113(05)88002-2; Lou YL, 2011, CATENA, V87, P386, DOI 10.1016/j.catena.2011.07.006; LYNCH JM, 1980, SOIL BIOL BIOCHEM, V12, P547, DOI 10.1016/0038-0717(80)90033-4; Majumder B, 2008, SOIL SCI SOC AM J, V72, P775, DOI 10.2136/sssaj2006.0378; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Melero S, 2009, SOIL TILL RES, V104, P292, DOI 10.1016/j.still.2009.04.001; Nayak AK, 2012, FIELD CROP RES, V127, P129, DOI 10.1016/j.fcr.2011.11.011; OCIO JA, 1991, SOIL BIOL BIOCHEM, V23, P655, DOI 10.1016/0038-0717(91)90079-Y; Ouedraogo E, 2007, SOIL TILL RES, V94, P64, DOI 10.1016/j.still.2006.07.001; Powlson DS, 2012, AGR ECOSYST ENVIRON, V146, P23, DOI 10.1016/j.agee.2011.10.004; Puget P, 2001, SOIL SCI SOC AM J, V65, P771, DOI 10.2136/sssaj2001.653771x; Purakayastha TJ, 2008, GEODERMA, V144, P370, DOI 10.1016/j.geoderma.2007.12.006; Rudrappa L, 2006, SOIL TILL RES, V88, P180, DOI 10.1016/j.still.2005.05.008; Sa JCD, 2009, SOIL TILL RES, V103, P46, DOI 10.1016/j.still.2008.09.003; Saviozzi A, 2001, PLANT SOIL, V233, P251, DOI 10.1023/A:1010526209076; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Su YZ, 2006, NUTR CYCL AGROECOSYS, V75, P285, DOI 10.1007/s10705-006-9034-x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Verma S, 2007, BIOL FERT SOILS, V44, P235, DOI 10.1007/s00374-007-0207-9; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Wu TY, 2005, J PLANT NUTR SOIL SC, V168, P100, DOI 10.1002/jpln.200321295; Xing N., 2001, STUDY DRYLAND AGR N; Xu MG, 2011, BIOL FERT SOILS, V47, P745, DOI 10.1007/s00374-011-0579-8; Zhang WJ, 2009, NUTR CYCL AGROECOSYS, V84, P59, DOI 10.1007/s10705-008-9226-7; Zhang X, 1998, HYDROL PROCESS, V12, P171, DOI 10.1002/(SICI)1099-1085(199801)12:1&lt;171::AID-HYP570&gt;3.0.CO;2-L	48	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56536	10.1371/journal.pone.0056536	http://dx.doi.org/10.1371/journal.pone.0056536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23468976	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200099
J	Liu, N; He, S; Ma, L; Ponnusamy, M; Tang, JH; Tolbert, E; Bayliss, G; Zhao, TC; Yan, HD; Zhuang, SG				Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhao, Ting C.; Yan, Haidong; Zhuang, Shougang			Blocking the Class I Histone Deacetylase Ameliorates Renal Fibrosis and Inhibits Renal Fibroblast Activation via Modulating TGF-Beta and EGFR Signaling	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CHRONIC KIDNEY-DISEASE; OBSTRUCTIVE NEPHROPATHY; INTERSTITIAL FIBROSIS; MOLECULAR-MECHANISMS; CARDIAC-HYPERTROPHY; FACTOR RECEPTOR; ANGIOTENSIN-II; SOLID TUMORS; INJURY	Background: Histone deacetylase (HDAC) inhibitors are promising anti-fibrosis drugs; however, nonselective inhibition of class I and class II HDACs does not allow a detailed elucidation of the individual HDAC functions in renal fibrosis. In this study, we investigated the effect of MS-275, a selective class I HDAC inhibitor, on the development of renal fibrosis in a murine model of unilateral ureteral obstruction (UUO) and activation of cultured renal interstitial fibroblasts. Methods/Findings: The UUO model was established by ligation of the left ureter and the contralateral kidney was used as a control. At seven days after UUO injury, kidney developed fibrosis as indicated by deposition of collagen fibrils and increased expression of collagen I, fibronectin and alpha-smooth muscle actin (alpha-SMA). Administration of MS-275 inhibited all these fibrotic responses and suppressed UUO-induced production of transforming growth factor-beta1 (TGF- beta), increased expression of TGF-beta receptor I, and phosphorylation of Smad-3. MS-275 was also effective in suppressing phosphorylation and expression of epidermal growth factor receptor (EGFR) and its downstream signaling molecule, signal transducer and activator of transcription-3. Moreover, class I HDAC inhibition reduced the number of renal tubular cells arrested in the G2/M phase of the cell cycle, a cellular event associated with TGF-beta1overproduction. In cultured renal interstitial fibroblasts, MS-275 treatment inhibited TGF-beta induced phosphorylation of Smad-3, differentiation of renal fibroblasts to myofibroblasts and proliferation of myofibroblasts. Conclusions and Significance: These results demonstrate that class I HDACs are critically involved in renal fibrogenesis and renal fibroblast activation through modulating TGF-beta and EGFR signaling and suggest that blockade of class I HDAC may be a useful treatment for renal fibrosis.	[Liu, Na; Tang, Jinhua; Yan, Haidong; Zhuang, Shougang] Tongji Univ, Sch Med, Shanghai E Hosp, Dept Nephrol, Shanghai 200092, Peoples R China; [Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [He, Song] Shekou Peoples Hosp, Dept Lab Med, Shenzhen, Guangdong, Peoples R China; [Zhao, Ting C.] Boston Univ, Sch Med, Roger William Med Ctr, Dept Surg, Providence, RI USA	Tongji University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Boston University; Roger Williams Medical Center	Yan, HD (corresponding author), Tongji Univ, Sch Med, Shanghai E Hosp, Dept Nephrol, Shanghai 200092, Peoples R China.	yhdcmu@sina.com; szhuang@lifespan.org	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	National Institutes of Health [DK-085065]; national nature science foundation of China [81270778, 81170638, 81200492]; Pudong New District Foundation of China [PWZxk2010-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); national nature science foundation of China(National Natural Science Foundation of China (NSFC)); Pudong New District Foundation of China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK-085065 to SZ), the national nature science foundation of China (81270778 to SZ, 81170638 to HY, 81200492 to NL), and Pudong New District Foundation of China (PWZxk2010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bogaard HJ, 2011, AM J RESP CRIT CARE, V183, P1402, DOI 10.1164/rccm.201007-1106OC; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Bruzzese F, 2011, J CELL PHYSIOL, V226, P2378, DOI 10.1002/jcp.22574; Cavasin MA, 2012, CIRC RES, V110, P739, DOI 10.1161/CIRCRESAHA.111.258426; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Choi Y, 2008, EXP MOL MED, V40, P574, DOI 10.3858/emm.2008.40.5.574; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Fraczek J, 2009, J CELL MOL MED, V13, P2990, DOI 10.1111/j.1582-4934.2009.00831.x; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Gilbert RE, 2011, KIDNEY INT, V79, P1312, DOI 10.1038/ki.2011.39; Glasgow E, 2008, ENDOCR-RELAT CANCER, V15, P59, DOI 10.1677/ERC-07-0168; Hemmatazad H, 2009, ARTHRITIS RHEUM-US, V60, P1519, DOI 10.1002/art.24494; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Knipstein J, 2011, EXPERT OPIN INV DRUG, V20, P1455, DOI 10.1517/13543784.2011.613822; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lan HY, 2011, CONTRIB NEPHROL, V170, P75, DOI 10.1159/000324949; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Liu N, 2011, J AM SOC NEPHROL, V22, P1064, DOI 10.1681/ASN.2010090956; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Ma L, 2010, P NATL ACAD SCI USA, V107, P19314, DOI 10.1073/pnas.1010253107; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Marumo T, 2010, AM J PHYSIOL-RENAL, V298, pF133, DOI 10.1152/ajprenal.00400.2009; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; Noronha IL, 2002, NEPHROL DIAL TRANSPL, V17, P363, DOI 10.1093/ndt/17.3.363; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Qi W, 2008, INT J BIOCHEM CELL B, V40, P9, DOI 10.1016/j.biocel.2007.01.006; Ryan QC, 2005, J CLIN ONCOL, V23, P3912, DOI 10.1200/JCO.2005.02.188; Singh BN, 2010, EXPERT REV ANTICANC, V10, P935, DOI [10.1586/era.10.62, 10.1586/ERA.10.62]; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Terzi F, 2000, J CLIN INVEST, V106, P225, DOI 10.1172/JCI8315; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Walkinshaw DR, 2008, J CELL BIOCHEM, V104, P1541, DOI 10.1002/jcb.21746; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	52	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54001	10.1371/journal.pone.0054001	http://dx.doi.org/10.1371/journal.pone.0054001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23468976	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700073
J	Li, K; Chi, Y; Gao, K; Yan, QJ; Matsue, H; Takeda, M; Kitamura, M; Yao, J				Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Matsue, Hiroyuki; Takeda, Masayuki; Kitamura, Masanori; Yao, Jian			Connexin43 Hemichannel-Mediated Regulation of Connexin43	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; GAP-JUNCTIONS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; LLC-PK1 CELLS; CADMIUM CD2+; C-JUN; PLASMA-MEMBRANE; UP-REGULATION	Background: Many signaling molecules and pathways that regulate gap junctions (GJs) protein expression and function are, in fact, also controlled by GJs. We, therefore, speculated an existence of the GJ channel-mediated self-regulation of GJs. Using a cell culture model in which nonjunctional connexin43 (Cx43) hemichannels were activated by cadmium (Cd2+), we tested this hypothesis. Principal Findings: Incubation of Cx43-transfected LLC-PK1 cells with Cd2+ led to an increased expression of Cx43. This effect of Cd2+ was tightly associated with JNK activation. Inhibition of JNK abolished the elevation of Cx43. Further analysis revealed that the changes of JNK and Cx43 were controlled by GSH. Supplement of a membrane-permeable GSH analogue GSH ethyl ester or GSH precursor N-acetyl-cystein abrogated the effects of Cd2+ on JNK activation and Cx43 expression. Indeed, Cd2+ induced extracellular release of GSH. Blockade of Cx43 hemichannels with heptanol or Cx43 mimetic peptide Gap26 to prevent the efflux of GSH significantly attenuated the Cx43-elevating effects of Cd2+. Conclusions: Collectively, our results thus indicate that Cd2+-induced upregulation of Cx43 is through activation of nonjunctional Cx43 hemichannels. Our findings thus support the existence of a hemichannel-mediated self-regulation of Cx43 and provide novel insights into the molecular mechanisms of Cx43 expression and function.	[Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Kitamura, Masanori; Yao, Jian] Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Li, Kai; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Chuo Ku, Yamanashi, Japan; [Li, Kai] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China; [Matsue, Hiroyuki] Chiba Univ, Sch Med, Dept Dermatol, Chiba 280, Japan	University of Yamanashi; University of Yamanashi; China Medical University; Chiba University	Li, K (corresponding author), Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.	cmu_likai@hotmail.com; yao@yamanashi.ac.jp	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	Ministry of Education, Culture, Sports, Science and Technology, Japan [17659255, 20590953, B21390324]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (17659255 and 20590953 to JY; B21390324 to HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Carmeli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029341; Chaytor AT, 1998, J PHYSIOL-LONDON, V508, P561, DOI 10.1111/j.1469-7793.1998.561bq.x; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P120, DOI 10.1167/iovs.06-0770; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; Gao FH, 2007, BIOCHEM BIOPH RES CO, V356, P505, DOI 10.1016/j.bbrc.2007.03.009; Gennari A, 2003, TOXICOLOGY, V183, P211, DOI 10.1016/S0300-483X(02)00546-2; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Lawal AO, 2010, J TOXICOL SCI, V35, P465, DOI 10.2131/jts.35.465; Li K, 2011, J BIOL CHEM, V286, P41552, DOI 10.1074/jbc.M111.274449; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Loch-Caruso R, 2005, TOXICOL SCI, V85, P694, DOI 10.1093/toxsci/kfi123; Majoul IV, 2009, HISTOCHEM CELL BIOL, V132, P263, DOI 10.1007/s00418-009-0617-x; Martin PEM, 2001, J CELL SCI, V114, P3845; Mendoza-Naranjo A, 2007, J IMMUNOL, V178, P6949, DOI 10.4049/jimmunol.178.11.6949; Mitchell JA, 2001, CELL COMMUN ADHES, V8, P299, DOI 10.3109/15419060109080741; Oviedo-Orta E, 2001, FASEB J, V15, P768, DOI 10.1096/fj.00-0288com; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; PROZIALECK WC, 1991, TOXICOL APPL PHARM, V107, P81, DOI 10.1016/0041-008X(91)90333-A; PROZIALECK WC, 1995, TOXICOL APPL PHARM, V134, P285, DOI 10.1006/taap.1995.1194; Prozialeck WC, 1997, IN VITRO CELL DEV-AN, V33, P516; Prozialeck WC, 1998, TOXICOL IN VITRO, V12, P633, DOI 10.1016/S0887-2333(98)00054-X; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Salameh A, 2008, J PHARMACOL EXP THER, V326, P315, DOI 10.1124/jpet.108.136663; Shyu KG, 2004, CARDIOVASC RES, V63, P98, DOI 10.1016/j.cardiores.2004.02.018; Son MH, 2001, BIOCHEM PHARMACOL, V62, P1379, DOI 10.1016/S0006-2952(01)00780-8; Stridh MH, 2008, J BIOL CHEM, V283, P10347, DOI 10.1074/jbc.M704153200; Stridh MH, 2010, NEUROCHEM RES, V35, P1231, DOI 10.1007/s11064-010-0179-2; Tacheau C, 2008, J CELL PHYSIOL, V217, P759, DOI 10.1002/jcp.21551; Thevenod F, 2000, J BIOL CHEM, V275, P1887, DOI 10.1074/jbc.275.3.1887; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; Wilhelm D, 1997, MOL CELL BIOL, V17, P4792, DOI 10.1128/MCB.17.8.4792; Yao J, 2003, CIRC RES, V93, P338, DOI 10.1161/01.RES.0000086802.21850.5D; Yao J, 2010, BRIT J PHARM, P9999; Yao J, 2007, J MEMBRANE BIOL, V217, P123, DOI 10.1007/s00232-007-9023-2; Yao J, 2009, AM J PHYSIOL-RENAL, V296, pF939, DOI 10.1152/ajprenal.90612.2008; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200	47	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58057	10.1371/journal.pone.0058057	http://dx.doi.org/10.1371/journal.pone.0058057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23874530	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000181
J	Li, KR; Zhang, ZQ; Yao, J; Zhao, YX; Duan, J; Cao, C; Jiang, Q				Li, Ke-ran; Zhang, Zhi-qing; Yao, Jin; Zhao, Yu-xia; Duan, Jing; Cao, Cong; Jiang, Qin			Ginsenoside Rg-1 Protects Retinal Pigment Epithelium (RPE) Cells from Cobalt Chloride (CoCl2) and Hypoxia Assaults	PLOS ONE			English	Article							N-TERMINAL KINASE; SIGNALING PATHWAY; INDUCED APOPTOSIS; OXIDATIVE STRESS; IN-VITRO; RG1 PROTECTS; CANCER CELLS; PC12 CELLS; P38 MAPK; ACTIVATION	Severe retinal ischemia causes persistent visual impairments in eye diseases. Retinal pigment epithelium (RPE) cells are located near the choroidal capillaries, and are easily affected by ischemic or hypoxia. Ginsenoside Rg-1 has shown significant neuroprotective effects. This study was performed to test the cytoprotective effect of ginsenoside Rg-1 in RPE cells against hypoxia and cobalt chloride (CoCl2) assaults, and to understand the underlying mechanisms. We found that Rg-1 pre-administration significantly inhibited CoCl2- and hypoxia-induced RPE cell death and apoptosis. Reactive oxygen specisis (ROS)-dependent p38 and c-Jun NH(2)-terminal kinases (JNK) MAPK activation was required for CoCl2-induced RPE cell death, and Rg-1 pre-treatment significantly inhibited ROS production and following p38/JNK activation. Further, CoCl2 suppressed pro-survival mTOR complex 1 (mTORC1) activation in RPE cells through activating of AMP-activated protein kinase (AMPK), while Rg-1 restored mTORC1 activity through inhibiting AMPK activation. CoCl2-induced AMPK activation was also dependent on ROS production, and anti-oxidant N-acetylcysteine (NAC) prevented AMPK activation and RPE cell death by CoCl2. Our results indicated that Rg-1 could be further investigated as a novel cell-protective agent for retinal ischemia.	[Li, Ke-ran; Yao, Jin; Zhao, Yu-xia; Jiang, Qin] Nanjing Med Univ, Affiliated Eye Hosp, Dept Eye, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Duan, Jing] China Pharmaceut Univ, Acad Inst Pharmaceut Sci, Ctr Safety Evaluat Drugs, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Soochow University - China; China Pharmaceutical University	Cao, C (corresponding author), Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China.	caocong@suda.edu.cn; dryaojin@yahoo.com	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	National Natural Science Foundation of China [81070744, 81271028]; Jiangsu Province [1002009B]; Medical Science and Technology Development Project Fund of Nanjing [ZKX12047, YKK12208, YKK12207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province; Medical Science and Technology Development Project Fund of Nanjing	This work was generously supported by grants from the National Natural Science Foundation of China (Nos. 81070744, 81271028), post-doc fund of Jiangsu Province (No. 1002009B) and Medical Science and Technology Development Project Fund of Nanjing (ZKX12047, YKK12208, YKK12207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borutaite Vilmante, 2008, Biochem J, V412, pe15, DOI 10.1042/BJ20080712; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Buettner C, 2006, ANN PHARMACOTHER, V40, P83, DOI 10.1345/aph.1G216; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen MB, 2012, INT J CANC; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Chen WF, 2013, NEUROCHEM INT, V62, P1065, DOI 10.1016/j.neuint.2013.03.018; Chen XC, 2002, ACTA PHARMACOL SIN, V23, P829; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Du JH, 2005, BIOCHEM BIOPH RES CO, V337, P1139, DOI 10.1016/j.bbrc.2005.09.174; Du ZJ, 2011, INVEST OPHTH VIS SCI, V52, P987, DOI 10.1167/iovs.10-5557; Fang F, 2012, BBA-MOL BASIS DIS, V1822, P286, DOI 10.1016/j.bbadis.2011.10.004; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Huong NTT, 1998, BIOL PHARM BULL, V21, P978, DOI 10.1248/bpb.21.978; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Joo SS, 2005, PLANTA MED, V71, P476, DOI 10.1055/s-2005-864145; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kim HJ, 2013, J GINSENG RES, V37, P8, DOI 10.5142/jgr.2013.37.8; Kim MH, 2008, APOPTOSIS, V13, P295, DOI 10.1007/s10495-007-0160-y; Kunz M, 2001, CELL GROWTH DIFFER, V12, P137; Lee MS, 2010, PHYTOTHER RES, V24, P1857, DOI 10.1002/ptr.3210; Leung KW, 2007, NEUROPHARMACOLOGY, V52, P827, DOI 10.1016/j.neuropharm.2006.10.001; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J. Q., 1997, Yaoxue Xuebao, V32, P406; Li W, 2012, BRAIN RES BULL, V88, P501, DOI 10.1016/j.brainresbull.2012.05.002; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Liu ZJ, 2010, BRAIN RES, V1333, P1, DOI 10.1016/j.brainres.2010.03.096; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushina Y, 2000, BIOCHEM J, V350, P757, DOI 10.1042/0264-6021:3500757; Mu Yan-Yue, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P1539; Nag SA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00025; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Shen L, 2007, ACTA PHARMACOL SIN, V28, P392, DOI 10.1111/j.1745-7254.2007.00511.x; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang Qiao-Yun, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P229; Wang Wei-xia, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P89; Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021; Wu JY, 2012, NEUROPHARMACOLOGY, V63, P349, DOI 10.1016/j.neuropharm.2012.04.005; Xu HM, 2010, NEUROPHARMACOLOGY, V58, P488, DOI 10.1016/j.neuropharm.2009.09.002; Yang XH, 2010, WORLD J GASTROENTERO, V16, P3385, DOI 10.3748/wjg.v16.i27.3385; Yao J, 2013, INT J MOL SCI, V14, P10355, DOI 10.3390/ijms140510355; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P3622, DOI 10.1167/iovs.07-1559; Zheng QY, 2012, BIOCH BIOPHYS RES CO; Zhu D, 2009, J CELL BIOCHEM, V108, P117, DOI 10.1002/jcb.22233; Zong Y, 2012, CURR MED CHEM, V19, P770, DOI 10.2174/092986712798992066	62	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84171	10.1371/journal.pone.0084171	http://dx.doi.org/10.1371/journal.pone.0084171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	23874530	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900080
